Citrus Sinensis ID: 006112
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 660 | 2.2.26 [Sep-21-2011] | |||||||
| Q9M345 | 677 | L-type lectin-domain cont | yes | no | 0.966 | 0.942 | 0.502 | 0.0 | |
| Q9FIF1 | 674 | Probable L-type lectin-do | no | no | 0.977 | 0.956 | 0.505 | 1e-178 | |
| Q9M1G4 | 674 | Probable L-type lectin-do | no | no | 0.907 | 0.888 | 0.523 | 1e-177 | |
| Q9FIF0 | 694 | Putative L-type lectin-do | no | no | 0.960 | 0.913 | 0.492 | 1e-176 | |
| Q9LSR9 | 657 | L-type lectin-domain cont | no | no | 0.921 | 0.925 | 0.519 | 1e-176 | |
| O80939 | 675 | L-type lectin-domain cont | no | no | 0.962 | 0.940 | 0.495 | 1e-175 | |
| Q9SZD5 | 669 | L-type lectin-domain cont | no | no | 0.953 | 0.940 | 0.484 | 1e-175 | |
| Q9LSR8 | 766 | L-type lectin-domain cont | no | no | 0.880 | 0.758 | 0.526 | 1e-175 | |
| O81291 | 669 | L-type lectin-domain cont | no | no | 0.937 | 0.925 | 0.489 | 1e-173 | |
| Q9FJI4 | 675 | Putative L-type lectin-do | no | no | 0.986 | 0.964 | 0.502 | 1e-172 |
| >sp|Q9M345|LRK42_ARATH L-type lectin-domain containing receptor kinase IV.2 OS=Arabidopsis thaliana GN=LECRK42 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 636 bits (1641), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 334/665 (50%), Positives = 457/665 (68%), Gaps = 27/665 (4%)
Query: 19 IFSASAQEENQFIHHGFEG--SKLKLDGLAKIHPNGLLQLTNTSERISGHAFYPFPFKFN 76
I +S+Q N F ++GF + + L GLA + PNGLL+LTNTS + +GHAF +F
Sbjct: 17 IMISSSQNLN-FTYNGFHPPLTDISLQGLATVTPNGLLKLTNTSVQKTGHAFCTERIRFK 75
Query: 77 SSSSQSLS-FSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQF 135
S + ++S FST+FVFA+ ++P GHG+AF ++P+ A+ ++G+FN SNNG
Sbjct: 76 DSQNGNVSSFSTTFVFAIHSQIPTLSGHGIAFVVAPTLGLPFALPSQYIGLFNISNNGND 135
Query: 136 TNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKP 195
TNHIFA+E DT+QS EF D + NHVGID+NGL+S ++A Y D K F++L L S K
Sbjct: 136 TNHIFAVEFDTIQSSEFGDPNDNHVGIDLNGLRSANYSTAGYRDDHDK-FQNLSLISRKR 194
Query: 196 IQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTRVSDY 255
IQ+WIDY+ + ++VT+AP + KP +PL+S DLS IL + MYVG S+ATG+ +S++
Sbjct: 195 IQVWIDYDNRSHRIDVTVAPFDSDKPRKPLVSYVRDLSSILLEDMYVGFSSATGSVLSEH 254
Query: 256 YILGWSFNKSGPAQNLDISKLPPLPPPPPTPGKKLNHTVIVSIVAAAVVLITIAAAVYFV 315
+++GWSF +G A L +SKLP LP P + + + + +++ +++ I A Y V
Sbjct: 255 FLVGWSFRLNGEAPMLSLSKLPKLPRFEPRRISEF-YKIGMPLISLSLIFSIIFLAFYIV 313
Query: 316 K-KKKYEEVYEDWEKEYSPHRFSYKNLYKATKG----------GSGKVYRGVLPSSHAEI 364
+ KKKYEE +DWE E+ +RF +K LY ATKG G G+VYRG+LP++ E+
Sbjct: 314 RRKKKYEEELDDWETEFGKNRFRFKELYHATKGFKEKDLLGSGGFGRVYRGILPTTKLEV 373
Query: 365 AVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKIL 424
AVK+V HDS GMK+FV+EIVS+G++ HRNLV L GYCRR+GELLLVYDYMPNGSLDK L
Sbjct: 374 AVKRVSHDSKQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLDKYL 433
Query: 425 YSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGL 484
Y+N +L+W QR IIKGVA GL YLHEEWEQVV+HRD+K +NVLLDAD G+LGDFGL
Sbjct: 434 YNNPETTLDWKQRSTIIKGVASGLFYLHEEWEQVVIHRDVKASNVLLDADFNGRLGDFGL 493
Query: 485 ARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQ---- 540
ARLYDHG+D TT+VVGT+GYLAPE R GR TT+TDVYAFG F+LEV GRRP++
Sbjct: 494 ARLYDHGSDPQTTHVVGTLGYLAPEHSRTGRATTTTDVYAFGAFLLEVVSGRRPIEFHSA 553
Query: 541 -PGELDLLDWVIDYWQKGDVLDASDPRL-EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMR 598
L++WV W +G++++A DP+L Y E++E+VLKLGL CSHS+P RPSMR
Sbjct: 554 SDDTFLLVEWVFSLWLRGNIMEAKDPKLGSSGYDLEEVEMVLKLGLLCSHSDPRARPSMR 613
Query: 599 QVVQYLDGGALLPDI-PLNSSVFGVLTAKNEAPNNG--MASFASLVRSDSPHTMSTIDSI 655
QV+QYL G LP++ PL+ S V+ +G M F+++ + + + S DS+
Sbjct: 614 QVLQYLRGDMALPELTPLDLSAGSVMNLGGRDGFSGIAMTDFSTVFKGFTGGS-SIADSL 672
Query: 656 ITVGR 660
++ GR
Sbjct: 673 LSGGR 677
|
Required during pollen development. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FIF1|LRK21_ARATH Probable L-type lectin-domain containing receptor kinase II.1 OS=Arabidopsis thaliana GN=LECRK21 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 626 bits (1614), Expect = e-178, Method: Compositional matrix adjust.
Identities = 347/686 (50%), Positives = 443/686 (64%), Gaps = 41/686 (5%)
Query: 1 MAALPRLVSFWFLFKVTLIFSASAQEENQFIHHGFEGSKLKLDGLAKIHPNGLLQLTNTS 60
MA + V FW + + + F AQE + F+++ F + L+LDG+A + +G L LTN +
Sbjct: 1 MAGVLGSVVFWLIIGIHVTFLVFAQEGDHFVYYDFRNADLELDGMANTN-HGPLHLTNNT 59
Query: 61 ERISGHAFYPFPFKFNSSSSQSLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDF-SEAV 119
+GHAFY P KF +SS S SFST FVFA+FP + GHGMAF +SP+ D S
Sbjct: 60 NTGTGHAFYNIPIKFTASSLSSFSFSTEFVFAIFPLQKSTYGHGMAFVVSPTKDLRSNGS 119
Query: 120 AGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFS 179
A S+LGIFNR+N+ + HIFA+ELDT Q+ E D GN VGID+N + S ESA A YF+
Sbjct: 120 ANSNLGIFNRANDNKTATHIFAVELDTNQNSESFDKGGNDVGIDINSIVSVESADASYFN 179
Query: 180 DEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRP-----------LLST 228
K + SL L SGK I +WIDY+G EK++NVTLAPV PKP P LLS
Sbjct: 180 ARKGKNISLPLASGKSILVWIDYDGIEKVLNVTLAPVQTPKPDSPYFSSFIKPKVPLLSR 239
Query: 229 SIDLSQILQDSMYVGLSAATGTRVSDYYILGWSFNKSGPAQNLDISKLPPLPPPPPTPGK 288
SI+LS+I ++MYVG S +TG+ S+ YILGWSF + G A++LDIS+L PPP+P K
Sbjct: 240 SINLSEIFTETMYVGFSGSTGSIKSNQYILGWSFKQGGKAESLDISRLSN---PPPSP-K 295
Query: 289 KLNHTVIVSIVAAAVVLITIAAAVYFVKKKKYEEVYEDWEKEYSPHRFSYKNLYKATKG- 347
+ ++ + + +T+ VY KKKKY EV E WEKEYSP R+S++ LYKATKG
Sbjct: 296 RFPLKEVLGATISTIAFLTLGGIVYLYKKKKYAEVLEQWEKEYSPQRYSFRILYKATKGF 355
Query: 348 ---------GSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQL 398
G GKVY+G+LPS +IAVK+V HD++ GMKQ+V+EI SMG+LRH+NLV L
Sbjct: 356 RENQLLGAGGFGKVYKGILPSG-TQIAVKRVYHDAEQGMKQYVAEIASMGRLRHKNLVHL 414
Query: 399 RGYCRRKGELLLVYDYMPNGSLDKILY-SNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQ 457
GYCRRKGELLLVYDYMPNGSLD L+ N L W QR IIKGVA LLYLHEEWEQ
Sbjct: 415 LGYCRRKGELLLVYDYMPNGSLDDYLFHKNKLKDLTWSQRVNIIKGVASALLYLHEEWEQ 474
Query: 458 VVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGT 517
VVLHRDIK +N+LLDADL GKLGDFGLAR +D G +L T VVGT+GY+APEL G T
Sbjct: 475 VVLHRDIKASNILLDADLNGKLGDFGLARFHDRGVNLEATRVVGTIGYMAPELTAMGVTT 534
Query: 518 TSTDVYAFGVFMLEVACGRRPVQPG----ELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573
T TDVYAFG F+LEV CGRRPV P ++ L+ WV ++ + D D +L VE
Sbjct: 535 TCTDVYAFGAFILEVVCGRRPVDPDAPREQVILVKWVASCGKRDALTDTVDSKLIDFKVE 594
Query: 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGALLPDIPLNSSVFGVLTAKNEAPNNG 633
E +++LKLG+ CS NP+ RPSMRQ++QYL+G +P I + G+ PN
Sbjct: 595 EA-KLLLKLGMLCSQINPENRPSMRQILQYLEGNVSVPAISFGTVALGI-------PNIS 646
Query: 634 MASFASLVRSDSPHTMSTIDSIITVG 659
+ + + S S D + G
Sbjct: 647 HETVTQMTTTSSSANFSFEDVTVLFG 672
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M1G4|LRK15_ARATH Probable L-type lectin-domain containing receptor kinase I.5 OS=Arabidopsis thaliana GN=LECRK15 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 621 bits (1602), Expect = e-177, Method: Compositional matrix adjust.
Identities = 326/623 (52%), Positives = 434/623 (69%), Gaps = 24/623 (3%)
Query: 7 LVSFWFLFKVTLIFSASAQEENQFIHHGFEGSKLKLDGLAKIHPNGLLQLTNTSERISGH 66
L W + LI +++ ++ F+ +GF S L LDG A + PNGLLQL S+ GH
Sbjct: 5 LFLIWLISSFHLISFSTSSKDTSFVFNGFGQSNLALDGSATLLPNGLLQLAKDSQHQMGH 64
Query: 67 AFYPFPFKFNSSSSQSLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGI 126
AF P F SSS+ LSFST FV A+ PK GGHG+ F ISP+ DF+ A ++GI
Sbjct: 65 AFIKKPIDF--SSSKPLSFSTHFVCALVPKPGFEGGHGITFVISPTVDFTRAQPTRYMGI 122
Query: 127 FNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFE 186
FN S NG ++H+FA+ELDTV++P+F + + NH+GIDVN S ESA A YFS ++
Sbjct: 123 FNASTNGSPSSHLFAVELDTVRNPDFRETNNNHIGIDVNNPISVESAPASYFSKTAQKNV 182
Query: 187 SLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQIL-QDSMYVGLS 245
S+ L SGKPIQ+W+DY+G ++NV++AP+ KPS PLLS S++LS+I + ++VG +
Sbjct: 183 SINLSSGKPIQVWVDYHGN--VLNVSVAPLEAEKPSLPLLSRSMNLSEIFSRRRLFVGFA 240
Query: 246 AATGTRVSDYYILGWSFNKSGP-AQNLDISKLPPLPPPPPTPGKKLNHTVIVSI-VAAAV 303
AATGT +S +Y+LGWSF+ + +Q LD SKLP +P P KK+ +I+++ V A+
Sbjct: 241 AATGTSISYHYLLGWSFSTNRELSQLLDFSKLPQVPRPR-AEHKKVQFALIIALPVILAI 299
Query: 304 VLITIAAAVYFVKKKKYEEVYEDWEKEYSPHRFSYKNLYKATKG----------GSGKVY 353
V++ + A VY+ +KKKY EV E WEK+Y HRFSYK+LY ATKG G G+VY
Sbjct: 300 VVMAVLAGVYYHRKKKYAEVSEPWEKKYGTHRFSYKSLYIATKGFHKDRFLGRGGFGEVY 359
Query: 354 RGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413
RG LP + +AVK+V HD + GMKQFV+E+VSM L+HRNLV L GYCRRKGELLLV +
Sbjct: 360 RGDLPLNKT-VAVKRVSHDGEQGMKQFVAEVVSMKSLKHRNLVPLLGYCRRKGELLLVSE 418
Query: 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDA 473
YMPNGSLD+ L+ + P L+W QRF I+KG+A L YLH E EQVVLHRDIK +NV+LDA
Sbjct: 419 YMPNGSLDQHLFDDQSPVLSWSQRFVILKGIASALFYLHTEAEQVVLHRDIKASNVMLDA 478
Query: 474 DLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVA 533
+L G+LGDFG+AR +DHG + TT VGTVGY+APEL+ G +T TDVYAFGVF+LEVA
Sbjct: 479 ELNGRLGDFGMARFHDHGGNAATTAAVGTVGYMAPELITMG-ASTITDVYAFGVFLLEVA 537
Query: 534 CGRRPVQPG----ELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHS 589
CGR+PV+ G + L+ WV + W+K +LDA DPRL +V E++E+V+KLGL C++
Sbjct: 538 CGRKPVEFGVQVEKRFLIKWVCECWKKDSLLDAKDPRLGEEFVPEEVELVMKLGLLCTNI 597
Query: 590 NPDTRPSMRQVVQYLDGGALLPD 612
P++RP+M QVV YL G LPD
Sbjct: 598 VPESRPAMGQVVLYLSGNLPLPD 620
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIF0|LRK22_ARATH Putative L-type lectin-domain containing receptor kinase II.2 OS=Arabidopsis thaliana GN=LECRK22 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 620 bits (1598), Expect = e-176, Method: Compositional matrix adjust.
Identities = 337/684 (49%), Positives = 448/684 (65%), Gaps = 50/684 (7%)
Query: 1 MAALPRLVSFWFLFKVTLIFSASAQEENQFIHHGFEGSKLKLDGLAKIHPNGLLQLTNTS 60
MA + R + FW + V ++ AQ+ ++F++H F + L LDG+A I +G L LTN +
Sbjct: 1 MAGVLRSLRFWMIICVQVLSLVLAQDRDEFVYHDFSQADLHLDGMASID-DGRLHLTNNT 59
Query: 61 ERISGHAFYPFPFKFNSSSSQSLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFS-EAV 119
+ +GHAF+ P F +S S SLSFST FVFA+FP L + G GMAF ++P D
Sbjct: 60 TKSTGHAFWKIPMNFTTSPSSSLSFSTEFVFAIFPLLGD--GQGMAFVVAPFMDIRYSGD 117
Query: 120 AGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFS 179
A S+LG+FNR N+ + NHI A+ELDT SPE + NHVGID+N + S +SA+A YFS
Sbjct: 118 AASYLGLFNRKNDNKTENHILAVELDTNSSPEAIEDSDNHVGIDINSIISEDSANASYFS 177
Query: 180 DEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPS-----------RPLLST 228
+ + S L S K I +WIDYNG EKL+NVT+APVP PKP+ +PLLS
Sbjct: 178 GTEGKNISFRLASEKSILVWIDYNGTEKLLNVTVAPVPTPKPALPYLSSSIKPRKPLLSR 237
Query: 229 SIDLSQILQDSMYVGLSAATGTRVSDYYILGWSFNKSGPAQNLDISKL------------ 276
I++S+I +M+VG S +TGT SD YILGWSF K G A++LD+SK+
Sbjct: 238 FINISEIFNGTMFVGFSGSTGTVKSDQYILGWSFKKGGQAESLDLSKILDPPNRPPPPSS 297
Query: 277 -----PPLPPPPPTPGKKLNHTVIVSIVAAAVV-LITIAAAVYFVKKKKYEEVYEDWEKE 330
PP P PP + K + +I+ + ++ L+ + +Y KKKKY EV E WE E
Sbjct: 298 PPPPPPPPPTPPTSRSKDSKNIIIICVTVTSIAFLLMLGGFLYLYKKKKYAEVLEHWENE 357
Query: 331 YSPHRFSYKNLYKATKG----------GSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQF 380
YSP R+S++NLYKA +G G GKVY+G LPS +IAVK+V H+++ GMKQ+
Sbjct: 358 YSPQRYSFRNLYKAIRGFRENRLLGAGGFGKVYKGELPSG-TQIAVKRVYHNAEQGMKQY 416
Query: 381 VSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYS-NTRPSLNWFQRFR 439
+EI SMG+LRH+NLVQL GYCRRKGELLLVYDYMPNGSLD L++ N L W QR
Sbjct: 417 AAEIASMGRLRHKNLVQLLGYCRRKGELLLVYDYMPNGSLDDYLFNKNKLKDLTWSQRVN 476
Query: 440 IIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNV 499
IIKGVA LLYLHEEWEQVVLHRDIK +N+LLDADL G+LGDFGLAR +D G +L T V
Sbjct: 477 IIKGVASALLYLHEEWEQVVLHRDIKASNILLDADLNGRLGDFGLARFHDRGENLQATRV 536
Query: 500 VGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPG----ELDLLDWVIDYWQ 555
VGT+GY+APEL G TT TD+YAFG F+LEV CGRRPV+P ++ LL WV +
Sbjct: 537 VGTIGYMAPELTAMGVATTKTDIYAFGSFILEVVCGRRPVEPDRPPEQMHLLKWVATCGK 596
Query: 556 KGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGALLPDIPL 615
+ ++D D +L G + ++ +++LKLG+ CS SNP++RPSMR ++QYL+G A +P I
Sbjct: 597 RDTLMDVVDSKL-GDFKAKEAKLLLKLGMLCSQSNPESRPSMRHIIQYLEGNATIPSISF 655
Query: 616 NSSVFGVLTAKNEAPNNGMASFAS 639
+++ FG+ NE A+ +S
Sbjct: 656 DTAGFGIPNISNETITQMTATSSS 679
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LSR9|LRK18_ARATH L-type lectin-domain containing receptor kinase I.8 OS=Arabidopsis thaliana GN=LECRK18 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 619 bits (1597), Expect = e-176, Method: Compositional matrix adjust.
Identities = 330/635 (51%), Positives = 432/635 (68%), Gaps = 27/635 (4%)
Query: 5 PRLVSFWFLFKVTLIFSASAQEENQFIHHGFEGSKLKLDGLAKIHPNGLLQLTNTSERIS 64
P L W + L+ S+Q+E F +GF L +DG+A+I P GLL+LT+TSE+
Sbjct: 3 PGLDLIWMVISFLLLIHLSSQQETGFSFNGFRQGDLHVDGVAQILPGGLLRLTDTSEQKK 62
Query: 65 GHAFYPFPFKFNSSSSQSLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHL 124
GHAF+ P FNSS + LSFST FV AM K GG+G+AFF+SPS D + A A +L
Sbjct: 63 GHAFFRQPLVFNSS--EPLSFSTHFVCAMVRKPGVTGGNGIAFFLSPSMDLTNADATQYL 120
Query: 125 GIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKE 184
G+FN + N ++HIFAIELDTVQS EF+DID NHVGIDVN L S ESA A YFSD+K
Sbjct: 121 GLFNTTTNRSPSSHIFAIELDTVQSAEFDDIDNNHVGIDVNSLTSVESAPASYFSDKKGL 180
Query: 185 FESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGL 244
+S+ L SG IQ+W+D++G ++NV+LAP+ KPS+ L+S S++LS+++QD M+VG
Sbjct: 181 NKSISLLSGDSIQVWVDFDG--TVLNVSLAPLGIRKPSQSLISRSMNLSEVIQDRMFVGF 238
Query: 245 SAATGTRVSDYYILGWSFNKSGPA-QNLDISKLPPLPPPPPTPGKKLNHTVIVSIVAAAV 303
SAATG +++YILGWSF++S + Q+LDISKLP +P P K + +I+ ++ +
Sbjct: 239 SAATGQLANNHYILGWSFSRSKASLQSLDISKLPQVPHPK----MKTSLLLILLLIVLGI 294
Query: 304 VLITIAAAVYFVKKKKYEEVYEDWEKEYSPHRFSYKNLYKATKG----------GSGKVY 353
+L+ + Y ++ KY EV E+WEKEY PHR+SYK+LYKATKG G G+VY
Sbjct: 295 ILLVLLVGAYLYRRNKYAEVREEWEKEYGPHRYSYKSLYKATKGFHKDGFLGKGGFGEVY 354
Query: 354 RGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413
+G LP +IAVK+ H + GMKQFV+EI SMG L HRNLV L GYCRRKGE LLV
Sbjct: 355 KGTLP--QEDIAVKRFSHHGERGMKQFVAEIASMGCLDHRNLVPLFGYCRRKGEFLLVSK 412
Query: 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDA 473
YMPNGSLD+ L+ N PSL W +R I+KG+A L YLH E QVVLHRDIK +NV+LD
Sbjct: 413 YMPNGSLDQFLFHNREPSLTWSKRLGILKGIASALKYLHTEATQVVLHRDIKASNVMLDT 472
Query: 474 DLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVA 533
D GKLGDFG+AR +DHG + TT VGTVGY+ PEL G +T TDVYAFG +LEV
Sbjct: 473 DFTGKLGDFGMARFHDHGANPTTTGAVGTVGYMGPELTSMG-ASTKTDVYAFGALILEVT 531
Query: 534 CGRRPVQPG----ELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHS 589
CGRRPV+P + L+ WV D W++ D++ A DP+L G + Q+E+VLKLGL C++
Sbjct: 532 CGRRPVEPNLPIEKQLLVKWVCDCWKRKDLISARDPKLSGELI-PQIEMVLKLGLLCTNL 590
Query: 590 NPDTRPSMRQVVQYLDGGALLPDIPLNSSVFGVLT 624
P++RP M +VVQYLD LPD +S G++T
Sbjct: 591 VPESRPDMVKVVQYLDRQVSLPDFSPDSPGIGIVT 625
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O80939|LRK41_ARATH L-type lectin-domain containing receptor kinase IV.1 OS=Arabidopsis thaliana GN=LECRK41 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 617 bits (1591), Expect = e-175, Method: Compositional matrix adjust.
Identities = 327/660 (49%), Positives = 455/660 (68%), Gaps = 25/660 (3%)
Query: 22 ASAQEENQFIHHGFEG-SKLKLDGLAKIHPNGLLQLTNTSERISGHAFYPFPFKFNSSSS 80
+S+Q N ++GF + L + G+ + PNGLL+LTNT+ + +GHAFY P +F S +
Sbjct: 20 SSSQSLNFAYNNGFNPPTDLSIQGITTVTPNGLLKLTNTTVQKTGHAFYTKPIRFKDSPN 79
Query: 81 QSLS-FSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHI 139
++S FSTSFVFA+ ++ GHG+AF ++P+ ++G+FN +NNG TNH+
Sbjct: 80 GTVSSFSTSFVFAIHSQIAILSGHGIAFVVAPNASLPYGNPSQYIGLFNLANNGNETNHV 139
Query: 140 FAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPIQIW 199
FA+ELDT+ S EFND + NHVGID+N L+S +S+ A Y+ DEK +F++L L S KP+Q+W
Sbjct: 140 FAVELDTILSTEFNDTNDNHVGIDINSLKSVQSSPAGYW-DEKGQFKNLTLISRKPMQVW 198
Query: 200 IDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTRVSDYYILG 259
+DY+G+ ++VT+AP KP+RPL++ DLS +L MYVG S+ATG+ +S++YILG
Sbjct: 199 VDYDGRTNKIDVTMAPFNEDKPTRPLVTAVRDLSSVLLQDMYVGFSSATGSVLSEHYILG 258
Query: 260 WSFNKSGPAQNLDISKLPPLPPPPPTPGKKLN--HTVIVSIVAAAVVLITIAAAVYFVKK 317
WSF + A L +S+LP LP P K+++ + + + +++ ++ I Y V++
Sbjct: 259 WSFGLNEKAPPLALSRLPKLPRFEP---KRISEFYKIGMPLISLFLIFSFIFLVCYIVRR 315
Query: 318 K-KYEEVYEDWEKEYSPHRFSYKNLYKATKG----------GSGKVYRGVLPSSHAEIAV 366
+ K+ E E+WEKE+ +RF +K+LY ATKG G G VY+GV+P + EIAV
Sbjct: 316 RRKFAEELEEWEKEFGKNRFRFKDLYYATKGFKEKGLLGTGGFGSVYKGVMPGTKLEIAV 375
Query: 367 KKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYS 426
K+V H+S GMK+FV+EIVS+G++ HRNLV L GYCRR+GELLLVYDYMPNGSLDK LY+
Sbjct: 376 KRVSHESRQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLDKYLYN 435
Query: 427 NTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLAR 486
+LNW QR ++I GVA GL YLHEEWEQVV+HRD+K +NVLLD +L G+LGDFGLAR
Sbjct: 436 TPEVTLNWKQRIKVILGVASGLFYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR 495
Query: 487 LYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQ-PGELD 545
LYDHG+D TT+VVGT+GYLAPE R GR T +TDV+AFG F+LEVACGRRP++ E D
Sbjct: 496 LYDHGSDPQTTHVVGTLGYLAPEHTRTGRATMATDVFAFGAFLLEVACGRRPIEFQQETD 555
Query: 546 ----LLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVV 601
L+DWV W KGD+L A DP + E+++E+VLKLGL CSHS+P RPSMRQV+
Sbjct: 556 ETFLLVDWVFGLWNKGDILAAKDPNMGSECDEKEVEMVLKLGLLCSHSDPRARPSMRQVL 615
Query: 602 QYLDGGALLPDI-PLNSSVFGVLTAKNEAPNNGMASFASLVRSDSPHTMSTIDSIITVGR 660
YL G A LP++ PL+ S G++ ++ + S++S V S DS ++ GR
Sbjct: 616 HYLRGDAKLPELSPLDLSGSGMMFGVHDGFSELGMSYSSSVFKGFTGGSSIADSQLSGGR 675
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SZD5|LRK59_ARATH L-type lectin-domain containing receptor kinase V.9 OS=Arabidopsis thaliana GN=LECRK59 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 616 bits (1589), Expect = e-175, Method: Compositional matrix adjust.
Identities = 319/658 (48%), Positives = 436/658 (66%), Gaps = 29/658 (4%)
Query: 23 SAQEENQFIHHGFEGSKLKLDGLAKIHPNGLLQLTNTSERISGHAFYPFPFKFNSSSSQS 82
S EE +F GF G G+A + GL++LTN+SE GH FY P +F +S + +
Sbjct: 21 SQSEEGEF---GFNGYLYDNSGIAITNSKGLMKLTNSSEFSYGHVFYNSPVRFKNSPNGT 77
Query: 83 LS-FSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFA 141
+S FST+FVFA+ + GHG+AF ISP+ + + +LG+FN +NNG +NHI A
Sbjct: 78 VSSFSTTFVFAIVSNVNALDGHGLAFVISPTKGLPYSSSSQYLGLFNLTNNGDPSNHIVA 137
Query: 142 IELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPIQIWID 201
+E DT Q+ EF+D+D NHVGID+N L S ++++A Y+ D+ F+++ L + KPIQ WI+
Sbjct: 138 VEFDTFQNQEFDDMDNNHVGIDINSLSSEKASTAGYYEDDDGTFKNIRLINQKPIQAWIE 197
Query: 202 YNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTRVSDYYILGWS 261
Y+ + +NVT+ P+ PKP PLLS + DLS L DSMYVG ++ATG S +YILGW+
Sbjct: 198 YDSSRRQLNVTIHPIHLPKPKIPLLSLTKDLSPYLFDSMYVGFTSATGRLRSSHYILGWT 257
Query: 262 FNKSGPAQNLDISKLPPLPPPPPTPGKKLNHTVIVSIVAAAVVLITIAAAVYFVKKKKYE 321
F +G A N+DIS+LP LP + K + +S+ + A+++ + + F+K+KK
Sbjct: 258 FKLNGTASNIDISRLPKLPRDSRSTSVKKILAISLSLTSLAILVFLTISYMLFLKRKKLM 317
Query: 322 EVYEDWEKEYSPHRFSYKNLYKATKG----------GSGKVYRGVLPSSHAEIAVKKVCH 371
EV EDWE ++ PHRF+YK+LY ATKG G GKVY+G L +S+ +IAVKKV H
Sbjct: 318 EVLEDWEVQFGPHRFAYKDLYIATKGFRNSELLGKGGFGKVYKGTLSTSNMDIAVKKVSH 377
Query: 372 DSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPS 431
DS GM++FV+EI ++G+LRH NLV+L GYCRRKGEL LVYD MP GSLDK LY S
Sbjct: 378 DSRQGMREFVAEIATIGRLRHPNLVRLLGYCRRKGELYLVYDCMPKGSLDKFLYHQPEQS 437
Query: 432 LNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491
L+W QRF+IIK VA GL YLH +W QV++HRDIKPANVLLD + GKLGDFGLA+L +HG
Sbjct: 438 LDWSQRFKIIKDVASGLCYLHHQWVQVIIHRDIKPANVLLDDSMNGKLGDFGLAKLCEHG 497
Query: 492 NDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPV-----QPGELDL 546
D T+NV GT GY++PEL R G+ +TS+DV+AFG+ MLE+ CGRRPV P E+ L
Sbjct: 498 FDPQTSNVAGTFGYISPELSRTGKASTSSDVFAFGILMLEITCGRRPVLPRASSPSEMVL 557
Query: 547 LDWVIDYWQKGDVLDASDPRL--EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYL 604
DWV+D W+ D+L D R+ + Y+EEQ+ +VLKLGLFCSH RPSM V+Q+L
Sbjct: 558 TDWVLDCWED-DILQVVDERVKQDDKYLEEQVALVLKLGLFCSHPVAAVRPSMSSVIQFL 616
Query: 605 DGGALLPDIPLNSSVFGVLTAK-NEAPNNGMASFA-SLVRSDSPHTMSTIDSIITVGR 660
DG A LP+ ++F ++ A+ N G A SL S T++ + ++ GR
Sbjct: 617 DGVAQLPN-----NLFDIVKARENVGAIEGFGEAAESLAEPCSVATLTFTEPFVSHGR 669
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LSR8|LRK19_ARATH L-type lectin-domain containing receptor kinase I.9 OS=Arabidopsis thaliana GN=LECRK19 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 616 bits (1589), Expect = e-175, Method: Compositional matrix adjust.
Identities = 319/606 (52%), Positives = 423/606 (69%), Gaps = 25/606 (4%)
Query: 25 QEENQFIHHGF-EGSKLKLDGLAKIHPNGLLQLTNTSERISGHAFYPFPFKFNSSSSQSL 83
Q+E F++ F + L LD A + P+GLLQLTN SE GHAF+ P +F SSS L
Sbjct: 22 QQETSFVYESFLDRQNLYLDKSAIVLPSGLLQLTNASEHQMGHAFHKKPIEF--SSSGPL 79
Query: 84 SFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIE 143
SFST FV A+ PK GGHG+ F +SPS DF+ A + +LGIFN S NG + H+ A+E
Sbjct: 80 SFSTHFVCALVPKPGFEGGHGIVFVLSPSMDFTHAESTRYLGIFNASTNGSSSYHVLAVE 139
Query: 144 LDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPIQIWIDYN 203
LDT+ +P+F DID NHVGIDVN S ASA Y+SD K ES+ L SG PIQ+W+DY
Sbjct: 140 LDTIWNPDFKDIDHNHVGIDVNSPISVAIASASYYSDMKGSNESINLLSGNPIQVWVDYE 199
Query: 204 GQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQIL--QDSMYVGLSAATGTRVSDYYILGWS 261
G L+NV++AP+ KP+RPLLS I+L+++ + S++ G SAATGT +SD YIL WS
Sbjct: 200 G--TLLNVSVAPLEVQKPTRPLLSHPINLTELFPNRSSLFAGFSAATGTAISDQYILWWS 257
Query: 262 FN-KSGPAQNLDISKLPPLPPPPPTPGKKLNHTVIVSIVAAAVVLITIAAAVYFVKKKKY 320
F+ G Q LDISKLP +P P P KK++ +I+ V A++++ + A +YF +++KY
Sbjct: 258 FSIDRGSLQRLDISKLPEVPHPR-APHKKVSTLIILLPVCLAILVLAVLAGLYFRRRRKY 316
Query: 321 EEVYEDWEKEYSPHRFSYKNLYKATKG----------GSGKVYRGVLPSSHAEIAVKKVC 370
EV E WEKE+ HRFSY++L+KATKG G G+VYRG LP EIAVK+V
Sbjct: 317 SEVSETWEKEFDAHRFSYRSLFKATKGFSKDEFLGKGGFGEVYRGNLPQGR-EIAVKRVS 375
Query: 371 HDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRP 430
H+ D G+KQFV+E+VSM L+HRNLV L GYCRRK ELLLV +YMPNGSLD+ L+ + +P
Sbjct: 376 HNGDEGVKQFVAEVVSMRCLKHRNLVPLFGYCRRKRELLLVSEYMPNGSLDEHLFDDQKP 435
Query: 431 SLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDH 490
L+W QR ++KG+A L YLH +QVVLHRD+K +N++LDA+ G+LGDFG+AR ++H
Sbjct: 436 VLSWSQRLVVVKGIASALWYLHTGADQVVLHRDVKASNIMLDAEFHGRLGDFGMARFHEH 495
Query: 491 GNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPG----ELDL 546
G + TT VGTVGY+APEL+ G +T TDVYAFGVFMLEV CGRRPV+P + +
Sbjct: 496 GGNAATTAAVGTVGYMAPELITMG-ASTGTDVYAFGVFMLEVTCGRRPVEPQLQVEKRHM 554
Query: 547 LDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606
+ WV + W+K +LDA+DPRL G +V E++E+V+KLGL CS+ P++RP+M QVV YL+
Sbjct: 555 IKWVCECWKKDSLLDATDPRLGGKFVAEEVEMVMKLGLLCSNIVPESRPTMEQVVLYLNK 614
Query: 607 GALLPD 612
LPD
Sbjct: 615 NLPLPD 620
|
May be involved in protein-protein interactions with RGD motif-containing proteins as potential ligands. Plays probably a structural and signaling role at the plant cell surfaces. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81291|LRK44_ARATH L-type lectin-domain containing receptor kinase IV.4 OS=Arabidopsis thaliana GN=LECRK44 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 608 bits (1569), Expect = e-173, Method: Compositional matrix adjust.
Identities = 318/649 (48%), Positives = 439/649 (67%), Gaps = 30/649 (4%)
Query: 20 FSASAQEENQFIHHGFEG-----SKLKLDGLAKIHPNGLLQLTNTSERISGHAFYPFPFK 74
F S + +Q I + G + + + G+A I PNGLL+LTNT+ + +GHAFY P +
Sbjct: 15 FWQSLKSSSQIIDFTYNGFRPPPTDISILGIATITPNGLLKLTNTTMQSTGHAFYTKPIR 74
Query: 75 FNSSSSQSLS-FSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNG 133
F S + ++S FST+FVFA+ ++P HGMAF I+P+ +LG+FN +NNG
Sbjct: 75 FKDSPNGTVSSFSTTFVFAIHSQIPI--AHGMAFVIAPNPRLPFGSPLQYLGLFNVTNNG 132
Query: 134 QFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESG 193
NH+FA+ELDT+ + EFND + NHVGID+N L S +S+ A Y+ DE +F +L L S
Sbjct: 133 NVRNHVFAVELDTIMNIEFNDTNNNHVGIDINSLNSVKSSPAGYW-DENDQFHNLTLISS 191
Query: 194 KPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTRVS 253
K +Q+W+D++G L++VT+AP KP +PL+S DLS +L M+VG S+ATG VS
Sbjct: 192 KRMQVWVDFDGPTHLIDVTMAPFGEVKPRKPLVSIVRDLSSVLLQDMFVGFSSATGNIVS 251
Query: 254 DYYILGWSFNKSGPAQNLDISKLPPLP--PPPPTPGKKLNHTVIVSIVAAAVVLITIAAA 311
+ ++LGWSF +G AQ L +SKLP LP PT + + I + + I
Sbjct: 252 EIFVLGWSFGVNGEAQPLALSKLPRLPVWDLKPTRVYRFYKNWVPLISLLLIPFLLIIFL 311
Query: 312 VYFV--KKKKYEEVYEDWEKEYSPHRFSYKNLYKATKG----------GSGKVYRGVLPS 359
V F+ +++K+ E EDWE E+ +R +K+LY ATKG G G VY+G++P
Sbjct: 312 VRFIMKRRRKFAEEVEDWETEFGKNRLRFKDLYYATKGFKDKNILGSGGFGSVYKGIMPK 371
Query: 360 SHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGS 419
+ EIAVK+V ++S G+K+FV+EIVS+G++ HRNLV L GYCRR+ ELLLVYDYMPNGS
Sbjct: 372 TKKEIAVKRVSNESRQGLKEFVAEIVSIGQMSHRNLVPLVGYCRRRDELLLVYDYMPNGS 431
Query: 420 LDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKL 479
LDK LY++ +L+W QRF++I GVA L YLHEEWEQVV+HRD+K +NVLLDA+L G+L
Sbjct: 432 LDKYLYNSPEVTLDWKQRFKVINGVASALFYLHEEWEQVVIHRDVKASNVLLDAELNGRL 491
Query: 480 GDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPV 539
GDFGLA+L DHG+D TT VVGT GYLAP+ +R GR TT+TDV+AFGV +LEVACGRRP+
Sbjct: 492 GDFGLAQLCDHGSDPQTTRVVGTWGYLAPDHIRTGRATTTTDVFAFGVLLLEVACGRRPI 551
Query: 540 ----QPGE-LDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTR 594
Q GE + L+DWV +W + ++LDA DP L Y ++++E+VLKLGL CSHS+P R
Sbjct: 552 EINNQSGERVVLVDWVFRFWMEANILDAKDPNLGSEYDQKEVEMVLKLGLLCSHSDPLAR 611
Query: 595 PSMRQVVQYLDGGALLPDI-PLNSSVFGVLTAKNEAPN-NGMASFASLV 641
P+MRQV+QYL G A+LPD+ PL+ G++ + N +GM + S V
Sbjct: 612 PTMRQVLQYLRGDAMLPDLSPLDLRGSGIMLGTHNGSNESGMFTSGSSV 660
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FJI4|LK111_ARATH Putative L-type lectin-domain containing receptor kinase I.11 OS=Arabidopsis thaliana GN=LECRK111 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 605 bits (1561), Expect = e-172, Method: Compositional matrix adjust.
Identities = 340/677 (50%), Positives = 445/677 (65%), Gaps = 26/677 (3%)
Query: 3 ALPRLVSFWFLFKVTLIFSASAQEENQFIHHGFEGSK--LKLDGLAKI-HPNGLLQLTNT 59
A RL +F L F S QEE FI++GF ++ L LDG AKI P+GLLQLTN
Sbjct: 2 ASERLHLILLVFFNHLTFLLSQQEEAGFIYNGFGQAQAGLHLDGAAKILFPDGLLQLTNA 61
Query: 60 SERISGHAFYPFPFKFNSSSSQSLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAV 119
S + GHAF+ PFKF+S + LSFST FV A+ PK GGHG+AF +S S DF++A
Sbjct: 62 STQQMGHAFFKKPFKFDSYEKK-LSFSTHFVCALVPKPGADGGHGIAFVVSSSIDFTQAD 120
Query: 120 AGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFS 179
+LG+ N S NG ++ + AIELDTV+S EF+DID NHVGID+ L S ESASA YFS
Sbjct: 121 PTQYLGLLNISTNGSPSSQLLAIELDTVESAEFDDIDKNHVGIDIKSLNSVESASASYFS 180
Query: 180 DEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQD- 238
+ K + +S+ L SG PIQIW+DY G L+NVT+AP+ KP+ PLLS SI+L+ I D
Sbjct: 181 NAKGKNQSIKLLSGDPIQIWVDYEG--ALLNVTVAPLSIQKPNHPLLSRSINLTDIFPDR 238
Query: 239 SMYVGLSAATGTRVSDYYILGWSFNKSGPA-QNLDISKLPPLPPPPPTPGKKLNHTVIVS 297
++ G SAATGT VS YILGWSF++S Q+LD SKLP +P P ++ + +IV
Sbjct: 239 KLFFGFSAATGTLVSYQYILGWSFSRSRMLLQSLDFSKLPQIPHPKAKQ-EQTSPLLIVL 297
Query: 298 IVAAAVVLITIAAAVYFVKKKKYEEVYEDWEKEYSPHRFSYKNLYKAT----------KG 347
++ ++++ + +Y ++KKY EV E WEKEYSPHRFSYK+LYKAT KG
Sbjct: 298 LMLLVLIMLAVLGGIYLYRRKKYAEVREVWEKEYSPHRFSYKSLYKATNRFDKDGRLGKG 357
Query: 348 GSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGE 407
G G+VYRG LP +IAVK+VCHD+ GMKQFV+E+V+MG L+HRNLV L GYCRRKGE
Sbjct: 358 GFGEVYRGNLPHV-GDIAVKRVCHDAKQGMKQFVAEVVTMGSLKHRNLVPLLGYCRRKGE 416
Query: 408 LLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPA 467
LLLV +YM NGSLD+ L+ +P+L+W QR I+K +A L YLH QVVLHRDIK +
Sbjct: 417 LLLVSEYMSNGSLDQYLFHREKPALSWSQRLVILKDIASALSYLHTGANQVVLHRDIKAS 476
Query: 468 NVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGV 527
NV+LD++ G+LGDFG+AR D+G+ + T VGT+GY+APEL G +T TDVYAFGV
Sbjct: 477 NVMLDSEFNGRLGDFGMARFEDYGDSVPVTAAVGTMGYMAPELTTMGT-STRTDVYAFGV 535
Query: 528 FMLEVACGRRPVQPG----ELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLG 583
MLEV CGRRP+ P + L+ WV D W++ ++DA D RL G Y E+ +VLKLG
Sbjct: 536 LMLEVTCGRRPLDPKIPSEKRHLIKWVCDCWRRDSIVDAIDTRLGGQYSVEETVMVLKLG 595
Query: 584 LFCSHSNPDTRPSMRQVVQYLDGGALLPDIPLNSSVFGVLT-AKNEAPNNGMASFASLVR 642
L C++ ++RP+M QV+QY++ LP+ S GV T E+ N +S A +
Sbjct: 596 LICTNIVAESRPTMEQVIQYINQNLPLPNFSPGSLGIGVSTPVLLESVFNSRSSLAPSIS 655
Query: 643 SDSPHTMSTIDSIITVG 659
S H + IT G
Sbjct: 656 PPSSHNSMFVTHTITYG 672
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 660 | ||||||
| 224106407 | 675 | predicted protein [Populus trichocarpa] | 0.993 | 0.971 | 0.578 | 0.0 | |
| 255559006 | 667 | kinase, putative [Ricinus communis] gi|2 | 0.981 | 0.971 | 0.578 | 0.0 | |
| 255559000 | 670 | kinase, putative [Ricinus communis] gi|2 | 0.987 | 0.973 | 0.589 | 0.0 | |
| 224106419 | 607 | predicted protein [Populus trichocarpa] | 0.892 | 0.970 | 0.614 | 0.0 | |
| 225434861 | 675 | PREDICTED: L-type lectin-domain containi | 0.998 | 0.976 | 0.582 | 0.0 | |
| 255558978 | 662 | kinase, putative [Ricinus communis] gi|2 | 0.975 | 0.972 | 0.550 | 0.0 | |
| 224106425 | 674 | predicted protein [Populus trichocarpa] | 0.95 | 0.930 | 0.599 | 0.0 | |
| 224059452 | 599 | predicted protein [Populus trichocarpa] | 0.883 | 0.973 | 0.604 | 0.0 | |
| 359481749 | 1258 | PREDICTED: L-type lectin-domain containi | 0.957 | 0.502 | 0.539 | 0.0 | |
| 255559002 | 667 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.846 | 0.838 | 0.572 | 0.0 |
| >gi|224106407|ref|XP_002314156.1| predicted protein [Populus trichocarpa] gi|222850564|gb|EEE88111.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 796 bits (2055), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 393/679 (57%), Positives = 497/679 (73%), Gaps = 23/679 (3%)
Query: 1 MAALPRLVSFWFLFKVTLIFSASAQEENQFIHHGFEGSKLKLDGLAKIHPNGLLQLTNTS 60
M A + + F V+L A AQEEN FI+HGF G+ L L +AKIHPNGLL+LTNTS
Sbjct: 1 MIASFKTLHFLLGLFVSLKLLALAQEENHFIYHGFTGANLLLSEIAKIHPNGLLELTNTS 60
Query: 61 ERISGHAFYPFPFKFNSS---SSQSLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSE 117
+ G AF PFPF+FN+S +S+SLSFST F FAM P+LP +GG GMAF ISPS DF+
Sbjct: 61 KPQIGRAFLPFPFQFNTSLFNNSRSLSFSTQFAFAMVPELPTHGGQGMAFTISPSVDFTG 120
Query: 118 AVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARY 177
AVA + GI N + +G +NH+ A+ELDTVQS + DI+ +HVGID+N L S ESA Y
Sbjct: 121 AVAAQYFGILNSTTDGLPSNHLLAVELDTVQSQDLKDINESHVGIDLNSLISIESAPVTY 180
Query: 178 FSDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQ 237
FSDE+ E +SL L SG + +WIDY+ EKL+NVT+AP+ KP+ PLLS +DLS ++
Sbjct: 181 FSDEENENKSLTLISGHVMHVWIDYDEVEKLLNVTVAPITRTKPTLPLLSKPLDLSSVML 240
Query: 238 DSMYVGLSAATGTRVSDYYILGWSFNKSGPAQNLDISKLPPLPPPPPTPGKKLNHTVIVS 297
DSMYVG SA+TG S +YILGWSFN+ G AQ+LD+SKLP LPP + KK ++V
Sbjct: 241 DSMYVGFSASTGAVASSHYILGWSFNRGGQAQSLDVSKLPSLPPQRKSR-KKPYLIILVP 299
Query: 298 IVAAAVVLITIAAAVYFVKKKKYEEVYEDWEKEYSPHRFSYKNLYKAT----------KG 347
+ A ++L+ I+ A +++KKYEE+ EDWE+EY P RFSYK+LYKAT G
Sbjct: 300 TITAIILLVAISGAASIIRRKKYEELREDWEQEYGPQRFSYKDLYKATTGFTDRKLLGSG 359
Query: 348 GSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGE 407
G GKVYRGVLPSS+ ++A+KKV HDS G KQFV+EI SMG+LRHRNLVQL GYCRRKGE
Sbjct: 360 GFGKVYRGVLPSSNMQVAIKKVSHDSKQGTKQFVAEIASMGRLRHRNLVQLLGYCRRKGE 419
Query: 408 LLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPA 467
LLLVYDYMPNGSLDK+L+ N PSLNW QR+++++GVA LLYLHEEWEQVVLHRD+K +
Sbjct: 420 LLLVYDYMPNGSLDKLLFRNDTPSLNWVQRYQVLRGVASALLYLHEEWEQVVLHRDVKAS 479
Query: 468 NVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGV 527
N+LLD D G+LGDFGLA+ YD G + TT VVGTVGY+APE+ R GR TTS+DV+AFG
Sbjct: 480 NILLDDDFNGRLGDFGLAKFYDRGANPQTTCVVGTVGYIAPEVTRTGRATTSSDVFAFGT 539
Query: 528 FMLEVACGRRPVQPGE----LDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLG 583
FMLE+ACGR+P++P + + L+DWV+D W+ GD+L DPRLEG YV E+ME+VLKLG
Sbjct: 540 FMLEMACGRKPLEPEQSAEKMILVDWVLDSWKIGDILRTGDPRLEGNYVVEEMELVLKLG 599
Query: 584 LFCSHSNPDTRPSMRQVVQYLDGGALLPDIPLNSSVFGVLTAKNEAPNNGMASFASLVRS 643
L C S P RPSMRQ+ QYLDG A LP+IPL+ + G++ +E P + SF RS
Sbjct: 600 LLCCFSTPHARPSMRQIGQYLDGNASLPEIPLDGASIGLMPVSHEEPGDFNLSFH---RS 656
Query: 644 D--SPHTMSTIDSIITVGR 660
+ S H+ S+IDSI++ GR
Sbjct: 657 NDYSAHSFSSIDSILSCGR 675
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255559006|ref|XP_002520526.1| kinase, putative [Ricinus communis] gi|223540368|gb|EEF41939.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 788 bits (2035), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 393/679 (57%), Positives = 505/679 (74%), Gaps = 31/679 (4%)
Query: 1 MAALPRLVSFWFLFKVTLIFSASAQEENQFIHHGFEGSKLKLDGLAKIHPNGLLQLTNTS 60
MAAL +S F V A AQE +QFI++GF G+ L L+G A IHPNGLL+LTNTS
Sbjct: 1 MAALFISLSILFTLFVHSKPLAFAQEADQFIYNGFNGANLSLNGAANIHPNGLLELTNTS 60
Query: 61 ERISGHAFYPFPFKFNSSSSQS-----LSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDF 115
+ GHAF+PFP FNSS S + +SFST+FVFAM P+ P GHG+AF ISPS +F
Sbjct: 61 HQQIGHAFFPFPLHFNSSLSNNSRTSLVSFSTNFVFAMVPESPGLDGHGLAFAISPSLEF 120
Query: 116 SEAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASA 175
A+A +LG+FN + G +NH+ AIELDTV++PEF DIDGNHVG+DVN L S +S SA
Sbjct: 121 KGAIATQYLGLFNSTTIGLSSNHLLAIELDTVKNPEFGDIDGNHVGVDVNNLTSIQSVSA 180
Query: 176 RYFSDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQI 235
YFS+ +++ +SL L SG+P+Q+WIDY+ EKL+NVTLAP+ KP +PLLST+IDLS +
Sbjct: 181 SYFSETEEKNKSLELTSGRPMQMWIDYDEMEKLLNVTLAPIERMKPEKPLLSTNIDLSAL 240
Query: 236 LQDSMYVGLSAATGTRVSDYYILGWSFNKSGPAQNLDISKLPPLPPPPPTPGKKLNHTVI 295
L +SMYVG SA+TG+ S++YILGWSFN+SG AQ+LD SKLP LP + GK L ++
Sbjct: 241 LLESMYVGFSASTGSVSSNHYILGWSFNRSGQAQSLDPSKLPSLPQERKSRGK-LAMKIM 299
Query: 296 VSIVAAAVVLITIAAAVYFVKKKKYEEVYEDWEKEYSPHRFSYKNLYKATKG-------- 347
+ +V V+L+TI+A +Y + +K+YEE+ EDWE++Y P RFSYK+LYKATKG
Sbjct: 300 LPLVIVIVLLMTISATIY-IMRKRYEEIREDWEQQYGPQRFSYKDLYKATKGFKDKELLG 358
Query: 348 --GSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK 405
G GKVYRG LPSS+ E+AVKKV HDS GMK+FV+EI SMG+LRHRNLVQL GYCRRK
Sbjct: 359 CGGFGKVYRGTLPSSNVEVAVKKVSHDSRQGMKEFVAEIASMGRLRHRNLVQLLGYCRRK 418
Query: 406 GELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIK 465
GEL LVYD+MPNGSLDK L+SN +P+++W +R++IIKGVA L YLHEEWEQVVLHRD+K
Sbjct: 419 GELFLVYDHMPNGSLDKFLFSNEKPNIDWVRRYQIIKGVASALYYLHEEWEQVVLHRDVK 478
Query: 466 PANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAF 525
+NVLLDADL G+LGDFGLA+LYDHG+ TT+VVGT+GYLAPEL G+ TTS+DV+AF
Sbjct: 479 ASNVLLDADLNGRLGDFGLAKLYDHGSTPQTTHVVGTLGYLAPELTTTGKATTSSDVFAF 538
Query: 526 GVFMLEVACGRRPVQ----PGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLK 581
G+FMLEVACGR+PV+ P E+ L+DWV++ W++G++L DPRLE YV E+ E+VLK
Sbjct: 539 GIFMLEVACGRKPVKSERPPEEVILVDWVLECWERGNILGTIDPRLEDSYVAEETELVLK 598
Query: 582 LGLFCSHSNPDTRPSMRQVVQYLDGGALLPDIPLNSSVFGVLTAKNEAPNNGMASFASLV 641
LGL + P RP++RQV+QYLDG A LP I L ++ G L +EAP
Sbjct: 599 LGLLSTQRIPTARPTIRQVMQYLDGNATLPQISLYNAGIGFLPGNHEAP----------T 648
Query: 642 RSDSPHTMSTIDSIITVGR 660
S+ +++S DSI+T+GR
Sbjct: 649 ESNLSYSLSHSDSILTIGR 667
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255559000|ref|XP_002520523.1| kinase, putative [Ricinus communis] gi|223540365|gb|EEF41936.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 786 bits (2030), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 400/678 (58%), Positives = 514/678 (75%), Gaps = 26/678 (3%)
Query: 1 MAALPRLVSFWFLFKVTLIFSASAQEENQFIHHGFEGSKLKLDGLAKIHPNGLLQLTNTS 60
M ++ RL+ L V L S AQ+ NQFI+HGF S L L+G+AKIHPNGLL+LTN S
Sbjct: 1 MFSVFRLLLIVLLNSVFLKHSGFAQDRNQFIYHGFNESNLNLNGIAKIHPNGLLELTNIS 60
Query: 61 ERISGHAFYPFPFKFNSSS---SQSLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSE 117
G AF+PFP KF+ SS ++SLSFSTSFVFA+ P++P GGHG+ F ISP+ +F
Sbjct: 61 YYQIGRAFFPFPLKFDKSSPKNAESLSFSTSFVFAIDPEIPTLGGHGLVFTISPTVEFIG 120
Query: 118 AVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARY 177
A+ +LG+FN S NG+ +NH+FA+ELDT+ +P+F DI+ NHVGIDVNGL SN SASA Y
Sbjct: 121 ALGIQYLGLFNSSTNGRDSNHVFAVELDTIWTPDFRDINDNHVGIDVNGLISNASASATY 180
Query: 178 FSDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQ 237
FSD + + SL L S P+Q+WIDY+ EKL+NVTLAP+ + KP +PLLST+IDLS +L
Sbjct: 181 FSDNQNK--SLELISRSPMQVWIDYDAVEKLLNVTLAPITSKKPEKPLLSTTIDLSIVLL 238
Query: 238 DSMYVGLSAATGTRVSDYYILGWSFNKSGPAQNLDISKLPPLPPPPPTPGKKLNHTVIVS 297
DSMYVG S++TG+ S +YILGWSFN+SGPAQ+LD+SKLP LPP P + GKK N +++
Sbjct: 239 DSMYVGFSSSTGSMASYHYILGWSFNRSGPAQSLDMSKLPSLPPKPKS-GKKPNLRIMIP 297
Query: 298 IVAAAVVLITIAAAVYFVKKKKYEEVYEDWEKEYSPHRFSYKNLYKATKG---------- 347
++ A++VLITI AVY +K+KKYEE++EDWE+EY P RFSY++LY+ATKG
Sbjct: 298 LITASIVLITIFGAVY-IKRKKYEELHEDWEQEYGPQRFSYRDLYRATKGFQDKELLGSG 356
Query: 348 GSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGE 407
G GKVY+GVLPSS+ ++AVK+ H S GMK+FV+EI SMG+LRHRNLVQL GYCRRK E
Sbjct: 357 GFGKVYKGVLPSSNTQVAVKQFSHGSQQGMKEFVAEIASMGRLRHRNLVQLLGYCRRKRE 416
Query: 408 LLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPA 467
LLLVYDYMPNGSLD+ L+ N +LNW QR +I+KGVA LLYLHEEW+QVVLHRD+K +
Sbjct: 417 LLLVYDYMPNGSLDRFLFQNDTLNLNWVQRLQILKGVASALLYLHEEWDQVVLHRDVKAS 476
Query: 468 NVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGV 527
NV+LDA+L+G+LGDFGLA+ YDHG+ TT VVGT+GYLAPE+ R GR TTS+DV+AFG
Sbjct: 477 NVMLDAELKGRLGDFGLAKFYDHGSLPQTTRVVGTIGYLAPEISRTGRFTTSSDVFAFGT 536
Query: 528 FMLEVACGRRPVQPG----ELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLG 583
+LEVACGR+ ++P E+ L+DWV++ W+KG +LD SDP L+G Y+ E+ME VLKLG
Sbjct: 537 LILEVACGRKTIEPERPPREVILVDWVLECWKKGVILDTSDPELQGKYMAEEMEFVLKLG 596
Query: 584 LFCSHSNPDTRPSMRQVVQYLDGGALLPDIPLNSSVFG-VLTAKNEAPNNGMASFASLVR 642
L C+H P RP+MRQV+QYLDG A LPDIPLNS G VL +NEA + ++S AS
Sbjct: 597 LLCAHPAPAVRPTMRQVMQYLDGKADLPDIPLNSPRTGLVLVNQNEAEDCILSSVASYEY 656
Query: 643 SDSPHTMSTIDSIITVGR 660
S ++S S+++ GR
Sbjct: 657 S----SLSITASVLSTGR 670
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224106419|ref|XP_002314159.1| predicted protein [Populus trichocarpa] gi|222850567|gb|EEE88114.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 778 bits (2009), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/607 (61%), Positives = 467/607 (76%), Gaps = 18/607 (2%)
Query: 24 AQEENQFIHHGFEGSKLKLDGLAKIHPNGLLQLTNTSERISGHAFYPFPFKFNSS---SS 80
AQEENQFI+HGF G+ L L +AKIHPNGLL+LTNTS++ G AF+PFPF+FN+S +S
Sbjct: 2 AQEENQFIYHGFTGANLLLSEIAKIHPNGLLELTNTSKQQIGRAFFPFPFQFNTSLFNNS 61
Query: 81 QSLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIF 140
+SLSFST F F+M P+LP GG GMAF ISPS DF+ AVA + GI N +++G +NH+
Sbjct: 62 RSLSFSTQFAFSMVPELPTLGGQGMAFAISPSVDFTGAVAAQYFGILNSTSDGLPSNHLL 121
Query: 141 AIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPIQIWI 200
A+ELDTVQS + DI+ +HVGIDVN L S ESA YFSDE+KE +SL L SG + +WI
Sbjct: 122 AVELDTVQSQDLKDINESHVGIDVNSLISIESAPVTYFSDEEKENKSLTLISGHAMHVWI 181
Query: 201 DYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTRVSDYYILGW 260
DY+ E L+NVT+APV KP+ PLLST +DLS ++ +SMYVG S++TG S+ YILGW
Sbjct: 182 DYDEVEMLLNVTVAPVTRTKPTLPLLSTPLDLSSVMLNSMYVGFSSSTGAMASNNYILGW 241
Query: 261 SFNKSGPAQNLDISKLPPLPPPPPTPGKKLNHTVIVSIVAAAVVLITIAAAVYFVKKKKY 320
SFN+ G AQ+LD+SKLP LP + KK ++V + A ++L+ I+ V+ +++KKY
Sbjct: 242 SFNRGGQAQSLDVSKLPTLPTRRKSR-KKPQLRIVVPTITAIILLVAISGDVFIIRRKKY 300
Query: 321 EEVYEDWEKEYSPHRFSYKNLYKATKG----------GSGKVYRGVLPSSHAEIAVKKVC 370
EE+ EDWE+EY P R SYK+LYKATKG G GKVYRGVLPSS+ ++AVKKV
Sbjct: 301 EELREDWEQEYGPQRISYKDLYKATKGFTDKELLGCGGFGKVYRGVLPSSNMQVAVKKVS 360
Query: 371 HDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRP 430
HDS G K+FV+EIVSMG+LRHRNLVQL GYCRRKGELLLVYDYMPNGSLDK+L+ N P
Sbjct: 361 HDSRQGTKEFVAEIVSMGRLRHRNLVQLFGYCRRKGELLLVYDYMPNGSLDKLLFRNETP 420
Query: 431 SLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDH 490
SLNW +R++II+GVA LLYLHEEWEQVVLHRD+K +NVLLDADL G+LGDFGLA+ +DH
Sbjct: 421 SLNWGRRYQIIRGVASALLYLHEEWEQVVLHRDVKASNVLLDADLNGRLGDFGLAKFHDH 480
Query: 491 GNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQ----PGELDL 546
G+ TT VVGTVGYLAPE+ R G+ TT +DV++FG FMLEVACGR+PV+ P E+ L
Sbjct: 481 GSTPQTTKVVGTVGYLAPEITRTGKSTTCSDVFSFGTFMLEVACGRKPVESERPPEEVVL 540
Query: 547 LDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606
+DWV++ W +G +L DPR+EG +VEE+ME+VLKLGL C+H P RPSMRQ VQYLDG
Sbjct: 541 VDWVLECWNRGAILGTVDPRIEGNHVEEEMEVVLKLGLLCTHRTPAARPSMRQTVQYLDG 600
Query: 607 GALLPDI 613
A LPD+
Sbjct: 601 NATLPDL 607
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225434861|ref|XP_002280641.1| PREDICTED: L-type lectin-domain containing receptor kinase IV.2 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 771 bits (1990), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 394/676 (58%), Positives = 493/676 (72%), Gaps = 17/676 (2%)
Query: 1 MAALPRLVSFWFLFKVTLIFSASAQEENQFIHHGFEGSKLKLDGLAKIHPNGLLQLTNTS 60
MA + F + ++ A A+EE QFIH+GF+G+ L L G+AKIHPNGLLQLTNTS
Sbjct: 1 MATTVTSLHFLIILFTSVKLLALAEEEAQFIHNGFQGASLHLGGIAKIHPNGLLQLTNTS 60
Query: 61 ERISGHAFYPFPFKFNSSS--SQSLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEA 118
++ G AF+P P KFN+SS S+SLSFST F FA+ P+ GGHG+ F I+PS DF A
Sbjct: 61 KQQIGRAFFPLPLKFNTSSGDSRSLSFSTIFAFAIVPEWQALGGHGIVFTIAPSMDFPGA 120
Query: 119 VAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYF 178
VA +LG+FN +NNG +NH+FA+ELDT+ SP+ D DGNHVG+DVN L S SA YF
Sbjct: 121 VASQYLGLFNVTNNGNSSNHVFAVELDTILSPDLKDTDGNHVGVDVNSLDSEVSAPVTYF 180
Query: 179 SDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQD 238
S+++ + +SL L SGK +Q+WIDY+ +KL+NVT+AP+ +PKPS PLLST I+LS I +
Sbjct: 181 SNKEGKNKSLELISGKAMQVWIDYDDVQKLINVTVAPLKSPKPSMPLLSTPINLSSIFLE 240
Query: 239 SMYVGLSAATGTRVSDYYILGWSFNKSGPAQNLDISKLPPLPPPPPTPGKKLNHTVIVSI 298
SMYVG S+ATG SD+YILGWSFN+SG AQ+L+IS+LP LPP K L V++S+
Sbjct: 241 SMYVGFSSATGAMASDHYILGWSFNRSGEAQSLEISELPSLPPRKKER-KTLVVIVLLSL 299
Query: 299 VAAAVVLITIAAAVYFVKKKKYEEVYEDWEKEYSPHRFSYKNLYKATKG----------G 348
+VL+ + A Y ++K K+EE+ E+WE EY P RFSYK+LYKATKG G
Sbjct: 300 TTLVIVLVVLMGAGYIIRKLKFEELREEWEGEYGPQRFSYKDLYKATKGFKDKELLGAGG 359
Query: 349 SGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGEL 408
GKVYRG LPSS+ EIAVKKV HDS GM++FV+EI SMG+LRHRNLVQL GYCRR+GEL
Sbjct: 360 FGKVYRGRLPSSNLEIAVKKVSHDSKQGMREFVAEIASMGRLRHRNLVQLLGYCRRRGEL 419
Query: 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPAN 468
LLVYD+MPNGSLDK L+S+ P L W QR+ I++GVA LLYLHEEWEQVVLHRD+K +N
Sbjct: 420 LLVYDHMPNGSLDKFLFSDENPILTWPQRYHILRGVASSLLYLHEEWEQVVLHRDVKASN 479
Query: 469 VLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVF 528
VLLDA+L G+LGDFGLA+LYDH + TT+VVGTVGYLAPEL R G+ T+STDV+AFG F
Sbjct: 480 VLLDANLNGRLGDFGLAKLYDHDTNPQTTHVVGTVGYLAPELTRTGKATSSTDVFAFGAF 539
Query: 529 MLEVACGRRPVQ----PGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGL 584
MLE ACGRRPV+ P LLDWV++ W++G +L SDPRLEG YV E+ME+VLKLGL
Sbjct: 540 MLETACGRRPVELQGYPEGGVLLDWVLECWKRGAILLTSDPRLEGHYVAEEMELVLKLGL 599
Query: 585 FCSHSNPDTRPSMRQVVQYLDGGALLPDIPLNSSVFGVLTAKNEAPNNGMASFASLVRSD 644
CS P RPSMRQV+QYL+G A LP+IP N S G A E + SF S +
Sbjct: 600 LCSSPIPAVRPSMRQVMQYLNGDAPLPEIPRNFSSMGTFGANGEESAEVITSFPSSSGTT 659
Query: 645 SPHTMSTIDSIITVGR 660
+ + S+ DSI+ GR
Sbjct: 660 TIRSFSSSDSILNQGR 675
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255558978|ref|XP_002520512.1| kinase, putative [Ricinus communis] gi|223540354|gb|EEF41925.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 766 bits (1977), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/678 (55%), Positives = 487/678 (71%), Gaps = 34/678 (5%)
Query: 1 MAALPRLVSFWFLFKVTLIFSASAQEENQFIHHGFEGSKLKLDGLAKIHPNGLLQLTNTS 60
M AL L++ + V+L ASAQE NQFI++GF+G+ L L G+A IHPNGLL+LTNTS
Sbjct: 1 MGALHILLTLF----VSLKLLASAQEINQFIYNGFQGANLSLSGIATIHPNGLLELTNTS 56
Query: 61 ERISGHAFYPFPFKFNSSSSQ----SLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFS 116
++ G AF+P PF+FN+SSS +LSFST+FVFAM P+LP +GGHG+AF ISPS
Sbjct: 57 YQMIGRAFFPLPFRFNTSSSNNFQSALSFSTNFVFAMVPELPTHGGHGIAFAISPSKLCV 116
Query: 117 EAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASAR 176
++A +LG+ N + +G +NH+FA+ELD+ +SP+ D++ NHVGID+N L+SNESA
Sbjct: 117 GSMATQYLGLLNSTTDGLSSNHLFAVELDSAKSPDLEDMNANHVGIDINSLKSNESAPVT 176
Query: 177 YFSDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQIL 236
Y+ D++ ++L L SG P+Q+WIDY +EKL+NVT+AP+ KPSRPLLS S++LSQ+L
Sbjct: 177 YYLDKEGRNQTLELNSGDPMQVWIDYKEEEKLLNVTVAPIGVSKPSRPLLSKSLNLSQVL 236
Query: 237 QDSMYVGLSAATGTRVSDYYILGWSFNKSGPAQNLDISKLPPLPPPPPTPGKKLNHTVIV 296
+SMYVG SAATG+ S +YILGWSFNKSG +Q LD SKLP LP + L +++
Sbjct: 237 LESMYVGFSAATGSVSSRHYILGWSFNKSGESQTLDPSKLPSLPSLAKSRKLNLRLIILL 296
Query: 297 SIVAAAVVLITIAAAVYFVKKKKYEEVYEDWEKEYSPHRFSYKNLYKATK---------- 346
++ +++T F+++K+YEE+ EDWEK Y P RFSY+ LYKAT+
Sbjct: 297 AVTLTVTIIVTAVLGTMFIRRKRYEEIREDWEKAYGPQRFSYEVLYKATRDFRDKDLLGA 356
Query: 347 GGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKG 406
GG GKVYRG+L S + ++AVKK+ H+S GMK+F++EI SMG+LRHRNLVQL GYCRRKG
Sbjct: 357 GGFGKVYRGILSSCNTQVAVKKISHNSAQGMKEFIAEIASMGRLRHRNLVQLLGYCRRKG 416
Query: 407 ELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKP 466
ELLLVY+YMPNGSLDK L+S LNW QR RII+GVA GLLYLH +WEQVVLHRD+K
Sbjct: 417 ELLLVYEYMPNGSLDKFLFSKKEAKLNWDQRHRIIRGVASGLLYLHHDWEQVVLHRDVKA 476
Query: 467 ANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFG 526
+NVLLDA+ +LGDFGLA+ YDHG + TT VVGTVGYLAPEL++ G+ TTS+DV+AFG
Sbjct: 477 SNVLLDANFNARLGDFGLAKFYDHGTNPQTTCVVGTVGYLAPELIKTGKPTTSSDVFAFG 536
Query: 527 VFMLEVACGRRPVQPG----ELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKL 582
FMLE+ACGR+P +P E L DWV++ W++GD+L +SDPRLEG YV ++ME+VLKL
Sbjct: 537 NFMLEIACGRKPFEPKCLPEETILADWVLECWKRGDILSSSDPRLEGNYVVQEMELVLKL 596
Query: 583 GLFCSHSNPDTRPSMRQVVQYLDGGALLPDIPLNSSVFGVLTAKNEAPNNGMASFASLVR 642
GL C+HS P RP MRQVV YLD LP+I G +T N N
Sbjct: 597 GLLCAHSTPAARPDMRQVVNYLDHNVSLPEISQYGGPAGSITVNNHDTFN---------- 646
Query: 643 SDSPHTMSTIDSIITVGR 660
S ++ S+ DSI+T GR
Sbjct: 647 --SANSWSSTDSILTCGR 662
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224106425|ref|XP_002314160.1| predicted protein [Populus trichocarpa] gi|222850568|gb|EEE88115.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 759 bits (1959), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 387/646 (59%), Positives = 486/646 (75%), Gaps = 19/646 (2%)
Query: 1 MAALPRLVSFWFLFKVTLIFSASAQEENQFIHHGFEGSKLKLDGLAKIHPNGLLQLTNTS 60
M AL R + F ++L A AQE NQFI+HGF G+ L L+G+A IHPNGLL+LTNTS
Sbjct: 1 MEALLRSLHFLLALFISLKHLALAQEVNQFIYHGFTGANLSLNGIASIHPNGLLELTNTS 60
Query: 61 ERISGHAFYPFPFKFNSS---SSQSLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSE 117
++ GHAF+PFPF F SS +S+SLSFST+FVFAM P+ P GGHG+A ISPST+F
Sbjct: 61 KQQIGHAFFPFPFHFKSSFPNNSRSLSFSTNFVFAMVPETPTRGGHGIALAISPSTEFKG 120
Query: 118 AVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARY 177
A A +LG+FN + G +NH+ AIELD V+SPEF DI NHVGIDVN L S +SA A Y
Sbjct: 121 ATATQYLGLFNSTTVGLSSNHLLAIELDAVRSPEFRDIGDNHVGIDVNNLTSIQSAPASY 180
Query: 178 FSDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQ 237
FS ++E ESL L SG P+Q+WIDY+ E L+NVTLAPV KP +PLLST I+LS ++
Sbjct: 181 FSKHERENESLQLISGDPMQVWIDYDEMENLLNVTLAPVSIMKPQKPLLSTPINLSLVVL 240
Query: 238 DSMYVGLSAATGTRVSDYYILGWSFNKSGPAQNLDISKLPPLPPPPPTPGKKLNHTVIVS 297
+SMYVG S++TG+ S +YILGWSFNKSG AQ+LD SKLP LPP + K +++
Sbjct: 241 ESMYVGFSSSTGSVSSHHYILGWSFNKSGQAQSLDTSKLPSLPPERNSTNKPYLR-IMIP 299
Query: 298 IVAAAVVLITIAAAVYFVKKKKYEEVYEDWEKEYSPHRFSYKNLYKATKG---------- 347
++ +V+LI A +Y + +K+YEEV+EDWE++Y P RF YK+LYKATKG
Sbjct: 300 LITVSVLLIASFATMY-IMRKRYEEVHEDWEQQYGPQRFRYKDLYKATKGFKVKGLLGYG 358
Query: 348 GSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGE 407
G G+VYRG L SS EIAVKK+ HDS+ GMK+FV+EI +MG+LRHRNLVQL GYCRRKGE
Sbjct: 359 GFGRVYRGELRSSKVEIAVKKITHDSNQGMKEFVAEIATMGRLRHRNLVQLLGYCRRKGE 418
Query: 408 LLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPA 467
LLLVYDYMPNGSLDK L+ +P+LNW QR++II+GVA LLYLHEEWEQVVLHRD+K +
Sbjct: 419 LLLVYDYMPNGSLDKFLFCKVKPNLNWAQRYQIIRGVASALLYLHEEWEQVVLHRDVKAS 478
Query: 468 NVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGV 527
NVLLDADL G+LGDFGLA+ +DHG+ TTNVVGTVGYLAPE+ R G+ TT +DV++FG
Sbjct: 479 NVLLDADLNGRLGDFGLAKFHDHGSTPQTTNVVGTVGYLAPEITRTGKSTTCSDVFSFGT 538
Query: 528 FMLEVACGRRPVQ----PGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLG 583
FMLEVACGR+PV+ P E+ L+DWV++ W++G +L DPR EG +VEE+ME+VLKLG
Sbjct: 539 FMLEVACGRKPVESERPPEEVVLVDWVLECWKRGAILGTVDPRFEGNHVEEEMELVLKLG 598
Query: 584 LFCSHSNPDTRPSMRQVVQYLDGGALLPDIPLNSSVFGVLTAKNEA 629
L C+H P RPSMRQ +QYLDG A LPD+PL+ + G++ NEA
Sbjct: 599 LLCTHRTPAARPSMRQAMQYLDGNATLPDLPLHGAGIGLVPVSNEA 644
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224059452|ref|XP_002299853.1| predicted protein [Populus trichocarpa] gi|222847111|gb|EEE84658.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 709 bits (1829), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 364/602 (60%), Positives = 459/602 (76%), Gaps = 19/602 (3%)
Query: 29 QFIHHGFEGSKLKLDGLAKIHPNGLLQLTNTSERISGHAFYPFPFKFNSSS--SQSLSFS 86
QF ++GF+G+ L LDG+A IHPNGLL+LTN S++ GHAF+PFPF FN+SS S+SLSFS
Sbjct: 1 QFFYNGFKGANLSLDGIASIHPNGLLELTNASKQQIGHAFFPFPFHFNTSSNNSRSLSFS 60
Query: 87 TSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIELDT 146
T+FVFAM P+ P GGHG+AF ISPSTDF+ A A +LG+FN + G +NH+ AIELD
Sbjct: 61 TNFVFAMVPESPMRGGHGIAFTISPSTDFNGATATQYLGLFNSTTIGLSSNHLLAIELDA 120
Query: 147 VQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPIQIWIDYNGQE 206
++SPEF DI+ NHVGIDVN L S +SA A YFS+ E L L SG P+Q+WIDY+ +
Sbjct: 121 IRSPEFGDINDNHVGIDVNNLTSIQSAPASYFSEHGGN-EILQLISGDPMQVWIDYDEMD 179
Query: 207 KLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTRVSDYYILGWSFNKSG 266
KL++VTLAPV KP +PLLST+IDLSQ+L DSMYVG S++TG+ S +YILGWSFNKSG
Sbjct: 180 KLLDVTLAPVSVTKPRKPLLSTTIDLSQVLLDSMYVGFSSSTGSVSSHHYILGWSFNKSG 239
Query: 267 PAQNLDISKLPPLPPPPPTPGKKLNHTVIVSIVAAAVVLITIAAAVYFVKKKKYEEVYED 326
AQ+L SKLP LPP + K + +++ ++ +V+LI + A + + KYEEV ED
Sbjct: 240 QAQSLGTSKLPSLPPERNSSNKP-DLRIVIPLITVSVLLIA-SFATMCIMRNKYEEVRED 297
Query: 327 WEKEYSPHRFSYKNLYKATKG----------GSGKVYRGVLPSSHAEIAVKKVCHDSDHG 376
WE++Y P RF YK+LYKATKG G G+VYRG L SS EIAVKK+ H S+ G
Sbjct: 298 WEQQYGPQRFRYKDLYKATKGFKDKELLGTGGFGRVYRGELRSSKVEIAVKKISHGSNQG 357
Query: 377 MKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQ 436
MK+FV+EI SMG+LRHRNLVQL GYCRRKGELLLVYDYMPNGSLDK L+ N +P+L+W +
Sbjct: 358 MKEFVAEIASMGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKFLFCNEKPNLDWPR 417
Query: 437 RFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT 496
R++I++GV LLYLHEEW+QVVLHRD+K +NVLLD DL G+LGDFGLA+ +DHG+ T
Sbjct: 418 RYQILRGVGSALLYLHEEWQQVVLHRDVKASNVLLDGDLNGRLGDFGLAKFHDHGSTPQT 477
Query: 497 TNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQ----PGELDLLDWVID 552
TNVVGTVGYLAPE+ R G+ TTS+DV+AFG FMLEV CGRRPV+ P E+ L+DWV++
Sbjct: 478 TNVVGTVGYLAPEITRTGKATTSSDVFAFGTFMLEVVCGRRPVESERPPEEVVLVDWVLE 537
Query: 553 YWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGALLPD 612
W++G +L DPRL Y +++E+VLKLGL C+H P RPSMRQVVQ+L+G A LPD
Sbjct: 538 CWKRGAILGTVDPRLNVNYEVKEVELVLKLGLLCTHRTPAARPSMRQVVQFLEGDATLPD 597
Query: 613 IP 614
IP
Sbjct: 598 IP 599
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359481749|ref|XP_003632669.1| PREDICTED: L-type lectin-domain containing receptor kinase IV.2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 695 bits (1793), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 352/652 (53%), Positives = 464/652 (71%), Gaps = 20/652 (3%)
Query: 26 EENQFIHHGFE-GSKLKLDGLAKIHPNGLLQLTNTSERISGHAFYPFPFKF-NSSSSQSL 83
E+ F ++GF+ + L LDGLA+ PNGLL LTN +++ +GHAFY P +F NSS++ +
Sbjct: 610 EDVSFTYNGFQTAANLSLDGLAQFTPNGLLILTNRTKQETGHAFYSHPMRFKNSSNAPAF 669
Query: 84 SFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIE 143
SFST+FVFA+ P+ P GHG+AF I+P+ A+ HLG+F+ +NNG TNHI A+E
Sbjct: 670 SFSTTFVFAIHPQYPTLSGHGIAFVIAPTRGLPGALPSQHLGLFSDANNGNSTNHIVAVE 729
Query: 144 LDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPIQIWIDYN 203
LDT+Q+ E DI+ NHVGID+NGL+S+++A A YF+ + +F++L L SG+P+Q+W+DYN
Sbjct: 730 LDTIQNEELGDINDNHVGIDINGLKSDKAAPAGYFASKNGDFKNLSLISGRPMQVWVDYN 789
Query: 204 GQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTRVSDYYILGWSFN 263
EK ++V LAPV KP PLLS DLS IL ++MYVG S++TG+ ++ +Y+LGWSF
Sbjct: 790 ALEKQIDVRLAPVSVDKPDIPLLSLPRDLSLILNNTMYVGFSSSTGSVLTSHYLLGWSFK 849
Query: 264 KSGPAQNLDISKLPPLPPPPPTPGKKLNH--TVIVSIVAAAVVLITIAAAVYFVK-KKKY 320
+G AQ L IS+LP LP G+K + T + ++ +L ++ AVY ++ KKK+
Sbjct: 850 MNGQAQPLAISQLPKLPR---IGGQKKSAFLTSGLPVICVVSILAVMSGAVYLIRRKKKF 906
Query: 321 EEVYEDWEKEYSPHRFSYKNLYKATKG----------GSGKVYRGVLPSSHAEIAVKKVC 370
E EDWE +Y PHRF YK+LY ATKG G G+VYRGVLP+S EIAVKK+
Sbjct: 907 AEELEDWELDYGPHRFKYKDLYFATKGFKDKELLGSGGFGRVYRGVLPTSKLEIAVKKIS 966
Query: 371 HDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRP 430
H+S GMK+FV+EIVS+G+LRHRN+V L GYCRRKGELLLVYDYMPNGSLDK LY +
Sbjct: 967 HESRQGMKEFVAEIVSIGRLRHRNIVSLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKV 1026
Query: 431 SLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDH 490
+LNW QRFR++KGVA GL YLH EWEQVV+HRD+K +NVLLD +L G+LGDFGLARLYDH
Sbjct: 1027 TLNWNQRFRVLKGVASGLSYLHGEWEQVVVHRDVKASNVLLDGELNGRLGDFGLARLYDH 1086
Query: 491 GNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGE-LDLLDW 549
G D TT+VVGT+GYLAPE R G+ TT TDVYAFG F+LEVACGRRP+ P E L L+DW
Sbjct: 1087 GTDPQTTHVVGTLGYLAPEHTRTGKATTRTDVYAFGAFLLEVACGRRPIAPMEDLILVDW 1146
Query: 550 VIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGAL 609
V +W +G++L ASDP+L Y E+ME+VLKLGL CSHS P+ RPSM QVVQYL+
Sbjct: 1147 VFFFWNRGEILQASDPKLGVDYNAEEMELVLKLGLMCSHSEPNARPSMPQVVQYLERTVP 1206
Query: 610 LPDI-PLNSSVFGVLTAKNEAPNNGMASFASLVRSDSPHTMSTIDSIITVGR 660
LP+ L S G+ A E ++ S+ + H + +S+++ GR
Sbjct: 1207 LPEFTSLGLSANGLSFAHREGFDDFALSYPFSLDKTFSHASTVPESLLSGGR 1258
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255559002|ref|XP_002520524.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223540366|gb|EEF41937.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 682 bits (1759), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 350/611 (57%), Positives = 444/611 (72%), Gaps = 52/611 (8%)
Query: 12 FLFKVTLIFS---ASAQEENQFIHHGFEGSKLKLDGLAKIHPNGLLQLTNTSERISGHAF 68
F+ +T +FS + AQ++NQFI+HGF S L L GLA +HPNGLL+LTN + G AF
Sbjct: 3 FVLLITFVFSKHLSFAQDQNQFIYHGFNESNLNLSGLANVHPNGLLELTNITYLKVGRAF 62
Query: 69 YPFPFKFNSSSSQSLSFSTSFVFAMFPK------LPNYGGHGMAFFISPSTDFSEAVAGS 122
+ P KFN SS FST+FVFA+ P+ P GGHG AF ISPS +F A+A
Sbjct: 63 FQLPLKFNKSS-----FSTNFVFAIDPERLPLGETPGLGGHGFAFTISPSMEFPGALATQ 117
Query: 123 HLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEK 182
+ G+FN ++NG F+NH+ AIE DT+Q+ + DI+ NHVGIDVNG+ SN SA A YFSD
Sbjct: 118 YFGLFNSTSNGLFSNHLVAIEFDTIQTLDCGDINNNHVGIDVNGVTSNVSAPAAYFSD-- 175
Query: 183 KEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYV 242
KE+++L L SGKP+Q+WIDY+ + ++N+TLAP+ KP +PLLST+IDLS IL DSMYV
Sbjct: 176 KEYKNLTLISGKPMQVWIDYDEVQMILNITLAPITVMKPEKPLLSTTIDLSLILLDSMYV 235
Query: 243 GLSAATGTRVSDYYILGWSFNKSGPAQNLDISKLPPLPPPPPTPG--------------- 287
G S++TG+ S +YILGWSFNKSGPAQ+LD SKLP LP PP+P
Sbjct: 236 GFSSSTGSMASYHYILGWSFNKSGPAQSLDTSKLPSLPLAPPSPSLPVTPPAPPPSLPAP 295
Query: 288 -----KKLNHTVIVSIVAAAVVLITIAAAVYFVKKKKYEEVYEDWEKEYSPHRFSYKNLY 342
KKL + S + A VVLI I +Y +K+KK+EE+ EDWEKEY P RFSY++LY
Sbjct: 296 PSHPPKKL--IITASSIVAGVVLIAIFGTLYILKRKKFEELREDWEKEYGPQRFSYRDLY 353
Query: 343 KATK----------GGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRH 392
KATK GG GKVYRGVLPSS+ ++AVKK HDS GMK+F++EIVSMG+LRH
Sbjct: 354 KATKAFKDKELLGFGGFGKVYRGVLPSSNTQVAVKKFSHDSQQGMKEFIAEIVSMGRLRH 413
Query: 393 RNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLH 452
RNLVQL GYCRRKGELLLVYDYMPNGSLDK L+ N P+LNW QR++I++GVA LLYLH
Sbjct: 414 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKFLFQNDTPNLNWVQRYQILRGVASALLYLH 473
Query: 453 EEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLR 512
EEWEQVVLHRD+K +NV+LDADL G+LGDFGLA+ +D G+ T VVGTVGYLAPE+ R
Sbjct: 474 EEWEQVVLHRDVKASNVMLDADLSGRLGDFGLAKFHDRGSAPQTICVVGTVGYLAPEVSR 533
Query: 513 NGRGTTSTDVYAFGVFMLEVACGRRPVQP----GELDLLDWVIDYWQKGDVLDASDPRLE 568
GR TT +DV++FG MLE+ACGR+ ++P GE+ L+DWV++ W+ G +L+ SDPRLE
Sbjct: 534 TGRVTTGSDVFSFGTLMLEMACGRKTIEPQKPAGEVILVDWVLESWKNGVLLEISDPRLE 593
Query: 569 GIYVEEQMEIV 579
G Y+ E+ME++
Sbjct: 594 GKYMMEEMELL 604
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 660 | ||||||
| TAIR|locus:2040681 | 675 | RLK "receptor lectin kinase" [ | 0.493 | 0.482 | 0.569 | 1.3e-154 | |
| TAIR|locus:2084375 | 677 | AT3G53810 [Arabidopsis thalian | 0.493 | 0.481 | 0.563 | 5.7e-152 | |
| TAIR|locus:2168509 | 674 | AT5G59260 [Arabidopsis thalian | 0.446 | 0.437 | 0.573 | 2e-147 | |
| TAIR|locus:2133239 | 669 | AT4G02420 [Arabidopsis thalian | 0.466 | 0.460 | 0.566 | 3.3e-145 | |
| TAIR|locus:2144025 | 657 | AT5G60280 [Arabidopsis thalian | 0.436 | 0.438 | 0.562 | 1.8e-144 | |
| TAIR|locus:2119936 | 669 | AT4G29050 [Arabidopsis thalian | 0.487 | 0.481 | 0.536 | 8.9e-143 | |
| TAIR|locus:2085587 | 669 | AT3G45440 [Arabidopsis thalian | 0.439 | 0.433 | 0.555 | 3.8e-142 | |
| TAIR|locus:2133229 | 674 | LPK1 "lectin-like protein kina | 0.445 | 0.436 | 0.590 | 5.6e-141 | |
| TAIR|locus:2158309 | 675 | AT5G60320 [Arabidopsis thalian | 0.493 | 0.482 | 0.510 | 1.2e-140 | |
| TAIR|locus:2144045 | 766 | LecRK-I.9 "lectin receptor kin | 0.419 | 0.361 | 0.563 | 3.1e-140 |
| TAIR|locus:2040681 RLK "receptor lectin kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 963 (344.1 bits), Expect = 1.3e-154, Sum P(2) = 1.3e-154
Identities = 196/344 (56%), Positives = 248/344 (72%)
Query: 334 HRFSYKNLYKATKG----------GSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSE 383
+RF +K+LY ATKG G G VY+GV+P + EIAVK+V H+S GMK+FV+E
Sbjct: 333 NRFRFKDLYYATKGFKEKGLLGTGGFGSVYKGVMPGTKLEIAVKRVSHESRQGMKEFVAE 392
Query: 384 IVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKG 443
IVS+G++ HRNLV L GYCRR+GELLLVYDYMPNGSLDK LY+ +LNW QR ++I G
Sbjct: 393 IVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLDKYLYNTPEVTLNWKQRIKVILG 452
Query: 444 VAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTV 503
VA GL YLHEEWEQVV+HRD+K +NVLLD +L G+LGDFGLARLYDHG+D TT+VVGT+
Sbjct: 453 VASGLFYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGSDPQTTHVVGTL 512
Query: 504 GYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQ-PGELD----LLDWVIDYWQKGD 558
GYLAPE R GR T +TDV+AFG F+LEVACGRRP++ E D L+DWV W KGD
Sbjct: 513 GYLAPEHTRTGRATMATDVFAFGAFLLEVACGRRPIEFQQETDETFLLVDWVFGLWNKGD 572
Query: 559 VLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGALLPDI-PLNS 617
+L A DP + E+++E+VLKLGL CSHS+P RPSMRQV+ YL G A LP++ PL+
Sbjct: 573 ILAAKDPNMGSECDEKEVEMVLKLGLLCSHSDPRARPSMRQVLHYLRGDAKLPELSPLDL 632
Query: 618 SVFGVLTAKNEAPNN-GMASFASLVRSDSPHTMSTIDSIITVGR 660
S G++ ++ + GM S++S V S DS ++ GR
Sbjct: 633 SGSGMMFGVHDGFSELGM-SYSSSVFKGFTGGSSIADSQLSGGR 675
|
|
| TAIR|locus:2084375 AT3G53810 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 963 (344.1 bits), Expect = 5.7e-152, Sum P(2) = 5.7e-152
Identities = 195/346 (56%), Positives = 251/346 (72%)
Query: 334 HRFSYKNLYKATKG----------GSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSE 383
+RF +K LY ATKG G G+VYRG+LP++ E+AVK+V HDS GMK+FV+E
Sbjct: 333 NRFRFKELYHATKGFKEKDLLGSGGFGRVYRGILPTTKLEVAVKRVSHDSKQGMKEFVAE 392
Query: 384 IVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKG 443
IVS+G++ HRNLV L GYCRR+GELLLVYDYMPNGSLDK LY+N +L+W QR IIKG
Sbjct: 393 IVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLDKYLYNNPETTLDWKQRSTIIKG 452
Query: 444 VAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTV 503
VA GL YLHEEWEQVV+HRD+K +NVLLDAD G+LGDFGLARLYDHG+D TT+VVGT+
Sbjct: 453 VASGLFYLHEEWEQVVIHRDVKASNVLLDADFNGRLGDFGLARLYDHGSDPQTTHVVGTL 512
Query: 504 GYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQ-PGELD----LLDWVIDYWQKGD 558
GYLAPE R GR TT+TDVYAFG F+LEV GRRP++ D L++WV W +G+
Sbjct: 513 GYLAPEHSRTGRATTTTDVYAFGAFLLEVVSGRRPIEFHSASDDTFLLVEWVFSLWLRGN 572
Query: 559 VLDASDPRLEGI-YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGALLPDI-PLN 616
+++A DP+L Y E++E+VLKLGL CSHS+P RPSMRQV+QYL G LP++ PL+
Sbjct: 573 IMEAKDPKLGSSGYDLEEVEMVLKLGLLCSHSDPRARPSMRQVLQYLRGDMALPELTPLD 632
Query: 617 SSVFGVLTAKNEAPNNGMA--SFASLVRSDSPHTMSTIDSIITVGR 660
S V+ +G+A F+++ + + + S DS+++ GR
Sbjct: 633 LSAGSVMNLGGRDGFSGIAMTDFSTVFKGFTGGS-SIADSLLSGGR 677
|
|
| TAIR|locus:2168509 AT5G59260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 884 (316.2 bits), Expect = 2.0e-147, Sum P(2) = 2.0e-147
Identities = 179/312 (57%), Positives = 219/312 (70%)
Query: 332 SPHRFSYKNLYKATKG----------GSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFV 381
SP R+S++ LYKATKG G GKVY+G+LPS +IAVK+V HD++ GMKQ+V
Sbjct: 339 SPQRYSFRILYKATKGFRENQLLGAGGFGKVYKGILPSG-TQIAVKRVYHDAEQGMKQYV 397
Query: 382 SEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILY-SNTRPSLNWFQRFRI 440
+EI SMG+LRH+NLV L GYCRRKGELLLVYDYMPNGSLD L+ N L W QR I
Sbjct: 398 AEIASMGRLRHKNLVHLLGYCRRKGELLLVYDYMPNGSLDDYLFHKNKLKDLTWSQRVNI 457
Query: 441 IKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVV 500
IKGVA LLYLHEEWEQVVLHRDIK +N+LLDADL GKLGDFGLAR +D G +L T VV
Sbjct: 458 IKGVASALLYLHEEWEQVVLHRDIKASNILLDADLNGKLGDFGLARFHDRGVNLEATRVV 517
Query: 501 GTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPG----ELDLLDWVIDYWQK 556
GT+GY+APEL G TT TDVYAFG F+LEV CGRRPV P ++ L+ WV ++
Sbjct: 518 GTIGYMAPELTAMGVTTTCTDVYAFGAFILEVVCGRRPVDPDAPREQVILVKWVASCGKR 577
Query: 557 GDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGALLPDIPLN 616
+ D D +L VEE +++LKLG+ CS NP+ RPSMRQ++QYL+G +P I
Sbjct: 578 DALTDTVDSKLIDFKVEEA-KLLLKLGMLCSQINPENRPSMRQILQYLEGNVSVPAISFG 636
Query: 617 SSVFGVLTAKNE 628
+ G+ +E
Sbjct: 637 TVALGIPNISHE 648
|
|
| TAIR|locus:2133239 AT4G02420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 937 (334.9 bits), Expect = 3.3e-145, Sum P(2) = 3.3e-145
Identities = 184/325 (56%), Positives = 242/325 (74%)
Query: 334 HRFSYKNLYKATKG----------GSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSE 383
+R +K+LY ATKG G G VY+G++P + EIAVK+V ++S G+K+FV+E
Sbjct: 336 NRLRFKDLYYATKGFKDKNILGSGGFGSVYKGIMPKTKKEIAVKRVSNESRQGLKEFVAE 395
Query: 384 IVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKG 443
IVS+G++ HRNLV L GYCRR+ ELLLVYDYMPNGSLDK LY++ +L+W QRF++I G
Sbjct: 396 IVSIGQMSHRNLVPLVGYCRRRDELLLVYDYMPNGSLDKYLYNSPEVTLDWKQRFKVING 455
Query: 444 VAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTV 503
VA L YLHEEWEQVV+HRD+K +NVLLDA+L G+LGDFGLA+L DHG+D TT VVGT
Sbjct: 456 VASALFYLHEEWEQVVIHRDVKASNVLLDAELNGRLGDFGLAQLCDHGSDPQTTRVVGTW 515
Query: 504 GYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPV----QPGE-LDLLDWVIDYWQKGD 558
GYLAP+ +R GR TT+TDV+AFGV +LEVACGRRP+ Q GE + L+DWV +W + +
Sbjct: 516 GYLAPDHIRTGRATTTTDVFAFGVLLLEVACGRRPIEINNQSGERVVLVDWVFRFWMEAN 575
Query: 559 VLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGALLPDI-PLNS 617
+LDA DP L Y ++++E+VLKLGL CSHS+P RP+MRQV+QYL G A+LPD+ PL+
Sbjct: 576 ILDAKDPNLGSEYDQKEVEMVLKLGLLCSHSDPLARPTMRQVLQYLRGDAMLPDLSPLDL 635
Query: 618 SVFGVLTAKNEAPN-NGMASFASLV 641
G++ + N +GM + S V
Sbjct: 636 RGSGIMLGTHNGSNESGMFTSGSSV 660
|
|
| TAIR|locus:2144025 AT5G60280 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 835 (299.0 bits), Expect = 1.8e-144, Sum P(2) = 1.8e-144
Identities = 172/306 (56%), Positives = 210/306 (68%)
Query: 333 PHRFSYKNLYKATKG----------GSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVS 382
PHR+SYK+LYKATKG G G+VY+G LP +IAVK+ H + GMKQFV+
Sbjct: 324 PHRYSYKSLYKATKGFHKDGFLGKGGFGEVYKGTLPQE--DIAVKRFSHHGERGMKQFVA 381
Query: 383 EIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIK 442
EI SMG L HRNLV L GYCRRKGE LLV YMPNGSLD+ L+ N PSL W +R I+K
Sbjct: 382 EIASMGCLDHRNLVPLFGYCRRKGEFLLVSKYMPNGSLDQFLFHNREPSLTWSKRLGILK 441
Query: 443 GVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGT 502
G+A L YLH E QVVLHRDIK +NV+LD D GKLGDFG+AR +DHG + TT VGT
Sbjct: 442 GIASALKYLHTEATQVVLHRDIKASNVMLDTDFTGKLGDFGMARFHDHGANPTTTGAVGT 501
Query: 503 VGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPG---ELDLL-DWVIDYWQKGD 558
VGY+ PEL G +T TDVYAFG +LEV CGRRPV+P E LL WV D W++ D
Sbjct: 502 VGYMGPELTSMG-ASTKTDVYAFGALILEVTCGRRPVEPNLPIEKQLLVKWVCDCWKRKD 560
Query: 559 VLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGALLPDIPLNSS 618
++ A DP+L G + Q+E+VLKLGL C++ P++RP M +VVQYLD LPD +S
Sbjct: 561 LISARDPKLSGELIP-QIEMVLKLGLLCTNLVPESRPDMVKVVQYLDRQVSLPDFSPDSP 619
Query: 619 VFGVLT 624
G++T
Sbjct: 620 GIGIVT 625
|
|
| TAIR|locus:2119936 AT4G29050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 901 (322.2 bits), Expect = 8.9e-143, Sum P(2) = 8.9e-143
Identities = 186/347 (53%), Positives = 238/347 (68%)
Query: 333 PHRFSYKNLYKATKG----------GSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVS 382
PHRF+YK+LY ATKG G GKVY+G L +S+ +IAVKKV HDS GM++FV+
Sbjct: 329 PHRFAYKDLYIATKGFRNSELLGKGGFGKVYKGTLSTSNMDIAVKKVSHDSRQGMREFVA 388
Query: 383 EIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIK 442
EI ++G+LRH NLV+L GYCRRKGEL LVYD MP GSLDK LY SL+W QRF+IIK
Sbjct: 389 EIATIGRLRHPNLVRLLGYCRRKGELYLVYDCMPKGSLDKFLYHQPEQSLDWSQRFKIIK 448
Query: 443 GVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGT 502
VA GL YLH +W QV++HRDIKPANVLLD + GKLGDFGLA+L +HG D T+NV GT
Sbjct: 449 DVASGLCYLHHQWVQVIIHRDIKPANVLLDDSMNGKLGDFGLAKLCEHGFDPQTSNVAGT 508
Query: 503 VGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPV-----QPGELDLLDWVIDYWQKG 557
GY++PEL R G+ +TS+DV+AFG+ MLE+ CGRRPV P E+ L DWV+D W+
Sbjct: 509 FGYISPELSRTGKASTSSDVFAFGILMLEITCGRRPVLPRASSPSEMVLTDWVLDCWED- 567
Query: 558 DVLDASDPRL--EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGALLPDIPL 615
D+L D R+ + Y+EEQ+ +VLKLGLFCSH RPSM V+Q+LDG A LP+
Sbjct: 568 DILQVVDERVKQDDKYLEEQVALVLKLGLFCSHPVAAVRPSMSSVIQFLDGVAQLPN--- 624
Query: 616 NSSVFGVLTAK-NEAPNNGMASFA-SLVRSDSPHTMSTIDSIITVGR 660
++F ++ A+ N G A SL S T++ + ++ GR
Sbjct: 625 --NLFDIVKARENVGAIEGFGEAAESLAEPCSVATLTFTEPFVSHGR 669
|
|
| TAIR|locus:2085587 AT3G45440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 856 (306.4 bits), Expect = 3.8e-142, Sum P(2) = 3.8e-142
Identities = 170/306 (55%), Positives = 214/306 (69%)
Query: 333 PHRFSYKNLYKAT----------KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVS 382
PHRFSYK+LY AT KGG GKVY+G LPS +IAVK+V HD++ GMKQFV+
Sbjct: 327 PHRFSYKDLYIATNGFNKDGLLGKGGFGKVYKGTLPSK-GQIAVKRVSHDAEEGMKQFVA 385
Query: 383 EIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIK 442
EIVSMG L+H+N+V L GYCRRKGELLLV +YMPNGSLD+ L+++ +P +W +R IIK
Sbjct: 386 EIVSMGNLKHKNMVPLLGYCRRKGELLLVSEYMPNGSLDQYLFNDEKPPFSWRRRLLIIK 445
Query: 443 GVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGT 502
+A L Y+H QVVLHRDIK +NV+LD + G+LGDFG+AR +DHG D TT VGT
Sbjct: 446 DIATALNYMHTGAPQVVLHRDIKASNVMLDTEFNGRLGDFGMARFHDHGKDPATTAAVGT 505
Query: 503 VGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPG----ELDLLDWVIDYWQKGD 558
+GY+APEL G T+TDVY FG F+LEV CGRRPV+PG ++ WV + W+
Sbjct: 506 IGYMAPELATVG-ACTATDVYGFGAFLLEVTCGRRPVEPGLSAERWYIVKWVCECWKMAS 564
Query: 559 VLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGALLPDIPLNSS 618
+L A DPR+ G E++E+VLKLGL C++ PD RPSM +VQYL+G LPDI NS
Sbjct: 565 LLGARDPRMRGEISAEEVEMVLKLGLLCTNGVPDLRPSMEDIVQYLNGSLELPDISPNSP 624
Query: 619 VFGVLT 624
G T
Sbjct: 625 GIGSFT 630
|
|
| TAIR|locus:2133229 LPK1 "lectin-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 918 (328.2 bits), Expect = 5.6e-141, Sum P(2) = 5.6e-141
Identities = 183/310 (59%), Positives = 231/310 (74%)
Query: 334 HRFSYKNLYKATKG----------GSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSE 383
+R +K+LY ATKG G G+VYRGV+P++ EIAVK+V ++S G+K+FV+E
Sbjct: 341 NRLRFKDLYYATKGFKDKDLLGSGGFGRVYRGVMPTTKKEIAVKRVSNESRQGLKEFVAE 400
Query: 384 IVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKG 443
IVS+G++ HRNLV L GYCRR+ ELLLVYDYMPNGSLDK LY +L+W QRF +I G
Sbjct: 401 IVSIGRMSHRNLVPLLGYCRRRDELLLVYDYMPNGSLDKYLYDCPEVTLDWKQRFNVIIG 460
Query: 444 VAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTV 503
VA GL YLHEEWEQVV+HRDIK +NVLLDA+ G+LGDFGLARL DHG+D TT VVGT
Sbjct: 461 VASGLFYLHEEWEQVVIHRDIKASNVLLDAEYNGRLGDFGLARLCDHGSDPQTTRVVGTW 520
Query: 504 GYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPG-ELD----LLDWVIDYWQKGD 558
GYLAP+ +R GR TT+TDV+AFGV +LEVACGRRP++ E D L+D V +W +G+
Sbjct: 521 GYLAPDHVRTGRATTATDVFAFGVLLLEVACGRRPIEIEIESDESVLLVDSVFGFWIEGN 580
Query: 559 VLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGALLPDI-PLNS 617
+LDA+DP L +Y + ++E VLKLGL CSHS+P RP+MRQV+QYL G A LPD+ PL+
Sbjct: 581 ILDATDPNLGSVYDQREVETVLKLGLLCSHSDPQVRPTMRQVLQYLRGDATLPDLSPLDF 640
Query: 618 SVFGVLTAKN 627
G + N
Sbjct: 641 RGSGKMLGMN 650
|
|
| TAIR|locus:2158309 AT5G60320 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 835 (299.0 bits), Expect = 1.2e-140, Sum P(2) = 1.2e-140
Identities = 175/343 (51%), Positives = 226/343 (65%)
Query: 332 SPHRFSYKNLYKAT----------KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFV 381
SPHRFSYK+LYKAT KGG G+VYRG LP +IAVK+VCHD+ GMKQFV
Sbjct: 332 SPHRFSYKSLYKATNRFDKDGRLGKGGFGEVYRGNLPHV-GDIAVKRVCHDAKQGMKQFV 390
Query: 382 SEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRII 441
+E+V+MG L+HRNLV L GYCRRKGELLLV +YM NGSLD+ L+ +P+L+W QR I+
Sbjct: 391 AEVVTMGSLKHRNLVPLLGYCRRKGELLLVSEYMSNGSLDQYLFHREKPALSWSQRLVIL 450
Query: 442 KGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVG 501
K +A L YLH QVVLHRDIK +NV+LD++ G+LGDFG+AR D+G+ + T VG
Sbjct: 451 KDIASALSYLHTGANQVVLHRDIKASNVMLDSEFNGRLGDFGMARFEDYGDSVPVTAAVG 510
Query: 502 TVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPG----ELDLLDWVIDYWQKG 557
T+GY+APEL G +T TDVYAFGV MLEV CGRRP+ P + L+ WV D W++
Sbjct: 511 TMGYMAPELTTMGT-STRTDVYAFGVLMLEVTCGRRPLDPKIPSEKRHLIKWVCDCWRRD 569
Query: 558 DVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGALLPDIPLNS 617
++DA D RL G Y E+ +VLKLGL C++ ++RP+M QV+QY++ LP+ S
Sbjct: 570 SIVDAIDTRLGGQYSVEETVMVLKLGLICTNIVAESRPTMEQVIQYINQNLPLPNFSPGS 629
Query: 618 SVFGVLT-AKNEAPNNGMASFASLVRSDSPHTMSTIDSIITVG 659
GV T E+ N +S A + S H + IT G
Sbjct: 630 LGIGVSTPVLLESVFNSRSSLAPSISPPSSHNSMFVTHTITYG 672
|
|
| TAIR|locus:2144045 LecRK-I.9 "lectin receptor kinase I.9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 840 (300.8 bits), Expect = 3.1e-140, Sum P(2) = 3.1e-140
Identities = 165/293 (56%), Positives = 216/293 (73%)
Query: 334 HRFSYKNLYKATKG----------GSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSE 383
HRFSY++L+KATKG G G+VYRG LP EIAVK+V H+ D G+KQFV+E
Sbjct: 330 HRFSYRSLFKATKGFSKDEFLGKGGFGEVYRGNLPQGR-EIAVKRVSHNGDEGVKQFVAE 388
Query: 384 IVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKG 443
+VSM L+HRNLV L GYCRRK ELLLV +YMPNGSLD+ L+ + +P L+W QR ++KG
Sbjct: 389 VVSMRCLKHRNLVPLFGYCRRKRELLLVSEYMPNGSLDEHLFDDQKPVLSWSQRLVVVKG 448
Query: 444 VAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTV 503
+A L YLH +QVVLHRD+K +N++LDA+ G+LGDFG+AR ++HG + TT VGTV
Sbjct: 449 IASALWYLHTGADQVVLHRDVKASNIMLDAEFHGRLGDFGMARFHEHGGNAATTAAVGTV 508
Query: 504 GYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPG----ELDLLDWVIDYWQKGDV 559
GY+APEL+ G +T TDVYAFGVFMLEV CGRRPV+P + ++ WV + W+K +
Sbjct: 509 GYMAPELITMG-ASTGTDVYAFGVFMLEVTCGRRPVEPQLQVEKRHMIKWVCECWKKDSL 567
Query: 560 LDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGALLPD 612
LDA+DPRL G +V E++E+V+KLGL CS+ P++RP+M QVV YL+ LPD
Sbjct: 568 LDATDPRLGGKFVAEEVEMVMKLGLLCSNIVPESRPTMEQVVLYLNKNLPLPD 620
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9M345 | LRK42_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5022 | 0.9666 | 0.9423 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.IX.4097.1 | hypothetical protein (607 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 660 | |||
| pfam00139 | 231 | pfam00139, Lectin_legB, Legume lectin domain | 1e-100 | |
| cd06899 | 236 | cd06899, lectin_legume_LecRK_Arcelin_ConA, legume | 2e-95 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-51 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-48 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-47 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-46 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-46 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-45 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-43 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-36 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-32 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-32 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-30 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-30 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-28 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-27 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-26 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-26 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-25 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-25 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-25 | |
| cd01951 | 223 | cd01951, lectin_L-type, legume lectins | 8e-25 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-24 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-24 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-24 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-23 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-22 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-22 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-22 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-22 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-22 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-22 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 9e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-21 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-20 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-20 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-20 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-20 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-20 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-20 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-20 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-19 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-19 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-19 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-18 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-18 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-18 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-18 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-18 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 9e-18 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-17 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-17 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-17 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-17 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-17 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 9e-17 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-17 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 9e-17 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-16 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-16 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-16 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-16 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-16 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-15 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-15 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-15 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-15 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-15 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-15 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-15 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-15 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-14 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-14 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-14 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-14 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-14 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-14 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-14 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-13 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-13 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-13 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 9e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-12 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-12 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-12 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-12 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-11 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-11 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-11 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 8e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-10 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 8e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 9e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 9e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 8e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 9e-06 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-04 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.002 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 0.002 |
| >gnl|CDD|215744 pfam00139, Lectin_legB, Legume lectin domain | Back alignment and domain information |
|---|
Score = 305 bits (784), Expect = e-100
Identities = 118/241 (48%), Positives = 151/241 (62%), Gaps = 13/241 (5%)
Query: 26 EENQFIHHGFEGSK-LKLDGLAKIHPNGLLQLTNTSERISGHAFYPFPFKF-NSSSSQSL 83
F ++GF L L G A + PNGLLQLTN + +G A Y P + +SS+ +
Sbjct: 1 STVSFNYNGFSNVSNLTLQGDATVLPNGLLQLTNVTNNSAGRALYSKPIRLWDSSTGKVA 60
Query: 84 SFSTSFVFAMFPKLPNY-GGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAI 142
SFSTSFVFA+ + GG G+AFF++PS A +G +LG+FN SNNG +NHI A+
Sbjct: 61 SFSTSFVFAIKNIPKSTNGGDGLAFFLAPSGTQPGASSGGYLGLFNSSNNGNSSNHIVAV 120
Query: 143 ELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPIQIWIDY 202
E DT +PEFNDID NHVGIDVN + S S SA F L L SGKPIQ+WIDY
Sbjct: 121 EFDTFLNPEFNDIDDNHVGIDVNSIISVASESAS--------FVPLDLNSGKPIQVWIDY 172
Query: 203 NGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTRVSDYYILGWSF 262
+G K ++VTLA KP RPLLS S+DLS +L + +YVG SA+TG +Y+L WSF
Sbjct: 173 DGSSKRLSVTLA--YPNKPKRPLLSASVDLSTVLPEWVYVGFSASTGGATESHYVLSWSF 230
Query: 263 N 263
+
Sbjct: 231 S 231
|
Length = 231 |
| >gnl|CDD|173887 cd06899, lectin_legume_LecRK_Arcelin_ConA, legume lectins, lectin-like receptor kinases, arcelin, concanavalinA, and alpha-amylase inhibitor | Back alignment and domain information |
|---|
Score = 293 bits (752), Expect = 2e-95
Identities = 113/243 (46%), Positives = 150/243 (61%), Gaps = 13/243 (5%)
Query: 29 QFIHHGFEG--SKLKLDGLAKIHPNGLLQLTNTSERIS--GHAFYPFPFKF-NSSSSQSL 83
F +GF S L L G A I NG LQLTN + S G A Y P + +S++ +
Sbjct: 2 SFNFNGFSSDQSNLTLQGDATISSNGALQLTNDTSPASSVGRALYSKPVRLWDSTTGKVA 61
Query: 84 SFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIE 143
SFSTSF F++ P P+ GG G+AFF++P+ A +G +LG+FN SNNG +NHI A+E
Sbjct: 62 SFSTSFSFSITPPNPSLGGDGLAFFLAPTDSLPPASSGGYLGLFNSSNNGNSSNHIVAVE 121
Query: 144 LDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPIQIWIDYN 203
DT Q+PEF D D NHVGIDVN L S A Y+ D + L+SGKP+Q WIDY+
Sbjct: 122 FDTFQNPEFGDPDDNHVGIDVNSL---VSVKAGYWDD-----DGGKLKSGKPMQAWIDYD 173
Query: 204 GQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTRVSDYYILGWSFN 263
K ++VTLA KP +PLLS +DLS++L + +YVG SA+TG +YIL WSF+
Sbjct: 174 SSSKRLSVTLAYSGVAKPKKPLLSYPVDLSKVLPEEVYVGFSASTGLLTELHYILSWSFS 233
Query: 264 KSG 266
+G
Sbjct: 234 SNG 236
|
This alignment model includes the legume lectins (also known as agglutinins), the arcelin (also known as phytohemagglutinin-L) family of lectin-like defense proteins, the LecRK family of lectin-like receptor kinases, concanavalinA (ConA), and an alpha-amylase inhibitor. Arcelin is a major seed glycoprotein discovered in kidney beans (Phaseolus vulgaris) that has insecticidal properties and protects the seeds from predation by larvae of various bruchids. Arcelin is devoid of monosaccharide binding properties and lacks a key metal-binding loop that is present in other members of this family. Phytohaemagglutinin (PHA) is a lectin found in plants, especially beans, that affects cell metabolism by inducing mitosis and by altering the permeability of the cell membrane to various proteins. PHA agglutinates most mammalian red blood cell types by binding glycans on the cell surface. Medically, PHA is used as a mitogen to trigger cell division in T-lymphocytes and to activate latent HIV-1 from human peripheral lymphocytes. Plant L-type lectins are primarily found in the seeds of leguminous plants where they constitute about 10% of the total soluble protein of the seed extracts. They are synthesized during seed development several weeks after flowering and transported to the vacuole where they become condensed into specialized vesicles called protein bodies. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. Length = 236 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 2e-51
Identities = 72/260 (27%), Positives = 115/260 (44%), Gaps = 15/260 (5%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMK--QFVSEIVSMGKLRHRNLVQLRGYCR 403
G G VY+ + +AVK + S+ K EI + +L H N+V+L
Sbjct: 9 SGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFE 68
Query: 404 RKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRD 463
K L LV +Y G L L L+ + +I + GL YLH ++HRD
Sbjct: 69 DKDHLYLVMEYCEGGDLFDYLSRGGP--LSEDEAKKIALQILRGLEYLHSNG---IIHRD 123
Query: 464 IKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRG-TTSTDV 522
+KP N+LLD + K+ DFGLA+ + T VGT Y+APE+L G G DV
Sbjct: 124 LKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDV 182
Query: 523 YAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKL 582
++ GV + E+ G+ P + +I + + E+ + ++K
Sbjct: 183 WSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPL---EFDEPKWSSGSEEAKDLIK- 238
Query: 583 GLFCSHSNPDTRPSMRQVVQ 602
C + +P RP+ +++Q
Sbjct: 239 --KCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 8e-48
Identities = 78/258 (30%), Positives = 125/258 (48%), Gaps = 17/258 (6%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGM-KQFVSEIVSMGKLRHRNLVQLRGYCRR 404
+G GKVY + +A+K + ++ + EI + KL+H N+V+L
Sbjct: 9 EGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFED 68
Query: 405 KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDI 464
+ +L LV +Y G L +L R S + + ++ + L YLH + ++HRD+
Sbjct: 69 EDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARF--YLRQILSALEYLHSKG---IVHRDL 123
Query: 465 KPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYA 524
KP N+LLD D KL DFGLAR D G L T VGT Y+APE+L + D+++
Sbjct: 124 KPENILLDEDGHVKLADFGLARQLDPGEKLTT--FVGTPEYMAPEVLLGKGYGKAVDIWS 181
Query: 525 FGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGL 584
GV + E+ G+ P PG+ LL + ++K P E E +++ KL L
Sbjct: 182 LGVILYELLTGKPPF-PGDDQLL----ELFKKIGKPKPPFPPPEWDISPEAKDLIRKL-L 235
Query: 585 FCSHSNPDTRPSMRQVVQ 602
+P+ R + + +Q
Sbjct: 236 ---VKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 7e-47
Identities = 66/189 (34%), Positives = 102/189 (53%), Gaps = 8/189 (4%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKV-CHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR 404
+GG G VY + ++A+K + DS +++ + EI + KL H N+V+L G
Sbjct: 3 EGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED 62
Query: 405 KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDI 464
+ L LV +Y GSL +L N L+ + RI+ + GL YLH ++HRD+
Sbjct: 63 ENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLH---SNGIIHRDL 118
Query: 465 KPANVLLDADLEG-KLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRG-TTSTDV 522
KP N+LLD+D KL DFGL++L L T +VGT Y+APE+L + +D+
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT-IVGTPAYMAPEVLLGKGYYSEKSDI 177
Query: 523 YAFGVFMLE 531
++ GV + E
Sbjct: 178 WSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 2e-46
Identities = 74/261 (28%), Positives = 127/261 (48%), Gaps = 21/261 (8%)
Query: 350 GKVYRGVL----PSSHAEIAVKKVCHDSD-HGMKQFVSEIVSMGKLRHRNLVQLRGYCRR 404
G+VY+G L E+AVK + D+ +++F+ E M KL H N+V+L G C
Sbjct: 13 GEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTE 72
Query: 405 KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDI 464
+ L++V +YMP G L L N L+ +A G+ YL + + HRD+
Sbjct: 73 EEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES--KNFI-HRDL 129
Query: 465 KPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYA 524
N L+ +L K+ DFGL+R + + ++APE L+ G+ T+ +DV++
Sbjct: 130 AARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWS 189
Query: 525 FGVFMLEVA-CGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLG 583
FGV + E+ G P + + V++Y +KG L +Y +++L+
Sbjct: 190 FGVLLWEIFTLGEEP--YPGMSNAE-VLEYLKKGYRLPKPPNCPPELY-----KLMLQ-- 239
Query: 584 LFCSHSNPDTRPSMRQVVQYL 604
C +P+ RP+ ++V+ L
Sbjct: 240 --CWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 4e-46
Identities = 73/261 (27%), Positives = 126/261 (48%), Gaps = 22/261 (8%)
Query: 350 GKVYRGVL----PSSHAEIAVKKVCHDSD-HGMKQFVSEIVSMGKLRHRNLVQLRGYCRR 404
G+VY+G L E+AVK + D+ +++F+ E M KL H N+V+L G C
Sbjct: 13 GEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTE 72
Query: 405 KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDI 464
+ L +V +YM G L L RP L+ +A G+ YL + + HRD+
Sbjct: 73 EEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEYLES--KNFI-HRDL 128
Query: 465 KPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYA 524
N L+ +L K+ DFGL+R + + ++APE L+ G+ T+ +DV++
Sbjct: 129 AARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWS 188
Query: 525 FGVFMLEVA-CGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLG 583
FGV + E+ G +P + + V++Y + G L +Y +++L+
Sbjct: 189 FGVLLWEIFTLGEQP--YPGMSNEE-VLEYLKNGYRLPQPPNCPPELY-----DLMLQ-- 238
Query: 584 LFCSHSNPDTRPSMRQVVQYL 604
C +P+ RP+ ++V+ L
Sbjct: 239 --CWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 4e-45
Identities = 81/272 (29%), Positives = 130/272 (47%), Gaps = 34/272 (12%)
Query: 350 GKVYRGVL---PSSHAEIAVKKVCHDSDHG-MKQFVSEIVSMGKLRHRNLVQLRGYCRRK 405
G+VY+G L E+AVK + D+ K F+ E M KL H N+V+L G C +
Sbjct: 9 GEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEE 68
Query: 406 GELLLVYDYMPNGSLDKIL-------YSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQV 458
L LV +YM G L L S + +L+ +A G+ YL +
Sbjct: 69 EPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKK 125
Query: 459 VLHRDIKPANVLLDADLEGKLGDFGLAR-LYDHGNDLHTTNVVGTVGYLAPELLRNGRGT 517
+HRD+ N L+ DL K+ DFGL+R +YD T + ++APE L++G T
Sbjct: 126 FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFT 185
Query: 518 TSTDVYAFGVFMLEVAC-GRRP---VQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573
+ +DV++FGV + E+ G P + E V++Y +KG L + + +Y
Sbjct: 186 SKSDVWSFGVLLWEIFTLGATPYPGLSNEE------VLEYLRKGYRLPKPEYCPDELY-- 237
Query: 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
E++L C +P+ RP+ ++V+ L+
Sbjct: 238 ---ELMLS----CWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 154 bits (393), Expect = 6e-43
Identities = 71/262 (27%), Positives = 130/262 (49%), Gaps = 23/262 (8%)
Query: 350 GKVYRGVL----PSSHAEIAVKKVCHDSDHGMKQ-FVSEIVSMGKLRHRNLVQLRGYCRR 404
G+VY+G L + ++AVK + + ++ F+ E M KL H N+V+L G C +
Sbjct: 13 GEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQ 72
Query: 405 KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDI 464
L +V +YMP G L L + L ++ +A G+ YL + +HRD+
Sbjct: 73 GEPLYIVTEYMPGGDLLDFLRKH-GEKLTLKDLLQMALQIAKGMEYLE---SKNFVHRDL 128
Query: 465 KPANVLLDADLEGKLGDFGLAR-LYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVY 523
N L+ +L K+ DFGL+R +Y+ + ++APE L++G+ T+ +DV+
Sbjct: 129 AARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVW 188
Query: 524 AFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKL 582
+FGV + E+ G +P + + V++ + G L + + +Y E++L+
Sbjct: 189 SFGVLLWEIFTLGEQPYP--GMSNEE-VLELLEDGYRLPRPENCPDELY-----ELMLQ- 239
Query: 583 GLFCSHSNPDTRPSMRQVVQYL 604
C +P+ RP+ ++V+ L
Sbjct: 240 ---CWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 2e-36
Identities = 61/200 (30%), Positives = 101/200 (50%), Gaps = 14/200 (7%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKV--CHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCR 403
+G G VY + + +AVK V DS+ ++ EI + L+H N+V+ G R
Sbjct: 10 RGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSER 69
Query: 404 --RKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRF--RIIKGVAFGLLYLHEEWEQVV 459
K L + +Y+ GSL +L + +++ +I++G L YLH +
Sbjct: 70 DEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEG----LAYLHS---NGI 122
Query: 460 LHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTN-VVGTVGYLAPELLRNGRGTT 518
+HRDIK AN+L+D+D KL DFG A+ T V GT ++APE++R
Sbjct: 123 VHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGR 182
Query: 519 STDVYAFGVFMLEVACGRRP 538
+ D+++ G ++E+A G+ P
Sbjct: 183 AADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 66/201 (32%), Positives = 108/201 (53%), Gaps = 6/201 (2%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQ 397
++ L K KGG G+VY+ + E+A+K + +S ++ ++EI + K +H N+V+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 398 LRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQ 457
G +K EL +V ++ GSL +L S + L Q + K + GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT-LTESQIAYVCKELLKGLEYLH---SN 117
Query: 458 VVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGT 517
++HRDIK AN+LL +D E KL DFGL+ +T VGT ++APE++
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM--VGTPYWMAPEVINGKPYD 175
Query: 518 TSTDVYAFGVFMLEVACGRRP 538
D+++ G+ +E+A G+ P
Sbjct: 176 YKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 8e-32
Identities = 69/263 (26%), Positives = 124/263 (47%), Gaps = 24/263 (9%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKK--VCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCR 403
+G SG VY+ + A+KK V D + KQ + E+ ++ +V+ G
Sbjct: 11 QGSSGVVYKVRHKPTGKIYALKKIHVDGDEEF-RKQLLRELKTLRSCESPYVVKCYGAFY 69
Query: 404 RKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRF--RIIKGVAFGLLYLHEEWEQVVLH 461
++GE+ +V +YM GSL +L + I + + GL YLH + + H
Sbjct: 70 KEGEISIVLEYMDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKRHII--H 123
Query: 462 RDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTD 521
RDIKP+N+L+++ E K+ DFG++++ ++ D T VGTV Y++PE ++ + + D
Sbjct: 124 RDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF-VGTVTYMSPERIQGESYSYAAD 182
Query: 522 VYAFGVFMLEVACGRRPVQPGELDLLDWV--IDYWQKGDVLDASDPRLEGIYVEEQMEIV 579
+++ G+ +LE A G+ P P + + + D P L +
Sbjct: 183 IWSLGLTLLECALGKFPFLP--PGQPSFFELMQA-----ICDGPPPSLPAEEFSPEFRDF 235
Query: 580 LKLGLFCSHSNPDTRPSMRQVVQ 602
+ C +P RPS +++Q
Sbjct: 236 ISA---CLQKDPKKRPSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 6e-30
Identities = 83/264 (31%), Positives = 124/264 (46%), Gaps = 31/264 (11%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHG--MKQFVSEIVSMGKLRHRNLVQLRGYCR 403
KG G V G ++AVK + D + F++E M LRH NLVQL G
Sbjct: 16 KGEFGDVMLGDYRGQ--KVAVKCL---KDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 404 RKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRD 463
+ L +V +YM GSL L S R + Q+ V G+ YL E+ +HRD
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRD 127
Query: 464 IKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGT--VGYLAPELLRNGRGTTSTD 521
+ NVL+ DL K+ DFGLA+ G D G V + APE LR + +T +D
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAKEASQGQD------SGKLPVKWTAPEALREKKFSTKSD 181
Query: 522 VYAFGVFMLEV-ACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVL 580
V++FG+ + E+ + GR P P L V+ + +KG ++A + +Y
Sbjct: 182 VWSFGILLWEIYSFGRVPY-PRI--PLKDVVPHVEKGYRMEAPEGCPPEVY--------- 229
Query: 581 KLGLFCSHSNPDTRPSMRQVVQYL 604
K+ C +P RP+ +Q+ + L
Sbjct: 230 KVMKDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 6e-30
Identities = 81/277 (29%), Positives = 131/277 (47%), Gaps = 36/277 (12%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKK---VCHDSDHGMKQFVSEIVSMGKLRHRN 394
Y+ + + KG GKVY V S ++ V K + + S+ + ++E+ + KL H N
Sbjct: 2 YEIIKQIGKGSFGKVYL-VRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 395 LVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPS--------LNWF-QRFRIIKGVA 445
+++ KG+L +V +Y G L + + + L+WF Q +
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ-------LC 113
Query: 446 FGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGY 505
L YLH + +LHRDIKP N+ L ++ KLGDFG++++ DL T VVGT Y
Sbjct: 114 LALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT-VVGTPYY 169
Query: 506 LAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDP 565
L+PEL +N +D+++ G + E+ + P + L L I KG P
Sbjct: 170 LSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKI---LKGQY-----P 221
Query: 566 RLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602
+ Y E +V L L +P+ RPS+ Q++Q
Sbjct: 222 PIPSQYSSELRNLVSSL-L---QKDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 70/219 (31%), Positives = 116/219 (52%), Gaps = 18/219 (8%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDH-GMKQ-FVSEIVSMGKLRHRNL 395
Y+ L K +G G VY+ + +A+KK+ D++ G+ + EI + +L+H N+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 396 VQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRP-SLNWFQR--FRIIKGVAFGLLYLH 452
V+L + +L LV++Y L K L P S N + +++++G+A Y H
Sbjct: 61 VKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLA----YCH 115
Query: 453 EEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLR 512
+LHRD+KP N+L++ D KL DFGLAR + +T VV T+ Y APE+L
Sbjct: 116 SHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILL 171
Query: 513 NGRG-TTSTDVYAFGVFMLEVACGRRPVQPG--ELDLLD 548
+ +T+ D+++ G E+ G +P+ PG E+D L
Sbjct: 172 GSKHYSTAVDIWSVGCIFAEMITG-KPLFPGDSEIDQLF 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 62/196 (31%), Positives = 103/196 (52%), Gaps = 10/196 (5%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKV--CHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCR 403
+G G VY+G+ + +A+K++ + +K + EI + L+H N+V+ G
Sbjct: 10 RGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE 69
Query: 404 RKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRD 463
L ++ +Y NGSL +I+ + + + V GL YLHE Q V+HRD
Sbjct: 70 TSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVY--VYQVLQGLAYLHE---QGVIHRD 124
Query: 464 IKPANVLLDADLEGKLGDFGLA-RLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDV 522
IK AN+L D KL DFG+A +L D D + VVGT ++APE++ +T++D+
Sbjct: 125 IKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEVIEMSGASTASDI 182
Query: 523 YAFGVFMLEVACGRRP 538
++ G ++E+ G P
Sbjct: 183 WSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 78/269 (28%), Positives = 132/269 (49%), Gaps = 36/269 (13%)
Query: 350 GKVYRGVL--PSSHAE-IAVKKVCHDSDHGMK-QFVSEIVSMGKLRHRNLVQLRGYCRRK 405
G+V RG L P +A+K + S + F++E MG+ H N+++L G +
Sbjct: 18 GEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS 77
Query: 406 GELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIK 465
++++ +YM NGSLDK L Q +++G+A G+ YL E +HRD+
Sbjct: 78 RPVMIITEYMENGSLDKFL-RENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLA 133
Query: 466 PANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVG---TVGYLAPELLRNGRGTTSTDV 522
N+L++++L K+ DFGL+R + +TT G + + APE + + T+++DV
Sbjct: 134 ARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK--GGKIPIRWTAPEAIAYRKFTSASDV 191
Query: 523 YAFGVFMLEV-ACGRRPVQPGELDLLDWVIDYWQ--KGDVLDASDPRLEGIYVEEQM--- 576
++FG+ M EV + G RP YW DV+ A + +G + M
Sbjct: 192 WSFGIVMWEVMSYGERP--------------YWDMSNQDVIKAVE---DGYRLPPPMDCP 234
Query: 577 EIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
+ +L L C + + RP+ Q+V LD
Sbjct: 235 SALYQLMLDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 9e-28
Identities = 74/283 (26%), Positives = 128/283 (45%), Gaps = 24/283 (8%)
Query: 337 SYKNLYKATKGGSGKVYRGVLPSSHA-EIAVKKVCHDSDHGMKQFVSEIVSMGKLRH-RN 394
SY+ L K +G G+VY A ++ KK+ S +++F+ EI + L H N
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKE-VERFLREIQILASLNHPPN 59
Query: 395 LVQLRGYCRRKGELLLVYDYMPNGSLDKILYSN-TRPSLNWFQRFRIIKGVAFGLLYLHE 453
+V+L + + +G L LV +Y+ GSL+ +L + L+ + I+ + L YLH
Sbjct: 60 IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119
Query: 454 EWEQVVLHRDIKPANVLLDADL-EGKLGDFGLARLYDHGND-----LHTTNVVGTVGYLA 507
+ ++HRDIKP N+LLD D KL DFGLA+L + VGT GY+A
Sbjct: 120 ---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 508 PELLR---NGRGTTSTDVYAFGVFMLEVACGRRPVQ-PGELDLLDWVIDYWQKG---DVL 560
PE+L ++S+D+++ G+ + E+ G P + + + +
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236
Query: 561 DASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603
P + + +++ K +P R S + +
Sbjct: 237 SPLSPSNPELISKAASDLLKK----LLAKDPKNRLSSSSDLSH 275
|
Length = 384 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 73/277 (26%), Positives = 123/277 (44%), Gaps = 27/277 (9%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNL 395
Y+ L KG G V + S + K++ + ++ +Q VSE+ + +L+H N+
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 396 VQLRGYCRR-----KGELLLVYDYMPNGSLDKIL--YSNTRPSLNWFQRFRIIKGVAFGL 448
V+ Y R L +V +Y G L +++ R + +RI+ + L
Sbjct: 62 VR---YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118
Query: 449 LYLH--EEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYL 506
H + VLHRD+KPAN+ LDA+ KLGDFGLA++ H + T VGT Y+
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT-YVGTPYYM 177
Query: 507 APELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPR 566
+PE L + +D+++ G + E+ P L ++G R
Sbjct: 178 SPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQL---ASKIKEGKF-----RR 229
Query: 567 LEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603
+ Y E E++ + +PD RPS +++Q
Sbjct: 230 IPYRYSSELNEVI----KSMLNVDPDKRPSTEELLQL 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 73/233 (31%), Positives = 116/233 (49%), Gaps = 35/233 (15%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQF----VSEIVSMGKLRHR 393
Y+ + + +G G+VY+ + +A+KK+ ++ + F + EI + KLRH
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKI--RMENEKEGFPITAIREIKLLQKLRHP 58
Query: 394 NLVQLRGYC--RRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRI--IKGVAF--- 446
N+V+L+ + KG + +V++YM + L +L S +F IK
Sbjct: 59 NIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPE-------VKFTESQIKCYMKQLL 110
Query: 447 -GLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGY 505
GL YLH +LHRDIK +N+L++ D KL DFGLAR Y N TN V T+ Y
Sbjct: 111 EGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWY 167
Query: 506 LAPELLRNGRGTTS----TDVYAFGVFMLEVACGRRPVQPG--ELDLLDWVID 552
PELL G T D+++ G + E+ G +P+ G EL+ L+ + +
Sbjct: 168 RPPELL---LGATRYGPEVDMWSVGCILAELFLG-KPIFQGSTELEQLEKIFE 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 67/201 (33%), Positives = 102/201 (50%), Gaps = 6/201 (2%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQ 397
YKNL K +G SG+VY+ ++ E+A+KK+ + + ++EI+ M +H N+V
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQN-KELIINEILIMKDCKHPNIVD 79
Query: 398 LRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQ 457
EL +V +YM GSL I+ +N Q + + V GL YLH Q
Sbjct: 80 YYDSYLVGDELWVVMEYMDGGSLTDIIT-QNFVRMNEPQIAYVCREVLQGLEYLHS---Q 135
Query: 458 VVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGT 517
V+HRDIK N+LL D KL DFG A + VVGT ++APE+++
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS-VVGTPYWMAPEVIKRKDYG 194
Query: 518 TSTDVYAFGVFMLEVACGRRP 538
D+++ G+ +E+A G P
Sbjct: 195 PKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 73/223 (32%), Positives = 118/223 (52%), Gaps = 18/223 (8%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVC--HDSDHGMKQFVSEIVSMGKLRHRNL 395
Y+ L K +G G VY+ + +A+KK+ +S+ K + EI + +L H N+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 396 VQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRP---SLNWFQRFRIIKGVAFGLLYLH 452
++L R KG+L LV+++M + L K++ R SL +++++G+AF H
Sbjct: 61 IKLLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAF----CH 115
Query: 453 EEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLR 512
+LHRD+KP N+L++ + KL DFGLAR + +T VV T Y APELL
Sbjct: 116 SHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-TRWYRAPELLL 171
Query: 513 NGRG-TTSTDVYAFGVFMLEVACGRRPVQPG--ELDLLDWVID 552
+G +T D+++ G E+ RRP+ PG E+D L +
Sbjct: 172 GDKGYSTPVDIWSVGCIFAELL-SRRPLFPGKSEIDQLFKIFR 213
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 76/258 (29%), Positives = 132/258 (51%), Gaps = 19/258 (7%)
Query: 346 KGGSGKVYRGV-LPSSHAEIAVKKVCHDSDHGM-KQFVSEIVSMGKLRHRNLVQLRGYCR 403
G SG V + + P+ +AVK + + + + KQ + E+ + K +V G
Sbjct: 11 AGNSGVVSKVLHRPTGKI-MAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFY 69
Query: 404 RKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRD 463
G++ + +YM GSLDKI + + +I V GL YLHE+ + ++HRD
Sbjct: 70 NNGDISICMEYMDGGSLDKI-LKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRD 126
Query: 464 IKPANVLLDADLEGKLGDFGLA-RLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDV 522
+KP+N+L+++ + KL DFG++ +L N L T VGT Y+APE ++ + +D+
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVSGQLV---NSLAKTF-VGTSSYMAPERIQGNDYSVKSDI 182
Query: 523 YAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL-EGIYVEEQMEIVLK 581
++ G+ ++E+A GR P P E D D + + Q +++ PRL G + + + V
Sbjct: 183 WSLGLSLIELATGRFPY-PPENDPPDGIFELLQY--IVNEPPPRLPSGKFSPDFQDFVNL 239
Query: 582 LGLFCSHSNPDTRPSMRQ 599
C +P RPS ++
Sbjct: 240 ----CLIKDPRERPSYKE 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 62/202 (30%), Positives = 110/202 (54%), Gaps = 17/202 (8%)
Query: 347 GGSGKVYRGVLPSSHAEIAVKKV-CHDSDHGM-KQFVSEIVSMGKLRHRNLVQLRGYCRR 404
G GKVY V + +AVK++ D+D K+ E+ + L+H NLV+ G
Sbjct: 11 GTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH 70
Query: 405 KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRF--RIIKGVAFGLLYLHEEWEQVVLHR 462
+ ++ + +Y G+L+++L + + + ++++G+A YLH ++HR
Sbjct: 71 REKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLA----YLHS---HGIVHR 123
Query: 463 DIKPANVLLDADLEGKLGDFGLA-RLYDHGNDLHTT--NVVGTVGYLAPELLRNGRGT-- 517
DIKPAN+ LD + KLGDFG A +L ++ + ++ GT Y+APE++ G+G
Sbjct: 124 DIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGH 183
Query: 518 -TSTDVYAFGVFMLEVACGRRP 538
+ D+++ G +LE+A G+RP
Sbjct: 184 GRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 83/297 (27%), Positives = 132/297 (44%), Gaps = 47/297 (15%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVK--KVCHDSDHGMKQFVSEIVSMGKLRHRNL 395
Y+ L +G G V + ++ +A+K K D + K + E+ + +LRH N+
Sbjct: 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENI 62
Query: 396 VQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQR--FRIIKGVAFGLLYLHE 453
V L+ RRKG L LV++Y+ L+ + S + + +++++ +A Y H
Sbjct: 63 VNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIA----YCHS 118
Query: 454 EWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRN 513
++HRDIKP N+L+ KL DFG AR T+ V T Y APELL
Sbjct: 119 ---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELL-- 173
Query: 514 GRGTTS----TDVYAFGVFMLEVACGRRPVQPG--ELDLLDWVIDYWQK--GDVLDA--- 562
G T+ DV+A G M E+ G P+ PG ++D L ++I QK G + +
Sbjct: 174 -VGDTNYGKPVDVWAIGCIMAELLDG-EPLFPGDSDIDQL-YLI---QKCLGPLPPSHQE 227
Query: 563 ---SDPRLEG-----IYVEEQME---------IVLKLGLFCSHSNPDTRPSMRQVVQ 602
S+PR G E +E L C +P R + +++Q
Sbjct: 228 LFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173886 cd01951, lectin_L-type, legume lectins | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 8e-25
Identities = 57/216 (26%), Positives = 90/216 (41%), Gaps = 22/216 (10%)
Query: 51 NGLLQLTNTSERISGHAFYPFPFKFNSSSSQSLSFSTSFVFAMFPKLPNYGGHGMAFFIS 110
+G+L+LT + +G A+Y P S F+T+F F + K N G G+AF +
Sbjct: 28 SGVLRLTPDTGNQAGSAWYKTPI------DLSKDFTTTFKFYLGTKGTN-GADGIAFVLQ 80
Query: 111 PSTDFSEAVAGS--HLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQ 168
+ G LG + A+E DT ++ + ND +GNH+ IDVNG
Sbjct: 81 NDPAGALGGGGGGGGLGY-------GGIGNSVAVEFDTYKNDDNNDPNGNHISIDVNG-- 131
Query: 169 SNESASARYFSDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLST 228
N + +A S G + I Y+ + V L + ++
Sbjct: 132 -NGNNTALATSLGSASL-PNGTGLGNEHTVRITYDPTTNTLTVYLDNGST--LTSLDITI 187
Query: 229 SIDLSQILQDSMYVGLSAATGTRVSDYYILGWSFNK 264
+DL Q+ Y G +A+TG + + IL WSF
Sbjct: 188 PVDLIQLGPTKAYFGFTASTGGLTNLHDILNWSFTS 223
|
The L-type (legume-type) lectins are a highly diverse family of carbohydrate binding proteins that generally display no enzymatic activity toward the sugars they bind. This family includes arcelin, concanavalinA, the lectin-like receptor kinases, the ERGIC-53/VIP36/EMP46 type1 transmembrane proteins, and an alpha-amylase inhibitor. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. Length = 223 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 82/282 (29%), Positives = 135/282 (47%), Gaps = 25/282 (8%)
Query: 327 WEKEYSPHRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVS 386
WE E + + K+ K G G+VY GV +AVK + D+ +++F+ E
Sbjct: 1 WEMERT--DITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAV 55
Query: 387 MGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAF 446
M +++H NLVQL G C R+ ++ ++M G+L L R +N + ++
Sbjct: 56 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 115
Query: 447 GLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGT--VG 504
+ YL ++ +HRD+ N L+ + K+ DFGL+RL D +T + +
Sbjct: 116 AMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPIK 170
Query: 505 YLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDAS 563
+ APE L + + +DV+AFGV + E+A G P PG +DL V + +KG ++
Sbjct: 171 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY-PG-IDLSQ-VYELLEKGYRME-- 225
Query: 564 DPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
R EG + V +L C NP RPS ++ Q +
Sbjct: 226 --RPEGCPPK-----VYELMRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 78/271 (28%), Positives = 135/271 (49%), Gaps = 33/271 (12%)
Query: 347 GGSGKVYRGVLP-SSHAEIAVKKVCHDSDHGMKQ---FVSEIVSMGKLRHRNLVQLRGYC 402
G G+V+RG+L E+AV + KQ F+SE MG+ H N+++L G
Sbjct: 16 GEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVV 75
Query: 403 RRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHR 462
+ +++ +YM NG+LDK L + + +Q +++G+A G+ YL + +HR
Sbjct: 76 TKFKPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLS---DMNYVHR 131
Query: 463 DIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVG--YLAPELLRNGRGTTST 520
D+ N+L++++LE K+ DFGL+R+ + + T G + + APE + + T+++
Sbjct: 132 DLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSAS 191
Query: 521 DVYAFGVFMLEV-ACGRRPVQPGELDLLDWVIDYWQKG--DVLDASDPRLEGIYVEEQME 577
DV++FG+ M EV + G RP YW +V+ A + +G + M+
Sbjct: 192 DVWSFGIVMWEVMSFGERP--------------YWDMSNHEVMKAIN---DGFRLPAPMD 234
Query: 578 I---VLKLGLFCSHSNPDTRPSMRQVVQYLD 605
V +L L C + RP +V LD
Sbjct: 235 CPSAVYQLMLQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 72/215 (33%), Positives = 122/215 (56%), Gaps = 21/215 (9%)
Query: 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGM-KQFVSEIVSMGKLRHRNL 395
++K L K +G VY+G ++ +A+K++ D++ G + EI M +L+H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 396 VQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRP------SLNWFQRFRIIKGVAFGLL 449
V+L + +L+LV++YM + L K + ++ ++ F ++++KG+AF
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFT-YQLLKGIAF--- 115
Query: 450 YLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT-TNVVGTVGYLAP 508
HE VLHRD+KP N+L++ E KL DFGLAR + G ++T +N V T+ Y AP
Sbjct: 116 -CHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAF--GIPVNTFSNEVVTLWYRAP 169
Query: 509 ELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPG 542
++L R +TS D+++ G M E+ G RP+ PG
Sbjct: 170 DVLLGSRTYSTSIDIWSVGCIMAEMITG-RPLFPG 203
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 350 GKVYRGVLPSSHAEIAVKK--VCH--DSDHGMKQ-FVSEIVSMGKLRHRNLVQLRGYCRR 404
VY+ + +A+KK + ++ G+ + EI + +L+H N++ L
Sbjct: 14 AVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH 73
Query: 405 KGELLLVYDYMPNGSLDKILYSNTRPSL------NWFQRFRIIKGVAFGLLYLHEEWEQV 458
K + LV+++M L+K++ + L ++ ++G+ YLH W
Sbjct: 74 KSNINLVFEFME-TDLEKVI-KDKSIVLTPADIKSYMLM--TLRGLE----YLHSNW--- 122
Query: 459 VLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRG-T 517
+LHRD+KP N+L+ +D KL DFGLAR + N T VV T Y APELL R
Sbjct: 123 ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELLFGARHYG 181
Query: 518 TSTDVYAFGVFMLEVACGRRPVQPGELDL 546
D+++ G E+ R P PG+ D+
Sbjct: 182 VGVDMWSVGCIFAEL-LLRVPFLPGDSDI 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 2e-23
Identities = 62/203 (30%), Positives = 99/203 (48%), Gaps = 6/203 (2%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKV-CHDSDHGMK-QFVSEIVSMGKLRHRNL 395
++ L K KG G V++ V + A+K++ + + + + E + KL +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 396 VQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEW 455
++ KG+L +V +Y NG L K+L L Q +R + GL +LH
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS-- 119
Query: 456 EQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGR 515
+ +LHRDIK N+ LDA K+GD G+A+L + T +VGT YL+PEL +
Sbjct: 120 -KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLSPELCEDKP 177
Query: 516 GTTSTDVYAFGVFMLEVACGRRP 538
+DV+A GV + E G+ P
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 4e-23
Identities = 57/202 (28%), Positives = 100/202 (49%), Gaps = 13/202 (6%)
Query: 339 KNLYKATKGGSGKVYRGVLP----SSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHR 393
K + + +G GKV ++ ++AVK + H + F EI + L H
Sbjct: 7 KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHE 66
Query: 394 NLVQLRGYCRRKGE--LLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYL 451
N+V+ +G C + G L L+ +Y+P+GSL L R +N + + G+ YL
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL-QRHRDQINLKRLLLFSSQICKGMDYL 125
Query: 452 HEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGT--VGYLAPE 509
Q +HRD+ N+L++++ K+ DFGLA++ D + G + + APE
Sbjct: 126 GS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182
Query: 510 LLRNGRGTTSTDVYAFGVFMLE 531
LR + ++++DV++FGV + E
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYE 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 9e-23
Identities = 63/218 (28%), Positives = 106/218 (48%), Gaps = 35/218 (16%)
Query: 347 GGSGKVYRG----VLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRG 400
G GKV+ G + P + E+ K + S+ K F E + +H N+V+ G
Sbjct: 16 GAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYG 75
Query: 401 YCRRKGELLLVYDYMPNGSLDKILYSNTRPS------------LNWFQRFRIIKGVAFGL 448
C ++V++YM +G L+K L S+ + L Q +I +A G+
Sbjct: 76 VCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGM 135
Query: 449 LYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTN---VVGT--- 502
+YL Q +HRD+ N L+ DL K+GDFG++R D++TT+ V G
Sbjct: 136 VYLA---SQHFVHRDLATRNCLVGYDLVVKIGDFGMSR------DVYTTDYYRVGGHTML 186
Query: 503 -VGYLAPELLRNGRGTTSTDVYAFGVFMLEV-ACGRRP 538
+ ++ PE + + TT +DV++FGV + E+ G++P
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 9/207 (4%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD-SDHGMKQFVSEIVSMGKLRHRNLV 396
Y+ + G + VY + ++ ++A+K++ + + + E+ +M + H N+V
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVV 62
Query: 397 QLRGYCRRKGELLLVYDYMPNGS-LDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEW 455
+ EL LV Y+ GS LD + S R L+ ++K V GL YLH
Sbjct: 63 KYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS-- 120
Query: 456 EQVVLHRDIKPANVLLDADLEGKLGDFGL-ARLYDHGNDLHT--TNVVGTVGYLAPELLR 512
+HRDIK N+LL D K+ DFG+ A L D G+ VGT ++APE++
Sbjct: 121 -NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179
Query: 513 NGRGTTS-TDVYAFGVFMLEVACGRRP 538
G D+++FG+ +E+A G P
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 1e-22
Identities = 52/192 (27%), Positives = 95/192 (49%), Gaps = 7/192 (3%)
Query: 347 GGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKG 406
G G VY+ + + +A+K V + D +++ + EI + + +V+ G +
Sbjct: 14 GSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNT 71
Query: 407 ELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKP 466
+L +V +Y GS+ I+ T +L + I+ GL YLH +HRDIK
Sbjct: 72 DLWIVMEYCGAGSVSDIMKI-TNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKA 127
Query: 467 ANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFG 526
N+LL+ + + KL DFG++ T V+GT ++APE+++ D+++ G
Sbjct: 128 GNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQEIGYNNKADIWSLG 186
Query: 527 VFMLEVACGRRP 538
+ +E+A G+ P
Sbjct: 187 ITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (242), Expect = 2e-22
Identities = 60/209 (28%), Positives = 89/209 (42%), Gaps = 35/209 (16%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSD--HGMKQFV-SEIVSMG-------------K 389
KG GKV V+K D+ + MK +I+ +
Sbjct: 3 KGSFGKVL-----------LVRKK--DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSR 49
Query: 390 LRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLL 449
+ H +V+L + + +L LV +Y P G L L R S + + + L
Sbjct: 50 INHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFY--AAEIVLALE 107
Query: 450 YLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPE 509
YLH +++RD+KP N+LLDAD KL DFGLA+ T GT YLAPE
Sbjct: 108 YLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNTFCGTPEYLAPE 163
Query: 510 LLRNGRGTTSTDVYAFGVFMLEVACGRRP 538
+L + D ++ GV + E+ G+ P
Sbjct: 164 VLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 6e-22
Identities = 66/209 (31%), Positives = 109/209 (52%), Gaps = 24/209 (11%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKV------CHDSDHGMKQFV----SEIVSMGKLRHRNL 395
KG G+VY + ++ +AVK+V D K V SEI ++ L H N+
Sbjct: 11 KGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNI 70
Query: 396 VQLRGYCRRKGELLLVYDYMPNGSLDKIL--YSNTRPSLNWFQRFRIIKGVAFGLLYLHE 453
VQ G+ + L + +Y+P GS+ L Y L F ++++G+A YLH
Sbjct: 71 VQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLA----YLHS 126
Query: 454 EWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYD--HGNDLHTTNVVGTVGYLAPELL 511
+ +LHRD+K N+L+DAD K+ DFG+++ D + ND ++ G+V ++APE++
Sbjct: 127 ---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDND-QNMSMQGSVFWMAPEVI 182
Query: 512 RNGRGTTS--TDVYAFGVFMLEVACGRRP 538
+ S D+++ G +LE+ GRRP
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 6e-22
Identities = 69/214 (32%), Positives = 104/214 (48%), Gaps = 15/214 (7%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHG--MKQFVSEIVSMGKLRHRNL 395
YK L + +G G V++ + +A+KKV G Q + EI ++ +H +
Sbjct: 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYV 61
Query: 396 VQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRP-SLNWFQRF--RIIKGVAFGLLYLH 452
V+L +LV +YMP L ++L RP + + ++KGVA Y+H
Sbjct: 62 VKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVA----YMH 116
Query: 453 EEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLR 512
++HRD+KPAN+L+ AD K+ DFGLARL+ ++ V T Y APELL
Sbjct: 117 AN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLY 173
Query: 513 NGRG-TTSTDVYAFGVFMLEVACGRRPVQPGELD 545
R D++A G E+ G P+ PGE D
Sbjct: 174 GARKYDPGVDLWAVGCIFAELLNG-SPLFPGEND 206
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 6e-22
Identities = 93/379 (24%), Positives = 161/379 (42%), Gaps = 62/379 (16%)
Query: 263 NKSGPAQNLDI------SKLPPLPPPPPTPGKKLNHTVIVSIVAAAVVLITIAAAVYFVK 316
N S A N+D+ S LPP TP I + A +VL +A F++
Sbjct: 597 NASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWF---YITCTLGAFLVLALVAFGFVFIR 653
Query: 317 KKKYEEV----YED--WEKEYSPHRFSYKNLYKA-----------TKGGSGKVYRGVLPS 359
+ E+ ED WE ++ + S ++G G Y+G
Sbjct: 654 GRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIK 713
Query: 360 SHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGS 419
+ + VK++ +D + +++ MGKL+H N+V+L G CR + L+++Y+ +
Sbjct: 714 NGMQFVVKEI-NDVNSIPSSEIAD---MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKN 769
Query: 420 LDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKL 479
L ++L +L+W +R +I G+A L +LH V+ ++ P +++D E L
Sbjct: 770 LSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824
Query: 480 GDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPV 539
RL G T + Y+APE T +D+Y FG+ ++E+ G+ P
Sbjct: 825 ------RLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPA 878
Query: 540 QP---GELDLLDWV--------IDYWQKGDVLDASDPRLEGIYVEEQMEIV--LKLGLFC 586
+++W +D W DP + G Q EIV + L L C
Sbjct: 879 DAEFGVHGSIVEWARYCYSDCHLDMW--------IDPSIRGDVSVNQNEIVEVMNLALHC 930
Query: 587 SHSNPDTRPSMRQVVQYLD 605
+ ++P RP V++ L+
Sbjct: 931 TATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 7e-22
Identities = 55/184 (29%), Positives = 93/184 (50%), Gaps = 7/184 (3%)
Query: 350 GKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELL 409
G+V+ G L + +A+K + D + F E+ ++ +LRH++L+ L C +
Sbjct: 20 GEVWEG-LWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVY 78
Query: 410 LVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANV 469
++ + M GSL L S L + VA G+ YL E Q +HRD+ N+
Sbjct: 79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNI 135
Query: 470 LLDADLEGKLGDFGLARLYDHGNDLHTT-NVVGTVGYLAPELLRNGRGTTSTDVYAFGVF 528
L+ DL K+ DFGLARL D++ + + + APE +G +T +DV++FG+
Sbjct: 136 LVGEDLVCKVADFGLARLIK--EDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGIL 193
Query: 529 MLEV 532
+ E+
Sbjct: 194 LYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 7e-22
Identities = 72/243 (29%), Positives = 117/243 (48%), Gaps = 23/243 (9%)
Query: 363 EIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDK 422
++AVK + D + F+ E M KL H+NLV+L G G L +V + M G+L
Sbjct: 31 KVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELMSKGNLVN 87
Query: 423 ILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDF 482
L + R ++ Q + VA G+ YL + ++HRD+ N+L+ D K+ DF
Sbjct: 88 FLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDF 144
Query: 483 GLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEV-ACGRRPVQP 541
GLAR+ G D N V + APE L++ + ++ +DV+++GV + EV + GR P
Sbjct: 145 GLARVGSMGVD----NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPK 200
Query: 542 GELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVV 601
L V + +KG ++ + +YV L C + P RPS ++
Sbjct: 201 MS---LKEVKECVEKGYRMEPPEGCPADVYV---------LMTSCWETEPKKRPSFHKLR 248
Query: 602 QYL 604
+ L
Sbjct: 249 EKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 7e-22
Identities = 68/241 (28%), Positives = 121/241 (50%), Gaps = 29/241 (12%)
Query: 373 SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSL 432
++ + F+SE MG+ H N++ L G + +++V +YM NGSLD L +
Sbjct: 45 TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHD-GQF 103
Query: 433 NWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492
Q +++G+A G+ YL + +HRD+ N+L++++L K+ DFGL+R+ +
Sbjct: 104 TVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160
Query: 493 DLHTTNVVGT--VGYLAPELLRNGRGTTSTDVYAFGVFMLEV-ACGRRPVQPGELDLLDW 549
+ T G + + APE + + T+++DV+++G+ M EV + G RP
Sbjct: 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP----------- 209
Query: 550 VIDYWQ--KGDVLDASDPRLEGIYVEEQME---IVLKLGLFCSHSNPDTRPSMRQVVQYL 604
YW+ DV+ A + EG + M+ + +L L C + + RP Q+V L
Sbjct: 210 ---YWEMSNQDVIKAIE---EGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263
Query: 605 D 605
D
Sbjct: 264 D 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 8e-22
Identities = 72/222 (32%), Positives = 109/222 (49%), Gaps = 30/222 (13%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGM--KQFVSEIVSMGKLRHRNL 395
Y+NL +G G V + + +A+KK D M K + EI + +LRH NL
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENL 62
Query: 396 VQLRGYCRRKGELLLVYDYMPNGSLDK-------ILYSNTRPSLNWFQRFRIIKGVAFGL 448
V L RRK L LV++++ + LD + S R L F+I++G+ F
Sbjct: 63 VNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYL-----FQILRGIEF-- 115
Query: 449 LYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAP 508
+ H ++HRDIKP N+L+ KL DFG AR +++ T+ V T Y AP
Sbjct: 116 CHSHN-----IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY-TDYVATRWYRAP 169
Query: 509 ELL----RNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDL 546
ELL + GR + D++A G + E+ G P+ PG+ D+
Sbjct: 170 ELLVGDTKYGR---AVDIWAVGCLVTEMLTG-EPLFPGDSDI 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 9e-22
Identities = 81/276 (29%), Positives = 135/276 (48%), Gaps = 41/276 (14%)
Query: 347 GGSGKVYRGVL-PSSHAEIAVK----KVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGY 401
G G+V RG L EI V K + ++ + F+SE MG+ H N++ L G
Sbjct: 15 GEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGV 73
Query: 402 CRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLH 461
+ ++++ ++M NG+LD L N Q +++G+A G+ YL E +H
Sbjct: 74 VTKSRPVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLS---EMNYVH 129
Query: 462 RDIKPANVLLDADLEGKLGDFGLAR-LYDHGNDLHTTNVVG---TVGYLAPELLRNGRGT 517
RD+ N+L++++L K+ DFGL+R L D +D T+ +G + + APE + + T
Sbjct: 130 RDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFT 189
Query: 518 TSTDVYAFGVFMLEV-ACGRRPVQPGELDLLDWVIDYWQKG--DVLDA--SDPRLEGIYV 572
+++DV+++G+ M EV + G RP YW DV++A D RL
Sbjct: 190 SASDVWSYGIVMWEVMSYGERP--------------YWDMSNQDVINAIEQDYRL----- 230
Query: 573 EEQME---IVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
M+ + +L L C + + RP Q+V LD
Sbjct: 231 PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-21
Identities = 86/266 (32%), Positives = 126/266 (47%), Gaps = 33/266 (12%)
Query: 346 KGGSGKV----YRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGY 401
KG G V YRG ++AVK C +D + F++E M +LRH NLVQL G
Sbjct: 16 KGEFGDVMLGDYRGN------KVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGV 67
Query: 402 -CRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVL 460
KG L +V +YM GSL L S R L + V + YL +
Sbjct: 68 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFV 124
Query: 461 HRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTST 520
HRD+ NVL+ D K+ DFGL + D T + V + APE LR + +T +
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKL--PVKWTAPEALREKKFSTKS 180
Query: 521 DVYAFGVFMLEV-ACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIV 579
DV++FG+ + E+ + GR P + L D V+ +KG +DA D +Y +++
Sbjct: 181 DVWSFGILLWEIYSFGRVPYP--RIPLKD-VVPRVEKGYKMDAPDGCPPVVY-----DVM 232
Query: 580 LKLGLFCSHSNPDTRPSMRQVVQYLD 605
+ C H + TRPS Q+ + L+
Sbjct: 233 KQ----CWHLDAATRPSFLQLREQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 3e-21
Identities = 64/202 (31%), Positives = 102/202 (50%), Gaps = 21/202 (10%)
Query: 347 GGSGKVYRGVLPSSHAEIAVKKVCHDSDHG-----MKQFVSEIVSMGKLRHRNLVQLRGY 401
G G VY G+ AVK+V D +KQ EI + KL+H N+VQ G
Sbjct: 11 GSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGT 70
Query: 402 CRRKGELLLVYDYMPNGSLDKILY---SNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQV 458
R + L + + +P GSL K+L S P + + R +I+ G+ YLH+ +
Sbjct: 71 EREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QILLGLE----YLHD---RN 122
Query: 459 VLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTT-NVVGTVGYLAPE-LLRNGRG 516
+HRDIK AN+L+D + KL DFG+A+ + + G+ ++APE + + G
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMAK---QVVEFSFAKSFKGSPYWMAPEVIAQQGGY 179
Query: 517 TTSTDVYAFGVFMLEVACGRRP 538
+ D+++ G +LE+A G+ P
Sbjct: 180 GLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 5e-21
Identities = 80/276 (28%), Positives = 127/276 (46%), Gaps = 32/276 (11%)
Query: 327 WEKEYSPHRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGM--KQFVSEI 384
WE + R S + L K G G+V+ G+ ++ +AVK + + M K F++E
Sbjct: 1 WEID----RTSIQLLRKLGAGQFGEVWEGLWNNT-TPVAVKTLKPGT---MDPKDFLAEA 52
Query: 385 VSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGV 444
M KLRH L+QL C + + +V + M GSL + L +L Q + V
Sbjct: 53 QIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQV 112
Query: 445 AFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGT-- 502
A G+ YL Q +HRD+ NVL+ + K+ DFGLAR+ D++ G
Sbjct: 113 ASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIK--EDIYEAR-EGAKF 166
Query: 503 -VGYLAPELLRNGRGTTSTDVYAFGVFMLE-VACGRRPVQPGELDLLDWVIDYWQKGDVL 560
+ + APE R + +DV++FG+ + E V GR P PG + V+ +G +
Sbjct: 167 PIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPY-PGMTNA--EVLQQVDQGYRM 223
Query: 561 DASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPS 596
+ +Y +I+L C +PD RP+
Sbjct: 224 PCPPGCPKELY-----DIMLD----CWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 73/278 (26%), Positives = 119/278 (42%), Gaps = 35/278 (12%)
Query: 346 KGGSGKVYRGVL-----PSSHAEIAVKKVC-HDSDHGMKQFVSEIVSMGKLRHRNLVQLR 399
+G G VY G+ +A+K V + S +F++E M + ++V+L
Sbjct: 16 QGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLL 75
Query: 400 GYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKG----------VAFGLL 449
G L+V + M G L L S RP +A G+
Sbjct: 76 GVVSTGQPTLVVMELMAKGDLKSYLRS-RRPE-AENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 450 YLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLAR-LYDHGNDLHTTNVVGTVGYLAP 508
YL + +HRD+ N ++ DL K+GDFG+ R +Y+ + V ++AP
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 509 ELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL 567
E L++G TT +DV++FGV + E+A +P Q G + + V+ + G LD
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQ-GLSN--EEVLKFVIDGGHLD------ 241
Query: 568 EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
E + +L+L C NP RP+ ++V L
Sbjct: 242 ---LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 77/234 (32%), Positives = 110/234 (47%), Gaps = 33/234 (14%)
Query: 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVC-HDSDHGMK-QFVSEIVSMGKLRHRN 394
Y+ L K +G G+VY+ + +A+KK+ H+ G + EI + KL+H N
Sbjct: 9 DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPN 68
Query: 395 LVQL--------RGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAF 446
+V L R++G + +V YM + L +L N L Q + +
Sbjct: 69 VVPLIDMAVERPDKSKRKRGSVYMVTPYM-DHDLSGLL-ENPSVKLTESQIKCYMLQLLE 126
Query: 447 GLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYD----------HGNDLHT 496
G+ YLHE +LHRDIK AN+L+D K+ DFGLAR YD G
Sbjct: 127 GINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKY 183
Query: 497 TNVVGTVGYLAPELLRNGRG-TTSTDVYAFG-VF--MLEVACGRRPVQPGELDL 546
TN+V T Y PELL R TT+ D++ G VF M RRP+ G+ D+
Sbjct: 184 TNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT----RRPILQGKSDI 233
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 1e-20
Identities = 64/218 (29%), Positives = 105/218 (48%), Gaps = 25/218 (11%)
Query: 342 YKATK----GGSGKVYRGVLPSSHAEIAVKKVCH--DSDHGMKQFVSEIVSMGKLRHRNL 395
Y+ K G G V V + ++A+KK+ + D K+ + EI + LRH N+
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 396 VQLR-----GYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRF--RIIKGVAFGL 448
+ L ++ +V + M L K++ S + + Q F +I++G L
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRG----L 116
Query: 449 LYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARL--YDHGNDLHTTNVVGTVGYL 506
YLH V+HRD+KP+N+L++++ + K+ DFGLAR D T V T Y
Sbjct: 117 KYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR 173
Query: 507 APELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPGE 543
APELL + T + D+++ G E+ R+P+ PG
Sbjct: 174 APELLLSSSRYTKAIDIWSVGCIFAELL-TRKPLFPGR 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 70/218 (32%), Positives = 114/218 (52%), Gaps = 16/218 (7%)
Query: 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKV-CHDSDHGMKQF-VSEIVSMGKLRHRN 394
Y+ L K +G G V++ +H +A+K+V D D G+ + EI + +L+H+N
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 395 LVQLRGYCRRKGELLLVYDYMPNGSLDKILYS-NTRPSLNWFQRF--RIIKGVAFGLLYL 451
+V+L +L LV++Y + L K S N + F +++KG+AF
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAF----C 115
Query: 452 HEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELL 511
H VLHRD+KP N+L++ + E KL DFGLAR + ++ VV T+ Y P++L
Sbjct: 116 HS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVL 171
Query: 512 RNGRG-TTSTDVYAFGVFMLEVACGRRPVQPGELDLLD 548
+ +TS D+++ G E+A RP+ PG D+ D
Sbjct: 172 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-DVDD 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 72/269 (26%), Positives = 114/269 (42%), Gaps = 39/269 (14%)
Query: 347 GGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKG 406
G G V+ G ++A+K + + F+ E M KL H NLVQL G C ++
Sbjct: 15 GQFGVVHLGKW-RGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR 72
Query: 407 ELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKP 466
+ +V +YM NG L L + L + V + YL +HRD+
Sbjct: 73 PIFIVTEYMANGCLLNYLRER-KGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAA 128
Query: 467 ANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGT---VGYLAPELLRNGRGTTSTDVY 523
N L+ D K+ DFGLAR D T+ GT V + PE+ R ++ +DV+
Sbjct: 129 RNCLVGEDNVVKVSDFGLARYV---LDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVW 185
Query: 524 AFGVFMLEV-ACGRRPVQPGELDLLDWVIDYWQKGDVLDA-------SDPRLEGIYVEEQ 575
+FGV M EV + G+ P + + +V+++ P+L V
Sbjct: 186 SFGVLMWEVFSEGKMP------------YERFSNSEVVESVSAGYRLYRPKLAPTEVYTI 233
Query: 576 MEIVLKLGLFCSHSNPDTRPSMRQVVQYL 604
M C H P+ RP+ ++++ L
Sbjct: 234 MYS-------CWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 5e-20
Identities = 64/217 (29%), Positives = 100/217 (46%), Gaps = 33/217 (15%)
Query: 338 YKNLYKATKGGSGKVYRGVL--PSSHAEIAVKKVCHDSDH--GMKQ-FVSEIVSMGKLRH 392
Y+ +G G+VY+ E A+KK D + G+ Q EI + +L+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 393 RNLVQLRGYC--RRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAF---- 446
N+V L + L++DY + L +I+ + + ++K + +
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPP-SMVKSLLWQILN 119
Query: 447 GLLYLHEEWEQVVLHRDIKPANVLL--DADLEG--KLGDFGLARLYD-------HGNDLH 495
G+ YLH W VLHRD+KPAN+L+ + G K+GD GLARL++ +
Sbjct: 120 GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD--- 173
Query: 496 TTNVVGTVGYLAPELLRNGRG-TTSTDVYAFGVFMLE 531
VV T+ Y APELL R T + D++A G E
Sbjct: 174 --PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAE 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 5e-20
Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 19/217 (8%)
Query: 347 GGSGKVYRGVLPSSHAEIAVKKV-CHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYC--R 403
G G V + L ++ A+K + + KQ + E+ + +V+ G
Sbjct: 12 GAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE 71
Query: 404 RKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRF---RIIKGVAFGLLYLHEEWEQVVL 460
+ + +Y GSLD I Y + +I + V GL YLH + ++
Sbjct: 72 SSSSIGIAMEYCEGGSLDSI-YKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKII 127
Query: 461 HRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTST 520
HRDIKP+N+LL + KL DFG++ + N L T GT Y+APE ++ + ++
Sbjct: 128 HRDIKPSNILLTRKGQVKLCDFGVSG--ELVNSLAGT-FTGTSFYMAPERIQGKPYSITS 184
Query: 521 DVYAFGVFMLEVACGRRPVQP------GELDLLDWVI 551
DV++ G+ +LEVA R P P G ++LL +++
Sbjct: 185 DVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV 221
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 6e-20
Identities = 73/228 (32%), Positives = 111/228 (48%), Gaps = 26/228 (11%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVS--EIVSMGKLRHRNL 395
++ L + +G G VYR +S +A+KKV D++ S EI + LRH N+
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 396 VQLRGYC--RRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRI--IKGVAF----G 447
V+L+ + + LV +Y L +L + P F +K + G
Sbjct: 69 VELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTP-------FSESQVKCLMLQLLRG 120
Query: 448 LLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLA 507
L YLHE + ++HRD+K +N+LL K+ DFGLAR Y T VV T+ Y A
Sbjct: 121 LQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRA 176
Query: 508 PELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPG--ELDLLDWVID 552
PELL TT+ D++A G + E+ +P+ PG E++ LD +I
Sbjct: 177 PELLLGCTTYTTAIDMWAVGCILAELLAH-KPLLPGKSEIEQLDLIIQ 223
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 6e-20
Identities = 65/218 (29%), Positives = 107/218 (49%), Gaps = 21/218 (9%)
Query: 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD--HGMKQFVSEIVSMGKLRHRN 394
YK + G G V + S ++A+KK+ H D K+ + E+ + +H N
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 395 LVQLRGYCRRKGELL----LVYDYMPNGSLDKILYSNTRPSLNWFQRF--RIIKGVAFGL 448
++ +R R G +V D M + L I++S+ + + F ++++G L
Sbjct: 66 IIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRG----L 120
Query: 449 LYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT---TNVVGTVGY 505
Y+H V+HRD+KP+N+L++ D E ++GDFG+AR H T V T Y
Sbjct: 121 KYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWY 177
Query: 506 LAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPG 542
APELL + TT+ D+++ G E+ GRR + PG
Sbjct: 178 RAPELLLSLPEYTTAIDMWSVGCIFAEM-LGRRQLFPG 214
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 7e-20
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 8/204 (3%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQ 397
Y+ + + G G VY+ ++ +A+K + + + EI + + RH N+V
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64
Query: 398 LRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQ 457
G R+ +L +V +Y GSL I Y TR L+ Q + + GL YLHE
Sbjct: 65 YFGSYLRRDKLWIVMEYCGGGSLQDI-YQVTRGPLSELQIAYVCRETLKGLAYLHE---T 120
Query: 458 VVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELL---RNG 514
+HRDIK AN+LL D + KL DFG++ + +GT ++APE+ R G
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS-FIGTPYWMAPEVAAVERKG 179
Query: 515 RGTTSTDVYAFGVFMLEVACGRRP 538
D++A G+ +E+A + P
Sbjct: 180 GYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 7e-20
Identities = 84/287 (29%), Positives = 126/287 (43%), Gaps = 48/287 (16%)
Query: 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQ-------FVSEIVSM 387
R S K K G G+V+ G + ++AVK +K F+ E M
Sbjct: 5 RESLKLERKLGAGQFGEVWMGTW-NGTTKVAVKT--------LKPGTMSPEAFLQEAQIM 55
Query: 388 GKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFG 447
KLRH LVQL C + + +V +YM GSL L S L Q + +A G
Sbjct: 56 KKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEG 115
Query: 448 LLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGT---VG 504
+ YL + +HRD+ N+L+ +L K+ DFGLARL + D T G +
Sbjct: 116 MAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIE---DDEYTAREGAKFPIK 169
Query: 505 YLAPELLRNGRGTTSTDVYAFGVFMLE-VACGRRPVQPGELDLLDWVIDYWQKGDVLDAS 563
+ APE GR T +DV++FG+ + E V GR P PG +VL+
Sbjct: 170 WTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPY-PG-----------MTNREVLEQV 217
Query: 564 D-----PRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
+ PR EE +++L+ C +P+ RP+ + +L+
Sbjct: 218 ERGYRMPRPPNC-PEELYDLMLQ----CWDKDPEERPTFEYLQSFLE 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 58/218 (26%), Positives = 89/218 (40%), Gaps = 38/218 (17%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVK---KVCHDSDHGMKQFVSEIVSMGKLRHRN 394
++ L KG GKV + A+K K ++ ++E + +L H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 395 LVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAF-------- 446
LV L + + + LV D + G L R+ + + V F
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDL----------------RYHLSQKVKFSEEQVKFW 105
Query: 447 ------GLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVV 500
L YLH + ++HRDIKP N+LLD + DF +A D TT+
Sbjct: 106 ICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVT--PDTLTTSTS 160
Query: 501 GTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRP 538
GT GY+APE+L + + D ++ GV E G+RP
Sbjct: 161 GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 1e-19
Identities = 54/190 (28%), Positives = 95/190 (50%), Gaps = 25/190 (13%)
Query: 364 IAVKKVCH------DSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPN 417
+AVK+V + + + ++ EI M +L H +++++ G L ++M
Sbjct: 28 MAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAG 87
Query: 418 GSLDKILYSNTRPSLNWFQR---FRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDA- 473
GS+ +L S F+ + + GL YLHE Q++ HRD+K AN+L+D+
Sbjct: 88 GSVSHLL-SKYGA----FKEAVIINYTEQLLRGLSYLHEN--QII-HRDVKGANLLIDST 139
Query: 474 --DLEGKLGDFGLA-RLYDH--GNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVF 528
L ++ DFG A RL G ++GT+ ++APE+LR + S DV++ G
Sbjct: 140 GQRL--RIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCV 197
Query: 529 MLEVACGRRP 538
++E+A + P
Sbjct: 198 IIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 83/292 (28%), Positives = 129/292 (44%), Gaps = 58/292 (19%)
Query: 347 GGSGKVYRGVL-----PSSHAEIAVKKVCHD-SDHGMKQFVSEIVSMGKL-RHRNLVQLR 399
G G+V + P+ + +AVK + D ++ + VSE+ M + +H+N++ L
Sbjct: 23 GAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL 82
Query: 400 GYCRRKGELLLVYDYMPNGSLDKILYSNTRP--SLNWFQRFRIIKG-------------V 444
G C ++G L +V +Y +G+L L + RP R + V
Sbjct: 83 GVCTQEGPLYVVVEYAAHGNLRDFLRAR-RPPGEYASPDDPRPPEETLTQKDLVSFAYQV 141
Query: 445 AFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYD-HGNDLH--TTNVVG 501
A G+ +L + +HRD+ NVL+ D K+ DFGLAR D H D + TTN
Sbjct: 142 ARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLAR--DIHHIDYYRKTTNGRL 196
Query: 502 TVGYLAPELLRNGRGTTSTDVYAFGVFMLE-VACGRRPVQPGELDLLDWVIDYWQKGDVL 560
V ++APE L + T +DV++FGV + E G P PG I + +L
Sbjct: 197 PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY-PG--------IPVEELFKLL 247
Query: 561 DASDPRLEGIYVEEQMEI-------VLKLGLFCSHSNPDTRPSMRQVVQYLD 605
EG +ME + L C H P RP+ +Q+V+ LD
Sbjct: 248 K------EG----YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLD 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 3e-19
Identities = 79/298 (26%), Positives = 123/298 (41%), Gaps = 68/298 (22%)
Query: 347 GGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQ-FVS--------EIVSMGKL-RHRNLV 396
G G VY + +A+KK MK+ F S E+ S+ KL H N+V
Sbjct: 10 GTFGSVYLARNKETGELVAIKK--------MKKKFYSWEECMNLREVKSLRKLNEHPNIV 61
Query: 397 QLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWE 456
+L+ R EL V++YM G+L +++ + II + GL ++H +
Sbjct: 62 KLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---K 117
Query: 457 QVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT------TNVVGTVGYLAPE- 509
HRD+KP N+L+ K+ DFGLAR T+ V T Y APE
Sbjct: 118 HGFFHRDLKPENLLVSGPEVVKIADFGLAR--------EIRSRPPYTDYVSTRWYRAPEI 169
Query: 510 LLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPG--ELDLLDWVIDYWQKGDVLDASDPRL 567
LLR+ ++ D++A G M E+ RP+ PG E+D L ++ VL +
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTL-RPLFPGSSEIDQL------YKICSVLGTPTKQD 222
Query: 568 --EGIYVEEQMEIVLKLG-------LFCSHS-------------NPDTRPSMRQVVQY 603
EG + ++ L + S +P RP+ Q +Q+
Sbjct: 223 WPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 3e-19
Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 33/217 (15%)
Query: 348 GS-GKVYRGVLPSSHAEIAVKKVCHDSDHGMKQ----FVS-EIVSMGKL-RHRNLVQLRG 400
GS V ++ E A+K + D +K+ +V E + +L H +++L
Sbjct: 12 GSFSTVVLAKEKETNKEYAIK-IL-DKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYY 69
Query: 401 YCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVL 460
+ + L V +Y PNG L + + SL+ + L YLH + ++
Sbjct: 70 TFQDEENLYFVLEYAPNGELLQYI--RKYGSLDEKCTRFYAAEILLALEYLHS---KGII 124
Query: 461 HRDIKPANVLLDADLEGKLGDFGLARLYD-------------------HGNDLHTTNVVG 501
HRD+KP N+LLD D+ K+ DFG A++ D N + VG
Sbjct: 125 HRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVG 184
Query: 502 TVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRP 538
T Y++PELL S+D++A G + ++ G+ P
Sbjct: 185 TAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 3e-19
Identities = 61/203 (30%), Positives = 101/203 (49%), Gaps = 20/203 (9%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK 405
KG G VY S+ IA+K++ ++ EI L+HRN+VQ G
Sbjct: 18 KGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN 77
Query: 406 GELLLVYDYMPNGSLDKILYS------NTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVV 459
G + + +P GSL +L S + ++ ++ + +I++ GL YLH + +
Sbjct: 78 GFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-QILE----GLKYLH---DNQI 129
Query: 460 LHRDIKPANVLLDADLEG--KLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNG-RG 516
+HRDIK NVL++ G K+ DFG ++ N T GT+ Y+APE++ G RG
Sbjct: 130 VHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGINPC-TETFTGTLQYMAPEVIDKGPRG 187
Query: 517 -TTSTDVYAFGVFMLEVACGRRP 538
D+++ G ++E+A G+ P
Sbjct: 188 YGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 9e-19
Identities = 67/215 (31%), Positives = 111/215 (51%), Gaps = 19/215 (8%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKV-CHDSDHGMKQF-VSEIVSMGKLR---HRNLVQLRG 400
+G G VY+ ++ +A+KKV S+ G+ + EI + +L H N+V+L
Sbjct: 9 EGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLD 68
Query: 401 YC---RRKGE--LLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEW 455
C R E L LV++++ + L L +P L +++ + G+ +LH
Sbjct: 69 VCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS-- 125
Query: 456 EQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGR 515
++HRD+KP N+L+ +D + K+ DFGLAR+Y ++ T+VV T+ Y APE+L
Sbjct: 126 -HRIVHRDLKPQNILVTSDGQVKIADFGLARIYS--FEMALTSVVVTLWYRAPEVLLQSS 182
Query: 516 GTTSTDVYAFGVFMLEVACGRRPVQPG--ELDLLD 548
T D+++ G E+ RRP+ G E D LD
Sbjct: 183 YATPVDMWSVGCIFAELF-RRRPLFRGTSEADQLD 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 78/270 (28%), Positives = 122/270 (45%), Gaps = 35/270 (12%)
Query: 347 GGSGKVYRGV-LPSSHAEIAVK-KVCHDSD--HGMKQFVSEIVSMGKLRHRNLVQLRGYC 402
G G V +GV L S E+ V K G K+F+ E M +L H +V+L G C
Sbjct: 6 GNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVC 65
Query: 403 RRKGE-LLLVYDYMPNGSLDKIL--YSNTRPS--LNWFQRFRIIKGVAFGLLYLHEEWEQ 457
KGE L+LV + P G L K L S + VA G+ YL +
Sbjct: 66 --KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYLES---K 114
Query: 458 VVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGT--VGYLAPELLRNGR 515
+HRD+ NVLL + K+ DFG++R G+D + G + + APE + G+
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174
Query: 516 GTTSTDVYAFGVFMLEV-ACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEE 574
++ +DV+++GV + E + G +P GE+ + VI + G+ L + + IY
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAKPY--GEMKGAE-VIAMLESGERLPRPEECPQEIY--- 228
Query: 575 QMEIVLKLGLFCSHSNPDTRPSMRQVVQYL 604
I+L C P+ RP+ ++
Sbjct: 229 --SIMLS----CWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 68/207 (32%), Positives = 111/207 (53%), Gaps = 20/207 (9%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGM--KQFVSEIVSMGKLRHRNLVQLRGY-- 401
+G G V ++ ++A+KK+ + D+ + K+ + EI + L H N++ ++
Sbjct: 15 RGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMP 74
Query: 402 --CRRKGE-LLLVYDYMPNGSLDKILYSNTRPSLNWFQRF--RIIKGVAFGLLYLHEEWE 456
R + +VY+ M + L +I+ S+ S + Q F ++++G L Y+H
Sbjct: 75 PPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLRG----LKYIHS--- 126
Query: 457 QVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRG 516
VLHRD+KP+N+LL+A+ + K+ DFGLAR D T VV T Y APELL N
Sbjct: 127 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAPELLLNCSE 185
Query: 517 -TTSTDVYAFGVFMLEVACGRRPVQPG 542
TT+ DV++ G E+ GR+P+ PG
Sbjct: 186 YTTAIDVWSVGCIFAELL-GRKPLFPG 211
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 70/227 (30%), Positives = 106/227 (46%), Gaps = 23/227 (10%)
Query: 379 QFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRF 438
+F+ E M KL H LVQL G C ++ + +V +YM NG L L Q
Sbjct: 45 EFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLRE-HGKRFQPSQLL 103
Query: 439 RIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTN 498
+ K V G+ YL E +Q +HRD+ N L+D K+ DFGL+R + D T+
Sbjct: 104 EMCKDVCEGMAYL--ESKQF-IHRDLAARNCLVDDQGCVKVSDFGLSR---YVLDDEYTS 157
Query: 499 VVGT---VGYLAPELLRNGRGTTSTDVYAFGVFMLEV-ACGRRPVQPGELDLLDWVIDYW 554
VG+ V + PE+L + ++ +DV+AFGV M EV + G+ P E ++
Sbjct: 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGK---MPYERFNNSETVEKV 214
Query: 555 QKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVV 601
+G L P L E V + C H + RP+ +Q++
Sbjct: 215 SQGLRL--YRPHLAS-------EKVYAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 70/263 (26%), Positives = 113/263 (42%), Gaps = 17/263 (6%)
Query: 343 KATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYC 402
K +G G+V+ G + +A+K + + F+ E M KLRH LVQL
Sbjct: 13 KLGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 70
Query: 403 RRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHR 462
+ + +V +YM GSL L L Q + +A G+ Y+ +HR
Sbjct: 71 SEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 126
Query: 463 DIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDV 522
D++ AN+L+ +L K+ DFGLARL + + + APE GR T +DV
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 523 YAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKL 582
++FG+ + E+ R PG ++ +VLD + E E + L
Sbjct: 187 WSFGILLTELTTKGRVPYPGMVNR-----------EVLDQVERGYRMPCPPECPESLHDL 235
Query: 583 GLFCSHSNPDTRPSMRQVVQYLD 605
C P+ RP+ + +L+
Sbjct: 236 MCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 74/275 (26%), Positives = 114/275 (41%), Gaps = 42/275 (15%)
Query: 347 GGSGKVYRGVLPSS---HAEIAVKKVCHDSDHG-MKQFVSEIVSMGKLRHRNLVQLRGYC 402
G G V RG +S +AVK + D M F+ E M L H NL++L G
Sbjct: 6 GSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVV 65
Query: 403 RRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHR 462
L++V + P GSL L + +A G+ YL + +HR
Sbjct: 66 LTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRFIHR 121
Query: 463 DIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTV--GYLAPELLRNGRGTTST 520
D+ N+LL +D + K+GDFGL R D + V + APE LR + ++
Sbjct: 122 DLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHAS 181
Query: 521 DVYAFGVFMLEV-ACGRRPVQPGELDLLDWV----------IDYWQKGDVLDASDPRLEG 569
DV+ FGV + E+ G P W ID ++G+ L+ + +
Sbjct: 182 DVWMFGVTLWEMFTYGEEP----------WAGLSGSQILKKID--KEGERLERPEACPQD 229
Query: 570 IYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYL 604
IY ++L+ C NP RP+ + ++L
Sbjct: 230 IY-----NVMLQ----CWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 48/137 (35%), Positives = 81/137 (59%), Gaps = 9/137 (6%)
Query: 406 GELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIK 465
GE+ + ++M GSLD++L R N + I V GL YL E+ + ++HRD+K
Sbjct: 72 GEISICMEHMDGGSLDQVLKKAGRIPENILGK--ISIAVLRGLTYLREKHK--IMHRDVK 127
Query: 466 PANVLLDADLEGKLGDFGLA-RLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYA 524
P+N+L+++ E KL DFG++ +L D + VGT Y++PE L+ T +D+++
Sbjct: 128 PSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWS 183
Query: 525 FGVFMLEVACGRRPVQP 541
G+ ++E+A GR P+ P
Sbjct: 184 LGLSLVEMAIGRYPIPP 200
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 4e-18
Identities = 69/215 (32%), Positives = 105/215 (48%), Gaps = 16/215 (7%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD--HGMKQFVSEIVSMGKLRHRNL 395
Y+ L K +G G V++ + +A+KK D K + EI + +L+H NL
Sbjct: 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNL 62
Query: 396 VQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEW 455
V L RRK +L LV++Y + L++ L N R + +II + + H+
Sbjct: 63 VNLIEVFRRKRKLHLVFEYCDHTVLNE-LEKNPR-GVPEHLIKKIIWQTLQAVNFCHK-- 118
Query: 456 EQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGR 515
+HRD+KP N+L+ + KL DFG AR+ D + T+ V T Y APELL
Sbjct: 119 -HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY-TDYVATRWYRAPELL---V 173
Query: 516 GTT----STDVYAFGVFMLEVACGRRPVQPGELDL 546
G T DV+A G E+ G +P+ PG+ D+
Sbjct: 174 GDTQYGPPVDVWAIGCVFAELLTG-QPLWPGKSDV 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 6e-18
Identities = 56/174 (32%), Positives = 89/174 (51%), Gaps = 11/174 (6%)
Query: 364 IAVKKVCHDSDHGMKQ-FVSEIVSMGKLRHRNLVQLRGYCRRKGE--LLLVYDYMPNGSL 420
+AVK + + + EI + L H N+V+ +G C +G L L+ +Y+P GSL
Sbjct: 36 VAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSL 95
Query: 421 DKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLG 480
L + LN Q + + G+ YLH Q +HRD+ NVLLD D K+G
Sbjct: 96 RDYL---PKHKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIG 149
Query: 481 DFGLARLYDHGNDLHTTNVVGT--VGYLAPELLRNGRGTTSTDVYAFGVFMLEV 532
DFGLA+ G++ + G V + A E L+ + + ++DV++FGV + E+
Sbjct: 150 DFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYEL 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 6e-18
Identities = 70/270 (25%), Positives = 119/270 (44%), Gaps = 24/270 (8%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKV--CHDSDHGMKQFVSEIVSMGKLRHRNL 395
+K L K KG G VY+ S + A+K+V S + V+EI + + H N+
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61
Query: 396 VQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQR---FRIIKGVAFGLLYLH 452
+ + +L +V +Y P G L K + S + +RI + GL LH
Sbjct: 62 ISYKEAFLDGNKLCIVMEYAPFGDLSKAI-SKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 453 EEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLR 512
E Q +LHRD+K AN+LL A+ K+GD G++++ N T +GT Y+APE+ +
Sbjct: 121 E---QKILHRDLKSANILLVANDLVKIGDLGISKVLK-KNMAKT--QIGTPHYMAPEVWK 174
Query: 513 NGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYV 572
+ +D+++ G + E+A P + + D K V P + IY
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ------DLRYK--VQRGKYPPIPPIYS 226
Query: 573 EEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602
++ + P RP+ +++
Sbjct: 227 QDLQNFI----RSMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 8e-18
Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 347 GGSGKVYRGV----LPSSHAEIAVKKVCHDSD-HGMKQFVSEIVSMGKLRHRNLVQLRGY 401
G G VY+GV +A+K + ++ K+ + E M + H ++V+L G
Sbjct: 18 GAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGI 77
Query: 402 CRRKGELLLVYDYMPNGSLDKILYSNT-----RPSLNWFQRFRIIKGVAFGLLYLHEEWE 456
C ++ L+ MP G L + ++ + LNW + +A G+ YL E
Sbjct: 78 CLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEE--- 127
Query: 457 QVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND-LHTTNVVGTVGYLAPELLRNGR 515
+ ++HRD+ NVL+ K+ DFGLA+L D H + ++A E + +
Sbjct: 128 KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRI 187
Query: 516 GTTSTDVYAFGVFMLEVAC-GRRP 538
T +DV+++GV + E+ G +P
Sbjct: 188 YTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 9e-18
Identities = 69/222 (31%), Positives = 113/222 (50%), Gaps = 24/222 (10%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKV-CHDSDHGM-KQFVSEIVSMGKLRHRNL 395
Y+ + K +G G VY+ ++ IA+KK+ D G+ + EI + +++H N+
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 396 VQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQR------FRIIKGVAFGLL 449
V+L+ + L LV++Y+ LD + ++ P R ++I++G+A
Sbjct: 64 VRLQDVVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA---- 116
Query: 450 YLHEEWEQVVLHRDIKPANVLLDADLEG-KLGDFGLARLYDHGNDLHTTNVVGTVGYLAP 508
Y H VLHRD+KP N+L+D KL DFGLAR + T VV T+ Y AP
Sbjct: 117 YCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAP 172
Query: 509 ELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPG--ELDLL 547
E+L R +T D+++ G E+ ++P+ PG E+D L
Sbjct: 173 EILLGSRHYSTPVDIWSVGCIFAEMV-NQKPLFPGDSEIDEL 213
|
Length = 294 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-17
Identities = 65/223 (29%), Positives = 110/223 (49%), Gaps = 27/223 (12%)
Query: 338 YKNLYKATKGGSGKVY--RGVLPSSHA---EIAVKKVCHDSDHGMKQFVSEIVSMGKLRH 392
Y+ + K +G GK+Y + S H EI + K+ K+ E++ + K++H
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK---EVILLAKMKH 58
Query: 393 RNLVQLRGYCRRKGELLLVYDYMPNGSLDK-------ILYSNTRPSLNWFQRFRIIKGVA 445
N+V + G L +V +Y G L K +L+S + L+WF + ++
Sbjct: 59 PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQ-ILSWFVQ------IS 111
Query: 446 FGLLYLHEEWEQVVLHRDIKPANVLLDAD-LEGKLGDFGLARLYDHGNDLHTTNVVGTVG 504
GL ++H+ + +LHRDIK N+ L + + KLGDFG+AR + +L T VGT
Sbjct: 112 LGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT-CVGTPY 167
Query: 505 YLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLL 547
YL+PE+ +N TD+++ G + E+ + P + L L
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 70/263 (26%), Positives = 119/263 (45%), Gaps = 29/263 (11%)
Query: 347 GGSGKVYRGVL--PSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYC 402
G G++ RG L PS SD + F++E +++G+ H N+V+L G
Sbjct: 16 GRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVI 75
Query: 403 RRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHR 462
R +++V +YM NG+LD L + L Q ++ G+A G+ YL E +H+
Sbjct: 76 TRGNTMMIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLS---EMGYVHK 131
Query: 463 DIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVG--TVGYLAPELLRNGRGTTST 520
+ VL+++DL K+ F RL + ++ T + G V + APE ++ ++++
Sbjct: 132 GLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSAS 189
Query: 521 DVYAFGVFMLEV-ACGRRPVQPGELDLLDWVIDYWQKG--DVLDASDPRLEGIYVEEQME 577
DV++FG+ M EV + G RP YW DV+ A +
Sbjct: 190 DVWSFGIVMWEVMSYGERP--------------YWDMSGQDVIKAVEDGFRLPAPRNCPN 235
Query: 578 IVLKLGLFCSHSNPDTRPSMRQV 600
++ +L L C RP Q+
Sbjct: 236 LLHQLMLDCWQKERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 68/257 (26%), Positives = 116/257 (45%), Gaps = 43/257 (16%)
Query: 364 IAVKKVCH-DSDHGM-KQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLD 421
+ KKV H + + KQ + E+ M + R +V G + + + ++M GSLD
Sbjct: 32 VMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLD 91
Query: 422 KIL--YSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKL 479
+I + +I V GL YL+ ++HRDIKP+N+L+++ + KL
Sbjct: 92 RIYKKGGPIPVEILG----KIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKL 145
Query: 480 GDFGLARLYDHG---NDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGR 536
DFG++ G N + T VGT Y++PE ++ G+ T +DV++ G+ ++E+A G+
Sbjct: 146 CDFGVS-----GELINSIADT-FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199
Query: 537 RPV------------QPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGL 584
P G LDLL ++ PRL E + +
Sbjct: 200 FPFAFSNIDDDGQDDPMGILDLLQQIV---------QEPPPRLPSSDFPEDLRDFVDA-- 248
Query: 585 FCSHSNPDTRPSMRQVV 601
C +P RP+ +Q+
Sbjct: 249 -CLLKDPTERPTPQQLC 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 78/270 (28%), Positives = 129/270 (47%), Gaps = 30/270 (11%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHG-MKQFVSEIVSMGKLRHRNLVQLRGYCRR 404
KG G VY+ + + +A+K++ + D Q + E+ + K +V G
Sbjct: 11 KGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI 70
Query: 405 KGELLLVYDYMPNGSLDKILY--SNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHR 462
+G + + +YM GSLDK LY + RI V GL +L EE ++HR
Sbjct: 71 EGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHR 127
Query: 463 DIKPANVLLDADLEGKLGDFGLARLYDHGN---DLHTTNVVGTVGYLAPELLR----NGR 515
D+KP NVL++ + + KL DFG++ GN L TN +G Y+APE ++ N
Sbjct: 128 DVKPTNVLVNGNGQVKLCDFGVS-----GNLVASLAKTN-IGCQSYMAPERIKSGGPNQN 181
Query: 516 GT--TSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573
T +DV++ G+ +LE+A GR P P + + Q ++D P L Y +
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYPPETYANI-----FAQLSAIVDGDPPTLPSGYSD 236
Query: 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603
+ + V K C + P+ RP+ Q++++
Sbjct: 237 DAQDFVAK----CLNKIPNRRPTYAQLLEH 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 60/201 (29%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYC 402
KGG G+V + ++ A KK+ G + ++E + K+ R +V L
Sbjct: 3 KGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF 62
Query: 403 RRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRII---KGVAFGLLYLHEEWEQVV 459
K +L LV M G L +Y+ P F R I + GL +LH+ +
Sbjct: 63 ETKDDLCLVMTLMNGGDLKYHIYNVGEPG---FPEARAIFYAAQIICGLEHLHQRR---I 116
Query: 460 LHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTS 519
++RD+KP NVLLD ++ D GLA G + GT GY+APE+L+ S
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR--AGTPGYMAPEVLQGEVYDFS 174
Query: 520 TDVYAFGVFMLEVACGRRPVQ 540
D +A G + E+ GR P +
Sbjct: 175 VDWFALGCTLYEMIAGRSPFR 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 70/271 (25%), Positives = 130/271 (47%), Gaps = 28/271 (10%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKV-CHDSDHGMKQFVSEIVSMGKLRHRNLV 396
+ L K KG G+V++G+ + +A+K + +++ ++ EI + + +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 397 QLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWE 456
+ G + +L ++ +Y+ GS +L L+ Q I++ + GL YLH E +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKK 122
Query: 457 QVVLHRDIKPANVLLDADLEGKLGDFGLA-RLYDHGNDLHTTNVVGTVGYLAPELLRNGR 515
+HRDIK ANVLL E KL DFG+A +L D + VGT ++APE+++
Sbjct: 123 ---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQSA 177
Query: 516 GTTSTDVYAFGVFMLEVACGRRP---VQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYV 572
+ D+++ G+ +E+A G P + P ++ L + + P LEG Y
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL-----------IPKNNPPTLEGNYS 226
Query: 573 EEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603
+ E V C + P RP+ ++++++
Sbjct: 227 KPLKEFVEA----CLNKEPSFRPTAKELLKH 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 69/219 (31%), Positives = 105/219 (47%), Gaps = 29/219 (13%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQF----VSEIVSMGKLRHRNLVQLR-- 399
+G G+VY+ + +A+KKV D+ + F + EI + +L HRN+V L+
Sbjct: 17 EGTYGQVYKARDKDTGELVALKKV--RLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI 74
Query: 400 --------GYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRI---IKGVAFGL 448
+ + KG LV++YM D L L F I +K + GL
Sbjct: 75 VTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSEDHIKSFMKQLLEGL 129
Query: 449 LYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAP 508
Y H+ + LHRDIK +N+LL+ + KL DFGLARLY+ TN V T+ Y P
Sbjct: 130 NYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPP 186
Query: 509 ELLR-NGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDL 546
ELL R + DV++ G + E+ ++P+ +L
Sbjct: 187 ELLLGEERYGPAIDVWSCGCILGELFT-KKPIFQANQEL 224
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 4e-17
Identities = 57/196 (29%), Positives = 93/196 (47%), Gaps = 13/196 (6%)
Query: 347 GGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKG 406
G G V+ G ++A+K + + + F+ E M KL H LVQL G C +
Sbjct: 15 GQFGLVWLGYW-LEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERS 72
Query: 407 ELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKP 466
+ LV+++M +G L L + R + + V G+ YL V+HRD+
Sbjct: 73 PICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAA 128
Query: 467 ANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGT---VGYLAPELLRNGRGTTSTDVY 523
N L+ + K+ DFG+ R D T+ GT V + +PE+ + ++ +DV+
Sbjct: 129 RNCLVGENQVVKVSDFGMTRFV---LDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVW 185
Query: 524 AFGVFMLEV-ACGRRP 538
+FGV M EV + G+ P
Sbjct: 186 SFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 70/222 (31%), Positives = 116/222 (52%), Gaps = 25/222 (11%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-DHGM-KQFVSEIVSMGKLRHRNL 395
Y+ + K +G G VY+ + +A+KK+ ++ D G+ + EI + +L H N+
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60
Query: 396 VQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQR------FRIIKGVAFGLL 449
V+L + +L LV++++ LD Y ++ P +++++G+A
Sbjct: 61 VRLLDVVHSENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIA---- 113
Query: 450 YLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT-TNVVGTVGYLAP 508
Y H VLHRD+KP N+L+D + KL DFGLAR + G + T T+ V T+ Y AP
Sbjct: 114 YCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAF--GVPVRTYTHEVVTLWYRAP 168
Query: 509 ELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPG--ELDLL 547
E+L R +T D+++ G E+ RRP+ PG E+D L
Sbjct: 169 EILLGSRQYSTPVDIWSIGCIFAEM-VNRRPLFPGDSEIDQL 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 7e-17
Identities = 58/214 (27%), Positives = 105/214 (49%), Gaps = 30/214 (14%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKV--CHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCR 403
+G G V + + +A+KK +++ + + E+ + L+ N+V+L+ R
Sbjct: 11 EGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFR 70
Query: 404 RKGELLLVYDY-----------MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLH 452
R+G+L LV++Y MPNG + + S +++IK + H
Sbjct: 71 RRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYI---------YQLIKAI-------H 114
Query: 453 EEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLR 512
+ ++HRDIKP N+L+ + KL DFG AR G++ + T V T Y +PELL
Sbjct: 115 WCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLL 174
Query: 513 NGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDL 546
+ D+++ G + E++ G +P+ PGE ++
Sbjct: 175 GAPYGKAVDMWSVGCILGELSDG-QPLFPGESEI 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 9e-17
Identities = 67/223 (30%), Positives = 120/223 (53%), Gaps = 25/223 (11%)
Query: 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD-HGM-KQFVSEIVSMGKLRHRN 394
+++ + K +G G VY+ + +A+KK+ D++ G+ + EI + +L H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 395 LVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRP----SLNWFQR--FRIIKGVAFGL 448
+V+L + +L LV++++ + L K + + P L + F++++G+AF
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKK--FMDASPLSGIPLPLIKSYLFQLLQGLAF-- 115
Query: 449 LYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT-TNVVGTVGYLA 507
+ H VLHRD+KP N+L++ + KL DFGLAR + G + T T+ V T+ Y A
Sbjct: 116 CHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRA 168
Query: 508 PELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPG--ELDLL 547
PE+L + +T+ D+++ G E+ RR + PG E+D L
Sbjct: 169 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQL 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 9e-17
Identities = 69/270 (25%), Positives = 119/270 (44%), Gaps = 34/270 (12%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQ-FVSEIVSMGKLRHRNLVQLRGYCRR 404
KG G VY+GVL + E+AVK +K+ F+ E + + H N+V+L G C +
Sbjct: 5 KGNFGDVYKGVL-KGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ 63
Query: 405 KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDI 464
K + +V + +P GSL L + L + ++ A G+ YL + +HRD+
Sbjct: 64 KQPIYIVMELVPGGSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDL 119
Query: 465 KPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGT----VGYLAPELLRNGRGTTST 520
N L+ + K+ DFG++R + G ++T + G + + APE L GR T+ +
Sbjct: 120 AARNCLVGENNVLKISDFGMSREEEGG--IYTVSD-GLKQIPIKWTAPEALNYGRYTSES 176
Query: 521 DVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASD-----PRLEGIYVEEQ 575
DV+++G+ + E PG + + P + E
Sbjct: 177 DVWSYGILLWETFSLGDTPYPG-----------MSNQQTRERIESGYRMPAPQLCPEE-- 223
Query: 576 MEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
+ +L L C +P+ RPS ++ L
Sbjct: 224 ---IYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 9e-17
Identities = 56/194 (28%), Positives = 97/194 (50%), Gaps = 28/194 (14%)
Query: 364 IAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKI 423
+AVK + SD+ K F E + L+H ++V+ G C L++V++YM +G L+K
Sbjct: 38 VAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKF 97
Query: 424 LYS-----------NTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLD 472
L + N L Q I + +A G++YL Q +HRD+ N L+
Sbjct: 98 LRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVG 154
Query: 473 ADLEGKLGDFGLARLYDHGNDLHTTNVVGTVG-------YLAPELLRNGRGTTSTDVYAF 525
+L K+GDFG++R D+++T+ G ++ PE + + TT +DV++
Sbjct: 155 ENLLVKIGDFGMSR------DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSL 208
Query: 526 GVFMLEV-ACGRRP 538
GV + E+ G++P
Sbjct: 209 GVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 9e-17
Identities = 67/218 (30%), Positives = 117/218 (53%), Gaps = 16/218 (7%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-DHGM-KQFVSEIVSMGKLRHRNL 395
Y + K +G G VY+G + +A+KK+ +S + G+ + EI + +L+H N+
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 396 VQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRI---IKGVAFGLLYLH 452
V L+ ++ L L+++++ S+D Y ++ P + + + + G+L+ H
Sbjct: 62 VCLQDVLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118
Query: 453 EEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPE-LL 511
+ VLHRD+KP N+L+D KL DFGLAR + ++T VV T+ Y APE LL
Sbjct: 119 S---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-TLWYRAPEVLL 174
Query: 512 RNGRGTTSTDVYAFGVFMLEVACGRRPVQPG--ELDLL 547
+ R +T D+++ G E+A ++P+ G E+D L
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMAT-KKPLFHGDSEIDQL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 9e-17
Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 24/207 (11%)
Query: 347 GGSGKVYRGVL----PSSHAEIAVKKVCHDSDHGMKQ--FVSEIVSMGKLRHRNLVQLRG 400
G GKVY+G L A K ++ Q F E M L+H N+V L G
Sbjct: 16 GAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLG 75
Query: 401 YCRRKGELLLVYDYMPNGSLDKILYSN--------------TRPSLNWFQRFRIIKGVAF 446
C ++ ++++Y+ +G L + L N + SL+ I +A
Sbjct: 76 VCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAA 135
Query: 447 GLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARL-YDHGNDLHTTNVVGTVGY 505
G+ YL +HRD+ N L+ L K+ DFGL+R Y + + V +
Sbjct: 136 GMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRW 192
Query: 506 LAPELLRNGRGTTSTDVYAFGVFMLEV 532
+ PE + G+ TT +D+++FGV + E+
Sbjct: 193 MPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 76/267 (28%), Positives = 130/267 (48%), Gaps = 35/267 (13%)
Query: 358 PSSHAEIAVKKVCHD-SDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVYDYM 415
P+ +AVK + D +D + VSE+ M + +H+N++ L G C + G L ++ +Y
Sbjct: 41 PNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYA 100
Query: 416 PNGSLDKILYSNTRPSLNW-FQRFRIIK-------------GVAFGLLYLHEEWEQVVLH 461
G+L + L + P +++ F ++ + VA G+ YL Q +H
Sbjct: 101 SKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIH 157
Query: 462 RDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH--TTNVVGTVGYLAPELLRNGRGTTS 519
RD+ NVL+ D K+ DFGLAR H D + TTN V ++APE L + T
Sbjct: 158 RDLAARNVLVTEDNVMKIADFGLARDV-HNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ 216
Query: 520 TDVYAFGVFMLEV-ACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEI 578
+DV++FGV + E+ G P PG ++ + ++G +D +Y +
Sbjct: 217 SDVWSFGVLLWEIFTLGGSPY-PG--IPVEELFKLLKEGHRMDKPANCTHELY------M 267
Query: 579 VLKLGLFCSHSNPDTRPSMRQVVQYLD 605
+++ C H+ P RP+ +Q+V+ LD
Sbjct: 268 IMRE---CWHAVPSQRPTFKQLVEDLD 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 71/263 (26%), Positives = 124/263 (47%), Gaps = 19/263 (7%)
Query: 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRN 394
R + K + K G G+V+ G + H ++A+K + S + F++E M +L+H
Sbjct: 5 RETLKLVKKLGAGQFGEVWMG-YYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPR 62
Query: 395 LVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEE 454
LV+L ++ + ++ +YM NGSL L + L + + +A G+ ++
Sbjct: 63 LVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER- 120
Query: 455 WEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNG 514
+ +HRD++ AN+L+ L K+ DFGLARL + + + APE + G
Sbjct: 121 --KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 178
Query: 515 RGTTSTDVYAFGVFMLE-VACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573
T +DV++FG+ + E V GR P PG + VI ++G + D E +Y
Sbjct: 179 TFTIKSDVWSFGILLTEIVTYGRIPY-PGMTN--PEVIQNLERGYRMPRPDNCPEELY-- 233
Query: 574 EQMEIVLKLGLFCSHSNPDTRPS 596
E++ C P+ RP+
Sbjct: 234 ---ELMRL----CWKEKPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 3e-16
Identities = 76/267 (28%), Positives = 121/267 (45%), Gaps = 33/267 (12%)
Query: 350 GKVYRGVLPSSHAEIAVKKVCHDSDHGMKQ--FVSEIVSMGKLRHRNLVQLRGYCRRKGE 407
G+ +RG+ S A + VK++ S +Q F+ E+ +L H N++Q G C
Sbjct: 14 GEAHRGM---SKARVVVKEL-RASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIP 69
Query: 408 LLLVYDYMPNGSLDKILYSNTRPSLNWFQR---FRIIKGVAFGLLYLHEEWEQVVLHRDI 464
LLV ++ P G L L SN Q+ R+ VA GLL+LH + +H D+
Sbjct: 70 YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDL 126
Query: 465 KPANVLLDADLEGKLGDFGLARLYDHGNDLHTTN--VVGTVGYLAPEL-------LRNGR 515
N L ADL K+GD+GLA L + D + T + +LAPEL L
Sbjct: 127 ALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKD 185
Query: 516 GTTSTDVYAFGVFMLEVA-CGRRPV-QPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573
T +++++ GV M E+ +P + +L V+ + P+L+ Y +
Sbjct: 186 QTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQD----IKLPKPQLDLKYSD 241
Query: 574 EQMEIVLKLGLFCSHSNPDTRPSMRQV 600
E++ FC P+TRP+ +V
Sbjct: 242 RWYEVM----QFCWLD-PETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 51/173 (29%), Positives = 91/173 (52%), Gaps = 8/173 (4%)
Query: 364 IAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKG--ELLLVYDYMPNGSLD 421
+AVKK+ H + ++ F EI + L+H N+V+ +G C G L LV +Y+P GSL
Sbjct: 36 VAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLR 95
Query: 422 KILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGD 481
L + R L+ + + G+ YL + +HRD+ N+L++++ K+GD
Sbjct: 96 DYLQKH-RERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGD 151
Query: 482 FGLARLYDHGNDLHTTNVVGT--VGYLAPELLRNGRGTTSTDVYAFGVFMLEV 532
FGL ++ + + G + + APE L + + ++DV++FGV + E+
Sbjct: 152 FGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 55/208 (26%), Positives = 103/208 (49%), Gaps = 20/208 (9%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKV-CHDSDHGMKQFVSEIVSMGKLRHRNLV 396
+ L KG G+VY+ + ++ +A+K + +++ ++ EI + + R +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 397 Q-----LRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYL 451
+ L+G +L ++ +Y GS +L L+ I++ V GL YL
Sbjct: 63 KYYGSFLKGS-----KLWIIMEYCGGGSCLDLLKPGK---LDETYIAFILREVLLGLEYL 114
Query: 452 HEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLA-RLYDHGNDLHTTNVVGTVGYLAPEL 510
HE + +HRDIK AN+LL + + KL DFG++ +L + +T VGT ++APE+
Sbjct: 115 HE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF--VGTPFWMAPEV 169
Query: 511 LRNGRGTTSTDVYAFGVFMLEVACGRRP 538
++ D+++ G+ +E+A G P
Sbjct: 170 IKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 3e-16
Identities = 70/248 (28%), Positives = 119/248 (47%), Gaps = 27/248 (10%)
Query: 379 QFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRF 438
Q + E+ + + +V G GE+ + ++M GSLD++L R +
Sbjct: 49 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKV 108
Query: 439 RIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLA-RLYDHGNDLHTT 497
I V GL YL E+ + ++HRD+KP+N+L+++ E KL DFG++ +L D
Sbjct: 109 SI--AVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MAN 160
Query: 498 NVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKG 557
+ VGT Y++PE L+ + +D+++ G+ ++E+A GR P+ P + L+ + +G
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEG 220
Query: 558 DVLD---ASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGALLPDIP 614
D + + PR G + S PD+RP M + + LD P
Sbjct: 221 DPAESETSPRPRPPGRPL--------------SSYGPDSRPPM-AIFELLDYIVNEPPPK 265
Query: 615 LNSSVFGV 622
L S VFG
Sbjct: 266 LPSGVFGA 273
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 82/265 (30%), Positives = 128/265 (48%), Gaps = 25/265 (9%)
Query: 346 KGGSGKVYRGVLPSSHAE---IAVKKVCHDSDHG-MKQFVSEIVSMGKLRHRNLVQLRGY 401
KG G VY G L S + AVK + +D ++QF+ E + M H N++ L G
Sbjct: 5 KGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGI 64
Query: 402 C-RRKGELLLVYDYMPNGSLDKILYSNTR-PSLNWFQRFRIIKGVAFGLLYLHEEWEQVV 459
C +G L+V YM +G L + S T P++ F + VA G+ YL +
Sbjct: 65 CLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL--QVAKGMEYLAS---KKF 119
Query: 460 LHRDIKPANVLLDADLEGKLGDFGLAR-LYDHGND-LHT-TNVVGTVGYLAPELLRNGRG 516
+HRD+ N +LD K+ DFGLAR +YD +H T V ++A E L+ +
Sbjct: 120 VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKF 179
Query: 517 TTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQM 576
TT +DV++FGV + E+ P P ++D D + Y +G L + + +Y
Sbjct: 180 TTKSDVWSFGVLLWELMTRGAPPYP-DVDSFD-ITVYLLQGRRLLQPEYCPDPLY----- 232
Query: 577 EIVLKLGLFCSHSNPDTRPSMRQVV 601
E++L C H P+ RP+ ++V
Sbjct: 233 EVMLS----CWHPKPEMRPTFSELV 253
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 7/152 (4%)
Query: 387 MGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAF 446
+ + H +V+L + K + ++ +Y G L IL + RF I V
Sbjct: 47 LEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFD-EYTARF-YIACVVL 104
Query: 447 GLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYL 506
YLH + +++RD+KP N+LLD++ KL DFG A+ G T GT Y+
Sbjct: 105 AFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT--FCGTPEYV 159
Query: 507 APELLRNGRGTTSTDVYAFGVFMLEVACGRRP 538
APE++ N S D ++ G+ + E+ GR P
Sbjct: 160 APEIILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 3e-16
Identities = 76/273 (27%), Positives = 124/273 (45%), Gaps = 31/273 (11%)
Query: 347 GGSGKVYRGVLPSSHAEIAVKKVCHD-SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK 405
G G VY+ + +AVK + D + KQ +SE+ + K ++ G +
Sbjct: 12 GNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE 71
Query: 406 GELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIK 465
+ + ++M GSLD + L RI V GL YL W +LHRD+K
Sbjct: 72 NRISICTEFMDGGSLD-VYRKIPEHVLG-----RIAVAVVKGLTYL---WSLKILHRDVK 122
Query: 466 PANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAF 525
P+N+L++ + KL DFG++ N + T VGT Y+APE + + +DV++
Sbjct: 123 PSNMLVNTRGQVKLCDFGVST--QLVNSIAKT-YVGTNAYMAPERISGEQYGIHSDVWSL 179
Query: 526 GVFMLEVACGRRP---VQPGELDLLDWVIDYWQKGDVLDASDPRL-EGIYVEEQMEIVLK 581
G+ +E+A GR P +Q + L+ + Q ++D P L G + E+ + + +
Sbjct: 180 GISFMELALGRFPYPQIQKNQGSLMP--LQLLQC--IVDEDPPVLPVGQFSEKFVHFITQ 235
Query: 582 LGLFCSHSNPDTRPSMRQV------VQYLDGGA 608
C P RP+ + VQY DG A
Sbjct: 236 ----CMRKQPKERPAPENLMDHPFIVQYNDGNA 264
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-16
Identities = 50/164 (30%), Positives = 89/164 (54%), Gaps = 9/164 (5%)
Query: 379 QFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRF 438
Q + E+ + + +V G GE+ + ++M GSLD++L R +
Sbjct: 49 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKV 108
Query: 439 RIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLA-RLYDHGNDLHTT 497
I V GL YL E+ + ++HRD+KP+N+L+++ E KL DFG++ +L D
Sbjct: 109 SI--AVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MAN 160
Query: 498 NVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQP 541
+ VGT Y++PE L+ + +D+++ G+ ++E+A GR P+ P
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 6/208 (2%)
Query: 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRN 394
R S + + K G G+V+ G + + ++AVK + + F+ E M KLRH
Sbjct: 5 RESLQLIKKLGNGQFGEVWMGTW-NGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDK 62
Query: 395 LVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEE 454
LVQL + + +V +YM GSL L +L + VA G+ Y+
Sbjct: 63 LVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER- 120
Query: 455 WEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNG 514
+HRD++ AN+L+ L K+ DFGLARL + + + APE G
Sbjct: 121 --MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 178
Query: 515 RGTTSTDVYAFGVFMLEVACGRRPVQPG 542
R T +DV++FG+ + E+ R PG
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 4e-16
Identities = 65/224 (29%), Positives = 114/224 (50%), Gaps = 24/224 (10%)
Query: 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQF----VSEIVSMGKLRH 392
Y+ L + +G G VYR + +A+KK+ + + + F + EI + KL+H
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKE--KEGFPITSLREINILLKLQH 63
Query: 393 RNLVQLR----GYCRRKGELLLVYDYMPNGSLD-KILYSNTRPSLNWFQRFRIIKGVAFG 447
N+V ++ G K + +V +Y+ + D K L + + ++ + G
Sbjct: 64 PNIVTVKEVVVGSNLDK--IYMVMEYVEH---DLKSLMETMKQPFLQSEVKCLMLQLLSG 118
Query: 448 LLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLA 507
+ +LH+ W +LHRD+K +N+LL+ K+ DFGLAR Y +T VV T+ Y A
Sbjct: 119 VAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRA 174
Query: 508 PELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPG--ELDLLD 548
PELL + +T+ D+++ G E+ ++P+ PG E+D L+
Sbjct: 175 PELLLGAKEYSTAIDMWSVGCIFAELLT-KKPLFPGKSEIDQLN 217
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 5e-16
Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 22/205 (10%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKV--CHDSDHGMK---QFVSEIVSMGKLRHRNLVQLRG 400
+G G+VY + E+AVK+V DS K EI + L+H +VQ G
Sbjct: 12 QGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYG 71
Query: 401 YCRRKGELLLVYDYMPNGSL-DKI-LYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQV 458
R L + +YMP GS+ D++ Y ++ +I++GV YLH +
Sbjct: 72 CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVE----YLHS---NM 124
Query: 459 VLHRDIKPANVLLDADLEGKLGDFG----LARLYDHGNDLHTTNVVGTVGYLAPELLRNG 514
++HRDIK AN+L D+ KLGDFG L + G + + V GT +++PE++ +G
Sbjct: 125 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS--VTGTPYWMSPEVI-SG 181
Query: 515 RG-TTSTDVYAFGVFMLEVACGRRP 538
G DV++ G ++E+ + P
Sbjct: 182 EGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 6e-16
Identities = 49/157 (31%), Positives = 79/157 (50%), Gaps = 18/157 (11%)
Query: 383 EIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDK-------ILYSNTRPSLNWF 435
E+ + ++H N+VQ + G L +V DY G L K +L+ L+WF
Sbjct: 49 EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPE-DQILDWF 107
Query: 436 QRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495
+ + L ++H+ + +LHRDIK N+ L D KLGDFG+AR+ + +L
Sbjct: 108 VQ------ICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA 158
Query: 496 TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEV 532
T +GT YL+PE+ N +D++A G + E+
Sbjct: 159 RT-CIGTPYYLSPEICENRPYNNKSDIWALGCVLYEM 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 6e-16
Identities = 68/273 (24%), Positives = 123/273 (45%), Gaps = 24/273 (8%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKV--CHDSDHGMKQ-FVSEIVSMGKLRHRN 394
+K K KG VY+ + +A+KKV D +Q + EI + +L H N
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63
Query: 395 LVQLRGYCRRKGELLLVYDYMPNGSLDKIL--YSNTRPSLNWFQRFRIIKGVAFGLLYLH 452
+++ EL +V + G L +++ + + + ++ + L ++H
Sbjct: 64 VIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH 123
Query: 453 EEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTT---NVVGTVGYLAPE 509
+ ++HRDIKPANV + A KLGD GL R + TT ++VGT Y++PE
Sbjct: 124 S---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS----KTTAAHSLVGTPYYMSPE 176
Query: 510 LLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEG 569
+ +D+++ G + E+A + P +++L + +K D P
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-LCKKIEKCDY----PPLPAD 231
Query: 570 IYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602
Y EE ++V + C + +P+ RP + V+Q
Sbjct: 232 HYSEELRDLVSR----CINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 6e-16
Identities = 56/186 (30%), Positives = 84/186 (45%), Gaps = 20/186 (10%)
Query: 363 EIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSL-D 421
EI + K + K E V + K++H N+V + G L +V +Y G L
Sbjct: 32 EIRLPKSSSAVEDSRK----EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQ 87
Query: 422 KILYSNTR--PS---LNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLE 476
KI + P L WF + + G+ ++HE + VLHRDIK N+ L + +
Sbjct: 88 KIKLQRGKLFPEDTILQWFVQ------MCLGVQHIHE---KRVLHRDIKSKNIFLTQNGK 138
Query: 477 GKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGR 536
KLGDFG ARL T VGT Y+ PE+ N +D+++ G + E+ +
Sbjct: 139 VKLGDFGSARLLTSPGAYACT-YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLK 197
Query: 537 RPVQPG 542
P Q
Sbjct: 198 HPFQAN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 7e-16
Identities = 72/241 (29%), Positives = 104/241 (43%), Gaps = 40/241 (16%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLV- 396
Y +L G +G V+ V +AVKK+ +K + EI + +L H N+V
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66
Query: 397 ----------QLRGYCRRKGELLLVY---DYMPNGSLDKILYSNTRPS----LNWFQRFR 439
L EL VY +YM L +L L +Q R
Sbjct: 67 VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLSEEHARLFMYQLLR 125
Query: 440 IIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDA-DLEGKLGDFGLARL----YDHGNDL 494
GL Y+H VLHRD+KPANV ++ DL K+GDFGLAR+ Y H L
Sbjct: 126 -------GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYL 175
Query: 495 HTTNVVGTVGYLAPELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPG--ELDLLDWVI 551
V T Y +P LL + T + D++A G E+ G +P+ G EL+ + ++
Sbjct: 176 SEGLV--TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KPLFAGAHELEQMQLIL 232
Query: 552 D 552
+
Sbjct: 233 E 233
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 7e-16
Identities = 61/241 (25%), Positives = 106/241 (43%), Gaps = 34/241 (14%)
Query: 373 SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSL-DKILYSNTRPS 431
S+ + ++EIV + L+H N++ + LL+ +Y G+L DKI+ R
Sbjct: 39 SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIV----RQK 94
Query: 432 LNWFQR-------FRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGL 484
F+ F+I+ V+ Y+H+ +LHRDIK N+ L KLGDFG+
Sbjct: 95 GQLFEEEMVLWYLFQIVSAVS----YIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGI 147
Query: 485 ARLYDHGND-LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGE 543
+++ G++ VVGT Y++PEL + + +D++A G + E+ +R
Sbjct: 148 SKIL--GSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN 205
Query: 544 LDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603
L I V P + Y E + +V +P+ RP+ +V+
Sbjct: 206 PLNLVVKI-------VQGNYTPVVSV-YSSELISLVHS----LLQQDPEKRPTADEVLDQ 253
Query: 604 L 604
Sbjct: 254 P 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 7e-16
Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 30/197 (15%)
Query: 364 IAVKKVCHDSDHGM--KQFVSEIVSMGKLR-HRNLVQLRGYCRRKGELLLVYDYMPNG-- 418
+A+KK+ + + K+ + E+ + R H+N+ L ++ +V+ N
Sbjct: 30 VAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLY-------DMDIVFPGNFNELY 82
Query: 419 --------SLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVL 470
L +I+ S + FQ F I + GL Y+H VLHRD+KP N+L
Sbjct: 83 LYEELMEADLHQIIRSGQPLTDAHFQSF--IYQILCGLKYIHS---ANVLHRDLKPGNLL 137
Query: 471 LDADLEGKLGDFGLARLYDHG---NDLHTTNVVGTVGYLAPE-LLRNGRGTTSTDVYAFG 526
++AD E K+ DFGLAR + N T V T Y APE +L T + DV++ G
Sbjct: 138 VNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVG 197
Query: 527 VFMLEVACGRRPVQPGE 543
+ E+ GR+PV G+
Sbjct: 198 CILAEL-LGRKPVFKGK 213
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 7e-16
Identities = 67/263 (25%), Positives = 117/263 (44%), Gaps = 39/263 (14%)
Query: 364 IAVKKV-CHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDK 422
+AVK + SD+ + F+ E+ + +L N+ +L G C L ++ +YM NG L++
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 423 ILY---------SNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDA 473
L + SL++ + +A G+ YL E V HRD+ N L+
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL-ESLNFV--HRDLATRNCLVGK 165
Query: 474 DLEGKLGDFGLAR-LYDHGNDLHTT--NVVGTVGYLAPELLRNGRGTTSTDVYAFGVFML 530
+ K+ DFG++R LY +D + + ++A E + G+ TT +DV+AFGV +
Sbjct: 166 NYTIKIADFGMSRNLYS--SDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLW 223
Query: 531 EVA--CGRRPVQPGELDLLDWVID------YWQKGDVLDASDPRL-EGIYVEEQMEIVLK 581
E+ C +P + L VI+ + P + IY +
Sbjct: 224 EILTLCREQPYE--HLT-DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIY---------E 271
Query: 582 LGLFCSHSNPDTRPSMRQVVQYL 604
L L C + + RP+ R++ +L
Sbjct: 272 LMLECWRRDEEDRPTFREIHLFL 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 9e-16
Identities = 71/277 (25%), Positives = 130/277 (46%), Gaps = 31/277 (11%)
Query: 333 PHRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKV-CHDSDHGMKQFVSEIVSMGKLR 391
P + L + KG G+VY+G+ + +A+K + +++ ++ EI + +
Sbjct: 2 PEEL-FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 392 HRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPS-LNWFQRFRIIKGVAFGLLY 450
+ + G + +L ++ +Y+ GS +L +P L I++ + GL Y
Sbjct: 61 SPYITRYYGSYLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDY 116
Query: 451 LHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLA-RLYDHGNDLHTTNVVGTVGYLAPE 509
LH E + +HRDIK ANVLL + KL DFG+A +L D + VGT ++APE
Sbjct: 117 LHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPE 171
Query: 510 LLRNGRGTTSTDVYAFGVFMLEVACGRRP---VQPGELDLLDWVIDYWQKGDVLDASDPR 566
+++ D+++ G+ +E+A G P + P + L + S P
Sbjct: 172 VIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL-----------IPKNSPPT 220
Query: 567 LEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603
LEG Y + E V C + +P RP+ ++++++
Sbjct: 221 LEGQYSKPFKEFVEA----CLNKDPRFRPTAKELLKH 253
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 54/189 (28%), Positives = 93/189 (49%), Gaps = 17/189 (8%)
Query: 364 IAVKKVCHDSDHGMKQ-FVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDK 422
+AVK + D + F+ EI M +L++ N+++L G C L ++ +YM NG L++
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 423 IL----------YSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLD 472
L ++N PS++ + +A G+ YL +HRD+ N L+
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCLVG 163
Query: 473 ADLEGKLGDFGLAR-LYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLE 531
K+ DFG++R LY V + ++A E + G+ TT++DV+AFGV + E
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 223
Query: 532 V--ACGRRP 538
+ C +P
Sbjct: 224 MFTLCKEQP 232
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 61/248 (24%), Positives = 113/248 (45%), Gaps = 20/248 (8%)
Query: 360 SHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGS 419
+ ++A+K + ++ + F+ E M KL H LVQL G C ++ L +V ++M NG
Sbjct: 27 AQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGC 85
Query: 420 LDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKL 479
L L + L+ + + V G+ YL +HRD+ N L+ + K+
Sbjct: 86 LLNYLRQR-QGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKV 141
Query: 480 GDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRP 538
DFG+ R ++ V + PE+ + ++ +DV++FGV M EV G+ P
Sbjct: 142 SDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMP 201
Query: 539 VQP-GELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSM 597
+ ++++ + +G L P+L + V E M C H P+ RP+
Sbjct: 202 FEKKSNYEVVEMI----SRGFRL--YRPKLASMTVYEVM-------YSCWHEKPEGRPTF 248
Query: 598 RQVVQYLD 605
++++ +
Sbjct: 249 AELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 7/201 (3%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQ 397
Y K +G SG VY + ++ E+A+K++ + ++EI+ M + +H N+V
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN 80
Query: 398 LRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQ 457
EL +V +Y+ GSL ++ T ++ Q + + L +LH
Sbjct: 81 YLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHS---N 134
Query: 458 VVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGT 517
V+HRDIK N+LL D KL DFG +T +VGT ++APE++
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYG 193
Query: 518 TSTDVYAFGVFMLEVACGRRP 538
D+++ G+ +E+ G P
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 55/203 (27%), Positives = 104/203 (51%), Gaps = 10/203 (4%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKV-CHDSDHGMKQFVSEIVSMGKLRHRNLV 396
+ L + KG G+V++G+ + +A+K + +++ ++ EI + + +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 397 QLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWE 456
+ G + +L ++ +Y+ GS +L + + FQ ++K + GL YLH E +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEKK 122
Query: 457 QVVLHRDIKPANVLLDADLEGKLGDFGLA-RLYDHGNDLHTTNVVGTVGYLAPELLRNGR 515
+HRDIK ANVLL + KL DFG+A +L D + VGT ++APE+++
Sbjct: 123 ---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIQQSA 177
Query: 516 GTTSTDVYAFGVFMLEVACGRRP 538
+ D+++ G+ +E+A G P
Sbjct: 178 YDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 81/272 (29%), Positives = 119/272 (43%), Gaps = 42/272 (15%)
Query: 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGK-LRHRNL 395
+YK L K +G VY+G + +A+K++ + + G S+ K L+H N+
Sbjct: 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANI 65
Query: 396 VQLRGYCRRKGELLLVYDYM-----------PNGSLDKILYSNTRPSLNWFQRFRIIKGV 444
V L K L LV++Y+ G + N R L FQ R
Sbjct: 66 VTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGG----LSMHNVR--LFLFQLLR----- 114
Query: 445 AFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVG 504
GL Y H+ + VLHRD+KP N+L+ E KL DFGLAR + ++ VV T+
Sbjct: 115 --GLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-TLW 168
Query: 505 YLAPE-LLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDAS 563
Y P+ LL + +TS D++ G E+A G RP+ PG D+ D + +
Sbjct: 169 YRPPDVLLGSTEYSTSLDMWGVGCIFYEMATG-RPLFPGSTDVEDQLHKIF--------- 218
Query: 564 DPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRP 595
R+ G EE V F +S P P
Sbjct: 219 --RVLGTPTEETWPGVSSNPEFKPYSFPFYPP 248
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 31/209 (14%)
Query: 346 KGGSGKVYRGVLPSSHAEI-----AVKKVCHDSDHGMKQFVSEIVSMGKL-RHRNLVQLR 399
+G G+V + + + +K+ DH + F E+ + KL H N++ L
Sbjct: 5 EGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLGHHPNIINLL 62
Query: 400 GYCRRKGELLLVYDYMPNGSL------DKILYSN--------TRPSLNWFQRFRIIKGVA 445
G C +G L L +Y P+G+L ++L ++ T +L+ Q VA
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 446 FGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVG--TV 503
G+ YL + + +HRD+ N+L+ + K+ DFGL+R G +++ +G V
Sbjct: 123 RGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGRLPV 175
Query: 504 GYLAPELLRNGRGTTSTDVYAFGVFMLEV 532
++A E L TT++DV+++GV + E+
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEI 204
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 58/199 (29%), Positives = 102/199 (51%), Gaps = 18/199 (9%)
Query: 347 GGSGKVYRGVLPSSHAEIAVKKVC--HDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR 404
G G VY+ + + A+K + H+ D +Q EI + + H N+V+
Sbjct: 85 GAGGTVYKVIHRPTGRLYALKVIYGNHE-DTVRRQICREIEILRDVNHPNVVKCHDMFDH 143
Query: 405 KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDI 464
GE+ ++ ++M GSL+ + L R +I+ G+A YLH + ++HRDI
Sbjct: 144 NGEIQVLLEFMDGGSLEGT-HIADEQFLADVAR-QILSGIA----YLHR---RHIVHRDI 194
Query: 465 KPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPEL----LRNGR-GTTS 519
KP+N+L+++ K+ DFG++R+ D ++ VGT+ Y++PE L +G +
Sbjct: 195 KPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS-VGTIAYMSPERINTDLNHGAYDGYA 253
Query: 520 TDVYAFGVFMLEVACGRRP 538
D+++ GV +LE GR P
Sbjct: 254 GDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 68/229 (29%), Positives = 106/229 (46%), Gaps = 25/229 (10%)
Query: 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMK-QFVSEIVSMGKLRHRNL 395
SY NL K +G VY+G+ + +A+K + ++ G+ + E + L+H N+
Sbjct: 6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANI 65
Query: 396 VQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPS--------LNWFQRFRIIKGVAFG 447
V L K L V++YM D Y P L FQ R G
Sbjct: 66 VLLHDIIHTKETLTFVFEYM---HTDLAQYMIQHPGGLHPYNVRLFMFQLLR-------G 115
Query: 448 LLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLA 507
L Y+H Q +LHRD+KP N+L+ E KL DFGLAR + +++ VV T+ Y
Sbjct: 116 LAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRP 171
Query: 508 PE-LLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQ 555
P+ LL +++ D++ G +E+ G +P PG D+ + + W
Sbjct: 172 PDVLLGATDYSSALDIWGAGCIFIEMLQG-QPAFPGVSDVFEQLEKIWT 219
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 70/271 (25%), Positives = 123/271 (45%), Gaps = 16/271 (5%)
Query: 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRN 394
R S K + K G G+V+ G +S ++AVK + ++ F+ E M L+H
Sbjct: 5 RESIKLVKKLGAGQFGEVWMGYYNNS-TKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDK 62
Query: 395 LVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEE 454
LV+L ++ + ++ +YM GSL L S+ + + +A G+ Y+
Sbjct: 63 LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER- 121
Query: 455 WEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNG 514
+ +HRD++ ANVL+ L K+ DFGLAR+ + + + APE + G
Sbjct: 122 --KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 179
Query: 515 RGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEE 574
T +DV++FG+ + E+ + PG + V+ Q+G + PR+E E
Sbjct: 180 SFTIKSDVWSFGILLYEIVTYGKIPYPGMSN--SDVMSALQRGYRM----PRMENCPDE- 232
Query: 575 QMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
+ ++K C + RP+ + LD
Sbjct: 233 -LYDIMKT---CWKEKAEERPTFDYLQSVLD 259
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 60/200 (30%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 350 GKVYRGVLPSSHAE---IAVK--KVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR 404
G VY+GV S E +AVK K C K F+ E M + H ++V+L G
Sbjct: 20 GDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-FLQEAYIMRQFDHPHIVKLIGVITE 78
Query: 405 KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIK---GVAFGLLYLHEEWEQVVLH 461
+ +V + P G L L N +I ++ L YL + +H
Sbjct: 79 N-PVWIVMELAPLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLES---KRFVH 130
Query: 462 RDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTD 521
RDI NVL+ + KLGDFGL+R + + + + ++APE + R T+++D
Sbjct: 131 RDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASD 190
Query: 522 VYAFGVFMLEV-ACGRRPVQ 540
V+ FGV M E+ G +P Q
Sbjct: 191 VWMFGVCMWEILMLGVKPFQ 210
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 72/280 (25%), Positives = 126/280 (45%), Gaps = 38/280 (13%)
Query: 346 KGGSGKVYRGVLP---SSHAEIAVK--KVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRG 400
+G G V G L S ++AVK K+ + +++F+SE M H N+++L G
Sbjct: 9 EGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIG 68
Query: 401 YCRRKGEL------LLVYDYMPNGSLDK-ILYSNTRPSLNWFQRFRIIK---GVAFGLLY 450
C L +++ +M +G L +LYS ++K +A G+ Y
Sbjct: 69 VCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEY 128
Query: 451 LHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGT-VGYLAPE 509
L + +HRD+ N +L D+ + DFGL++ G+ + V ++A E
Sbjct: 129 LSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIE 185
Query: 510 LLRNGRGTTSTDVYAFGVFMLEVAC-GRRP---VQPGELDLLDWVIDYWQKGDVLDASDP 565
L + T+ +DV+AFGV M E+A G+ P V+ E + DY + G+ L +
Sbjct: 186 SLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE------IYDYLRHGNRLKQPED 239
Query: 566 RLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
L+ +Y L C ++P RP+ ++ + L+
Sbjct: 240 CLDELY---------DLMYSCWRADPKDRPTFTKLREVLE 270
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 84/281 (29%), Positives = 128/281 (45%), Gaps = 40/281 (14%)
Query: 346 KGGSGKVYRG----VLPSSHAEI--AVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQL 398
G G+VY G +L I AVK + + D K+F+ E M H N+V+L
Sbjct: 5 SGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKL 64
Query: 399 RGYCRRKGELLLVYDYMPNGSL-----DKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHE 453
G C ++ + M G L D + P L + I VA G +YL
Sbjct: 65 LGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL-- 122
Query: 454 EWEQV-VLHRDIKPANVLL-----DADLEGKLGDFGLAR-LYDHGNDLHTTNVVG--TVG 504
EQ+ +HRD+ N L+ DAD K+GDFGLAR +Y +D + G V
Sbjct: 123 --EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK--SDYYRKEGEGLLPVR 178
Query: 505 YLAPELLRNGRGTTSTDVYAFGVFMLEV-ACGRRPVQPGELDLLDWVIDYWQKGDVLDAS 563
++APE L +G+ TT +DV++FGV M E+ G++P P L+ + V+ + G L
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY-PA-LNNQE-VLQHVTAGGRLQKP 235
Query: 564 DPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYL 604
+ + IY +L C +P RP+ ++ + L
Sbjct: 236 ENCPDKIY---------QLMTNCWAQDPSERPTFDRIQEIL 267
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 3e-15
Identities = 73/270 (27%), Positives = 125/270 (46%), Gaps = 41/270 (15%)
Query: 358 PSSHAEIAVKKVCHD-SDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVYDYM 415
P +AVK + + +D + +SE+ M + +H+N++ L G C ++G L ++ +Y
Sbjct: 41 PDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYA 100
Query: 416 PNGSLDKILYSNTRPSLNW-FQRFRIIKG-------------VAFGLLYLHEEWEQVVLH 461
G+L + L + P ++ F ++ + VA G+ YL + +H
Sbjct: 101 AKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIH 157
Query: 462 RDIKPANVLLDADLEGKLGDFGLAR-LYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTST 520
RD+ NVL+ D K+ DFGLAR ++D T+N V ++APE L + T +
Sbjct: 158 RDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQS 217
Query: 521 DVYAFGVFMLEV---ACGRRPVQPGE--LDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQ 575
DV++FG+ M E+ P P E LL ++G +D +Y+
Sbjct: 218 DVWSFGILMWEIFTLGGSPYPGIPVEELFKLL-------REGHRMDKPSNCTHELYM--- 267
Query: 576 MEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
L C H+ P RP+ +Q+V+ LD
Sbjct: 268 ------LMRECWHAVPTQRPTFKQLVEALD 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 74/272 (27%), Positives = 125/272 (45%), Gaps = 45/272 (16%)
Query: 358 PSSHAEIAVKKVCHD-SDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVYDYM 415
P +AVK + D ++ + VSE+ M + +H+N++ L G C + G L ++ +Y
Sbjct: 44 PKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 103
Query: 416 PNGSLDKILYSNTRPSLNW-FQRFRI-------------IKGVAFGLLYLHEEWEQVVLH 461
G+L + L + P + + + R+ VA G+ YL Q +H
Sbjct: 104 SKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIH 160
Query: 462 RDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH-------TTNVVGTVGYLAPELLRNG 514
RD+ NVL+ + K+ DFGLAR D++ TTN V ++APE L +
Sbjct: 161 RDLAARNVLVTENNVMKIADFGLAR------DVNNIDYYKKTTNGRLPVKWMAPEALFDR 214
Query: 515 RGTTSTDVYAFGVFMLEV-ACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573
T +DV++FGV M E+ G P PG ++ + ++G +D +Y+
Sbjct: 215 VYTHQSDVWSFGVLMWEIFTLGGSPY-PG--IPVEELFKLLKEGHRMDKPANCTNELYMM 271
Query: 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
+ C H+ P RP+ +Q+V+ LD
Sbjct: 272 MRD---------CWHAIPSHRPTFKQLVEDLD 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 72/272 (26%), Positives = 127/272 (46%), Gaps = 45/272 (16%)
Query: 358 PSSHAEIAVKKVCHD-SDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVYDYM 415
P+ ++AVK + D ++ + +SE+ M + +H+N++ L G C + G L ++ +Y
Sbjct: 47 PNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 106
Query: 416 PNGSLDKILYSNTRPSLNW----------FQRFRIIKGVAF----GLLYLHEEWEQVVLH 461
G+L + L + P + + F+ + A+ G+ YL + +H
Sbjct: 107 SKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIH 163
Query: 462 RDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH-------TTNVVGTVGYLAPELLRNG 514
RD+ NVL+ D K+ DFGLAR D+H TTN V ++APE L +
Sbjct: 164 RDLAARNVLVTEDNVMKIADFGLAR------DIHHIDYYKKTTNGRLPVKWMAPEALFDR 217
Query: 515 RGTTSTDVYAFGVFMLEV-ACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573
T +DV++FGV + E+ G P PG ++ + ++G +D +Y+
Sbjct: 218 IYTHQSDVWSFGVLLWEIFTLGGSPY-PGV--PVEELFKLLKEGHRMDKPSNCTNELYMM 274
Query: 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
+ C H+ P RP+ +Q+V+ LD
Sbjct: 275 MRD---------CWHAVPSQRPTFKQLVEDLD 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 41/229 (17%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKV----CHDSDHGMKQFVS----------EIVSMGKLR 391
+G GKV + + +A+KKV + +Q V E+ M +++
Sbjct: 19 EGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK 78
Query: 392 HRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYL 451
H N++ L + LV D M L K++ R + + Q I+ + GL L
Sbjct: 79 HENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTES--QVKCILLQILNGLNVL 135
Query: 452 HEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND----------------LH 495
H+ + +HRD+ PAN+ +++ K+ DFGLAR Y G
Sbjct: 136 HKWY---FMHRDLSPANIFINSKGICKIADFGLARRY--GYPPYSDTLSKDETMQRREEM 190
Query: 496 TTNVVGTVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQPGE 543
T+ VV T+ Y APELL + + D+++ G E+ G +P+ PGE
Sbjct: 191 TSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KPLFPGE 237
|
Length = 335 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 31/209 (14%)
Query: 346 KGGSGKVYRGVLPS-----SHAEIAVKKVCHDSDHGMKQFVSEIVSMGKL-RHRNLVQLR 399
+G G+V R ++ + A +K+ ++DH + F E+ + KL H N++ L
Sbjct: 12 EGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDH--RDFAGELEVLCKLGHHPNIINLL 69
Query: 400 GYCRRKGELLLVYDYMPNGSL------DKILYSN--------TRPSLNWFQRFRIIKGVA 445
G C +G L + +Y P G+L ++L ++ T +L Q + VA
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 446 FGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVG--TV 503
G+ YL E + +HRD+ NVL+ +L K+ DFGL+R G +++ +G V
Sbjct: 130 TGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVKKTMGRLPV 182
Query: 504 GYLAPELLRNGRGTTSTDVYAFGVFMLEV 532
++A E L TT +DV++FGV + E+
Sbjct: 183 RWMAIESLNYSVYTTKSDVWSFGVLLWEI 211
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 4e-15
Identities = 70/209 (33%), Positives = 105/209 (50%), Gaps = 27/209 (12%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQF--VSEIVSMGK-LRHRNLVQLR 399
KG G VY G L + IAVK+V D+ K++ + E V + K L+H N+VQ
Sbjct: 10 KGAYGTVYCG-LTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYL 68
Query: 400 GYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRF--RIIKGVAFGLLYLHEEWEQ 457
G C + + +++P GS+ IL F ++ +I+ GVA YLH
Sbjct: 69 GTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA----YLH---NN 121
Query: 458 VVLHRDIKPANVLLDADLEGKLGDFGLARLY-------DHGNDLHTTNVVGTVGYLAPEL 510
V+HRDIK NV+L + KL DFG AR H N L + + GT ++APE+
Sbjct: 122 CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS--MHGTPYWMAPEV 179
Query: 511 LR-NGRGTTSTDVYAFGVFMLEVACGRRP 538
+ +G G S D+++ G + E+A G+ P
Sbjct: 180 INESGYGRKS-DIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 70/266 (26%), Positives = 126/266 (47%), Gaps = 49/266 (18%)
Query: 364 IAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKI 423
+AVK + + K F E + L+H ++V+ G C L++V++YM +G L+K
Sbjct: 38 VAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKF 97
Query: 424 LYSN--------------TRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANV 469
L ++ + L Q I +A G++YL Q +HRD+ N
Sbjct: 98 LRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNC 154
Query: 470 LLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVG-------YLAPELLRNGRGTTSTDV 522
L+ A+L K+GDFG++R D+++T+ G ++ PE + + TT +DV
Sbjct: 155 LVGANLLVKIGDFGMSR------DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDV 208
Query: 523 YAFGVFMLEV-ACGRRP---VQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEI 578
++FGV + E+ G++P + E VI+ +G VL+ PR + +E +I
Sbjct: 209 WSFGVILWEIFTYGKQPWFQLSNTE------VIECITQGRVLER--PR---VCPKEVYDI 257
Query: 579 VLKLGLFCSHSNPDTRPSMRQVVQYL 604
+L C P R +++++ + L
Sbjct: 258 MLG----CWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 51/197 (25%), Positives = 95/197 (48%), Gaps = 10/197 (5%)
Query: 347 GGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKG 406
G GKVY+ + A K + +S+ ++ F+ EI + + +H N+V L +
Sbjct: 16 GAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN 75
Query: 407 ELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKP 466
+L ++ ++ G+LD I+ R L Q + + + L +LH V+HRD+K
Sbjct: 76 KLWILIEFCDGGALDSIMLELERG-LTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKA 131
Query: 467 ANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELL-----RNGRGTTSTD 521
N+LL D + KL DFG++ T +GT ++APE++ ++ D
Sbjct: 132 GNILLTLDGDVKLADFGVSAKNKSTLQKRDT-FIGTPYWMAPEVVACETFKDNPYDYKAD 190
Query: 522 VYAFGVFMLEVACGRRP 538
+++ G+ ++E+A P
Sbjct: 191 IWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 6e-15
Identities = 65/212 (30%), Positives = 101/212 (47%), Gaps = 27/212 (12%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQF----VSEIVSMGKLRHR 393
Y+ L K +G G+V++ + +A+KKV +++ + F + EI + L+H
Sbjct: 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK--EGFPITALREIKILQLLKHE 71
Query: 394 NLVQLRGYCRR--------KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVA 445
N+V L CR KG LV+++ + L +L SN + +++K +
Sbjct: 72 NVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLL-SNKNVKFTLSEIKKVMKMLL 129
Query: 446 FGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLY-----DHGNDLHTTNVV 500
GL Y+H +LHRD+K AN+L+ D KL DFGLAR + N +T VV
Sbjct: 130 NGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPN-RYTNRVV 185
Query: 501 GTVGYLAPELLRNGRG-TTSTDVYAFGVFMLE 531
T+ Y PELL R D++ G M E
Sbjct: 186 -TLWYRPPELLLGERDYGPPIDMWGAGCIMAE 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 7e-15
Identities = 58/223 (26%), Positives = 103/223 (46%), Gaps = 29/223 (13%)
Query: 387 MGKLRHRNLVQLR-GYCRRKGELLLVYDYMPNGSLDKILYSNT------RPSLNWFQRFR 439
+ +L+H N+V R + G L +V + G L L + WF +
Sbjct: 53 LSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQ-- 110
Query: 440 IIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNV 499
+A L YLHE+ +LHRD+K NV L K+GD G+AR+ ++ D+ +T +
Sbjct: 111 ----IAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST-L 162
Query: 500 VGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDV 559
+GT Y++PEL N +DV+A G + E+A + +++ L + I
Sbjct: 163 IGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI-------- 214
Query: 560 LDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602
++ P + Y E E++ + P+ RPS++ +++
Sbjct: 215 IEGKLPPMPKDYSPELGELIATM----LSKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 7e-15
Identities = 63/226 (27%), Positives = 105/226 (46%), Gaps = 15/226 (6%)
Query: 380 FVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFR 439
F+ E M KLRH LV L + + +V ++M GSL L L Q
Sbjct: 48 FLQEAQIMKKLRHDKLVPLYAVVSEE-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVD 106
Query: 440 IIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNV 499
+ +A G+ Y+ +HRD++ AN+L+ +L K+ DFGLARL +
Sbjct: 107 MAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGA 163
Query: 500 VGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDV 559
+ + APE GR T +DV++FG+ + E+ R PG ++ V++ ++G
Sbjct: 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN--REVLEQVERGYR 221
Query: 560 LDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
+ P +G E + ++KL C +PD RP+ + +L+
Sbjct: 222 M----PCPQG--CPESLHELMKL---CWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 9e-15
Identities = 53/165 (32%), Positives = 80/165 (48%), Gaps = 12/165 (7%)
Query: 377 MKQ---FVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLN 433
+KQ ++E + +RH LV L G + L LV +Y+P G L L + R
Sbjct: 42 LKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEP 101
Query: 434 WFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493
RF + V L YLH +++RD+KP N+LLD+D K+ DFG A+
Sbjct: 102 V-ARFYAAQ-VVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154
Query: 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRP 538
T + GT YLAPE++ + + D +A G+ + E+ G P
Sbjct: 155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-14
Identities = 60/193 (31%), Positives = 92/193 (47%), Gaps = 20/193 (10%)
Query: 362 AEIAVKKVCHDSDHGMKQ---FVSEIVSMGKLRHRNLVQL--RGYCRRKGELLLVYDYMP 416
E+A+K + D+ Q F E +L H N+V L G G L V++Y+P
Sbjct: 4 HEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAP-PGLLFAVFEYVP 62
Query: 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDA-DL 475
+L ++L +L + R++ V L H Q ++HRD+KP N+++ +
Sbjct: 63 GRTLREVL--AADGALPAGETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTGV 117
Query: 476 E--GKLGDFGLARLYDHGNDL------HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGV 527
K+ DFG+ L D TT V+GT Y APE LR T ++D+YA+G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 528 FMLEVACGRRPVQ 540
LE G+R VQ
Sbjct: 178 IFLECLTGQRVVQ 190
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 40/113 (35%), Positives = 59/113 (52%), Gaps = 16/113 (14%)
Query: 435 FQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494
+Q + +K Y+H V+HRD+KP+N+LL++D KL DFGLAR +
Sbjct: 114 YQLLKALK-------YIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163
Query: 495 HTTNV----VGTVGYLAPE-LLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPG 542
V V T Y APE LL + R T D+++ G + E+ G +P+ PG
Sbjct: 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG-KPLFPG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 52/189 (27%), Positives = 96/189 (50%), Gaps = 10/189 (5%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMK-QFVSEIVSMGKLRHRNLVQLRGYCRR 404
KG G+V++G L +AVK D +K +F+SE + + H N+V+L G C +
Sbjct: 5 KGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ 63
Query: 405 KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDI 464
+ + +V + +P G L + L Q + A G+ YL + +HRD+
Sbjct: 64 RQPIYIVMELVPGGDFLSFL-RKKKDELKTKQLVKFALDAAAGMAYLES---KNCIHRDL 119
Query: 465 KPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTV--GYLAPELLRNGRGTTSTDV 522
N L+ + K+ DFG++R D G +++++ + + + APE L GR ++ +DV
Sbjct: 120 AARNCLVGENNVLKISDFGMSRQEDDG--IYSSSGLKQIPIKWTAPEALNYGRYSSESDV 177
Query: 523 YAFGVFMLE 531
+++G+ + E
Sbjct: 178 WSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 74/277 (26%), Positives = 128/277 (46%), Gaps = 33/277 (11%)
Query: 346 KGGSGKVYRGVLPSSHA--EIAVKK----VCHDSDHGMKQFVSEIVSMGKLRHRNLVQLR 399
+G G V G L + ++AVK +C S+ M+ F+SE V M + H N+++L
Sbjct: 9 EGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSE--MEDFLSEAVCMKEFDHPNVMRLI 66
Query: 400 GYCRRKGEL------LLVYDYMPNGSLDK-ILYSNTRPSLNWFQRFRIIK---GVAFGLL 449
G C + E +++ +M +G L +LYS + ++K +A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 450 YLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGT-VGYLAP 508
YL + +HRD+ N +L+ ++ + DFGL++ +G+ + V ++A
Sbjct: 127 YLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 509 ELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLE 568
E L + TT +DV++FGV M E+A + PG + + DY ++G+ L L+
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--SEIYDYLRQGNRLKQPPDCLD 241
Query: 569 GIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
G+Y L C NP RPS + L+
Sbjct: 242 GLY---------SLMSSCWLLNPKDRPSFETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 44/141 (31%), Positives = 65/141 (46%), Gaps = 10/141 (7%)
Query: 405 KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDI 464
K L LV +Y+ G ++ + +W +++ I V G+ LH+ ++HRDI
Sbjct: 69 KDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQY--IAEVVLGVEDLHQRG---IIHRDI 123
Query: 465 KPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYA 524
KP N+L+D KL DFGL+R N L VGT YLAPE + +D ++
Sbjct: 124 KPENLLIDQTGHLKLTDFGLSR-----NGLENKKFVGTPDYLAPETILGVGDDKMSDWWS 178
Query: 525 FGVFMLEVACGRRPVQPGELD 545
G + E G P D
Sbjct: 179 LGCVIFEFLFGYPPFHAETPD 199
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 23/208 (11%)
Query: 347 GGSGKVYRGVLPSSHAEIAVKKV-----CHDSDHGMKQFVS----EIVSMGKLRHRNLVQ 397
G G VY G+ SS +AVK+V S + + EI + +L+H N+VQ
Sbjct: 11 GSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQ 70
Query: 398 LRGYCRRKGELLLVYDYMPNGSLDKIL--YSNTRPSLNWFQRFRIIKGVAFGLLYLHEEW 455
G L + +Y+P GS+ +L Y +L + F ++ + GL YLH
Sbjct: 71 YLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL--VRNF--VRQILKGLNYLHN-- 124
Query: 456 EQVVLHRDIKPANVLLDADLEGKLGDFGL-----ARLYDHGNDLHTTNVVGTVGYLAPEL 510
+ ++HRDIK AN+L+D K+ DFG+ A + ++ G+V ++APE+
Sbjct: 125 -RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEV 183
Query: 511 LRNGRGTTSTDVYAFGVFMLEVACGRRP 538
++ T D+++ G ++E+ G+ P
Sbjct: 184 VKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 68/268 (25%), Positives = 119/268 (44%), Gaps = 20/268 (7%)
Query: 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGK-LRHRNL 395
++ +YK K +G+ + + A K + D + VSE+ + + LRH N+
Sbjct: 12 AFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNI 71
Query: 396 VQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIK---GVAFGLLYLH 452
V+ L +V D + L + +++ + F RI + L YLH
Sbjct: 72 VRYYKTFLENDRLYIVMDLIEGAPLGE-HFNSLKEKKQRFTEERIWNIFVQMVLALRYLH 130
Query: 453 EEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLR 512
+E + ++HRD+ P N++L D + + DFGLA+ + T+VVGT+ Y PE+++
Sbjct: 131 KE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTILYSCPEIVK 186
Query: 513 NGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYV 572
N DV+AFG + ++ + P + L I V +P EG+Y
Sbjct: 187 NEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKI-------VEAVYEPLPEGMY- 238
Query: 573 EEQMEIVLKLGLFCSHSNPDTRPSMRQV 600
E + V+ C + + RP + QV
Sbjct: 239 SEDVTDVIT---SCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 61/222 (27%), Positives = 108/222 (48%), Gaps = 41/222 (18%)
Query: 346 KGGSGKVY----RGVLPSSHAE-IAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRG 400
+G GKV+ +LP +AVK + S+ + F E + L+H+++V+ G
Sbjct: 15 EGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYG 74
Query: 401 YCRRKGELLLVYDYMPNGSLDKILYSNTRPS-------------LNWFQRFRIIKGVAFG 447
C LL+V++YM +G L++ L S+ + L Q I +A G
Sbjct: 75 VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASG 134
Query: 448 LLY---LHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNV--VG- 501
++Y LH +HRD+ N L+ L K+GDFG++R D+++T+ VG
Sbjct: 135 MVYLASLH------FVHRDLATRNCLVGQGLVVKIGDFGMSR------DIYSTDYYRVGG 182
Query: 502 ----TVGYLAPELLRNGRGTTSTDVYAFGVFMLEV-ACGRRP 538
+ ++ PE + + TT +D+++FGV + E+ G++P
Sbjct: 183 RTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 75/288 (26%), Positives = 120/288 (41%), Gaps = 35/288 (12%)
Query: 336 FSYKNLYKAT---KGGSGKVYRGVLPSSHAE-----IAVKKVCH-DSDHGMKQFVSEIVS 386
F NL + T +G G+V+ E + VK + ++ +F E+
Sbjct: 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61
Query: 387 MGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKIL-------YSNTRPSLNWFQRFR 439
KL H+N+V+L G CR ++ +Y G L + L P L+ Q+
Sbjct: 62 FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121
Query: 440 IIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND--LHTT 497
+ +A G+ +L +HRD+ N L+ + E K+ L++ D N
Sbjct: 122 LCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSK--DVYNSEYYKLR 176
Query: 498 NVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEV-ACGRRPVQPGELDLLDWVIDYWQK 556
N + + +LAPE ++ +T +DV++FGV M EV G P G D + V++ Q
Sbjct: 177 NALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELP-FYGLSD--EEVLNRLQA 233
Query: 557 GDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYL 604
G LE E + KL C NP RPS ++V L
Sbjct: 234 GK--------LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 67/271 (24%), Positives = 125/271 (46%), Gaps = 17/271 (6%)
Query: 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRN 394
R S K K G G+V+ + H ++AVK + ++ F++E M L+H
Sbjct: 5 RESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDK 62
Query: 395 LVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEE 454
LV+L ++ + ++ ++M GSL L S+ + +A G+ ++ +
Sbjct: 63 LVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ- 120
Query: 455 WEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNG 514
+ +HRD++ AN+L+ A L K+ DFGLAR+ + + + APE + G
Sbjct: 121 --RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 178
Query: 515 RGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEE 574
T +DV++FG+ ++E+ R PG + VI ++G + + E +Y
Sbjct: 179 SFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRALERGYRMPRPENCPEELY--- 233
Query: 575 QMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
I+++ C + P+ RP+ + LD
Sbjct: 234 --NIMMR----CWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 74/278 (26%), Positives = 122/278 (43%), Gaps = 41/278 (14%)
Query: 346 KGGSGKVYR----GVLPSS-HAEIAVKKVCHDSDHGMK-QFVSEIVSMGKLRHRNLVQLR 399
+G G+V++ G+LP +AVK + ++ M+ F E M + H N+V+L
Sbjct: 15 QGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLL 74
Query: 400 GYCRRKGELLLVYDYMPNGSLDKILYSNT--------------------RPSLNWFQRFR 439
G C + L+++YM G L++ L + L+ ++
Sbjct: 75 GVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLC 134
Query: 440 IIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLAR-LYDHGNDLHTTN 498
I K VA G+ YL E+ +HRD+ N L+ ++ K+ DFGL+R +Y + N
Sbjct: 135 IAKQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASEN 191
Query: 499 VVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGD 558
+ ++ PE + R TT +DV+A+GV + E+ +QP + VI Y + G+
Sbjct: 192 DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF--SYGMQPYYGMAHEEVIYYVRDGN 249
Query: 559 VLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPS 596
VL D +Y L C P RPS
Sbjct: 250 VLSCPDNCPLELY---------NLMRLCWSKLPSDRPS 278
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 60/209 (28%), Positives = 104/209 (49%), Gaps = 18/209 (8%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRH---R 393
Y+ L +G G VYRG + +A+K + D+ D + E+ + +LR
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 394 NLVQLRGYCRRKG-ELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFR--IIKGVAFGLLY 450
N+ + G KG L ++ +Y GS+ ++ + +++ II+ V L Y
Sbjct: 63 NITKYYG-SYLKGPRLWIIMEYAEGGSVRTLMKAGPIA-----EKYISVIIREVLVALKY 116
Query: 451 LHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPEL 510
+H+ V+HRDIK AN+L+ KL DFG+A L + + +T VGT ++APE+
Sbjct: 117 IHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAPEV 172
Query: 511 LRNGRG-TTSTDVYAFGVFMLEVACGRRP 538
+ G+ T D+++ G+ + E+A G P
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 16/208 (7%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRN 394
+ +L + G G VY + +A+KK+ + S+ + + E+ + KLRH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 395 LVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEE 454
+Q RG R+ LV +Y GS +L + +P L + + G GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLHS- 133
Query: 455 WEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPEL---L 511
++HRD+K N+LL KLGDFG A + N VGT ++APE+ +
Sbjct: 134 --HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF-----VGTPYWMAPEVILAM 186
Query: 512 RNGRGTTSTDVYAFGVFMLEVACGRRPV 539
G+ DV++ G+ +E+A + P+
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 15/211 (7%)
Query: 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMK-QFVSEIVSMGKLRHRNL 395
+Y L K +G V++G + +A+K++ + + G + E+ + L+H N+
Sbjct: 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66
Query: 396 VQLRGYCRRKGELLLVYDYMPNGSLDKIL--YSNTRPSLNWFQRFRI-IKGVAFGLLYLH 452
V L L LV++Y LDK L Y + ++ +I + + GL Y H
Sbjct: 67 VTLHDIVHTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH 121
Query: 453 EEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPE-LL 511
+ VLHRD+KP N+L++ E KL DFGLAR ++ VV T+ Y P+ LL
Sbjct: 122 R---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLL 177
Query: 512 RNGRGTTSTDVYAFGVFMLEVACGRRPVQPG 542
+ +T D++ G E+A G RP+ PG
Sbjct: 178 GSSEYSTQIDMWGVGCIFFEMASG-RPLFPG 207
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 60/198 (30%), Positives = 90/198 (45%), Gaps = 8/198 (4%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYC 402
KGG G+V + ++ A KK+ G ++E + K+ R +V L
Sbjct: 10 KGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAY 69
Query: 403 RRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHR 462
K L LV M G L +Y + + GL LH+E +++R
Sbjct: 70 ETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYR 126
Query: 463 DIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDV 522
D+KP N+LLD ++ D GLA G + VGTVGY+APE+++N R T S D
Sbjct: 127 DLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR--VGTVGYMAPEVVKNERYTFSPDW 184
Query: 523 YAFGVFMLEVACGRRPVQ 540
+A G + E+ G+ P Q
Sbjct: 185 WALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 51/153 (33%), Positives = 72/153 (47%), Gaps = 11/153 (7%)
Query: 389 KLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRII---KGVA 445
K+ + +V L K L LV M G L +Y+ P F+ R + +
Sbjct: 56 KVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG---FEEERALFYAAEIL 112
Query: 446 FGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGY 505
GL LH E ++RD+KP N+LLD ++ D GLA G + VGTVGY
Sbjct: 113 CGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR--VGTVGY 167
Query: 506 LAPELLRNGRGTTSTDVYAFGVFMLEVACGRRP 538
+APE+L N R T S D + G + E+ G+ P
Sbjct: 168 MAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 6e-14
Identities = 64/213 (30%), Positives = 104/213 (48%), Gaps = 19/213 (8%)
Query: 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMK-QFVSEIVSMGKLRHRNL 395
+Y L K +G V++G + +A+K++ + + G + E+ + L+H N+
Sbjct: 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI 65
Query: 396 VQLRGYCRRKGELLLVYDYMPNG---SLDKI--LYSNTRPSLNWFQRFRIIKGVAFGLLY 450
V L + L LV++Y+ + LD L S + FQ R GL Y
Sbjct: 66 VTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLR-------GLSY 118
Query: 451 LHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPE- 509
H+ + +LHRD+KP N+L++ E KL DFGLAR ++ VV T+ Y P+
Sbjct: 119 CHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDV 174
Query: 510 LLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPG 542
LL + +T D++ G + E+A G RP+ PG
Sbjct: 175 LLGSTEYSTPIDMWGVGCILYEMATG-RPMFPG 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 6e-14
Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 11/206 (5%)
Query: 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRN 394
R +N K +G +G V S ++AVK + + +E+V M +H+N
Sbjct: 20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQN 79
Query: 395 LVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEE 454
+V++ EL ++ +++ G+L I+ S TR LN Q + + V L YLH
Sbjct: 80 VVEMYKSYLVGEELWVLMEFLQGGALTDIV-SQTR--LNEEQIATVCESVLQALCYLHS- 135
Query: 455 WEQVVLHRDIKPANVLLDADLEGKLGDFGL-ARLYDHGNDL-HTTNVVGTVGYLAPELLR 512
Q V+HRDIK ++LL D KL DFG A++ D+ ++VGT ++APE++
Sbjct: 136 --QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSLVGTPYWMAPEVIS 190
Query: 513 NGRGTTSTDVYAFGVFMLEVACGRRP 538
T D+++ G+ ++E+ G P
Sbjct: 191 RTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 59/206 (28%), Positives = 89/206 (43%), Gaps = 26/206 (12%)
Query: 346 KGGSGKVYRGV---LPSSHAEIAVK-----KVCHDSDHGMKQFVSEIVSMGKLRHRNLVQ 397
G G+VY G+ E+ V + C + D F+ E + M K H+N+V+
Sbjct: 16 HGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDE--SDFLMEALIMSKFNHQNIVR 73
Query: 398 LRGYCRRKGELLLVYDYMPNGSLDKILYSN----TRPS-LNWFQRFRIIKGVAFGLLYLH 452
L G + ++ + M G L L N RPS L + VA G YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 453 EEWEQVVLHRDIKPANVLLDADLEG---KLGDFGLAR-LYDHGNDLHTTN--VVGTVGYL 506
E +HRDI N LL G K+ DFG+AR +Y + + + ++
Sbjct: 134 ENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIY--RASYYRKGGRAMLPIKWM 188
Query: 507 APELLRNGRGTTSTDVYAFGVFMLEV 532
PE +G T+ TDV++FGV + E+
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 9e-14
Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 26/208 (12%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKV-----CHDSDHGMKQFVSEIVSMGKLRHRNLVQLRG 400
+G G+VY + E+AVK+V ++ + EI + LRH +VQ G
Sbjct: 12 RGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYG 71
Query: 401 YCRRKGE---LLLVYDYMPNGSLDKILYSNTRPSLNWFQRF--RIIKGVAFGLLYLHEEW 455
C R E L + +YMP GS+ L + + N +R+ +I++GV+ YLH
Sbjct: 72 -CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVS----YLHS-- 124
Query: 456 EQVVLHRDIKPANVLLDADLEGKLGDFGLAR----LYDHGNDLHTTNVVGTVGYLAPELL 511
+++HRDIK AN+L D+ KLGDFG ++ + G + + V GT +++PE++
Sbjct: 125 -NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS--VTGTPYWMSPEVI 181
Query: 512 RNGRG-TTSTDVYAFGVFMLEVACGRRP 538
+G G DV++ ++E+ + P
Sbjct: 182 -SGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 76/274 (27%), Positives = 120/274 (43%), Gaps = 34/274 (12%)
Query: 346 KGGSGKVYRGVLPS--SHAEIAVKKV-CHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYC 402
G GKV G + S + A++ VK++ S +F+ E L+H NL+Q G C
Sbjct: 5 NGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQC 64
Query: 403 RRKGELLLVYDYMPNGSLDKILYS-----NTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQ 457
LLV ++ P G L L S P QR +A GLL+LH +
Sbjct: 65 TEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMAC--EIALGLLHLH---KN 119
Query: 458 VVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTT--NVVGTVGYLAPELLRNGR 515
+H D+ N LL ADL K+GD+GL+ + D + T + + ++APEL+
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHN-KYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 516 G-------TTSTDVYAFGVFMLEV-ACGRRPV-QPGELDLLDWVIDYWQKGDVLDASDPR 566
G T ++V++ GV + E+ G +P + +L + + Q L PR
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQ----LKLPKPR 234
Query: 567 LEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQV 600
L+ + E++ L P+ RPS +V
Sbjct: 235 LKLPLSDRWYEVMQFCWL-----QPEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 64/219 (29%), Positives = 113/219 (51%), Gaps = 27/219 (12%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGM--KQFVSEIVSMGKLRHRNL 395
Y+NL +G G V + ++A+KK+ +H ++ + EI + + +H N+
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI-SPFEHQTFCQRTLREIKILRRFKHENI 65
Query: 396 VQL------RGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRF--RIIKGVAFG 447
+ + + ++ +V + M L K++ + S + Q F +I++G
Sbjct: 66 IGILDIIRPPSFESFN-DVYIVQELMET-DLYKLIKTQ-HLSNDHIQYFLYQILRG---- 118
Query: 448 LLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT---TNVVGTVG 504
L Y+H VLHRD+KP+N+LL+ + + K+ DFGLAR+ D +D HT T V T
Sbjct: 119 LKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD-HTGFLTEYVATRW 174
Query: 505 YLAPELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPG 542
Y APE++ N +G T + D+++ G + E+ RP+ PG
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPLFPG 212
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 66/266 (24%), Positives = 119/266 (44%), Gaps = 18/266 (6%)
Query: 343 KATKGGSGKVYRGVLPSSHAEIAVKKV--CHDSDHGMKQ-FVSEIVSMGKLRHRNLVQLR 399
K +G +VYR +A+KKV D +Q V EI + +L H N+++
Sbjct: 9 KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYL 68
Query: 400 GYCRRKGELLLVYDYMPNGSLDKIL--YSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQ 457
EL +V + G L +++ + + + ++ + + ++H +
Sbjct: 69 DSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---R 125
Query: 458 VVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGT 517
V+HRDIKPANV + A KLGD GL R + ++VGT Y++PE +
Sbjct: 126 RVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERIHENGYN 184
Query: 518 TSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQME 577
+D+++ G + E+A + P +++L QK + D P L + E++
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLC----QKIEQCDY--PPLPTEHYSEKLR 238
Query: 578 IVLKLGLFCSHSNPDTRPSMRQVVQY 603
++ + C + +PD RP + V Q
Sbjct: 239 ELVSM---CIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 15/211 (7%)
Query: 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMK-QFVSEIVSMGKLRHRNL 395
+Y L K +G VY+G + +A+K++ + + G + E+ + L+H N+
Sbjct: 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66
Query: 396 VQLRGYCRRKGELLLVYDYMPNGSLDKIL---YSNTRPSLNWFQRFRIIKGVAFGLLYLH 452
V L + L LV++Y LDK L + S+N + + GL Y H
Sbjct: 67 VTLHDIIHTEKSLTLVFEY-----LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH 121
Query: 453 EEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPE-LL 511
+ VLHRD+KP N+L++ E KL DFGLAR ++ VV T+ Y P+ LL
Sbjct: 122 R---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILL 177
Query: 512 RNGRGTTSTDVYAFGVFMLEVACGRRPVQPG 542
+ +T D++ G E++ G RP+ PG
Sbjct: 178 GSTDYSTQIDMWGVGCIFYEMSTG-RPLFPG 207
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 53/157 (33%), Positives = 80/157 (50%), Gaps = 24/157 (15%)
Query: 407 ELLLVYDYMPNGSLDKILYSNTRPSLNWFQRF--RIIKGVAFGLLYLHEEWEQVVLHRDI 464
E+ +V + M L KI+ S S + + F +I++G L YLH +LHRDI
Sbjct: 78 EIYVVTELM-QSDLHKIIVSPQPLSSDHVKVFLYQILRG----LKYLHSAG---ILHRDI 129
Query: 465 KPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRG-TTSTDVY 523
KP N+L++++ K+ DFGLAR+ + H T V T Y APE+L R T++ D++
Sbjct: 130 KPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIW 189
Query: 524 AFGVFMLEVACGRR-------PVQPGELDLLDWVIDY 553
+ G E+ GRR P+Q LD + D
Sbjct: 190 SVGCIFAEL-LGRRILFQAQSPIQQ-----LDLITDL 220
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 67/273 (24%), Positives = 122/273 (44%), Gaps = 33/273 (12%)
Query: 346 KGGSGKVYRGVLP-----SSHAEIAVKKVCHDSDHGMK-QFVSEIVSMGKLRHRNLVQLR 399
+G G VY G+ +A+K V + + +F++E M + ++V+L
Sbjct: 16 QGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 75
Query: 400 GYCRRKGELLLVYDYMPNGSLDKILYS----------NTRPSLNWFQRFRIIKGVAFGLL 449
G + L++ + M G L L S PSL + ++ +A G+
Sbjct: 76 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLK--KMIQMAGEIADGMA 133
Query: 450 YLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLAR-LYDHGNDLHTTNVVGTVGYLAP 508
YL+ +HRD+ N ++ D K+GDFG+ R +Y+ + V +++P
Sbjct: 134 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 509 ELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLE 568
E L++G TT +DV++FGV + E+A QP + + V+ + +G +LD D
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIATLAE--QPYQGMSNEQVLRFVMEGGLLDKPD---- 244
Query: 569 GIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVV 601
+++ +L C NP RPS +++
Sbjct: 245 -----NCPDMLFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 51/146 (34%), Positives = 73/146 (50%), Gaps = 9/146 (6%)
Query: 395 LVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRI-IKGVAFGLLYLHE 453
+V L+ + +L LV DYM G L L R S R + I + L +LH+
Sbjct: 58 IVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSE---DRAKFYIAELVLALEHLHK 114
Query: 454 EWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRN 513
+++RD+KP N+LLDA L DFGL++ N T GT YLAPE+L +
Sbjct: 115 ---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT-TNTFCGTTEYLAPEVLLD 170
Query: 514 GRG-TTSTDVYAFGVFMLEVACGRRP 538
+G T D ++ GV + E+ CG P
Sbjct: 171 EKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 32/95 (33%), Positives = 53/95 (55%), Gaps = 4/95 (4%)
Query: 444 VAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTV 503
+ GL +LHE + +++RD+K NVLLD++ K+ DFG+ + + T+ GT
Sbjct: 105 IVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCK-EGILGGVTTSTFCGTP 160
Query: 504 GYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRP 538
Y+APE+L + D +A GV + E+ G+ P
Sbjct: 161 DYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 3e-13
Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 7/201 (3%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQ 397
Y K +G SG V+ + ++ E+A+K++ + ++EI+ M +L++ N+V
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80
Query: 398 LRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQ 457
EL +V +Y+ GSL ++ T ++ Q + + L +LH
Sbjct: 81 FLDSFLVGDELFVVMEYLAGGSLTDVV---TETCMDEAQIAAVCRECLQALEFLHA---N 134
Query: 458 VVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGT 517
V+HRDIK NVLL D KL DFG +T +VGT ++APE++
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYG 193
Query: 518 TSTDVYAFGVFMLEVACGRRP 538
D+++ G+ +E+ G P
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 66/225 (29%), Positives = 112/225 (49%), Gaps = 28/225 (12%)
Query: 338 YKNLYKATKGGSGKVYRGV-LPSSHAEIAVKKV-CHDSDHGMKQFVSEIVSMGKLR---- 391
Y+ + + +G GKV++ L + +A+K+V + GM +S I + LR
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP--LSTIREVAVLRHLET 60
Query: 392 --HRNLVQLRGYCR-----RKGELLLVYDYMPNG---SLDKILYSNTRPSLNWFQRFRII 441
H N+V+L C R+ +L LV++++ LDK+ F+++
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 442 KGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVG 501
+G+ F L+ H V+HRD+KP N+L+ + + KL DFGLAR+Y + T+VV
Sbjct: 121 RGLDF--LHSHR-----VVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVV 171
Query: 502 TVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDL 546
T+ Y APE+L T D+++ G E+ R+P+ G D+
Sbjct: 172 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKPLFRGSSDV 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 52/184 (28%), Positives = 92/184 (50%), Gaps = 26/184 (14%)
Query: 366 VKKVCHDSDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVYDYMPNGSL---- 420
+K+ DH + F E+ + KL H N++ L G C +G L L +Y P+G+L
Sbjct: 42 MKEYASKDDH--RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL 99
Query: 421 --DKILYSN--------TRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVL 470
++L ++ T +L+ Q VA G+ YL ++ +HRD+ N+L
Sbjct: 100 RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNIL 156
Query: 471 LDADLEGKLGDFGLARLYDHGNDLHTTNVVG--TVGYLAPELLRNGRGTTSTDVYAFGVF 528
+ + K+ DFGL+R G +++ +G V ++A E L TT++DV+++GV
Sbjct: 157 VGENYVAKIADFGLSR----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVL 212
Query: 529 MLEV 532
+ E+
Sbjct: 213 LWEI 216
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 80/290 (27%), Positives = 133/290 (45%), Gaps = 37/290 (12%)
Query: 332 SPHRFSYKNLYKATKGGSGKVYRGVL----PSSHAEIAVKKVC-HDSDHGMKQFVSEIVS 386
S R + +L + +G G+++ G+L P E+ VK V H S+ + + E
Sbjct: 4 SRDRVTLSDLLQ--EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCL 61
Query: 387 MGKLRHRNLVQLRGYCRRKGELLLV-YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVA 445
+ L H+N++ + C GE V Y YM G+L L N Q + V
Sbjct: 62 LYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVH 121
Query: 446 F------GLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLAR-LYDHGNDLHT-- 496
G+ YLH+ + V+H+DI N ++D +L+ K+ D L+R L+ D H
Sbjct: 122 MAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFP--MDYHCLG 176
Query: 497 TNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLE-VACGRRPVQPGELDLLDWVIDYWQ 555
N V ++A E L N ++++DV++FGV + E + G+ P E+D + + Y +
Sbjct: 177 DNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYV--EIDPFE-MAAYLK 233
Query: 556 KGDVLDASDPRLEG-IYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYL 604
G RL I +++ V+ C +P+ RPS Q+VQ L
Sbjct: 234 DGY-------RLAQPINCPDELFAVM---ACCWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 5e-13
Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 7/201 (3%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQ 397
Y K +G SG VY + ++ E+A+K++ + ++EI+ M + ++ N+V
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVN 80
Query: 398 LRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQ 457
EL +V +Y+ GSL ++ T ++ Q + + L +LH
Sbjct: 81 YLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALDFLHS---N 134
Query: 458 VVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGT 517
V+HRDIK N+LL D KL DFG +T +VGT ++APE++
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYG 193
Query: 518 TSTDVYAFGVFMLEVACGRRP 538
D+++ G+ +E+ G P
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 17/207 (8%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRN 394
+ +L + G G VY ++ +A+KK+ + S+ + + E+ + +LRH N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 395 LVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEE 454
++ +G R+ LV +Y GS IL + +P L + I G GL YLH
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKP-LQEVEIAAICHGALQGLAYLHS- 133
Query: 455 WEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPEL---L 511
+HRDIK N+LL KL DFG A L N VGT ++APE+ +
Sbjct: 134 --HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSF-----VGTPYWMAPEVILAM 186
Query: 512 RNGRGTTSTDVYAFGVFMLEVACGRRP 538
G+ DV++ G+ +E+A R+P
Sbjct: 187 DEGQYDGKVDVWSLGITCIELA-ERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 5e-13
Identities = 62/270 (22%), Positives = 117/270 (43%), Gaps = 26/270 (9%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQ-----FVSEIVSMGKLRH 392
Y+ + +G G V+ + + +K++ M + +E + L H
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQI---PVEQMTKDERLAAQNECQVLKLLSH 58
Query: 393 RNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLH 452
N+++ L++V +Y P G+L + + + I+ LL LH
Sbjct: 59 PNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCN---SLLDEDTILHFFVQILLALH 115
Query: 453 EEWEQVVLHRDIKPANVLLDA-DLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELL 511
+++LHRD+K N+LLD + K+GDFG++++ + +T VVGT Y++PEL
Sbjct: 116 HVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISPELC 173
Query: 512 RNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIY 571
+D++A G + E+A +R + L L I G SD Y
Sbjct: 174 EGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKI---MSGTFAPISDR-----Y 225
Query: 572 VEEQMEIVLKLGLFCSHSNPDTRPSMRQVV 601
+ +++L + + +P RP + Q++
Sbjct: 226 SPDLRQLILSM----LNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 6e-13
Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 22/206 (10%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSD-----HGMKQFVSEIVSMGKLRHRNLVQLRG 400
+G G+VY + E+A K+V D + + EI + L+H +VQ G
Sbjct: 12 QGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYG 71
Query: 401 YCRRKGE--LLLVYDYMPNGSLDKIL--YSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWE 456
R + E L + +YMP GS+ L Y S+ +I++G++ YLH
Sbjct: 72 CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMS----YLHS--- 124
Query: 457 QVVLHRDIKPANVLLDADLEGKLGDFGLARLYD----HGNDLHTTNVVGTVGYLAPELLR 512
+++HRDIK AN+L D+ KLGDFG ++ G + + V GT +++PE++
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS--VTGTPYWMSPEVIS 182
Query: 513 NGRGTTSTDVYAFGVFMLEVACGRRP 538
DV++ G ++E+ + P
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 6e-13
Identities = 51/189 (26%), Positives = 93/189 (49%), Gaps = 8/189 (4%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCR 403
+G G+V+ G L + + +AVK C ++ +F+ E + + H N+V+L G C
Sbjct: 5 RGNFGEVFSGRLRADNTPVAVKS-CRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT 63
Query: 404 RKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRD 463
+K + +V + + G L P L + ++++ A G+ YL + +HRD
Sbjct: 64 QKQPIYIVMELVQGGDFLTFL-RTEGPRLKVKELIQMVENAAAGMEYLES---KHCIHRD 119
Query: 464 IKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGT-VGYLAPELLRNGRGTTSTDV 522
+ N L+ K+ DFG++R + G T + V + APE L GR ++ +DV
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDV 179
Query: 523 YAFGVFMLE 531
++FG+ + E
Sbjct: 180 WSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 8e-13
Identities = 70/268 (26%), Positives = 123/268 (45%), Gaps = 27/268 (10%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHD-SDHGMKQFVSEI-VSMGKLRHRNLVQLRGYCR 403
+G G V + + +AVK++ + K+ + ++ +SM + V G
Sbjct: 11 RGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF 70
Query: 404 RKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRF--RIIKGVAFGLLYLHEEWEQVVLH 461
R+G++ + + M + SLDK L + +I + L YLH + V+H
Sbjct: 71 REGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIH 127
Query: 462 RDIKPANVLLDADLEGKLGDFGLA-RLYDHGNDLHTTNVVGTVGYLAPELL---RNGRG- 516
RD+KP+NVL++ + + KL DFG++ L D + T G Y+APE + N +G
Sbjct: 128 RDVKPSNVLINRNGQVKLCDFGISGYLVD---SVAKTIDAGCKPYMAPERINPELNQKGY 184
Query: 517 TTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL-EGIYVEEQ 575
+DV++ G+ M+E+A GR P W + Q V++ P+L + E
Sbjct: 185 DVKSDVWSLGITMIELATGRFPYD-------SWKTPFQQLKQVVEEPSPQLPAEKFSPEF 237
Query: 576 MEIVLKLGLFCSHSNPDTRPSMRQVVQY 603
+ V K C N RP+ +++Q+
Sbjct: 238 QDFVNK----CLKKNYKERPNYPELLQH 261
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 9e-13
Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 7/199 (3%)
Query: 340 NLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLR 399
+ K +G +G V + ++AVKK+ + +E+V M H N+V +
Sbjct: 26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMY 85
Query: 400 GYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVV 459
EL +V +++ G+L I+ T +N Q + V L YLH Q V
Sbjct: 86 NSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIATVCLSVLRALSYLHN---QGV 139
Query: 460 LHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTS 519
+HRDIK ++LL +D KL DFG ++VGT ++APE++ T
Sbjct: 140 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSK-EVPKRKSLVGTPYWMAPEVISRLPYGTE 198
Query: 520 TDVYAFGVFMLEVACGRRP 538
D+++ G+ ++E+ G P
Sbjct: 199 VDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 9e-13
Identities = 44/134 (32%), Positives = 62/134 (46%), Gaps = 5/134 (3%)
Query: 405 KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDI 464
K L LV M G L +Y+ L + + G+L+LH +++RD+
Sbjct: 65 KTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDM 121
Query: 465 KPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYA 524
KP NVLLD +L D GLA G T GT GY+APE+L+ + D +A
Sbjct: 122 KPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPYSYPVDWFA 179
Query: 525 FGVFMLEVACGRRP 538
G + E+ GR P
Sbjct: 180 MGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 1e-12
Identities = 66/222 (29%), Positives = 101/222 (45%), Gaps = 25/222 (11%)
Query: 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMK-QFVSEIVSMGKLRHRNL 395
SY+ L K +G VY+G + +A+K + + G + E + L+H N+
Sbjct: 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65
Query: 396 VQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRP--------SLNWFQRFRIIKGVAFG 447
V L K L LV++Y+ D Y + P L FQ R G
Sbjct: 66 VLLHDIIHTKETLTLVFEYV---HTDLCQYMDKHPGGLHPENVKLFLFQLLR-------G 115
Query: 448 LLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLA 507
L Y+H+ + +LHRD+KP N+L+ E KL DFGLAR + ++ VV T+ Y
Sbjct: 116 LSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRP 171
Query: 508 PE-LLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLD 548
P+ LL + +T D++ G +E+ G PG D+ D
Sbjct: 172 PDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF-PGMKDIQD 212
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 25/207 (12%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDH-GMKQFVSEI-VSMGKLRHRNLVQLRGYCR 403
+G G V + + S +AVK++ D K+ + ++ V M +V+ G
Sbjct: 14 RGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALF 73
Query: 404 RKGELLLVYDYMPNGSLD---KILYSNTRPSLNWFQRFRIIKGVAF----GLLYLHEEWE 456
R+G+ + + M + SLD K +Y + + I+ +A L YL EE +
Sbjct: 74 REGDCWICMELM-DISLDKFYKYVYEVLKSVIPE----EILGKIAVATVKALNYLKEELK 128
Query: 457 QVVLHRDIKPANVLLDADLEGKLGDFGLA-RLYDHGNDLHTTNVVGTVGYLAPELL---- 511
++HRD+KP+N+LLD + KL DFG++ +L D + T G Y+APE +
Sbjct: 129 --IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD---SIAKTRDAGCRPYMAPERIDPSA 183
Query: 512 RNGRGTTSTDVYAFGVFMLEVACGRRP 538
R+G S DV++ G+ + EVA G+ P
Sbjct: 184 RDGYDVRS-DVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 40/142 (28%), Positives = 68/142 (47%), Gaps = 20/142 (14%)
Query: 408 LLLVYDYMPNGSLDKILYSNTRPSLNWFQ----RFRIIKGVAFGLLYLHEEWEQVVLHRD 463
L LV +Y+P G L +L + + R I + L YLH ++HRD
Sbjct: 68 LYLVMEYLPGGDLASLLEN-----VGSLDEDVARI-YIAEIVLALEYLHS---NGIIHRD 118
Query: 464 IKPANVLLDADLEGKLGDFGLAR-------LYDHGNDLHTTNVVGTVGYLAPELLRNGRG 516
+KP N+L+D++ KL DFGL++ + + ++ +VGT Y+APE++
Sbjct: 119 LKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH 178
Query: 517 TTSTDVYAFGVFMLEVACGRRP 538
+ + D ++ G + E G P
Sbjct: 179 SKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 57/199 (28%), Positives = 92/199 (46%), Gaps = 7/199 (3%)
Query: 340 NLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLR 399
N K +G +G V + SS +AVKK+ + +E+V M +H N+V++
Sbjct: 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMY 83
Query: 400 GYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVV 459
EL +V +++ G+L I+ T +N Q + V L LH Q V
Sbjct: 84 NSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLKALSVLH---AQGV 137
Query: 460 LHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTS 519
+HRDIK ++LL D KL DFG ++VGT ++APEL+
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKSLVGTPYWMAPELISRLPYGPE 196
Query: 520 TDVYAFGVFMLEVACGRRP 538
D+++ G+ ++E+ G P
Sbjct: 197 VDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 61/207 (29%), Positives = 92/207 (44%), Gaps = 26/207 (12%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYC 402
KGG G+V + ++ A KK+ G ++E + K+ R +V L
Sbjct: 10 KGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY 69
Query: 403 RRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRII---KGVAFGLLYLHEEWEQVV 459
K L LV M G L +Y+ P F R + + GL LH E +
Sbjct: 70 ETKDALCLVLTLMNGGDLKFHIYNMGNPG---FDEERAVFYAAEITCGLEDLHRE---RI 123
Query: 460 LHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTN------VVGTVGYLAPELLRN 513
++RD+KP N+LLD D+G R+ D G + VGTVGY+APE+++N
Sbjct: 124 VYRDLKPENILLD--------DYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKN 175
Query: 514 GRGTTSTDVYAFGVFMLEVACGRRPVQ 540
R T S D + G + E+ G+ P +
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 57/205 (27%), Positives = 88/205 (42%), Gaps = 10/205 (4%)
Query: 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRN 394
R Y L T G G+V+ + + H + KKV + G K EI + + HR
Sbjct: 91 RMQYNILSSLTPGSEGEVF---VCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRA 147
Query: 395 LVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEE 454
++ L R K + +V MP D Y + L Q I + + L YLH
Sbjct: 148 IINLIHAYRWKSTVCMV---MPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHG- 203
Query: 455 WEQVVLHRDIKPANVLLDADLEGKLGDFGLA-RLYDHGNDLHTTNVVGTVGYLAPELLRN 513
+ ++HRD+K N+ LD LGDFG A +L H + GT+ +PELL
Sbjct: 204 --RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLAL 261
Query: 514 GRGTTSTDVYAFGVFMLEVACGRRP 538
TD+++ G+ + E++
Sbjct: 262 DPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 74/278 (26%), Positives = 124/278 (44%), Gaps = 37/278 (13%)
Query: 346 KGGSGKVYRGVLP-----SSHAEIAVKKVCHDSDHGMK-QFVSEIVSMGKLRHRNLVQLR 399
+G G VY G + +AVK V + + +F++E M ++V+L
Sbjct: 16 QGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLL 75
Query: 400 GYCRRKGELLLVYDYMPNGSLDKILYS--------NTRPSLNWFQRFRIIKGVAFGLLYL 451
G + L+V + M +G L L S RP + ++ +A G+ YL
Sbjct: 76 GVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYL 135
Query: 452 HEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLAR-LYDHGNDLHTTNVVG--TVGYLAP 508
+ + +HRD+ N ++ D K+GDFG+ R +Y+ D + G V ++AP
Sbjct: 136 NA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE--TDYYRKGGKGLLPVRWMAP 190
Query: 509 ELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQP-GELDLLDWVIDYWQKGDVLDASDPR 566
E L++G TTS+D+++FGV + E+ +P Q +L +V+D G LD D
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD----GGYLDQPDNC 246
Query: 567 LEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYL 604
E + +M C NP RP+ ++V L
Sbjct: 247 PERVTDLMRM---------CWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 1e-12
Identities = 57/208 (27%), Positives = 100/208 (48%), Gaps = 16/208 (7%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRN 394
+ +L + G G VY ++ +A+KK+ + S+ + + E+ + +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 395 LVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEE 454
++ +G R+ LV +Y GS +L + +P L + I G GL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKP-LQEVEIAAITHGALQGLAYLHS- 143
Query: 455 WEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPEL---L 511
++HRDIK N+LL + KL DFG A + N VGT ++APE+ +
Sbjct: 144 --HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF-----VGTPYWMAPEVILAM 196
Query: 512 RNGRGTTSTDVYAFGVFMLEVACGRRPV 539
G+ DV++ G+ +E+A + P+
Sbjct: 197 DEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 50/173 (28%), Positives = 82/173 (47%), Gaps = 6/173 (3%)
Query: 363 EIAVKKVCHDSDHGMKQ-FVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVYDYMPNGSL 420
++AVK + + ++ +SE+ M L H N+V L G C G +L++ +Y G L
Sbjct: 67 KVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDL 126
Query: 421 DKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLG 480
L L VA G+ +L + +HRD+ NVLL K+
Sbjct: 127 LNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKIC 183
Query: 481 DFGLAR-LYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEV 532
DFGLAR + + N + N V ++APE + N T +DV+++G+ + E+
Sbjct: 184 DFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 46/135 (34%), Positives = 63/135 (46%), Gaps = 10/135 (7%)
Query: 408 LLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPA 467
L +V +YMP G L L SN W RF + V L +H +HRD+KP
Sbjct: 118 LYMVMEYMPGGDLVN-LMSNYDIPEKW-ARFYTAE-VVLALDAIHS---MGFIHRDVKPD 171
Query: 468 NVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTT----STDVY 523
N+LLD KL DFG D + VGT Y++PE+L++ G D +
Sbjct: 172 NMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWW 231
Query: 524 AFGVFMLEVACGRRP 538
+ GVF+ E+ G P
Sbjct: 232 SVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 22/206 (10%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSD-----HGMKQFVSEIVSMGKLRHRNLVQLRG 400
+G G+VY + E+AVK+V D + + EI + L H +VQ G
Sbjct: 12 QGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYG 71
Query: 401 YCRRKGE--LLLVYDYMPNGSLDKILYSNTRPSLNWFQRF--RIIKGVAFGLLYLHEEWE 456
R E L + ++MP GS+ L S + N +++ +I++GV YLH
Sbjct: 72 CLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGV----SYLHS--- 124
Query: 457 QVVLHRDIKPANVLLDADLEGKLGDFGLARLYD----HGNDLHTTNVVGTVGYLAPELLR 512
+++HRDIK AN+L D+ KLGDFG ++ G + + V GT +++PE++
Sbjct: 125 NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS--VTGTPYWMSPEVIS 182
Query: 513 NGRGTTSTDVYAFGVFMLEVACGRRP 538
D+++ G ++E+ + P
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 62/264 (23%), Positives = 114/264 (43%), Gaps = 20/264 (7%)
Query: 343 KATKGGSGKVYRGVLPSSHAEIAVKKV----CHDSDHGMKQFVSEIVSMGKLRHRNLVQL 398
K +G +VYR +A+KKV D+ + EI + +L H N+++
Sbjct: 9 KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAK-ARADCIKEIDLLKQLNHPNVIKY 67
Query: 399 RGYCRRKGELLLVYDYMPNGSLDKIL--YSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWE 456
EL +V + G L +++ + + + ++ + L ++H
Sbjct: 68 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS--- 124
Query: 457 QVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRG 516
+ V+HRDIKPANV + A KLGD GL R + ++VGT Y++PE +
Sbjct: 125 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERIHENGY 183
Query: 517 TTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQM 576
+D+++ G + E+A + P +++L Y + P L + E++
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMNL------YSLCKKIEQCDYPPLPSDHYSEEL 237
Query: 577 EIVLKLGLFCSHSNPDTRPSMRQV 600
+L C + +P+ RP + V
Sbjct: 238 R---QLVNMCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 17/207 (8%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRN 394
+ L++ G G VY ++ +AVKK+ + ++ + + E+ + +L+H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 395 LVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEE 454
++ +G ++ LV +Y GS +L + +P L + I G GL YLH
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKP-LQEVEIAAITHGALQGLAYLHS- 139
Query: 455 WEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPEL---L 511
++HRDIK N+LL + KL DFG A N VGT ++APE+ +
Sbjct: 140 --HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSF-----VGTPYWMAPEVILAM 192
Query: 512 RNGRGTTSTDVYAFGVFMLEVACGRRP 538
G+ DV++ G+ +E+A R+P
Sbjct: 193 DEGQYDGKVDVWSLGITCIELA-ERKP 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 59/206 (28%), Positives = 104/206 (50%), Gaps = 11/206 (5%)
Query: 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRN 394
R N K +G +G V S+ ++AVKK+ + +E+V M +H N
Sbjct: 18 RSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPN 77
Query: 395 LVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEE 454
+V++ EL +V +++ G+L I+ ++TR +N Q + V L +LH
Sbjct: 78 IVEMYSSYLVGDELWVVMEFLEGGALTDIV-THTR--MNEEQIATVCLAVLKALSFLHA- 133
Query: 455 WEQVVLHRDIKPANVLLDADLEGKLGDFGL-ARLYDHGNDL-HTTNVVGTVGYLAPELLR 512
Q V+HRDIK ++LL +D KL DFG A++ ++ ++VGT ++APE++
Sbjct: 134 --QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK---EVPRRKSLVGTPYWMAPEVIS 188
Query: 513 NGRGTTSTDVYAFGVFMLEVACGRRP 538
T D+++ G+ ++E+ G P
Sbjct: 189 RLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 53/202 (26%), Positives = 97/202 (48%), Gaps = 9/202 (4%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQ 397
Y K +G SG VY + ++ E+A++++ + ++EI+ M + ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 398 LRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQ 457
EL +V +Y+ GSL ++ T ++ Q + + L +LH
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHS---N 135
Query: 458 VVLHRDIKPANVLLDADLEGKLGDFGL-ARLYDHGNDLHTTNVVGTVGYLAPELLRNGRG 516
V+HRDIK N+LL D KL DFG A++ + + +VGT ++APE++
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAY 193
Query: 517 TTSTDVYAFGVFMLEVACGRRP 538
D+++ G+ +E+ G P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 62/199 (31%), Positives = 90/199 (45%), Gaps = 11/199 (5%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVS---MGKLRHRNLVQLRGYC 402
KGG G+V + ++ A KK+ K + +V + K+ R +V L
Sbjct: 3 KGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF 62
Query: 403 RRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVA---FGLLYLHEEWEQVV 459
+ K +L LV M G L +Y N F R A GL +LH+ + +
Sbjct: 63 QTKTDLCLVMTIMNGGDLRYHIY-NVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRI 118
Query: 460 LHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTS 519
++RD+KP NVLLD D ++ D GLA G T GT G++APELL+ S
Sbjct: 119 IYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKGYAGTPGFMAPELLQGEEYDFS 177
Query: 520 TDVYAFGVFMLEVACGRRP 538
D +A GV + E+ R P
Sbjct: 178 VDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 45/154 (29%), Positives = 85/154 (55%), Gaps = 8/154 (5%)
Query: 383 EIVSMGKLRHRNLVQLRGYCRRKGE--LLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRI 440
EI + L H N+V+ +G C G + L+ +++P+GSL + L N + +N Q+ +
Sbjct: 56 EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRN-KNKINLKQQLKY 114
Query: 441 IKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTT--N 498
+ G+ YL + +HRD+ NVL++++ + K+GDFGL + + + +T +
Sbjct: 115 AVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDD 171
Query: 499 VVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEV 532
+ V + APE L + ++DV++FGV + E+
Sbjct: 172 LDSPVFWYAPECLIQSKFYIASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 29/212 (13%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLR----HRNLVQLRGY 401
+G GKVY+ + +A+K + D ++ + E ++ LR H N+ G
Sbjct: 16 EGTYGKVYKARHKKTGQLVAIKIM--DIIEDEEEEIKEEYNI--LRKYSNHPNIATFYGA 71
Query: 402 CRRKG------ELLLVYDYMPNGS----LDKILYSNTRPSLNWFQRFRIIKGVAFGLLYL 451
+K +L LV + GS + + R W I++ GL YL
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY--ILRETLRGLAYL 129
Query: 452 HEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELL 511
HE V+HRDIK N+LL + E KL DFG++ D T +GT ++APE++
Sbjct: 130 HE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT-FIGTPYWMAPEVI 185
Query: 512 RNGRGTTST-----DVYAFGVFMLEVACGRRP 538
++ DV++ G+ +E+A G+ P
Sbjct: 186 ACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 67/266 (25%), Positives = 125/266 (46%), Gaps = 28/266 (10%)
Query: 347 GGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKG 406
G GKVY+ + A A K + S+ ++ ++ EI + H +V+L G G
Sbjct: 23 GAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG 82
Query: 407 ELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKP 466
+L ++ ++ P G++D I+ R L Q I + + L YLH ++HRD+K
Sbjct: 83 KLWIMIEFCPGGAVDAIMLELDR-GLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKA 138
Query: 467 ANVLLDADLEGKLGDFGLARLYDHGNDLHT----TNVVGTVGYLAPEL-----LRNGRGT 517
NVLL D + KL DFG++ ++ T + +GT ++APE+ +++
Sbjct: 139 GNVLLTLDGDIKLADFGVS-----AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYD 193
Query: 518 TSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQME 577
D+++ G+ ++E+A P EL+ + V+ K + S P + + ++
Sbjct: 194 YKADIWSLGITLIEMAQIEPPHH--ELNPMR-VLLKIAKSEPPTLSQPSKWSMEFRDFLK 250
Query: 578 IVLKLGLFCSHSNPDTRPSMRQVVQY 603
L +P+TRPS Q++++
Sbjct: 251 TALD-------KHPETRPSAAQLLEH 269
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 6e-12
Identities = 66/218 (30%), Positives = 106/218 (48%), Gaps = 19/218 (8%)
Query: 347 GGSGKVYRGVLPSSHAEIAVKKV-CHDSDHGMK-QFVSEIVSMGKLR---HRNLVQLRGY 401
G G VY+ P S +A+K V ++ G+ V E+ + +L H N+V+L
Sbjct: 11 GAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDV 70
Query: 402 CR-----RKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWE 456
C R+ ++ LV++++ + L L P L +++ GL +LH
Sbjct: 71 CATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA--- 126
Query: 457 QVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRG 516
++HRD+KP N+L+ + + KL DFGLAR+Y L T VV T+ Y APE+L
Sbjct: 127 NCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMAL--TPVVVTLWYRAPEVLLQSTY 184
Query: 517 TTSTDVYAFGVFMLEVACGRRPVQPG--ELDLLDWVID 552
T D+++ G E+ R+P+ G E D L + D
Sbjct: 185 ATPVDMWSVGCIFAEMF-RRKPLFCGNSEADQLGKIFD 221
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 64/213 (30%), Positives = 101/213 (47%), Gaps = 24/213 (11%)
Query: 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLV 396
+Y ++YKA +G++ A I V K+ D + Q EI+ M +H N+V
Sbjct: 21 TYGDVYKARNVNTGEL---------AAIKVIKLEPGEDFAVVQ--QEIIMMKDCKHSNIV 69
Query: 397 QLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWE 456
G R+ +L + ++ GSL I Y T P L+ Q + + GL YLH + +
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSLQDI-YHVTGP-LSESQIAYVSRETLQGLYYLHSKGK 127
Query: 457 QVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELL---RN 513
+HRDIK AN+LL + KL DFG++ + +GT ++APE+ R
Sbjct: 128 ---MHRDIKGANILLTDNGHVKLADFGVSAQIT-ATIAKRKSFIGTPYWMAPEVAAVERK 183
Query: 514 GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDL 546
G D++A G+ +E+A +QP DL
Sbjct: 184 GGYNQLCDIWAVGITAIELA----ELQPPMFDL 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 6e-12
Identities = 63/213 (29%), Positives = 95/213 (44%), Gaps = 15/213 (7%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVK-----KVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRG 400
KG GKV L + A+K + D D I+++ +H L L
Sbjct: 5 KGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLTALHC 63
Query: 401 YCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKG-VAFGLLYLHEEWEQVV 459
+ K L V +Y+ G L ++ R R R V L++LH V
Sbjct: 64 CFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTLALMFLHR---HGV 117
Query: 460 LHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTS 519
++RD+K N+LLDA+ KL DFG+ + N + TT GT Y+APE+L+ S
Sbjct: 118 IYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIAPEILQELEYGPS 176
Query: 520 TDVYAFGVFMLEVACGRRPVQP-GELDLLDWVI 551
D +A GV M E+ G+ P + E DL + ++
Sbjct: 177 VDWWALGVLMYEMMAGQPPFEADNEDDLFESIL 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 36/105 (34%), Positives = 59/105 (56%), Gaps = 4/105 (3%)
Query: 447 GLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYL 506
GL +LH++ +++RD+K NVLLD D K+ DFG+ + +G + + GT Y+
Sbjct: 108 GLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG-EGKASTFCGTPDYI 163
Query: 507 APELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVI 551
APE+L+ + S D ++FGV + E+ G+ P + D L I
Sbjct: 164 APEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 8e-12
Identities = 41/99 (41%), Positives = 58/99 (58%), Gaps = 8/99 (8%)
Query: 444 VAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLAR-LYDHGNDLHTTNVVGT 502
+A L +LH +++RD+KP N+LLD + KL DFGL++ DH + GT
Sbjct: 107 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGT 161
Query: 503 VGYLAPELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQ 540
V Y+APE++ N RG T S D ++FGV M E+ G P Q
Sbjct: 162 VEYMAPEVV-NRRGHTQSADWWSFGVLMFEMLTGSLPFQ 199
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 50/165 (30%), Positives = 65/165 (39%), Gaps = 45/165 (27%)
Query: 408 LLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKG------VAFGLLYLHEEWEQVVLH 461
L LV +YMP G L +N R + +A +L L + +H
Sbjct: 76 LYLVMEYMPGGDL-----------MNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIH 124
Query: 462 RDIKPANVLLDADLEGKLGDFGLA-----------RLYDHGNDLHTTN------------ 498
RDIKP N+L+DAD KL DFGL L D N L N
Sbjct: 125 RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRR 184
Query: 499 -----VVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRP 538
VGT Y+APE+LR D ++ GV + E+ G P
Sbjct: 185 VRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 1e-11
Identities = 80/283 (28%), Positives = 127/283 (44%), Gaps = 44/283 (15%)
Query: 346 KGGSGKVYRGVLPS---SHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRG 400
KG G V L S S ++AVK + D S +++F+ E M + H N+++L G
Sbjct: 9 KGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIG 68
Query: 401 ---YCRRKGEL---LLVYDYMPNGSLDKILYSN---TRP---SLNWFQRFRIIKGVAFGL 448
R KG L +++ +M +G L L + P L RF I +A G+
Sbjct: 69 VSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI--DIASGM 126
Query: 449 LYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGT--VGYL 506
YL + +HRD+ N +L+ ++ + DFGL++ G D + V +L
Sbjct: 127 EYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSG-DYYRQGCASKLPVKWL 182
Query: 507 APELLRNGRGTTSTDVYAFGVFMLEVAC-GRRP---VQPGELDLLDWVIDYWQKGDVLDA 562
A E L + TT +DV+AFGV M E+ G+ P V+ E + +Y KG+ L
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE------IYNYLIKGNRLKQ 236
Query: 563 SDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
LE +Y E++ + C P RPS + + L+
Sbjct: 237 PPDCLEDVY-----ELMCQ----CWSPEPKCRPSFQHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 66/225 (29%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDH--GMKQFVSEIVSMGKLRHRNLVQLRGYC- 402
KG G V + + ++A+KK+ +H + + EI + LRH ++V+++
Sbjct: 10 KGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIML 69
Query: 403 ----RRKGELLLVYDYMPNGSLDKILYSN---TRPSLNWF--QRFRIIKGVAFGLLYLHE 453
R ++ +V++ M L +++ +N T +F Q R L Y+H
Sbjct: 70 PPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLR-------ALKYIHT 121
Query: 454 EWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT----TNVVGTVGYLAPE 509
V HRD+KP N+L +AD + K+ DFGLAR+ ND T T+ V T Y APE
Sbjct: 122 ---ANVFHRDLKPKNILANADCKLKICDFGLARV--AFNDTPTAIFWTDYVATRWYRAPE 176
Query: 510 LLRN--GRGTTSTDVYAFGVFMLEVACGRRPVQPG-----ELDLL 547
L + + T + D+++ G EV G +P+ PG +LDL+
Sbjct: 177 LCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQLDLI 220
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-11
Identities = 44/162 (27%), Positives = 82/162 (50%), Gaps = 17/162 (10%)
Query: 379 QFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLV--------YDYMPNGSLDKILYSNTRP 430
Q +EI+++G+L H N++++ R + ++ Y +M + + D RP
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD----WKDRP 264
Query: 431 SLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDH 490
L Q I+K + + Y+H+ + ++HRDIK N+ L+ D + LGDFG A ++
Sbjct: 265 LL--KQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEK 319
Query: 491 GNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEV 532
+ VGTV +PE+L TD+++ G+ +L++
Sbjct: 320 EREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361
|
Length = 501 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 47/150 (31%), Positives = 70/150 (46%), Gaps = 5/150 (3%)
Query: 389 KLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGL 448
K+ R +V L K L LV M G L +Y+ P + + + GL
Sbjct: 56 KVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGL 115
Query: 449 LYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAP 508
L E +++RD+KP N+LLD ++ D GLA G + VGTVGY+AP
Sbjct: 116 EDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR--VGTVGYMAP 170
Query: 509 ELLRNGRGTTSTDVYAFGVFMLEVACGRRP 538
E++ N + T S D + G + E+ G+ P
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 63/202 (31%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKK-----VCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRG 400
KG GKV+ L ++ A+K V D D ++S+ H L L
Sbjct: 5 KGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTHL-- 61
Query: 401 YC--RRKGELLLVYDYMPNGSLDKILYSNTRPSL--NWFQRFRIIKGVAFGLLYLHEEWE 456
YC + K L V +Y+ G L + S + L F II GL +LH +
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEII----CGLQFLHSKG- 116
Query: 457 QVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRG 516
+++RD+K N+LLD D K+ DFG+ + G D T GT Y+APE+L +
Sbjct: 117 --IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG-DAKTCTFCGTPDYIAPEILLGQKY 173
Query: 517 TTSTDVYAFGVFMLEVACGRRP 538
TS D ++FGV + E+ G+ P
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 50/154 (32%), Positives = 71/154 (46%), Gaps = 10/154 (6%)
Query: 395 LVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEE 454
+ QL+ + K L LV +Y P G L +L +F + + V L +H
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELV----LAIHSV 118
Query: 455 WEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLR-- 512
+ +HRDIKP NVL+D KL DFG A +++ VGT Y+APE+L
Sbjct: 119 HQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTM 178
Query: 513 NGRGTTSTDV----YAFGVFMLEVACGRRPVQPG 542
NG G + V ++ GV E+ GR P G
Sbjct: 179 NGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG 212
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 24/213 (11%)
Query: 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLV 396
+Y ++YKA +G++ A + + K+ D + Q EI + + +H N+V
Sbjct: 21 TYGDVYKARNLHTGEL---------AAVKIIKLEPGDDFSLIQ--QEIFMVKECKHCNIV 69
Query: 397 QLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWE 456
G + +L + +Y GSL I Y T P L+ Q + + GL YLH + +
Sbjct: 70 AYFGSYLSREKLWICMEYCGGGSLQDI-YHVTGP-LSELQIAYVCRETLQGLAYLHSKGK 127
Query: 457 QVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELL---RN 513
+HRDIK AN+LL + + KL DFG+A + +GT ++APE+ +N
Sbjct: 128 ---MHRDIKGANILLTDNGDVKLADFGVAAKIT-ATIAKRKSFIGTPYWMAPEVAAVEKN 183
Query: 514 GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDL 546
G D++A G+ +E+A +QP DL
Sbjct: 184 GGYNQLCDIWAVGITAIELA----ELQPPMFDL 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 37/95 (38%), Positives = 54/95 (56%), Gaps = 4/95 (4%)
Query: 444 VAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTV 503
++ L +LHE + +++RD+K NVLLDA+ KL D+G+ + D T+ GT
Sbjct: 105 ISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT-TSTFCGTP 160
Query: 504 GYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRP 538
Y+APE+LR S D +A GV M E+ GR P
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 49/204 (24%), Positives = 95/204 (46%), Gaps = 24/204 (11%)
Query: 350 GKVYRG--VLPS-SHAEIAVKKVCHDSDHGMK--QFVSEIVSMGKLRHRNLVQLRGYCRR 404
GK+Y+G LP HA++ K D ++ + +F E M +L H N+V L G +
Sbjct: 19 GKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ 78
Query: 405 KGELLLVYDYMPNGSLDKILY---------------SNTRPSLNWFQRFRIIKGVAFGLL 449
+ + ++++Y+ G L + L + SL+ I +A G+
Sbjct: 79 EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGME 138
Query: 450 YLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLAR-LYDHGNDLHTTNVVGTVGYLAP 508
YL + +H+D+ N+L+ L K+ D GL+R +Y + + ++ P
Sbjct: 139 YLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPP 195
Query: 509 ELLRNGRGTTSTDVYAFGVFMLEV 532
E + G+ ++ +D+++FGV + E+
Sbjct: 196 EAIMYGKFSSDSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-11
Identities = 67/249 (26%), Positives = 112/249 (44%), Gaps = 21/249 (8%)
Query: 359 SSHAEIAVKKVCHDSDHGMKQFV-SEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPN 417
S E V K +D + SE+ + H +V+ + +LLL+ +Y
Sbjct: 90 SDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSG 149
Query: 418 GSLDKILYSNTRPSLNWFQRFRIIKGVAFG--LLYLHEEWEQVVLHRDIKPANVLLDADL 475
G L+K + + L FQ + + G+ F +L L E + ++HRD+K AN+ L
Sbjct: 150 GDLNKQIKQRLKEHLP-FQEYEV--GLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG 206
Query: 476 EGKLGDFGLARLYDHGNDLHT-TNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC 534
KLGDFG ++ Y L ++ GT YLAPEL R + D+++ GV + E+
Sbjct: 207 IIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
Query: 535 GRRPVQ-PGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDT 593
RP + P + +++ V+ + K D V M+ +L L NP
Sbjct: 267 LHRPFKGPSQREIMQQVL--YGKYDPFPCP--------VSSGMKALLDPLL---SKNPAL 313
Query: 594 RPSMRQVVQ 602
RP+ +Q++
Sbjct: 314 RPTTQQLLH 322
|
Length = 478 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 50/144 (34%), Positives = 69/144 (47%), Gaps = 6/144 (4%)
Query: 395 LVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEE 454
LV L + L LV +Y+ G L R RF + + L +LHE
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDL-MFHMQRQRKLPEEHARFYAAE-ICIALNFLHE- 114
Query: 455 WEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNG 514
+ +++RD+K NVLLDAD KL D+G+ + D T+ GT Y+APE+LR
Sbjct: 115 --RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT-TSTFCGTPNYIAPEILRGE 171
Query: 515 RGTTSTDVYAFGVFMLEVACGRRP 538
S D +A GV M E+ GR P
Sbjct: 172 EYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 36/101 (35%), Positives = 59/101 (58%), Gaps = 4/101 (3%)
Query: 447 GLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYL 506
GL +LH + +++RD+K NV+LD D K+ DFG+ + G++ +T GT Y+
Sbjct: 108 GLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYI 163
Query: 507 APELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLL 547
APE+L+ + T S D ++FGV + E+ G+ P + D L
Sbjct: 164 APEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 4e-11
Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 347 GGSGKVYRG--VLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCR 403
G G+VY+G V A I V V D + +KQ EI + K HRN+ G
Sbjct: 17 GTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ---EINMLKKYSHHRNIATYYGAFI 73
Query: 404 RKG------ELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQ 457
+K +L LV ++ GS+ ++ + +L I + + GL +LH+
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---H 130
Query: 458 VVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGT 517
V+HRDIK NVLL + E KL DFG++ D T +GT ++APE++
Sbjct: 131 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEVIACDENP 189
Query: 518 TST-----DVYAFGVFMLEVACGRRPV 539
+T D+++ G+ +E+A G P+
Sbjct: 190 DATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 5e-11
Identities = 46/148 (31%), Positives = 69/148 (46%), Gaps = 10/148 (6%)
Query: 395 LVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEE 454
+VQL + L +V +YMP G L ++ SN W + + V L +H
Sbjct: 105 VVQLFCAFQDDKYLYMVMEYMPGGDLVNLM-SNYDVPEKWAKFY--TAEVVLALDAIHS- 160
Query: 455 WEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNG 514
++HRD+KP N+LLD KL DFG D + VGT Y++PE+L++
Sbjct: 161 --MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQ 218
Query: 515 RGT----TSTDVYAFGVFMLEVACGRRP 538
G D ++ GVF+ E+ G P
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 5e-11
Identities = 62/218 (28%), Positives = 91/218 (41%), Gaps = 42/218 (19%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHD-SDHGM--KQFVSEIVSMGKLRHRNLVQLRGYC 402
KGG G+VY P +A+KK+ D S++ + K+F+ E L H +V + C
Sbjct: 12 KGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSIC 71
Query: 403 RRKGELLLVYDYMP--NGSLDKILYSNTR------------PSLNWFQRFRIIKGVAFGL 448
VY MP G K L + S+ F I + +
Sbjct: 72 SDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF--LSIFHKICATI 126
Query: 449 LYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARL------------YDHGNDLHT 496
Y+H + VLHRD+KP N+LL E + D+G A D N ++
Sbjct: 127 EYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 497 T-----NVVGTVGYLAPELLRNGRGTTSTDVYAFGVFM 529
+ +VGT Y+APE L + STD+YA GV +
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVIL 221
|
Length = 932 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 5e-11
Identities = 54/189 (28%), Positives = 95/189 (50%), Gaps = 11/189 (5%)
Query: 350 GKVYRGV-LP---SSHAEIAVKKVCHDSDHGMKQFVSE-IVSMGKLRHRNLVQLRGYCRR 404
G V++G+ +P S +A+K + S Q +++ +++MG L H +V+L G C
Sbjct: 21 GTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP- 79
Query: 405 KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDI 464
L LV P GSL + + R SL+ + +A G+ YL E ++HR++
Sbjct: 80 GASLQLVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNL 135
Query: 465 KPANVLLDADLEGKLGDFGLAR-LYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVY 523
N+LL +D ++ DFG+A LY + + ++A E + GR T +DV+
Sbjct: 136 AARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVW 195
Query: 524 AFGVFMLEV 532
++GV + E+
Sbjct: 196 SYGVTVWEM 204
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 6e-11
Identities = 43/147 (29%), Positives = 71/147 (48%), Gaps = 9/147 (6%)
Query: 395 LVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKG-VAFGLLYLHE 453
LV L + +L L+ DY+ G L LY + R+ + L +LH+
Sbjct: 67 LVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTE---SEVRVYIAEIVLALDHLHQ 123
Query: 454 EWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRN 513
+++RDIK N+LLD++ L DFGL++ + + + GT+ Y+APE++R
Sbjct: 124 ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRG 180
Query: 514 GRG--TTSTDVYAFGVFMLEVACGRRP 538
G G + D ++ GV E+ G P
Sbjct: 181 GSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 6e-11
Identities = 53/198 (26%), Positives = 99/198 (50%), Gaps = 28/198 (14%)
Query: 364 IAVKKVCHDSDHGMKQ-FVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDK 422
+AVK + D++ + F+ E+ + +L+ N+++L G C + L ++ +YM NG L++
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 423 ILYSNTR-----------------PSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIK 465
L S+ P++++ + +A G+ YL +HRD+
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLA 165
Query: 466 PANVLLDADLEGKLGDFGLAR-LYDHGNDLHTTN--VVGTVGYLAPELLRNGRGTTSTDV 522
N L+ +L K+ DFG++R LY D + V + ++A E + G+ TT++DV
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLY--AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDV 223
Query: 523 YAFGVFMLEV--ACGRRP 538
+AFGV + E+ C +P
Sbjct: 224 WAFGVTLWEILMLCKEQP 241
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 6e-11
Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 30/217 (13%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVS---------EIVSMG 388
Y +L G G V + +A+KK+ MK F + E+ +
Sbjct: 12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI-------MKPFSTPVLAKRTYRELKLLK 64
Query: 389 KLRHRNLVQLRG-YCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFG 447
LRH N++ L + ++ V + + L ++L +RP F ++ + + + G
Sbjct: 65 HLRHENIISLSDIFISPLEDIYFVTELLGT-DLHRLL--TSRPLEKQFIQYFLYQ-ILRG 120
Query: 448 LLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLA 507
L Y+H V+HRD+KP+N+L++ + + K+ DFGLAR+ D T V T Y A
Sbjct: 121 LKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDP----QMTGYVSTRYYRA 173
Query: 508 PE-LLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGE 543
PE +L + D+++ G E+ G +P+ PG+
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPLFPGK 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 7e-11
Identities = 48/159 (30%), Positives = 73/159 (45%), Gaps = 14/159 (8%)
Query: 388 GKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRII---KGV 444
RH LV L + + + V +Y G L ++++ F R + V
Sbjct: 57 NSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDV------FSEPRAVFYAACV 110
Query: 445 AFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVG 504
GL YLHE +++RD+K N+LLD + K+ DFGL + G T+ GT
Sbjct: 111 VLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFCGTPE 166
Query: 505 YLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGE 543
+LAPE+L T + D + GV + E+ G P PG+
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPF-PGD 204
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 7e-11
Identities = 49/204 (24%), Positives = 89/204 (43%), Gaps = 23/204 (11%)
Query: 334 HRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMK-QFVSEIVSMGKLRH 392
Y + T G G+V+ P + V K+ G K + E + + + H
Sbjct: 64 ASLGYTVIKTLTPGSEGRVFVATKPGQ-PDPVVLKI------GQKGTTLIEAMLLQNVNH 116
Query: 393 RNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYS----NTRPSLNWFQRFRIIKGVAFGL 448
++++++ +V +P+ S D LY+ +RP L Q I K + GL
Sbjct: 117 PSVIRMKDTLVSGAITCMV---LPHYSSD--LYTYLTKRSRP-LPIDQALIIEKQILEGL 170
Query: 449 LYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAP 508
YLH Q ++HRD+K N+ ++ + +GD G A+ + GTV AP
Sbjct: 171 RYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQF--PVVAPAFLGLAGTVETNAP 225
Query: 509 ELLRNGRGTTSTDVYAFGVFMLEV 532
E+L + + D+++ G+ + E+
Sbjct: 226 EVLARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 8e-11
Identities = 62/234 (26%), Positives = 107/234 (45%), Gaps = 41/234 (17%)
Query: 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLV 396
+Y+ L K +G GKVY+ ++ +A+KK + D E + LR +L+
Sbjct: 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-------EEGIPPTALREISLL 54
Query: 397 QLRGYC---------------RRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQR---- 437
Q+ K L LV++Y+ + L K + SN R
Sbjct: 55 QMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIK 113
Query: 438 ---FRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEG-KLGDFGLARLYDHGND 493
++++KGVA + H+ V+HRD+KP N+L+D K+ D GL R +
Sbjct: 114 SFMYQLLKGVA----HCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK 166
Query: 494 LHTTNVVGTVGYLAPELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPGELDL 546
+T +V T+ Y APE+L +T D+++ G E++ ++P+ PG+ +L
Sbjct: 167 SYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS-RKQPLFPGDSEL 218
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 8e-11
Identities = 36/98 (36%), Positives = 53/98 (54%), Gaps = 9/98 (9%)
Query: 447 GLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYL 506
GL Y+H ++HRD+KP+N+ ++ D E K+ DFGLAR D T V T Y
Sbjct: 130 GLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDD----EMTGYVATRWYR 182
Query: 507 APELLRNGRGTTST-DVYAFGVFMLEVACGRRPVQPGE 543
APE++ N T D+++ G M E+ G + + PG
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLTG-KTLFPGS 219
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 25/209 (11%)
Query: 347 GGSGKVYRG--VLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCR 403
G G+VY+G V A I V V D + +K EI + K HRN+ G
Sbjct: 27 GTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL---EINMLKKYSHHRNIATYYGAFI 83
Query: 404 RKG------ELLLVYDYMPNGSLDKILYSNTRPSL--NWFQRFRIIKGVAFGLLYLHEEW 455
+K +L LV ++ GS+ ++ + +L +W I + + GL +LH
Sbjct: 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHA-- 139
Query: 456 EQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGR 515
V+HRDIK NVLL + E KL DFG++ D T +GT ++APE++
Sbjct: 140 -HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEVIACDE 197
Query: 516 GTTST-----DVYAFGVFMLEVACGRRPV 539
+T D+++ G+ +E+A G P+
Sbjct: 198 NPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 49/188 (26%), Positives = 91/188 (48%), Gaps = 16/188 (8%)
Query: 364 IAVKKVCHDSDHGMKQ-FVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDK 422
+AVK + D++ + F+ EI M +L+ N+++L C L ++ +YM NG L++
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 423 IL---------YSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDA 473
L ++++ + +A G+ YL +HRD+ N L+
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGK 165
Query: 474 DLEGKLGDFGLAR-LYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEV 532
+ K+ DFG++R LY V + +++ E + G+ TT++DV+AFGV + E+
Sbjct: 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225
Query: 533 A--CGRRP 538
C +P
Sbjct: 226 LTLCKEQP 233
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 25/199 (12%)
Query: 347 GGSGKVYRGV-LPSSHA-EIAVKKVCHDSDHGMK---QFVSEIVSMGKLRHRNLVQLRGY 401
G G VY+G+ +P +I V + G K +F+ E + M + H +LV+L G
Sbjct: 18 GAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGV 77
Query: 402 CRRKGELLLVYDYMPNGSLDKILYSN-----TRPSLNWFQRFRIIKGVAFGLLYLHEEWE 456
C + LV MP+G L ++ + ++ LNW + +A G++YL E
Sbjct: 78 CLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE--- 127
Query: 457 QVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVG---TVGYLAPELLRN 513
+ ++HRD+ NVL+ + K+ DFGLARL + D N G + ++A E +
Sbjct: 128 RRLVHRDLAARNVLVKSPNHVKITDFGLARLLE--GDEKEYNADGGKMPIKWMALECIHY 185
Query: 514 GRGTTSTDVYAFGVFMLEV 532
+ T +DV+++GV + E+
Sbjct: 186 RKFTHQSDVWSYGVTIWEL 204
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 49/147 (33%), Positives = 71/147 (48%), Gaps = 6/147 (4%)
Query: 392 HRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYL 451
H LV L + + L V +Y+ G L R RF + ++ L YL
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDL-MFHMQRQRKLPEEHARFYSAE-ISLALNYL 112
Query: 452 HEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELL 511
HE + +++RD+K NVLLD++ KL D+G+ + D T+ GT Y+APE+L
Sbjct: 113 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TSTFCGTPNYIAPEIL 168
Query: 512 RNGRGTTSTDVYAFGVFMLEVACGRRP 538
R S D +A GV M E+ GR P
Sbjct: 169 RGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 21/217 (9%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSE--IVSMGKLRHRNLVQLRG 400
KG GKV L S AVK + D D ++ ++E I+S+ + H L QL
Sbjct: 5 KGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQLY- 62
Query: 401 YCRRKGE-LLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRI---IKGVAFGLLYLHEEWE 456
C + + L V +++ G L + + R F R + L++LH++
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRR-----FDEARARFYAAEITSALMFLHDKG- 116
Query: 457 QVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRG 516
+++RD+K NVLLD + KL DFG+ + N T+ GT Y+APE+L+
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF-NGKTTSTFCGTPDYIAPEILQEMLY 173
Query: 517 TTSTDVYAFGVFMLEVACGRRPVQP-GELDLLDWVID 552
S D +A GV + E+ CG P + E DL + +++
Sbjct: 174 GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 55/208 (26%), Positives = 88/208 (42%), Gaps = 30/208 (14%)
Query: 347 GGSGKVYRGVL---------PSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQ 397
G +Y+GVL V KV F M +L H++LV+
Sbjct: 6 GTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVK 65
Query: 398 LRGYCRRKGELLLVYDYMPNGSLDKILYSNTR-PSLNWFQRFRIIKGVAFGLLYLHEEWE 456
L G C R E ++V +Y+ G LD L+ SL+W + K +A L YL +
Sbjct: 66 LYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLE---D 119
Query: 457 QVVLHRDIKPANVLL-DADLEG------KLGDFGLARLYDHGNDLHTTNVVGTVGYLAPE 509
+ ++H ++ N+L+ L KL D G+ L V + ++APE
Sbjct: 120 KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI-----TVLSREERVERIPWIAPE 174
Query: 510 LLRNGRG--TTSTDVYAFGVFMLEVACG 535
+RNG+ T + D ++FG +LE+
Sbjct: 175 CIRNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-10
Identities = 64/231 (27%), Positives = 112/231 (48%), Gaps = 31/231 (13%)
Query: 321 EEVYEDWEKEYSPHRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQF 380
EE D + SP++ SYK G G VY + + ++A+KKV D + +
Sbjct: 52 EEKMIDNDINRSPNK-SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR-- 108
Query: 381 VSEIVSMGKLRHRNLVQLRGY----CRRKGE----LLLVYDYMPNGSLDKIL--YSNTRP 430
E++ M L H N++ L+ Y C +K E L +V +++P ++ K + Y+
Sbjct: 109 --ELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNH 165
Query: 431 SLNWFQRFRIIKGVAF----GLLYLHEEWEQVVLHRDIKPANVLLDADLEG-KLGDFGLA 485
+L F ++K ++ L Y+H ++ + HRD+KP N+L+D + KL DFG A
Sbjct: 166 ALPLF----LVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSA 218
Query: 486 RLYDHGNDLHTTNVVGTVGYLAPELLRNGRG-TTSTDVYAFGVFMLEVACG 535
+ G + + + + Y APEL+ TT D+++ G + E+ G
Sbjct: 219 KNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 34/96 (35%), Positives = 55/96 (57%), Gaps = 6/96 (6%)
Query: 444 VAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNV-VGT 502
+A GL +LH + +++RD+K NV+LDA+ K+ DFG+ + ++ TT GT
Sbjct: 110 IAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGT 164
Query: 503 VGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRP 538
Y+APE++ S D +AFGV + E+ G+ P
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 37/96 (38%), Positives = 54/96 (56%), Gaps = 10/96 (10%)
Query: 448 LLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLA-RLYDHGNDLHTTNVVGTVGYL 506
L YL E+ V+HRD+KP+N+LLDA KL DFG++ RL D T G Y+
Sbjct: 127 LHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD---SKAKTRSAGCAAYM 181
Query: 507 APELL----RNGRGTTSTDVYAFGVFMLEVACGRRP 538
APE + N + DV++ G+ ++E+A G+ P
Sbjct: 182 APERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCH--DSDHGMKQFVSEIVSMGKLRHRNL 395
Y++L + G G V + + A++A+KK+ S+ K+ E+ + ++H N+
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENV 76
Query: 396 VQLRGY------CRRKGELLLVYDYMPNGSLDKIL----YSNTRPSLNWFQRFRIIKGVA 445
+ L R + LV +M L K++ S R +Q +
Sbjct: 77 IGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLK------ 129
Query: 446 FGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGY 505
GL Y+H ++HRD+KP N+ ++ D E K+ DFGLAR D T V T Y
Sbjct: 130 -GLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR----QTDSEMTGYVVTRWY 181
Query: 506 LAPELLRNG-RGTTSTDVYAFGVFMLEVACGR 536
APE++ N T + D+++ G M E+ G+
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 47/153 (30%), Positives = 79/153 (51%), Gaps = 15/153 (9%)
Query: 389 KLRHRNLVQLRGYCRRKGE--LLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAF 446
++ H +++L + + L ++ +Y+P G L L ++ R S N F + V
Sbjct: 57 EVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFS-NSTGLFYASEIVC- 112
Query: 447 GLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLAR-LYDHGNDLHTTNVVGTVGY 505
L YLH + +++RD+KP N+LLD + KL DFG A+ L D T + GT Y
Sbjct: 113 ALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-----RTWTLCGTPEY 164
Query: 506 LAPELLRNGRGTTSTDVYAFGVFMLEVACGRRP 538
LAPE++++ + D +A G+ + E+ G P
Sbjct: 165 LAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 43/146 (29%), Positives = 70/146 (47%), Gaps = 7/146 (4%)
Query: 395 LVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEE 454
LV L + +L L+ DY+ G L L R Q + + L +LH+
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIY--SGEIVLALEHLHK- 123
Query: 455 WEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNG 514
+++RDIK N+LLD++ L DFGL++ + + GT+ Y+AP+++R G
Sbjct: 124 --LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGG 181
Query: 515 RG--TTSTDVYAFGVFMLEVACGRRP 538
G + D ++ GV M E+ G P
Sbjct: 182 DGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 50/196 (25%), Positives = 93/196 (47%), Gaps = 18/196 (9%)
Query: 347 GGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKG 406
G GKVY+ + A K + S+ ++ ++ EI + H N+V+L +
Sbjct: 16 GAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN 75
Query: 407 ELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKP 466
L ++ ++ G++D ++ RP L Q + K L YLHE ++HRD+K
Sbjct: 76 NLWILIEFCAGGAVDAVMLELERP-LTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKA 131
Query: 467 ANVLLDADLEGKLGDFGLARLYDHGNDLHTT----NVVGTVGYLAPELL-----RNGRGT 517
N+L D + KL DFG++ + T + +GT ++APE++ ++
Sbjct: 132 GNILFTLDGDIKLADFGVS-----AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 186
Query: 518 TSTDVYAFGVFMLEVA 533
DV++ G+ ++E+A
Sbjct: 187 YKADVWSLGITLIEMA 202
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCH--DSDHGMKQFVSEIVSMGKLRHRNL 395
Y +L + G G V + + ++A+KK+ S+ K+ E+ + ++H N+
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76
Query: 396 VQLRGY------CRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLL 449
+ L + LV YM L KI+ + ++++ G L
Sbjct: 77 IGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLSEDKVQYLVYQMLCG----LK 131
Query: 450 YLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPE 509
Y+H ++HRD+KP N+ ++ D E K+ DFGLAR H D T V T Y APE
Sbjct: 132 YIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR---HA-DAEMTGYVVTRWYRAPE 184
Query: 510 LLRNGRGTTST-DVYAFGVFMLEVACGR 536
++ N T D+++ G M E+ G+
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 57/193 (29%), Positives = 84/193 (43%), Gaps = 18/193 (9%)
Query: 348 GSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGE 407
SGK Y + IA +V H ++E + RH L L+ + K
Sbjct: 18 ASGKYYAMKILKKEVIIAKDEVAHT--------LTESRVLKNTRHPFLTSLKYSFQTKDR 69
Query: 408 LLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKG-VAFGLLYLHEEWEQVVLHRDIKP 466
L V +Y+ G L + +R + R R + L YLH +++RD+K
Sbjct: 70 LCFVMEYVNGGEL---FFHLSRERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKL 123
Query: 467 ANVLLDADLEGKLGDFGLARLYDHGNDLHTTNV-VGTVGYLAPELLRNGRGTTSTDVYAF 525
N++LD D K+ DFGL + + D T GT YLAPE+L + + D +
Sbjct: 124 ENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 181
Query: 526 GVFMLEVACGRRP 538
GV M E+ CGR P
Sbjct: 182 GVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 7e-10
Identities = 34/93 (36%), Positives = 55/93 (59%), Gaps = 3/93 (3%)
Query: 448 LLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDH--GNDLHTTNVVGTVGY 505
LL +H + ++HRDIK AN+LL ++ KLGDFG +++Y +D+ T GT Y
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT-FCGTPYY 211
Query: 506 LAPELLRNGRGTTSTDVYAFGVFMLEVACGRRP 538
+APE+ R + D+++ GV + E+ +RP
Sbjct: 212 VAPEIWRRKPYSKKADMFSLGVLLYELLTLKRP 244
|
Length = 496 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 68/275 (24%), Positives = 120/275 (43%), Gaps = 56/275 (20%)
Query: 364 IAVKKVCHDSDHG-MKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDK 422
+AVK + ++ ++ +SE + ++ H ++++L G C + G LLL+ +Y GSL
Sbjct: 33 VAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRS 92
Query: 423 IL---------YSNTRPSLNWFQRF-----------------RIIKGVAFGLLYLHEEWE 456
L Y + + N +I +G+ YL E
Sbjct: 93 FLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQ----YLAE--- 145
Query: 457 QVVLHRDIKPANVLLDADLEGKLGDFGLAR-LYDHGNDLHTTNVVGTVGYLAPELLRNGR 515
++HRD+ NVL+ + K+ DFGL+R +Y+ + + + V ++A E L +
Sbjct: 146 MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHI 205
Query: 516 GTTSTDVYAFGVFMLE-VACGRRP---VQPGEL-DLLDWVIDYWQKGDVLDASDPRLEGI 570
TT +DV++FGV + E V G P + P L +LL + G ++ + E +
Sbjct: 206 YTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLL-------KTGYRMERPENCSEEM 258
Query: 571 YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
Y L L C PD RP+ + + L+
Sbjct: 259 Y---------NLMLTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 49/150 (32%), Positives = 69/150 (46%), Gaps = 9/150 (6%)
Query: 391 RHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKG-VAFGLL 449
RH L L+ + L V +Y G L + +R + R R + L
Sbjct: 53 RHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALD 109
Query: 450 YLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARL-YDHGNDLHTTNVVGTVGYLAP 508
YLH E V++RD+K N++LD D K+ DFGL + G + T GT YLAP
Sbjct: 110 YLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAP 165
Query: 509 ELLRNGRGTTSTDVYAFGVFMLEVACGRRP 538
E+L + + D + GV M E+ CGR P
Sbjct: 166 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 8e-10
Identities = 34/91 (37%), Positives = 47/91 (51%), Gaps = 4/91 (4%)
Query: 448 LLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLA 507
L YLH V++RD+K N++LD D K+ DFGL + + GT YLA
Sbjct: 108 LGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLA 163
Query: 508 PELLRNGRGTTSTDVYAFGVFMLEVACGRRP 538
PE+L + + D + GV M E+ CGR P
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 9e-10
Identities = 32/89 (35%), Positives = 54/89 (60%), Gaps = 5/89 (5%)
Query: 446 FGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGY 505
G+ Y+H+ + +LHRD+K N+ L +L K+GDFG++RL DL TT GT Y
Sbjct: 117 LGVHYMHQ---RRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATT-FTGTPYY 171
Query: 506 LAPELLRNGRGTTSTDVYAFGVFMLEVAC 534
++PE L++ + +D+++ G + E+ C
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYEMCC 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 9e-10
Identities = 63/211 (29%), Positives = 97/211 (45%), Gaps = 35/211 (16%)
Query: 346 KGGSGKVY--RGVLPSSHAEIAVKKVCH---------DSDHGMKQFVSEIVSMGKLRHRN 394
KGG GKV+ R V + +I KV D+ H +E + ++H
Sbjct: 6 KGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTK----AERNILEAVKHPF 61
Query: 395 LVQLRGYCRRKGELLLVYDYMPNGSL------DKILYSNTRPSLNWFQRFRIIKGVAFGL 448
+V L + G+L L+ +Y+ G L + I +T F I L
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTAC----FYLSEIS----LAL 113
Query: 449 LYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAP 508
+LH+ Q +++RD+KP N+LLDA KL DFGL + H + T GT+ Y+AP
Sbjct: 114 EHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV-THTFCGTIEYMAP 169
Query: 509 ELL-RNGRGTTSTDVYAFGVFMLEVACGRRP 538
E+L R+G G + D ++ G M ++ G P
Sbjct: 170 EILMRSGHG-KAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 49/159 (30%), Positives = 72/159 (45%), Gaps = 8/159 (5%)
Query: 381 VSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRI 440
V+E + RH L L+ + L V +Y G L + +R + +R R
Sbjct: 43 VTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARF 99
Query: 441 IKG-VAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNV 499
+ L YLH + V++RDIK N++LD D K+ DFGL + +
Sbjct: 100 YGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTF 155
Query: 500 VGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRP 538
GT YLAPE+L + + D + GV M E+ CGR P
Sbjct: 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 55/199 (27%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 347 GGSGKVYRGVLPSSHAE--IAVKKVCHDS-DHGMK-QFVSEIVSMGKLRHRNLVQLRGYC 402
G G V +G+ +E +AVK + +D+ D +K + + E M +L + +V++ G C
Sbjct: 6 GNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC 65
Query: 403 RRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHR 462
+ +LV + G L+K L N + ++ V+ G+ YL E +HR
Sbjct: 66 EAES-WMLVMELAELGPLNKFLQKNKHVTEK--NITELVHQVSMGMKYLEE---TNFVHR 119
Query: 463 DIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGT--VGYLAPELLRNGRGTTST 520
D+ NVLL K+ DFGL++ + + G V + APE + + ++ +
Sbjct: 120 DLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKS 179
Query: 521 DVYAFGVFMLEV-ACGRRP 538
DV++FGV M E + G++P
Sbjct: 180 DVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 35/106 (33%), Positives = 60/106 (56%), Gaps = 8/106 (7%)
Query: 444 VAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLAR--LYDHGNDLHTTNVVG 501
+A GL +LH + +++RD+K NV+LD++ K+ DFG+ + ++D + T G
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD---GVTTKTFCG 163
Query: 502 TVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLL 547
T Y+APE++ S D +AFGV + E+ G+ P + + D L
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 48/198 (24%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 347 GGSGKVYRGV--LPSSHAEIAVKKVCHDSDHGMK-QFVSEIVSMGKLRHRNLVQLRGYCR 403
G G V +GV + ++A+K + ++++ ++ + + E M +L + +V++ G C
Sbjct: 6 GNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE 65
Query: 404 RKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRD 463
+ L+LV + G L+K L S + + ++ V+ G+ YL + +HRD
Sbjct: 66 AEA-LMLVMEMASGGPLNKFL-SGKKDEITVSNVVELMHQVSMGMKYLEG---KNFVHRD 120
Query: 464 IKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGT--VGYLAPELLRNGRGTTSTD 521
+ NVLL K+ DFGL++ + + G + + APE + + ++ +D
Sbjct: 121 LAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSD 180
Query: 522 VYAFGVFMLEV-ACGRRP 538
V+++G+ M E + G++P
Sbjct: 181 VWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 43/146 (29%), Positives = 73/146 (50%), Gaps = 8/146 (5%)
Query: 395 LVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKG-VAFGLLYLHE 453
LV L + + +L L+ DY+ G + LY S + R G + L +LH+
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED---EVRFYSGEIILALEHLHK 123
Query: 454 EWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRN 513
+++RDIK N+LLD++ L DFGL++ + T + GT+ Y+APE++R
Sbjct: 124 ---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRG 180
Query: 514 GRG-TTSTDVYAFGVFMLEVACGRRP 538
G + D ++ G+ + E+ G P
Sbjct: 181 KGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 63/275 (22%), Positives = 117/275 (42%), Gaps = 46/275 (16%)
Query: 351 KVYRGV------LPSSHAEIAVKKVCHDSDHG--MKQFVSEIVSMGKLRHRNLVQLRGYC 402
K+++G+ H + KV D H + F M +L H++LV G C
Sbjct: 10 KIFKGIRREVGDYGELHKTEVLLKVL-DKSHRNYSESFFEAASMMSQLSHKHLVLNYGVC 68
Query: 403 RRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHR 462
E ++V +Y+ GSLD L N + +N + + K +A+ L +L ++ + H
Sbjct: 69 VCGDESIMVQEYVKFGSLDTYLKKN-KNLINISWKLEVAKQLAWALHFLE---DKGLTHG 124
Query: 463 DIKPANVLLDADLEGKLGDFGLARLYDHGND---LHTTNVVGTVGYLAPELLRNGRG-TT 518
++ NVLL + + K G+ +L D G L ++ + ++ PE + N + +
Sbjct: 125 NVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECIENPQNLSL 184
Query: 519 STDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDV-LDASDPRLEGIYVEEQME 577
+ D ++FG + E+ G GD L A D + + + E++ +
Sbjct: 185 AADKWSFGTTLWEIFSG---------------------GDKPLSALDSQKKLQFYEDRHQ 223
Query: 578 I-------VLKLGLFCSHSNPDTRPSMRQVVQYLD 605
+ + L C PD RPS R +++ L+
Sbjct: 224 LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 20/208 (9%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCH--DSDHGMKQFVSEIVSMGKLRHRNL 395
Y+NL G G V + +AVKK+ S K+ E+ + ++H N+
Sbjct: 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 78
Query: 396 VQLRGY---CRRKGELLLVY--DYMPNGSLDKILYSNTRPSLN-WFQRFRIIKGVAFGLL 449
+ L R E VY ++ L+ I+ + F ++I++G L
Sbjct: 79 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG----LK 134
Query: 450 YLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPE 509
Y+H ++HRD+KP+N+ ++ D E K+ DFGLAR H +D T V T Y APE
Sbjct: 135 YIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDD-EMTGYVATRWYRAPE 187
Query: 510 LLRNGRGTTST-DVYAFGVFMLEVACGR 536
++ N T D+++ G M E+ GR
Sbjct: 188 IMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 31/84 (36%), Positives = 43/84 (51%), Gaps = 5/84 (5%)
Query: 460 LHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLR-----NG 514
+HRDIKP NVLLD + +L DFG + + VGT Y++PE+L+ G
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183
Query: 515 RGTTSTDVYAFGVFMLEVACGRRP 538
R D ++ GV M E+ G P
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 43/135 (31%), Positives = 64/135 (47%), Gaps = 10/135 (7%)
Query: 408 LLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPA 467
L +V +YMP G L ++ + P W RF + V L +H +HRD+KP
Sbjct: 118 LYMVMEYMPGGDLVNLMSNYDVPE-KW-ARFYTAE-VVLALDAIHS---MGFIHRDVKPD 171
Query: 468 NVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGT----TSTDVY 523
N+LLD KL DFG + + VGT Y++PE+L++ G D +
Sbjct: 172 NMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWW 231
Query: 524 AFGVFMLEVACGRRP 538
+ GVF+ E+ G P
Sbjct: 232 SVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 49/164 (29%), Positives = 79/164 (48%), Gaps = 13/164 (7%)
Query: 382 SEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTR-PS-LNWFQRFR 439
SE + + H V L G + + L LV +++ G L N R P+ + F +
Sbjct: 80 SERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQ 139
Query: 440 IIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNV 499
I+ L++ + + +V +RD+KP N+LLD D K+ DFG A++ D T +
Sbjct: 140 IV------LIFEYLQSLNIV-YRDLKPENLLLDKDGFIKMTDFGFAKVV----DTRTYTL 188
Query: 500 VGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGE 543
GT Y+APE+L N + D + G+F+ E+ G P E
Sbjct: 189 CGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE 232
|
Length = 340 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 35/197 (17%)
Query: 367 KKVCHDSDHGMKQFVSEIVSMGKLR-HRNLVQLRG--YCRRKGELLLVYDYMPNGSLDKI 423
KK + + EI ++ +L H N+++L + R+ G L LV++ M D
Sbjct: 33 KKHFKSLEQVNN--LREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELM-----DMN 85
Query: 424 LYSNTR--------PSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADL 475
LY + + + ++++K + +H + HRDIKP N+L+ D+
Sbjct: 86 LYELIKGRKRPLPEKRVKSYM-YQLLKSLDH----MHRNG---IFHRDIKPENILIKDDI 137
Query: 476 EGKLGDFGLAR-LYDHGNDLHTTNVVGTVGYLAPE-LLRNGRGTTSTDVYAFGVFMLEVA 533
KL DFG R +Y T + T Y APE LL +G D++A G E+
Sbjct: 138 -LKLADFGSCRGIYSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEIL 193
Query: 534 CGRRPVQPG--ELDLLD 548
P+ PG ELD +
Sbjct: 194 -SLFPLFPGTNELDQIA 209
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 49/204 (24%), Positives = 90/204 (44%), Gaps = 24/204 (11%)
Query: 350 GKVYRGVL----PSSHAEIAVKKVCHDSDHG--MKQFVSEIVSMGKLRHRNLVQLRGYCR 403
GKVY+G L P + K D G ++F E + +L+H N+V L G
Sbjct: 19 GKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT 78
Query: 404 RKGELLLVYDYMPNGSLDKILY--------------SNTRPSLNWFQRFRIIKGVAFGLL 449
++ L +++ Y + L + L + +L I+ +A G+
Sbjct: 79 KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGME 138
Query: 450 YLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLAR-LYDHGNDLHTTNVVGTVGYLAP 508
+L V+H+D+ NVL+ L K+ D GL R +Y N + + +++P
Sbjct: 139 FLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSP 195
Query: 509 ELLRNGRGTTSTDVYAFGVFMLEV 532
E + G+ + +D++++GV + EV
Sbjct: 196 EAIMYGKFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 7e-09
Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 12/222 (5%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGM---KQFVSEIVSMGKLRHRN 394
++ L + +GG G+V+ + +A+K++ + + ++E + +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 395 LVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEE 454
LV+L + L L +Y+P G + L +N RF + + + LHE
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDF-RTLLNNLGVLSEDHARFYMAEMFE-AVDALHE- 119
Query: 455 WEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNG 514
+HRD+KP N L+DA KL DFGL++ G + +VVG+ Y+APE+LR
Sbjct: 120 --LGYIHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPEVLRGK 173
Query: 515 RGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQK 556
+ D ++ G + E CG P + + YW++
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE 215
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 44/136 (32%), Positives = 63/136 (46%), Gaps = 9/136 (6%)
Query: 408 LLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPA 467
L LV DY G L +L RF I + V L +H + +HRDIKP
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMV----LAIHSIHQLHYVHRDIKPD 131
Query: 468 NVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRN-----GRGTTSTDV 522
NVLLD + +L DFG + + ++ VGT Y++PE+L+ G+ D
Sbjct: 132 NVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDW 191
Query: 523 YAFGVFMLEVACGRRP 538
++ GV M E+ G P
Sbjct: 192 WSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 8e-09
Identities = 61/195 (31%), Positives = 92/195 (47%), Gaps = 47/195 (24%)
Query: 372 DSDHGMKQF---------VSEIVSMGKLRHRNLVQLR----GYCRRKGELLLVYDYMPNG 418
D D+ +KQ EI + +L+H N++ L+ + RK + L++DY +
Sbjct: 28 DRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRK--VWLLFDYAEHD 85
Query: 419 SLDKILY-----SNTRPSLNWFQRFR-IIKGVAF----GLLYLHEEWEQVVLHRDIKPAN 468
I + +N +P Q R ++K + + G+ YLH W VLHRD+KPAN
Sbjct: 86 LWHIIKFHRASKANKKP----VQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPAN 138
Query: 469 VLLDADLEG------KLGDFGLARLYDHG----NDLHTTNVVGTVGYLAPELLRNGRG-T 517
+L+ EG K+ D G ARL++ DL VV T Y APELL R T
Sbjct: 139 ILVMG--EGPERGRVKIADMGFARLFNSPLKPLADLDP--VVVTFWYRAPELLLGARHYT 194
Query: 518 TSTDVYAFGVFMLEV 532
+ D++A G E+
Sbjct: 195 KAIDIWAIGCIFAEL 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 33/98 (33%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 444 VAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTV 503
+ GL ++H + V++RD+KPAN+LLD ++ D GLA + H + VGT
Sbjct: 106 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-HAS--VGTH 159
Query: 504 GYLAPELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQ 540
GY+APE+L+ G +S D ++ G + ++ G P +
Sbjct: 160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 33/98 (33%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 444 VAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTV 503
+ GL ++H + V++RD+KPAN+LLD ++ D GLA + H + VGT
Sbjct: 106 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-HAS--VGTH 159
Query: 504 GYLAPELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQ 540
GY+APE+L+ G +S D ++ G + ++ G P +
Sbjct: 160 GYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 16/223 (7%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVC---HDSDHGMKQFVSEIVSMGKLRHRN 394
Y+NL G G V +A+KK+ + H + + E+V M + H+N
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKN 84
Query: 395 LVQLRGYCRRKGELLLVYD-YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHE 453
++ L + L D Y+ +D L + L+ + ++ + G+ +LH
Sbjct: 85 IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 144
Query: 454 EWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRN 513
++HRD+KP+N+++ +D K+ DFGLAR G T V T Y APE++
Sbjct: 145 AG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 199
Query: 514 GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQK 556
+ D+++ G M E+ G + PG D ID W K
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKG-GVLFPGT----DH-IDQWNK 236
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 48/185 (25%), Positives = 86/185 (46%), Gaps = 13/185 (7%)
Query: 364 IAVKKVCHDS-DHGMKQFV-SEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLD 421
+AVKK+ DS + + EI++ +L+H N++ EL +V M GS +
Sbjct: 28 VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87
Query: 422 KILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGD 481
+L ++ L I+K V L Y+H + +HR +K +++LL D + L
Sbjct: 88 DLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSG 144
Query: 482 FGLAR-LYDHGN-----DLHTTNVVGTVGYLAPELLR-NGRG-TTSTDVYAFGVFMLEVA 533
+ + HG + V + +L+PE+L+ N +G +D+Y+ G+ E+A
Sbjct: 145 LRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELA 204
Query: 534 CGRRP 538
G P
Sbjct: 205 NGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 48/154 (31%), Positives = 70/154 (45%), Gaps = 6/154 (3%)
Query: 385 VSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGV 444
V + ++H LV L + +L V DY+ G L L R RF + +
Sbjct: 48 VLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHL-QRERSFPEPRARFYAAE-I 105
Query: 445 AFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVG 504
A L YLH +++RD+KP N+LLD+ L DFGL + + T+ GT
Sbjct: 106 ASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT-TSTFCGTPE 161
Query: 505 YLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRP 538
YLAPE+LR + D + G + E+ G P
Sbjct: 162 YLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 33/80 (41%), Positives = 44/80 (55%), Gaps = 1/80 (1%)
Query: 459 VLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTT 518
V++RD+KP N+LLD L DFGL +L + +D T GT YLAPELL T
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKL-NMKDDDKTNTFCGTPEYLAPELLLGHGYTK 172
Query: 519 STDVYAFGVFMLEVACGRRP 538
+ D + GV + E+ G P
Sbjct: 173 AVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 33/96 (34%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 444 VAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNV-VGT 502
++ GL +LH + +++RD+K NV+LD++ K+ DFG+ + +H D TT GT
Sbjct: 110 ISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGT 164
Query: 503 VGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRP 538
Y+APE++ S D +A+GV + E+ G+ P
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 3e-08
Identities = 59/223 (26%), Positives = 101/223 (45%), Gaps = 16/223 (7%)
Query: 338 YKNLYKATKGGSGKV---YRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRN 394
Y+NL G G V Y VL + A + + + H + + E+V M + H+N
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKN 77
Query: 395 LVQLRGYCRRKGELLLVYD-YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHE 453
++ L + L D Y+ +D L + L+ + ++ + G+ +LH
Sbjct: 78 IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 137
Query: 454 EWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRN 513
++HRD+KP+N+++ +D K+ DFGLAR G T V T Y APE++
Sbjct: 138 AG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 192
Query: 514 GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQK 556
+ D+++ G M E+ + + PG D+ ID W K
Sbjct: 193 MGYKENVDIWSVGCIMGEMV-RHKILFPGR----DY-IDQWNK 229
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 62/198 (31%), Positives = 86/198 (43%), Gaps = 12/198 (6%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEI-----VSMGKLRHRNLVQLRG 400
KG GKV S + AVK V K+ + I V + L+H LV L
Sbjct: 5 KGSFGKVLLAKRKSDGSFYAVK-VLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHY 63
Query: 401 YCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVL 460
+ +L V DY+ G L L R L RF + VA + YLH ++
Sbjct: 64 SFQTAEKLYFVLDYVNGGELFFHL-QRERCFLEPRARFYAAE-VASAIGYLHS---LNII 118
Query: 461 HRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTST 520
+RD+KP N+LLD+ L DFGL + + T+ GT YLAPE+LR +
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET-TSTFCGTPEYLAPEVLRKEPYDRTV 177
Query: 521 DVYAFGVFMLEVACGRRP 538
D + G + E+ G P
Sbjct: 178 DWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 72/271 (26%), Positives = 122/271 (45%), Gaps = 42/271 (15%)
Query: 347 GGSGKVYRGV-LPSSH---AEIAVKKVCHD-SDHGMKQFVSEIVSMGKLRHRNLVQLRGY 401
G G VY+G+ +P +A+K + + S K+ + E M + + +L G
Sbjct: 18 GAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGI 77
Query: 402 CRRKGELLLVYDYMPNGSLDKILYSN-----TRPSLNWFQRFRIIKGVAFGLLYLHEEWE 456
C + LV MP G L + N ++ LNW + +A G+ YL E
Sbjct: 78 CL-TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE--- 127
Query: 457 QVVLHRDIKPANVLLDADLEGKLGDFGLARLYD-HGNDLHTTNVVGTVGYLAPELLRNGR 515
++HRD+ NVL+ + K+ DFGLARL D + H + ++A E + + R
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRR 187
Query: 516 GTTSTDVYAFGVFMLEVAC-GRRP---VQPGEL-DLLDWVIDYWQKGDVLDASDPRLEGI 570
T +DV+++GV + E+ G +P + E+ DLL +KG+ L +
Sbjct: 188 FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL-------EKGERLPQPPICTIDV 240
Query: 571 YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVV 601
Y+ I++K C + + RP R++V
Sbjct: 241 YM-----IMVK----CWMIDSECRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 62/224 (27%), Positives = 96/224 (42%), Gaps = 35/224 (15%)
Query: 327 WEKEYSPHRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD---HGMKQFVSE 383
WE P R Y+NL G G V ++AVKK+ H + + E
Sbjct: 11 WE---VPER--YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTY-RE 64
Query: 384 IVSMGKLRHRNLVQL------RGYCRRKGELLLVYDYMPNGSLDKIL----YSNTRPSLN 433
+ + ++H N++ L E+ LV + M L+ I+ S+
Sbjct: 65 LRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFL 123
Query: 434 WFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493
+Q R GL Y+H ++HRD+KP+NV ++ D E ++ DFGLAR D
Sbjct: 124 IYQLLR-------GLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADD--- 170
Query: 494 LHTTNVVGTVGYLAPELLRNGRGTTST-DVYAFGVFMLEVACGR 536
T V T Y APE++ N T D+++ G M E+ G+
Sbjct: 171 -EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 5e-08
Identities = 57/175 (32%), Positives = 86/175 (49%), Gaps = 38/175 (21%)
Query: 383 EIVSMGKLRHRNLVQLR----GYCRRKGELLLVYDYMPNGSLDKILY-----SNTRPSLN 433
EI + +L+H N++ L+ + RK + L++DY + I + +N +P
Sbjct: 48 EIALLRELKHPNVIALQKVFLSHSDRK--VWLLFDYAEHDLWHIIKFHRASKANKKP--- 102
Query: 434 WFQRFR-IIKGVAF----GLLYLHEEWEQVVLHRDIKPANVLLDADLEG------KLGDF 482
Q R ++K + + G+ YLH W VLHRD+KPAN+L+ EG K+ D
Sbjct: 103 -MQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMG--EGPERGRVKIADM 156
Query: 483 GLARLYDHG----NDLHTTNVVGTVGYLAPELLRNGRG-TTSTDVYAFGVFMLEV 532
G ARL++ DL VV T Y APELL R T + D++A G E+
Sbjct: 157 GFARLFNSPLKPLADLDP--VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 31/90 (34%), Positives = 48/90 (53%), Gaps = 9/90 (10%)
Query: 450 YLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLA-RLYDHGNDLHTTNVVGTVGYLAP 508
YLH + +++RD+KP N+LLD K+ DFG A ++ D T + GT YLAP
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-----RTFTLCGTPEYLAP 184
Query: 509 ELLRNGRGTTSTDVYAFGVFMLEVACGRRP 538
E++++ + D + GV + E G P
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 61/228 (26%), Positives = 101/228 (44%), Gaps = 26/228 (11%)
Query: 390 LRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNT--RPSLNWFQRFRIIKGVAFG 447
L+H N++Q G C LLV++Y G L L R + R+ +A G
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAG 111
Query: 448 LLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTT--NVVGTVGY 505
+ ++H+ LH D+ N L +DL K+GD+G+ + D T + + +
Sbjct: 112 VTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRW 167
Query: 506 LAPELLRNGRG-------TTSTDVYAFGVFMLEV-ACGRRPVQP-GELDLLDWVIDYWQK 556
LAPEL+ G T ++V+A GV + E+ +P + ++L+ VI K
Sbjct: 168 LAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVI----K 223
Query: 557 GDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYL 604
+ P+LE Y E E++ FC S P+ R + +V + L
Sbjct: 224 DQQVKLFKPQLELPYSERWYEVL----QFCWLS-PEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 55/223 (24%), Positives = 95/223 (42%), Gaps = 16/223 (7%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVC---HDSDHGMKQFVSEIVSMGKLRHRN 394
Y+ L G G V +AVKK+ + H + + E+V + + H+N
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY-RELVLLKCVNHKN 81
Query: 395 LVQLRGYCRRKGELLLVYD-YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHE 453
++ L + L D Y+ +D L L+ + ++ + G+ +LH
Sbjct: 82 IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHS 141
Query: 454 EWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRN 513
++HRD+KP+N+++ +D K+ DFGLAR + T V T Y APE++
Sbjct: 142 AG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRAPEVILG 196
Query: 514 GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQK 556
+ D+++ G M E+ G Q + ID W K
Sbjct: 197 MGYKENVDIWSVGCIMGELVKGSVIFQGTDH------IDQWNK 233
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 1e-07
Identities = 56/230 (24%), Positives = 88/230 (38%), Gaps = 46/230 (20%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVK---KVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYC 402
KG G+V+ L + A+K K + +K+ ++E + L H L L Y
Sbjct: 11 KGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL--YA 68
Query: 403 RRKGE--LLLVYDYMPNGSLDKILYSNTRPSLNWFQ----RFRIIKGVAFGLLYLHEEWE 456
+ E L LV DY P G L ++L +P RF + V L YLH
Sbjct: 69 SFQTETYLCLVMDYCPGGELFRLL--QRQPG-KCLSEEVARFYAAE-VLLALEYLHL--- 121
Query: 457 QVVLHRDIKPANVLL---------DADLEGKLGDFGLARLYDHGNDLHTTNV-------- 499
+++RD+KP N+LL D DL + ++V
Sbjct: 122 LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETF 181
Query: 500 -----------VGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRP 538
VGT Y+APE++ ++ D + G+ + E+ G P
Sbjct: 182 SEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 44/153 (28%), Positives = 77/153 (50%), Gaps = 15/153 (9%)
Query: 460 LHRDIKPANVLLDADLEGKLGDFGLAR-LYDHGNDLHTTNVVGTVGYLAPELLRNGRGTT 518
+HRD+ N+LL + K+ DFGLAR +Y + + + + ++APE + + T
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 260
Query: 519 STDVYAFGVFMLEV-ACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQME 577
+DV++FGV + E+ + G P PG + + + ++G + A D Y +M
Sbjct: 261 QSDVWSFGVLLWEIFSLGASPY-PG-VKIDEEFCRRLKEGTRMRAPD------YTTPEMY 312
Query: 578 IVLKLGLFCSHSNPDTRPSMRQVVQYLDGGALL 610
+ L C H P RP+ ++V++L G LL
Sbjct: 313 QTM---LDCWHGEPSQRPTFSELVEHL--GNLL 340
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 4e-07
Identities = 30/85 (35%), Positives = 48/85 (56%), Gaps = 7/85 (8%)
Query: 460 LHRDIKPANVLLDADLEGKLGDFG-LARLYDHGNDLHTTNVVGTVGYLAPELLR-----N 513
+HRDIKP N+L+D + +L DFG +L + G + ++ VGT Y++PE+L+
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGK 182
Query: 514 GRGTTSTDVYAFGVFMLEVACGRRP 538
G+ D ++ GV M E+ G P
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 51/163 (31%), Positives = 72/163 (44%), Gaps = 9/163 (5%)
Query: 378 KQFVSEI-VSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQ 436
K +SE V + ++H LV L + +L V DY+ G L Y R
Sbjct: 40 KHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL---FYHLQRERCFLEP 96
Query: 437 RFRIIKG-VAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495
R R +A L YLH +++RD+KP N+LLD+ L DFGL + N
Sbjct: 97 RARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT- 152
Query: 496 TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRP 538
T+ GT YLAPE+L + D + G + E+ G P
Sbjct: 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 9e-07
Identities = 46/188 (24%), Positives = 91/188 (48%), Gaps = 25/188 (13%)
Query: 351 KVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLL 410
KV VL SH +I++ F M ++ H+++V L G C R E ++
Sbjct: 34 KVILKVLDPSHRDISLA------------FFETASMMRQVSHKHIVLLYGVCVRDVENIM 81
Query: 411 VYDYMPNGSLDKILYSNTRP-SLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANV 469
V +++ G LD ++ + + W +F++ K +A L YL ++ ++H ++ N+
Sbjct: 82 VEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSYLE---DKDLVHGNVCTKNI 136
Query: 470 LLDAD-LEGKLGDFGLARLYDHG---NDLHTTNVVGTVGYLAPELLRNGRG-TTSTDVYA 524
LL + ++G+ G F +L D G L V + ++APE + + + + + D ++
Sbjct: 137 LLAREGIDGECGPF--IKLSDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWS 194
Query: 525 FGVFMLEV 532
FG + E+
Sbjct: 195 FGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 9e-07
Identities = 50/191 (26%), Positives = 87/191 (45%), Gaps = 37/191 (19%)
Query: 379 QFVSEIVSMGKLRHRNLVQL--RGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQ 436
Q V E+ M +L+H+N+V+ R + +L ++ ++ G L + N + F
Sbjct: 58 QLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSR----NIQKCYKMFG 113
Query: 437 RFR------IIKGVAFGLLYLHEEWE----QVVLHRDIKPANVLLDA------------- 473
+ I + + L Y H + + VLHRD+KP N+ L
Sbjct: 114 KIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQAN 173
Query: 474 DLEG----KLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGT--TSTDVYAFGV 527
+L G K+GDFGL++ + G + + VGT Y +PELL + + +D++A G
Sbjct: 174 NLNGRPIAKIGDFGLSK--NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGC 231
Query: 528 FMLEVACGRRP 538
+ E+ G+ P
Sbjct: 232 IIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 43/153 (28%), Positives = 75/153 (49%), Gaps = 15/153 (9%)
Query: 460 LHRDIKPANVLLDADLEGKLGDFGLAR-LYDHGNDLHTTNVVGTVGYLAPELLRNGRGTT 518
+HRD+ N+LL + K+ DFGLAR +Y + + + + ++APE + + TT
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTT 255
Query: 519 STDVYAFGVFMLEV-ACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQME 577
+DV++FGV + E+ + G P PG + + + + G + A + IY
Sbjct: 256 QSDVWSFGVLLWEIFSLGASPY-PG-VQINEEFCQRLKDGTRMRAPENATPEIY------ 307
Query: 578 IVLKLGLFCSHSNPDTRPSMRQVVQYLDGGALL 610
++ L C +P RP+ +V+ L G LL
Sbjct: 308 ---RIMLACWQGDPKERPTFSALVEIL--GDLL 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 42/147 (28%), Positives = 76/147 (51%), Gaps = 13/147 (8%)
Query: 460 LHRDIKPANVLLDADLEGKLGDFGLAR-LYDHGNDLHTTNVVGTVGYLAPELLRNGRGTT 518
+HRD+ N+LL + K+ DFGLAR +Y + + + + ++APE + + TT
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTT 254
Query: 519 STDVYAFGVFMLEV-ACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQME 577
+DV++FGV + E+ + G P PG + + + ++G + A + IY
Sbjct: 255 QSDVWSFGVLLWEIFSLGASPY-PG-VQIDEEFCRRLKEGTRMRAPEYATPEIY------ 306
Query: 578 IVLKLGLFCSHSNPDTRPSMRQVVQYL 604
+ L C H+NP+ RP+ ++V+ L
Sbjct: 307 ---SIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 37/106 (34%), Positives = 52/106 (49%), Gaps = 19/106 (17%)
Query: 448 LLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLAR---------LYDHGNDLHT-- 496
L YLH ++HRD+KP N+L+ + KL DFGL++ LY+ + T
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 497 ---TNVVGTVGYLAPE-LLRNGRGTTSTDVYAFGVFMLEVACGRRP 538
V GT Y+APE +LR G G D +A G+ + E G P
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYG-KPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 30/90 (33%), Positives = 48/90 (53%), Gaps = 5/90 (5%)
Query: 447 GLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYL 506
G+ +LH ++HRD+KP+N+++ +D K+ DFGLAR G T V T Y
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYR 184
Query: 507 APELLRNGRGTTSTDVYAFGVFMLEVACGR 536
APE++ + D+++ G M E+ G
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 50/206 (24%), Positives = 90/206 (43%), Gaps = 26/206 (12%)
Query: 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLL 471
Y + + +L + L VA G+ +L + +HRD+ NVLL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLL 270
Query: 472 DADLEGKLGDFGLARLYDHGNDLHTTNVVGT------VGYLAPELLRNGRGTTSTDVYAF 525
K+ DFGLAR + +H +N V V ++APE + + TT +DV+++
Sbjct: 271 AQGKIVKICDFGLAR-----DIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSY 325
Query: 526 GVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLF 585
G+ + E+ PG + + + + G + D + +Y +I++K
Sbjct: 326 GILLWEIFSLGGTPYPGMI-VDSTFYNKIKSGYRMAKPDHATQEVY-----DIMVK---- 375
Query: 586 CSHSNPDTRPSMRQVVQYLDGGALLP 611
C +S P+ RPS + ++ +LLP
Sbjct: 376 CWNSEPEKRPSFLHLSDIVE--SLLP 399
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 48/154 (31%), Positives = 71/154 (46%), Gaps = 6/154 (3%)
Query: 385 VSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGV 444
V + ++H LV L + +L V D++ G L L R RF + +
Sbjct: 48 VLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHL-QRERSFPEPRARFYAAE-I 105
Query: 445 AFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVG 504
A L YLH +++RD+KP N+LLD+ L DFGL + +D TT GT
Sbjct: 106 ASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT-TTTFCGTPE 161
Query: 505 YLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRP 538
YLAPE++R + D + G + E+ G P
Sbjct: 162 YLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 55/197 (27%), Positives = 81/197 (41%), Gaps = 62/197 (31%)
Query: 405 KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQ----RFRIIKGVAFGLLYLHEEWEQVVL 460
K L V DY+P G + +L L F+ RF I + + + +H+ +
Sbjct: 73 KDNLYFVMDYIPGGDMMSLLIR-----LGIFEEDLARFYIAE-LTCAIESVHK---MGFI 123
Query: 461 HRDIKPANVLLDADLEGKLGDFGL---------ARLYDHGNDL----------------- 494
HRDIKP N+L+D D KL DFGL ++ Y G+
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRC 183
Query: 495 ------------HTT----NVVGTVGYLAPE-LLRNGRGTTSTDVYAFGVFMLEVACGRR 537
H ++VGT Y+APE LLR G T D ++ GV + E+ G+
Sbjct: 184 RLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYEMLVGQP 242
Query: 538 PV---QPGE--LDLLDW 549
P P E L +++W
Sbjct: 243 PFLADTPAETQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 64/264 (24%), Positives = 111/264 (42%), Gaps = 46/264 (17%)
Query: 351 KVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLL 410
+V VL SH +IA+ F M ++ H +L + G C R E ++
Sbjct: 46 RVVLKVLDPSHRDIALA------------FFETASLMSQVSHIHLAFVHGVCVRGSENIM 93
Query: 411 VYDYMPNGSLDKILYSNT-RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANV 469
V +++ +G LD L R + W + + + +A L YL ++ ++H ++ N+
Sbjct: 94 VEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQLASALSYLE---DKNLVHGNVCAKNI 148
Query: 470 LLDADLEGKLGDFGLARLYDHG---NDLHTTNVVGTVGYLAPELLRNGRG-TTSTDVYAF 525
LL A L G +L D G L V + ++APE + G +T+ D ++F
Sbjct: 149 LL-ARLGLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSF 207
Query: 526 GVFMLEVAC--GRRPVQ---PGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVL 580
G +LE+ C G P++ P E + Y +K + + S L + +
Sbjct: 208 GTTLLEI-CFDGEVPLKERTPSEKERF-----YEKKHRLPEPSCKELATLISQ------- 254
Query: 581 KLGLFCSHSNPDTRPSMRQVVQYL 604
C P RPS R +++ L
Sbjct: 255 -----CLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 30/213 (14%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKV--CHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCR 403
KG GKVY+ + AVK + D D ++ + + S+ H N+V+ G
Sbjct: 32 KGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPN--HPNVVKFYGMFY 89
Query: 404 RK-----GELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFR------IIKGVAFGLLYLH 452
+ G+L LV + GS+ +++ + L QR I+ G GL +LH
Sbjct: 90 KADKLVGGQLWLVLELCNGGSVTELV----KGLLICGQRLDEAMISYILYGALLGLQHLH 145
Query: 453 EEWEQVVLHRDIKPANVLLDADLEGKLGDFGL-ARLYDHGNDLHTTNVVGTVGYLAPELL 511
++HRD+K N+LL + KL DFG+ A+L L VGT ++APE++
Sbjct: 146 N---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS--TRLRRNTSVGTPFWMAPEVI 200
Query: 512 RNGRGTTST-----DVYAFGVFMLEVACGRRPV 539
+ + DV++ G+ +E+ G P+
Sbjct: 201 ACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 8e-06
Identities = 35/117 (29%), Positives = 46/117 (39%), Gaps = 39/117 (33%)
Query: 460 LHRDIKPANVLLDADLEGKLGDFGL------------ARLYDH--GNDLHTT-------- 497
+HRDIKP N+LLDA KL DFGL R+ H ++
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 498 ---------------NVVGTVGYLAPE-LLRNGRGTTSTDVYAFGVFMLEVACGRRP 538
+ VGT Y+APE L+ G D ++ GV M E+ G P
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKEC-DWWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 9e-06
Identities = 39/156 (25%), Positives = 67/156 (42%), Gaps = 6/156 (3%)
Query: 381 VSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRI 440
+E + + H +++QL+G L+ +P D Y + ++ I
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDILAI 187
Query: 441 IKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVV 500
+ V + YLHE ++HRDIK N+ ++ + LGDFG A N
Sbjct: 188 ERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA 244
Query: 501 GTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGR 536
GT+ APELL + D+++ G+ + E+A
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 64/267 (23%), Positives = 122/267 (45%), Gaps = 34/267 (12%)
Query: 347 GGSGKVYRGV-LPSSHA---EIAVKKVCH-DSDHGMKQFVSEIVSMGKLRHRNLVQLRGY 401
G G VY+G+ +P +A+K++ S K+ + E M + + ++ +L G
Sbjct: 18 GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 77
Query: 402 CRRKGELLLVYDYMPNGSLDKILYSN-----TRPSLNWFQRFRIIKGVAFGLLYLHEEWE 456
C + L+ MP G L + + ++ LNW + +A G+ YL E
Sbjct: 78 CL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLEE--- 127
Query: 457 QVVLHRDIKPANVLLDADLEGKLGDFGLARLYD-HGNDLHTTNVVGTVGYLAPELLRNGR 515
+ ++HRD+ NVL+ K+ DFGLA+L + H + ++A E + +
Sbjct: 128 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRI 187
Query: 516 GTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEE 574
T +DV+++GV + E+ G +P + ++ +KG+ L P+ ++
Sbjct: 188 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL---EKGERL----PQPPICTIDV 240
Query: 575 QMEIVLKLGLFCSHSNPDTRPSMRQVV 601
M I++K C + D+RP R+++
Sbjct: 241 YM-IMVK----CWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 53/198 (26%), Positives = 80/198 (40%), Gaps = 60/198 (30%)
Query: 405 KGELLLVYDYMPNGSLDKILYS-NTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRD 463
K L V DY+P G + +L P + RF I + + + +H+ +HRD
Sbjct: 73 KDNLYFVMDYIPGGDMMSLLIRMEVFPEV--LARFYIAE-LTLAIESVHK---MGFIHRD 126
Query: 464 IKPANVLLDADLEGKLGDFGL---------ARLYDHGNDLHTT----------------- 497
IKP N+L+D D KL DFGL ++ Y G+ +
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186
Query: 498 --------------------NVVGTVGYLAPE-LLRNGRGTTSTDVYAFGVFMLEVACGR 536
++VGT Y+APE LLR G T D ++ GV + E+ G+
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY-TQLCDWWSVGVILFEMLVGQ 245
Query: 537 RPV---QPGE--LDLLDW 549
P P E L +++W
Sbjct: 246 PPFLAPTPTETQLKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 6e-05
Identities = 27/81 (33%), Positives = 46/81 (56%), Gaps = 2/81 (2%)
Query: 460 LHRDIKPANVLLDADLEGKLGDFGLAR-LYDHGNDLHTTNVVGTVGYLAPELLRNGRGTT 518
+HRD+ NVLL K+ DFGLAR + + N + N V ++APE + + T
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTV 293
Query: 519 STDVYAFGVFMLEV-ACGRRP 538
+DV+++G+ + E+ + G+ P
Sbjct: 294 QSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 36/125 (28%), Positives = 59/125 (47%), Gaps = 10/125 (8%)
Query: 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLL 471
Y + N P+L++ VA G+ +L + +HRD+ NVL+
Sbjct: 216 YLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLI 272
Query: 472 DADLEGKL---GDFGLAR-LYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGV 527
EGKL DFGLAR + N + + + ++APE + N TT +DV++FG+
Sbjct: 273 ---CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGI 329
Query: 528 FMLEV 532
+ E+
Sbjct: 330 LLWEI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 8e-05
Identities = 40/137 (29%), Positives = 63/137 (45%), Gaps = 23/137 (16%)
Query: 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPAN 468
+L+ DY+ +G L +L + L+ + +II+ + L LH+ ++H DIK N
Sbjct: 85 VLIMDYIKDGDLFDLLKKEGK--LSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLEN 139
Query: 469 VLLD-ADLEGKLGDFGLAR------LYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTD 521
VL D A L D+GL + YD GT+ Y +PE ++ S D
Sbjct: 140 VLYDRAKDRIYLCDYGLCKIIGTPSCYD-----------GTLDYFSPEKIKGHNYDVSFD 188
Query: 522 VYAFGVFMLEVACGRRP 538
+A GV E+ G+ P
Sbjct: 189 WWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 15/178 (8%)
Query: 373 SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSL 432
++ +K +E+V RH N++ L ++ +M GS + +L + +
Sbjct: 39 TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGM 98
Query: 433 NWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492
+ I+ G GL YLH+ +HR+IK +++L+ D G + GL+ LY
Sbjct: 99 SEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGD--GLVSLSGLSHLYSLVR 153
Query: 493 DLHTTNVV--------GTVGYLAPELLRNGRG--TTSTDVYAFGVFMLEVACGRRPVQ 540
+ VV + +L+PELLR +D+Y+ G+ E+A GR P Q
Sbjct: 154 NGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQ 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 49/185 (26%), Positives = 73/185 (39%), Gaps = 61/185 (32%)
Query: 405 KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQ----RFRIIKGVAFGLLYLHEEWEQVVL 460
K L V DY+P G + +L + F RF I + + + +H+ +
Sbjct: 73 KDNLYFVMDYIPGGDMMSLLIR-----MGIFPEDLARFYIAE-LTCAVESVHK---MGFI 123
Query: 461 HRDIKPANVLLDADLEGKLGDFGL---------ARLYDHGNDLHTT-------------- 497
HRDIKP N+L+D D KL DFGL ++ Y G+ +
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANC 183
Query: 498 -----------------------NVVGTVGYLAPE-LLRNGRGTTSTDVYAFGVFMLEVA 533
++VGT Y+APE LLR G T D ++ GV + E+
Sbjct: 184 RCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYEML 242
Query: 534 CGRRP 538
G+ P
Sbjct: 243 VGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 30/213 (14%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKV--CHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCR 403
KG GKV++ + + ++ AVK + HD D ++ + + ++ H N+V+ G
Sbjct: 28 KGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSD--HPNVVKFYGMYY 85
Query: 404 RKG-----ELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFR------IIKGVAFGLLYLH 452
+K +L LV + GS+ ++ + L +R I+ GL +LH
Sbjct: 86 KKDVKNGDQLWLVLELCNGGSVTDLV----KGFLKRGERMEEPIIAYILHEALMGLQHLH 141
Query: 453 EEWEQVVLHRDIKPANVLLDADLEGKLGDFGL-ARLYDHGNDLHTTNVVGTVGYLAPELL 511
+HRD+K N+LL + KL DFG+ A+L L VGT ++APE++
Sbjct: 142 V---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS--TRLRRNTSVGTPFWMAPEVI 196
Query: 512 RNGRGTTST-----DVYAFGVFMLEVACGRRPV 539
+ ST DV++ G+ +E+ G P+
Sbjct: 197 ACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 39/148 (26%), Positives = 74/148 (50%), Gaps = 13/148 (8%)
Query: 460 LHRDIKPANVLLDADLEGKLGDFGLAR-LYDHGNDLHTTNVVGTVGYLAPELLRNGRGTT 518
+HRD+ N+LL K+ DFGLAR + + N + N V ++APE + N T
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTF 295
Query: 519 STDVYAFGVFMLEV-ACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQME 577
+DV+++G+ + E+ + G P PG + + ++G + + + +M
Sbjct: 296 ESDVWSYGILLWEIFSLGSSPY-PG-MPVDSKFYKMIKEGYRMLSPE------CAPSEMY 347
Query: 578 IVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
++K C ++P RP+ +Q+VQ ++
Sbjct: 348 DIMKS---CWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 43/168 (25%), Positives = 66/168 (39%), Gaps = 39/168 (23%)
Query: 405 KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDI 464
K L L+ +++P G + +L + Q + +A +L + + +HRDI
Sbjct: 73 KLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFY-----IAETVLAIDSIHQLGFIHRDI 127
Query: 465 KPANVLLDADLEGKLGDFGLA------------RLYDHG--NDLHTTNV----------- 499
KP N+LLD+ KL DFGL R +H +D N+
Sbjct: 128 KPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKR 187
Query: 500 ---------VGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRP 538
VGT Y+APE+ D ++ GV M E+ G P
Sbjct: 188 NRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 36/100 (36%), Positives = 51/100 (51%), Gaps = 12/100 (12%)
Query: 441 IKGVAFGLL----YLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG---ND 493
+ VA LL Y+H E ++HRDIK NVL++ + LGDFG A + G
Sbjct: 262 VTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFG-AACFARGSWSTP 317
Query: 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVA 533
H + GTV APE+L T S D+++ G+ + E A
Sbjct: 318 FH-YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAA 356
|
Length = 461 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 45/168 (26%), Positives = 65/168 (38%), Gaps = 39/168 (23%)
Query: 405 KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDI 464
K L L+ +++P G + +L S Q + +A +L + + +HRDI
Sbjct: 73 KRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFY-----IAETVLAIDAIHQLGFIHRDI 127
Query: 465 KPANVLLDADLEGKLGDFGLA------------RLYDHG--NDLHTTNV----------- 499
KP N+LLDA KL DFGL R H +D N+
Sbjct: 128 KPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKK 187
Query: 500 ---------VGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRP 538
VGT Y+APE+ D ++ GV M E+ G P
Sbjct: 188 NRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 6e-04
Identities = 41/151 (27%), Positives = 71/151 (47%), Gaps = 18/151 (11%)
Query: 345 TKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVS----MGKLRHRNLVQLRG 400
++G GKVY G ++ AVK V +D K V ++ + + + +V L
Sbjct: 13 SRGAFGKVYLGRKKNNSKLYAVK-VVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 401 YCRRKGELLLVYDYMPNGSLDKIL----YSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWE 456
+ + LV +Y+ G + +L Y + ++ + I VA L YLH
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKY------ISEVALALDYLHR--- 122
Query: 457 QVVLHRDIKPANVLLDADLEGKLGDFGLARL 487
++HRD+KP N+L+ + KL DFGL+++
Sbjct: 123 HGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 15/26 (57%), Positives = 19/26 (73%)
Query: 460 LHRDIKPANVLLDADLEGKLGDFGLA 485
+HRDIKP N+L+D KL DFGL+
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.002
Identities = 40/239 (16%), Positives = 96/239 (40%), Gaps = 35/239 (14%)
Query: 377 MKQFVSEIVSMGKLRHRNLVQLRGY--------CRRKGELLLVYDYMPNGSLDKILYSNT 428
+ +EI ++ ++ N++++ G+ R L L+ +Y G L ++L
Sbjct: 62 IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPR----LSLILEYCTRGYLREVLDKEK 117
Query: 429 RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLY 488
L++ + + GL L++ + ++++ + L+ + + K+ GL ++
Sbjct: 118 --DLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKIL 173
Query: 489 DHGNDLHTTNVVGTVGYLAPELLRN--GRGTTSTDVYAFGVFMLEVACGRRPVQPGEL-D 545
V + Y + ++L + T D+Y+ GV + E+ G+ P + +
Sbjct: 174 SSP----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE 229
Query: 546 LLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYL 604
+ D +I+ L P VE C+ + RP++++++ L
Sbjct: 230 IYDLIINK-NNSLKLPLDCPLEIKCIVEA-----------CTSHDSIKRPNIKEILYNL 276
|
Length = 283 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 660 | |||
| cd06899 | 236 | lectin_legume_LecRK_Arcelin_ConA legume lectins, l | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PF00139 | 236 | Lectin_legB: Legume lectin domain; InterPro: IPR00 | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd01951 | 223 | lectin_L-type legume lectins. The L-type (legume-t | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.98 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.98 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| cd07308 | 218 | lectin_leg-like legume-like lectins: ERGIC-53, ERG | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.75 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.73 | |
| cd06901 | 248 | lectin_VIP36_VIPL VIP36 and VIPL type 1 transmembr | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.73 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| cd06902 | 225 | lectin_ERGIC-53_ERGL ERGIC-53 and ERGL type 1 tran | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.62 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.56 | |
| cd06903 | 215 | lectin_EMP46_EMP47 EMP46 and EMP47 type 1 transmem | 99.45 | |
| PF03388 | 229 | Lectin_leg-like: Legume-like lectin family; InterP | 99.44 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.41 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.4 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.36 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.31 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.26 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.16 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.14 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.13 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.11 | |
| KOG3838 | 497 | consensus Mannose lectin ERGIC-53, involved in gly | 99.04 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.02 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.0 | |
| KOG3839 | 351 | consensus Lectin VIP36, involved in the transport | 98.97 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.96 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.9 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.84 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.75 | |
| cd06900 | 255 | lectin_VcfQ VcfQ bacterial pilus biogenesis protei | 98.64 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.56 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.55 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.52 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.5 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.28 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.24 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.18 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.17 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.12 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.11 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.99 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.99 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.95 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.86 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.77 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.72 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.63 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.63 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.62 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.59 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.58 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.55 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.34 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.33 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.29 | |
| PLN02236 | 344 | choline kinase | 97.09 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.09 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.84 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.81 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.34 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.25 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.16 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.09 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.07 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.05 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.93 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.82 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.67 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.45 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.42 |
| >cd06899 lectin_legume_LecRK_Arcelin_ConA legume lectins, lectin-like receptor kinases, arcelin, concanavalinA, and alpha-amylase inhibitor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-55 Score=438.12 Aligned_cols=230 Identities=47% Similarity=0.757 Sum_probs=209.5
Q ss_pred ceeeeCCCCC--CCeeEecceeEcCCCcEEecCCC--CCeeEEEEeCCCeeeccCC-CCceeEEEEEEEEEecCCCCCCC
Q 006112 28 NQFIHHGFEG--SKLKLDGLAKIHPNGLLQLTNTS--ERISGHAFYPFPFKFNSSS-SQSLSFSTSFVFAMFPKLPNYGG 102 (660)
Q Consensus 28 ~~f~~~~f~~--~~l~~~g~a~~~~~g~l~Lt~~~--~~~~G~~~y~~pv~~~~~~-~~~~sFst~F~F~i~~~~~~~~g 102 (660)
++|+|++|.. .+|+|+|+|.+.++|.|+||++. .+++|||+|++||++|++. +.++||+|+|+|.|.+.....+|
T Consensus 1 ~~f~f~~f~~~~~~l~l~G~A~~~~~~~i~LT~~~~~~~~~G~v~y~~pi~l~~~~~~~~~sFst~F~F~i~~~~~~~~g 80 (236)
T cd06899 1 LSFNFNGFSSDQSNLTLQGDATISSNGALQLTNDTSPASSVGRALYSKPVRLWDSTTGKVASFSTSFSFSITPPNPSLGG 80 (236)
T ss_pred CceecCCCCCCCCCEEEecceEcCCCCeEEecCCCCCCcceEEEEeCCCEEeecCCCCCceeEEEEEEEEEEcCCCCCCC
Confidence 4799999985 69999999999878999999998 8999999999999999987 88999999999999987667789
Q ss_pred CceEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCeeEEEcCCcccccccccccccccc
Q 006112 103 HGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEK 182 (660)
Q Consensus 103 ~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~~ 182 (660)
|||||+|+|....+.+..|++|||++.++.+.+.+++|||||||++|.+++||++||||||+|++.|..+..+..
T Consensus 81 dGlAF~i~~~~~~~~~~~G~~lG~~~~~~~~~~~~~~vAVEFDT~~n~~~~D~~~nHigIdvn~~~S~~~~~~~~----- 155 (236)
T cd06899 81 DGLAFFLAPTDSLPPASSGGYLGLFNSSNNGNSSNHIVAVEFDTFQNPEFGDPDDNHVGIDVNSLVSVKAGYWDD----- 155 (236)
T ss_pred CeEEEEEecCCCCCCCCCcceeeeecCCCCCCcccceEEEEeecccCcccCCCCCCeEEEEcCCcccceeecccc-----
Confidence 999999999876666789999999999887777899999999999999888999999999999998877665431
Q ss_pred ccccccccCCCccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeecccCceeeeeeecCccc
Q 006112 183 KEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTRVSDYYILGWSF 262 (660)
Q Consensus 183 ~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg~~~~~h~i~~wsf 262 (660)
..+.|.+|+.++|||+||+.+++|+|+|...+..+|..|+|++.+||+.+|+++||||||||||...|.|+|++|+|
T Consensus 156 ---~~~~l~~g~~~~v~I~Y~~~~~~L~V~l~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFSasTG~~~~~h~i~sWsF 232 (236)
T cd06899 156 ---DGGKLKSGKPMQAWIDYDSSSKRLSVTLAYSGVAKPKKPLLSYPVDLSKVLPEEVYVGFSASTGLLTELHYILSWSF 232 (236)
T ss_pred ---ccccccCCCeEEEEEEEcCCCCEEEEEEEeCCCCCCcCCEEEEeccHHHhCCCceEEEEEeEcCCCcceEEEEEEEE
Confidence 23457899999999999999999999999877678999999999999999999999999999999999999999999
Q ss_pred ccC
Q 006112 263 NKS 265 (660)
Q Consensus 263 ~~~ 265 (660)
++.
T Consensus 233 ~s~ 235 (236)
T cd06899 233 SSN 235 (236)
T ss_pred EcC
Confidence 875
|
This alignment model includes the legume lectins (also known as agglutinins), the arcelin (also known as phytohemagglutinin-L) family of lectin-like defense proteins, the LecRK family of lectin-like receptor kinases, concanavalinA (ConA), and an alpha-amylase inhibitor. Arcelin is a major seed glycoprotein discovered in kidney beans (Phaseolus vulgaris) that has insecticidal properties and protects the seeds from predation by larvae of various bruchids. Arcelin is devoid of monosaccharide binding properties and lacks a key metal-binding loop that is present in other members of this family. Phytohaemagglutinin (PHA) is a lectin found in plants, especially beans, that affects cell metabolism by inducing mitosis and by altering the permeability of the cell membrane to various proteins. PHA agglutinates most mammalian red blood cell types by bindin |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-54 Score=454.48 Aligned_cols=267 Identities=43% Similarity=0.775 Sum_probs=234.9
Q ss_pred cccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecC-eeEEEEecCCCC
Q 006112 340 NLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKG-ELLLVYDYMPNG 418 (660)
Q Consensus 340 ~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-~~~lV~E~~~~g 418 (660)
.-..+|+|+||.||+|.+.+ ++.||||++.....+..++|.+|+.++.+++|||+|+|+|||.+.+ +.+||||||++|
T Consensus 79 ~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nG 157 (361)
T KOG1187|consen 79 ESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNG 157 (361)
T ss_pred hhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCC
Confidence 33468899999999999965 4899999886654431566999999999999999999999999999 599999999999
Q ss_pred ChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccC-CCCceee
Q 006112 419 SLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDH-GNDLHTT 497 (660)
Q Consensus 419 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~-~~~~~~~ 497 (660)
+|+++|+......++|.+|++|+.++|+||+|||+.+.+.||||||||+|||||+++++||+|||+|+.... .......
T Consensus 158 sL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~ 237 (361)
T KOG1187|consen 158 SLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTT 237 (361)
T ss_pred CHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccceeee
Confidence 999999876543789999999999999999999999988999999999999999999999999999976544 2221111
Q ss_pred ccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCC----CCcchHHHHHHHHhcCCcccCCCCccc-ccCc
Q 006112 498 NVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQP----GELDLLDWVIDYWQKGDVLDASDPRLE-GIYV 572 (660)
Q Consensus 498 ~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~----~~~~~~~~~~~~~~~~~~~~~~d~~l~-~~~~ 572 (660)
. .||.+|+|||++..+..+.|+|||||||+|+||+||+++.+. .+..+++|++..+..++..+.+||++. +.+.
T Consensus 238 ~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~ 316 (361)
T KOG1187|consen 238 V-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYP 316 (361)
T ss_pred c-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCC
Confidence 1 899999999999999999999999999999999999999875 344589999999999999999999987 6666
Q ss_pred H-HHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCCC
Q 006112 573 E-EQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGA 608 (660)
Q Consensus 573 ~-~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (660)
. +++..+.+++.+|++.+|.+||+|.||++.|+...
T Consensus 317 ~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 317 DEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred hHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 4 78999999999999999999999999999996543
|
|
| >PF00139 Lectin_legB: Legume lectin domain; InterPro: IPR001220 Legume lectins are one of the largest lectin families with more than 70 lectins reported | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-53 Score=426.32 Aligned_cols=231 Identities=43% Similarity=0.691 Sum_probs=204.8
Q ss_pred cceeeeCCC-CCCCeeEecceeEcCCCcEEecCCCC-CeeEEEEeCCCeeeccCC-CCceeEEEEEEEEEecC--CCCCC
Q 006112 27 ENQFIHHGF-EGSKLKLDGLAKIHPNGLLQLTNTSE-RISGHAFYPFPFKFNSSS-SQSLSFSTSFVFAMFPK--LPNYG 101 (660)
Q Consensus 27 ~~~f~~~~f-~~~~l~~~g~a~~~~~g~l~Lt~~~~-~~~G~~~y~~pv~~~~~~-~~~~sFst~F~F~i~~~--~~~~~ 101 (660)
+++|+|++| +..+++|+|+|.+..+|.|+||++.. +++|||||++||+||++. +.++||+|+|+|.|... ....+
T Consensus 1 ~~~F~~~~F~~~~~~~l~G~A~~~~~~~l~LT~~~~~~~~G~~~y~~pi~l~d~~~~~~~sF~t~F~f~i~~~~~~~~~~ 80 (236)
T PF00139_consen 1 SVSFSFPSFSNSSNLTLNGDASISSNGSLQLTPDSTNNQAGRAWYNNPIQLWDSTTGNVASFSTSFSFSITNGPGSSNNG 80 (236)
T ss_dssp EEEEEESSBTTGTTEEEEETEEEETTSEEESSTBETSSEEEEEEESSEEESBETTTTEBEEEEEEEEEEEEESSSSSSS-
T ss_pred CceEEcCCCCCCCceEEEeeEEeccCCeEEcCCCCCCCcEEEEEECCcEEEeCCCCcceeeeeeEEEEEEeccCCCCccC
Confidence 368999999 56899999999996689999999987 999999999999999987 77899999999999643 56668
Q ss_pred CCceEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCeeEEEcCCccccccccccccccc
Q 006112 102 GHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDE 181 (660)
Q Consensus 102 g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~ 181 (660)
||||||+|+|....+.++.|++||+++..+.+.+.+++|||||||++|++++||++||||||+|++.|..+.+++++.
T Consensus 81 ~dGlAFvi~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~vAVEFDT~~N~~~~d~~~nHIgI~~n~~~s~~~~~~~~~~-- 158 (236)
T PF00139_consen 81 GDGLAFVIQPDPNLPGGSSGGYLGLFNSSTDGNGINNSVAVEFDTYKNPEYNDPDDNHIGIDVNSVVSNKTASAGYYS-- 158 (236)
T ss_dssp BEEEEEEEEETTSSTTTSSGGGTTTSSSSSTTGGGGCEEEEEEETSTCGGGTTTSSSEEEEEESSSSESEEEE----E--
T ss_pred CCceEEEEecCcccccCCCCCccCccccccCCCccCcEEEEEEeeeecccccccCCCEEEEECCCCcccccccccccc--
Confidence 999999999988777778999999999988777789999999999999999999999999999999998887776552
Q ss_pred cccccccccCCCccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeecccCceeeeeeecCcc
Q 006112 182 KKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTRVSDYYILGWS 261 (660)
Q Consensus 182 ~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg~~~~~h~i~~ws 261 (660)
....++.+|+.++|||+||+.+++|+|++.... .+|..|+|++.+||+++|+++||||||||||...|.|.|++|+
T Consensus 159 ---~~~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~~l~~~vdL~~~l~~~v~vGFsasTG~~~~~h~I~sW~ 234 (236)
T PF00139_consen 159 ---SPSFSLSDGKWHTVWIDYDASTKRLSVYLDDNS-SKPSSPVLSVNVDLSAVLPEQVYVGFSASTGGSYQTHDILSWS 234 (236)
T ss_dssp ---EEEHHHGTTSEEEEEEEEETTTTEEEEEEEETT-TTSEEEEEEEE--HHHHSCSEEEEEEEEEESSSSEEEEEEEEE
T ss_pred ---cccccccCCcEEEEEEEEcCCccEEEEEEeccc-CCCcceeEEEEEchHHhcCCCcEEEEEeecCCCcceEEEEEEE
Confidence 346788999999999999999999999999763 6899999999999999999999999999999999999999999
Q ss_pred cc
Q 006112 262 FN 263 (660)
Q Consensus 262 f~ 263 (660)
|+
T Consensus 235 F~ 236 (236)
T PF00139_consen 235 FS 236 (236)
T ss_dssp EE
T ss_pred eC
Confidence 95
|
Leguminous plant lectins resemble each other in their physicochemical properties although they differ in their carbohydrate specificities. They consist of two or four subunits with relative molecular mass of 30 kDa and each subunit has one carbohydrate-binding site. The interaction with sugars requires tightly bound calcium and manganese ions. The structural similarities of these lectins are reported by the primary structural analyses and X-ray crystallographic studies. X-ray studies have shown that the folding of the polypeptide chains in the region of the carbohydrate-binding sites is also similar, despite differences in the primary sequences. The carbohydrate-binding sites of these lectins consist of two conserved amino acids on beta pleated sheets. One of these loops contains transition metals, calcium and manganese, which keep the amino acid residues of the sugar-binding site at the required positions. Amino acid sequences of this loop play an important role in the carbohydrate-binding specificities of these lectins. These lectins bind either glucose/mannose or galactose. The exact function of legume lectins is not known but they may be involved in the attachment of nitrogen-fixing bacteria to legumes and in the protection against pathogens. Some legume lectins are proteolytically processed to produce two chains, beta (which corresponds to the N-terminal) and alpha (C-terminal) (IPR000985 from INTERPRO). The lectin concanavalin A (conA) from jack bean is exceptional in that the two chains are transposed and ligated (by formation of a new peptide bond). The N terminus of mature conA thus corresponds to that of the alpha chain and the C terminus to the beta chain.; GO: 0005488 binding; PDB: 1VLN_B 2GDF_C 2JE9_C 2JEC_C 1DGL_B 2P37_B 2CWM_A 2P34_D 2OW4_A 3IPV_B .... |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-47 Score=401.14 Aligned_cols=250 Identities=32% Similarity=0.455 Sum_probs=206.8
Q ss_pred ccccccCccEEEEEEEeCCCCeE-EEEEEeccCCC--hhhHHHHHHHHHHhccCCCCceeEeeeeeecC-eeEEEEecCC
Q 006112 341 LYKATKGGSGKVYRGVLPSSHAE-IAVKKVCHDSD--HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKG-ELLLVYDYMP 416 (660)
Q Consensus 341 l~~lg~G~fg~Vy~g~~~~~~~~-vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-~~~lV~E~~~ 416 (660)
.+.+|.|+||+||+|.+. |+. ||||++..... ...++|.+|+.+|.+++|||||+++|+|.+.. .+++|||||+
T Consensus 46 ~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 345999999999999994 455 99999975432 22679999999999999999999999999887 7999999999
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCc-eeccCccCCcEEEcCCC-CeEEeecccceeccCCCCc
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQV-VLHRDIKPANVLLDADL-EGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivHrDikp~NIll~~~~-~~kl~DFGla~~~~~~~~~ 494 (660)
+|+|.++++......+++..+++++.|||+||.|||+ .+ ||||||||+|||++.++ ++||+|||+++...... .
T Consensus 124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~ 199 (362)
T KOG0192|consen 124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-T 199 (362)
T ss_pred CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-c
Confidence 9999999988545679999999999999999999998 66 99999999999999997 99999999998765432 2
Q ss_pred eeeccccCccccCccccc--CCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCc
Q 006112 495 HTTNVVGTVGYLAPELLR--NGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~--~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
..+...||+.|||||++. ...++.|+|||||||+||||+||+.||.......+ +......+.. |. ..
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~--~~~v~~~~~R-----p~----~p 268 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV--ASAVVVGGLR-----PP----IP 268 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHhcCCC-----CC----CC
Confidence 334478999999999999 56899999999999999999999999987544222 2222222221 11 11
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
..+...+..++.+||+.||..||++.+++..|+..
T Consensus 269 ~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 269 KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence 22555677888889999999999999999999854
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-47 Score=382.86 Aligned_cols=254 Identities=29% Similarity=0.420 Sum_probs=211.3
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecC-eeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKG-ELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-~~~lV~E~ 414 (660)
+.+.+..||+|..|+|||++++.+++.+|+|.+..+. +...+++.+|++++++.+||+||+++|.|..++ ++.++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 4555678999999999999999999999999996553 455789999999999999999999999999998 59999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
|.+|||++++...+ .+++...-+|+.+|++||.|||+ ++.||||||||+|||++..|++||+|||.++.+.+.
T Consensus 160 MDgGSLd~~~k~~g--~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRVG--RIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred cCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 99999999997654 48999999999999999999997 399999999999999999999999999999876554
Q ss_pred eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHH
Q 006112 495 HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEE 574 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 574 (660)
.....+||..|||||.+.+..|+.++||||||+.++|+++|+.||.+......+|..-+. .+.+..-|++... .
T Consensus 233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~---~Iv~~ppP~lP~~---~ 306 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLC---AIVDEPPPRLPEG---E 306 (364)
T ss_pred hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHH---HHhcCCCCCCCcc---c
Confidence 345689999999999999999999999999999999999999999874221111111110 0112223444443 2
Q ss_pred HHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 575 QMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 575 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
....+..++..|+++||.+||+++|++++
T Consensus 307 fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 307 FSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 33446677888999999999999999973
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=395.06 Aligned_cols=256 Identities=30% Similarity=0.465 Sum_probs=219.0
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
+-.++.+++||+|-||.||.|.+. ....||+|.+... .-..+.|.+|+++|++|+|+|||+++|+|..++.++|||||
T Consensus 205 r~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 205 REELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred HHHHHHHHHhcCCccceEEEEEEc-CCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 446777899999999999999995 3458999999665 33457899999999999999999999999998899999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
|+.|+|.++|+...+..+...+.+.++.|||+||+||++ +++|||||.++||||+++..+||+||||||...++...
T Consensus 283 m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~ 359 (468)
T KOG0197|consen 283 MPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT 359 (468)
T ss_pred cccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCcee
Confidence 999999999998666779999999999999999999998 99999999999999999999999999999965554443
Q ss_pred eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 495 HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
......-+..|+|||.+..++++.|||||||||+||||+| |+.||.... ...+.+....|..+.. +.
T Consensus 360 ~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms---n~ev~~~le~GyRlp~---------P~ 427 (468)
T KOG0197|consen 360 ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS---NEEVLELLERGYRLPR---------PE 427 (468)
T ss_pred ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC---HHHHHHHHhccCcCCC---------CC
Confidence 4444455779999999999999999999999999999998 888876533 2345555666655433 23
Q ss_pred HHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
.++..+.++|..||+.+|++|||++.+...|+..
T Consensus 428 ~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 428 GCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred CCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 4667789999999999999999999999888764
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=371.28 Aligned_cols=203 Identities=26% Similarity=0.438 Sum_probs=184.9
Q ss_pred CceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEE
Q 006112 334 HRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 334 ~~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 411 (660)
....|...++||.|+|++||+|+++.++..||||.+.+. .+...+....|+++|++++|||||++++++..++.++||
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 445788888999999999999999999999999999776 566678889999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCC------CCeEEeecccc
Q 006112 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDAD------LEGKLGDFGLA 485 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~------~~~kl~DFGla 485 (660)
||||.||+|.+||+..+ .+++.....++.|||.||++||+ ++||||||||.||||+.. -.+||+|||+|
T Consensus 88 MEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999999998765 48999999999999999999998 999999999999999765 45899999999
Q ss_pred eeccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCC
Q 006112 486 RLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGE 543 (660)
Q Consensus 486 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~ 543 (660)
|.+..+. .....+|++-|||||++..++|+.|+|+||.|++|||+++|+.||+...
T Consensus 163 R~L~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 163 RFLQPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred hhCCchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 9876433 3345899999999999999999999999999999999999999998643
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=384.58 Aligned_cols=255 Identities=25% Similarity=0.408 Sum_probs=215.2
Q ss_pred CCceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeE
Q 006112 333 PHRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELL 409 (660)
Q Consensus 333 ~~~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 409 (660)
+++-.|+..+.||+|||..||+++...+|+.||+|++.+. .....+...+||++.++|+|||||++++++++.+.+|
T Consensus 15 ~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVY 94 (592)
T KOG0575|consen 15 PRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVY 94 (592)
T ss_pred CCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceE
Confidence 4446799999999999999999999999999999999763 4456778999999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceecc
Q 006112 410 LVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYD 489 (660)
Q Consensus 410 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 489 (660)
||.|+|++++|..+++. +..+++.++..++.||+.||.|||+ .+|+|||||..|++|++++++||+|||||..+.
T Consensus 95 ivLELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 95 IVLELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE 169 (592)
T ss_pred EEEEecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeec
Confidence 99999999999999974 4569999999999999999999998 999999999999999999999999999999887
Q ss_pred CCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccc
Q 006112 490 HGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEG 569 (660)
Q Consensus 490 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 569 (660)
...... .+.+|||.|+|||++.....+..+||||+||+||-|++|++||+..... ......+..+. .++.
T Consensus 170 ~~~Erk-~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk---ety~~Ik~~~Y------~~P~ 239 (592)
T KOG0575|consen 170 YDGERK-KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK---ETYNKIKLNEY------SMPS 239 (592)
T ss_pred Cccccc-ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH---HHHHHHHhcCc------cccc
Confidence 554433 4579999999999999889999999999999999999999999865432 22222222221 1222
Q ss_pred cCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH--HhhC
Q 006112 570 IYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ--YLDG 606 (660)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~ 606 (660)
..+.+ ..+|+..++++||.+|||+++|+. ++..
T Consensus 240 ~ls~~----A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 240 HLSAE----AKDLIRKLLRPNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred ccCHH----HHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence 23333 345556679999999999999996 5643
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=356.88 Aligned_cols=259 Identities=26% Similarity=0.385 Sum_probs=213.2
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeee-eeecCe-eEE
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGY-CRRKGE-LLL 410 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~-~~~~~~-~~l 410 (660)
.-.|++++++|+|.||+|||+....+|..+|.|.+.-+ +....++...|+.+|++|+|||||+++++ +.++++ ++|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 44689999999999999999999999999999998643 34556789999999999999999999995 445555 899
Q ss_pred EEecCCCCChhhhhhh--CCCCCcchhHHHHHHHHHHHHHHHhhhcccC-ceeccCccCCcEEEcCCCCeEEeeccccee
Q 006112 411 VYDYMPNGSLDKILYS--NTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQ-VVLHRDIKPANVLLDADLEGKLGDFGLARL 487 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDikp~NIll~~~~~~kl~DFGla~~ 487 (660)
|||||..|+|...++. ..+..+++..+|+++.|++.||+++|..+.+ -|+||||||.||+|+.+|.+||+||||++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999999999999864 3456799999999999999999999986644 489999999999999999999999999998
Q ss_pred ccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcc
Q 006112 488 YDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL 567 (660)
Q Consensus 488 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 567 (660)
+..... ..+..+|||-||+||.+...+|+.||||||+||++|||+.-+.||.++.. ....+.+..|+. |++
T Consensus 178 l~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~---~~L~~KI~qgd~-----~~~ 248 (375)
T KOG0591|consen 178 LSSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL---LSLCKKIEQGDY-----PPL 248 (375)
T ss_pred hcchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH---HHHHHHHHcCCC-----CCC
Confidence 865443 34568999999999999999999999999999999999999999997632 222333444432 222
Q ss_pred cccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhh
Q 006112 568 EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605 (660)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (660)
.+ .-....+.+|+..|+..||+.||+.-.+++.+.
T Consensus 249 p~---~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 249 PD---EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred cH---HHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 21 233455777888899999999998555544443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=365.66 Aligned_cols=251 Identities=24% Similarity=0.337 Sum_probs=206.5
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC-------hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD-------HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELL 409 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~-------~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 409 (660)
.|...+.+|+|+||.|-+|..+.+++.||||.+.+... .......+|+++|++|+|||||++++++...+..|
T Consensus 173 ~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Y 252 (475)
T KOG0615|consen 173 YYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSY 252 (475)
T ss_pred eeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceE
Confidence 57788899999999999999999999999999965311 12334679999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCC---CCeEEeecccce
Q 006112 410 LVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDAD---LEGKLGDFGLAR 486 (660)
Q Consensus 410 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~---~~~kl~DFGla~ 486 (660)
|||||++||+|.+.+-.+.. +.+..-.-+++|++.|+.|||+ +||+||||||+|||+..+ ..+||+|||+|+
T Consensus 253 mVlE~v~GGeLfd~vv~nk~--l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 253 MVLEYVEGGELFDKVVANKY--LREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred EEEEEecCccHHHHHHhccc--cccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 99999999999999987654 6666778899999999999998 999999999999999665 779999999999
Q ss_pred eccCCCCceeeccccCccccCcccccCCCC---CcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCC
Q 006112 487 LYDHGNDLHTTNVVGTVGYLAPELLRNGRG---TTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDAS 563 (660)
Q Consensus 487 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~---t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (660)
... +.......+||+.|.|||++.+... ..+.|+||+||+||-++||..||.....+. -..+....|+...
T Consensus 328 ~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~eQI~~G~y~f-- 401 (475)
T KOG0615|consen 328 VSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKEQILKGRYAF-- 401 (475)
T ss_pred ccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHHHHhcCcccc--
Confidence 865 3344567899999999999987643 347899999999999999999997633221 0222333443321
Q ss_pred CCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 564 DPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 564 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
......+..++.+.++.+++..||++|||+.|+++
T Consensus 402 ----~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 402 ----GPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred ----cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 11234455677889999999999999999999996
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=387.91 Aligned_cols=256 Identities=29% Similarity=0.451 Sum_probs=219.8
Q ss_pred eeecccccccCccEEEEEEEeCC-----CCeEEEEEEeccCCCh-hhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPS-----SHAEIAVKKVCHDSDH-GMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLL 410 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~-----~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 410 (660)
+.+..+.+|+|+||+||+|+..+ ....||||.++..... ..++|.+|++++..++|||||+|+|.|.+++.+++
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M 566 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM 566 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence 45556789999999999998753 3478999999877665 78899999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhhCC------------CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeE
Q 006112 411 VYDYMPNGSLDKILYSNT------------RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGK 478 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~k 478 (660)
|+|||..|||.+||.... +++|+..+.+.|+.|||.||+||-+ +.+|||||..+|+||.++..+|
T Consensus 567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceEEE
Confidence 999999999999996432 2348889999999999999999998 9999999999999999999999
Q ss_pred EeecccceeccCCCCcee-eccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhc
Q 006112 479 LGDFGLARLYDHGNDLHT-TNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQK 556 (660)
Q Consensus 479 l~DFGla~~~~~~~~~~~-~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~ 556 (660)
|+||||+|..-...-+.. ....-..+||+||.+..+++|.+||||||||+|||+++ |+.||++-. -+.|++..+.
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS---n~EVIe~i~~ 720 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS---NQEVIECIRA 720 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc---hHHHHHHHHc
Confidence 999999986544332222 23455789999999999999999999999999999998 999988633 2456777788
Q ss_pred CCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 557 GDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 557 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
|+++... +.++..+..||+.||+.+|.+||++.||-..|+.-
T Consensus 721 g~lL~~P---------e~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 721 GQLLSCP---------ENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred CCcccCC---------CCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 8775433 45667799999999999999999999999999864
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=342.31 Aligned_cols=260 Identities=27% Similarity=0.336 Sum_probs=204.7
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC-h-hhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD-H-GMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~-~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
.|+.+.++|+|++|.|||++++++|+.||||++....+ . ..+-.++||++|++++|+|+|.++.+|..+..++||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 47888999999999999999999999999999965433 3 345568999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
|+..=|++ |...+. .++.....+++.|++.|+.|+|+ +++|||||||+||||+.++.+||+|||+||.+... ..
T Consensus 83 ~dhTvL~e-Le~~p~-G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-gd 156 (396)
T KOG0593|consen 83 CDHTVLHE-LERYPN-GVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP-GD 156 (396)
T ss_pred cchHHHHH-HHhccC-CCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCC-cc
Confidence 96655544 444443 48889999999999999999998 99999999999999999999999999999987642 23
Q ss_pred eeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCC-CcchHHHHHHHH-----------hcCCc-c
Q 006112 495 HTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPG-ELDLLDWVIDYW-----------QKGDV-L 560 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~-~~~~~~~~~~~~-----------~~~~~-~ 560 (660)
..+..+.|.+|.|||++.+ .+|....||||.||++.||++|..-|.+. +.+..-.+.... ..... .
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 3456788999999999886 78999999999999999999999877653 222222222111 11111 0
Q ss_pred -----cCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 561 -----DASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 561 -----~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
+..++...+.--+.....+++++..|++.||++|++-+|++.
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 111111111111223347899999999999999999999984
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=349.56 Aligned_cols=248 Identities=25% Similarity=0.341 Sum_probs=205.4
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
-.|+.++.+|+|+||+||.++.+++++.+|+|++++. .....+...+|..+|.+++||.||+++-.+++.+.+|||+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 3678899999999999999999999999999998654 3446778999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
||+.||.|..+|++... +++..+.-++..|+.||.|||+ ++||||||||+|||||++|.++|+||||++......
T Consensus 105 d~~~GGeLf~hL~~eg~--F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 105 DYLNGGELFYHLQREGR--FSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred eccCCccHHHHHHhcCC--cchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 99999999999987654 8888899999999999999998 999999999999999999999999999998543322
Q ss_pred CceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCc
Q 006112 493 DLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 493 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
..+...+||+.|||||++....|+..+|.||+||++|||++|.+||...+... +.+....++ -+......+
T Consensus 180 -~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~---~~~~I~~~k-----~~~~p~~ls 250 (357)
T KOG0598|consen 180 -DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK---MYDKILKGK-----LPLPPGYLS 250 (357)
T ss_pred -CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH---HHHHHhcCc-----CCCCCccCC
Confidence 23445899999999999999999999999999999999999999998755332 222223333 112223234
Q ss_pred HHHHHHHHHHhhhccCCCCCCCC----CHHHHH
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRP----SMRQVV 601 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RP----s~~evl 601 (660)
.+..+.+ ...++.||++|. .+.+|.
T Consensus 251 ~~ardll----~~LL~rdp~~RLg~~~d~~~ik 279 (357)
T KOG0598|consen 251 EEARDLL----KKLLKRDPRQRLGGPGDAEEIK 279 (357)
T ss_pred HHHHHHH----HHHhccCHHHhcCCCCChHHhh
Confidence 4444444 445999999995 455553
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=379.57 Aligned_cols=258 Identities=28% Similarity=0.435 Sum_probs=217.4
Q ss_pred ecccccccCccEEEEEEEeCCCC---eEEEEEEeccCCC-hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 339 KNLYKATKGGSGKVYRGVLPSSH---AEIAVKKVCHDSD-HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 339 ~~l~~lg~G~fg~Vy~g~~~~~~---~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
++-+.||.|.||.||+|+++..+ ..||||.++.... ....+|+.|..||.++.||||++|.|+......++||.||
T Consensus 632 ~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEy 711 (996)
T KOG0196|consen 632 KIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEY 711 (996)
T ss_pred EEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhh
Confidence 34567899999999999997544 6899999987644 4567999999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
|+||+|+.||+.+.. .+.+.|...++++||.||.||-+ .++|||||..+|||++.+..+|++||||+|.++++...
T Consensus 712 MENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~ 787 (996)
T KOG0196|consen 712 MENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 787 (996)
T ss_pred hhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccceeecccCCCc
Confidence 999999999998774 59999999999999999999998 99999999999999999999999999999988765533
Q ss_pred eeeccc--cCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccC
Q 006112 495 HTTNVV--GTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIY 571 (660)
Q Consensus 495 ~~~~~~--gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 571 (660)
..+..- -+.+|.|||.+...++|.+||||||||+|||.++ |.+||..... +.|+...++|-.+ ..
T Consensus 788 ~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN---QdVIkaIe~gyRL---------Pp 855 (996)
T KOG0196|consen 788 AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVIKAIEQGYRL---------PP 855 (996)
T ss_pred cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch---HHHHHHHHhccCC---------CC
Confidence 333332 3579999999999999999999999999999887 9999875332 2233333333221 12
Q ss_pred cHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCCCCCCC
Q 006112 572 VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGALLPD 612 (660)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p~ 612 (660)
+.+++..|.+||+.||++|..+||.+.||+..|+.....|.
T Consensus 856 PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 856 PMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 34567789999999999999999999999999987655543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=350.76 Aligned_cols=257 Identities=26% Similarity=0.389 Sum_probs=207.7
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecC--eeEEEEe
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKG--ELLLVYD 413 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~lV~E 413 (660)
.++...+.+|+|.||.||++...++|...|||.+........+.+.+|+.+|.+++|||||+.+|...... .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45677788999999999999998889999999986654334678999999999999999999999755444 6899999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcC-CCCeEEeecccceeccC--
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDA-DLEGKLGDFGLARLYDH-- 490 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~-~~~~kl~DFGla~~~~~-- 490 (660)
|+++|+|.+++.+.+. .+++..+.++++||++||+|||+ ++||||||||+|||++. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred ccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999988775 69999999999999999999998 99999999999999999 79999999999987653
Q ss_pred CCCceeeccccCccccCcccccCCC-CCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccc
Q 006112 491 GNDLHTTNVVGTVGYLAPELLRNGR-GTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEG 569 (660)
Q Consensus 491 ~~~~~~~~~~gt~~Y~aPE~~~~~~-~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 569 (660)
..........||+.|||||++..+. ...++||||+||++.||+||+.||..- ....+++......+ ..|.+..
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~~~~~~~~ig~~~-----~~P~ip~ 246 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FEEAEALLLIGRED-----SLPEIPD 246 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cchHHHHHHHhccC-----CCCCCCc
Confidence 2222344578999999999998643 335999999999999999999999753 22233333332222 1222332
Q ss_pred cCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 570 IYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
. ..+...+++..|++.||++|||+.+++++---
T Consensus 247 ~----ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 247 S----LSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred c----cCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 2 23345566677999999999999999986543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=353.90 Aligned_cols=260 Identities=29% Similarity=0.380 Sum_probs=210.2
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeeec--CeeEEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK--GELLLV 411 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV 411 (660)
-.|+.+++||+|.||.||+++...+|+.||+|+++.+. ........+||.||++|+||||++|.+...+. +.+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 36888899999999999999999999999999997664 44456778999999999999999999988776 689999
Q ss_pred EecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCC
Q 006112 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 491 (660)
+||| .-+|..++... .-.++..++..+++||+.||+|||. ++|+|||||.+|||||.+|++||+|||||+.+...
T Consensus 197 FeYM-dhDL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 197 FEYM-DHDLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred Eecc-cchhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9999 56888887643 3469999999999999999999998 99999999999999999999999999999998877
Q ss_pred CCceeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCC-CcchHHHHHHHHhcCCcccCCCC--cc
Q 006112 492 NDLHTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPG-ELDLLDWVIDYWQKGDVLDASDP--RL 567 (660)
Q Consensus 492 ~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~-~~~~~~~~~~~~~~~~~~~~~d~--~l 567 (660)
.....+..+-|.+|.|||++.+ ..|+.+.|+||.||||.||+.|+..+.+. +.+....+.++. |...+...+ .+
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklc--GSP~e~~W~~~kL 349 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLC--GSPTEDYWPVSKL 349 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHh--CCCChhccccccC
Confidence 7666777888999999999876 47999999999999999999999888763 333333333332 222221111 11
Q ss_pred c--------ccCc-------HHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 568 E--------GIYV-------EEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 568 ~--------~~~~-------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
. ..+. .......++|+..+|..||.+|.|+.++++
T Consensus 350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 0 1111 111234566777789999999999999985
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=350.08 Aligned_cols=262 Identities=26% Similarity=0.402 Sum_probs=214.3
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
.+...++||+|.||.|.++... .+..||||.++.+. .+..++|.+|+++|.+++||||++++|+|..++.+++|+|||
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred heehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 4556789999999999999984 46899999998764 455689999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 495 (660)
++|+|.+|+..+..+.+.-....+|+.|||.||+||.+ .++|||||.++|||+|.++++||+|||++|-+-.+....
T Consensus 618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 99999999998866556777888999999999999998 999999999999999999999999999999655444333
Q ss_pred e-eccccCccccCcccccCCCCCcceeEEehHHHHHHHh--hCCCCCCCCCc-chHHHHHHHHhcCCcccCCCCcccccC
Q 006112 496 T-TNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVA--CGRRPVQPGEL-DLLDWVIDYWQKGDVLDASDPRLEGIY 571 (660)
Q Consensus 496 ~-~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ell--tG~~p~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~ 571 (660)
. .+.+-+.+|||||.+..++++.++|||+||+++||++ |...||..... +.++..-.....+. ...+- ..
T Consensus 695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~-~~~~l-----~~ 768 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQG-RQVVL-----SR 768 (807)
T ss_pred eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCC-cceec-----cC
Confidence 2 3455678999999999999999999999999999984 67888875222 22222222222211 11111 12
Q ss_pred cHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCCC
Q 006112 572 VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGA 608 (660)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (660)
+.-++..+.++++.||..|.++||+++++...|+..+
T Consensus 769 P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 769 PPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred CCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 3345667889999999999999999999999997653
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=358.60 Aligned_cols=254 Identities=26% Similarity=0.388 Sum_probs=216.2
Q ss_pred CCceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEE
Q 006112 333 PHRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 333 ~~~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
..+..|...+++|+|+.|.||.++...+++.||||++........+-+.+|+.+|+..+|+|||+++..+...+++++||
T Consensus 270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 34567999999999999999999999999999999997766666677899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
|||++|+|.+.+... .+++.++..|++++++||+|||. ++|+|||||.+|||++.++.+||+|||++..+....
T Consensus 350 Eym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred eecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 999999999998654 38999999999999999999998 999999999999999999999999999998776544
Q ss_pred CceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCc
Q 006112 493 DLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 493 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
. .....+||+-|||||+.....|.+|.||||||++++||+-|..||-.+..-..-|.+ ...|. |.+. ..
T Consensus 424 ~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI--a~ng~------P~lk--~~ 492 (550)
T KOG0578|consen 424 S-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI--ATNGT------PKLK--NP 492 (550)
T ss_pred C-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH--hhcCC------CCcC--Cc
Confidence 3 445689999999999999999999999999999999999999999864433333322 22222 1111 12
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
+.....+.++..+||+.|+++||++.|+|++
T Consensus 493 ~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 493 EKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred cccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 2233457777888999999999999999973
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=340.64 Aligned_cols=268 Identities=24% Similarity=0.318 Sum_probs=215.4
Q ss_pred hccCCCceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHhccCCCCceeEeeeeeecCe
Q 006112 329 KEYSPHRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD-HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGE 407 (660)
Q Consensus 329 ~~~~~~~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 407 (660)
.++.+..-.|+....+|.|..++||+|+....++.||||++..+.- ..++.+.+|++.|+.++||||++++..|..+.+
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~ 98 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSE 98 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecce
Confidence 3455667789999999999999999999999999999999965432 347889999999999999999999999999999
Q ss_pred eEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeeccccee
Q 006112 408 LLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARL 487 (660)
Q Consensus 408 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 487 (660)
+|+||.||.+||+.++++..-...+++..+..|++++++||.|||+ +|.||||||+.||||+.+|.+||+|||.+..
T Consensus 99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~ 175 (516)
T KOG0582|consen 99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSAS 175 (516)
T ss_pred eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeee
Confidence 9999999999999999987766679999999999999999999998 9999999999999999999999999998754
Q ss_pred ccCCCCcee---eccccCccccCcccccC--CCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccC
Q 006112 488 YDHGNDLHT---TNVVGTVGYLAPELLRN--GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDA 562 (660)
Q Consensus 488 ~~~~~~~~~---~~~~gt~~Y~aPE~~~~--~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 562 (660)
+-....... ...+||+.|||||++.. ..|+.|+|||||||+.+||++|..||...... +...... .++....
T Consensus 176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm--kvLl~tL-qn~pp~~ 252 (516)
T KOG0582|consen 176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM--KVLLLTL-QNDPPTL 252 (516)
T ss_pred ecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH--HHHHHHh-cCCCCCc
Confidence 433222211 45689999999999643 46899999999999999999999999864321 1111111 2222111
Q ss_pred CCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 563 SDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 563 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
.-..+...-.......+.+++..|++.||.+|||++++++
T Consensus 253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1111111222233346788888999999999999999985
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=353.06 Aligned_cols=260 Identities=25% Similarity=0.328 Sum_probs=208.8
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhH-HHHHHHHHHhccC-CCCceeEeeeeeecC-eeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMK-QFVSEIVSMGKLR-HRNLVQLRGYCRRKG-ELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~-~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~-~~~lV~E 413 (660)
.|..++++|.|.||.||+|+...++..||||+++..-....+ .=++|++.|++|. |||||+|...+.+.+ .+++|||
T Consensus 11 RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE 90 (538)
T KOG0661|consen 11 RYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFE 90 (538)
T ss_pred HHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHH
Confidence 688899999999999999999999999999998655333222 2368999999998 999999999999887 9999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
|| ..+|.+++++. +..+++.++..|+.||++||+|+|. +|+.|||+||+|||+..+..+||+||||||.....
T Consensus 91 ~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk-- 163 (538)
T KOG0661|consen 91 FM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVRSK-- 163 (538)
T ss_pred hh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccccC--
Confidence 99 78999999877 5679999999999999999999998 99999999999999999999999999999976543
Q ss_pred ceeeccccCccccCcccc-cCCCCCcceeEEehHHHHHHHhhCCCCCCC-CCcchHHHHHHHHhcCCc------------
Q 006112 494 LHTTNVVGTVGYLAPELL-RNGRGTTSTDVYAFGVFMLEVACGRRPVQP-GELDLLDWVIDYWQKGDV------------ 559 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~-~~~~~t~ksDV~S~Gvvl~elltG~~p~~~-~~~~~~~~~~~~~~~~~~------------ 559 (660)
...|..+.|.+|.|||++ +.+.|+.+.|+|++||+++|+.+-+.-|.+ .+.+.+-.+.+.......
T Consensus 164 pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~ 243 (538)
T KOG0661|consen 164 PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASA 243 (538)
T ss_pred CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHH
Confidence 334668889999999986 567899999999999999999998877765 223333222222222111
Q ss_pred ccCCCCcccc----cCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 560 LDASDPRLEG----IYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 560 ~~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
+...-|...+ ...+.......+++.+|+..||++|||+.|++++
T Consensus 244 mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 244 MNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 0111111111 1123355678889999999999999999999974
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=318.19 Aligned_cols=271 Identities=27% Similarity=0.372 Sum_probs=212.4
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC-hh-hHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD-HG-MKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~-~~-~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
+|..++++|+|.||.||+|++..+|+.||||+++.... ++ .....+||+.|+.++|+||+.+++.+...+.+.||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 57888999999999999999999999999999975532 22 45688999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
| ..+|+..+++... .+...++..++.++++||+|||. +.|+||||||.|+|++.+|.+||+|||+|+.+......
T Consensus 83 m-~tdLe~vIkd~~i-~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 83 M-PTDLEVVIKDKNI-ILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred c-cccHHHHhccccc-ccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 9 5799999987653 58889999999999999999998 99999999999999999999999999999998765443
Q ss_pred eeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcc------
Q 006112 495 HTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL------ 567 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l------ 567 (660)
.. ..+-|.+|.|||++.+ ..|+...|+||.||++.||+-|. ||-+++.++-+-..-+..-|...+..-|.+
T Consensus 158 ~~-~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~-P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 158 QT-HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRV-PFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred cc-cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccC-CCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence 33 3367999999999876 46899999999999999999766 555444333222222222222222111111
Q ss_pred ----------cccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH--hhCCCCCCCCCC
Q 006112 568 ----------EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY--LDGGALLPDIPL 615 (660)
Q Consensus 568 ----------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~~~~p~~p~ 615 (660)
....-..+....++++..++..||.+|+++.|++++ +.. .+.|..|.
T Consensus 236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~-~P~pt~~~ 294 (318)
T KOG0659|consen 236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS-LPLPTPPS 294 (318)
T ss_pred HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc-CCCCCChh
Confidence 111223334456888999999999999999999963 443 45555443
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=344.86 Aligned_cols=251 Identities=26% Similarity=0.340 Sum_probs=205.2
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
+|+.++.||+|+||.||++....+++.||+|.+.... ......+.+|+.++++++|+||+++++++.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 4778899999999999999998899999999986432 2334568899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
||++|+|..++.......+++.++..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 9999999988876544568999999999999999999998 999999999999999999999999999998754322
Q ss_pred ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcch-HHHHHHHHhcCCcccCCCCcccccCc
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDL-LDWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
......||..|+|||++.+..++.++|||||||++|||++|+.||....... .+.+........ . .+.
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------~----~~~ 225 (285)
T cd05631 157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ------E----EYS 225 (285)
T ss_pred -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccc------c----cCC
Confidence 2234578999999999999999999999999999999999999998643321 111221111111 0 111
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCC-----HHHHHH
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRPS-----MRQVVQ 602 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 602 (660)
......+.+++..||+.||++||+ ++++++
T Consensus 226 ~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 226 EKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 122345678888899999999997 788886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=352.41 Aligned_cols=254 Identities=23% Similarity=0.359 Sum_probs=208.9
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccC----CC-hhhHHHHHHHHHHhccC-CCCceeEeeeeeecCee
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD----SD-HGMKQFVSEIVSMGKLR-HRNLVQLRGYCRRKGEL 408 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~-~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~ 408 (660)
.-.|...+.+|+|.||+|+.|.+..++..||+|.+... .. ...+.+.+|+.++++++ ||||++++.++.....+
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 34788999999999999999999999999999976543 12 34556778999999999 99999999999999999
Q ss_pred EEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCC-CCeEEeeccccee
Q 006112 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDAD-LEGKLGDFGLARL 487 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~-~~~kl~DFGla~~ 487 (660)
++|||||.||+|.+++... ..+.+..+.+++.|++.|++|||+ ++|+||||||+|||+|.+ +++||+|||++..
T Consensus 96 ~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred EEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 9999999999999999873 358889999999999999999998 999999999999999999 9999999999998
Q ss_pred ccCCCCceeeccccCccccCcccccCCC-CC-cceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCC
Q 006112 488 YDHGNDLHTTNVVGTVGYLAPELLRNGR-GT-TSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDP 565 (660)
Q Consensus 488 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~t-~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 565 (660)
.. .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+....... ......+..
T Consensus 171 ~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l---~~ki~~~~~------ 240 (370)
T KOG0583|consen 171 SP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL---YRKIRKGEF------ 240 (370)
T ss_pred cC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH---HHHHhcCCc------
Confidence 74 2233445689999999999999876 75 789999999999999999999987433222 112223221
Q ss_pred cccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH--HhhC
Q 006112 566 RLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ--YLDG 606 (660)
Q Consensus 566 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~ 606 (660)
.+..... ...+..|+.+|+..||.+|+++.+|++ +++.
T Consensus 241 ~~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 241 KIPSYLL---SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred cCCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 1112221 334567777899999999999999995 4444
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=342.88 Aligned_cols=252 Identities=15% Similarity=0.243 Sum_probs=202.2
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChh---hHHHHHHHHHHhccCCCCceeEeeeeee----cCe
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHG---MKQFVSEIVSMGKLRHRNLVQLRGYCRR----KGE 407 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~---~~~~~~Ei~~l~~l~H~nIv~l~g~~~~----~~~ 407 (660)
.+.......+++|++|.||+|++ +++.||||++....... .+.|.+|+.++++++||||++++|++.+ ...
T Consensus 19 ~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~ 96 (283)
T PHA02988 19 DIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPR 96 (283)
T ss_pred HcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCc
Confidence 33444456789999999999999 68899999997653322 5788899999999999999999999876 356
Q ss_pred eEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeeccccee
Q 006112 408 LLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARL 487 (660)
Q Consensus 408 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 487 (660)
+++||||+++|+|.+++.... .++|....+++.|++.||.|||+ ..+++||||||+|||+++++.+||+|||+++.
T Consensus 97 ~~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~ 172 (283)
T PHA02988 97 LSLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKI 172 (283)
T ss_pred eEEEEEeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhh
Confidence 899999999999999997643 58999999999999999999997 24788999999999999999999999999986
Q ss_pred ccCCCCceeeccccCccccCcccccC--CCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCC
Q 006112 488 YDHGNDLHTTNVVGTVGYLAPELLRN--GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDP 565 (660)
Q Consensus 488 ~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 565 (660)
..... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||....... ........+.. +
T Consensus 173 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~--~~~~i~~~~~~-----~ 241 (283)
T PHA02988 173 LSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE--IYDLIINKNNS-----L 241 (283)
T ss_pred hcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHhcCCC-----C
Confidence 54321 23468899999999976 688999999999999999999999998643221 11111111111 1
Q ss_pred cccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 566 RLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 566 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
.+. ......+.+++.+||+.||++|||++|+++.|+..
T Consensus 242 ~~~----~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 242 KLP----LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred CCC----CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 111 12344578888999999999999999999999753
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=353.23 Aligned_cols=256 Identities=25% Similarity=0.384 Sum_probs=202.8
Q ss_pred eeecccccccCccEEEEEEEeC-----CCCeEEEEEEeccCC-ChhhHHHHHHHHHHhcc-CCCCceeEeeeeeec-Cee
Q 006112 337 SYKNLYKATKGGSGKVYRGVLP-----SSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRK-GEL 408 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~-----~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~-~~~ 408 (660)
.|+..+.||+|+||.||+|.+. ..+..||||++.... ....+.+.+|+.++.++ +||||++++++|... +.+
T Consensus 8 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 87 (338)
T cd05102 8 RLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPL 87 (338)
T ss_pred HceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCce
Confidence 5778899999999999999752 345689999986543 23456799999999999 899999999998765 458
Q ss_pred EEEEecCCCCChhhhhhhCC------------------------------------------------------------
Q 006112 409 LLVYDYMPNGSLDKILYSNT------------------------------------------------------------ 428 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~------------------------------------------------------------ 428 (660)
++||||+++|+|.+++....
T Consensus 88 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (338)
T cd05102 88 MVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLW 167 (338)
T ss_pred EEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccc
Confidence 99999999999999986432
Q ss_pred CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc-eeeccccCccccC
Q 006112 429 RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL-HTTNVVGTVGYLA 507 (660)
Q Consensus 429 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~a 507 (660)
...+++.++.+++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++........ ......++..|+|
T Consensus 168 ~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 244 (338)
T cd05102 168 KSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA 244 (338)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccC
Confidence 1247788899999999999999998 89999999999999999999999999999865432221 1223456789999
Q ss_pred cccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhc
Q 006112 508 PELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFC 586 (660)
Q Consensus 508 PE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C 586 (660)
||++.+..++.++|||||||++|||++ |..||...... +........+... .... .....+.+++..|
T Consensus 245 PE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~--~~~~~~~~~~~~~-----~~~~----~~~~~l~~li~~c 313 (338)
T cd05102 245 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN--EEFCQRLKDGTRM-----RAPE----NATPEIYRIMLAC 313 (338)
T ss_pred cHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHHHhcCCCC-----CCCC----CCCHHHHHHHHHH
Confidence 999998899999999999999999997 99999763322 1122222232221 1111 2234577899999
Q ss_pred cCCCCCCCCCHHHHHHHhhC
Q 006112 587 SHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 587 l~~dP~~RPs~~evl~~L~~ 606 (660)
|+.||++|||+.|+++.|+.
T Consensus 314 l~~dp~~RPs~~el~~~l~~ 333 (338)
T cd05102 314 WQGDPKERPTFSALVEILGD 333 (338)
T ss_pred ccCChhhCcCHHHHHHHHHH
Confidence 99999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=376.25 Aligned_cols=258 Identities=30% Similarity=0.421 Sum_probs=211.7
Q ss_pred ceeeecccccccCccEEEEEEEeCCCC-----eEEEEEEeccC-CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCee
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSH-----AEIAVKKVCHD-SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGEL 408 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~-----~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 408 (660)
+.+.+.+..||+|.||.||+|...+.. ..||||.+.+. +.+...+|++|..+|++++|||||+++|.|.+.+..
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 456667788999999999999986432 35999999776 445678999999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhhhCC-----CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecc
Q 006112 409 LLVYDYMPNGSLDKILYSNT-----RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFG 483 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG 483 (660)
+|++|||++|+|..||++.. ...|.-.+.+.++.|||+|+.||++ +.+|||||..+|+||++...+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999998752 2458889999999999999999998 999999999999999999999999999
Q ss_pred cceeccCCCCceee-ccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCccc
Q 006112 484 LARLYDHGNDLHTT-NVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLD 561 (660)
Q Consensus 484 la~~~~~~~~~~~~-~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 561 (660)
|||.+......... ...-..+|||||.+..+.++.|+|||||||+|||++| |..||...... .+...+.+|..++
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~---~v~~~~~~ggRL~ 924 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF---EVLLDVLEGGRLD 924 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH---HHHHHHHhCCccC
Confidence 99944333222222 2234579999999999999999999999999999998 88888753322 1222223332222
Q ss_pred CCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 562 ASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 562 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
.+..+++.+.+||+.||+.+|++||++..|++.+...
T Consensus 925 ---------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i 961 (1025)
T KOG1095|consen 925 ---------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI 961 (1025)
T ss_pred ---------CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence 1345667789999999999999999999999977653
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=356.40 Aligned_cols=253 Identities=28% Similarity=0.380 Sum_probs=206.5
Q ss_pred ccccccCccEEEEEEEeCCCCe---E-EEEEEecc---CCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 341 LYKATKGGSGKVYRGVLPSSHA---E-IAVKKVCH---DSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 341 l~~lg~G~fg~Vy~g~~~~~~~---~-vavK~~~~---~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
.++||+|+||.||+|++...+. . ||||.... .....+++|++|.++|++++|||||+++|++..+..+++|||
T Consensus 162 ~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmE 241 (474)
T KOG0194|consen 162 GKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVME 241 (474)
T ss_pred cceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEE
Confidence 3899999999999999965422 3 89999874 345678899999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
+|+||+|+++|+..+. .++..++.+++.+.|.||+|||+ ++++||||..+|+|++.++.+||+||||++.... ..
T Consensus 242 l~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~-~~ 316 (474)
T KOG0194|consen 242 LCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ-YV 316 (474)
T ss_pred ecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccCCcc-ee
Confidence 9999999999988764 69999999999999999999998 9999999999999999999999999999975431 11
Q ss_pred ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHH-hcCCcccCCCCcccccC
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYW-QKGDVLDASDPRLEGIY 571 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~-~~~~~~~~~d~~l~~~~ 571 (660)
.......-+.+|+|||.+..+.++.++|||||||++||+.+ |..||.+..... +.... ..+-... .
T Consensus 317 ~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~---v~~kI~~~~~r~~---------~ 384 (474)
T KOG0194|consen 317 MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE---VKAKIVKNGYRMP---------I 384 (474)
T ss_pred eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH---HHHHHHhcCccCC---------C
Confidence 11111234679999999999999999999999999999998 888988644321 22222 2222211 1
Q ss_pred cHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCCCCC
Q 006112 572 VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGALL 610 (660)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 610 (660)
+...+..+..++..||..||++||+|.++.+.|+.....
T Consensus 385 ~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 385 PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred CCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 123455667777799999999999999999999875433
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=354.95 Aligned_cols=257 Identities=25% Similarity=0.372 Sum_probs=206.4
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
.....++||+|.||+||+|+|.+ .||||.+..+ .++..+.|++|+..+++-+|-||+=++|||..+.. .||..+
T Consensus 393 ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqw 468 (678)
T KOG0193|consen 393 EVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQW 468 (678)
T ss_pred Hhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehh
Confidence 34567889999999999999943 4999999765 34567899999999999999999999999998877 999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC-C
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN-D 493 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~-~ 493 (660)
|+|.+|..+|+... ..++..+.++|+.|||+||.|||. ++|||||||..||+|.+++.|||+||||+..-..-. .
T Consensus 469 CeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~ 544 (678)
T KOG0193|consen 469 CEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGE 544 (678)
T ss_pred ccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeeeeeeccc
Confidence 99999999998654 468899999999999999999998 999999999999999999999999999996532221 1
Q ss_pred ceeeccccCccccCcccccCC---CCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCccccc
Q 006112 494 LHTTNVVGTVGYLAPELLRNG---RGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGI 570 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~---~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 570 (660)
.......|...|||||+++.+ +|+..+||||||+|+|||+||..||.....+.+-| ..|+-.-..|...
T Consensus 545 ~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIif-----mVGrG~l~pd~s~--- 616 (678)
T KOG0193|consen 545 QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIF-----MVGRGYLMPDLSK--- 616 (678)
T ss_pred cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEE-----EecccccCccchh---
Confidence 112234577899999998754 67899999999999999999999998443332222 2222211122211
Q ss_pred CcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCCCC
Q 006112 571 YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGAL 609 (660)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 609 (660)
....+.+.+.+|+..||..++++||.+.+|+..|+...+
T Consensus 617 ~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 617 IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 123455667778888999999999999999998876543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=345.70 Aligned_cols=248 Identities=25% Similarity=0.334 Sum_probs=207.1
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCeeEEEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
+|+..+.+|+|+|++|++|+...+++++|||++.+. .....+-...|-.+|.+| .||.|++|+-.++++..+|+|+
T Consensus 74 DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvL 153 (604)
T KOG0592|consen 74 DFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVL 153 (604)
T ss_pred hcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEE
Confidence 466677899999999999999999999999998543 223345577888999999 8999999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
||++||+|.++|.+.+ .+++.....++.+|+.||+|||+ +|||||||||+|||||++|++||+|||.|+.+....
T Consensus 154 e~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 154 EYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred EecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 9999999999998765 59999999999999999999998 999999999999999999999999999998775421
Q ss_pred Cc------------eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchH-HHHHHHHhcCCc
Q 006112 493 DL------------HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLL-DWVIDYWQKGDV 559 (660)
Q Consensus 493 ~~------------~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~-~~~~~~~~~~~~ 559 (660)
.. ....++||..|.+||++..+..++.+|+|+|||+||+|+.|..||......+. +.+.
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~-------- 300 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQ-------- 300 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHH--------
Confidence 11 11458999999999999999999999999999999999999999987554332 2221
Q ss_pred ccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 560 LDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 560 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
..+-.+...+++ .+.+|+...+..||.+|++.+||.++
T Consensus 301 --~l~y~fp~~fp~----~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 301 --ALDYEFPEGFPE----DARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred --HhcccCCCCCCH----HHHHHHHHHHccCccccccHHHHhhC
Confidence 223334444543 34555556699999999999999874
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=348.80 Aligned_cols=244 Identities=28% Similarity=0.437 Sum_probs=202.8
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 416 (660)
...+|+=+|.|+.|.||+|++ .++.||||+++.- -..+|+-|++|+|+||+.+.|+|....-+|||||||.
T Consensus 125 ~IsELeWlGSGaQGAVF~Grl--~netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa 195 (904)
T KOG4721|consen 125 EISELEWLGSGAQGAVFLGRL--HNETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCA 195 (904)
T ss_pred HhhhhhhhccCcccceeeeec--cCceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccc
Confidence 456788899999999999999 4688999988422 2357888999999999999999999999999999999
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCcee
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT 496 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 496 (660)
.|-|...|+... .+.-.....+.++||.||.|||. +.|||||||.-||||..+..+||+|||-++..... ...
T Consensus 196 ~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STk 268 (904)
T KOG4721|consen 196 QGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STK 268 (904)
T ss_pred cccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhh
Confidence 999999997654 47778889999999999999998 99999999999999999999999999999865433 222
Q ss_pred eccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHH
Q 006112 497 TNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQM 576 (660)
Q Consensus 497 ~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 576 (660)
..++||..|||||++++.+.++|.||||||||||||+||..||..-+. ..- .|.-| ...+.-.....++
T Consensus 269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds--sAI---IwGVG------sNsL~LpvPstcP 337 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS--SAI---IWGVG------SNSLHLPVPSTCP 337 (904)
T ss_pred hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch--hee---EEecc------CCcccccCcccCc
Confidence 357899999999999999999999999999999999999999964211 111 11222 1222223345566
Q ss_pred HHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 577 EIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 577 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
+-+.-|+++||+..|..||++++|+.+|+-.
T Consensus 338 ~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 338 DGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred hHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 6677788889999999999999999999864
|
|
| >cd01951 lectin_L-type legume lectins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=324.35 Aligned_cols=206 Identities=29% Similarity=0.406 Sum_probs=172.3
Q ss_pred CCCeeEecceeEcC-CCcEEecCCCCCeeEEEEeCCCeeeccCCCCceeEEEEEEEEEecCCCCCCCCceEEEEecCCCC
Q 006112 37 GSKLKLDGLAKIHP-NGLLQLTNTSERISGHAFYPFPFKFNSSSSQSLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDF 115 (660)
Q Consensus 37 ~~~l~~~g~a~~~~-~g~l~Lt~~~~~~~G~~~y~~pv~~~~~~~~~~sFst~F~F~i~~~~~~~~g~GlaF~l~p~~~~ 115 (660)
.+++.++|+|.+.+ ++.|+||++..+++|++||++||++| .+|+|+|+|.|.+.. ..+||||||+|+|....
T Consensus 13 ~~~~~~~G~A~~~~~~~~l~Lt~~~~~~~G~~~~~~~i~~~------~~F~~~F~f~i~~~~-~~~gdG~aF~l~~~~~~ 85 (223)
T cd01951 13 QSNWQLNGSATLTTDSGVLRLTPDTGNQAGSAWYKTPIDLS------KDFTTTFKFYLGTKG-TNGADGIAFVLQNDPAG 85 (223)
T ss_pred hhhcEEcccEEecCCCCEEEECCCCCCcEEEEEECCcEecc------CCEEEEEEEEEeCCC-CCCCCcEEEEEecCCCC
Confidence 36899999999976 78999999999999999999999997 679999999999864 56899999999997755
Q ss_pred CCCCCC--CcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCeeEEEcCCccccc--cccccccccccccccccccC
Q 006112 116 SEAVAG--SHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNE--SASARYFSDEKKEFESLVLE 191 (660)
Q Consensus 116 ~~~~~g--~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~--~~~~~~~~~~~~~~~~~~l~ 191 (660)
+.+.+| ++||. ...++.+||||||++|.+++||+.||||||+|+..+.. ..+..+.. .+....
T Consensus 86 ~~~~~g~~~~lG~-------~~~~~~~aVefDT~~N~~~~dp~~~higi~~n~~~~~~~~~~~~~~~~------~~~~~~ 152 (223)
T cd01951 86 ALGGGGGGGGLGY-------GGIGNSVAVEFDTYKNDDNNDPNGNHISIDVNGNGNNTALATSLGSAS------LPNGTG 152 (223)
T ss_pred ccccCCCCCccCc-------cccCCeEEEEEeccccCCCCCCCCCEEEEEcCCCCCCcccccccceee------CCCccC
Confidence 555555 78886 34678999999999999888999999999999997541 11111110 112222
Q ss_pred CCccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeecccCceeeeeeecCccccc
Q 006112 192 SGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTRVSDYYILGWSFNK 264 (660)
Q Consensus 192 ~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg~~~~~h~i~~wsf~~ 264 (660)
+|+.++|||+|++.+++|+|+|..... |..|.++.++||+.+++++||||||||||...+.|.|++|+|+.
T Consensus 153 ~g~~~~v~I~Y~~~~~~L~v~l~~~~~--~~~~~l~~~~~l~~~~~~~~yvGFTAsTG~~~~~h~V~~wsf~~ 223 (223)
T cd01951 153 LGNEHTVRITYDPTTNTLTVYLDNGST--LTSLDITIPVDLIQLGPTKAYFGFTASTGGLTNLHDILNWSFTS 223 (223)
T ss_pred CCCEEEEEEEEeCCCCEEEEEECCCCc--cccccEEEeeeecccCCCcEEEEEEcccCCCcceeEEEEEEecC
Confidence 389999999999999999999986543 67789999999999999999999999999999999999999963
|
The L-type (legume-type) lectins are a highly diverse family of carbohydrate binding proteins that generally display no enzymatic activity toward the sugars they bind. This family includes arcelin, concanavalinA, the lectin-like receptor kinases, the ERGIC-53/VIP36/EMP46 type1 transmembrane proteins, and an alpha-amylase inhibitor. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=347.19 Aligned_cols=253 Identities=23% Similarity=0.309 Sum_probs=205.8
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
.|+.++.||+|+||.||+|++..+++.||||++... .....+.+.+|++++.+++||||+++++++...+..++|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 478899999999999999999988999999998653 22345678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
|+++|+|.+++.... .+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 82 YVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred CCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 999999999997543 48899999999999999999998 9999999999999999999999999999986543
Q ss_pred ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+. .... .+.... ...
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~--~~~~~~-~~~ 227 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK--ETLQ--RPVYDD-PRF 227 (333)
T ss_pred -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc--cccc--CCCCCc-ccc
Confidence 2334679999999999998899999999999999999999999997644322111111111 1111 111100 001
Q ss_pred HHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.....+.+++..|+..+|.+||+++|++++
T Consensus 228 ~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 228 NLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 223456778888999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=341.65 Aligned_cols=260 Identities=23% Similarity=0.363 Sum_probs=203.8
Q ss_pred eeecccccccCccEEEEEEEeCC----------------CCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPS----------------SHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLR 399 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~----------------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~ 399 (660)
.|+..+++|+|+||.||++.+.. ++..||+|.+.... .....+|.+|++++.+++||||++++
T Consensus 6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 85 (304)
T cd05096 6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLL 85 (304)
T ss_pred hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEE
Confidence 57777889999999999998632 34579999987643 33456899999999999999999999
Q ss_pred eeeeecCeeEEEEecCCCCChhhhhhhCC-----------------CCCcchhHHHHHHHHHHHHHHHhhhcccCceecc
Q 006112 400 GYCRRKGELLLVYDYMPNGSLDKILYSNT-----------------RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHR 462 (660)
Q Consensus 400 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHr 462 (660)
+++.+.+..++||||+++|+|.+++.... ...++|.++.+++.||+.||+|||+ .+|+||
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH~ 162 (304)
T cd05096 86 GVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHR 162 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCcccc
Confidence 99999999999999999999999985432 1247888999999999999999998 899999
Q ss_pred CccCCcEEEcCCCCeEEeecccceeccCCCCc-eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh--CCCCC
Q 006112 463 DIKPANVLLDADLEGKLGDFGLARLYDHGNDL-HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC--GRRPV 539 (660)
Q Consensus 463 Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt--G~~p~ 539 (660)
||||+|||++.++.+||+|||+++........ ......++..|+|||++..+.++.++||||||+++|||++ +..||
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 242 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCC
Confidence 99999999999999999999999865443221 1223456789999999988899999999999999999986 55677
Q ss_pred CCCC-cchHHHHHHHHhcCCc-ccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 540 QPGE-LDLLDWVIDYWQKGDV-LDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 540 ~~~~-~~~~~~~~~~~~~~~~-~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
.... ......+......... ..... ...+...+.+++.+||+.||++|||++||.+.|+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 243 GELTDEQVIENAGEFFRDQGRQVYLFR-------PPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CcCCHHHHHHHHHHHhhhccccccccC-------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 6432 2223333322222111 00001 11233567889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=338.91 Aligned_cols=262 Identities=23% Similarity=0.294 Sum_probs=204.7
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
+|+.++.+|+|+||.||++++..+++.+|+|++.... ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 4788899999999999999999899999999986542 33456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
++++.|..+.... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 82 ~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 82 VEKNMLELLEEMP--NGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred CCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 9988776654332 358899999999999999999998 89999999999999999999999999999876543333
Q ss_pred eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcc-hHHHHHH------------HHhcCCccc
Q 006112 495 HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELD-LLDWVID------------YWQKGDVLD 561 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~------------~~~~~~~~~ 561 (660)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....+.. .........
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence 334467899999999999888999999999999999999999999753321 1111110 000000000
Q ss_pred CCCCccc------ccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 562 ASDPRLE------GIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 562 ~~d~~l~------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
...+... ..+.......+.+++..|++.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0001100 00111123468899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=347.50 Aligned_cols=246 Identities=25% Similarity=0.351 Sum_probs=207.2
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
+|...+.+|+|.||+||||+.+.+.+.||+|.+.+.. +...+.+.+|++++++++|||||.+++|++...++++|.||
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~ 82 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY 82 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence 5777889999999999999999999999999996653 34577899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
|.| +|..+|..... ++++++..|+.++..||.|||+ .+|+|||+||.|||++.++.+|++|||+||.+..+. .
T Consensus 83 a~g-~L~~il~~d~~--lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t-~ 155 (808)
T KOG0597|consen 83 AVG-DLFTILEQDGK--LPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT-S 155 (808)
T ss_pred hhh-hHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccCc-e
Confidence 965 99999987654 9999999999999999999998 999999999999999999999999999999876543 3
Q ss_pred eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHH
Q 006112 495 HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEE 574 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 574 (660)
..+...|||-|||||+..++.|+..+|.||+||++||++.|++||..... .+.+.. +... ++.......
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si--~~Lv~~-I~~d------~v~~p~~~S-- 224 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI--TQLVKS-ILKD------PVKPPSTAS-- 224 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH--HHHHHH-HhcC------CCCCccccc--
Confidence 45668899999999999999999999999999999999999999975332 121221 1111 111122222
Q ss_pred HHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 575 QMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 575 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
..+..+....+..||.+|.+..+++.
T Consensus 225 --~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 225 --SSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred --HHHHHHHHHHhhcChhhcccHHHHhc
Confidence 33445555569999999999999986
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=387.06 Aligned_cols=255 Identities=26% Similarity=0.489 Sum_probs=211.6
Q ss_pred eecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCCC
Q 006112 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPN 417 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 417 (660)
+++...+|+|+||.||+|++..++..||||++..... ....|++++++++|||||+++|+|.+++..++|||||++
T Consensus 692 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~ 767 (968)
T PLN00113 692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEG 767 (968)
T ss_pred CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCC
Confidence 4556789999999999999988899999999854332 223568899999999999999999999999999999999
Q ss_pred CChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCceee
Q 006112 418 GSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTT 497 (660)
Q Consensus 418 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 497 (660)
|+|.++++ .++|.++.+|+.|+|+||+|||+.+.++|+||||||+||+++.++.+++. ||....... ..
T Consensus 768 g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-----~~ 836 (968)
T PLN00113 768 KNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-----DT 836 (968)
T ss_pred CcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----CC
Confidence 99999995 28999999999999999999997667899999999999999999988875 666543321 12
Q ss_pred ccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCC---CcchHHHHHHHHhcCCcccCCCCcccc--cCc
Q 006112 498 NVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPG---ELDLLDWVIDYWQKGDVLDASDPRLEG--IYV 572 (660)
Q Consensus 498 ~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~---~~~~~~~~~~~~~~~~~~~~~d~~l~~--~~~ 572 (660)
...||+.|||||++.+..++.++|||||||++|||+||+.||+.. .....+|+.............|+.+.. ...
T Consensus 837 ~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (968)
T PLN00113 837 KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN 916 (968)
T ss_pred CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCcc
Confidence 336889999999999999999999999999999999999998642 335667766555444444455665533 234
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
.+++..+.+++.+||+.||++||+|+||++.|+..
T Consensus 917 ~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 917 QNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred HHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence 56777889999999999999999999999999875
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=344.01 Aligned_cols=261 Identities=23% Similarity=0.337 Sum_probs=206.3
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD-HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
-.|+.++.+|+|+||.||++++..++..+|+|.+..... ...+++.+|++++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 368889999999999999999999999999999876533 3456899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
+++|+|.+++.... .+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 157 (331)
T cd06649 85 MDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (331)
T ss_pred CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccccc---
Confidence 99999999997644 48889999999999999999997 246999999999999999999999999999765332
Q ss_pred eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHH-hcCC--cccCCCCc-----
Q 006112 495 HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYW-QKGD--VLDASDPR----- 566 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~-~~~~--~~~~~d~~----- 566 (660)
......||+.|+|||++.+..++.++|||||||++|||++|+.||............... ..+. ......+.
T Consensus 158 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (331)
T cd06649 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPG 237 (331)
T ss_pred ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccc
Confidence 223457899999999999889999999999999999999999999754332221111000 0000 00000000
Q ss_pred ---------------------------ccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 567 ---------------------------LEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 567 ---------------------------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
............+.+++.+||+.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 238 RPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000001123457889999999999999999999975
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=345.18 Aligned_cols=242 Identities=24% Similarity=0.263 Sum_probs=199.5
Q ss_pred cccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCCCC
Q 006112 342 YKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNG 418 (660)
Q Consensus 342 ~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g 418 (660)
+.||+|+||.||+++...+++.||+|++... .......+.+|+.++++++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3589999999999999999999999998653 2334567889999999999999999999999999999999999999
Q ss_pred ChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCceeec
Q 006112 419 SLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTN 498 (660)
Q Consensus 419 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 498 (660)
+|.+++.... .+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..... ......
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~ 154 (323)
T cd05571 81 ELFFHLSRER--VFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMKT 154 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcccc
Confidence 9999987643 58999999999999999999998 89999999999999999999999999999753221 122334
Q ss_pred cccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHHH
Q 006112 499 VVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEI 578 (660)
Q Consensus 499 ~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 578 (660)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... ......+. ..+.... ...
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~---~~~~~~~~------~~~p~~~----~~~ 221 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FELILMEE------IRFPRTL----SPE 221 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH---HHHHHcCC------CCCCCCC----CHH
Confidence 6799999999999988999999999999999999999999976443221 11111111 1122222 344
Q ss_pred HHHHhhhccCCCCCCCC-----CHHHHHH
Q 006112 579 VLKLGLFCSHSNPDTRP-----SMRQVVQ 602 (660)
Q Consensus 579 l~~l~~~Cl~~dP~~RP-----s~~evl~ 602 (660)
+.+++..||+.||++|| ++.++++
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 222 AKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 67788889999999999 7999886
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=333.71 Aligned_cols=255 Identities=26% Similarity=0.378 Sum_probs=205.4
Q ss_pred eeeecccccccCccEEEEEEEeC---CCCeEEEEEEeccCCC-hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLP---SSHAEIAVKKVCHDSD-HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~---~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 411 (660)
..|+..+.||+|+||.||+|.+. ..+..||+|.+..... ...+.|.+|+.++++++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 36788889999999999999874 3467899999876533 3456799999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCC
Q 006112 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 491 (660)
|||+++|+|++++.... ..++|.+++.++.|++.||+|||+ ++++||||||+|||++.++.+|++|||.+......
T Consensus 85 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 85 TEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999997643 358999999999999999999998 89999999999999999999999999987653322
Q ss_pred CCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCccccc
Q 006112 492 NDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGI 570 (660)
Q Consensus 492 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 570 (660)
.........++..|+|||.+.+..++.++|||||||++||+++ |+.||...... ...+....+... + .
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~~~~~~~~~~----~-~--- 229 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVIKAVEDGFRL----P-A--- 229 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHHHCCCCC----C-C---
Confidence 2112222345678999999999999999999999999999775 99999754322 122222222111 1 1
Q ss_pred CcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 571 YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
.......+.+++..||+.+|++||+++||.+.|++
T Consensus 230 -~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 230 -PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred -CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 12234567888899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=341.58 Aligned_cols=246 Identities=18% Similarity=0.228 Sum_probs=204.1
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
-+|+..+.||+|+||.||+|++..+++.||+|.+... .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 3688889999999999999999999999999998643 2234567899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
||+++|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 98 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred cCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 9999999999997654 47888899999999999999998 999999999999999999999999999998654321
Q ss_pred CceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCc
Q 006112 493 DLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 493 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+....+.. .+...+
T Consensus 173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~~~i~~~~~------~~p~~~- 238 (329)
T PTZ00263 173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF---RIYEKILAGRL------KFPNWF- 238 (329)
T ss_pred ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH---HHHHHHhcCCc------CCCCCC-
Confidence 2357999999999999988999999999999999999999999754321 11222222221 111112
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCC-----HHHHHHH
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRPS-----MRQVVQY 603 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 603 (660)
...+.+++..||+.||.+||+ +++++++
T Consensus 239 ---~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 239 ---DGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ---CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 234678888999999999996 6888754
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=335.63 Aligned_cols=250 Identities=33% Similarity=0.552 Sum_probs=198.1
Q ss_pred cccccccCccEEEEEEEeC----CCCeEEEEEEeccCCC-hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 340 NLYKATKGGSGKVYRGVLP----SSHAEIAVKKVCHDSD-HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 340 ~l~~lg~G~fg~Vy~g~~~----~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
..+.||.|.||.||+|.+. ..+..|+||.+..... +..++|.+|++.+++++||||++++|+|...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4568999999999999997 3467899999965433 3578999999999999999999999999988889999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC-
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND- 493 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~- 493 (660)
|++|+|.++|.......+++.++.+|+.||++||+|||+ ++++|+||+++||+++.++.+||+|||+++.......
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred ccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence 999999999998755679999999999999999999998 8999999999999999999999999999987633222
Q ss_pred ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCc
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
.......+...|+|||.+....++.++||||||+++|||++ |+.||..... .+ +......+..... .
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--~~-~~~~~~~~~~~~~---------~ 227 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN--EE-IIEKLKQGQRLPI---------P 227 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--HH-HHHHHHTTEETTS---------B
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc--cc-cccccccccccee---------c
Confidence 22233457789999999998889999999999999999999 6788865422 22 2222233333221 1
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCCHHHHHHHh
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYL 604 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (660)
......+.+++..||+.||++||+++++++.|
T Consensus 228 ~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 228 DNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 12234577888999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=330.41 Aligned_cols=254 Identities=28% Similarity=0.410 Sum_probs=209.1
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 416 (660)
.|...+.+|+|++|.||+|.+...++.||+|.+..+ ....+++.+|++++++++|+||++++++|..++..++||||++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 466778899999999999999888999999998643 3446789999999999999999999999999999999999999
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCcee
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT 496 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 496 (660)
+++|.+++.......+++..+..++.|+++||+|||+ ++++||||||+||++++++.+||+|||+++..........
T Consensus 86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~ 162 (263)
T cd05052 86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 162 (263)
T ss_pred CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceeecc
Confidence 9999999976655568999999999999999999998 8999999999999999999999999999987654322222
Q ss_pred eccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHH
Q 006112 497 TNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQ 575 (660)
Q Consensus 497 ~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 575 (660)
....++..|+|||.+.+..++.++|||||||++|||++ |..||...... ........+.. +... ...
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~~~~~~~~~~~-----~~~~----~~~ 230 (263)
T cd05052 163 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELLEKGYR-----MERP----EGC 230 (263)
T ss_pred CCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHHCCCC-----CCCC----CCC
Confidence 22334678999999988899999999999999999998 89998754322 22222222211 1111 122
Q ss_pred HHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 576 MEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 576 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
...+.+++.+||+.||++||++.++++.|+.
T Consensus 231 ~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 231 PPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 3557788899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=342.09 Aligned_cols=260 Identities=23% Similarity=0.360 Sum_probs=205.4
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD-HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
-.|+.++++|+|+||.||++.+..++..+|+|.+..... ...+++.+|++++++++|+||++++++|.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 368889999999999999999998999999998865433 3456799999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
+++|+|.+++.... .+++.....++.|++.||.|||+ ..+|+||||||+|||++.++.+||+|||++......
T Consensus 85 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--- 157 (333)
T cd06650 85 MDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (333)
T ss_pred CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---
Confidence 99999999997643 48888999999999999999997 247999999999999999999999999999755322
Q ss_pred eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCC----------
Q 006112 495 HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASD---------- 564 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d---------- 564 (660)
......|+..|+|||++.+..++.++|||||||++|||++|+.||.................+.......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (333)
T cd06650 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRP 237 (333)
T ss_pred ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccch
Confidence 1233568999999999998889999999999999999999999997644332222221111111100000
Q ss_pred -----Cccc------------------ccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 565 -----PRLE------------------GIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 565 -----~~l~------------------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
|... ..........+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 238 LSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred hhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 0000 0000011245778999999999999999999986
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=333.07 Aligned_cols=255 Identities=27% Similarity=0.443 Sum_probs=208.3
Q ss_pred eeecccccccCccEEEEEEEeCCCC-----eEEEEEEeccCCC-hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSH-----AEIAVKKVCHDSD-HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLL 410 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~-----~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 410 (660)
+|+.++.+|+|+||.||+|.....+ ..||+|.+..... ....+|.+|+.++++++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 5778899999999999999986544 6899999865433 345679999999999999999999999999899999
Q ss_pred EEecCCCCChhhhhhhCCC--------------CCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCC
Q 006112 411 VYDYMPNGSLDKILYSNTR--------------PSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLE 476 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~ 476 (660)
+|||+++|+|.+++..... ..+++.++..++.|++.||.|||+ .+++||||||+||++++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCc
Confidence 9999999999999975421 457889999999999999999998 89999999999999999999
Q ss_pred eEEeecccceeccCCCC-ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHH
Q 006112 477 GKLGDFGLARLYDHGND-LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYW 554 (660)
Q Consensus 477 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~ 554 (660)
+||+|||+++....... .......+++.|+|||.+.++.++.++|||||||++|||++ |..||...... ......
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~~~~i 239 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EVIEMI 239 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH
Confidence 99999999986543322 22234467889999999988899999999999999999998 99998764332 122222
Q ss_pred hcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 555 QKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 555 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
..+.... ........+.+++.+||+.||++||+++||++.|+.
T Consensus 240 ~~~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 240 RSRQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HcCCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 2322211 112334668889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=339.67 Aligned_cols=240 Identities=23% Similarity=0.283 Sum_probs=196.3
Q ss_pred cccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCCCCCh
Q 006112 344 ATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSL 420 (660)
Q Consensus 344 lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 420 (660)
||+|+||.||+++...+++.||+|++... .......+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 68999999999999989999999998643 334566788999999999999999999999999999999999999999
Q ss_pred hhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCceeeccc
Q 006112 421 DKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVV 500 (660)
Q Consensus 421 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 500 (660)
.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... .......
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 154 (312)
T cd05585 81 FHHLQREG--RFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFC 154 (312)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccccc
Confidence 99997643 48899999999999999999998 999999999999999999999999999997543222 2233467
Q ss_pred cCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHH
Q 006112 501 GTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVL 580 (660)
Q Consensus 501 gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 580 (660)
||+.|+|||++.+..++.++|||||||++|||++|+.||...... + ..+....+. ..+.... ...+.
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~--~-~~~~~~~~~------~~~~~~~----~~~~~ 221 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN--E-MYRKILQEP------LRFPDGF----DRDAK 221 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH--H-HHHHHHcCC------CCCCCcC----CHHHH
Confidence 999999999999989999999999999999999999999764322 1 111111111 1111222 23466
Q ss_pred HHhhhccCCCCCCCCC---HHHHHH
Q 006112 581 KLGLFCSHSNPDTRPS---MRQVVQ 602 (660)
Q Consensus 581 ~l~~~Cl~~dP~~RPs---~~evl~ 602 (660)
+++..||+.||++||+ +.|+++
T Consensus 222 ~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 222 DLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred HHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 7888899999999985 556554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=327.48 Aligned_cols=254 Identities=26% Similarity=0.401 Sum_probs=207.6
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
-+|+.++++|+|+||.||+|... ++..||+|.+.... ...+.+.+|+.++++++|+||+++++.+...+..++||||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 36888899999999999999975 55679999876433 34578999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 495 (660)
++++|.+++.......+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.........
T Consensus 84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence 99999999976655568999999999999999999998 899999999999999999999999999998765433222
Q ss_pred eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHH
Q 006112 496 TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEE 574 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 574 (660)
.....++..|+|||++..+.++.++|||||||++|||++ |+.||....... .......+... +. .. .
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~~~~~~----~~-~~----~ 228 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSALQRGYRM----PR-ME----N 228 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHHHcCCCC----CC-CC----C
Confidence 233456778999999988889999999999999999998 999986533221 11112222111 11 11 1
Q ss_pred HHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 575 QMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 575 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
....+.+++.+|++.+|++||+++++.+.|+.
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 229 CPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 23457788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=339.20 Aligned_cols=245 Identities=21% Similarity=0.240 Sum_probs=202.8
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
+|+.++.||+|+||.||++....+++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 4778899999999999999998889999999986432 2345678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
|+++|+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-- 154 (291)
T cd05612 82 YVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-- 154 (291)
T ss_pred CCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence 999999999997654 48899999999999999999998 99999999999999999999999999999865432
Q ss_pred ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+....+.. .+....
T Consensus 155 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~------~~~~~~-- 221 (291)
T cd05612 155 --TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG---IYEKILAGKL------EFPRHL-- 221 (291)
T ss_pred --cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhCCc------CCCccC--
Confidence 223568999999999998889999999999999999999999997644321 1122222211 111122
Q ss_pred HHHHHHHHHhhhccCCCCCCCCC-----HHHHHHH
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPS-----MRQVVQY 603 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 603 (660)
...+.+++..|++.||.+||+ +++++++
T Consensus 222 --~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 222 --DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred --CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 234678888999999999995 8887754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=346.03 Aligned_cols=257 Identities=25% Similarity=0.332 Sum_probs=204.2
Q ss_pred eeeecccccccCccEEEEEEEe-----CCCCeEEEEEEeccCC-ChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCee
Q 006112 336 FSYKNLYKATKGGSGKVYRGVL-----PSSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGEL 408 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~-----~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 408 (660)
.+|+..+.||+|+||.||+|++ ..++..||||++.... ....+.+.+|+.++..+ +||||++++++|...+..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 3688889999999999999974 3456789999986443 33456789999999999 899999999999999999
Q ss_pred EEEEecCCCCChhhhhhhCC------------------------------------------------------------
Q 006112 409 LLVYDYMPNGSLDKILYSNT------------------------------------------------------------ 428 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~------------------------------------------------------------ 428 (660)
++|||||++|+|.+++....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 99999999999999986422
Q ss_pred -------------CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce
Q 006112 429 -------------RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495 (660)
Q Consensus 429 -------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 495 (660)
...++|..+.+++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 1247889999999999999999998 899999999999999999999999999998664432211
Q ss_pred -eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 496 -TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 496 -~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
.....++..|+|||.+.+..++.++|||||||++|||++ |..||....... ...+....+.... .+ .
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~~~~~~~~--~~---~---- 340 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMIKEGYRML--SP---E---- 340 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHHHhCccCC--CC---C----
Confidence 122345678999999999999999999999999999998 888886533211 1122222221111 11 1
Q ss_pred HHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
.....+.+++.+||+.||++||++.||++.|+.
T Consensus 341 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 341 CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 112457788899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=344.80 Aligned_cols=252 Identities=23% Similarity=0.290 Sum_probs=205.0
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
+|+.++.||+|+||.||+|+...+++.||||++... .....+.+.+|++++..++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 478889999999999999999989999999998653 22456678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC-
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN- 492 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~- 492 (660)
|+++++|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 82 YMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 99999999999765 358899999999999999999998 999999999999999999999999999998654432
Q ss_pred ---------------------------CceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcc
Q 006112 493 ---------------------------DLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELD 545 (660)
Q Consensus 493 ---------------------------~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~ 545 (660)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 11223457999999999999999999999999999999999999999865422
Q ss_pred hHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCC-HHHHHHH
Q 006112 546 LLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPS-MRQVVQY 603 (660)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~ 603 (660)
.. ........... ..|.. .. ....+.+++..|+. ||.+||+ ++|++++
T Consensus 237 ~~--~~~i~~~~~~~--~~p~~-~~----~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 ET--YNKIINWKESL--RFPPD-PP----VSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HH--HHHHhccCCcc--cCCCC-CC----CCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 11 11111100000 01110 11 23446677778997 9999999 9999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=331.12 Aligned_cols=260 Identities=28% Similarity=0.414 Sum_probs=202.4
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhc--cCCCCceeEeeeeeecC----eeEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGK--LRHRNLVQLRGYCRRKG----ELLL 410 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~H~nIv~l~g~~~~~~----~~~l 410 (660)
..+.++.+|+|+||.||||.+ .++.||||++.. +..+.|.+|-.|.+. ++|+||++++++-+... +.+|
T Consensus 211 pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred chhhHHHhhcCccceeehhhc--cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 456677899999999999999 458999999843 445678888777654 58999999999876655 8999
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhc------ccCceeccCccCCcEEEcCCCCeEEeeccc
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEE------WEQVVLHRDIKPANVLLDADLEGKLGDFGL 484 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~ivHrDikp~NIll~~~~~~kl~DFGl 484 (660)
|+||.++|||.+||..+. ++|....+|+.-+++||+|||++ ++++|+|||||++||||..++.+.|+||||
T Consensus 286 Vt~fh~kGsL~dyL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred EeeeccCCcHHHHHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 999999999999998754 99999999999999999999986 367899999999999999999999999999
Q ss_pred ceeccCCCCce-eeccccCccccCcccccCCC------CCcceeEEehHHHHHHHhhCCCCCCC--------------CC
Q 006112 485 ARLYDHGNDLH-TTNVVGTVGYLAPELLRNGR------GTTSTDVYAFGVFMLEVACGRRPVQP--------------GE 543 (660)
Q Consensus 485 a~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~------~t~ksDV~S~Gvvl~elltG~~p~~~--------------~~ 543 (660)
|..+..+.... ....+||.+|||||++.+.- .-.+.||||+|.|||||++....+++ +.
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 99887665432 34579999999999987532 22479999999999999986654431 11
Q ss_pred cchHHHHHHHHhcCCcccCCCCcccccC-cHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCCC
Q 006112 544 LDLLDWVIDYWQKGDVLDASDPRLEGIY-VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGA 608 (660)
Q Consensus 544 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (660)
....+.++......+ ..|.+.... ....+..+.+.+..||..||+.|.|+.=|.+.+....
T Consensus 443 hPt~e~mq~~VV~kK----~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKK----QRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred CCCHHHHHHHHHhhc----cCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 122233333222211 122222111 1245678899999999999999999998888776544
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=334.58 Aligned_cols=260 Identities=27% Similarity=0.349 Sum_probs=198.3
Q ss_pred eeecccccccCccEEEEEEEeCC-CCeEEEEEEeccCC--ChhhHHHHHHHHHHhcc---CCCCceeEeeeee-----ec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPS-SHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKL---RHRNLVQLRGYCR-----RK 405 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l---~H~nIv~l~g~~~-----~~ 405 (660)
+|+.++.||+|+||.||+|+... ++..||+|++.... ......+.+|+.+++.+ +||||++++++|. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 57888999999999999999854 56889999986432 22234566777777665 6999999999985 24
Q ss_pred CeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccc
Q 006112 406 GELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLA 485 (660)
Q Consensus 406 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla 485 (660)
..+++||||++ ++|.+++.......+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccce
Confidence 56899999995 799999976655568999999999999999999998 99999999999999999999999999999
Q ss_pred eeccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHHHHHHhcCCcc----
Q 006112 486 RLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVIDYWQKGDVL---- 560 (660)
Q Consensus 486 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~~~~~~~~---- 560 (660)
+..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... +....+..........
T Consensus 158 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (290)
T cd07862 158 RIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 235 (290)
T ss_pred EeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence 876433 223345789999999999888899999999999999999999999976432 2222222211100000
Q ss_pred ------cCCCCcc---cccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 561 ------DASDPRL---EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 561 ------~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
....+.. .....+.....+.+++.+|++.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000000 00011122345678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=344.28 Aligned_cols=255 Identities=23% Similarity=0.315 Sum_probs=200.8
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
.|+.++.||+|+||+||+|+...+++.||+|++... .....+.+.+|++++++++||||+++++++.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 477889999999999999999999999999999653 23445678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
||++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 999999999997654 48888999999999999999998 9999999999999999999999999999864311000
Q ss_pred ----------------------------------------------ceeeccccCccccCcccccCCCCCcceeEEehHH
Q 006112 494 ----------------------------------------------LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGV 527 (660)
Q Consensus 494 ----------------------------------------------~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gv 527 (660)
.......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 0012357999999999999888999999999999
Q ss_pred HHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 528 FMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 528 vl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
++|||++|+.||.......... .......... .| ....++.+..+.+.++ .|+..+|..||+++|++++
T Consensus 237 il~elltG~~Pf~~~~~~~~~~--~i~~~~~~~~--~~-~~~~~s~~~~dli~~l--l~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQL--KVINWENTLH--IP-PQVKLSPEAVDLITKL--CCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHH--HHHccccccC--CC-CCCCCCHHHHHHHHHH--ccCcccccCCCCHHHHhcC
Confidence 9999999999997644322111 1111111111 01 0112344444444443 3677888889999999974
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=340.29 Aligned_cols=243 Identities=23% Similarity=0.263 Sum_probs=199.4
Q ss_pred cccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCCCC
Q 006112 342 YKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNG 418 (660)
Q Consensus 342 ~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g 418 (660)
+.||+|+||.||++....+++.||+|++... .......+.+|+.++++++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3589999999999999989999999999653 2345678899999999999999999999999999999999999999
Q ss_pred ChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCceeec
Q 006112 419 SLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTN 498 (660)
Q Consensus 419 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 498 (660)
+|..++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~ 154 (328)
T cd05593 81 ELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKT 154 (328)
T ss_pred CHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccccc
Confidence 9999886543 48999999999999999999998 899999999999999999999999999987532221 12234
Q ss_pred cccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHHH
Q 006112 499 VVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEI 578 (660)
Q Consensus 499 ~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 578 (660)
..||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+....+ +..+...+ ...
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~---~~~~~~~~------~~~~p~~~----~~~ 221 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFELILME------DIKFPRTL----SAD 221 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH---HHHHhccC------CccCCCCC----CHH
Confidence 579999999999998899999999999999999999999997543221 11111111 11122222 234
Q ss_pred HHHHhhhccCCCCCCCC-----CHHHHHHH
Q 006112 579 VLKLGLFCSHSNPDTRP-----SMRQVVQY 603 (660)
Q Consensus 579 l~~l~~~Cl~~dP~~RP-----s~~evl~~ 603 (660)
+.+++..|++.||++|| ++.|++++
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 222 AKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 66788889999999997 89999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=341.19 Aligned_cols=253 Identities=22% Similarity=0.234 Sum_probs=203.8
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
+|+..+.+|+|+||.||+++...+++.||+|++.... ....+.+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 4778899999999999999999999999999986532 2345678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
|+++|+|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 82 YQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999999997653 358999999999999999999998 9999999999999999999999999999987655443
Q ss_pred ceeeccccCccccCccccc------CCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcc
Q 006112 494 LHTTNVVGTVGYLAPELLR------NGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL 567 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~------~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 567 (660)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||...... ................+.
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~-- 233 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA--KTYNNIMNFQRFLKFPED-- 233 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH--HHHHHHHcCCCccCCCCC--
Confidence 3344467999999999986 456788999999999999999999999764322 111221111111111110
Q ss_pred cccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 568 EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
......+.+++..|++ +|++||++++++++
T Consensus 234 -----~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 234 -----PKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred -----CCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 1122345667777887 99999999999863
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=331.90 Aligned_cols=252 Identities=26% Similarity=0.339 Sum_probs=206.0
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
+|+.++.+|+|+||.||++....+++.||+|++.... ......+.+|+.++++++||||+++++++..++.+++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999998889999999986432 2234567899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
|+++|+|..++.......+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||+++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 9999999998876554568999999999999999999998 8999999999999999999999999999987543322
Q ss_pred ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchH-HHHHHHHhcCCcccCCCCcccccCc
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLL-DWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
.....|++.|+|||.+.+..++.++||||+||++|||++|+.||........ +.+......+. ..+.
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~----------~~~~ 225 (285)
T cd05605 158 --IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ----------EEYS 225 (285)
T ss_pred --cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc----------cccC
Confidence 2235789999999999988899999999999999999999999986433211 11221111110 1112
Q ss_pred HHHHHHHHHHhhhccCCCCCCCC-----CHHHHHHH
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRP-----SMRQVVQY 603 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 603 (660)
......+.+++..||+.||++|| ++++++++
T Consensus 226 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 226 EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 22344577888999999999999 88888754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=340.79 Aligned_cols=243 Identities=25% Similarity=0.271 Sum_probs=198.8
Q ss_pred cccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCCCC
Q 006112 342 YKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNG 418 (660)
Q Consensus 342 ~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g 418 (660)
+.+|+|+||.||+++...++..||+|++... .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3589999999999999889999999998653 2344567889999999999999999999999999999999999999
Q ss_pred ChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCceeec
Q 006112 419 SLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTN 498 (660)
Q Consensus 419 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 498 (660)
+|..++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 154 (323)
T cd05595 81 ELFFHLSRER--VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKT 154 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccccc
Confidence 9999886543 48899999999999999999998 899999999999999999999999999987532221 12234
Q ss_pred cccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHHH
Q 006112 499 VVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEI 578 (660)
Q Consensus 499 ~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 578 (660)
..||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......+. ..+...+ ...
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~---~~~~~~~~------~~~p~~~----~~~ 221 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---FELILMEE------IRFPRTL----SPE 221 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH---HHHHhcCC------CCCCCCC----CHH
Confidence 5799999999999988999999999999999999999999976443211 11111111 1112222 234
Q ss_pred HHHHhhhccCCCCCCCC-----CHHHHHHH
Q 006112 579 VLKLGLFCSHSNPDTRP-----SMRQVVQY 603 (660)
Q Consensus 579 l~~l~~~Cl~~dP~~RP-----s~~evl~~ 603 (660)
+.+++..||+.||++|| ++.+++++
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 222 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred HHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 66788889999999998 89998763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=349.56 Aligned_cols=257 Identities=25% Similarity=0.361 Sum_probs=203.3
Q ss_pred eeeecccccccCccEEEEEEEeCC-----CCeEEEEEEeccCC-ChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCee
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPS-----SHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGEL 408 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~-----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 408 (660)
.+|+..+.||+|+||.||++++.. ++..||+|++.... ....+.+.+|+.+++.+ +|+||++++++|...+..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 368888999999999999998643 33579999996543 33456789999999999 899999999999999999
Q ss_pred EEEEecCCCCChhhhhhhCC------------------------------------------------------------
Q 006112 409 LLVYDYMPNGSLDKILYSNT------------------------------------------------------------ 428 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~------------------------------------------------------------ 428 (660)
++|||||++|+|.+++....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 99999999999999985421
Q ss_pred --------CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce-eecc
Q 006112 429 --------RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH-TTNV 499 (660)
Q Consensus 429 --------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~-~~~~ 499 (660)
...+++.++.+++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++......... ....
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 1247888999999999999999998 999999999999999999999999999998654432211 1223
Q ss_pred ccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHHH
Q 006112 500 VGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEI 578 (660)
Q Consensus 500 ~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 578 (660)
.++..|||||++.+..++.++|||||||++|||++ |+.||....... ........+.. ...+ .. ....
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~~~~~~~~--~~~~---~~----~~~~ 343 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYKMVKRGYQ--MSRP---DF----APPE 343 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHHHHHcccC--ccCC---CC----CCHH
Confidence 45678999999988899999999999999999997 999997533211 11111122111 1111 11 1245
Q ss_pred HHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 579 VLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 579 l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
+.+++..||+.||++||++.+|++.|+.
T Consensus 344 l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 344 IYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 7788889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=343.48 Aligned_cols=250 Identities=25% Similarity=0.325 Sum_probs=209.6
Q ss_pred eecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
|+..+.||.|+-|.|-.|++..+|+..|||.+... .......+.+||-+|+-+.|||++++++.+.+..++|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 66678899999999999999999999999999654 223456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
+++|.|.+++...+ .+++.++.+++.||..|+.|+|. .+|+||||||+|+|||.++++||+|||||.+...+.
T Consensus 94 v~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk-- 166 (786)
T KOG0588|consen 94 VPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK-- 166 (786)
T ss_pred cCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCCc--
Confidence 99999999997755 48999999999999999999998 999999999999999999999999999998754443
Q ss_pred eeeccccCccccCcccccCCCC-CcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 495 HTTNVVGTVGYLAPELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
...+.+|.+.|.|||++.+.+| ..++||||.|||||.|++|+.||++++. +......+.|.... .....
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi---r~LLlKV~~G~f~M------Ps~Is- 236 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI---RVLLLKVQRGVFEM------PSNIS- 236 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH---HHHHHHHHcCcccC------CCcCC-
Confidence 3345799999999999999887 5699999999999999999999996543 33344444554321 11222
Q ss_pred HHHHHHHHHhhhccCCCCCCCCCHHHHHHH--hhCC
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQY--LDGG 607 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~ 607 (660)
.....|+..|+..||+.|.|++||+++ |.+-
T Consensus 237 ---~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~ 269 (786)
T KOG0588|consen 237 ---SEAQDLLRRMLDVDPSTRITTEEILKHPFLSGY 269 (786)
T ss_pred ---HHHHHHHHHHhccCccccccHHHHhhCchhhcC
Confidence 234566667899999999999999984 4443
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=354.70 Aligned_cols=256 Identities=21% Similarity=0.292 Sum_probs=208.7
Q ss_pred CCCceeeecccccccCccEEEEEEEeCCC-CeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEE
Q 006112 332 SPHRFSYKNLYKATKGGSGKVYRGVLPSS-HAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLL 410 (660)
Q Consensus 332 ~~~~~~~~~l~~lg~G~fg~Vy~g~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 410 (660)
.|....|...+.+|+|+||.||++....+ +..||+|.+..........+.+|+.+++.++||||++++++|..++..+|
T Consensus 63 ~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 63 NPREHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred CCcceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 34455699999999999999999998776 78899998766555556678899999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhhC--CCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceec
Q 006112 411 VYDYMPNGSLDKILYSN--TRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLY 488 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 488 (660)
||||+++|+|.+++... ....+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 99999999999988643 23458888999999999999999998 89999999999999999999999999999876
Q ss_pred cCCCC-ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcc
Q 006112 489 DHGND-LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL 567 (660)
Q Consensus 489 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 567 (660)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+......+... + .
T Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~---~~~~~~~~~~~~----~-~ 291 (478)
T PTZ00267 220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR---EIMQQVLYGKYD----P-F 291 (478)
T ss_pred CCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCC----C-C
Confidence 54322 1234467999999999999989999999999999999999999999754321 112222222211 1 1
Q ss_pred cccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 568 EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
... ....+.+++..||+.||++||+++++++
T Consensus 292 ~~~----~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 PCP----VSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred Ccc----CCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 111 2235778888999999999999999874
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=312.78 Aligned_cols=237 Identities=24% Similarity=0.333 Sum_probs=198.8
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC---hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD---HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
-+|+.++.+|.|+||+|.+.+.+.+|..+|+|++....- ...+...+|..+|+.+.||+++++.+.|.+.+.++|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 367789999999999999999999999999999965432 34556788999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
||.+||.|..+|++.++ +++..+.-++.||+.||+|||+ .+|++|||||+|||||.+|.+||+|||+|+.....
T Consensus 124 eyv~GGElFS~Lrk~~r--F~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGR--FSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred eccCCccHHHHHHhcCC--CCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 99999999999987664 8999999999999999999998 99999999999999999999999999999876432
Q ss_pred CceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCc
Q 006112 493 DLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 493 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
+-+.+|||.|+|||++....+..++|.|||||++|||+.|..||..... ..+.+.+-++++ .++..++
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~---~~iY~KI~~~~v------~fP~~fs 265 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP---IQIYEKILEGKV------KFPSYFS 265 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh---HHHHHHHHhCcc------cCCcccC
Confidence 4568999999999999999999999999999999999999999987554 222333333332 2233344
Q ss_pred HHHHHHHHHHhhhccCCCCCCC
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTR 594 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~R 594 (660)
.+..+.+ ...++.|-.+|
T Consensus 266 ~~~kdLl----~~LL~vD~t~R 283 (355)
T KOG0616|consen 266 SDAKDLL----KKLLQVDLTKR 283 (355)
T ss_pred HHHHHHH----HHHHhhhhHhh
Confidence 4433333 33466777777
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=336.28 Aligned_cols=252 Identities=21% Similarity=0.271 Sum_probs=201.3
Q ss_pred eeecccccccCccEEEEEEEeC---CCCeEEEEEEeccC----CChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCee
Q 006112 337 SYKNLYKATKGGSGKVYRGVLP---SSHAEIAVKKVCHD----SDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGEL 408 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~---~~~~~vavK~~~~~----~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 408 (660)
+|+.++.||+|+||.||+++.. .+++.||+|.+... .....+.+..|++++.++ +|+||+++++++..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 3778899999999999998864 46789999998643 223356788999999999 599999999999999999
Q ss_pred EEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceec
Q 006112 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLY 488 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 488 (660)
++||||+++|+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.+
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 99999999999999997643 48899999999999999999998 89999999999999999999999999999865
Q ss_pred cCCCCceeeccccCccccCcccccCC-CCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHHHHHHhcCCcccCCCCc
Q 006112 489 DHGNDLHTTNVVGTVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVIDYWQKGDVLDASDPR 566 (660)
Q Consensus 489 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~~~~~~~~~~~d~~ 566 (660)
............||+.|+|||++.+. .++.++|||||||++|||++|+.||..... .....+...... .++.
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~------~~~~ 229 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK------CDPP 229 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc------CCCC
Confidence 44433334456799999999998765 478899999999999999999999974321 122222222111 1222
Q ss_pred ccccCcHHHHHHHHHHhhhccCCCCCCCC-----CHHHHHHH
Q 006112 567 LEGIYVEEQMEIVLKLGLFCSHSNPDTRP-----SMRQVVQY 603 (660)
Q Consensus 567 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 603 (660)
+.... ...+.+++..|++.||++|| ++++++++
T Consensus 230 ~~~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 230 FPSFI----GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCCCC----CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 22222 23466788889999999999 77788764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=330.34 Aligned_cols=254 Identities=27% Similarity=0.393 Sum_probs=211.1
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
.+|+.++.+|+|+||.||+|.+.. +..+|+|.+.........++.+|+.++++++|+||+++++++......++||||+
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 367888999999999999999976 8889999997766656778999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 495 (660)
++++|.+++.......+++.++.+++.|++.||+|||+ ++++||||||+||++++++.+||+|||++........ .
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~-~ 160 (261)
T cd05148 85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY-L 160 (261)
T ss_pred ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCccc-c
Confidence 99999999987655668999999999999999999998 8999999999999999999999999999976543221 1
Q ss_pred eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHH
Q 006112 496 TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEE 574 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 574 (660)
.....++..|++||.+....++.++||||||+++|+|++ |+.||...... ........+... . ....
T Consensus 161 ~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~~~~~~~~~~-----~----~~~~ 228 (261)
T cd05148 161 SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVYDQITAGYRM-----P----CPAK 228 (261)
T ss_pred ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHHHHhCCcC-----C----CCCC
Confidence 223456778999999988889999999999999999998 89998754321 111111121111 0 1122
Q ss_pred HHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 575 QMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 575 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
....+.+++.+||+.||.+|||++++++.|+.
T Consensus 229 ~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 229 CPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 33557889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=343.79 Aligned_cols=257 Identities=19% Similarity=0.214 Sum_probs=200.3
Q ss_pred CceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 334 HRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 334 ~~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
.+..|+.++.||+|+||.||++.+..+++.||+|... .+.+.+|++++++++||||+++++++..+...++|+|
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 3457999999999999999999999999999999753 2357899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
++ +++|..++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 164 ~~-~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 164 RY-KTDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred cC-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 99 578988886543 48899999999999999999998 8999999999999999999999999999975433222
Q ss_pred ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCc--------chHHHHHHHHhcCCc------
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGEL--------DLLDWVIDYWQKGDV------ 559 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~--------~~~~~~~~~~~~~~~------ 559 (660)
.......||+.|+|||++....++.++|||||||++|||++|+.|+..... .....+.........
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 233346799999999999988999999999999999999999988754210 111111111100000
Q ss_pred -------------ccCCCCcccc--cCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 560 -------------LDASDPRLEG--IYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 560 -------------~~~~d~~l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
.....+.... .........+.+++.+|++.||++|||++|+++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000 001123446788999999999999999999996
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=342.54 Aligned_cols=248 Identities=23% Similarity=0.384 Sum_probs=196.8
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD-HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
+|+.++.||+|+||.||+|++..+++.||||.+..... ...+.+.+|++++++++|+||+++++++..++.+++|||||
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 56677899999999999999988899999999865433 34567899999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 495 (660)
++|+|.... ..++..+..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++....... .
T Consensus 155 ~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~ 224 (353)
T PLN00034 155 DGGSLEGTH------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-P 224 (353)
T ss_pred CCCcccccc------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-c
Confidence 999996532 24567788999999999999998 8999999999999999999999999999987643322 2
Q ss_pred eeccccCccccCcccccC-----CCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCccccc
Q 006112 496 TTNVVGTVGYLAPELLRN-----GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGI 570 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~~~-----~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 570 (660)
.....||..|+|||++.. ...+.++|||||||++|||++|+.||.................... +...
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-----~~~~-- 297 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP-----PEAP-- 297 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCC-----CCCC--
Confidence 234579999999998753 2335689999999999999999999974332221111111111111 1111
Q ss_pred CcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 571 YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
......+.+++.+||+.||++||++.|++++
T Consensus 298 --~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 298 --ATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred --CccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1223457788889999999999999999974
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=324.64 Aligned_cols=250 Identities=25% Similarity=0.404 Sum_probs=202.1
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 416 (660)
+|+.++.+|+|+||.||++.+. .+..+|+|.+... ....+++.+|+.++++++||||++++++|..++..++||||++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HcEEeeEecCCcCceEEEEEec-cCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4666788999999999999985 4567999987543 2335688999999999999999999999999999999999999
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCcee
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT 496 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 496 (660)
+|+|.+++.... ..++|..+..++.|++.||.|||+ ++|+||||||+||++++++.+||+|||+++..........
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 83 NGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 999999987543 358999999999999999999998 8999999999999999999999999999986543322222
Q ss_pred eccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCc-chHHHHHHHHhcCCcccCCCCcccccCcHH
Q 006112 497 TNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGEL-DLLDWVIDYWQKGDVLDASDPRLEGIYVEE 574 (660)
Q Consensus 497 ~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 574 (660)
....++..|+|||.+....++.++||||||+++|||++ |+.||..... +.... ...+... ..+. .
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~----i~~~~~~--~~~~-------~ 225 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEM----ISRGFRL--YRPK-------L 225 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----HHCCCCC--CCCC-------C
Confidence 23345678999999988889999999999999999999 8999875432 22222 2222211 1111 1
Q ss_pred HHHHHHHHhhhccCCCCCCCCCHHHHHHHhh
Q 006112 575 QMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605 (660)
Q Consensus 575 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (660)
....+.+++.+||+.+|++||++.++++.|.
T Consensus 226 ~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 226 ASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1245788999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=341.53 Aligned_cols=262 Identities=28% Similarity=0.421 Sum_probs=222.1
Q ss_pred hhhhhccCCCceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeee
Q 006112 325 EDWEKEYSPHRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR 404 (660)
Q Consensus 325 ~~~~~~~~~~~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~ 404 (660)
++|+.+ |-....-.+||-|.||.||.|.|+.-...||||.++.+. -..++|+.|..+|+.++|||+|+|+|+|..
T Consensus 260 DkWEme----RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~ 334 (1157)
T KOG4278|consen 260 DKWEME----RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTH 334 (1157)
T ss_pred chhhcc----chheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhcc
Confidence 566654 334455568999999999999999988999999986554 357899999999999999999999999999
Q ss_pred cCeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeeccc
Q 006112 405 KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGL 484 (660)
Q Consensus 405 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGl 484 (660)
+..+|||.|||..|+|.+||....+..++--..+.++.||++||+||.. +.+|||||..+|+|+.++-.+|++||||
T Consensus 335 EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGL 411 (1157)
T KOG4278|consen 335 EPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGL 411 (1157)
T ss_pred CCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccch
Confidence 9999999999999999999998887778888889999999999999998 9999999999999999999999999999
Q ss_pred ceeccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCC
Q 006112 485 ARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDAS 563 (660)
Q Consensus 485 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (660)
+|++..+.........-.+.|.|||-+....++.|+|||+|||+||||.| |..||.+-+ ...+..+.++|-.++.
T Consensus 412 sRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid---lSqVY~LLEkgyRM~~- 487 (1157)
T KOG4278|consen 412 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID---LSQVYGLLEKGYRMDG- 487 (1157)
T ss_pred hhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc---HHHHHHHHhccccccC-
Confidence 99986543322222334678999999999999999999999999999998 888887643 2345666666654432
Q ss_pred CCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 564 DPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 564 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
.+.++..+.+||+.||+.+|.+||+++|+-+.|+.
T Consensus 488 --------PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 488 --------PEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred --------CCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 34566779999999999999999999999887764
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=339.90 Aligned_cols=246 Identities=22% Similarity=0.293 Sum_probs=202.4
Q ss_pred eeeecccccccCccEEEEEEEeCCCC-eEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSH-AEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~-~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 411 (660)
-.|+.++.+|+|+||.||+|.+...+ ..||+|++... .....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 36888899999999999999876554 68999998543 233456788999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCC
Q 006112 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 491 (660)
|||+++|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 110 ~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 99999999999997654 48899999999999999999998 99999999999999999999999999999865432
Q ss_pred CCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccC
Q 006112 492 NDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIY 571 (660)
Q Consensus 492 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 571 (660)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......+.. .+....
T Consensus 185 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~---~~~~i~~~~~------~~p~~~ 251 (340)
T PTZ00426 185 ----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL---IYQKILEGII------YFPKFL 251 (340)
T ss_pred ----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH---HHHHHhcCCC------CCCCCC
Confidence 234579999999999998889999999999999999999999998644321 1222222211 111222
Q ss_pred cHHHHHHHHHHhhhccCCCCCCCC-----CHHHHHHH
Q 006112 572 VEEQMEIVLKLGLFCSHSNPDTRP-----SMRQVVQY 603 (660)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 603 (660)
+ ..+.+++..|++.||.+|+ ++++++++
T Consensus 252 ~----~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 252 D----NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred C----HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 2 3356788889999999995 89998864
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=341.40 Aligned_cols=255 Identities=21% Similarity=0.268 Sum_probs=198.4
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
.|+.++.||+|+||+||+++...+++.||+|++.... ......+.+|+.++.+++|+||+++++.+.+...+++|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 4778899999999999999999899999999986532 2345678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
||++|+|.+++.... .+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 82 FLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 999999999997643 48999999999999999999998 9999999999999999999999999999975432110
Q ss_pred ----------------------------------ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCC
Q 006112 494 ----------------------------------LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPV 539 (660)
Q Consensus 494 ----------------------------------~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~ 539 (660)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0012357999999999999989999999999999999999999999
Q ss_pred CCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 540 QPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 540 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
........ ......... ....|. ......+..+.+.++ .|...++..||+++||+++
T Consensus 237 ~~~~~~~~---~~~i~~~~~-~~~~p~-~~~~s~~~~~li~~l--~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 237 CSETPQET---YKKVMNWKE-TLIFPP-EVPISEKAKDLILRF--CCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCHHHH---HHHHHcCcC-cccCCC-cCCCCHHHHHHHHHH--cCChhhcCCCCCHHHHhCC
Confidence 76443211 111111110 011111 012334444444443 2444455578999999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=336.15 Aligned_cols=246 Identities=24% Similarity=0.310 Sum_probs=197.4
Q ss_pred eecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHH---hccCCCCceeEeeeeeecCeeEEE
Q 006112 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSM---GKLRHRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l---~~l~H~nIv~l~g~~~~~~~~~lV 411 (660)
|+.++.||+|+||.||++.+..+++.||||++... .....+.+.+|+.++ ++++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 56788999999999999999989999999999643 223345666676554 567899999999999999999999
Q ss_pred EecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCC
Q 006112 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 491 (660)
|||+++|+|..++.. ..+++.++..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 999999999988854 348999999999999999999998 99999999999999999999999999998753222
Q ss_pred CCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccC
Q 006112 492 NDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIY 571 (660)
Q Consensus 492 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 571 (660)
. .......|++.|+|||.+.+..++.++|||||||++|||++|+.||........ ......+.. ......
T Consensus 155 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~---~~~i~~~~~------~~p~~~ 224 (324)
T cd05589 155 G-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV---FDSIVNDEV------RYPRFL 224 (324)
T ss_pred C-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhCCC------CCCCCC
Confidence 1 223346799999999999998999999999999999999999999976443211 111122111 111222
Q ss_pred cHHHHHHHHHHhhhccCCCCCCCC-----CHHHHHHH
Q 006112 572 VEEQMEIVLKLGLFCSHSNPDTRP-----SMRQVVQY 603 (660)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 603 (660)
...+.+++.+||+.||.+|| ++.+++++
T Consensus 225 ----~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 225 ----SREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred ----CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 34467788899999999999 57777653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=323.58 Aligned_cols=253 Identities=28% Similarity=0.395 Sum_probs=206.1
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 416 (660)
+|+..+.+|+|++|.||+|.+. +++.||+|.+.... ...+++.+|++++++++|+||+++++++...+..++||||++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 7 SIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred heeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 5777899999999999999975 45789999986543 345679999999999999999999999999999999999999
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCcee
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT 496 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 496 (660)
+++|.+++.......+++.++.+++.|++.||.|||+ ++++||||||+||++++++.+||+|||+++..........
T Consensus 85 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05068 85 YGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAR 161 (261)
T ss_pred CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccccc
Confidence 9999999976554568999999999999999999998 8999999999999999999999999999987653322222
Q ss_pred eccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHH
Q 006112 497 TNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQ 575 (660)
Q Consensus 497 ~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 575 (660)
.....+..|+|||++.+..++.++||||||+++|||++ |+.||....... .......+... + .....
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~~~~~----~-----~~~~~ 229 (261)
T cd05068 162 EGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VLQQVDQGYRM----P-----CPPGC 229 (261)
T ss_pred CCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHcCCCC----C-----CCCcC
Confidence 22233468999999998899999999999999999999 999987533221 12222221111 0 11123
Q ss_pred HHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 576 MEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 576 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
...+.+++.+|++.+|++||++.++++.|+.
T Consensus 230 ~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 230 PKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 3567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=338.88 Aligned_cols=261 Identities=24% Similarity=0.344 Sum_probs=198.2
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeec-----CeeE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK-----GELL 409 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~~ 409 (660)
.|+..+.+|+|+||.||+|+...++..||||++... ......++.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 377889999999999999999989999999998643 223456789999999999999999999987543 2489
Q ss_pred EEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceecc
Q 006112 410 LVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYD 489 (660)
Q Consensus 410 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 489 (660)
+||||| +++|.+++.... .+++..+..++.||++||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELM-ESDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecC-CCCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 999999 578999886543 48999999999999999999998 899999999999999999999999999998643
Q ss_pred CCCC--ceeeccccCccccCcccccC--CCCCcceeEEehHHHHHHHhhCCCCCCCCCcc-hHHHHHHHHhc--------
Q 006112 490 HGND--LHTTNVVGTVGYLAPELLRN--GRGTTSTDVYAFGVFMLEVACGRRPVQPGELD-LLDWVIDYWQK-------- 556 (660)
Q Consensus 490 ~~~~--~~~~~~~gt~~Y~aPE~~~~--~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~~~~~-------- 556 (660)
.... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+.+......
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 2221 12234579999999999865 67899999999999999999999999754321 11111111000
Q ss_pred ---CC---cccCCCCcccccC---cHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 557 ---GD---VLDASDPRLEGIY---VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 557 ---~~---~~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.. ............+ .+.....+.+++..||+.||++||+++|++++
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00 0000000000000 01122346788999999999999999999963
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=329.37 Aligned_cols=261 Identities=23% Similarity=0.292 Sum_probs=201.4
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
.|+.++.+|+|+||.||+|+...++..||+|++.... ......+.+|+.++++++||||+++++++..++..++||||+
T Consensus 6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (288)
T cd07871 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL 85 (288)
T ss_pred cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCC
Confidence 5888999999999999999999899999999986543 233457889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 495 (660)
+ |+|.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 86 ~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-~ 159 (288)
T cd07871 86 D-SDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-T 159 (288)
T ss_pred C-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-c
Confidence 6 59999886543 347888999999999999999998 9999999999999999999999999999976543221 2
Q ss_pred eeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCcc-hHHHHHHHHhcCC------------ccc
Q 006112 496 TTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGELD-LLDWVIDYWQKGD------------VLD 561 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~~------------~~~ 561 (660)
.....|++.|+|||.+.+ ..++.++||||+||++|||++|+.||...... ....+........ ...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 234568999999998865 56889999999999999999999999764322 1222221111100 000
Q ss_pred CCCCcccccC----cHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 562 ASDPRLEGIY----VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 562 ~~d~~l~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
...+...... .........+++..|++.||.+|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0011110000 00112346788889999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=334.47 Aligned_cols=251 Identities=26% Similarity=0.423 Sum_probs=212.4
Q ss_pred CceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccC-CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEE
Q 006112 334 HRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD-SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 334 ~~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
....|..+..+|+|.||.||||.+..+++.||+|.+..+ .....+++.+|+.++.+++++||.+++|.+..+..++++|
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 344678889999999999999999999999999999765 4456788999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
|||.||++.+.|.... .+++..+.-|++++..||.|||. .+.+|||||+.|||+..+|.+||+|||.+-.+....
T Consensus 91 ey~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HHhcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 9999999999997543 35788888899999999999998 899999999999999999999999999998765544
Q ss_pred CceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCc
Q 006112 493 DLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 493 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
... ...+||+-|||||++....|+.|+||||||++.+||++|.+|+......-+ . --+....-|.+.+.+.
T Consensus 166 ~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv---l-----flIpk~~PP~L~~~~S 236 (467)
T KOG0201|consen 166 KRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV---L-----FLIPKSAPPRLDGDFS 236 (467)
T ss_pred hcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE---E-----EeccCCCCCccccccC
Confidence 333 668999999999999988999999999999999999999999875322100 0 0112234455666444
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
+ .+.+++..|++.||+.||++.++++
T Consensus 237 ~----~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 237 P----PFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred H----HHHHHHHHHhhcCcccCcCHHHHhh
Confidence 3 4667778899999999999999985
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=334.32 Aligned_cols=237 Identities=25% Similarity=0.286 Sum_probs=189.7
Q ss_pred ccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHH-HHhccCCCCceeEeeeeeecCeeEEEEecCCCC
Q 006112 343 KATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIV-SMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNG 418 (660)
Q Consensus 343 ~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g 418 (660)
.||+|+||.||+++...+++.||+|.+.... ....+.+..|.. +++.++||||+++++++.+.+..++|||||++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 5899999999999999899999999986432 223445666654 678899999999999999999999999999999
Q ss_pred ChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCceeec
Q 006112 419 SLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTN 498 (660)
Q Consensus 419 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 498 (660)
+|..++.... .+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 82 ~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (321)
T cd05603 82 ELFFHLQRER--CFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTST 155 (321)
T ss_pred CHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccccc
Confidence 9998886543 47888899999999999999998 899999999999999999999999999987532221 22334
Q ss_pred cccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHHH
Q 006112 499 VVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEI 578 (660)
Q Consensus 499 ~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 578 (660)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.... .+....+.. .+. ......
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~------~~~----~~~~~~ 222 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM---YDNILHKPL------QLP----GGKTVA 222 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH---HHHHhcCCC------CCC----CCCCHH
Confidence 6799999999999988899999999999999999999999986543221 111111111 111 112335
Q ss_pred HHHHhhhccCCCCCCCCCHH
Q 006112 579 VLKLGLFCSHSNPDTRPSMR 598 (660)
Q Consensus 579 l~~l~~~Cl~~dP~~RPs~~ 598 (660)
+.+++.+|++.||.+||+..
T Consensus 223 ~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 223 ACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHHHHccCCHhhcCCCC
Confidence 67888899999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=341.97 Aligned_cols=252 Identities=21% Similarity=0.254 Sum_probs=199.5
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
+|+.++.||+|+||.||+++...+++.||||++... .....+.+.+|+.++..++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 578889999999999999999989999999999643 23345678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
||++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 82 ~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 82 YLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 999999999997644 48999999999999999999998 8999999999999999999999999999875432110
Q ss_pred c-------------------------------------eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCC
Q 006112 494 L-------------------------------------HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGR 536 (660)
Q Consensus 494 ~-------------------------------------~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~ 536 (660)
. .....+||+.|+|||++....++.++|||||||++|||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 0 011246999999999999889999999999999999999999
Q ss_pred CCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCC---HHHHHHH
Q 006112 537 RPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPS---MRQVVQY 603 (660)
Q Consensus 537 ~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~~ 603 (660)
.||....... .............. +. ...+++ .+.+++..|+. +|.+|++ ++|++++
T Consensus 237 ~Pf~~~~~~~--~~~~i~~~~~~~~~--~~-~~~~s~----~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 237 PPFCSDNPQE--TYRKIINWKETLQF--PD-EVPLSP----EAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCHHH--HHHHHHcCCCccCC--CC-CCCCCH----HHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9997644321 11111111111111 10 011222 34455566775 9999998 9998863
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=314.05 Aligned_cols=259 Identities=24% Similarity=0.302 Sum_probs=206.7
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCCh-h-hHHHHHHHHHHhccCCCCceeEeeeee--ecCeeEEEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDH-G-MKQFVSEIVSMGKLRHRNLVQLRGYCR--RKGELLLVY 412 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~-~-~~~~~~Ei~~l~~l~H~nIv~l~g~~~--~~~~~~lV~ 412 (660)
.|+.+.+|++|.||.||+|+++.+++.||+|+++.+... + --..++||.+|.+++|||||.+..+.. +.+.+||||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 578889999999999999999999999999999765422 2 235689999999999999999988764 346799999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
||| .-+|..++.... ..+...+...++.|+++||+|||. +.|+|||||++|+|++..|.+||+||||||.+....
T Consensus 157 e~~-EhDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 157 EYV-EHDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred HHH-HhhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 999 579999998765 458888999999999999999998 899999999999999999999999999999987653
Q ss_pred CceeeccccCccccCcccccCC-CCCcceeEEehHHHHHHHhhCCCCCCC-CCcchHHHHHHHHhcCCcccCCCCcc---
Q 006112 493 DLHTTNVVGTVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQP-GELDLLDWVIDYWQKGDVLDASDPRL--- 567 (660)
Q Consensus 493 ~~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~-~~~~~~~~~~~~~~~~~~~~~~d~~l--- 567 (660)
. ..+..+-|.+|.|||++.+. .|++..|+||+|||+.|++++++-|.+ ++.+.++.+.+... ...+.+.|.+
T Consensus 232 k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llG--tPte~iwpg~~~l 308 (419)
T KOG0663|consen 232 K-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLG--TPSEAIWPGYSEL 308 (419)
T ss_pred c-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhC--CCccccCCCcccc
Confidence 3 34556779999999998765 589999999999999999999987765 44455555554433 2223332221
Q ss_pred ----------------cccCcHH-HHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 568 ----------------EGIYVEE-QMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 568 ----------------~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
+..|... ..+.-++|+...+..||.+|.|+.|.+++
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 1111111 12445666777899999999999998863
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=322.37 Aligned_cols=258 Identities=25% Similarity=0.367 Sum_probs=210.6
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
+|+..+.+|+|+||.||+|+...+++.||||.+... .......+.+|++++++++||||+++++++...+..++|+|
T Consensus 3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08228 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence 577888999999999999999889999999987542 23345678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhC--CCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCC
Q 006112 414 YMPNGSLDKILYSN--TRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491 (660)
Q Consensus 414 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 491 (660)
|+++++|.+++... ....+++.++..++.|+++||.|||+ ++++||||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 99999999988542 23457888999999999999999998 99999999999999999999999999999876432
Q ss_pred CCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccC
Q 006112 492 NDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIY 571 (660)
Q Consensus 492 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 571 (660)
.. ......|++.|+|||.+.+..++.++|+||||+++|||++|+.||........+.... ..... .+.. .
T Consensus 160 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~-~~~~~-----~~~~---~ 229 (267)
T cd08228 160 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQK-IEQCD-----YPPL---P 229 (267)
T ss_pred hH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHH-HhcCC-----CCCC---C
Confidence 21 1223568899999999988888999999999999999999999997654433332222 11111 1111 1
Q ss_pred cHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 572 VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
.......+.+++.+||+.+|++||++.+|++.|+..
T Consensus 230 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 230 TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 123345678889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=331.21 Aligned_cols=261 Identities=24% Similarity=0.278 Sum_probs=199.5
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD-HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
-+|+.++.+|+|+||.||+|+...+++.||||++..... .....+.+|+.++++++||||+++++++..+...++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 368889999999999999999988899999999865432 2345678999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
++ ++|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 85 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 158 (303)
T cd07869 85 VH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-H 158 (303)
T ss_pred CC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-c
Confidence 94 78888776543 358888999999999999999998 999999999999999999999999999997543322 1
Q ss_pred eeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCc--chHHHHHHHHhcCCcc--------cCC
Q 006112 495 HTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGEL--DLLDWVIDYWQKGDVL--------DAS 563 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~--~~~~~~~~~~~~~~~~--------~~~ 563 (660)
......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||..... ...+.+.......... ...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence 2234568999999998865 4578899999999999999999999975322 1111111111110000 000
Q ss_pred CCc-ccccCc---H------HHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 564 DPR-LEGIYV---E------EQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 564 d~~-l~~~~~---~------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
.+. ...... . .....+.+++..|++.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000 000000 0 01134668888999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=338.17 Aligned_cols=244 Identities=24% Similarity=0.269 Sum_probs=198.7
Q ss_pred cccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCCCC
Q 006112 342 YKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNG 418 (660)
Q Consensus 342 ~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g 418 (660)
+.+|+|+||.||+++...+++.||+|.+... .......+.+|++++..++||||+++++++..++.+++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3589999999999999889999999998653 2334567889999999999999999999999999999999999999
Q ss_pred ChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCceeec
Q 006112 419 SLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTN 498 (660)
Q Consensus 419 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 498 (660)
+|..++.... .+++.++..++.||+.||+|||+ ..+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 155 (325)
T cd05594 81 ELFFHLSRER--VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKT 155 (325)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-ccccc
Confidence 9999886543 48999999999999999999996 2699999999999999999999999999987532221 12234
Q ss_pred cccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHHH
Q 006112 499 VVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEI 578 (660)
Q Consensus 499 ~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 578 (660)
..||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......+. ..+...++ ..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~---~~~i~~~~------~~~p~~~~----~~ 222 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FELILMEE------IRFPRTLS----PE 222 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH---HHHHhcCC------CCCCCCCC----HH
Confidence 5799999999999988999999999999999999999999976443211 11111111 11122222 34
Q ss_pred HHHHhhhccCCCCCCCC-----CHHHHHHH
Q 006112 579 VLKLGLFCSHSNPDTRP-----SMRQVVQY 603 (660)
Q Consensus 579 l~~l~~~Cl~~dP~~RP-----s~~evl~~ 603 (660)
+.+++.+|++.||++|+ ++.+++++
T Consensus 223 ~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 223 AKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 66788889999999996 89999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=319.29 Aligned_cols=250 Identities=28% Similarity=0.409 Sum_probs=208.1
Q ss_pred eecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
|+..+.+|+|++|.||+++...+++.|++|.+... .....+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 66678899999999999999989999999998643 3445678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 495 (660)
++++|.+++.......+++.++.+++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++........
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~- 157 (256)
T cd08529 82 ENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF- 157 (256)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccch-
Confidence 99999999987655578999999999999999999998 89999999999999999999999999999876543222
Q ss_pred eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHH
Q 006112 496 TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQ 575 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 575 (660)
.....|++.|+|||++.+..++.++|+||||+++|||++|+.||...... ........+.. +.+.. ..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~-----~~~~~----~~ 225 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---ALILKIIRGVF-----PPVSQ----MY 225 (256)
T ss_pred hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHcCCC-----CCCcc----cc
Confidence 23356889999999999988999999999999999999999999764421 11222222211 11111 23
Q ss_pred HHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 576 MEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 576 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
...+.+++.+||+.+|++||++.++++.
T Consensus 226 ~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 226 SQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 3457888999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=322.29 Aligned_cols=251 Identities=27% Similarity=0.402 Sum_probs=203.0
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 416 (660)
.|+.++.+|+|+||.||+|.+.. +..+|+|.+.... ...++|.+|+.++++++||||++++++|......++||||++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 47778899999999999998854 4569999986443 235679999999999999999999999999889999999999
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCcee
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT 496 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 496 (660)
+|+|.+++..... .+++.++++++.||+.||+|||+ .+++|+||||+||+++.++.+||+|||+++..........
T Consensus 83 ~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 83 NGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 9999999976543 58999999999999999999998 8999999999999999999999999999986544322222
Q ss_pred eccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHH
Q 006112 497 TNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQ 575 (660)
Q Consensus 497 ~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 575 (660)
....++..|++||.+....++.++|||||||++|||++ |+.||....... .......+.... .... .
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~~~~~~-----~~~~----~ 226 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVEKVSQGLRLY-----RPHL----A 226 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHHhcCCCCC-----CCCC----C
Confidence 23345678999999988889999999999999999998 999987533221 111222221110 1111 2
Q ss_pred HHHHHHHhhhccCCCCCCCCCHHHHHHHhh
Q 006112 576 MEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605 (660)
Q Consensus 576 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (660)
...+.+++.+||+.||.+||++.++++.|+
T Consensus 227 ~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 227 SEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 356788999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=333.09 Aligned_cols=242 Identities=25% Similarity=0.339 Sum_probs=194.0
Q ss_pred cccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhc-cCCCCceeEeeeeeecCeeEEEEecCCC
Q 006112 342 YKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGK-LRHRNLVQLRGYCRRKGELLLVYDYMPN 417 (660)
Q Consensus 342 ~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~-l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 417 (660)
+.||+|+||.||+|++..+++.||+|.+... .....+.+..|..++.. .+||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3589999999999999989999999998653 22344556677777765 4899999999999999999999999999
Q ss_pred CChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCceee
Q 006112 418 GSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTT 497 (660)
Q Consensus 418 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 497 (660)
|+|..++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~ 154 (316)
T cd05592 81 GDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAS 154 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccc
Confidence 99999987654 48889999999999999999998 999999999999999999999999999998643322 2233
Q ss_pred ccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHH
Q 006112 498 NVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQME 577 (660)
Q Consensus 498 ~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 577 (660)
...||+.|+|||++.+..++.++|||||||++|||++|+.||........ ....... .+.+...+ ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~---~~~i~~~------~~~~~~~~----~~ 221 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL---FDSILND------RPHFPRWI----SK 221 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH---HHHHHcC------CCCCCCCC----CH
Confidence 46799999999999988899999999999999999999999986443211 1111111 11112222 23
Q ss_pred HHHHHhhhccCCCCCCCCCHH-HHHH
Q 006112 578 IVLKLGLFCSHSNPDTRPSMR-QVVQ 602 (660)
Q Consensus 578 ~l~~l~~~Cl~~dP~~RPs~~-evl~ 602 (660)
.+.+++..||+.||++||++. ++++
T Consensus 222 ~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 222 EAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHHHc
Confidence 456778889999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=332.58 Aligned_cols=252 Identities=22% Similarity=0.263 Sum_probs=202.4
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
-+|+.|+.||+|+||.||+++.+.+|..+|+|++++.. ....+....|=.+|....+|+||+|+-.+++...+||||
T Consensus 141 ~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiM 220 (550)
T KOG0605|consen 141 DDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIM 220 (550)
T ss_pred ccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEE
Confidence 47889999999999999999999999999999997653 455677889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCC-
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG- 491 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~- 491 (660)
||++||++..+|...+ .|++..+..++.+.+.|+..||+ .|+|||||||+|+|||..|++||+||||+.-+...
T Consensus 221 EylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 221 EYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred EecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 9999999999997654 58999999999999999999998 99999999999999999999999999999532110
Q ss_pred ---------------------CCc-----ee-------------------eccccCccccCcccccCCCCCcceeEEehH
Q 006112 492 ---------------------NDL-----HT-------------------TNVVGTVGYLAPELLRNGRGTTSTDVYAFG 526 (660)
Q Consensus 492 ---------------------~~~-----~~-------------------~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~G 526 (660)
... .. -..+|||-|||||++.+..|+..+|.||+|
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG 375 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence 000 00 015799999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCC---HHHHHH
Q 006112 527 VFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPS---MRQVVQ 602 (660)
Q Consensus 527 vvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~ 602 (660)
||+|||+.|.+||..+.....-..+..|+.. +....+. ... .+..+|+.+|+. ||++|.- ++||.+
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~-l~fP~~~----~~s----~eA~DLI~rll~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNWRET-LKFPEEV----DLS----DEAKDLITRLLC-DPENRLGSKGAEEIKK 444 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh-ccCCCcC----ccc----HHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence 9999999999999976654332222222221 1111111 112 334555656666 9999974 777764
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=326.27 Aligned_cols=254 Identities=26% Similarity=0.414 Sum_probs=206.8
Q ss_pred eeecccccccCccEEEEEEEeCC-----CCeEEEEEEeccCCCh-hhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPS-----SHAEIAVKKVCHDSDH-GMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLL 410 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~-----~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 410 (660)
+|..++.+|+|+||.||+|.... .+..||+|.+...... ..+.+.+|++++++++|+||+++++++......++
T Consensus 6 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 85 (280)
T cd05049 6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIM 85 (280)
T ss_pred HhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEE
Confidence 57788899999999999998743 3578999998765444 56789999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhhCC------------CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeE
Q 006112 411 VYDYMPNGSLDKILYSNT------------RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGK 478 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~k 478 (660)
||||+++++|.+++.... ...+++.++..++.|++.||+|||+ ++++||||||+||+++.++.+|
T Consensus 86 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~k 162 (280)
T cd05049 86 VFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVVK 162 (280)
T ss_pred EEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeEE
Confidence 999999999999997542 2457899999999999999999998 8999999999999999999999
Q ss_pred EeecccceeccCCCC-ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhc
Q 006112 479 LGDFGLARLYDHGND-LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQK 556 (660)
Q Consensus 479 l~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~ 556 (660)
|+|||+++....... .......+++.|+|||++.++.++.++|||||||++|||++ |..||....... .......
T Consensus 163 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~~~~~ 239 (280)
T cd05049 163 IGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIECITQ 239 (280)
T ss_pred ECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHc
Confidence 999999976533221 11223456789999999999999999999999999999998 999986533221 1222223
Q ss_pred CCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhh
Q 006112 557 GDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605 (660)
Q Consensus 557 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (660)
+..... . ......+.+++..||+.||++||++.||++.|+
T Consensus 240 ~~~~~~-----~----~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 240 GRLLQR-----P----RTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred CCcCCC-----C----CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 222111 1 122345788899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=334.02 Aligned_cols=256 Identities=23% Similarity=0.356 Sum_probs=205.1
Q ss_pred eeeecccccccCccEEEEEEEeCCCCe----EEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHA----EIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLL 410 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 410 (660)
.+|+.++.+|+|+||.||+|++..++. .||+|.+.... ....+++.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 368899999999999999999865554 48999986543 34567899999999999999999999999764 5789
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccC
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDH 490 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 490 (660)
|+||+++|+|.+++.... ..+++..+++++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccccC
Confidence 999999999999997654 358899999999999999999998 8999999999999999999999999999987654
Q ss_pred CCCce-eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCccc
Q 006112 491 GNDLH-TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLE 568 (660)
Q Consensus 491 ~~~~~-~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 568 (660)
..... .....++..|+|||++.+..++.++|||||||++|||++ |+.||........ ......+.... .+
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~---~~~~~~~~~~~--~~--- 233 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---SSILEKGERLP--QP--- 233 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHhCCCCCC--CC---
Confidence 33222 122345678999999999999999999999999999997 9999875432221 22222221111 11
Q ss_pred ccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCCC
Q 006112 569 GIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGA 608 (660)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (660)
.. ....+.+++..||+.||++||++.++++.|....
T Consensus 234 ~~----~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 234 PI----CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred CC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11 2234678889999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=341.52 Aligned_cols=252 Identities=22% Similarity=0.265 Sum_probs=196.9
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
.|+.++.||+|+||.||+++...+++.||||.+.... ....+.+.+|+.++++++|+||+++++.+.+++.+++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 5888999999999999999999999999999986432 2345678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC-
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN- 492 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~- 492 (660)
||++|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|..+....
T Consensus 82 ~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 82 YIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 999999999997643 47888889999999999999998 999999999999999999999999999985321100
Q ss_pred -----------------------------------------CceeeccccCccccCcccccCCCCCcceeEEehHHHHHH
Q 006112 493 -----------------------------------------DLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLE 531 (660)
Q Consensus 493 -----------------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~e 531 (660)
........||+.|+|||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 000123579999999999999899999999999999999
Q ss_pred HhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCC---CHHHHHHH
Q 006112 532 VACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRP---SMRQVVQY 603 (660)
Q Consensus 532 lltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP---s~~evl~~ 603 (660)
|++|+.||........ ............ .+ .......+..+ ++..|+ .+|.+|+ ++.|++++
T Consensus 237 ll~G~~Pf~~~~~~~~--~~~i~~~~~~~~--~~-~~~~~s~~~~~----li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 237 MLVGQPPFLADTPAET--QLKVINWETTLH--IP-SQAKLSREASD----LILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhhCCCCCCCCCHHHH--HHHHhccCcccc--CC-CCCCCCHHHHH----HHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999999986543221 111111111110 11 11123333333 333344 4999999 89999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=334.50 Aligned_cols=244 Identities=24% Similarity=0.309 Sum_probs=197.0
Q ss_pred ccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCeeEEEEecCCCC
Q 006112 343 KATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVYDYMPNG 418 (660)
Q Consensus 343 ~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~g 418 (660)
.||+|+||.||+++...+++.+|+|.+... .....+.+..|+.++.++ +||||+++++++..++..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~ 81 (329)
T cd05618 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 81 (329)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence 589999999999999999999999998753 233456688899988877 7999999999999999999999999999
Q ss_pred ChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCceeec
Q 006112 419 SLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTN 498 (660)
Q Consensus 419 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 498 (660)
+|..++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 82 ~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~~ 155 (329)
T cd05618 82 DLMFHMQRQR--KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTST 155 (329)
T ss_pred CHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Ccccc
Confidence 9998886543 48999999999999999999998 899999999999999999999999999997532221 12234
Q ss_pred cccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCC------CcchHHHHHHHHhcCCcccCCCCcccccCc
Q 006112 499 VVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPG------ELDLLDWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 499 ~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~------~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
..||+.|+|||++.+..++.++|||||||++|||++|+.||... .....++..+....... .+....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~p~~~- 228 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RIPRSL- 228 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------CCCCCC-
Confidence 67999999999999999999999999999999999999999531 11222333333322221 111222
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCC------HHHHHH
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRPS------MRQVVQ 602 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RPs------~~evl~ 602 (660)
...+.+++..||+.||++||+ +.++++
T Consensus 229 ---~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 229 ---SVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred ---CHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 234667888899999999998 567764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=339.31 Aligned_cols=253 Identities=23% Similarity=0.235 Sum_probs=201.8
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
-.|+.++.||+|+||.||+++...+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+++.+++||
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM 122 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence 3688889999999999999999999999999998642 2234456789999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
|||++|+|.+++... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 123 Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 123 EYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred cCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence 999999999998653 37778888999999999999998 899999999999999999999999999998765433
Q ss_pred CceeeccccCccccCcccccCC----CCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCccc
Q 006112 493 DLHTTNVVGTVGYLAPELLRNG----RGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLE 568 (660)
Q Consensus 493 ~~~~~~~~gt~~Y~aPE~~~~~----~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 568 (660)
........||+.|+|||.+.+. .++.++|||||||++|||++|+.||....... ............. +.
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--~~~~i~~~~~~~~-----~~ 269 (370)
T cd05596 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG--TYSKIMDHKNSLT-----FP 269 (370)
T ss_pred cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH--HHHHHHcCCCcCC-----CC
Confidence 3333456799999999998653 47889999999999999999999998644321 1111111111111 11
Q ss_pred ccCcHHHHHHHHHHhhhccCCCCCC--CCCHHHHHHH
Q 006112 569 GIYVEEQMEIVLKLGLFCSHSNPDT--RPSMRQVVQY 603 (660)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~ 603 (660)
.. ......+.+++..|++.+|++ ||++.|++++
T Consensus 270 ~~--~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 270 DD--IEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred Cc--CCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 10 012244667778899989987 9999999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=322.95 Aligned_cols=254 Identities=30% Similarity=0.458 Sum_probs=206.1
Q ss_pred eeecccccccCccEEEEEEEeCCC---CeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSS---HAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~---~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
.|+..+.+|+|+||.||+|++... ...||||.+.... .....+|.+|+.++++++||||+++++++...+..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 84 (266)
T cd05033 5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIIT 84 (266)
T ss_pred HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEE
Confidence 467788999999999999998643 4589999986543 334568999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
||+++++|.+++.... ..+++.++.+++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++......
T Consensus 85 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 85 EYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999999997644 358999999999999999999998 999999999999999999999999999998775222
Q ss_pred Cc-eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCccccc
Q 006112 493 DL-HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGI 570 (660)
Q Consensus 493 ~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 570 (660)
.. ......++..|+|||.+.+..++.++||||||+++|||++ |..||...... ........+... +.
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~~~~~~~----~~---- 229 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DVIKAVEDGYRL----PP---- 229 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HHHHHHHcCCCC----CC----
Confidence 22 2222345678999999998899999999999999999998 99998653322 122222222111 10
Q ss_pred CcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 571 YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
.......+.+++.+||+.+|++||+++||++.|+.
T Consensus 230 -~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 230 -PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred -CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 11223457899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=332.03 Aligned_cols=238 Identities=25% Similarity=0.262 Sum_probs=190.9
Q ss_pred cccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHH-HHhccCCCCceeEeeeeeecCeeEEEEecCCC
Q 006112 342 YKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIV-SMGKLRHRNLVQLRGYCRRKGELLLVYDYMPN 417 (660)
Q Consensus 342 ~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 417 (660)
+.||+|+||+||+|+...+++.||+|++.... ....+++..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 35899999999999999999999999986432 223445566655 56789999999999999999999999999999
Q ss_pred CChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCceee
Q 006112 418 GSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTT 497 (660)
Q Consensus 418 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 497 (660)
|+|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (323)
T cd05575 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTS 154 (323)
T ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cccc
Confidence 99999987643 48889999999999999999998 899999999999999999999999999987532221 2233
Q ss_pred ccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHH
Q 006112 498 NVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQME 577 (660)
Q Consensus 498 ~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 577 (660)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...+... ..+....+.. .+.... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~------~~~~~~----~~ 221 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE---MYDNILNKPL------RLKPNI----SV 221 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH---HHHHHHcCCC------CCCCCC----CH
Confidence 4679999999999999899999999999999999999999997644321 1111111111 111122 34
Q ss_pred HHHHHhhhccCCCCCCCCCHH
Q 006112 578 IVLKLGLFCSHSNPDTRPSMR 598 (660)
Q Consensus 578 ~l~~l~~~Cl~~dP~~RPs~~ 598 (660)
.+.+++..|++.||.+||+++
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 222 SARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHHHHhhcCHHhCCCCC
Confidence 467788889999999999884
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=326.53 Aligned_cols=245 Identities=25% Similarity=0.326 Sum_probs=197.3
Q ss_pred cccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCCCCCh
Q 006112 344 ATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSL 420 (660)
Q Consensus 344 lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 420 (660)
||+|+||+||++.+..+++.+|+|++.... ....+.+..|++++++++|+||+++.+++..+...++|||||++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 689999999999999899999999986432 23346778999999999999999999999999999999999999999
Q ss_pred hhhhhhC--CCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCceeec
Q 006112 421 DKILYSN--TRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTN 498 (660)
Q Consensus 421 ~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 498 (660)
..++... ....+++.++..++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 9887542 23458999999999999999999998 8999999999999999999999999999986544322 2234
Q ss_pred cccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcch-HHHHHHHHhcCCcccCCCCcccccCcHHHHH
Q 006112 499 VVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDL-LDWVIDYWQKGDVLDASDPRLEGIYVEEQME 577 (660)
Q Consensus 499 ~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 577 (660)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ..........+. . .+......
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------~----~~~~~~~~ 226 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDS------V----TYPDKFSP 226 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccC------C----CCcccCCH
Confidence 578999999999999999999999999999999999999997643221 111111111110 0 11122334
Q ss_pred HHHHHhhhccCCCCCCCC-----CHHHHHH
Q 006112 578 IVLKLGLFCSHSNPDTRP-----SMRQVVQ 602 (660)
Q Consensus 578 ~l~~l~~~Cl~~dP~~RP-----s~~evl~ 602 (660)
.+.+++..|++.||++|| +++++++
T Consensus 227 ~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 227 ASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred HHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 567888889999999999 6777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=333.94 Aligned_cols=243 Identities=26% Similarity=0.328 Sum_probs=197.6
Q ss_pred cccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCeeEEEEecCCC
Q 006112 342 YKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVYDYMPN 417 (660)
Q Consensus 342 ~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~ 417 (660)
+.||+|+||.||+|+...+++.||+|++... .....+.+..|.+++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 3589999999999999888999999998653 234456788899998866 799999999999999999999999999
Q ss_pred CChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCceee
Q 006112 418 GSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTT 497 (660)
Q Consensus 418 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 497 (660)
|+|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~ 154 (321)
T cd05591 81 GDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTT 154 (321)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCC-cccc
Confidence 99999887554 48899999999999999999998 899999999999999999999999999997543222 2233
Q ss_pred ccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHH
Q 006112 498 NVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQME 577 (660)
Q Consensus 498 ~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 577 (660)
...||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+....+.. ...... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~---~~~~i~~~~~------~~p~~~----~~ 221 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD---LFESILHDDV------LYPVWL----SK 221 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH---HHHHHHcCCC------CCCCCC----CH
Confidence 4579999999999998899999999999999999999999998644321 1111222211 111112 23
Q ss_pred HHHHHhhhccCCCCCCCC-------CHHHHHHH
Q 006112 578 IVLKLGLFCSHSNPDTRP-------SMRQVVQY 603 (660)
Q Consensus 578 ~l~~l~~~Cl~~dP~~RP-------s~~evl~~ 603 (660)
.+.+++..|++.||++|| ++++++++
T Consensus 222 ~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 222 EAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 466788889999999999 88888754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=350.00 Aligned_cols=257 Identities=23% Similarity=0.262 Sum_probs=209.8
Q ss_pred CceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccC-CCCceeEeee-eee------c
Q 006112 334 HRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLR-HRNLVQLRGY-CRR------K 405 (660)
Q Consensus 334 ~~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~-~~~------~ 405 (660)
.+.+++..+.|.+|||+.||.+.....+.++|+|++-..+++..+...+||++|++|+ |+|||.+++. ... .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 3557888899999999999999998887999999998888889999999999999997 9999999993 221 2
Q ss_pred CeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccc
Q 006112 406 GELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLA 485 (660)
Q Consensus 406 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla 485 (660)
-+++|.||||+||+|-+++.......|++.++++|+.|+++|+++||. +..+|||||||-+||||+.+++.||||||.|
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 368999999999999999986655569999999999999999999997 4678999999999999999999999999998
Q ss_pred eeccCCC-Cc-------eeeccccCccccCccccc---CCCCCcceeEEehHHHHHHHhhCCCCCCCCC-cchHHHHHHH
Q 006112 486 RLYDHGN-DL-------HTTNVVGTVGYLAPELLR---NGRGTTSTDVYAFGVFMLEVACGRRPVQPGE-LDLLDWVIDY 553 (660)
Q Consensus 486 ~~~~~~~-~~-------~~~~~~gt~~Y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~-~~~~~~~~~~ 553 (660)
.-.-... .. ......-|+.|.|||++. +...++|+|||+|||+||-|+....||+... ..+.
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl------ 267 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL------ 267 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE------
Confidence 6432221 10 011235699999999864 5678999999999999999999999998642 1111
Q ss_pred HhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 554 WQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 554 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
+-...-.-.+...+.+..|+..||++||++||++-||+..+-..
T Consensus 268 ----------ng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 268 ----------NGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred ----------eccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 11111111245677888999999999999999999999877543
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=323.91 Aligned_cols=249 Identities=25% Similarity=0.306 Sum_probs=198.8
Q ss_pred cccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCCCCCh
Q 006112 344 ATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSL 420 (660)
Q Consensus 344 lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 420 (660)
||+|+||.||++....+++.+|+|++.... ....+.+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 689999999999999899999999985432 22334566799999999999999999999999999999999999999
Q ss_pred hhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCceeeccc
Q 006112 421 DKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVV 500 (660)
Q Consensus 421 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 500 (660)
..++.......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++....... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence 998876655568999999999999999999998 999999999999999999999999999998664332 223457
Q ss_pred cCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchH-HHHHHHHhcCCcccCCCCcccccCcHHHHHHH
Q 006112 501 GTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLL-DWVIDYWQKGDVLDASDPRLEGIYVEEQMEIV 579 (660)
Q Consensus 501 gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 579 (660)
|+..|+|||++.+..++.++||||+||++|||++|+.||........ ..+......... .. .... ....+
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~-~~~~----~~~~~ 226 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEV----KF-EHQN----FTEES 226 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccc----cc-cccc----CCHHH
Confidence 89999999999988899999999999999999999999975322111 111111111111 00 0111 23346
Q ss_pred HHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 580 LKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 580 ~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
.+++..||+.||++||+++|+++.+..
T Consensus 227 ~~li~~~L~~~P~~R~~~~~~~~~~~~ 253 (277)
T cd05607 227 KDICRLFLAKKPEDRLGSREKNDDPRK 253 (277)
T ss_pred HHHHHHHhccCHhhCCCCccchhhhhc
Confidence 788888999999999999877654443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=332.80 Aligned_cols=244 Identities=26% Similarity=0.327 Sum_probs=197.0
Q ss_pred ccccccCccEEEEEEEeC---CCCeEEEEEEeccC----CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 341 LYKATKGGSGKVYRGVLP---SSHAEIAVKKVCHD----SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 341 l~~lg~G~fg~Vy~g~~~---~~~~~vavK~~~~~----~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
++.||+|+||.||+++.. ..++.||+|.+... .......+.+|+.++++++||||+++++++..++..++|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 367999999999999864 46789999998643 22334567899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
|+++|+|.+++.... .+.+..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (323)
T cd05584 81 YLSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG- 154 (323)
T ss_pred CCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence 999999999987654 47788888999999999999998 999999999999999999999999999997543222
Q ss_pred ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... + .......+.. .+....
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~--~-~~~~~~~~~~------~~~~~~-- 223 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK--K-TIDKILKGKL------NLPPYL-- 223 (323)
T ss_pred CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH--H-HHHHHHcCCC------CCCCCC--
Confidence 1223457999999999999888999999999999999999999999764432 1 1222222211 111112
Q ss_pred HHHHHHHHHhhhccCCCCCCCC-----CHHHHHHH
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRP-----SMRQVVQY 603 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 603 (660)
...+.+++..|++.||++|| ++++++++
T Consensus 224 --~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 224 --TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred --CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 23467888889999999999 88888763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=324.73 Aligned_cols=255 Identities=25% Similarity=0.385 Sum_probs=203.6
Q ss_pred eeecccccccCccEEEEEEEeCCCCe----EEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHA----EIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 411 (660)
+|+.++.+|+|+||.||+|.+..++. .+++|.+.... ....+++..|+.++++++||||+++++++. ....+++
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i 86 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLV 86 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEE
Confidence 57778899999999999999876665 47778775432 234567888999999999999999999885 4557899
Q ss_pred EecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCC
Q 006112 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 491 (660)
+||+++|+|.+++.... ..++|..+..++.||+.||+|||+ ++++||||||+|||+++++.+||+|||+++.....
T Consensus 87 ~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 87 TQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 99999999999997643 358999999999999999999998 89999999999999999999999999999875433
Q ss_pred CC-ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccc
Q 006112 492 ND-LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEG 569 (660)
Q Consensus 492 ~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 569 (660)
.. .......++..|+|||.+.++.++.++|||||||++||+++ |+.||........ .+....+.... .+.
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~---~~~~~~~~~~~--~~~--- 234 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV---PDLLEKGERLA--QPQ--- 234 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHHCCCcCC--CCC---
Confidence 22 22234567789999999998899999999999999999998 9999976543322 22223332221 111
Q ss_pred cCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCCC
Q 006112 570 IYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGA 608 (660)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (660)
. ....+.+++..||..||++||++.|+++.|+...
T Consensus 235 ~----~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 235 I----CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred C----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1 1234567888999999999999999999997743
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=341.87 Aligned_cols=260 Identities=25% Similarity=0.352 Sum_probs=206.7
Q ss_pred CceeeecccccccCccEEEEEEEeCC-----CCeEEEEEEeccCCC-hhhHHHHHHHHHHhccC-CCCceeEeeeeeecC
Q 006112 334 HRFSYKNLYKATKGGSGKVYRGVLPS-----SHAEIAVKKVCHDSD-HGMKQFVSEIVSMGKLR-HRNLVQLRGYCRRKG 406 (660)
Q Consensus 334 ~~~~~~~l~~lg~G~fg~Vy~g~~~~-----~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~ 406 (660)
.+..|...+.||+|+||.||+|++.. .+..||||++..... ...+.+.+|+++++++. ||||++++++|.+.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 45578889999999999999998743 235799999965433 34567999999999996 999999999999999
Q ss_pred eeEEEEecCCCCChhhhhhhCC----------------------------------------------------------
Q 006112 407 ELLLVYDYMPNGSLDKILYSNT---------------------------------------------------------- 428 (660)
Q Consensus 407 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 428 (660)
..++|||||++|+|.++|....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 9999999999999999886431
Q ss_pred ------------------------------------CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEc
Q 006112 429 ------------------------------------RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLD 472 (660)
Q Consensus 429 ------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~ 472 (660)
...+++.++.+++.|+++||+|||+ .+|+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEe
Confidence 1247888899999999999999998 8999999999999999
Q ss_pred CCCCeEEeecccceeccCCCCc-eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHH
Q 006112 473 ADLEGKLGDFGLARLYDHGNDL-HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWV 550 (660)
Q Consensus 473 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~ 550 (660)
.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||...... ...
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~--~~~ 349 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD--STF 349 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh--HHH
Confidence 9999999999999865433221 1223457789999999988889999999999999999997 88998753221 111
Q ss_pred HHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 551 IDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 551 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
......+... .. .......+.+++.+||+.||++||++.+|.+.|+..
T Consensus 350 ~~~~~~~~~~-----~~----~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 350 YNKIKSGYRM-----AK----PDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred HHHHhcCCCC-----CC----CccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 1222222111 11 122345678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=333.79 Aligned_cols=247 Identities=23% Similarity=0.309 Sum_probs=199.4
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCC-CceeEeeeeeecCeeEEEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHR-NLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~-nIv~l~g~~~~~~~~~lV~ 412 (660)
+|+.++.||+|+||.||+|+...+++.||+|++... .....+.+..|++++..++|+ +|+++++++...+.+++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 377889999999999999999988999999998653 234567788999999999764 5888999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
||+++|+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 81 EYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 9999999999987654 48899999999999999999998 899999999999999999999999999987532221
Q ss_pred CceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCc
Q 006112 493 DLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 493 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ........ +.+....
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~---~~~i~~~~------~~~~~~~- 224 (324)
T cd05587 156 -KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL---FQSIMEHN------VSYPKSL- 224 (324)
T ss_pred -CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---HHHHHcCC------CCCCCCC-
Confidence 123345799999999999998999999999999999999999999976443211 11111111 1111222
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCCH-----HHHHH
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRPSM-----RQVVQ 602 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~ 602 (660)
...+.+++..|++.||.+|++. +++++
T Consensus 225 ---~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 225 ---SKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred ---CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 2346678888999999999976 56654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=326.62 Aligned_cols=257 Identities=26% Similarity=0.401 Sum_probs=208.9
Q ss_pred eeecccccccCccEEEEEEEeC-----CCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLP-----SSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~-----~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 411 (660)
.|.....+|+|+||.||+|+.. .++..+++|.+........+.+.+|++++++++|+||+++++++...+..++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV 85 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence 4566688999999999999853 24567999998766666667899999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhhCC--------------CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCe
Q 006112 412 YDYMPNGSLDKILYSNT--------------RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEG 477 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~ 477 (660)
|||+++++|.+++.... ...++|.++++++.||+.||+|||+ ++|+||||||+||+++.++.+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcE
Confidence 99999999999996532 2348999999999999999999998 999999999999999999999
Q ss_pred EEeecccceeccCCCC-ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHh
Q 006112 478 KLGDFGLARLYDHGND-LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQ 555 (660)
Q Consensus 478 kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~ 555 (660)
||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||+| |+.||...... ..++...
T Consensus 163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~~~~ 239 (291)
T cd05094 163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---EVIECIT 239 (291)
T ss_pred EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHh
Confidence 9999999976543221 12233456889999999998899999999999999999998 99998654322 1222333
Q ss_pred cCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCCC
Q 006112 556 KGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGA 608 (660)
Q Consensus 556 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (660)
.+..... . ......+.+++.+||+.||++||++++|++.|+...
T Consensus 240 ~~~~~~~-----~----~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~ 283 (291)
T cd05094 240 QGRVLER-----P----RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283 (291)
T ss_pred CCCCCCC-----C----ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 3322211 1 122345788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=337.10 Aligned_cols=252 Identities=20% Similarity=0.220 Sum_probs=197.0
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
.|+.++.||+|+||.||++....+++.||||++... .....+.+.+|++++++++||||+++++++.+.+.+++|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 477889999999999999999999999999998543 23345678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
|+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 82 ~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 82 FLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 999999999997643 48888999999999999999998 9999999999999999999999999999964321100
Q ss_pred ------------c----------------------------------eeeccccCccccCcccccCCCCCcceeEEehHH
Q 006112 494 ------------L----------------------------------HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGV 527 (660)
Q Consensus 494 ------------~----------------------------------~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gv 527 (660)
. ......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 001246999999999999889999999999999
Q ss_pred HHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCC---CCHHHHHHH
Q 006112 528 FMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTR---PSMRQVVQY 603 (660)
Q Consensus 528 vl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps~~evl~~ 603 (660)
++|||++|+.||........ ..............+. ...+ ..+.+++..|+. +|.+| +++.|++++
T Consensus 237 il~elltG~~Pf~~~~~~~~--~~~i~~~~~~~~~p~~---~~~s----~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 237 IMFECLIGWPPFCSENSHET--YRKIINWRETLYFPDD---IHLS----VEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHH--HHHHHccCCccCCCCC---CCCC----HHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 99999999999976443211 1111111111111110 0122 234566666776 66665 699999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=338.29 Aligned_cols=251 Identities=23% Similarity=0.314 Sum_probs=195.8
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
.|+.++.||+|+||.||+|+...+++.||+|++.... ....+.+.+|+.++++++||||+++++.+.+++.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 3778899999999999999999999999999986432 3345678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC-
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN- 492 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~- 492 (660)
||++|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 999999999997643 47888899999999999999998 899999999999999999999999999975321100
Q ss_pred ---------------------------------------------CceeeccccCccccCcccccCCCCCcceeEEehHH
Q 006112 493 ---------------------------------------------DLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGV 527 (660)
Q Consensus 493 ---------------------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gv 527 (660)
........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00012347999999999999889999999999999
Q ss_pred HHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCC---HHHHHH
Q 006112 528 FMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPS---MRQVVQ 602 (660)
Q Consensus 528 vl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~ 602 (660)
++|||++|+.||........ ............ .|. .....++..+.+.++ | .+|.+|++ +.|+++
T Consensus 237 il~elltG~~Pf~~~~~~~~--~~~i~~~~~~~~--~p~-~~~~s~~~~~li~~l---~--~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLET--QMKVINWQTSLH--IPP-QAKLSPEASDLIIKL---C--RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHH--HHHHHccCCCcC--CCC-cccCCHHHHHHHHHH---c--cCHhHcCCCCCHHHHhc
Confidence 99999999999976443211 111111111110 110 122344444444442 3 48999987 888875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=320.78 Aligned_cols=249 Identities=22% Similarity=0.364 Sum_probs=214.9
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEE
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 411 (660)
+..|+..+.+|+|.||.|-++.....|+.||||.++++ +.+.+-.+.+||+||+.|+||||++++.+|+..+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 44688899999999999999999889999999999765 445566788999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCC
Q 006112 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 491 (660)
|||..+|.|.+|+...+ .|++.++..+++||.+|+.|+|. ++++|||||.+|||||.|+++||+||||+.++...
T Consensus 132 MEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 132 MEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 99999999999997654 59999999999999999999998 99999999999999999999999999999988655
Q ss_pred CCceeeccccCccccCcccccCCCC-CcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCccccc
Q 006112 492 NDLHTTNVVGTVGYLAPELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGI 570 (660)
Q Consensus 492 ~~~~~~~~~gt~~Y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 570 (660)
+. .+.++|.+-|.+||++.+.+| .+..|-||+||+||-|+.|..||++-+.. ...+.+..|...+...
T Consensus 207 kf--LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---~lvrQIs~GaYrEP~~------ 275 (668)
T KOG0611|consen 207 KF--LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---RLVRQISRGAYREPET------ 275 (668)
T ss_pred cH--HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---HHHHHhhcccccCCCC------
Confidence 43 456899999999999998877 57899999999999999999999975432 2333444554433322
Q ss_pred CcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHh
Q 006112 571 YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYL 604 (660)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (660)
+.....|+.||+..+|++|-|+.+|..+.
T Consensus 276 -----PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 276 -----PSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred -----CchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 23356788899999999999999998765
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=332.95 Aligned_cols=244 Identities=24% Similarity=0.308 Sum_probs=197.9
Q ss_pred ccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCeeEEEEecCCCC
Q 006112 343 KATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVYDYMPNG 418 (660)
Q Consensus 343 ~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~g 418 (660)
.||+|+||.||++++..+++.||+|.+... .....+.+..|..++.++ +||||+++++++..++.+++|||||++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 589999999999999999999999999753 233456788999999998 7999999999999999999999999999
Q ss_pred ChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCceeec
Q 006112 419 SLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTN 498 (660)
Q Consensus 419 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 498 (660)
+|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 82 ~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 155 (329)
T cd05588 82 DLMFHMQRQR--KLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTST 155 (329)
T ss_pred CHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCC-Ccccc
Confidence 9999886543 58999999999999999999998 999999999999999999999999999987422211 22234
Q ss_pred cccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCC------CcchHHHHHHHHhcCCcccCCCCcccccCc
Q 006112 499 VVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPG------ELDLLDWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 499 ~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~------~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
..||+.|+|||++.+..++.++|||||||++|||++|+.||+.. .....++..+....+.. .+....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~p~~~- 228 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RIPRSL- 228 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CCCCCC-
Confidence 67999999999999989999999999999999999999999631 11122333333322211 112222
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCC------HHHHHH
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRPS------MRQVVQ 602 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RPs------~~evl~ 602 (660)
...+.+++..|++.||.+||+ ++++++
T Consensus 229 ---~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 229 ---SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred ---CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 234677888899999999997 678875
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=336.76 Aligned_cols=253 Identities=23% Similarity=0.242 Sum_probs=199.1
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
-.|+.++.||+|+||.||+++...+++.+|+|.+... .....+.+.+|+.+++.++||||+++++++.+++.+++||
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM 122 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4688899999999999999999999999999998542 2233456889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
|||++|+|.+++... .+++.++..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++......
T Consensus 123 Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 123 EYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196 (370)
T ss_pred cCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence 999999999998643 37888999999999999999998 999999999999999999999999999998765433
Q ss_pred CceeeccccCccccCcccccCC----CCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCccc
Q 006112 493 DLHTTNVVGTVGYLAPELLRNG----RGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLE 568 (660)
Q Consensus 493 ~~~~~~~~gt~~Y~aPE~~~~~----~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 568 (660)
........||+.|+|||++... .++.++||||+||++|||++|+.||...... .............. +.
T Consensus 197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~--~~~~~i~~~~~~~~-----~p 269 (370)
T cd05621 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV--GTYSKIMDHKNSLN-----FP 269 (370)
T ss_pred ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH--HHHHHHHhCCcccC-----CC
Confidence 3333456799999999998753 3788999999999999999999999764422 11111111111111 11
Q ss_pred ccCcHHHHHHHHHHhhhccCCCCC--CCCCHHHHHHH
Q 006112 569 GIYVEEQMEIVLKLGLFCSHSNPD--TRPSMRQVVQY 603 (660)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~--~RPs~~evl~~ 603 (660)
.. ......+.+++..|+..++. .||++.|++++
T Consensus 270 ~~--~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 270 ED--VEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred Cc--ccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 10 11223355566667765443 38999999985
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=320.69 Aligned_cols=252 Identities=28% Similarity=0.415 Sum_probs=204.4
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 416 (660)
.|+..+++|+|+||.||+|++..+ ..||+|++.... ...++|.+|++++++++|+||+++++.+. ....++||||++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 7 SLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 588899999999999999998654 469999986433 23467999999999999999999999875 456899999999
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCcee
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT 496 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 496 (660)
+|+|.+++.......+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++..........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~ 160 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 160 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccccc
Confidence 9999999976544568999999999999999999998 9999999999999999999999999999987654433222
Q ss_pred eccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHH
Q 006112 497 TNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQ 575 (660)
Q Consensus 497 ~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 575 (660)
....++..|+|||+..+..++.++||||||+++|||++ |..||...... ........+... ....+.
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~~~~~~~~~~~~---------~~~~~~ 228 (262)
T cd05071 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQVERGYRM---------PCPPEC 228 (262)
T ss_pred cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---HHHHHHhcCCCC---------CCcccc
Confidence 33456778999999988889999999999999999999 78788653322 112222221110 112234
Q ss_pred HHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 576 MEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 576 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
...+.+++..|++.||++||++.++++.|+.
T Consensus 229 ~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 229 PESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 4567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=333.45 Aligned_cols=242 Identities=24% Similarity=0.314 Sum_probs=196.8
Q ss_pred cccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCeeEEEEecCCC
Q 006112 342 YKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVYDYMPN 417 (660)
Q Consensus 342 ~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~ 417 (660)
+.||+|+||.||+++...+++.||+|++... .....+.+..|..++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3589999999999999989999999998643 234456788899988876 699999999999999999999999999
Q ss_pred CChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCceee
Q 006112 418 GSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTT 497 (660)
Q Consensus 418 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 497 (660)
|+|..++.... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~ 154 (320)
T cd05590 81 GDLMFHIQKSR--RFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTS 154 (320)
T ss_pred chHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cccc
Confidence 99999987654 48899999999999999999998 999999999999999999999999999987543221 2233
Q ss_pred ccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHH
Q 006112 498 NVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQME 577 (660)
Q Consensus 498 ~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 577 (660)
...||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+....+.. .+... ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---~~~~i~~~~~------~~~~~----~~~ 221 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD---LFEAILNDEV------VYPTW----LSQ 221 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---HHHHHhcCCC------CCCCC----CCH
Confidence 4579999999999998889999999999999999999999997644321 1222222211 11111 223
Q ss_pred HHHHHhhhccCCCCCCCCCH------HHHHH
Q 006112 578 IVLKLGLFCSHSNPDTRPSM------RQVVQ 602 (660)
Q Consensus 578 ~l~~l~~~Cl~~dP~~RPs~------~evl~ 602 (660)
.+.+++..|++.||++||++ +++++
T Consensus 222 ~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~ 252 (320)
T cd05590 222 DAVDILKAFMTKNPTMRLGSLTLGGEEAILR 252 (320)
T ss_pred HHHHHHHHHcccCHHHCCCCCCCCCHHHHHc
Confidence 46778888999999999998 66654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=318.46 Aligned_cols=248 Identities=26% Similarity=0.394 Sum_probs=199.5
Q ss_pred cccccCccEEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCCCCCh
Q 006112 342 YKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSL 420 (660)
Q Consensus 342 ~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 420 (660)
+.+|+|+||.||+|++..+++.+|+|.+.... ......+.+|++++++++||||++++++|...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36899999999999998889999999876443 34457799999999999999999999999999999999999999999
Q ss_pred hhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCcee-ecc
Q 006112 421 DKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT-TNV 499 (660)
Q Consensus 421 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~-~~~ 499 (660)
.+++.... ..+++.++..++.|++.||.|||+ ++++||||||+|||++.++.+||+|||+++.......... ...
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 81 LTFLRTEG-PRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 99986543 358999999999999999999998 8999999999999999999999999999976443211111 111
Q ss_pred ccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHHH
Q 006112 500 VGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEI 578 (660)
Q Consensus 500 ~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 578 (660)
.++..|+|||.+.++.++.++||||||+++|||++ |..||....... .......+... .........
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~---~~~~~~~~~~~---------~~~~~~~~~ 224 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ---TREAIEQGVRL---------PCPELCPDA 224 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH---HHHHHHcCCCC---------CCcccCCHH
Confidence 23467999999998899999999999999999998 888886433221 11111111111 111122446
Q ss_pred HHHHhhhccCCCCCCCCCHHHHHHHhh
Q 006112 579 VLKLGLFCSHSNPDTRPSMRQVVQYLD 605 (660)
Q Consensus 579 l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (660)
+.+++.+|++.||++||++.++++.|+
T Consensus 225 ~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 225 VYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=324.11 Aligned_cols=259 Identities=27% Similarity=0.409 Sum_probs=209.7
Q ss_pred ceeeecccccccCccEEEEEEEeC-----CCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeE
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLP-----SSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELL 409 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~-----~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 409 (660)
+-+|...+.+|+|+||.||++... .++..+|+|.+........+.+.+|++++++++||||++++++|...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 346788889999999999999852 345679999987666666778999999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhhhCC-----------CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeE
Q 006112 410 LVYDYMPNGSLDKILYSNT-----------RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGK 478 (660)
Q Consensus 410 lV~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~k 478 (660)
+||||+++++|.+++.... ...+++.++..++.|++.||+|||+ ++++||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEE
Confidence 9999999999999986432 2348999999999999999999998 8999999999999999999999
Q ss_pred EeecccceeccCCCC-ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhc
Q 006112 479 LGDFGLARLYDHGND-LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQK 556 (660)
Q Consensus 479 l~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~ 556 (660)
|+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||...... ........
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~---~~~~~i~~ 237 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIECITQ 237 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHc
Confidence 999999986543221 11223446788999999998889999999999999999998 89888654322 12222333
Q ss_pred CCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCCC
Q 006112 557 GDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGA 608 (660)
Q Consensus 557 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (660)
+.... ..... ...+.+++..||+.||.+|||++++++.|+...
T Consensus 238 ~~~~~-----~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 238 GRVLQ-----RPRTC----PKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred CCcCC-----CCCCC----CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 32211 11122 234788999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=324.25 Aligned_cols=253 Identities=27% Similarity=0.357 Sum_probs=201.2
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC--------------hhhHHHHHHHHHHhccCCCCceeEeee
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD--------------HGMKQFVSEIVSMGKLRHRNLVQLRGY 401 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~--------------~~~~~~~~Ei~~l~~l~H~nIv~l~g~ 401 (660)
-+|+.++.||+|.||.|-+|+...+++.||||++.+... ...++..+||.+|++++|||||+|+.+
T Consensus 97 Nqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEv 176 (576)
T KOG0585|consen 97 NQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEV 176 (576)
T ss_pred hheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEe
Confidence 379999999999999999999999999999999854311 113578999999999999999999998
Q ss_pred eeec--CeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEE
Q 006112 402 CRRK--GELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKL 479 (660)
Q Consensus 402 ~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl 479 (660)
..+. +.+|||+|||..|.+...-. ....+...+++++++++..||+|||. ++||||||||+|+||++++++||
T Consensus 177 LDDP~s~~~YlVley~s~G~v~w~p~--d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~VKI 251 (576)
T KOG0585|consen 177 LDDPESDKLYLVLEYCSKGEVKWCPP--DKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGTVKI 251 (576)
T ss_pred ecCcccCceEEEEEeccCCccccCCC--CcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCcEEe
Confidence 8765 57999999999988865321 22338999999999999999999998 99999999999999999999999
Q ss_pred eecccceeccCCCC----ceeeccccCccccCcccccCCC----CCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHH
Q 006112 480 GDFGLARLYDHGND----LHTTNVVGTVGYLAPELLRNGR----GTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWV 550 (660)
Q Consensus 480 ~DFGla~~~~~~~~----~~~~~~~gt~~Y~aPE~~~~~~----~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~ 550 (660)
+|||.+.....+.. ......+|||.|||||++.++. .+.+.||||+||+||+|+.|+.||..+.. ++.+.+
T Consensus 252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KI 331 (576)
T KOG0585|consen 252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKI 331 (576)
T ss_pred eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHH
Confidence 99999986643321 2223478999999999987743 35689999999999999999999975322 222211
Q ss_pred HHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhh
Q 006112 551 IDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605 (660)
Q Consensus 551 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (660)
.. +.+... -.+++-+.+.+|++.+|.+||++|.+..+|..+.-
T Consensus 332 ----vn-~pL~fP-------~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 332 ----VN-DPLEFP-------ENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred ----hc-CcccCC-------CcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 11 111111 11244566788888999999999999999988764
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=337.04 Aligned_cols=251 Identities=24% Similarity=0.389 Sum_probs=212.8
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCe-eEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGE-LLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~-~~lV~E 413 (660)
.|.-++.+|+|+||.++..+++.++..+++|++... .....+...+|+.++++++|||||.+.+.+.+++. ++|||+
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~ 84 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME 84 (426)
T ss_pred hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence 578889999999999999999999999999998654 33445578899999999999999999999988887 999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
||+||+|.+.+.+.....++++++++++.|++.|+.|||+ +.|+|||||+.||+++.+..+||+|||+|+.+.....
T Consensus 85 Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 85 YCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred ecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence 9999999999987766678999999999999999999997 9999999999999999999999999999998766542
Q ss_pred ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
....+.||+-||.||++.+.+|..|+|||||||++|||++-+++|...+..- -+.+..+. . ..| +...
T Consensus 162 -~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~--Li~ki~~~-~----~~P-lp~~--- 229 (426)
T KOG0589|consen 162 -LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE--LILKINRG-L----YSP-LPSM--- 229 (426)
T ss_pred -hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH--HHHHHhhc-c----CCC-CCcc---
Confidence 3445899999999999999999999999999999999999999998755321 12221111 1 112 2222
Q ss_pred HHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
....+..++..|+..+|..||++.+++..
T Consensus 230 -ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 230 -YSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -ccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 33457778888999999999999999864
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=327.81 Aligned_cols=241 Identities=23% Similarity=0.324 Sum_probs=194.8
Q ss_pred cccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCeeEEEEecCCC
Q 006112 342 YKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVYDYMPN 417 (660)
Q Consensus 342 ~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~ 417 (660)
+.||+|+||.||+|++..+++.||+|.+.... ....+.+..|..++..+ +||||+++++++.+++.+++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36899999999999999999999999986532 23455677788888754 899999999999999999999999999
Q ss_pred CChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCceee
Q 006112 418 GSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTT 497 (660)
Q Consensus 418 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 497 (660)
|+|..++.... .+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (316)
T cd05620 81 GDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRAS 154 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Ccee
Confidence 99999987643 48889999999999999999998 999999999999999999999999999987532222 2234
Q ss_pred ccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHH
Q 006112 498 NVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQME 577 (660)
Q Consensus 498 ~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 577 (660)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+....+. +.+.... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~~~~~~~~------~~~~~~~----~~ 221 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELFESIRVDT------PHYPRWI----TK 221 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCC------CCCCCCC----CH
Confidence 567999999999999989999999999999999999999999764432 1222222211 1111222 23
Q ss_pred HHHHHhhhccCCCCCCCCCHH-HHH
Q 006112 578 IVLKLGLFCSHSNPDTRPSMR-QVV 601 (660)
Q Consensus 578 ~l~~l~~~Cl~~dP~~RPs~~-evl 601 (660)
.+.+++..|++.||++||++. +++
T Consensus 222 ~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 222 ESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHHH
Confidence 456788889999999999984 665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=323.88 Aligned_cols=255 Identities=22% Similarity=0.383 Sum_probs=203.7
Q ss_pred eeecccccccCccEEEEEEEeC----CCCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLP----SSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~----~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 411 (660)
+|+..+.+|+|+||.||+|.+. ..+..+|+|.+.... .+....+.+|+.++++++||||+++++++..+...++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 85 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML 85 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence 4667788999999999999852 355789999986433 34457899999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhhCC---------------CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCC
Q 006112 412 YDYMPNGSLDKILYSNT---------------RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLE 476 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~ 476 (660)
|||+++++|.+++.... ...+++.+...++.|++.||+|||+ ++++||||||+|||+++++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCCc
Confidence 99999999999985321 2347889999999999999999998 89999999999999999999
Q ss_pred eEEeecccceeccCCCC-ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHH
Q 006112 477 GKLGDFGLARLYDHGND-LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYW 554 (660)
Q Consensus 477 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~ 554 (660)
+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||...... .+.+..
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~~~~~~ 239 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---EVIEMV 239 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH
Confidence 99999999986543322 12233446778999999988889999999999999999998 88898653321 222222
Q ss_pred hcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 555 QKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 555 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
..+.... ... .....+.+++.+||+.||++||++.+|.+.|+.
T Consensus 240 ~~~~~~~-----~~~----~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 240 RKRQLLP-----CSE----DCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HcCCcCC-----CCC----CCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 2222111 111 223457788889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=318.50 Aligned_cols=252 Identities=28% Similarity=0.436 Sum_probs=203.2
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 416 (660)
.|+.++++|+|+||.||++... ++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 7 SLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 5778889999999999999875 456799999865433 3467999999999999999999999875 456899999999
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCcee
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT 496 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 496 (660)
+++|.+++.......+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||+|||++...........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccc
Confidence 9999999976555568999999999999999999998 8999999999999999999999999999987654332222
Q ss_pred eccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHH
Q 006112 497 TNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQ 575 (660)
Q Consensus 497 ~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 575 (660)
....++..|+|||.+.+..++.++||||||+++|||++ |..||...... + ..+....+... .. ....
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~-~~~~~~~~~~~-----~~----~~~~ 228 (260)
T cd05070 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--E-VLEQVERGYRM-----PC----PQDC 228 (260)
T ss_pred cCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--H-HHHHHHcCCCC-----CC----CCcC
Confidence 23345678999999988889999999999999999999 88888653321 1 11222221111 11 1122
Q ss_pred HHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 576 MEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 576 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
...+.+++.+|++.+|++|||++++.+.|+.
T Consensus 229 ~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 229 PISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 3458889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=324.48 Aligned_cols=259 Identities=28% Similarity=0.412 Sum_probs=207.5
Q ss_pred CceeeecccccccCccEEEEEEEeCCC-----CeEEEEEEeccC-CChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecC
Q 006112 334 HRFSYKNLYKATKGGSGKVYRGVLPSS-----HAEIAVKKVCHD-SDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKG 406 (660)
Q Consensus 334 ~~~~~~~l~~lg~G~fg~Vy~g~~~~~-----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 406 (660)
.+..|+..+.+|+|+||.||++..... ...+|+|.+... ..+...++.+|++++.++ +|+||++++++|..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 344678889999999999999998543 378999998654 234456789999999999 7999999999999999
Q ss_pred eeEEEEecCCCCChhhhhhhC--------------CCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEc
Q 006112 407 ELLLVYDYMPNGSLDKILYSN--------------TRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLD 472 (660)
Q Consensus 407 ~~~lV~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~ 472 (660)
..+++|||+++|+|..++... ....+++..+++++.|++.||+|||+ .+|+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEc
Confidence 999999999999999998642 23458999999999999999999998 9999999999999999
Q ss_pred CCCCeEEeecccceeccCCCCce-eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHH
Q 006112 473 ADLEGKLGDFGLARLYDHGNDLH-TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWV 550 (660)
Q Consensus 473 ~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~ 550 (660)
.++.+||+|||+++.+....... .....++..|+|||.+.+..++.++|||||||++|||++ |..||....... .
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~ 243 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---L 243 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH---H
Confidence 99999999999998765432211 222345678999999988889999999999999999997 888987543221 2
Q ss_pred HHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 551 IDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 551 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
.+....+.... ........+.+++.+||+.||++|||+.|+++.|+..
T Consensus 244 ~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 244 FKLLKEGYRME---------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HHHHHcCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 22222221111 1112234577899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=330.57 Aligned_cols=242 Identities=24% Similarity=0.347 Sum_probs=195.2
Q ss_pred cccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHhc-cCCCCceeEeeeeeecCeeEEEEecCCC
Q 006112 342 YKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSMGK-LRHRNLVQLRGYCRRKGELLLVYDYMPN 417 (660)
Q Consensus 342 ~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~-l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 417 (660)
+.||+|+||.||+|++..+++.||+|.+.... ....+.+..|..++.. ++||||+++++++.+++.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36899999999999999889999999986532 2345567778888876 4899999999999999999999999999
Q ss_pred CChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCceee
Q 006112 418 GSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTT 497 (660)
Q Consensus 418 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 497 (660)
|+|.+++.... .+++.++..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (316)
T cd05619 81 GDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTC 154 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Ccee
Confidence 99999997543 48899999999999999999998 899999999999999999999999999997532222 1233
Q ss_pred ccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHH
Q 006112 498 NVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQME 577 (660)
Q Consensus 498 ~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 577 (660)
...||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+....+. +.+.... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~~i~~~~------~~~~~~~----~~ 221 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---LFQSIRMDN------PCYPRWL----TR 221 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhCC------CCCCccC----CH
Confidence 4679999999999998899999999999999999999999997644321 122222111 1111112 23
Q ss_pred HHHHHhhhccCCCCCCCCCHH-HHHH
Q 006112 578 IVLKLGLFCSHSNPDTRPSMR-QVVQ 602 (660)
Q Consensus 578 ~l~~l~~~Cl~~dP~~RPs~~-evl~ 602 (660)
.+.+++..|++.||++||++. ++.+
T Consensus 222 ~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 222 EAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HHHHHHHHHhccCHhhcCCChHHHHc
Confidence 466778889999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=323.78 Aligned_cols=251 Identities=25% Similarity=0.322 Sum_probs=203.2
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
+|+..+.+|+|+||+||++.+..+++.+|+|.+.... ....+.+.+|++++++++|+||+++.+.+..++..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 3667788999999999999999899999999986432 2234567889999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
|+++++|..++.......+++..+..++.|++.||.|||+ ++|+||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 9999999999876555569999999999999999999998 8999999999999999999999999999976543221
Q ss_pred ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchH-HHHHHHHhcCCcccCCCCcccccCc
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLL-DWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
.....|+..|+|||++.+..++.++|+|||||++|||++|+.||........ +.+......+. ... .
T Consensus 158 --~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~------~~~----~ 225 (285)
T cd05632 158 --IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE------EVY----S 225 (285)
T ss_pred --ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc------ccc----C
Confidence 2345789999999999888999999999999999999999999976433211 11111111111 111 1
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCC-----HHHHHH
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRPS-----MRQVVQ 602 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 602 (660)
......+.+++..|++.||++||+ +.++++
T Consensus 226 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 226 AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 222334677888899999999999 666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=325.56 Aligned_cols=264 Identities=25% Similarity=0.350 Sum_probs=201.5
Q ss_pred eecccccccCccEEEEEEEe----CCCCeEEEEEEeccCCC-hhhHHHHHHHHHHhccCCCCceeEeeeeeec--CeeEE
Q 006112 338 YKNLYKATKGGSGKVYRGVL----PSSHAEIAVKKVCHDSD-HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK--GELLL 410 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~----~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~l 410 (660)
|+.++.+|+|+||+||++.. ..++..||+|.+..... ...+.+.+|++++++++||||++++++|... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 47888999999999987653 34677899999865432 3467889999999999999999999988754 45899
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccC
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDH 490 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 490 (660)
||||+++++|.+++... .+++.++..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 86 v~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 99999999999999653 48999999999999999999998 8999999999999999999999999999987654
Q ss_pred CCCce--eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHH---hcCCcccCCCC
Q 006112 491 GNDLH--TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYW---QKGDVLDASDP 565 (660)
Q Consensus 491 ~~~~~--~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~---~~~~~~~~~d~ 565 (660)
..... .....++..|+|||.+....++.++||||||+++|||++|+.|+........+...... ......+..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER 239 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhc
Confidence 32211 12234567799999998888999999999999999999999998643221111100000 00000000111
Q ss_pred cccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 566 RLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 566 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
.............+.+++..||++||++||+++++++.|+..
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred CCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 111111222345688899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=324.88 Aligned_cols=251 Identities=25% Similarity=0.334 Sum_probs=203.7
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
+|+..+.+|+|+||.||++....+++.+|+|.+.... ....+.+.+|+.++++++|+|++++++.+..++..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677788999999999999999999999999986432 2234567889999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
|+++++|.+++.......+++.++..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 9999999999876554568999999999999999999998 9999999999999999999999999999976543222
Q ss_pred ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHH-HHHhcCCcccCCCCcccccCc
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVI-DYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~-~~~~~~~~~~~~d~~l~~~~~ 572 (660)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||............ ...... .......
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~------~~~~~~~-- 227 (285)
T cd05630 158 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV------QEEYSEK-- 227 (285)
T ss_pred --ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh------hhhcCcc--
Confidence 22347899999999999989999999999999999999999999864322211111 111110 0111112
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCC-----HHHHHH
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRPS-----MRQVVQ 602 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 602 (660)
....+.+++..||+.||++||+ ++|+++
T Consensus 228 --~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 228 --FSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred --CCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 2334678888899999999999 888886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=319.05 Aligned_cols=251 Identities=26% Similarity=0.376 Sum_probs=201.4
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 416 (660)
+|+..+.+|+|+||.||++.+. ++..+|+|.+.... ....++.+|++++++++|+||+++++++...+..++||||++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 4677889999999999999985 46689999885432 234578899999999999999999999999999999999999
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCcee
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT 496 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 496 (660)
+++|.+++..... .+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++..........
T Consensus 83 ~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 83 NGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 9999999976543 58999999999999999999998 8999999999999999999999999999986543222222
Q ss_pred eccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHH
Q 006112 497 TNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQ 575 (660)
Q Consensus 497 ~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 575 (660)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||........ ......+.. .... ...
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~~~~~~~-----~~~~----~~~ 226 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV---VESVSAGYR-----LYRP----KLA 226 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH---HHHHHcCCc-----CCCC----CCC
Confidence 22234568999999998899999999999999999999 8889875332211 111122111 1111 123
Q ss_pred HHHHHHHhhhccCCCCCCCCCHHHHHHHhh
Q 006112 576 MEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605 (660)
Q Consensus 576 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (660)
...+.+++.+||+.+|++||++.|+++.|.
T Consensus 227 ~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 227 PTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 446888999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=324.70 Aligned_cols=261 Identities=23% Similarity=0.337 Sum_probs=206.5
Q ss_pred eeeecccccccCccEEEEEEEeCCCC----------------eEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSH----------------AEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQL 398 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~----------------~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l 398 (660)
-.|+.++.+|+|+||.||++++...+ ..||+|.+.... ....+++.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 36788899999999999999875433 568999987553 3456789999999999999999999
Q ss_pred eeeeeecCeeEEEEecCCCCChhhhhhhCC---------CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcE
Q 006112 399 RGYCRRKGELLLVYDYMPNGSLDKILYSNT---------RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANV 469 (660)
Q Consensus 399 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NI 469 (660)
+++|..++..++||||+++++|.+++.... ...+++..++.++.|++.||+|||+ .+|+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhce
Confidence 999999999999999999999999997543 1258999999999999999999998 8999999999999
Q ss_pred EEcCCCCeEEeecccceeccCCCC-ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh--CCCCCCCCCc-c
Q 006112 470 LLDADLEGKLGDFGLARLYDHGND-LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC--GRRPVQPGEL-D 545 (660)
Q Consensus 470 ll~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt--G~~p~~~~~~-~ 545 (660)
+++.++.+||+|||+++....... .......++..|+|||.+..+.++.++|||||||++|||++ +..||..... .
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence 999999999999999986543322 12234456789999999988889999999999999999998 6677764322 2
Q ss_pred hHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhh
Q 006112 546 LLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605 (660)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (660)
..+.....+..+...... .........+.+++.+|++.||++||++.||++.|+
T Consensus 242 ~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 242 VIENAGHFFRDDGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHHhccccccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 222222222221111110 011122356889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=331.23 Aligned_cols=247 Identities=23% Similarity=0.313 Sum_probs=199.3
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCeeEEEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
+|+.++.||+|+||.||+|+...+++.||+|.+.... ....+.+..|..++..+ +|++|+++++++...+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 3677889999999999999999899999999986542 23445677888888877 5899999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
||+++|+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 9999999999987654 48899999999999999999998 899999999999999999999999999997543221
Q ss_pred CceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCc
Q 006112 493 DLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 493 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......... .+...
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~---~~~i~~~~~------~~p~~-- 223 (323)
T cd05616 156 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL---FQSIMEHNV------AYPKS-- 223 (323)
T ss_pred -CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH---HHHHHhCCC------CCCCc--
Confidence 123346799999999999999999999999999999999999999986443221 111222111 11112
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCCH-----HHHHH
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRPSM-----RQVVQ 602 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~ 602 (660)
....+.+++..|++.||.+|++. .++.+
T Consensus 224 --~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 224 --MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred --CCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 23446778888999999999984 56654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=329.01 Aligned_cols=240 Identities=25% Similarity=0.298 Sum_probs=193.8
Q ss_pred ccccccCccEEEEEEEe---CCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 341 LYKATKGGSGKVYRGVL---PSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 341 l~~lg~G~fg~Vy~g~~---~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
++.||+|+||.||+++. ..+++.+|+|++.... ......+..|++++++++||||+++++++..++..++||||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 35789999999999876 3568899999986532 223456788999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 495 (660)
++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~ 154 (318)
T cd05582 81 RGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KK 154 (318)
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cc
Confidence 9999999986543 48999999999999999999998 899999999999999999999999999998654332 22
Q ss_pred eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHH
Q 006112 496 TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQ 575 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 575 (660)
.....||+.|+|||.+....++.++|||||||++|||++|+.||........ ......... .+....
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~---~~~i~~~~~------~~p~~~---- 221 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET---MTMILKAKL------GMPQFL---- 221 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH---HHHHHcCCC------CCCCCC----
Confidence 3346799999999999988889999999999999999999999976432211 111111111 111112
Q ss_pred HHHHHHHhhhccCCCCCCCCCHHH
Q 006112 576 MEIVLKLGLFCSHSNPDTRPSMRQ 599 (660)
Q Consensus 576 ~~~l~~l~~~Cl~~dP~~RPs~~e 599 (660)
...+.+++..||+.||++||++.+
T Consensus 222 ~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 222 SPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CHHHHHHHHHHhhcCHhHcCCCCC
Confidence 234667888899999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=322.97 Aligned_cols=255 Identities=24% Similarity=0.415 Sum_probs=202.7
Q ss_pred eeecccccccCccEEEEEEEeCC-----CCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPS-----SHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLL 410 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~-----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 410 (660)
.|+..+.+|+|+||.||+|.+.. .+..||+|++.... .....++.+|+.++++++||||+++++++.++...++
T Consensus 7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l 86 (277)
T cd05062 7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 86 (277)
T ss_pred HceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEE
Confidence 57788899999999999998642 35689999985433 2345678999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhhCC--------CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeec
Q 006112 411 VYDYMPNGSLDKILYSNT--------RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDF 482 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DF 482 (660)
||||+++|+|.+++.... ...+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||+||
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l~df 163 (277)
T cd05062 87 IMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDF 163 (277)
T ss_pred EEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEECCC
Confidence 999999999999986532 1246788999999999999999998 89999999999999999999999999
Q ss_pred ccceeccCCCCce-eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcc
Q 006112 483 GLARLYDHGNDLH-TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVL 560 (660)
Q Consensus 483 Gla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 560 (660)
|+++......... .....+++.|+|||.+.++.++.++|||||||++|||++ |..||...... ...+....+...
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~~~~~~~~~~~~ 240 (277)
T cd05062 164 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QVLRFVMEGGLL 240 (277)
T ss_pred CCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHHcCCcC
Confidence 9997654332211 122355788999999998889999999999999999999 68888653322 122222222211
Q ss_pred cCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 561 DASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 561 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
. +. ......+.+++.+|++.||++||++.|+++.|+.
T Consensus 241 ~-----~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 241 D-----KP----DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred C-----CC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1 11 1223467889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=326.89 Aligned_cols=255 Identities=23% Similarity=0.244 Sum_probs=198.0
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
+|+.++.||+|+||.||+++...+++.||+|.+... .....+.+.+|+.++..++|+||+++++++.+++.+++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 578899999999999999999989999999998642 23345678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
|+++|+|.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 82 YYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred cCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 999999999996533 358889999999999999999998 9999999999999999999999999999976554333
Q ss_pred ceeeccccCccccCcccccC-----CCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCccc
Q 006112 494 LHTTNVVGTVGYLAPELLRN-----GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLE 568 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~-----~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 568 (660)
.......||+.|+|||++.. +.++.++|||||||++|||++|+.||...... +.............. +...
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~--~~~~~i~~~~~~~~~--~~~~ 233 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV--ETYGKIMNHKEHFQF--PPDV 233 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH--HHHHHHHcCCCcccC--CCcc
Confidence 33334579999999999863 45788999999999999999999999754321 211222111111111 1111
Q ss_pred ccCcHHHHHHHHHHhhh--ccCCCCCCCCCHHHHHHH
Q 006112 569 GIYVEEQMEIVLKLGLF--CSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 569 ~~~~~~~~~~l~~l~~~--Cl~~dP~~RPs~~evl~~ 603 (660)
...+.+ +.+++.. |...++..||++++++++
T Consensus 234 ~~~~~~----~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 234 TDVSEE----AKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCCCHH----HHHHHHHHccCcccccCCCCHHHHhcC
Confidence 122333 3333333 445555668999999975
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=324.32 Aligned_cols=259 Identities=23% Similarity=0.376 Sum_probs=203.6
Q ss_pred eeeecccccccCccEEEEEEEe----CCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeee--cCeeE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVL----PSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR--KGELL 409 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~----~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~ 409 (660)
..|+.++.+|+|+||.||++.. ..++..||+|++........+.+.+|++++++++||||+++++++.. ...++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4688899999999999999985 34678999999977666677889999999999999999999998754 34689
Q ss_pred EEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceecc
Q 006112 410 LVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYD 489 (660)
Q Consensus 410 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 489 (660)
+||||+++|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++...
T Consensus 84 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 9999999999999997543 358999999999999999999998 899999999999999999999999999998765
Q ss_pred CCCCcee--eccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchH-------------HHHHHHH
Q 006112 490 HGNDLHT--TNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLL-------------DWVIDYW 554 (660)
Q Consensus 490 ~~~~~~~--~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~-------------~~~~~~~ 554 (660)
....... ....++..|+|||++.+..++.++|||||||++|||++|..++........ ....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 4332211 122344569999999888899999999999999999998877543221111 0011111
Q ss_pred hcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 555 QKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 555 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
..+.. + .........+.+++.+||+.+|++|||++||++.|+..
T Consensus 240 ~~~~~-------~--~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 240 KNNGR-------L--PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hcCCc-------C--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11100 0 00112234588899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=319.39 Aligned_cols=257 Identities=23% Similarity=0.373 Sum_probs=208.7
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
+|+..+.||+|+||.||++....++..+|||.+... .....+++.+|+.+++.++|+||+++++++.+++..+++||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 466778899999999999999888999999987543 22345688999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhC--CCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCC
Q 006112 414 YMPNGSLDKILYSN--TRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491 (660)
Q Consensus 414 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 491 (660)
|+++++|.+++... ....+++.++..++.||+.||.|||+ ++++|+||||+||+++.++.+||+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 99999999998642 23458999999999999999999998 99999999999999999999999999998865433
Q ss_pred CCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccC
Q 006112 492 NDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIY 571 (660)
Q Consensus 492 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 571 (660)
.. ......|+..|+|||++.+..++.++||||||+++|||++|..||............. ... ...+...
T Consensus 160 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~-----~~~~~~~--- 229 (267)
T cd08229 160 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK-IEQ-----CDYPPLP--- 229 (267)
T ss_pred Cc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhh-hhc-----CCCCCCC---
Confidence 22 1223568899999999988889999999999999999999999997544332222111 111 1111111
Q ss_pred cHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 572 VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
.......+.+++.+||+.||++||||.+|++.++.
T Consensus 230 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 230 SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 11234457788889999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=319.56 Aligned_cols=255 Identities=26% Similarity=0.404 Sum_probs=205.8
Q ss_pred eeecccccccCccEEEEEEEeCCC-----CeEEEEEEeccCCC-hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSS-----HAEIAVKKVCHDSD-HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLL 410 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~-----~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 410 (660)
+|+..+.+|+|+||.||+|..... +..||+|.+..... .....+.+|+.+++.++|+||+++++++......++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~ 86 (277)
T cd05032 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLV 86 (277)
T ss_pred HeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEE
Confidence 577788999999999999998643 37899999865432 345678999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhhCC--------CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeec
Q 006112 411 VYDYMPNGSLDKILYSNT--------RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDF 482 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DF 482 (660)
||||+++|+|.+++.... ...++|.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+||
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~df 163 (277)
T cd05032 87 VMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDF 163 (277)
T ss_pred EEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEECCc
Confidence 999999999999986532 2347889999999999999999998 99999999999999999999999999
Q ss_pred ccceeccCCCC-ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcc
Q 006112 483 GLARLYDHGND-LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVL 560 (660)
Q Consensus 483 Gla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 560 (660)
|+++....... .......++..|+|||.+.++.++.++|||||||++||+++ |..||....... ..+....+...
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~~~~~~~~ 240 (277)
T cd05032 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VLKFVIDGGHL 240 (277)
T ss_pred ccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HHHHHhcCCCC
Confidence 99976543322 12233456889999999988889999999999999999998 888986533221 22222222221
Q ss_pred cCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 561 DASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 561 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
.. ... ....+.+++..||+.+|++|||+.++++.|+.
T Consensus 241 ~~-----~~~----~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 241 DL-----PEN----CPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred CC-----CCC----CCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 11 111 24567889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=324.46 Aligned_cols=261 Identities=28% Similarity=0.332 Sum_probs=198.8
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhcc---CCCCceeEeeeeee-----cC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKL---RHRNLVQLRGYCRR-----KG 406 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l---~H~nIv~l~g~~~~-----~~ 406 (660)
+|+.++.+|+|+||.||+|+...+++.||+|.+.... ......+.+|+.+++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999999999999999986532 22234566777777665 69999999998764 24
Q ss_pred eeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccce
Q 006112 407 ELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLAR 486 (660)
Q Consensus 407 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 486 (660)
..++||||++ ++|.+++.......+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 5899999996 589898876655568999999999999999999998 899999999999999999999999999998
Q ss_pred eccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcc-hHHHHHHHHhcCCc------
Q 006112 487 LYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELD-LLDWVIDYWQKGDV------ 559 (660)
Q Consensus 487 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~~~------ 559 (660)
...... ......||..|+|||++.+..++.++||||+||++|||++|+.||...... ....+.........
T Consensus 157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 157 IYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 764322 223456899999999998888999999999999999999999998653321 11122211110000
Q ss_pred -------ccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 560 -------LDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 560 -------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.....+.......+...+.+.+++..|++.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000011112234567788999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=331.03 Aligned_cols=243 Identities=25% Similarity=0.333 Sum_probs=198.5
Q ss_pred cccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCeeEEEEecCCC
Q 006112 342 YKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVYDYMPN 417 (660)
Q Consensus 342 ~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~ 417 (660)
+.+|+|+||.||++++..+++.||||.+... .....+.+..|++++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3589999999999999988999999998753 234456778899999888 699999999999999999999999999
Q ss_pred CChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCceee
Q 006112 418 GSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTT 497 (660)
Q Consensus 418 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 497 (660)
|+|..++.... .+++.++..++.|++.||.|||+ ++|+||||||+|||+++++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (318)
T cd05570 81 GDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTS 154 (318)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cccc
Confidence 99999887653 48999999999999999999998 999999999999999999999999999987532221 1223
Q ss_pred ccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHH
Q 006112 498 NVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQME 577 (660)
Q Consensus 498 ~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 577 (660)
...||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......+.. .... ....
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~---~~~~i~~~~~------~~~~----~~~~ 221 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE---LFQSILEDEV------RYPR----WLSK 221 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH---HHHHHHcCCC------CCCC----cCCH
Confidence 4578999999999999999999999999999999999999997644221 1222222111 1111 1234
Q ss_pred HHHHHhhhccCCCCCCCCCH-----HHHHHH
Q 006112 578 IVLKLGLFCSHSNPDTRPSM-----RQVVQY 603 (660)
Q Consensus 578 ~l~~l~~~Cl~~dP~~RPs~-----~evl~~ 603 (660)
.+.+++..||+.||++||++ .+++++
T Consensus 222 ~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 222 EAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 56788889999999999999 888753
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=329.79 Aligned_cols=241 Identities=24% Similarity=0.229 Sum_probs=192.1
Q ss_pred cccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHH-HHhccCCCCceeEeeeeeecCeeEEEEecCCC
Q 006112 342 YKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIV-SMGKLRHRNLVQLRGYCRRKGELLLVYDYMPN 417 (660)
Q Consensus 342 ~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 417 (660)
+.||+|+||.||+++...+++.+|+|++... .....+++..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3589999999999999989999999998643 2234456666665 46779999999999999999999999999999
Q ss_pred CChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCceee
Q 006112 418 GSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTT 497 (660)
Q Consensus 418 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 497 (660)
|+|..++.... .+++.++..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~ 154 (325)
T cd05604 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTT 154 (325)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCcc
Confidence 99998886543 48899999999999999999998 999999999999999999999999999987532221 2233
Q ss_pred ccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHH
Q 006112 498 NVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQME 577 (660)
Q Consensus 498 ~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 577 (660)
...||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+....+.. .+.... ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~~~~~~~~------~~~~~~----~~ 221 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE---MYDNILHKPL------VLRPGA----SL 221 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH---HHHHHHcCCc------cCCCCC----CH
Confidence 4679999999999999999999999999999999999999997644321 1111122111 111112 23
Q ss_pred HHHHHhhhccCCCCCCCCCHHHHH
Q 006112 578 IVLKLGLFCSHSNPDTRPSMRQVV 601 (660)
Q Consensus 578 ~l~~l~~~Cl~~dP~~RPs~~evl 601 (660)
.+.+++..|++.||.+||++++.+
T Consensus 222 ~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 222 TAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred HHHHHHHHHhccCHHhcCCCCCCH
Confidence 456778889999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=319.52 Aligned_cols=255 Identities=25% Similarity=0.345 Sum_probs=204.3
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
-+|+..+.+|+|+||.||+|+...+++.||+|++........+.+.+|+.++++++||||+++++++..++..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 36888999999999999999998889999999997655555667889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 495 (660)
++++|.+++.... .+++.++..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++....... .
T Consensus 89 ~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~ 162 (267)
T cd06646 89 GGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-K 162 (267)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccccc-c
Confidence 9999999986543 48899999999999999999998 8999999999999999999999999999986543221 1
Q ss_pred eeccccCccccCccccc---CCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCc
Q 006112 496 TTNVVGTVGYLAPELLR---NGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
.....|+..|+|||.+. ...++.++|||||||++|||++|+.||........ .. ....... ..+.+.. .
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--~~-~~~~~~~---~~~~~~~--~ 234 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LF-LMSKSNF---QPPKLKD--K 234 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--he-eeecCCC---CCCCCcc--c
Confidence 23356889999999874 34578899999999999999999999864321100 00 0001110 1111111 1
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCCHHHHHHHh
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYL 604 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (660)
......+.+++.+||+.||++||++++++++|
T Consensus 235 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 235 TKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred cccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 12234677889999999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=315.20 Aligned_cols=258 Identities=24% Similarity=0.365 Sum_probs=211.6
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
+|+..+.+|+|+||.||+|....+++.||+|.+... .....+.+.+|++++++++|+|++++++++..++..++|||
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 82 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence 577788999999999999999888999999988532 23346789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhC--CCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCC
Q 006112 414 YMPNGSLDKILYSN--TRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491 (660)
Q Consensus 414 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 491 (660)
|+++++|.+++... ....+++.++..++.++++||.|||+ .+++||||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 99999999998643 23458899999999999999999998 99999999999999999999999999999865433
Q ss_pred CCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccC
Q 006112 492 NDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIY 571 (660)
Q Consensus 492 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 571 (660)
.. ......|+..|+|||.+.+..++.++|||||||++|||++|+.||........+... ....+... + ..
T Consensus 160 ~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~----~-~~--- 229 (267)
T cd08224 160 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK-KIEKCDYP----P-LP--- 229 (267)
T ss_pred Cc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHh-hhhcCCCC----C-CC---
Confidence 22 123356889999999998888999999999999999999999999765544333222 12222111 1 11
Q ss_pred cHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 572 VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
.......+.+++.+||+.+|++||++.+|++.|+..
T Consensus 230 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 230 ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 113345678889999999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=324.03 Aligned_cols=255 Identities=24% Similarity=0.376 Sum_probs=204.2
Q ss_pred eeecccccccCccEEEEEEEeCC-----CCeEEEEEEeccCCCh-hhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPS-----SHAEIAVKKVCHDSDH-GMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLL 410 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~-----~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 410 (660)
.|+.++.+|+|+||.||+|.+.. .+..||+|++...... ..+.+.+|+.++.+++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 46778889999999999998754 3578999999755433 34678899999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhhCC--------------CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCC
Q 006112 411 VYDYMPNGSLDKILYSNT--------------RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLE 476 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~ 476 (660)
++||+++++|.+++.... +..+++..+.+++.|++.||+|||+ ++|+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCc
Confidence 999999999999985321 2347888999999999999999998 89999999999999999999
Q ss_pred eEEeecccceeccCCCCc-eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHH
Q 006112 477 GKLGDFGLARLYDHGNDL-HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYW 554 (660)
Q Consensus 477 ~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~ 554 (660)
+||+|||+++........ ......+++.|+|||.+..+.++.++|||||||++|||++ |..||...... ...+..
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~~i 239 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DVIEMI 239 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH
Confidence 999999998865433221 1223456789999999988889999999999999999998 88888653321 122222
Q ss_pred hcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 555 QKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 555 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
..+.... . .......+.+++..||+.+|++||++++|++.|+.
T Consensus 240 ~~~~~~~-----~----~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 240 RNRQVLP-----C----PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HcCCcCC-----C----CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 3322211 1 11234457789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=332.37 Aligned_cols=257 Identities=26% Similarity=0.392 Sum_probs=202.9
Q ss_pred eeecccccccCccEEEEEEEeCC-----CCeEEEEEEeccCC-ChhhHHHHHHHHHHhcc-CCCCceeEeeeeeec-Cee
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPS-----SHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRK-GEL 408 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~-----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~-~~~ 408 (660)
.|+.++.||+|+||.||+|.... +++.||+|++.... ....+.+..|+.++.++ +|+||++++++|... ..+
T Consensus 8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~ 87 (337)
T cd05054 8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPL 87 (337)
T ss_pred HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCE
Confidence 57888999999999999997543 34789999986543 33456788999999999 899999999988754 568
Q ss_pred EEEEecCCCCChhhhhhhCC-----------------------------------------------------------C
Q 006112 409 LLVYDYMPNGSLDKILYSNT-----------------------------------------------------------R 429 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~-----------------------------------------------------------~ 429 (660)
+++|||+++++|.+++.... .
T Consensus 88 ~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (337)
T cd05054 88 MVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYK 167 (337)
T ss_pred EEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhh
Confidence 89999999999999985422 1
Q ss_pred CCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC-ceeeccccCccccCc
Q 006112 430 PSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND-LHTTNVVGTVGYLAP 508 (660)
Q Consensus 430 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aP 508 (660)
..++|.++.+++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.+..... .......++..|+||
T Consensus 168 ~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 168 EPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 258999999999999999999998 8999999999999999999999999999987543322 122234567789999
Q ss_pred ccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhcc
Q 006112 509 ELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCS 587 (660)
Q Consensus 509 E~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl 587 (660)
|++.+..++.++|||||||++|||++ |..||...... +........+.... . .......+.+++.+||
T Consensus 245 E~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~~~~-----~----~~~~~~~~~~l~~~cl 313 (337)
T cd05054 245 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID--EEFCRRLKEGTRMR-----A----PEYATPEIYSIMLDCW 313 (337)
T ss_pred HHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc--HHHHHHHhccCCCC-----C----CccCCHHHHHHHHHHc
Confidence 99999999999999999999999998 99998653221 11122222221111 1 1122345788899999
Q ss_pred CCCCCCCCCHHHHHHHhhCC
Q 006112 588 HSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 588 ~~dP~~RPs~~evl~~L~~~ 607 (660)
+.+|++||++.|++++|+..
T Consensus 314 ~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 314 HNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred cCChhhCcCHHHHHHHHHHH
Confidence 99999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=338.22 Aligned_cols=260 Identities=25% Similarity=0.296 Sum_probs=200.5
Q ss_pred eecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeecC-----eeEE
Q 006112 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKG-----ELLL 410 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~~l 410 (660)
|+..+.||+|+||.||++....+++.||||++... .....+++.+|+.+++.++|+||+++++++...+ ..++
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 81 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV 81 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence 56788999999999999999889999999998643 2234568899999999999999999999998776 7899
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccC
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDH 490 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 490 (660)
|+||+. ++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 82 v~e~~~-~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 82 VTELMQ-SDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred Eeeccc-cCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 999995 68888775543 58999999999999999999998 8999999999999999999999999999987654
Q ss_pred CCCceeeccccCccccCcccccCC-CCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHHHHHHhcCCc---------
Q 006112 491 GNDLHTTNVVGTVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVIDYWQKGDV--------- 559 (660)
Q Consensus 491 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~~~~~~~--------- 559 (660)
..........+|+.|+|||.+.+. .++.++|||||||++|||++|+.||..... ...+.+.+.......
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence 433333445689999999998764 478999999999999999999999976432 111111111100000
Q ss_pred ------ccCCCC-cccc--cCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 560 ------LDASDP-RLEG--IYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 560 ------~~~~d~-~l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.....+ .... .......+.+.+++..|++.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000 0000 0111223457788999999999999999999973
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=318.38 Aligned_cols=254 Identities=26% Similarity=0.439 Sum_probs=201.8
Q ss_pred eecccccccCccEEEEEEEeCCC---CeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCe-----
Q 006112 338 YKNLYKATKGGSGKVYRGVLPSS---HAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGE----- 407 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~~~---~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~----- 407 (660)
|+..+.+|+|+||.||+|.+..+ +..||+|++.... ....+++.+|++.+++++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 45678899999999999998643 3789999987542 3446789999999999999999999998876554
Q ss_pred -eEEEEecCCCCChhhhhhhC----CCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeec
Q 006112 408 -LLLVYDYMPNGSLDKILYSN----TRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDF 482 (660)
Q Consensus 408 -~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DF 482 (660)
.++|+||+++|+|..++... ....+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence 79999999999999998543 22458999999999999999999998 89999999999999999999999999
Q ss_pred ccceeccCCCCce-eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcc
Q 006112 483 GLARLYDHGNDLH-TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVL 560 (660)
Q Consensus 483 Gla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 560 (660)
|+++......... .....++..|+|||.+....++.++|||||||++|||++ |..||...... + ..+....+...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~-~~~~~~~~~~~ 234 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--E-IYDYLRHGNRL 234 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--H-HHHHHHcCCCC
Confidence 9998765433221 122345678999999988889999999999999999999 88888653321 1 12222222211
Q ss_pred cCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 561 DASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 561 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
. .. ......+.+++.+||+.||++||++.|+++.|+.
T Consensus 235 ~-----~~----~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 235 K-----QP----EDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred C-----CC----cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 1 11 1234467888889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=323.39 Aligned_cols=252 Identities=24% Similarity=0.356 Sum_probs=207.8
Q ss_pred CceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 334 HRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 334 ~~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
....|+.++.+|+|++|.||+|....++..||+|.+........+.+.+|+.++++++|+||+++++.+..+...++|||
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 34588999999999999999999988899999999976665666789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
|+++++|.+++... .+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 98 ~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 98 YLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred ccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 99999999998643 37889999999999999999998 8999999999999999999999999999876543221
Q ss_pred ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
......|++.|+|||.+.+..++.++|||||||++|||++|+.||...... .........+. +.+ ....
T Consensus 172 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~--~~~~~~~~~~~------~~~--~~~~ 240 (296)
T cd06654 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RALYLIATNGT------PEL--QNPE 240 (296)
T ss_pred -ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH--HhHHHHhcCCC------CCC--CCcc
Confidence 123356889999999998888899999999999999999999999754321 11111111111 001 0112
Q ss_pred HHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
.....+.+++.+||..||++||++.++++
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred ccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 23345778889999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=315.95 Aligned_cols=254 Identities=26% Similarity=0.421 Sum_probs=205.7
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
+.+|+.++++|+|+||.||+|... +++.||+|.+.... ...+++.+|+.++++++|+||+++++++ ..+..+++|||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~ 81 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEY 81 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEc
Confidence 346888899999999999999875 56789999986543 3356899999999999999999999986 45678999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
+++++|.+++.......+++.++..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 999999999976655678999999999999999999998 89999999999999999999999999999876533322
Q ss_pred eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 495 HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
......++..|+|||++....++.++||||||+++||+++ |+.||....... .......+.... ...
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~~~~~~-----~~~---- 226 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---VIQNLERGYRMP-----RPD---- 226 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---HHHHHHcCCCCC-----CCC----
Confidence 2233456788999999988889999999999999999999 999997543221 111122221111 111
Q ss_pred HHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
.....+.+++.+|++.+|++||+++++++.|+.
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 227 NCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 123458889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=318.66 Aligned_cols=254 Identities=30% Similarity=0.431 Sum_probs=204.9
Q ss_pred eecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhh--HHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGM--KQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~--~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
|+..+.||+|+||+||+++...+++.+|+|.+........ ....+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 6788999999999999999999999999999976644332 23456999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 495 (660)
++++|.+++... ..+++.++..++.|+++||.+||+ .+|+||||||+||++++++.++|+|||.+.... .....
T Consensus 81 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNEN 154 (260)
T ss_dssp TTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSE
T ss_pred cccccccccccc--cccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-ccccc
Confidence 999999999833 348999999999999999999998 899999999999999999999999999998652 22233
Q ss_pred eeccccCccccCccccc-CCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHH
Q 006112 496 TTNVVGTVGYLAPELLR-NGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEE 574 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~~-~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 574 (660)
.....++..|+|||.+. ....+.++||||+|+++|+|++|+.||......................... ....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~ 228 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ------QSRE 228 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT------SHTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc------ccch
Confidence 44567899999999998 7888999999999999999999999998652222222221111111000000 0001
Q ss_pred HHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 575 QMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 575 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
....+.+++..|++.||++||++.+++++
T Consensus 229 ~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 229 KSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp SHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred hHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 12678889999999999999999999853
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=321.15 Aligned_cols=255 Identities=24% Similarity=0.382 Sum_probs=204.9
Q ss_pred eeecccccccCccEEEEEEEeC-----CCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLP-----SSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~-----~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 411 (660)
++...+++|+|+||.||++... .++..+|+|.+........+.+.+|++++++++|+||+++++++...+..++|
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (280)
T cd05092 6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMV 85 (280)
T ss_pred hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEE
Confidence 5666789999999999999753 24678999998776666778899999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhhCCC-------------CCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeE
Q 006112 412 YDYMPNGSLDKILYSNTR-------------PSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGK 478 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~k 478 (660)
|||+++++|.+++..... ..+++.++..++.|++.||+|||+ .+++||||||+|||+++++.+|
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 86 FEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred EecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCEE
Confidence 999999999999875421 348899999999999999999998 9999999999999999999999
Q ss_pred EeecccceeccCCCCc-eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhc
Q 006112 479 LGDFGLARLYDHGNDL-HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQK 556 (660)
Q Consensus 479 l~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~ 556 (660)
|+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |..||........ ......
T Consensus 163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~~~~~ 239 (280)
T cd05092 163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA---IECITQ 239 (280)
T ss_pred ECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH---HHHHHc
Confidence 9999999765432211 1223345788999999998899999999999999999998 8999865332111 111122
Q ss_pred CCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 557 GDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 557 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
+.... . .. .....+.+++.+||+.||++||++++|++.|+.
T Consensus 240 ~~~~~--~---~~----~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 240 GRELE--R---PR----TCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred CccCC--C---CC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 21111 0 11 123457788899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=347.57 Aligned_cols=253 Identities=24% Similarity=0.307 Sum_probs=204.6
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeecC-------
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKG------- 406 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------- 406 (660)
-+|+..+.||+|+||.||+++...+++.||||++... .......+.+|+.++..++|+||++++..+...+
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 3788899999999999999999889999999998654 3345667889999999999999999988765332
Q ss_pred -eeEEEEecCCCCChhhhhhhCC--CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecc
Q 006112 407 -ELLLVYDYMPNGSLDKILYSNT--RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFG 483 (660)
Q Consensus 407 -~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG 483 (660)
.+++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 3689999999999999986532 3458889999999999999999998 899999999999999999999999999
Q ss_pred cceeccCCCC-ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccC
Q 006112 484 LARLYDHGND-LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDA 562 (660)
Q Consensus 484 la~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 562 (660)
+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+......+...
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~---~~~~~~~~~~~~-- 263 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME---EVMHKTLAGRYD-- 263 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHhcCCCC--
Confidence 9987653321 2233467999999999999989999999999999999999999999764332 122222222211
Q ss_pred CCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 563 SDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 563 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
+ +.. .....+.+++..||+.||.+||++.+++++
T Consensus 264 --~-~~~----~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 264 --P-LPP----SISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred --C-CCC----CCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1 111 223457788889999999999999999864
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=321.16 Aligned_cols=254 Identities=26% Similarity=0.407 Sum_probs=202.9
Q ss_pred eeecccccccCccEEEEEEEeCC-----CCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPS-----SHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLL 410 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~-----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 410 (660)
.|+..+.+|+|++|.||+|.+.. .+..||+|.+.... ......|.+|+.++++++|+||+++++++.+.+..++
T Consensus 7 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 86 (277)
T cd05036 7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFI 86 (277)
T ss_pred HcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEE
Confidence 57788899999999999999976 67889999886543 3345679999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhhCCC-----CCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCC---CeEEeec
Q 006112 411 VYDYMPNGSLDKILYSNTR-----PSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADL---EGKLGDF 482 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~---~~kl~DF 482 (660)
||||+++++|.+++..... ..++|.++.+++.||+.||+|||+ ++++||||||+||+++.++ .+||+||
T Consensus 87 v~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~df 163 (277)
T cd05036 87 LLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADF 163 (277)
T ss_pred EEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEeccC
Confidence 9999999999999875431 258999999999999999999998 8999999999999998754 5999999
Q ss_pred ccceeccCCCCc-eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcc
Q 006112 483 GLARLYDHGNDL-HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVL 560 (660)
Q Consensus 483 Gla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 560 (660)
|+++........ .......+..|+|||++.+..++.++|||||||++|||++ |+.||....... ...........
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~~~~~~~~~~~ 240 (277)
T cd05036 164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---VMEFVTGGGRL 240 (277)
T ss_pred ccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHcCCcC
Confidence 999865322211 1112234568999999998899999999999999999997 999987543221 11222211111
Q ss_pred cCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhh
Q 006112 561 DASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605 (660)
Q Consensus 561 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (660)
. ........+.+++.+|++.+|++||++.+|+++|+
T Consensus 241 ~---------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 241 D---------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred C---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1 11122346778899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=315.16 Aligned_cols=252 Identities=27% Similarity=0.403 Sum_probs=202.4
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 416 (660)
.|.....+|+|++|.||++.+..+ ..+|+|.+.... ...+.+.+|++++++++|+|++++++++. .+..++||||++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 7 SLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 477778899999999999998654 469999875433 33467899999999999999999999875 456899999999
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCcee
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT 496 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 496 (660)
+++|.+++.......++|..+..++.|++.||.|||+ .+++||||||+||++++++.+||+|||+++..........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence 9999999976555568999999999999999999998 8999999999999999999999999999987644332222
Q ss_pred eccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHH
Q 006112 497 TNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQ 575 (660)
Q Consensus 497 ~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 575 (660)
....++..|+|||...+..++.++||||||+++|||++ |+.||....... .......+.. +. .....
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~~~~-----~~----~~~~~ 228 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLEQVERGYR-----MP----CPQGC 228 (260)
T ss_pred CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCCC-----CC----CCccc
Confidence 23456778999999988889999999999999999999 888987533211 1111122111 00 11223
Q ss_pred HHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 576 MEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 576 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
...+.+++.+||+.||++||++++|++.|+.
T Consensus 229 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 229 PESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 4567888899999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=316.06 Aligned_cols=247 Identities=23% Similarity=0.377 Sum_probs=197.4
Q ss_pred ccccCccEEEEEEEeC--CCCeEEEEEEeccCCC-hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCCCCC
Q 006112 343 KATKGGSGKVYRGVLP--SSHAEIAVKKVCHDSD-HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGS 419 (660)
Q Consensus 343 ~lg~G~fg~Vy~g~~~--~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gs 419 (660)
.+|+|+||.||+|.+. ..+..||+|.+..... ...+.+.+|+.++++++||||++++++|. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999874 4456799999865533 34567999999999999999999999885 457899999999999
Q ss_pred hhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCcee--e
Q 006112 420 LDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT--T 497 (660)
Q Consensus 420 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~--~ 497 (660)
|.+++.... ..+++.++.+++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++.......... .
T Consensus 81 L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 81 LNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 999987543 358999999999999999999998 8999999999999999999999999999986544332211 2
Q ss_pred ccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHH
Q 006112 498 NVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQM 576 (660)
Q Consensus 498 ~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 576 (660)
...++..|+|||.+....++.++|||||||++||+++ |..||....... +......+.... .+....
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~~~~~~---------~~~~~~ 224 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE---VMSFIEQGKRLD---------CPAECP 224 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHHHCCCCCC---------CCCCCC
Confidence 2234578999999988889999999999999999996 999997543221 222223332211 111234
Q ss_pred HHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 577 EIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 577 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
..+.+++..||..||++||++.+|.+.|+.
T Consensus 225 ~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 225 PEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 557788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=315.96 Aligned_cols=251 Identities=25% Similarity=0.341 Sum_probs=203.4
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC-----ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-----DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 411 (660)
+|+..+.+|+|++|.||++....+++.+|+|.+.... ....+.+.+|++++++++||||+++++++.++...++|
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 82 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF 82 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence 4677889999999999999998889999999986432 12345788999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCC
Q 006112 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 491 (660)
+||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++||||||+||++++++.+||+|||+++.....
T Consensus 83 ~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 83 MEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 99999999999987643 47888999999999999999998 89999999999999999999999999999765432
Q ss_pred CCcee--eccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccc
Q 006112 492 NDLHT--TNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEG 569 (660)
Q Consensus 492 ~~~~~--~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 569 (660)
..... ....|+..|+|||.+.+..++.++||||||+++|||++|+.||...+.. ........... .+.+.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~-----~~~~~- 229 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM--AAIFKIATQPT-----NPQLP- 229 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH--HHHHHHhccCC-----CCCCC-
Confidence 21111 2356788999999999888999999999999999999999998753321 11111111111 11111
Q ss_pred cCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 570 IYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
......+.+++..||..+|++||++.|++++
T Consensus 230 ---~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 230 ---SHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ---ccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 2233457788889999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=314.60 Aligned_cols=251 Identities=25% Similarity=0.350 Sum_probs=206.7
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC-CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD-SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
+|+..+.+|+|+||.||++....++..+|+|.+... .....+.+.+|+.++++++|+||+++++.+..++.+++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 367788999999999999999989999999998643 3345678889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 495 (660)
++++|.+++.......+++.....++.|++.||.|||+ ++|+|+||||+||++++++.++|+|||+++....... .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence 99999999876554568899999999999999999998 9999999999999999999999999999986643322 2
Q ss_pred eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHH
Q 006112 496 TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQ 575 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 575 (660)
.....|++.|+|||++.+..++.++|+||||+++|+|++|+.||........ ... ...+.... +.. ..
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~-~~~~~~~~-----~~~----~~ 224 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL--ILK-VCQGSYKP-----LPS----HY 224 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH--HHH-HhcCCCCC-----CCc----cc
Confidence 2345689999999999888899999999999999999999999976443211 111 12222111 111 12
Q ss_pred HHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 576 MEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 576 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
...+.+++.+||+.||++||++.+++..
T Consensus 225 ~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 225 SYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 2346788889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=316.11 Aligned_cols=246 Identities=25% Similarity=0.374 Sum_probs=197.5
Q ss_pred ccccCccEEEEEEEe--CCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCCCC
Q 006112 343 KATKGGSGKVYRGVL--PSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNG 418 (660)
Q Consensus 343 ~lg~G~fg~Vy~g~~--~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g 418 (660)
++|+|+||.||+|.+ ..++..+|+|++.... ....+++.+|+.++++++||||+++++++. ....++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999975 3467899999986443 234678999999999999999999999885 45678999999999
Q ss_pred ChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce--e
Q 006112 419 SLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH--T 496 (660)
Q Consensus 419 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~--~ 496 (660)
+|.+++.... .+++..+.+++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++......... .
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 9999996543 48899999999999999999998 899999999999999999999999999998765443221 1
Q ss_pred eccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHH
Q 006112 497 TNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQ 575 (660)
Q Consensus 497 ~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 575 (660)
....++..|+|||.+....++.++|||||||++|||++ |+.||....... .......+.... .... .
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~i~~~~~~~-----~~~~----~ 223 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---VTQMIESGERME-----CPQR----C 223 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHCCCCCC-----CCCC----C
Confidence 22344679999999988889999999999999999998 999997543221 122223322111 1122 2
Q ss_pred HHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 576 MEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 576 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
...+.+++.+||+.||++||++.+|++.|++
T Consensus 224 ~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 224 PPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 3457789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=332.56 Aligned_cols=254 Identities=22% Similarity=0.240 Sum_probs=199.7
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
-.|+.++.+|+|+||.||++++..+++.+|+|.+... .....+.+.+|+.+++.++||||+++++++.+++.+++||
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 122 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 4788899999999999999999999999999998542 2233456889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
|||++|+|.+++... .++...+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 123 Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~ 196 (371)
T cd05622 123 EYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 196 (371)
T ss_pred cCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC
Confidence 999999999998653 37888889999999999999998 999999999999999999999999999998765433
Q ss_pred CceeeccccCccccCcccccCC----CCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCccc
Q 006112 493 DLHTTNVVGTVGYLAPELLRNG----RGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLE 568 (660)
Q Consensus 493 ~~~~~~~~gt~~Y~aPE~~~~~----~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 568 (660)
........||+.|+|||++... .++.++|||||||++|||++|+.||...... ................+.
T Consensus 197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~--- 271 (371)
T cd05622 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--GTYSKIMNHKNSLTFPDD--- 271 (371)
T ss_pred cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH--HHHHHHHcCCCcccCCCc---
Confidence 3333456799999999998753 3788999999999999999999999864432 111111111111111110
Q ss_pred ccCcHHHHHHHHHHhhhccCCCCCC--CCCHHHHHHHh
Q 006112 569 GIYVEEQMEIVLKLGLFCSHSNPDT--RPSMRQVVQYL 604 (660)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~L 604 (660)
......+.+++..|+..++.+ ||+++|++++.
T Consensus 272 ----~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 272 ----NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred ----CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 112234556677788744433 78999999854
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=314.08 Aligned_cols=264 Identities=25% Similarity=0.320 Sum_probs=207.8
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCCh--hhHHHHHHHHHHhccCCCC-ceeEeeeeeecC-----
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDH--GMKQFVSEIVSMGKLRHRN-LVQLRGYCRRKG----- 406 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~H~n-Iv~l~g~~~~~~----- 406 (660)
...|+.++++|+|.||+||+|+...+|+.||+|+++....+ .-....+|+.++++++|+| |+++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 45688889999999999999999999999999999766442 3456789999999999999 999999998877
Q ss_pred -eeEEEEecCCCCChhhhhhhCCC--CCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecc
Q 006112 407 -ELLLVYDYMPNGSLDKILYSNTR--PSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFG 483 (660)
Q Consensus 407 -~~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG 483 (660)
.+++|+||+ .-+|.+++..... ..++...+..++.||+.||+|||+ ++|+||||||.||||+++|.+||+|||
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccc
Confidence 789999999 7899999987653 357778899999999999999998 999999999999999999999999999
Q ss_pred cceeccCCCCceeeccccCccccCcccccCC-CCCcceeEEehHHHHHHHhhCCCCCCCCC-cchHHHHHHHHhcCCcc-
Q 006112 484 LARLYDHGNDLHTTNVVGTVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQPGE-LDLLDWVIDYWQKGDVL- 560 (660)
Q Consensus 484 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~-~~~~~~~~~~~~~~~~~- 560 (660)
+|+.+.-.... .+..++|..|.|||++.+. .|+...||||+||++.||++++.-|.+.. .+....+.+........
T Consensus 166 lAra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 166 LARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred hHHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 99976543322 3456789999999998876 78999999999999999999887776532 22333333332221110
Q ss_pred -----cCCC-----Cccc--ccCcHHHH---HHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 561 -----DASD-----PRLE--GIYVEEQM---EIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 561 -----~~~d-----~~l~--~~~~~~~~---~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
...+ +... ........ ....+++.+|++.+|.+|.|++.++++
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0000 0111 01111111 357788889999999999999999975
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=300.52 Aligned_cols=248 Identities=27% Similarity=0.345 Sum_probs=208.9
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
+++..+.+|+|.||.||.|+.+.++-.||+|++.+.. .+..+++.+|++|-+.|+||||+++++|+.+...+||++|
T Consensus 23 dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilE 102 (281)
T KOG0580|consen 23 DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILE 102 (281)
T ss_pred hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEE
Confidence 4667788999999999999999999999999986542 2345689999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
|.++|+|.+.|.......+++.....++.|+|.||.|+|. ++|+||||||+|+|++.++..||+|||-+.... .
T Consensus 103 ya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---~ 176 (281)
T KOG0580|consen 103 YAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---S 176 (281)
T ss_pred ecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC---C
Confidence 9999999999997666679999999999999999999998 999999999999999999999999999987543 2
Q ss_pred ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
......+||.-|.+||+..+...+.+.|+|++|++.||++.|..||...... ...+.+.+ .+..+| ..
T Consensus 177 ~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~---etYkrI~k---~~~~~p---~~--- 244 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS---ETYKRIRK---VDLKFP---ST--- 244 (281)
T ss_pred CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH---HHHHHHHH---ccccCC---cc---
Confidence 3345689999999999999999999999999999999999999999864421 11111111 122222 22
Q ss_pred HHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
......+++..|+..+|.+|.+..|++++
T Consensus 245 -is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 245 -ISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -cChhHHHHHHHHhccCccccccHHHHhhh
Confidence 22345677778999999999999999975
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=327.13 Aligned_cols=244 Identities=25% Similarity=0.305 Sum_probs=196.9
Q ss_pred ccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCeeEEEEecCCCC
Q 006112 343 KATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVYDYMPNG 418 (660)
Q Consensus 343 ~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~g 418 (660)
.||+|+||.||+++...+++.||+|++... .....+.+.+|+.++.++ +||||+++++++...+.+++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG 81 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence 589999999999999999999999999754 233456788999999888 6999999999999999999999999999
Q ss_pred ChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCceeec
Q 006112 419 SLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTN 498 (660)
Q Consensus 419 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 498 (660)
+|..++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 82 ~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (327)
T cd05617 82 DLMFHMQRQR--KLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTST 155 (327)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cceec
Confidence 9999886543 48999999999999999999998 899999999999999999999999999997532211 12334
Q ss_pred cccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCC----CcchHHHHHHHHhcCCcccCCCCcccccCcHH
Q 006112 499 VVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPG----ELDLLDWVIDYWQKGDVLDASDPRLEGIYVEE 574 (660)
Q Consensus 499 ~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~----~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 574 (660)
..||+.|+|||++.+..++.++|||||||++|||++|+.||... .....++..+....... .+....+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~p~~~~-- 227 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI------RIPRFLS-- 227 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC------CCCCCCC--
Confidence 67999999999999999999999999999999999999999641 11222333333322211 1112222
Q ss_pred HHHHHHHHhhhccCCCCCCCCC------HHHHHH
Q 006112 575 QMEIVLKLGLFCSHSNPDTRPS------MRQVVQ 602 (660)
Q Consensus 575 ~~~~l~~l~~~Cl~~dP~~RPs------~~evl~ 602 (660)
..+.+++..|++.||++||+ ++++++
T Consensus 228 --~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 259 (327)
T cd05617 228 --VKASHVLKGFLNKDPKERLGCQPQTGFSDIKS 259 (327)
T ss_pred --HHHHHHHHHHhccCHHHcCCCCCCCCHHHHHc
Confidence 34567788899999999998 457765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=312.41 Aligned_cols=246 Identities=25% Similarity=0.392 Sum_probs=199.4
Q ss_pred ccccCccEEEEEEEeCCCCeEEEEEEeccCCCh-hhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCCCCChh
Q 006112 343 KATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDH-GMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLD 421 (660)
Q Consensus 343 ~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~ 421 (660)
.+|+|+||.||+|... ++..+|+|.+...... ....+.+|++++++++||||++++++|...+..++||||+++++|.
T Consensus 2 ~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 2 LLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred ccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 5899999999999975 5788999998655433 3457899999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCceeecccc
Q 006112 422 KILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVG 501 (660)
Q Consensus 422 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~g 501 (660)
+++.... ..+++.++..++.|++.+|.|||+ ++++||||||+||+++.++.+||+|||+++..............+
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 9986543 358899999999999999999998 899999999999999999999999999997644332222222344
Q ss_pred CccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHH
Q 006112 502 TVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVL 580 (660)
Q Consensus 502 t~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 580 (660)
+..|+|||++..+.++.++||||||+++||+++ |..||....... .......+.... ........+.
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~---~~~~~~~~~~~~---------~~~~~~~~~~ 224 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ---AREQVEKGYRMS---------CPQKCPDDVY 224 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH---HHHHHHcCCCCC---------CCCCCCHHHH
Confidence 678999999998899999999999999999998 999997543221 222222221111 1112335678
Q ss_pred HHhhhccCCCCCCCCCHHHHHHHhh
Q 006112 581 KLGLFCSHSNPDTRPSMRQVVQYLD 605 (660)
Q Consensus 581 ~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (660)
+++.+|++.+|++||++.|+++.|.
T Consensus 225 ~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 225 KVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHcccCcccCCCHHHHHHHhc
Confidence 8999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=321.60 Aligned_cols=255 Identities=21% Similarity=0.214 Sum_probs=197.4
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
+|+.++.||+|+||.||++++..+++.+|+|.+... .....+.+.+|+.++..++|+||+++++++.+.+.+++|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 578889999999999999999989999999998542 22334568889999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
|+++|+|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 y~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 82 YYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred ccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 999999999997643 348889999999999999999998 9999999999999999999999999999976543333
Q ss_pred ceeeccccCccccCccccc-----CCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCccc
Q 006112 494 LHTTNVVGTVGYLAPELLR-----NGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLE 568 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 568 (660)
.......||+.|+|||++. .+.++.++|||||||++|||++|+.||...... +............ .-|...
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~--~~~~~i~~~~~~~--~~p~~~ 233 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV--ETYGKIMNHKERF--QFPAQV 233 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH--HHHHHHhCCCccc--cCCCcc
Confidence 3334467999999999986 346788999999999999999999999764322 2222221111111 111111
Q ss_pred ccCcHHHHHHHHHHhhhcc--CCCCCCCCCHHHHHHH
Q 006112 569 GIYVEEQMEIVLKLGLFCS--HSNPDTRPSMRQVVQY 603 (660)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl--~~dP~~RPs~~evl~~ 603 (660)
...+. .+.+++..|+ .+++..|++++|++++
T Consensus 234 ~~~s~----~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 234 TDVSE----DAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ccCCH----HHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 12233 2334444444 5555568999999875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=322.70 Aligned_cols=259 Identities=24% Similarity=0.363 Sum_probs=202.4
Q ss_pred eeecccccccCccEEEEEEEeCCC--------------CeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeee
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSS--------------HAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGY 401 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~--------------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~ 401 (660)
.|+..++||+|+||.||+++.... ...||+|.+.... ....+.|.+|++++++++|+|+++++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~ 85 (295)
T cd05097 6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGV 85 (295)
T ss_pred hCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEE
Confidence 577788999999999999987432 2358999986543 3345679999999999999999999999
Q ss_pred eeecCeeEEEEecCCCCChhhhhhhCC----------CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEE
Q 006112 402 CRRKGELLLVYDYMPNGSLDKILYSNT----------RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLL 471 (660)
Q Consensus 402 ~~~~~~~~lV~E~~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll 471 (660)
+..++..++||||+++++|.+++.... ...++|.++..++.|++.||+|||+ .+++||||||+||++
T Consensus 86 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nill 162 (295)
T cd05097 86 CVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCLV 162 (295)
T ss_pred EcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEEE
Confidence 999999999999999999999986432 1247889999999999999999998 899999999999999
Q ss_pred cCCCCeEEeecccceeccCCCCce-eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh--CCCCCCCCCc-chH
Q 006112 472 DADLEGKLGDFGLARLYDHGNDLH-TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC--GRRPVQPGEL-DLL 547 (660)
Q Consensus 472 ~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt--G~~p~~~~~~-~~~ 547 (660)
++++.+||+|||+++......... .....++..|+|||.+..+.++.++|||||||++|||++ +..||..... ...
T Consensus 163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~ 242 (295)
T cd05097 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVI 242 (295)
T ss_pred cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHH
Confidence 999999999999997654332211 223345778999999988899999999999999999988 5667764322 222
Q ss_pred HHHHHHHhcC-CcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhh
Q 006112 548 DWVIDYWQKG-DVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605 (660)
Q Consensus 548 ~~~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (660)
....+.+... ....... .......+.+++.+||+.||++||++.+|++.|+
T Consensus 243 ~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 243 ENTGEFFRNQGRQIYLSQ-------TPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHhhhhccccccCCC-------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 2222222211 1111111 1112346889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=316.98 Aligned_cols=254 Identities=28% Similarity=0.483 Sum_probs=204.1
Q ss_pred eeecccccccCccEEEEEEEeCCCCe---EEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHA---EIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~---~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
.|+..+.+|+|+||.||+|++..++. .+|+|.+.... ....+++.+|++++++++|+||+++.+++...+..++||
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (268)
T cd05063 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIIT 85 (268)
T ss_pred HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEE
Confidence 45667889999999999999865443 79999986553 334567999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
||+++++|.+++.... ..+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 86 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 86 EYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 9999999999997643 358999999999999999999998 899999999999999999999999999998664432
Q ss_pred Ccee--eccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccc
Q 006112 493 DLHT--TNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEG 569 (660)
Q Consensus 493 ~~~~--~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 569 (660)
.... .....+..|+|||++..+.++.++|||||||++|||++ |+.||...... + .......+... +.
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--~-~~~~i~~~~~~----~~--- 231 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--E-VMKAINDGFRL----PA--- 231 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--H-HHHHHhcCCCC----CC---
Confidence 2211 12223567999999988889999999999999999997 99999654322 1 22222222111 11
Q ss_pred cCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 570 IYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
.......+.+++.+||+.+|++||++.+|++.|+.
T Consensus 232 --~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~ 266 (268)
T cd05063 232 --PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266 (268)
T ss_pred --CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 11223457899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=319.75 Aligned_cols=258 Identities=25% Similarity=0.356 Sum_probs=205.6
Q ss_pred eeecccccccCccEEEEEEEeCCCCe----EEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHA----EIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 411 (660)
.|+.++.+|+|+||.||+|++..++. .||+|.+.... ....+++.+|+.++..++|+||++++++|.. ...+++
T Consensus 8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~ 86 (279)
T cd05109 8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLV 86 (279)
T ss_pred heeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEE
Confidence 57788999999999999999866655 48999986543 3446788999999999999999999999975 457899
Q ss_pred EecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCC
Q 006112 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 491 (660)
+||+++|+|.+++.... ..+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 87 ~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 87 TQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred EEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 99999999999997643 358999999999999999999998 99999999999999999999999999999876543
Q ss_pred CCc-eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccc
Q 006112 492 NDL-HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEG 569 (660)
Q Consensus 492 ~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 569 (660)
... ......++..|+|||.+.+..++.++|||||||++|||++ |..||........ ......+..... .
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~~~~~~~~~-----~- 233 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI---PDLLEKGERLPQ-----P- 233 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHHCCCcCCC-----C-
Confidence 221 1222345678999999988899999999999999999998 8999875433222 122222221111 1
Q ss_pred cCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCCCCCC
Q 006112 570 IYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGALLP 611 (660)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p 611 (660)
......+.+++..||+.||++||++.++++.|+.....|
T Consensus 234 ---~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 234 ---PICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 112345778888999999999999999999998765444
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=319.28 Aligned_cols=260 Identities=23% Similarity=0.358 Sum_probs=202.3
Q ss_pred eeecccccccCccEEEEEEEeCC----------------CCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPS----------------SHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLR 399 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~----------------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~ 399 (660)
.|+..+.+|+|+||.||++.... +...+|+|++.... ....++|.+|+.++++++|+||++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~ 85 (296)
T cd05095 6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLL 85 (296)
T ss_pred hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 47778899999999999986432 34579999987543 34567899999999999999999999
Q ss_pred eeeeecCeeEEEEecCCCCChhhhhhhCCC---------CCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEE
Q 006112 400 GYCRRKGELLLVYDYMPNGSLDKILYSNTR---------PSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVL 470 (660)
Q Consensus 400 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIl 470 (660)
+++..++..++||||+++++|.+++..... ..+++.++.+++.|++.||+|||+ .+++||||||+|||
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Nil 162 (296)
T cd05095 86 AVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCL 162 (296)
T ss_pred EEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheEE
Confidence 999999999999999999999999875421 247788999999999999999998 89999999999999
Q ss_pred EcCCCCeEEeecccceeccCCCCce-eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh--CCCCCCCCCc-ch
Q 006112 471 LDADLEGKLGDFGLARLYDHGNDLH-TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC--GRRPVQPGEL-DL 546 (660)
Q Consensus 471 l~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt--G~~p~~~~~~-~~ 546 (660)
++.++.+||+|||+++.+....... .....++..|++||....+.++.++|||||||++|||++ |..||..... ..
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~ 242 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV 242 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH
Confidence 9999999999999998654332211 222345678999999888889999999999999999998 6778764322 22
Q ss_pred HHHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhh
Q 006112 547 LDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605 (660)
Q Consensus 547 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (660)
............. ....+. ...+...+.+++.+||+.||++||++.||++.|+
T Consensus 243 ~~~~~~~~~~~~~-~~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 243 IENTGEFFRDQGR-QVYLPK-----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHHHhhccc-cccCCC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 2222222111110 011111 1122356888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=311.10 Aligned_cols=249 Identities=32% Similarity=0.491 Sum_probs=205.3
Q ss_pred cccccCccEEEEEEEeCCC---CeEEEEEEeccCCCh-hhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCCC
Q 006112 342 YKATKGGSGKVYRGVLPSS---HAEIAVKKVCHDSDH-GMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPN 417 (660)
Q Consensus 342 ~~lg~G~fg~Vy~g~~~~~---~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 417 (660)
+.+|+|+||.||++..... +..+++|.+...... ..+++.+|++++++++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 3689999999999999765 889999999765443 377899999999999999999999999999999999999999
Q ss_pred CChhhhhhhCC-------CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccC
Q 006112 418 GSLDKILYSNT-------RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDH 490 (660)
Q Consensus 418 gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 490 (660)
++|.+++.... ...+++.++.+++.|+++||.|||+ ++++||||||+||+++.++.+||+|||.++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999997652 2468999999999999999999998 9999999999999999999999999999987654
Q ss_pred CCC-ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCccc
Q 006112 491 GND-LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLE 568 (660)
Q Consensus 491 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 568 (660)
... .......++..|+|||.+....++.++||||+|+++|||++ |+.||...... ...+....+.... .
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~~~~~~~-----~- 228 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---EVLEYLRKGYRLP-----K- 228 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHHcCCCCC-----C-
Confidence 331 12234567889999999988889999999999999999999 68998764321 2222222221111 1
Q ss_pred ccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhh
Q 006112 569 GIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605 (660)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (660)
.......+.+++.+|++.||++||++.|+++.|+
T Consensus 229 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 229 ---PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1122456778888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=318.01 Aligned_cols=252 Identities=27% Similarity=0.405 Sum_probs=199.7
Q ss_pred cccccccCccEEEEEEEeCCCCe--EEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeec------CeeE
Q 006112 340 NLYKATKGGSGKVYRGVLPSSHA--EIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK------GELL 409 (660)
Q Consensus 340 ~l~~lg~G~fg~Vy~g~~~~~~~--~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~~ 409 (660)
..+.+|+|+||.||+|.+...+. .+|+|.+... .....+.+.+|++++++++|+||++++++|... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 45679999999999999876654 6899987643 344567899999999999999999999987532 2468
Q ss_pred EEEecCCCCChhhhhhhC----CCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccc
Q 006112 410 LVYDYMPNGSLDKILYSN----TRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLA 485 (660)
Q Consensus 410 lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla 485 (660)
++|||+++|+|.+++... ....+++.....++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCcc
Confidence 999999999999987432 22358999999999999999999998 89999999999999999999999999999
Q ss_pred eeccCCCCce-eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCC
Q 006112 486 RLYDHGNDLH-TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDAS 563 (660)
Q Consensus 486 ~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (660)
+......... .....+++.|++||.+....++.++||||||+++|||++ |+.||..... ....+....+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~~~~~~-- 234 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SEIYDYLRQGNRLK-- 234 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHcCCCCC--
Confidence 8764432211 122346778999999998889999999999999999999 7888865332 12223333332211
Q ss_pred CCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 564 DPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 564 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
.. ......+.+++.+||+.||++|||+.++++.|+.
T Consensus 235 ---~~----~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 235 ---QP----PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred ---CC----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 11 1223457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=321.50 Aligned_cols=255 Identities=25% Similarity=0.374 Sum_probs=203.6
Q ss_pred eecccccccCccEEEEEEEeCC-----CCeEEEEEEeccCCC-hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEE
Q 006112 338 YKNLYKATKGGSGKVYRGVLPS-----SHAEIAVKKVCHDSD-HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~~-----~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 411 (660)
|+..+.+|+|+||.||+|+... ....+++|.+..... ...+++.+|+.++++++||||+++++.|..++..++|
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI 81 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence 5667889999999999998743 235788888865433 3457899999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhhCC----------------------CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcE
Q 006112 412 YDYMPNGSLDKILYSNT----------------------RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANV 469 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NI 469 (660)
+||+.+++|.+++.... ...+++.+++.++.|++.||+|||+ .+++||||||+||
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~ni 158 (290)
T cd05045 82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNV 158 (290)
T ss_pred EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhheE
Confidence 99999999999986421 1347899999999999999999998 9999999999999
Q ss_pred EEcCCCCeEEeecccceeccCCCCc-eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchH
Q 006112 470 LLDADLEGKLGDFGLARLYDHGNDL-HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLL 547 (660)
Q Consensus 470 ll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~ 547 (660)
|+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-- 236 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-- 236 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH--
Confidence 9999999999999999865332221 1223355778999999988889999999999999999998 99998754322
Q ss_pred HHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 548 DWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 548 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
.+++....+.... ... .....+.+++..|++.+|++||++.|+++.|+..
T Consensus 237 -~~~~~~~~~~~~~-----~~~----~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 237 -RLFNLLKTGYRME-----RPE----NCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred -HHHHHHhCCCCCC-----CCC----CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 2233333221111 111 2234577889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=313.64 Aligned_cols=248 Identities=28% Similarity=0.440 Sum_probs=200.1
Q ss_pred cccccCccEEEEEEEeCCCC---eEEEEEEeccCCC-hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCCC
Q 006112 342 YKATKGGSGKVYRGVLPSSH---AEIAVKKVCHDSD-HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPN 417 (660)
Q Consensus 342 ~~lg~G~fg~Vy~g~~~~~~---~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 417 (660)
++||+|+||.||+|++...+ ..+|+|.+..... ...+++.+|+++++++.|+||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 36899999999999875544 7899999875543 35678999999999999999999999876 4568999999999
Q ss_pred CChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCcee-
Q 006112 418 GSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT- 496 (660)
Q Consensus 418 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~- 496 (660)
|+|.+++.... .+++..+..++.|++.||+|||. .+++||||||+|||++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999997654 58999999999999999999998 8999999999999999999999999999987654433221
Q ss_pred -eccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHH
Q 006112 497 -TNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEE 574 (660)
Q Consensus 497 -~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 574 (660)
....++..|+|||.+....++.++|||||||++|||++ |..||...... .+......+..... ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~~~~~~~~~---------~~~ 222 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAMLESGERLPR---------PEE 222 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHHcCCcCCC---------CCC
Confidence 12234568999999998899999999999999999998 99998754321 12222222221111 112
Q ss_pred HHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 575 QMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 575 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
....+.+++.+||+.+|++||++.++++.|++.
T Consensus 223 ~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 223 CPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 234678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=326.68 Aligned_cols=241 Identities=25% Similarity=0.306 Sum_probs=190.2
Q ss_pred cccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHhcc---CCCCceeEeeeeeecCeeEEEEecCCC
Q 006112 344 ATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKL---RHRNLVQLRGYCRRKGELLLVYDYMPN 417 (660)
Q Consensus 344 lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l---~H~nIv~l~g~~~~~~~~~lV~E~~~~ 417 (660)
||+|+||+||+|+...+++.||||++.... ......+..|..++.+. +||||+++++++..+...++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 689999999999999899999999985432 22344566677777665 699999999999999999999999999
Q ss_pred CChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCceee
Q 006112 418 GSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTT 497 (660)
Q Consensus 418 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 497 (660)
|+|..++.... .+++..+..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~ 154 (330)
T cd05586 81 GELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTN 154 (330)
T ss_pred ChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCcc
Confidence 99999987643 48899999999999999999998 899999999999999999999999999997543222 1223
Q ss_pred ccccCccccCcccccCC-CCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHH
Q 006112 498 NVVGTVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQM 576 (660)
Q Consensus 498 ~~~gt~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 576 (660)
...||+.|+|||.+.+. .++.++|||||||++|||++|+.||...... ........+.. ++... ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~---~~~~~i~~~~~------~~~~~---~~~ 222 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ---QMYRNIAFGKV------RFPKN---VLS 222 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH---HHHHHHHcCCC------CCCCc---cCC
Confidence 46799999999998754 4789999999999999999999999764432 12222222221 11111 112
Q ss_pred HHHHHHhhhccCCCCCCCC----CHHHHHH
Q 006112 577 EIVLKLGLFCSHSNPDTRP----SMRQVVQ 602 (660)
Q Consensus 577 ~~l~~l~~~Cl~~dP~~RP----s~~evl~ 602 (660)
..+.+++..||+.||++|| ++.++++
T Consensus 223 ~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 223 DEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred HHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 3456778889999999998 5666665
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=313.65 Aligned_cols=248 Identities=33% Similarity=0.445 Sum_probs=205.5
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 416 (660)
+|+..+.+|+|+||.||+|.. .++.||+|.+..... ..+++.+|+.++++++|+||+++++++...+..++||||++
T Consensus 7 ~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 7 ELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 567778899999999999988 478899999976544 56789999999999999999999999998899999999999
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCcee
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT 496 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 496 (660)
+++|.+++.......+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--- 157 (256)
T cd05039 84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--- 157 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc---
Confidence 9999999977655569999999999999999999998 9999999999999999999999999999986532221
Q ss_pred eccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHH
Q 006112 497 TNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQ 575 (660)
Q Consensus 497 ~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 575 (660)
...++..|+|||.+..+.++.++||||||+++||+++ |+.||....... .......+.... . ....
T Consensus 158 -~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~~~~~~-----~----~~~~ 224 (256)
T cd05039 158 -SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPHVEKGYRME-----A----PEGC 224 (256)
T ss_pred -cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHhcCCCCC-----C----ccCC
Confidence 2345678999999988889999999999999999997 999987543221 222222211111 1 1122
Q ss_pred HHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 576 MEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 576 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
...+.+++.+|+..+|++||++.++++.|+.
T Consensus 225 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 225 PPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 4567788899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=322.33 Aligned_cols=255 Identities=21% Similarity=0.220 Sum_probs=198.0
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
+|+.++.||+|+||.||+++...+++.||+|.+... .....+.+.+|+.++..++|+||+++++++.+++..++|||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 578889999999999999999989999999998642 22334568889999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
|+++|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 y~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 82 YYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred CCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999999997643 358888999999999999999998 9999999999999999999999999999987654433
Q ss_pred ceeeccccCccccCcccccC-----CCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCccc
Q 006112 494 LHTTNVVGTVGYLAPELLRN-----GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLE 568 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~-----~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 568 (660)
.......||+.|+|||++.. +.++.++|||||||++|||++|+.||...... +............. -|...
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--~~~~~i~~~~~~~~--~p~~~ 233 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV--ETYGKIMNHEERFQ--FPSHI 233 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH--HHHHHHHcCCCccc--CCCcc
Confidence 33344679999999999875 56788999999999999999999999764322 11111111111111 01111
Q ss_pred ccCcHHHHHHHHHHhhhccCCCCCC--CCCHHHHHHH
Q 006112 569 GIYVEEQMEIVLKLGLFCSHSNPDT--RPSMRQVVQY 603 (660)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~ 603 (660)
... .+.+.+++.+|+..++++ |+++++++++
T Consensus 234 ~~~----~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 234 TDV----SEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ccC----CHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 112 234555566666654433 5688888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=333.10 Aligned_cols=202 Identities=24% Similarity=0.316 Sum_probs=177.0
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
.|+.++.||+|+||.||+++...+++.||+|.+... .....+.+.+|+.++.+++|+||+++++.+.+++.+++|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 477889999999999999999999999999998643 23345678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
||++|+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 82 FLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred CCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 999999999997643 48899999999999999999998 9999999999999999999999999999875432110
Q ss_pred ----------------------------------ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCC
Q 006112 494 ----------------------------------LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPV 539 (660)
Q Consensus 494 ----------------------------------~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~ 539 (660)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0012357999999999999999999999999999999999999999
Q ss_pred CCCC
Q 006112 540 QPGE 543 (660)
Q Consensus 540 ~~~~ 543 (660)
....
T Consensus 237 ~~~~ 240 (360)
T cd05627 237 CSET 240 (360)
T ss_pred CCCC
Confidence 7644
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=317.56 Aligned_cols=251 Identities=25% Similarity=0.323 Sum_probs=200.2
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhcc-CCCCceeEeeeeeec------CeeE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRK------GELL 409 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~------~~~~ 409 (660)
.|+..+.+|+|+||.||+|....+++.||+|++.... .....+.+|+.++.++ +|+||+++++++... ...+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (272)
T cd06637 7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 85 (272)
T ss_pred hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence 4677788999999999999999899999999986543 3456788999999998 799999999998753 4589
Q ss_pred EEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceecc
Q 006112 410 LVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYD 489 (660)
Q Consensus 410 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 489 (660)
+||||+++++|.+++.......+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++...
T Consensus 86 iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~ 162 (272)
T cd06637 86 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 162 (272)
T ss_pred EEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence 99999999999999987555568999999999999999999998 899999999999999999999999999998654
Q ss_pred CCCCceeeccccCccccCccccc-----CCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCC
Q 006112 490 HGNDLHTTNVVGTVGYLAPELLR-----NGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASD 564 (660)
Q Consensus 490 ~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d 564 (660)
... .......|+..|+|||++. ...++.++|||||||++|||++|+.||......... ....... .
T Consensus 163 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~--~~~~~~~------~ 233 (272)
T cd06637 163 RTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL--FLIPRNP------A 233 (272)
T ss_pred ccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH--HHHhcCC------C
Confidence 322 1233467899999999986 335788999999999999999999999653321111 1111110 1
Q ss_pred CcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 565 PRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 565 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
+.+. .......+.+++.+||+.||.+|||+.|++++
T Consensus 234 ~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 234 PRLK---SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CCCC---CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 1111 11223457788899999999999999999863
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=334.89 Aligned_cols=258 Identities=24% Similarity=0.371 Sum_probs=204.5
Q ss_pred ceeeecccccccCccEEEEEEEeC-----CCCeEEEEEEeccCCC-hhhHHHHHHHHHHhccC-CCCceeEeeeeeecCe
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLP-----SSHAEIAVKKVCHDSD-HGMKQFVSEIVSMGKLR-HRNLVQLRGYCRRKGE 407 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~-----~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~ 407 (660)
+-+|...+.||+|+||.||+|++. ..++.||+|++..... ...+.+.+|++++.++. ||||++++++|...+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 346778899999999999999964 2456899999975433 33457899999999997 9999999999999999
Q ss_pred eEEEEecCCCCChhhhhhhCC-----------------------------------------------------------
Q 006112 408 LLLVYDYMPNGSLDKILYSNT----------------------------------------------------------- 428 (660)
Q Consensus 408 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 428 (660)
.++|||||++|+|.++++...
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 999999999999999986432
Q ss_pred -------------------------------------CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEE
Q 006112 429 -------------------------------------RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLL 471 (660)
Q Consensus 429 -------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll 471 (660)
...++|.+..+++.||+.||+|||+ ++++||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEEE
Confidence 1246778889999999999999998 899999999999999
Q ss_pred cCCCCeEEeecccceeccCCCC-ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHH
Q 006112 472 DADLEGKLGDFGLARLYDHGND-LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDW 549 (660)
Q Consensus 472 ~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~ 549 (660)
++++.+||+|||+++....... .......++..|+|||.+....++.++|||||||++|||++ |..||...... +.
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~--~~ 350 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN--EQ 350 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch--HH
Confidence 9999999999999986543221 11223457889999999998889999999999999999998 88898653221 11
Q ss_pred HHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 550 VIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 550 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
.......+.... . .. .....+.+++..||+.+|.+||++++|++.|+.
T Consensus 351 ~~~~~~~~~~~~--~---p~----~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 398 (401)
T cd05107 351 FYNAIKRGYRMA--K---PA----HASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398 (401)
T ss_pred HHHHHHcCCCCC--C---CC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 122222221111 1 11 123457788889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=322.89 Aligned_cols=257 Identities=25% Similarity=0.378 Sum_probs=203.6
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD-HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
.|+.++.+|+|+||.||++.+..++..+|+|.+..... ...+++.+|++++.+++||||+++++.|..++..++||||+
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~ 81 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM 81 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence 47888999999999999999988899999999865433 34567899999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 495 (660)
++++|.+++.... .+++..+..++.|+++||.|||+ ..+++||||||+|||++.++.+||+|||++...... .
T Consensus 82 ~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~ 154 (308)
T cd06615 82 DGGSLDQVLKKAG--RIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M 154 (308)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCccccccc---c
Confidence 9999999997653 48889999999999999999997 258999999999999999999999999998754322 1
Q ss_pred eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhc-CCcc--------------
Q 006112 496 TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQK-GDVL-------------- 560 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~-~~~~-------------- 560 (660)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||................. ....
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence 2345789999999999888899999999999999999999999865332211111110000 0000
Q ss_pred -------------cCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 561 -------------DASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 561 -------------~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
....|.+.. ......+.+++.+||+.||++||+++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 235 RPMAIFELLDYIVNEPPPKLPS---GAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred chhhHHHHHHHHhcCCCccCcC---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000 0123357889999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=312.21 Aligned_cols=251 Identities=25% Similarity=0.368 Sum_probs=205.9
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeee-cCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR-KGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~lV~E 413 (660)
.|+.++.+|+|++|.||++....+++.+|+|++.... ....+.+.+|++++++++|+|++++++.+.. +..+++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 3788899999999999999998889999999986532 3445678999999999999999999998764 456899999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
|+++++|.+++.......+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 9999999999987555568999999999999999999998 8999999999999999999999999999987644322
Q ss_pred ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
......|++.|+|||.+.+..++.++||||||++++||++|+.||...+.. ..... ...+.. +.+ ..
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~~-~~~~~~-----~~~----~~ 224 (257)
T cd08223 158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN--SLVYR-IIEGKL-----PPM----PK 224 (257)
T ss_pred -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH--HHHHH-HHhcCC-----CCC----cc
Confidence 223456899999999999888999999999999999999999999754422 22222 222221 111 12
Q ss_pred HHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.....+.+++.+|++.||++||++.+++++
T Consensus 225 ~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 225 DYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 233467788999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=318.60 Aligned_cols=252 Identities=24% Similarity=0.351 Sum_probs=204.5
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 416 (660)
.|+.++++|+|+||.||+|+...+++.+++|.+........+.+.+|++++++++|+||+++++.+..++..++||||++
T Consensus 13 ~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 92 (292)
T cd06644 13 VWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCP 92 (292)
T ss_pred hhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCC
Confidence 68899999999999999999988899999999977766777889999999999999999999999999999999999999
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCcee
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT 496 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 496 (660)
+++|..++.... ..+++.++..++.|++.+|+|||+ .+++||||||+||+++.++.+||+|||++....... ...
T Consensus 93 ~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~ 167 (292)
T cd06644 93 GGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QRR 167 (292)
T ss_pred CCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccccc-ccc
Confidence 999998876543 358999999999999999999998 899999999999999999999999999987543321 112
Q ss_pred eccccCccccCccccc-----CCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccC
Q 006112 497 TNVVGTVGYLAPELLR-----NGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIY 571 (660)
Q Consensus 497 ~~~~gt~~Y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 571 (660)
....++..|+|||++. ...++.++|||||||++|||++|+.||..... ....... ..... +... .
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~~~~~~~-~~~~~-----~~~~--~ 237 (292)
T cd06644 168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--MRVLLKI-AKSEP-----PTLS--Q 237 (292)
T ss_pred ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH--HHHHHHH-hcCCC-----ccCC--C
Confidence 3356889999999984 34567899999999999999999999875332 1112221 11111 1110 0
Q ss_pred cHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 572 VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.......+.+++.+||+.||++||++++++++
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 238 PSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred CcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11223346778889999999999999999863
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=316.07 Aligned_cols=257 Identities=23% Similarity=0.381 Sum_probs=203.8
Q ss_pred eeecccccccCccEEEEEEEe----CCCCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeec--CeeE
Q 006112 337 SYKNLYKATKGGSGKVYRGVL----PSSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK--GELL 409 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~----~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~ 409 (660)
.|+.++.+|+|+||.||++++ ..++..||+|.+.... ....+.+.+|++++++++||||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 578899999999999999985 3467899999986543 34457899999999999999999999998875 5689
Q ss_pred EEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceecc
Q 006112 410 LVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYD 489 (660)
Q Consensus 410 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 489 (660)
+||||+++++|.+++.... ..++|.++..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++...
T Consensus 85 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 9999999999999986543 358999999999999999999998 999999999999999999999999999998765
Q ss_pred CCCCc--eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCc------------chHHHHHHHHh
Q 006112 490 HGNDL--HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGEL------------DLLDWVIDYWQ 555 (660)
Q Consensus 490 ~~~~~--~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~------------~~~~~~~~~~~ 555 (660)
..... ......++..|+|||.+.+..++.++|||||||++|||++++.|...... ...........
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE 240 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH
Confidence 43321 11234567789999999888899999999999999999998776432110 01111111222
Q ss_pred cCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 556 KGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 556 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
.+.... .. ......+.+++.+|++.||++||++.++++.|+.
T Consensus 241 ~~~~~~-----~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 241 EGKRLP-----RP----PNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred cCccCC-----CC----CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 221111 01 1234568889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=312.58 Aligned_cols=249 Identities=28% Similarity=0.374 Sum_probs=202.1
Q ss_pred cccccCccEEEEEEEeCC-CC--eEEEEEEeccCCC-hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCCC
Q 006112 342 YKATKGGSGKVYRGVLPS-SH--AEIAVKKVCHDSD-HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPN 417 (660)
Q Consensus 342 ~~lg~G~fg~Vy~g~~~~-~~--~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 417 (660)
+.+|+|++|.||+|.+.. ++ ..||+|.+..... ...+.+.+|++++++++||||+++++.+.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 358999999999999855 33 3699999977665 667899999999999999999999999988 889999999999
Q ss_pred CChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce--
Q 006112 418 GSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH-- 495 (660)
Q Consensus 418 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~-- 495 (660)
++|.+++.......++|...+.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 999999977543468999999999999999999998 899999999999999999999999999998765432211
Q ss_pred eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHH
Q 006112 496 TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEE 574 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 574 (660)
.....++..|+|||++....++.++|||||||++|||++ |+.||...... +........+.... ....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~~~~---------~~~~ 225 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS--QILKKIDKEGERLE---------RPEA 225 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHhcCCcCC---------CCcc
Confidence 123457889999999998899999999999999999998 99998653222 11111111111110 0112
Q ss_pred HHHHHHHHhhhccCCCCCCCCCHHHHHHHhh
Q 006112 575 QMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605 (660)
Q Consensus 575 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (660)
....+.+++.+|++.+|++||++.++++.|.
T Consensus 226 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 226 CPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 3356788999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=317.26 Aligned_cols=251 Identities=22% Similarity=0.319 Sum_probs=202.6
Q ss_pred eecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCCC
Q 006112 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPN 417 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 417 (660)
|+.++.+|+|+||.||+|.+..++..+++|.+........+.+.+|+++++.++||||+++++++..++..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 56778899999999999999988999999999766666678899999999999999999999999999999999999999
Q ss_pred CChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCceee
Q 006112 418 GSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTT 497 (660)
Q Consensus 418 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 497 (660)
++|..++.... ..+++..+..++.|+++||.|||+ .+++||||||+||+++.++.+||+|||+++...... ....
T Consensus 87 ~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~ 161 (282)
T cd06643 87 GAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRD 161 (282)
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEccccccccccccc-cccc
Confidence 99999886533 358999999999999999999998 899999999999999999999999999987643222 1223
Q ss_pred ccccCccccCccccc-----CCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCc
Q 006112 498 NVVGTVGYLAPELLR-----NGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 498 ~~~gt~~Y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
...|+..|+|||++. ...++.++|||||||++|||++|+.||..... .+.+... ..........+
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~~~~~~~-~~~~~~~~~~~------- 231 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP--MRVLLKI-AKSEPPTLAQP------- 231 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH--HHHHHHH-hhcCCCCCCCc-------
Confidence 356899999999974 34567899999999999999999999875332 1111111 11111111111
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
......+.+++..||+.||.+||++.+++++
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 232 SRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1123457788889999999999999998854
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=315.54 Aligned_cols=240 Identities=21% Similarity=0.377 Sum_probs=191.1
Q ss_pred ccccCccEEEEEEEeCC------------CCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEE
Q 006112 343 KATKGGSGKVYRGVLPS------------SHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLL 410 (660)
Q Consensus 343 ~lg~G~fg~Vy~g~~~~------------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 410 (660)
.+|+|+||.||+|++.. ....|++|.+..........|.+|+.+++.++||||++++++|..+...++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 58999999999998642 234689998766555566788999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCC-------eEEeecc
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLE-------GKLGDFG 483 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~-------~kl~DFG 483 (660)
||||+++|+|+.++.... ..+++..+.+++.||++||+|||+ ++|+||||||+|||++.++. +|++|||
T Consensus 82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 82 VEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999886543 358999999999999999999998 99999999999999987654 8999999
Q ss_pred cceeccCCCCceeeccccCccccCccccc-CCCCCcceeEEehHHHHHHHh-hCCCCCCCCCcchHHHHHHHHhcCCccc
Q 006112 484 LARLYDHGNDLHTTNVVGTVGYLAPELLR-NGRGTTSTDVYAFGVFMLEVA-CGRRPVQPGELDLLDWVIDYWQKGDVLD 561 (660)
Q Consensus 484 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~t~ksDV~S~Gvvl~ell-tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 561 (660)
++...... ....++..|+|||.+. ...++.++|||||||++|||+ +|+.|+.......... ... +.. .
T Consensus 158 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~---~~~-~~~-~ 227 (262)
T cd05077 158 IPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER---FYE-GQC-M 227 (262)
T ss_pred CCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH---HHh-cCc-c
Confidence 98754322 2345788999999886 466889999999999999997 5888876533222211 111 111 0
Q ss_pred CCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhh
Q 006112 562 ASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605 (660)
Q Consensus 562 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (660)
... .....+.+++..||+.||++||++.+|++.|+
T Consensus 228 ~~~---------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 228 LVT---------PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred CCC---------CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 111 11245778899999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=313.05 Aligned_cols=252 Identities=28% Similarity=0.396 Sum_probs=193.0
Q ss_pred ccccCccEEEEEEEeCC--CCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCCCCC
Q 006112 343 KATKGGSGKVYRGVLPS--SHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGS 419 (660)
Q Consensus 343 ~lg~G~fg~Vy~g~~~~--~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gs 419 (660)
.||+|+||.||+|.+.. ++..+|+|++.... ......+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999998743 34679999986543 2345678999999999999999999999999999999999999999
Q ss_pred hhhhhhhCC---CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc-e
Q 006112 420 LDKILYSNT---RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL-H 495 (660)
Q Consensus 420 L~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~-~ 495 (660)
|.+++.... ....++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++........ .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 999997532 2246777888999999999999998 89999999999999999999999999999754332211 1
Q ss_pred eeccccCccccCcccccCC-------CCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcc
Q 006112 496 TTNVVGTVGYLAPELLRNG-------RGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL 567 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~~~~-------~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 567 (660)
.....|+..|+|||++... .++.++||||||+++|||++ |+.||........ ......+......++.+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~ 235 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LTYTVREQQLKLPKPRL 235 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHHHhhcccCCCCCCcc
Confidence 2234578899999998632 35789999999999999996 9999965332211 11111122222233333
Q ss_pred cccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhh
Q 006112 568 EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605 (660)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (660)
.... .+.+.+++..|| .+|++|||++||++.|+
T Consensus 236 ~~~~----~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 236 KLPL----SDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCC----ChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 2222 233566777898 58999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=322.00 Aligned_cols=253 Identities=26% Similarity=0.388 Sum_probs=199.7
Q ss_pred eeecccccccCccEEEEEEEeCCCCe--EEEEEEeccC-CChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCeeEEEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHA--EIAVKKVCHD-SDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
+|+..+.+|+|+||.||+|.+..++. .+|+|++... .....+++.+|++++.++ +|+||+++++++..++..++||
T Consensus 8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 87 (303)
T cd05088 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 87 (303)
T ss_pred hceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEE
Confidence 46667889999999999999876664 4577777543 334567889999999999 8999999999999999999999
Q ss_pred ecCCCCChhhhhhhCC--------------CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeE
Q 006112 413 DYMPNGSLDKILYSNT--------------RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGK 478 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~k 478 (660)
||+++++|.+++.... ...+++.+++.++.|++.||+|||+ ++++||||||+|||+++++.+|
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~k 164 (303)
T cd05088 88 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAK 164 (303)
T ss_pred EeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcEE
Confidence 9999999999996532 2357899999999999999999998 9999999999999999999999
Q ss_pred EeecccceeccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcC
Q 006112 479 LGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKG 557 (660)
Q Consensus 479 l~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 557 (660)
|+|||+++..... .......++..|+|||++....++.++|||||||++|||++ |..||....... ..+....+
T Consensus 165 l~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~~~~~ 239 (303)
T cd05088 165 IADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKLPQG 239 (303)
T ss_pred eCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH---HHHHHhcC
Confidence 9999998643211 11122234678999999988888999999999999999998 999997543221 11111111
Q ss_pred CcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 558 DVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 558 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
.... ... .....+.+++.+||+.+|++||+++++++.|+.
T Consensus 240 ~~~~-----~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~ 279 (303)
T cd05088 240 YRLE-----KPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 279 (303)
T ss_pred CcCC-----CCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1100 111 123357788999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=314.17 Aligned_cols=261 Identities=25% Similarity=0.352 Sum_probs=203.3
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEec--cCCChhhHHHHHHHHHHhccCCCCceeEeeeeee-----cCeeE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVC--HDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR-----KGELL 409 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~--~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-----~~~~~ 409 (660)
.|..++.+|+|++|.|+.++...+|+.||||++. -...-..++-.+|+++++.++|+||+.+++.... -+.+|
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY 102 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY 102 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence 4555889999999999999999999999999997 3445567888999999999999999999998765 35789
Q ss_pred EEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceecc
Q 006112 410 LVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYD 489 (660)
Q Consensus 410 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 489 (660)
+|+|+| +.+|.+.++... .|+.....-++.|+++||.|+|+ .+|+||||||+|++++.+...||+||||||...
T Consensus 103 iV~elM-etDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 103 LVFELM-ETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLARYLD 176 (359)
T ss_pred EehhHH-hhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccceeecc
Confidence 999999 789999997654 38889999999999999999998 999999999999999999999999999999875
Q ss_pred CC-CCceeeccccCccccCccccc-CCCCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHHHHHHhcCCc-------
Q 006112 490 HG-NDLHTTNVVGTVGYLAPELLR-NGRGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVIDYWQKGDV------- 559 (660)
Q Consensus 490 ~~-~~~~~~~~~gt~~Y~aPE~~~-~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~~~~~~~------- 559 (660)
.. .....+..+.|.+|.|||++. ...|+...||||.||++.||++|+.-|.+.+. +....+.+....+..
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~ 256 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR 256 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence 43 223346778899999999875 46799999999999999999999988876321 222222222111100
Q ss_pred -------ccCCCCcccccC---cHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 560 -------LDASDPRLEGIY---VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 560 -------~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
+...-......+ -+......++|..+|+..||.+|+|++|++++
T Consensus 257 s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 257 SEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred cHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000000000 01122345677777899999999999999973
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=337.43 Aligned_cols=258 Identities=21% Similarity=0.214 Sum_probs=199.2
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
.+.|.....||+|+||.||++++...++.||||... ...+.+|++++++++|+||+++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 446888899999999999999999999999999642 23467899999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
+ .++|..++.... ..++|.++..|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 242 ~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 242 Y-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 9 578988886543 359999999999999999999998 89999999999999999999999999999876433221
Q ss_pred -eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCC-----cchHHHHHHHHhcCCcccCCCCc--
Q 006112 495 -HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGE-----LDLLDWVIDYWQKGDVLDASDPR-- 566 (660)
Q Consensus 495 -~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~d~~-- 566 (660)
......||..|+|||++.+..++.++|||||||++|||++|..|+.... ......+.+............+.
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 1234579999999999999899999999999999999999887654311 11111222222221111000000
Q ss_pred -------------------ccccCcH---HHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 567 -------------------LEGIYVE---EQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 567 -------------------l~~~~~~---~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
....... .....+.+|+.+||+.||++|||+.|++++
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000000 111246778889999999999999999975
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=327.04 Aligned_cols=243 Identities=24% Similarity=0.243 Sum_probs=191.4
Q ss_pred cccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHH-HHhccCCCCceeEeeeeeecCeeEEEEecCCC
Q 006112 342 YKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIV-SMGKLRHRNLVQLRGYCRRKGELLLVYDYMPN 417 (660)
Q Consensus 342 ~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 417 (660)
+.||+|+||.||++++..+++.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36899999999999999899999999986432 223344555544 56788999999999999999999999999999
Q ss_pred CChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCceee
Q 006112 418 GSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTT 497 (660)
Q Consensus 418 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 497 (660)
|+|.+++.... .+.+.+...++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~ 154 (325)
T cd05602 81 GELFYHLQRER--CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTS 154 (325)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCcc
Confidence 99999997643 47778888999999999999998 999999999999999999999999999997542221 2233
Q ss_pred ccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHH
Q 006112 498 NVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQME 577 (660)
Q Consensus 498 ~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 577 (660)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... +...... .... .+.. ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~-~~~~------~~~~----~~~~ 221 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--EMYDNIL-NKPL------QLKP----NITN 221 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH--HHHHHHH-hCCc------CCCC----CCCH
Confidence 467999999999999989999999999999999999999999754322 1111111 1110 1111 1233
Q ss_pred HHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 578 IVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 578 ~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.+.+++..|++.||.+||++.+.++.
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 222 SARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred HHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 46677888999999999988754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=311.07 Aligned_cols=252 Identities=22% Similarity=0.314 Sum_probs=209.3
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
.|+.++.+|+|+||.||.++...+++.+++|.+... .....+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 378889999999999999999989999999998643 345567899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
+++++|.+++.......+++.++..++.|++.||.|||+ .+++||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 999999999987645568999999999999999999998 8999999999999999999999999999987644332
Q ss_pred eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHH
Q 006112 495 HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEE 574 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 574 (660)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... +..... ..+..... ...
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~--~~~~~~-~~~~~~~~---------~~~ 224 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL--NLVVKI-VQGNYTPV---------VSV 224 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH--HHHHHH-HcCCCCCC---------ccc
Confidence 233456899999999998888899999999999999999999999754322 222221 22222111 112
Q ss_pred HHHHHHHHhhhccCCCCCCCCCHHHHHHHh
Q 006112 575 QMEIVLKLGLFCSHSNPDTRPSMRQVVQYL 604 (660)
Q Consensus 575 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (660)
....+.+++..||+.+|++||++.++++++
T Consensus 225 ~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 225 YSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred cCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 234577888889999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=326.38 Aligned_cols=241 Identities=22% Similarity=0.298 Sum_probs=194.9
Q ss_pred eecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccC-CCCceeEeeeeeecCeeEEEEe
Q 006112 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLR-HRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E 413 (660)
|+.++.||+|+||.||+++...+++.||+|++... .....+.+..|..++..+. |++|+++++++...+.+++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 56678899999999999999999999999998653 2334567888999998885 5778889999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
|+++|+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 82 y~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~- 155 (323)
T cd05615 82 YVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG- 155 (323)
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-
Confidence 999999999987654 48999999999999999999998 899999999999999999999999999997543221
Q ss_pred ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+....+.. ......
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~~i~~~~~------~~p~~~-- 224 (323)
T cd05615 156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE---LFQSIMEHNV------SYPKSL-- 224 (323)
T ss_pred ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHHhCCC------CCCccC--
Confidence 12234569999999999998889999999999999999999999997644321 1111112111 111122
Q ss_pred HHHHHHHHHhhhccCCCCCCCCCH
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPSM 597 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~ 597 (660)
...+.+++.+|++.||.+|++.
T Consensus 225 --~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 225 --SKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --CHHHHHHHHHHcccCHhhCCCC
Confidence 2346778888999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=332.77 Aligned_cols=241 Identities=24% Similarity=0.352 Sum_probs=200.7
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCeeEEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 411 (660)
-++..++.||+|.||+|+++..+.+++.+|||.++++ .++..+..+.|..|+... +||.+++++..++.+.+++.|
T Consensus 368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv 447 (694)
T KOG0694|consen 368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV 447 (694)
T ss_pred cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence 3677889999999999999999999999999999876 456678888898888777 599999999999999999999
Q ss_pred EecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCC
Q 006112 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 491 (660)
|||+.||++..+.+ ...+++..+.-++..|+.||+|||+ ++|||||||.+|||||.+|.+||+||||++.-- .
T Consensus 448 mey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m-~ 520 (694)
T KOG0694|consen 448 MEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM-G 520 (694)
T ss_pred EEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccccC-C
Confidence 99999999554443 2358999999999999999999998 999999999999999999999999999998532 2
Q ss_pred CCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcc-hHHHHHHHHhcCCcccCCCCccccc
Q 006112 492 NDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELD-LLDWVIDYWQKGDVLDASDPRLEGI 570 (660)
Q Consensus 492 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~d~~l~~~ 570 (660)
....+.+.+|||.|||||++.+..|+...|.|||||+||||+.|..||.+++.+ +.+.+. ..++..+..
T Consensus 521 ~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~----------~d~~~yP~~ 590 (694)
T KOG0694|consen 521 QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV----------NDEVRYPRF 590 (694)
T ss_pred CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh----------cCCCCCCCc
Confidence 233566799999999999999999999999999999999999999999865443 333222 123333333
Q ss_pred CcHHHHHHHHHHhhhccCCCCCCCCCH
Q 006112 571 YVEEQMEIVLKLGLFCSHSNPDTRPSM 597 (660)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 597 (660)
.+. ....++...+..+|++|.-+
T Consensus 591 ls~----ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 591 LSK----EAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ccH----HHHHHHHHHhccCcccccCC
Confidence 333 34556666799999999866
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=323.42 Aligned_cols=254 Identities=27% Similarity=0.380 Sum_probs=200.8
Q ss_pred eeecccccccCccEEEEEEEeCCCCe--EEEEEEeccC-CChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCeeEEEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHA--EIAVKKVCHD-SDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
.|+..+.||+|+||.||+|.+..++. .+++|.+... .....+.+.+|++++.++ +||||+++++++...+..++|+
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 82 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAI 82 (297)
T ss_pred cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEE
Confidence 46677789999999999999876654 4788887643 334567899999999999 7999999999999999999999
Q ss_pred ecCCCCChhhhhhhCC--------------CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeE
Q 006112 413 DYMPNGSLDKILYSNT--------------RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGK 478 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~k 478 (660)
||+++++|.+++.... ...+++.++..++.|++.||+|||+ ++|+||||||+|||+++++.+|
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 83 EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeEE
Confidence 9999999999996532 1248889999999999999999998 9999999999999999999999
Q ss_pred EeecccceeccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcC
Q 006112 479 LGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKG 557 (660)
Q Consensus 479 l~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 557 (660)
|+|||++...... ........+..|+|||++....++.++|||||||++|||++ |+.||....... .......+
T Consensus 160 l~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---~~~~~~~~ 234 (297)
T cd05089 160 IADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---LYEKLPQG 234 (297)
T ss_pred ECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHhcC
Confidence 9999998643221 11111233567999999988889999999999999999997 999997643321 12222221
Q ss_pred CcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 558 DVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 558 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
. .+.... .....+.+++..||+.+|.+||+++++++.|+..
T Consensus 235 ~-----~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 275 (297)
T cd05089 235 Y-----RMEKPR----NCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM 275 (297)
T ss_pred C-----CCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1 111111 1234577889999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=324.05 Aligned_cols=257 Identities=25% Similarity=0.346 Sum_probs=205.8
Q ss_pred eeeecccccccCccEEEEEEEe-----CCCCeEEEEEEeccCC-ChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCee
Q 006112 336 FSYKNLYKATKGGSGKVYRGVL-----PSSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGEL 408 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~-----~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 408 (660)
..|...+.+|+|+||.||++.. ...+..||||++.... ....+.+.+|+.+++++ +||||++++++|...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 3577788999999999999975 2345689999986543 33456789999999999 799999999999999999
Q ss_pred EEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceec
Q 006112 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLY 488 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 488 (660)
++||||+++|+|.+++.......+++.++..++.|++.||+|||+ ++|+|+||||+|||++.++.+||+|||+++..
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 191 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARDI 191 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCcccccc
Confidence 999999999999999976544458999999999999999999998 89999999999999999999999999999865
Q ss_pred cCCCCc-eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCc
Q 006112 489 DHGNDL-HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPR 566 (660)
Q Consensus 489 ~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 566 (660)
...... ......++..|+|||.+....++.++|||||||++|||++ |..||...... +........+....
T Consensus 192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~--~~~~~~~~~~~~~~----- 264 (302)
T cd05055 192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD--SKFYKLIKEGYRMA----- 264 (302)
T ss_pred cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch--HHHHHHHHcCCcCC-----
Confidence 433221 1222346788999999998889999999999999999998 99998753321 11112222221110
Q ss_pred ccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 567 LEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 567 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
... .....+.+++..|++.+|++||++.|+++.|+.
T Consensus 265 ~~~----~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 265 QPE----HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred CCC----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 111 123457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=329.79 Aligned_cols=257 Identities=23% Similarity=0.279 Sum_probs=196.4
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeecC------ee
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKG------EL 408 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------~~ 408 (660)
.|+.++.||+|+||.||++....++..||||++... .....+.+.+|+.+++.++||||+++++++...+ ..
T Consensus 22 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 101 (359)
T cd07876 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDV 101 (359)
T ss_pred ceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccccee
Confidence 688899999999999999999889999999998643 2334567889999999999999999999886443 47
Q ss_pred EEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceec
Q 006112 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLY 488 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 488 (660)
++||||++ ++|...+.. .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 102 ~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 102 YLVMELMD-ANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred EEEEeCCC-cCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 99999996 566666532 37888899999999999999998 99999999999999999999999999999754
Q ss_pred cCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcc-hHHHHHH---------------
Q 006112 489 DHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELD-LLDWVID--------------- 552 (660)
Q Consensus 489 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~--------------- 552 (660)
... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.. ....+.+
T Consensus 174 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (359)
T cd07876 174 CTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251 (359)
T ss_pred ccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence 322 2223457899999999999989999999999999999999999999754321 1000110
Q ss_pred ----HHhcCCcccCC-----CCcc----cccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 553 ----YWQKGDVLDAS-----DPRL----EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 553 ----~~~~~~~~~~~-----d~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
........... .+.. ...........+.+++..|++.||++|||+.|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000000 0000 000011123457788899999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=314.97 Aligned_cols=258 Identities=26% Similarity=0.424 Sum_probs=206.7
Q ss_pred eeecccccccCccEEEEEEEeCC----CCeEEEEEEeccCCCh-hhHHHHHHHHHHhccCCCCceeEeeeeee--cCeeE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPS----SHAEIAVKKVCHDSDH-GMKQFVSEIVSMGKLRHRNLVQLRGYCRR--KGELL 409 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~----~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~ 409 (660)
.|+.++.+|+|+||.||++++.. ++..+|||.+...... ..++|.+|++++++++|+||+++++++.. +...+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 56777899999999999999753 3789999999765443 56789999999999999999999999987 55789
Q ss_pred EEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceecc
Q 006112 410 LVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYD 489 (660)
Q Consensus 410 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 489 (660)
+||||+++++|.+++.... ..+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 85 lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 9999999999999997654 258999999999999999999998 899999999999999999999999999998765
Q ss_pred CCCCce--eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcch------------HHHHHHHHh
Q 006112 490 HGNDLH--TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDL------------LDWVIDYWQ 555 (660)
Q Consensus 490 ~~~~~~--~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~------------~~~~~~~~~ 555 (660)
...... .....++..|++||.+.+..++.++||||||++++||++|+.|+....... .....+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 332211 112345667999999988889999999999999999999999986532221 111122222
Q ss_pred cCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 556 KGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 556 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
.+.... ........+.+++.+||+.+|++||++.||++.|+..
T Consensus 241 ~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 241 EGERLP---------RPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cCCcCC---------CCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 211110 0112235688899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=317.08 Aligned_cols=247 Identities=25% Similarity=0.339 Sum_probs=198.7
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC-CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD-SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
.|+.++.+|+|+||.||+|++..++..||+|.+... .....+++.+|++++++++||||+++++++..++..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 356778899999999999999889999999998654 3344567999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 495 (660)
++++|..+. .+++..+..++.|++.||.|||+ .+|+|+||||+|||++.++.+||+|||++...... .
T Consensus 82 ~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~ 149 (279)
T cd06619 82 DGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---I 149 (279)
T ss_pred CCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---c
Confidence 999997652 36788889999999999999998 99999999999999999999999999999765432 2
Q ss_pred eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcc----hHHHHHHHHhcCCcccCCCCcccccC
Q 006112 496 TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELD----LLDWVIDYWQKGDVLDASDPRLEGIY 571 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~----~~~~~~~~~~~~~~~~~~d~~l~~~~ 571 (660)
.....||..|+|||++.+..++.++||||||+++|||++|+.||...... ............. .+.+..
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~-- 222 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVLPV-- 222 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCCCC--
Confidence 23457899999999999888999999999999999999999999642111 0011111111111 111111
Q ss_pred cHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 572 VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
......+.+++..|++.||++||+++|++++
T Consensus 223 -~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 223 -GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred -CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1122346788889999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=325.60 Aligned_cols=257 Identities=20% Similarity=0.273 Sum_probs=197.1
Q ss_pred cccccccC--ccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 340 NLYKATKG--GSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 340 ~l~~lg~G--~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
.+..||+| +|++||++....+++.||+|++.... ....+.+.+|+.+++.++||||++++++|..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35678998 78999999999999999999986542 334556778999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC-c
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND-L 494 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~-~ 494 (660)
++|+|.+++.......+++..+.+++.|++.||+|||+ .+|+||||||+|||++.++.+++.||+.+........ .
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 99999999976544568999999999999999999998 8999999999999999999999999987543221111 0
Q ss_pred -----eeeccccCccccCcccccC--CCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCC---
Q 006112 495 -----HTTNVVGTVGYLAPELLRN--GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASD--- 564 (660)
Q Consensus 495 -----~~~~~~gt~~Y~aPE~~~~--~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d--- 564 (660)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ .... ..+......+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~-~~~~~~~~~~~~~ 235 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEK-LNGTVPCLLDTTT 235 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHH-hcCCccccccccc
Confidence 0112356788999999875 4588999999999999999999999975322111 1111 1111100000
Q ss_pred ----------------Cc-----------------ccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 565 ----------------PR-----------------LEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 565 ----------------~~-----------------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
.. ............+.+++..||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00 000111223346788999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=314.86 Aligned_cols=254 Identities=28% Similarity=0.457 Sum_probs=203.3
Q ss_pred eeecccccccCccEEEEEEEeCCCCe---EEEEEEeccC-CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHA---EIAVKKVCHD-SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~---~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
.|+..+.+|+|+||.||+|.+..+++ .||||.+... .....++|..|+.++++++||||+++++++.++...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46778899999999999999876554 6999998654 3445678999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
||+++++|.+++.... ..+++.++..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++......
T Consensus 85 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 85 EFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred ecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999987643 358999999999999999999998 999999999999999999999999999997654332
Q ss_pred Cce--eeccc--cCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcc
Q 006112 493 DLH--TTNVV--GTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL 567 (660)
Q Consensus 493 ~~~--~~~~~--gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 567 (660)
... ..... .+..|+|||.+....++.++|||||||++||+++ |..||....... ........... +.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~i~~~~~~----~~- 232 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINAIEQDYRL----PP- 232 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHHHHcCCcC----CC-
Confidence 211 11111 2457999999998899999999999999999886 999987543221 11111111110 10
Q ss_pred cccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 568 EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
..+.+..+.+++..||+.+|++||++++|++.|+.
T Consensus 233 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 233 ----PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred ----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 11223457788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=297.29 Aligned_cols=260 Identities=25% Similarity=0.246 Sum_probs=208.3
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeec-----CeeEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK-----GELLL 410 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~~l 410 (660)
-.|++.+++|+|||.-||.++...++..+|+|++...+.+..+..++|++..++++|||++++++++..+ .+.||
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl 100 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL 100 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence 3688999999999999999998889999999999888888899999999999999999999999988544 34899
Q ss_pred EEecCCCCChhhhhhhCC--CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceec
Q 006112 411 VYDYMPNGSLDKILYSNT--RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLY 488 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 488 (660)
+++|...|+|.+.+.... +..+++.+.++|+.+|++||++||+. ...++||||||.|||+.+.+.++|.|||.+...
T Consensus 101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a 179 (302)
T KOG2345|consen 101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQA 179 (302)
T ss_pred EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcccc
Confidence 999999999999987543 34689999999999999999999982 235999999999999999999999999998754
Q ss_pred cCCCCc--------eeeccccCccccCccccc---CCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcC
Q 006112 489 DHGNDL--------HTTNVVGTVGYLAPELLR---NGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKG 557 (660)
Q Consensus 489 ~~~~~~--------~~~~~~gt~~Y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 557 (660)
.-.... ......-|..|.|||++. +...++++|||||||+||+|+.|..||+... .+.|
T Consensus 180 ~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~----------~~Gg 249 (302)
T KOG2345|consen 180 PIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY----------QQGG 249 (302)
T ss_pred ceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh----------hcCC
Confidence 322111 011234588999999986 3456899999999999999999999997411 1222
Q ss_pred Cccc-CCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 558 DVLD-ASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 558 ~~~~-~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
.+.- ...+.+.-.-.....+.+.+++.+|++.||.+||+..+++..++.
T Consensus 250 SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 250 SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 2211 111111111112255678899999999999999999999998875
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=323.32 Aligned_cols=260 Identities=23% Similarity=0.318 Sum_probs=200.0
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
.|..++.+|+|+||.||+|+...+++.||+|++.... ......+.+|++++++++||||+++++++..++..++||||+
T Consensus 7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 86 (309)
T cd07872 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL 86 (309)
T ss_pred ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCC
Confidence 5888999999999999999998889999999986543 233456789999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 495 (660)
+ ++|.+++.... ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 87 ~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 160 (309)
T cd07872 87 D-KDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-T 160 (309)
T ss_pred C-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-c
Confidence 6 58888876543 347889999999999999999998 8999999999999999999999999999976433221 1
Q ss_pred eeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCcc-hHHHHHHHHhcCCc------------cc
Q 006112 496 TTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGELD-LLDWVIDYWQKGDV------------LD 561 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~~~------------~~ 561 (660)
.....+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||...... ....+......... ..
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 223467899999998865 46789999999999999999999999764321 11111111110000 00
Q ss_pred CCCCcccc----cCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 562 ASDPRLEG----IYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 562 ~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
...+.... .........+.+++..|++.||.+|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000 000112334678889999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=318.23 Aligned_cols=240 Identities=22% Similarity=0.324 Sum_probs=189.8
Q ss_pred ccccCccEEEEEEEeCC------------------------CCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeE
Q 006112 343 KATKGGSGKVYRGVLPS------------------------SHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQL 398 (660)
Q Consensus 343 ~lg~G~fg~Vy~g~~~~------------------------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l 398 (660)
.||+|+||.||+|.+.. ....|++|.+..........|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999998632 124689998865555556688999999999999999999
Q ss_pred eeeeeecCeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCC---
Q 006112 399 RGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADL--- 475 (660)
Q Consensus 399 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~--- 475 (660)
+++|.++...++||||+++|+|+.++.... ..+++..+.+++.||++||+|||+ ++|+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCccc
Confidence 999999999999999999999999986543 358899999999999999999998 8999999999999997654
Q ss_pred ----CeEEeecccceeccCCCCceeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHh-hCCCCCCCCCcchHHH
Q 006112 476 ----EGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVA-CGRRPVQPGELDLLDW 549 (660)
Q Consensus 476 ----~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~ell-tG~~p~~~~~~~~~~~ 549 (660)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++||++ +|+.||..........
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 3799999998643221 22357888999998865 56789999999999999995 6898887543322222
Q ss_pred HHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhh
Q 006112 550 VIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605 (660)
Q Consensus 550 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (660)
. ..... .+.... ...+.+++..||+.+|++||++.+|++.|.
T Consensus 233 ~---~~~~~-------~~~~~~----~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 233 F---YEKKH-------RLPEPS----CKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred H---HHhcc-------CCCCCC----ChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1 11111 011111 134778889999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=311.27 Aligned_cols=247 Identities=32% Similarity=0.416 Sum_probs=200.5
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeee-ecCeeEEEEecC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCR-RKGELLLVYDYM 415 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~-~~~~~~lV~E~~ 415 (660)
.|+..+.+|+|+||.||++.. .+..+|+|.+... ...+.+.+|+.++++++|+|++++++++. .++..++||||+
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred hCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 577788999999999999987 4678999988543 23567999999999999999999999764 456789999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 495 (660)
++++|.+++.......+++..+.+++.|++.||+|||+ ++++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 99999999987665568999999999999999999998 899999999999999999999999999997543322
Q ss_pred eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHH
Q 006112 496 TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEE 574 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 574 (660)
....++..|+|||++....++.++|||||||++|||++ |+.||....... .......+... .. ...
T Consensus 157 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~~~~~~~-----~~----~~~ 223 (256)
T cd05082 157 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEKGYKM-----DA----PDG 223 (256)
T ss_pred -CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHhcCCCC-----CC----CCC
Confidence 22345678999999988889999999999999999997 999987543221 11111222111 11 112
Q ss_pred HHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 575 QMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 575 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
....+.+++.+|++.+|++|||+.++++.|+.
T Consensus 224 ~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 224 CPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 34567788899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=319.15 Aligned_cols=251 Identities=24% Similarity=0.360 Sum_probs=206.4
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
...|+.++.+|+|+||.||++....+++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 35788899999999999999999888999999999766555667889999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
+++++|.+++... .+++.++..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~- 170 (297)
T cd06656 98 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (297)
T ss_pred cCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-
Confidence 9999999998643 47889999999999999999998 8999999999999999999999999999976543322
Q ss_pred eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHH
Q 006112 495 HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEE 574 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 574 (660)
......+++.|+|||.+.+..++.++|||||||++|++++|+.||...+.... .......+ .+.+ .....
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~--~~~~~~~~------~~~~--~~~~~ 240 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYLIATNG------TPEL--QNPER 240 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh--eeeeccCC------CCCC--CCccc
Confidence 22345688999999999988899999999999999999999999975432110 00000111 0111 01122
Q ss_pred HHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 575 QMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 575 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
....+.+++..||+.||++||+++++++
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 241 LSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 3345678888999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=313.56 Aligned_cols=253 Identities=24% Similarity=0.331 Sum_probs=203.4
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 416 (660)
+|+..+.+|+|+||.||+++...+++.||+|.+..........+.+|+.+++.++||||+++++.+..++..++||||++
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 89 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCG 89 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Confidence 67888899999999999999988899999999876655556678899999999999999999999999999999999999
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCcee
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT 496 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 496 (660)
+++|.+++.... .+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++....... ...
T Consensus 90 ~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~~ 163 (267)
T cd06645 90 GGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AKR 163 (267)
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-ccc
Confidence 999999986544 48899999999999999999998 899999999999999999999999999987654321 122
Q ss_pred eccccCccccCccccc---CCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 497 TNVVGTVGYLAPELLR---NGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 497 ~~~~gt~~Y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
....|+..|+|||++. .+.++.++|||||||++|||++|+.||........ +... ...... .+.+... .
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~--~~~~-~~~~~~---~~~~~~~--~ 235 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LFLM-TKSNFQ---PPKLKDK--M 235 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh--HHhh-hccCCC---CCccccc--C
Confidence 3457899999999874 45678899999999999999999999865332111 1111 111111 1111110 0
Q ss_pred HHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.....+.+++..|++.||++||++++++++
T Consensus 236 ~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 236 KWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred CCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 122346788889999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=319.33 Aligned_cols=259 Identities=24% Similarity=0.365 Sum_probs=210.5
Q ss_pred CCCceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEE
Q 006112 332 SPHRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 332 ~~~~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 411 (660)
+.....|+.++.+|.|++|.||+|....+++.|++|.+........+.+.+|+.+++.++||||+++++++......++|
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 15 GDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred CCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 34445789999999999999999999889999999999766555667889999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCC
Q 006112 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 491 (660)
+||+++++|..++... .+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 95 ~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 95 MEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred EEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 9999999999988643 48999999999999999999998 89999999999999999999999999998765433
Q ss_pred CCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccC
Q 006112 492 NDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIY 571 (660)
Q Consensus 492 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 571 (660)
.. ......|+..|+|||.+.+..++.++|||||||++|||++|+.||...+.. .........+ ... +. .
T Consensus 169 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~--~~~~~~~~~~-~~~-----~~--~ 237 (296)
T cd06655 169 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--RALYLIATNG-TPE-----LQ--N 237 (296)
T ss_pred cc-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcC-Ccc-----cC--C
Confidence 22 123356889999999999888999999999999999999999999764431 1111111111 100 00 0
Q ss_pred cHHHHHHHHHHhhhccCCCCCCCCCHHHHHH--HhhCC
Q 006112 572 VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ--YLDGG 607 (660)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~ 607 (660)
.......+.+++.+||..||++||++.++++ +++..
T Consensus 238 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 238 PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred cccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence 1122335677888999999999999999996 45443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=314.01 Aligned_cols=254 Identities=28% Similarity=0.457 Sum_probs=203.7
Q ss_pred eeecccccccCccEEEEEEEeCCC---CeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSS---HAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~---~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
.|+..+.+|+|+||.||+|++..+ +..+|+|.+.... ....+.+.+|+.++++++||||+++++++..++..++||
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (267)
T cd05066 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVT 84 (267)
T ss_pred HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence 467788999999999999988543 3479999886543 334568999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
||+++++|.+++.... ..+++.++..++.|++.||+|||+ ++++||||||+|||++.++.+||+|||+++......
T Consensus 85 e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 85 EYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999997654 358999999999999999999998 999999999999999999999999999998765433
Q ss_pred Cceee--ccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccc
Q 006112 493 DLHTT--NVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEG 569 (660)
Q Consensus 493 ~~~~~--~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 569 (660)
..... ...++..|+|||++.+..++.++||||||+++||+++ |..||....... .......+... +. .
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~~~~~~~----~~-~- 231 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAIEEGYRL----PA-P- 231 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHHhCCCcC----CC-C-
Confidence 22211 2233568999999998889999999999999999886 999987533211 11112222110 11 1
Q ss_pred cCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 570 IYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
...+..+.+++.+|++.+|.+||+|.++++.|+.
T Consensus 232 ---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 232 ---MDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred ---CCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 1123456788899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=312.02 Aligned_cols=254 Identities=29% Similarity=0.439 Sum_probs=206.5
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
-.|+..+.+|+|+||.||++.+. ++..+|||.+.... ...+++.+|++++++++|+||+++++++..+...++||||+
T Consensus 6 ~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 6 ESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 36778889999999999999985 45779999986543 34578999999999999999999999999889999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 495 (660)
++++|.+++.......+++.++..++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||+++.........
T Consensus 84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (261)
T cd05034 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160 (261)
T ss_pred CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhhhh
Confidence 99999999987655568999999999999999999998 899999999999999999999999999998765432222
Q ss_pred eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHH
Q 006112 496 TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEE 574 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 574 (660)
.....++..|+|||.+.+..++.++||||||+++||+++ |+.||...... ........+... .. . ..
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~~~~~~~~--~~---~----~~ 228 (261)
T cd05034 161 REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLEQVERGYRM--PR---P----PN 228 (261)
T ss_pred hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcCCCC--CC---C----CC
Confidence 223345678999999998889999999999999999998 99998653321 122222221110 00 1 11
Q ss_pred HHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 575 QMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 575 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
....+.+++.+|++.+|++||+++++++.|+.
T Consensus 229 ~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 229 CPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 23457888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=310.29 Aligned_cols=254 Identities=26% Similarity=0.417 Sum_probs=205.2
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
+-+|+..+.+|+|+||.||++.+. .+..+|+|.+... ....+.+.+|++++++++|+||+++.+.+.+ ...+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 346888899999999999999874 4567999988643 2345789999999999999999999999877 778999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
+++++|.+++.......+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 999999999977555568999999999999999999998 89999999999999999999999999999866443322
Q ss_pred eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 495 HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
......++..|+|||++..+.++.++|+|||||++||+++ |+.||....... .......+..... ..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~~~~~~~~---------~~ 226 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRALERGYRMPR---------PE 226 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHhCCCCCCC---------cc
Confidence 2233456678999999988889999999999999999999 898987533221 1122222211110 11
Q ss_pred HHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
.....+.+++.+|++.+|++||++.++++.|+.
T Consensus 227 ~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 227 NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 223457788899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=319.43 Aligned_cols=253 Identities=26% Similarity=0.381 Sum_probs=206.0
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
.+|+.++.+|+|+||+||++....+++.+|+|.+.... ....+++.+|+++++.++||||+++++.+...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 36888899999999999999998889999999886543 34567899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
+++++|.+++.... .+++.....++.+++.+|.|||+ ..+++||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-- 158 (284)
T cd06620 85 MDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-- 158 (284)
T ss_pred CCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence 99999999886543 48899999999999999999997 3589999999999999999999999999987543221
Q ss_pred eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcc---------hHHHHHHHHhcCCcccCCCC
Q 006112 495 HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELD---------LLDWVIDYWQKGDVLDASDP 565 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~---------~~~~~~~~~~~~~~~~~~d~ 565 (660)
.....|+..|+|||.+.+..++.++|||||||++||+++|+.||...... ..++....... ..+
T Consensus 159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 231 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE------PPP 231 (284)
T ss_pred -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc------cCC
Confidence 22357899999999998888999999999999999999999999753321 11221111111 011
Q ss_pred cccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHh
Q 006112 566 RLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYL 604 (660)
Q Consensus 566 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (660)
.+.. ......+.+++.+|++.||++||++.|++++.
T Consensus 232 ~~~~---~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 232 RLPS---SDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CCCc---hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 1111 12334577888899999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=329.09 Aligned_cols=251 Identities=29% Similarity=0.432 Sum_probs=207.8
Q ss_pred cccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCCCCChh
Q 006112 342 YKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLD 421 (660)
Q Consensus 342 ~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~ 421 (660)
-.+|+|.+|+||.|++..+...+|||.+.....+..+-+..||.+-++|+|+|||+++|.|.+++.+-+.||-++||||.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 36899999999999999999999999998777777888999999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCc--chhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcC-CCCeEEeecccceeccCCCCceeec
Q 006112 422 KILYSNTRPSL--NWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDA-DLEGKLGDFGLARLYDHGNDLHTTN 498 (660)
Q Consensus 422 ~~l~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~ 498 (660)
.+|...=. ++ ++...-.+.+||++||.|||+ +.|||||||-+|||++. .|.+||+|||-++.+. +....+..
T Consensus 661 sLLrskWG-PlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA-ginP~TET 735 (1226)
T KOG4279|consen 661 SLLRSKWG-PLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA-GINPCTET 735 (1226)
T ss_pred HHHHhccC-CCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhc-cCCccccc
Confidence 99976432 34 667778899999999999998 99999999999999965 6899999999998654 34556677
Q ss_pred cccCccccCcccccCC--CCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHH
Q 006112 499 VVGTVGYLAPELLRNG--RGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQM 576 (660)
Q Consensus 499 ~~gt~~Y~aPE~~~~~--~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 576 (660)
..||..|||||++..+ .|..++|||||||++.||.||++||..-...... .++-|- -.+.|. .+.+..
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA----MFkVGm--yKvHP~----iPeels 805 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA----MFKVGM--YKVHPP----IPEELS 805 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh----hhhhcc--eecCCC----CcHHHH
Confidence 8899999999999865 4888999999999999999999999753222111 111111 112232 234555
Q ss_pred HHHHHHhhhccCCCCCCCCCHHHHHH--HhhCC
Q 006112 577 EIVLKLGLFCSHSNPDTRPSMRQVVQ--YLDGG 607 (660)
Q Consensus 577 ~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~ 607 (660)
.....++++|..+||.+||++.++++ +|+..
T Consensus 806 aeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 806 AEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred HHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 66778889999999999999999996 55543
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=325.06 Aligned_cols=251 Identities=25% Similarity=0.277 Sum_probs=211.5
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC---hhhHHHHHHHHHHhccC-CCCceeEeeeeeecCeeEEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD---HGMKQFVSEIVSMGKLR-HRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV 411 (660)
..|+..+.+|+|.||.||+++.+.+|+.+|+|.+.+... ...+.+.+|+++|+++. |||||++.+.++....+++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 357777899999999999999999999999999976533 24568999999999998 99999999999999999999
Q ss_pred EecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCC----CCeEEeeccccee
Q 006112 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDAD----LEGKLGDFGLARL 487 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~----~~~kl~DFGla~~ 487 (660)
||+|.||.|.+.+... .+++..+..++.|++.++.|||+ .+|+||||||+|+|+... +.+|++|||++..
T Consensus 115 mEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred EEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 9999999999999766 28999999999999999999998 999999999999999543 4799999999998
Q ss_pred ccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcc
Q 006112 488 YDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL 567 (660)
Q Consensus 488 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 567 (660)
... .......+||+.|+|||.+....|+..+||||+||++|.|++|..||.......... ....++. .+
T Consensus 189 ~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~---~i~~~~~------~f 257 (382)
T KOG0032|consen 189 IKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL---AILRGDF------DF 257 (382)
T ss_pred ccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH---HHHcCCC------CC
Confidence 766 445567899999999999999999999999999999999999999998755332221 2223332 12
Q ss_pred cccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 568 EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.........+...+++..|+..||.+|+|+.+++++
T Consensus 258 ~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 258 TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 222223334456677778999999999999999985
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=318.46 Aligned_cols=257 Identities=27% Similarity=0.424 Sum_probs=203.6
Q ss_pred eeeecccccccCccEEEEEEEeCC-----CCeEEEEEEeccCCC-hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPS-----SHAEIAVKKVCHDSD-HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELL 409 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~-----~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 409 (660)
..|+.++.+|+|+||.||+|...+ .+..||+|.+..... .....+.+|+.++++++||||+++++++.+.+..+
T Consensus 6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (288)
T cd05061 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL 85 (288)
T ss_pred HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 467888999999999999997642 345899998864432 33456889999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhhhCC--------CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEee
Q 006112 410 LVYDYMPNGSLDKILYSNT--------RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGD 481 (660)
Q Consensus 410 lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~D 481 (660)
+||||+++|+|.+++.... ...+++..+.+++.|++.||.|||+ ++|+||||||+||++++++.+||+|
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L~D 162 (288)
T cd05061 86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGD 162 (288)
T ss_pred EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEECc
Confidence 9999999999999996532 2345677889999999999999998 9999999999999999999999999
Q ss_pred cccceeccCCCCc-eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCc
Q 006112 482 FGLARLYDHGNDL-HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDV 559 (660)
Q Consensus 482 FGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 559 (660)
||+++........ ......++..|+|||.+.++.++.++|||||||++|||++ |..||...... .+......+..
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~---~~~~~~~~~~~ 239 (288)
T cd05061 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---QVLKFVMDGGY 239 (288)
T ss_pred CCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcCCC
Confidence 9999865432211 1222345778999999998899999999999999999998 78888653322 12222222211
Q ss_pred ccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 560 LDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 560 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
.. .. ......+.+++.+|++.||++||++.++++.|+..
T Consensus 240 ~~-----~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 240 LD-----QP----DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred CC-----CC----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 11 11 12235688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=311.24 Aligned_cols=239 Identities=26% Similarity=0.415 Sum_probs=192.2
Q ss_pred cccccCccEEEEEEEeCCCC----------eEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEE
Q 006112 342 YKATKGGSGKVYRGVLPSSH----------AEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 342 ~~lg~G~fg~Vy~g~~~~~~----------~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 411 (660)
+.+|+|+||.||+|.+..++ ..+++|.+...... ...|.+|+.++++++||||++++++|.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 35899999999999997665 45888877544433 6789999999999999999999999988 788999
Q ss_pred EecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCC-------CeEEeeccc
Q 006112 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADL-------EGKLGDFGL 484 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~-------~~kl~DFGl 484 (660)
|||+++|+|.+++..... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999976543 58899999999999999999998 9999999999999999887 799999999
Q ss_pred ceeccCCCCceeeccccCccccCcccccCC--CCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCccc
Q 006112 485 ARLYDHGNDLHTTNVVGTVGYLAPELLRNG--RGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLD 561 (660)
Q Consensus 485 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 561 (660)
++.... .....++..|+|||++... .++.++||||||+++|||++ |..|+...... ++ ...+.......
T Consensus 155 a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--~~-~~~~~~~~~~~ 226 (259)
T cd05037 155 PITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--EK-ERFYQDQHRLP 226 (259)
T ss_pred cccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--hH-HHHHhcCCCCC
Confidence 986543 2234567789999998876 78999999999999999999 57777543221 11 11111111110
Q ss_pred CCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhh
Q 006112 562 ASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605 (660)
Q Consensus 562 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (660)
.+. ...+.+++..||+.+|.+||++.++++.|+
T Consensus 227 --~~~---------~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 227 --MPD---------CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred --CCC---------chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 010 156788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=313.38 Aligned_cols=248 Identities=25% Similarity=0.409 Sum_probs=205.1
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
+|+.++.+|.|++|.||+|++..+++.||+|.+.... ......+.+|++++++++|+||+++++++.++...++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 4677889999999999999999899999999986543 344567899999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 495 (660)
++++|.+++... .+++..+..++.|++.||.|||+ ++++||||+|+||++++++.++|+|||+++...... ..
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~ 154 (274)
T cd06609 82 GGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SK 154 (274)
T ss_pred CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccc-cc
Confidence 999999998754 58999999999999999999998 899999999999999999999999999998765432 22
Q ss_pred eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHH
Q 006112 496 TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQ 575 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 575 (660)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||...... . .......+. .+.+... ..
T Consensus 155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~--~-~~~~~~~~~-----~~~~~~~---~~ 223 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM--R-VLFLIPKNN-----PPSLEGN---KF 223 (274)
T ss_pred cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH--H-HHHHhhhcC-----CCCCccc---cc
Confidence 23456888999999999888999999999999999999999999754321 1 111111111 1111111 02
Q ss_pred HHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 576 MEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 576 ~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
...+.+++..||+.||++||+++++++
T Consensus 224 ~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 224 SKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 334677888899999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=321.57 Aligned_cols=257 Identities=27% Similarity=0.398 Sum_probs=204.6
Q ss_pred eeeecccccccCccEEEEEEEeCC-------CCeEEEEEEeccCC-ChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecC
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPS-------SHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKG 406 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~-------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~ 406 (660)
-.|...+.||+|+||.||+++... ....+|+|.+.... ....+++.+|+++++++ +||||++++++|...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 468888999999999999998643 23579999987543 34456788999999999 7999999999999999
Q ss_pred eeEEEEecCCCCChhhhhhhCC--------------CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEc
Q 006112 407 ELLLVYDYMPNGSLDKILYSNT--------------RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLD 472 (660)
Q Consensus 407 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~ 472 (660)
..++||||+++|+|.+++.... ...++|.++.+++.|++.||+|||+ ++++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEEc
Confidence 9999999999999999997542 1348899999999999999999998 8999999999999999
Q ss_pred CCCCeEEeecccceeccCCCCce-eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHH
Q 006112 473 ADLEGKLGDFGLARLYDHGNDLH-TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWV 550 (660)
Q Consensus 473 ~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~ 550 (660)
.++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||...... .+
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~---~~ 251 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---EL 251 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH---HH
Confidence 99999999999997654322111 122234578999999988889999999999999999998 88888654322 22
Q ss_pred HHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 551 IDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 551 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
......+...+ ........+.+++..||+.+|++||++.+|++.|+..
T Consensus 252 ~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 252 FKLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred HHHHHcCCCCC---------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 22222222111 1112234677888999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=317.85 Aligned_cols=256 Identities=27% Similarity=0.436 Sum_probs=205.5
Q ss_pred eeeecccccccCccEEEEEEEeCC-----CCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPS-----SHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELL 409 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~-----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 409 (660)
.+|+.+..+|+|+||.||++.... ++..+|+|.+.... ....+++.+|+.++++++||||++++++|..+...+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC 84 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence 467888999999999999998743 56889999986543 334567999999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhhhCC--------------------CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcE
Q 006112 410 LVYDYMPNGSLDKILYSNT--------------------RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANV 469 (660)
Q Consensus 410 lV~E~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NI 469 (660)
+||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+ ++++||||||+||
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~ni 161 (288)
T cd05050 85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNC 161 (288)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhhe
Confidence 9999999999999996431 1347888999999999999999998 8999999999999
Q ss_pred EEcCCCCeEEeecccceeccCCCCc-eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchH
Q 006112 470 LLDADLEGKLGDFGLARLYDHGNDL-HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLL 547 (660)
Q Consensus 470 ll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~ 547 (660)
++++++.+||+|||+++........ .......+..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~-- 239 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE-- 239 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--
Confidence 9999999999999999765432211 1122345678999999988899999999999999999997 88888653322
Q ss_pred HHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 548 DWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 548 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
........+..... . ......+.+++.+|++.||++||++.|+++.|+.
T Consensus 240 -~~~~~~~~~~~~~~-----~----~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 -EVIYYVRDGNVLSC-----P----DNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -HHHHHHhcCCCCCC-----C----CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 12222333332211 1 1223457889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=338.53 Aligned_cols=257 Identities=24% Similarity=0.319 Sum_probs=193.5
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeec--------Ce
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK--------GE 407 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--------~~ 407 (660)
..|+..+.||+|+||.||+|....+++.||||++.... ....+|+.++++++||||+++++++... ..
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 36889999999999999999998899999999985432 2345799999999999999999876432 24
Q ss_pred eEEEEecCCCCChhhhhhh--CCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCC-CeEEeeccc
Q 006112 408 LLLVYDYMPNGSLDKILYS--NTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADL-EGKLGDFGL 484 (660)
Q Consensus 408 ~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~-~~kl~DFGl 484 (660)
+++||||++ ++|.+++.. .....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+
T Consensus 142 l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 142 LNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred EEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeecccc
Confidence 679999996 577776643 223468999999999999999999998 9999999999999998665 699999999
Q ss_pred ceeccCCCCceeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHHHHHHhcCC----
Q 006112 485 ARLYDHGNDLHTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVIDYWQKGD---- 558 (660)
Q Consensus 485 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~~~~~~---- 558 (660)
++.+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|..||..... +....+.+......
T Consensus 218 a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~ 295 (440)
T PTZ00036 218 AKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295 (440)
T ss_pred chhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 986643322 234578999999998865 4689999999999999999999999976432 22222222111100
Q ss_pred ------cccCCCCc-----ccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 559 ------VLDASDPR-----LEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 559 ------~~~~~d~~-----l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
..+..-+. +...+.......+.+++..||+.||.+|||+.|+++
T Consensus 296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 00000010 111111122356788999999999999999999995
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=316.52 Aligned_cols=247 Identities=27% Similarity=0.413 Sum_probs=196.3
Q ss_pred ccccCccEEEEEEEeCCCCe--EEEEEEeccC-CChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCeeEEEEecCCCC
Q 006112 343 KATKGGSGKVYRGVLPSSHA--EIAVKKVCHD-SDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVYDYMPNG 418 (660)
Q Consensus 343 ~lg~G~fg~Vy~g~~~~~~~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~g 418 (660)
.+|+|+||.||+|++.+++. .+++|.+... .....+.+.+|++++.++ +||||++++++|...+..++||||+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 58999999999999977664 5688888643 344567899999999999 7999999999999999999999999999
Q ss_pred ChhhhhhhCC--------------CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeeccc
Q 006112 419 SLDKILYSNT--------------RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGL 484 (660)
Q Consensus 419 sL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGl 484 (660)
+|.+++.... ...+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999986532 1247899999999999999999998 8999999999999999999999999999
Q ss_pred ceeccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCC
Q 006112 485 ARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDAS 563 (660)
Q Consensus 485 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (660)
++..... ........+..|+|||++....++.++|||||||++|||++ |+.||...... + ..+....+...+
T Consensus 159 ~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~-~~~~~~~~~~~~-- 231 (270)
T cd05047 159 SRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--E-LYEKLPQGYRLE-- 231 (270)
T ss_pred ccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH--H-HHHHHhCCCCCC--
Confidence 8632211 11112234667999999988889999999999999999997 99999653321 1 111111211111
Q ss_pred CCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 564 DPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 564 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
.. ......+.+++.+||+.||.+||++.++++.|+.
T Consensus 232 ---~~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~ 267 (270)
T cd05047 232 ---KP----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 267 (270)
T ss_pred ---CC----CcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 11 1123457789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=350.81 Aligned_cols=257 Identities=25% Similarity=0.328 Sum_probs=202.8
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
.|+..+.+|+|+||.||+|++..+++.||+|++.... ....++|.+|++++++++||||+++++++.+++..++|||
T Consensus 3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME 82 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP 82 (932)
T ss_pred CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence 5788899999999999999999899999999986532 2345679999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCC---------CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeeccc
Q 006112 414 YMPNGSLDKILYSNT---------RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGL 484 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGl 484 (660)
|++||+|.+++.... ...+++..+.+++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecCc
Confidence 999999999986421 1235677889999999999999998 8999999999999999999999999999
Q ss_pred ceeccCCCC-----------------ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchH
Q 006112 485 ARLYDHGND-----------------LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLL 547 (660)
Q Consensus 485 a~~~~~~~~-----------------~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~ 547 (660)
++....... .......||+.|+|||++.+..++.++|||||||++|||+||+.||........
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 986621110 011134699999999999999999999999999999999999999976332211
Q ss_pred HHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCC-CHHHHHHHhhC
Q 006112 548 DWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRP-SMRQVVQYLDG 606 (660)
Q Consensus 548 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~ 606 (660)
.. . ........... ..+....+.+++.+|++.||++|| +++++++.|+.
T Consensus 240 ~~--~----~~i~~P~~~~p----~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 240 SY--R----DVILSPIEVAP----YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred hh--h----hhccChhhccc----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11 0 01111000000 112334577888899999999996 56777766654
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=317.90 Aligned_cols=260 Identities=27% Similarity=0.329 Sum_probs=199.4
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
+|+.++.+|+|++|.||+|+...+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 3778889999999999999998889999999986432 23356788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCC-CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 415 MPNGSLDKILYSNT-RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 415 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
++ ++|.+++.... ...+++.++..++.||++||+|||+ ++|+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 96 68988886543 2468999999999999999999998 9999999999999999999999999999976543221
Q ss_pred ceeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhc-CCcccCCC-------
Q 006112 494 LHTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQK-GDVLDASD------- 564 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~-~~~~~~~d------- 564 (660)
......+++.|+|||.+.+ ..++.++|||||||++|||+||+.||...... +........ +...+...
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 157 -VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI--DQLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred -cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhcchhhH
Confidence 1223467889999998865 45788999999999999999999999754321 111111100 00000000
Q ss_pred ------Cccccc----CcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 565 ------PRLEGI----YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 565 ------~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
+..... ........+.+++.+||+.||++|||+++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000 001122456688899999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=320.33 Aligned_cols=260 Identities=27% Similarity=0.390 Sum_probs=206.9
Q ss_pred CCceeeecccccccCccEEEEEEEeC-------CCCeEEEEEEeccCC-ChhhHHHHHHHHHHhcc-CCCCceeEeeeee
Q 006112 333 PHRFSYKNLYKATKGGSGKVYRGVLP-------SSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKL-RHRNLVQLRGYCR 403 (660)
Q Consensus 333 ~~~~~~~~l~~lg~G~fg~Vy~g~~~-------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~ 403 (660)
.....|+..+.+|+|+||.||+++.. ..+..||+|.+.... ....+++.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 34457888899999999999999752 234579999886442 34567899999999999 8999999999999
Q ss_pred ecCeeEEEEecCCCCChhhhhhhCC--------------CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcE
Q 006112 404 RKGELLLVYDYMPNGSLDKILYSNT--------------RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANV 469 (660)
Q Consensus 404 ~~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NI 469 (660)
..+..++||||+++|+|.+++.... ...++|.++..++.||++||+|||+ ++++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceE
Confidence 9999999999999999999997532 1347888999999999999999998 8999999999999
Q ss_pred EEcCCCCeEEeecccceeccCCCCc-eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchH
Q 006112 470 LLDADLEGKLGDFGLARLYDHGNDL-HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLL 547 (660)
Q Consensus 470 ll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~ 547 (660)
+++.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--- 245 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--- 245 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---
Confidence 9999999999999999876443222 1223456778999999988889999999999999999998 7788765332
Q ss_pred HHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 548 DWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 548 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
....+....+..... .......+.+++.+||+.+|++||++.|+++.|+..
T Consensus 246 ~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 246 EELFKLLKEGHRMDK---------PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred HHHHHHHHcCCcCCC---------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence 222222222221110 112335577888999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=310.43 Aligned_cols=249 Identities=25% Similarity=0.380 Sum_probs=204.4
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 416 (660)
.|+..+.+|+|+||.||+|.+..++..+++|.+..... .+++.+|++++++++|+||+++++++..+...++++||++
T Consensus 4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 57888899999999999999988889999999865432 6789999999999999999999999999999999999999
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCcee
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT 496 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 496 (660)
+++|.+++.... ..+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||++........ ..
T Consensus 82 ~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~ 156 (256)
T cd06612 82 AGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KR 156 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-cc
Confidence 999999986543 458999999999999999999998 8999999999999999999999999999986644321 22
Q ss_pred eccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHH
Q 006112 497 TNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQM 576 (660)
Q Consensus 497 ~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 576 (660)
....|+..|+|||++.+..++.++||||||+++|||++|+.||........ .. ..... ..+.+ .......
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~--~~-~~~~~-----~~~~~--~~~~~~~ 226 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA--IF-MIPNK-----PPPTL--SDPEKWS 226 (256)
T ss_pred ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh--hh-hhccC-----CCCCC--CchhhcC
Confidence 335588999999999988999999999999999999999999875322111 00 00000 00111 1112233
Q ss_pred HHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 577 EIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 577 ~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
..+.+++..||+.||++||++.|+++
T Consensus 227 ~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 227 PEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred HHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 45788889999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=316.49 Aligned_cols=241 Identities=23% Similarity=0.376 Sum_probs=191.4
Q ss_pred cccccCccEEEEEEEeCCCCe-------EEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 342 YKATKGGSGKVYRGVLPSSHA-------EIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 342 ~~lg~G~fg~Vy~g~~~~~~~-------~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
+.+|+|+||.||+|.....+. ++|+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 368999999999998855433 4888888655555667899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCC--------eEEeecccce
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLE--------GKLGDFGLAR 486 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~--------~kl~DFGla~ 486 (660)
+++|+|..++..... .+++..+.+++.||+.||+|||+ ++|+||||||+||+++.++. +|++|||++.
T Consensus 81 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999976543 58999999999999999999998 99999999999999987765 5899999886
Q ss_pred eccCCCCceeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCC-CCCCCCCcchHHHHHHHHhcCCcccCCC
Q 006112 487 LYDHGNDLHTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGR-RPVQPGELDLLDWVIDYWQKGDVLDASD 564 (660)
Q Consensus 487 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~d 564 (660)
.... .....++..|+|||++.+ ..++.++||||||+++|||++|. .|+...+.... .......
T Consensus 157 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~---~~~~~~~------- 221 (258)
T cd05078 157 TVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK---LQFYEDR------- 221 (258)
T ss_pred ccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH---HHHHHcc-------
Confidence 5432 123467889999999976 45789999999999999999995 45443222111 1111111
Q ss_pred CcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhh
Q 006112 565 PRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605 (660)
Q Consensus 565 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (660)
..+... ....+.+++..||+.||++|||++++++.|+
T Consensus 222 ~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 HQLPAP----KWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ccCCCC----CcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 011111 1234778888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=310.19 Aligned_cols=251 Identities=24% Similarity=0.374 Sum_probs=207.4
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
+|+.++.+|+|+||.+|+++...+++.+|+|++... .....+++.+|+.++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 478889999999999999999889999999998643 234456899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
+++++|.+++.......+++.++.+++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 999999999876554468899999999999999999998 8999999999999999999999999999986544321
Q ss_pred eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHH
Q 006112 495 HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEE 574 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 574 (660)
......|++.|+|||.+.+...+.++|+|||||+++||++|+.||...+.. +.+... ..+... ... ..
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~--~~~~~~-~~~~~~-----~~~----~~ 224 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK--NLVLKI-IRGSYP-----PVS----SH 224 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH--HHHHHH-hcCCCC-----CCc----cc
Confidence 122346889999999999888999999999999999999999999754322 222222 222211 111 12
Q ss_pred HHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 575 QMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 575 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
....+.+++.+||+.+|++||++.+|+++
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 225 YSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 23457788889999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=311.62 Aligned_cols=246 Identities=28% Similarity=0.397 Sum_probs=198.2
Q ss_pred cccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCCCCChh
Q 006112 342 YKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLD 421 (660)
Q Consensus 342 ~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~ 421 (660)
..+|+|+||.||+|++..++..||+|.+........+.+.+|++++++++|+||+++++++..++..++|+||+++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 47999999999999998889999999987776667788999999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCc--chhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcC-CCCeEEeecccceeccCCCCceeec
Q 006112 422 KILYSNTRPSL--NWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDA-DLEGKLGDFGLARLYDHGNDLHTTN 498 (660)
Q Consensus 422 ~~l~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~ 498 (660)
+++..... .+ ++..+..++.||+.||+|||+ ++|+||||||+||+++. ++.+||+|||++........ ....
T Consensus 94 ~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~ 168 (268)
T cd06624 94 ALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTET 168 (268)
T ss_pred HHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-cccc
Confidence 99976432 24 788889999999999999998 89999999999999976 67899999999976543221 2223
Q ss_pred cccCccccCcccccCCC--CCcceeEEehHHHHHHHhhCCCCCCCCCcch-HHHHHHHHhcCCcccCCCCcccccCcHHH
Q 006112 499 VVGTVGYLAPELLRNGR--GTTSTDVYAFGVFMLEVACGRRPVQPGELDL-LDWVIDYWQKGDVLDASDPRLEGIYVEEQ 575 (660)
Q Consensus 499 ~~gt~~Y~aPE~~~~~~--~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 575 (660)
..|++.|+|||++.... ++.++||||||+++|||++|+.||....... ..+..... ...+.+ ....
T Consensus 169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~-------~~~~~~----~~~~ 237 (268)
T cd06624 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF-------KIHPEI----PESL 237 (268)
T ss_pred CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhh-------ccCCCC----Cccc
Confidence 46889999999986543 7889999999999999999999986532211 11111000 011111 1223
Q ss_pred HHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 576 MEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 576 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
...+.+++.+||+.+|++||++.|++++
T Consensus 238 ~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 238 SAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred CHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 3457788899999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=313.85 Aligned_cols=257 Identities=26% Similarity=0.381 Sum_probs=205.7
Q ss_pred ceeeecccccccCccEEEEEEEeCC-----CCeEEEEEEeccCCCh-hhHHHHHHHHHHhccCCCCceeEeeeeeecCee
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPS-----SHAEIAVKKVCHDSDH-GMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGEL 408 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~-----~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 408 (660)
+-+|+.++.+|+|+||.||+|+... ..+.+++|.+...... ..+.+.+|++++++++|+||+++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 3468889999999999999999743 3467999988654443 567899999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhhhCCC-------CCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEee
Q 006112 409 LLVYDYMPNGSLDKILYSNTR-------PSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGD 481 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~D 481 (660)
++||||+++|+|.+++..... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEcc
Confidence 999999999999999975541 258999999999999999999998 8999999999999999999999999
Q ss_pred cccceeccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcc
Q 006112 482 FGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVL 560 (660)
Q Consensus 482 FGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 560 (660)
||+++..............++..|+|||.+.+...+.++||||||+++|||++ |..||...... . .......+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--~-~~~~~~~~~~~ 237 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--E-VLNRLQAGKLE 237 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--H-HHHHHHcCCcC
Confidence 99987543322222233456788999999988888999999999999999998 78888643221 1 12222222211
Q ss_pred cCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhh
Q 006112 561 DASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605 (660)
Q Consensus 561 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (660)
... .......+.+++.+||+.||++||++.|+++.|.
T Consensus 238 ~~~--------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 238 LPV--------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCC--------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 110 1122346888999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=316.39 Aligned_cols=248 Identities=25% Similarity=0.381 Sum_probs=203.6
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
.|+.++.+|+|+||.||+|.+..++..||+|.+.... ....+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4677888999999999999998889999999986443 345567899999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 495 (660)
++++|.+++.. ..+++..+..++.|++.||.|||+ ++++|+||+|+||++++++.+||+|||++........ .
T Consensus 85 ~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06642 85 GGGSALDLLKP---GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred CCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcch-h
Confidence 99999998854 348899999999999999999998 8999999999999999999999999999976543221 1
Q ss_pred eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHH
Q 006112 496 TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQ 575 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 575 (660)
.....|+..|+|||++.+..++.++|||||||++|||++|+.|+......... .....+ ..+.+. ...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---~~~~~~-----~~~~~~----~~~ 225 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL---FLIPKN-----SPPTLE----GQY 225 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH---hhhhcC-----CCCCCC----ccc
Confidence 22346889999999999888999999999999999999999998643221111 111111 111122 223
Q ss_pred HHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 576 MEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 576 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
...+.+++..||+.+|++||++.+++++
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 226 SKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 4457788899999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=315.36 Aligned_cols=263 Identities=25% Similarity=0.343 Sum_probs=202.7
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhc--cCCCCceeEeeeeeec----CeeEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGK--LRHRNLVQLRGYCRRK----GELLL 410 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~H~nIv~l~g~~~~~----~~~~l 410 (660)
+....+.+|+|.||.||+|.| .|+.||||++...+ .+.+.+|.+|.+. |+|+||+.+++.-..+ .+++|
T Consensus 212 qI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred eeEEEEEecCccccceeeccc--cCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 566778899999999999999 57889999995433 3567778777765 5999999999976544 36899
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhc-----ccCceeccCccCCcEEEcCCCCeEEeecccc
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEE-----WEQVVLHRDIKPANVLLDADLEGKLGDFGLA 485 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivHrDikp~NIll~~~~~~kl~DFGla 485 (660)
|.+|.++|||.+||... .++-...++++..+|.||++||.+ .++.|.|||||+.|||+..++.+.|+|+|||
T Consensus 287 vTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA 363 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 363 (513)
T ss_pred eeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence 99999999999999764 488999999999999999999975 3789999999999999999999999999999
Q ss_pred eeccCCCC---ceeeccccCccccCcccccCCCC------CcceeEEehHHHHHHHhhC----------CCCCCC---CC
Q 006112 486 RLYDHGND---LHTTNVVGTVGYLAPELLRNGRG------TTSTDVYAFGVFMLEVACG----------RRPVQP---GE 543 (660)
Q Consensus 486 ~~~~~~~~---~~~~~~~gt~~Y~aPE~~~~~~~------t~ksDV~S~Gvvl~elltG----------~~p~~~---~~ 543 (660)
........ ......+||.+|||||++...-. -..+||||||.|+||++.. +.||.+ .+
T Consensus 364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D 443 (513)
T KOG2052|consen 364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD 443 (513)
T ss_pred EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC
Confidence 87765432 23345789999999999865422 2368999999999999752 245543 11
Q ss_pred cchHHHHHHHHhcCCcccCCCCcccc-cCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCCCCCCC
Q 006112 544 LDLLDWVIDYWQKGDVLDASDPRLEG-IYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGALLPD 612 (660)
Q Consensus 544 ~~~~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p~ 612 (660)
.. .+.+.+.. ..+...|.++. -.+.+.+..+.++|..||..+|.-|-|+-.|.+.|......++
T Consensus 444 Ps-~eeMrkVV----Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~e 508 (513)
T KOG2052|consen 444 PS-FEEMRKVV----CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSDE 508 (513)
T ss_pred CC-HHHHhcce----eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcChh
Confidence 11 11111111 11122222221 2345778889999999999999999999999999887654433
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=314.60 Aligned_cols=261 Identities=26% Similarity=0.306 Sum_probs=202.5
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
.|+.++.+|+|++|.||+|++..+++.||+|++.... ....+.+.+|++++++++|+||+++++++......++||||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 4778889999999999999998889999999986442 23346788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
+++++|..++.... .+++.++..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07847 82 CDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD- 155 (286)
T ss_pred cCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence 99999988775433 48999999999999999999998 9999999999999999999999999999987654322
Q ss_pred eeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHh------------cCCcc-
Q 006112 495 HTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQ------------KGDVL- 560 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~------------~~~~~- 560 (660)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.........+...... .....
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence 2223467889999999875 457899999999999999999999997543221111111100 00000
Q ss_pred cCCCCcccccC-----cHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 561 DASDPRLEGIY-----VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 561 ~~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
....+...... .......+.+++.+||+.||++||++.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00011111000 01123567889999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=313.24 Aligned_cols=255 Identities=26% Similarity=0.346 Sum_probs=203.9
Q ss_pred eeeecccccccCccEEEEEEEeCCC---CeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSS---HAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~---~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 411 (660)
.+|...+.+|+|+||.||+|.+... ...||||...... ....+.+.+|+.++++++||||++++++|.+ ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 3567778999999999999987543 3578999886654 3456789999999999999999999998875 567899
Q ss_pred EecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCC
Q 006112 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 491 (660)
|||+++|+|.+++.... ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 85 MELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 99999999999997643 358999999999999999999998 89999999999999999999999999999876544
Q ss_pred CCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCccccc
Q 006112 492 NDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGI 570 (660)
Q Consensus 492 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 570 (660)
.........++..|+|||.+....++.++||||||+++||+++ |..||........ . .....+.... ...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~--~-~~~~~~~~~~-----~~~- 231 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV--I-GRIENGERLP-----MPP- 231 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH--H-HHHHcCCcCC-----CCC-
Confidence 3222233345678999999988889999999999999999986 9999976432211 1 1122222111 111
Q ss_pred CcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 571 YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
.....+.+++.+|+..+|++|||+.++++.|+..
T Consensus 232 ---~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 232 ---NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred ---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 2234577888899999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=307.98 Aligned_cols=250 Identities=31% Similarity=0.504 Sum_probs=204.1
Q ss_pred cccccccCccEEEEEEEeCCCC----eEEEEEEeccCCCh-hhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 340 NLYKATKGGSGKVYRGVLPSSH----AEIAVKKVCHDSDH-GMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 340 ~l~~lg~G~fg~Vy~g~~~~~~----~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
..+.+|.|+||.||++++...+ ..||+|.+...... ..+.+..|+.++++++|+||+++++++.+.+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 4567899999999999997765 89999999765443 577899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
+++++|.+++.......+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 999999999976544338999999999999999999998 89999999999999999999999999999876554322
Q ss_pred eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 495 HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
......++..|+|||.+.+..++.++||||+|++++||++ |+.||...... ...+....+..... . .
T Consensus 160 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~---~~~~~~~~~~~~~~-----~----~ 227 (258)
T smart00219 160 KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE---EVLEYLKKGYRLPK-----P----E 227 (258)
T ss_pred ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHhcCCCCCC-----C----C
Confidence 2222347889999999988889999999999999999998 78887653221 11222222221111 1 1
Q ss_pred HHHHHHHHHhhhccCCCCCCCCCHHHHHHHh
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQYL 604 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (660)
.....+.+++.+|+..||++|||+.|+++.|
T Consensus 228 ~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 228 NCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred cCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1344577888999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=311.03 Aligned_cols=253 Identities=27% Similarity=0.367 Sum_probs=190.8
Q ss_pred cccccCccEEEEEEEeCC--CCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCCCC
Q 006112 342 YKATKGGSGKVYRGVLPS--SHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNG 418 (660)
Q Consensus 342 ~~lg~G~fg~Vy~g~~~~--~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g 418 (660)
+.||+|+||.||+|.... ....+++|.+.... ......+.+|+++++.++|+||+++++.|......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 358999999999997643 34578899875443 334567899999999999999999999999999999999999999
Q ss_pred ChhhhhhhCCC---CCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc-
Q 006112 419 SLDKILYSNTR---PSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL- 494 (660)
Q Consensus 419 sL~~~l~~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~- 494 (660)
+|.+++..... ...++.....++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999976432 235678889999999999999998 89999999999999999999999999998754322111
Q ss_pred eeeccccCccccCcccccC-------CCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCc
Q 006112 495 HTTNVVGTVGYLAPELLRN-------GRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPR 566 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~-------~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 566 (660)
......++..|+|||++.. ..++.++|||||||++|||++ |..||...... +....... ........+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--~~~~~~~~-~~~~~~~~~~ 234 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE--QVLKQVVR-EQDIKLPKPQ 234 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH--HHHHHHhh-ccCccCCCCc
Confidence 1123346778999998743 356789999999999999999 77787653221 11111112 2222223333
Q ss_pred ccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhh
Q 006112 567 LEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605 (660)
Q Consensus 567 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (660)
+...+ ...+.+++..|| .||++||++++|++.|.
T Consensus 235 ~~~~~----~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 235 LDLKY----SDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred ccccC----CHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 33222 234455667788 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=315.49 Aligned_cols=262 Identities=25% Similarity=0.308 Sum_probs=205.1
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
+|+..+.+|+|++|.||+|++..+++.||+|++.... ....+.+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 3778889999999999999998889999999986543 34457899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
+ +++|.+++.... ..+++.++..++.||++||+|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 9 999999987544 458999999999999999999998 89999999999999999999999999999876544322
Q ss_pred eeeccccCccccCcccccCC-CCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHHHHHHhcCCc------------c
Q 006112 495 HTTNVVGTVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVIDYWQKGDV------------L 560 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~~~~~~~------------~ 560 (660)
......|+..|+|||.+.+. .++.++||||+|++++||++|+.+|..... ....++......... .
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhh
Confidence 23345789999999998654 468899999999999999999777754322 122222221111000 0
Q ss_pred cCCCCccc----ccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 561 DASDPRLE----GIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 561 ~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
....+.-. ....++....+.+++.+|++.||++||++++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000 00111233678889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=315.10 Aligned_cols=253 Identities=27% Similarity=0.411 Sum_probs=203.5
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC-CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD-SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
+|+.++.+|+|+||.||++.+..++..+|+|.+... .....+++.+|+.++++++|+||+++++.+..++..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 477889999999999999999888999999988654 3344578999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCC-CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 416 PNGSLDKILYSNT-RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 416 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
++++|..++.... ...+++..+..++.|++.||.|||+ ..+|+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 157 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-- 157 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc--
Confidence 9999999886532 2358999999999999999999996 2589999999999999999999999999997653321
Q ss_pred eeeccccCccccCcccccCCC------CCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCccc
Q 006112 495 HTTNVVGTVGYLAPELLRNGR------GTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLE 568 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~------~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 568 (660)
.....++..|+|||.+.+.. ++.++|+|||||++|||++|+.||.................+. .+.+
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-----~~~~- 230 (286)
T cd06622 158 -AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD-----PPTL- 230 (286)
T ss_pred -cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcC-----CCCC-
Confidence 22346888999999986543 4789999999999999999999997543322211221111111 1111
Q ss_pred ccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 569 GIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.......+.+++.+||+.+|++||++++++++
T Consensus 231 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 231 ---PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ---CcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 12234557788889999999999999999973
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=324.37 Aligned_cols=257 Identities=25% Similarity=0.362 Sum_probs=200.9
Q ss_pred eeecccccccCccEEEEEEEeC-----CCCeEEEEEEeccCC-ChhhHHHHHHHHHHhcc-CCCCceeEeeeeeec-Cee
Q 006112 337 SYKNLYKATKGGSGKVYRGVLP-----SSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRK-GEL 408 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~-----~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~-~~~ 408 (660)
.|+..+.||+|+||.||+|.+. .+++.||||++.... ....+.+.+|+.++.++ +||||++++++|... ...
T Consensus 8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 87 (343)
T cd05103 8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 87 (343)
T ss_pred HhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCce
Confidence 5888899999999999999852 356789999997543 33456788999999999 689999999988654 467
Q ss_pred EEEEecCCCCChhhhhhhCC------------------------------------------------------------
Q 006112 409 LLVYDYMPNGSLDKILYSNT------------------------------------------------------------ 428 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~------------------------------------------------------------ 428 (660)
++|||||++|+|.+++....
T Consensus 88 ~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (343)
T cd05103 88 MVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAE 167 (343)
T ss_pred EEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhh
Confidence 99999999999999986431
Q ss_pred -----CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC-ceeeccccC
Q 006112 429 -----RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND-LHTTNVVGT 502 (660)
Q Consensus 429 -----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt 502 (660)
...++|.++.+++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++....... .......++
T Consensus 168 ~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd05103 168 QEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244 (343)
T ss_pred hhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCC
Confidence 1236888899999999999999998 9999999999999999999999999999976533221 112223456
Q ss_pred ccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHHH
Q 006112 503 VGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLK 581 (660)
Q Consensus 503 ~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 581 (660)
..|+|||.+.+..++.++||||||+++|||++ |..||...... .........+..... .... ...+.+
T Consensus 245 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~-----~~~~----~~~~~~ 313 (343)
T cd05103 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFCRRLKEGTRMRA-----PDYT----TPEMYQ 313 (343)
T ss_pred cceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HHHHHHHhccCCCCC-----CCCC----CHHHHH
Confidence 78999999988889999999999999999997 88898653322 111222222221111 1111 234778
Q ss_pred HhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 582 LGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 582 l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
++..||+.||++||++.||+++|+..
T Consensus 314 ~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 314 TMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHH
Confidence 88999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=325.91 Aligned_cols=249 Identities=27% Similarity=0.382 Sum_probs=209.5
Q ss_pred cccccccCccEEEEEEEeCCC----CeEEEEEEecc-CCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 340 NLYKATKGGSGKVYRGVLPSS----HAEIAVKKVCH-DSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 340 ~l~~lg~G~fg~Vy~g~~~~~----~~~vavK~~~~-~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
.-+.||+|.||.||+|.+..- .-.||||..+. +..+..+.|+.|..+|++++||||++++|.|.+. ..+||||.
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmEL 471 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVMEL 471 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEec
Confidence 346789999999999998432 34689998876 4566788999999999999999999999999654 68999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
++-|.|..||+.+.. .|+......++.||+.+|+|||+ ...|||||..+|||+.....+||+||||+|.++....+
T Consensus 472 ~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yY 547 (974)
T KOG4257|consen 472 APLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYY 547 (974)
T ss_pred ccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhccccchh
Confidence 999999999987753 68888999999999999999998 99999999999999999999999999999998887766
Q ss_pred eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 495 HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
..+...-+..|||||.+.-.+++.+||||-|||.+||++. |..||.+-.... ++...++|+.+ ..++
T Consensus 548 kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD---VI~~iEnGeRl---------P~P~ 615 (974)
T KOG4257|consen 548 KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD---VIGHIENGERL---------PCPP 615 (974)
T ss_pred hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc---eEEEecCCCCC---------CCCC
Confidence 6666667889999999999999999999999999999976 999998622110 12222333322 2345
Q ss_pred HHHHHHHHHhhhccCCCCCCCCCHHHHHHHhh
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (660)
.++..|..|+.+||+.||.+||++.|+...|.
T Consensus 616 nCPp~LYslmskcWayeP~kRPrftei~~~ls 647 (974)
T KOG4257|consen 616 NCPPALYSLMSKCWAYEPSKRPRFTEIKAILS 647 (974)
T ss_pred CCChHHHHHHHHHhccCcccCCcHHHHHHHHH
Confidence 56677899999999999999999999886654
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=328.09 Aligned_cols=257 Identities=23% Similarity=0.293 Sum_probs=197.6
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeec------Cee
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK------GEL 408 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~ 408 (660)
.|+.++.+|+|+||.||++.....++.||||++... .....+.+.+|+.+++.++||||+++++++... ...
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 97 (355)
T cd07874 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDV 97 (355)
T ss_pred ceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccccee
Confidence 688889999999999999999888999999998653 233456788999999999999999999987643 357
Q ss_pred EEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceec
Q 006112 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLY 488 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 488 (660)
++||||++ ++|.+.+.. .+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 98 ~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 98 YLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred EEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 99999995 567666642 37888999999999999999998 99999999999999999999999999999865
Q ss_pred cCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHHHHHH-------------
Q 006112 489 DHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVIDYW------------- 554 (660)
Q Consensus 489 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~~------------- 554 (660)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .....+.+..
T Consensus 170 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (355)
T cd07874 170 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_pred CCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence 332 122345789999999999988899999999999999999999999975432 1111111100
Q ss_pred ------hcC-CcccCCCCcc--------cccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 555 ------QKG-DVLDASDPRL--------EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 555 ------~~~-~~~~~~d~~l--------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
... .......+.. ...........+.+++.+|++.||++|||+.|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000 0000000000 000111223467889999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=319.47 Aligned_cols=258 Identities=28% Similarity=0.410 Sum_probs=204.4
Q ss_pred ceeeecccccccCccEEEEEEEeC-------CCCeEEEEEEeccCC-ChhhHHHHHHHHHHhcc-CCCCceeEeeeeeec
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLP-------SSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRK 405 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~-------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~ 405 (660)
+-.|...+.+|+|+||.||+++.. .....+|+|.+.... .....++.+|+.+++++ +||||++++++|..+
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 346778899999999999999753 234578999886543 34567789999999999 699999999999999
Q ss_pred CeeEEEEecCCCCChhhhhhhCC--------------CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEE
Q 006112 406 GELLLVYDYMPNGSLDKILYSNT--------------RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLL 471 (660)
Q Consensus 406 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll 471 (660)
+..++||||+++|+|.+++.... ...++|.++.+++.|++.||.|||+ ++++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEE
Confidence 99999999999999999996532 1348899999999999999999998 999999999999999
Q ss_pred cCCCCeEEeecccceeccCCCCc-eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHH
Q 006112 472 DADLEGKLGDFGLARLYDHGNDL-HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDW 549 (660)
Q Consensus 472 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~ 549 (660)
+.++.+||+|||+++........ ......++..|+|||.+.++.++.++|||||||++|||++ |..||...... .
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~---~ 244 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE---E 244 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH---H
Confidence 99999999999999865432211 1112234568999999988889999999999999999999 88888654322 2
Q ss_pred HHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 550 VIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 550 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
..+....+...+. .......+.+++.+||+.||++||++.|+++.|+..
T Consensus 245 ~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 293 (314)
T cd05099 245 LFKLLREGHRMDK---------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293 (314)
T ss_pred HHHHHHcCCCCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 2222222221111 112234577888999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=308.06 Aligned_cols=253 Identities=26% Similarity=0.360 Sum_probs=207.3
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 416 (660)
+|+..+.+|+|+||.||++....+++.+++|.+........+.+.+|++++++++||||+++++++...+.++++|||++
T Consensus 4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~ 83 (262)
T cd06613 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCG 83 (262)
T ss_pred ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCC
Confidence 67888999999999999999988889999999977666667889999999999999999999999999999999999999
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCcee
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT 496 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 496 (660)
+++|.+++.... ..+++.++..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++........ ..
T Consensus 84 ~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~ 158 (262)
T cd06613 84 GGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-KR 158 (262)
T ss_pred CCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh-cc
Confidence 999999987642 358899999999999999999998 8999999999999999999999999999976543221 22
Q ss_pred eccccCccccCcccccCC---CCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 497 TNVVGTVGYLAPELLRNG---RGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 497 ~~~~gt~~Y~aPE~~~~~---~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
....++..|+|||.+... .++.++||||||+++|||++|+.||........ ... ...... ..+.+ ....
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~--~~~-~~~~~~---~~~~~--~~~~ 230 (262)
T cd06613 159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA--LFL-ISKSNF---PPPKL--KDKE 230 (262)
T ss_pred ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHhccC---CCccc--cchh
Confidence 345688899999998776 788999999999999999999999975332211 111 111110 01111 1122
Q ss_pred HHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
.....+.+++.+||+.+|.+||++.+|++
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 231 KWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred hhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 33456889999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=312.94 Aligned_cols=248 Identities=24% Similarity=0.399 Sum_probs=206.0
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
.|+.++.+|+|+||.||+|.+..++..||+|.+.... ....+.+.+|++++++++|+||+++++.+.++...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 5778889999999999999998889999999986543 345678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 495 (660)
++++|.+++... .+++.+...++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........ .
T Consensus 85 ~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06640 85 GGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred CCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-c
Confidence 999999998643 47888999999999999999998 8999999999999999999999999999976644321 2
Q ss_pred eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHH
Q 006112 496 TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQ 575 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 575 (660)
.....++..|+|||.+.+...+.++|||||||++|||++|..||........ ......+. .+ ......
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~~~~~~~-----~~----~~~~~~ 225 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV---LFLIPKNN-----PP----TLTGEF 225 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH---hhhhhcCC-----CC----CCchhh
Confidence 2335688899999999888899999999999999999999999875432211 11111110 11 122345
Q ss_pred HHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 576 MEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 576 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
...+.+++..||+.+|++||++.+++++
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 226 SKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 5668889999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=311.25 Aligned_cols=249 Identities=24% Similarity=0.376 Sum_probs=201.0
Q ss_pred eecccccccCccEEEEEEEeCCCCeEEEEEEeccCCCh---------hhHHHHHHHHHHhccCCCCceeEeeeeeecCee
Q 006112 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDH---------GMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGEL 408 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~---------~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 408 (660)
|.....+|+|++|.||+|....+++.+|+|.+...... ..+.+.+|++++++++||||+++++++.+.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 45567899999999999999888899999988643221 235688999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceec
Q 006112 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLY 488 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 488 (660)
++||||+++++|.+++.... .+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++..
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred EEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 99999999999999997643 48889999999999999999998 89999999999999999999999999999876
Q ss_pred cCCCC-----ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCC
Q 006112 489 DHGND-----LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDAS 563 (660)
Q Consensus 489 ~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (660)
..... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||..... ...+... .. ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~-~~-----~~ 228 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ--LQAIFKI-GE-----NA 228 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH--HHHHHHH-hc-----cC
Confidence 53211 111234588999999999888899999999999999999999999975322 1111111 11 11
Q ss_pred CCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 564 DPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 564 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.+.+.. .....+.+++.+||++||++||++.|++++
T Consensus 229 ~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 229 SPEIPS----NISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred CCcCCc----ccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 122222 233457788889999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=321.05 Aligned_cols=195 Identities=27% Similarity=0.366 Sum_probs=161.1
Q ss_pred ccccccCccEEEEEEEeCC--CCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeee--cCeeEEEEecCC
Q 006112 341 LYKATKGGSGKVYRGVLPS--SHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR--KGELLLVYDYMP 416 (660)
Q Consensus 341 l~~lg~G~fg~Vy~g~~~~--~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV~E~~~ 416 (660)
.+++|+|+||.||+|+... +++.+|+|.+.... ....+.+|++++++++||||+++++++.. +...++||||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~- 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA- 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc-
Confidence 3579999999999999753 56889999985432 23467899999999999999999998854 45689999999
Q ss_pred CCChhhhhhhCC-------CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEE----cCCCCeEEeecccc
Q 006112 417 NGSLDKILYSNT-------RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLL----DADLEGKLGDFGLA 485 (660)
Q Consensus 417 ~gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll----~~~~~~kl~DFGla 485 (660)
+++|..++.... ...+++..+..++.||+.||+|||+ ++|+||||||+|||+ +.++.+||+|||++
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 468888775321 2348888999999999999999998 899999999999999 45678999999999
Q ss_pred eeccCCCC--ceeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCC
Q 006112 486 RLYDHGND--LHTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQP 541 (660)
Q Consensus 486 ~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~ 541 (660)
+....... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 87654322 12234678999999999876 4588999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=313.39 Aligned_cols=258 Identities=25% Similarity=0.345 Sum_probs=205.4
Q ss_pred ceeeecccccccCccEEEEEEEeCC----CCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeee-cCee
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPS----SHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR-KGEL 408 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~ 408 (660)
+..|+..+.+|+|+||.||+|.+.. .+..|++|++.... ....+.+.+|+.++++++|+||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 3467778899999999999999865 35789999886543 3446778999999999999999999999876 4678
Q ss_pred EEEEecCCCCChhhhhhhCCC------CCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeec
Q 006112 409 LLVYDYMPNGSLDKILYSNTR------PSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDF 482 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DF 482 (660)
++++||+++++|.+++..... ..+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCC
Confidence 999999999999999865422 458999999999999999999998 89999999999999999999999999
Q ss_pred ccceeccCCCCce-eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcc
Q 006112 483 GLARLYDHGNDLH-TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVL 560 (660)
Q Consensus 483 Gla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 560 (660)
|+++.+....... .....++..|+|||++.+..++.++||||||+++||+++ |+.||...... + .......+...
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~-~~~~~~~~~~~ 238 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF--E-MAAYLKDGYRL 238 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH--H-HHHHHHcCCCC
Confidence 9998654332211 122346778999999988889999999999999999998 99999754321 1 11222222111
Q ss_pred cCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 561 DASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 561 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
. . .......+.+++.+||+.||++|||+.++++.|+..
T Consensus 239 ~--~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 239 A--Q-------PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred C--C-------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0 0 111234578899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=327.38 Aligned_cols=257 Identities=22% Similarity=0.264 Sum_probs=197.4
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeec------Cee
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK------GEL 408 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~ 408 (660)
.|+.++.+|+|+||.||++.....++.||||++... .....+.+.+|+.+++.++||||+++++++... ...
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~ 104 (364)
T cd07875 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 104 (364)
T ss_pred ceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeE
Confidence 688889999999999999999888999999998653 233456788999999999999999999987543 357
Q ss_pred EEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceec
Q 006112 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLY 488 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 488 (660)
++||||++ ++|.+++.. .+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 105 ~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 105 YIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred EEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 99999995 577777642 37888999999999999999998 89999999999999999999999999999865
Q ss_pred cCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHHHHHHhc-----------
Q 006112 489 DHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVIDYWQK----------- 556 (660)
Q Consensus 489 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~~~~----------- 556 (660)
.... ......||..|+|||++.+..++.++|||||||++|||++|+.||...+. .....+......
T Consensus 177 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (364)
T cd07875 177 GTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254 (364)
T ss_pred CCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH
Confidence 3321 22345789999999999999999999999999999999999999975332 111111111000
Q ss_pred -------CCc--c----cCCCCcc----cccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 557 -------GDV--L----DASDPRL----EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 557 -------~~~--~----~~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
... . +...+.. ...........+.+++.+|++.||.+|||+.|++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000 0 0000000 000011123457789999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=320.84 Aligned_cols=259 Identities=28% Similarity=0.411 Sum_probs=205.5
Q ss_pred ceeeecccccccCccEEEEEEEeCC-------CCeEEEEEEeccCC-ChhhHHHHHHHHHHhcc-CCCCceeEeeeeeec
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPS-------SHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRK 405 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~-------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~ 405 (660)
+..|+..+.||+|+||.||++.... ....||+|.+.... ....+++.+|+++++++ +||||++++++|..+
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 3468889999999999999998632 22478999886443 34567899999999999 799999999999999
Q ss_pred CeeEEEEecCCCCChhhhhhhCC--------------CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEE
Q 006112 406 GELLLVYDYMPNGSLDKILYSNT--------------RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLL 471 (660)
Q Consensus 406 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll 471 (660)
+..+++|||+++|+|.+++.... ...++|.++..++.|++.||+|||+ ++++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEE
Confidence 99999999999999999987532 2348889999999999999999998 999999999999999
Q ss_pred cCCCCeEEeecccceeccCCCCc-eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHH
Q 006112 472 DADLEGKLGDFGLARLYDHGNDL-HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDW 549 (660)
Q Consensus 472 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~ 549 (660)
+.++.+||+|||+++........ ......++..|+|||.+....++.++||||||+++|||++ |..||...... +
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~- 244 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE--E- 244 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH--H-
Confidence 99999999999999865433211 1222344578999999998889999999999999999998 88888654322 1
Q ss_pred HHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCCC
Q 006112 550 VIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGA 608 (660)
Q Consensus 550 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (660)
.......+...+. .......+.+++..||+.+|++||++.|+++.|+...
T Consensus 245 ~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 245 LFKLLKEGHRMDK---------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred HHHHHHcCCCCCC---------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 2222222211111 1122345778899999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=314.48 Aligned_cols=252 Identities=23% Similarity=0.339 Sum_probs=204.8
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 416 (660)
.|+.++.+|+|++|.||++.+..++..+|+|.+........+.|.+|++++++++|+||+++++.+..+...++||||++
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCD 85 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccC
Confidence 58888999999999999999988899999999976666667889999999999999999999999999999999999999
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCcee
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT 496 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 496 (660)
+++|.+++.... ..+++.++..++.|++.||.|||+ .+|+|+||||+||+++.++.+||+|||++....... ...
T Consensus 86 ~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~ 160 (280)
T cd06611 86 GGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-QKR 160 (280)
T ss_pred CCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcccc-ccc
Confidence 999999987643 358999999999999999999998 899999999999999999999999999987543322 122
Q ss_pred eccccCccccCccccc-----CCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccC
Q 006112 497 TNVVGTVGYLAPELLR-----NGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIY 571 (660)
Q Consensus 497 ~~~~gt~~Y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 571 (660)
....|++.|+|||.+. ...++.++||||||+++|||++|+.||...+.. +.... ...+.. +.+. .
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--~~~~~-~~~~~~-----~~~~--~ 230 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--RVLLK-ILKSEP-----PTLD--Q 230 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--HHHHH-HhcCCC-----CCcC--C
Confidence 3456899999999875 344678999999999999999999999754321 11111 122211 1110 0
Q ss_pred cHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 572 VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.......+.+++..||+.+|.+||++.+++++
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 231 PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 11122346778888999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=307.22 Aligned_cols=251 Identities=26% Similarity=0.429 Sum_probs=201.8
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 416 (660)
.|+..+.+|+|+||.||++.+. .+..+|+|.+.... ....+|.+|++++++++|||++++++++......++||||++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred HeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4666788999999999999885 36689999886432 234678999999999999999999999999999999999999
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCcee
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT 496 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 496 (660)
+++|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++..........
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 83 HGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 999999987543 358899999999999999999998 8999999999999999999999999999986543322112
Q ss_pred eccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHH
Q 006112 497 TNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQ 575 (660)
Q Consensus 497 ~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 575 (660)
....++.+|+|||.+.++.++.++||||||+++|||++ |+.||....... ..+....+.. ...+.. .
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~~~~--~~~~~~-------~ 226 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VVETINAGFR--LYKPRL-------A 226 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHHHhCCCC--CCCCCC-------C
Confidence 22345678999999988889999999999999999998 999987543221 1222222211 111211 2
Q ss_pred HHHHHHHhhhccCCCCCCCCCHHHHHHHhh
Q 006112 576 MEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605 (660)
Q Consensus 576 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (660)
.+.+.+++.+||+.+|++||++.|+++.|.
T Consensus 227 ~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 227 SQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 356888999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=326.68 Aligned_cols=192 Identities=21% Similarity=0.320 Sum_probs=167.3
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
..|+.++.||+|+||.||+|+...++..||+|..... ....|+.++++++||||+++++++...+..++|+||+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 4699999999999999999999988899999975322 3356999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 495 (660)
.++|.+++.... ..+++.++..|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 140 -~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~ 212 (357)
T PHA03209 140 -SSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PA 212 (357)
T ss_pred -CCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccC--cc
Confidence 578888886543 358999999999999999999998 89999999999999999999999999999753222 12
Q ss_pred eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCC
Q 006112 496 TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQ 540 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~ 540 (660)
.....||+.|+|||++.+..++.++|||||||++|||+++..++.
T Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 234579999999999999899999999999999999998766653
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=306.35 Aligned_cols=250 Identities=22% Similarity=0.377 Sum_probs=205.1
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
+|+.++.+|+|++|.||++....+++.+|+|.+... .....+.+.+|++++++++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 377888999999999999999889999999998654 334567899999999999999999999999989999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCC-CCeEEeecccceeccCCCC
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDAD-LEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~-~~~kl~DFGla~~~~~~~~ 493 (660)
+++++|.+++.......+++..+..++.+++.+|.|||+ ++++|+||||+||+++.+ +.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 999999999987555568999999999999999999998 899999999999999865 4589999999987644322
Q ss_pred ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
.....|+..|+|||.+....++.++||||||+++|+|++|+.||...+.. ...... ..+.... +..
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--~~~~~~-~~~~~~~-----~~~---- 223 (256)
T cd08220 158 --AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP--ALVLKI-MSGTFAP-----ISD---- 223 (256)
T ss_pred --ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH--HHHHHH-HhcCCCC-----CCC----
Confidence 22356889999999998888899999999999999999999999764332 112211 1111111 111
Q ss_pred HHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.....+.+++..||+.||++|||++|++++
T Consensus 224 ~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 224 RYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 123457788889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=310.70 Aligned_cols=260 Identities=27% Similarity=0.343 Sum_probs=202.9
Q ss_pred CCceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecC-----e
Q 006112 333 PHRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKG-----E 407 (660)
Q Consensus 333 ~~~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~ 407 (660)
....+|+..+.+|.|+||.||+|....+++.||||++..+.+ .--+|+++|++++|||||+++-++.... .
T Consensus 21 ~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 21 KVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVY 96 (364)
T ss_pred ceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence 356789999999999999999999999999999999865543 2246999999999999999999876432 3
Q ss_pred eEEEEecCCCCChhhhhhhC--CCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCC-CCeEEeeccc
Q 006112 408 LLLVYDYMPNGSLDKILYSN--TRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDAD-LEGKLGDFGL 484 (660)
Q Consensus 408 ~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~-~~~kl~DFGl 484 (660)
+.+|||||+ .+|.+.++.. .+..++...+.-+..||.+||.|||+ .+|+||||||.|+|+|.+ +.+||+|||.
T Consensus 97 lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGS 172 (364)
T KOG0658|consen 97 LNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGS 172 (364)
T ss_pred HHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCc
Confidence 578999996 6888888642 23457777888899999999999998 999999999999999987 8999999999
Q ss_pred ceeccCCCCceeeccccCccccCcccccCC-CCCcceeEEehHHHHHHHhhCCCCCCCCC-cchHHHHHHHHhcCC----
Q 006112 485 ARLYDHGNDLHTTNVVGTVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQPGE-LDLLDWVIDYWQKGD---- 558 (660)
Q Consensus 485 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~-~~~~~~~~~~~~~~~---- 558 (660)
|+....++.. ....-|.-|.|||.+.+. .|+.+.||||.|||+.||+-|+.-|.++. .+....+.+......
T Consensus 173 AK~L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 173 AKVLVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDI 250 (364)
T ss_pred ceeeccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9988766543 334558889999998764 68999999999999999999998887633 233333343333221
Q ss_pred ------cccCCCCccccc-----CcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 559 ------VLDASDPRLEGI-----YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 559 ------~~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
..+...|.+... +........++++.+|++.+|.+|.++.|++.
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 112222333221 22334456778888899999999999999985
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=311.32 Aligned_cols=256 Identities=28% Similarity=0.393 Sum_probs=203.5
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC----------hhhHHHHHHHHHHhccCCCCceeEeeeeeec
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD----------HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK 405 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~----------~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~ 405 (660)
|.|...+.+|+|+||.||+|....+++.+|+|.+..... ...+.+.+|++++++++|+|++++++++...
T Consensus 1 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 80 (272)
T cd06629 1 FKWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE 80 (272)
T ss_pred CceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC
Confidence 568888899999999999999988899999998753211 1235688899999999999999999999999
Q ss_pred CeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccc
Q 006112 406 GELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLA 485 (660)
Q Consensus 406 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla 485 (660)
+..++||||+++++|.+++.... .+++..+..++.||+.||.|||+ ++++||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecccc
Confidence 99999999999999999997653 58899999999999999999998 89999999999999999999999999999
Q ss_pred eeccCCCC-ceeeccccCccccCcccccCCC--CCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccC
Q 006112 486 RLYDHGND-LHTTNVVGTVGYLAPELLRNGR--GTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDA 562 (660)
Q Consensus 486 ~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~--~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 562 (660)
+....... .......|+..|+|||.+.... ++.++||||||+++||+++|..||...+. .....+...... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~-~~~ 232 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA--IAAMFKLGNKRS-APP 232 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch--HHHHHHhhcccc-CCc
Confidence 76543221 1223456889999999987654 78999999999999999999999964322 122222111111 111
Q ss_pred CCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 563 SDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 563 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.. ..........+.+++..||+.||++||++++|+++
T Consensus 233 ~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 233 IP----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CC----ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 11 11122234567788889999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=309.26 Aligned_cols=249 Identities=29% Similarity=0.405 Sum_probs=193.3
Q ss_pred ccccCccEEEEEEEeCC---CCeEEEEEEeccC-CChhhHHHHHHHHHHhccCCCCceeEeeeee-ecCeeEEEEecCCC
Q 006112 343 KATKGGSGKVYRGVLPS---SHAEIAVKKVCHD-SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCR-RKGELLLVYDYMPN 417 (660)
Q Consensus 343 ~lg~G~fg~Vy~g~~~~---~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~-~~~~~~lV~E~~~~ 417 (660)
.+|+|+||.||+|.+.. ....+|+|++... .....+.+.+|+.+++.++||||++++++|. .++..++||||+++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 81 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH 81 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence 58999999999998743 3467999998543 3345678899999999999999999999876 45568999999999
Q ss_pred CChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc---
Q 006112 418 GSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL--- 494 (660)
Q Consensus 418 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~--- 494 (660)
|+|.+++.... ..+++..+..++.|+++||.|||+ .+++||||||+|||++.++.+||+|||+++........
T Consensus 82 ~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 82 GDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999997643 246778889999999999999998 89999999999999999999999999999755332111
Q ss_pred eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCC-CCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 495 HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRR-PVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~-p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
......++..|+|||.+....++.++|||||||++|||++|.. ||..... .+... ....+... ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~~-~~~~~~~~-----~~~~---- 225 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--FDITV-YLLQGRRL-----LQPE---- 225 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHH-HHhcCCCC-----CCCC----
Confidence 1123456778999999988889999999999999999999654 5543221 12111 11222111 1111
Q ss_pred HHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
..+..+.+++..||+.+|++||++.||++.|+..
T Consensus 226 ~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 226 YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1234577899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=308.33 Aligned_cols=246 Identities=30% Similarity=0.435 Sum_probs=200.5
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 416 (660)
+|+..+.+|+|+||.||+|.. .++.+|+|.+.... ..+.+.+|+.++++++|||++++++++..+ ..++||||++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 7 KLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 577788999999999999976 67789999985432 346789999999999999999999998654 4799999999
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCcee
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT 496 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 496 (660)
+++|.+++.......+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence 9999999987655568999999999999999999998 999999999999999999999999999997643221
Q ss_pred eccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHH
Q 006112 497 TNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQ 575 (660)
Q Consensus 497 ~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 575 (660)
.....+..|+|||.+.++.++.++|+|||||++|||++ |+.||....... .......+..... . ...
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~~~~~~~-----~----~~~ 222 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE---VKECVEKGYRMEP-----P----EGC 222 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH---HHHHHhCCCCCCC-----C----CcC
Confidence 12234578999999988899999999999999999997 999987644322 1222222211111 1 122
Q ss_pred HHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 576 MEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 576 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
...+.+++.+||+.+|++||+++++++.|+.
T Consensus 223 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 223 PADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 3557788899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=305.60 Aligned_cols=247 Identities=27% Similarity=0.407 Sum_probs=199.8
Q ss_pred cccccCccEEEEEEEeCCCCeEEEEEEeccCCCh-hhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCCCCCh
Q 006112 342 YKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDH-GMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSL 420 (660)
Q Consensus 342 ~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 420 (660)
+.+|+|+||.||++.+.. ++.||+|.+...... ..+.+.+|++++++++|+||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 368999999999999977 899999998765443 567899999999999999999999999999999999999999999
Q ss_pred hhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCcee-ecc
Q 006112 421 DKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT-TNV 499 (660)
Q Consensus 421 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~-~~~ 499 (660)
.+++.... ..+++..+..++.+++.+|.|||+ ++++||||||+||+++.++.+||+|||+++.......... ...
T Consensus 80 ~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 80 LTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 99997643 257889999999999999999998 8999999999999999999999999999986543221111 122
Q ss_pred ccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHHH
Q 006112 500 VGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEI 578 (660)
Q Consensus 500 ~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 578 (660)
.++..|+|||.+.++.++.++||||||+++|||++ |..||......... .....+... .........
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~---~~~~~~~~~---------~~~~~~~~~ 223 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR---ERIESGYRM---------PAPQLCPEE 223 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH---HHHhcCCCC---------CCCccCCHH
Confidence 34667999999988889999999999999999999 88888654322111 111111100 011122346
Q ss_pred HHHHhhhccCCCCCCCCCHHHHHHHhh
Q 006112 579 VLKLGLFCSHSNPDTRPSMRQVVQYLD 605 (660)
Q Consensus 579 l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (660)
+.+++.+|++.+|++||++.|+++.|+
T Consensus 224 ~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 224 IYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=311.62 Aligned_cols=249 Identities=28% Similarity=0.431 Sum_probs=198.2
Q ss_pred ccccCccEEEEEEEeCCCC------eEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 343 KATKGGSGKVYRGVLPSSH------AEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 343 ~lg~G~fg~Vy~g~~~~~~------~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
.+|+|+||.||+|+..... +.+|+|.+.... .....++.+|++++++++||||++++++|...+..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 5899999999999985433 689999886543 345678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCC-----CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCC-----CeEEeecccc
Q 006112 416 PNGSLDKILYSNT-----RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADL-----EGKLGDFGLA 485 (660)
Q Consensus 416 ~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~-----~~kl~DFGla 485 (660)
++++|.+++.... ...++|.++..++.|++.||+|||+ .+++|+||||+||+++.+. .+||+|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999999997532 2347899999999999999999998 8999999999999999877 8999999999
Q ss_pred eeccCCCCc-eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCC
Q 006112 486 RLYDHGNDL-HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDAS 563 (660)
Q Consensus 486 ~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (660)
+........ ......++..|+|||.+.++.++.++|||||||++|||++ |+.||...... +. ......+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--~~-~~~~~~~~~~~-- 233 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EV-LQHVTAGGRLQ-- 233 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--HH-HHHHhcCCccC--
Confidence 765432211 1122345788999999999999999999999999999998 99998643321 11 11111111110
Q ss_pred CCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 564 DPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 564 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
........+.+++.+||..+|.+||++.+|++.|+.
T Consensus 234 -------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 234 -------KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred -------CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 112234567889999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=309.28 Aligned_cols=249 Identities=25% Similarity=0.374 Sum_probs=196.8
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC-----ChhhHHHHHHHHHHhccCCCCceeEeeeeee--cCeeE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-----DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR--KGELL 409 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~ 409 (660)
+|+..+.+|+|+||.||++....++..||+|++.... .+..+.+.+|+.++++++||||+++++++.+ +...+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 5778889999999999999998889999999885432 2345678899999999999999999998865 35789
Q ss_pred EEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceecc
Q 006112 410 LVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYD 489 (660)
Q Consensus 410 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 489 (660)
+++||+++++|.+++.... .+++.....++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 83 l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 9999999999999997644 37889999999999999999998 899999999999999999999999999997653
Q ss_pred CCC--CceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcc
Q 006112 490 HGN--DLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL 567 (660)
Q Consensus 490 ~~~--~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 567 (660)
... ........++..|+|||++.+..++.++|||||||++|||++|+.||..... ...+...... ...+.+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~--~~~~~~~~~~-----~~~~~~ 230 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA--MAAIFKIATQ-----PTNPQL 230 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch--HHHHHHHhcC-----CCCCCC
Confidence 321 1112235688999999999988899999999999999999999999975321 1222211111 112222
Q ss_pred cccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 568 EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
... ..+.+..++ .||..+|++||+++||++
T Consensus 231 ~~~----~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 231 PSH----ISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred chh----cCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 221 222334444 688899999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=307.84 Aligned_cols=256 Identities=26% Similarity=0.387 Sum_probs=207.0
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
+|+..+.+|.|+||+||+|....++..+++|++.... ....+.+.+|+++++.++|+||+++++.+..++..++||||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 81 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYL 81 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEecc
Confidence 4778889999999999999998889999999986443 335678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCC-CCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 416 PNGSLDKILYSNTR-PSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 416 ~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
++++|.+++..... ..+++.....++.|++.||+|||+ .+++||||||+||++++++.+||+|||++..+......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 82 SGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred CCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 99999999976432 468999999999999999999998 99999999999999999999999999999766543322
Q ss_pred ---eeeccccCccccCcccccCC-CCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCccccc
Q 006112 495 ---HTTNVVGTVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGI 570 (660)
Q Consensus 495 ---~~~~~~gt~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 570 (660)
......|+..|+|||.+... .++.++|+|||||++|||++|+.||...... ....+..... .+.+...
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--~~~~~~~~~~------~~~~~~~ 230 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--KVLMLTLQND------PPSLETG 230 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--hhHHHHhcCC------CCCcCCc
Confidence 22345689999999998876 7899999999999999999999999753321 1111111111 1111111
Q ss_pred C-cHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 571 Y-VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 571 ~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
. .......+.+++..|++.||++||++++++++
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 231 ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred cccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1 12334557788889999999999999999864
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=309.28 Aligned_cols=254 Identities=26% Similarity=0.398 Sum_probs=203.8
Q ss_pred eeecccccccCccEEEEEEEeCC-CCeEEEEEEeccC----------CChhhHHHHHHHHHHhc-cCCCCceeEeeeeee
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPS-SHAEIAVKKVCHD----------SDHGMKQFVSEIVSMGK-LRHRNLVQLRGYCRR 404 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~-~~~~vavK~~~~~----------~~~~~~~~~~Ei~~l~~-l~H~nIv~l~g~~~~ 404 (660)
.|+..+.+|+|+||.||+|.+.. .++.+|+|.+... ......++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36778899999999999999977 6789999987532 22345668889998875 799999999999999
Q ss_pred cCeeEEEEecCCCCChhhhhhhC--CCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeec
Q 006112 405 KGELLLVYDYMPNGSLDKILYSN--TRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDF 482 (660)
Q Consensus 405 ~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DF 482 (660)
++..++||||+++++|.+++... ....+++..+++++.|++.||.|||+ ..+++|+||||+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999988542 23458899999999999999999995 268999999999999999999999999
Q ss_pred ccceeccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccC
Q 006112 483 GLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDA 562 (660)
Q Consensus 483 Gla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 562 (660)
|++....... ......|+..|++||.+.++.++.++||||||+++|||++|+.||........ . .....+...
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~--~-~~~~~~~~~-- 231 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL--A-TKIVEAVYE-- 231 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH--H-HHHhhccCC--
Confidence 9998754432 23445789999999999988899999999999999999999999975432211 1 111121111
Q ss_pred CCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhh
Q 006112 563 SDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605 (660)
Q Consensus 563 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (660)
+..... ....+.+++.+||+.||++||++.|+..+|+
T Consensus 232 --~~~~~~----~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 232 --PLPEGM----YSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred --cCCccc----CCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 111111 2345778888999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=300.61 Aligned_cols=250 Identities=26% Similarity=0.378 Sum_probs=204.9
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC-----C---hhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-----D---HGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGE 407 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~-----~---~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 407 (660)
.|..-+.+|.|..+.|-++.++.++.++|+|++.... + +..+.-.+|+.||+++ .||+|+++.+.++.+..
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF 97 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF 97 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence 4666678999999999999999999999999985321 1 1234556799999998 69999999999999999
Q ss_pred eEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeeccccee
Q 006112 408 LLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARL 487 (660)
Q Consensus 408 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 487 (660)
+++|+|.|+.|.|.++|... -.+++....+|++|+..|++|||. +.||||||||+|||+|++.++||+|||+++.
T Consensus 98 ~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 98 VFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFACQ 172 (411)
T ss_pred hhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccceeec
Confidence 99999999999999999654 358999999999999999999998 9999999999999999999999999999998
Q ss_pred ccCCCCceeeccccCccccCcccccC------CCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCccc
Q 006112 488 YDHGNDLHTTNVVGTVGYLAPELLRN------GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLD 561 (660)
Q Consensus 488 ~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 561 (660)
+..++. ....+|||+|+|||.+.. ..|+...|.|++||++|-|+.|..||.....- .+.+.+.+|+..
T Consensus 173 l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm---lMLR~ImeGkyq- 246 (411)
T KOG0599|consen 173 LEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM---LMLRMIMEGKYQ- 246 (411)
T ss_pred cCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH---HHHHHHHhcccc-
Confidence 776543 456899999999998863 35788999999999999999999999742211 123334444431
Q ss_pred CCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 562 ASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 562 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
...|. ..+......+|+.+|++.||.+|.|++|++.
T Consensus 247 F~spe-----Wadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 247 FRSPE-----WADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred cCCcc-----hhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 11221 1223345678888999999999999999986
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=328.88 Aligned_cols=257 Identities=23% Similarity=0.264 Sum_probs=197.5
Q ss_pred eeeecccccccCccEEEEEEEeCC--CCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPS--SHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~--~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
..|+.++.||+|+||.||++...+ .+..||+|.+... +...+|++++++++||||+++++++......++|||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 368899999999999999997643 4578999987543 345689999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
++ +++|.+++... ..+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 167 ~~-~~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 167 KY-KCDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred hc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 99 47888888433 358999999999999999999998 8999999999999999999999999999976544322
Q ss_pred -ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcc----hHHHHHHHHhcCCcc--------
Q 006112 494 -LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELD----LLDWVIDYWQKGDVL-------- 560 (660)
Q Consensus 494 -~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~----~~~~~~~~~~~~~~~-------- 560 (660)
.......||+.|+|||++....++.++|||||||++|||++|+.||...... ....+.+........
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320 (392)
T ss_pred cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence 2223467999999999999889999999999999999999999999763321 111111111110000
Q ss_pred ---------cCCCCc--ccccC-cHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 561 ---------DASDPR--LEGIY-VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 561 ---------~~~d~~--l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
....+. +.... .......+..++..|++.||++||++.|++.+
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000 00000 00112346678889999999999999999975
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=312.44 Aligned_cols=254 Identities=24% Similarity=0.373 Sum_probs=204.1
Q ss_pred eeecccccccCccEEEEEEEeCCCCe----EEEEEEeccCCC-hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHA----EIAVKKVCHDSD-HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~----~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 411 (660)
.|+.++.+|+|+||.||+|.+..++. .+|+|.+..... ....++.+|+.++++++||||++++++|.. ...++|
T Consensus 8 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v 86 (279)
T cd05057 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLI 86 (279)
T ss_pred HcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEE
Confidence 57788899999999999999866554 689998865543 345789999999999999999999999987 789999
Q ss_pred EecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCC
Q 006112 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 491 (660)
|||+++|+|.+++..... .+++..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++.....
T Consensus 87 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 87 TQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred EecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 999999999999976543 48999999999999999999998 99999999999999999999999999999876533
Q ss_pred CCcee-eccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccc
Q 006112 492 NDLHT-TNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEG 569 (660)
Q Consensus 492 ~~~~~-~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 569 (660)
..... ....++..|+|||.+....++.++||||||+++||+++ |+.||....... +......+... ..+ .
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~~~~~--~~~---~ 234 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---IPDLLEKGERL--PQP---P 234 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH---HHHHHhCCCCC--CCC---C
Confidence 22211 12234568999999988889999999999999999998 999997644322 22222222211 111 1
Q ss_pred cCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 570 IYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
. +...+.+++..||..||++||++.++++.|+..
T Consensus 235 ~----~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 235 I----CTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred C----CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1 123467788899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=307.69 Aligned_cols=248 Identities=27% Similarity=0.406 Sum_probs=202.4
Q ss_pred eecccccccCccEEEEEEEeCCCCeEEEEEEeccCC-----ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEE
Q 006112 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-----DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
|+..+.+|+|++|.||+|....++..|++|.+.... .+..+.+.+|++++++++|+||+++++++..+...++||
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 556678999999999999998889999999986533 235678999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
||+++++|.+++.... .+++.++..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 82 ELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 9999999999997653 48899999999999999999998 899999999999999999999999999998654332
Q ss_pred CceeeccccCccccCcccccCCC-CCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccC
Q 006112 493 DLHTTNVVGTVGYLAPELLRNGR-GTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIY 571 (660)
Q Consensus 493 ~~~~~~~~gt~~Y~aPE~~~~~~-~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 571 (660)
......|+..|++||.+.... ++.++|+||||+++|||++|+.||..... .+........... +.+..
T Consensus 157 --~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~-----~~~~~-- 225 (258)
T cd06632 157 --FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG--VAAVFKIGRSKEL-----PPIPD-- 225 (258)
T ss_pred --cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH--HHHHHHHHhcccC-----CCcCC--
Confidence 223456889999999987766 88999999999999999999999975432 2222221111111 11111
Q ss_pred cHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 572 VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.....+.+++.+||+.+|++||++.+++++
T Consensus 226 --~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 226 --HLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred --CcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 123456778889999999999999999853
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=328.92 Aligned_cols=249 Identities=26% Similarity=0.347 Sum_probs=208.6
Q ss_pred eecccccccCccEEEEEEEeCCC---CeEEEEEEeccCCCh-hhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 338 YKNLYKATKGGSGKVYRGVLPSS---HAEIAVKKVCHDSDH-GMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~~~---~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
.+..++||+|.||.|++|.|... -..||||.++.+... .+.+|++|+.+|-+|+|+|+++|+|...+ ..+.||+|
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 34456799999999999999653 257999999877554 78899999999999999999999999877 78899999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
+++.|||.+.|++..+..+-......++.|||.||.||.. +++|||||..+|+||-....+||+||||.|.+..++.
T Consensus 191 LaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred hcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 9999999999988666778888999999999999999998 9999999999999999999999999999998877655
Q ss_pred cee--eccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCccccc
Q 006112 494 LHT--TNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGI 570 (660)
Q Consensus 494 ~~~--~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 570 (660)
... ....-...|+|||.++..+++-++|||+|||++|||+| |..||-+-.... +.+...++..+ .
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q---IL~~iD~~erL---------p 335 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ---ILKNIDAGERL---------P 335 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH---HHHhccccccC---------C
Confidence 432 12234668999999999999999999999999999998 788887643322 22222232221 2
Q ss_pred CcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 571 YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
..+.+.+.+.++++.||..+|++|||+..|.+
T Consensus 336 RPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 336 RPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred CCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 23456788999999999999999999999974
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=307.11 Aligned_cols=252 Identities=24% Similarity=0.342 Sum_probs=190.6
Q ss_pred ccccCccEEEEEEEeCCC--CeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCCCCC
Q 006112 343 KATKGGSGKVYRGVLPSS--HAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGS 419 (660)
Q Consensus 343 ~lg~G~fg~Vy~g~~~~~--~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gs 419 (660)
.||+|+||.||+|..... ...+++|.+.... ....+.|.+|+.+++.++||||+++++.|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999976433 3456777765443 3456789999999999999999999999999999999999999999
Q ss_pred hhhhhhhCC--CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC-Ccee
Q 006112 420 LDKILYSNT--RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN-DLHT 496 (660)
Q Consensus 420 L~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~-~~~~ 496 (660)
|.+++.... ....++..+..++.||+.||+|||+ .+++||||||+|||++.++.+||+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999997542 2346677788999999999999998 899999999999999999999999999986432211 1122
Q ss_pred eccccCccccCcccccC-------CCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCccc
Q 006112 497 TNVVGTVGYLAPELLRN-------GRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLE 568 (660)
Q Consensus 497 ~~~~gt~~Y~aPE~~~~-------~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 568 (660)
....++..|+|||++.. ..++.++|||||||++|||++ |..||..... .+...... .+......++.+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~~~~~~~~-~~~~~~~~~~~~~ 235 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--REVLNHVI-KDQQVKLFKPQLE 235 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHH-hhcccccCCCccC
Confidence 34567899999998753 245789999999999999997 5667754322 12222222 2222333444443
Q ss_pred ccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhh
Q 006112 569 GIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605 (660)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (660)
..+. +.+.+++..|| .+|++||+++||++.|.
T Consensus 236 ~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 236 LPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 3333 34556777799 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=311.51 Aligned_cols=255 Identities=21% Similarity=0.258 Sum_probs=199.4
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhcc-CCCCceeEeeeee-----ecCee
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCR-----RKGEL 408 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~-----~~~~~ 408 (660)
.-+|+.++.||+|+||.||+++...+++.+|+|.+.... ....++.+|+.+++++ +||||++++++|. .++..
T Consensus 17 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 95 (286)
T cd06638 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL 95 (286)
T ss_pred ccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence 347888899999999999999999899999999875432 2346788999999999 6999999999874 34568
Q ss_pred EEEEecCCCCChhhhhhhC--CCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccce
Q 006112 409 LLVYDYMPNGSLDKILYSN--TRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLAR 486 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 486 (660)
++||||+++++|.+++... ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~ 172 (286)
T cd06638 96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSA 172 (286)
T ss_pred EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEEEccCCcee
Confidence 9999999999999987632 23458889999999999999999998 899999999999999999999999999998
Q ss_pred eccCCCCceeeccccCccccCcccccC-----CCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCccc
Q 006112 487 LYDHGNDLHTTNVVGTVGYLAPELLRN-----GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLD 561 (660)
Q Consensus 487 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 561 (660)
....... ......|++.|+|||++.. ..++.++|||||||++|||++|+.||...... ...... ..+....
T Consensus 173 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~--~~~~~~-~~~~~~~ 248 (286)
T cd06638 173 QLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM--RALFKI-PRNPPPT 248 (286)
T ss_pred ecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh--HHHhhc-cccCCCc
Confidence 7643321 2233568999999998753 44788999999999999999999998753321 111111 1111111
Q ss_pred CCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHh
Q 006112 562 ASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYL 604 (660)
Q Consensus 562 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (660)
..++ . .....+.+++.+||+.||++||++.|+++++
T Consensus 249 ~~~~---~----~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 249 LHQP---E----LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ccCC---C----CcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 1111 1 1123577888999999999999999999764
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=335.67 Aligned_cols=257 Identities=22% Similarity=0.256 Sum_probs=192.8
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCC------CCceeEeeeeeec-Cee
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRH------RNLVQLRGYCRRK-GEL 408 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H------~nIv~l~g~~~~~-~~~ 408 (660)
..|+.++.||+|+||+||+|.+..+++.||||++.... ...+++..|++++.+++| .+++++++++..+ +..
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 46889999999999999999998889999999986432 234456677777777654 4588999988754 578
Q ss_pred EEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCC-------------
Q 006112 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADL------------- 475 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~------------- 475 (660)
++|||++ +++|.+++.... .+++.++..|+.||+.||+|||+ +.+||||||||+|||++.++
T Consensus 208 ~iv~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 208 CIVMPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred EEEEecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 9999998 788988887543 58999999999999999999996 25999999999999998765
Q ss_pred ---CeEEeecccceeccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHHH
Q 006112 476 ---EGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVI 551 (660)
Q Consensus 476 ---~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~ 551 (660)
.+||+|||++..... ..+...||+.|+|||++.+..++.++|||||||++|||++|+.||..... +....+.
T Consensus 283 ~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~ 358 (467)
T PTZ00284 283 DPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLME 358 (467)
T ss_pred CCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 499999998864322 23456899999999999999999999999999999999999999976432 1111111
Q ss_pred HHHh---------------------cCCcccCCCCccc-----c--cCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 552 DYWQ---------------------KGDVLDASDPRLE-----G--IYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 552 ~~~~---------------------~~~~~~~~d~~l~-----~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
.... .+......++... . .........+.+|+..||+.||++|||++|+++
T Consensus 359 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 359 KTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 1100 0000000000000 0 000011245778999999999999999999997
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=316.50 Aligned_cols=250 Identities=24% Similarity=0.330 Sum_probs=202.7
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 416 (660)
.|..+..+|+|+||.||++....++..||||++........+.+.+|+.++++++|+||+++++.+...+..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 45556789999999999999988899999999876555566789999999999999999999999999999999999999
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCcee
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT 496 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 496 (660)
+++|.+++... .+++.++..++.||+.||.|||+ ++|+||||||+||++++++.+||+|||++........ ..
T Consensus 103 ~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~ 175 (292)
T cd06658 103 GGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KR 175 (292)
T ss_pred CCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cC
Confidence 99999988542 48899999999999999999998 8999999999999999999999999999875533222 22
Q ss_pred eccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHH
Q 006112 497 TNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQM 576 (660)
Q Consensus 497 ~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 576 (660)
....|+..|+|||.+.+..++.++||||||+++|||++|+.||........ .. ..... ..+.+... ....
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~-~~~~~-----~~~~~~~~--~~~~ 245 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA--MR-RIRDN-----LPPRVKDS--HKVS 245 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH-HHHhc-----CCCccccc--cccC
Confidence 335689999999999888899999999999999999999999975432111 11 11111 11111111 1122
Q ss_pred HHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 577 EIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 577 ~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
..+..++..|++.||++|||++|++++
T Consensus 246 ~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 246 SVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 346677788999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=323.96 Aligned_cols=256 Identities=24% Similarity=0.307 Sum_probs=195.9
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeeec------Cee
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK------GEL 408 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~ 408 (660)
.|+.++.||+|+||.||+|....+++.||||++.... ....+.+.+|+.++++++||||+++++++... ...
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07878 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEV 95 (343)
T ss_pred hhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcE
Confidence 5888999999999999999998899999999986532 23446788999999999999999999987543 357
Q ss_pred EEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceec
Q 006112 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLY 488 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 488 (660)
++++|++ +++|.+++.. ..+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 96 ~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 96 YLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred EEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccceec
Confidence 9999998 8899888753 248999999999999999999998 99999999999999999999999999999865
Q ss_pred cCCCCceeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCcc-hHHHHHHHHhcCCc--ccCC-
Q 006112 489 DHGNDLHTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGELD-LLDWVIDYWQKGDV--LDAS- 563 (660)
Q Consensus 489 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~~~--~~~~- 563 (660)
... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.. ....+......... ....
T Consensus 169 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07878 169 DDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS 244 (343)
T ss_pred CCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 432 234578999999999876 56889999999999999999999999753321 11111111100000 0000
Q ss_pred ----------CCccccc----CcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 564 ----------DPRLEGI----YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 564 ----------d~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.+..... ........+.+++..|++.||++|||+.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 000112246788999999999999999999964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=318.54 Aligned_cols=194 Identities=28% Similarity=0.377 Sum_probs=160.0
Q ss_pred cccccCccEEEEEEEeCC--CCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeee--cCeeEEEEecCCC
Q 006112 342 YKATKGGSGKVYRGVLPS--SHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR--KGELLLVYDYMPN 417 (660)
Q Consensus 342 ~~lg~G~fg~Vy~g~~~~--~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV~E~~~~ 417 (660)
.++|+|+||.||+|+... ++..||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 579999999999999754 45789999985432 23467899999999999999999998853 567899999995
Q ss_pred CChhhhhhhC-------CCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEE----cCCCCeEEeecccce
Q 006112 418 GSLDKILYSN-------TRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLL----DADLEGKLGDFGLAR 486 (660)
Q Consensus 418 gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll----~~~~~~kl~DFGla~ 486 (660)
++|.+++... ....+++..+..++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 5777776422 12348888999999999999999998 899999999999999 566789999999998
Q ss_pred eccCCCC--ceeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCC
Q 006112 487 LYDHGND--LHTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQP 541 (660)
Q Consensus 487 ~~~~~~~--~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~ 541 (660)
....... .......||+.|+|||.+.+ ..++.++|||||||++|||+||+.||..
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 7654322 12234578999999999876 4578999999999999999999999965
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=306.50 Aligned_cols=252 Identities=27% Similarity=0.433 Sum_probs=203.7
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD--HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
.|+..+.+|+|+||.||+|....++..|++|.+..... ...+.+.+|++++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 36778899999999999999988899999999875544 3678899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
+++++|.+++.... .+++..+..++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 99999999997643 47889999999999999999998 89999999999999999999999999999876543322
Q ss_pred eee---ccccCccccCcccccCCC---CCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCccc
Q 006112 495 HTT---NVVGTVGYLAPELLRNGR---GTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLE 568 (660)
Q Consensus 495 ~~~---~~~gt~~Y~aPE~~~~~~---~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 568 (660)
... ...++..|++||++.... .+.++||||||+++||+++|+.||...+... ...... ..+ ..+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-~~~~~~-~~~-----~~~~~~ 228 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-QIMFHV-GAG-----HKPPIP 228 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-HHHHHH-hcC-----CCCCCC
Confidence 211 356789999999998766 7899999999999999999999997543211 111111 111 111111
Q ss_pred ccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 569 GIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
.. ......+.+++.+||+.+|++||++.++++
T Consensus 229 ~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 229 DS--LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred cc--cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11 112344668888999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=315.17 Aligned_cols=260 Identities=24% Similarity=0.321 Sum_probs=200.2
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
.|+.++.||+|+||.||+|+...+++.||+|.+.... ......+.+|+.++++++||||+++++++..++..++||||+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~ 86 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 86 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecc
Confidence 5888999999999999999998889999999986543 333456789999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 495 (660)
+ ++|..++.... ..+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++....... .
T Consensus 87 ~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~ 160 (301)
T cd07873 87 D-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-T 160 (301)
T ss_pred c-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-c
Confidence 6 68988886543 358899999999999999999998 9999999999999999999999999999976433221 1
Q ss_pred eeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCcc-hHHHHHHHHhcC------------Cccc
Q 006112 496 TTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGELD-LLDWVIDYWQKG------------DVLD 561 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~------------~~~~ 561 (660)
.....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...... ....+....... ....
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence 223457899999998865 45788999999999999999999999764321 111111111000 0000
Q ss_pred CCCCcccccC----cHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 562 ASDPRLEGIY----VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 562 ~~d~~l~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
...+...... .......+.+++.+|++.||.+|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0001110000 0112335678889999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=314.77 Aligned_cols=261 Identities=28% Similarity=0.375 Sum_probs=201.6
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
+|+.++.+|+|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 4778899999999999999998889999999875432 22456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
+++++|..+..... .++|.++..++.||++||+|||+ .+++||||+|+||++++++.+||+|||++....... .
T Consensus 82 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~ 155 (286)
T cd07846 82 VDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-E 155 (286)
T ss_pred CCccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-c
Confidence 99999988775432 48999999999999999999998 899999999999999999999999999998754433 2
Q ss_pred eeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHHHHHHh-----------cCCcc-
Q 006112 495 HTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVIDYWQ-----------KGDVL- 560 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~~~-----------~~~~~- 560 (660)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||..... +.......... .....
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence 2234568899999998865 4578899999999999999999988865332 11111110000 00000
Q ss_pred cCCCCcccc-----cCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 561 DASDPRLEG-----IYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 561 ~~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
....+.... ...+.....+.+++.+||+.+|++||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 000000000 0011234568889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=313.02 Aligned_cols=260 Identities=28% Similarity=0.337 Sum_probs=204.9
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
+|+..+.+|+|++|.||+|.+..+++.||+|++... .....+.+.+|++++++++|+||+++++++..++..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 478888999999999999999888999999988643 233457899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
++++.|..++... ..+++.++..++.||+.||.|||+ .+++||||||+||++++++.+||+|||++.........
T Consensus 82 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 82 VERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred CCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence 9987777665443 348999999999999999999998 89999999999999999999999999999876554432
Q ss_pred eeeccccCccccCcccccCC-CCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhc-C--------------C
Q 006112 495 HTTNVVGTVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQK-G--------------D 558 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~-~--------------~ 558 (660)
......++..|+|||++... .++.++||||||+++|||++|+.||...... +..+..... + .
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI--DQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 33446788999999999887 7899999999999999999999998754321 111111100 0 0
Q ss_pred c-----ccCCCCc-ccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 559 V-----LDASDPR-LEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 559 ~-----~~~~d~~-l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
. .+..++. +...+.......+.+++..||+.+|++||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0 0000000 0001112225668899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=318.55 Aligned_cols=252 Identities=24% Similarity=0.313 Sum_probs=204.5
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC---hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD---HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
.|+.++.+|+|++|.||++....+++.+|+|.+..... ...+.+.+|++++++++|+||+++++.+......++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 47788899999999999999988899999999865432 255678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
|+.+++|.+++.......+++..+..++.|+++||+|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 9999999999976555568999999999999999999998 8999999999999999999999999999875432211
Q ss_pred c----------------------------eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcc
Q 006112 494 L----------------------------HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELD 545 (660)
Q Consensus 494 ~----------------------------~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~ 545 (660)
. ......||..|+|||++.+..++.++||||||+++|||++|+.||...+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 0 111346889999999999888999999999999999999999999754322
Q ss_pred hHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCC----HHHHHH
Q 006112 546 LLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPS----MRQVVQ 602 (660)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs----~~evl~ 602 (660)
.. ..... .... .... .......+.+++.+|++.||++||+ ++|+++
T Consensus 239 ~~--~~~~~-~~~~------~~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 239 ET--FSNIL-KKEV------TFPG--SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HH--HHHHh-cCCc------cCCC--ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 11 11111 1111 0111 1113456888889999999999999 667665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=316.09 Aligned_cols=253 Identities=24% Similarity=0.338 Sum_probs=204.6
Q ss_pred CceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 334 HRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 334 ~~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
.+..|+....+|+|+||.||++....+++.||+|.+........+.+.+|+.+++.++||||+++++.+..++..++|||
T Consensus 19 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 19 PRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred chhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 34456667789999999999999988899999999866555556778999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
|+++++|..++.. ..+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~ 172 (297)
T cd06659 99 FLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 172 (297)
T ss_pred cCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence 9999999998754 248899999999999999999998 8999999999999999999999999999875543221
Q ss_pred ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
......|+..|+|||++.+..++.++|||||||++|||++|+.||........ ... ...... +... ...
T Consensus 173 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~-~~~~~~-----~~~~--~~~ 241 (297)
T cd06659 173 -KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA--MKR-LRDSPP-----PKLK--NAH 241 (297)
T ss_pred -cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HhccCC-----CCcc--ccC
Confidence 22345689999999999888899999999999999999999999975432211 111 111110 0000 011
Q ss_pred HHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.....+.+++..|++.+|++||++++++++
T Consensus 242 ~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 242 KISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 122346788889999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=305.48 Aligned_cols=254 Identities=26% Similarity=0.384 Sum_probs=206.0
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeee--cCeeEEEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR--KGELLLVY 412 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV~ 412 (660)
+|+.++.+|.|+||.||++....++..+|+|.+... .....+++..|++++++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 377888999999999999999889999999998643 33445678999999999999999999998754 45689999
Q ss_pred ecCCCCChhhhhhhC--CCCCcchhHHHHHHHHHHHHHHHhhhcc--cCceeccCccCCcEEEcCCCCeEEeecccceec
Q 006112 413 DYMPNGSLDKILYSN--TRPSLNWFQRFRIIKGVAFGLLYLHEEW--EQVVLHRDIKPANVLLDADLEGKLGDFGLARLY 488 (660)
Q Consensus 413 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 488 (660)
||+++++|.+++... ....+++.+++.++.||+.||.|||..+ ..+++|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998653 2346899999999999999999999322 389999999999999999999999999999876
Q ss_pred cCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCccc
Q 006112 489 DHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLE 568 (660)
Q Consensus 489 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 568 (660)
...... .....|++.|+|||.+....++.++||||||+++++|++|+.||...+.. ...+....+.. +.
T Consensus 161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~-----~~-- 229 (265)
T cd08217 161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLASKIKEGKF-----RR-- 229 (265)
T ss_pred cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHHHHHhcCCC-----CC--
Confidence 544321 23356899999999999888999999999999999999999999865422 12222222221 11
Q ss_pred ccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 569 GIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
........+.+++.+|++.+|++||++++|+++
T Consensus 230 --~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 230 --IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred --CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 122334567888999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=315.82 Aligned_cols=254 Identities=24% Similarity=0.385 Sum_probs=201.6
Q ss_pred eeecccccccCccEEEEEEEeCCCCe----EEEEEEeccCCC-hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHA----EIAVKKVCHDSD-HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~----~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 411 (660)
.|+.++.+|+|+||.||+|.+..++. .+|+|.+..... ....++.+|+.++++++||||++++++|... ..+++
T Consensus 8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v 86 (303)
T cd05110 8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLV 86 (303)
T ss_pred hceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceee
Confidence 56788899999999999999876664 578888865433 3345789999999999999999999998754 46799
Q ss_pred EecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCC
Q 006112 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 491 (660)
+||+++|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 87 ~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 87 TQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred ehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccCc
Confidence 99999999999987643 358899999999999999999998 89999999999999999999999999999876533
Q ss_pred CCc-eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccc
Q 006112 492 NDL-HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEG 569 (660)
Q Consensus 492 ~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 569 (660)
... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ..+....+.... . ..
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~~~~~~~~~~~--~---~~ 234 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPDLLEKGERLP--Q---PP 234 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHCCCCCC--C---CC
Confidence 221 1223445778999999988889999999999999999997 899987543221 122222222111 0 11
Q ss_pred cCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 570 IYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
. ....+.+++..||..+|++||+++++++.|+..
T Consensus 235 ~----~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 235 I----CTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred C----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1 223567888899999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=298.98 Aligned_cols=250 Identities=24% Similarity=0.293 Sum_probs=202.3
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
.|+.-+.||+|.|+.||++.+..+|+.+|+|.+... +....+++.+|+.|-+.|+|||||++.....+.+..+||+|+
T Consensus 12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~ 91 (355)
T KOG0033|consen 12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 91 (355)
T ss_pred hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEec
Confidence 466677899999999999999999999999987532 445778899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCC---CCeEEeecccceeccCC
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDAD---LEGKLGDFGLARLYDHG 491 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~---~~~kl~DFGla~~~~~~ 491 (660)
|.|++|..-+-.. ...++..+-..+.||+.+|.|+|. ++|||||+||+|++|-.. --+||+|||+|.....
T Consensus 92 m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~- 165 (355)
T KOG0033|consen 92 VTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND- 165 (355)
T ss_pred ccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeCC-
Confidence 9999997655432 346777888999999999999998 999999999999999433 4589999999988762
Q ss_pred CCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccC
Q 006112 492 NDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIY 571 (660)
Q Consensus 492 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 571 (660)
.......+|||+|||||+++..+|+..+|||+.||+||-|+.|+.||.+.... ...+.+..|... .+++....
T Consensus 166 -g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rlye~I~~g~yd--~~~~~w~~- 238 (355)
T KOG0033|consen 166 -GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYEQIKAGAYD--YPSPEWDT- 238 (355)
T ss_pred -ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HHHHHHhccccC--CCCcccCc-
Confidence 23344578999999999999999999999999999999999999999874332 122333333321 12211222
Q ss_pred cHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 572 VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
..+....|+.+|+..||.+|.|+.|.++
T Consensus 239 ---is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 239 ---VTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ---CCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 2234556777799999999999999875
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=306.70 Aligned_cols=251 Identities=23% Similarity=0.373 Sum_probs=202.5
Q ss_pred eecccccccCccEEEEEEEeCCCCeEEEEEEeccCC------ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEE
Q 006112 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS------DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 411 (660)
|+..+.+|+|++|.||++....+++.+|+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 81 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF 81 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence 667788999999999999998899999999986432 12357899999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCC-CeEEeecccceeccC
Q 006112 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADL-EGKLGDFGLARLYDH 490 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~-~~kl~DFGla~~~~~ 490 (660)
|||+++++|.+++.... .+++..+..++.|++.||.|||+ ++++|+||||+||+++.++ .+||+|||++..+..
T Consensus 82 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 82 VEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 99999999999997543 48899999999999999999998 8999999999999998776 599999999976643
Q ss_pred CCC---ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcc-hHHHHHHHHhcCCcccCCCCc
Q 006112 491 GND---LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELD-LLDWVIDYWQKGDVLDASDPR 566 (660)
Q Consensus 491 ~~~---~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~d~~ 566 (660)
... .......|+..|+|||.+.+..++.++||||+|++++||++|+.||...... ......+..... ..+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----~~~- 230 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT-----TAP- 230 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccC-----CCC-
Confidence 311 1122346889999999998888899999999999999999999999753322 112111111110 011
Q ss_pred ccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 567 LEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 567 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
.........+.+++.+|++.+|++||++.++++
T Consensus 231 ---~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 231 ---SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 122233456778889999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=313.88 Aligned_cols=261 Identities=27% Similarity=0.336 Sum_probs=198.9
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
.|+.++.+|+|+||.||+|+...+|+.+|+|++.... ......+.+|++++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 3777889999999999999999899999999986432 22345788899999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
++ ++|.+++.... ..+++.++..++.||++||.|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 154 (284)
T cd07839 81 CD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR- 154 (284)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence 96 68888776543 358999999999999999999998 8999999999999999999999999999986543322
Q ss_pred eeeccccCccccCcccccCC-CCCcceeEEehHHHHHHHhhCCCCCCCCCcch--HHHHHHHHhcC---------CcccC
Q 006112 495 HTTNVVGTVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQPGELDL--LDWVIDYWQKG---------DVLDA 562 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~--~~~~~~~~~~~---------~~~~~ 562 (660)
......++..|+|||.+.+. .++.++|||||||++|||++|+.|+....... .+......... ...+.
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 12234678899999998764 46899999999999999999999975433211 11111110000 00000
Q ss_pred -CCCccccc-----CcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 563 -SDPRLEGI-----YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 563 -~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.-+..... ..+.....+.+++..|++.||.+|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00000100 011223466788999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=312.27 Aligned_cols=260 Identities=25% Similarity=0.325 Sum_probs=201.2
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
+|+.++.+|+|++|.||+|+...+++.||||++.... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 3778899999999999999998889999999986443 22346789999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
+. ++|.+++.......+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence 95 689999876655678999999999999999999998 8999999999999999999999999999976543321
Q ss_pred eeeccccCccccCcccccCCC-CCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhc-CCcccCCCC-------
Q 006112 495 HTTNVVGTVGYLAPELLRNGR-GTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQK-GDVLDASDP------- 565 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~-~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~-~~~~~~~d~------- 565 (660)
......++..|+|||.+.+.. ++.++||||||+++|||+||+.||...... +...+.... +.......+
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhhhhHHHH
Confidence 122345788999999887644 588999999999999999999999754321 111111110 100000000
Q ss_pred ------cc-ccc---CcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 566 ------RL-EGI---YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 566 ------~l-~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.. ... ..+.....+.+++.+|++.||.+||++++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00 000 001112346788899999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=311.36 Aligned_cols=256 Identities=25% Similarity=0.355 Sum_probs=208.0
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
-+|+.++.+|+|+||.||++....++..||+|.+........+.+.+|+.++++++||||+++++.|...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 47888899999999999999988888999999986655555678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 495 (660)
++++|.+++... .+++.++..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++........ .
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~ 171 (293)
T cd06647 99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 171 (293)
T ss_pred CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-c
Confidence 999999998653 37889999999999999999998 8999999999999999999999999999876543322 2
Q ss_pred eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHH
Q 006112 496 TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQ 575 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 575 (660)
.....|++.|++||.+..+.++.++||||||+++||+++|+.||...... +.+......+. +.+ ......
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~--~~~~~~~~~~~------~~~--~~~~~~ 241 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--RALYLIATNGT------PEL--QNPEKL 241 (293)
T ss_pred cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh--hheeehhcCCC------CCC--CCcccc
Confidence 23356889999999998888999999999999999999999999753321 11111111110 101 011223
Q ss_pred HHHHHHHhhhccCCCCCCCCCHHHHHHH--hhCCC
Q 006112 576 MEIVLKLGLFCSHSNPDTRPSMRQVVQY--LDGGA 608 (660)
Q Consensus 576 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~~ 608 (660)
...+.+++..||+.+|++||++.+++++ ++...
T Consensus 242 ~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 242 SAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 3457788899999999999999999964 44443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=322.12 Aligned_cols=259 Identities=23% Similarity=0.302 Sum_probs=207.1
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccC-C-----CCceeEeeeeeecCeeE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLR-H-----RNLVQLRGYCRRKGELL 409 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H-----~nIv~l~g~~~~~~~~~ 409 (660)
+.|+.++.||+|.||.|-+|.+..+++.||||+++.. +.-..+-..|+.+|..|+ | -|+|++++++..++++|
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 4789999999999999999999999999999999643 445677788999999996 4 57999999999999999
Q ss_pred EEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCC--CCeEEeeccccee
Q 006112 410 LVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDAD--LEGKLGDFGLARL 487 (660)
Q Consensus 410 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~--~~~kl~DFGla~~ 487 (660)
||+|.+ .-+|.++|+.+.-..++...+..++.||+.||.+||+ .+||||||||+||||.+. ..+||+|||.++.
T Consensus 265 iVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 265 IVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecccccc
Confidence 999999 7899999999887789999999999999999999998 999999999999999654 3699999999986
Q ss_pred ccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCC-CcchHHHHHHHHhcC---------
Q 006112 488 YDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPG-ELDLLDWVIDYWQKG--------- 557 (660)
Q Consensus 488 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~-~~~~~~~~~~~~~~~--------- 557 (660)
....-- ...-+.-|.|||++.+.+|+.+.||||||||+.||++|..-|.++ +.+....+.+.....
T Consensus 341 ~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~ 416 (586)
T KOG0667|consen 341 ESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK 416 (586)
T ss_pred cCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 543221 345678899999999999999999999999999999997666542 233333333222110
Q ss_pred -----------Cc-------------------------ccCCCC----cccccCcHHHHHHHHHHhhhccCCCCCCCCCH
Q 006112 558 -----------DV-------------------------LDASDP----RLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSM 597 (660)
Q Consensus 558 -----------~~-------------------------~~~~d~----~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 597 (660)
.. .+..-| .+...........+.++++.|++.||.+|+|.
T Consensus 417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp 496 (586)
T KOG0667|consen 417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP 496 (586)
T ss_pred ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence 00 000001 00011112344578899999999999999999
Q ss_pred HHHHHH
Q 006112 598 RQVVQY 603 (660)
Q Consensus 598 ~evl~~ 603 (660)
.|++++
T Consensus 497 ~qal~H 502 (586)
T KOG0667|consen 497 AQALNH 502 (586)
T ss_pred HHHhcC
Confidence 999973
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=307.10 Aligned_cols=256 Identities=25% Similarity=0.332 Sum_probs=202.5
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHhccCCCCceeEeeeeeec--CeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD-HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK--GELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV~E 413 (660)
+|+.++++|.|++|.||++.+..+++.+|+|.+..... ....++.+|++++++++||||++++++|... +.+++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 47788999999999999999988899999999875433 4567899999999999999999999988643 46899999
Q ss_pred cCCCCChhhhhhhC--CCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCC
Q 006112 414 YMPNGSLDKILYSN--TRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491 (660)
Q Consensus 414 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 491 (660)
|+++++|.+++... ....+++..+..++.||+.||.|||+ .+++|+||+|+||+++.++.+||+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 99999999887532 23458888999999999999999998 99999999999999999999999999998754332
Q ss_pred CCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCc---chHHHHHHHHhcCCcccCCCCccc
Q 006112 492 NDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGEL---DLLDWVIDYWQKGDVLDASDPRLE 568 (660)
Q Consensus 492 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~---~~~~~~~~~~~~~~~~~~~d~~l~ 568 (660)
.. ....++..|+|||.+.+..++.++|||||||++|||++|+.||..... ...+. .............+. ..
T Consensus 159 ~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~-~~ 233 (287)
T cd06621 159 LA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIEL-LSYIVNMPNPELKDE-PG 233 (287)
T ss_pred cc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHH-HHHHhcCCchhhccC-CC
Confidence 21 234578899999999988999999999999999999999999976421 11121 111111111111110 00
Q ss_pred ccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 569 GIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
. .......+.+++.+||+.+|.+|||+.|+++
T Consensus 234 ~--~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 234 N--GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred C--CCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0 0123456789999999999999999999997
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=311.30 Aligned_cols=263 Identities=25% Similarity=0.286 Sum_probs=202.1
Q ss_pred eecccccccCccEEEEEEEeCCCCeEEEEEEeccCCCh-----hhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEE
Q 006112 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDH-----GMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~-----~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
|+..+.+|+|++|.||+|....+++.||||++...... ....+..|++++++++|+||+++++++.+.+..++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 66678899999999999999888999999999755322 3456778999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
||+ +|+|.+++.... ..+++..+..++.||++||+|||+ .+|+|+||||+||+++.++.+||+|||+++......
T Consensus 82 e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 82 EFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred ccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 999 999999997654 358999999999999999999998 899999999999999999999999999998765432
Q ss_pred CceeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHHHHHHhcC---------Cccc
Q 006112 493 DLHTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVIDYWQKG---------DVLD 561 (660)
Q Consensus 493 ~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~~~~~---------~~~~ 561 (660)
. ......+++.|+|||.+.+ ..++.++|||||||++|||++|..+|..... ............. ....
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (298)
T cd07841 157 R-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD 235 (298)
T ss_pred c-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence 2 1223456889999998854 4578899999999999999999777654321 1111111110000 0000
Q ss_pred CCCCcc-----cccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH--hhC
Q 006112 562 ASDPRL-----EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY--LDG 606 (660)
Q Consensus 562 ~~d~~l-----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~ 606 (660)
...... ...........+.+++..||+.||++|||+.|++++ |++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~ 287 (298)
T cd07841 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN 287 (298)
T ss_pred cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccC
Confidence 000000 000112234568899999999999999999999974 544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=307.20 Aligned_cols=249 Identities=27% Similarity=0.367 Sum_probs=199.0
Q ss_pred eecccccccCccEEEEEEEeCCCCeEEEEEEeccCC------ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEE
Q 006112 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS------DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 411 (660)
|+..+.+|+|+||.||+|.. .++..+|+|.+.... ....+.+.+|++++++++|+||++++++|.+.+..++|
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred ccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 56678899999999999987 467889999886432 12345788999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCC
Q 006112 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 491 (660)
|||+++++|.+++.... .+++..+..++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||+++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 99999999999997643 47899999999999999999998 89999999999999999999999999998754321
Q ss_pred -----CCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCc
Q 006112 492 -----NDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPR 566 (660)
Q Consensus 492 -----~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 566 (660)
.........|+..|+|||.+.+..++.++||||||+++|||++|+.||...+... ..... .... ...+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~~~~-~~~~---~~~~~ 229 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA--AMFYI-GAHR---GLMPR 229 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH--HHHHh-hhcc---CCCCC
Confidence 1111233568999999999998889999999999999999999999997533211 11111 1110 11122
Q ss_pred ccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 567 LEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 567 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
+... ....+.+++.+||+.+|++||++.|+++
T Consensus 230 ~~~~----~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 230 LPDS----FSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCC----CCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 2222 2345678888999999999999999885
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=305.93 Aligned_cols=251 Identities=23% Similarity=0.290 Sum_probs=207.7
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
.++.+++||.|.-|+||++++..++..+|+|++.+. ..+...+...|-+||+.++||.+..|++.++.+...|||||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 567889999999999999999999999999999664 34456678889999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccC---
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDH--- 490 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~--- 490 (660)
||+||+|..++++.....+++..+.-++..|+-||+|||. .|||.|||||+||||.++|++-|+||.|+.....
T Consensus 158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 9999999999998888889999999999999999999998 9999999999999999999999999998843210
Q ss_pred ------------------------------C-CC---------------------ceeeccccCccccCcccccCCCCCc
Q 006112 491 ------------------------------G-ND---------------------LHTTNVVGTVGYLAPELLRNGRGTT 518 (660)
Q Consensus 491 ------------------------------~-~~---------------------~~~~~~~gt~~Y~aPE~~~~~~~t~ 518 (660)
. +. ..+...+||-.|+|||++++...+.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 0 00 0112357999999999999999999
Q ss_pred ceeEEehHHHHHHHhhCCCCCCCCCcchH-HHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCC-
Q 006112 519 STDVYAFGVFMLEVACGRRPVQPGELDLL-DWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPS- 596 (660)
Q Consensus 519 ksDV~S~Gvvl~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs- 596 (660)
+.|.|+|||++|||+.|..||.+...... ..+. . + ++.+.+. ++....+.+|+...+.+||.+|..
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv---~--~-----~l~Fp~~--~~vs~~akDLIr~LLvKdP~kRlg~ 382 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIV---G--Q-----PLKFPEE--PEVSSAAKDLIRKLLVKDPSKRLGS 382 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHh---c--C-----CCcCCCC--CcchhHHHHHHHHHhccChhhhhcc
Confidence 99999999999999999999987543211 1111 1 1 1112111 133455667777789999999998
Q ss_pred ---HHHHHH
Q 006112 597 ---MRQVVQ 602 (660)
Q Consensus 597 ---~~evl~ 602 (660)
+.||.+
T Consensus 383 ~rGA~eIK~ 391 (459)
T KOG0610|consen 383 KRGAAEIKR 391 (459)
T ss_pred ccchHHhhc
Confidence 888876
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=313.65 Aligned_cols=255 Identities=21% Similarity=0.246 Sum_probs=204.3
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
.|+.++.+|+|+||.||++....+++.|++|.+.... ....+.+.+|+++++.++||||+++++.+..++..++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 4778899999999999999999999999999986543 2345678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC-
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN- 492 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~- 492 (660)
|+++++|.+++.... .+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 82 YVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 999999999997653 48899999999999999999998 899999999999999999999999999987421110
Q ss_pred -------------CceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCc
Q 006112 493 -------------DLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDV 559 (660)
Q Consensus 493 -------------~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 559 (660)
........|+..|+|||.+....++.++|+|||||++|||++|+.||.+.... .+......+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~---~~~~~~~~~~~ 233 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---ELFGQVISDDI 233 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhccc
Confidence 00112345788999999998888999999999999999999999999754322 12222222211
Q ss_pred ccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 560 LDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 560 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
..+.... .....+.+++.+||+.||++||++.++.+.|+.
T Consensus 234 ---~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 234 ---EWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ---CCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1111111 123446788889999999999997777766665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=344.93 Aligned_cols=257 Identities=22% Similarity=0.326 Sum_probs=201.5
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeee--cCeeEEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR--KGELLLV 411 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV 411 (660)
-.|+.++.||+|+||.||++.+..++..+|+|.+... .......|..|+.++++++|||||++++++.. ...++||
T Consensus 13 ~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIV 92 (1021)
T PTZ00266 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYIL 92 (1021)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEE
Confidence 3789999999999999999999999999999998643 33446789999999999999999999998754 3568999
Q ss_pred EecCCCCChhhhhhhCC--CCCcchhHHHHHHHHHHHHHHHhhhcc----cCceeccCccCCcEEEcC------------
Q 006112 412 YDYMPNGSLDKILYSNT--RPSLNWFQRFRIIKGVAFGLLYLHEEW----EQVVLHRDIKPANVLLDA------------ 473 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~----~~~ivHrDikp~NIll~~------------ 473 (660)
|||+++|+|.++|.... ...+++..++.|+.||+.||+|||+.. ..+||||||||+||||+.
T Consensus 93 MEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~ 172 (1021)
T PTZ00266 93 MEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172 (1021)
T ss_pred EeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccc
Confidence 99999999999986532 245899999999999999999999732 145999999999999964
Q ss_pred -----CCCeEEeecccceeccCCCCceeeccccCccccCcccccC--CCCCcceeEEehHHHHHHHhhCCCCCCCCCcch
Q 006112 474 -----DLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRN--GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDL 546 (660)
Q Consensus 474 -----~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~ 546 (660)
...+||+|||+++.+.... ......||+.|+|||++.. ..++.++|||||||+||||++|+.||.....
T Consensus 173 ~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~-- 248 (1021)
T PTZ00266 173 NNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN-- 248 (1021)
T ss_pred cccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc--
Confidence 2348999999998654322 2234579999999999854 4578999999999999999999999975332
Q ss_pred HHHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH--HhhC
Q 006112 547 LDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ--YLDG 606 (660)
Q Consensus 547 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~ 606 (660)
...+......+.. ..+ . .....+.+|+..||+.+|.+||++.|+++ ++..
T Consensus 249 ~~qli~~lk~~p~-----lpi-~----~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~ 300 (1021)
T PTZ00266 249 FSQLISELKRGPD-----LPI-K----GKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN 300 (1021)
T ss_pred HHHHHHHHhcCCC-----CCc-C----CCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhh
Confidence 1222222222211 101 1 11245778888999999999999999994 5543
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=310.57 Aligned_cols=251 Identities=24% Similarity=0.319 Sum_probs=198.9
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhcc-CCCCceeEeeeeee------cCee
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRR------KGEL 408 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~------~~~~ 408 (660)
..|+..+.+|+|+||.||+|++..+++.+|+|.+.... ....++..|+.++.++ +|+||+++++++.. ....
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 94 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL 94 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence 36777889999999999999999899999999985443 3446788999999998 69999999998853 4578
Q ss_pred EEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceec
Q 006112 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLY 488 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 488 (660)
+++|||+++|+|.+++.......+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++..
T Consensus 95 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~ 171 (282)
T cd06636 95 WLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 171 (282)
T ss_pred EEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence 999999999999999976555568888899999999999999998 89999999999999999999999999998755
Q ss_pred cCCCCceeeccccCccccCccccc-----CCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCC
Q 006112 489 DHGNDLHTTNVVGTVGYLAPELLR-----NGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDAS 563 (660)
Q Consensus 489 ~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (660)
..... ......|+..|+|||.+. ...++.++|||||||++|||++|+.||...... ........ ..
T Consensus 172 ~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~--~~~~~~~~------~~ 242 (282)
T cd06636 172 DRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM--RALFLIPR------NP 242 (282)
T ss_pred hcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH--hhhhhHhh------CC
Confidence 32211 123356899999999875 345788999999999999999999999653321 11111101 11
Q ss_pred CCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 564 DPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 564 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
.+.+. .......+.+++..||+.||.+||++.|+++
T Consensus 243 ~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 243 PPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 11111 1123345788899999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=308.27 Aligned_cols=247 Identities=27% Similarity=0.438 Sum_probs=201.6
Q ss_pred eecccccccCccEEEEEEEeCCCCeEEEEEEeccC-CChhhHHHHHHHHHHhccC---CCCceeEeeeeeecCeeEEEEe
Q 006112 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD-SDHGMKQFVSEIVSMGKLR---HRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~lV~E 413 (660)
|+.++.+|+|+||.||+|.+..++..+|+|.+... .....+++.+|+.++++++ |||+++++++|..+...++|||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 67788999999999999999889999999998654 3345678899999999997 9999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
|+++++|.+++... .+++.....++.|++.||.|||+ .+|+||||+|+||+++.++.++|+|||++........
T Consensus 83 ~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 83 YAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred cCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 99999999998653 58999999999999999999998 8999999999999999999999999999987654332
Q ss_pred ceeeccccCccccCcccccCC-CCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCc
Q 006112 494 LHTTNVVGTVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
......|+..|+|||.+.++ .++.++||||||+++|||++|+.||...... .... ..... ..+.+...
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~-~~~~~-----~~~~~~~~-- 225 (277)
T cd06917 157 -KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF--RAMM-LIPKS-----KPPRLEDN-- 225 (277)
T ss_pred -ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh--hhhh-ccccC-----CCCCCCcc--
Confidence 22345689999999998754 4688999999999999999999999754321 1111 11111 11112111
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
.....+.+++..||+.||++||++.|+++
T Consensus 226 -~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 226 -GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred -cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 13345778888999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=320.24 Aligned_cols=245 Identities=26% Similarity=0.393 Sum_probs=204.7
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCCh---hhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDH---GMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
-|.+|+.||.|+||.||.+++..+.+.||||++.-..++ ...+++.|+..|++++|||++.+.|++..+...+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 467888999999999999999999999999999765444 45678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
|| -||-.++|.-.. .++.+..+..|+.+.+.||+|||+ .+.||||||..||||++.|.+||+|||.|.+....
T Consensus 107 YC-lGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-- 179 (948)
T KOG0577|consen 107 YC-LGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-- 179 (948)
T ss_pred HH-hccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCch--
Confidence 99 678888876544 458888999999999999999998 99999999999999999999999999999876443
Q ss_pred ceeeccccCccccCccccc---CCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCccccc
Q 006112 494 LHTTNVVGTVGYLAPELLR---NGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGI 570 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 570 (660)
..++|||-|||||++. .|.|+.|.||||+||+..||.-.++|+...+.-.. ...... .-.|.+.
T Consensus 180 ---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA--LYHIAQ------NesPtLq-- 246 (948)
T KOG0577|consen 180 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIAQ------NESPTLQ-- 246 (948)
T ss_pred ---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH--HHHHHh------cCCCCCC--
Confidence 3578999999999864 68899999999999999999999999875332111 111111 1122232
Q ss_pred CcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 571 YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
..+..+.+..++..|++.-|.+|||.+++++
T Consensus 247 -s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 247 -SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred -CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 3455667788888899999999999999875
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=309.30 Aligned_cols=260 Identities=27% Similarity=0.336 Sum_probs=198.0
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD-HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
.|+..+.+|+|++|.||+|....+++.||+|.+..... .....+.+|++++++++|+||+++++++.+++..++||||+
T Consensus 6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07844 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL 85 (291)
T ss_pred ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecC
Confidence 57888999999999999999988899999999865432 23356788999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 495 (660)
. ++|.+++..... .+++.....++.|+++||.|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 86 ~-~~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~- 159 (291)
T cd07844 86 D-TDLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT- 159 (291)
T ss_pred C-CCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc-
Confidence 7 599998876543 58899999999999999999998 89999999999999999999999999998754322111
Q ss_pred eeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCc--chHHHHHHHHhcCCcc------------
Q 006112 496 TTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGEL--DLLDWVIDYWQKGDVL------------ 560 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~--~~~~~~~~~~~~~~~~------------ 560 (660)
.....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||..... +.....++........
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 122356889999998865 4578999999999999999999999965431 1111111111110000
Q ss_pred c----CCCCc-ccccC-cHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 561 D----ASDPR-LEGIY-VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 561 ~----~~d~~-l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
. ...+. +.... .......+.+++..|++.||++||++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 00000 00000 0001145678889999999999999999885
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=306.19 Aligned_cols=252 Identities=27% Similarity=0.399 Sum_probs=204.9
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
.|+..+.+|+|++|.||++.+..+++.+|+|++.... ....+++.+|++++++++||||+++++.+..++..++|+||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 4667788999999999999998889999999987653 345678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 495 (660)
++++|.+++.... ..+++.....++.|++.||+|||+ ..+++|+||||+||++++++.+||+|||.+........
T Consensus 82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 156 (265)
T cd06605 82 DGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-- 156 (265)
T ss_pred CCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--
Confidence 9999999997653 458889999999999999999996 37999999999999999999999999999875533221
Q ss_pred eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCC---cchHHHHHHHHhcCCcccCCCCcccccCc
Q 006112 496 TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGE---LDLLDWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~---~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
....++..|+|||++.+..++.++||||||+++|+|++|+.||.... ....+.... ...+. .+.+...
T Consensus 157 -~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~-----~~~~~~~-- 227 (265)
T cd06605 157 -KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQY-IVNEP-----PPRLPSG-- 227 (265)
T ss_pred -hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHH-HhcCC-----CCCCChh--
Confidence 12678899999999988899999999999999999999999997542 122222221 11111 1111111
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.....+.+++..||+.||++||++.|++++
T Consensus 228 -~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 228 -KFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred -hcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 134457788889999999999999999853
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=309.90 Aligned_cols=261 Identities=29% Similarity=0.357 Sum_probs=202.9
Q ss_pred eecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeeec--CeeEEEEe
Q 006112 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK--GELLLVYD 413 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV~E 413 (660)
|+.++.+|+|++|.||+|+...+++.+|+|++.... ....+.+.+|++++++++|+|++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567788999999999999998889999999997653 33456788999999999999999999999888 88999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
|++ ++|.+++.... ..+++.++..++.||++||+|||+ .+++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred ccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 996 58988886543 368999999999999999999998 8999999999999999999999999999987655443
Q ss_pred ceeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCcc-hHHHHHHHHhcCCc------------
Q 006112 494 LHTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGELD-LLDWVIDYWQKGDV------------ 559 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~~~------------ 559 (660)
...+...++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ....+.........
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence 23344567889999998764 45789999999999999999999999764321 11111111110000
Q ss_pred -----ccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 560 -----LDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 560 -----~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.......+...+...+...+.+++..||+.+|.+||++++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000000111111124568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=304.30 Aligned_cols=250 Identities=24% Similarity=0.307 Sum_probs=196.6
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC-----ChhhHHHHHHHHHHhccCCCCceeEeeeeeec--CeeE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-----DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK--GELL 409 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~ 409 (660)
.|+..+.+|+|+||.||+|....++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ..++
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS 82 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence 4677889999999999999999899999999885321 23356788999999999999999999987653 4678
Q ss_pred EEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceecc
Q 006112 410 LVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYD 489 (660)
Q Consensus 410 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 489 (660)
+||||+++++|.+++.... .+++....+++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+++...
T Consensus 83 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 83 IFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 9999999999999987543 37888899999999999999998 899999999999999999999999999997654
Q ss_pred CCCC--ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcc
Q 006112 490 HGND--LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL 567 (660)
Q Consensus 490 ~~~~--~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 567 (660)
.... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||...... ....+.... ...+..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~-----~~~~~~ 230 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM--AAIFKIATQ-----PTNPVL 230 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH--HHHHHHhcC-----CCCCCC
Confidence 3211 1123356889999999998888999999999999999999999999753211 111111111 111111
Q ss_pred cccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 568 EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.......+..++..|+. +|++||+++||+++
T Consensus 231 ----~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 231 ----PPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred ----chhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 22333445566667774 89999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=304.67 Aligned_cols=248 Identities=25% Similarity=0.291 Sum_probs=205.8
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
.|+..+.+|+|+||.||++....+++.+|+|.+.... ....+.+.+|++++++++||||+++++.+.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 3778889999999999999998889999999986432 2456789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
|+++++|.+++... ..+++.++..++.|+++||.|||+ .+++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999999765 358899999999999999999998 899999999999999999999999999997654332
Q ss_pred ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||........++........ .+. ...
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------~~~----~~~ 223 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETA------DVL----YPA 223 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccc------ccc----Ccc
Confidence 223456889999999998888999999999999999999999999865543333333322211 011 111
Q ss_pred HHHHHHHHHhhhccCCCCCCCCCH--HHHH
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPSM--RQVV 601 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~--~evl 601 (660)
.....+.+++.+||+.||.+||++ +|++
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 224 TWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 223567788889999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=311.10 Aligned_cols=255 Identities=25% Similarity=0.350 Sum_probs=199.0
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHhccC-CCCceeEeeeeeecCeeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLR-HRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
.|+.+..+|+|+||.||++....+++.+|+|++.... ......+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556778999999999999999999999999986543 345667899999999996 99999999999999999999999
Q ss_pred CCCCChhhhh---hhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCC
Q 006112 415 MPNGSLDKIL---YSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491 (660)
Q Consensus 415 ~~~gsL~~~l---~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 491 (660)
+. ++|.++. .......+++....+++.|++.||+|||+ ..+++||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 85 5655443 33333568999999999999999999997 358999999999999999999999999999755332
Q ss_pred CCceeeccccCccccCcccccCC---CCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCccc
Q 006112 492 NDLHTTNVVGTVGYLAPELLRNG---RGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLE 568 (660)
Q Consensus 492 ~~~~~~~~~gt~~Y~aPE~~~~~---~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 568 (660)
. ......|+..|+|||.+.+. .++.++|||||||++|||++|+.||.... ...+...+.. .+ ..+.+.
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~~-~~-----~~~~~~ 232 (288)
T cd06616 162 I--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-SVFDQLTQVV-KG-----DPPILS 232 (288)
T ss_pred C--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-hHHHHHhhhc-CC-----CCCcCC
Confidence 2 12334688999999998766 68899999999999999999999997543 1112222111 11 112222
Q ss_pred ccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 569 GIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
..........+.+++.+||+.||++||++++|+++
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 233 NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 21112334567888999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=306.57 Aligned_cols=248 Identities=25% Similarity=0.424 Sum_probs=202.9
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
-|+.++.+|+|+||.||+|....++..+|+|.+.... ....+.+.+|++++++++||||+++++++..+...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3677889999999999999998889999999885432 334567899999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 495 (660)
++++|.+++... .+++..+..++.|++.+|.|||+ .+++|+||||+||+++.++.++|+|||++....... ..
T Consensus 85 ~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~ 157 (277)
T cd06641 85 GGGSALDLLEPG---PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IK 157 (277)
T ss_pred CCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccch-hh
Confidence 999999998642 48899999999999999999998 999999999999999999999999999997654322 12
Q ss_pred eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHH
Q 006112 496 TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQ 575 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 575 (660)
.....|+..|+|||.+.+...+.++|||||||++|||++|..|+........ ......+. .+.+.. ..
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~-----~~~~~~----~~ 225 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV---LFLIPKNN-----PPTLEG----NY 225 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH---HHHHhcCC-----CCCCCc----cc
Confidence 2335688899999999888889999999999999999999999875332111 11111111 111222 22
Q ss_pred HHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 576 MEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 576 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
...+.+++.+||+.+|.+||++.+++++
T Consensus 226 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 226 SKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 3456778889999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=309.03 Aligned_cols=244 Identities=24% Similarity=0.307 Sum_probs=202.4
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
.|+..+.+|+|++|.||++.+..+++.+|+|.+.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 4778899999999999999998889999999986432 2345678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
|+++++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 82 YVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred cCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 999999999997653 58899999999999999999998 99999999999999999999999999999876443
Q ss_pred ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
.....|++.|+|||.+.+...+.++||||||+++|||++|+.||...... ...+....+.. .+....
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~------~~~~~~-- 221 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI---QIYEKILEGKV------RFPSFF-- 221 (290)
T ss_pred --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhcCCc------cCCccC--
Confidence 23456899999999998888899999999999999999999999764421 11222222211 111112
Q ss_pred HHHHHHHHHhhhccCCCCCCCC-----CHHHHHH
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRP-----SMRQVVQ 602 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 602 (660)
...+.+++..||+.||.+|| +++|+++
T Consensus 222 --~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 222 --SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred --CHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 34567888889999999999 6777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=303.84 Aligned_cols=251 Identities=25% Similarity=0.387 Sum_probs=204.9
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
+|+..+.+|+|+||.||+|....++..+|+|.+.... ....+.+.+|++++++++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 3677888999999999999999899999999986542 23456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCC-CeEEeecccceeccCCCC
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADL-EGKLGDFGLARLYDHGND 493 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~-~~kl~DFGla~~~~~~~~ 493 (660)
+++++|.+++.......+++..+..++.|+++||.|||+ .+++|+||||+||++++++ .+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 999999999976655568999999999999999999998 8999999999999998885 469999999976643322
Q ss_pred ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
......|++.|+|||.+.+..++.++||||||+++|||++|..||.... ..+++..... +... .. . .
T Consensus 158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~-~~~~-~~----~----~ 224 (257)
T cd08225 158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN--LHQLVLKICQ-GYFA-PI----S----P 224 (257)
T ss_pred -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--HHHHHHHHhc-ccCC-CC----C----C
Confidence 2223468999999999988889999999999999999999999997533 2233332221 1111 11 1 1
Q ss_pred HHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.....+.+++.+|++.+|++|||+.|++++
T Consensus 225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 225 NFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 122457788889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=305.75 Aligned_cols=250 Identities=24% Similarity=0.320 Sum_probs=195.6
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHH-HhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-DHGMKQFVSEIVS-MGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~-l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
+|+.++.+|+|+||.||++++..+++.||+|++.... .....++..|+.+ ++.++||||+++++++..++..++||||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 81 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEV 81 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhh
Confidence 4778889999999999999999899999999986543 2334566667765 5667899999999999999999999999
Q ss_pred CCCCChhhhhhhC--CCCCcchhHHHHHHHHHHHHHHHhhhcccC-ceeccCccCCcEEEcCCCCeEEeecccceeccCC
Q 006112 415 MPNGSLDKILYSN--TRPSLNWFQRFRIIKGVAFGLLYLHEEWEQ-VVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491 (660)
Q Consensus 415 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 491 (660)
++ |+|.+++... ....+++..++.++.||+.||+|||+ + +++||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 82 MD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 95 7888887642 23468999999999999999999997 5 8999999999999999999999999999865332
Q ss_pred CCceeeccccCccccCcccccC----CCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcc
Q 006112 492 NDLHTTNVVGTVGYLAPELLRN----GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL 567 (660)
Q Consensus 492 ~~~~~~~~~gt~~Y~aPE~~~~----~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 567 (660)
. ..+...|+..|+|||.+.. ..++.++|+|||||++|||++|+.||....... +....... + ..+.+
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~-~-----~~~~~ 228 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-QQLKQVVE-E-----PSPQL 228 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-HHHHHHHh-c-----CCCCC
Confidence 1 1233568899999998864 446889999999999999999999996432211 11111111 1 11111
Q ss_pred cccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 568 EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
.. ....+.+.+++..||+.+|++||++.++++
T Consensus 229 ~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 229 PA---EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred Cc---cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11 112345778888999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=308.18 Aligned_cols=249 Identities=24% Similarity=0.324 Sum_probs=204.3
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 416 (660)
.|...+.+|+|++|.||++....+++.+++|++........+.+.+|+.++++++|+||+++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 46667899999999999999988899999999866555556778999999999999999999999999999999999999
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCcee
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT 496 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 496 (660)
+++|.+++.. ..+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++........ ..
T Consensus 100 ~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~ 172 (285)
T cd06648 100 GGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RR 172 (285)
T ss_pred CCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cc
Confidence 9999999876 248899999999999999999998 8999999999999999999999999998875443221 22
Q ss_pred eccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHH
Q 006112 497 TNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQM 576 (660)
Q Consensus 497 ~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 576 (660)
....|+..|+|||.+.+..++.++||||||+++|||++|+.||...... ..... ...+.. +.+.. .....
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~--~~~~~-~~~~~~-----~~~~~--~~~~~ 242 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL--QAMKR-IRDNLP-----PKLKN--LHKVS 242 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH--HHHHH-HHhcCC-----CCCcc--cccCC
Confidence 3356899999999998888999999999999999999999998754321 11211 111111 11111 11123
Q ss_pred HHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 577 EIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 577 ~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
..+.+++.+||+.+|++||++.++++
T Consensus 243 ~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 243 PRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHHHHHHHHcccChhhCcCHHHHcc
Confidence 46788999999999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=297.74 Aligned_cols=250 Identities=29% Similarity=0.432 Sum_probs=206.8
Q ss_pred eecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCCC
Q 006112 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPN 417 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 417 (660)
|+..+.+|+|++|.||++....+++.+++|++........+++.+|++++++++|+|++++++.+..+...++++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 66778899999999999999888999999999766555678899999999999999999999999999999999999999
Q ss_pred CChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCceee
Q 006112 418 GSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTT 497 (660)
Q Consensus 418 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 497 (660)
++|.+++.... ..+++..+..++.|++.+|.|||+ .+++||||+|+||++++++.+||+|||.+........ ..
T Consensus 82 ~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~ 155 (253)
T cd05122 82 GSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RN 155 (253)
T ss_pred CcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc--cc
Confidence 99999987653 358999999999999999999998 9999999999999999999999999999987654432 33
Q ss_pred ccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHH
Q 006112 498 NVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQME 577 (660)
Q Consensus 498 ~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 577 (660)
...++..|++||.+.....+.++||||||+++++|++|+.||...... ...... ....... +.. ......
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~-~~~~~~~-----~~~--~~~~~~ 225 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM--KALFKI-ATNGPPG-----LRN--PEKWSD 225 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH--HHHHHH-HhcCCCC-----cCc--ccccCH
Confidence 457889999999998888999999999999999999999999754321 111111 1111111 110 011134
Q ss_pred HHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 578 IVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 578 ~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.+.+++..|++.||++|||+.|++++
T Consensus 226 ~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 226 EFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcC
Confidence 57788889999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=308.75 Aligned_cols=259 Identities=26% Similarity=0.324 Sum_probs=200.2
Q ss_pred eecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
|+.++.+|+|++|.||+|.+..+++.||+|++.... ....+.+.+|++++++++|||++++++++.+++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566788999999999999998899999999986543 223467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 495 (660)
+++|.+++.......+++.++..++.|+++||+|||+ ++++||||+|+||+++.++.+||+|||+++........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~- 155 (283)
T cd07835 81 -DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT- 155 (283)
T ss_pred -CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence 5799999876654568999999999999999999998 89999999999999999999999999999765432211
Q ss_pred eeccccCccccCcccccCC-CCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhc-CCcccCC----------
Q 006112 496 TTNVVGTVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQK-GDVLDAS---------- 563 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~-~~~~~~~---------- 563 (660)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||...+.. +...+.... +......
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI--DQLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChHHhhhhhhchhh
Confidence 1223568899999987654 5688999999999999999999999754321 111111110 0000000
Q ss_pred ---CCcc----cccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 564 ---DPRL----EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 564 ---d~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
-+.. ...........+.+++.+|++.||.+||+++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000 000011122457789999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=308.63 Aligned_cols=261 Identities=22% Similarity=0.261 Sum_probs=200.8
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHhccCCCCceeEeeeeeec--CeeEEEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD--HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK--GELLLVY 412 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV~ 412 (660)
.|+..+.+|+|+||.||+|.+..+++.+|+|.+..... .....+.+|+.++++++||||+++++++... +..++||
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 57788899999999999999988899999999865432 2334678899999999999999999998877 8899999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
||++ ++|.+++.... ..+++.++..++.||+.||+|||+ .+++|+||||+||+++.++.+||+|||+++......
T Consensus 86 e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 86 EYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred hhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 9996 59999887644 358999999999999999999998 899999999999999999999999999998765432
Q ss_pred CceeeccccCccccCcccccCC-CCCcceeEEehHHHHHHHhhCCCCCCCCCcc-hHHHHHHHHh-----------c---
Q 006112 493 DLHTTNVVGTVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQPGELD-LLDWVIDYWQ-----------K--- 556 (660)
Q Consensus 493 ~~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~~~~-----------~--- 556 (660)
. ......+++.|+|||.+.+. .++.++|+||||+++|||++|+.||...... ....+..... .
T Consensus 161 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 161 K-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred c-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 1 12234578899999998754 4688999999999999999999999753321 1111111100 0
Q ss_pred ---CCcccCCCCcccccCcHH-HHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 557 ---GDVLDASDPRLEGIYVEE-QMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 557 ---~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
..........+...+... ..+.+.+++..|++.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000001111111112111 24557788899999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=307.04 Aligned_cols=261 Identities=23% Similarity=0.259 Sum_probs=197.2
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD-HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
.|+.++.||+|+||.||+|....++..||+|++..... .....+.+|+.++++++|+||+++++++..++..++||||+
T Consensus 6 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07870 6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYM 85 (291)
T ss_pred eeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEecc
Confidence 68889999999999999999988899999999865433 23456789999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 495 (660)
. ++|..++.... ..+.+.++..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++....... .
T Consensus 86 ~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~ 159 (291)
T cd07870 86 H-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ-T 159 (291)
T ss_pred c-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC-C
Confidence 5 77777765443 347888899999999999999998 8999999999999999999999999999976433221 1
Q ss_pred eeccccCccccCcccccCC-CCCcceeEEehHHHHHHHhhCCCCCCCCCcc--hHHHHHHHHhcC------------Ccc
Q 006112 496 TTNVVGTVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQPGELD--LLDWVIDYWQKG------------DVL 560 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~--~~~~~~~~~~~~------------~~~ 560 (660)
.....+++.|+|||.+.+. .++.++|||||||++|||++|+.||...... .....+...... ...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence 2234578999999998753 5788999999999999999999999753321 111111111100 000
Q ss_pred cCCCCcc-cccC-----cHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 561 DASDPRL-EGIY-----VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 561 ~~~d~~l-~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
....+.. .... .......+.+++.+|++.||++|||+.|++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0000000 0000 00113456788899999999999999998853
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=300.55 Aligned_cols=253 Identities=27% Similarity=0.433 Sum_probs=207.8
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD-HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
+|+..+.+|+|++|.||+++...+++.|++|++..... ...+.+.+|++.+.+++|+||+++++++...+..++||||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 46778899999999999999998899999999876544 45678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 495 (660)
++++|.+++... ..+++..+.+++.|+++||+|||+ ..+++||||+|+||+++.++.+||+|||++.........
T Consensus 82 ~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~- 156 (264)
T cd06623 82 DGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ- 156 (264)
T ss_pred CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc-
Confidence 999999999765 358999999999999999999995 289999999999999999999999999999876543322
Q ss_pred eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHHHHHHhcCCcccCCCCcccccCcHH
Q 006112 496 TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVIDYWQKGDVLDASDPRLEGIYVEE 574 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 574 (660)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||..... ...+.... ..... .+.+... .
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~-~~~~~-----~~~~~~~---~ 227 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA-ICDGP-----PPSLPAE---E 227 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH-HhcCC-----CCCCCcc---c
Confidence 2245688999999999988899999999999999999999999976432 22221111 11111 1111111 0
Q ss_pred HHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 575 QMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 575 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
....+.+++..|++++|++||++.|++++
T Consensus 228 ~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 228 FSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 34567788888999999999999999973
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=305.31 Aligned_cols=255 Identities=28% Similarity=0.404 Sum_probs=199.2
Q ss_pred eecccccccCccEEEEEEEeCC---CCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeecC------
Q 006112 338 YKNLYKATKGGSGKVYRGVLPS---SHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKG------ 406 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~~---~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------ 406 (660)
|+..+.+|+|+||.||+|.+.. ++..||||++... .....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 4567789999999999998643 4689999998654 3345678999999999999999999999886432
Q ss_pred eeEEEEecCCCCChhhhhhhCC----CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeec
Q 006112 407 ELLLVYDYMPNGSLDKILYSNT----RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDF 482 (660)
Q Consensus 407 ~~~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DF 482 (660)
..++++||+++|+|..++.... ...+++....+++.|++.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence 2478999999999998875321 2247888999999999999999998 89999999999999999999999999
Q ss_pred ccceeccCCCCc-eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcc
Q 006112 483 GLARLYDHGNDL-HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVL 560 (660)
Q Consensus 483 Gla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 560 (660)
|+++........ ......+++.|++||.+....++.++|||||||++|||++ |+.||...... + .......+...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~--~-~~~~~~~~~~~ 234 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS--E-IYNYLIKGNRL 234 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH--H-HHHHHHcCCcC
Confidence 999865433211 1223345678999999988889999999999999999999 88888654321 1 11112222111
Q ss_pred cCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 561 DASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 561 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
. .. ......+.+++.+||+.+|++||++.|+++.|+..
T Consensus 235 ~-----~~----~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 235 K-----QP----PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred C-----CC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1 01 12234688899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=303.26 Aligned_cols=252 Identities=25% Similarity=0.317 Sum_probs=200.6
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecC------ee
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKG------EL 408 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~------~~ 408 (660)
-.|+..+.+|+|++|.||+|....+++.+++|.+..... ..+++.+|+.+++++ +|+||+++++++.... ..
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL 84 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence 368888999999999999999988889999999865433 457899999999999 6999999999997644 48
Q ss_pred EEEEecCCCCChhhhhhhCC--CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccce
Q 006112 409 LLVYDYMPNGSLDKILYSNT--RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLAR 486 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 486 (660)
++||||+++++|.+++.... ...+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++.
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCccce
Confidence 99999999999999986533 3468999999999999999999998 899999999999999999999999999997
Q ss_pred eccCCCCceeeccccCccccCcccccC-----CCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCccc
Q 006112 487 LYDHGNDLHTTNVVGTVGYLAPELLRN-----GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLD 561 (660)
Q Consensus 487 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 561 (660)
...... .......|+..|+|||.+.. ..++.++|||||||+++||++|+.||...... ....+ ...+.
T Consensus 162 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~-~~~~~--- 234 (275)
T cd06608 162 QLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--RALFK-IPRNP--- 234 (275)
T ss_pred ecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--HHHHH-hhccC---
Confidence 654322 12234568999999998753 34678999999999999999999999743211 11111 11111
Q ss_pred CCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 562 ASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 562 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
.+.+ .........+.+++.+|+..||++|||+.|+++
T Consensus 235 --~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 235 --PPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred --CCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1111 111224456788999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=308.59 Aligned_cols=246 Identities=27% Similarity=0.408 Sum_probs=199.2
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
.|+.++.+|+|+||.||+|+...+++.||+|++.... ....+++.+|++++++++||||++++++|..++..++|||
T Consensus 16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e 95 (307)
T cd06607 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME 95 (307)
T ss_pred hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence 4888899999999999999998889999999986432 2344678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
|+. |+|.+++.... ..+++.++..++.|++.||.|||+ .+|+||||+|+||+++.++.+||+|||++......
T Consensus 96 ~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 96 YCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred hhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence 996 67777765433 358999999999999999999998 89999999999999999999999999999765322
Q ss_pred ceeeccccCccccCccccc---CCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCccccc
Q 006112 494 LHTTNVVGTVGYLAPELLR---NGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGI 570 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 570 (660)
....++..|+|||.+. .+.++.++||||||+++|||++|+.||...+.... .... .... .+.+.
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~--~~~~-~~~~-----~~~~~-- 235 (307)
T cd06607 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHI-AQND-----SPTLS-- 235 (307)
T ss_pred ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH--HHHH-hcCC-----CCCCC--
Confidence 2346788999999874 45678899999999999999999999875432211 1111 1111 01111
Q ss_pred CcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 571 YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.......+.+++..||+.||++||++.+|+++
T Consensus 236 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 236 -SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 12234568889999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=305.43 Aligned_cols=253 Identities=23% Similarity=0.294 Sum_probs=199.3
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhcc-CCCCceeEeeeeeec-----CeeE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRK-----GELL 409 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~-----~~~~ 409 (660)
-+|+....+|+|+||.||++....+++.+|+|.+.... ....++.+|+.+++++ +|||++++++++... +..+
T Consensus 22 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~ 100 (291)
T cd06639 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW 100 (291)
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence 36888889999999999999998899999999985432 2346778899999999 799999999998754 3589
Q ss_pred EEEecCCCCChhhhhhhC--CCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeeccccee
Q 006112 410 LVYDYMPNGSLDKILYSN--TRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARL 487 (660)
Q Consensus 410 lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 487 (660)
+||||+++++|.+++... ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.
T Consensus 101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~kl~dfg~~~~ 177 (291)
T cd06639 101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177 (291)
T ss_pred EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence 999999999999988642 23458999999999999999999998 8999999999999999999999999999976
Q ss_pred ccCCCCceeeccccCccccCcccccCCC-----CCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccC
Q 006112 488 YDHGNDLHTTNVVGTVGYLAPELLRNGR-----GTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDA 562 (660)
Q Consensus 488 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-----~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 562 (660)
...... ......|+..|+|||.+.... ++.++|||||||++|||++|+.||..... ...+... ..+.....
T Consensus 178 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~--~~~~~~~-~~~~~~~~ 253 (291)
T cd06639 178 LTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP--VKTLFKI-PRNPPPTL 253 (291)
T ss_pred cccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH--HHHHHHH-hcCCCCCC
Confidence 543221 122356889999999986432 68899999999999999999999875332 1111111 11111111
Q ss_pred CCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 563 SDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 563 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.+ .......+.+++.+||+.+|++||++.|++++
T Consensus 254 ~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 254 LH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred Cc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11 11223457888999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=299.33 Aligned_cols=243 Identities=25% Similarity=0.329 Sum_probs=198.9
Q ss_pred cccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCCCCCh
Q 006112 344 ATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSL 420 (660)
Q Consensus 344 lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 420 (660)
+|.|++|.||+++...+++.+|+|.+.... ....+.+.+|++++++++||||+++++.+.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 588999999999998889999999986532 23457799999999999999999999999999999999999999999
Q ss_pred hhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCceeeccc
Q 006112 421 DKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVV 500 (660)
Q Consensus 421 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 500 (660)
.+++.+.. .+++.++..++.||+.||.|||+ ++++|+||||+||+++.++.+||+|||+++...... ......
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~ 153 (262)
T cd05572 81 WTILRDRG--LFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFC 153 (262)
T ss_pred HHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccccc
Confidence 99997653 48899999999999999999998 999999999999999999999999999998765432 223356
Q ss_pred cCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHH
Q 006112 501 GTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVL 580 (660)
Q Consensus 501 gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 580 (660)
|+..|++||.+....++.++|+||||+++|||++|..||.....+..+........... + .+.......+.
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-----~----~~~~~~~~~~~ 224 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGK-----L----EFPNYIDKAAK 224 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCC-----C----CCCcccCHHHH
Confidence 88999999999888899999999999999999999999976543222222221110111 1 11111245678
Q ss_pred HHhhhccCCCCCCCCC-----HHHHHH
Q 006112 581 KLGLFCSHSNPDTRPS-----MRQVVQ 602 (660)
Q Consensus 581 ~l~~~Cl~~dP~~RPs-----~~evl~ 602 (660)
+++..||+.||++||+ ++|+++
T Consensus 225 ~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 225 DLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHccCChhhCcCCcccCHHHHhc
Confidence 8899999999999999 777765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=301.21 Aligned_cols=250 Identities=25% Similarity=0.348 Sum_probs=208.5
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 416 (660)
-|..+.++|+|+||.||++.++.+|..+|||++..+ ..++++..|+.+|++.+.|++|+++|.+.....+++|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 466788999999999999999999999999998654 457899999999999999999999999999999999999999
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCcee
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT 496 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 496 (660)
.|+..+.++... .+|.+.++..+++.-++||+|||. ..-+|||||..||||+.+|.+||+|||.|-.+.... ...
T Consensus 112 AGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-AKR 186 (502)
T KOG0574|consen 112 AGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-AKR 186 (502)
T ss_pred CCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhH-Hhh
Confidence 999999987554 569999999999999999999998 888999999999999999999999999997654322 223
Q ss_pred eccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHH
Q 006112 497 TNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQM 576 (660)
Q Consensus 497 ~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 576 (660)
..+.||+.|||||++..-.|..++||||+|++..||..|++||..-..--. -.+-.-.|...-.-+++..
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA----------IFMIPT~PPPTF~KPE~WS 256 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA----------IFMIPTKPPPTFKKPEEWS 256 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce----------eEeccCCCCCCCCChHhhh
Confidence 457899999999999999999999999999999999999999864211000 0000111111111234455
Q ss_pred HHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 577 EIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 577 ~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
..+-+++..|+-.+|++|-|+-+++++
T Consensus 257 ~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 257 SEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 678889999999999999999999874
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=296.26 Aligned_cols=251 Identities=27% Similarity=0.376 Sum_probs=207.7
Q ss_pred eecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHhccCCCCceeEeeeeeec--CeeEEEEe
Q 006112 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD--HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK--GELLLVYD 413 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV~E 413 (660)
|+..+.+++|++|.||+|....+++.|++|++..... ...+.+.+|++++++++|+||+++++.+... ...++|+|
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 81 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE 81 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence 6677889999999999999988899999999865543 5577899999999999999999999999988 88999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
|+++++|.+++.... .+++.++..++.|++.+|+|||+ .+++|+||+|+||+++.++.+||+|||.+........
T Consensus 82 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 82 YVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred ecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 999999999997654 68999999999999999999998 9999999999999999999999999999987655432
Q ss_pred c-eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCc
Q 006112 494 L-HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 494 ~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
. ......++..|++||.+.....+.++||||||+++++|++|+.||...+ ............... +. ..
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~-----~~----~~ 226 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-NPMAALYKIGSSGEP-----PE----IP 226 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-chHHHHHhccccCCC-----cC----CC
Confidence 1 1234568899999999988889999999999999999999999998654 222222221111111 11 11
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
......+.+++.+|++.||++||++.|++++
T Consensus 227 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 227 EHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred cccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 2224568888899999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=311.98 Aligned_cols=262 Identities=25% Similarity=0.299 Sum_probs=198.0
Q ss_pred eecccccccCccEEEEEEEeCC--CCeEEEEEEeccCC---ChhhHHHHHHHHHHhccCCCCceeEeeeeeec--CeeEE
Q 006112 338 YKNLYKATKGGSGKVYRGVLPS--SHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK--GELLL 410 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~~--~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~l 410 (660)
|+.++.+|+|+||.||+|.... .+..||+|.+.... ....+.+.+|+.++++++||||+++++++... ..+++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 6778889999999999999987 78999999997633 44456788999999999999999999999888 78999
Q ss_pred EEecCCCCChhhhhhhCC---CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcC----CCCeEEeecc
Q 006112 411 VYDYMPNGSLDKILYSNT---RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDA----DLEGKLGDFG 483 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~----~~~~kl~DFG 483 (660)
||||++ ++|.+++.... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||
T Consensus 82 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 999996 46766664322 2358888999999999999999998 89999999999999999 8999999999
Q ss_pred cceeccCCCC--ceeeccccCccccCcccccCC-CCCcceeEEehHHHHHHHhhCCCCCCCCCcch----------HHHH
Q 006112 484 LARLYDHGND--LHTTNVVGTVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQPGELDL----------LDWV 550 (660)
Q Consensus 484 la~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~----------~~~~ 550 (660)
+++....... .......++..|+|||.+.+. .++.++|||||||+++||++|+.||....... ...+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9987644322 122345678999999987664 57899999999999999999999997533221 1111
Q ss_pred HHHHhcC------------Cccc----CCC-----CcccccCcH--HHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 551 IDYWQKG------------DVLD----ASD-----PRLEGIYVE--EQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 551 ~~~~~~~------------~~~~----~~d-----~~l~~~~~~--~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
....... .... ... ..+...+.. .....+.+++.+|++.||++|||+.|++++
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1110000 0000 000 000000000 223457889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=305.60 Aligned_cols=262 Identities=27% Similarity=0.368 Sum_probs=201.9
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD-HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
+|+.++.+|+|++|.||+|+...+++.||||++..... ...+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 47888999999999999999998999999999875533 33567789999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCC-CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 416 PNGSLDKILYSNT-RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 416 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
+ ++|.+++.... ...+++.++.+++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++.......
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 7 58888886543 2458999999999999999999998 8999999999999999999999999999976543221
Q ss_pred eeeccccCccccCcccccCC-CCCcceeEEehHHHHHHHhhCCCCCCCCCcc-hHHHHHHHHhcC-----------Cccc
Q 006112 495 HTTNVVGTVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQPGELD-LLDWVIDYWQKG-----------DVLD 561 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~-----------~~~~ 561 (660)
......++..|++||++.+. .++.++|||||||++|||++|+.||...... ....+.+..... ....
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 12234578899999988653 5688999999999999999999999764321 111111111000 0000
Q ss_pred CCCCccc----ccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 562 ASDPRLE----GIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 562 ~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
...+... ....+.....+.+++..|++.||.+||++.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0001000 00111224567788999999999999999999853
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=302.95 Aligned_cols=244 Identities=25% Similarity=0.309 Sum_probs=195.6
Q ss_pred cccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCCCCCh
Q 006112 344 ATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSL 420 (660)
Q Consensus 344 lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 420 (660)
+|+|+||+||++....+++.+|+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 589999999999998889999999986432 23355678899999999999999999999999999999999999999
Q ss_pred hhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCceeeccc
Q 006112 421 DKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVV 500 (660)
Q Consensus 421 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 500 (660)
.+++.......+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++....... ......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccccc
Confidence 999987655568999999999999999999998 899999999999999999999999999987654322 223346
Q ss_pred cCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcc-hHHHHHHHHhcCCcccCCCCcccccCcHHHHHHH
Q 006112 501 GTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELD-LLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIV 579 (660)
Q Consensus 501 gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 579 (660)
++..|+|||.+.++.++.++||||||++++||++|+.||...... ..+....... ......... ....+
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------~~~~~~~~~----~~~~~ 225 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL------EMAVEYPDK----FSPEA 225 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc------cccccCCcc----CCHHH
Confidence 788999999998888999999999999999999999999764331 1111111100 001111112 23456
Q ss_pred HHHhhhccCCCCCCCC-----CHHHHHH
Q 006112 580 LKLGLFCSHSNPDTRP-----SMRQVVQ 602 (660)
Q Consensus 580 ~~l~~~Cl~~dP~~RP-----s~~evl~ 602 (660)
.+++..||+.||.+|| ++.++++
T Consensus 226 ~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 226 KDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHHHHHccCChhHccCCCcccHHHHHh
Confidence 7888889999999999 5555654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=303.67 Aligned_cols=251 Identities=30% Similarity=0.417 Sum_probs=206.2
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
-.|+....+++|++|.||+|.+..++..+++|++..... ..+.+.+|++++++++|+|++++++.+...+..++|+||+
T Consensus 19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 97 (286)
T cd06614 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYM 97 (286)
T ss_pred ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEecc
Confidence 358888999999999999999988889999999976544 5678899999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 495 (660)
++++|.+++.... ..+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++........ .
T Consensus 98 ~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 172 (286)
T cd06614 98 DGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-K 172 (286)
T ss_pred CCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-h
Confidence 9999999998754 359999999999999999999998 9999999999999999999999999999865543221 2
Q ss_pred eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHH
Q 006112 496 TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQ 575 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 575 (660)
.....++..|++||.+.+..++.++||||||+++|||++|+.||....... ..... ....... ... ....
T Consensus 173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~--~~~~~-~~~~~~~-----~~~--~~~~ 242 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR--ALFLI-TTKGIPP-----LKN--PEKW 242 (286)
T ss_pred hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH-HhcCCCC-----Ccc--hhhC
Confidence 233457889999999988889999999999999999999999987533221 11111 1111110 110 1113
Q ss_pred HHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 576 MEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 576 ~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
...+.+++.+|++.+|.+||++.++++
T Consensus 243 ~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 243 SPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 356778899999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=303.56 Aligned_cols=243 Identities=21% Similarity=0.255 Sum_probs=189.8
Q ss_pred ccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHH---hccCCCCceeEeeeeeecCeeEEEEecCC
Q 006112 343 KATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSM---GKLRHRNLVQLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 343 ~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l---~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 416 (660)
.+|+|+||.||++....+++.+|+|.+.... ......+.+|..++ ...+||||+++++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 3799999999999998889999999886532 12223344554433 33479999999999999999999999999
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCcee
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT 496 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 496 (660)
+|+|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||++....... .
T Consensus 81 ~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~ 152 (279)
T cd05633 81 GGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P 152 (279)
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---c
Confidence 999999987543 48999999999999999999998 899999999999999999999999999997654322 1
Q ss_pred eccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHH
Q 006112 497 TNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQ 575 (660)
Q Consensus 497 ~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 575 (660)
....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||................ .....+.. ..
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~------~~~~~~~~----~~ 222 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL------TVNVELPD----SF 222 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh------cCCcCCcc----cc
Confidence 23468999999999864 457899999999999999999999997543322222221111 11111222 23
Q ss_pred HHHHHHHhhhccCCCCCCCC-----CHHHHHHH
Q 006112 576 MEIVLKLGLFCSHSNPDTRP-----SMRQVVQY 603 (660)
Q Consensus 576 ~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 603 (660)
...+.+++..|++.||++|| +++|++++
T Consensus 223 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 223 SPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 34567788889999999999 69999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=301.03 Aligned_cols=260 Identities=28% Similarity=0.337 Sum_probs=198.7
Q ss_pred eecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHhcc---CCCCceeEeeeeeecCe-----
Q 006112 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD--HGMKQFVSEIVSMGKL---RHRNLVQLRGYCRRKGE----- 407 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l---~H~nIv~l~g~~~~~~~----- 407 (660)
|+....+|+|+||.||+|++..+++.+|+|++..... .....+.+|+.+++++ +|+||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5677889999999999999988899999999964322 2234566788777665 69999999999988776
Q ss_pred eEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeeccccee
Q 006112 408 LLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARL 487 (660)
Q Consensus 408 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 487 (660)
.+++|||++ ++|.+++.......+++.++..++.|+++||+|||+ .+++|+||||+||+++.++.+||+|||++..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 999999996 589998876554568999999999999999999998 8999999999999999999999999999987
Q ss_pred ccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcc-hHHHHHHHHhcCCccc-----
Q 006112 488 YDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELD-LLDWVIDYWQKGDVLD----- 561 (660)
Q Consensus 488 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~----- 561 (660)
+...... ....++..|+|||.+.+..++.++|||||||++|||++|+.||...... ....+.+.........
T Consensus 157 ~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 157 YSFEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred ccCCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 6543221 2345788999999999888999999999999999999999888753321 1111111111000000
Q ss_pred -----CCCC---cccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 562 -----ASDP---RLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 562 -----~~d~---~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.... .......+.....+.+++.+||+.||++||+++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0000 00011112334567889999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=295.37 Aligned_cols=251 Identities=26% Similarity=0.393 Sum_probs=207.8
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD--HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
+|+..+.+|.|+||.||++.+..++..+++|++..... ...+.+.+|++++++++|+|++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 36777889999999999999988899999999875533 5567899999999999999999999999989999999999
Q ss_pred CCCCChhhhhhhCC--CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 415 MPNGSLDKILYSNT--RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 415 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
+++++|.+++.... ...+++.++..++.+++.||.|||+ .+++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999997643 3568999999999999999999998 899999999999999999999999999998765543
Q ss_pred CceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCc
Q 006112 493 DLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 493 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
.......|++.|+|||.+....++.++||||+|+++++|++|+.||...+.. + .......... +.+..
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--~-~~~~~~~~~~-----~~~~~--- 225 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL--E-LALKILKGQY-----PPIPS--- 225 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH--H-HHHHHhcCCC-----CCCCC---
Confidence 2233457889999999998888999999999999999999999999764422 1 1111122111 11111
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.....+.+++.+||+.+|++||++.|++++
T Consensus 226 -~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 226 -QYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 223457788889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=309.83 Aligned_cols=251 Identities=25% Similarity=0.411 Sum_probs=197.5
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEecc--CCChhhHHHHHHHHHHhccC-CCCceeEeeeeeecCeeEEEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCH--DSDHGMKQFVSEIVSMGKLR-HRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~ 412 (660)
-.|+++++||.||.+.||++... +.+.+|+|++.. .+.+...-|.+|+..|.+|+ |.+||+|++|-..++.+||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 36999999999999999999874 456788887643 34566788999999999995 999999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
||= +.+|.++|.........| .+..+..|++.++.++|+ .+|||.||||.|+|+- .|.+||+|||.|..+....
T Consensus 440 E~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDT 513 (677)
T ss_pred ecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEE-eeeEEeeeechhcccCccc
Confidence 975 789999998876655556 777899999999999998 9999999999999995 4689999999998776543
Q ss_pred -CceeeccccCccccCcccccCC-----------CCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcc
Q 006112 493 -DLHTTNVVGTVGYLAPELLRNG-----------RGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVL 560 (660)
Q Consensus 493 -~~~~~~~~gt~~Y~aPE~~~~~-----------~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 560 (660)
.......+||+.||+||.+... +.++++||||+||+||+|+.|+.||..- .....++ .
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~----~n~~aKl------~ 583 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI----INQIAKL------H 583 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH----HHHHHHH------H
Confidence 3344567999999999988532 2467999999999999999999999731 1111111 1
Q ss_pred cCCCCcccccCcH-HHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 561 DASDPRLEGIYVE-EQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 561 ~~~d~~l~~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
...+|...-.|.. .....++++|..|++.||++||+..|++++
T Consensus 584 aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 584 AITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred hhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 1222311111110 011128899999999999999999999974
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=312.90 Aligned_cols=256 Identities=22% Similarity=0.255 Sum_probs=197.6
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeec------Cee
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK------GEL 408 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~ 408 (660)
.|+.++.+|+|+||.||++....+++.||+|.+... .....+++.+|+.++++++|+||+++++++... ...
T Consensus 17 ~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 96 (353)
T cd07850 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDV 96 (353)
T ss_pred ceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcE
Confidence 588889999999999999999989999999998643 233456788999999999999999999987643 357
Q ss_pred EEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceec
Q 006112 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLY 488 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 488 (660)
++||||+. ++|.+.+... +++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 97 ~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 97 YLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred EEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 99999995 6888877532 7888999999999999999998 89999999999999999999999999999875
Q ss_pred cCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcc-hHHHHHHHHh------------
Q 006112 489 DHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELD-LLDWVIDYWQ------------ 555 (660)
Q Consensus 489 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~~~~------------ 555 (660)
.... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.. ....+.....
T Consensus 169 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (353)
T cd07850 169 GTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP 246 (353)
T ss_pred CCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 4322 123346789999999999989999999999999999999999999754321 1111111000
Q ss_pred ------cCCccc-----------CCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 556 ------KGDVLD-----------ASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 556 ------~~~~~~-----------~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
...... ...+.............+.+++.+|++.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000000 00000000001123456789999999999999999999996
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=306.18 Aligned_cols=255 Identities=24% Similarity=0.384 Sum_probs=202.9
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
.|+.++.+|+|+||.||+++...++..+|+|++.... ....+++.+|++++++++|||+++++++|.++...++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 4778889999999999999998889999999986432 2345678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
|++ |+|.+++.... ..++|.++..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 106 ~~~-g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 106 YCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred CCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 996 57877775443 358999999999999999999998 89999999999999999999999999998754322
Q ss_pred ceeeccccCccccCccccc---CCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCccccc
Q 006112 494 LHTTNVVGTVGYLAPELLR---NGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGI 570 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 570 (660)
....|+..|+|||++. .+.++.++|||||||++|||++|+.||...... ..... ...+.. +...
T Consensus 179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~-~~~~~~-----~~~~-- 245 (317)
T cd06635 179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYH-IAQNES-----PTLQ-- 245 (317)
T ss_pred ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH--HHHHH-HHhccC-----CCCC--
Confidence 2346889999999974 456889999999999999999999998753221 11111 111111 1111
Q ss_pred CcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCCCCCCC
Q 006112 571 YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGALLPD 612 (660)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p~ 612 (660)
.......+.+++.+||+.+|.+||++.++++++-.....+.
T Consensus 246 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 286 (317)
T cd06635 246 -SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPE 286 (317)
T ss_pred -CccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCcc
Confidence 11233457888899999999999999999987654443333
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=294.59 Aligned_cols=248 Identities=27% Similarity=0.405 Sum_probs=205.6
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD--HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
+|+..+.+|+|++|.||+++...+++.+++|.+..... ...+.+.+|++++++++|+|++++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 36778899999999999999988899999999976644 4567899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
+++++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 9999999998765 358999999999999999999998 89999999999999999999999999999876543322
Q ss_pred eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHH
Q 006112 495 HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEE 574 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 574 (660)
.....++..|+|||.+.....+.++||||+|+++|+|++|+.||......... +... ... .+.+.. .
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~--~~~~-~~~-----~~~~~~----~ 222 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL--FRIV-QDD-----HPPLPE----G 222 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH--HHHh-ccC-----CCCCCC----C
Confidence 23356889999999998878899999999999999999999998754322111 1111 111 111111 2
Q ss_pred HHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 575 QMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 575 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
....+.+++.+|++.+|++||++.+++.
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 223 ISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 2345778888999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=298.87 Aligned_cols=247 Identities=23% Similarity=0.343 Sum_probs=200.3
Q ss_pred cccCccEEEEEEEeCCCCeEEEEEEeccCCC---hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCCCCCh
Q 006112 344 ATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD---HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSL 420 (660)
Q Consensus 344 lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 420 (660)
+|+|+||.||++++..+++.+++|.+..... ...+.+.+|++++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 5789999999999988899999999865433 4567899999999999999999999999999999999999999999
Q ss_pred hhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC-------
Q 006112 421 DKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND------- 493 (660)
Q Consensus 421 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~------- 493 (660)
.+++.... .+++..+..++.||+.||+|||+ .+++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99997654 58999999999999999999998 8999999999999999999999999999876443321
Q ss_pred ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
.......++..|++||.+.....+.++||||||+++||+++|..||....... .......+... .....
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~~~~~~~~~------~~~~~-- 224 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE---IFQNILNGKIE------WPEDV-- 224 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHhcCCcC------CCccc--
Confidence 12234568889999999988888999999999999999999999997544221 11111221111 00000
Q ss_pred HHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
.....+.+++..|++.+|++||++.++.+.|+.
T Consensus 225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 225 EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 024557788889999999999999776666653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=312.45 Aligned_cols=263 Identities=24% Similarity=0.347 Sum_probs=199.1
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC-CChhhHHHHHHHHHHhccCCCCceeEeeeeeec-----CeeEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD-SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK-----GELLL 410 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~~l 410 (660)
+|+..+.+|+|+||.||+|++..+++.||+|++... .......+.+|+.++++++|+||+++++++... ...++
T Consensus 6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 85 (336)
T cd07849 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYI 85 (336)
T ss_pred ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEE
Confidence 588889999999999999999889999999998643 233456788999999999999999999987654 35899
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccC
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDH 490 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 490 (660)
|+||+. ++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 86 v~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 86 VQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred Eehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 999995 588877753 248999999999999999999998 8999999999999999999999999999986543
Q ss_pred CCCc--eeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCcc-hHHHHHHHHhcCCc-------
Q 006112 491 GNDL--HTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGELD-LLDWVIDYWQKGDV------- 559 (660)
Q Consensus 491 ~~~~--~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~~~------- 559 (660)
.... ......||..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.. ....+.........
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII 238 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 3221 1233578999999998754 46889999999999999999999999653321 11111111111000
Q ss_pred -------ccCC--CCccc-ccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH--hhC
Q 006112 560 -------LDAS--DPRLE-GIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY--LDG 606 (660)
Q Consensus 560 -------~~~~--d~~l~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~ 606 (660)
.... .+... ....+.....+.+++.+||+.||++||++.|++++ |+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~ 297 (336)
T cd07849 239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQ 297 (336)
T ss_pred chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccc
Confidence 0000 00000 00001123457899999999999999999999985 543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=323.78 Aligned_cols=255 Identities=26% Similarity=0.361 Sum_probs=212.2
Q ss_pred eeecccccccCccEEEEEEEeCCCC----eEEEEEEeccC-CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSH----AEIAVKKVCHD-SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~----~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 411 (660)
..+..++||.|+||+||||.+-..+ .+||+|++... ..+...+++.|+.+|.+++|||+++|+|+|.... +.||
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 4556788999999999999995544 47889987544 4556789999999999999999999999998776 8999
Q ss_pred EecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCC
Q 006112 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 491 (660)
++||+.|+|.+|++.+. ..+.-...+.+..|||+||.|||+ +++|||||..+|||+.+...+||.|||+++.....
T Consensus 776 tq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 99999999999998754 458888999999999999999998 99999999999999999999999999999988765
Q ss_pred CCc-eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccc
Q 006112 492 NDL-HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEG 569 (660)
Q Consensus 492 ~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 569 (660)
... ......-.+.|||-|.+....++.++|||||||++||++| |..|+++...+ .+-+.++.|+.+..
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~---eI~dlle~geRLsq------- 921 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE---EIPDLLEKGERLSQ------- 921 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH---HhhHHHhccccCCC-------
Confidence 433 3333344678999999999999999999999999999998 99999875543 34455566654322
Q ss_pred cCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCCC
Q 006112 570 IYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGA 608 (660)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (660)
++-+.-.+..++..||..|++.||+++++...+.+-+
T Consensus 922 --PpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 922 --PPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred --CCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 2233445788899999999999999999998776543
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=304.19 Aligned_cols=249 Identities=24% Similarity=0.320 Sum_probs=201.9
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 416 (660)
.|+...++|+|+||.||++....+++.||+|++........+.+.+|+.++++++|+||+++++.+...+..++||||++
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence 45556789999999999999988999999999866555566789999999999999999999999999999999999999
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCcee
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT 496 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 496 (660)
+++|.+++... .+++.....++.|++.||+|||+ .+++|+||||+||++++++.++|+|||++....... ...
T Consensus 101 ~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~ 173 (292)
T cd06657 101 GGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRR 173 (292)
T ss_pred CCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccc
Confidence 99999987532 47899999999999999999998 899999999999999999999999999987654322 122
Q ss_pred eccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHH
Q 006112 497 TNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQM 576 (660)
Q Consensus 497 ~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 576 (660)
....|+..|++||.+.+..++.++||||||+++|||++|..||........ ......+. .+.+.. .....
T Consensus 174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~---~~~~~~~~-----~~~~~~--~~~~~ 243 (292)
T cd06657 174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MKMIRDNL-----PPKLKN--LHKVS 243 (292)
T ss_pred cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhhC-----CcccCC--cccCC
Confidence 335688999999999888889999999999999999999999875432211 11111110 111111 01123
Q ss_pred HHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 577 EIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 577 ~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
..+.+++.+|++.||.+||++.++++
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 34667888999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=304.18 Aligned_cols=261 Identities=25% Similarity=0.314 Sum_probs=197.8
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
.|+....+|+|++|.||+|+...+++.||+|++.... ....+.+.+|++++++++|+||+++++++......++||||
T Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY 82 (294)
T ss_pred ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEec
Confidence 4778889999999999999998889999999986432 23346788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcC-CCCeEEeecccceeccCCCC
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDA-DLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~-~~~~kl~DFGla~~~~~~~~ 493 (660)
++ ++|.+++.......+++.....++.||+.||+|||+ ++++||||||+||+++. ++.+||+|||+++.......
T Consensus 83 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 83 LD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred cc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 95 688888765554456788888999999999999998 89999999999999985 55799999999976543221
Q ss_pred ceeeccccCccccCcccccCC-CCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHHHHHHhcCC--ccc--------
Q 006112 494 LHTTNVVGTVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVIDYWQKGD--VLD-------- 561 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~~~~~~--~~~-------- 561 (660)
......+++.|+|||++.+. .++.++|||||||++|||++|+.||..... +............. ...
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (294)
T PLN00009 159 -TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDY 237 (294)
T ss_pred -ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhh
Confidence 12334678899999988664 578899999999999999999999975332 11111111111100 000
Q ss_pred -CCCCcccc----cCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 562 -ASDPRLEG----IYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 562 -~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
...+.... ...+.....+.+++.+|++.+|++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 238 KSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000000 011122345778888999999999999999996
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=300.50 Aligned_cols=258 Identities=23% Similarity=0.238 Sum_probs=196.9
Q ss_pred eecccccccCccEEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHhccC-CCCceeEeeeeeec--CeeEEEEe
Q 006112 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLR-HRNLVQLRGYCRRK--GELLLVYD 413 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~--~~~~lV~E 413 (660)
|+.++.+|+|+||.||+|+...++..+|+|++.... ........+|+.++.++. |+|++++++++.++ +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 566788999999999999998889999999986542 222334568999999985 99999999999887 88999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
|++ ++|.+++.... ..++|.++..++.|++.||+|||+ .+++||||||+||+++. +.+||+|||+++.......
T Consensus 81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 81 LMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred cCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 996 68888876543 358999999999999999999998 89999999999999999 9999999999986543322
Q ss_pred ceeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHHHHHHh-----------cCCcc
Q 006112 494 LHTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVIDYWQ-----------KGDVL 560 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~~~-----------~~~~~ 560 (660)
.....++..|+|||.+.. +.++.++|||||||++|||++|..||...+. +...+...... .....
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07831 155 --YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM 232 (282)
T ss_pred --cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence 123467899999997654 5578899999999999999999999975432 22222221111 11111
Q ss_pred cCCCCccccc----CcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 561 DASDPRLEGI----YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 561 ~~~d~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
....+...+. ........+.+++..||+.+|++||++++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 1111111000 012335678899999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=304.44 Aligned_cols=260 Identities=23% Similarity=0.280 Sum_probs=197.1
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccC-CCCceeEeeeeeecCe-----e
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLR-HRNLVQLRGYCRRKGE-----L 408 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~-----~ 408 (660)
+|+..+.+|+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++ ||||+++++++..... .
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 4778889999999999999999899999999876543 223467889999999995 6999999999877665 8
Q ss_pred EEEEecCCCCChhhhhhhCC---CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcC-CCCeEEeeccc
Q 006112 409 LLVYDYMPNGSLDKILYSNT---RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDA-DLEGKLGDFGL 484 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~-~~~~kl~DFGl 484 (660)
++||||+++ +|.+++.... ...+++.++..++.||+.||+|||+ ++|+||||||+||+++. ++.+||+|||+
T Consensus 82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeeccc
Confidence 999999975 8988886532 2358999999999999999999998 89999999999999998 88999999999
Q ss_pred ceeccCCCCceeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhc-CCcccC
Q 006112 485 ARLYDHGNDLHTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQK-GDVLDA 562 (660)
Q Consensus 485 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~-~~~~~~ 562 (660)
++.+..... ......+++.|+|||++.+ ..++.++||||||+++|||++|..||..... .+........ +.....
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~ 234 (295)
T cd07837 158 GRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE--LQQLLHIFKLLGTPTEQ 234 (295)
T ss_pred ceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHHHHhCCCChh
Confidence 986543221 1223356889999998865 4578999999999999999999999975332 1111111110 000000
Q ss_pred CC------------Cccc----ccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 563 SD------------PRLE----GIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 563 ~d------------~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.. +... ....+.....+.+++..|++.||.+||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00 0000 00011234567889999999999999999999853
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=320.36 Aligned_cols=248 Identities=23% Similarity=0.354 Sum_probs=199.1
Q ss_pred cccccCccEEEEEEEeCCCCeEEEEEEecc----CCChhhHHHHHHHHHHhccCCCCceeEeeeeeecC--eeEEEEecC
Q 006112 342 YKATKGGSGKVYRGVLPSSHAEIAVKKVCH----DSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKG--ELLLVYDYM 415 (660)
Q Consensus 342 ~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~----~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~lV~E~~ 415 (660)
..||+|+|-+||||.+..+|.+||--.++. ..+...++|..|+.+|+.|+||||++++.+..+.. .+.+|+|.|
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 469999999999999988998888654432 24456789999999999999999999999876654 488999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCC-CCeEEeecccceeccCCCCc
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDAD-LEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~-~~~kl~DFGla~~~~~~~~~ 494 (660)
..|+|..|+.+..+ ++......+++||++||.|||+. .++|+|||||.+||+|+.+ |.+||+|+|||.+.....
T Consensus 126 TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-- 200 (632)
T KOG0584|consen 126 TSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-- 200 (632)
T ss_pred cCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc--
Confidence 99999999988765 77788999999999999999984 5899999999999999876 789999999998865432
Q ss_pred eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHH
Q 006112 495 HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEE 574 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 574 (660)
...+.|||.|||||+.. ..|++..||||||+.++||+|+..||.... -...+.+....|..... +..-
T Consensus 201 -aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~--n~AQIYKKV~SGiKP~s--------l~kV 268 (632)
T KOG0584|consen 201 -AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT--NPAQIYKKVTSGIKPAA--------LSKV 268 (632)
T ss_pred -cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC--CHHHHHHHHHcCCCHHH--------hhcc
Confidence 34489999999999986 789999999999999999999999996422 22333333333322111 1111
Q ss_pred HHHHHHHHhhhccCCCCCCCCCHHHHHH--HhhCC
Q 006112 575 QMEIVLKLGLFCSHSNPDTRPSMRQVVQ--YLDGG 607 (660)
Q Consensus 575 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~ 607 (660)
....+.+++..|+.. ..+|||+.|+++ +|..+
T Consensus 269 ~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 269 KDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred CCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 122467788889999 999999999996 55543
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=308.10 Aligned_cols=255 Identities=20% Similarity=0.272 Sum_probs=194.6
Q ss_pred ccccC--ccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCCCC
Q 006112 343 KATKG--GSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNG 418 (660)
Q Consensus 343 ~lg~G--~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g 418 (660)
.+|+| +||+||++++..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 45555 99999999998899999999986432 234578899999999999999999999999999999999999999
Q ss_pred ChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce---
Q 006112 419 SLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH--- 495 (660)
Q Consensus 419 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~--- 495 (660)
+|.+++.......+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+|++||+.+..........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 99999987654568999999999999999999998 899999999999999999999999998654322111100
Q ss_pred ---eeccccCccccCcccccCC--CCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCc-----------
Q 006112 496 ---TTNVVGTVGYLAPELLRNG--RGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDV----------- 559 (660)
Q Consensus 496 ---~~~~~gt~~Y~aPE~~~~~--~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~----------- 559 (660)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||....... ...........
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCccccccchh
Confidence 0112356679999998763 47899999999999999999999997533211 11111100000
Q ss_pred -------------------------ccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 560 -------------------------LDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 560 -------------------------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
....+..+...........+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0000111111122334567889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=304.73 Aligned_cols=261 Identities=28% Similarity=0.336 Sum_probs=198.7
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeeecC--------
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKG-------- 406 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-------- 406 (660)
.|+..+.+|+|+||.||+|++..+++.||+|++.... ......+.+|++++++++||||+++++++.+..
T Consensus 8 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~ 87 (302)
T cd07864 8 KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKD 87 (302)
T ss_pred hhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcccc
Confidence 5777889999999999999999889999999986543 233457788999999999999999999987654
Q ss_pred --eeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeeccc
Q 006112 407 --ELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGL 484 (660)
Q Consensus 407 --~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGl 484 (660)
.+++|+||+++ +|..++... ...+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+
T Consensus 88 ~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~dfg~ 162 (302)
T cd07864 88 KGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGL 162 (302)
T ss_pred CCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeCcccc
Confidence 78999999975 777777554 3358999999999999999999998 8999999999999999999999999999
Q ss_pred ceeccCCCCceeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHHHHHHhcCCcc--
Q 006112 485 ARLYDHGNDLHTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVIDYWQKGDVL-- 560 (660)
Q Consensus 485 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~~~~~~~~-- 560 (660)
+...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+. .....+.+........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (302)
T cd07864 163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242 (302)
T ss_pred cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence 98765443222233456788999998764 4568899999999999999999999975432 1122222211111000
Q ss_pred -cC--------CCC------cccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 561 -DA--------SDP------RLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 561 -~~--------~d~------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
+. .++ +....+ ......+.+++..||+.||.+||++++++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 243 PDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred ccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 000 000000 1123567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=297.04 Aligned_cols=249 Identities=27% Similarity=0.375 Sum_probs=206.4
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
+|+..+.+++|++|.||+++...+++.+++|.+... ......++.+|++++++++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 367788999999999999999888999999998653 234456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhC--CCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 415 MPNGSLDKILYSN--TRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 415 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
+++++|.+++... ....+++..++.++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999998652 23458999999999999999999998 89999999999999999999999999999876544
Q ss_pred CceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCc
Q 006112 493 DLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 493 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
......++..|++||.+.+..++.++|+||||+++|||++|+.||...+.... ......+.. + ...
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~---~~~~~~~~~-----~----~~~ 222 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL---RYKVQRGKY-----P----PIP 222 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHhcCCC-----C----CCc
Confidence 12234688999999999988899999999999999999999999976543211 111122111 1 111
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
......+.+++..|++.+|++||++.|++++
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 223 PIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred hhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 2344568889999999999999999999865
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=301.14 Aligned_cols=260 Identities=27% Similarity=0.315 Sum_probs=202.8
Q ss_pred eecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD--HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
|+.++.+|+|++|.||++....+++.+++|++..... ...+.+.+|++++++++|+||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 4567789999999999999988899999999865432 34578889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 495 (660)
+ ++|.+++.... ..+++.++..++.|++.||.|||+ .+|+|+||||+||+++.++.+||+|||.+....... ..
T Consensus 81 ~-~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~ 154 (283)
T cd05118 81 D-TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP 154 (283)
T ss_pred C-CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence 6 48888886643 458999999999999999999998 899999999999999999999999999998765433 12
Q ss_pred eeccccCccccCcccccCC-CCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHHHHHHhcCCc--ccCC-C------
Q 006112 496 TTNVVGTVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVIDYWQKGDV--LDAS-D------ 564 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~~~~~~~--~~~~-d------ 564 (660)
.....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+. +......+....... .... +
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 2334678899999998776 789999999999999999999999865432 111111111111000 0000 0
Q ss_pred ---Ccc----cccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 565 ---PRL----EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 565 ---~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
+.. .....+.....+.+++..||++||.+||++++++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000 001112345678899999999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=296.92 Aligned_cols=245 Identities=24% Similarity=0.249 Sum_probs=192.9
Q ss_pred cccccCccEEEEEEEeCCCCeEEEEEEeccCCC---hhhHHHHHHHHHH-hccCCCCceeEeeeeeecCeeEEEEecCCC
Q 006112 342 YKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD---HGMKQFVSEIVSM-GKLRHRNLVQLRGYCRRKGELLLVYDYMPN 417 (660)
Q Consensus 342 ~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l-~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 417 (660)
+.+|+|+||.||+|....+++.||+|.+..... .....+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 568999999999999988899999999865432 2233455555544 455899999999999999999999999999
Q ss_pred CChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCceee
Q 006112 418 GSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTT 497 (660)
Q Consensus 418 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 497 (660)
++|.+++.... .+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||+++.... ..
T Consensus 82 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~ 151 (260)
T cd05611 82 GDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NK 151 (260)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc-----cc
Confidence 99999997643 48889999999999999999998 8999999999999999999999999999875432 22
Q ss_pred ccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHH
Q 006112 498 NVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQME 577 (660)
Q Consensus 498 ~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 577 (660)
...|+..|+|||.+.+..++.++||||||+++|||++|..||....... .......+... ...........
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~------~~~~~~~~~~~ 222 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA---VFDNILSRRIN------WPEEVKEFCSP 222 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHhcccC------CCCcccccCCH
Confidence 3468899999999988888999999999999999999999997644321 22222222111 00111112345
Q ss_pred HHHHHhhhccCCCCCCCCCHHHHHHHhh
Q 006112 578 IVLKLGLFCSHSNPDTRPSMRQVVQYLD 605 (660)
Q Consensus 578 ~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (660)
.+.+++..||+.||++||++.++.+.|+
T Consensus 223 ~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 223 EAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred HHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 5788899999999999998766655544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=309.88 Aligned_cols=262 Identities=24% Similarity=0.333 Sum_probs=200.7
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeec-----CeeE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK-----GELL 409 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~~ 409 (660)
.|+.++.+|+|+||.||+++...+++.||||++... .......+.+|+.+++.++|+||+++++++... ...+
T Consensus 6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 85 (337)
T cd07858 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY 85 (337)
T ss_pred ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence 578889999999999999999989999999998643 233456778999999999999999999988644 3489
Q ss_pred EEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceecc
Q 006112 410 LVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYD 489 (660)
Q Consensus 410 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 489 (660)
+||||+. ++|.+++.... .+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++...
T Consensus 86 lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 86 IVYELMD-TDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred EEEeCCC-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 9999995 78988886543 48999999999999999999998 899999999999999999999999999998664
Q ss_pred CCCCceeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCcc-hHHHHHHHHhc-----------
Q 006112 490 HGNDLHTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGELD-LLDWVIDYWQK----------- 556 (660)
Q Consensus 490 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~~~~~----------- 556 (660)
... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||...+.. ......+....
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 160 EKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred CCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 332 22234567899999998765 46889999999999999999999999754321 11111111000
Q ss_pred CC-------cccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH--hhC
Q 006112 557 GD-------VLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY--LDG 606 (660)
Q Consensus 557 ~~-------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~ 606 (660)
+. .....++.+.. ..+.....+.+++.+|++.||++|||++|++++ |+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred hhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 00 00000111100 011234567899999999999999999999976 554
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=302.95 Aligned_cols=260 Identities=26% Similarity=0.329 Sum_probs=196.4
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeeecC--------
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKG-------- 406 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-------- 406 (660)
.|+.++.+|+|+||.||+++...+++.||||.+.... ......+.+|++++++++||||++++++|....
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 92 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG 92 (310)
T ss_pred heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence 6888999999999999999999899999999986432 223345678999999999999999999987553
Q ss_pred eeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccce
Q 006112 407 ELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLAR 486 (660)
Q Consensus 407 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 486 (660)
..++||||+. ++|.+++.... ..+++.++..++.||+.||+|||+ ++++|+||||+||+++.++.+||+|||++.
T Consensus 93 ~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 93 SFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred eEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 4599999995 58888876543 358999999999999999999998 899999999999999999999999999998
Q ss_pred eccCCCCc---eeeccccCccccCcccccCC-CCCcceeEEehHHHHHHHhhCCCCCCCCCcc-hHHHHHHHHhcCCccc
Q 006112 487 LYDHGNDL---HTTNVVGTVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQPGELD-LLDWVIDYWQKGDVLD 561 (660)
Q Consensus 487 ~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~ 561 (660)
........ ......++..|+|||.+.+. .++.++||||||+++|||++|+.||...... ....+.... +....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~--~~~~~ 245 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLC--GSITP 245 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh--CCCCh
Confidence 66433221 12234678899999988654 4688999999999999999999998764322 111111111 11100
Q ss_pred CCCCc-----------ccccCc---------HHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 562 ASDPR-----------LEGIYV---------EEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 562 ~~d~~-----------l~~~~~---------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
...+. +..... ......+.+++.+||+.||.+|||++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00000 000000 0012346689999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=328.83 Aligned_cols=263 Identities=20% Similarity=0.286 Sum_probs=187.6
Q ss_pred eeecccccccCccEEEEEEEeCCCCe-EEEEEE--------------ec---cCCChhhHHHHHHHHHHhccCCCCceeE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHA-EIAVKK--------------VC---HDSDHGMKQFVSEIVSMGKLRHRNLVQL 398 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~-~vavK~--------------~~---~~~~~~~~~~~~Ei~~l~~l~H~nIv~l 398 (660)
.|+.++.||+|+||+||++.+..... ..++|. +. ........++.+|+.++++++||||+++
T Consensus 149 ~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 228 (501)
T PHA03210 149 HFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKI 228 (501)
T ss_pred ccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcE
Confidence 58899999999999999987643221 111111 10 1122345678899999999999999999
Q ss_pred eeeeeecCeeEEEEecCCCCChhhhhhhCC---CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCC
Q 006112 399 RGYCRRKGELLLVYDYMPNGSLDKILYSNT---RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADL 475 (660)
Q Consensus 399 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~ 475 (660)
++++...+..++|+|++ +++|..++.... .......+...++.||+.||+|||+ ++|+||||||+|||++.++
T Consensus 229 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 229 EEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred eEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCC
Confidence 99999999999999999 567777765432 1123345677899999999999998 8999999999999999999
Q ss_pred CeEEeecccceeccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCC-CCCCCcchHHHHHHHH
Q 006112 476 EGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRP-VQPGELDLLDWVIDYW 554 (660)
Q Consensus 476 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p-~~~~~~~~~~~~~~~~ 554 (660)
.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..+ +............+..
T Consensus 305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~ 384 (501)
T PHA03210 305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKII 384 (501)
T ss_pred CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHH
Confidence 999999999987765443334456799999999999998999999999999999999998764 4332211111121111
Q ss_pred hcCCcc--cCCCC------------------cccccC-cHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 555 QKGDVL--DASDP------------------RLEGIY-VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 555 ~~~~~~--~~~d~------------------~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
..-... +..++ .+...+ .......+.+++.+|++.||++|||+.|++++
T Consensus 385 ~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 385 DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 110000 00000 000000 00011235666788999999999999999863
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=300.43 Aligned_cols=260 Identities=26% Similarity=0.313 Sum_probs=199.6
Q ss_pred eecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHhccC-CCCceeEeeeeeecCeeEEEEecC
Q 006112 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD-HGMKQFVSEIVSMGKLR-HRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
|+..+.+|+|++|.||+|+...+++.|+||++..... .......+|+..+++++ |+||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 5667889999999999999988899999999865432 23334567999999999 999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 495 (660)
+|+|.+++.......+++.++..++.|++.+|.|||+ ++++|+||||+||++++++.+||+|||++........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 8899998876654568999999999999999999998 8999999999999999999999999999986543222
Q ss_pred eeccccCccccCccccc-CCCCCcceeEEehHHHHHHHhhCCCCCCCCCcc-hHHHHHHHHh--------cCC-cccCCC
Q 006112 496 TTNVVGTVGYLAPELLR-NGRGTTSTDVYAFGVFMLEVACGRRPVQPGELD-LLDWVIDYWQ--------KGD-VLDASD 564 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~~-~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~~~~--------~~~-~~~~~d 564 (660)
.....++..|+|||.+. ...++.++|+||||++++||++|+.||...... .......... .+. .....+
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 23356788999999875 445789999999999999999999998654321 1111111000 000 000000
Q ss_pred Cccc-------ccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 565 PRLE-------GIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 565 ~~l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
..+. ....+.....+.+++..||+.||++||+++|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000 00011123568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=287.15 Aligned_cols=250 Identities=24% Similarity=0.352 Sum_probs=202.4
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC-CChhhHHHHHHHHHHhccC-CCCceeEeeeeeecCeeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD-SDHGMKQFVSEIVSMGKLR-HRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
..+.+..+|.|..|.|++++...+|..+|||.+... ..+..++++..+.++..-+ .|.||+.+||+..+..+++.||.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 456677889999999999999999999999999765 4566788999998887765 89999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
| ...++++|..... ++++..+-++...+.+||.||.+ +++|+|||+||+|||+|+.|++||+|||.+-.+-.. .
T Consensus 173 M-s~C~ekLlkrik~-piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS--k 246 (391)
T KOG0983|consen 173 M-STCAEKLLKRIKG-PIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS--K 246 (391)
T ss_pred H-HHHHHHHHHHhcC-CchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecc--c
Confidence 9 6778888776543 58888888999999999999998 689999999999999999999999999999655433 2
Q ss_pred eeeccccCccccCccccc---CCCCCcceeEEehHHHHHHHhhCCCCCCCCCcch--HHHHHHHHhcCCcccCCCCcccc
Q 006112 495 HTTNVVGTVGYLAPELLR---NGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDL--LDWVIDYWQKGDVLDASDPRLEG 569 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~d~~l~~ 569 (660)
..+..+|.+.|||||.+. ..+|+.++|||||||+|+||.||+.||.....+. ...+.. ..-|.+++
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln---------~ePP~L~~ 317 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN---------EEPPLLPG 317 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh---------cCCCCCCc
Confidence 345568999999999985 3468889999999999999999999998744432 222221 11133432
Q ss_pred cCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 570 IYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.- .....+.++...|+..|+.+||...+++++
T Consensus 318 ~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 318 HM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred cc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 21 122346667777999999999999999863
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=308.46 Aligned_cols=261 Identities=25% Similarity=0.336 Sum_probs=199.6
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeee----cCeeEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR----KGELLL 410 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~l 410 (660)
.|+..+.+|+|+||.||+|....+++.||+|++.... ....+.+.+|+.++++++||||+++++++.. ...+++
T Consensus 6 ~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 85 (334)
T cd07855 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYV 85 (334)
T ss_pred ceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEE
Confidence 5778889999999999999999999999999986542 2345678899999999999999999998753 346899
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccC
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDH 490 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 490 (660)
||||+. ++|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+||++++++.+||+|||+++....
T Consensus 86 v~e~~~-~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 86 VMDLME-SDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred EEehhh-hhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 999995 69999886543 48999999999999999999998 8999999999999999999999999999976543
Q ss_pred CCCc---eeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCcch-HHHHHHHHh----------
Q 006112 491 GNDL---HTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDL-LDWVIDYWQ---------- 555 (660)
Q Consensus 491 ~~~~---~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~-~~~~~~~~~---------- 555 (660)
.... ......|+..|+|||.+.. ..++.++|||||||++|||++|+.||...+... ...+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~ 239 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI 239 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence 3221 1234578999999998765 468899999999999999999999997543211 111111000
Q ss_pred -cCCcc---cCCCCccc---ccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 556 -KGDVL---DASDPRLE---GIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 556 -~~~~~---~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
..... ........ ..........+.+++..|++.||++||++.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000 00000000 00112234568899999999999999999999973
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=304.92 Aligned_cols=249 Identities=25% Similarity=0.322 Sum_probs=203.7
Q ss_pred CceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEE
Q 006112 334 HRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLL 410 (660)
Q Consensus 334 ~~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 410 (660)
..-.++.-+.+|+||||.||-+..+.+|+.+|.|++.+. .+++....++|-+++.++..+.||.+--.++.++.+|+
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 344677788999999999999999999999999988543 23455667899999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccC
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDH 490 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 490 (660)
|+..|.||+|.-+|+..+.+.+++..+.-++.+|+.||++||. .+||.||+||+|||||+.|+++|+|+|||..+..
T Consensus 263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 9999999999999999888889999999999999999999998 9999999999999999999999999999988766
Q ss_pred CCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHHHHHHhcCCcccCCCCcccc
Q 006112 491 GNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVIDYWQKGDVLDASDPRLEG 569 (660)
Q Consensus 491 ~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~ 569 (660)
+... ...+||.+|||||++.++.|+...|.||+||+||||+.|+.||..... ...+.+.+.... ....+..
T Consensus 340 g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~------~~~ey~~ 411 (591)
T KOG0986|consen 340 GKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE------DPEEYSD 411 (591)
T ss_pred CCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc------chhhccc
Confidence 5443 334899999999999999999999999999999999999999975221 111122221111 1112233
Q ss_pred cCcHHHHHHHHHHhhhccCCCCCCCCCH
Q 006112 570 IYVEEQMEIVLKLGLFCSHSNPDTRPSM 597 (660)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 597 (660)
.++++ ...+....++.||++|.--
T Consensus 412 kFS~e----akslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 412 KFSEE----AKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred ccCHH----HHHHHHHHHccCHHHhccC
Confidence 34333 3444444689999998643
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=297.15 Aligned_cols=250 Identities=24% Similarity=0.337 Sum_probs=199.0
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC-----CChhhHHHHHHHHHHhccCCCCceeEeeeeeec--CeeE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD-----SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK--GELL 409 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~ 409 (660)
.|+..+.+|+|+||.||+|++..++..+|+|.+... ..+..+.+.+|++++++++|+||+++++++.+. +.++
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence 577888999999999999999888999999987432 233456889999999999999999999988654 4688
Q ss_pred EEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceecc
Q 006112 410 LVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYD 489 (660)
Q Consensus 410 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 489 (660)
+|+||+++++|.+++.... .+++....+++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++...
T Consensus 83 ~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 83 IFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 9999999999999987543 37888999999999999999998 899999999999999999999999999998653
Q ss_pred CCC--CceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcc
Q 006112 490 HGN--DLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL 567 (660)
Q Consensus 490 ~~~--~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 567 (660)
... ........|+..|+|||++.+..++.++|+|||||+++||++|+.||..... .+.+.+....+ ..+.+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~-----~~~~~ 230 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA--MAAIFKIATQP-----TKPML 230 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH--HHHHHHHHcCC-----CCCCC
Confidence 321 1122345689999999999888889999999999999999999999975321 12222211111 11112
Q ss_pred cccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 568 EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.....+.+.+++..||+ +|..||+..+++++
T Consensus 231 ----p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 231 ----PDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ----CcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 22233456777788999 57999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=309.12 Aligned_cols=260 Identities=27% Similarity=0.384 Sum_probs=198.3
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhcc-CCCCceeEeeeeeec--CeeEEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRK--GELLLV 411 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~--~~~~lV 411 (660)
.|+..+.+|+|+||.||+|.+..+++.+|+|++... .......+.+|+.+++++ +||||++++++|... ...++|
T Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv 87 (337)
T cd07852 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLV 87 (337)
T ss_pred HHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEE
Confidence 577888999999999999999888999999998542 233456678899999999 999999999998654 368999
Q ss_pred EecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCC
Q 006112 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 491 (660)
|||++ ++|..++... .++|.++..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 88 ~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 88 FEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred ecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 99996 6999888654 58899999999999999999998 89999999999999999999999999999866443
Q ss_pred CC----ceeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHHHHHHhc---------
Q 006112 492 ND----LHTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVIDYWQK--------- 556 (660)
Q Consensus 492 ~~----~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~~~~--------- 556 (660)
.. .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ............
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 22 12334568999999998754 4578899999999999999999999965322 111111111000
Q ss_pred -----CCcccCCC---CcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 557 -----GDVLDASD---PRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 557 -----~~~~~~~d---~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
....+... ........+.....+.+++.+||+.||++|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000 000001111134567889999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=315.11 Aligned_cols=252 Identities=23% Similarity=0.332 Sum_probs=207.2
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 416 (660)
-|.++..+|.|+||.||++..+.++..-|.|.+...+.+.+++|+-||+||....||+||+|++.|..++.++++.|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 47778889999999999999988888888899988888889999999999999999999999999999999999999999
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCcee
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT 496 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 496 (660)
||-.+..+..-++ .|++.++.-+++|++.||.|||+ +.|||||||..|||++-+|.++|+|||.+..... .....
T Consensus 113 GGAVDaimlEL~r-~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qkR 187 (1187)
T KOG0579|consen 113 GGAVDAIMLELGR-VLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQKR 187 (1187)
T ss_pred CchHhHHHHHhcc-ccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchh-HHhhh
Confidence 9999998876654 69999999999999999999998 9999999999999999999999999998853221 11233
Q ss_pred eccccCccccCcccc-----cCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccC
Q 006112 497 TNVVGTVGYLAPELL-----RNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIY 571 (660)
Q Consensus 497 ~~~~gt~~Y~aPE~~-----~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 571 (660)
..+.|||.|||||+. ...+|+.++|||||||+|.||..+.+|-..-. ... |+-...+........|
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln--pMR-VllKiaKSePPTLlqP------ 258 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN--PMR-VLLKIAKSEPPTLLQP------ 258 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc--hHH-HHHHHhhcCCCcccCc------
Confidence 457899999999976 45789999999999999999999998865322 122 2222222222222222
Q ss_pred cHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 572 VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
......+.++...|+..||..||++.+++++
T Consensus 259 -S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 259 -SHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred -chhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 2333456677778999999999999999863
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=300.58 Aligned_cols=253 Identities=18% Similarity=0.215 Sum_probs=186.4
Q ss_pred eeeecccccccCccEEEEEEEeCCC---CeEEEEEEeccCCChhh-----------HHHHHHHHHHhccCCCCceeEeee
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSS---HAEIAVKKVCHDSDHGM-----------KQFVSEIVSMGKLRHRNLVQLRGY 401 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~---~~~vavK~~~~~~~~~~-----------~~~~~Ei~~l~~l~H~nIv~l~g~ 401 (660)
..|+..+.||+|+||.||+|.+..+ +..+|+|.......... .....+...+..+.|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 3688999999999999999998776 56677776433222111 112334455667789999999997
Q ss_pred eeecC----eeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCe
Q 006112 402 CRRKG----ELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEG 477 (660)
Q Consensus 402 ~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~ 477 (660)
+.... ..++++|++ ..++.+.+.... ..++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+
T Consensus 92 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKL-VENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred eeEecCCceEEEEEEehh-ccCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCcE
Confidence 76543 347788887 446666664432 35678889999999999999998 899999999999999999999
Q ss_pred EEeecccceeccCCCC------ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCc--chHHH
Q 006112 478 KLGDFGLARLYDHGND------LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGEL--DLLDW 549 (660)
Q Consensus 478 kl~DFGla~~~~~~~~------~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~--~~~~~ 549 (660)
||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .....
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 9999999987643211 111234699999999999999999999999999999999999999976421 11111
Q ss_pred H----HHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhh
Q 006112 550 V----IDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605 (660)
Q Consensus 550 ~----~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (660)
. ......+.. . .....+.+.+++..|++.+|++||++.++++.|+
T Consensus 246 ~~~~~~~~~~~~~~------~-----~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 246 AKCDFIKRLHEGKI------K-----IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred hHHHHHHHhhhhhh------c-----cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1 111111111 0 1112355778888899999999999999998774
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=302.01 Aligned_cols=253 Identities=24% Similarity=0.354 Sum_probs=197.4
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHhccC-CCCceeEeeeeeecCeeEEEEe
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLR-HRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E 413 (660)
.+|+..+.+|+|+||.||+|.+..+++.||||++.... .....++..|+.++.+.. |+||++++++|.++...++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 46788899999999999999998889999999996543 234566778888777775 9999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
|+ +++|.+++.... ..+++.++..++.|++.||+|||+ ..+|+||||+|+||++++++.+||+|||++..+.....
T Consensus 95 ~~-~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 95 LM-STCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred cc-CcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 98 457877775533 368999999999999999999996 25899999999999999999999999999976543222
Q ss_pred ceeeccccCccccCcccccCCC----CCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccc
Q 006112 494 LHTTNVVGTVGYLAPELLRNGR----GTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEG 569 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~----~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 569 (660)
.....++..|+|||.+.... ++.++||||||+++|||++|+.||...... .+...... .+.. +....
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~-~~~~-----~~~~~ 241 (296)
T cd06618 171 --KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FEVLTKIL-QEEP-----PSLPP 241 (296)
T ss_pred --ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-HHHHHHHh-cCCC-----CCCCC
Confidence 12345788999999987553 788999999999999999999999753221 11111111 1111 11110
Q ss_pred cCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 570 IYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
. ......+.+++.+||+.||++||++++++++
T Consensus 242 ~--~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 242 N--EGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred C--CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 0123457888899999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=302.69 Aligned_cols=250 Identities=23% Similarity=0.311 Sum_probs=189.9
Q ss_pred ccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCCCCChhhhhh
Q 006112 348 GSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILY 425 (660)
Q Consensus 348 ~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~ 425 (660)
++|.||.++...+++.||||++... .....+.+.+|++++++++|+||+++++++.+.+..+++|||+++|+|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 3444555555558899999998754 34456789999999999999999999999999999999999999999999998
Q ss_pred hCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC------ceeecc
Q 006112 426 SNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND------LHTTNV 499 (660)
Q Consensus 426 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~------~~~~~~ 499 (660)
......+++.....++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||.+........ ......
T Consensus 92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~ 168 (314)
T cd08216 92 THFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSS 168 (314)
T ss_pred HhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccc
Confidence 6544568899999999999999999998 8999999999999999999999999999875432211 111234
Q ss_pred ccCccccCcccccC--CCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCccc----------------
Q 006112 500 VGTVGYLAPELLRN--GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLD---------------- 561 (660)
Q Consensus 500 ~gt~~Y~aPE~~~~--~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---------------- 561 (660)
.++..|+|||++.. ..++.++|||||||++|||++|+.||........ ..+... +....
T Consensus 169 ~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 245 (314)
T cd08216 169 VKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVR-GTVPCLLDKSTYPLYEDSMSQ 245 (314)
T ss_pred cccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHh-ccCccccccCchhhhcCCcCc
Confidence 57889999999865 3578899999999999999999999975332111 111111 00000
Q ss_pred ----CCCCcc----cccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 562 ----ASDPRL----EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 562 ----~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
..++.. ...........+.+++..||+.||++|||++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 246 SRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred ccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000000 011122233567889999999999999999999963
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=317.09 Aligned_cols=255 Identities=29% Similarity=0.351 Sum_probs=197.8
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccC-CChhhHHHHHHHHHHhccCCCCceeEeeeeeecC------ee
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD-SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKG------EL 408 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------~~ 408 (660)
..+..-+.+|+||||.||+|+.+.+|+.||||.++.. .....+...+|+++|++++|+|||++.+.-++.. ..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 4556667899999999999999999999999998764 3445678899999999999999999999765443 46
Q ss_pred EEEEecCCCCChhhhhhhCC-CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEc--CCC--CeEEeecc
Q 006112 409 LLVYDYMPNGSLDKILYSNT-RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLD--ADL--EGKLGDFG 483 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~--~~~--~~kl~DFG 483 (660)
.+|||||.+|||+..|.+.. ...|++.+.+.++.+++.||.|||+ ++||||||||.||++- +++ ..||+|||
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 89999999999999997643 3469999999999999999999997 9999999999999992 333 47999999
Q ss_pred cceeccCCCCceeeccccCccccCccccc-CCCCCcceeEEehHHHHHHHhhCCCCCCCCCc----chHHHHHHHHhcCC
Q 006112 484 LARLYDHGNDLHTTNVVGTVGYLAPELLR-NGRGTTSTDVYAFGVFMLEVACGRRPVQPGEL----DLLDWVIDYWQKGD 558 (660)
Q Consensus 484 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~----~~~~~~~~~~~~~~ 558 (660)
.||-.+.+. ..+..+||..|.+||++. .+.|+..+|.|||||++||.+||..||.+-.. ....|.....+...
T Consensus 170 ~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 170 AARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred ccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 999877654 566789999999999998 48889999999999999999999999976322 22334332222221
Q ss_pred cccCCCCccc------------ccCcHHHHHHHHHHhhhccCCCCCCCC
Q 006112 559 VLDASDPRLE------------GIYVEEQMEIVLKLGLFCSHSNPDTRP 595 (660)
Q Consensus 559 ~~~~~d~~l~------------~~~~~~~~~~l~~l~~~Cl~~dP~~RP 595 (660)
..-..++... -........++-+....++..+|++|.
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 2111221111 112333444555555556777888887
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=302.93 Aligned_cols=259 Identities=29% Similarity=0.340 Sum_probs=197.6
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHhccCCCCceeEeeeeeec--CeeEEEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD--HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK--GELLLVY 412 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV~ 412 (660)
+|+..+.+|+|+||.||+|+...+++.||+|++..... .....+.+|+.++++++|+||+++++++... +..++||
T Consensus 8 ~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (309)
T cd07845 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVM 87 (309)
T ss_pred ceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEE
Confidence 68888999999999999999998999999999865432 2234567899999999999999999998654 5689999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
||+. ++|.+++.... ..+++.++..++.|+++||+|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 88 e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 88 EYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred ecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 9995 58888886543 458999999999999999999998 899999999999999999999999999998765432
Q ss_pred CceeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCcc-hHHHHHHHHhcCCcccCCCC-----
Q 006112 493 DLHTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGELD-LLDWVIDYWQKGDVLDASDP----- 565 (660)
Q Consensus 493 ~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~d~----- 565 (660)
. ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||...... ....+....... .....+
T Consensus 163 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 239 (309)
T cd07845 163 K-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTP--NESIWPGFSDL 239 (309)
T ss_pred C-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC--Chhhchhhhcc
Confidence 1 1223345788999999865 45789999999999999999999999754321 111111111100 000000
Q ss_pred ------ccccc---Cc----HHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 566 ------RLEGI---YV----EEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 566 ------~l~~~---~~----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.+... .. ......+.+++..|++.||++|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000 00 0123456788899999999999999999963
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=306.67 Aligned_cols=265 Identities=25% Similarity=0.306 Sum_probs=205.4
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeeecC-----eeE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKG-----ELL 409 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~~ 409 (660)
+|+..+.+|+|++|.||+|+...+++.||+|++.... ....+.+.+|+.+++.++|+||+++++++.... .++
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 3677889999999999999998889999999986543 445678999999999999999999999988775 789
Q ss_pred EEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceecc
Q 006112 410 LVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYD 489 (660)
Q Consensus 410 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 489 (660)
+||||++ ++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999997 58988886543 68999999999999999999998 899999999999999999999999999998765
Q ss_pred CCCC--ceeeccccCccccCcccccCC-CCCcceeEEehHHHHHHHhhCCCCCCCCCcc-hHHHHHHHHhcCC-------
Q 006112 490 HGND--LHTTNVVGTVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQPGELD-LLDWVIDYWQKGD------- 558 (660)
Q Consensus 490 ~~~~--~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~~------- 558 (660)
.... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...... ....+........
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 5431 123345678899999999877 7899999999999999999999999764321 1111111110000
Q ss_pred ----cccCC---CCcc---cccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH--HhhCC
Q 006112 559 ----VLDAS---DPRL---EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ--YLDGG 607 (660)
Q Consensus 559 ----~~~~~---d~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~ 607 (660)
..+.. .... ...........+.+++.+||+.+|++||+++++++ +|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 00000 0000 00001112345788999999999999999999997 36544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=294.50 Aligned_cols=236 Identities=22% Similarity=0.260 Sum_probs=184.7
Q ss_pred ccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCeeEEEEecCCCCChh
Q 006112 343 KATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVYDYMPNGSLD 421 (660)
Q Consensus 343 ~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~ 421 (660)
++|+|+||.||++....++..+|+|.+........ |+.....+ +||||+++++++..++..++||||+++++|.
T Consensus 23 ~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~ 97 (267)
T PHA03390 23 KLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLF 97 (267)
T ss_pred eecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHH
Confidence 36999999999999998999999999854322111 22222222 6999999999999999999999999999999
Q ss_pred hhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCC-CeEEeecccceeccCCCCceeeccc
Q 006112 422 KILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADL-EGKLGDFGLARLYDHGNDLHTTNVV 500 (660)
Q Consensus 422 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~-~~kl~DFGla~~~~~~~~~~~~~~~ 500 (660)
+++.... .++|.++..++.|+++||.|||+ .+++||||||+||+++.++ .++|+|||+++...... ...
T Consensus 98 ~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-----~~~ 167 (267)
T PHA03390 98 DLLKKEG--KLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS-----CYD 167 (267)
T ss_pred HHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc-----cCC
Confidence 9997654 58999999999999999999998 8999999999999999998 99999999997654322 246
Q ss_pred cCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHH
Q 006112 501 GTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVL 580 (660)
Q Consensus 501 gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 580 (660)
|+..|+|||++.+..++.++||||||+++|||++|+.||........+...-...... .... .......+.
T Consensus 168 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----~~~~----~~~~~~~~~ 238 (267)
T PHA03390 168 GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK-----KLPF----IKNVSKNAN 238 (267)
T ss_pred CCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcc-----cCCc----ccccCHHHH
Confidence 8899999999998889999999999999999999999997543322211110000110 0011 112334577
Q ss_pred HHhhhccCCCCCCCCC-HHHHHH
Q 006112 581 KLGLFCSHSNPDTRPS-MRQVVQ 602 (660)
Q Consensus 581 ~l~~~Cl~~dP~~RPs-~~evl~ 602 (660)
+++..|++.||.+||+ ++|+++
T Consensus 239 ~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 239 DFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHHhccChhhCCchHHHHhc
Confidence 7888899999999995 698885
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=295.16 Aligned_cols=242 Identities=21% Similarity=0.261 Sum_probs=189.2
Q ss_pred ccccCccEEEEEEEeCCCCeEEEEEEeccCCC---hhhHHHHHHH---HHHhccCCCCceeEeeeeeecCeeEEEEecCC
Q 006112 343 KATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD---HGMKQFVSEI---VSMGKLRHRNLVQLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 343 ~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei---~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 416 (660)
.+|+|+||.||++....+++.||+|.+..... .....+..|. +.++...||||+++++++..++..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 37999999999999988899999999865321 2222344443 34445679999999999999999999999999
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCcee
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT 496 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 496 (660)
+|+|..++.... .+++.++..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~ 152 (278)
T cd05606 81 GGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P 152 (278)
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---C
Confidence 999999886543 58999999999999999999998 899999999999999999999999999997553322 1
Q ss_pred eccccCccccCcccccCC-CCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHH
Q 006112 497 TNVVGTVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQ 575 (660)
Q Consensus 497 ~~~~gt~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 575 (660)
....|+..|+|||.+.++ .++.++||||+||++|||++|+.||................. ..+.+....
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------~~~~~~~~~---- 222 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT------MAVELPDSF---- 222 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc------cCCCCCCcC----
Confidence 234689999999998754 588999999999999999999999976432222222211111 112222222
Q ss_pred HHHHHHHhhhccCCCCCCCC-----CHHHHHH
Q 006112 576 MEIVLKLGLFCSHSNPDTRP-----SMRQVVQ 602 (660)
Q Consensus 576 ~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 602 (660)
...+.+++..|+..+|.+|| ++.++++
T Consensus 223 s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 223 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 34567777889999999999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=299.50 Aligned_cols=248 Identities=27% Similarity=0.392 Sum_probs=198.8
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
.|+.++.+|+|+||.||+|+...++..+|+|.+... .....+++.+|+++++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 477888999999999999999888999999998642 23345678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
|+. |+|.+++.... ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 96 YCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred ccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence 996 68877775443 348899999999999999999998 89999999999999999999999999998765432
Q ss_pred ceeeccccCccccCccccc---CCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCccccc
Q 006112 494 LHTTNVVGTVGYLAPELLR---NGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGI 570 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 570 (660)
....|+..|+|||.+. .+.++.++|||||||++|||++|+.||...... +.... ...+.. +...
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~-~~~~~~-----~~~~-- 235 (308)
T cd06634 169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYH-IAQNES-----PALQ-- 235 (308)
T ss_pred ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH--HHHHH-HhhcCC-----CCcC--
Confidence 2346788999999874 356788999999999999999999998653221 11111 111111 1111
Q ss_pred CcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhh
Q 006112 571 YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605 (660)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (660)
.......+.+++.+||+.+|++||++.+++++..
T Consensus 236 -~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 236 -SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred -cccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 1123345778889999999999999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=325.44 Aligned_cols=254 Identities=25% Similarity=0.438 Sum_probs=209.9
Q ss_pred ecccccccCccEEEEEEEeCC-------CCeEEEEEEeccCC-ChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCeeE
Q 006112 339 KNLYKATKGGSGKVYRGVLPS-------SHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELL 409 (660)
Q Consensus 339 ~~l~~lg~G~fg~Vy~g~~~~-------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~ 409 (660)
+..+.+|+|.||.|++|.... ....||||.++... ....+.+..|+++|+.+ +|+||+.++|+|..++.++
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~ 378 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY 378 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence 444589999999999998631 25689999987553 35678899999999999 5999999999999999999
Q ss_pred EEEecCCCCChhhhhhhCC------C--------CCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCC
Q 006112 410 LVYDYMPNGSLDKILYSNT------R--------PSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADL 475 (660)
Q Consensus 410 lV~E~~~~gsL~~~l~~~~------~--------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~ 475 (660)
+|+||+..|+|.++|+... . ..+...+.+.++.|||.|++||++ .++|||||..+|||+.++.
T Consensus 379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi~~~~ 455 (609)
T KOG0200|consen 379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLITKNK 455 (609)
T ss_pred EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEecCCC
Confidence 9999999999999998665 0 138888999999999999999998 8999999999999999999
Q ss_pred CeEEeecccceeccCCCCceeecccc--CccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHH
Q 006112 476 EGKLGDFGLARLYDHGNDLHTTNVVG--TVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVID 552 (660)
Q Consensus 476 ~~kl~DFGla~~~~~~~~~~~~~~~g--t~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~ 552 (660)
.+||+|||+||...+..........| ...|||||.+....++.|+|||||||+||||++ |..||.+ ......+.+
T Consensus 456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~--~~~~~~l~~ 533 (609)
T KOG0200|consen 456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG--IPPTEELLE 533 (609)
T ss_pred EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC--CCcHHHHHH
Confidence 99999999999765554444333333 456999999999999999999999999999998 7778764 221233355
Q ss_pred HHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 553 YWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 553 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
..+.|..++... .+...+..+|+.||+.+|++||++.|+.+.|+.
T Consensus 534 ~l~~G~r~~~P~---------~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 534 FLKEGNRMEQPE---------HCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred HHhcCCCCCCCC---------CCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 667776654433 234557799999999999999999999999987
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=291.40 Aligned_cols=256 Identities=24% Similarity=0.289 Sum_probs=200.1
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCeeEEEEe
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD-HGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
-.++++..+|.|+||+|+|..++..|+.+|||+++.... ..+++++.|.+...+- +.||||+++|.+..++..++.||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 356778889999999999999999999999999987654 5678899998765554 79999999999999999999999
Q ss_pred cCCCCChhhhh---hhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccC
Q 006112 414 YMPNGSLDKIL---YSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDH 490 (660)
Q Consensus 414 ~~~~gsL~~~l---~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 490 (660)
.| .-||+.+- +.-....+++...-+|......||.||.+ +..|||||+||+|||||..|.+||+|||.+-.+..
T Consensus 144 LM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 144 LM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 99 67887654 33344568888888999999999999998 48999999999999999999999999999865533
Q ss_pred CCCceeeccccCccccCcccccC--CCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCccc
Q 006112 491 GNDLHTTNVVGTVGYLAPELLRN--GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLE 568 (660)
Q Consensus 491 ~~~~~~~~~~gt~~Y~aPE~~~~--~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 568 (660)
+...+.-+|...|||||.+.. ..|..+|||||+|++|+|+.||+.|+..-+. ..+.+. ....|+......+.
T Consensus 221 --SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-vfeql~-~Vv~gdpp~l~~~~-- 294 (361)
T KOG1006|consen 221 --SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-VFEQLC-QVVIGDPPILLFDK-- 294 (361)
T ss_pred --HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-HHHHHH-HHHcCCCCeecCcc--
Confidence 233455678999999999864 3488899999999999999999999975322 222222 12223221111110
Q ss_pred ccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 569 GIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
-..+....+...+..|+..|-++||...++.+
T Consensus 295 --~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 295 --ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred --cccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 01122345667777799999999999999875
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=299.04 Aligned_cols=245 Identities=26% Similarity=0.411 Sum_probs=195.8
Q ss_pred eecccccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
|..++++|+|+||.||+|+...+++.|++|++.... ....+.+.+|++++++++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 556678999999999999998889999999986432 23446788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
+. |+|.+++.... ..+++.++..++.|++.+|.|||+ .+++|+||||+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 103 CL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 95 67877775443 358999999999999999999998 8999999999999999999999999999864321
Q ss_pred eeeccccCccccCccccc---CCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccC
Q 006112 495 HTTNVVGTVGYLAPELLR---NGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIY 571 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 571 (660)
.....|+..|+|||++. .+.++.++|||||||++|||++|..||...+.. ......... .. +...
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~~-~~-----~~~~--- 241 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIAQN-DS-----PTLQ--- 241 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHhc-CC-----CCCC---
Confidence 22356889999999974 456788999999999999999999998754321 111111111 11 1111
Q ss_pred cHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 572 VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.......+.+++.+||+.+|.+||++.+++++
T Consensus 242 ~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11122347788889999999999999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=297.03 Aligned_cols=254 Identities=22% Similarity=0.266 Sum_probs=200.5
Q ss_pred eecccccccCccEEEEEEEeC---CCCeEEEEEEeccCC----ChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCeeE
Q 006112 338 YKNLYKATKGGSGKVYRGVLP---SSHAEIAVKKVCHDS----DHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELL 409 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~---~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~ 409 (660)
|+..+.+|+|++|.||+++.. .+++.||||.+.... ....+.+.+|++++.++ +||||+++++.+..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 677888999999999999864 356889999986432 23456788999999999 5999999999999999999
Q ss_pred EEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceecc
Q 006112 410 LVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYD 489 (660)
Q Consensus 410 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 489 (660)
+||||+++|+|.+++.... .+++..+..++.|++++|.|||+ .+++||||||+||+++.++.+||+|||+++...
T Consensus 82 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 82 LILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 9999999999999986543 48889999999999999999998 999999999999999999999999999998654
Q ss_pred CCCCceeeccccCccccCcccccCCC--CCcceeEEehHHHHHHHhhCCCCCCCCCcc-hHHHHHHHHhcCCcccCCCCc
Q 006112 490 HGNDLHTTNVVGTVGYLAPELLRNGR--GTTSTDVYAFGVFMLEVACGRRPVQPGELD-LLDWVIDYWQKGDVLDASDPR 566 (660)
Q Consensus 490 ~~~~~~~~~~~gt~~Y~aPE~~~~~~--~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~d~~ 566 (660)
...........|+..|+|||.+.+.. .+.++||||||+++|||++|..||...... ......+..... .+.
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~------~~~ 230 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS------KPP 230 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc------CCC
Confidence 43332233456899999999987655 688999999999999999999998642211 111111111111 111
Q ss_pred ccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 567 LEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 567 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
....+ ...+.+++.+||+.||++|||+.++.+.|+.
T Consensus 231 ~~~~~----~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 231 FPKTM----SAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred CCccc----CHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 11222 2346778888999999999999999888765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=306.22 Aligned_cols=250 Identities=24% Similarity=0.342 Sum_probs=206.0
Q ss_pred CCceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEE
Q 006112 333 PHRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLL 410 (660)
Q Consensus 333 ~~~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 410 (660)
.+-..|..++.||+|.|+.|..+++..++..||+|.+.+.. ....+.+.+|+++|..+.|||||+++.+......+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 45567999999999999999999999999999999997653 2344568999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccC
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDH 490 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 490 (660)
||||+.+|.+.+++..+++ +....+..++.|+.++++|||+ +.|||||||++||||+.++++||+|||++..+..
T Consensus 133 V~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeecc
Confidence 9999999999999988775 5668888999999999999998 9999999999999999999999999999988764
Q ss_pred CCCceeeccccCccccCcccccCCCC-CcceeEEehHHHHHHHhhCCCCCCCCCcchH-HHHHHHHhcCCcccCCCCccc
Q 006112 491 GNDLHTTNVVGTVGYLAPELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPGELDLL-DWVIDYWQKGDVLDASDPRLE 568 (660)
Q Consensus 491 ~~~~~~~~~~gt~~Y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~d~~l~ 568 (660)
+ ......+|++.|.|||++.+..+ .+++|+||+|++||-|++|..||++...... +.+. .|+ -++.
T Consensus 208 ~--~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl----~gk------~rIp 275 (596)
T KOG0586|consen 208 G--LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVL----RGK------YRIP 275 (596)
T ss_pred c--ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhe----eee------eccc
Confidence 3 33456899999999999988766 6799999999999999999999986443211 1111 000 0111
Q ss_pred ccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 569 GIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
-....+ +.+++...+-++|.+|++++++++.
T Consensus 276 ~~ms~d----ce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 276 FYMSCD----CEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ceeech----hHHHHHHhhccCccccCCHHHhhhh
Confidence 111122 3345555789999999999999864
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=296.58 Aligned_cols=251 Identities=22% Similarity=0.279 Sum_probs=196.9
Q ss_pred eeecccccccCccEEEEEEEeC---CCCeEEEEEEeccCC----ChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCee
Q 006112 337 SYKNLYKATKGGSGKVYRGVLP---SSHAEIAVKKVCHDS----DHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGEL 408 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~---~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 408 (660)
.|+..+.+|+|+||.||+++.. .++..||+|++.... ....+.+.+|++++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 3677889999999999999874 367899999986532 23346788999999999 599999999999999999
Q ss_pred EEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceec
Q 006112 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLY 488 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 488 (660)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 99999999999999997643 48888999999999999999998 99999999999999999999999999999876
Q ss_pred cCCCCceeeccccCccccCcccccCC--CCCcceeEEehHHHHHHHhhCCCCCCCCCcc-hHHHHHHHHhcCCcccCCCC
Q 006112 489 DHGNDLHTTNVVGTVGYLAPELLRNG--RGTTSTDVYAFGVFMLEVACGRRPVQPGELD-LLDWVIDYWQKGDVLDASDP 565 (660)
Q Consensus 489 ~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~d~ 565 (660)
............|+..|+|||.+... .++.++||||||+++|||++|+.||...... ............ .+
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~------~~ 229 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS------EP 229 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc------CC
Confidence 44332333345689999999998753 4678999999999999999999998642211 111111111111 11
Q ss_pred cccccCcHHHHHHHHHHhhhccCCCCCCCC-----CHHHHHH
Q 006112 566 RLEGIYVEEQMEIVLKLGLFCSHSNPDTRP-----SMRQVVQ 602 (660)
Q Consensus 566 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 602 (660)
... ......+.+++..|++.||++|| +.+++++
T Consensus 230 ~~~----~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 230 PYP----QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred CCC----ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 111 12234567888899999999997 6666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=296.90 Aligned_cols=248 Identities=24% Similarity=0.317 Sum_probs=202.9
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccC-CCCceeEeeeeeecCeeEEEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLR-HRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~ 412 (660)
+|...+.+|+|++|.||+++...+++.||+|.+... .....+.+.+|++++++++ |+||+++++++..++..++||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 477888999999999999999889999999998653 2334567889999999998 999999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
||+++++|.+++.... .+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 82 EYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 9999999999997654 59999999999999999999998 899999999999999999999999999997654322
Q ss_pred C-------------------ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHH
Q 006112 493 D-------------------LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDY 553 (660)
Q Consensus 493 ~-------------------~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~ 553 (660)
. .......|+..|++||.+....++.++||||||++++|+++|+.||....... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~- 233 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL--TFQK- 233 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH--HHHH-
Confidence 1 12223467899999999988889999999999999999999999997543211 1111
Q ss_pred HhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCH----HHHHH
Q 006112 554 WQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSM----RQVVQ 602 (660)
Q Consensus 554 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~----~evl~ 602 (660)
.... .. .+.......+.+++..||+.||.+||++ +++++
T Consensus 234 ~~~~------~~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 234 ILKL------EY----SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHhc------CC----CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 1111 01 1111224557788889999999999999 77765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=299.99 Aligned_cols=262 Identities=29% Similarity=0.313 Sum_probs=196.0
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHhccCCCCceeEeeeeeec--------
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD--HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK-------- 405 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-------- 405 (660)
-+|+.++.+|+|+||.||+|++..+++.+|+|++..... .....+.+|++++++++||||+++++++.+.
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 87 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR 87 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence 378889999999999999999988899999999864422 2235678999999999999999999987443
Q ss_pred CeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccc
Q 006112 406 GELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLA 485 (660)
Q Consensus 406 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla 485 (660)
..+++|+||+. ++|...+.... ..+++.++..++.|+++||+|||+ ++|+||||||+||++++++.+||+|||++
T Consensus 88 ~~~~lv~~~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 88 GSVYMVTPYMD-HDLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred ceEEEEEecCC-cCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 34799999995 57777765432 359999999999999999999998 89999999999999999999999999999
Q ss_pred eeccCCCCc----------eeeccccCccccCcccccCC-CCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHHHHH
Q 006112 486 RLYDHGNDL----------HTTNVVGTVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVIDY 553 (660)
Q Consensus 486 ~~~~~~~~~----------~~~~~~gt~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~ 553 (660)
+........ ..+...|++.|+|||.+.+. .++.++|||||||++|||++|+.||..... .....+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~ 242 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 765432211 11234678899999987654 578999999999999999999999875332 112222211
Q ss_pred HhcCC---------cccC--------CCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 554 WQKGD---------VLDA--------SDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 554 ~~~~~---------~~~~--------~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
..... .... ..+.+...+ ......+.+++.+|++.||.+|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 11000 0000 001110000 1112457789999999999999999998853
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=304.19 Aligned_cols=260 Identities=24% Similarity=0.260 Sum_probs=197.2
Q ss_pred eeecc-cccccCccEEEEEEEeCCCCeEEEEEEeccCCChh--------------hHHHHHHHHHHhccCCCCceeEeee
Q 006112 337 SYKNL-YKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHG--------------MKQFVSEIVSMGKLRHRNLVQLRGY 401 (660)
Q Consensus 337 ~~~~l-~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~--------------~~~~~~Ei~~l~~l~H~nIv~l~g~ 401 (660)
.|..+ +.+|+|+||.||+|.+..+++.||||++....... ...+.+|++++++++|+||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 35443 56999999999999998889999999986432211 1257899999999999999999999
Q ss_pred eeecCeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEee
Q 006112 402 CRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGD 481 (660)
Q Consensus 402 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~D 481 (660)
+..++..++||||+. |+|.+++.... .+++.....++.|++.||+|||+ .+|+||||||+||+++.++.+||+|
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~d 162 (335)
T PTZ00024 89 YVEGDFINLVMDIMA-SDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIAD 162 (335)
T ss_pred EecCCcEEEEEeccc-cCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECC
Confidence 999999999999996 79999886543 48889999999999999999998 9999999999999999999999999
Q ss_pred cccceeccCCC-------------CceeeccccCccccCcccccCC-CCCcceeEEehHHHHHHHhhCCCCCCCCCc-ch
Q 006112 482 FGLARLYDHGN-------------DLHTTNVVGTVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DL 546 (660)
Q Consensus 482 FGla~~~~~~~-------------~~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~ 546 (660)
||+++...... ........++..|+|||.+.+. .++.++|||||||++|||++|+.||...+. ..
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~ 242 (335)
T PTZ00024 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ 242 (335)
T ss_pred ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99998664111 1111223568899999998764 468899999999999999999999975432 22
Q ss_pred HHHHHHHHhcCCcc---c--------CC----CCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 547 LDWVIDYWQKGDVL---D--------AS----DPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 547 ~~~~~~~~~~~~~~---~--------~~----d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
...+.......... . .. .+.+.. ........+.+++..|++.+|++||+++|++.+
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 243 LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 22222222111100 0 00 000000 011123457788999999999999999999963
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=295.15 Aligned_cols=260 Identities=27% Similarity=0.331 Sum_probs=201.7
Q ss_pred eecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
|+..+.+|+|++|.||+|+...+++.+|+|.+.... ....+.+..|+.++++++|+|++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456678999999999999999889999999987653 334567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 495 (660)
+ ++|.+++.... ..+++.++.+++.|++.||+|||+ .+|+||||+|+||++++++.+||+|||+++....... .
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-T 154 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-c
Confidence 7 69999997653 358999999999999999999998 8999999999999999999999999999986544322 1
Q ss_pred eeccccCccccCcccccCC-CCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHHHHHHhcC---------Cc--ccC
Q 006112 496 TTNVVGTVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVIDYWQKG---------DV--LDA 562 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~~~~~---------~~--~~~ 562 (660)
.....++..|+|||.+.+. .++.++|||||||++|||++|+.||..... .....+....... .. .+.
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 2234567889999998766 789999999999999999999999875432 1111111111000 00 000
Q ss_pred CCCccccc----CcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 563 SDPRLEGI----YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 563 ~d~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.-+..... ..+.....+.+++..||..||++||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00111000 011124568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=296.32 Aligned_cols=254 Identities=22% Similarity=0.315 Sum_probs=210.0
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
-|..-+.||+|-|..|-++++.-+|+.||||++.+.. .-...++.+|+..|+-++|||||+|+.+......+|||+|+
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 4666778999999999999999999999999997653 33456789999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEE-cCCCCeEEeecccceeccCCCC
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLL-DADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll-~~~~~~kl~DFGla~~~~~~~~ 493 (660)
=.+|+|.+||-++.. .+.+....+++.||..|+.|+|+ ..+|||||||+||.+ .+-|-+||.|||++..+..++.
T Consensus 99 GD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k 174 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK 174 (864)
T ss_pred cCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence 999999999987653 58999999999999999999998 899999999999977 4557899999999988776654
Q ss_pred ceeeccccCccccCcccccCCCCC-cceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCc
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGT-TSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t-~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
.+..+|...|-|||++.+..|. ++.||||+||+||.|+||+.||+..+.... +...+|... ..+
T Consensus 175 --L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET-----------LTmImDCKY--tvP 239 (864)
T KOG4717|consen 175 --LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET-----------LTMIMDCKY--TVP 239 (864)
T ss_pred --hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh-----------hhhhhcccc--cCc
Confidence 3457999999999999987774 689999999999999999999986432211 111122211 122
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCCHHHHHH--HhhCCCC
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ--YLDGGAL 609 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~~ 609 (660)
........+|+..|+..||++|-+.+||+. +|+...+
T Consensus 240 shvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 240 SHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred hhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence 334455677888899999999999999985 6665543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=326.49 Aligned_cols=251 Identities=27% Similarity=0.433 Sum_probs=195.5
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC-CChhhHHHHHHHHHHhccCCCCceeEeeee-------------
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD-SDHGMKQFVSEIVSMGKLRHRNLVQLRGYC------------- 402 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~------------- 402 (660)
.+++++.||+||||.|||++.+-+|+.+|||++... +........+|+..+++|+|||||+++...
T Consensus 480 DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~ 559 (1351)
T KOG1035|consen 480 DFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIV 559 (1351)
T ss_pred hhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccccc
Confidence 578999999999999999999999999999999655 344567789999999999999999998311
Q ss_pred ------------------------------------------------------e-----------e-------------
Q 006112 403 ------------------------------------------------------R-----------R------------- 404 (660)
Q Consensus 403 ------------------------------------------------------~-----------~------------- 404 (660)
. +
T Consensus 560 ~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~ 639 (1351)
T KOG1035|consen 560 ASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGS 639 (1351)
T ss_pred ccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCc
Confidence 0 0
Q ss_pred --------------------c--------CeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhccc
Q 006112 405 --------------------K--------GELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWE 456 (660)
Q Consensus 405 --------------------~--------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 456 (660)
+ ..+||=||||+...|++++.++.... .-...++++++|+.||.|+|+
T Consensus 640 ~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH~--- 715 (1351)
T KOG1035|consen 640 VILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIHD--- 715 (1351)
T ss_pred cccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHHh---
Confidence 0 12578899999999999887765321 356788999999999999998
Q ss_pred CceeccCccCCcEEEcCCCCeEEeecccceecc----------------CC-CCceeeccccCccccCcccccCC---CC
Q 006112 457 QVVLHRDIKPANVLLDADLEGKLGDFGLARLYD----------------HG-NDLHTTNVVGTVGYLAPELLRNG---RG 516 (660)
Q Consensus 457 ~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~----------------~~-~~~~~~~~~gt~~Y~aPE~~~~~---~~ 516 (660)
++||||||||.||+||++.++||+|||+|.... .+ .....+..+||.-|+|||++.+. +|
T Consensus 716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y 795 (1351)
T KOG1035|consen 716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY 795 (1351)
T ss_pred CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence 999999999999999999999999999997621 00 11234667899999999998754 49
Q ss_pred CcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCC
Q 006112 517 TTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPS 596 (660)
Q Consensus 517 t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 596 (660)
+.|+|+||+|||++||+ .||.... + ...+....+.|.+... ..+...++..=.+++.++++.||++|||
T Consensus 796 n~KiDmYSLGIVlFEM~---yPF~TsM-E-Ra~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kRPt 864 (1351)
T KOG1035|consen 796 NSKIDMYSLGIVLFEML---YPFGTSM-E-RASILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSKRPT 864 (1351)
T ss_pred cchhhhHHHHHHHHHHh---ccCCchH-H-HHHHHHhcccCCCCCC------cccccccchHHHHHHHHHhcCCCccCCC
Confidence 99999999999999998 4666432 1 1223344444444322 2233344444567888999999999999
Q ss_pred HHHHHH
Q 006112 597 MRQVVQ 602 (660)
Q Consensus 597 ~~evl~ 602 (660)
+.|+++
T Consensus 865 A~eLL~ 870 (1351)
T KOG1035|consen 865 ATELLN 870 (1351)
T ss_pred HHHHhh
Confidence 999874
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=304.14 Aligned_cols=258 Identities=26% Similarity=0.328 Sum_probs=195.4
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeec----------
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK---------- 405 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~---------- 405 (660)
-.|+..+.||+|+||.||+|+...+++.||+|++........+.+.+|++++++++||||+++++.+...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 3688899999999999999999999999999999776666678899999999999999999999876543
Q ss_pred ----CeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcC-CCCeEEe
Q 006112 406 ----GELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDA-DLEGKLG 480 (660)
Q Consensus 406 ----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~-~~~~kl~ 480 (660)
...++||||++ ++|.+++... .+++..+..++.||++||.|||+ .+|+||||||+||+++. ++.+||+
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEEC
Confidence 35789999996 6898887542 48899999999999999999998 89999999999999974 5578999
Q ss_pred ecccceeccCCCCc--eeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcC
Q 006112 481 DFGLARLYDHGNDL--HTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKG 557 (660)
Q Consensus 481 DFGla~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~ 557 (660)
|||+++........ ......++..|+|||.+.. ..++.++|||||||++|||++|+.||...... +.........
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~--~~~~~~~~~~ 235 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL--EQMQLILESV 235 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhc
Confidence 99999865432211 1123467889999998754 45788999999999999999999999753321 1111110000
Q ss_pred Cc---------cc---------CCCCcc-cccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 558 DV---------LD---------ASDPRL-EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 558 ~~---------~~---------~~d~~l-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
.. .. ...++. .....+.....+.+++..|++.||++||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00 00 000000 00001112345778899999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=334.06 Aligned_cols=253 Identities=28% Similarity=0.409 Sum_probs=204.6
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEE
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
.|.+..-..+|.|.||.||-|...++|+-.|+|.+.-. .....+.+.+|++++..++|||+|+++|+-.++++++|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 35666677899999999999999999999999987543 3445678899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
|||++|+|.+.+.... -+++.....+..|++.|++|||+ .+||||||||.||+|+.+|.+|++|||.|.......
T Consensus 1314 EyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 9999999999997543 36667777889999999999998 999999999999999999999999999998775543
Q ss_pred C---ceeeccccCccccCcccccCCC---CCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHh-cCCcccCCCC
Q 006112 493 D---LHTTNVVGTVGYLAPELLRNGR---GTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQ-KGDVLDASDP 565 (660)
Q Consensus 493 ~---~~~~~~~gt~~Y~aPE~~~~~~---~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~-~~~~~~~~d~ 565 (660)
. .......||+.|||||.+.+.. ...+.||||+|||++||+||++||..-+. +|.+.+.. .|. -|
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn---e~aIMy~V~~gh-----~P 1460 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN---EWAIMYHVAAGH-----KP 1460 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc---hhHHHhHHhccC-----CC
Confidence 1 1224578999999999987533 45689999999999999999999975332 34443322 222 23
Q ss_pred cccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHh
Q 006112 566 RLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYL 604 (660)
Q Consensus 566 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (660)
.++.. ....-.+++..|++.||++|.++.|++++=
T Consensus 1461 q~P~~----ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1461 QIPER----LSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred CCchh----hhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 33222 233345667789999999999999988764
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=288.74 Aligned_cols=250 Identities=24% Similarity=0.355 Sum_probs=197.6
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC-----CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD-----SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 411 (660)
+|...+.+|+|+||.||++++...+..+++|.+... ......++..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 367778999999999999999776666666665432 223344677899999999999999999999999999999
Q ss_pred EecCCCCChhhhhhh--CCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceecc
Q 006112 412 YDYMPNGSLDKILYS--NTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYD 489 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 489 (660)
|||+++++|..++.. .....+++.++..++.|++.||.|||+ .+++|+||||+||+++. +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998864 233468999999999999999999998 99999999999999975 469999999998764
Q ss_pred CCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccc
Q 006112 490 HGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEG 569 (660)
Q Consensus 490 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 569 (660)
.... ......|++.|+|||.+....++.++|+||||+++|+|++|+.||..... ....... ..+ ..+..
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~~~~~-~~~-----~~~~~-- 225 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF--LSVVLRI-VEG-----PTPSL-- 225 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH--HHHHHHH-HcC-----CCCCC--
Confidence 3322 22235688999999999888889999999999999999999999964322 2222211 111 11111
Q ss_pred cCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 570 IYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.......+.+++.+||+.||++||++.|++++
T Consensus 226 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 226 --PETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred --cchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 22334567788999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=301.21 Aligned_cols=260 Identities=24% Similarity=0.324 Sum_probs=195.6
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeec------Cee
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK------GEL 408 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~ 408 (660)
.|.....+|+|+||.||+|+...+++.||||++... .......+.+|+.++++++||||+++++++... ...
T Consensus 16 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 95 (342)
T cd07879 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDF 95 (342)
T ss_pred ceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceE
Confidence 577889999999999999999888999999998643 223345788999999999999999999988654 346
Q ss_pred EEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceec
Q 006112 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLY 488 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 488 (660)
++|+||+. .+|..++. ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++..
T Consensus 96 ~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 96 YLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred EEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 99999995 47776652 248899999999999999999998 89999999999999999999999999999764
Q ss_pred cCCCCceeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHHHHHHh-----------
Q 006112 489 DHGNDLHTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVIDYWQ----------- 555 (660)
Q Consensus 489 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~~~----------- 555 (660)
... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... .....++....
T Consensus 168 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07879 168 DAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE 243 (342)
T ss_pred CCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc
Confidence 322 223467889999999876 4688999999999999999999999986432 11111111000
Q ss_pred cCCcccC--CCCccc-ccC---cHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH--hhCCC
Q 006112 556 KGDVLDA--SDPRLE-GIY---VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY--LDGGA 608 (660)
Q Consensus 556 ~~~~~~~--~d~~l~-~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~~ 608 (660)
....... ..+... ... .+.....+.+++..||+.||++||+++|++++ ++...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 0000000 000000 000 01123457789999999999999999999954 66543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=299.12 Aligned_cols=258 Identities=23% Similarity=0.327 Sum_probs=197.7
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeecC------ee
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKG------EL 408 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------~~ 408 (660)
.|+.++.+|+|+||.||++....++..||||++... .....+.+.+|+.++++++||||+++++++..+. ..
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07880 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDF 95 (343)
T ss_pred ceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceE
Confidence 588899999999999999999889999999998543 2234567889999999999999999999887553 45
Q ss_pred EEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceec
Q 006112 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLY 488 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 488 (660)
++||||+ +++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 96 ~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 96 YLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred EEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 8999999 7899988764 248899999999999999999998 89999999999999999999999999999865
Q ss_pred cCCCCceeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcC-Cc-------
Q 006112 489 DHGNDLHTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKG-DV------- 559 (660)
Q Consensus 489 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~-~~------- 559 (660)
... .....+++.|+|||.+.+ ..++.++|+||||+++|++++|+.||...... .......... ..
T Consensus 169 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07880 169 DSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL--DQLMEIMKVTGTPSKEFVQK 242 (343)
T ss_pred ccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCCHHHHHh
Confidence 432 223467889999999875 45789999999999999999999999754321 1111111100 00
Q ss_pred ------cc--CCCCccc----ccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH--HhhCC
Q 006112 560 ------LD--ASDPRLE----GIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ--YLDGG 607 (660)
Q Consensus 560 ------~~--~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~ 607 (660)
.. ...+... ..........+.+++.+|++.||++|||+.++++ +++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 00 0000000 0001122335778899999999999999999994 45443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=284.18 Aligned_cols=237 Identities=25% Similarity=0.300 Sum_probs=195.0
Q ss_pred cccCccEEEEEEEeCCCCeEEEEEEeccCCC---hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCCCCCh
Q 006112 344 ATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD---HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSL 420 (660)
Q Consensus 344 lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 420 (660)
+|+|+||.||++....+++.+|+|.+..... .....+..|++++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 5899999999999988899999999865432 2466889999999999999999999999999999999999999999
Q ss_pred hhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCceeeccc
Q 006112 421 DKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVV 500 (660)
Q Consensus 421 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 500 (660)
.+++.... .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++....... .......
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~ 154 (250)
T cd05123 81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC 154 (250)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCc
Confidence 99997654 48999999999999999999998 999999999999999999999999999998754432 1233456
Q ss_pred cCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHH
Q 006112 501 GTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVL 580 (660)
Q Consensus 501 gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 580 (660)
++..|++||...+...+.++|+||||+++||+++|+.||...+.. +.... ...+. ..+... ....+.
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~~~-~~~~~------~~~~~~----~~~~l~ 221 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK--EIYEK-ILKDP------LRFPEF----LSPEAR 221 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HHHHH-HhcCC------CCCCCC----CCHHHH
Confidence 889999999998888899999999999999999999999754431 11111 11111 111111 134567
Q ss_pred HHhhhccCCCCCCCCCHHH
Q 006112 581 KLGLFCSHSNPDTRPSMRQ 599 (660)
Q Consensus 581 ~l~~~Cl~~dP~~RPs~~e 599 (660)
+++..|+..||++||++.+
T Consensus 222 ~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 222 DLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHhcCCHhhCCCccc
Confidence 8888999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=296.21 Aligned_cols=256 Identities=22% Similarity=0.277 Sum_probs=196.0
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeee-cCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR-KGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~lV~E 413 (660)
.|+.++.+|+|+||.||++....+++.||+|++... .....+.+.+|++++++++||||+++++++.. ....++|+|
T Consensus 11 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e 90 (328)
T cd07856 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTE 90 (328)
T ss_pred ceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEee
Confidence 588899999999999999999989999999988543 23345678899999999999999999998865 457899999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
|+ +++|.+++... .+++.....++.|+++||+|||+ .+|+||||||+||++++++.+||+|||+++.....
T Consensus 91 ~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-- 161 (328)
T cd07856 91 LL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ-- 161 (328)
T ss_pred hh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccCCC--
Confidence 99 67898888643 37788888999999999999998 89999999999999999999999999999754321
Q ss_pred ceeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCcchH-HHHHHHHh-----------cCCcc
Q 006112 494 LHTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLL-DWVIDYWQ-----------KGDVL 560 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~-~~~~~~~~-----------~~~~~ 560 (660)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.... ....+... .+...
T Consensus 162 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd07856 162 --MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL 239 (328)
T ss_pred --cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence 223467889999998766 5688999999999999999999999975432111 10111000 00000
Q ss_pred cCC-CCcccccCc-----HHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 561 DAS-DPRLEGIYV-----EEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 561 ~~~-d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
+.. .-....... +.....+.+++.+|++.+|++||++.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 000000000 1123568888999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=257.37 Aligned_cols=261 Identities=27% Similarity=0.338 Sum_probs=198.5
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD--HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
.|+.+++||+|.+|+||+|+..++++.||+|+++.++. ......++||-+++.++|+|||++++....++.+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 46778899999999999999999999999999976533 2356789999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
| ..+|.++..... ..++.+....++.|+++||.|+|+ +.+.|||+||.|.||+.+|+.|++|||++|.++-.-..
T Consensus 83 c-dqdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipvrc 157 (292)
T KOG0662|consen 83 C-DQDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC 157 (292)
T ss_pred h-hHHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence 9 678888876543 358888899999999999999998 99999999999999999999999999999987654322
Q ss_pred eeeccccCccccCcccccCCC-CCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcc------
Q 006112 495 HTTNVVGTVGYLAPELLRNGR-GTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL------ 567 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~-~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l------ 567 (660)
....+-|..|.+|.++.+.+ |+...|+||.||++.|+....+|..++....-+...-++.-|...+..-|.+
T Consensus 158 -ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy 236 (292)
T KOG0662|consen 158 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY 236 (292)
T ss_pred -eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence 23345699999999988754 7899999999999999998666655543322222222223333322222211
Q ss_pred --cccCc---------HHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 568 --EGIYV---------EEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 568 --~~~~~---------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
-..+. +..-..-.++....+.-+|.+|.++++.+++
T Consensus 237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 11111 1111112233333455599999999998864
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=297.42 Aligned_cols=258 Identities=25% Similarity=0.331 Sum_probs=193.7
Q ss_pred eecccccccCccEEEEEEEeCCC--CeEEEEEEeccC--CChhhHHHHHHHHHHhcc-CCCCceeEeeeeeec----Cee
Q 006112 338 YKNLYKATKGGSGKVYRGVLPSS--HAEIAVKKVCHD--SDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRK----GEL 408 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~~~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~----~~~ 408 (660)
|+..+.+|+|+||.||++..... +..||+|++... .....+.+.+|+.+++++ +||||+++++.+... ...
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 67778899999999999999877 889999998643 223356788999999999 599999999975432 457
Q ss_pred EEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceec
Q 006112 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLY 488 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 488 (660)
++++||+. ++|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 82 YLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 88999985 7899988654 358999999999999999999998 89999999999999999999999999999865
Q ss_pred cCCCC---ceeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHHHHHHh--------
Q 006112 489 DHGND---LHTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVIDYWQ-------- 555 (660)
Q Consensus 489 ~~~~~---~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~~~-------- 555 (660)
..... .......||..|+|||.+.+ ..++.++||||+||++|+|++|+.||...+. .....+.....
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 43221 11234578999999998765 4678999999999999999999999875331 11111111100
Q ss_pred ---cCCc------c-cCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 556 ---KGDV------L-DASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 556 ---~~~~------~-~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
.... . ......+.. ........+.+++.+|++.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 236 RIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000 0 000000000 01112346778999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=300.85 Aligned_cols=256 Identities=23% Similarity=0.319 Sum_probs=197.1
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCe------e
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGE------L 408 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~------~ 408 (660)
+|+.+..+|+|++|.||+|++..+++.||+|++... .....+.+.+|+.++++++|+||+++++++...+. .
T Consensus 16 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07851 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDV 95 (343)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccE
Confidence 588899999999999999999888999999998643 23345678899999999999999999998766554 8
Q ss_pred EEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceec
Q 006112 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLY 488 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 488 (660)
++|+||+ +++|.+++.. ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 96 ~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 96 YLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred EEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 9999999 7799998864 348999999999999999999998 89999999999999999999999999999865
Q ss_pred cCCCCceeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCcc-hHHHHHHHHhcCC--------
Q 006112 489 DHGNDLHTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGELD-LLDWVIDYWQKGD-------- 558 (660)
Q Consensus 489 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~~-------- 558 (660)
... .....++..|+|||.+.+ ..++.++|||||||++||+++|+.||...... ....+........
T Consensus 169 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 169 DDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred ccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence 432 233467889999999865 36788999999999999999999999754321 1111111100000
Q ss_pred ------cccCCCCcccccCc---HHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 559 ------VLDASDPRLEGIYV---EEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 559 ------~~~~~d~~l~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
............+. ......+.+++.+|++.||++|||+.||+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00000000000000 1124568889999999999999999999863
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=296.96 Aligned_cols=256 Identities=25% Similarity=0.324 Sum_probs=194.0
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeeec------Cee
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK------GEL 408 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~ 408 (660)
.|+.++.+|+|+||.||+|....+++.||+|++.... ....+.+.+|+.++++++||||+++++++... ...
T Consensus 18 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 97 (345)
T cd07877 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 97 (345)
T ss_pred ceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccE
Confidence 5788899999999999999998889999999986532 23356788999999999999999999987543 346
Q ss_pred EEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceec
Q 006112 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLY 488 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 488 (660)
++++|++ +++|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++..
T Consensus 98 ~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 98 YLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred EEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 8888887 88998887543 48999999999999999999998 89999999999999999999999999999764
Q ss_pred cCCCCceeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHHHHHHhcC--CcccCCC
Q 006112 489 DHGNDLHTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVIDYWQKG--DVLDASD 564 (660)
Q Consensus 489 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~~~~~--~~~~~~d 564 (660)
... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... .....+....... .......
T Consensus 171 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T cd07877 171 DDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 246 (345)
T ss_pred ccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence 322 234567899999998866 5678899999999999999999999864322 1111111110000 0000000
Q ss_pred -----------Ccccc-cC---cHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 565 -----------PRLEG-IY---VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 565 -----------~~l~~-~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
+.... .+ .......+.+++..|++.||.+||++.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00000 00 00123356788999999999999999999863
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=279.83 Aligned_cols=247 Identities=24% Similarity=0.286 Sum_probs=201.3
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
.+.-|+.+|+|.||+|-+++.+.+++.+|+|+++++. +.....-+.|-.+|+..+||.+..+.-.++..+.+|+|||
T Consensus 169 dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMe 248 (516)
T KOG0690|consen 169 DFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVME 248 (516)
T ss_pred hhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEE
Confidence 4667899999999999999999999999999997653 3445566789999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
|..||.|.-+|.+. ..+++....-+-..|..||.|||+ ++||.||||.+|.|||.+|.+||+||||++.-- ...
T Consensus 249 yanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-~~g 322 (516)
T KOG0690|consen 249 YANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI-KYG 322 (516)
T ss_pred EccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcc-ccc
Confidence 99999999999664 357888888899999999999998 999999999999999999999999999997421 222
Q ss_pred ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
..+...+|||.|+|||++....|....|.|.+||++|||+||+.||...+.+..- +++.. -|-+++....+
T Consensus 323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLF---eLIl~------ed~kFPr~ls~ 393 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLF---ELILM------EDLKFPRTLSP 393 (516)
T ss_pred ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHH---HHHHh------hhccCCccCCH
Confidence 3455789999999999999999999999999999999999999999875543221 11111 12233344445
Q ss_pred HHHHHHHHHhhhccCCCCCCCC-----CHHHHHH
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRP-----SMRQVVQ 602 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 602 (660)
+....|.. .+..||.+|. .+.||++
T Consensus 394 eAktLLsG----LL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 394 EAKTLLSG----LLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred HHHHHHHH----HhhcChHhhcCCCchhHHHHHh
Confidence 54444444 4889999995 4666664
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=294.07 Aligned_cols=244 Identities=26% Similarity=0.350 Sum_probs=196.8
Q ss_pred cccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCCCCC
Q 006112 342 YKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGS 419 (660)
Q Consensus 342 ~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gs 419 (660)
+.+|.|.||+||-|+++.+|+.||||.+.+. ......++.+|+.||++++||.||.+.-.|+..+.+++|||.+ +|+
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~GD 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HGD 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cch
Confidence 5689999999999999999999999999654 3344578899999999999999999999999999999999999 677
Q ss_pred hhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCC---CCeEEeecccceeccCCCCcee
Q 006112 420 LDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDAD---LEGKLGDFGLARLYDHGNDLHT 496 (660)
Q Consensus 420 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~---~~~kl~DFGla~~~~~~~~~~~ 496 (660)
..+.+.......|++.....++.||+.||.|||. ++|+||||||+||||... -++||+|||+||.+.... ..
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--FR 723 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--FR 723 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhh--hh
Confidence 7666666666679999999999999999999998 999999999999999543 479999999999876543 33
Q ss_pred eccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHH
Q 006112 497 TNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQM 576 (660)
Q Consensus 497 ~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 576 (660)
..++|||.|+|||++++..|...-|+||.||++|--++|..||..++. +.+ .++.-..+-...| ..+...+
T Consensus 724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-Ind----QIQNAaFMyPp~P--W~eis~~-- 794 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-IND----QIQNAAFMYPPNP--WSEISPE-- 794 (888)
T ss_pred hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-hhH----HhhccccccCCCc--hhhcCHH--
Confidence 458999999999999999999999999999999999999999975442 222 2222222222222 2333333
Q ss_pred HHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 577 EIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 577 ~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
.++++...++..-.+|-+..+.+.
T Consensus 795 --AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 795 --AIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred --HHHHHHHHHHHHHHHhcchHhhcc
Confidence 444555557778888888877653
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=273.54 Aligned_cols=259 Identities=23% Similarity=0.314 Sum_probs=203.7
Q ss_pred cccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhcc-CCCCceeEeeeeee----cCeeEEEEecCC
Q 006112 342 YKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRR----KGELLLVYDYMP 416 (660)
Q Consensus 342 ~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~----~~~~~lV~E~~~ 416 (660)
+.||-|-.|.|..+..+.+++++|+|++... ....+|+++--.. .|||||++++++.. ...+++|||.|+
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~me 142 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECME 142 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeeccc
Confidence 5789999999999999999999999998533 2345677665444 69999999998753 456899999999
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcC---CCCeEEeecccceeccCCCC
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDA---DLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~---~~~~kl~DFGla~~~~~~~~ 493 (660)
||.|...++..+...+++.++-.|++||+.|++|||+ .+|.||||||+|+|... |..+||+|||+|+.-...
T Consensus 143 GGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~-- 217 (400)
T KOG0604|consen 143 GGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP-- 217 (400)
T ss_pred chHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccccccccCCC--
Confidence 9999999998888889999999999999999999998 99999999999999964 456899999999864432
Q ss_pred ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCC-cchHHHHHHHHhcCCcccCCCCcccccCc
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGE-LDLLDWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
......+-|+-|.|||++...+|+..+|+||+||++|-|+||..||+... ..+..-+...++.|.. +..+|. .
T Consensus 218 ~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy-~FP~pE-----W 291 (400)
T KOG0604|consen 218 GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQY-EFPEPE-----W 291 (400)
T ss_pred ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCc-cCCChh-----H
Confidence 22344577999999999999999999999999999999999999997532 2233333334444432 112221 2
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCCHHHHHH--HhhCCCCCCCCCCC
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ--YLDGGALLPDIPLN 616 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~~~p~~p~~ 616 (660)
....+...++++..+..+|.+|.|+.|++. ++......|..|+.
T Consensus 292 s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~ 337 (400)
T KOG0604|consen 292 SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLS 337 (400)
T ss_pred hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCch
Confidence 233445667777789999999999999997 55555566666544
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=317.38 Aligned_cols=146 Identities=27% Similarity=0.368 Sum_probs=132.7
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
-.|+.+++||+|+||.||+|.+..+++.||||++.... ....+++..|+.++..++||||+++++++...+.+++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 36888999999999999999998889999999986432 234567899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccce
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLAR 486 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 486 (660)
||+.+++|.+++.... .+++..++.|+.||+.||.|||. .+|+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999997543 47888999999999999999998 899999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=281.42 Aligned_cols=220 Identities=19% Similarity=0.161 Sum_probs=177.7
Q ss_pred CccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCCCCChhhhhhh
Q 006112 347 GGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYS 426 (660)
Q Consensus 347 G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~ 426 (660)
|.+|.||++++..+++.+|+|++.... .+..|...+....||||+++++++.+....++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999999999999999986543 234455556666799999999999999999999999999999999876
Q ss_pred CCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCceeeccccCcccc
Q 006112 427 NTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYL 506 (660)
Q Consensus 427 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~ 506 (660)
.. .+++..+..++.|+++||.|||+ ++|+||||||+||+++.++.++++|||++...... .....++..|+
T Consensus 79 ~~--~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~ 149 (237)
T cd05576 79 FL--NIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYC 149 (237)
T ss_pred hc--CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcccc
Confidence 43 48999999999999999999998 89999999999999999999999999988655432 12234577899
Q ss_pred CcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhc
Q 006112 507 APELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFC 586 (660)
Q Consensus 507 aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C 586 (660)
|||.+....++.++||||+|+++|||++|+.|+....... .. .....+.. .....+.+++.+|
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~--------~~-----~~~~~~~~----~~~~~~~~li~~~ 212 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI--------NT-----HTTLNIPE----WVSEEARSLLQQL 212 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc--------cc-----ccccCCcc----cCCHHHHHHHHHH
Confidence 9999988888999999999999999999998865321110 00 00001111 1234567788889
Q ss_pred cCCCCCCCCCH
Q 006112 587 SHSNPDTRPSM 597 (660)
Q Consensus 587 l~~dP~~RPs~ 597 (660)
++.||++||++
T Consensus 213 l~~dp~~R~~~ 223 (237)
T cd05576 213 LQFNPTERLGA 223 (237)
T ss_pred ccCCHHHhcCC
Confidence 99999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=274.39 Aligned_cols=250 Identities=22% Similarity=0.265 Sum_probs=196.3
Q ss_pred cccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCeeEEEEecCCCCCh
Q 006112 342 YKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVYDYMPNGSL 420 (660)
Q Consensus 342 ~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 420 (660)
+.+|+|+++.|--++...++.++|||++.+...+...+..+|++++.+. .|+||++|+.|++++..+|||||-|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 3578999999999999999999999999888778889999999999988 499999999999999999999999999999
Q ss_pred hhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCC---eEEeecccceeccCC------
Q 006112 421 DKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLE---GKLGDFGLARLYDHG------ 491 (660)
Q Consensus 421 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~---~kl~DFGla~~~~~~------ 491 (660)
..+|++.. .+++.++.+++++||.||.|||. ++|.|||+||+|||..+... +||+||.|..-+...
T Consensus 164 LshI~~~~--~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spa 238 (463)
T KOG0607|consen 164 LSHIQKRK--HFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPA 238 (463)
T ss_pred HHHHHHhh--hccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCC
Confidence 99997754 48999999999999999999998 99999999999999976544 799999988543221
Q ss_pred CCceeeccccCccccCccccc-----CCCCCcceeEEehHHHHHHHhhCCCCCCCCCc------------chHHHHHHHH
Q 006112 492 NDLHTTNVVGTVGYLAPELLR-----NGRGTTSTDVYAFGVFMLEVACGRRPVQPGEL------------DLLDWVIDYW 554 (660)
Q Consensus 492 ~~~~~~~~~gt~~Y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~------------~~~~~~~~~~ 554 (660)
........+|+..|||||+.. ...|+.++|.||+|||||-|++|..||.+.-. ...+...+-+
T Consensus 239 stP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesI 318 (463)
T KOG0607|consen 239 STPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESI 318 (463)
T ss_pred CCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHH
Confidence 122334568899999999863 23578899999999999999999999976111 1122222333
Q ss_pred hcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 555 QKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 555 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
++|.. +..|.. .........+++...+..|+.+|.++.++++
T Consensus 319 QEGkY-eFPdkd-----WahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 319 QEGKY-EFPDKD-----WAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred hccCC-cCChhh-----hHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 33332 111111 1111223344445567799999999999987
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=271.66 Aligned_cols=239 Identities=29% Similarity=0.365 Sum_probs=196.4
Q ss_pred ccEEEEEEEeCCCCeEEEEEEeccCCChh-hHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCCCCChhhhhhh
Q 006112 348 GSGKVYRGVLPSSHAEIAVKKVCHDSDHG-MKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYS 426 (660)
Q Consensus 348 ~fg~Vy~g~~~~~~~~vavK~~~~~~~~~-~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~ 426 (660)
+||.||+|+...+++.+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999998888999999997655444 78999999999999999999999999999999999999999999999876
Q ss_pred CCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCceeeccccCcccc
Q 006112 427 NTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYL 506 (660)
Q Consensus 427 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~ 506 (660)
... +++.+++.++.+++.+|.|||+ .+++|+||+|+||+++.++.++|+|||.+....... ......++..|+
T Consensus 81 ~~~--~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~ 153 (244)
T smart00220 81 RGR--LSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYM 153 (244)
T ss_pred ccC--CCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCC
Confidence 543 8899999999999999999998 899999999999999999999999999998765432 233456888999
Q ss_pred CcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhc
Q 006112 507 APELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFC 586 (660)
Q Consensus 507 aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C 586 (660)
+||.+.....+.++||||||++++++++|..||..... .....+....+.... .. ........+.+++.+|
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~~~~~~~~~~~-~~------~~~~~~~~~~~~i~~~ 224 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELFKKIGKPKPPF-PP------PEWKISPEAKDLIRKL 224 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHhccCCCC-cc------ccccCCHHHHHHHHHH
Confidence 99999888889999999999999999999999975211 111222222211110 00 0000335678889999
Q ss_pred cCCCCCCCCCHHHHHH
Q 006112 587 SHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 587 l~~dP~~RPs~~evl~ 602 (660)
+..+|++||++.++++
T Consensus 225 l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 225 LVKDPEKRLTAEEALQ 240 (244)
T ss_pred ccCCchhccCHHHHhh
Confidence 9999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=305.33 Aligned_cols=259 Identities=19% Similarity=0.221 Sum_probs=172.7
Q ss_pred ceeeecccccccCccEEEEEEEeCCC----CeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeee------eee
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSS----HAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGY------CRR 404 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~----~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~------~~~ 404 (660)
.-+|+..+.||+|+||.||+|++..+ +..||||++..... .+.+..| .+....+.+++.++.. +..
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhccccccc
Confidence 34788899999999999999999888 89999999754322 1112221 1222223333222221 345
Q ss_pred cCeeEEEEecCCCCChhhhhhhCCCC------------------CcchhHHHHHHHHHHHHHHHhhhcccCceeccCccC
Q 006112 405 KGELLLVYDYMPNGSLDKILYSNTRP------------------SLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKP 466 (660)
Q Consensus 405 ~~~~~lV~E~~~~gsL~~~l~~~~~~------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp 466 (660)
+.+.++||||+++++|.+++...... ...+..+..++.||+.||+|||+ ++|+||||||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP 283 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKP 283 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCH
Confidence 67899999999999999988653211 11233456799999999999998 8999999999
Q ss_pred CcEEEcC-CCCeEEeecccceeccCCCCceeeccccCccccCcccccCC----------------------CCCcceeEE
Q 006112 467 ANVLLDA-DLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNG----------------------RGTTSTDVY 523 (660)
Q Consensus 467 ~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----------------------~~t~ksDV~ 523 (660)
+|||++. ++.+||+|||+++..............+|+.|||||.+... .++.++|||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 9999986 57899999999987655444444567889999999965322 234567999
Q ss_pred ehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcc----cCCCCc----ccccCc--HHHHHHHHHHhhhccCCCCCC
Q 006112 524 AFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVL----DASDPR----LEGIYV--EEQMEIVLKLGLFCSHSNPDT 593 (660)
Q Consensus 524 S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~----~~~d~~----l~~~~~--~~~~~~l~~l~~~Cl~~dP~~ 593 (660)
||||+||||+++..+.+.. ...........+... ....+. +...+. ........+|+..|++.||++
T Consensus 364 SlGviL~el~~~~~~~~~~---~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 364 SAGLIFLQMAFPNLRSDSN---LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred HHHHHHHHHHhCcCCCchH---HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 9999999999977665431 111111111111000 000110 000000 001123457889999999999
Q ss_pred CCCHHHHHHH
Q 006112 594 RPSMRQVVQY 603 (660)
Q Consensus 594 RPs~~evl~~ 603 (660)
|||++|++++
T Consensus 441 R~ta~e~L~H 450 (566)
T PLN03225 441 RISAKAALAH 450 (566)
T ss_pred CCCHHHHhCC
Confidence 9999999974
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9e-33 Score=309.23 Aligned_cols=256 Identities=27% Similarity=0.298 Sum_probs=206.2
Q ss_pred CCCceeeecccccccCccEEEEEEEeCCCCeEEEEEEecc---CCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCee
Q 006112 332 SPHRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCH---DSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGEL 408 (660)
Q Consensus 332 ~~~~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~---~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 408 (660)
...+-+|.+++.||+|+||.|...+++.+++.+|.|++.+ -.......|..|=.+|..-..+-|++++-.++++..+
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L 150 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL 150 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence 3456689999999999999999999999999999999865 2344566789999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceec
Q 006112 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLY 488 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 488 (660)
|+|||||+||+|-.++.+.. .+++..+..++..|.-||.-||+ .|+|||||||+|||||..|++||+|||.+-.+
T Consensus 151 YlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGsClkm 225 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGSCLKM 225 (1317)
T ss_pred EEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchhHHhc
Confidence 99999999999999997766 48888888999999999999998 99999999999999999999999999999877
Q ss_pred cCCCCceeeccccCccccCccccc----C-CCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCC
Q 006112 489 DHGNDLHTTNVVGTVGYLAPELLR----N-GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDAS 563 (660)
Q Consensus 489 ~~~~~~~~~~~~gt~~Y~aPE~~~----~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (660)
.......+...+|||-|++||++. + +.|.+.+|.||+||++|||+.|..||+.+. +++-.-........+...
T Consensus 226 ~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads--lveTY~KIm~hk~~l~FP 303 (1317)
T KOG0612|consen 226 DADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS--LVETYGKIMNHKESLSFP 303 (1317)
T ss_pred CCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH--HHHHHHHHhchhhhcCCC
Confidence 766666666789999999999986 2 678999999999999999999999998533 222222221111222222
Q ss_pred CCcccccCcHHHHHHHHHHhhhccCCCCCCCCC---HHHHHH
Q 006112 564 DPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPS---MRQVVQ 602 (660)
Q Consensus 564 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~ 602 (660)
+. -..+++.-..+..++ | +|+.|.. .+++..
T Consensus 304 ~~---~~VSeeakdLI~~ll--~---~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 304 DE---TDVSEEAKDLIEALL--C---DREVRLGRNGIEDIKN 337 (1317)
T ss_pred cc---cccCHHHHHHHHHHh--c---ChhhhcccccHHHHHh
Confidence 11 113344334444432 3 7788877 888876
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-33 Score=279.48 Aligned_cols=240 Identities=25% Similarity=0.317 Sum_probs=193.0
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCeeEEEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
.+..+..||+|+||.|.++..+.+.+.+|||+++++. .+..+--+.|-++|.-. +-|.+++++.+++..+.+|.||
T Consensus 350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM 429 (683)
T KOG0696|consen 350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM 429 (683)
T ss_pred ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence 4566888999999999999999999999999997752 33445556677777666 5789999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
||+.||+|-.++++-++ +.++.+.-++..||-||-+||+ ++|+.||||.+|||||.+|.+||+|||+++.--- .
T Consensus 430 EyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~-~ 503 (683)
T KOG0696|consen 430 EYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF-D 503 (683)
T ss_pred EEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeeccccccccc-C
Confidence 99999999999987664 7888999999999999999998 9999999999999999999999999999974211 1
Q ss_pred CceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCc
Q 006112 493 DLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 493 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
...+...+|||.|+|||++..++|..+.|.|||||+||||+.|+.||++++.+.+-. .+.+... . ....++
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~---aI~ehnv---s---yPKslS 574 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ---AIMEHNV---S---YPKSLS 574 (683)
T ss_pred CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---HHHHccC---c---Cccccc
Confidence 223456899999999999999999999999999999999999999999865433221 1122111 1 123333
Q ss_pred HHHHHHHHHHhhhccCCCCCCCC
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRP 595 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RP 595 (660)
.+ ...++..-+...|.+|.
T Consensus 575 kE----Av~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 575 KE----AVAICKGLLTKHPGKRL 593 (683)
T ss_pred HH----HHHHHHHHhhcCCcccc
Confidence 33 34454555788888884
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=273.28 Aligned_cols=251 Identities=24% Similarity=0.322 Sum_probs=200.3
Q ss_pred ccccccCccEEEEEEEeCCCC-----eEEEEEEeccC-CChhhHHHHHHHHHHhccCCCCceeEeeeeeecC-eeEEEEe
Q 006112 341 LYKATKGGSGKVYRGVLPSSH-----AEIAVKKVCHD-SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKG-ELLLVYD 413 (660)
Q Consensus 341 l~~lg~G~fg~Vy~g~~~~~~-----~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-~~~lV~E 413 (660)
.-.+-+|.||+||+|.|.+.. +.|-+|.++.. ++-....++.|--.+..+.|||+.++.+.|.++. ..+.+|.
T Consensus 289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~ 368 (563)
T KOG1024|consen 289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYP 368 (563)
T ss_pred hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEe
Confidence 334567999999999886432 45566666433 3345667889999999999999999999998765 4688899
Q ss_pred cCCCCChhhhhhhC------CCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeeccccee
Q 006112 414 YMPNGSLDKILYSN------TRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARL 487 (660)
Q Consensus 414 ~~~~gsL~~~l~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 487 (660)
++.-|+|..||... ....++-.+...++.|++.|++|||. .+|||.||..+|++||+..++||+|-.|+|.
T Consensus 369 ~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~LqVkltDsaLSRD 445 (563)
T KOG1024|consen 369 ATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQLQVKLTDSALSRD 445 (563)
T ss_pred ccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhheeEEeccchhccc
Confidence 99999999999721 23457888999999999999999998 9999999999999999999999999999986
Q ss_pred ccCCCCce-eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCC
Q 006112 488 YDHGNDLH-TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDP 565 (660)
Q Consensus 488 ~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 565 (660)
+-...-.. ......+..||+||.+.+..|+..+|||||||+||||+| |+.|+..-+... +..+.++|..+..
T Consensus 446 LFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE---m~~ylkdGyRlaQ--- 519 (563)
T KOG1024|consen 446 LFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE---MEHYLKDGYRLAQ--- 519 (563)
T ss_pred cCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH---HHHHHhccceecC---
Confidence 54432221 122334678999999999999999999999999999998 899987644333 3334455543322
Q ss_pred cccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 566 RLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 566 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
+.+++++++.+|..||..+|++||+++|++..|..
T Consensus 520 ------P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 520 ------PFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred ------CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 23567789999999999999999999999998864
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-32 Score=295.84 Aligned_cols=261 Identities=22% Similarity=0.257 Sum_probs=179.0
Q ss_pred ceeeecccccccCccEEEEEEEeC----------------CCCeEEEEEEeccCCChhhHHH--------------HHHH
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLP----------------SSHAEIAVKKVCHDSDHGMKQF--------------VSEI 384 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~----------------~~~~~vavK~~~~~~~~~~~~~--------------~~Ei 384 (660)
.-+|++.++||+|+||.||+|.+. ..++.||||++........++| ..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 346888999999999999999752 2346799999865543333333 4477
Q ss_pred HHHhccCCCCc-----eeEeeeeee--------cCeeEEEEecCCCCChhhhhhhCC----------------------C
Q 006112 385 VSMGKLRHRNL-----VQLRGYCRR--------KGELLLVYDYMPNGSLDKILYSNT----------------------R 429 (660)
Q Consensus 385 ~~l~~l~H~nI-----v~l~g~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~----------------------~ 429 (660)
.++.+++|.++ ++++++|.. ++..+|||||+++++|.++++... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777776654 778888753 356899999999999999986421 1
Q ss_pred CCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCceeeccccCccccCcc
Q 006112 430 PSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPE 509 (660)
Q Consensus 430 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE 509 (660)
..++|..+..++.|++.+|.|||+ .+|+||||||+|||++.++.+||+|||+++..............+|+.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 235677889999999999999998 89999999999999999999999999999765443322222334588999999
Q ss_pred cccCCCC----------------------CcceeEEehHHHHHHHhhCCC-CCCCCC-----cchHHHHHHHHhcCCccc
Q 006112 510 LLRNGRG----------------------TTSTDVYAFGVFMLEVACGRR-PVQPGE-----LDLLDWVIDYWQKGDVLD 561 (660)
Q Consensus 510 ~~~~~~~----------------------t~ksDV~S~Gvvl~elltG~~-p~~~~~-----~~~~~~~~~~~~~~~~~~ 561 (660)
.+..... ..+.||||+||+++||++|.. |+.... ....+.....|+.-...
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~- 459 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ- 459 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc-
Confidence 8754321 235799999999999999875 664311 00001111111110000
Q ss_pred CCCCcccccCcHHHHHHHHHHhhhccCCCC---CCCCCHHHHHHH
Q 006112 562 ASDPRLEGIYVEEQMEIVLKLGLFCSHSNP---DTRPSMRQVVQY 603 (660)
Q Consensus 562 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP---~~RPs~~evl~~ 603 (660)
..+-...... .+...+++..++..+| .+|+|++|++++
T Consensus 460 ~~~~~~~d~~----s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 460 KYDFSLLDRN----KEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred CCCccccccc----ChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 0111111112 2334555555666554 789999999864
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=267.63 Aligned_cols=278 Identities=28% Similarity=0.345 Sum_probs=202.3
Q ss_pred ceeeecccccccCccEEEEEEEeCCCC----eEEEEEEeccCCCh--hhHHHHHHHHHHhccCCCCceeEeeeeee-cCe
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSH----AEIAVKKVCHDSDH--GMKQFVSEIVSMGKLRHRNLVQLRGYCRR-KGE 407 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~----~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-~~~ 407 (660)
.+.|+.+..||+|.+|.||++.-.+++ +.+|+|+++...+. .-....+|+.++++++||||+.|..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 457899999999999999999665443 37899999655332 23467899999999999999999998877 788
Q ss_pred eEEEEecCCCCChhhhhhhCC---CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCC----CCeEEe
Q 006112 408 LLLVYDYMPNGSLDKILYSNT---RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDAD----LEGKLG 480 (660)
Q Consensus 408 ~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~----~~~kl~ 480 (660)
++|++||.+ -+|...|+-.. ...++-.....|+.||+.|+.|||+ +=|+||||||.|||+..+ |.+||+
T Consensus 103 v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEee
Confidence 999999994 68888775432 2458888899999999999999998 779999999999999877 899999
Q ss_pred ecccceeccCCCCc--eeeccccCccccCcccccCC-CCCcceeEEehHHHHHHHhhCCCCCCCCCcc-------hHHHH
Q 006112 481 DFGLARLYDHGNDL--HTTNVVGTVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQPGELD-------LLDWV 550 (660)
Q Consensus 481 DFGla~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-------~~~~~ 550 (660)
|+|++|.+...-.. ....++-|..|.|||++.+. .||.+.|||+.||++.||++-.+-|...+.. ..+.+
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 99999998765332 23456789999999998875 5899999999999999999988777552221 11222
Q ss_pred HHHHh-cCCcccCCCCccccc--------------CcH----HH-------HHHHHHHhhhccCCCCCCCCCHHHHHHHh
Q 006112 551 IDYWQ-KGDVLDASDPRLEGI--------------YVE----EQ-------MEIVLKLGLFCSHSNPDTRPSMRQVVQYL 604 (660)
Q Consensus 551 ~~~~~-~~~~~~~~d~~l~~~--------------~~~----~~-------~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (660)
.+.++ -|...+..-|.+... ++. .. ...-++|...++..||.+|.|++|.+++-
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 22211 122211111111100 000 00 01245666778999999999999999753
Q ss_pred h-CCCCCCCCCCC
Q 006112 605 D-GGALLPDIPLN 616 (660)
Q Consensus 605 ~-~~~~~p~~p~~ 616 (660)
- ...++|..|..
T Consensus 339 yF~~d~lpp~pt~ 351 (438)
T KOG0666|consen 339 YFTEDPLPPLPTS 351 (438)
T ss_pred ccccCCCCCCccc
Confidence 2 22345544433
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-32 Score=274.16 Aligned_cols=258 Identities=21% Similarity=0.252 Sum_probs=204.0
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccC-C-CC----ceeEeeeeeecCeeE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLR-H-RN----LVQLRGYCRRKGELL 409 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H-~n----Iv~l~g~~~~~~~~~ 409 (660)
-.|+.+..+|+|.||.|.++.+..++..||||+++... ...+.-+-|+++++++. + |+ +|++.+|+.-.++.|
T Consensus 89 ~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC 167 (415)
T KOG0671|consen 89 NRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC 167 (415)
T ss_pred cceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence 36899999999999999999999899999999986433 34456678999999993 2 23 889999999999999
Q ss_pred EEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcC----------------
Q 006112 410 LVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDA---------------- 473 (660)
Q Consensus 410 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~---------------- 473 (660)
||+|.+ |-|+.++|..+.-.+++..++..|+.|++++++|||+ .+++|-||||+|||+..
T Consensus 168 ivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~ 243 (415)
T KOG0671|consen 168 IVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKKKVCFI 243 (415)
T ss_pred EEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCCcccee
Confidence 999999 7899999998877789999999999999999999998 99999999999999931
Q ss_pred ----CCCeEEeecccceeccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHH
Q 006112 474 ----DLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLD 548 (660)
Q Consensus 474 ----~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~ 548 (660)
+..+||+|||.|+.-... ....+.|..|.|||++.+-.++.++||||+||+|.|+++|..-|+.-+. +-..
T Consensus 244 r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLa 319 (415)
T KOG0671|consen 244 RPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLA 319 (415)
T ss_pred ccCCCcceEEEecCCcceeccC----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHH
Confidence 235899999999864322 2456789999999999999999999999999999999999999876331 1111
Q ss_pred H-----------------HHHHHhcCCcccCC------------C-Cccc---ccCcHHHHHHHHHHhhhccCCCCCCCC
Q 006112 549 W-----------------VIDYWQKGDVLDAS------------D-PRLE---GIYVEEQMEIVLKLGLFCSHSNPDTRP 595 (660)
Q Consensus 549 ~-----------------~~~~~~~~~~~~~~------------d-~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RP 595 (660)
. ..++...| .++-. + +.+. -.....+...|++|+..++..||.+|+
T Consensus 320 MMerIlGp~P~~mi~r~~~~Kyf~~~-rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~Ri 398 (415)
T KOG0671|consen 320 MMERILGPIPSRMIKKTRKEKYFRRG-RLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRI 398 (415)
T ss_pred HHHHhhCCCcHHHhhhhhhHhhhhcc-cccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccc
Confidence 1 11111122 11100 0 0000 012345566899999999999999999
Q ss_pred CHHHHHHH
Q 006112 596 SMRQVVQY 603 (660)
Q Consensus 596 s~~evl~~ 603 (660)
|++|++++
T Consensus 399 Tl~EAL~H 406 (415)
T KOG0671|consen 399 TLREALSH 406 (415)
T ss_pred cHHHHhcC
Confidence 99999863
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=290.47 Aligned_cols=239 Identities=23% Similarity=0.233 Sum_probs=192.6
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCeeEEEEec
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
-+|+....+|+|+|+.|-++.+..+++..+||++.... .+-.+|+.++... +||||+++.+.|.++.+.++|||+
T Consensus 322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL 397 (612)
T ss_pred hhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence 35666677999999999999999999999999996542 2345677666555 699999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEE-cCCCCeEEeecccceeccCCCC
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLL-DADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll-~~~~~~kl~DFGla~~~~~~~~ 493 (660)
+.++-|.+.+..... .. .++..|+.+|+.++.|||+ +++|||||||+|||+ +..++++|+|||.++.....
T Consensus 398 l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 398 LDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred ccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 999988877765442 22 6777899999999999998 999999999999999 58899999999999876543
Q ss_pred ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
....+-|..|.|||++....|++++|+||||++||+|+||+.||...... ..+......+. +..
T Consensus 470 --~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~~i~~~~------------~s~ 533 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHTRIQMPK------------FSE 533 (612)
T ss_pred --hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHHhhcCCc------------ccc
Confidence 22335588999999999999999999999999999999999999764433 12222222221 223
Q ss_pred HHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
...+...+|+.+|++.||.+||+|.++..
T Consensus 534 ~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 534 CVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 33344567777899999999999999986
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=291.13 Aligned_cols=251 Identities=23% Similarity=0.313 Sum_probs=207.3
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhcc-CCCCceeEeeeeee-----cCeeEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRR-----KGELLL 410 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~-----~~~~~l 410 (660)
.+++.+.+|+|.+|.||+++...+++..|||+...+.. ..++...|.++++.+ .|||++.++|++.. +++++|
T Consensus 20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL 98 (953)
T KOG0587|consen 20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL 98 (953)
T ss_pred ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence 56777889999999999999999999999998865543 456788899999888 69999999998853 468999
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccC
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDH 490 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 490 (660)
|||||.+||..++++.-....+.|..+.-|+..++.||++||. ..++|||||-.|||++.++.+||.|||++...+.
T Consensus 99 VMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFGvSaQlds 175 (953)
T KOG0587|consen 99 VMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS 175 (953)
T ss_pred EeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence 9999999999999987666779999999999999999999998 8999999999999999999999999999987654
Q ss_pred CCCceeeccccCccccCcccccC-----CCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCC
Q 006112 491 GNDLHTTNVVGTVGYLAPELLRN-----GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDP 565 (660)
Q Consensus 491 ~~~~~~~~~~gt~~Y~aPE~~~~-----~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 565 (660)
... ......||+.|||||++.. ..|+..+|+||+|++..||.-|.+|+...... ..++. + ...|
T Consensus 176 T~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm-----raLF~---I--pRNP 244 (953)
T KOG0587|consen 176 TVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM-----RALFL---I--PRNP 244 (953)
T ss_pred ccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh-----hhhcc---C--CCCC
Confidence 332 3345789999999999863 34667899999999999999999998643221 11111 1 1223
Q ss_pred cccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 566 RLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 566 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
.+.-.-.....+.+.+.+..|+..|-.+||++.++++
T Consensus 245 PPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 245 PPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred CccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 3333345667788899999999999999999999875
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=251.69 Aligned_cols=199 Identities=25% Similarity=0.348 Sum_probs=170.1
Q ss_pred eecccccccCccEEEEEEEeCCCCeEEEEEEeccC-CChhhHHHHHHHHHHhc-cCCCCceeEeeeeeecCeeEEEEecC
Q 006112 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD-SDHGMKQFVSEIVSMGK-LRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~-l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
+.-+..||+|++|.|-+.++..+|+..|+|++... ..+.+++.++|+.+..+ ...|.+|.++|...+.+.+++.||.|
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M 127 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM 127 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence 34456799999999999999999999999999765 45667888999987655 47999999999999999999999999
Q ss_pred CCCChhhhhhh--CCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 416 PNGSLDKILYS--NTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 416 ~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
..||+.+-.+ .....+++..+-+|+..+.+||.|||+ +..++|||+||+|||++.+|++|++|||.+-.+.+..
T Consensus 128 -~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi- 203 (282)
T KOG0984|consen 128 -DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI- 203 (282)
T ss_pred -hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhh-
Confidence 7899887543 123458889999999999999999999 6899999999999999999999999999997664432
Q ss_pred ceeeccccCccccCcccccC----CCCCcceeEEehHHHHHHHhhCCCCCCC
Q 006112 494 LHTTNVVGTVGYLAPELLRN----GRGTTSTDVYAFGVFMLEVACGRRPVQP 541 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~----~~~t~ksDV~S~Gvvl~elltG~~p~~~ 541 (660)
..+...|...|||||.+.. ..|+-|+||||+|+++.||.+++.||+.
T Consensus 204 -Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 204 -AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred -HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 2333578899999998753 3688999999999999999999999975
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=279.27 Aligned_cols=241 Identities=24% Similarity=0.361 Sum_probs=193.3
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
--|..++.||-|+||+|+++...++...+|.|.+++.+ ++.....++|-.||.....+-||+|+-.+++++.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 34667788999999999999998899999999986643 334556788999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeeccccee-----
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARL----- 487 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~----- 487 (660)
||++||++-.+|-+.+ .+++..+..++..++.|+++.|. .|+|||||||+|||||.+|.+||.||||+.-
T Consensus 709 dYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred eccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceecc
Confidence 9999999999987654 48888888999999999999998 9999999999999999999999999999842
Q ss_pred ----ccCCCC--------------------------------ceeeccccCccccCcccccCCCCCcceeEEehHHHHHH
Q 006112 488 ----YDHGND--------------------------------LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLE 531 (660)
Q Consensus 488 ----~~~~~~--------------------------------~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~e 531 (660)
+..+.. ......+||+.|+|||++....++..+|.||.||+|||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 111100 00012579999999999999999999999999999999
Q ss_pred HhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCC
Q 006112 532 VACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHS 589 (660)
Q Consensus 532 lltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~ 589 (660)
|+.|+.||........+.....|+ ..++-...+....++...+.+| |+..
T Consensus 864 m~~g~~pf~~~tp~~tq~kv~nw~-----~~l~~~~~~~ls~e~~~li~kL---c~sa 913 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQYKVINWR-----NFLHIPYQGNLSKEALDLIQKL---CCSA 913 (1034)
T ss_pred HhhCCCCccCCCCCcceeeeeehh-----hccccccccccCHHHHHHHHHH---hcCh
Confidence 999999997533221111111111 2333334567788888888887 6544
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=268.07 Aligned_cols=255 Identities=25% Similarity=0.327 Sum_probs=196.0
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC-------ChhhHHHHHHHHHHhccCCCCceeEeeeeee-cCee
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-------DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR-KGEL 408 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~-------~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~ 408 (660)
.|-.|..+|+|||+.||++.+....+.||||+-..+. ....+...+|..|-+.|.||.||++++|+.- .+.+
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF 543 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF 543 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence 5777889999999999999998888899999753221 1224567789999999999999999999864 4678
Q ss_pred EEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEc---CCCCeEEeecccc
Q 006112 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLD---ADLEGKLGDFGLA 485 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~---~~~~~kl~DFGla 485 (660)
|-|+|||+|.+|+-+|+.+. .+++.++..|+.||+.||.||.+. ..+|||-||||.||||- .-|.+||.||||+
T Consensus 544 CTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred eeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 99999999999999998764 589999999999999999999974 68999999999999994 3478999999999
Q ss_pred eeccCCCCc------eeeccccCccccCcccccCC----CCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHh
Q 006112 486 RLYDHGNDL------HTTNVVGTVGYLAPELLRNG----RGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQ 555 (660)
Q Consensus 486 ~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~~----~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~ 555 (660)
+.++..... .+....||.+|++||++.-+ +.+.|.||||.||++|..+.|+.||...... .+...
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ-----QdILq 695 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ-----QDILQ 695 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH-----HHHHh
Confidence 998764322 23457899999999998654 4678999999999999999999999863321 11122
Q ss_pred cCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHH
Q 006112 556 KGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVV 601 (660)
Q Consensus 556 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 601 (660)
...++.+..-.+... +........++.+|++.--++|....++.
T Consensus 696 eNTIlkAtEVqFP~K--PvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 696 ENTILKATEVQFPPK--PVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred hhchhcceeccCCCC--CccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 222322222111110 11112344567779999999998776654
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=259.84 Aligned_cols=261 Identities=29% Similarity=0.417 Sum_probs=199.1
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC-Chh-hHHHHHHHHHHhccCCCCceeEeeeeeec--------
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-DHG-MKQFVSEIVSMGKLRHRNLVQLRGYCRRK-------- 405 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~-~~~-~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-------- 405 (660)
..|+.+.++|+|.||.||+++..++++.||+|++..+. +++ -...++|+++|..++|+|++.++..|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 36888899999999999999999999999999875532 222 35678999999999999999999998532
Q ss_pred CeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccc
Q 006112 406 GELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLA 485 (660)
Q Consensus 406 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla 485 (660)
..+++|+++| .-+|..+|... ...++...+.+++.++..||.|+|. ..|+|||+|+.|+||+.++.+||+|||++
T Consensus 97 ~t~ylVf~~c-ehDLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 97 ATFYLVFDFC-EHDLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ceeeeeHHHh-hhhHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 3589999999 56888887543 2458888999999999999999997 99999999999999999999999999999
Q ss_pred eeccCCCC---ceeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHHHHHHhcCCcc
Q 006112 486 RLYDHGND---LHTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVIDYWQKGDVL 560 (660)
Q Consensus 486 ~~~~~~~~---~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~~~~~~~~ 560 (660)
|.+...+. ...+..+-|..|.+||.+.+ ..|+++.|||..||++.||+++.+-+++... .....+..+. |...
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~Lc--Gs~t 249 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLC--GSIT 249 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHh--ccCC
Confidence 87765433 22345667999999998875 5689999999999999999999877765322 2222222222 2111
Q ss_pred cCCCCc--------------c-cccC--cHHHHH------HHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 561 DASDPR--------------L-EGIY--VEEQME------IVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 561 ~~~d~~--------------l-~~~~--~~~~~~------~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
..+-|. + .+.+ .++.++ ..++|+..++..||.+|+++.+++.+
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 111111 1 1111 111121 45677777899999999999999864
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-30 Score=285.60 Aligned_cols=244 Identities=25% Similarity=0.377 Sum_probs=185.1
Q ss_pred eecccccccCccE-EEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCeeEEEEecC
Q 006112 338 YKNLYKATKGGSG-KVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 338 ~~~l~~lg~G~fg-~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
+..-+.+|.|.-| .||+|.. .++.||||++..+. .....+|+..++.- +|||||++++.-.+++.+||+.|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 3334556777766 5899999 67899999985432 34557899999888 5999999999888889999999999
Q ss_pred CCCChhhhhhhC--CCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcC---C--CCeEEeecccceec
Q 006112 416 PNGSLDKILYSN--TRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDA---D--LEGKLGDFGLARLY 488 (660)
Q Consensus 416 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~---~--~~~kl~DFGla~~~ 488 (660)
..+|+++++.. ......-...+.++.|+++||++||+ .+||||||||.||||+. + ..++|+|||+++.+
T Consensus 586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 78999999874 11111113457889999999999998 99999999999999966 2 56899999999987
Q ss_pred cCCCCc--eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhC-CCCCCCCCcchHHHHHHHHhcCCcccCCCC
Q 006112 489 DHGNDL--HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACG-RRPVQPGELDLLDWVIDYWQKGDVLDASDP 565 (660)
Q Consensus 489 ~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 565 (660)
..+... ......||-||+|||++...+.+...||||+||++|+.++| ..||...-.... ........+..+.+
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~----NIl~~~~~L~~L~~ 737 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA----NILTGNYTLVHLEP 737 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh----hhhcCccceeeecc
Confidence 765443 23467899999999999998889999999999999999986 899975221111 01111111111111
Q ss_pred cccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 566 RLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 566 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
..++ ...+|+..|+++||..||++.+|+.
T Consensus 738 ------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 738 ------LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ------CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 1111 5678888899999999999999974
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-31 Score=275.16 Aligned_cols=247 Identities=24% Similarity=0.306 Sum_probs=199.2
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
+++.+..+|-||||.|=+.........+|+|.+++. .....+....|-.+|.+.+.|.||+++-.+.+...+|++||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 456667789999999999988665556888887543 34456778899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
-|-||.|...|.+.+ .++......++..+.+|++|||. ++||.|||||+|.|||.+|-+||.|||+|+.+..+.
T Consensus 501 aClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~- 574 (732)
T KOG0614|consen 501 ACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR- 574 (732)
T ss_pred hhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccCC-
Confidence 999999999997654 58888999999999999999998 999999999999999999999999999999876554
Q ss_pred ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHHHHHHhcCCcccCCCCcccccCc
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
.+...+|||.|.|||++.+...+.+.|.||+|+++|||++|++||...+. .....+..-. +.+ .++
T Consensus 575 -KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi---d~i---------~~P 641 (732)
T KOG0614|consen 575 -KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI---DKI---------EFP 641 (732)
T ss_pred -ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh---hhh---------hcc
Confidence 35568999999999999999999999999999999999999999986432 2111111111 111 112
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCC-----HHHHHH
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRPS-----MRQVVQ 602 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 602 (660)
....+...+|++..+..+|.+|.- ..+|-+
T Consensus 642 r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk 676 (732)
T KOG0614|consen 642 RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK 676 (732)
T ss_pred cccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence 222334455566667889999976 566654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-29 Score=241.68 Aligned_cols=212 Identities=32% Similarity=0.528 Sum_probs=185.7
Q ss_pred cccCccEEEEEEEeCCCCeEEEEEEeccCCCh-hhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCCCCChhh
Q 006112 344 ATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDH-GMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDK 422 (660)
Q Consensus 344 lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~ 422 (660)
+|+|++|.||++....+++.+++|++...... ..+.+.+|++.+++++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 57899999999999877899999998765433 45789999999999999999999999999999999999999999999
Q ss_pred hhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcC-CCCeEEeecccceeccCCCCceeecccc
Q 006112 423 ILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDA-DLEGKLGDFGLARLYDHGNDLHTTNVVG 501 (660)
Q Consensus 423 ~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~g 501 (660)
++.... ..+++..+..++.+++++|++||+ .+++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~ 155 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG 155 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence 987653 358899999999999999999998 89999999999999999 89999999999987654321 1233567
Q ss_pred CccccCcccccCC-CCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHH
Q 006112 502 TVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVL 580 (660)
Q Consensus 502 t~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 580 (660)
...|++||.+... ..+.+.|+|++|+++++| ..+.
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------~~~~ 191 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------PELK 191 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------HHHH
Confidence 8899999999877 788999999999999999 4577
Q ss_pred HHhhhccCCCCCCCCCHHHHHHHh
Q 006112 581 KLGLFCSHSNPDTRPSMRQVVQYL 604 (660)
Q Consensus 581 ~l~~~Cl~~dP~~RPs~~evl~~L 604 (660)
+++..|++.||++||+++++++.|
T Consensus 192 ~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 192 DLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHhhCCcccCcCHHHHhhCC
Confidence 888889999999999999998754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=250.20 Aligned_cols=245 Identities=24% Similarity=0.294 Sum_probs=194.4
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCeeEE
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLL 410 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~l 410 (660)
--.+..+..||+|++.+|..++++++.+.+|+|++++. ..+.+.-...|-.+..+. +||.+|-++.+++.+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 34678899999999999999999999999999998754 344455566677776665 69999999999999999999
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccC
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDH 490 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 490 (660)
|.||++||+|--++++.. .|+++.+.-+...|..||.|||+ +||+.||||.+|||||..|.+||.|+|+++.--.
T Consensus 329 vieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 999999999988876543 49999999999999999999998 9999999999999999999999999999975322
Q ss_pred CCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCC-----CCcchHHHHHHHHhcCCcccCCCC
Q 006112 491 GNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQP-----GELDLLDWVIDYWQKGDVLDASDP 565 (660)
Q Consensus 491 ~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~-----~~~~~~~~~~~~~~~~~~~~~~d~ 565 (660)
. ...+...+|||.|+|||++++..|....|.|++||+++||+.|+.||+. .+...-++..+..-+.++.
T Consensus 404 ~-gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir----- 477 (593)
T KOG0695|consen 404 P-GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR----- 477 (593)
T ss_pred C-CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc-----
Confidence 2 2234568999999999999999999999999999999999999999974 2233334444433332221
Q ss_pred cccccCcHHHHHHHHHHhhhccCCCCCCCC
Q 006112 566 RLEGIYVEEQMEIVLKLGLFCSHSNPDTRP 595 (660)
Q Consensus 566 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 595 (660)
++...+.. ...+...-++.||.+|.
T Consensus 478 -iprslsvk----as~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 478 -IPRSLSVK----ASHVLKGFLNKDPKERL 502 (593)
T ss_pred -ccceeehh----hHHHHHHhhcCCcHHhc
Confidence 11111222 22334446888998884
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-30 Score=248.92 Aligned_cols=259 Identities=29% Similarity=0.381 Sum_probs=197.9
Q ss_pred ccccccCccEEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHhccCCCCceeEeeeeeec-----CeeEEEEe
Q 006112 341 LYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD--HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK-----GELLLVYD 413 (660)
Q Consensus 341 l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~~lV~E 413 (660)
-+-||-|+||.||..+++.+|+.||.|++.+.-. ...+.+.+|++++..++|.|++..++..+.. .++|++.|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 3468999999999999999999999999865432 3467899999999999999999999876544 36789999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
.| ..+|.+.+-... .++-..+.-++.||++||.|||+ .+|.||||||.|.|++.|...||+|||++|..+....
T Consensus 138 Lm-QSDLHKIIVSPQ--~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 138 LM-QSDLHKIIVSPQ--ALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR 211 (449)
T ss_pred HH-HhhhhheeccCC--CCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccchhhh
Confidence 99 678888886543 47777888889999999999998 9999999999999999999999999999998877776
Q ss_pred ceeeccccCccccCcccccCC-CCCcceeEEehHHHHHHHhhCCCCCCC-CCcchHHHHHHHHhcCCc------------
Q 006112 494 LHTTNVVGTVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQP-GELDLLDWVIDYWQKGDV------------ 559 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~-~~~~~~~~~~~~~~~~~~------------ 559 (660)
...+..+-|.-|.|||++.+. .|+...||||.||++.||+..+.-|+. +..+..+.+.++......
T Consensus 212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~ 291 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN 291 (449)
T ss_pred hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence 777777779999999998864 689999999999999999988877765 223333444333322111
Q ss_pred --ccC--CCCcccccC---c--HHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 560 --LDA--SDPRLEGIY---V--EEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 560 --~~~--~d~~l~~~~---~--~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
+.. ..|.+.-.+ + ..+ ..-..+...++..||++|.+..+.+.++..
T Consensus 292 H~LR~~~k~Ps~~vLYtlsS~~~~~-heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 292 HVLRAGLRAPDTQRLYKIASPDDKN-HEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred HhhccCCCCCCccceeeecCCcccc-hHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 000 011111101 0 111 122333445789999999999999887643
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=238.02 Aligned_cols=200 Identities=32% Similarity=0.433 Sum_probs=175.0
Q ss_pred eecccccccCccEEEEEEEeCCCCeEEEEEEeccCCCh-hhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCC
Q 006112 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDH-GMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 416 (660)
|+....+++|++|.||++....+++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 34567789999999999999887899999999766554 67889999999999999999999999999999999999999
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCcee
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT 496 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 496 (660)
+++|.+++..... .+++..+..++.+++.+|.+||+ .+++|+||+|+||+++.++.++|+|||.+...........
T Consensus 81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 9999999976432 27899999999999999999998 8999999999999999999999999999987655431122
Q ss_pred eccccCccccCcccc-cCCCCCcceeEEehHHHHHHHhhCCCCCCC
Q 006112 497 TNVVGTVGYLAPELL-RNGRGTTSTDVYAFGVFMLEVACGRRPVQP 541 (660)
Q Consensus 497 ~~~~gt~~Y~aPE~~-~~~~~t~ksDV~S~Gvvl~elltG~~p~~~ 541 (660)
....++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 345678899999998 666778899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=231.31 Aligned_cols=197 Identities=24% Similarity=0.412 Sum_probs=167.8
Q ss_pred CceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccC-CCCceeEeeeeeecC--eeEE
Q 006112 334 HRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLR-HRNLVQLRGYCRRKG--ELLL 410 (660)
Q Consensus 334 ~~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~--~~~l 410 (660)
..-.|+.++++|+|.++.||.|....+.++++||.++.. ..+.+.+|+++|..|+ ||||+++++...+.. ...|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 345899999999999999999998888999999998543 3467899999999997 999999999987663 4689
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCC-CCeEEeecccceecc
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDAD-LEGKLGDFGLARLYD 489 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~-~~~kl~DFGla~~~~ 489 (660)
|+||+.+.+...+- +.++...+...+.++++||.|+|+ +||.|||+||.|+|||.. -..+|+|+|||..+.
T Consensus 113 iFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred HhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 99999998887654 247777888999999999999998 999999999999999875 569999999999887
Q ss_pred CCCCceeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCC
Q 006112 490 HGNDLHTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGE 543 (660)
Q Consensus 490 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~ 543 (660)
.+..... .+.+.-|.-||++.. +.|+.+-|+|||||++..|+..+.||..+.
T Consensus 185 p~~eYnV--RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~ 237 (338)
T KOG0668|consen 185 PGKEYNV--RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 237 (338)
T ss_pred CCceeee--eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC
Confidence 7655432 345667888999865 567889999999999999999999997543
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=259.46 Aligned_cols=199 Identities=27% Similarity=0.399 Sum_probs=173.2
Q ss_pred Cce-eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--------ChhhHHHHHHHHHHhccC---CCCceeEeee
Q 006112 334 HRF-SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--------DHGMKQFVSEIVSMGKLR---HRNLVQLRGY 401 (660)
Q Consensus 334 ~~~-~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~---H~nIv~l~g~ 401 (660)
++| +|..++.+|+|+||.|+.+.++.+...|+||.+.+.. ....-..-.||+||..++ |+||++++++
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 344 6999999999999999999999999999999986542 122234667999999997 9999999999
Q ss_pred eeecCeeEEEEecC-CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEe
Q 006112 402 CRRKGELLLVYDYM-PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLG 480 (660)
Q Consensus 402 ~~~~~~~~lV~E~~-~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~ 480 (660)
+++++..||+||-. ++-+|.+++...+ .+++.++.-|++||+.|+++||+ ++|||||||-+||.++.+|-+||+
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEe
Confidence 99999999999986 4568889987654 49999999999999999999998 999999999999999999999999
Q ss_pred ecccceeccCCCCceeeccccCccccCcccccCCCC-CcceeEEehHHHHHHHhhCCCCCC
Q 006112 481 DFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQ 540 (660)
Q Consensus 481 DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~ 540 (660)
|||.|.....+. ....+||..|.|||++.+.+| ...-|||++|++||-++....||+
T Consensus 713 dfgsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 713 DFGSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eccchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999997654432 335789999999999998877 556899999999999999888886
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=245.20 Aligned_cols=132 Identities=26% Similarity=0.300 Sum_probs=116.7
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccC-----C---CCceeEeeeeee---
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLR-----H---RNLVQLRGYCRR--- 404 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----H---~nIv~l~g~~~~--- 404 (660)
-.|...++||.|-|++||++.+.++.+.||+|+++. ..+..+.-+.||++|++++ | .+||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 469999999999999999999999999999999853 3445677889999999984 2 469999999874
Q ss_pred -cCeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEE
Q 006112 405 -KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLL 471 (660)
Q Consensus 405 -~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll 471 (660)
+.++|||+|++ |.+|.++|....-..++...+.+|++||+.||.|||.+ .+|||-||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeee
Confidence 35799999999 88999999887777899999999999999999999995 699999999999999
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=228.72 Aligned_cols=247 Identities=22% Similarity=0.301 Sum_probs=187.5
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhcc-CCCCceeEeee-eeecCeeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKL-RHRNLVQLRGY-CRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~-~~~~~~~~lV~E~ 414 (660)
.|.+.+.+|+|.||.+.+++++++.+.+++|-+... .-.+++|.+|..---.| .|.||+.-+.. ++..+..++++||
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~ 103 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF 103 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence 577889999999999999999999999999988543 23467899998766666 59999987764 5667788899999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEE-cC-CCCeEEeecccceeccCCC
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLL-DA-DLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll-~~-~~~~kl~DFGla~~~~~~~ 492 (660)
++.|+|..-+... .+.+.--.+++.|+++|+.|+|+ +++||||||.+|||| +. ...+||+|||+.+..+..
T Consensus 104 aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t- 176 (378)
T KOG1345|consen 104 APRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT- 176 (378)
T ss_pred CccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCce-
Confidence 9999999888654 37777888999999999999998 999999999999999 33 347999999998754321
Q ss_pred CceeeccccCccccCcccccCC-----CCCcceeEEehHHHHHHHhhCCCCCCCCC-cchHHHHHHHHhcCCcccCCCCc
Q 006112 493 DLHTTNVVGTVGYLAPELLRNG-----RGTTSTDVYAFGVFMLEVACGRRPVQPGE-LDLLDWVIDYWQKGDVLDASDPR 566 (660)
Q Consensus 493 ~~~~~~~~gt~~Y~aPE~~~~~-----~~t~ksDV~S~Gvvl~elltG~~p~~~~~-~~~~~~~~~~~~~~~~~~~~d~~ 566 (660)
.....-+..|.+||..... ...+.+|||.|||+++.++||+.||+... .+..-|-+..|..+... .-|+
T Consensus 177 ---V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~--~~P~ 251 (378)
T KOG1345|consen 177 ---VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP--ALPK 251 (378)
T ss_pred ---ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc--cCch
Confidence 1122345679999986532 24678999999999999999999998632 23345556666665443 3333
Q ss_pred ccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHH
Q 006112 567 LEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQV 600 (660)
Q Consensus 567 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev 600 (660)
.-..+.+..+. +-..-+.++|++|=...++
T Consensus 252 ~F~~fs~~a~r----~Fkk~lt~~~~drcki~~~ 281 (378)
T KOG1345|consen 252 KFNPFSEKALR----LFKKSLTPRFKDRCKIWTA 281 (378)
T ss_pred hhcccCHHHHH----HHHHhcCCcccccchhHHH
Confidence 33445554443 4444689999999444443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-28 Score=240.01 Aligned_cols=256 Identities=23% Similarity=0.255 Sum_probs=197.9
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeec------Ce
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK------GE 407 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------~~ 407 (660)
..|..++.++.|.- .|.-+.+.-.++.||+|++... .....++..+|..++..+.|+||++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46888899999988 7777777778899999988543 223456778999999999999999999988543 46
Q ss_pred eEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeeccccee
Q 006112 408 LLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARL 487 (660)
Q Consensus 408 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 487 (660)
.|+||||| ..+|...+.- .++-.....|..|++.|++|||+ .+|+||||||+||++..+..+||.|||+|+.
T Consensus 96 ~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhcc
Confidence 89999999 7899888862 36777889999999999999998 9999999999999999999999999999986
Q ss_pred ccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcc-------
Q 006112 488 YDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVL------- 560 (660)
Q Consensus 488 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~------- 560 (660)
.... ...+..+.|.-|.|||++.+..+.+..||||.||++.||++|+.-|.+ ...+.+|..-.-.-|...
T Consensus 168 e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g-~d~idQ~~ki~~~lgtpd~~F~~qL 244 (369)
T KOG0665|consen 168 EDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG-KDHIDQWNKIIEQLGTPDPSFMKQL 244 (369)
T ss_pred cCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC-chHHHHHHHHHHHhcCCCHHHHHHh
Confidence 4433 345667889999999999888899999999999999999999988864 222333322111111000
Q ss_pred ---------------------cCCCCcccc--cCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 561 ---------------------DASDPRLEG--IYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 561 ---------------------~~~d~~l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
...|..+.. +.++........++..|+..||++|.+.++++++
T Consensus 245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 000111111 1122344567788889999999999999999984
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-28 Score=259.28 Aligned_cols=253 Identities=26% Similarity=0.332 Sum_probs=204.0
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
-.|+.++++|.|.+|.|||+++..+++..|+|.++.......+-...|+-+++..+||||+.++|-+..+..++++||||
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc 94 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC 94 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence 37899999999999999999999999999999998887777888889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 495 (660)
.+|+|++.-+.. ..+++.++..+++...+||.|||+ .+-+|||||-.|||+++.+.+|++|||.+-.+.... ..
T Consensus 95 gggslQdiy~~T--gplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati-~K 168 (829)
T KOG0576|consen 95 GGGSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI-AK 168 (829)
T ss_pred CCCcccceeeec--ccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhhh-hh
Confidence 999999865433 458999999999999999999998 899999999999999999999999999986654321 23
Q ss_pred eeccccCccccCccccc---CCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCc
Q 006112 496 TTNVVGTVGYLAPELLR---NGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
.....||+-|||||+.. .+.|..++|||+.|+...|+.--+.|...... ..+..+..+. . ..-|.+.+ .
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp---mr~l~LmTkS-~--~qpp~lkD--k 240 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP---MRALFLMTKS-G--FQPPTLKD--K 240 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch---HHHHHHhhcc-C--CCCCcccC--C
Confidence 34578999999999863 56789999999999999999877766432111 1111111111 0 11122221 1
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
...-+.+.++++.|+..+|++||+++.+++
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 233445777888899999999999988764
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.5e-27 Score=243.12 Aligned_cols=259 Identities=22% Similarity=0.232 Sum_probs=200.0
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccC------CCCceeEeeeeeecCeeEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLR------HRNLVQLRGYCRRKGELLL 410 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~------H~nIv~l~g~~~~~~~~~l 410 (660)
.|......|+|-|++|.+|.+...+..||||+|..+. -..+.=+.|+++|++|. --|+++|+-.|...+++||
T Consensus 433 RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLCl 511 (752)
T KOG0670|consen 433 RYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCL 511 (752)
T ss_pred eeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEE
Confidence 5667777899999999999999989999999996542 33455678999999994 4689999999999999999
Q ss_pred EEecCCCCChhhhhhhCCC-CCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCC-CeEEeecccceec
Q 006112 411 VYDYMPNGSLDKILYSNTR-PSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADL-EGKLGDFGLARLY 488 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~-~~kl~DFGla~~~ 488 (660)
|+|-+ .-+|.+.|...++ ..|....+..++.|+.-||..|-. .+|+|+||||+|||+++.. .+||||||.|...
T Consensus 512 VFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~ 587 (752)
T KOG0670|consen 512 VFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESKNILKLCDFGSASFA 587 (752)
T ss_pred Eehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCcceeeeccCcccccc
Confidence 99988 7899999986543 458888999999999999999998 8999999999999998864 5899999999765
Q ss_pred cCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHHHHH--------HhcCCc
Q 006112 489 DHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVIDY--------WQKGDV 559 (660)
Q Consensus 489 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~--------~~~~~~ 559 (660)
.... .+...-...|.|||++.+-.|+...|+||.||+||||.||+..|.+... ..+....+. .++|..
T Consensus 588 ~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF 664 (752)
T KOG0670|consen 588 SENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQF 664 (752)
T ss_pred cccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcch
Confidence 4332 2334446689999999999999999999999999999999999976322 222222211 112211
Q ss_pred cc---------------------------CCCC------cccc--cCc---HHHHHHHHHHhhhccCCCCCCCCCHHHHH
Q 006112 560 LD---------------------------ASDP------RLEG--IYV---EEQMEIVLKLGLFCSHSNPDTRPSMRQVV 601 (660)
Q Consensus 560 ~~---------------------------~~d~------~l~~--~~~---~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 601 (660)
.+ .+.| .+.+ .+. ......+..|...|+..||++|.|..|++
T Consensus 665 ~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL 744 (752)
T KOG0670|consen 665 KDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQAL 744 (752)
T ss_pred hhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHh
Confidence 11 1111 0000 122 23345677888899999999999999988
Q ss_pred HH
Q 006112 602 QY 603 (660)
Q Consensus 602 ~~ 603 (660)
++
T Consensus 745 ~H 746 (752)
T KOG0670|consen 745 KH 746 (752)
T ss_pred cC
Confidence 64
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.1e-27 Score=276.83 Aligned_cols=195 Identities=18% Similarity=0.283 Sum_probs=140.9
Q ss_pred ccCC-CCceeEeeee-------eecCeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCcee
Q 006112 389 KLRH-RNLVQLRGYC-------RRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVL 460 (660)
Q Consensus 389 ~l~H-~nIv~l~g~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv 460 (660)
.++| +||++++++| .+...+++++||+ +++|.++|.... ..+++.++..++.||++||.|||+ ++|+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAHS---QGIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHHh---CCee
Confidence 4556 6888899987 2334578889988 779999997543 459999999999999999999998 9999
Q ss_pred ccCccCCcEEEcC-------------------CCCeEEeecccceeccCCC---------------CceeeccccCcccc
Q 006112 461 HRDIKPANVLLDA-------------------DLEGKLGDFGLARLYDHGN---------------DLHTTNVVGTVGYL 506 (660)
Q Consensus 461 HrDikp~NIll~~-------------------~~~~kl~DFGla~~~~~~~---------------~~~~~~~~gt~~Y~ 506 (660)
||||||+||||+. ++.+|++|||+++...... ........||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999954 4456677777765422100 00011246899999
Q ss_pred CcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhc
Q 006112 507 APELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFC 586 (660)
Q Consensus 507 aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C 586 (660)
|||++.+..++.++|||||||+||||++|..|+....... .. ..... ..+.. .........++.+|
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~----~~-~~~~~----~~~~~-----~~~~~~~~~~~~~~ 248 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTM----SS-LRHRV----LPPQI-----LLNWPKEASFCLWL 248 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHH----HH-HHHhh----cChhh-----hhcCHHHHHHHHHh
Confidence 9999999999999999999999999999988765321111 11 11100 11111 01122345677889
Q ss_pred cCCCCCCCCCHHHHHH
Q 006112 587 SHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 587 l~~dP~~RPs~~evl~ 602 (660)
|++||.+||+|.|+++
T Consensus 249 L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 249 LHPEPSCRPSMSELLQ 264 (793)
T ss_pred CCCChhhCcChHHHhh
Confidence 9999999999999986
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-26 Score=235.67 Aligned_cols=259 Identities=25% Similarity=0.377 Sum_probs=195.3
Q ss_pred ceeeecccccccCccEEEEEEEeCC---CCeEEEEEEeccCCChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCeeEE
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPS---SHAEIAVKKVCHDSDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLL 410 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~---~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~l 410 (660)
.-.|..+.++|+|.|++||++++.. ....||+|.+...+. .....+|+++|..+ .+.||+++.++...++..++
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~i 112 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAI 112 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCeeEE
Confidence 3468889999999999999999977 678999999865443 45689999999999 49999999999999999999
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCC-CCeEEeecccceecc
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDAD-LEGKLGDFGLARLYD 489 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~-~~~kl~DFGla~~~~ 489 (660)
|+||++.....++... ++..++..++..+.+||.++|. +|||||||||+|+|.+.. +.-.|.|||||..++
T Consensus 113 vlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 113 VLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD 184 (418)
T ss_pred EecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHHHH
Confidence 9999999999888753 6678899999999999999998 999999999999999765 567899999997221
Q ss_pred CCC--------------C-----------------------------ceeeccccCccccCccccc-CCCCCcceeEEeh
Q 006112 490 HGN--------------D-----------------------------LHTTNVVGTVGYLAPELLR-NGRGTTSTDVYAF 525 (660)
Q Consensus 490 ~~~--------------~-----------------------------~~~~~~~gt~~Y~aPE~~~-~~~~t~ksDV~S~ 525 (660)
... . ......+||+||.|||++. .+..++++||||.
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence 000 0 0011247999999999875 4567899999999
Q ss_pred HHHHHHHhhCCCCCCCCCc--chHHHHHHHHh----------cCC--ccc---------------CCC-Cccc-------
Q 006112 526 GVFMLEVACGRRPVQPGEL--DLLDWVIDYWQ----------KGD--VLD---------------ASD-PRLE------- 568 (660)
Q Consensus 526 Gvvl~elltG~~p~~~~~~--~~~~~~~~~~~----------~~~--~~~---------------~~d-~~l~------- 568 (660)
||+++-+++++.||..... .....+..... .|. +.+ ..+ ..+.
T Consensus 265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~ 344 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT 344 (418)
T ss_pred cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence 9999999999999975222 11111111100 122 111 000 0000
Q ss_pred --ccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 569 --GIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 569 --~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
..........++++..+|+..||.+|.|+++.+++
T Consensus 345 ~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 345 EREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred eeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 00111122367888999999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.7e-25 Score=211.84 Aligned_cols=166 Identities=21% Similarity=0.174 Sum_probs=125.3
Q ss_pred CChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCceee
Q 006112 418 GSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTT 497 (660)
Q Consensus 418 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 497 (660)
|+|.+++.... ..++|.+++.++.||+.||+|||+ ++ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----- 63 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----- 63 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc-----
Confidence 78999997643 359999999999999999999998 44 999999999999999 99998754322
Q ss_pred ccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHH
Q 006112 498 NVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQME 577 (660)
Q Consensus 498 ~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 577 (660)
..||+.|||||++.+..++.++|||||||++|||++|+.||..... .............. .++.. ........+
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~-~~~~~~~~~~~~~~---~~~~~-~~~~~~~~~ 137 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE-LSAILEILLNGMPA---DDPRD-RSNLESVSA 137 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch-hcHHHHHHHHHhcc---CCccc-cccHHHHHh
Confidence 2689999999999999999999999999999999999999965321 11111111111110 11100 001112222
Q ss_pred --HHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 578 --IVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 578 --~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
.+.+++.+||+.||++||++.|+++++..
T Consensus 138 ~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 138 ARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred hhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 58899999999999999999999998754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.6e-24 Score=224.05 Aligned_cols=162 Identities=20% Similarity=0.219 Sum_probs=129.2
Q ss_pred eeeecccccccCccEEEEEEEeCC-CCeEEEEEEeccC-----CChhhHHHHHHHHHHhccCCCCcee-EeeeeeecCee
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPS-SHAEIAVKKVCHD-----SDHGMKQFVSEIVSMGKLRHRNLVQ-LRGYCRRKGEL 408 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~-~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~H~nIv~-l~g~~~~~~~~ 408 (660)
..|...+.||+|+||+||+|.+.. +++.+|||++... .....+.|.+|++++++++|+|+++ ++.+ +..
T Consensus 18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~ 93 (365)
T PRK09188 18 ARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GKD 93 (365)
T ss_pred CCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CCc
Confidence 468889999999999999999875 6778899987533 1223567999999999999999985 4432 468
Q ss_pred EEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCc-cCCcEEEcCCCCeEEeeccccee
Q 006112 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDI-KPANVLLDADLEGKLGDFGLARL 487 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDi-kp~NIll~~~~~~kl~DFGla~~ 487 (660)
++|||||+|++|... . .. ....++.+++++|.|||+ ++|+|||| ||+|||++.++++||+|||+|+.
T Consensus 94 ~LVmE~~~G~~L~~~-~--~~------~~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 94 GLVRGWTEGVPLHLA-R--PH------GDPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred EEEEEccCCCCHHHh-C--cc------chHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 999999999999632 1 11 114678899999999998 99999999 99999999999999999999987
Q ss_pred ccCCCCc-------eeeccccCccccCcccccC
Q 006112 488 YDHGNDL-------HTTNVVGTVGYLAPELLRN 513 (660)
Q Consensus 488 ~~~~~~~-------~~~~~~gt~~Y~aPE~~~~ 513 (660)
+...... ..+...+++.|+|||++..
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 6543211 1135678999999999864
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.1e-23 Score=216.93 Aligned_cols=259 Identities=22% Similarity=0.193 Sum_probs=195.6
Q ss_pred eeecccccccCccEEEEEEEeCCCC-eEEEEEEeccCCChhhHHHHHHHHHHhccCC----CCceeEeeee-eecCeeEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSH-AEIAVKKVCHDSDHGMKQFVSEIVSMGKLRH----RNLVQLRGYC-RRKGELLL 410 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~-~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H----~nIv~l~g~~-~~~~~~~l 410 (660)
.|+..+++|+|+||.||++.....+ ..+|+|............+..|+.++..+.. +++.++++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 7999999999999999999987664 6788887765433333378889999988873 6888999888 47778899
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCC-----CCeEEeecccc
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDAD-----LEGKLGDFGLA 485 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~-----~~~kl~DFGla 485 (660)
||+.+ |.+|.++........++.....+|+.|++.+|++||+ .|++||||||+|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999 9999998866655679999999999999999999998 999999999999999765 46999999999
Q ss_pred e--eccCCCC-----c-e-eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcc-hHHHHHHHHh
Q 006112 486 R--LYDHGND-----L-H-TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELD-LLDWVIDYWQ 555 (660)
Q Consensus 486 ~--~~~~~~~-----~-~-~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~~~~ 555 (660)
+ .+..... . . .....||.+|++++...+...+.+.|+||++.++.|+..|..||...+.. ....+.+...
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 8 3221111 1 1 22356999999999999999999999999999999999999999764322 2221111111
Q ss_pred cCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCCC
Q 006112 556 KGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGA 608 (660)
Q Consensus 556 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (660)
. ..... .....+.+ +.++...+-..+..++|....+...|+...
T Consensus 255 ~-~~~~~-----~~~~~~~~---~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 255 K-LLTDR-----FGDLKPEE---FAKILEYIDSLDYEDKPDYEKLAELLKDVF 298 (322)
T ss_pred h-hcccc-----ccCCChHH---HHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence 1 11110 11122333 334444455689999999999998876543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.7e-24 Score=206.05 Aligned_cols=247 Identities=21% Similarity=0.348 Sum_probs=185.4
Q ss_pred eecccccccCccEEEEEEEeCCCCeEEEEEEecc--CCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCH--DSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
+..+.++.+.-.|..|+|+|.+ ..+++|++.. .....-++|..|.-.++-+.||||+.++|.|.....+.++..||
T Consensus 192 lnl~tkl~e~hsgelwrgrwqg--ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQG--NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhccCCCcccccccccC--cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 3344556678889999999954 4466676532 33445578999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEe--ecccceeccCCCC
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLG--DFGLARLYDHGND 493 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~--DFGla~~~~~~~~ 493 (660)
+-|||...|+....-..+..|+.+++.++|+|++|||+- ++-|.---|.+..+++|++..+||. |--++.
T Consensus 270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsf------- 341 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSF------- 341 (448)
T ss_pred cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeee-------
Confidence 999999999988777788999999999999999999983 3445555789999999999988874 221111
Q ss_pred ceeeccccCccccCcccccCCCC---CcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCccccc
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRG---TTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGI 570 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~---t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 570 (660)
......=.|.||+||.++..+. -..+|+|||.+++|||.|...||..-..- +.-.+.. ++. ++-.
T Consensus 342 -qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm--ecgmkia-----leg----lrv~ 409 (448)
T KOG0195|consen 342 -QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM--ECGMKIA-----LEG----LRVH 409 (448)
T ss_pred -eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch--hhhhhhh-----hcc----cccc
Confidence 1111233678999999976544 35799999999999999999999752211 1111111 111 2222
Q ss_pred CcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 571 YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
.++.....+.+|+.-|+..||.+||.+..|+-.|+.
T Consensus 410 ippgis~hm~klm~icmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 410 IPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred CCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence 333344456677777999999999999999988875
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-21 Score=202.26 Aligned_cols=259 Identities=28% Similarity=0.398 Sum_probs=197.6
Q ss_pred eecccccccCccEEEEEEEeCCCCeEEEEEEeccCCCh---hhHHHHHHHHHHhccCCC-CceeEeeeeeecCeeEEEEe
Q 006112 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDH---GMKQFVSEIVSMGKLRHR-NLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~H~-nIv~l~g~~~~~~~~~lV~E 413 (660)
|...+.+|.|+||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +++++.+.+......++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 566778999999999999996 67899998655332 477899999999999988 79999999977777899999
Q ss_pred cCCCCChhhhhhhCCC-CCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCC-CeEEeecccceeccCC
Q 006112 414 YMPNGSLDKILYSNTR-PSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADL-EGKLGDFGLARLYDHG 491 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~-~~kl~DFGla~~~~~~ 491 (660)
++.+++|.+++..... ..+.......++.|++.++.|+|. .+++|||+||+||+++... .++++|||+++.....
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999977655432 258888999999999999999998 8899999999999999988 7999999999865443
Q ss_pred CCc-----eeeccccCccccCcccccC---CCCCcceeEEehHHHHHHHhhCCCCCCCCCcc-hHHHHHHHHhcCCcccC
Q 006112 492 NDL-----HTTNVVGTVGYLAPELLRN---GRGTTSTDVYAFGVFMLEVACGRRPVQPGELD-LLDWVIDYWQKGDVLDA 562 (660)
Q Consensus 492 ~~~-----~~~~~~gt~~Y~aPE~~~~---~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~ 562 (660)
... ......||..|++||.+.. .......|+||+|++++++++|..|+...... ............... .
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~ 234 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-S 234 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-c
Confidence 322 2356789999999999987 57889999999999999999999997654321 112222222211110 0
Q ss_pred CCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 563 SDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 563 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
................+.+++..|+..+|..|.++.+....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00001111002223456677778899999999999887764
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.5e-22 Score=188.58 Aligned_cols=257 Identities=21% Similarity=0.226 Sum_probs=195.0
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCC-CCceeEeeeeeecCeeEEEEec
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRH-RNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
-+|+.+++||.|+||.+|.|.....|++||||.-.... ...++..|.++.+.|+| ..|..+..+..++..-.+|||.
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL 92 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL 92 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence 47999999999999999999999999999999864433 33567888899988875 5677777778888889999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCC---CCeEEeecccceeccCC
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDAD---LEGKLGDFGLARLYDHG 491 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~---~~~kl~DFGla~~~~~~ 491 (660)
+ |-||++++.-..+ .++....+.++.|++.-++|+|. ++.+||||||+|+|..-+ .++.++|||||+.+.+.
T Consensus 93 L-GPsLEdLfnfC~R-~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~ 167 (341)
T KOG1163|consen 93 L-GPSLEDLFNFCSR-RFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI 167 (341)
T ss_pred c-CccHHHHHHHHhh-hhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhhccc
Confidence 9 9999998865443 48888999999999999999998 999999999999999543 46889999999877543
Q ss_pred CC------ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCC
Q 006112 492 ND------LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDP 565 (660)
Q Consensus 492 ~~------~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 565 (660)
.. .......||.+|.+-....+-..+.+.|+-|+|.+|...-.|..||++-.........+.+.+.+....+ .
T Consensus 168 ~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i-e 246 (341)
T KOG1163|consen 168 RTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI-E 246 (341)
T ss_pred cccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH-H
Confidence 32 1234568999999988777777788999999999999999999999974433322222222222221111 1
Q ss_pred cccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHh
Q 006112 566 RLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYL 604 (660)
Q Consensus 566 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (660)
.+.. ..+.++...+..|-..--++-|...-+.+.+
T Consensus 247 ~LC~----G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlF 281 (341)
T KOG1163|consen 247 VLCK----GFPAEFAMYLNYCRGLGFEEKPDYMYLRQLF 281 (341)
T ss_pred HHhC----CCcHHHHHHHHHHhhcCCCCCCcHHHHHHHH
Confidence 1112 2233455566678888888888876555543
|
|
| >cd07308 lectin_leg-like legume-like lectins: ERGIC-53, ERGL, VIP36, VIPL, EMP46, and EMP47 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-20 Score=185.27 Aligned_cols=195 Identities=21% Similarity=0.231 Sum_probs=132.2
Q ss_pred CCeeEecceeEcCCCcEEecCCCCCeeEEEEeCCCeeeccCCCCceeEEEEEEEEEecCCCCCCCCceEEEEecCCCCCC
Q 006112 38 SKLKLDGLAKIHPNGLLQLTNTSERISGHAFYPFPFKFNSSSSQSLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSE 117 (660)
Q Consensus 38 ~~l~~~g~a~~~~~g~l~Lt~~~~~~~G~~~y~~pv~~~~~~~~~~sFst~F~F~i~~~~~~~~g~GlaF~l~p~~~~~~ 117 (660)
.++.+.|+|.+. ++.|+||++..++.|++||+.|+++ .+|+|+|+|.|.+.. ..+||||||+++|....
T Consensus 20 ~~w~~~G~a~~~-~~~i~LT~~~~~~~G~~~~~~pi~~-------~~F~~~f~F~i~~~~-~~~gdG~af~~~~~~~~-- 88 (218)
T cd07308 20 GNWTVGGSTVIT-KNYIRLTPDVPSQSGSLWSRVPIPA-------KDFEIEVEFSIHGGS-GLGGDGFAFWYTEEPGS-- 88 (218)
T ss_pred CCeEEcCCeEEe-CCEEEeCCCCCCCEeEEEeCCCccC-------CCEEEEEEEEEeCCC-CCCCCEEEEEEECCCCC--
Confidence 689999999997 8899999999999999999999998 469999999998763 55899999999986432
Q ss_pred CCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCeeEEEcC-CccccccccccccccccccccccccC-CCcc
Q 006112 118 AVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVN-GLQSNESASARYFSDEKKEFESLVLE-SGKP 195 (660)
Q Consensus 118 ~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~n-s~~s~~~~~~~~~~~~~~~~~~~~l~-~g~~ 195 (660)
.|..+|- ....+-+||||||+.|. +...++|.+-+| ...+.....-+......++ .+... ++.+
T Consensus 89 --~g~~~G~-------~~~~~Glai~fdt~~n~---~~~~p~i~~~~Ndg~~~~~~~~d~~~~~~~~c--~~~~~~~~~~ 154 (218)
T cd07308 89 --DGPLFGG-------PDKFKGLAIFFDTYDND---GKGFPSISVFLNDGTKSYDYETDGEKLELASC--SLKFRNSNAP 154 (218)
T ss_pred --CCccccc-------CCCCCEEEEEEEcCCCC---CCCCCeEEEEEeCCCceecccCCCccccccce--eEecccCCCC
Confidence 3344443 12345689999999985 333444444332 1111100000000000011 11111 2679
Q ss_pred EEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeecccCceeeeeeecCcccc
Q 006112 196 IQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTRVSDYYILGWSFN 263 (660)
Q Consensus 196 ~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg~~~~~h~i~~wsf~ 263 (660)
++++|.|+ .+.|.|.+.... +....+...++.- .+|+.+|+||||+||...+.|.|++|.+.
T Consensus 155 ~~~~I~y~--~~~l~v~i~~~~---~~~~~~c~~~~~~-~l~~~~y~G~sA~tg~~~d~~dIls~~~~ 216 (218)
T cd07308 155 TTLRISYL--NNTLKVDITYSE---GNNWKECFTVEDV-ILPSQGYFGFSAQTGDLSDNHDILSVHTY 216 (218)
T ss_pred eEEEEEEE--CCEEEEEEeCCC---CCCccEEEEcCCc-ccCCCCEEEEEeccCCCcCcEEEEEEEee
Confidence 99999999 578888886431 1122233333322 46789999999999999999999999654
|
The legume-like (leg-like) lectins are eukaryotic intracellular sugar transport proteins with a carbohydrate recognition domain similar to that of the legume lectins. This domain binds high-mannose-type oligosaccharides for transport from the endoplasmic reticulum to the Golgi complex. These leg-like lectins include ERGIC-53, ERGL, VIP36, VIPL, EMP46, EMP47, and the UIP5 (ULP1-interacting protein 5) precursor protein. Leg-like lectins have different intracellular distributions and dynamics in the endoplasmic reticulum-Golgi system of the secretory pathway and interact with N-glycans of glycoproteins in a calcium-dependent manner, suggesting a role in glycoprotein sorting and trafficking. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "ba |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-22 Score=226.65 Aligned_cols=253 Identities=20% Similarity=0.209 Sum_probs=187.2
Q ss_pred cccccccCccEEEEEEEeCCCCeEEEEEEec----cC-CC-hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 340 NLYKATKGGSGKVYRGVLPSSHAEIAVKKVC----HD-SD-HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 340 ~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~----~~-~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
....+|.|++|.|+........+..+.|..+ .. .. .....+..|+.+-..++|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4556788999988877776555555555443 11 11 112236678888889999999998888877777666699
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
||++ +|..++.... .+.-.++..+++|+..|+.|||+ .||.|||+|++|++++.++.+||+|||.+..+...-.
T Consensus 402 ~~~~-Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred cccH-HHHHHHhccc--ccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 9999 9999987653 37778899999999999999998 9999999999999999999999999999987654433
Q ss_pred ---ceeeccccCccccCcccccCCCCCc-ceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccc
Q 006112 494 ---LHTTNVVGTVGYLAPELLRNGRGTT-STDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEG 569 (660)
Q Consensus 494 ---~~~~~~~gt~~Y~aPE~~~~~~~t~-ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 569 (660)
......+|...|+|||.+....|.+ ..||||.|+++..|++|+.||.......... ....+.. ......-..
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~---~~~~~~~-~~~~~~~~~ 551 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF---KTNNYSD-QRNIFEGPN 551 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch---hhhcccc-ccccccChH
Confidence 3445678999999999999888865 6899999999999999999997532221111 0000000 000000011
Q ss_pred cCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 570 IYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
......+.....++.+++++||.+|.|+++|++
T Consensus 552 ~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 552 RLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred HHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 122344556777888899999999999999985
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.4e-20 Score=187.10 Aligned_cols=254 Identities=19% Similarity=0.198 Sum_probs=192.7
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCeeEEEEecC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
.|+..++||+|.||..+.|+.--+++.||||.-...++ .-++..|....+.| ..++|.+.+-+-.++..-.||+|++
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 68889999999999999999988999999997644332 34667777777777 4789999888888888889999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCC-----CeEEeecccceeccC
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADL-----EGKLGDFGLARLYDH 490 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~-----~~kl~DFGla~~~~~ 490 (660)
|-||+++..-.++ .++......|+.|+..-++|+|+ +.+|.|||||+|+||...+ .+.|+|||||+.+.+
T Consensus 107 -GPSLEDLFD~CgR-~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 107 -GPSLEDLFDLCGR-RFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred -CcCHHHHHHHhcC-cccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 9999998865554 58999999999999999999998 9999999999999996543 489999999998765
Q ss_pred CCCc------eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCC
Q 006112 491 GNDL------HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASD 564 (660)
Q Consensus 491 ~~~~------~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d 564 (660)
.... ......||.+||+-....+...+.+.|+-|+|-++...+.|..||++-...-.....+.+.+.+....++
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~ 261 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIE 261 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHH
Confidence 5432 2345679999999999889999999999999999999999999999854443333333333322222222
Q ss_pred CcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 565 PRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 565 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
. |...+ +++....++. .-..+-.+-|..+-+..
T Consensus 262 ~-Lc~g~-P~efa~Yl~y---vR~L~F~E~PDYdylr~ 294 (449)
T KOG1165|consen 262 V-LCEGF-PEEFATYLRY---VRRLDFFETPDYDYLRK 294 (449)
T ss_pred H-HHhcC-HHHHHHHHHH---HHhcCcccCCCHHHHHH
Confidence 1 11122 3333333333 34457778887665544
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.3e-21 Score=204.07 Aligned_cols=215 Identities=29% Similarity=0.411 Sum_probs=163.8
Q ss_pred HhccCCCCceeEeeeeeecCeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccC
Q 006112 387 MGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKP 466 (660)
Q Consensus 387 l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp 466 (660)
|+.+.|.|+.+++|.|.++...+.|.+||..|+|.+.+.... ..++|.....++++|++||+|||. .+--.|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-IKLDYFFILSFIRDISKGLAYLHN--SPIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-cCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeeecc
Confidence 467899999999999999999999999999999999998743 469999999999999999999998 34449999999
Q ss_pred CcEEEcCCCCeEEeecccceeccCC-CCceeeccccCccccCcccccCCC-------CCcceeEEehHHHHHHHhhCCCC
Q 006112 467 ANVLLDADLEGKLGDFGLARLYDHG-NDLHTTNVVGTVGYLAPELLRNGR-------GTTSTDVYAFGVFMLEVACGRRP 538 (660)
Q Consensus 467 ~NIll~~~~~~kl~DFGla~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~-------~t~ksDV~S~Gvvl~elltG~~p 538 (660)
+|+++|..+.+||+|||+....... .........-..-|.|||.++... .+.+.||||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999999999999999998776421 111111222345799999987631 46789999999999999999999
Q ss_pred CCCCCcc-hHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 539 VQPGELD-LLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 539 ~~~~~~~-~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
|+..... ..+.+....+. .......|.+... .+....+..++..||..+|.+||++++|-..++..
T Consensus 158 ~~~~~~~~~~~eii~~~~~-~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKK-GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred cccccccCChHHHHHHHHh-cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 9862221 11223322222 1122233333211 13444788999999999999999999999888754
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.9e-20 Score=182.10 Aligned_cols=139 Identities=14% Similarity=0.064 Sum_probs=107.5
Q ss_pred cccccCccEEEEEEEeCCCCeEEEEEEeccCCCh--h-------hH-----------------HHHHHHHHHhccCCCCc
Q 006112 342 YKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDH--G-------MK-----------------QFVSEIVSMGKLRHRNL 395 (660)
Q Consensus 342 ~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~--~-------~~-----------------~~~~Ei~~l~~l~H~nI 395 (660)
..||+|+||.||+|... +|+.||||+++..... . .. ....|++.+.++.|+++
T Consensus 3 ~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 3 GCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 56899999999999996 7899999998654211 1 11 22359999999988776
Q ss_pred eeEeeeeeecCeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHh-hhcccCceeccCccCCcEEEcCC
Q 006112 396 VQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYL-HEEWEQVVLHRDIKPANVLLDAD 474 (660)
Q Consensus 396 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrDikp~NIll~~~ 474 (660)
.....+. ....+|||||+++++|...+... ..+++.+..+++.|++.+|.|| |+ .+|+||||||+|||++ +
T Consensus 82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~-~ 153 (190)
T cd05147 82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCcEEE--ecCCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-C
Confidence 4333222 12338999999988776553322 3588889999999999999999 56 8999999999999998 4
Q ss_pred CCeEEeecccceecc
Q 006112 475 LEGKLGDFGLARLYD 489 (660)
Q Consensus 475 ~~~kl~DFGla~~~~ 489 (660)
+.++|+|||+|....
T Consensus 154 ~~v~LiDFG~a~~~~ 168 (190)
T cd05147 154 GKLYIIDVSQSVEHD 168 (190)
T ss_pred CcEEEEEccccccCC
Confidence 789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.5e-20 Score=183.89 Aligned_cols=170 Identities=12% Similarity=0.139 Sum_probs=131.3
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhh---HH------HHHHHHHHhccCCCCceeEeeeeeec
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGM---KQ------FVSEIVSMGKLRHRNLVQLRGYCRRK 405 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~---~~------~~~Ei~~l~~l~H~nIv~l~g~~~~~ 405 (660)
+..|+.++.+++|+||.||.... ++..+|||.+........ .. +.+|++.+.++.|++|..+..++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 44799999999999999999655 466899999965433222 22 68999999999999999998875533
Q ss_pred --------CeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCe
Q 006112 406 --------GELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEG 477 (660)
Q Consensus 406 --------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~ 477 (660)
+..+|||||++|.+|.++.. ++. ....+++.+|..||+ .+++|||+||+||+++.++ +
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC-E
Confidence 35799999999999988731 221 346699999999998 9999999999999999988 9
Q ss_pred EEeecccceeccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHh
Q 006112 478 KLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVA 533 (660)
Q Consensus 478 kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ell 533 (660)
+|+|||........... ..+.....+..++|+|+||+++..+.
T Consensus 174 ~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99999988754322111 01333445667999999999987654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.2e-19 Score=175.09 Aligned_cols=142 Identities=17% Similarity=0.110 Sum_probs=110.6
Q ss_pred ccccccCccEEEEEEEeCCCCeEEEEEEeccCCChh--------------------------hHHHHHHHHHHhccCCCC
Q 006112 341 LYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHG--------------------------MKQFVSEIVSMGKLRHRN 394 (660)
Q Consensus 341 l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~Ei~~l~~l~H~n 394 (660)
+..||+|++|.||+|++. +|+.||||+++...... ...+..|.+.+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 457899999999999986 79999999987542110 112457899999999998
Q ss_pred ceeEeeeeeecCeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCC
Q 006112 395 LVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDAD 474 (660)
Q Consensus 395 Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~ 474 (660)
+.....+... ..+|||||++++++....... ..++..+..+++.|++.+|.+||+ +.+|+||||||+|||++ +
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~-~ 153 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH-D 153 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-C
Confidence 7544433322 248999999888654432222 246778889999999999999997 37999999999999999 7
Q ss_pred CCeEEeecccceeccC
Q 006112 475 LEGKLGDFGLARLYDH 490 (660)
Q Consensus 475 ~~~kl~DFGla~~~~~ 490 (660)
+.++|+|||++....+
T Consensus 154 ~~~~liDFG~a~~~~~ 169 (190)
T cd05145 154 GKPYIIDVSQAVELDH 169 (190)
T ss_pred CCEEEEEcccceecCC
Confidence 8999999999987544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.8e-19 Score=180.00 Aligned_cols=235 Identities=22% Similarity=0.188 Sum_probs=155.2
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHhccCC----------CCceeEeee
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKLRH----------RNLVQLRGY 401 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H----------~nIv~l~g~ 401 (660)
.-++.....||.|+++.||.+++..+++++|||...... ....+++.+|......+.+ -.++.-++.
T Consensus 11 ~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~ 90 (288)
T PF14531_consen 11 PRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL 90 (288)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred ceEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence 336777788999999999999999999999999875433 3356788888776666433 112111111
Q ss_pred e---------eecC--------eeEEEEecCCCCChhhhhh---hCCC--CCcchhHHHHHHHHHHHHHHHhhhcccCce
Q 006112 402 C---------RRKG--------ELLLVYDYMPNGSLDKILY---SNTR--PSLNWFQRFRIIKGVAFGLLYLHEEWEQVV 459 (660)
Q Consensus 402 ~---------~~~~--------~~~lV~E~~~~gsL~~~l~---~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 459 (660)
. .... ..+++|+-+ -+||.+++. .... ..+....+..+..|+.+.+++||. .|+
T Consensus 91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~Gl 166 (288)
T PF14531_consen 91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGL 166 (288)
T ss_dssp EEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred EEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cce
Confidence 1 1111 236788888 688888754 2221 235556677888999999999998 999
Q ss_pred eccCccCCcEEEcCCCCeEEeecccceeccCCCCceeeccccCccccCcccccCC--------CCCcceeEEehHHHHHH
Q 006112 460 LHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNG--------RGTTSTDVYAFGVFMLE 531 (660)
Q Consensus 460 vHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--------~~t~ksDV~S~Gvvl~e 531 (660)
+|+||||+|++++.+|.++|+||+.....+.... ....+..|.+||..... .++.+.|.|++|+++|.
T Consensus 167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp EEST-SGGGEEE-TTS-EEE--GGGEEETTEEEE----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred EecccceeeEEEcCCCCEEEcChHHHeecCceee----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 9999999999999999999999998765432111 13345789999976432 46889999999999999
Q ss_pred HhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCC
Q 006112 532 VACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTR 594 (660)
Q Consensus 532 lltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R 594 (660)
|+|++.||+....... ++..-..+. +.++.+..|+...++.||.+|
T Consensus 243 lWC~~lPf~~~~~~~~----------------~~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 243 LWCGRLPFGLSSPEAD----------------PEWDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHSS-STCCCGGGST----------------SGGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHccCCCCCCCcccc----------------ccccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999999985322110 000112333 667778888889999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.1e-19 Score=172.95 Aligned_cols=138 Identities=17% Similarity=0.209 Sum_probs=110.6
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhcc-----CCCCceeEeeeeeecC---ee
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKL-----RHRNLVQLRGYCRRKG---EL 408 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-----~H~nIv~l~g~~~~~~---~~ 408 (660)
.+...+.||+|+||.||. ++.+... +||++........+++.+|+.+++++ .||||++++|+++++. .+
T Consensus 3 ~L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 3 RLSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred ecCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 456677899999999996 6666655 69998765555667899999999999 5799999999998873 43
Q ss_pred -EEEEec--CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHH-HHhhhcccCceeccCccCCcEEEcC----CCCeEEe
Q 006112 409 -LLVYDY--MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGL-LYLHEEWEQVVLHRDIKPANVLLDA----DLEGKLG 480 (660)
Q Consensus 409 -~lV~E~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivHrDikp~NIll~~----~~~~kl~ 480 (660)
.+|+|| +.+|+|.+++.+. .+++. ..++.+++.++ +|||+ .+|+||||||+|||++. +.+++|+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEE
Confidence 478999 5589999999653 25544 35678888787 99998 99999999999999974 3479999
Q ss_pred ecccc
Q 006112 481 DFGLA 485 (660)
Q Consensus 481 DFGla 485 (660)
||+.+
T Consensus 152 Dg~G~ 156 (210)
T PRK10345 152 DNIGE 156 (210)
T ss_pred ECCCC
Confidence 95544
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.1e-20 Score=205.68 Aligned_cols=250 Identities=22% Similarity=0.220 Sum_probs=179.8
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHH--HhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-DHGMKQFVSEIVS--MGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~--l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
.+.-.+.+|.+.|=+|.+|++++ |. |+||++-+.. .-..+.|.++++- ...++|||++++.-+-..+...|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 45666789999999999999954 43 8899875443 3345555554433 445589999999999877888899999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceecc--CC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYD--HG 491 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~--~~ 491 (660)
|. .-+|.+.|. .++-+...+...|+.|++.||..+|. .+|+|+|||.+||||+.-.-+.|+||..-+..- .+
T Consensus 102 yv-khnLyDRlS--TRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 102 YV-KHNLYDRLS--TRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HH-hhhhhhhhc--cchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 98 568888774 35568888889999999999999998 999999999999999998889999998775432 11
Q ss_pred CCceee----ccccCccccCcccccCC-----------CCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHh
Q 006112 492 NDLHTT----NVVGTVGYLAPELLRNG-----------RGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQ 555 (660)
Q Consensus 492 ~~~~~~----~~~gt~~Y~aPE~~~~~-----------~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~ 555 (660)
.....+ ....-..|+|||.+... ..+++-||||+||++.||++ |+++|.- .+ ... ++
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-----SQ-L~a-Yr 248 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-----SQ-LLA-YR 248 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-----HH-HHh-Hh
Confidence 111111 11223479999987531 25788999999999999988 5777652 11 111 12
Q ss_pred cCCcccCCCCc--ccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCCC
Q 006112 556 KGDVLDASDPR--LEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGA 608 (660)
Q Consensus 556 ~~~~~~~~d~~--l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (660)
.|. ..++. +++. +...+..+++.|++.||.+|.++++.++.-.+..
T Consensus 249 ~~~---~~~~e~~Le~I----ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~ 296 (1431)
T KOG1240|consen 249 SGN---ADDPEQLLEKI----EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLV 296 (1431)
T ss_pred ccC---ccCHHHHHHhC----cCccHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence 221 11110 0110 1125778889999999999999999998766543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-18 Score=168.66 Aligned_cols=184 Identities=15% Similarity=0.036 Sum_probs=137.8
Q ss_pred cccccccCccEEEEEEEeCCCCeEEEEEEeccCCCh----hhHHHHHHHHHHhccC-CCCceeEeeeeeecCeeEEEEec
Q 006112 340 NLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDH----GMKQFVSEIVSMGKLR-HRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 340 ~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~----~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
....++.|+||+||.+.. .+.+++.+.+.....- ....+.+|+++|++|. |+++.+++++ +..+++|||
T Consensus 6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 345789999999997655 5677777776544321 1235889999999995 5889999987 346999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCc-cCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDI-KPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDi-kp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
+.|.+|...+.. ....++.|++.+|.++|+ .+|+|||| ||+|||++.++.++|+|||+|........
T Consensus 80 I~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 80 LAGAAMYQRPPR---------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred ecCccHHhhhhh---------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 999998754321 123577899999999998 99999999 79999999999999999999986543221
Q ss_pred c----e--------eeccccCccccCcccccCC-CCC-cceeEEehHHHHHHHhhCCCCCCC
Q 006112 494 L----H--------TTNVVGTVGYLAPELLRNG-RGT-TSTDVYAFGVFMLEVACGRRPVQP 541 (660)
Q Consensus 494 ~----~--------~~~~~gt~~Y~aPE~~~~~-~~t-~ksDV~S~Gvvl~elltG~~p~~~ 541 (660)
. . ......++.|++|+...-- ..+ ...+.++-|.-+|.++|++.+...
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 0 1112367888888864322 222 567888999999999999988643
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=7e-19 Score=189.42 Aligned_cols=186 Identities=25% Similarity=0.303 Sum_probs=153.3
Q ss_pred cccCccEEEEEEEe---CCCCeEEEEEEeccCCCh--hhHHHHHHHHHHhccC-CCCceeEeeeeeecCeeEEEEecCCC
Q 006112 344 ATKGGSGKVYRGVL---PSSHAEIAVKKVCHDSDH--GMKQFVSEIVSMGKLR-HRNLVQLRGYCRRKGELLLVYDYMPN 417 (660)
Q Consensus 344 lg~G~fg~Vy~g~~---~~~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~~ 417 (660)
+|+|.||.|+++.- .+.+.-+|.|..++.... .......|-.++...+ ||.+|++.-.++.+..++++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 68899999886543 234566777776543211 1114566778888887 99999999999999999999999999
Q ss_pred CChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCceee
Q 006112 418 GSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTT 497 (660)
Q Consensus 418 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 497 (660)
|.|...+.... ..+..........++-+++++|+ .+|+|||+|++||+++.+|.+|+.|||+++..-..+.
T Consensus 82 g~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~---- 152 (612)
T KOG0603|consen 82 GDLFTRLSKEV--MFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI---- 152 (612)
T ss_pred chhhhccccCC--chHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhh----
Confidence 99999886654 36667777788899999999998 9999999999999999999999999999986533222
Q ss_pred ccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCC
Q 006112 498 NVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQP 541 (660)
Q Consensus 498 ~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~ 541 (660)
.+||..|||||++. ......|.||||++++||++|..||..
T Consensus 153 -~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 -ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred -cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 28999999999997 567889999999999999999999986
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.7e-17 Score=166.95 Aligned_cols=143 Identities=15% Similarity=0.108 Sum_probs=111.3
Q ss_pred eeecccccccCccEEEEEEE-eCCCCeEEEEEEeccCCCh------------------------hhHHHHHHHHHHhccC
Q 006112 337 SYKNLYKATKGGSGKVYRGV-LPSSHAEIAVKKVCHDSDH------------------------GMKQFVSEIVSMGKLR 391 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~-~~~~~~~vavK~~~~~~~~------------------------~~~~~~~Ei~~l~~l~ 391 (660)
-|+..+.+|+|++|.||+|. ...+|+.||+|.+...... ....+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46667789999999999999 5568899999998653210 0123568999999997
Q ss_pred CCC--ceeEeeeeeecCeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCc-eeccCccCCc
Q 006112 392 HRN--LVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQV-VLHRDIKPAN 468 (660)
Q Consensus 392 H~n--Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivHrDikp~N 468 (660)
+.+ +.+++++ ...++||||+++.+|....... ..+...+...++.|++.+|++||+ .+ |+||||||+|
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~N 179 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYN 179 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhh
Confidence 633 4455543 2358999999998887665332 235556678999999999999998 88 9999999999
Q ss_pred EEEcCCCCeEEeecccceecc
Q 006112 469 VLLDADLEGKLGDFGLARLYD 489 (660)
Q Consensus 469 Ill~~~~~~kl~DFGla~~~~ 489 (660)
|+++ +++++|+|||++....
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEEE-CCCEEEEEChhhhccC
Confidence 9999 8899999999987543
|
|
| >cd06901 lectin_VIP36_VIPL VIP36 and VIPL type 1 transmembrane proteins, lectin domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.4e-16 Score=157.89 Aligned_cols=201 Identities=17% Similarity=0.163 Sum_probs=125.0
Q ss_pred CCCeeEecceeEcCCCcEEecCCCCCeeEEEEeCCCeeeccCCCCceeEEEEEEEEEecCCCCCCCCceEEEEecCCCCC
Q 006112 37 GSKLKLDGLAKIHPNGLLQLTNTSERISGHAFYPFPFKFNSSSSQSLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFS 116 (660)
Q Consensus 37 ~~~l~~~g~a~~~~~g~l~Lt~~~~~~~G~~~y~~pv~~~~~~~~~~sFst~F~F~i~~~~~~~~g~GlaF~l~p~~~~~ 116 (660)
.+++.+.|+|.+. ++.|+||++.+++.|++||+.|+++ .+|+++|+|.|.+.....+||||||+++....
T Consensus 19 i~~w~~~G~a~v~-~~~IrLTp~~~~~~G~~w~~~p~~~-------~~F~~~f~F~I~~~~~~~~GdGlAfw~t~~~~-- 88 (248)
T cd06901 19 MPLWDFLGSTMVT-SQYIRLTPDHQSKQGSIWNRVPCYL-------RDWEMHVHFKVHGSGKNLFGDGFAIWYTKERM-- 88 (248)
T ss_pred CCCEEEcceEEEc-CCeEEECCCCCCCEEEEeccCCccC-------CCEEEEEEEEEeCCCCCCCCCEEEEEEEcCCC--
Confidence 4689999999997 6799999999889999999999998 45999999999987666789999999998642
Q ss_pred CCCCCCcccccccCCCCCCCccEEEEEeecccCCCC-CCCCCCeeEEEc-CCccccccccccccccccccccccccCCCc
Q 006112 117 EAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEF-NDIDGNHVGIDV-NGLQSNESASARYFSDEKKEFESLVLESGK 194 (660)
Q Consensus 117 ~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~-~d~~~~Hvgid~-ns~~s~~~~~~~~~~~~~~~~~~~~l~~g~ 194 (660)
..|..+|-.+ . -.=+||-|||+.|.+- .....+-|-+-+ |+...-....-+......++...+ -..+.
T Consensus 89 --~~G~~fG~~~---~----f~Gl~I~~Dt~~n~~~~~~~~~P~i~~~~NDGt~~yd~~~Dg~~~~~~~C~~~~-rn~~~ 158 (248)
T cd06901 89 --QPGPVFGSKD---N----FHGLAIFFDTYSNQNGEHEHVHPYISAMVNNGSLSYDHDRDGTHTELAGCSAPF-RNKDH 158 (248)
T ss_pred --ccCcccccCC---C----CceEEEEEECCCCCCCcccCCCceEEEEEcCCCeeecccCCCchhhcCceeeec-cCCCC
Confidence 2233333211 1 1126999999998631 011222332222 222111000000000001111111 12455
Q ss_pred cEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchh-hhccceeeeeecccCceeeeeeecCccccc
Q 006112 195 PIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQ-ILQDSMYVGLSAATGTRVSDYYILGWSFNK 264 (660)
Q Consensus 195 ~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~-~l~~~~~vGFsastg~~~~~h~i~~wsf~~ 264 (660)
+.+++|.|... .|.|.+...+. -..-.+ .+... .||...|+||||+||...+.|.|++-.+..
T Consensus 159 ~t~~rI~Y~~~--~l~v~vd~~~~--~~w~~C---f~~~~v~LP~~~yfGiSA~Tg~~sd~hdIlsv~~~~ 222 (248)
T cd06901 159 DTFVAIRYSKG--RLTVMTDIDGK--NEWKEC---FDVTGVRLPTGYYFGASAATGDLSDNHDIISMKLYE 222 (248)
T ss_pred CeEEEEEEECC--eEEEEEecCCC--Cceeee---EEeCCeecCCCCEEEEEecCCCCCCcEEEEEEEEec
Confidence 67899999975 46666653221 111111 11222 367789999999999999999998865553
|
The vesicular integral protein of 36 kDa (VIP36) is a type 1 transmembrane protein of the mammalian early secretory pathway that acts as a cargo receptor transporting high mannose type glycoproteins between the Golgi and the endoplasmic reticulum (ER). Lectins of the early secretory pathway are involved in the selective transport of newly synthesized glycoproteins from the ER to the ER-Golgi intermediate compartment (ERGIC). The most prominent cycling lectin is the mannose-binding type1 membrane protein ERGIC-53, which functions as a cargo receptor to facilitate export of glycoproteins from the ER. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded she |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.7e-17 Score=162.85 Aligned_cols=135 Identities=19% Similarity=0.273 Sum_probs=114.3
Q ss_pred ccccccCccEEEEEEEeCCCCeEEEEEEeccCCCh--------hhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEE
Q 006112 341 LYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDH--------GMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 341 l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~--------~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
++.+|+|++|.||+|.+ .+..+++|+....... ....+.+|+.++..++|+++.....++...+..++||
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence 35789999999999998 5677999986543211 1246788999999999999988887777778889999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeeccccee
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARL 487 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 487 (660)
||++|++|.+++.... + .+..++.+++.+|.+||+ .+++|||++|.|||++ ++.++|+|||+++.
T Consensus 79 e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999986432 2 788999999999999998 9999999999999999 78899999999874
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.4e-17 Score=189.31 Aligned_cols=244 Identities=17% Similarity=0.160 Sum_probs=181.1
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccC---CCCceeEeeeeeecCeeEEEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLR---HRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~lV~ 412 (660)
..|.+-+.+|+|+||+||+|...+ ++.||+|+-.... .-+|.--.+++.+|+ -+.|..+...+.-.+..+||+
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~---~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ 773 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPN---PWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVS 773 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCC---ceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence 367777889999999999999976 9999999864433 234444455555665 234555555556677889999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcC-------CCCeEEeecccc
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDA-------DLEGKLGDFGLA 485 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~-------~~~~kl~DFGla 485 (660)
||.+-|+|.+++.. ...++|.....++.|++..++.||. .+|||+||||+|+||.. +..++|+|||-+
T Consensus 774 ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s 848 (974)
T KOG1166|consen 774 EYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS 848 (974)
T ss_pred eccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence 99999999999973 4469999999999999999999998 99999999999999932 345899999998
Q ss_pred eeccCC-CCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCC
Q 006112 486 RLYDHG-NDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASD 564 (660)
Q Consensus 486 ~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d 564 (660)
-.+.-- ........++|-.+-.+|+..+..++...|-|.++.+++.|+.|+..- ...|... .++
T Consensus 849 iDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q--------------~~~g~~~-~~~ 913 (974)
T KOG1166|consen 849 IDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME--------------VKNGSSW-MVK 913 (974)
T ss_pred eeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH--------------hcCCcce-ecc
Confidence 644322 223445678899999999999999999999999999999999987421 1222221 122
Q ss_pred CcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 565 PRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 565 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
..+..-...+....++.+++. +|-..=|...++...|+.
T Consensus 914 ~~~~Ry~~~~~W~~~F~~lLN---~~~~~~p~l~~lr~~~~~ 952 (974)
T KOG1166|consen 914 TNFPRYWKRDMWNKFFDLLLN---PDCDTLPNLQELRTELEE 952 (974)
T ss_pred ccchhhhhHHHHHHHHHHHhC---cCcccchhHHHHHHHHHH
Confidence 223333344555666666444 666666888887776664
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=3e-17 Score=166.91 Aligned_cols=198 Identities=23% Similarity=0.275 Sum_probs=138.2
Q ss_pred CCCCceeEeeeeee---------------------------cCeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHH
Q 006112 391 RHRNLVQLRGYCRR---------------------------KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKG 443 (660)
Q Consensus 391 ~H~nIv~l~g~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ 443 (660)
+|||||++++.+.+ +..+|+||..+ ..+|+.++..+. .+...+.-|+.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC---CchHHHHHHHHH
Confidence 68888888876522 23579999888 579999997654 344556678899
Q ss_pred HHHHHHHhhhcccCceeccCccCCcEEE--cCCC--CeEEeecccceeccCC-----CCceeeccccCccccCcccccCC
Q 006112 444 VAFGLLYLHEEWEQVVLHRDIKPANVLL--DADL--EGKLGDFGLARLYDHG-----NDLHTTNVVGTVGYLAPELLRNG 514 (660)
Q Consensus 444 ia~gL~yLH~~~~~~ivHrDikp~NIll--~~~~--~~kl~DFGla~~~~~~-----~~~~~~~~~gt~~Y~aPE~~~~~ 514 (660)
+++|+.|||. ++|.|||+|++|||+ |++. ...|+|||.+...+.. ........-|.-.-||||+....
T Consensus 350 lLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 9999999998 999999999999999 4443 4789999988543321 11122234577789999997643
Q ss_pred C------CCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccC
Q 006112 515 R------GTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSH 588 (660)
Q Consensus 515 ~------~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~ 588 (660)
+ .-.|.|.|+.|.+.||+++...||+.......+.. .+++ .--|.+.....+ .+.+++...++
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r--~Yqe-----~qLPalp~~vpp----~~rqlV~~lL~ 495 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR--TYQE-----SQLPALPSRVPP----VARQLVFDLLK 495 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechh--hhhh-----hhCCCCcccCCh----HHHHHHHHHhc
Confidence 2 13589999999999999999999986322111110 1122 223334443333 35556666699
Q ss_pred CCCCCCCCHHHHHHHhhC
Q 006112 589 SNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 589 ~dP~~RPs~~evl~~L~~ 606 (660)
.||.+|++..-....|+-
T Consensus 496 r~pskRvsp~iAANvl~L 513 (598)
T KOG4158|consen 496 RDPSKRVSPNIAANVLNL 513 (598)
T ss_pred CCccccCCccHHHhHHHH
Confidence 999999998877766653
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.5e-17 Score=158.66 Aligned_cols=129 Identities=18% Similarity=0.272 Sum_probs=106.8
Q ss_pred cccCccEEEEEEEeCCCCeEEEEEEeccCCC---h-----hhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 344 ATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD---H-----GMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 344 lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~---~-----~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
||+|+||.||+|.+ .+..+++|+...... . ..+++.+|++++..++|+++.....++......++||||+
T Consensus 2 ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 2 IAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 79999999999996 567899998643321 1 1356788999999999987666555666677789999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeeccccee
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARL 487 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 487 (660)
+|++|.+++..... .++.+++.+|.+||+ .+++|+|+||+||+++ ++.++++|||+++.
T Consensus 80 ~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND---------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH---------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999998754211 789999999999998 9999999999999999 78999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.2e-16 Score=156.89 Aligned_cols=138 Identities=14% Similarity=0.134 Sum_probs=109.4
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCCh----------------------hhHHHHHHHHHHhccCCCC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDH----------------------GMKQFVSEIVSMGKLRHRN 394 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~Ei~~l~~l~H~n 394 (660)
.|...+.|++|+||.||++... +++.||||++...... ....+..|+.++.++.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 4667788999999999999885 6899999987543210 1123677899999998874
Q ss_pred --ceeEeeeeeecCeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEc
Q 006112 395 --LVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLD 472 (660)
Q Consensus 395 --Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~ 472 (660)
+.+.++. ...++||||+++++|...... .....++.+++.++.++|+ .+|+||||||+||+++
T Consensus 95 i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~ 159 (198)
T cd05144 95 FPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVD 159 (198)
T ss_pred CCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEc
Confidence 4455443 345899999999999775421 2456788999999999998 9999999999999999
Q ss_pred CCCCeEEeecccceeccC
Q 006112 473 ADLEGKLGDFGLARLYDH 490 (660)
Q Consensus 473 ~~~~~kl~DFGla~~~~~ 490 (660)
+++.++|+|||++.....
T Consensus 160 ~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 160 DDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCCcEEEEECCccccCCC
Confidence 999999999999965443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.7e-18 Score=180.66 Aligned_cols=122 Identities=29% Similarity=0.475 Sum_probs=107.8
Q ss_pred eeEEEEecCCCCChhhhhhhC-CCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccc
Q 006112 407 ELLLVYDYMPNGSLDKILYSN-TRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLA 485 (660)
Q Consensus 407 ~~~lV~E~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla 485 (660)
.+++.|++|...+|.+||.+. .....+|.....++.|++.|+.| ++.+|||+||.||+...+.++||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999743 34557888999999999999999 68999999999999999999999999999
Q ss_pred eeccCCC-----CceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh
Q 006112 486 RLYDHGN-----DLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC 534 (660)
Q Consensus 486 ~~~~~~~-----~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt 534 (660)
....... ....+...||..||+||.+.+..|+.|+||||||++|+|++.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 7765544 223456789999999999999999999999999999999986
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.6e-16 Score=179.37 Aligned_cols=136 Identities=18% Similarity=0.200 Sum_probs=111.3
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CC------hhhHHHHHHHHHHhccCCCCceeEeeeeeecCee
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SD------HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGEL 408 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~------~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 408 (660)
.|...+.||+|+||.||+|.+... .+++|+.... .. ...+.+.+|++++++++|++++....++......
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 345568899999999999998543 3444433211 11 1235688999999999999999888888777788
Q ss_pred EEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceec
Q 006112 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLY 488 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 488 (660)
++||||+++++|.+++. ....++.+++.+|.|||+ .+++||||||+|||+ +++.++|+|||+++..
T Consensus 412 ~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 99999999999999874 356789999999999998 999999999999999 6779999999999753
|
|
| >cd06902 lectin_ERGIC-53_ERGL ERGIC-53 and ERGL type 1 transmembrane proteins, N-terminal lectin domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.8e-15 Score=146.66 Aligned_cols=200 Identities=17% Similarity=0.223 Sum_probs=129.7
Q ss_pred CCeeEecceeEcCCCcEEecCCCCCeeEEEEeCCCeeeccCCCCceeEEEEEEEEEecCCCCCCCCceEEEEecCCCCCC
Q 006112 38 SKLKLDGLAKIHPNGLLQLTNTSERISGHAFYPFPFKFNSSSSQSLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSE 117 (660)
Q Consensus 38 ~~l~~~g~a~~~~~g~l~Lt~~~~~~~G~~~y~~pv~~~~~~~~~~sFst~F~F~i~~~~~~~~g~GlaF~l~p~~~~~~ 117 (660)
++..+.|+|.+. ++.|+||++.+++.|.+|.+.|++.. +|+.+|+|.|.+.. ..+||||||+++....
T Consensus 22 ~~W~~~G~t~~~-~~~IrLTp~~~~~~G~iw~~~~~~~~-------~w~ie~~Fri~g~~-~~~gdG~a~W~t~~~~--- 89 (225)
T cd06902 22 PFWSHGGDAIAS-LEQVRLTPSLRSKKGSVWTKNPFSFE-------NWEVEVTFRVTGRG-RIGADGLAIWYTKERG--- 89 (225)
T ss_pred CceEecccEEec-CCEEEECCCCCCCEEEEeeCCCcCCC-------CEEEEEEEEEecCC-CCCCCEEEEEEECCCC---
Confidence 689999999986 78999999999999999999999853 49999999998753 3578999999997542
Q ss_pred CCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCeeEEEcC-CccccccccccccccccccccccccCCCccE
Q 006112 118 AVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVN-GLQSNESASARYFSDEKKEFESLVLESGKPI 196 (660)
Q Consensus 118 ~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~n-s~~s~~~~~~~~~~~~~~~~~~~~l~~g~~~ 196 (660)
..|..+|-.+ .-.=+||.|||+.|.+ ..+.+.|-+-+| +........-+......++..... +...+.
T Consensus 90 -~~G~~~G~~~-------~f~Gl~I~~Dt~~n~~--~~~~p~i~~~~NDGt~~yd~~~D~~~~~~~~C~~~~r-n~~~p~ 158 (225)
T cd06902 90 -EEGPVFGSSD-------KWNGVGIFFDSFDNDG--KKNNPAILVVGNDGTKSYDHQNDGLTQALGSCLRDFR-NKPYPV 158 (225)
T ss_pred -CCCCccCCCC-------cccEEEEEEECCCCCC--CCCCcEEEEEECCCCeeccccCCCcccccceEEEecc-CCCCCe
Confidence 2344444322 1123699999998863 234456644333 222211110000000001111111 235689
Q ss_pred EEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchh-hhccceeeeeecccCceeeeeeecCccccc
Q 006112 197 QIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQ-ILQDSMYVGLSAATGTRVSDYYILGWSFNK 264 (660)
Q Consensus 197 ~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~-~l~~~~~vGFsastg~~~~~h~i~~wsf~~ 264 (660)
+++|.|... .|.|.+.... .+.......-.++.. .||+..|+||||+||...+.|.|++|++.+
T Consensus 159 ~~rI~Y~~~--~l~V~~d~~~--~~~~~~~~~Cf~~~~v~LP~~~yfGiSA~Tg~l~d~hDIls~~~~s 223 (225)
T cd06902 159 RAKITYYQN--VLTVSINNGF--TPNKDDYELCTRVENMVLPPNGYFGVSAATGGLADDHDVLSFLTFS 223 (225)
T ss_pred EEEEEEECC--eEEEEEeCCc--CCCCCcccEEEecCCeeCCCCCEEEEEecCCCCCCcEeEEEEEEec
Confidence 999999984 5888886321 222111222223333 377889999999999999999999998763
|
ERGIC-53 and ERGL, N-terminal carbohydrate recognition domain. ERGIC-53 and ERGL are eukaryotic mannose-binding type 1 transmembrane proteins of the early secretory pathway that transport newly synthesized glycoproteins from the endoplasmic reticulum (ER) to the ER-Golgi intermediate compartment (ERGIC). ERGIC-53 and ERGL have an N-terminal lectin-like carbohydrate recognition domain (represented by this alignment model) as well as a C-terminal transmembrane domain. ERGIC-53 functions as a 'cargo receptor' to facilitate the export of glycoproteins with different characteristics from the ER, while the ERGIC-53-like protein (ERGL) which may act as a regulator of ERGIC-53. In mammals, ERGIC-53 forms a complex with MCFD2 (multi-coagulation factor deficiency 2) which then recruits blood coagulation factors V and VIII. Mutations in either MCFD2 or ERGIC-53 cause a mild form of inherite |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.7e-15 Score=140.41 Aligned_cols=136 Identities=18% Similarity=0.139 Sum_probs=115.6
Q ss_pred cccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCC--CCceeEeeeeeecCeeEEEEecCCC
Q 006112 340 NLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRH--RNLVQLRGYCRRKGELLLVYDYMPN 417 (660)
Q Consensus 340 ~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H--~nIv~l~g~~~~~~~~~lV~E~~~~ 417 (660)
+++.+++|.++.||++...+ ..+++|....... ...+.+|+.++..++| .++.+++++....+..+++|||+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 45678999999999999843 6799998855433 5678999999999977 5899999988888889999999998
Q ss_pred CChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceec
Q 006112 418 GSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLY 488 (660)
Q Consensus 418 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 488 (660)
+.+..+ +......++.+++++|++||.....+++|+|++|+||++++.+.+++.|||.++..
T Consensus 78 ~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 78 ETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred eecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 888654 44567788999999999999855568999999999999999899999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.7e-16 Score=178.93 Aligned_cols=210 Identities=23% Similarity=0.294 Sum_probs=141.5
Q ss_pred CCceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEE
Q 006112 333 PHRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 333 ~~~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
|....+..++.+..|++|.||..+++.+.+.+|.|.- +.. .+.+. ++.....|.+|
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trqrfa~kiN-kq~-----lilRn--ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQN-----LILRN--ILTFAGNPFVV---------------- 135 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeeccccccchhhccc-ccc-----hhhhc--cccccCCccee----------------
Confidence 5566788999999999999999999888888888432 211 11111 22222333333
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
|+=...+...+. ++- +++.+++|||+ .+|+|||+||+|.+|+.-|.+|+.|||+.+......
T Consensus 136 -----gDc~tllk~~g~--lPv--------dmvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 -----GDCATLLKNIGP--LPV--------DMVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred -----chhhhhcccCCC--Ccc--------hhhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 333344433222 221 22788999998 999999999999999999999999999987432110
Q ss_pred --------------CceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHHHHHHhcC
Q 006112 493 --------------DLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVIDYWQKG 557 (660)
Q Consensus 493 --------------~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~~~~~ 557 (660)
......++||+.|+|||++..+.|....|.|++|+++||.+-|+.||.++.. ++...++....
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i-- 275 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI-- 275 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc--
Confidence 1122457899999999999999999999999999999999999999987633 23332222110
Q ss_pred CcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCC
Q 006112 558 DVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRP 595 (660)
Q Consensus 558 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 595 (660)
...+. |+ ...++ ...++...++.+|.+|-
T Consensus 276 ~wpE~-de----a~p~E----a~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 276 EWPEE-DE----ALPPE----AQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ccccc-Cc----CCCHH----HHHHHHHHHHhChHhhc
Confidence 11111 11 22222 33444456888998885
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=7.9e-15 Score=142.29 Aligned_cols=137 Identities=18% Similarity=0.132 Sum_probs=97.9
Q ss_pred ccccccCccEEEEEEEeCCCCeEEEEEEeccCCCh--hhHHH----------------------HHHHHHHhccCCCC--
Q 006112 341 LYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDH--GMKQF----------------------VSEIVSMGKLRHRN-- 394 (660)
Q Consensus 341 l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~--~~~~~----------------------~~Ei~~l~~l~H~n-- 394 (660)
.+.+|+|+||.||+|... +++.||||++...... ....+ ..|...+.++.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 357899999999999986 7889999998653221 11111 34555666654433
Q ss_pred ceeEeeeeeecCeeEEEEecCCCCChhhh-hhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcC
Q 006112 395 LVQLRGYCRRKGELLLVYDYMPNGSLDKI-LYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDA 473 (660)
Q Consensus 395 Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~ 473 (660)
+.+.++. ...++||||++++.+... +.... .. .+..+++.+++.++.++|. +.+|+||||||+||+++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~- 149 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD- 149 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-
Confidence 3444432 245899999998554321 21111 11 5678899999999999996 37999999999999999
Q ss_pred CCCeEEeecccceecc
Q 006112 474 DLEGKLGDFGLARLYD 489 (660)
Q Consensus 474 ~~~~kl~DFGla~~~~ 489 (660)
++.++|+|||++....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8899999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.7e-14 Score=145.57 Aligned_cols=134 Identities=16% Similarity=0.150 Sum_probs=104.7
Q ss_pred cccc-cCccEEEEEEEeCCCCeEEEEEEeccCC-------------ChhhHHHHHHHHHHhccCCCCc--eeEeeeeeec
Q 006112 342 YKAT-KGGSGKVYRGVLPSSHAEIAVKKVCHDS-------------DHGMKQFVSEIVSMGKLRHRNL--VQLRGYCRRK 405 (660)
Q Consensus 342 ~~lg-~G~fg~Vy~g~~~~~~~~vavK~~~~~~-------------~~~~~~~~~Ei~~l~~l~H~nI--v~l~g~~~~~ 405 (660)
..+| .||.|+||+.... +..++||++.... ......+.+|+.++.+++|+++ ++.++++..+
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4576 7999999998883 6789999874321 1223568889999999998885 6777765443
Q ss_pred Ce----eEEEEecCCC-CChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEe
Q 006112 406 GE----LLLVYDYMPN-GSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLG 480 (660)
Q Consensus 406 ~~----~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~ 480 (660)
.. .++|||+++| .+|.+++... .++. ..+.+|+.+|.+||+ .+|+||||||+|||++.++.++|+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~----~~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA---PLSE----EQWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC---CCCH----HHHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEEE
Confidence 22 3599999997 6999887542 2333 236789999999998 999999999999999998899999
Q ss_pred eccccee
Q 006112 481 DFGLARL 487 (660)
Q Consensus 481 DFGla~~ 487 (660)
|||.++.
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=6.8e-16 Score=174.10 Aligned_cols=257 Identities=25% Similarity=0.287 Sum_probs=189.1
Q ss_pred ceeeecccccccCccEEEEEEEeCC-CCeEEEEEEeccCC--ChhhHHHHHHHHHHhccC-CCCceeEeeeeeecCeeEE
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPS-SHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLR-HRNLVQLRGYCRRKGELLL 410 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~l 410 (660)
...|...+.+|+|.|+.|-...... ....+|+|.+.... ....++...|..+-..+. |+|++++++.....+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 4578888889999999998777633 34566777664433 223344555777777776 9999999999999999999
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhh-hcccCceeccCccCCcEEEcCCC-CeEEeecccceec
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLH-EEWEQVVLHRDIKPANVLLDADL-EGKLGDFGLARLY 488 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivHrDikp~NIll~~~~-~~kl~DFGla~~~ 488 (660)
+.||..++++..-+........+....-.++.|+..++.|+| . .++.||||||+|.+++..+ ..|++|||+|..+
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 999999999998884222224566677888999999999999 6 8999999999999999999 9999999999887
Q ss_pred cC--CCCceeecccc-CccccCcccccCC-CCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCC
Q 006112 489 DH--GNDLHTTNVVG-TVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASD 564 (660)
Q Consensus 489 ~~--~~~~~~~~~~g-t~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d 564 (660)
.. +........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++........+ ..+.... +
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~--~~~~~~~-----~ 248 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY--SSWKSNK-----G 248 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc--eeecccc-----c
Confidence 66 33444456678 9999999998774 45678999999999999999999987533221110 0011100 0
Q ss_pred CcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 565 PRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 565 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
...............++...|+..+|..|.+.+++..
T Consensus 249 -~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 249 -RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred -ccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 0000111222234556666678899999999888753
|
|
| >cd06903 lectin_EMP46_EMP47 EMP46 and EMP47 type 1 transmembrane proteins, N-terminal lectin domain | Back alignment and domain information |
|---|
Probab=99.45 E-value=4.9e-12 Score=124.14 Aligned_cols=189 Identities=16% Similarity=0.219 Sum_probs=119.8
Q ss_pred CCeeEecceeEcCCCcEEecCCCCCeeEEEEeCCCeeeccCCCCceeEEEEEEEEEecCCCCCCCCceEEEEecCCCCCC
Q 006112 38 SKLKLDGLAKIHPNGLLQLTNTSERISGHAFYPFPFKFNSSSSQSLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSE 117 (660)
Q Consensus 38 ~~l~~~g~a~~~~~g~l~Lt~~~~~~~G~~~y~~pv~~~~~~~~~~sFst~F~F~i~~~~~~~~g~GlaF~l~p~~~~~~ 117 (660)
++..+.|+|.+. ++.|+||++ +++.|.+|-+.|+++.+ +|+.+|+|.|.+.. ..+||||||+++.......
T Consensus 21 ~~W~~~G~t~v~-~~~IrLTp~-~s~~G~iWs~~pl~~~~------~w~ie~~Fri~G~~-~~~gdGla~W~t~~~~~~~ 91 (215)
T cd06903 21 PNWQTSGNPKLE-SGRIILTPP-GNQRGSLWLKKPLSLKD------EWTIEWTFRSTGPE-GRSGGGLNFWLVKDGNADV 91 (215)
T ss_pred CCeEEcCcEEee-CCeEEECCC-CCceEeEeeCCcCCCCC------CEEEEEEEEecccC-CcCCCEEEEEEECCCcccC
Confidence 689999999997 789999999 99999999999999852 59999999998753 3689999999997543211
Q ss_pred CCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCeeEEEcCCccccccccccccccccccccccccCCCccEE
Q 006112 118 AVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPIQ 197 (660)
Q Consensus 118 ~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~~~~~~~~~l~~g~~~~ 197 (660)
+ ....|- ... -.=+||.|||+.|. .| ...++-.++........- .-....++... -.+.+.+.+
T Consensus 92 g--~~~fG~---~~~----f~Gl~I~~Dt~~n~---~p--~i~~~~NDGt~~yd~~~d-~~~~~g~C~~~-~rn~~~p~~ 155 (215)
T cd06903 92 G--TSSIYG---PSK----FDGLQLLIDNNGGS---GG--SLRGFLNDGSKDYKNEDV-DSLAFGSCLFA-YQDSGVPST 155 (215)
T ss_pred C--ccccCC---CCC----CcEEEEEEECCCCC---Cc--eEEEEECCCCeeccccCC-cccccceeeEe-ccCCCCCEE
Confidence 1 011111 100 01159999999873 12 122222223221111100 00000111111 124567899
Q ss_pred EEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhc-cceeeeeecccCceeeeeeecCcc
Q 006112 198 IWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQ-DSMYVGLSAATGTRVSDYYILGWS 261 (660)
Q Consensus 198 ~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~-~~~~vGFsastg~~~~~h~i~~ws 261 (660)
++|.|......|+|.+.. + +...++ .-.|| .-.|+||||+||...+.|.|++-.
T Consensus 156 iri~Y~~~~~~l~v~vd~----~-----~Cf~~~-~v~lP~~~y~fGiSAaTg~~~d~hdIl~~~ 210 (215)
T cd06903 156 IRLSYDALNSLFKVQVDN----R-----LCFQTD-KVQLPQGGYRFGITAANADNPESFEILKLK 210 (215)
T ss_pred EEEEEECCCCEEEEEECC----C-----EEEecC-CeecCCCCCEEEEEEcCCCCCCcEEEEEEE
Confidence 999999877788888852 1 122111 01256 556799999999999999998753
|
EMP46 and EMP47, N-terminal carbohydrate recognition domain. EMP46 and EMP47 are fungal type-I transmembrane proteins that cycle between the endoplasmic reticulum and the golgi apparatus and are thought to function as cargo receptors that transport newly synthesized glycoproteins. EMP47 is a receptor for EMP46 responsible for the selective transport of EMP46 by forming hetero-oligomerization between the two proteins. EMP46 and EMP47 have an N-terminal lectin-like carbohydrate recognition domain (represented by this alignment model) as well as a C-terminal transmembrane domain. EMP46 and EMP47 are 45% sequence-identical to one another and have sequence homology to a class of intracellular lectins defined by ERGIC-53 and VIP36. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat s |
| >PF03388 Lectin_leg-like: Legume-like lectin family; InterPro: IPR005052 Lectins are structurally diverse proteins that bind to specific carbohydrates | Back alignment and domain information |
|---|
Probab=99.44 E-value=3.2e-12 Score=127.58 Aligned_cols=198 Identities=22% Similarity=0.283 Sum_probs=117.2
Q ss_pred CCeeEecceeEcCCCcEEecCCCCCeeEEEEeCCCeeeccCCCCceeEEEEEEEEEecCCCCCCCCceEEEEecCCCCCC
Q 006112 38 SKLKLDGLAKIHPNGLLQLTNTSERISGHAFYPFPFKFNSSSSQSLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSE 117 (660)
Q Consensus 38 ~~l~~~g~a~~~~~g~l~Lt~~~~~~~G~~~y~~pv~~~~~~~~~~sFst~F~F~i~~~~~~~~g~GlaF~l~p~~~~~~ 117 (660)
++..+.|+|.+. ++.|+||++.+++.|.+|.+.|++.. +|+.+|+|.|........||||||+++.....
T Consensus 22 ~~W~~~G~t~i~-~~~IrLTp~~~~~~G~iws~~~~~~~-------~w~i~~~Fri~g~~~~~~g~G~a~W~t~~~~~-- 91 (229)
T PF03388_consen 22 PNWDIGGSTVIT-DNFIRLTPDRQSQSGSIWSRKPIPFD-------NWEIEFTFRISGQEKGLGGDGMAFWYTKDPGS-- 91 (229)
T ss_dssp TTEEEEET-EEE-SSEEEEE-SSTTEEEEEEESS-BEES-------EEEEEEEEEEESS-SSS-S-EEEEEEESSSSS--
T ss_pred CCEEECCeEEec-CCEEEECCCcccCEEEEEEcCCCCcc-------CEEEEEEEEEeccccCcCCCeEEEEEEcCccc--
Confidence 479999999998 88999999999999999999999984 49999999999876667899999999975432
Q ss_pred CCCCCcccccccCCCCCCCccEEEEEeecccCCCCC-CCCCCeeEEEcCC-ccccccccccccccccccccccccCCCcc
Q 006112 118 AVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFN-DIDGNHVGIDVNG-LQSNESASARYFSDEKKEFESLVLESGKP 195 (660)
Q Consensus 118 ~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~-d~~~~Hvgid~ns-~~s~~~~~~~~~~~~~~~~~~~~l~~g~~ 195 (660)
.|..+|..+. -.=+||=||||.|.+-. ......|.+-+|. ..+.....-+......++...+. ..+.+
T Consensus 92 --~G~~fG~~~~-------f~Gl~i~idt~~N~~~~~~~~~p~i~~~~NDGt~~~~~~~dg~~~~~~~C~~~~r-n~~~p 161 (229)
T PF03388_consen 92 --DGPVFGGPDK-------FDGLGIFIDTYDNDEGGHKRGFPYISAMLNDGTKSYDHDNDGKDQSLGSCSADYR-NSDVP 161 (229)
T ss_dssp --SCSBTTB-SS--------EEEEEEEEES-TTCTTCTSTSSEEEEEEEESSS---GGGTTTTT-SEEEE---B-TESSE
T ss_pred --cccccCCCcc-------cceEEEEEEcccCCCcccccccceEEEEecCCCccccccccCcccccccceeccC-cCCCC
Confidence 3344443111 11159999999986321 1233455444332 11111110000000011111111 23557
Q ss_pred EEEEEEEeCcceeEEEEEeeC--CCCCCCCCcceeecCchhhhccceeeeeecccCceeeeeeecCc
Q 006112 196 IQIWIDYNGQEKLVNVTLAPV--PNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTRVSDYYILGW 260 (660)
Q Consensus 196 ~~~~I~Y~~~~~~l~v~~~~~--~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg~~~~~h~i~~w 260 (660)
.+++|.|.... +.|.+... .....-. ....++ .-.||+..|+||||+||...+.|.|++-
T Consensus 162 ~~~ri~Y~~~~--l~v~id~~~~~~~~~~~--~Cf~~~-~v~LP~~~yfGvSA~Tg~~~d~hdi~s~ 223 (229)
T PF03388_consen 162 TRIRISYSKNT--LTVSIDSNYLKNQDDWE--LCFTTD-GVDLPEGYYFGVSAATGELSDNHDILSV 223 (229)
T ss_dssp EEEEEEEETTE--EEEEEETSCCSECCTTE--EEEEES-TEEGGSSBEEEEEEEESSSGGEEEEEEE
T ss_pred EEEEEEEECCe--EEEEEecccccCCcCCc--EEEEcC-CeecCCCCEEEEEecCCCCCCcEEEEEE
Confidence 79999999864 55555421 1111111 111221 1137888999999999999999999874
|
This family includes the VIP36 and ERGIC-53 lectins. These two proteins were the first members of the family of animal lectins similar to the leguminous plant lectins []. The alignment for this family is towards the N terminus, where the similarity of VIP36 and ERGIC-53 is greatest. Although they have been identified as a family of animal lectins, this alignment also includes yeast sequences[]. ERGIC-53 is a 53kDa protein, localised to the intermediate region between the endoplasmic reticulum and the Golgi apparatus (ER-Golgi-Intermediate Compartment, ERGIC). It was identified as a calcium-dependent, mannose-specific lectin []. Its dysfunction has been associated with combined factors V and VIII deficiency, suggesting an important and substrate-specific role for ERGIC-53 in the glycoprotein-secreting pathway [,]. The L-type lectin-like domain has an overall globular shape composed of a beta-sandwich of two major twisted antiparallel beta-sheets. The beta-sandwich comprises a major concave beta-sheet and a minor convex beta-sheet, in a variation of the jelly roll fold [, , , ]. ; GO: 0016020 membrane; PDB: 3A4U_A 3LCP_B 2A6Z_A 2A71_C 2A70_B 2A6Y_A 2A6X_A 2A6W_B 2A6V_B 2E6V_B .... |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.41 E-value=8.2e-13 Score=144.70 Aligned_cols=146 Identities=19% Similarity=0.188 Sum_probs=101.6
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhh--------------------------------------
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGM-------------------------------------- 377 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~-------------------------------------- 377 (660)
|.+-+-+.++.|++|.||+|++. +|+.||||+.+.......
T Consensus 117 F~~fd~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~ 195 (437)
T TIGR01982 117 FAEFEEKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLR 195 (437)
T ss_pred HhhCCCcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHH
Confidence 34444567999999999999985 678999999865421110
Q ss_pred --HHHHHHHHHHhccC----CCCceeEeeeee-ecCeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHH-HHH
Q 006112 378 --KQFVSEIVSMGKLR----HRNLVQLRGYCR-RKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAF-GLL 449 (660)
Q Consensus 378 --~~~~~Ei~~l~~l~----H~nIv~l~g~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~-gL~ 449 (660)
-+|.+|...+.+++ |.+-+.+-..+. ..+..+|||||++|++|.++...... .. .+.+++..++. .+.
T Consensus 196 ~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ 271 (437)
T TIGR01982 196 RELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLN 271 (437)
T ss_pred HHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHH
Confidence 02455555555552 333333333332 23457999999999999887653211 12 34556666666 467
Q ss_pred HhhhcccCceeccCccCCcEEEcCCCCeEEeecccceecc
Q 006112 450 YLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYD 489 (660)
Q Consensus 450 yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 489 (660)
.+|. .+++|+|+||.||+++++++++++|||++..+.
T Consensus 272 ql~~---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 272 QVLR---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHh---CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 7786 899999999999999999999999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.6e-13 Score=135.58 Aligned_cols=201 Identities=21% Similarity=0.283 Sum_probs=138.4
Q ss_pred HHHhccCCCCceeEeeeeeec-----CeeEEEEecCCCCChhhhhhhCC--CCCcchhHHHHHHHHHHHHHHHhhhcccC
Q 006112 385 VSMGKLRHRNLVQLRGYCRRK-----GELLLVYDYMPNGSLDKILYSNT--RPSLNWFQRFRIIKGVAFGLLYLHEEWEQ 457 (660)
Q Consensus 385 ~~l~~l~H~nIv~l~g~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 457 (660)
.-|-++-|.|||+++.|..+. .+..++.|||..|+|..+|++.. ...+......+++.||..||.|||+ |.+
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence 345566799999999987543 45789999999999999997543 2457777788999999999999998 679
Q ss_pred ceeccCccCCcEEEcCCCCeEEeecccceeccC---CCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh
Q 006112 458 VVLHRDIKPANVLLDADLEGKLGDFGLARLYDH---GNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC 534 (660)
Q Consensus 458 ~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~---~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt 534 (660)
.|+|+++..+-|++..++-+|++----...... ..........+-++|.+||+-..-..+..+|||+||+..+||.-
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 999999999999999999888753211110000 01111222356789999999887788889999999999999987
Q ss_pred CCCCCCCCCc-chHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 535 GRRPVQPGEL-DLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 535 G~~p~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
+..--..++. ...+.... ...-.....+ =..++..|++..|+.||+|++++.
T Consensus 278 lEiq~tnseS~~~~ee~ia-----~~i~~len~l-----------qr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIA-----NVIIGLENGL-----------QRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred heeccCCCcceeehhhhhh-----hheeeccCcc-----------ccCcCcccccCCCCCCcchhhhhc
Confidence 6643222111 11111110 0000000001 123456699999999999999864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.36 E-value=9.2e-13 Score=142.56 Aligned_cols=248 Identities=23% Similarity=0.267 Sum_probs=181.5
Q ss_pred eeeccccccc--CccEEEEEEEe--CCCCeEEEEEEecc--CCChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCeeE
Q 006112 337 SYKNLYKATK--GGSGKVYRGVL--PSSHAEIAVKKVCH--DSDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELL 409 (660)
Q Consensus 337 ~~~~l~~lg~--G~fg~Vy~g~~--~~~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~ 409 (660)
.+...+.+|. |.+|.||.+.. ..++..+|+|+-+. ........=.+|+..-.++ .|+|.++........+.++
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4555677888 99999999999 78889999998433 2233334445667666666 4999999888888999999
Q ss_pred EEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHH----HHHHhhhcccCceeccCccCCcEEEcCC-CCeEEeeccc
Q 006112 410 LVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAF----GLLYLHEEWEQVVLHRDIKPANVLLDAD-LEGKLGDFGL 484 (660)
Q Consensus 410 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivHrDikp~NIll~~~-~~~kl~DFGl 484 (660)
+-.|+| +.+|..+..... ..++....+.+..+..+ ||.++|. ..++|-|+||.||++..+ ..++++|||+
T Consensus 195 iqtE~~-~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eeeccc-cchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCcce
Confidence 999999 688888775433 23666777888888888 9999998 999999999999999999 8999999999
Q ss_pred ceeccCCCCc----eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcc
Q 006112 485 ARLYDHGNDL----HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVL 560 (660)
Q Consensus 485 a~~~~~~~~~----~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 560 (660)
...+..+.-. ......|...|++||..+ +-++.+.|+|++|.+.+|..++..+...+... .|...+.+.
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~----~W~~~r~~~-- 342 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS----SWSQLRQGY-- 342 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC----Ccccccccc--
Confidence 9887655421 122336888999999874 56788999999999999999988765433111 111111111
Q ss_pred cCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 561 DASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 561 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
+..++...-...+..+...+++.+|..|++.+.+..
T Consensus 343 ------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 343 ------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 111111111223444667789999999999888764
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.31 E-value=8.1e-12 Score=118.93 Aligned_cols=131 Identities=19% Similarity=0.151 Sum_probs=96.8
Q ss_pred ccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCce-eEeeeeeecCeeEEEEecCCCCC
Q 006112 341 LYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLV-QLRGYCRRKGELLLVYDYMPNGS 419 (660)
Q Consensus 341 l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~lV~E~~~~gs 419 (660)
++.++.|.++.||+++.. +..+++|....... ....+..|+.+++.+.+.+++ +++.+. ....++||||++|.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence 456788999999999874 67899998754432 234568899999998765554 455443 234579999999988
Q ss_pred hhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcc--cCceeccCccCCcEEEcCCCCeEEeeccccee
Q 006112 420 LDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEW--EQVVLHRDIKPANVLLDADLEGKLGDFGLARL 487 (660)
Q Consensus 420 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 487 (660)
+...- . ....++.+++++|+.||... ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus 78 l~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 86530 1 12345689999999999832 22369999999999999 66899999998863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.26 E-value=6.3e-12 Score=139.43 Aligned_cols=141 Identities=15% Similarity=0.179 Sum_probs=90.2
Q ss_pred cccccCccEEEEEEEeCCCCeEEEEEEeccCCChh----------------------------------hH------HHH
Q 006112 342 YKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHG----------------------------------MK------QFV 381 (660)
Q Consensus 342 ~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~----------------------------------~~------~~~ 381 (660)
+.++.|++|.||+|+++++|+.||||+++..-.+. .+ +|.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 78999999999999998779999999986542110 11 134
Q ss_pred HHHHHHhccC----CCCceeEeeeeee-cCeeEEEEecCCCCChhhhh--hhCCCCCcchhHHHHHHHHHHHHHHHhhhc
Q 006112 382 SEIVSMGKLR----HRNLVQLRGYCRR-KGELLLVYDYMPNGSLDKIL--YSNTRPSLNWFQRFRIIKGVAFGLLYLHEE 454 (660)
Q Consensus 382 ~Ei~~l~~l~----H~nIv~l~g~~~~-~~~~~lV~E~~~~gsL~~~l--~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~ 454 (660)
+|...+.+++ +.+.+.+-..+.+ ..+.+|||||+.|+.|.++- ...+ .+ +..++...+. .|+++-
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g---~d---~~~la~~~v~--~~~~Qi 276 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG---TD---MKLLAERGVE--VFFTQV 276 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC---CC---HHHHHHHHHH--HHHHHH
Confidence 4444444442 3333333232222 34568999999999998742 2211 11 1122222222 122222
Q ss_pred ccCceeccCccCCcEEEcCCC----CeEEeecccceeccC
Q 006112 455 WEQVVLHRDIKPANVLLDADL----EGKLGDFGLARLYDH 490 (660)
Q Consensus 455 ~~~~ivHrDikp~NIll~~~~----~~kl~DFGla~~~~~ 490 (660)
.+.+++|+|+||.||+++.++ ++++.|||++..++.
T Consensus 277 f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 238999999999999999888 999999999976643
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.16 E-value=2e-10 Score=125.72 Aligned_cols=188 Identities=16% Similarity=0.212 Sum_probs=136.8
Q ss_pred CceeeecccccccCccEEEE-EEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEE
Q 006112 334 HRFSYKNLYKATKGGSGKVY-RGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 334 ~~~~~~~l~~lg~G~fg~Vy-~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
..|.|+.. ...-++.+ +| .|..+.++.+|.|+..............+-++.++.+|||||++++.....++.+|||+
T Consensus 11 ~~fpY~le-~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvT 88 (690)
T KOG1243|consen 11 SQFPYDLE-ETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVT 88 (690)
T ss_pred ccCCcccc-cccCCCcc-cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEe
Confidence 45566652 22222222 34 57777788899999887665544556778889999999999999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
|-+ --|..++.... -....-.+.||+.||.|||+ +.+++|++|.-+.|++++.|.-||++|.++.......
T Consensus 89 ErV--~Pl~~~lk~l~-----~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~ 159 (690)
T KOG1243|consen 89 ERV--RPLETVLKELG-----KEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFN 159 (690)
T ss_pred ecc--ccHHHHHHHhH-----HHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCC
Confidence 987 35666665432 34555678899999999997 4799999999999999999999999999886543222
Q ss_pred CceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhC
Q 006112 493 DLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACG 535 (660)
Q Consensus 493 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG 535 (660)
. ......--..|..|+.+.... -..|.|-|||+++|++.|
T Consensus 160 ~-~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 160 A-PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c-ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 1 011111122466666543221 356999999999999988
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.14 E-value=3.1e-10 Score=112.81 Aligned_cols=143 Identities=17% Similarity=0.175 Sum_probs=111.1
Q ss_pred ccccccCccEEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHhccCC--CCceeEeeeeeecC---eeEEEEec
Q 006112 341 LYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD-HGMKQFVSEIVSMGKLRH--RNLVQLRGYCRRKG---ELLLVYDY 414 (660)
Q Consensus 341 l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H--~nIv~l~g~~~~~~---~~~lV~E~ 414 (660)
++.++.|..+.+|+++..+ |+.+++|....... ....++..|.++++.+++ .++.+++.++.... ..++||||
T Consensus 3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred ceecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 4567899999999998843 57899998754332 245678999999999976 44677888776543 56899999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhc----------------------------------------
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEE---------------------------------------- 454 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------------------------------------- 454 (660)
++|.+|...+.. ..++..++..++.++++.|..||+.
T Consensus 82 i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 82 VDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred eCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 999988776532 2367778888889999999999852
Q ss_pred -------------ccCceeccCccCCcEEEcC--CCCeEEeeccccee
Q 006112 455 -------------WEQVVLHRDIKPANVLLDA--DLEGKLGDFGLARL 487 (660)
Q Consensus 455 -------------~~~~ivHrDikp~NIll~~--~~~~kl~DFGla~~ 487 (660)
....++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1357899999999999998 56689999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.13 E-value=6.7e-10 Score=107.61 Aligned_cols=137 Identities=17% Similarity=0.071 Sum_probs=97.6
Q ss_pred ccccCccEEEEEEEeCC------CCeEEEEEEeccCC----------------------ChhhHHHH----HHHHHHhcc
Q 006112 343 KATKGGSGKVYRGVLPS------SHAEIAVKKVCHDS----------------------DHGMKQFV----SEIVSMGKL 390 (660)
Q Consensus 343 ~lg~G~fg~Vy~g~~~~------~~~~vavK~~~~~~----------------------~~~~~~~~----~Ei~~l~~l 390 (660)
.++.|.-+.||.|.... .+..+|||..+... ....+.+. +|+..|+++
T Consensus 4 ~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~rl 83 (197)
T cd05146 4 CISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKRM 83 (197)
T ss_pred ccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 57889999999998653 35789999764210 00122233 799999888
Q ss_pred CC--CCceeEeeeeeecCeeEEEEecCCCCChhh-hhhhCCCCCcchhHHHHHHHHHHHHHHHh-hhcccCceeccCccC
Q 006112 391 RH--RNLVQLRGYCRRKGELLLVYDYMPNGSLDK-ILYSNTRPSLNWFQRFRIIKGVAFGLLYL-HEEWEQVVLHRDIKP 466 (660)
Q Consensus 391 ~H--~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrDikp 466 (660)
.. -++.+.+++ ..-+|||||+.+..+.. .+.. ..++..+...+..+++.+|..| |. .+|||+||++
T Consensus 84 ~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDLs~ 153 (197)
T cd05146 84 QKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADLSE 153 (197)
T ss_pred HHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCCCH
Confidence 53 455666654 46789999997654422 2221 1244456677889999999999 66 8999999999
Q ss_pred CcEEEcCCCCeEEeecccceeccC
Q 006112 467 ANVLLDADLEGKLGDFGLARLYDH 490 (660)
Q Consensus 467 ~NIll~~~~~~kl~DFGla~~~~~ 490 (660)
.|||++ ++.++|+|||.+...++
T Consensus 154 ~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 154 YNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred HHEEEE-CCcEEEEECCCceeCCC
Confidence 999997 46899999999876554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.11 E-value=8.5e-11 Score=127.46 Aligned_cols=245 Identities=18% Similarity=0.209 Sum_probs=167.0
Q ss_pred eeeecccccccCccEEEEEEEeC-CCCeEEEEEEeccCCChhhH--HHHHHHHHHhcc-CCCCceeEeeeeeecCeeEEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLP-SSHAEIAVKKVCHDSDHGMK--QFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~-~~~~~vavK~~~~~~~~~~~--~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 411 (660)
-++.++..++.|.|+.|++.... .++..+++|.+......... .-+.|+.+...+ .|.++++...-.......++-
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip 344 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP 344 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence 35778889999999999988765 67788999987654322211 223455555555 477777766555555566799
Q ss_pred EecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCC-CCeEEeecccceeccC
Q 006112 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDAD-LEGKLGDFGLARLYDH 490 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~-~~~kl~DFGla~~~~~ 490 (660)
-|||+++++...+.-. ..++...++++..|++.++.++|+ +.++|+|+||+||++..+ +..+++|||.+..+.-
T Consensus 345 ~e~~~~~s~~l~~~~~--~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~ 419 (524)
T KOG0601|consen 345 LEFCEGGSSSLRSVTS--QMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF 419 (524)
T ss_pred hhhhcCcchhhhhHHH--HhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccccccccce
Confidence 9999999987766322 236777889999999999999998 999999999999999876 8899999999864211
Q ss_pred CCCceeeccccCcccc--CcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCccc
Q 006112 491 GNDLHTTNVVGTVGYL--APELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLE 568 (660)
Q Consensus 491 ~~~~~~~~~~gt~~Y~--aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 568 (660)
. .....+.-+++ +++......+..+.|+||||..+.|.+++..--. ... .| ...+.+. -+.+.
T Consensus 420 ~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~-~~~---~~--~~i~~~~-----~p~~~ 484 (524)
T KOG0601|consen 420 S----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE-SGV---QS--LTIRSGD-----TPNLP 484 (524)
T ss_pred e----cccccccccccccchhhccccccccccccccccccccccccCcccCc-ccc---cc--eeeeccc-----ccCCC
Confidence 1 11112233444 5666667778899999999999999998764322 111 11 1111121 22222
Q ss_pred ccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhh
Q 006112 569 GIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605 (660)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (660)
+.. +.+..+..-+..+++..||.+.+...+.+
T Consensus 485 ~~~-----~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 485 GLK-----LQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred chH-----HhhhhhhhhhcCCccccchhhhhhcccch
Confidence 221 23334444588999999999988876554
|
|
| >KOG3838 consensus Mannose lectin ERGIC-53, involved in glycoprotein traffic [Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.04 E-value=7.2e-09 Score=105.17 Aligned_cols=194 Identities=16% Similarity=0.249 Sum_probs=123.4
Q ss_pred eeEecceeEcCCCcEEecCCCCCeeEEEEeCCCeeeccCCCCceeEEEEEEEEEecCCCCCCCCceEEEEecCCCCCCCC
Q 006112 40 LKLDGLAKIHPNGLLQLTNTSERISGHAFYPFPFKFNSSSSQSLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAV 119 (660)
Q Consensus 40 l~~~g~a~~~~~g~l~Lt~~~~~~~G~~~y~~pv~~~~~~~~~~sFst~F~F~i~~~~~~~~g~GlaF~l~p~~~~~~~~ 119 (660)
....|||... .-.|+|+++-.++.|-+|-+.-+.+.+ |..+-+|.|++. ...++|||||+-+.... -
T Consensus 56 W~~~GdAIas-~eqvRlaPSmrsrkGavWtka~~~fe~-------weVev~~rVtGr-GRiGAdGlaiWYt~~~G----~ 122 (497)
T KOG3838|consen 56 WSHHGDAIAS-SEQVRLAPSMRSRKGAVWTKASVPFEN-------WEVEVQFRVTGR-GRIGADGLAIWYTRGRG----H 122 (497)
T ss_pred eeecCccccc-ccceeeccccccccCceeecccCCccc-------ceEEEEEEeccc-ccccCCceEEEEecCCC----c
Confidence 4567888764 678999999999999999998888765 889999999986 56689999999986432 1
Q ss_pred CCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCeeEEEcCC-ccccccccccccccccccccccccCCCccEEE
Q 006112 120 AGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNG-LQSNESASARYFSDEKKEFESLVLESGKPIQI 198 (660)
Q Consensus 120 ~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns-~~s~~~~~~~~~~~~~~~~~~~~l~~g~~~~~ 198 (660)
-|.-+|-... =| =+++-||.|.|. +--|+.-|.|-.|. -.+.-...-+.--...++..++. +---+..|
T Consensus 123 ~GpVfGg~d~------Wn-GigiffDSfdnD--~qknnP~Is~~lndGt~~ydh~~DGasQ~LssCqrDFR-NkPyPvRa 192 (497)
T KOG3838|consen 123 VGPVFGGLDS------WN-GIGIFFDSFDND--GQKNNPAISVLLNDGTIPYDHPGDGASQGLSSCQRDFR-NKPYPVRA 192 (497)
T ss_pred cccccccccc------cc-ceEEEeeccccc--CCcCCccEEEEecCCcccccCCCccHHHHHHHhhHHhc-cCCCCceE
Confidence 1222221111 11 158999999986 34566677765553 22111110000000001111111 11247889
Q ss_pred EEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchh-hhccceeeeeecccCceeeeeeecCcc
Q 006112 199 WIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQ-ILQDSMYVGLSAATGTRVSDYYILGWS 261 (660)
Q Consensus 199 ~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~-~l~~~~~vGFsastg~~~~~h~i~~ws 261 (660)
+|+|-. .+|.|.+.. +. .|..+ -..-++... +||..-|+|.|||||.....|.|++..
T Consensus 193 rItY~~--nvLtv~inn-Gm-tp~d~-yE~C~rve~~~lp~nGyFGvSAATGgLADDHDVl~Fl 251 (497)
T KOG3838|consen 193 RITYYG--NVLTVMINN-GM-TPSDD-YEFCVRVENLLLPPNGYFGVSAATGGLADDHDVLSFL 251 (497)
T ss_pred EEEEec--cEEEEEEcC-CC-CCCCC-cceeEeccceeccCCCeeeeeecccccccccceeeeE
Confidence 999986 678888863 33 33221 122223323 478899999999999999999999963
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.1e-09 Score=100.23 Aligned_cols=143 Identities=18% Similarity=0.197 Sum_probs=106.0
Q ss_pred cccccccCccEEEEEEEeCCCCeEEEEEEeccC--------CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEE
Q 006112 340 NLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--------SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 340 ~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--------~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 411 (660)
.+..+-+|+-+.|+++.+ .|+...||.-... ..-..++-++|++++.+++--.|.--.-++.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 566778999999999998 5677777754321 111245678899999998755554444445566667899
Q ss_pred EecCCC-CChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCC---CeEEeeccccee
Q 006112 412 YDYMPN-GSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADL---EGKLGDFGLARL 487 (660)
Q Consensus 412 ~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~---~~kl~DFGla~~ 487 (660)
|||++| .++.+++...............++.+|-+.+.-||. .+|||+||..+||+|..++ .+.++|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999966 478888865543333334447888999999999998 9999999999999996554 358999999864
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=3.5e-09 Score=99.40 Aligned_cols=130 Identities=19% Similarity=0.214 Sum_probs=98.6
Q ss_pred ccccCccEEEEEEEeCCCCeEEEEEEeccCC---Ch-----hhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 343 KATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DH-----GMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 343 ~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~-----~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
.+.+|+-..+|.+.+ -|.++++|.--... ++ ..+.-.+|..++.+++--.|..-+=+..+.....|+|||
T Consensus 3 ~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 3 LIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred hhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 467899999999977 34456666532211 11 134567899999998765555444455677778899999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeeccccee
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARL 487 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 487 (660)
++|..|.+.+... +..++..+-.-+.-||. .+|||+||.++||++.... +.++||||+..
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888654 25677788888889998 9999999999999997764 99999999974
|
|
| >KOG3839 consensus Lectin VIP36, involved in the transport of glycoproteins carrying high mannose-type glycans [Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=98.97 E-value=8.9e-09 Score=103.20 Aligned_cols=193 Identities=17% Similarity=0.202 Sum_probs=127.9
Q ss_pred CCeeEecceeEcCCCcEEecCCCCCeeEEEEeCCCeeeccCCCCceeEEEEEEEEEecCCCCCCCCceEEEEecCCCCCC
Q 006112 38 SKLKLDGLAKIHPNGLLQLTNTSERISGHAFYPFPFKFNSSSSQSLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSE 117 (660)
Q Consensus 38 ~~l~~~g~a~~~~~g~l~Lt~~~~~~~G~~~y~~pv~~~~~~~~~~sFst~F~F~i~~~~~~~~g~GlaF~l~p~~~~~~ 117 (660)
.+..+.|.+.+. ..-++||.+.+++.|-+|-.+||-..+ |...+.|.|..+....-|||||++.+-.+..|+
T Consensus 72 ~~W~~~Gstvv~-~~~irLT~d~qsk~GAv~n~~Pv~s~~-------wev~v~fkv~~~s~~lfgdG~Aiw~t~Er~q~G 143 (351)
T KOG3839|consen 72 PNWNLSGSTVVT-SNYIRLTPDEQSKSGAVWNRQPVFSRD-------WEVLVHFKVHGQSKNLFGDGMAIWYTKERAQPG 143 (351)
T ss_pred cCccccccEEEE-eeeeeccccccccccccccCCCccccc-------eeEEEEEEEecCCCcccccceEEEeecccccCC
Confidence 578999999998 667999999999999999999998654 999999999999888899999999997665433
Q ss_pred CCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCC--CCeeEEEcCCcccccccccccccccccccc-----cccc
Q 006112 118 AVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDID--GNHVGIDVNGLQSNESASARYFSDEKKEFE-----SLVL 190 (660)
Q Consensus 118 ~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~--~~Hvgid~ns~~s~~~~~~~~~~~~~~~~~-----~~~l 190 (660)
.-+|-+. .-+.+||-.|||.|.+ +-+. ..-+.+.+|.. ++.|+-+.++... ...+
T Consensus 144 ----PvFG~~d-------kF~GL~vfidtY~n~~-g~~~~v~P~isvmv~~g------s~sYD~~~Dg~~tel~gc~a~~ 205 (351)
T KOG3839|consen 144 ----PVFGSKD-------KFTGLAVFIDTYGNHN-GPHEHVFPYISVMVNIG------SLSYDHSKDGTHTELAGCTANF 205 (351)
T ss_pred ----CCCCCcc-------cceeEEEEEeccCCcC-CCcccceeeEEEEeccC------CcccccCCCCCccccccceeee
Confidence 3344321 1234799999998852 1111 12233333211 1122222111100 0111
Q ss_pred CCC-ccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhh-hccceeeeeecccCceeeeeeecCcccc
Q 006112 191 ESG-KPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQI-LQDSMYVGLSAATGTRVSDYYILGWSFN 263 (660)
Q Consensus 191 ~~g-~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~-l~~~~~vGFsastg~~~~~h~i~~wsf~ 263 (660)
.+. -.-..-|.|+. ++|++.....+ |. ....-.++..+ +|.--|+|+||+||..++.|.|.+-.+.
T Consensus 206 rn~~~dt~~~iry~~--~~l~~~~dl~~---~~--~~~~c~~~n~v~lp~g~~fg~SasTGdlSd~HdivS~kl~ 273 (351)
T KOG3839|consen 206 RNLPHDTLVVIRYEK--KTLSISIDLEG---PN--EWIDCFSLNNVELPLGYFFGVSASTGDLSDSHDIVSLKLF 273 (351)
T ss_pred ccCCCcceeEEEecC--CceEEEEecCC---Cc--eeeeeeeecceecccceEEeeeeccCccchhhHHHHhhhh
Confidence 111 12356788988 55666655322 22 24555677775 7788899999999999999999886543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.96 E-value=8.2e-09 Score=109.82 Aligned_cols=170 Identities=19% Similarity=0.300 Sum_probs=131.4
Q ss_pred ccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeee----ecCeeEEEEecCCC-CChhh
Q 006112 348 GSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCR----RKGELLLVYDYMPN-GSLDK 422 (660)
Q Consensus 348 ~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~----~~~~~~lV~E~~~~-gsL~~ 422 (660)
.-.+.||+...-+|..+++|++..+..+....-..-+++++++.|.|+|++..++. .+..+++||+|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 44678999999999999999995554444444556688899999999999999876 34578999999986 56766
Q ss_pred hhhhCC-------------CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceecc
Q 006112 423 ILYSNT-------------RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYD 489 (660)
Q Consensus 423 ~l~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 489 (660)
+-+... ....++..+|.++.|++.||.++|+ .|+.-+-|.+.+|+++.+.+++|...|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 543221 2347788999999999999999998 899999999999999999999998888776554
Q ss_pred CCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCC
Q 006112 490 HGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRP 538 (660)
Q Consensus 490 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p 538 (660)
.... |.+.. -.+-|.=.||.+++.|.||+.-
T Consensus 445 ~d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPT---------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 3220 11111 1345777899999999999643
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.8e-08 Score=103.04 Aligned_cols=132 Identities=17% Similarity=0.089 Sum_probs=95.6
Q ss_pred EEEEEEeCCCCeEEEEEEeccCCCh-hhH----------HHHHHHHHHhccCCCCc--eeEeeeeee-----cCeeEEEE
Q 006112 351 KVYRGVLPSSHAEIAVKKVCHDSDH-GMK----------QFVSEIVSMGKLRHRNL--VQLRGYCRR-----KGELLLVY 412 (660)
Q Consensus 351 ~Vy~g~~~~~~~~vavK~~~~~~~~-~~~----------~~~~Ei~~l~~l~H~nI--v~l~g~~~~-----~~~~~lV~ 412 (660)
.|++..+ .|+.+.||+....... ..+ .+.+|...+.++...+| .+.+++... ...-+||+
T Consensus 37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 4667666 5678999976432211 112 47889998888854333 344455432 23578999
Q ss_pred ecCCCC-ChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcC-------CCCeEEeeccc
Q 006112 413 DYMPNG-SLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDA-------DLEGKLGDFGL 484 (660)
Q Consensus 413 E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~-------~~~~kl~DFGl 484 (660)
|++++. +|.+++........+...+..++.+++..+.-||. .||+|+|++++|||++. +..+.|+||+.
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r 191 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHR 191 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence 999876 89998854322234556777899999999999998 99999999999999975 46799999998
Q ss_pred cee
Q 006112 485 ARL 487 (660)
Q Consensus 485 a~~ 487 (660)
++.
T Consensus 192 ~~~ 194 (268)
T PRK15123 192 AQI 194 (268)
T ss_pred ccc
Confidence 863
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.84 E-value=2.1e-09 Score=122.54 Aligned_cols=244 Identities=23% Similarity=0.219 Sum_probs=157.6
Q ss_pred cccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCC
Q 006112 340 NLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 340 ~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 416 (660)
+.+-+..|.++.++..+-...+...++|..... .....+....+-.+.-..+||-+++..--+.-....+||++|..
T Consensus 808 i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~ 887 (1205)
T KOG0606|consen 808 ITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLN 887 (1205)
T ss_pred ecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhc
Confidence 344555688888887766555544444443221 11222233333333333445666655544445567899999999
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceecc-------
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYD------- 489 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~------- 489 (660)
+++|...|+..+ ..+..-....+..+..+++|||. ..+.|||++|.|++...++..++.|||......
T Consensus 888 ~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~ 962 (1205)
T KOG0606|consen 888 GGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTD 962 (1205)
T ss_pred cCCchhhhhcCC--CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccccccccCcCC
Confidence 999999887654 34555555667778899999997 669999999999999999999999998432110
Q ss_pred --------------CCCC---------ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcch
Q 006112 490 --------------HGND---------LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDL 546 (660)
Q Consensus 490 --------------~~~~---------~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~ 546 (660)
.... .......||+.|.+||.+.+.......|.|++|++++|.++|..||.......
T Consensus 963 ~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~ 1042 (1205)
T KOG0606|consen 963 LSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQ 1042 (1205)
T ss_pred cccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhh
Confidence 0000 11224578999999999999999999999999999999999999997543321
Q ss_pred HHHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHH
Q 006112 547 LDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMR 598 (660)
Q Consensus 547 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 598 (660)
+.+....++ -+...+ ..+.......++..-+..+|.+|-.+.
T Consensus 1043 ---~f~ni~~~~-----~~~p~g--~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1043 ---IFENILNRD-----IPWPEG--PEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred ---hhhccccCC-----CCCCCC--ccccChhhhhhhhhhhccCchhccCcc
Confidence 111111111 111111 112222334444445678888887766
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.75 E-value=9.5e-08 Score=92.27 Aligned_cols=126 Identities=19% Similarity=0.243 Sum_probs=82.6
Q ss_pred EEEEEEeCCCCeEEEEEEeccCC-------------Ch-------------hhHHHHHHHHHHhccCCC--CceeEeeee
Q 006112 351 KVYRGVLPSSHAEIAVKKVCHDS-------------DH-------------GMKQFVSEIVSMGKLRHR--NLVQLRGYC 402 (660)
Q Consensus 351 ~Vy~g~~~~~~~~vavK~~~~~~-------------~~-------------~~~~~~~Ei~~l~~l~H~--nIv~l~g~~ 402 (660)
.||.|... ++..+|||..+... .. ......+|.+.|.++..- ++.+.+.+.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 38999884 57799999764310 00 012467799999999765 456666542
Q ss_pred eecCeeEEEEecCC--CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHh-hhcccCceeccCccCCcEEEcCCCCeEE
Q 006112 403 RRKGELLLVYDYMP--NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYL-HEEWEQVVLHRDIKPANVLLDADLEGKL 479 (660)
Q Consensus 403 ~~~~~~~lV~E~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrDikp~NIll~~~~~~kl 479 (660)
.-+|||||++ |..+..+. ... ++......++.+++..+..+ |. .+|+|+||.+.|||++++ .+.|
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~-~~~---~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLK-DVD---LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHH-HCG---GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE
T ss_pred ----CCEEEEEecCCCccchhhHH-hcc---ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEE
Confidence 3479999998 55554433 221 22456677888888866665 55 899999999999999988 9999
Q ss_pred eecccceecc
Q 006112 480 GDFGLARLYD 489 (660)
Q Consensus 480 ~DFGla~~~~ 489 (660)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999887544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >cd06900 lectin_VcfQ VcfQ bacterial pilus biogenesis protein, lectin domain | Back alignment and domain information |
|---|
Probab=98.64 E-value=2.2e-06 Score=83.13 Aligned_cols=199 Identities=18% Similarity=0.204 Sum_probs=115.4
Q ss_pred CCcEEecCCCCCeeEEEEeCCCeeeccCCCCceeEEEEEEEEEecCCCCCCCCceEEEEecCCC-CCCCCCCCccccccc
Q 006112 51 NGLLQLTNTSERISGHAFYPFPFKFNSSSSQSLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTD-FSEAVAGSHLGIFNR 129 (660)
Q Consensus 51 ~g~l~Lt~~~~~~~G~~~y~~pv~~~~~~~~~~sFst~F~F~i~~~~~~~~g~GlaF~l~p~~~-~~~~~~g~~lGl~~~ 129 (660)
+|.||||+...+++|-+.|.++++-.++ -...+|.+-.-.. ...++||+||||+-..- ...+..||.||+--+
T Consensus 31 ~g~LRLT~~~~nqata~~~~~~FPs~~n-----~v~veFd~yayg~-~g~GADGia~vLsDasv~p~~G~fGGsLGYa~~ 104 (255)
T cd06900 31 NNRLRLTDASGNQATAVTLQRLFPSAGN-----YVEVEFDYYAYGS-GGNGADGVALVLSDASVTPQAGAFGGSLGYAQR 104 (255)
T ss_pred cCeEEeccCccCcceeEEEeeeeccCCC-----eEEEEEEEEEecC-CCCCCceEEEEEeCCCcCCcCCCcCcccccccc
Confidence 6899999999999999999999986432 2677787776654 45689999999984332 224577899999766
Q ss_pred CC-CCCCCccEEEEEeecccCCCC-CCCC-------CCeeEEEcCCccccccccccccccccccccccccC------CCc
Q 006112 130 SN-NGQFTNHIFAIELDTVQSPEF-NDID-------GNHVGIDVNGLQSNESASARYFSDEKKEFESLVLE------SGK 194 (660)
Q Consensus 130 ~~-~~~~~~~~vaVEFDt~~n~~~-~d~~-------~~Hvgid~ns~~s~~~~~~~~~~~~~~~~~~~~l~------~g~ 194 (660)
.. .......-++|-||-|-|... .+.. -+-|+|- .-.+ .+....|........+.++.. -+-
T Consensus 105 ~~~~~GfaGGwLGiGlDEyGNFsn~~eg~~~~~g~r~~sV~vR--Gsg~-g~~gY~yl~gt~~~~~~id~~~~~~~~~~h 181 (255)
T cd06900 105 NDGVPGFAGGWLGIGLDEYGNFSNPNEGRNGFSGRRPQSVTVR--GSGS-GYTGYKYITGTGVLPPGIDNNSTSTPAPGH 181 (255)
T ss_pred cCCCCccccceEEEEEeccccccCCCCCccCCcccccceEEEE--CCCC-CCcCceEecccCCCCcccccCCCCCCCCce
Confidence 52 223456788999999876311 1211 1233331 1111 011122221111000111111 123
Q ss_pred cEEEEEEEe-CcceeEEEEEeeCCCCCCCCCcceeecC---ch--hhhccceeeeeecccCceeeeeeecCc
Q 006112 195 PIQIWIDYN-GQEKLVNVTLAPVPNPKPSRPLLSTSID---LS--QILQDSMYVGLSAATGTRVSDYYILGW 260 (660)
Q Consensus 195 ~~~~~I~Y~-~~~~~l~v~~~~~~~~~p~~~~l~~~~d---L~--~~l~~~~~vGFsastg~~~~~h~i~~w 260 (660)
++++.||=. +....|+|.-+..+... ..+ +-..+| .. .-+|+..+++|++|||...-.|.|...
T Consensus 182 rY~i~Ids~~~~~~~vsV~R~~~~gg~-~~~-~I~~~d~~~~~~q~avP~~f~lS~TgSTGgstN~HEIdnf 251 (255)
T cd06900 182 RYRITIDSTNGDNAWLSVERDIGNGGA-YFV-VILTFDALAEQNQDAIPENFYLSFTGSTGGSTNTHEIDNF 251 (255)
T ss_pred EEEEEEecCCCCceEEEEEEEccCCce-eEE-eecceeeccccCCCCCCccEEEEEEecCCCcccceeecce
Confidence 455555544 22344566655322211 111 222222 23 467999999999999999999999764
|
This family includes bacterial proteins homologous to the VcfQ (also known as MshQ) bacterial pilus biogenesis protein. VcfQ is encoded by the vcfQ gene of the type IV pilus gene cluster of Vibrio cholerae and is essential for type IV pilus assembly. VcfQ has a Laminin G-like domain as well as an L-type lectin domain. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.1e-06 Score=85.68 Aligned_cols=137 Identities=17% Similarity=0.163 Sum_probs=103.8
Q ss_pred ccCccEEEEEEEeCCCCeEEEEEEeccC------CChhhHHHHHHHHHHhccCCCC--ceeEeeeee-ec----CeeEEE
Q 006112 345 TKGGSGKVYRGVLPSSHAEIAVKKVCHD------SDHGMKQFVSEIVSMGKLRHRN--LVQLRGYCR-RK----GELLLV 411 (660)
Q Consensus 345 g~G~fg~Vy~g~~~~~~~~vavK~~~~~------~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~g~~~-~~----~~~~lV 411 (660)
++||-+-|++-.+ .|+.+-+|+-... .+.+...|.+|+..|.+|...+ +.+.. ++. .. -+-+||
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 5588888998776 3457889986421 1446778999999999986433 44444 332 11 246899
Q ss_pred EecCCC-CChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCC--eEEeeccccee
Q 006112 412 YDYMPN-GSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLE--GKLGDFGLARL 487 (660)
Q Consensus 412 ~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~--~kl~DFGla~~ 487 (660)
+|-++| -+|.+++........+..++..++.++++.++-||+ .++.|+|+-+.||+++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997754 689998866544456777888999999999999998 99999999999999986666 99999987653
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=2.3e-06 Score=89.29 Aligned_cols=189 Identities=19% Similarity=0.247 Sum_probs=128.5
Q ss_pred cccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhcc-CCCCceeEeeee------eecCe-eEEEEe
Q 006112 342 YKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKL-RHRNLVQLRGYC------RRKGE-LLLVYD 413 (660)
Q Consensus 342 ~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~------~~~~~-~~lV~E 413 (660)
..+|+|+-+.+|-.-.. + ..+.|+..........+...| |... .||-+-.=+.|= -++++ +-+.|.
T Consensus 17 r~LgqGgea~ly~l~e~--~-d~VAKIYh~Pppa~~aqk~a~---la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 17 RPLGQGGEADLYTLGEV--R-DQVAKIYHAPPPAAQAQKVAE---LAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred ccccCCccceeeecchh--h-chhheeecCCCchHHHHHHHH---hccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 46889999999954321 1 234576655444433333332 3332 465544323331 12233 678888
Q ss_pred cCCCCChhhhhhh-----CCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceec
Q 006112 414 YMPNGSLDKILYS-----NTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLY 488 (660)
Q Consensus 414 ~~~~gsL~~~l~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 488 (660)
.+++..=-..++. ..-+..+|.-.++.++.+|.+.+-||+ .|.+-+|+.++|+|+.++..+.|.|-..-...
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceeec
Confidence 8876532222221 122458999999999999999999998 89999999999999999999999987655544
Q ss_pred cCCCCceeeccccCccccCccccc-----CCCCCcceeEEehHHHHHHHhhC-CCCCCC
Q 006112 489 DHGNDLHTTNVVGTVGYLAPELLR-----NGRGTTSTDVYAFGVFMLEVACG-RRPVQP 541 (660)
Q Consensus 489 ~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltG-~~p~~~ 541 (660)
.++.. ..-.+|...|.+||.-. +-.-+...|-|.+|+++++++.| ++||.+
T Consensus 168 ~ng~~--~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 168 ANGTL--HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred cCCce--EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 33322 22357889999999754 33457789999999999999886 999975
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.52 E-value=9e-07 Score=87.34 Aligned_cols=107 Identities=23% Similarity=0.320 Sum_probs=84.5
Q ss_pred hHHHHHHHHHHhccCCCC--ceeEeeeeeecC----eeEEEEecCCCC-ChhhhhhhCCCCCcchhHHHHHHHHHHHHHH
Q 006112 377 MKQFVSEIVSMGKLRHRN--LVQLRGYCRRKG----ELLLVYDYMPNG-SLDKILYSNTRPSLNWFQRFRIIKGVAFGLL 449 (660)
Q Consensus 377 ~~~~~~Ei~~l~~l~H~n--Iv~l~g~~~~~~----~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~ 449 (660)
.....+|...+.++.... +.+.+++..... ..+||+|++++. +|.+++..... ++......++.+++..++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence 346788888888875433 455666655432 458999999884 89999876433 555677899999999999
Q ss_pred HhhhcccCceeccCccCCcEEEcCCC---CeEEeecccceec
Q 006112 450 YLHEEWEQVVLHRDIKPANVLLDADL---EGKLGDFGLARLY 488 (660)
Q Consensus 450 yLH~~~~~~ivHrDikp~NIll~~~~---~~kl~DFGla~~~ 488 (660)
-||+ .+|+|+|+++.|||++.+. .+.++||+-++..
T Consensus 133 ~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 133 KLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9998 9999999999999998887 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.50 E-value=5.4e-08 Score=107.33 Aligned_cols=152 Identities=20% Similarity=0.310 Sum_probs=102.0
Q ss_pred HHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCcee--------eccccCccccCccccc
Q 006112 441 IKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT--------TNVVGTVGYLAPELLR 512 (660)
Q Consensus 441 ~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~--------~~~~gt~~Y~aPE~~~ 512 (660)
+.+++.||.|+|. +.++||++|.|++|.+++++..||+.|+.+........... .-..-...|.|||++.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 4556699999998 68999999999999999999999999998865433221111 0112356899999999
Q ss_pred CCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCC
Q 006112 513 NGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPD 592 (660)
Q Consensus 513 ~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~ 592 (660)
..-.+.++|+||+|+++|-+..|..+.-........+-...... +.. ...+..+.+.++.+-+.+.+..++.
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~----~~~----~~~~s~~~p~el~~~l~k~l~~~~~ 254 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLL----NAG----AFGYSNNLPSELRESLKKLLNGDSA 254 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccc----ccc----cccccccCcHHHHHHHHHHhcCCcc
Confidence 88889999999999999999965555432221111111111110 000 1112233344455555667999999
Q ss_pred CCCCHHHHHH
Q 006112 593 TRPSMRQVVQ 602 (660)
Q Consensus 593 ~RPs~~evl~ 602 (660)
.||++.++..
T Consensus 255 ~rp~~~~l~~ 264 (700)
T KOG2137|consen 255 VRPTLDLLLS 264 (700)
T ss_pred cCcchhhhhc
Confidence 9998887764
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.28 E-value=6.4e-06 Score=82.19 Aligned_cols=132 Identities=17% Similarity=0.148 Sum_probs=91.0
Q ss_pred cccccCccEEEEEEEeCCCCeEEEEEEeccCC----------C------------hhhHHHHHHHHHHhccCCC--Ccee
Q 006112 342 YKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS----------D------------HGMKQFVSEIVSMGKLRHR--NLVQ 397 (660)
Q Consensus 342 ~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~----------~------------~~~~~~~~Ei~~l~~l~H~--nIv~ 397 (660)
..||.|.-+.||.|..+ .|.++|||--+... . -......+|.++|.+|.-. .+.+
T Consensus 97 ~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~ 175 (304)
T COG0478 97 TKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPK 175 (304)
T ss_pred cccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCC
Confidence 46889999999999996 57789999532110 0 0123467899999998655 6666
Q ss_pred EeeeeeecCeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCe
Q 006112 398 LRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEG 477 (660)
Q Consensus 398 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~ 477 (660)
.++| +.-.+||||++|-.|...-- +-...-.|+..|+.-+.-+-. .||||+|+.+-||+++++|.+
T Consensus 176 P~~~----nRHaVvMe~ieG~eL~~~r~-------~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~dg~~ 241 (304)
T COG0478 176 PIAW----NRHAVVMEYIEGVELYRLRL-------DVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTEDGDI 241 (304)
T ss_pred cccc----ccceeeeehcccceeecccC-------cccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEecCCCE
Confidence 6664 45689999998877755321 122223333333333333333 899999999999999999999
Q ss_pred EEeecccceec
Q 006112 478 KLGDFGLARLY 488 (660)
Q Consensus 478 kl~DFGla~~~ 488 (660)
.++||--+...
T Consensus 242 ~vIDwPQ~v~~ 252 (304)
T COG0478 242 VVIDWPQAVPI 252 (304)
T ss_pred EEEeCcccccC
Confidence 99999766543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.24 E-value=9e-06 Score=81.36 Aligned_cols=142 Identities=15% Similarity=0.146 Sum_probs=85.6
Q ss_pred ecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCC--ceeEeeeeeecCeeEEEEecCC
Q 006112 339 KNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRN--LVQLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 339 ~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~g~~~~~~~~~lV~E~~~ 416 (660)
+....+++|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.++++...+...+|||+++
T Consensus 4 ~~~~~i~~G~t~~~y~~----~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 4 SDWTQTGEGGNGESYTH----KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred hHheeecCCCCcceeEe----cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 34457899999999983 23456778765432 2345688999998886444 4677777777777889999998
Q ss_pred CCC-hhhhh---------------------hhCCCCCcchhHHH-HHHHH----------HHH-HHHHhhh-cccCceec
Q 006112 417 NGS-LDKIL---------------------YSNTRPSLNWFQRF-RIIKG----------VAF-GLLYLHE-EWEQVVLH 461 (660)
Q Consensus 417 ~gs-L~~~l---------------------~~~~~~~l~~~~~~-~i~~~----------ia~-gL~yLH~-~~~~~ivH 461 (660)
|.+ +...+ +............. ++..+ +.. ...+|.. .....++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 863 22111 11000011111110 00000 000 1112211 11356799
Q ss_pred cCccCCcEEEcCCCCeEEeeccccee
Q 006112 462 RDIKPANVLLDADLEGKLGDFGLARL 487 (660)
Q Consensus 462 rDikp~NIll~~~~~~kl~DFGla~~ 487 (660)
+|+.|.||++++++ +.|+||+.+..
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcCc
Confidence 99999999999887 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.18 E-value=7.7e-06 Score=90.67 Aligned_cols=141 Identities=18% Similarity=0.248 Sum_probs=89.4
Q ss_pred cccccCccEEEEEEEeCCCCeEEEEEEeccCCChhh------------------------------H----------HHH
Q 006112 342 YKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGM------------------------------K----------QFV 381 (660)
Q Consensus 342 ~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~------------------------------~----------~~~ 381 (660)
.-++.++-|.||+|++++ |+.||||+.+.+-.+.. + +|.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 356679999999999964 89999998765321110 0 133
Q ss_pred HHHHHHhccC-----CCCceeEeeeee-ecCeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcc
Q 006112 382 SEIVSMGKLR-----HRNLVQLRGYCR-RKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEW 455 (660)
Q Consensus 382 ~Ei~~l~~l~-----H~nIv~l~g~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 455 (660)
+|..-+.+++ .+++ ++=..|. -.+...|+|||+.|-.+.+...-.. ..++ +..++..++++ |+.+-.
T Consensus 210 ~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d---~k~ia~~~~~~--f~~q~~ 282 (517)
T COG0661 210 REAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGID---RKELAELLVRA--FLRQLL 282 (517)
T ss_pred HHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCC---HHHHHHHHHHH--HHHHHH
Confidence 3444444432 2222 2222222 2356789999999999988743222 2233 33334444332 222222
Q ss_pred cCceeccCccCCcEEEcCCCCeEEeecccceeccC
Q 006112 456 EQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDH 490 (660)
Q Consensus 456 ~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 490 (660)
+.++.|+|..|.||+++.++.+-+.|||+...++.
T Consensus 283 ~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 283 RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 37899999999999999999999999999876543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.7e-05 Score=79.13 Aligned_cols=143 Identities=20% Similarity=0.241 Sum_probs=85.4
Q ss_pred ccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCC--ceeEeeeeee---cCeeEEEEecC
Q 006112 341 LYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRN--LVQLRGYCRR---KGELLLVYDYM 415 (660)
Q Consensus 341 l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~g~~~~---~~~~~lV~E~~ 415 (660)
++.++.|..+.||+....+ ..+++|..... .....+..|..+++.+.... +.+++.++.. ....+++||++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 4568889999999999854 47999987444 45677888999988885433 4566665432 33468999999
Q ss_pred CCCChhh----------------hh---hhC--CCCCcchhH---------HHHH------------HHHHHH-HHHHhh
Q 006112 416 PNGSLDK----------------IL---YSN--TRPSLNWFQ---------RFRI------------IKGVAF-GLLYLH 452 (660)
Q Consensus 416 ~~gsL~~----------------~l---~~~--~~~~l~~~~---------~~~i------------~~~ia~-gL~yLH 452 (660)
++..+.. .+ +.. ......+.. .... ...+.. .++.++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9988877 11 111 111111110 0000 112222 333333
Q ss_pred h----cccCceeccCccCCcEEEc-CCCCeEEeeccccee
Q 006112 453 E----EWEQVVLHRDIKPANVLLD-ADLEGKLGDFGLARL 487 (660)
Q Consensus 453 ~----~~~~~ivHrDikp~NIll~-~~~~~kl~DFGla~~ 487 (660)
+ .....++|+|+.|.|||++ +++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2 1357899999999999999 556668999998754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.12 E-value=2.4e-05 Score=79.16 Aligned_cols=140 Identities=17% Similarity=0.135 Sum_probs=85.1
Q ss_pred cccccCcc-EEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccC-CCCceeEeeeeeecCeeEEEEecCCCCC
Q 006112 342 YKATKGGS-GKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLR-HRNLVQLRGYCRRKGELLLVYDYMPNGS 419 (660)
Q Consensus 342 ~~lg~G~f-g~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~~gs 419 (660)
..|..|.. ..||+.... +..+.||+..... ..+..+|+++++.+. +--+.+++++....+.-++|||+++|.+
T Consensus 4 ~~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~ 78 (244)
T cd05150 4 ERVTEGQSGATVYRLDGK--NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVP 78 (244)
T ss_pred eecCCCCCcCeEEEEcCC--CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCcc
Confidence 34556666 788998763 3577888764432 345678998888874 3445677887776667899999999988
Q ss_pred hhhhh-------------------hhCCCC--Ccc-h-hHHHHHHH--------------------HHHHHHHHhhh---
Q 006112 420 LDKIL-------------------YSNTRP--SLN-W-FQRFRIIK--------------------GVAFGLLYLHE--- 453 (660)
Q Consensus 420 L~~~l-------------------~~~~~~--~l~-~-~~~~~i~~--------------------~ia~gL~yLH~--- 453 (660)
|.... +..... ... + ........ .+...+..|-.
T Consensus 79 l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 158 (244)
T cd05150 79 AAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRP 158 (244)
T ss_pred HhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCC
Confidence 76432 110000 000 0 00000000 01111112211
Q ss_pred -cccCceeccCccCCcEEEcCCCCeEEeecccce
Q 006112 454 -EWEQVVLHRDIKPANVLLDADLEGKLGDFGLAR 486 (660)
Q Consensus 454 -~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 486 (660)
.....++|+|+.|.|||++++....|+||+.+.
T Consensus 159 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 159 AEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 123679999999999999998778899999775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.11 E-value=3.4e-05 Score=75.52 Aligned_cols=135 Identities=16% Similarity=0.182 Sum_probs=87.7
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHH---------HHHHHHHhccC---CCCceeEeeeeee
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQF---------VSEIVSMGKLR---HRNLVQLRGYCRR 404 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~---------~~Ei~~l~~l~---H~nIv~l~g~~~~ 404 (660)
.|+.++.+-......|.+-.. ++..+++|..+.......+.| .+++..+.+++ -.....++.++..
T Consensus 32 ~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ek 109 (229)
T PF06176_consen 32 NYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEK 109 (229)
T ss_pred CceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeee
Confidence 466666666666666666555 567889998765443333322 23344444442 2333333333322
Q ss_pred -----cCeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEE
Q 006112 405 -----KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKL 479 (660)
Q Consensus 405 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl 479 (660)
....+|+|||++|..|.++.. ++. .+...+.+++.-||+ .|++|+|..|.|++++++ .+++
T Consensus 110 k~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~-~i~i 175 (229)
T PF06176_consen 110 KIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN-GIRI 175 (229)
T ss_pred eeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC-cEEE
Confidence 234679999999988876532 221 345667788999998 999999999999999865 5999
Q ss_pred eeccccee
Q 006112 480 GDFGLARL 487 (660)
Q Consensus 480 ~DFGla~~ 487 (660)
+||+..+.
T Consensus 176 ID~~~k~~ 183 (229)
T PF06176_consen 176 IDTQGKRM 183 (229)
T ss_pred EECccccc
Confidence 99987764
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.99 E-value=2e-06 Score=94.15 Aligned_cols=184 Identities=20% Similarity=0.155 Sum_probs=132.6
Q ss_pred ecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCC-ceeEeeeeeecCeeEEEEecCCC
Q 006112 339 KNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRN-LVQLRGYCRRKGELLLVYDYMPN 417 (660)
Q Consensus 339 ~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~E~~~~ 417 (660)
......++|+.+++||.+-..+... .++.+... ....-++++|.+++||| .+..++-+..+...+++++++.+
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL-~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~ 318 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLL-QHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST 318 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhhe-eceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence 3345567899999999876544332 25554322 44556889999999999 77777777777889999999987
Q ss_pred C-ChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCcee
Q 006112 418 G-SLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT 496 (660)
Q Consensus 418 g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 496 (660)
+ +-..... .....+...+...+.+.-+++|+|||+ ..-+||| ||+..+ ...|..||+....+.... ..
T Consensus 319 ~rs~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~ 387 (829)
T KOG0576|consen 319 GRSSALEMT-VSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KP 387 (829)
T ss_pred CccccccCC-hhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc--cc
Confidence 7 2211111 011124444556677778889999997 4458998 887765 578999999887665443 23
Q ss_pred eccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCC
Q 006112 497 TNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPV 539 (660)
Q Consensus 497 ~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~ 539 (660)
....+|+.++|||......+..+.|+|+.|+--.++.-|-.|-
T Consensus 388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 4467899999999999999999999999998777777666654
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.99 E-value=1.8e-05 Score=76.63 Aligned_cols=104 Identities=23% Similarity=0.176 Sum_probs=82.8
Q ss_pred HHHHHHHhccCC-CCceeEeeeeeecCeeEEEEecCCCCChhhhhhh-CCCCCcchhHHHHHHHHHHHHHHHhhhcccCc
Q 006112 381 VSEIVSMGKLRH-RNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYS-NTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQV 458 (660)
Q Consensus 381 ~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 458 (660)
..|.-+++.+++ +++.+++|.|- .++|.||.+.+++...-.. ..-..-+|..|.+|+.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358888888876 69999999993 3689999987766432000 00123689999999999999999999866566
Q ss_pred eeccCccCCcEEEcCCCCeEEeecccceec
Q 006112 459 VLHRDIKPANVLLDADLEGKLGDFGLARLY 488 (660)
Q Consensus 459 ivHrDikp~NIll~~~~~~kl~DFGla~~~ 488 (660)
+.-+|++++|+-+++++++|++|...+-..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 999999999999999999999999877543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.95 E-value=8.9e-05 Score=88.32 Aligned_cols=81 Identities=11% Similarity=0.191 Sum_probs=58.6
Q ss_pred cccccccCccEEEEEEEeCCCC--eEEEEEEeccCC-ChhhHHHHHHHHHHhccC-CCCc--eeEeeeeeec---CeeEE
Q 006112 340 NLYKATKGGSGKVYRGVLPSSH--AEIAVKKVCHDS-DHGMKQFVSEIVSMGKLR-HRNL--VQLRGYCRRK---GELLL 410 (660)
Q Consensus 340 ~l~~lg~G~fg~Vy~g~~~~~~--~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-H~nI--v~l~g~~~~~---~~~~l 410 (660)
.++.++.|.+..+|+.....++ ..+++|+..... ......+.+|+++++.+. |.++ .+++.+|.+. +..++
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 3567788999999998775432 467777754332 123357889999999995 6665 7888888764 46789
Q ss_pred EEecCCCCCh
Q 006112 411 VYDYMPNGSL 420 (660)
Q Consensus 411 V~E~~~~gsL 420 (660)
||||++|..+
T Consensus 122 VME~v~G~~~ 131 (822)
T PLN02876 122 IMEYLEGRIF 131 (822)
T ss_pred EEEecCCccc
Confidence 9999987653
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.86 E-value=7.4e-05 Score=82.74 Aligned_cols=140 Identities=18% Similarity=0.220 Sum_probs=88.4
Q ss_pred cccccCccEEEEEEEeCCCCeEEEEEEeccCCChh-------------------------------------hHHHHHHH
Q 006112 342 YKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHG-------------------------------------MKQFVSEI 384 (660)
Q Consensus 342 ~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~-------------------------------------~~~~~~Ei 384 (660)
+.|+.-+.|.||+++++. |+.||||+-+..-++. .-+|.+|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 356778899999999976 8999999865432111 00255555
Q ss_pred HHHhcc----CCCC------ceeEeeeeeecCeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhc
Q 006112 385 VSMGKL----RHRN------LVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEE 454 (660)
Q Consensus 385 ~~l~~l----~H~n------Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~ 454 (660)
+-..++ .|-+ |.+++-. -.....|+||||+|..+.+.-.-.. ..++-. +|+..+.++ |++..
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~---~i~~~l~~~--~~~qI 317 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDK-RGISPH---DILNKLVEA--YLEQI 317 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHH-cCCCHH---HHHHHHHHH--HHHHH
Confidence 444333 4555 2233222 2246789999999998877543211 124433 333333332 33333
Q ss_pred ccCceeccCccCCcEEEcC----CCCeEEeecccceeccC
Q 006112 455 WEQVVLHRDIKPANVLLDA----DLEGKLGDFGLARLYDH 490 (660)
Q Consensus 455 ~~~~ivHrDikp~NIll~~----~~~~kl~DFGla~~~~~ 490 (660)
-..|++|+|=.|-||+++. ++.+.+-|||+.....+
T Consensus 318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 3368999999999999984 67899999999876543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00026 Score=70.22 Aligned_cols=137 Identities=18% Similarity=0.165 Sum_probs=86.2
Q ss_pred ccccCccEEEEEEEeCCCCeEEEEEEeccCCChh-------------------hHH-----HHHHHHHHhccC--CCCce
Q 006112 343 KATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHG-------------------MKQ-----FVSEIVSMGKLR--HRNLV 396 (660)
Q Consensus 343 ~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~-------------------~~~-----~~~Ei~~l~~l~--H~nIv 396 (660)
.+..|.-..||+|.. .++..+|||+........ .++ ..+|+.-|.++. +-.+.
T Consensus 55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 455688889999987 467899999875432111 011 123555555542 22222
Q ss_pred eEeeeeeecCeeEEEEecCCCCCh-hhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCC
Q 006112 397 QLRGYCRRKGELLLVYDYMPNGSL-DKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADL 475 (660)
Q Consensus 397 ~l~g~~~~~~~~~lV~E~~~~gsL-~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~ 475 (660)
+-+++. .-.|||||+...-+ .-.|... .+...+...+..++++.+.-|-. ..++||+||..=|||+. ++
T Consensus 134 ~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv---~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~~ 203 (268)
T COG1718 134 EPIAFR----NNVLVMEFIGDDGLPAPRLKDV---PLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-DG 203 (268)
T ss_pred Cceeec----CCeEEEEeccCCCCCCCCcccC---CcCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-CC
Confidence 223221 34799999954311 1111111 12222566777788888877765 47999999999999999 78
Q ss_pred CeEEeecccceeccC
Q 006112 476 EGKLGDFGLARLYDH 490 (660)
Q Consensus 476 ~~kl~DFGla~~~~~ 490 (660)
.+.|+|+|-|....+
T Consensus 204 ~p~iID~~QaV~~~h 218 (268)
T COG1718 204 EPYIIDVSQAVTIDH 218 (268)
T ss_pred eEEEEECccccccCC
Confidence 999999998876544
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00025 Score=66.62 Aligned_cols=130 Identities=20% Similarity=0.214 Sum_probs=89.1
Q ss_pred eecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCce-eEeeeeeecCeeEEEEecCC
Q 006112 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLV-QLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~lV~E~~~ 416 (660)
.+..+.|++|.+|.||+|.+ .+..+|+|+-+.+++ ...+..|.+++..+.--++- +++.|- +-.+.|||+.
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~ 95 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYID 95 (201)
T ss_pred hhhhhhhhcccccEEEEeec--cCceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhc
Confidence 34566789999999999999 456899998766654 46788999999988766654 444443 2345599998
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCcc-CCcEEEcCCCCeEEeeccccee
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIK-PANVLLDADLEGKLGDFGLARL 487 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik-p~NIll~~~~~~kl~DFGla~~ 487 (660)
|-.|.++-... + .+-+..+++.-.-|-. .||-|..|. |..++|-.+..+.|+||.-|..
T Consensus 96 G~~L~~~~~~~-----~----rk~l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 96 GRPLGKLEIGG-----D----RKHLLRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred Ccchhhhhhcc-----c----HHHHHHHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 88887765321 1 1223344555333343 889999886 4444444444899999998874
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00082 Score=65.57 Aligned_cols=130 Identities=18% Similarity=0.260 Sum_probs=89.4
Q ss_pred ecccccccCccEEEEEEEeCCCCeEEEEEEeccCC----------------ChhhHHHHHHHHHHhccC------CCCce
Q 006112 339 KNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS----------------DHGMKQFVSEIVSMGKLR------HRNLV 396 (660)
Q Consensus 339 ~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~----------------~~~~~~~~~Ei~~l~~l~------H~nIv 396 (660)
.....+++|+.-.||. ++.+ ....||+..... ....++..+|+.-...+. +.+|.
T Consensus 4 ~~~~~i~~G~~R~cy~--HP~d-p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~ 80 (199)
T PF10707_consen 4 SESDLIAQGGERDCYQ--HPDD-PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIP 80 (199)
T ss_pred CCCcccccCCCceEEE--CCCC-CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccc
Confidence 3456789999999995 4433 446788876554 223456677776655555 88999
Q ss_pred eEeeeeeecCeeEEEEecCCCC------ChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEE
Q 006112 397 QLRGYCRRKGELLLVYDYMPNG------SLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVL 470 (660)
Q Consensus 397 ~l~g~~~~~~~~~lV~E~~~~g------sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIl 470 (660)
+++|+.+.+...-+|+|.+.+. +|.+++.... ++. ...+.+. +-..||-+ ..|+.+|++|+||+
T Consensus 81 r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~---~~~-~~~~~L~---~f~~~l~~---~~Iv~~dl~~~NIv 150 (199)
T PF10707_consen 81 RFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG---LTE-ELRQALD---EFKRYLLD---HHIVIRDLNPHNIV 150 (199)
T ss_pred cEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC---ccH-HHHHHHH---HHHHHHHH---cCCeecCCCcccEE
Confidence 9999999999999999987542 4777775432 443 3333333 33455655 78999999999999
Q ss_pred EcCCC----CeEEee
Q 006112 471 LDADL----EGKLGD 481 (660)
Q Consensus 471 l~~~~----~~kl~D 481 (660)
+.... .+.|+|
T Consensus 151 ~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 151 VQRRDSGEFRLVLID 165 (199)
T ss_pred EEecCCCceEEEEEe
Confidence 95432 466776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00053 Score=68.86 Aligned_cols=76 Identities=16% Similarity=0.231 Sum_probs=47.7
Q ss_pred ccccccCccEEEEEEEeCC-CCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCc-eeEeeeeeecCeeEEEEecCCCC
Q 006112 341 LYKATKGGSGKVYRGVLPS-SHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNL-VQLRGYCRRKGELLLVYDYMPNG 418 (660)
Q Consensus 341 l~~lg~G~fg~Vy~g~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~E~~~~g 418 (660)
++.+..|-...+|+..... .+..+++|....... ..-...+|+.+++.+...++ .++++.+. + .+||||++|.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCC
Confidence 4556777788999987643 246788886643322 22233578888888854333 44444332 2 3799999987
Q ss_pred Chh
Q 006112 419 SLD 421 (660)
Q Consensus 419 sL~ 421 (660)
++.
T Consensus 78 ~l~ 80 (235)
T cd05157 78 TLE 80 (235)
T ss_pred cCC
Confidence 763
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00035 Score=70.31 Aligned_cols=72 Identities=14% Similarity=0.120 Sum_probs=43.4
Q ss_pred ccccCccE-EEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCC---CceeEeeeeeec---CeeEEEEecC
Q 006112 343 KATKGGSG-KVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHR---NLVQLRGYCRRK---GELLLVYDYM 415 (660)
Q Consensus 343 ~lg~G~fg-~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~---nIv~l~g~~~~~---~~~~lV~E~~ 415 (660)
.++.||.. .||+. +..+++|.... .....++.+|.+++..+... -+.+.++.+... +..+++||++
T Consensus 4 ~~~~gG~~n~vy~~-----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 4 PVDSGGTDNATFRL-----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eccCCCcccceEEc-----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 45556655 58874 12466775432 22345788999999877532 234444444332 2348899999
Q ss_pred CCCChh
Q 006112 416 PNGSLD 421 (660)
Q Consensus 416 ~~gsL~ 421 (660)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00036 Score=71.25 Aligned_cols=138 Identities=14% Similarity=0.013 Sum_probs=78.2
Q ss_pred ccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCc-eeEeeeeeecCeeEEEEecCCCCChh
Q 006112 343 KATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNL-VQLRGYCRRKGELLLVYDYMPNGSLD 421 (660)
Q Consensus 343 ~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~E~~~~gsL~ 421 (660)
.+..|-...+|+... ++..+++|..........-...+|..+++.+....+ .+++..+. -.+||||++|..+.
T Consensus 3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT 76 (256)
T ss_pred cCCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence 355677788998874 566788887543322211245788888888864433 34444332 36899999987764
Q ss_pred hh-----------------hhhCCC--CCcchhHH-HHHHHHH---------HHHHHHhhh-----cccCceeccCccCC
Q 006112 422 KI-----------------LYSNTR--PSLNWFQR-FRIIKGV---------AFGLLYLHE-----EWEQVVLHRDIKPA 467 (660)
Q Consensus 422 ~~-----------------l~~~~~--~~l~~~~~-~~i~~~i---------a~gL~yLH~-----~~~~~ivHrDikp~ 467 (660)
.. |+.... ..++...+ .....++ ...+..+-. .....++|+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 21 111111 11111111 1111111 111111111 11357999999999
Q ss_pred cEEEcCCCCeEEeeccccee
Q 006112 468 NVLLDADLEGKLGDFGLARL 487 (660)
Q Consensus 468 NIll~~~~~~kl~DFGla~~ 487 (660)
||++++++ ++|+||..+..
T Consensus 157 Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 157 NLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cEEEeCCC-CEEEeccccCc
Confidence 99999876 78999998753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00086 Score=70.05 Aligned_cols=80 Identities=8% Similarity=-0.046 Sum_probs=57.2
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCC---CCceeEeeeeee---cCeeEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRH---RNLVQLRGYCRR---KGELLL 410 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H---~nIv~l~g~~~~---~~~~~l 410 (660)
.....+.++.|..+.||+....+ + .+.+|..+.. .....+..|...++.+.. -.+.+++++|.. .+.-+|
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQ-G-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred hhheeeecCCccceeEEEEEcCC-C-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 34456678999999999986632 3 4666764321 123578899999988853 357888888754 366899
Q ss_pred EEecCCCCCh
Q 006112 411 VYDYMPNGSL 420 (660)
Q Consensus 411 V~E~~~~gsL 420 (660)
|||+++++++
T Consensus 91 VmE~i~G~~~ 100 (297)
T PRK10593 91 LLERLRGVSV 100 (297)
T ss_pred EEeccCCEec
Confidence 9999998765
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00091 Score=64.85 Aligned_cols=124 Identities=27% Similarity=0.366 Sum_probs=88.9
Q ss_pred eeecccccccCcc-EEEEEEEeCCCCeEEEEEEecc---CCC------------------hhhHHHHHHHHHHhccC---
Q 006112 337 SYKNLYKATKGGS-GKVYRGVLPSSHAEIAVKKVCH---DSD------------------HGMKQFVSEIVSMGKLR--- 391 (660)
Q Consensus 337 ~~~~l~~lg~G~f-g~Vy~g~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~Ei~~l~~l~--- 391 (660)
+++.++.+|.|.- |.||+.+. +|..+|+|.... ... .....|..|.....+|+
T Consensus 38 ~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 38 DIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred cEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 5677889999999 99999999 678999999321 100 12345889999888885
Q ss_pred CCCc--eeEeeeeeec------------------CeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHh
Q 006112 392 HRNL--VQLRGYCRRK------------------GELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYL 451 (660)
Q Consensus 392 H~nI--v~l~g~~~~~------------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL 451 (660)
+.++ |+.+||..-. ....||.||.+... .+. .+-+.+|.+-|..+
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~----~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQ----IRDIPQMLRDLKIL 180 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccc----hhHHHHHHHHHHHH
Confidence 4456 9999997322 11367788775433 112 23345666777888
Q ss_pred hhcccCceeccCccCCcEEEcCCCCeEEeecccc
Q 006112 452 HEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLA 485 (660)
Q Consensus 452 H~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla 485 (660)
|. .+|+-+|+|+.|.. .-||+|||.+
T Consensus 181 ~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HK---LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HH---CCeeeccCcccccc-----CCEEEecccC
Confidence 87 99999999999986 5689999864
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0012 Score=69.10 Aligned_cols=142 Identities=24% Similarity=0.284 Sum_probs=83.1
Q ss_pred ccccccCccEEEEEEEeCCC------CeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCc-eeEeeeeeecCeeEEEEe
Q 006112 341 LYKATKGGSGKVYRGVLPSS------HAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNL-VQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 341 l~~lg~G~fg~Vy~g~~~~~------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~E 413 (660)
++.+..|-...+|+.....+ ++.+++|...... ....+..+|.+++..+....+ .++++.+. + .+|+|
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e 77 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEE 77 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhh
Confidence 34556666778998876432 4678888865433 233456778888888754333 35555543 2 35899
Q ss_pred cCCCCChhhh-----------------hhhCCCC---------CcchhHHHH--------------------------HH
Q 006112 414 YMPNGSLDKI-----------------LYSNTRP---------SLNWFQRFR--------------------------II 441 (660)
Q Consensus 414 ~~~~gsL~~~-----------------l~~~~~~---------~l~~~~~~~--------------------------i~ 441 (660)
|++|..+... ++..... ..-|....+ +.
T Consensus 78 ~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (302)
T cd05156 78 FIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFL 157 (302)
T ss_pred eeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHH
Confidence 9988776431 1111100 000111100 11
Q ss_pred HHHHHHHHHhhh------cccCceeccCccCCcEEEcCC----CCeEEeeccccee
Q 006112 442 KGVAFGLLYLHE------EWEQVVLHRDIKPANVLLDAD----LEGKLGDFGLARL 487 (660)
Q Consensus 442 ~~ia~gL~yLH~------~~~~~ivHrDikp~NIll~~~----~~~kl~DFGla~~ 487 (660)
..+..-+..|.. .....++|+|+.+.|||++++ +.++++||..|..
T Consensus 158 ~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 158 EDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 122222334431 235789999999999999985 7899999998853
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.00085 Score=69.96 Aligned_cols=143 Identities=15% Similarity=0.124 Sum_probs=86.3
Q ss_pred ecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCC--ceeEeeee------eecCeeEE
Q 006112 339 KNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRN--LVQLRGYC------RRKGELLL 410 (660)
Q Consensus 339 ~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~g~~------~~~~~~~l 410 (660)
..++.+..|....+|+.... +..+++|+... ....+...|+.++..+.+.+ +.+++... ...+..++
T Consensus 17 ~~i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~ 91 (296)
T cd05153 17 LSFEGISAGIENTNYFVTTD--SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAA 91 (296)
T ss_pred hheecccCccccceEEEEeC--CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEE
Confidence 34566777877899988663 34688888753 23345667888887775433 44444321 23345689
Q ss_pred EEecCCCCChhh----hh----------hhC----CC-----CCcchhHHH----------HHHHHHHHHHHHhhh----
Q 006112 411 VYDYMPNGSLDK----IL----------YSN----TR-----PSLNWFQRF----------RIIKGVAFGLLYLHE---- 453 (660)
Q Consensus 411 V~E~~~~gsL~~----~l----------~~~----~~-----~~l~~~~~~----------~i~~~ia~gL~yLH~---- 453 (660)
|+||++|..+.. .. +.. .. ....|.... .....+...+.++..
T Consensus 92 l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~ 171 (296)
T cd05153 92 LVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPS 171 (296)
T ss_pred EEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhh
Confidence 999999877532 00 100 00 112332221 111223334444443
Q ss_pred cccCceeccCccCCcEEEcCCCCeEEeecccce
Q 006112 454 EWEQVVLHRDIKPANVLLDADLEGKLGDFGLAR 486 (660)
Q Consensus 454 ~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 486 (660)
....++||+|+.|.||+++++..+.|+||+.+.
T Consensus 172 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 172 DLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred cCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 224679999999999999988777899999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0038 Score=67.43 Aligned_cols=77 Identities=12% Similarity=0.046 Sum_probs=54.5
Q ss_pred ccccccCccEEEEEEEeCCCCeEEEEEEeccC------C-ChhhHHHHHHHHHHhccC---CCCceeEeeeeeecCeeEE
Q 006112 341 LYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD------S-DHGMKQFVSEIVSMGKLR---HRNLVQLRGYCRRKGELLL 410 (660)
Q Consensus 341 l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~------~-~~~~~~~~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~l 410 (660)
.+.+|.|.+..||+....++++.++||.-... . +-..+++..|.+.|..+. -.++.+++.+. ....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence 45689999999999999654468999985321 1 224566777888887763 34577777763 345789
Q ss_pred EEecCCCCC
Q 006112 411 VYDYMPNGS 419 (660)
Q Consensus 411 V~E~~~~gs 419 (660)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998644
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0039 Score=66.56 Aligned_cols=142 Identities=15% Similarity=0.175 Sum_probs=83.6
Q ss_pred ccccccCccEEEEEEEeCC----CCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCce-eEeeeeeecCeeEEEEecC
Q 006112 341 LYKATKGGSGKVYRGVLPS----SHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLV-QLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 341 l~~lg~G~fg~Vy~g~~~~----~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~lV~E~~ 415 (660)
++.+..|-.-.+|+..... .++.+++|...........+ .+|..+++.+...++. ++++.+. .+ .|+||+
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~-~g---~v~efi 115 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFP-NG---RVEEFI 115 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEEC-Cc---eEEEee
Confidence 4456667788999987643 23678888775544333333 7788888888654443 4555442 22 589999
Q ss_pred CCCChhhh-----------------hhhCC----CCCcchhHHHHHHHHH-----------------HHHHHHh----hh
Q 006112 416 PNGSLDKI-----------------LYSNT----RPSLNWFQRFRIIKGV-----------------AFGLLYL----HE 453 (660)
Q Consensus 416 ~~gsL~~~-----------------l~~~~----~~~l~~~~~~~i~~~i-----------------a~gL~yL----H~ 453 (660)
++.+|... ++... .....|.+..++..++ ...+..| ..
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 87776421 11111 0012233332222111 1112222 21
Q ss_pred -cccCceeccCccCCcEEEcC-CCCeEEeeccccee
Q 006112 454 -EWEQVVLHRDIKPANVLLDA-DLEGKLGDFGLARL 487 (660)
Q Consensus 454 -~~~~~ivHrDikp~NIll~~-~~~~kl~DFGla~~ 487 (660)
.....++|+|+++.|||+++ ++.++++||..+..
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 22458999999999999986 46799999998864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.00096 Score=78.39 Aligned_cols=197 Identities=17% Similarity=0.157 Sum_probs=131.4
Q ss_pred HHHHHHHHHhccCCCCceeEeeeeeecCe----eEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhc
Q 006112 379 QFVSEIVSMGKLRHRNLVQLRGYCRRKGE----LLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEE 454 (660)
Q Consensus 379 ~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~----~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~ 454 (660)
.-..|++.+.++.|+|++.++.|..++.. +.+..|+|+.-++...++... .++....+.+..++.+||.|+|+
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h~- 304 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLHS- 304 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHHH-
Confidence 34457778888999999999998765533 334568888888888887654 36777888889999999999998
Q ss_pred ccCceeccCccCC---cEEEcCCCCeEEe--ecccceeccCCCCceeeccccCccccCcccccCCCCCc--ceeEEehHH
Q 006112 455 WEQVVLHRDIKPA---NVLLDADLEGKLG--DFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTT--STDVYAFGV 527 (660)
Q Consensus 455 ~~~~ivHrDikp~---NIll~~~~~~kl~--DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~--ksDV~S~Gv 527 (660)
....|.-+..+ +--.+..+...++ ||+..+......... ...-+..|.+||......+.. ..|+|.+|.
T Consensus 305 --~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 305 --LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--SDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred --hccceeEEecccccccccCccceeecchhhhcccccCCCcccch--hhcCccccccccccccccchhhhhhHHHHHHH
Confidence 44444444443 3334555666766 888887654433221 122345678888876655443 479999999
Q ss_pred HHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHh
Q 006112 528 FMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYL 604 (660)
Q Consensus 528 vl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 604 (660)
.+..+..|..+-..... . -+-+...+.. .+......|+..++++|++..+++.+.
T Consensus 381 l~~~~~~~~~i~~~~~~--~----------------~~~l~~~~~~----~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKSAV--P----------------VSLLDVLSTS----ELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred HHhhhhhcCcccccccc--h----------------hhhhccccch----hhhhhhhhhcchhhhhccchhhhhhch
Confidence 99999887754321100 0 0000111111 344555679999999999999998754
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.013 Score=61.58 Aligned_cols=143 Identities=16% Similarity=0.140 Sum_probs=81.9
Q ss_pred cccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCC--ceeEeeee------eecCeeEEE
Q 006112 340 NLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRN--LVQLRGYC------RRKGELLLV 411 (660)
Q Consensus 340 ~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~g~~------~~~~~~~lV 411 (660)
.++.++.|-...+|+.... ++ .+++|...... ..++...|++++..|.... +.+++... ...+..+++
T Consensus 26 ~i~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l 101 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTTD-VG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACL 101 (307)
T ss_pred eccccCCccccceEEEEeC-CC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEE
Confidence 3555666767889987652 33 57788764421 1234456666666664222 34444322 224567899
Q ss_pred EecCCCCChhh-----------h---hhhCCC----C------CcchhHHH------------HHHHHHHHHHHHhhh--
Q 006112 412 YDYMPNGSLDK-----------I---LYSNTR----P------SLNWFQRF------------RIIKGVAFGLLYLHE-- 453 (660)
Q Consensus 412 ~E~~~~gsL~~-----------~---l~~~~~----~------~l~~~~~~------------~i~~~ia~gL~yLH~-- 453 (660)
+||++|..+.. . ++.... . .-.|.... .....+.+.++++..
T Consensus 102 ~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~ 181 (307)
T TIGR00938 102 VEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFW 181 (307)
T ss_pred EEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhh
Confidence 99998865421 1 111000 0 11222111 011223344555542
Q ss_pred --cccCceeccCccCCcEEEcCCCCeEEeecccce
Q 006112 454 --EWEQVVLHRDIKPANVLLDADLEGKLGDFGLAR 486 (660)
Q Consensus 454 --~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 486 (660)
....++||+|+.+.||++++++...|+||+.+.
T Consensus 182 ~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 182 PRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 235789999999999999988777899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.015 Score=61.20 Aligned_cols=142 Identities=16% Similarity=0.144 Sum_probs=76.3
Q ss_pred cccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCC--ceeEee------eeeecCeeEEE
Q 006112 340 NLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRN--LVQLRG------YCRRKGELLLV 411 (660)
Q Consensus 340 ~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~g------~~~~~~~~~lV 411 (660)
.++.+..|....+|+.... +| .+++|+..... .+....|+.++..|...+ +.+.+. +....+..+++
T Consensus 26 ~~~~l~~G~~n~~y~v~t~-~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l 100 (319)
T PRK05231 26 SLKGIAEGIENSNFFLTTT-QG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAI 100 (319)
T ss_pred ccchhccccccceEEEEeC-CC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEE
Confidence 3455666777889988763 33 68889875212 233334555554442211 223332 12234567899
Q ss_pred EecCCCCChhh-----------hh---hhCC---------CCCcch-hHHHH------------HHHH-HHHHHHHhhh-
Q 006112 412 YDYMPNGSLDK-----------IL---YSNT---------RPSLNW-FQRFR------------IIKG-VAFGLLYLHE- 453 (660)
Q Consensus 412 ~E~~~~gsL~~-----------~l---~~~~---------~~~l~~-~~~~~------------i~~~-ia~gL~yLH~- 453 (660)
+||++|..+.. .| +... ...+.| .+... .+.+ +...+..+..
T Consensus 101 ~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 180 (319)
T PRK05231 101 VTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASA 180 (319)
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcc
Confidence 99998875421 11 1100 011222 11111 1111 1112223221
Q ss_pred ---cccCceeccCccCCcEEEcCCCCeEEeecccce
Q 006112 454 ---EWEQVVLHRDIKPANVLLDADLEGKLGDFGLAR 486 (660)
Q Consensus 454 ---~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 486 (660)
....++||+|+.|.||+++.+...-|+||+.+.
T Consensus 181 ~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 181 AWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 135689999999999999976556899999875
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.041 Score=57.55 Aligned_cols=133 Identities=19% Similarity=0.183 Sum_probs=80.1
Q ss_pred CccEEEEEEEeCCCCeEEEEEEecc--CCChhhHHHHHHHHHHhccCC--CCceeEeeeeeecC--eeEEEEecCCCCCh
Q 006112 347 GGSGKVYRGVLPSSHAEIAVKKVCH--DSDHGMKQFVSEIVSMGKLRH--RNLVQLRGYCRRKG--ELLLVYDYMPNGSL 420 (660)
Q Consensus 347 G~fg~Vy~g~~~~~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~H--~nIv~l~g~~~~~~--~~~lV~E~~~~gsL 420 (660)
|-.-.+|..... ++++++. ... ..........+|..+|+.+.- --+.+.+++|.++. ..+.||+|++|..+
T Consensus 36 G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~ 112 (321)
T COG3173 36 GWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVV 112 (321)
T ss_pred CcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceec
Confidence 333445554442 5666666 221 222334566778888877642 23445677787766 67999999988544
Q ss_pred hhhhhhCCCCCcchhHHHHHH-HHHHHHHHHhhh----------------------------------------------
Q 006112 421 DKILYSNTRPSLNWFQRFRII-KGVAFGLLYLHE---------------------------------------------- 453 (660)
Q Consensus 421 ~~~l~~~~~~~l~~~~~~~i~-~~ia~gL~yLH~---------------------------------------------- 453 (660)
...+..... . .+.+ ..++..|+-||+
T Consensus 113 ~~~~~~~~~---~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~ 185 (321)
T COG3173 113 WSALPPESL---G----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIK 185 (321)
T ss_pred cCcCCcccc---h----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHH
Confidence 333211110 0 0111 233444444442
Q ss_pred ----c-----ccCceeccCccCCcEEEcCCCCeEEeecccceecc
Q 006112 454 ----E-----WEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYD 489 (660)
Q Consensus 454 ----~-----~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 489 (660)
. ....++|+|+.+.|++++.+.-+=|.||+++..-+
T Consensus 186 Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 186 WLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred HHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 1 24579999999999999998889999999997543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.25 E-value=0.037 Score=57.10 Aligned_cols=31 Identities=32% Similarity=0.608 Sum_probs=26.0
Q ss_pred CceeccCccCCcEEEcCCCC-eEEeeccccee
Q 006112 457 QVVLHRDIKPANVLLDADLE-GKLGDFGLARL 487 (660)
Q Consensus 457 ~~ivHrDikp~NIll~~~~~-~kl~DFGla~~ 487 (660)
..++|+|++|.|||+++++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 56899999999999997555 56999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.035 Score=58.94 Aligned_cols=141 Identities=14% Similarity=0.229 Sum_probs=79.7
Q ss_pred cccccCccEEEEEEEeCCC---CeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCc-eeEeeeeeecCeeEEEEecCCC
Q 006112 342 YKATKGGSGKVYRGVLPSS---HAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNL-VQLRGYCRRKGELLLVYDYMPN 417 (660)
Q Consensus 342 ~~lg~G~fg~Vy~g~~~~~---~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~E~~~~ 417 (660)
+.+..|=...+|+....+. +..|.+|........ .-.-.+|..+++.+..-++ .++++++. .+ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 3445566678898876432 237888876544332 2233678888888865555 35565542 22 58999987
Q ss_pred CChhh-------hh----------hhCC----CCCcchhHHHHHHHHH----------------------HHHHHHhhh-
Q 006112 418 GSLDK-------IL----------YSNT----RPSLNWFQRFRIIKGV----------------------AFGLLYLHE- 453 (660)
Q Consensus 418 gsL~~-------~l----------~~~~----~~~l~~~~~~~i~~~i----------------------a~gL~yLH~- 453 (660)
..|.. .+ +... ...--|....++..++ ..-+..+..
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 76532 01 1111 0011233332222221 111111111
Q ss_pred ----cccCceeccCccCCcEEEcC-CCCeEEeeccccee
Q 006112 454 ----EWEQVVLHRDIKPANVLLDA-DLEGKLGDFGLARL 487 (660)
Q Consensus 454 ----~~~~~ivHrDikp~NIll~~-~~~~kl~DFGla~~ 487 (660)
......+|.|+.+.|||+++ ++.++++||..|-.
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11246899999999999975 46899999998754
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.038 Score=57.27 Aligned_cols=79 Identities=15% Similarity=0.262 Sum_probs=49.0
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccC---CCCceeEeeeeeecCeeEEE
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLR---HRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~lV 411 (660)
.++.+..+.++-|....+|+.. .+++.+.||.-. ......|..|..-|+.|. --.+.+.+++....+.-+||
T Consensus 16 ~~~i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl 90 (288)
T PF03881_consen 16 DFKITSIEPVSGGDINEAYRLD--TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL 90 (288)
T ss_dssp -----EEEEE--SSSSEEEEEE--TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred CCceeeeEecCCCChhheEEEE--CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence 3455666778889999999877 467789999875 334467888888887773 45577888888777778999
Q ss_pred EecCCCC
Q 006112 412 YDYMPNG 418 (660)
Q Consensus 412 ~E~~~~g 418 (660)
+||++.+
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9999877
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.0013 Score=79.02 Aligned_cols=159 Identities=13% Similarity=0.038 Sum_probs=113.1
Q ss_pred HHHHHHHHhccCCCCceeEeeeee--ecCeeEEEEecCCCCChhhhhhhCC--CCCcchhHHHHHHHHHHHHHHHhhh--
Q 006112 380 FVSEIVSMGKLRHRNLVQLRGYCR--RKGELLLVYDYMPNGSLDKILYSNT--RPSLNWFQRFRIIKGVAFGLLYLHE-- 453 (660)
Q Consensus 380 ~~~Ei~~l~~l~H~nIv~l~g~~~--~~~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~-- 453 (660)
...|...+++..|+++.....-.. +..+.+.+++|+.+|.+.+.|-+.. .+.++..-......+...+..-+|.
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 344555566678998877655332 3346789999999999999886542 2334433333333333444444443
Q ss_pred cccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHh
Q 006112 454 EWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVA 533 (660)
Q Consensus 454 ~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ell 533 (660)
....-.+|+++|+-|.+|..+.++|++++|+.+...+... ......+++-|+.|++...-.++.++|+|..|+.+|+..
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s-f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS-FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCchHh-hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 2245679999999999999999999999999984333222 223456788899999998888898999999999999998
Q ss_pred hCCCCC
Q 006112 534 CGRRPV 539 (660)
Q Consensus 534 tG~~p~ 539 (660)
-|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 887665
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.05 E-value=0.0055 Score=66.47 Aligned_cols=163 Identities=22% Similarity=0.230 Sum_probs=90.0
Q ss_pred HHHHHHHHHHhccCCCCceeEeeeeeec-CeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhccc
Q 006112 378 KQFVSEIVSMGKLRHRNLVQLRGYCRRK-GELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWE 456 (660)
Q Consensus 378 ~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 456 (660)
.+++-..+.++.+.|+|+.+.+.+.... ....+|+|++ +.||++.+.... +.... ..+
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~---l~~~s------~~~----------- 85 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN---LKDES------LLA----------- 85 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc---cchhh------hcc-----------
Confidence 4566677888999999999999887654 3478899999 889999886432 11011 111
Q ss_pred CceeccCccCCcEEEcCCCCeEEeecccceeccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCC
Q 006112 457 QVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGR 536 (660)
Q Consensus 457 ~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~ 536 (660)
+++.|- || .+.+| -++. . | |- ...+|+||||+|.++.|+.-|.
T Consensus 86 ~~~~~~-----~~-------~~~td-~~~t---~--------------~--~~-----~~~pKsdVwsl~~i~~el~L~~ 128 (725)
T KOG1093|consen 86 HGVLHL-----NI-------IYITD-HFLT---K--------------Y--PS-----PIGPKSDVWSLGFIILELYLGI 128 (725)
T ss_pred ccccee-----hh-------hhccc-cccc---c--------------C--CC-----CCCcchhhhhHHHHHHHHHHhh
Confidence 222221 11 22233 0000 0 0 10 0114999999999999999887
Q ss_pred CCCCCCCcchHHHHHHHHhcCCcccC-CCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHH
Q 006112 537 RPVQPGELDLLDWVIDYWQKGDVLDA-SDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQV 600 (660)
Q Consensus 537 ~p~~~~~~~~~~~~~~~~~~~~~~~~-~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev 600 (660)
.-+.. ....+......+-+..-.. ..-.....+-.++.+.++++...|.-..|..||...+.
T Consensus 129 ~l~~~--~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~ 191 (725)
T KOG1093|consen 129 SLEAE--LTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMEL 191 (725)
T ss_pred HHHHH--HHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHH
Confidence 65532 1122222211111100000 00000112234455678888999999999888755443
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.93 E-value=0.024 Score=55.87 Aligned_cols=32 Identities=41% Similarity=0.560 Sum_probs=22.9
Q ss_pred cCceeccCccCCcEEE-cCCCCeEEeeccccee
Q 006112 456 EQVVLHRDIKPANVLL-DADLEGKLGDFGLARL 487 (660)
Q Consensus 456 ~~~ivHrDikp~NIll-~~~~~~kl~DFGla~~ 487 (660)
...++|+|+.+.|||+ +.++.++++||..|..
T Consensus 142 ~~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 142 PLVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp GEEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred CceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 3689999999999999 8889999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.034 Score=54.34 Aligned_cols=153 Identities=17% Similarity=0.137 Sum_probs=91.7
Q ss_pred CccEEEEEEEeCCCCeEEEEEEeccCCCh-hhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCCCCChhhhhh
Q 006112 347 GGSGKVYRGVLPSSHAEIAVKKVCHDSDH-GMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILY 425 (660)
Q Consensus 347 G~fg~Vy~g~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~ 425 (660)
+|-.+.-+|+..- -+..+|++..-.-. ...-|..+..++.+++ .|+++.. ...-..-++.|+|-.
T Consensus 73 ~gNsTl~~~kt~i--G~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~-------- 138 (308)
T PF07387_consen 73 NGNSTLLIGKTKI--GPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYK-------- 138 (308)
T ss_pred CCceEEEEecccc--chhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccC--------
Confidence 3444555544422 34677877544333 3456788888888875 4677763 133456789999831
Q ss_pred hCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCceeeccccCccc
Q 006112 426 SNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGY 505 (660)
Q Consensus 426 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y 505 (660)
. .. ...-.|.. =.+.|.-.|++ ..+.+|+|..|+|||-|..|.+||.|=+... .+ +..|
T Consensus 139 ---~-~i--~~~N~i~a-gi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll--~~-----------~V~~ 197 (308)
T PF07387_consen 139 ---I-KI--NFSNFITA-GIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLL--EN-----------QVNM 197 (308)
T ss_pred ---c-cc--chhHHHHH-hHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhh--hh-----------eeeE
Confidence 1 11 11112222 24677888965 4789999999999999999999999965431 10 1112
Q ss_pred cCcccccCCCCCcceeEEehHHHHHHHhhCCC
Q 006112 506 LAPELLRNGRGTTSTDVYAFGVFMLEVACGRR 537 (660)
Q Consensus 506 ~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~ 537 (660)
.--|+ ...|.++.+-+|=.-++++....+
T Consensus 198 vN~~Y---~~lT~~aE~~~fv~s~l~~v~~~~ 226 (308)
T PF07387_consen 198 VNIEY---ESLTQEAEVKVFVKSCLKLVEKQR 226 (308)
T ss_pred Eeeec---cccChHHHHHHHHHHHHHHHHHHh
Confidence 22111 234666777777666777765443
|
The function of this family is unknown. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.67 E-value=0.083 Score=55.49 Aligned_cols=33 Identities=24% Similarity=0.489 Sum_probs=29.4
Q ss_pred ccCceeccCccCCcEEEcCCCCeEEeeccccee
Q 006112 455 WEQVVLHRDIKPANVLLDADLEGKLGDFGLARL 487 (660)
Q Consensus 455 ~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 487 (660)
...++||+|+.+.|||+++++.+.++||..+..
T Consensus 194 ~~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 194 WRTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred cceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 356899999999999999999999999998864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.45 E-value=0.073 Score=57.25 Aligned_cols=75 Identities=9% Similarity=-0.012 Sum_probs=49.4
Q ss_pred ccccccCccEEEEEEEeCCCCeEEEEEEeccC------CChhhHHHHHHHHHHhccC--CC-CceeEeeeeeecCeeEEE
Q 006112 341 LYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD------SDHGMKQFVSEIVSMGKLR--HR-NLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 341 l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~------~~~~~~~~~~Ei~~l~~l~--H~-nIv~l~g~~~~~~~~~lV 411 (660)
++.+|.|.-.-||++.+..+++.|+||+-... -+-..++..-|.+.|+.+. -| .+.+++.+ ++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 56789999999999998544567999974321 1223456666777776653 34 45556654 34456788
Q ss_pred EecCCC
Q 006112 412 YDYMPN 417 (660)
Q Consensus 412 ~E~~~~ 417 (660)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998864
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.42 E-value=0.19 Score=54.38 Aligned_cols=74 Identities=12% Similarity=0.126 Sum_probs=50.0
Q ss_pred cccccccCccEEEEEEEeCCCCeEEEEEEeccC----C---ChhhHHHHHHHHHHhccC---CCCceeEeeeeeecCeeE
Q 006112 340 NLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD----S---DHGMKQFVSEIVSMGKLR---HRNLVQLRGYCRRKGELL 409 (660)
Q Consensus 340 ~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~----~---~~~~~~~~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~ 409 (660)
..+.+|.|....||+.... +..++||+-... . +....+-..|...|+.+. ..++.+++.+|.+ ..+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCE
Confidence 4567899999999998763 456899975421 1 123444455566665553 3578889998873 457
Q ss_pred EEEecCCC
Q 006112 410 LVYDYMPN 417 (660)
Q Consensus 410 lV~E~~~~ 417 (660)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999976
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 660 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 7e-50 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-49 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-37 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-37 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-34 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-34 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-34 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-32 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-22 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-21 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-20 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-20 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-20 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-20 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-20 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-20 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-20 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-20 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-20 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-20 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-20 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-20 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-20 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-20 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-20 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-20 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-20 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-20 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-20 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-20 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-20 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-19 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-19 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-19 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-19 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-19 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-19 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-19 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-18 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 9e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-18 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-17 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-17 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-17 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-17 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-16 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-16 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-16 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-16 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-16 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-16 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-16 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-16 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-16 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-16 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-16 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-16 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-15 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-15 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-15 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-15 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-15 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-15 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-15 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-15 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-15 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-15 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-15 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-15 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-15 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-15 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-15 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-15 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-15 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-15 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-15 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-15 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-15 | ||
| 1gnz_A | 257 | Lectin I-B4 From Griffonia Simplicifolia (Gs I-B4)m | 7e-15 | ||
| 1hql_A | 257 | The Xenograft Antigen In Complex With The B4 Isolec | 7e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-15 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-15 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 9e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-15 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 9e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-14 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-14 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-14 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-14 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-14 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-14 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-14 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-14 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-14 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-14 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-14 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-14 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-14 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-14 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-14 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-14 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-14 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-14 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-14 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-14 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-14 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-14 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-14 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-14 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-14 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-14 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 7e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 9e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 9e-14 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-13 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-13 | ||
| 3zvx_A | 261 | Structure Of The Lectin From Platypodium Elegans In | 3e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-13 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-13 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-13 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-13 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-13 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-13 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-13 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-13 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-13 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-13 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 9e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-12 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-12 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 9e-12 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 9e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-11 | ||
| 2fmd_A | 240 | Structural Basis Of Carbohydrate Recognition By Bow | 1e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-11 | ||
| 3ipv_A | 251 | Crystal Structure Of Spatholobus Parviflorus Seed L | 1e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-11 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-11 | ||
| 3ipv_B | 239 | Crystal Structure Of Spatholobus Parviflorus Seed L | 7e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 9e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 9e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 9e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 7e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 8e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-09 | ||
| 3usu_A | 256 | Crystal Structure Of Butea Monosperma Seed Lectin L | 2e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-09 | ||
| 3usu_B | 242 | Crystal Structure Of Butea Monosperma Seed Lectin L | 2e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-09 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 6e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-09 | ||
| 2bqp_A | 234 | The Structure Of The Pea Lectin-D-Glucopyranose Com | 6e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-09 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 7e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 8e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 9e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-08 | ||
| 1gz9_A | 239 | High-Resolution Crystal Structure Of Erythrina Cris | 2e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-08 | ||
| 1gsl_A | 243 | Lectin (Fourth Isolated From (Griffonia Simplicifol | 3e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-08 | ||
| 1wbf_A | 242 | Winged Bean Lectin, Saccharide Free Form Length = 2 | 3e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-08 | ||
| 1wbl_A | 241 | Winged Bean Lectin Complexed With Methyl-Alpha-D-Ga | 3e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-08 | ||
| 2sba_A | 253 | Soybean Agglutinin Complexed With 2,6-Pentasacchari | 4e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-08 | ||
| 3n35_A | 242 | Erythrina Corallodendron Lectin Mutant (Y106g) With | 6e-08 | ||
| 1qnw_A | 242 | Lectin Ii From Ulex Europaeus Length = 242 | 6e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 8e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 9e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 9e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-07 | ||
| 2e7q_A | 237 | Crystal Structure Of Basic Winged Bean Lectin In Co | 1e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-07 | ||
| 1lte_A | 239 | Structure Of A Legume Lectin With An Ordered N-Link | 2e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-07 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-07 | ||
| 1uzy_A | 242 | Erythrina Crystagalli Lectin Length = 242 | 2e-07 | ||
| 1fyu_A | 255 | Crystal Structure Of Erythrina Corallodendron Lecti | 2e-07 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-07 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-07 | ||
| 1fay_A | 238 | Winged Bean Acidic Lectin Complexed With Methyl-Alp | 2e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-07 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-07 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-07 | ||
| 1dbn_A | 239 | Maackia Amurensis Leukoagglutinin (Lectin) With Sia | 4e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-07 | ||
| 1qmo_E | 133 | Structure Of Fril, A Legume Lectin That Delays Hema | 4e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-07 | ||
| 1ax0_A | 239 | Erythrina Corallodendron Lectin In Complex With N-A | 5e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 6e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 7e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-07 | ||
| 1fat_A | 252 | Phytohemagglutinin-L Length = 252 | 7e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 8e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 8e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-07 | ||
| 1sfy_A | 239 | Crystal Structure Of Recombinant Erythrina Corallod | 9e-07 | ||
| 1g8w_A | 233 | Improved Structure Of Phytohemagglutinin-L From The | 9e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 9e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 9e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 9e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-06 | ||
| 1n47_A | 233 | Isolectin B4 From Vicia Villosa In Complex With The | 1e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-06 | ||
| 3u4x_A | 236 | Crystal Structure Of A Lectin From Camptosema Pedic | 1e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-06 | ||
| 2ovu_A | 237 | Crystal Strucure Of A Lectin From Canavalia Gladiat | 2e-06 | ||
| 2d3p_A | 236 | Cratylia Floribunda Seed Lectin Crystallized At Bas | 2e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-06 | ||
| 1fny_A | 237 | Legume Lectin Of The Bark Of Robinia Pseudoacacia. | 2e-06 | ||
| 1mvq_A | 236 | Cratylia Mollis Lectin (Isoform 1) In Complex With | 2e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-06 | ||
| 2yz4_A | 237 | The Neutron Structure Of Concanavalin A At 2.2 Angs | 2e-06 | ||
| 2ctv_A | 237 | High Resolution Crystallographic Studies Of Native | 2e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-06 | ||
| 1lgb_A | 181 | Interaction Of A Legume Lectin With The N2 Fragment | 2e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-06 | ||
| 1lgc_A | 181 | Interaction Of A Legume Lectin With The N2 Fragment | 2e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-06 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-06 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-06 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1GNZ|A Chain A, Lectin I-B4 From Griffonia Simplicifolia (Gs I-B4)metal Free Form Length = 257 | Back alignment and structure |
|
| >pdb|1HQL|A Chain A, The Xenograft Antigen In Complex With The B4 Isolectin Of Griffonia Simplicifolia Lectin-1 Length = 257 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ZVX|A Chain A, Structure Of The Lectin From Platypodium Elegans In Complex With A Trimannoside Length = 261 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2FMD|A Chain A, Structural Basis Of Carbohydrate Recognition By Bowringia Milbraedii Seed Agglutinin Length = 240 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3IPV|A Chain A, Crystal Structure Of Spatholobus Parviflorus Seed Lectin Length = 251 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3IPV|B Chain B, Crystal Structure Of Spatholobus Parviflorus Seed Lectin Length = 239 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3USU|A Chain A, Crystal Structure Of Butea Monosperma Seed Lectin Length = 256 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3USU|B Chain B, Crystal Structure Of Butea Monosperma Seed Lectin Length = 242 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2BQP|A Chain A, The Structure Of The Pea Lectin-D-Glucopyranose Complex Length = 234 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1GZ9|A Chain A, High-Resolution Crystal Structure Of Erythrina Cristagalli Lectin In Complex With 2'-Alpha-L-Fucosyllactose Length = 239 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1GSL|A Chain A, Lectin (Fourth Isolated From (Griffonia Simplicifolia)) Complex With Y Human Blood Group Determinant Length = 243 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1WBF|A Chain A, Winged Bean Lectin, Saccharide Free Form Length = 242 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1WBL|A Chain A, Winged Bean Lectin Complexed With Methyl-Alpha-D-Galactose Length = 241 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2SBA|A Chain A, Soybean Agglutinin Complexed With 2,6-Pentasaccharide Length = 253 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3N35|A Chain A, Erythrina Corallodendron Lectin Mutant (Y106g) With N- Acetylgalactosamine Length = 242 | Back alignment and structure |
|
| >pdb|1QNW|A Chain A, Lectin Ii From Ulex Europaeus Length = 242 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2E7Q|A Chain A, Crystal Structure Of Basic Winged Bean Lectin In Complex With B Blood Group Trisaccharide Length = 237 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1LTE|A Chain A, Structure Of A Legume Lectin With An Ordered N-Linked Carbohydrate In Complex With Lactose Length = 239 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1UZY|A Chain A, Erythrina Crystagalli Lectin Length = 242 | Back alignment and structure |
|
| >pdb|1FYU|A Chain A, Crystal Structure Of Erythrina Corallodendron Lectin In Hexagonal Crystal Form Length = 255 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1FAY|A Chain A, Winged Bean Acidic Lectin Complexed With Methyl-Alpha-D-Galactose (Monoclinic Form) Length = 238 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1DBN|A Chain A, Maackia Amurensis Leukoagglutinin (Lectin) With Sialyllactose Length = 239 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1QMO|E Chain E, Structure Of Fril, A Legume Lectin That Delays Hematopoietic Progenitor Maturation Length = 133 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1AX0|A Chain A, Erythrina Corallodendron Lectin In Complex With N-Actylgalactosamine Length = 239 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1FAT|A Chain A, Phytohemagglutinin-L Length = 252 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1SFY|A Chain A, Crystal Structure Of Recombinant Erythrina Corallodandron Lectin Length = 239 | Back alignment and structure |
|
| >pdb|1G8W|A Chain A, Improved Structure Of Phytohemagglutinin-L From The Kidney Bean Length = 233 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1N47|A Chain A, Isolectin B4 From Vicia Villosa In Complex With The Tn Antigen Length = 233 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3U4X|A Chain A, Crystal Structure Of A Lectin From Camptosema Pedicellatum Seeds In Complex With 5-Bromo-4-Chloro-3-Indolyl-Alpha-D-Mannose Length = 236 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2OVU|A Chain A, Crystal Strucure Of A Lectin From Canavalia Gladiata (Cgl) In Complex With Man1-2man-Ome Length = 237 | Back alignment and structure |
|
| >pdb|2D3P|A Chain A, Cratylia Floribunda Seed Lectin Crystallized At Basic Ph Length = 236 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1FNY|A Chain A, Legume Lectin Of The Bark Of Robinia Pseudoacacia. Length = 237 | Back alignment and structure |
|
| >pdb|1MVQ|A Chain A, Cratylia Mollis Lectin (Isoform 1) In Complex With Methyl-Alpha-D- Mannose Length = 236 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YZ4|A Chain A, The Neutron Structure Of Concanavalin A At 2.2 Angstroms Length = 237 | Back alignment and structure |
|
| >pdb|2CTV|A Chain A, High Resolution Crystallographic Studies Of Native Concanavalin A Using Rapid Laue Data Collection Methods And The Introduction Of A Monochromatic Large-Angle Oscillation Technique (Lot) Length = 237 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1LGB|A Chain A, Interaction Of A Legume Lectin With The N2 Fragment Of Human Lactotransferrin Or With The Isolated Biantennary Glycopeptide: Role Of The Fucose Moiety Length = 181 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1LGC|A Chain A, Interaction Of A Legume Lectin With The N2 Fragment Of Human Lactotransferrin Or With The Isolated Biantennary Glycopeptide: Role Of The Fucose Moiety Length = 181 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 333 bits (855), Expect = e-109
Identities = 114/298 (38%), Positives = 170/298 (57%), Gaps = 20/298 (6%)
Query: 332 SPHRFSYKNLYKATK----------GGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMK-QF 380
RFS + L A+ GG GKVY+G L +AVK++ + G + QF
Sbjct: 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADG-TLVAVKRLKEERTQGGELQF 74
Query: 381 VSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILY--SNTRPSLNWFQRF 438
+E+ + HRNL++LRG+C E LLVY YM NGS+ L ++P L+W +R
Sbjct: 75 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ 134
Query: 439 RIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTN 498
RI G A GL YLH+ + ++HRD+K AN+LLD + E +GDFGLA+L D+ + TT
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 194
Query: 499 VVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELD------LLDWVID 552
V GT+G++APE L G+ + TDV+ +GV +LE+ G+R L LLDWV
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254
Query: 553 YWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGALL 610
++ + D L+G Y +E++E ++++ L C+ S+P RP M +VV+ L+G L
Sbjct: 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 311 bits (799), Expect = e-101
Identities = 102/300 (34%), Positives = 145/300 (48%), Gaps = 32/300 (10%)
Query: 332 SPHRFSYKNLYKATK----------------GGSGKVYRGVLPSSHAEIAVKK----VCH 371
H FS+ L T GG G VY+G + ++ +AVKK V
Sbjct: 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT--TVAVKKLAAMVDI 68
Query: 372 DSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILY-SNTRP 430
++ +QF EI M K +H NLV+L G+ +L LVY YMPNGSL L + P
Sbjct: 69 TTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP 128
Query: 431 SLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDH 490
L+W R +I +G A G+ +LHE + HRDIK AN+LLD K+ DFGLAR +
Sbjct: 129 PLSWHMRCKIAQGAANGINFLHE--NHHI-HRDIKSANILLDEAFTAKISDFGLARASEK 185
Query: 491 GNDLH-TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPG--ELDLL 547
T+ +VGT Y+APE LR G T +D+Y+FGV +LE+ G V LL
Sbjct: 186 FAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 244
Query: 548 DWVIDYWQ-KGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606
D + + + D D ++ +E + + C H + RP +++V Q L
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 306 bits (786), Expect = 2e-99
Identities = 98/305 (32%), Positives = 157/305 (51%), Gaps = 21/305 (6%)
Query: 325 EDWEKEYSPHRFSYKNLYKATK----------GGSGKVYRGVLPSSHAEIAVKKVCHDSD 374
+ + +R +L +AT G GKVY+GVL A++A+K+ +S
Sbjct: 18 SSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG-AKVALKRRTPESS 76
Query: 375 HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPS--L 432
G+++F +EI ++ RH +LV L G+C + E++L+Y YM NG+L + LY + P+ +
Sbjct: 77 QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSM 136
Query: 433 NWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492
+W QR I G A GL YLH ++HRD+K N+LLD + K+ DFG+++ +
Sbjct: 137 SWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELD 193
Query: 493 DLH-TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQP----GELDLL 547
H +T V GT+GY+ PE GR T +DVY+FGV + EV C R + ++L
Sbjct: 194 QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA 253
Query: 548 DWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607
+W ++ G + DP L E + + C + + RPSM V+ L+
Sbjct: 254 EWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313
Query: 608 ALLPD 612
L +
Sbjct: 314 LRLQE 318
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 6e-72
Identities = 75/308 (24%), Positives = 125/308 (40%), Gaps = 37/308 (12%)
Query: 324 YEDWEKEYSPHRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSE 383
E+ + P +G G V++ L + +AVK Q E
Sbjct: 16 TENLYFQSMP--LQLLE--VKARGRFGCVWKAQLLNE--YVAVKIFPIQDKQSW-QNEYE 68
Query: 384 IVSMGKLRHRNLVQLRGYCRR----KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFR 439
+ S+ ++H N++Q G +R +L L+ + GSL L +N ++W +
Sbjct: 69 VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNELCH 125
Query: 440 IIKGVAFGLLYLHEE-------WEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492
I + +A GL YLHE+ + + HRDIK NVLL +L + DFGLA ++ G
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 493 DLH-TTNVVGTVGYLAPELLRNGRGTTST-----DVYAFGVFMLEVACGRRP----VQPG 542
T VGT Y+APE+L D+YA G+ + E+A V
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 543 ELDLLDWV-----IDYWQKGDVLDASDPRLEGIYVE-EQMEIVLKLGLFCSHSNPDTRPS 596
L + + ++ Q+ V P L + + M ++ + C + + R S
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 597 MRQVVQYL 604
V + +
Sbjct: 306 AGCVGERI 313
|
| >3ipv_A Lectin alpha chain; galactose binding, SEED lectin, hemagglutinin, legume lectin fungal, sugar binding protein; 2.04A {Spatholobus parviflorus} PDB: 3ipv_B 3usu_B* 3usu_A* Length = 251 | Back alignment and structure |
|---|
Score = 208 bits (530), Expect = 6e-63
Identities = 72/263 (27%), Positives = 115/263 (43%), Gaps = 29/263 (11%)
Query: 26 EENQFIHHGF--EGSKLKLDGLAKIHPNGLLQLTNTSERIS------GHAFYPFPFKF-N 76
EE F+ F L L G A + G+LQLTN + G A Y P +
Sbjct: 2 EETSFVFSKFKPLEPNLILQGDALVTVAGVLQLTNVDKNGVPEPSSLGRATYSAPINIWD 61
Query: 77 SSSSQSLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFT 136
S++ SF+TSF F ++ G+AFF++P ++ G LG+F+ + +G T
Sbjct: 62 SATGLVASFATSFRFTIYAPNIATIADGLAFFLAPVASAPDS-GGGFLGLFDSAVSGS-T 119
Query: 137 NHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPI 196
A+E DT ++ F D H+G DVN + S ++ L +G+
Sbjct: 120 YQTVAVEFDTYENTVFTDPPYTHIGFDVNSISSIKTV-------------KWSLANGEAA 166
Query: 197 QIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGT---RVS 253
++ I YN KL+ +L + +L+ +DLS +L + + VG SAATG ++
Sbjct: 167 KVLITYNSAVKLLVASLVYPSSKT--SFILADIVDLSSVLPEWVRVGFSAATGASGGKIE 224
Query: 254 DYYILGWSFNKSGPAQNLDISKL 276
+ + WSF S
Sbjct: 225 THDVFSWSFASKLAGXXTKDSSF 247
|
| >2fmd_A Lectin, agglutinin, BMA; legume lectin, beta sandwich, protein-carbohydrate complex, sugar binding protein; HET: MAN; 1.90A {Bowringia mildbraedii} Length = 240 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 4e-62
Identities = 70/252 (27%), Positives = 103/252 (40%), Gaps = 24/252 (9%)
Query: 29 QFIHHGFEGSK--LKLDGLAKIHPNGLLQLT------NTSERISGHAFYPFPFKFNSSSS 80
F FE + L G A + N LQLT N G A Y P + SSS
Sbjct: 5 CFTFTDFESGQQDLIFQGDASVGSNKALQLTKVDSKGNPQGGSVGRALYTAPIRLWQSSS 64
Query: 81 QSLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIF 140
SF T+F F++ F SP T G LG+F SNN N +
Sbjct: 65 LVASFETTFTFSISQGSSTPADALTFFIASPDTKIPSGSGGRLLGLFGSSNNAGSDNGVV 124
Query: 141 AIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPIQIWI 200
++E DT + + D + H+GIDVN ++S ++ + ++GK I
Sbjct: 125 SVEFDTYPNTDIGDPNYRHIGIDVNSIRSKAASKWDW-------------QNGKTATAHI 171
Query: 201 DYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTRVSDYYILGW 260
YN K ++V + P S ++S ++L+ + B + VG SA TG IL W
Sbjct: 172 SYNSASKRLSVVSSY---PNSSPVVVSFDVELNNVBPBWVRVGFSATTGQYTQTNNILAW 228
Query: 261 SFNKSGPAQNLD 272
SF S +
Sbjct: 229 SFRSSLMGYQAN 240
|
| >1hql_A Lectin; xenograft antigen, sugar BI protein; HET: GLA MBG NAG; 2.20A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1gnz_A* Length = 257 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 4e-62
Identities = 76/264 (28%), Positives = 121/264 (45%), Gaps = 28/264 (10%)
Query: 29 QFIHHGFEGSK---LKLDGLAKIHPNGLLQLTNTSERI------SGHAFYPFPFKF-NSS 78
F F + G A G LQL T++ +G A Y P + ++
Sbjct: 6 SFTFPNFWSDVEDSIIFQGDANT-TAGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWDNK 64
Query: 79 SSQSLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFT-N 137
+ SF T F F + N G+AFF++P D AG +LG+FN+S Q + N
Sbjct: 65 TESVASFYTEFTFFLKIT-GNGPADGLAFFLAPP-DSDVKDAGEYLGLFNKSTATQPSKN 122
Query: 138 HIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPIQ 197
+ A+E DT +P F + H+GI+VN + S + +E + SGK
Sbjct: 123 QVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATKR----------WEDSDIFSGKIAT 172
Query: 198 IWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTRVSD-YY 256
I Y+G +++ V L+ P S +LS S+D+ Q L +S+ VG+SA+TG Y
Sbjct: 173 ARISYDGSAEILTVVLSY---PDGSDYILSHSVDMRQNLPESVRVGISASTGNNQFLTVY 229
Query: 257 ILGWSFNKSGPAQNLDISKLPPLP 280
IL W F+ + + ++ + P +
Sbjct: 230 ILSWRFSSNLQSTSVKAAMEPEIT 253
|
| >3zyr_A Lectin; sugar binding protein, N-glycan; HET: NAG BMA MAN GOL; 1.65A {Platypodium elegans} PDB: 3zvx_A* 1ukg_A* 1q8o_A* 1q8q_A* 1q8s_A* 1q8v_A* 1q8p_A* 2auy_A* 2gme_A 2gmm_A* 2gmp_A* 2gn3_A* 2gn7_A* 2gnb_A* 2gnd_A* 2gnm_A* 2gnt_A 2phf_A* 2phr_A* 2pht_A* ... Length = 261 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 9e-62
Identities = 64/274 (23%), Positives = 108/274 (39%), Gaps = 32/274 (11%)
Query: 18 LIFSASAQEENQFIHHGFE--GSKLKLDGLAKIHPNGLLQLTNTSE------RISGHAFY 69
L+ A++ + F F+ L G A N +LQLT T G +
Sbjct: 2 LLNRANSTDSLSFSFINFDRDERNLIFQGDAHTSRNNILQLTRTDSNGAPVRSTVGRILH 61
Query: 70 PFPFKF-NSSSSQSLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFN 128
+ S+++ + T F F + L N F P T AG LG+FN
Sbjct: 62 SAQVRLWEKSTNRVANLQTQFSFFLSSPLSNPADGIAFFIAPPDTTIPSGSAGGLLGLFN 121
Query: 129 RSNN-GQFTNHIFAIELDTVQSP--EFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEF 185
+ N + A+E DT + D + H+GIDVN ++S++
Sbjct: 122 PRTALNESANQVLAVEFDTFFAQNSNTWDPNYQHIGIDVNSIRSSKVVR----------- 170
Query: 186 ESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLS 245
GK + + + YN + ++V P R LS +DL+ IL + + VG S
Sbjct: 171 --WERREGKTLNVLVTYNPSTRTIDVVATY---PDGQRYQLSHVVDLTTILPEWVRVGFS 225
Query: 246 AATGTRVSDYYILGWSFNKS----GPAQNLDISK 275
AA+G + + + WSF + ++ +++
Sbjct: 226 AASGEQFQTHNLESWSFTSTLLYTAQKEDEYLAR 259
|
| >1v6i_A Agglutinin, PNA, galactose-binding lectin; open quaternary association, orthorhombic, carbohydrate specificity, protein crystallography; HET: GAL GLC; 2.15A {Arachis hypogaea} SCOP: b.29.1.1 PDB: 1bzw_A* 1v6j_A* 1v6k_A* 1v6l_A* 1v6m_A 1v6n_A 1v6o_A 2dva_A* 1cq9_A 1ciw_A* 1qf3_A* 1rir_A* 1rit_A* 2dh1_A 1cr7_A* 2dv9_A* 2dvb_A* 2dvd_A* 2dvf_A 2dvg_A* ... Length = 232 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 5e-60
Identities = 59/242 (24%), Positives = 94/242 (38%), Gaps = 23/242 (9%)
Query: 29 QFIHHGFEGS--KLKLDGLAKIHPNGLLQLTN-TSERISGHAFYPFPFKF-NSSSSQSLS 84
F + F + G + NG +QLTN G Y P + +S++ S
Sbjct: 5 SFNFNSFSEGNPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIWSSATGNVAS 64
Query: 85 FSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIEL 144
F TSF F M G+ FFI+P A GS G ++ + H +E
Sbjct: 65 FLTSFSFEMKDIKDYDPADGIIFFIAPEDTQIPA--GSIGGGTLGVSDTKGAGHFVGVEF 122
Query: 145 DTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPIQIWIDYNG 204
DT + E+ND +HVGIDVN + S + SG +++ + Y+
Sbjct: 123 DTYSNSEYNDPPTDHVGIDVNSVDSV-------------KTVPWNSVSGAVVKVTVIYDS 169
Query: 205 QEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTR-VSDYYILGWSFN 263
K ++V + ++ +DL L + + G SA+ + I WSF
Sbjct: 170 STKTLSVAVTN---DNGDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIRSWSFT 226
Query: 264 KS 265
+
Sbjct: 227 ST 228
|
| >1gsl_A Griffonia simplicifolia lectin 4; glycoprotein, manganese; HET: FUC GAL MAG NAG BMA; 2.00A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1lec_A* 1led_A* Length = 243 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 1e-58
Identities = 65/250 (26%), Positives = 102/250 (40%), Gaps = 24/250 (9%)
Query: 28 NQFIHHGFEGSKLKLDGLAKIHPNGLLQLT------NTSERISGHAFYPFPFKFNSSSSQ 81
+ + + G+++ G A G LQLT N +G A Y P S+ +
Sbjct: 10 DFWSYSLKNGTEITFLGDATRI-PGALQLTKTDANGNPVRSSAGQASYSEPVFLWDSTGK 68
Query: 82 SLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFT-NHIF 140
+ SF TSF F + G+AFF++P D S G LG+F + N +
Sbjct: 69 AASFYTSFTFLLKN-YGAPTADGLAFFLAPV-DSSVKDYGGFLGLFRHETAADPSKNQVV 126
Query: 141 AIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPIQIWI 200
A+E DT + ++ND H+GIDVN + S + I
Sbjct: 127 AVEFDTWINKDWNDPPYPHIGIDVNSIVSVATTRWENDD----------AYGSSIATAHI 176
Query: 201 DYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTRVSDYYILGW 260
Y+ + K++ V L+ +LS +DL+++L + +G SA G YIL W
Sbjct: 177 TYDARSKILTVLLSY---EHGRDYILSHVVDLAKVLPQKVRIGFSAGVGY-DEVTYILSW 232
Query: 261 SFNKSGPAQN 270
F + N
Sbjct: 233 HFFSTLDGTN 242
|
| >1fny_A BARK lectin, BARK agglutinin I,polypeptide A; legume lectin, jelly roll, sugar binding protein; 1.81A {Robinia pseudoacacia} SCOP: b.29.1.1 PDB: 1fnz_A* Length = 237 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 1e-58
Identities = 68/251 (27%), Positives = 109/251 (43%), Gaps = 29/251 (11%)
Query: 29 QFIHHGFEGSK--LKLDGLAKIHPNGLLQLTNT-----SERISGHAFYPFPFKF-NSSSS 80
F F ++ L G A + G+LQLTN S + G A Y PF+ +S++
Sbjct: 5 SFSFPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDSTTG 64
Query: 81 QSLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIF 140
SF TSF F + P G+AFF++P D G LGIF +N I
Sbjct: 65 NVASFVTSFTFIIQAPNPATTADGLAFFLAPV-DTQPLDLGGMLGIFK-DGYFNKSNQIV 122
Query: 141 AIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPIQIWI 200
A+E DT + ++ D G H+GI+VN ++S ++ + + G+ ++I
Sbjct: 123 AVEFDTFSNGDW-DPKGRHLGINVNSIESIKTVPWNWTN-------------GEVANVFI 168
Query: 201 DYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTR---VSDYYI 257
Y K + +L + ++ +D+ +L + + G SA TG V +
Sbjct: 169 SYEASTKSLTASLVY--PSLETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQTNDV 226
Query: 258 LGWSFNKSGPA 268
L WSF + P
Sbjct: 227 LSWSFESNLPG 237
|
| >1fat_A Phytohemagglutinin-L; glycoprotein, plant defense protein, lectin; HET: NAG; 2.80A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1g8w_A* Length = 252 | Back alignment and structure |
|---|
Score = 196 bits (498), Expect = 3e-58
Identities = 66/262 (25%), Positives = 114/262 (43%), Gaps = 34/262 (12%)
Query: 29 QFIHHGFEGSKLKLDGLAKIHPNGLLQLTNTSERI------SGHAFYPFPFKF-NSSSSQ 81
F F + L L A + +G L+LTN + G AFY P + ++++
Sbjct: 5 YFNFQRFNETNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDNTTGT 64
Query: 82 SLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFA 141
SF+TSF F + G+AF + P G LG+F+ SN+ H A
Sbjct: 65 VASFATSFTFNIQVPNNAGPADGLAFALVPV-GSQPKDKGGFLGLFDGSNS---NFHTVA 120
Query: 142 IELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPIQIWID 201
+E DT+ + ++ D H+GIDVN ++S ++ + +G+ ++ I
Sbjct: 121 VEFDTLYNKDW-DPTERHIGIDVNSIRSIKTTRWDFV-------------NGENAEVLIT 166
Query: 202 YNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTR---VSDYYIL 258
Y+ L+ +L ++S ++DL +L + + VG SA TG V +L
Sbjct: 167 YDSSTNLLVASLVYPSQKT--SFIVSDTVDLKSVLPEWVSVGFSATTGINKGNVETNDVL 224
Query: 259 GWSFN----KSGPAQNLDISKL 276
WSF ++ L+++ L
Sbjct: 225 SWSFASKLSDETTSEGLNLANL 246
|
| >2eig_A Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG binding protein; HET: NAG; 2.00A {Lotus tetragonolobus} Length = 234 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 4e-58
Identities = 59/245 (24%), Positives = 97/245 (39%), Gaps = 24/245 (9%)
Query: 30 FIHHGFEGSK-LKLDGLAKIHPNGLLQLTNTS--ERISGHAFYPFPFKF-NSSSSQSLSF 85
F + F+ L G AKI +G L + R + HA Y P +S++ SF
Sbjct: 3 FNYTRFKDDGSLIFQGDAKIWTDGRLAMPTDPLVNRTTSHALYATPVPIWDSATGNVASF 62
Query: 86 STSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIELD 145
TSF F + G+ FF++P +E S G +++ N A+E D
Sbjct: 63 ITSFSFIVSNVQRYPPTDGVVFFLAPWG--TEIPPNSQGGYLGITDSSNSQNQFVAVEFD 120
Query: 146 TVQSP-EFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPIQIWIDYNG 204
+ + + + +H+GIDVN + S ++ + SG + I Y+
Sbjct: 121 SHPNVWDPKSLRSSHIGIDVNSIMSLKAV-------------NWNRVSGSLEKATIIYDS 167
Query: 205 QEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAAT-GTRVSDYYILGWSFN 263
K++ V + +S IDL +L + + VG SA T + I WSF
Sbjct: 168 DTKILTVVMTH---QNGQITTISQEIDLKTVLPEKVSVGFSATTWNPERERHDIYSWSFT 224
Query: 264 KSGPA 268
+
Sbjct: 225 STLKE 229
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 4e-58
Identities = 77/266 (28%), Positives = 128/266 (48%), Gaps = 24/266 (9%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHG--MKQFVSEIVSMGKLRHRNLVQLRGYCR 403
G G V+R S ++AVK + H + +F+ E+ M +LRH N+V G
Sbjct: 47 AGSFGTVHRAEWHGS--DVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT 104
Query: 404 RKGELLLVYDYMPNGSLDKILY-SNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHR 462
+ L +V +Y+ GSL ++L+ S R L+ +R + VA G+ YLH ++HR
Sbjct: 105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHR 163
Query: 463 DIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDV 522
++K N+L+D K+ DFGL+RL L + + GT ++APE+LR+ +DV
Sbjct: 164 NLKSPNLLVDKKYTVKVCDFGLSRLKAS-TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDV 222
Query: 523 YAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKG---DVLDASDPRLEGIYVEEQMEIV 579
Y+FGV + E+A ++P L+ V K ++ +P++ I +E
Sbjct: 223 YSFGVILWELATLQQPWG--NLNPAQVVAAVGFKCKRLEIPRNLNPQVAAI-----IEG- 274
Query: 580 LKLGLFCSHSNPDTRPSMRQVVQYLD 605
C + P RPS ++ L
Sbjct: 275 ------CWTNEPWKRPSFATIMDLLR 294
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 8e-58
Identities = 70/323 (21%), Positives = 113/323 (34%), Gaps = 48/323 (14%)
Query: 321 EEVYEDWEKEYSPHRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQF 380
E + + +G G VY+G L +AVK +
Sbjct: 2 EAAASEPSLDLDN--LKLLE--LIGRGRYGAVYKGSLDER--PVAVKVFSFANRQNFINE 55
Query: 381 VSEIVSMGKLRHRNLVQLRGYCRR-----KGELLLVYDYMPNGSLDKILYSNTRPSLNWF 435
I + + H N+ + R + E LLV +Y PNGSL K L +T +W
Sbjct: 56 K-NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWV 111
Query: 436 QRFRIIKGVAFGLLYLHEEWEQ------VVLHRDIKPANVLLDADLEGKLGDFGLARLYD 489
R+ V GL YLH E + + HRD+ NVL+ D + DFGL+
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171
Query: 490 HG-------NDLHTTNVVGTVGYLAPELLRN-------GRGTTSTDVYAFGVFMLEVACG 535
D + VGT+ Y+APE+L D+YA G+ E+
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231
Query: 536 RRPVQPGE------LDLLDWV-----IDYWQKGDVLDASDPRLEGIYVEEQ--MEIVLKL 582
+ PGE + V + Q + P+ + E + + +
Sbjct: 232 CTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKET 291
Query: 583 GLFCSHSNPDTRPSMRQVVQYLD 605
C + + R + + + +
Sbjct: 292 IEDCWDQDAEARLTAQXAEERMA 314
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 8e-57
Identities = 67/266 (25%), Positives = 119/266 (44%), Gaps = 30/266 (11%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK 405
+G G V + + ++A+K++ +S+ K F+ E+ + ++ H N+V+L G C
Sbjct: 18 RGAFGVVCKAKWRAK--DVAIKQIESESE--RKAFIVELRQLSRVNHPNIVKLYGACLNP 73
Query: 406 GELLLVYDYMPNGSLDKILYS-NTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDI 464
+ LV +Y GSL +L+ P + G+ YLH + ++HRD+
Sbjct: 74 --VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDL 131
Query: 465 KPANVLLDADLE-GKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVY 523
KP N+LL A K+ DFG A H TN G+ ++APE+ + DV+
Sbjct: 132 KPPNLLLVAGGTVLKICDFGTACDIQT----HMTNNKGSAAWMAPEVFEGSNYSEKCDVF 187
Query: 524 AFGVFMLEVACGRRPVQPGELDLLDWVIDYW-QKG---DVLDASDPRLEGIYVEEQMEIV 579
++G+ + EV R+P E+ + I + G ++ +E + M
Sbjct: 188 SWGIILWEVITRRKPFD--EIGGPAFRIMWAVHNGTRPPLIKNLPKPIESL-----MTR- 239
Query: 580 LKLGLFCSHSNPDTRPSMRQVVQYLD 605
C +P RPSM ++V+ +
Sbjct: 240 ------CWSKDPSQRPSMEEIVKIMT 259
|
| >1g7y_A Stem/LEAF lectin DB58; jelly roll fold, sugar binding protein; HET: NAG FUC FUL; 2.50A {Vigna unguiculata subsp} SCOP: b.29.1.1 PDB: 1lul_A 1lu1_A* 1bjq_A* 1lu2_A* Length = 253 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 1e-56
Identities = 64/265 (24%), Positives = 107/265 (40%), Gaps = 33/265 (12%)
Query: 26 EENQFIHHGFEGSKLKLDGLAKIHPNGLLQLTNTSE------RISGHAFYPFPFKF-NSS 78
+ F F S L G A + + L +LT G AFY P + + S
Sbjct: 2 DIQSFSFKNFNSSSFILQGDATVSSSKL-RLTKVKGNGLPTLSSLGRAFYSSPIQIYDKS 60
Query: 79 SSQSLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNH 138
+ S++TSF +F + G+AF + P ++ LG+F+ +
Sbjct: 61 TGAVASWATSFTANIFAPNKSSSADGIAFALVPVGSEPKS-NSGFLGVFDSDVYDN-SAQ 118
Query: 139 IFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPIQI 198
A+E DT + ++ D H+GIDVN ++S +AS L +G+ +I
Sbjct: 119 TVAVEFDTFSNTDW-DPTSRHIGIDVNSIKSIRTASWG-------------LANGQNAEI 164
Query: 199 WIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTR---VSDY 255
I YN L+ +L ++S +D++ L + + +G SA TG +
Sbjct: 165 LITYNAATSLLVASLVHPSRRTS--YIVSERVDITNELPEYVSIGFSATTGLSEGYTETH 222
Query: 256 YILGWSFN----KSGPAQNLDISKL 276
+L WSF + LDI+
Sbjct: 223 DVLSWSFASKLPDDSTTEPLDIASY 247
|
| >1dbn_A MAL, protein (leukoagglutinin); plant lectin, carbohydrate binding, sialyllactose, sugar BIN protein; HET: NAG SIA GAL BGC; 2.75A {Maackia amurensis} SCOP: b.29.1.1 Length = 239 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 2e-56
Identities = 68/253 (26%), Positives = 112/253 (44%), Gaps = 29/253 (11%)
Query: 26 EENQFIHHGFE--GSKLKLDGLAKIHPNGLLQLTNTS-----ERISGHAFYPFPFKF-NS 77
+E F + F + L G A + G+LQLT + G A Y P + +
Sbjct: 2 DELSFTINNFVPNEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWGN 61
Query: 78 SSSQSLSFSTSFVFAMFPKLPNYGGHGMAFFISP-STDFSEAVAGSHLGIFNRSNNGQFT 136
++ SFSTSF F + P+ G+AF+++P + +LG+FN +N +
Sbjct: 62 TTGSVASFSTSFTFVVKAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNN-SNSDSS 120
Query: 137 NHIFAIELDTVQSPEFNDID--GNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGK 194
N I A+E DT + ++ D H+GIDVNG++S ++ + + L K
Sbjct: 121 NQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIKTVQWDWINGGVAFATITYLAPNK 180
Query: 195 PIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATG--TRV 252
+ + Y + ++ S+DL +IL + + VG SAATG T V
Sbjct: 181 TLIASLVYPS---------------NQTTFSVAASVDLKEILPEWVRVGFSAATGYPTEV 225
Query: 253 SDYYILGWSFNKS 265
+ +L WSF +
Sbjct: 226 ETHDVLSWSFTST 238
|
| >1sbf_A Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {Glycine max} SCOP: b.29.1.1 PDB: 1sbd_A* 1sbe_A* 1g9f_A* 2sba_A* Length = 253 | Back alignment and structure |
|---|
Score = 191 bits (485), Expect = 2e-56
Identities = 63/261 (24%), Positives = 104/261 (39%), Gaps = 32/261 (12%)
Query: 29 QFIHHGFE--GSKLKLDGLAKIHPNGLLQLTNTSERI------SGHAFYPFPFKF-NSSS 79
F + F + L G A + +G LQL E G A Y P + +
Sbjct: 5 SFSWNKFVPKQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIWDKET 64
Query: 80 SQSLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHI 139
SF+ SF F + G+AFF++P +H G N + + +
Sbjct: 65 GSVASFAASFNFTFYAPDTKRLADGLAFFLAPIDTKP----QTHAGYLGLFNENESGDQV 120
Query: 140 FAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPIQIW 199
A+E DT ++ D H+GI+VN ++S ++ S L + K ++
Sbjct: 121 VAVEFDTFRNSW--DPPNPHIGINVNSIRSIKTTS-------------WDLANNKVAKVL 165
Query: 200 IDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTRVSD--YYI 257
I Y+ L+ +L +LS +DL L + + +G SAATG + + +
Sbjct: 166 ITYDASTSLLVASLVYPSQRT--SNILSDVVDLKTSLPEWVRIGFSAATGLDIPGESHDV 223
Query: 258 LGWSFNKSGPAQNLDISKLPP 278
L WSF + P + +I L
Sbjct: 224 LSWSFASNLPHASSNIDPLDL 244
|
| >2bqp_A Protein (PEA lectin); D-glucopyranose complex, sugar binding protein; HET: GLC; 1.90A {Pisum sativum} SCOP: b.29.1.1 Length = 234 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 4e-56
Identities = 59/245 (24%), Positives = 100/245 (40%), Gaps = 23/245 (9%)
Query: 26 EENQFIHHGF--EGSKLKLDGLAKIHPNGLLQLTNTSERISGHAFYPFPFKF-NSSSSQS 82
E F+ F + L G L LT + G A Y P + +
Sbjct: 2 ETTSFLITKFSPDQQNLIFQGDGYTTKEKL-TLTKAVKNTVGRALYSSPIHIWDRETGNV 60
Query: 83 LSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAI 142
+F TSF F + G FFI+P D G +LG+FN + + T A+
Sbjct: 61 ANFVTSFTFVINAPNSYNVADGFTFFIAPV-DTKPQTGGGYLGVFNSAEYDK-TTQTVAV 118
Query: 143 ELDTVQSPEFNDID-GNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPIQIWID 201
E DT + ++ + H+GIDVN ++S + S L++G+ + I
Sbjct: 119 EFDTFYNAAWDPSNRDRHIGIDVNSIKSVNTK-------------SWKLQNGEEANVVIA 165
Query: 202 YNGQEKLVNVTLAPV---PNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTRVSDYYIL 258
+N ++ V+L + + LS + L ++ + + +G SA TG + + +L
Sbjct: 166 FNAATNVLTVSLTYPNNSLEEEVTSYTLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVL 225
Query: 259 GWSFN 263
WSF+
Sbjct: 226 SWSFH 230
|
| >1qnw_A Chitin binding lectin, UEA-II; carbohydrate binding; HET: NAG; 2.35A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1dzq_A* 1qoo_A* 1qos_A* 1qot_A* Length = 242 | Back alignment and structure |
|---|
Score = 189 bits (480), Expect = 7e-56
Identities = 63/259 (24%), Positives = 116/259 (44%), Gaps = 28/259 (10%)
Query: 23 SAQEENQFIHHGFEGSK--LKLDGLAKIHPNGLLQLTNTSERIS---GHAFYPFPFKFNS 77
+ ++ F F ++ + G A + G+LQ+T S+ + G A Y P +
Sbjct: 1 NLSDDLSFNFDKFVPNQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWD 60
Query: 78 SSSQSLSF-STSFVFAMFPKLPNYGGHGMAFFISPS-TDFSEAVAGSHLGIFNRSNNGQF 135
S + ++ +TSF F + + G G+AFF++P+ + + G+F+ S++ +
Sbjct: 61 SITGKVASFATSFSFVVKAD-KSDGVDGLAFFLAPANSQIPSGSSAGMFGLFS-SSDSKS 118
Query: 136 TNHIFAIELDTVQSPEFN--DIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESG 193
+N I A+E DT +N D D H+GIDVN ++S ++ + +G
Sbjct: 119 SNQIIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKTVKWDWR-------------NG 165
Query: 194 KPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATG--TR 251
+ + I Y K + V L+ + +++ S+DL IL + + VG S G
Sbjct: 166 EVADVVITYRAPTKSLTVCLSYPSDGT--SNIITASVDLKAILPEWVSVGFSGGVGNAAE 223
Query: 252 VSDYYILGWSFNKSGPAQN 270
+ +L W F + A N
Sbjct: 224 FETHDVLSWYFTSNLEANN 242
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 7e-56
Identities = 63/277 (22%), Positives = 119/277 (42%), Gaps = 37/277 (13%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHG-------MKQFVSEIVSMGKLRHRNLVQL 398
KGG G V++G L + +A+K + G ++F E+ M L H N+V+L
Sbjct: 29 KGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKL 88
Query: 399 RGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQV 458
G +V +++P G L L P + W + R++ +A G+ Y+
Sbjct: 89 YGLMHNP--PRMVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEYMQ-NQNPP 144
Query: 459 VLHRDIKPANVLLDADLEG-----KLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELL-- 511
++HRD++ N+ L + E K+ DFGL++ H + ++G ++APE +
Sbjct: 145 IVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS----VSGLLGNFQWMAPETIGA 200
Query: 512 RNGRGTTSTDVYAFGVFMLEVACGRRP---VQPGELDLLDWVIDYWQKGDVLDASDPRLE 568
T D Y+F + + + G P G++ ++ + + + + + PRL
Sbjct: 201 EEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLR 260
Query: 569 GIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
+ +E+ C +P RP +V+ L
Sbjct: 261 NV-----IEL-------CWSGDPKKRPHFSYIVKELS 285
|
| >1wbf_A Protein (agglutinin); lectin (agglutinin), legume lectin, protein crystallography, group specificity, saccharide free form; HET: NAG; 2.30A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 2d3s_A* 2dtw_A* 1wbl_A* 2dty_A* 2du0_A* 2du1_A* 2e51_A* 2e53_A* 2zmk_A* 2zml_A* 2zmn_A* 2e7t_A* 2e7q_A* Length = 242 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 1e-55
Identities = 70/257 (27%), Positives = 113/257 (43%), Gaps = 38/257 (14%)
Query: 30 FIHHGFEGSK--LKLDGLAKIHPNGLLQLTNT-----SERISGHAFYPFPFKF-NSSSSQ 81
F + F ++ LKL A+I N +L+LT + +G A Y P + +S++
Sbjct: 6 FNFNQFHQNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDSTTGN 65
Query: 82 SLSFSTSFVFAMFPKLPN-YGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIF 140
SF T F F++ P + G+ FFI+P + G + GI+N +
Sbjct: 66 VASFETRFSFSIRQPFPRPHPADGLVFFIAPP-NTQTGEGGGYFGIYNPLSP----YPFV 120
Query: 141 AIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPIQIWI 200
A+E DT ++ D H+GIDVN + S ++ L++G + I
Sbjct: 121 AVEFDTFRNTW--DPQIPHIGIDVNSVISTKTVP-------------FTLDNGGIANVVI 165
Query: 201 DYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATG-------TRVS 253
Y+ K+++V L ++ +DL Q+L +S+ VG SAATG
Sbjct: 166 KYDASTKILHVVLVFPSLGT--IYTIADIVDLKQVLPESVNVGFSAATGDPSGKQRNATE 223
Query: 254 DYYILGWSFNKSGPAQN 270
+ IL WSF+ S P N
Sbjct: 224 THDILSWSFSASLPGTN 240
|
| >1fx5_A UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HOMO-dimer, fucose specific lectin, SUG binding protein; HET: NAG FUC BMA MAN; 2.20A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1jxn_A* Length = 242 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 1e-55
Identities = 65/250 (26%), Positives = 103/250 (41%), Gaps = 25/250 (10%)
Query: 26 EENQFIHHGFE--GSKLKLDGLAKIHPNGLLQLT----NTSERISGHAFYPFPFKF-NSS 78
++ F F G L G A + G+LQL N + G A Y P N +
Sbjct: 2 DDLSFKFKNFSQNGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWNCN 61
Query: 79 SSQSLSFSTSFVFAMFPKL-PNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTN 137
+ + SF TSF F M P G+ FF++P D AG + G+FN + +
Sbjct: 62 TGELASFITSFSFFMETSANPKAATDGLTFFLAPP-DSPLRRAGGYFGLFNDTKCD-SSY 119
Query: 138 HIFAIELDTVQSP-EFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPI 196
A+E DT+ SP F D H+GIDVN ++S + +
Sbjct: 120 QTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAERW-----------NKRYGLNNVA 168
Query: 197 QIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGT-RVSDY 255
+ I Y K + +L + +++ +DL +IL + + VG S +T R + +
Sbjct: 169 NVEIIYEASSKTLTASLT--YPSDQTSISVTSIVDLKEILPEWVSVGFSGSTYIGRQATH 226
Query: 256 YILGWSFNKS 265
+L W F +
Sbjct: 227 EVLNWYFTST 236
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 8e-55
Identities = 70/275 (25%), Positives = 118/275 (42%), Gaps = 37/275 (13%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDH----GMKQFVSEIVSMGKLRHRNLVQLRGY 401
GG GKVYR E+AVK HD D ++ E L+H N++ LRG
Sbjct: 17 IGGFGKVYRAFWIGD--EVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGV 74
Query: 402 CRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLH 461
C ++ L LV ++ G L+++L + + +A G+ YLH+E ++H
Sbjct: 75 CLKEPNLCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIH 131
Query: 462 RDIKPANVLLDADLEG--------KLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRN 513
RD+K +N+L+ +E K+ DFGLAR + + G ++APE++R
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRA 188
Query: 514 GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKG---DVLDASDPRLEGI 570
+ +DV+++GV + E+ G P + +D L + +
Sbjct: 189 SMFSKGSDVWSYGVLLWELLTGEVPFR--GIDGLAVAYGVAMNKLALPIPSTCPEPFAKL 246
Query: 571 YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
ME C + +P +RPS ++ L
Sbjct: 247 -----MED-------CWNPDPHSRPSFTNILDQLT 269
|
| >1gzc_A Erythrina crista-galli lectin; carbohydrate, sugar binding protein, saccharide, protein-carbohydrate interactions, lactose, glycoprotein; HET: LAT; 1.58A {Erythrina crista-galli} SCOP: b.29.1.1 PDB: 1gz9_A* 1fyu_A* 1ax0_A* 1ax1_A* 1ax2_A* 1axy_A* 1axz_A* 1lte_A* 1sfy_A* 1v00_A* 1uzz_A 1uzy_A* 3n35_A* 3n36_A* 3n3h_A* Length = 239 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 1e-54
Identities = 68/255 (26%), Positives = 111/255 (43%), Gaps = 31/255 (12%)
Query: 26 EENQFIHHGFE--GSKLKLDGLAKIHPNGLLQLTNTSE------RISGHAFYPFPFKF-N 76
E F FE L L G A I +G+LQLT ++ +G Y P +
Sbjct: 2 ETISFSFSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWD 61
Query: 77 SSSSQSLSFSTSFVFAMFPKLPN-YGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQF 135
S++ SF T F F++ G+ FF+ P+ A +LG+FN S
Sbjct: 62 STTGTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKS-KPAQGYGYLGVFNNSKQDN- 119
Query: 136 TNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKP 195
+ A+E DT +P ++ H+GIDVN ++S ++ L++G+
Sbjct: 120 SYQTLAVEFDTFSNP-WDPPQVPHIGIDVNSIRSIKTQP-------------FQLDNGQV 165
Query: 196 IQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTR---V 252
+ I Y+ K+++V L + ++ +D+ Q+L D + VGLS ATG +
Sbjct: 166 ANVVIKYDAPSKILHVVLVY--PSSGAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDAA 223
Query: 253 SDYYILGWSFNKSGP 267
+ + WSF S P
Sbjct: 224 ETHDVYSWSFQASLP 238
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 2e-54
Identities = 51/270 (18%), Positives = 109/270 (40%), Gaps = 33/270 (12%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVC--HDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCR 403
+ SG++++G + +I VK + S + F E + H N++ + G C+
Sbjct: 20 ENHSGELWKGRWQGN--DIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQ 77
Query: 404 R--KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLH 461
L+ +MP GSL +L+ T ++ Q + +A G+ +LH E ++
Sbjct: 78 SPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LEPLIPR 136
Query: 462 RDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTST- 520
+ +V++D D+ ++ + + + ++APE L+ T+
Sbjct: 137 HALNSRSVMIDEDMTARISMADVKFS------FQSPGRMYAPAWVAPEALQKKPEDTNRR 190
Query: 521 --DVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKG---DVLDASDPRLEGIYVEEQ 575
D+++F V + E+ P +L ++ + +G + P + +
Sbjct: 191 SADMWSFAVLLWELVTREVPFA--DLSNMEIGMKVALEGLRPTIPPGISPHVSKL----- 243
Query: 576 MEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
M+I C + +P RP +V L+
Sbjct: 244 MKI-------CMNEDPAKRPKFDMIVPILE 266
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 4e-54
Identities = 58/275 (21%), Positives = 104/275 (37%), Gaps = 31/275 (11%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK 405
KG G+ + + + +K++ + + F+ E+ M L H N+++ G +
Sbjct: 20 KGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD 79
Query: 406 GELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIK 465
L + +Y+ G+L I+ S W QR K +A G+ YLH ++HRD+
Sbjct: 80 KRLNFITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAKDIASGMAYLH---SMNIIHRDLN 135
Query: 466 PANVLLDADLEGKLGDFGLARLYDHGND-------------LHTTNVVGTVGYLAPELLR 512
N L+ + + DFGLARL VVG ++APE++
Sbjct: 136 SHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN 195
Query: 513 NGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASD--PRLEGI 570
DV++FG+ + E+ P L + P
Sbjct: 196 GRSYDEKVDVFSFGIVLCEIIGRVNA-DPDYLPRTMDFGLNVRGFLDRYCPPNCP----- 249
Query: 571 YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
+ + C +P+ RPS ++ +L+
Sbjct: 250 ------PSFFPITVRCCDLDPEKRPSFVKLEHWLE 278
|
| >1avb_A Arcelin-1; lectin-like glycoprotein, plant defense, insecticidal activi lectin; HET: NAG; 1.90A {Phaseolus vulgaris} SCOP: b.29.1.1 Length = 226 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 5e-54
Identities = 60/247 (24%), Positives = 107/247 (43%), Gaps = 31/247 (12%)
Query: 26 EENQFIHHGFEGSKLKLDGLAKIHPNGLLQLTNTSERIS---GHAFYPFPFKF-NSSSSQ 81
+ F F + L L G A + G L LTN G AFY P + + +
Sbjct: 2 NDASFNVETFNKTNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQINDRTIDN 61
Query: 82 SLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFA 141
SFST+F F + K +G+AF + P + G +LG+FN +N H A
Sbjct: 62 LASFSTNFTFRINAKNIENSAYGLAFALVPVGSRP-KLKGRYLGLFNTTNYD-RDAHTVA 119
Query: 142 IELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPIQIWID 201
+ DT N + IDVN ++ + S + + +G+ ++ I
Sbjct: 120 VVFDT---------VSNRIEIDVNSIRPIATESCNFGHN-----------NGEKAEVRIT 159
Query: 202 YNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTR---VSDYYIL 258
Y+ + + V+L + + + +S ++ L + ++D + VG SA +G++ + +L
Sbjct: 160 YDSPKNDLRVSLLYPSSEE--KCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETHNVL 217
Query: 259 GWSFNKS 265
WSF+ +
Sbjct: 218 SWSFSSN 224
|
| >1f9k_A Acidic lectin; legume lectin, glycosylated protein, H-antigenic specificity agglutinin, sugar binding protein; HET: NAG MAN AMG; 3.00A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 1fay_A* Length = 238 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 9e-54
Identities = 76/260 (29%), Positives = 112/260 (43%), Gaps = 37/260 (14%)
Query: 26 EENQFIHHGFE--GSKLKLDGLAKIHPNGLLQLTNTSE------RISGHAFYPFPFKF-N 76
E F FE +L L A I NG+L+LT ++ + +G A Y P K +
Sbjct: 1 ETQSFNFDHFEENSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWD 60
Query: 77 SSSSQSLSFSTSFVFAMFPKLPN-YGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQF 135
S++ SF T F F + G+ FF+ P + + G +LG+F
Sbjct: 61 STTGNVASFETRFSFNITQPYAYPEPADGLTFFMVPP-NSPQGEDGGNLGVFKPPEG--- 116
Query: 136 TNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKP 195
++ FA+E DT Q+ D H+GIDVN + S+++ LE+G
Sbjct: 117 -DNAFAVEFDTFQNTW--DPQVPHIGIDVNSIVSSKTL-------------HFQLENGGV 160
Query: 196 IQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDS--MYVGLSAATG---T 250
+ I Y+ K++NV LA LS +DL Q +S + VGLSA TG
Sbjct: 161 ANVVIKYDSPTKILNVVLAFHSVGTV--YTLSNIVDLKQEFPNSEWVNVGLSATTGYQKN 218
Query: 251 RVSDYYILGWSFNKSGPAQN 270
V + I+ WSF S N
Sbjct: 219 AVETHEIISWSFTSSLQETN 238
|
| >1n47_A Isolectin B4; cancer antigen, vicia villosa lectin, glycoprotein TN-bindin protein, carbohydrate recognition, sugar binding protein; HET: NAG FUC TNR; 2.70A {Vicia villosa} SCOP: b.29.1.1 Length = 233 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 3e-53
Identities = 66/251 (26%), Positives = 102/251 (40%), Gaps = 30/251 (11%)
Query: 26 EENQFIHHGFE--GSKLKLDGLAKIHPNGLLQLTNTSERIS-----GHAFYPFPFKFNSS 78
E F F + L L A ++ G L+LT + G A Y P + +
Sbjct: 2 ESTSFSFTNFNPNQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIHDN 61
Query: 79 SSQSLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNH 138
++ + SF+TSF F M G+AFF++P D G LG+F + +
Sbjct: 62 TTLA-SFTTSFSFVMAAPAAAAVADGLAFFLAPP-DTQPQARGGFLGLFADRAHDA-SYQ 118
Query: 139 IFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPIQI 198
A+E DT + D + H+GID NG++S ++ + G+ I
Sbjct: 119 TVAVEFDTYSNA--WDPNYTHIGIDTNGIESKKTTP-------------FDMVYGEKANI 163
Query: 199 WIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTR---VSDY 255
I Y K + +L + +S +DL IL + + VG SA TG V +
Sbjct: 164 VITYQASTKALAASLVF--PVSQTSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVETH 221
Query: 256 YILGWSFNKSG 266
I+ WSF S
Sbjct: 222 DIVSWSFAVSL 232
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-52
Identities = 68/266 (25%), Positives = 120/266 (45%), Gaps = 21/266 (7%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVK--KVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCR 403
G G VY+G H ++AVK V + ++ F +E+ + K RH N++ GY
Sbjct: 34 SGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 90
Query: 404 RKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRD 463
+L +V + SL L+++ + I + A G+ YLH + ++HRD
Sbjct: 91 -APQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHA---KSIIHRD 145
Query: 464 IKPANVLLDADLEGKLGDFGLARLYDH-GNDLHTTNVVGTVGYLAPELLRNGRGTTST-- 520
+K N+ L D K+GDFGLA + G++ ++APE++R +
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 521 -DVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIV 579
DVYAFG+ + E+ G+ P ++ D +I+ +G + P L + +
Sbjct: 206 SDVYAFGIVLYELMTGQLPYS--NINNRDQIIEMVGRGSLS----PDLSKVRSNCPKRMK 259
Query: 580 LKLGLFCSHSNPDTRPSMRQVVQYLD 605
+L C D RPS +++ ++
Sbjct: 260 -RLMAECLKKKRDERPSFPRILAEIE 284
|
| >1ioa_A Arcelin-5A, ARC5A; lectin-like proteins, plant defense proteins, lectin; HET: NAG FUC; 2.70A {Phaseolus vulgaris} SCOP: b.29.1.1 Length = 240 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 8e-52
Identities = 60/258 (23%), Positives = 98/258 (37%), Gaps = 35/258 (13%)
Query: 26 EENQFIHHGFE-GSKLKLDGLAKIHPNGLLQLTNTSE------RISGHAFYPFPFKFNSS 78
E F F KL L G A I G LQLT G AFY P + S
Sbjct: 2 TETSFNFPNFHTDDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIKDS 61
Query: 79 SSQSLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNH 138
++ + SF+T+F F + K + +G+AF + P + LGIFN +NN +
Sbjct: 62 NNVA-SFNTNFTFIIRAKNQSISAYGLAFALVPV-NSPPQKKQEFLGIFN-TNNPEPNAR 118
Query: 139 IFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPIQI 198
A+ +T ++ D D N + VN +G+ +
Sbjct: 119 TVAVVFNTFKNRI--DFDKNFIKPYVNENCDFH------------------KYNGEKTDV 158
Query: 199 WIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATG---TRVSDY 255
I Y+ + V L + +S ++ L + + + + VG S +G +
Sbjct: 159 QITYDSSNNDLRVFLHF--TVSQVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDTTETH 216
Query: 256 YILGWSFNKSGPAQNLDI 273
+L WSF+ + +I
Sbjct: 217 DVLSWSFSSKFRNKLSNI 234
|
| >1dhk_B Bean lectin-like inhibitor, porcine pancreatic alpha-amylase; CO (hydrolase-inhibitor), complex (hydrolase-inhibitor) comple; HET: NAG; 1.85A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1viw_B* Length = 223 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 9e-52
Identities = 56/258 (21%), Positives = 91/258 (35%), Gaps = 46/258 (17%)
Query: 26 EENQFIHHGFEGSKLKLDGLAKIHPNGLLQLTNTSERISGHAFYPFPFKF-NSSSSQSLS 84
E FI F + L L G A + NG LQL+ S AFY P + +S++ S
Sbjct: 2 TETSFIIDAFNKTNLILQGDATVSSNGNLQLSYNSYDSMSRAFYSAPIQIRDSTTGNVAS 61
Query: 85 FSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIEL 144
F T+F + G+ F + P S +E
Sbjct: 62 FDTNFTMNIRTHRQANSAVGLDFVLVPVQPES-------------------KGDTVTVEF 102
Query: 145 DTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPIQIWIDYNG 204
DT + + IDVN + G+ ++ I YN
Sbjct: 103 DTFL---------SRISIDVNNNDIKSVPWDVH------------DYDGQNAEVRITYNS 141
Query: 205 QEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGT---RVSDYYILGWS 261
K+ +V+L+ K +ST+++L + + D + VG SA +G + +L WS
Sbjct: 142 STKVFSVSLSNPSTGKS--NNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLSWS 199
Query: 262 FNKSGPAQNLDISKLPPL 279
F+ S+ +
Sbjct: 200 FSSKFINLKDQKSERSNI 217
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 5e-51
Identities = 58/275 (21%), Positives = 116/275 (42%), Gaps = 34/275 (12%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHG--MKQFVSEIVSMGKLRHRNLVQLRGYCR 403
KG G+VY G H E+A++ + + D+ +K F E+++ + RH N+V G C
Sbjct: 43 KGRFGQVYHGRW---HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM 99
Query: 404 RKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRD 463
L ++ +L ++ + + L+ + +I + + G+ YLH + +LH+D
Sbjct: 100 SPPHLAIITSLCKGRTLYSVVR-DAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKD 155
Query: 464 IKPANVLLDADLEGKLGDFGLARL----YDHGNDLHTTNVVGTVGYLAPELLRNGRG--- 516
+K NV D + + + DFGL + + G + +LAPE++R
Sbjct: 156 LKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTE 214
Query: 517 ------TTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGI 570
+ +DV+A G E+ P + + + W + K ++ +
Sbjct: 215 EDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKE--- 271
Query: 571 YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
+ + LFC + RP+ +++ L+
Sbjct: 272 --------ISDILLFCWAFEQEERPTFTKLMDMLE 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 7e-51
Identities = 67/287 (23%), Positives = 113/287 (39%), Gaps = 33/287 (11%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK 405
KG G+V+ G ++AVK ++ +EI +RH N++ +
Sbjct: 47 KGRYGEVWMGKWRGE--KVAVKVF-FTTEEASWFRETEIYQTVLMRHENILGFIAADIKG 103
Query: 406 G----ELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEE-----WE 456
+L L+ DY NGSL L S T L+ ++ GL +LH E +
Sbjct: 104 TGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGLCHLHTEIFSTQGK 160
Query: 457 QVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN---DLHTTNVVGTVGYLAPELL-- 511
+ HRD+K N+L+ + + D GLA + D+ VGT Y+ PE+L
Sbjct: 161 PAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE 220
Query: 512 ----RNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDW--------VIDYWQKGDV 559
+ + D+Y+FG+ + EVA E L + + ++
Sbjct: 221 SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVC 280
Query: 560 LDASDPRL-EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
+ P +E + + KL C NP +R + +V + L
Sbjct: 281 IKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 4e-50
Identities = 70/289 (24%), Positives = 115/289 (39%), Gaps = 37/289 (12%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSE--IVSMGKLRHRNLVQLRGYCR 403
KG G+V+RG +AVK S K + E + + LRH N++
Sbjct: 18 KGRYGEVWRGSWQGE--NVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIASDM 72
Query: 404 RKG----ELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQ-- 457
+L L+ Y GSL L T L+ RI+ +A GL +LH E
Sbjct: 73 TSRHSSTQLWLITHYHEMGSLYDYLQLTT---LDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 458 ---VVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN---DLHTTNVVGTVGYLAPELL 511
+ HRD+K N+L+ + + + D GLA ++ D+ VGT Y+APE+L
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 512 RNGRGTTST------DVYAFGVFMLEVACGRRPVQP--------GELDLLDWVIDYWQKG 557
D++AFG+ + EVA ++ D + +K
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKV 249
Query: 558 DVLDASDPRL-EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
+D P + + + + + KL C + NP R + ++ + L
Sbjct: 250 VCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-49
Identities = 68/287 (23%), Positives = 112/287 (39%), Gaps = 33/287 (11%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK 405
KG G+V+RG E+AVK + +EI LRH N++ +
Sbjct: 52 KGRFGEVWRGKWRGE--EVAVKIF-SSREERSWFREAEIYQTVMLRHENILGFIAADNKD 108
Query: 406 G----ELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQ---- 457
+L LV DY +GSL L T + ++ A GL +LH E
Sbjct: 109 NGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQGK 165
Query: 458 -VVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN---DLHTTNVVGTVGYLAPELLRN 513
+ HRD+K N+L+ + + D GLA +D D+ + VGT Y+APE+L +
Sbjct: 166 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 225
Query: 514 GRGTTS------TDVYAFGVFMLEVACGRRPVQP--------GELDLLDWVIDYWQKGDV 559
D+YA G+ E+A +L D ++ +K
Sbjct: 226 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 285
Query: 560 LDASDPRL-EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
P + E + ++ K+ C ++N R + ++ + L
Sbjct: 286 EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
|
| >2ltn_A PEA lectin, alpha chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1bqp_A* 1hkd_A 1ofs_A* 1rin_A* 1lof_C* 1len_A 1lem_A 1les_A* 2lal_A 1loe_A 1loa_A* 1loc_A* 1lod_A* 1lob_A 1lof_A* 1log_A* 1lgc_A* 1lgb_A* 2b7y_A* Length = 181 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 6e-45
Identities = 47/192 (24%), Positives = 76/192 (39%), Gaps = 20/192 (10%)
Query: 26 EENQFIHHGFEGSK--LKLDGLAKIHPNGLLQLTNTSERISGHAFYPFPFKF-NSSSSQS 82
E F+ F + L G L LT + G A Y P + +
Sbjct: 2 ETTSFLITKFSPDQQNLIFQGDGYTT-KEKLTLTKAVKNTVGRALYSSPIHIWDRETGNV 60
Query: 83 LSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAI 142
+F TSF F + G FFI+P D G +LG+FN + + T A+
Sbjct: 61 ANFVTSFTFVINAPNSYNVADGFTFFIAPV-DTKPQTGGGYLGVFNSAEYDK-TTQTVAV 118
Query: 143 ELDTVQSPEFNDID-GNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPIQIWID 201
E DT + ++ + H+GIDVN ++S + S L++G+ + I
Sbjct: 119 EFDTFYNAAWDPSNRDRHIGIDVNSIKSVNTK-------------SWKLQNGEEANVVIA 165
Query: 202 YNGQEKLVNVTL 213
+N ++ V+L
Sbjct: 166 FNAATNVLTVSL 177
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 2e-41
Identities = 61/263 (23%), Positives = 111/263 (42%), Gaps = 27/263 (10%)
Query: 350 GKVYRGVLPSSHAEIAVKKV-CHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGEL 408
G+V+ G L + + +AVK +F+ E + + H N+V+L G C +K +
Sbjct: 128 GEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 187
Query: 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPAN 468
+V + + G L + L +++ A G+ YL + +HRD+ N
Sbjct: 188 YIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARN 243
Query: 469 VLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGT---VGYLAPELLRNGRGTTSTDVYAF 525
L+ K+ DFG++R + ++ + V + APE L GR ++ +DV++F
Sbjct: 244 CLVTEKNVLKISDFGMSREEA--DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSF 301
Query: 526 GVFMLEVA-CGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL--EGIYVEEQMEIVLKL 582
G+ + E G P L ++ +KG L P L + ++ ++ +
Sbjct: 302 GILLWETFSLGASPYP--NLSNQQ-TREFVEKGGRLPC--PELCPDAVF-----RLMEQ- 350
Query: 583 GLFCSHSNPDTRPSMRQVVQYLD 605
C P RPS + Q L
Sbjct: 351 ---CWAYEPGQRPSFSTIYQELQ 370
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 2e-39
Identities = 69/259 (26%), Positives = 119/259 (45%), Gaps = 21/259 (8%)
Query: 350 GKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELL 409
G+VY GV +AVK + +++F+ E M +++H NLVQL G C R+
Sbjct: 234 GEVYEGVWKKYSLTVAVK-TLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 292
Query: 410 LVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANV 469
++ ++M G+L L R ++ + ++ + YL ++ +HR++ N
Sbjct: 293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNC 349
Query: 470 LLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFM 529
L+ + K+ DFGL+RL + + APE L + + +DV+AFGV +
Sbjct: 350 LVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLL 409
Query: 530 LEVA-CGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL--EGIYVEEQMEIVLKLGLFC 586
E+A G P PG +DL V + +K ++ P E +Y E++ C
Sbjct: 410 WEIATYGMSPY-PG-IDLSQ-VYELLEKDYRMER--PEGCPEKVY-----ELMRA----C 455
Query: 587 SHSNPDTRPSMRQVVQYLD 605
NP RPS ++ Q +
Sbjct: 456 WQWNPSDRPSFAEIHQAFE 474
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-38
Identities = 62/260 (23%), Positives = 108/260 (41%), Gaps = 18/260 (6%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCR 403
+G GK + +K++ S ++ E+ + ++H N+VQ R
Sbjct: 34 EGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFE 93
Query: 404 RKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRD 463
G L +V DY G L K + + Q + L ++H+ + +LHRD
Sbjct: 94 ENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKILHRD 150
Query: 464 IKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVY 523
IK N+ L D +LGDFG+AR+ + +L +GT YL+PE+ N +D++
Sbjct: 151 IKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA-CIGTPYYLSPEICENKPYNNKSDIW 209
Query: 524 AFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLG 583
A G + E+ + + G + L I G P + Y + +V +
Sbjct: 210 ALGCVLYELCTLKHAFEAGSMKNLVLKI---ISGSF-----PPVSLHYSYDLRSLVSQ-- 259
Query: 584 LFCSHSNPDTRPSMRQVVQY 603
NP RPS+ +++
Sbjct: 260 --LFKRNPRDRPSVNSILEK 277
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-38
Identities = 77/285 (27%), Positives = 132/285 (46%), Gaps = 25/285 (8%)
Query: 324 YEDWEKEYSPHRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSE 383
Y+ WE + K+ K G G+VY GV +AVK + +++F+ E
Sbjct: 5 YDKWE--MERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVK-TLKEDTMEVEEFLKE 59
Query: 384 IVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKG 443
M +++H NLVQL G C R+ ++ ++M G+L L R ++ +
Sbjct: 60 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 119
Query: 444 VAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGT- 502
++ + YL ++ +HRD+ N L+ + K+ DFGL+RL D +T +
Sbjct: 120 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKF 174
Query: 503 -VGYLAPELLRNGRGTTSTDVYAFGVFMLEVA-CGRRPVQPGELDLLDWVIDYWQKGDVL 560
+ + APE L + + +DV+AFGV + E+A G P PG +DL V + +K +
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY-PG-IDLSQ-VYELLEKDYRM 231
Query: 561 DASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
+ + E +Y E++ C NP RPS ++ Q +
Sbjct: 232 ERPEGCPEKVY-----ELMRA----CWQWNPSDRPSFAEIHQAFE 267
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 5e-38
Identities = 71/259 (27%), Positives = 116/259 (44%), Gaps = 23/259 (8%)
Query: 350 GKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELL 409
G+V+ G + +A+K + F+ E M KLRH LVQL + +
Sbjct: 198 GEVWMGTW-NGTTRVAIK-TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IY 254
Query: 410 LVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANV 469
+V +YM GSL L T L Q + +A G+ Y+ +HRD++ AN+
Sbjct: 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANI 311
Query: 470 LLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFM 529
L+ +L K+ DFGLARL + + + APE GR T +DV++FG+ +
Sbjct: 312 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 371
Query: 530 LEVA-CGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL--EGIYVEEQMEIVLKLGLFC 586
E+ GR P PG + + V+D ++G + P E ++ + M C
Sbjct: 372 TELTTKGRVPY-PG-MVNRE-VLDQVERGYRMPC--PPECPESLH--DLM-------CQC 417
Query: 587 SHSNPDTRPSMRQVVQYLD 605
P+ RP+ + +L+
Sbjct: 418 WRKEPEERPTFEYLQAFLE 436
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-37
Identities = 71/259 (27%), Positives = 116/259 (44%), Gaps = 23/259 (8%)
Query: 350 GKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELL 409
G+V+ G + +A+K + F+ E M KLRH LVQL + +
Sbjct: 281 GEVWMGTWNGTT-RVAIK-TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IY 337
Query: 410 LVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANV 469
+V +YM GSL L T L Q + +A G+ Y+ +HRD++ AN+
Sbjct: 338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANI 394
Query: 470 LLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFM 529
L+ +L K+ DFGLARL + + + APE GR T +DV++FG+ +
Sbjct: 395 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 454
Query: 530 LEVA-CGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL--EGIYVEEQMEIVLKLGLFC 586
E+ GR P PG + + V+D ++G + P E ++ + M C
Sbjct: 455 TELTTKGRVPY-PG-MVNRE-VLDQVERGYRMPC--PPECPESLH--DLM-------CQC 500
Query: 587 SHSNPDTRPSMRQVVQYLD 605
P+ RP+ + +L+
Sbjct: 501 WRKEPEERPTFEYLQAFLE 519
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 63/269 (23%), Positives = 111/269 (41%), Gaps = 32/269 (11%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVC---HDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYC 402
+G +VYR +A+KKV + EI + +L H N+++
Sbjct: 42 RGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF 101
Query: 403 RRKGELLLVYDYMPNGSLDKILYSNTRPS--------LNWF-QRFRIIKGVAFGLLYLHE 453
EL +V + G L +++ + +F Q + L ++H
Sbjct: 102 IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQ-------LCSALEHMHS 154
Query: 454 EWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRN 513
+ V+HRDIKPANV + A KLGD GL R + + +VGT Y++PE +
Sbjct: 155 ---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPERIHE 210
Query: 514 GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573
+D+++ G + E+A + P +++L + ++ D P Y E
Sbjct: 211 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-LCKKIEQCDY----PPLPSDHYSE 265
Query: 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602
E ++V C + +P+ RP + V
Sbjct: 266 ELRQLVNM----CINPDPEKRPDVTYVYD 290
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-36
Identities = 66/273 (24%), Positives = 112/273 (41%), Gaps = 35/273 (12%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRG--Y 401
G G+ + S + K++ + ++ + VSE+ + +L+H N+V+
Sbjct: 16 TGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 75
Query: 402 CRRKGELLLVYDYMPNGSLDKILYSNTRPS--------LNWF-QRFRIIKGVAFGLLYLH 452
R L +V +Y G L ++ T+ L Q + L H
Sbjct: 76 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ-------LTLALKECH 128
Query: 453 E--EWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPEL 510
+ VLHRD+KPANV LD KLGDFGLAR+ +H T VGT Y++PE
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT-FVGTPYYMSPEQ 187
Query: 511 LRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGI 570
+ +D+++ G + E+ P L I ++G R+
Sbjct: 188 MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI---REGKF-----RRIPYR 239
Query: 571 YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603
Y +E EI+ + + RPS+ ++++
Sbjct: 240 YSDELNEIITR----MLNLKDYHRPSVEEILEN 268
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 6e-36
Identities = 61/272 (22%), Positives = 121/272 (44%), Gaps = 24/272 (8%)
Query: 350 GKVYRGVL----PSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK 405
G V ++ +AVKK+ H ++ ++ F EI + L+H N+V+ +G C
Sbjct: 24 GSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83
Query: 406 GE--LLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRD 463
G L L+ +Y+P GSL L + + ++ + + + G+ YL + +HRD
Sbjct: 84 GRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLG---TKRYIHRD 139
Query: 464 IKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGT--VGYLAPELLRNGRGTTSTD 521
+ N+L++ + K+GDFGL ++ + G + + APE L + + ++D
Sbjct: 140 LATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASD 199
Query: 522 VYAFGVFMLEVA--CGRRPVQPGELDLLDWVIDYWQK--GDVLDASDPRLEGIYVEEQME 577
V++FGV + E+ + P E + Q +++ L+ + +
Sbjct: 200 VWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE----LLKNNGRLPRPD 255
Query: 578 I----VLKLGLFCSHSNPDTRPSMRQVVQYLD 605
+ + C ++N + RPS R + +D
Sbjct: 256 GCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-36
Identities = 62/272 (22%), Positives = 118/272 (43%), Gaps = 24/272 (8%)
Query: 350 GKVYRGVL----PSSHAEIAVKKV-CHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR 404
GKV ++ ++AVK + + + EI + L H N+V+ +G C
Sbjct: 35 GKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE 94
Query: 405 KGE--LLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHR 462
G + L+ +++P+GSL + L N + +N Q+ + + G+ YL + +HR
Sbjct: 95 DGGNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGS---RQYVHR 150
Query: 463 DIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGT--VGYLAPELLRNGRGTTST 520
D+ NVL++++ + K+GDFGL + + + +T V + APE L + ++
Sbjct: 151 DLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIAS 210
Query: 521 DVYAFGVFMLEVA-CGRRPVQPGELDLLDWVIDYWQKG--DVLDASDPRLEGIYVEEQME 577
DV++FGV + E+ P L L + Q +++ L+
Sbjct: 211 DVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT----LKEGKRLPCPP 266
Query: 578 I----VLKLGLFCSHSNPDTRPSMRQVVQYLD 605
V +L C P R S + +++ +
Sbjct: 267 NCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE 298
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 8e-36
Identities = 69/261 (26%), Positives = 117/261 (44%), Gaps = 27/261 (10%)
Query: 350 GKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELL 409
G V+ G + ++A+K + + F+ E M KL H LVQL G C + +
Sbjct: 22 GLVHLGYW-LNKDKVAIK-TIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 79
Query: 410 LVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANV 469
LV ++M +G L L + R + V G+ YL E V+ HRD+ N
Sbjct: 80 LVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYL--EEACVI-HRDLAARNC 135
Query: 470 LLDADLEGKLGDFGLARLYDHGNDLHTTNVVGT--VGYLAPELLRNGRGTTSTDVYAFGV 527
L+ + K+ DFG+ R +D +T++ V + +PE+ R ++ +DV++FGV
Sbjct: 136 LVGENQVIKVSDFGMTRFVL--DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGV 193
Query: 528 FMLEVA-CGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL--EGIYVEEQMEIVLKLGL 584
M EV G+ P + + V++ G L PRL +Y +I+
Sbjct: 194 LMWEVFSEGKIPYE--NRSNSE-VVEDISTGFRLYK--PRLASTHVY-----QIMNH--- 240
Query: 585 FCSHSNPDTRPSMRQVVQYLD 605
C P+ RP+ ++++ L
Sbjct: 241 -CWRERPEDRPAFSRLLRQLA 260
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 9e-36
Identities = 73/261 (27%), Positives = 122/261 (46%), Gaps = 27/261 (10%)
Query: 350 GKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELL 409
G V G + ++AVK + + +F E +M KL H LV+ G C ++ +
Sbjct: 22 GVVKLGKWKGQY-DVAVK-MIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY 79
Query: 410 LVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANV 469
+V +Y+ NG L L S+ L Q + V G+ +L E Q + HRD+ N
Sbjct: 80 IVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFL--ESHQFI-HRDLAARNC 135
Query: 470 LLDADLEGKLGDFGLARLYDHGNDLHTTNVVGT--VGYLAPELLRNGRGTTSTDVYAFGV 527
L+D DL K+ DFG+ R +D + ++V V + APE+ + ++ +DV+AFG+
Sbjct: 136 LVDRDLCVKVSDFGMTRYVL--DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGI 193
Query: 528 FMLEVA-CGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL--EGIYVEEQMEIVLKLGL 584
M EV G+ P + V+ +G L P L + IY +I+
Sbjct: 194 LMWEVFSLGKMPYD--LYTNSE-VVLKVSQGHRLYR--PHLASDTIY-----QIMYS--- 240
Query: 585 FCSHSNPDTRPSMRQVVQYLD 605
C H P+ RP+ +Q++ ++
Sbjct: 241 -CWHELPEKRPTFQQLLSSIE 260
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 9e-36
Identities = 60/270 (22%), Positives = 113/270 (41%), Gaps = 38/270 (14%)
Query: 350 GKVYRGVL--PSSHAEIAVK-KVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR 404
G VY+G+ +I V K + S K+ + E M + + ++ +L G C
Sbjct: 29 GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88
Query: 405 KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDI 464
+ L+ MP G L + + + ++ +A G+ YL + + ++HRD+
Sbjct: 89 S-TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDL 143
Query: 465 KPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGT---VGYLAPELLRNGRGTTSTD 521
NVL+ K+ DFGLA+L + G + ++A E + + T +D
Sbjct: 144 AARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKWMALESILHRIYTHQSD 201
Query: 522 VYAFGVFMLEVA-CGRRP---VQPGELDLLDWVIDYWQKGDVLDASDPRL--EGIYVEEQ 575
V+++GV + E+ G +P + E + +KG+ L P + +Y
Sbjct: 202 VWSYGVTVWELMTFGSKPYDGIPASE------ISSILEKGERLPQ--PPICTIDVY---- 249
Query: 576 MEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
I+ K C + D+RP R+++
Sbjct: 250 -MIMRK----CWMIDADSRPKFRELIIEFS 274
|
| >1qmo_E Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 Length = 133 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-35
Identities = 41/159 (25%), Positives = 65/159 (40%), Gaps = 26/159 (16%)
Query: 137 NHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPI 196
+++ A+E DT +P++ D + H+GIDVN ++S +A + + GK
Sbjct: 1 SNVVAVEFDTYLNPDYGDPNYIHIGIDVNSIRSKVTAKWDWQN-------------GKIA 47
Query: 197 QIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTRVSDYY 256
I YN K ++VT LS I+L +L + + VGLSA+TG
Sbjct: 48 TAHISYNSVSKRLSVTSYY---AGSKPATLSYDIELHTVLPEWVRVGLSASTGQDKERNT 104
Query: 257 ILGWSFNKSGPAQNLDISKLPPLPPPPPTPGKKLNHTVI 295
+ WSF S L K + V+
Sbjct: 105 VHSWSFT----------SSLWTNVAKKENENKYITRGVL 133
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 60/262 (22%), Positives = 116/262 (44%), Gaps = 23/262 (8%)
Query: 350 GKVYRGVLPSSHAEI--AVKKVCHDSDHGMKQ-FVSEIVSMGKLRHRNLVQLRGYCRRKG 406
G V +GV +I A+K + ++ + + E M +L + +V+L G C+ +
Sbjct: 24 GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE- 82
Query: 407 ELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKP 466
L+LV + G L K L R + ++ V+ G+ YL E + +HRD+
Sbjct: 83 ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAA 138
Query: 467 ANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGT--VGYLAPELLRNGRGTTSTDVYA 524
NVLL K+ DFGL++ + +T G + + APE + + ++ +DV++
Sbjct: 139 RNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWS 198
Query: 525 FGVFMLEVA-CGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLG 583
+GV M E G++P + ++ + V+ + ++G ++ +Y ++
Sbjct: 199 YGVTMWEALSYGQKPYK--KMKGPE-VMAFIEQGKRMECPPECPPELY-----ALMSD-- 248
Query: 584 LFCSHSNPDTRPSMRQVVQYLD 605
C + RP V Q +
Sbjct: 249 --CWIYKWEDRPDFLTVEQRMR 268
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 52/273 (19%), Positives = 113/273 (41%), Gaps = 42/273 (15%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGY---- 401
GG G+V++ +K+V ++++ + E+ ++ KL H N+V G
Sbjct: 21 SGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNIVHYNGCWDGF 76
Query: 402 ------------CRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLL 449
+ L + ++ G+L++ + L+ + + + G+
Sbjct: 77 DYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVD 136
Query: 450 YLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPE 509
Y+H + +++RD+KP+N+ L + K+GDFGL + + GT+ Y++PE
Sbjct: 137 YIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS--KGTLRYMSPE 191
Query: 510 LLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEG 569
+ + D+YA G+ + E+ E D D +
Sbjct: 192 QISSQDYGKEVDLYALGLILAELLHVCDT--AFETSKF-----------FTDLRDGIISD 238
Query: 570 IYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602
I+ +++ ++ KL L P+ RP+ ++++
Sbjct: 239 IFDKKEKTLLQKL-L---SKKPEDRPNTSEILR 267
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 70/262 (26%), Positives = 117/262 (44%), Gaps = 29/262 (11%)
Query: 350 GKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELL 409
G V G ++A+K + + +F+ E M L H LVQL G C ++ +
Sbjct: 38 GVVKYGKW-RGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF 95
Query: 410 LVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANV 469
++ +YM NG L L R Q + K V + YL E +Q + HRD+ N
Sbjct: 96 IITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYL--ESKQFL-HRDLAARNC 151
Query: 470 LLDADLEGKLGDFGLAR-LYDHGNDLHTTNVVGT--VGYLAPELLRNGRGTTSTDVYAFG 526
L++ K+ DFGL+R + D D +T++V V + PE+L + ++ +D++AFG
Sbjct: 152 LVNDQGVVKVSDFGLSRYVLD---DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFG 208
Query: 527 VFMLEVA-CGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL--EGIYVEEQMEIVLKLG 583
V M E+ G+ P + + ++ +G L P L E +Y M
Sbjct: 209 VLMWEIYSLGKMPYE--RFTNSE-TAEHIAQGLRLYR--PHLASEKVY--TIM------- 254
Query: 584 LFCSHSNPDTRPSMRQVVQYLD 605
C H D RP+ + ++ +
Sbjct: 255 YSCWHEKADERPTFKILLSNIL 276
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 66/316 (20%), Positives = 119/316 (37%), Gaps = 46/316 (14%)
Query: 318 KKYEEVYEDWEKEYSPHRFSYKNLYKATKGGSG---KVYRGVL----PSSHAEIAVKKVC 370
+ + P F ++L ++ G G V ++ A +AVK++
Sbjct: 2 GHHHHHHAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ 61
Query: 371 HDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGE--LLLVYDYMPNGSLDKILYSNT 428
H + F EI + L +V+ RG G L LV +Y+P+G L L +
Sbjct: 62 HSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH- 120
Query: 429 RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLY 488
R L+ + + G+ YL + +HRD+ N+L++++ K+ DFGLA+L
Sbjct: 121 RARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLL 177
Query: 489 DHGNDLHTTNVVGT--VGYLAPELLRNGRGTTSTDVYAFGVFMLEVA-CGRRPVQPGELD 545
D + G + + APE L + + +DV++FGV + E+ +
Sbjct: 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS------- 230
Query: 546 LLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLK----------------LGLFCSHS 589
+ L + + +E++ + L C
Sbjct: 231 -------CSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAP 283
Query: 590 NPDTRPSMRQVVQYLD 605
+P RPS + LD
Sbjct: 284 SPQDRPSFSALGPQLD 299
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-35
Identities = 83/262 (31%), Positives = 122/262 (46%), Gaps = 33/262 (12%)
Query: 350 GKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYC-RRKGEL 408
G V G + ++AVK + +D+ + F++E M +LRH NLVQL G KG L
Sbjct: 35 GDVMLGDYRGN--KVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 90
Query: 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPAN 468
+V +YM GSL L S R L + V + YL +HRD+ N
Sbjct: 91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARN 147
Query: 469 VLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGT--VGYLAPELLRNGRGTTSTDVYAFG 526
VL+ D K+ DFGL + + +T G V + APE LR + +T +DV++FG
Sbjct: 148 VLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFG 201
Query: 527 VFMLEVA-CGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL--EGIYVEEQMEIVLKLG 583
+ + E+ GR P P + L D V+ +KG +DA P +Y E M
Sbjct: 202 ILLWEIYSFGRVPY-PR-IPLKD-VVPRVEKGYKMDA--PDGCPPAVY--EVM------- 247
Query: 584 LFCSHSNPDTRPSMRQVVQYLD 605
C H + RPS Q+ + L+
Sbjct: 248 KNCWHLDAAMRPSFLQLREQLE 269
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-35
Identities = 61/263 (23%), Positives = 108/263 (41%), Gaps = 25/263 (9%)
Query: 350 GKVYRGVLPSSHAEI--AVK--KVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK 405
G V +G AVK K + + ++E M +L + +V++ G C +
Sbjct: 31 GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE 90
Query: 406 GELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIK 465
+LV + G L+K L N ++ V+ G+ YL E E +HRD+
Sbjct: 91 S-WMLVMEMAELGPLNKYLQQNRHVKDK--NIIELVHQVSMGMKYL--E-ESNFVHRDLA 144
Query: 466 PANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGT--VGYLAPELLRNGRGTTSTDVY 523
NVLL K+ DFGL++ + + G V + APE + + ++ +DV+
Sbjct: 145 ARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVW 204
Query: 524 AFGVFMLEVA-CGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKL 582
+FGV M E G++P + + + V +KG+ + +Y +++
Sbjct: 205 SFGVLMWEAFSYGQKPYR--GMKGSE-VTAMLEKGERMGCPAGCPREMY-----DLMNL- 255
Query: 583 GLFCSHSNPDTRPSMRQVVQYLD 605
C + + RP V L
Sbjct: 256 ---CWTYDVENRPGFAAVELRLR 275
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 7e-35
Identities = 61/272 (22%), Positives = 122/272 (44%), Gaps = 24/272 (8%)
Query: 350 GKVYRGVL----PSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK 405
G V ++ +AVKK+ H ++ ++ F EI + L+H N+V+ +G C
Sbjct: 55 GSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114
Query: 406 GE--LLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRD 463
G L L+ +Y+P GSL L + + ++ + + + G+ YL + +HRD
Sbjct: 115 GRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLG---TKRYIHRD 170
Query: 464 IKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGT--VGYLAPELLRNGRGTTSTD 521
+ N+L++ + K+GDFGL ++ + + G + + APE L + + ++D
Sbjct: 171 LATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASD 230
Query: 522 VYAFGVFMLEVA--CGRRPVQPGELDLLDWVIDYWQK--GDVLDASDPRLEGIYVEEQME 577
V++FGV + E+ + P E + Q +++ L+ + +
Sbjct: 231 VWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE----LLKNNGRLPRPD 286
Query: 578 I----VLKLGLFCSHSNPDTRPSMRQVVQYLD 605
+ + C ++N + RPS R + +D
Sbjct: 287 GCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 318
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 75/302 (24%), Positives = 120/302 (39%), Gaps = 41/302 (13%)
Query: 320 YEEVYEDWEKEYSPHRFSYKNLYKATKGGSGKVYRGVL---PSSHAEIAVK--KVCHDSD 374
+ + S + +G G VY G L AVK
Sbjct: 11 LVQAVQHVVIGPSSLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DI 67
Query: 375 HGMKQFVSEIVSMGKLRHRNLVQLRGYC-RRKGELLLVYDYMPNGSLDKILYSNTRPSLN 433
+ QF++E + M H N++ L G C R +G L+V YM +G L + + +
Sbjct: 68 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPT 126
Query: 434 WFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493
VA G+ YL + +HRD+ N +LD K+ DFGLAR D
Sbjct: 127 VKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLAR------D 177
Query: 494 LHTTN---VVGTVGYL------APELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGE 543
++ V G A E L+ + TT +DV++FGV + E+ G P +
Sbjct: 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP--D 235
Query: 544 LDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603
++ D + Y +G L + + +Y E++LK C H + RPS ++V
Sbjct: 236 VNTFD-ITVYLLQGRRLLQPEYCPDPLY-----EVMLK----CWHPKAEMRPSFSELVSR 285
Query: 604 LD 605
+
Sbjct: 286 IS 287
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 65/295 (22%), Positives = 121/295 (41%), Gaps = 29/295 (9%)
Query: 316 KKKKYEEVYEDWEKEY---SPHRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKV--C 370
++ + ++ E+ E + S K + +G VY+G+ + E+A ++
Sbjct: 3 ERNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDR 62
Query: 371 HDSDHGMKQFVSEIVSMGKLRHRNLVQLRGY----CRRKGELLLVYDYMPNGSLDKILYS 426
+ ++F E + L+H N+V+ + K ++LV + M +G+L L
Sbjct: 63 KLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR 122
Query: 427 NTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEG--KLGDFGL 484
+ + + + + GL +LH ++HRD+K N+ + G K+GD GL
Sbjct: 123 FKVMKIKVLRSW--CRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGP-TGSVKIGDLGL 178
Query: 485 ARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGEL 544
A L V+GT ++APE+ + DVYAFG+ MLE+A P
Sbjct: 179 ATL---KRASFAKAVIGTPEFMAPEMYEEKYDESV-DVYAFGMCMLEMATSEYP-----Y 229
Query: 545 DLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQ 599
+++ + + + E EI+ C N D R S++
Sbjct: 230 SECQNAAQIYRRV-TSGVKPASFDKVAIPEVKEIIEG----CIRQNKDERYSIKD 279
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 70/272 (25%), Positives = 111/272 (40%), Gaps = 26/272 (9%)
Query: 350 GKVYRGVL----PSSHAEIAVKKV-CHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR 404
GKV + +AVK + + EI + L H ++++ +G C
Sbjct: 45 GKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCED 104
Query: 405 KGE--LLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHR 462
G L LV +Y+P GSL L + S+ Q + + G+ YLH Q +HR
Sbjct: 105 AGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHA---QHYIHR 158
Query: 463 DIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGT--VGYLAPELLRNGRGTTST 520
D+ NVLLD D K+GDFGLA+ G++ + G V + APE L+ + ++
Sbjct: 159 DLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYAS 218
Query: 521 DVYAFGVFMLEVA-CGRRPVQPGELDLLDWVIDYWQK--GDVLDASDPRLEGIYVEEQME 577
DV++FGV + E+ P L I Q + + LE + +
Sbjct: 219 DVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE----LLERGERLPRPD 274
Query: 578 I----VLKLGLFCSHSNPDTRPSMRQVVQYLD 605
V L C + RP+ ++ L
Sbjct: 275 KCPAEVYHLMKNCWETEASFRPTFENLIPILK 306
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 68/261 (26%), Positives = 123/261 (47%), Gaps = 27/261 (10%)
Query: 350 GKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELL 409
G+V+ G ++AVK F++E M +L+H+ LV+L ++ +
Sbjct: 27 GEVWMGYYNGHT-KVAVK-SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-IY 83
Query: 410 LVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANV 469
++ +YM NGSL L + + L + + +A G+ ++ E + +HRD++ AN+
Sbjct: 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANI 140
Query: 470 LLDADLEGKLGDFGLARLYDHGNDLHTTNVVGT--VGYLAPELLRNGRGTTSTDVYAFGV 527
L+ L K+ DFGLARL + ++ +T + + APE + G T +DV++FG+
Sbjct: 141 LVSDTLSCKIADFGLARLIE--DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGI 198
Query: 528 FMLEVA-CGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL--EGIYVEEQMEIVLKLGL 584
+ E+ GR P PG + + VI ++G + P E +Y + M
Sbjct: 199 LLTEIVTHGRIPY-PG-MTNPE-VIQNLERGYRMVR--PDNCPEELY--QLM-------R 244
Query: 585 FCSHSNPDTRPSMRQVVQYLD 605
C P+ RP+ + L+
Sbjct: 245 LCWKERPEDRPTFDYLRSVLE 265
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-34
Identities = 81/262 (30%), Positives = 122/262 (46%), Gaps = 33/262 (12%)
Query: 350 GKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYC-RRKGEL 408
G V G + ++AVK + D + F++E M +LRH NLVQL G KG L
Sbjct: 207 GDVMLGDYRGN--KVAVK-CIKN-DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 262
Query: 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPAN 468
+V +YM GSL L S R L + V + YL +HRD+ N
Sbjct: 263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARN 319
Query: 469 VLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGT--VGYLAPELLRNGRGTTSTDVYAFG 526
VL+ D K+ DFGL + + +T G V + APE LR + +T +DV++FG
Sbjct: 320 VLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFG 373
Query: 527 VFMLEVA-CGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL--EGIYVEEQMEIVLKLG 583
+ + E+ GR P P + L D V+ +KG +DA P +Y +++
Sbjct: 374 ILLWEIYSFGRVPY-PR-IPLKD-VVPRVEKGYKMDA--PDGCPPAVY-----DVMKN-- 421
Query: 584 LFCSHSNPDTRPSMRQVVQYLD 605
C H + TRP+ Q+ + L+
Sbjct: 422 --CWHLDAATRPTFLQLREQLE 441
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 78/266 (29%), Positives = 127/266 (47%), Gaps = 29/266 (10%)
Query: 350 GKVYRGVLPSSHAE---IAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR 404
G+V G L +A+K ++ + F+SE MG+ H N+++L G R
Sbjct: 63 GEVCYGRLRVPGQRDVPVAIK-ALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121
Query: 405 KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDI 464
++V +YM NGSLD L ++ Q +++GV G+ YL + +HRD+
Sbjct: 122 GRLAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDL 177
Query: 465 KPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGT--VGYLAPELLRNGRGTTSTDV 522
NVL+D++L K+ DFGL+R+ + D T G + + APE + ++++DV
Sbjct: 178 AARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDV 237
Query: 523 YAFGVFMLEVA-CGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL--EGIYVEEQMEIV 579
++FGV M EV G RP + D VI ++G L A P ++ +++
Sbjct: 238 WSFGVVMWEVLAYGERPYW--NMTNRD-VISSVEEGYRLPA--PMGCPHALH-----QLM 287
Query: 580 LKLGLFCSHSNPDTRPSMRQVVQYLD 605
L C H + RP Q+V LD
Sbjct: 288 LD----CWHKDRAQRPRFSQIVSVLD 309
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-34
Identities = 65/259 (25%), Positives = 122/259 (47%), Gaps = 23/259 (8%)
Query: 350 GKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELL 409
G+V+ + H ++AVK ++ F++E M L+H LV+L ++ +
Sbjct: 202 GEVWMATY-NKHTKVAVK-TMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEP-IY 258
Query: 410 LVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANV 469
++ ++M GSL L S+ + +A G+ ++ + + +HRD++ AN+
Sbjct: 259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANI 315
Query: 470 LLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFM 529
L+ A L K+ DFGLAR+ + + + APE + G T +DV++FG+ +
Sbjct: 316 LVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILL 375
Query: 530 LEVA-CGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL--EGIYVEEQMEIVLKLGLFC 586
+E+ GR P PG + + VI ++G + P E +Y I+++ C
Sbjct: 376 MEIVTYGRIPY-PG-MSNPE-VIRALERGYRMPR--PENCPEELY-----NIMMR----C 421
Query: 587 SHSNPDTRPSMRQVVQYLD 605
+ P+ RP+ + LD
Sbjct: 422 WKNRPEERPTFEYIQSVLD 440
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-34
Identities = 60/279 (21%), Positives = 113/279 (40%), Gaps = 52/279 (18%)
Query: 350 GKVYRGVL-------PSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYC 402
K+++GV E+ +K + + + F M KL H++LV G C
Sbjct: 22 TKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVC 81
Query: 403 RRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHR 462
E +LV +++ GSLD L N + +N + + K +A + +L E ++H
Sbjct: 82 VCGDENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLE---ENTLIHG 137
Query: 463 DIKPANVLLDADLEG--------KLGDFGLARLYDHGNDLHTTNVVGTVGY------LAP 508
++ N+LL + + KL D G++ V+ + P
Sbjct: 138 NVCAKNILLIREEDRKTGNPPFIKLSDPGISIT-----------VLPKDILQERIPWVPP 186
Query: 509 ELLRNGRG-TTSTDVYAFGVFMLEVA-CGRRPVQPGELDLLDWVIDYWQKGDVLDASDPR 566
E + N + +TD ++FG + E+ G +P+ LD + +++ L A P+
Sbjct: 187 ECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS--ALDSQR-KLQFYEDRHQLPA--PK 241
Query: 567 LEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
+ ++ C PD RPS R +++ L+
Sbjct: 242 AAELA-----NLINN----CMDYEPDHRPSFRAIIRDLN 271
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-34
Identities = 74/272 (27%), Positives = 127/272 (46%), Gaps = 40/272 (14%)
Query: 350 GKVYRGVL--PSSHAEIAVK-KVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR 404
G+VY+G+L S E+ V K ++ F+ E MG+ H N+++L G +
Sbjct: 58 GEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117
Query: 405 KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDI 464
++++ +YM NG+LDK L + Q +++G+A G+ YL +HRD+
Sbjct: 118 YKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDL 173
Query: 465 KPANVLLDADLEGKLGDFGLAR-LYDHGNDLHTTNVVGT---VGYLAPELLRNGRGTTST 520
N+L++++L K+ DFGL+R L D +TT+ G + + APE + + T+++
Sbjct: 174 AARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS--GGKIPIRWTAPEAISYRKFTSAS 231
Query: 521 DVYAFGVFMLEVA-CGRRPVQPGELDLLDW----VIDYWQKGDVLDASDPRL--EGIYVE 573
DV++FG+ M EV G RP + V+ G L P IY
Sbjct: 232 DVWSFGIVMWEVMTYGERPYW-------ELSNHEVMKAINDGFRLPT--PMDCPSAIY-- 280
Query: 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
+++++ C RP +V LD
Sbjct: 281 ---QLMMQ----CWQQERARRPKFADIVSILD 305
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 9e-34
Identities = 54/299 (18%), Positives = 102/299 (34%), Gaps = 44/299 (14%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKV-CHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYC-- 402
+GG G V+ A+K++ + + ++ + E+ ++ KL H +V+
Sbjct: 15 RGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLE 74
Query: 403 ----------RRKGELLLVYDYMPNGSL-DKILYSNTRPSLNWFQRFRIIKGVAFGLLYL 451
K L + +L D + T I +A + +L
Sbjct: 75 KNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFL 134
Query: 452 HEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNV-----------V 500
H + ++HRD+KP+N+ D K+GDFGL D + T V
Sbjct: 135 HS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQV 191
Query: 501 GTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVL 560
GT Y++PE + + D+++ G+ + E+ E V
Sbjct: 192 GTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--PFSTQMERVRT------LTD--VR 241
Query: 561 DASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ--YLDGGALLPDIPLNS 617
+ P L + +V + L +P RP +++ + L
Sbjct: 242 NLKFPPLFTQKYPCEYVMVQDM-L---SPSPMERPEAINIIENAVFEDLDFPGKTVLRQ 296
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 59/268 (22%), Positives = 112/268 (41%), Gaps = 34/268 (12%)
Query: 350 GKVYRGVL--PSSHAEIAVK-KVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR 404
G VY+G+ +I V K + S K+ + E M + + ++ +L G C
Sbjct: 29 GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88
Query: 405 KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDI 464
+ L+ MP G L + + + ++ +A G+ YL + + ++HRD+
Sbjct: 89 S-TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDL 143
Query: 465 KPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGT---VGYLAPELLRNGRGTTSTD 521
NVL+ K+ DFGLA+L + G + ++A E + + T +D
Sbjct: 144 AARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKWMALESILHRIYTHQSD 201
Query: 522 VYAFGVFMLEVA-CGRRP---VQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQME 577
V+++GV + E+ G +P + E + +KG+ L +Y
Sbjct: 202 VWSYGVTVWELMTFGSKPYDGIPASE------ISSILEKGERLPQPPICTIDVY-----M 250
Query: 578 IVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
I++K C + D+RP R+++
Sbjct: 251 IMVK----CWMIDADSRPKFRELIIEFS 274
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 68/276 (24%), Positives = 118/276 (42%), Gaps = 39/276 (14%)
Query: 346 KGGSGKVYRGVL---PSSHAEIAVK--KVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRG 400
KG G VY G + + A+K ++ F+ E + M L H N++ L G
Sbjct: 31 KGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIG 89
Query: 401 YC-RRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVV 459
+G ++ YM +G L + + S + + VA G+ YL E Q
Sbjct: 90 IMLPPEGLPHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAE---QKF 145
Query: 460 LHRDIKPANVLLDADLEGKLGDFGLAR-LYDHGNDLHTTNVVGTVGYL-----APELLRN 513
+HRD+ N +LD K+ DFGLAR + D + + + L A E L+
Sbjct: 146 VHRDLAARNCMLDESFTVKVADFGLARDILD--RE-YYSVQQHRHARLPVKWTALESLQT 202
Query: 514 GRGTTSTDVYAFGVFMLEVA-CGRRP---VQPGELDLLDWVIDYWQKGDVLDASDPRLEG 569
R TT +DV++FGV + E+ G P + P + + + +G L + +
Sbjct: 203 YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD------LTHFLAQGRRLPQPEYCPDS 256
Query: 570 IYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
+Y +++ + C ++P RP+ R +V ++
Sbjct: 257 LY-----QVMQQ----CWEADPAVRPTFRVLVGEVE 283
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-33
Identities = 71/265 (26%), Positives = 127/265 (47%), Gaps = 27/265 (10%)
Query: 350 GKVYRGVLPSSHAE---IAVKKVCHD-SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK 405
G+V G L + +A+K + ++ + F+ E MG+ H N+++L G +
Sbjct: 59 GEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS 118
Query: 406 GELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIK 465
+++V +YM NGSLD L + Q +++G+A G+ YL + +HRD+
Sbjct: 119 KPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLA 174
Query: 466 PANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGT--VGYLAPELLRNGRGTTSTDVY 523
N+L++++L K+ DFGL R+ + + T G + + +PE + + T+++DV+
Sbjct: 175 ARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVW 234
Query: 524 AFGVFMLEVA-CGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL--EGIYVEEQMEIVL 580
++G+ + EV G RP E+ D VI +G L P +Y
Sbjct: 235 SYGIVLWEVMSYGERPYW--EMSNQD-VIKAVDEGYRLPP--PMDCPAALY--------- 280
Query: 581 KLGLFCSHSNPDTRPSMRQVVQYLD 605
+L L C + + RP Q+V LD
Sbjct: 281 QLMLDCWQKDRNNRPKFEQIVSILD 305
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-33
Identities = 75/297 (25%), Positives = 123/297 (41%), Gaps = 29/297 (9%)
Query: 319 KYEEVYEDWEKEYSPHRFSYKNLYKATKGGSGKVYRGVL---PSSHAEIAVK--KVCHDS 373
+ + + S + +G G VY G L AVK
Sbjct: 74 ELVQAVQHVVIGPSSLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-D 130
Query: 374 DHGMKQFVSEIVSMGKLRHRNLVQLRGYC-RRKGELLLVYDYMPNGSLDKILYSNTRPSL 432
+ QF++E + M H N++ L G C R +G L+V YM +G L + + +
Sbjct: 131 IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNP 189
Query: 433 NWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLAR-LYDHG 491
VA G+ +L + +HRD+ N +LD K+ DFGLAR +YD
Sbjct: 190 TVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246
Query: 492 NDLHTTNVVGT--VGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLD 548
D V ++A E L+ + TT +DV++FGV + E+ G P +++ D
Sbjct: 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP--DVNTFD 304
Query: 549 WVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
+ Y +G L + + +Y E++LK C H + RPS ++V +
Sbjct: 305 -ITVYLLQGRRLLQPEYCPDPLY-----EVMLK----CWHPKAEMRPSFSELVSRIS 351
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 76/267 (28%), Positives = 117/267 (43%), Gaps = 34/267 (12%)
Query: 350 GKVYRGVLPSSHAE---IAVKKVCHDSDHGMKQ-FVSEIVSMGKLRHRNLVQLRGYCRRK 405
G+VY GV + E +AVK D K+ F+SE V M L H ++V+L G +
Sbjct: 26 GEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE 85
Query: 406 GELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIK 465
++ + P G L L N + SL + + YL +HRDI
Sbjct: 86 -PTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIA 140
Query: 466 PANVLLDADLEGKLGDFGLAR-LYDHGNDLHTTNVVGT---VGYLAPELLRNGRGTTSTD 521
N+L+ + KLGDFGL+R + D T + +++PE + R TT++D
Sbjct: 141 VRNILVASPECVKLGDFGLSRYIEDE----DYYKASVTRLPIKWMSPESINFRRFTTASD 196
Query: 522 VYAFGVFMLEVA-CGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL--EGIYVEEQMEI 578
V+ F V M E+ G++P L+ D VI +KGD L P L +Y +
Sbjct: 197 VWMFAVCMWEILSFGKQPFF--WLENKD-VIGVLEKGDRLPK--PDLCPPVLY-----TL 246
Query: 579 VLKLGLFCSHSNPDTRPSMRQVVQYLD 605
+ + C +P RP ++V L
Sbjct: 247 MTR----CWDYDPSDRPRFTELVCSLS 269
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 61/198 (30%), Positives = 96/198 (48%), Gaps = 10/198 (5%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK 405
KG G VY G S+ IA+K++ + EI L+H+N+VQ G
Sbjct: 32 KGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN 91
Query: 406 GELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRII-KGVAFGLLYLHEEWEQVVLHRDI 464
G + + + +P GSL +L S P + Q K + GL YLH + ++HRDI
Sbjct: 92 GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDI 148
Query: 465 KPANVLLDADLEG--KLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRG--TTST 520
K NVL++ G K+ DFG ++ N T GT+ Y+APE++ G +
Sbjct: 149 KGDNVLINTY-SGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGYGKAA 206
Query: 521 DVYAFGVFMLEVACGRRP 538
D+++ G ++E+A G+ P
Sbjct: 207 DIWSLGCTIIEMATGKPP 224
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-33
Identities = 66/268 (24%), Positives = 113/268 (42%), Gaps = 36/268 (13%)
Query: 350 GKVYRGVLPSSHAE---IAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR 404
G V++G+ S +A+K C + SD ++F+ E ++M + H ++V+L G
Sbjct: 29 GDVHQGIYMSPENPALAVAIK-TCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE 87
Query: 405 KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDI 464
+ ++ + G L L + SL+ ++ L YL + +HRDI
Sbjct: 88 N-PVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLES---KRFVHRDI 142
Query: 465 KPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYL------APELLRNGRGTT 518
NVL+ ++ KLGDFGL+R + + APE + R T+
Sbjct: 143 AARNVLVSSNDCVKLGDFGLSR------YMEDSTYYKASKGKLPIKWMAPESINFRRFTS 196
Query: 519 STDVYAFGVFMLEVA-CGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQME 577
++DV+ FGV M E+ G +P Q + D VI + G+ L +Y
Sbjct: 197 ASDVWMFGVCMWEILMHGVKPFQ--GVKNND-VIGRIENGERLPMPPNCPPTLY-----S 248
Query: 578 IVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
++ K C +P RP ++ L
Sbjct: 249 LMTK----CWAYDPSRRPRFTELKAQLS 272
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 72/290 (24%), Positives = 124/290 (42%), Gaps = 51/290 (17%)
Query: 350 GKVYRGVL---PSSHAEIAVK--KVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYC-- 402
G V G L + ++AVK K+ + S +++F+SE M H N+++L G C
Sbjct: 48 GSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107
Query: 403 ---RRKGELLLVYDYMPNGSLDKIL----YSNTRPSLNWFQRFRIIKGVAFGLLYLHEEW 455
+ + +++ +M G L L + + + +A G+ YL
Sbjct: 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN-- 165
Query: 456 EQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNV--VGTVGYL-----AP 508
+ LHRD+ N +L D+ + DFGL++ +++ + G + + A
Sbjct: 166 -RNFLHRDLAARNCMLRDDMTVCVADFGLSK------KIYSGDYYRQGRIAKMPVKWIAI 218
Query: 509 ELLRNGRGTTSTDVYAFGVFMLEVA-CGRRP---VQPGELDLLDWVIDYWQKGDVLDASD 564
E L + T+ +DV+AFGV M E+A G P VQ E + DY G L +
Sbjct: 219 ESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE------MYDYLLHGHRLKQPE 272
Query: 565 PRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGALLPDIP 614
L+ +Y EI+ C ++P RP+ + L+ LL +P
Sbjct: 273 DCLDELY-----EIMYS----CWRTDPLDRPTFSVLRLQLE--KLLESLP 311
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 8e-33
Identities = 64/263 (24%), Positives = 101/263 (38%), Gaps = 31/263 (11%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKL-RHRNLVQLRGYC 402
G G+V++ AVK+ + ++E+ S K+ +H V+L
Sbjct: 67 HGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW 126
Query: 403 RRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHR 462
G L L + SL + SL Q + ++ L +LH Q ++H
Sbjct: 127 EEGGILYLQTELC-GPSLQQHC-EAWGASLPEAQVWGYLRDTLLALAHLHS---QGLVHL 181
Query: 463 DIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDV 522
D+KPAN+ L KLGDFGL G Y+APELL+ GT + DV
Sbjct: 182 DVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV--QEGDPRYMAPELLQGSYGTAA-DV 238
Query: 523 YAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQK---GDVLDASDPRLEGIYVEEQMEIV 579
++ G+ +LEVAC GE WQ+ G + P E ++
Sbjct: 239 FSLGLTILEVACNMELPHGGEG---------WQQLRQGYL----PPEFTAGLSSELRSVL 285
Query: 580 LKLGLFCSHSNPDTRPSMRQVVQ 602
+ +P R + ++
Sbjct: 286 VM----MLEPDPKLRATAEALLA 304
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 8e-33
Identities = 59/262 (22%), Positives = 116/262 (44%), Gaps = 23/262 (8%)
Query: 350 GKVYRGVLPSSHAEI--AVKKVCHDSDHGMKQ-FVSEIVSMGKLRHRNLVQLRGYCRRKG 406
G V +GV +I A+K + ++ + + E M +L + +V+L G C+ +
Sbjct: 350 GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE- 408
Query: 407 ELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKP 466
L+LV + G L K L R + ++ V+ G+ YL E + +HR++
Sbjct: 409 ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAA 464
Query: 467 ANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGT--VGYLAPELLRNGRGTTSTDVYA 524
NVLL K+ DFGL++ + +T G + + APE + + ++ +DV++
Sbjct: 465 RNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWS 524
Query: 525 FGVFMLEVA-CGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLG 583
+GV M E G++P + ++ + V+ + ++G ++ +Y ++
Sbjct: 525 YGVTMWEALSYGQKPYK--KMKGPE-VMAFIEQGKRMECPPECPPELY-----ALMSD-- 574
Query: 584 LFCSHSNPDTRPSMRQVVQYLD 605
C + RP V Q +
Sbjct: 575 --CWIYKWEDRPDFLTVEQRMR 594
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 64/268 (23%), Positives = 117/268 (43%), Gaps = 34/268 (12%)
Query: 350 GKVYRGVL--PSSHAEIAVK-KVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR 404
G V++GV +I V KV D + ++++G L H ++V+L G C
Sbjct: 27 GTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG 86
Query: 405 KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDI 464
L LV Y+P GSL + + R +L +A G+ YL E ++HR++
Sbjct: 87 S-SLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNL 141
Query: 465 KPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGT---VGYLAPELLRNGRGTTSTD 521
NVLL + + ++ DFG+A L + + + ++A E + G+ T +D
Sbjct: 142 AARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS--EAKTPIKWMALESIHFGKYTHQSD 199
Query: 522 VYAFGVFMLEVA-CGRRP---VQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQME 577
V+++GV + E+ G P ++ E V D +KG+ L +Y
Sbjct: 200 VWSYGVTVWELMTFGAEPYAGLRLAE------VPDLLEKGERLAQPQICTIDVY-----M 248
Query: 578 IVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
+++K C + + RP+ +++
Sbjct: 249 VMVK----CWMIDENIRPTFKELANEFT 272
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 78/295 (26%), Positives = 129/295 (43%), Gaps = 51/295 (17%)
Query: 350 GKVYRGVLPSSHAE-----IAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR 404
GKV+ + E +AVK + S+ + F E + L+H+++V+ G C
Sbjct: 55 GKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE 114
Query: 405 KGELLLVYDYMPNGSLDKILYSN-------------TRPSLNWFQRFRIIKGVAFGLLYL 451
LL+V++YM +G L++ L S+ L Q + VA G++YL
Sbjct: 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL 174
Query: 452 HEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNV--VGTVGYL--- 506
+HRD+ N L+ L K+GDFG++R D+++T+ VG L
Sbjct: 175 A---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSR------DIYSTDYYRVGGRTMLPIR 225
Query: 507 --APELLRNGRGTTSTDVYAFGVFMLEVA-CGRRPVQPGELDLLDWVIDYWQKGDVLDAS 563
PE + + TT +DV++FGV + E+ G++P +L + ID +G L+
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY--QLSNTE-AIDCITQGRELER- 281
Query: 564 DPRL--EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGALLPDIPLN 616
PR +Y I+ C P R S++ V L A P + L+
Sbjct: 282 -PRACPPEVY-----AIMRG----CWQREPQQRHSIKDVHARLQALAQAPPVYLD 326
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 46/212 (21%), Positives = 75/212 (35%), Gaps = 24/212 (11%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR- 404
+GG V A+K++ ++ E H N+++L YC R
Sbjct: 39 EGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRE 98
Query: 405 ---KGELLLVYDYMPNGSLDKILYSNTRPSLNWF----QRFRIIKGVAFGLLYLHEEWEQ 457
K E L+ + G+L + F Q ++ G+ GL +H +
Sbjct: 99 RGAKHEAWLLLPFFKRGTLWNEI--ERLKDKGNFLTEDQILWLLLGICRGLEAIHA---K 153
Query: 458 VVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTT--------NVVGTVGYLAPE 509
HRD+KP N+LL + + L D G + T+ Y APE
Sbjct: 154 GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE 213
Query: 510 LL---RNGRGTTSTDVYAFGVFMLEVACGRRP 538
L + TDV++ G + + G P
Sbjct: 214 LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 74/284 (26%), Positives = 129/284 (45%), Gaps = 50/284 (17%)
Query: 350 GKVYRGVLP-----SSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR 404
GKV+ +AVK + + K F E + L+H ++V+ G C
Sbjct: 29 GKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGD 88
Query: 405 KGELLLVYDYMPNGSLDKILYSN--------------TRPSLNWFQRFRIIKGVAFGLLY 450
L++V++YM +G L+K L ++ + L Q I +A G++Y
Sbjct: 89 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVY 148
Query: 451 LHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLAR-LYDHGNDLHTTNVVGTVGYL--- 506
L Q +HRD+ N L+ A+L K+GDFG++R +Y D + VG L
Sbjct: 149 LA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS--TDYYR---VGGHTMLPIR 200
Query: 507 --APELLRNGRGTTSTDVYAFGVFMLEVA-CGRRPVQPGELDLLDWVIDYWQKGDVLDAS 563
PE + + TT +DV++FGV + E+ G++P L + VI+ +G VL+
Sbjct: 201 WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW-FQ-LSNTE-VIECITQGRVLER- 256
Query: 564 DPRL--EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
PR+ + +Y +++L C P R +++++ + L
Sbjct: 257 -PRVCPKEVY-----DVMLG----CWQREPQQRLNIKEIYKILH 290
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 4e-32
Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 22/261 (8%)
Query: 350 GKVYRGVL-PSSHAEIAV-KKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK 405
G V++G+ + +AV K C + SD ++F+ E ++M + H ++V+L G
Sbjct: 404 GDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN 463
Query: 406 GELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIK 465
+ ++ + G L L + SL+ ++ L YL + +HRDI
Sbjct: 464 -PVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLES---KRFVHRDIA 518
Query: 466 PANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAF 525
NVL+ ++ KLGDFGL+R + + + ++APE + R T+++DV+ F
Sbjct: 519 ARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMF 578
Query: 526 GVFMLEVA-CGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGL 584
GV M E+ G +P Q + D VI + G+ L +Y ++ K
Sbjct: 579 GVCMWEILMHGVKPFQ--GVKNND-VIGRIENGERLPMPPNCPPTLY-----SLMTK--- 627
Query: 585 FCSHSNPDTRPSMRQVVQYLD 605
C +P RP ++ L
Sbjct: 628 -CWAYDPSRRPRFTELKAQLS 647
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-32
Identities = 71/310 (22%), Positives = 131/310 (42%), Gaps = 53/310 (17%)
Query: 322 EVYEDWEKEYSPHRFSYKNLYKATKGGSGKVYRGVLPSSHAE-----IAVK--KVCHDSD 374
+VY E E + + + + +G G VY GV + +A+K S
Sbjct: 13 DVYVPDEWEVAREKITMSR--ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SM 69
Query: 375 HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKIL--------YS 426
+F++E M + ++V+L G + L++ + M G L L +
Sbjct: 70 RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANN 129
Query: 427 NTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLAR 486
+ + ++ +A G+ YL + V HRD+ N ++ D K+GDFG+ R
Sbjct: 130 PVLAPPSLSKMIQMAGEIADGMAYL-NANKFV--HRDLAARNCMVAEDFTVKIGDFGMTR 186
Query: 487 LYDHGNDLHTTN--VVGTVGYL-----APELLRNGRGTTSTDVYAFGVFMLEVA-CGRRP 538
D++ T+ G G L +PE L++G TT +DV++FGV + E+A +P
Sbjct: 187 ------DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
Query: 539 ---VQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRP 595
+ + V+ + +G +LD D + ++ E++ C NP RP
Sbjct: 241 YQGLSNEQ------VLRFVMEGGLLDKPDNCPDMLF-----ELMRM----CWQYNPKMRP 285
Query: 596 SMRQVVQYLD 605
S +++ +
Sbjct: 286 SFLEIISSIK 295
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-32
Identities = 64/282 (22%), Positives = 115/282 (40%), Gaps = 50/282 (17%)
Query: 350 GKVYRGVL---PSSHAEIAVK--KVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR 404
G V L S ++AVK K + +++F+ E M + H ++ +L G R
Sbjct: 37 GSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96
Query: 405 KG------ELLLVYDYMPNGSLDKIL----YSNTRPSLNWFQRFRIIKGVAFGLLYLHEE 454
+++ +M +G L L +L R + +A G+ YL
Sbjct: 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS- 155
Query: 455 WEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNV--VGTVGYL-----A 507
+ +HRD+ N +L D+ + DFGL+R +++ + G L A
Sbjct: 156 --RNFIHRDLAARNCMLAEDMTVCVADFGLSR------KIYSGDYYRQGCASKLPVKWLA 207
Query: 508 PELLRNGRGTTSTDVYAFGVFMLEVA-CGRRP---VQPGELDLLDWVIDYWQKGDVLDAS 563
E L + T +DV+AFGV M E+ G+ P ++ E + +Y G+ L
Sbjct: 208 LESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE------IYNYLIGGNRLKQP 261
Query: 564 DPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
+E +Y +++ + C ++P RPS + L+
Sbjct: 262 PECMEEVY-----DLMYQ----CWSADPKQRPSFTCLRMELE 294
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 8e-32
Identities = 51/197 (25%), Positives = 88/197 (44%), Gaps = 11/197 (5%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMK-QFVSEIVSMGKLRHRNLVQLRGYC 402
KGG K + + A K V + + EI L H+++V G+
Sbjct: 51 KGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF 110
Query: 403 RRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHR 462
+ +V + SL ++ + + + ++ + G YLH V+HR
Sbjct: 111 EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY--LRQIVLGCQYLHR---NRVIHR 165
Query: 463 DIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRG-TTSTD 521
D+K N+ L+ DLE K+GDFGLA ++ + + GT Y+APE+L + +G + D
Sbjct: 166 DLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVL-SKKGHSFEVD 223
Query: 522 VYAFGVFMLEVACGRRP 538
V++ G M + G+ P
Sbjct: 224 VWSIGCIMYTLLVGKPP 240
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 8e-32
Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 10/197 (5%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGM-KQFVSEIVSMGKLRHRNLVQLRGYC 402
KG VYR + E+A+K + + GM ++ +E+ +L+H ++++L Y
Sbjct: 21 KGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF 80
Query: 403 RRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHR 462
+ LV + NG +++ L + +P R + + G+LYLH +LHR
Sbjct: 81 EDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR-HFMHQIITGMLYLHS---HGILHR 136
Query: 463 DIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRG-TTSTD 521
D+ +N+LL ++ K+ DFGLA ++ H T + GT Y++PE+ +D
Sbjct: 137 DLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIA-TRSAHGLESD 194
Query: 522 VYAFGVFMLEVACGRRP 538
V++ G + GR P
Sbjct: 195 VWSLGCMFYTLLIGRPP 211
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 67/277 (24%), Positives = 107/277 (38%), Gaps = 49/277 (17%)
Query: 350 GKVYRGVLPSSHAE---IAVK--KVCHDSDHGMKQ-FVSEIVSMGKLRHRNLVQLRGYCR 403
G V RG + + +AVK K S F+ E+ +M L HRNL++L G
Sbjct: 32 GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 91
Query: 404 RKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRD 463
+ +V + P GSL L + + R VA G+ YL + +HRD
Sbjct: 92 TPP-MKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRD 146
Query: 464 IKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGT--VGYLAPELLRNGRGTTSTD 521
+ N+LL K+GDFGL R +D + + APE L+ + ++D
Sbjct: 147 LAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASD 206
Query: 522 VYAFGVFMLEVA-CGRRPVQPGELDLLDWVIDYW--QKGDVLDASDP---RLE------- 568
+ FGV + E+ G+ P + +L D RL
Sbjct: 207 TWMFGVTLWEMFTYGQEP--------------WIGLNGSQILHKIDKEGERLPRPEDCPQ 252
Query: 569 GIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
IY ++++ C P+ RP+ + +L
Sbjct: 253 DIY-----NVMVQ----CWAHKPEDRPTFVALRDFLL 280
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 51/197 (25%), Positives = 88/197 (44%), Gaps = 11/197 (5%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMK-QFVSEIVSMGKLRHRNLVQLRGYC 402
KGG K + + A K V + + EI L H+++V G+
Sbjct: 25 KGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF 84
Query: 403 RRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHR 462
+ +V + SL ++ + + + ++ + G YLH V+HR
Sbjct: 85 EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY--LRQIVLGCQYLHR---NRVIHR 139
Query: 463 DIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRG-TTSTD 521
D+K N+ L+ DLE K+GDFGLA ++ + + GT Y+APE+L + +G + D
Sbjct: 140 DLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVL-SKKGHSFEVD 197
Query: 522 VYAFGVFMLEVACGRRP 538
V++ G M + G+ P
Sbjct: 198 VWSIGCIMYTLLVGKPP 214
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 68/283 (24%), Positives = 121/283 (42%), Gaps = 52/283 (18%)
Query: 350 GKVYRGVL--PSSHAEIAVKKVCHD-SDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRK 405
G+V + + + A+K++ S + F E+ + KL H N++ L G C +
Sbjct: 39 GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 98
Query: 406 GELLLVYDYMPNGSLDKIL--------------YSNTRPSLNWFQRFRIIKGVAFGLLYL 451
G L L +Y P+G+L L ++T +L+ Q VA G+ YL
Sbjct: 99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 158
Query: 452 HEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYL----- 506
++ +HRD+ N+L+ + K+ DFGL+R + V T+G L
Sbjct: 159 S---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKTMGRLPVRWM 208
Query: 507 APELLRNGRGTTSTDVYAFGVFMLEVA-CGRRP---VQPGELDLLDWVIDYWQKGDVLDA 562
A E L TT++DV+++GV + E+ G P + E + + +G L+
Sbjct: 209 AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYEKLPQGYRLEK 262
Query: 563 SDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
+ +Y +++ + C P RPS Q++ L+
Sbjct: 263 PLNCDDEVY-----DLMRQ----CWREKPYERPSFAQILVSLN 296
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 62/289 (21%), Positives = 119/289 (41%), Gaps = 53/289 (18%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRG----- 400
+G G+V + A+KK+ H + + +SE++ + L H+ +V+
Sbjct: 16 QGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVRYYAAWLER 74
Query: 401 --------YCRRKGELLLVYDYMPNGSL-DKI----LYSNTRPSLNWFQRFRIIKGVAFG 447
++K L + +Y NG+L D I L F++ I++ ++
Sbjct: 75 RNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ--ILEALS-- 130
Query: 448 LLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDH-------------GNDL 494
Y+H Q ++HRD+KP N+ +D K+GDFGLA+ G+
Sbjct: 131 --YIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 495 HTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDY 553
+ T+ +GT Y+A E+L G D+Y+ G+ E+ E + +
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNILKKL-- 241
Query: 554 WQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602
+ + P + ++ + +I+ L H +P+ RP R ++
Sbjct: 242 -RSVSI--EFPPDFDDNKMKVEKKIIRLL---IDH-DPNKRPGARTLLN 283
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 67/278 (24%), Positives = 112/278 (40%), Gaps = 43/278 (15%)
Query: 350 GKVYRGVLP-----SSHAEIAVKKVCHD-SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCR 403
G+VY G + S ++AVK + S+ F+ E + + K H+N+V+ G
Sbjct: 44 GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 103
Query: 404 RKGELLLVYDYMPNGSLDKILYSN-----TRPSLNWFQRFRIIKGVAFGLLYLHEEWEQV 458
+ ++ + M G L L SL + + +A G YL E
Sbjct: 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENH 160
Query: 459 VLHRDIKPANVLLDADLEG---KLGDFGLARLYDHGNDLHTTN--VVGTVGYL-----AP 508
+HRDI N LL G K+GDFG+AR D++ + G L P
Sbjct: 161 FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRASYYRKGGCAMLPVKWMPP 214
Query: 509 ELLRNGRGTTSTDVYAFGVFMLEVA-CGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL 567
E G T+ TD ++FGV + E+ G P P + V+++ G +D
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY-PS-KSNQE-VLEFVTSGGRMDPPKNCP 271
Query: 568 EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
+Y I+ + C P+ RP+ +++ ++
Sbjct: 272 GPVY-----RIMTQ----CWQHQPEDRPNFAIILERIE 300
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-31
Identities = 51/222 (22%), Positives = 86/222 (38%), Gaps = 27/222 (12%)
Query: 328 EKEYSPHRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSM 387
+ EY + + +G G+V+R + + AVKKV + + E+V+
Sbjct: 50 DYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV--RLEVFRVE---ELVAC 104
Query: 388 GKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFR------II 441
L +V L G R + + + + GSL +++ +
Sbjct: 105 AGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQ--------MGCLPEDRALYYL 156
Query: 442 KGVAFGLLYLHEEWEQVVLHRDIKPANVLLDAD-LEGKLGDFG----LARLYDHGNDLHT 496
GL YLH + +LH D+K NVLL +D L DFG L + L
Sbjct: 157 GQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG 213
Query: 497 TNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRP 538
+ GT ++APE++ D+++ ML + G P
Sbjct: 214 DYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 8e-31
Identities = 62/286 (21%), Positives = 112/286 (39%), Gaps = 53/286 (18%)
Query: 350 GKVYRGVLPSSHAE-----IAVKKVCHD-SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCR 403
GKVY+G L +A+K + ++F E + +L+H N+V L G
Sbjct: 23 GKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT 82
Query: 404 RKGELLLVYDYMPNGSLDKILYSN--------------TRPSLNWFQRFRIIKGVAFGLL 449
+ L +++ Y +G L + L + +L ++ +A G+
Sbjct: 83 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGME 142
Query: 450 YLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTN--VVGTVGYL- 506
YL V+H+D+ NVL+ L K+ D GL R +++ + + L
Sbjct: 143 YLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFR------EVYAADYYKLLGNSLLP 193
Query: 507 ----APELLRNGRGTTSTDVYAFGVFMLEVA-CGRRPVQPGELDLLDWVIDYWQKGDVLD 561
APE + G+ + +D++++GV + EV G +P D V++ + VL
Sbjct: 194 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC--GYSNQD-VVEMIRNRQVLP 250
Query: 562 ASDPRL--EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
P +Y L + C + P RP + + L
Sbjct: 251 C--PDDCPAWVY---------ALMIECWNEFPSRRPRFKDIHSRLR 285
|
| >1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... Length = 237 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-30
Identities = 35/129 (27%), Positives = 59/129 (45%), Gaps = 16/129 (12%)
Query: 137 NHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPI 196
+ I A+ELDT + + D H+GID+ ++S ++ +++GK
Sbjct: 2 DTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKT-------------AKWNMQNGKVG 48
Query: 197 QIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTRVSDYY 256
I YN +K ++ ++ P +S +DL +L + + VGLSA+TG
Sbjct: 49 TAHIIYNSVDKRLSAVVSY---PNADSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNT 105
Query: 257 ILGWSFNKS 265
IL WSF
Sbjct: 106 ILSWSFTSK 114
|
| >1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... Length = 237 | Back alignment and structure |
|---|
Score = 87.2 bits (215), Expect = 2e-19
Identities = 33/130 (25%), Positives = 48/130 (36%), Gaps = 10/130 (7%)
Query: 11 WFLFKVTLIFSASAQEENQFIHHGFEGSKLK--LDGLAKIHPNGLLQLTNTSERIS---- 64
W S F+ + F + L G A +G L+LT S S
Sbjct: 109 WSFTSKLKSNSTHETNALHFMFNQFSKDQKDLILQGDATTGTDGNLELTRVSSNGSPQGS 168
Query: 65 --GHAFYPFPFKFNSSSSQSLSFSTSFVFAMFPKLPNYGGHGMAFFISP-STDFSEAVAG 121
G A + P SS+ SF +F F + ++ G+AFFIS + G
Sbjct: 169 SVGRALFYAPVHIWESSAVVASFEATFTFLIKSP-DSHPADGIAFFISNIDSSIPSGSTG 227
Query: 122 SHLGIFNRSN 131
LG+F +N
Sbjct: 228 RLLGLFPDAN 237
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 65/278 (23%), Positives = 109/278 (39%), Gaps = 43/278 (15%)
Query: 350 GKVYRGVLPSSHAE-----IAVKKVCHD-SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCR 403
G+VY G + + +AVK + S+ F+ E + + K H+N+V+ G
Sbjct: 85 GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 144
Query: 404 RKGELLLVYDYMPNGSLDKILYSN-----TRPSLNWFQRFRIIKGVAFGLLYLHEEWEQV 458
+ ++ + M G L L SL + + +A G YL E
Sbjct: 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENH 201
Query: 459 VLHRDIKPANVLLDADLEG---KLGDFGLARLYDHGNDLHTTN--VVGTVGYL-----AP 508
+HRDI N LL G K+GDFG+AR D++ G L P
Sbjct: 202 FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIYRAGYYRKGGCAMLPVKWMPP 255
Query: 509 ELLRNGRGTTSTDVYAFGVFMLEVA-CGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL 567
E G T+ TD ++FGV + E+ G P + V+++ G +D
Sbjct: 256 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP--SKSNQE-VLEFVTSGGRMDPPKNCP 312
Query: 568 EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
+Y I+ + C P+ RP+ +++ ++
Sbjct: 313 GPVY-----RIMTQ----CWQHQPEDRPNFAIILERIE 341
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-30
Identities = 60/208 (28%), Positives = 88/208 (42%), Gaps = 16/208 (7%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFV-SEIVSMGKLRHRNLVQL------ 398
GG G V R + + ++A+K+ + ++ EI M KL H N+V
Sbjct: 24 TGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDG 83
Query: 399 RGYCRRKGELLLVYDYMPNGSLDKILYSNTRPS-LNWFQRFRIIKGVAFGLLYLHEEWEQ 457
LL +Y G L K L L ++ ++ L YLHE
Sbjct: 84 LQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---N 140
Query: 458 VVLHRDIKPANVLLDADLEG---KLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNG 514
++HRD+KP N++L + K+ D G A+ D G VGT+ YLAPELL
Sbjct: 141 RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE--FVGTLQYLAPELLEQK 198
Query: 515 RGTTSTDVYAFGVFMLEVACGRRPVQPG 542
+ T + D ++FG E G RP P
Sbjct: 199 KYTVTVDYWSFGTLAFECITGFRPFLPN 226
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 46/211 (21%), Positives = 90/211 (42%), Gaps = 28/211 (13%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNL--VQLRGY 401
GGS KV++ + A+K V + + + + +EI + KL+ + ++L Y
Sbjct: 38 SGGSSKVFQVLNEKKQ-IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96
Query: 402 CRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLH 461
+ +V + N L+ L + + K + + +H+ ++H
Sbjct: 97 EITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSY--WKNMLEAVHTIHQ---HGIVH 150
Query: 462 RDIKPANVLLDADLEG--KLGDFGLAR-LYDHGNDLHTTNVVGTVGYLAPELLRNGRG-- 516
D+KPAN L+ +G KL DFG+A + + + VGTV Y+ PE +++
Sbjct: 151 SDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 207
Query: 517 ---------TTSTDVYAFGVFMLEVACGRRP 538
+ +DV++ G + + G+ P
Sbjct: 208 ENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 73/323 (22%), Positives = 129/323 (39%), Gaps = 67/323 (20%)
Query: 321 EEVYEDWEKEYSPHRFSYKNLYKATKGGSG---KVYRGVLP-----SSHAEIAVKKV--- 369
++ D + E+ +R S+ G+G KV + +AVK +
Sbjct: 10 TQLPYDHKWEFPRNRLSFGK-----TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS 64
Query: 370 CHDSDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNT 428
H ++ + +SE+ + L H N+V L G C G L++ +Y G L L
Sbjct: 65 AHLTE--REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKR 122
Query: 429 RPSLNWFQRFRIIKG----------------VAFGLLYLHEEWEQVVLHRDIKPANVLLD 472
+ I++ VA G+ +L + +HRD+ N+LL
Sbjct: 123 DSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLT 179
Query: 473 ADLEGKLGDFGLARLYDHGNDLHTTNV--VGTVGYL-----APELLRNGRGTTSTDVYAF 525
K+ DFGLAR D+ + V L APE + N T +DV+++
Sbjct: 180 HGRITKICDFGLAR------DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY 233
Query: 526 GVFMLEVA-CGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL--EGIYVEEQMEIVLKL 582
G+F+ E+ G P PG + + ++G + + P +Y +I+
Sbjct: 234 GIFLWELFSLGSSPY-PG-MPVDSKFYKMIKEGFRMLS--PEHAPAEMY-----DIMKT- 283
Query: 583 GLFCSHSNPDTRPSMRQVVQYLD 605
C ++P RP+ +Q+VQ ++
Sbjct: 284 ---CWDADPLKRPTFKQIVQLIE 303
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 47/211 (22%), Positives = 93/211 (44%), Gaps = 28/211 (13%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNL--VQLRGY 401
GGS KV++ + A+K V + + + + +EI + KL+ + ++L Y
Sbjct: 19 SGGSSKVFQVLNEKKQ-IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 77
Query: 402 CRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLH 461
+ +V + N L+ L ++ ++R K + + +H+ ++H
Sbjct: 78 EITDQYIYMVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQ---HGIVH 131
Query: 462 RDIKPANVLLDADLEG--KLGDFGLAR-LYDHGNDLHTTNVVGTVGYLAPELLRNGRG-- 516
D+KPAN L+ +G KL DFG+A + + + VGTV Y+ PE +++
Sbjct: 132 SDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 188
Query: 517 ---------TTSTDVYAFGVFMLEVACGRRP 538
+ +DV++ G + + G+ P
Sbjct: 189 ENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 70/329 (21%), Positives = 131/329 (39%), Gaps = 77/329 (23%)
Query: 322 EVYEDWEKEYSPHRFSYKNLYKATKGGSG---KVYRGVLP-----SSHAEIAVKKV-CHD 372
++ ED + E+ G G KV + + + +AVK + +
Sbjct: 11 KILEDPKWEFPRKNLVLGK-----TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA 65
Query: 373 SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSL 432
S ++ +SE + ++ H ++++L G C + G LLL+ +Y GSL L + R
Sbjct: 66 SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRES-RKVG 124
Query: 433 NWFQRFRIIKG-----------------------VAFGLLYLHEEWEQVVLHRDIKPANV 469
+ + ++ G+ YL E ++HRD+ N+
Sbjct: 125 PGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNI 181
Query: 470 LLDADLEGKLGDFGLARLYDHGNDLHTTN--VVGTVGYL-----APELLRNGRGTTSTDV 522
L+ + K+ DFGL+R D++ + V + G + A E L + TT +DV
Sbjct: 182 LVAEGRKMKISDFGLSR------DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDV 235
Query: 523 YAFGVFMLEVA-CGRRP---VQPGELDLLDWVIDYWQKGDVLDASDPRL--EGIYVEEQM 576
++FGV + E+ G P + P + + + G ++ P E +Y
Sbjct: 236 WSFGVLLWEIVTLGGNPYPGIPPER------LFNLLKTGHRMER--PDNCSEEMY----- 282
Query: 577 EIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
++L+ C PD RP + + L+
Sbjct: 283 RLMLQ----CWKQEPDKRPVFADISKDLE 307
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 45/211 (21%), Positives = 88/211 (41%), Gaps = 28/211 (13%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNL--VQLRGY 401
GGS KV++ + A+K V + + + + +EI + KL+ + ++L Y
Sbjct: 66 SGGSSKVFQVLNEKKQ-IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 124
Query: 402 CRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLH 461
+ +V + N L+ L + + K + + +H+ ++H
Sbjct: 125 EITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSY--WKNMLEAVHTIHQ---HGIVH 178
Query: 462 RDIKPANVLLDADLEG--KLGDFGLARLY-DHGNDLHTTNVVGTVGYLAPELLRNGRG-- 516
D+KPAN L+ +G KL DFG+A + + VG V Y+ PE +++
Sbjct: 179 SDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSR 235
Query: 517 ---------TTSTDVYAFGVFMLEVACGRRP 538
+ +DV++ G + + G+ P
Sbjct: 236 ENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 53/286 (18%), Positives = 101/286 (35%), Gaps = 56/286 (19%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKL-RHRNLVQLRGYC 402
G G V++ V A+K+ + + E+ + L +H ++V+
Sbjct: 21 SGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAW 80
Query: 403 RRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRF------RIIKGVAFGLLYLHEEWE 456
+L+ +Y GSL + N R F ++ V GL Y+H
Sbjct: 81 AEDDHMLIQNEYCNGGSLADAISENYRI----MSYFKEAELKDLLLQVGRGLRYIHS--- 133
Query: 457 QVVLHRDIKPANVLLDAD-------------------LEGKLGDFGLARLYDHGNDLHTT 497
++H DIKP+N+ + + K+GD G +
Sbjct: 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT---RISSPQV- 189
Query: 498 NVVGTVGYLAPELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQK 556
G +LA E+L+ D++A + ++ A + G+ W +
Sbjct: 190 -EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---------WHE 239
Query: 557 GDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602
+ PR+ + +E E++ H +P+ RPS +V+
Sbjct: 240 --IRQGRLPRIPQVLSQEFTELLKV----MIHPDPERRPSAMALVK 279
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 70/319 (21%), Positives = 122/319 (38%), Gaps = 63/319 (19%)
Query: 321 EEVYEDWEKEYSPHRFSYKNLYKATKGGSG---KVYRGVLP-----SSHAEIAVKKV--- 369
++ + + E+ + + G+G KV + ++AVK +
Sbjct: 33 TQLPYNEKWEFPRNNLQFGK-----TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST 87
Query: 370 CHDSDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVYDYMPNGSL-------- 420
H + + +SE+ M L +H N+V L G C G +L++ +Y G L
Sbjct: 88 AHADE--KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKS 145
Query: 421 ----DKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLE 476
++ + + VA G+ +L + +HRD+ NVLL
Sbjct: 146 RVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHV 202
Query: 477 GKLGDFGLARLYDHGNDLHTTN--VVGTVGYL-----APELLRNGRGTTSTDVYAFGVFM 529
K+GDFGLAR D+ + +V L APE + + T +DV+++G+ +
Sbjct: 203 AKIGDFGLAR------DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 256
Query: 530 LEVA-CGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL--EGIYVEEQMEIVLKLGLFC 586
E+ G P PG L + G + P + IY I+ C
Sbjct: 257 WEIFSLGLNPY-PGILVNSK-FYKLVKDGYQMAQ--PAFAPKNIY-----SIMQA----C 303
Query: 587 SHSNPDTRPSMRQVVQYLD 605
P RP+ +Q+ +L
Sbjct: 304 WALEPTHRPTFQQICSFLQ 322
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-29
Identities = 66/286 (23%), Positives = 122/286 (42%), Gaps = 39/286 (13%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHG-MKQFVSEIVSMGKLRHRNLVQLRGYCRR 404
G G V++ S +A K + + Q + E+ + + +V G
Sbjct: 43 AGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 102
Query: 405 KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDI 464
GE+ + ++M GSLD++L R + ++ V GL YL E+ + ++HRD+
Sbjct: 103 DGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHK--IMHRDV 158
Query: 465 KPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYA 524
KP+N+L+++ E KL DFG++ + + + VGT Y++PE L+ + +D+++
Sbjct: 159 KPSNILVNSRGEIKLCDFGVSGQLI--DSMANSF-VGTRSYMSPERLQGTHYSVQSDIWS 215
Query: 525 FGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQME------- 577
G+ ++E+A GR P+ P + L+ + +GD + +
Sbjct: 216 MGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPM 275
Query: 578 --------IV------LKLGLF----------CSHSNPDTRPSMRQ 599
IV L G+F C NP R ++Q
Sbjct: 276 AIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 32/293 (10%), Positives = 71/293 (24%), Gaps = 48/293 (16%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVK---KVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYC 402
G V+ + A+K +S +++ + +L + + R
Sbjct: 72 VGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRR 131
Query: 403 R--------------------------RKGELLLVYDYMPNGSLDKIL-----YSNTRPS 431
R LL+ + L+ + R
Sbjct: 132 RLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVFRGD 190
Query: 432 LNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491
+ + L + ++H P N+ + D LGD
Sbjct: 191 EGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT- 246
Query: 492 NDLHTTNVVGTVGYLAPELLRNGRG--TTSTDVYAFGVFMLEVACGRRPVQPGELDLLDW 549
V Y E L T + + + G+ + V C P +
Sbjct: 247 ---RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS 303
Query: 550 VIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602
+ D+ + ++ + L + + R + ++
Sbjct: 304 WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRF-L---NFDRRRRLLPLEAME 352
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 49/209 (23%), Positives = 86/209 (41%), Gaps = 21/209 (10%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGM-KQFVSEIVSMGKLRHRNLVQLRGY--C 402
+G + V+RG + A+K + S + E + KL H+N+V+L
Sbjct: 19 QGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78
Query: 403 RRKGELLLVYDYMPNGSL-DKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLH 461
+L+ ++ P GSL + + L + +++ V G+ +L E ++H
Sbjct: 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVH 135
Query: 462 RDIKPANVLLDADLEG----KLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGT 517
R+IKP N++ +G KL DFG AR + + + GT YL P++
Sbjct: 136 RNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHPDMYERAVLR 193
Query: 518 TST--------DVYAFGVFMLEVACGRRP 538
D+++ GV A G P
Sbjct: 194 KDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 72/290 (24%), Positives = 122/290 (42%), Gaps = 58/290 (20%)
Query: 350 GKVYRGVL-------PSSHAEIAVKKVCHD-SDHGMKQFVSEIVSMGKL-RHRNLVQLRG 400
G+V P +AVK + D ++ + VSE+ M + +H+N++ L G
Sbjct: 49 GQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 108
Query: 401 YCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKG--------------VAF 446
C + G L ++ +Y G+L + L + P + + + +A
Sbjct: 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLAR 168
Query: 447 GLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTN--VVGTVG 504
G+ YL Q +HRD+ NVL+ + K+ DFGLAR D++ + T G
Sbjct: 169 GMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLAR------DINNIDYYKKTTNG 219
Query: 505 YL-----APELLRNGRGTTSTDVYAFGVFMLEVA-CGRRP---VQPGELDLLDWVIDYWQ 555
L APE L + T +DV++FGV M E+ G P + E + +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE------LFKLLK 273
Query: 556 KGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
+G +D +Y ++ C H+ P RP+ +Q+V+ LD
Sbjct: 274 EGHRMDKPANCTNELY-----MMMRD----CWHAVPSQRPTFKQLVEDLD 314
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 49/209 (23%), Positives = 86/209 (41%), Gaps = 21/209 (10%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQ-FVSEIVSMGKLRHRNLVQLRGY--C 402
+G + V+RG + A+K + S + E + KL H+N+V+L
Sbjct: 19 QGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78
Query: 403 RRKGELLLVYDYMPNGSL-DKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLH 461
+L+ ++ P GSL + + L + +++ V G+ +L E ++H
Sbjct: 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVH 135
Query: 462 RDIKPANVLLDADLEG----KLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGT 517
R+IKP N++ +G KL DFG AR + + + GT YL P++
Sbjct: 136 RNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHPDMYERAVLR 193
Query: 518 TST--------DVYAFGVFMLEVACGRRP 538
D+++ GV A G P
Sbjct: 194 KDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 54/201 (26%), Positives = 99/201 (49%), Gaps = 7/201 (3%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQ 397
+ L K +G G VY+ + + +A+K+V + +++ + EI M + ++V+
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPHVVK 88
Query: 398 LRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQ 457
G + +L +V +Y GS+ I+ + L + I++ GL YLH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT-LTEDEIATILQSTLKGLEYLHF---M 144
Query: 458 VVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGT 517
+HRDIK N+LL+ + KL DFG+A T V+GT ++APE+++
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT-VIGTPFWMAPEVIQEIGYN 203
Query: 518 TSTDVYAFGVFMLEVACGRRP 538
D+++ G+ +E+A G+ P
Sbjct: 204 CVADIWSLGITAIEMAEGKPP 224
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 55/196 (28%), Positives = 88/196 (44%), Gaps = 11/196 (5%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGM-KQFVSEIVSMGKLRHRNLVQLRGYC 402
KG G VY S +A+K + G+ Q E+ LRH N+++L GY
Sbjct: 19 KGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 78
Query: 403 RRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHR 462
+ L+ +Y P G++ + L ++ + + I +A L Y H + V+HR
Sbjct: 79 HDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHS---KRVIHR 133
Query: 463 DIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDV 522
DIKP N+LL + E K+ DFG + + GT+ YL PE++ D+
Sbjct: 134 DIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDL--CGTLDYLPPEMIEGRMHDEKVDL 190
Query: 523 YAFGVFMLEVACGRRP 538
++ GV E G+ P
Sbjct: 191 WSLGVLCYEFLVGKPP 206
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 73/290 (25%), Positives = 122/290 (42%), Gaps = 58/290 (20%)
Query: 350 GKVYRGVL-------PSSHAEIAVKKV-CHDSDHGMKQFVSEIVSMGKL-RHRNLVQLRG 400
G+V P+ ++AVK + ++ + +SE+ M + +H+N++ L G
Sbjct: 83 GQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG 142
Query: 401 YCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKG--------------VAF 446
C + G L ++ +Y G+L + L + P L + VA
Sbjct: 143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVAR 202
Query: 447 GLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTN--VVGTVG 504
G+ YL + +HRD+ NVL+ D K+ DFGLAR D+H + T G
Sbjct: 203 GMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLAR------DIHHIDYYKKTTNG 253
Query: 505 YL-----APELLRNGRGTTSTDVYAFGVFMLEVA-CGRRP---VQPGELDLLDWVIDYWQ 555
L APE L + T +DV++FGV + E+ G P V E + +
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------LFKLLK 307
Query: 556 KGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
+G +D +Y ++ C H+ P RP+ +Q+V+ LD
Sbjct: 308 EGHRMDKPSNCTNELY-----MMMRD----CWHAVPSQRPTFKQLVEDLD 348
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 42/216 (19%), Positives = 78/216 (36%), Gaps = 28/216 (12%)
Query: 346 KGGSGKVY---------------RGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKL 390
+G K+ + +L F +E+ + +
Sbjct: 41 QGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI 100
Query: 391 RHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRF------RIIKGV 444
++ + G E+ ++Y+YM N S+ K N+ IIK V
Sbjct: 101 KNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSV 160
Query: 445 AFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVG 504
Y+H E + + HRD+KP+N+L+D + KL DFG + + + GT
Sbjct: 161 LNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYMV-DKKIKGS--RGTYE 215
Query: 505 YLAPELLRNGRGT--TSTDVYAFGVFMLEVACGRRP 538
++ PE N D+++ G+ + + P
Sbjct: 216 FMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 64/288 (22%), Positives = 116/288 (40%), Gaps = 54/288 (18%)
Query: 350 GKVYRGVLP-----SSHAEIAVKKV-CHDSDHGMKQFVSEIVSMGKL-RHRNLVQLRGYC 402
G+V ++ +AVK + + + +SE+ + + H N+V L G C
Sbjct: 41 GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 100
Query: 403 RRKGE-LLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKG--------------VAFG 447
+ G L+++ ++ G+L L S + + + VA G
Sbjct: 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKG 160
Query: 448 LLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNV--VGTVGY 505
+ +L + +HRD+ N+LL K+ DFGLAR D++
Sbjct: 161 MEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLAR------DIYKDPDYVRKGDAR 211
Query: 506 L-----APELLRNGRGTTSTDVYAFGVFMLEVA-CGRRPVQPGELDLLDWVIDYWQKGDV 559
L APE + + T +DV++FGV + E+ G P PG + + + ++G
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-PG-VKIDEEFCRRLKEGTR 269
Query: 560 LDASDPRL--EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
+ A P +Y + +L C H P RP+ ++V++L
Sbjct: 270 MRA--PDYTTPEMY-----QTMLD----CWHGEPSQRPTFSELVEHLG 306
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-28
Identities = 77/321 (23%), Positives = 132/321 (41%), Gaps = 66/321 (20%)
Query: 322 EVYEDWEKEYSPHRFSYKNLYKATKGGSG---KVYRGVL-------PSSHAEIAVKKVCH 371
E+ ED + E+ + + G G +V P +AVK +
Sbjct: 69 ELPEDPKWEFPRDKLTLGK-----PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD 123
Query: 372 D-SDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTR 429
D ++ + VSE+ M + +H+N++ L G C + G L ++ +Y G+L + L +
Sbjct: 124 DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP 183
Query: 430 PSLNWFQRFRIIKG--------------VAFGLLYLHEEWEQVVLHRDIKPANVLLDADL 475
P + + + +A G+ YL Q +HRD+ NVL+ +
Sbjct: 184 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENN 240
Query: 476 EGKLGDFGLARLYDHGNDLHTTN--VVGTVGYL-----APELLRNGRGTTSTDVYAFGVF 528
K+ DFGLAR D++ + T G L APE L + T +DV++FGV
Sbjct: 241 VMKIADFGLAR------DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 294
Query: 529 MLEVAC-GRRP---VQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGL 584
M E+ G P + E + ++G +D +Y ++
Sbjct: 295 MWEIFTLGGSPYPGIPVEE------LFKLLKEGHRMDKPANCTNELY-----MMMRD--- 340
Query: 585 FCSHSNPDTRPSMRQVVQYLD 605
C H+ P RP+ +Q+V+ LD
Sbjct: 341 -CWHAVPSQRPTFKQLVEDLD 360
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 46/216 (21%), Positives = 82/216 (37%), Gaps = 24/216 (11%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLR-HRNLVQLRGYC-- 402
+GG VY S E A+K++ + + + + E+ M KL H N+VQ
Sbjct: 38 EGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASI 97
Query: 403 ------RRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWE 456
+ E LL+ + ++ + +R L+ +I + ++H + +
Sbjct: 98 GKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ-K 156
Query: 457 QVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTT-----------NVVGTVGY 505
++HRD+K N+LL KL DFG A H D + T Y
Sbjct: 157 PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMY 216
Query: 506 LAPELLRNGRG---TTSTDVYAFGVFMLEVACGRRP 538
PE++ D++A G + + + P
Sbjct: 217 RTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 73/297 (24%), Positives = 113/297 (38%), Gaps = 66/297 (22%)
Query: 350 GKVYRGVL-----PSSHAEIAVKKV---CHDSDHGMKQFVSEIVSMGKL-RHRNLVQLRG 400
GKV ++AVK + S+ + +SE+ M +L H N+V L G
Sbjct: 59 GKVMNATAYGISKTGVSIQVAVKMLKEKADSSE--REALMSELKMMTQLGSHENIVNLLG 116
Query: 401 YCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKG----------------- 443
C G + L+++Y G L L S R + + +
Sbjct: 117 ACTLSGPIYLIFEYCCYGDLLNYLRSK-REKFSEDEIEYENQKRLEEEEDLNVLTFEDLL 175
Query: 444 -----VAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTN 498
VA G+ +L + +HRD+ NVL+ K+ DFGLAR D+ + +
Sbjct: 176 CFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLAR------DIMSDS 226
Query: 499 --VVGTVGYL-----APELLRNGRGTTSTDVYAFGVFMLEVA-CGRRPVQPGELDLLDWV 550
VV L APE L G T +DV+++G+ + E+ G P PG + +
Sbjct: 227 NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY-PG-IPVDANF 284
Query: 551 IDYWQKGDVLDASDPRL--EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
Q G +D P E IY I+ C + RPS + +L
Sbjct: 285 YKLIQNGFKMDQ--PFYATEEIY-----IIMQS----CWAFDSRKRPSFPNLTSFLG 330
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 49/196 (25%), Positives = 77/196 (39%), Gaps = 10/196 (5%)
Query: 347 GGSGKVYRGVLPSSHAEIAVK----KVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYC 402
GG G VY +A+K + D + E + G+L+ ++V + +
Sbjct: 45 GGMGDVYEAEDTVRERIVALKLMSETLSSDPVF-RTRMQREARTAGRLQEPHVVPIHDFG 103
Query: 403 RRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHR 462
G+L + + L +L + L + I++ + L H HR
Sbjct: 104 EIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIGSALDAAHA---AGATHR 158
Query: 463 DIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDV 522
D+KP N+L+ AD L DFG+A N VGT+ Y+APE T D+
Sbjct: 159 DVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADI 218
Query: 523 YAFGVFMLEVACGRRP 538
YA + E G P
Sbjct: 219 YALTCVLYECLTGSPP 234
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 61/270 (22%), Positives = 115/270 (42%), Gaps = 39/270 (14%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHG-MKQFVSEI-VSMGKLRHRNLVQLRGYCR 403
+G G V + S +AVK++ + K+ + ++ +SM + V G
Sbjct: 17 RGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF 76
Query: 404 RKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRF------RIIKGVAFGLLYLHEEWEQ 457
R+G++ + + M + SLDK + ++ Q +I + L +LH +
Sbjct: 77 REGDVWICMELM-DTSLDKFY----KQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS- 130
Query: 458 VVLHRDIKPANVLLDADLEGKLGDFGL-ARLYDHGNDLHTTNVVGTVGYLAPELLRNGRG 516
V+HRD+KP+NVL++A + K+ DFG+ L +D+ G Y+APE +
Sbjct: 131 -VIHRDVKPSNVLINALGQVKMCDFGISGYL---VDDVAKDIDAGCKPYMAPERINPELN 186
Query: 517 ----TTSTDVYAFGVFMLEVACGRRPVQP--GELDLLDWVIDYWQKGDVLDASDPRL-EG 569
+ +D+++ G+ M+E+A R P L V+ + P+L
Sbjct: 187 QKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV---------EEPSPQLPAD 237
Query: 570 IYVEEQMEIVLKLGLFCSHSNPDTRPSMRQ 599
+ E ++ + C N RP+ +
Sbjct: 238 KFSAEFVDFTSQ----CLKKNSKERPTYPE 263
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 69/282 (24%), Positives = 118/282 (41%), Gaps = 34/282 (12%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVS--EIVSMGKLRHRNL 395
Y+NL +G G V + + +A+KK D M + ++ EI + +LRH NL
Sbjct: 27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENL 86
Query: 396 VQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRP-SLNWFQRF--RIIKGVAFGLLYLH 452
V L C++K LV++++ + ++ L Q++ +II G+ + H
Sbjct: 87 VNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIG----FCH 141
Query: 453 EEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLR 512
++HRDIKP N+L+ KL DFG AR +++ V T Y APELL
Sbjct: 142 SHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPELLV 197
Query: 513 NGRG-TTSTDVYAFGVFMLEVACGRRPVQPG--ELDLLDWVIDYWQKGDVLDASDPRLEG 569
+ DV+A G + E+ P+ PG ++D L ++ G
Sbjct: 198 GDVKYGKAVDVWAIGCLVTEM-FMGEPLFPGDSDIDQLYHIM--------------MCLG 242
Query: 570 IYVEEQMEIVLKLGLFCSHSNPDTRP--SMRQVVQYLDGGAL 609
+ E+ K +F P+ + + + L +
Sbjct: 243 NLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVI 284
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-28
Identities = 56/203 (27%), Positives = 90/203 (44%), Gaps = 16/203 (7%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHG-MKQFVSEI-VSMGKLRHRNLVQLRGYCR 403
+G G V + V S +AVK++ D KQ + ++ V M +VQ G
Sbjct: 32 RGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF 91
Query: 404 RKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRF---RIIKGVAFGLLYLHEEWEQVVL 460
R+G+ + + M + S DK + +I L +L E + ++
Sbjct: 92 REGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--II 148
Query: 461 HRDIKPANVLLDADLEGKLGDFGL-ARLYDHGNDLHTTNVVGTVGYLAPELLRNGRG--- 516
HRDIKP+N+LLD KL DFG+ +L + + T G Y+APE +
Sbjct: 149 HRDIKPSNILLDRSGNIKLCDFGISGQL---VDSIAKTRDAGCRPYMAPERIDPSASRQG 205
Query: 517 -TTSTDVYAFGVFMLEVACGRRP 538
+DV++ G+ + E+A GR P
Sbjct: 206 YDVRSDVWSLGITLYELATGRFP 228
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-28
Identities = 68/295 (23%), Positives = 120/295 (40%), Gaps = 63/295 (21%)
Query: 350 GKVYRGVLPSSHAE-----IAVKKVCHD-SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCR 403
G+V++ P +AVK + + S F E M + + N+V+L G C
Sbjct: 61 GRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120
Query: 404 RKGELLLVYDYMPNGSLDKILYSN----------------------TRPSLNWFQRFRII 441
+ L+++YM G L++ L S P L+ ++ I
Sbjct: 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIA 180
Query: 442 KGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTN--V 499
+ VA G+ YL E+ +HRD+ N L+ ++ K+ DFGL+R ++++ +
Sbjct: 181 RQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSR------NIYSADYYK 231
Query: 500 VGTVGYL-----APELLRNGRGTTSTDVYAFGVFMLEVA-CGRRP---VQPGELDLLDWV 550
+ PE + R TT +DV+A+GV + E+ G +P + E V
Sbjct: 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE------V 285
Query: 551 IDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
I Y + G++L + +Y ++ C P RPS + + L
Sbjct: 286 IYYVRDGNILACPENCPLELY-----NLMRL----CWSKLPADRPSFCSIHRILQ 331
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 68/282 (24%), Positives = 113/282 (40%), Gaps = 34/282 (12%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-DHGMKQF-VSEIVSMGKLRHRNL 395
Y+ + K +G G V++ + +A+KK D +K+ + EI + +L+H NL
Sbjct: 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNL 64
Query: 396 VQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRP-SLNWFQRF--RIIKGVAFGLLYLH 452
V L RRK L LV++Y + ++ L R + + + ++ V + H
Sbjct: 65 VNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVN----FCH 119
Query: 453 EEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLR 512
+ +HRD+KP N+L+ KL DFG ARL +D + V T Y +PELL
Sbjct: 120 KHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPELLV 175
Query: 513 NGRG-TTSTDVYAFGVFMLEVACGRRPVQPG--ELDLLDWVIDYWQKGDVLDASDPRLEG 569
DV+A G E+ P+ PG ++D L + + G
Sbjct: 176 GDTQYGPPVDVWAIGCVFAEL-LSGVPLWPGKSDVDQLYLIR--------------KTLG 220
Query: 570 IYVEEQMEIVLKLGLFCSHSNPDTRP--SMRQVVQYLDGGAL 609
+ ++ F PD + + AL
Sbjct: 221 DLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPAL 262
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 53/217 (24%), Positives = 97/217 (44%), Gaps = 17/217 (7%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHG-MKQFVSEI-VSMGKLRHRNLVQLRGYCR 403
G G+V++ + IAVK++ + K+ + ++ V + +VQ G
Sbjct: 35 SGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI 94
Query: 404 RKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRD 463
++ + + M +K+ P + ++ + L YL E+ V+HRD
Sbjct: 95 TNTDVFIAMELM-GTCAEKLKKRMQGP-IPERILGKMTVAIVKALYYLKEK--HGVIHRD 150
Query: 464 IKPANVLLDADLEGKLGDFGL-ARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTST-- 520
+KP+N+LLD + KL DFG+ RL D D G Y+APE + T
Sbjct: 151 VKPSNILLDERGQIKLCDFGISGRLVD---DKAKDRSAGCAAYMAPERIDPPDPTKPDYD 207
Query: 521 ---DVYAFGVFMLEVACGRRPVQP--GELDLLDWVID 552
DV++ G+ ++E+A G+ P + + ++L V+
Sbjct: 208 IRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ 244
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 47/196 (23%), Positives = 90/196 (45%), Gaps = 10/196 (5%)
Query: 347 GGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVS----EIVSMGKLRHRNLVQLRGYC 402
GG VY + ++A+K ++ + E+ + +L H+N+V +
Sbjct: 22 GGMSTVYLAEDTILNIKVAIK-AIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD 80
Query: 403 RRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHR 462
LV +Y+ +L + + + L+ + G+ + H+ ++HR
Sbjct: 81 EEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDGIKHAHD---MRIVHR 135
Query: 463 DIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDV 522
DIKP N+L+D++ K+ DFG+A+ + T +V+GTV Y +PE + TD+
Sbjct: 136 DIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDI 195
Query: 523 YAFGVFMLEVACGRRP 538
Y+ G+ + E+ G P
Sbjct: 196 YSIGIVLYEMLVGEPP 211
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 1e-27
Identities = 53/312 (16%), Positives = 99/312 (31%), Gaps = 38/312 (12%)
Query: 312 VYFVKKKKYEEVYEDWEKEY-------SPHRFSYKNLYKATKGGSGKVYRGVLPSSHAEI 364
Y +K+ + EK + A + ++ + +
Sbjct: 33 NYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKD 92
Query: 365 AVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSL-DKI 423
S M +I M +N V K L + +L D +
Sbjct: 93 ESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWM 152
Query: 424 LYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFG 483
+ I +A + +LH + ++HRD+KP+N+ D K+GDFG
Sbjct: 153 NRRCSLEDREHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFG 209
Query: 484 LARLYDHGNDLHT-----------TNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEV 532
L D + T T VGT Y++PE + + D+++ G+ + E+
Sbjct: 210 LVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFEL 269
Query: 533 ACGRRPVQPG-ELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNP 591
E +I + P L ++ +V + S +P
Sbjct: 270 LY---SFSTQMERVR---IITDVRNLKF-----PLLFTQKYPQEHMMVQDM---LSP-SP 314
Query: 592 DTRPSMRQVVQY 603
RP +++
Sbjct: 315 TERPEATDIIEN 326
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 9/202 (4%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQ 397
Y K +G SG VY + ++ E+A++++ + ++EI+ M + ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 398 LRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQ 457
EL +V +Y+ GSL ++ ++ Q + + L +LH
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLH---SN 135
Query: 458 VVLHRDIKPANVLLDADLEGKLGDFGL-ARLYDHGNDLHTTNVVGTVGYLAPELLRNGRG 516
V+HRDIK N+LL D KL DFG A++ + T +VGT ++APE++
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAY 193
Query: 517 TTSTDVYAFGVFMLEVACGRRP 538
D+++ G+ +E+ G P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP 215
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 54/228 (23%), Positives = 109/228 (47%), Gaps = 15/228 (6%)
Query: 316 KKKKYEEVYEDWEKEYSPHRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDH 375
K ++YE V D + P+ ++ + + G GKVY+ + A A K + S+
Sbjct: 4 KSREYEHVRRDLD----PNEV-WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE 58
Query: 376 GMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWF 435
++ ++ EI + H +V+L G G+L ++ ++ P G++D I+ R L
Sbjct: 59 ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG-LTEP 117
Query: 436 QRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495
Q + + + L +LH + ++HRD+K NVL+ + + +L DFG++
Sbjct: 118 QIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR 174
Query: 496 TTNVVGTVGYLAPELLRNGRGTTST-----DVYAFGVFMLEVACGRRP 538
+ +GT ++APE++ + D+++ G+ ++E+A P
Sbjct: 175 DS-FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 62/220 (28%), Positives = 98/220 (44%), Gaps = 19/220 (8%)
Query: 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGM-KQFVSEIVSMGKLRHRNL 395
+Y L K +G VY+G + +A+K++ + + G + E+ + L+H N+
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 396 VQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAF----GLLYL 451
V L + L LV++Y+ L + L +K F GL Y
Sbjct: 63 VTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINM-----HNVKLFLFQLLRGLAYC 116
Query: 452 HEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELL 511
H + VLHRD+KP N+L++ E KL DFGLAR + VV T+ Y P++L
Sbjct: 117 HRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDIL 172
Query: 512 RNGRG-TTSTDVYAFGVFMLEVACGRRPVQPG--ELDLLD 548
+T D++ G E+A RP+ PG + L
Sbjct: 173 LGSTDYSTQIDMWGVGCIFYEMAT-GRPLFPGSTVEEQLH 211
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 55/196 (28%), Positives = 86/196 (43%), Gaps = 11/196 (5%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKV--CHDSDHGM-KQFVSEIVSMGKLRHRNLVQLRGYC 402
KG G VY + +A+K + G+ Q EI LRH N++++ Y
Sbjct: 24 KGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF 83
Query: 403 RRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHR 462
+ + L+ ++ P G L K L + R + + ++ +A L Y HE + V+HR
Sbjct: 84 HDRKRIYLMLEFAPRGELYKELQKHGR--FDEQRSATFMEELADALHYCHE---RKVIHR 138
Query: 463 DIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDV 522
DIKP N+L+ E K+ DFG + T GT+ YL PE++ D+
Sbjct: 139 DIKPENLLMGYKGELKIADFGWSVHAP-SLRRRTM--CGTLDYLPPEMIEGKTHDEKVDL 195
Query: 523 YAFGVFMLEVACGRRP 538
+ GV E G P
Sbjct: 196 WCAGVLCYEFLVGMPP 211
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 9/202 (4%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQ 397
+ K +G +G V S ++AVK + + +E+V M +H N+V+
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 398 LRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQ 457
+ EL ++ +++ G+L I+ LN Q + + V L YLH Q
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQVR---LNEEQIATVCEAVLQALAYLH---AQ 160
Query: 458 VVLHRDIKPANVLLDADLEGKLGDFGL-ARLYDHGNDLHTTNVVGTVGYLAPELLRNGRG 516
V+HRDIK ++LL D KL DFG A++ + +VGT ++APE++
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRSLY 218
Query: 517 TTSTDVYAFGVFMLEVACGRRP 538
T D+++ G+ ++E+ G P
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPP 240
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 4e-27
Identities = 35/232 (15%), Positives = 64/232 (27%), Gaps = 42/232 (18%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVK---KVCHDSDHGMKQFVSEIVSMGKLRH-RNLVQLRGY 401
+ + V + +KQ E++ + LR +N Q + +
Sbjct: 88 QEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 147
Query: 402 CRRKGELLLV-----------------------YDYMP--NGSLDKIL-----YSNTRPS 431
R LV + P +L +S+T S
Sbjct: 148 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS 207
Query: 432 LNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491
L R ++ V L LH ++H ++P +++LD L F
Sbjct: 208 LVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS 264
Query: 492 NDLHTTNVVGTVGYLAPELLR-----NGRGTTSTDVYAFGVFMLEVACGRRP 538
A +L T + D + G+ + + C P
Sbjct: 265 AVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 15/213 (7%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDH-GMKQFVSEIVSMGKLRHRNLV 396
Y+ G + V ++A+K++ + M + + EI +M + H N+V
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 397 QLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFR------IIKGVAFGLLY 450
K EL LV + GS+ I+ + I++ V GL Y
Sbjct: 77 SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136
Query: 451 LHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGL-ARLYDHGNDLHTTN---VVGTVGYL 506
LH+ +HRD+K N+LL D ++ DFG+ A L G+ VGT ++
Sbjct: 137 LHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193
Query: 507 APELLRNGRG-TTSTDVYAFGVFMLEVACGRRP 538
APE++ RG D+++FG+ +E+A G P
Sbjct: 194 APEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 67/221 (30%), Positives = 108/221 (48%), Gaps = 21/221 (9%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-DHGM-KQFVSEIVSMGKLRHRNL 395
Y+ L K +G G V++ +H +A+K+V D D G+ + EI + +L+H+N+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 396 VQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAF----GLLYL 451
V+L +L LV+++ L K S I+K F GL +
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDP-----EIVKSFLFQLLKGLGFC 117
Query: 452 HEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT-TNVVGTVGYLAPEL 510
H VLHRD+KP N+L++ + E KL +FGLAR + G + + V T+ Y P++
Sbjct: 118 HSRN---VLHRDLKPQNLLINRNGELKLANFGLARAF--GIPVRCYSAEVVTLWYRPPDV 172
Query: 511 LRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPG--ELDLLD 548
L + +TS D+++ G E+A RP+ PG D L
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 213
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 8/202 (3%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQ-FVSEIVSMGKLRHRNLV 396
+ L K KG G+V++G+ + +A+K + + + EI + + +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 397 QLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWE 456
+ G + +L ++ +Y+ GS +L L+ Q I++ + GL YLH
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHS--- 137
Query: 457 QVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRG 516
+ +HRDIK ANVLL E KL DFG+A T VGT ++APE+++
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQSAY 196
Query: 517 TTSTDVYAFGVFMLEVACGRRP 538
+ D+++ G+ +E+A G P
Sbjct: 197 DSKADIWSLGITAIELARGEPP 218
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 70/221 (31%), Positives = 119/221 (53%), Gaps = 16/221 (7%)
Query: 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGM-KQFVSEIVSMGKLRHRNL 395
+K L K G VY+G+ ++ +A+K+V DS+ G + EI M +L+H N+
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENI 65
Query: 396 VQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAF----GLLYL 451
V+L + +L LV+++M N L K + S T + ++K + GL +
Sbjct: 66 VRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 452 HEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT-TNVVGTVGYLAPEL 510
HE +LHRD+KP N+L++ + KLGDFGLAR + G ++T ++ V T+ Y AP++
Sbjct: 125 HENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAF--GIPVNTFSSEVVTLWYRAPDV 179
Query: 511 LRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPG--ELDLLD 548
L R +TS D+++ G + E+ +P+ PG + + L
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMIT-GKPLFPGTNDEEQLK 219
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 34/209 (16%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVK-----KVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRG 400
KG V R V ++ E A K K+ +++ E KL+H N+V+L
Sbjct: 16 KGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EARICRKLQHPNIVRLHD 72
Query: 401 YCRRKGELLLVYDYMPNGSL-DKIL----YSNTRPSLNWFQRFRIIKGVAFGLLYLHEEW 455
+ + LV+D + G L + I+ YS S I+ + + Y H
Sbjct: 73 SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQILESIAYCHS-- 123
Query: 456 EQVVLHRDIKPANVLLDADLEG---KLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLR 512
++HR++KP N+LL + +G KL DFGLA + H GT GYL+PE+L+
Sbjct: 124 -NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG--FAGTPGYLSPEVLK 180
Query: 513 NGRGTTSTDVYAFGV---FMLEVACGRRP 538
+ D++A GV +L G P
Sbjct: 181 KDPYSKPVDIWACGVILYILL---VGYPP 206
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-26
Identities = 64/291 (21%), Positives = 108/291 (37%), Gaps = 36/291 (12%)
Query: 263 NKSGPAQNLDISKLPPLPPPPPTPGKKLNHTVIVSIVAAAVVLITIAAAVYFVKKKKYEE 322
NK G ++ + + +P + + IV Y+
Sbjct: 86 NKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGT-----------VSSNYDN 134
Query: 323 VYEDWEKEYSPHRFSYKN-----LYKATK----GGSGKVYRGVLPSSHAEIAVKKVCHDS 373
D K+Y P K+ Y + G G V+R ++ A K V
Sbjct: 135 YVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH 194
Query: 374 DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSL-DKILYSNTRPSL 432
+ + EI +M LRH LV L E++++Y++M G L +K+ + +
Sbjct: 195 ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA--DEHNKM 252
Query: 433 NWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEG--KLGDFGLARLYDH 490
+ + ++ V GL ++H E +H D+KP N++ KL DFGL D
Sbjct: 253 SEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309
Query: 491 GNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGV---FMLEVACGRRP 538
+ GT + APE+ TD+++ GV +L G P
Sbjct: 310 KQSVKV--TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILL---SGLSP 355
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-26
Identities = 47/213 (22%), Positives = 86/213 (40%), Gaps = 15/213 (7%)
Query: 338 YKNLYKATKGGS--GKVYRGVLPSSHAEIAVKKV--CHDSDHGMKQFVSEIVSMGKLRHR 393
Y+ L KG V + + V+++ S+ + E+ H
Sbjct: 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 394 NLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHE 453
N+V R EL +V +M GS ++ ++ +N I++GV L Y+H
Sbjct: 87 NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 146
Query: 454 EWEQVVLHRDIKPANVLLDADLEGKLGDFG-LARLYDHGNDLHT-----TNVVGTVGYLA 507
+HR +K +++L+ D + L + HG V + +L+
Sbjct: 147 ---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203
Query: 508 PELL-RNGRG-TTSTDVYAFGVFMLEVACGRRP 538
PE+L +N +G +D+Y+ G+ E+A G P
Sbjct: 204 PEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-26
Identities = 58/240 (24%), Positives = 99/240 (41%), Gaps = 29/240 (12%)
Query: 316 KKKKYEEVYEDWEKEYSPHRFSYKN-----LYKATK----GGSGKVYRGVLPSSHAEIAV 366
K Y++ YED K+Y P K Y + G G V+R V ++
Sbjct: 22 KINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVA 81
Query: 367 KKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSL-DKILY 425
K + +EI M +L H L+ L K E++L+ +++ G L D+I
Sbjct: 82 KFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA 141
Query: 426 SNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLL----DADLEGKLGD 481
+ ++ + ++ GL ++H E ++H DIKP N++ + + K+ D
Sbjct: 142 EDY--KMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSV--KIID 194
Query: 482 FGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGV---FMLEVACGRRP 538
FGLA + + T + APE++ TD++A GV +L G P
Sbjct: 195 FGLATKLNPDEIVKV--TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLL---SGLSP 249
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-26
Identities = 70/299 (23%), Positives = 122/299 (40%), Gaps = 54/299 (18%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVK---KVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYC 402
KG G+V + E AVK K + + E+ + +L H N+++L +
Sbjct: 36 KGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF 95
Query: 403 RRKGELLLVYDYMPNGSL-DKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLH 461
KG LV + G L D+I+ +R + RII+ V G+ Y+H + ++H
Sbjct: 96 EDKGYFYLVGEVYTGGELFDEII---SRKRFSEVDAARIIRQVLSGITYMH---KNKIVH 149
Query: 462 RDIKPANVLLDADLEG---KLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTT 518
RD+KP N+LL++ + ++ DFGL+ ++ + +GT Y+APE+L G
Sbjct: 150 RDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD--KIGTAYYIAPEVLH-GTYDE 206
Query: 519 STDVYAFGVFMLEVACGRRP------------VQPGELDLLDWVIDYWQKGDVLDASDPR 566
DV++ GV + + G P V+ G+ W+K S+
Sbjct: 207 KCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFEL---PQWKK-----VSE-- 256
Query: 567 LEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQV-----VQYLDGGALLPDIPLNSSVF 620
+++ K+ L P R S R +Q + D+P +
Sbjct: 257 -------SAKDLIRKM-L---TYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAI 304
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 65/231 (28%), Positives = 102/231 (44%), Gaps = 30/231 (12%)
Query: 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKV-CHDSDHGMKQFVS----EIVSMGKLR 391
Y+ + + G G VY+ P S +A+K V + G E+ + +L
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 392 ---HRNLVQLR-----GYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKG 443
H N+V+L R+ ++ LV++++ L L P L IK
Sbjct: 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAET----IKD 124
Query: 444 VAF----GLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNV 499
+ GL +LH ++HRD+KP N+L+ + KL DFGLAR+Y + T V
Sbjct: 125 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALTPV 179
Query: 500 VGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPG--ELDLLD 548
V T+ Y APE+L T D+++ G E+ R+P+ G E D L
Sbjct: 180 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQLG 229
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 44/195 (22%), Positives = 85/195 (43%), Gaps = 23/195 (11%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVK-----KVCHDSDHGMKQFV-SEIVSMGKLRHRNLVQLR 399
G V + S+ E A K + ++ + E+ + ++ H N++ L
Sbjct: 22 SGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLH 81
Query: 400 GYCRRKGELLLVYDYMPNGSL-DKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQV 458
+ +++L+ + + G L D + + SL+ + IK + G+ YLH +
Sbjct: 82 DVYENRTDVVLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLH---TKK 135
Query: 459 VLHRDIKPANVLL------DADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLR 512
+ H D+KP N++L + KL DFGLA + G + + GT ++APE++
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHI--KLIDFGLAHEIEDGVEFKN--IFGTPEFVAPEIVN 191
Query: 513 NGRGTTSTDVYAFGV 527
D+++ GV
Sbjct: 192 YEPLGLEADMWSIGV 206
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-25
Identities = 68/288 (23%), Positives = 125/288 (43%), Gaps = 32/288 (11%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKV--CHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCR 403
G G+V +H E A+K + S + + E+ + L H N+++L +
Sbjct: 47 SGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE 106
Query: 404 RKGELLLVYDYMPNGSL-DKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHR 462
K LV + G L D+I+ R N IIK V G+ YLH+ ++HR
Sbjct: 107 DKRNYYLVMECYKGGELFDEII---HRMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHR 160
Query: 463 DIKPANVLLDADLEG---KLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTS 519
D+KP N+LL++ + K+ DFGL+ ++++ + +GT Y+APE+LR +
Sbjct: 161 DLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKE--RLGTAYYIAPEVLR-KKYDEK 217
Query: 520 TDVYAFGVFMLEVACGRRPVQ-PGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEI 578
DV++ GV + + G P + ++L V +KG P + + E ++
Sbjct: 218 CDVWSIGVILFILLAGYPPFGGQTDQEILRKV----EKGK-YTFDSPEWKNV-SEGAKDL 271
Query: 579 VLKLGLFCSHSNPDTRPSMRQV------VQYLDGGALLPDIPLNSSVF 620
+ ++ L + R S +Q + ++P ++
Sbjct: 272 IKQM-L---QFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAI 315
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 57/217 (26%), Positives = 89/217 (41%), Gaps = 39/217 (17%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVK---------KVCHDSDHGMKQFVSEIVSMGKL-RHRNL 395
+G S V R + + E AVK + + + E+ + K+ H N+
Sbjct: 27 RGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 86
Query: 396 VQLRGYCRRKGELLLVYDYMPNGSL-DKIL----YSNTRPSLNWFQRFRIIKGVAFGLLY 450
+QL+ LV+D M G L D + S +I++ + +
Sbjct: 87 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR-------KIMRALLEVICA 139
Query: 451 LHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPEL 510
LH+ ++HRD+KP N+LLD D+ KL DFG + D G L V GT YLAPE+
Sbjct: 140 LHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE--VCGTPSYLAPEI 194
Query: 511 LRNGRGTTST------DVYAFGV---FMLEVACGRRP 538
+ D+++ GV +L G P
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLL---AGSPP 228
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 44/195 (22%), Positives = 85/195 (43%), Gaps = 23/195 (11%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVK-----KVCHDSDHGMKQFV-SEIVSMGKLRHRNLVQLR 399
G V + S+ E A K + ++ + E+ + ++ H N++ L
Sbjct: 22 SGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLH 81
Query: 400 GYCRRKGELLLVYDYMPNGSL-DKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQV 458
+ +++L+ + + G L D + + SL+ + IK + G+ YLH +
Sbjct: 82 DVYENRTDVVLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLH---TKK 135
Query: 459 VLHRDIKPANVLL------DADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLR 512
+ H D+KP N++L + KL DFGLA + G + + GT ++APE++
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHI--KLIDFGLAHEIEDGVEFKN--IFGTPEFVAPEIVN 191
Query: 513 NGRGTTSTDVYAFGV 527
D+++ GV
Sbjct: 192 YEPLGLEADMWSIGV 206
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-25
Identities = 41/199 (20%), Positives = 80/199 (40%), Gaps = 21/199 (10%)
Query: 347 GGSGKVYRGV-LPSSHAEIAVKKVCHDSDHG-MKQFVSEIVSMGKLRHRNLVQLRGY--- 401
GG G +Y + + + +K + H D ++E + ++ H ++VQ+ +
Sbjct: 91 GGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEH 150
Query: 402 --CRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVV 459
+V +Y+ SL + L + + + L YLH +
Sbjct: 151 TDRHGDPVGYIVMEYVGGQSLKRSK----GQKLPVAEAIAYLLEILPALSYLHS---IGL 203
Query: 460 LHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTS 519
++ D+KP N++L + + KL D G + + GT G+ APE++R T +
Sbjct: 204 VYNDLKPENIMLTEE-QLKLIDLGAVSRIN-----SFGYLYGTPGFQAPEIVR-TGPTVA 256
Query: 520 TDVYAFGVFMLEVACGRRP 538
TD+Y G + +
Sbjct: 257 TDIYTVGRTLAALTLDLPT 275
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 51/207 (24%), Positives = 85/207 (41%), Gaps = 28/207 (13%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFV-SEIVSMGKLRHRNLVQLRGYCRR 404
G G V+ SS E +K + D + + +EI + L H N++++
Sbjct: 32 SGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED 91
Query: 405 KGELLLVYDYMPNGSL-DKILYSNTRPSLNWFQRF------RIIKGVAFGLLYLHEEWEQ 457
+ +V + G L ++I+ + R ++K + L Y H Q
Sbjct: 92 YHNMYIVMETCEGGELLERIVSAQARGK-----ALSEGYVAELMKQMMNALAYFHS---Q 143
Query: 458 VVLHRDIKPANVLL---DADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNG 514
V+H+D+KP N+L K+ DFGLA L+ GT Y+APE+ +
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN--AAGTALYMAPEVFK-R 200
Query: 515 RGTTSTDVYAFGV---FMLEVACGRRP 538
T D+++ GV F+L G P
Sbjct: 201 DVTFKCDIWSAGVVMYFLL---TGCLP 224
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 16/202 (7%)
Query: 347 GGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVS----EIVSMGKLRHRNLVQLRGYC 402
GG +V+ H ++AVK V F E + L H +V +
Sbjct: 23 GGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG 81
Query: 403 RRKGELL----LVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQV 458
+ +V +Y+ +L I+++ + + +I L + H+
Sbjct: 82 EAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQ---NG 136
Query: 459 VLHRDIKPANVLLDADLEGKLGDFGLAR-LYDHGNDL-HTTNVVGTVGYLAPELLRNGRG 516
++HRD+KPAN+++ A K+ DFG+AR + D GN + T V+GT YL+PE R
Sbjct: 137 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSV 196
Query: 517 TTSTDVYAFGVFMLEVACGRRP 538
+DVY+ G + EV G P
Sbjct: 197 DARSDVYSLGCVLYEVLTGEPP 218
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 57/218 (26%), Positives = 92/218 (42%), Gaps = 42/218 (19%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVK--------KVCHDSDHGMKQFVSEIVSMGKLR-HRNLV 396
+G S V R V ++ E AVK + + E + ++ H +++
Sbjct: 104 RGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHII 163
Query: 397 QLRGYCRRKGELLLVYDYMPNGSL-DKIL----YS--NTRPSLNWFQRFRIIKGVAFGLL 449
L + LV+D M G L D + S TR I++ + +
Sbjct: 164 TLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETR---------SIMRSLLEAVS 214
Query: 450 YLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPE 509
+LH ++HRD+KP N+LLD +++ +L DFG + + G L + GT GYLAPE
Sbjct: 215 FLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE--LCGTPGYLAPE 269
Query: 510 LLRNGRGTTST------DVYAFGV---FMLEVACGRRP 538
+L+ T D++A GV +L G P
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGVILFTLL---AGSPP 304
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 49/239 (20%), Positives = 98/239 (41%), Gaps = 44/239 (18%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVK-----KVCHDSDHGMKQFV-SEIVSMGKLRHRNLVQLR 399
G V + + E A K ++ ++ + E+ + ++RH N++ L
Sbjct: 15 SGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLH 74
Query: 400 GYCRRKGELLLVYDYMPNGSL-DKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQV 458
K +++L+ + + G L D + + SL + + +K + G+ YLH +
Sbjct: 75 DIFENKTDVVLILELVSGGELFDFLA---EKESLTEDEATQFLKQILDGVHYLHS---KR 128
Query: 459 VLHRDIKPANVLL------DADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLR 512
+ H D+KP N++L + + KL DFG+A + GN+ + GT ++APE++
Sbjct: 129 IAHFDLKPENIMLLDKNVPNPRI--KLIDFGIAHKIEAGNEFKN--IFGTPEFVAPEIVN 184
Query: 513 NGRGTTSTDVYAFGV---FMLEVACGRRP------------VQPGELDLLDWVIDYWQK 556
D+++ GV +L G P + D + +Y+
Sbjct: 185 YEPLGLEADMWSIGVITYILL---SGASPFLGETKQETLTNISAVNYDFDE---EYFSN 237
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-25
Identities = 60/208 (28%), Positives = 89/208 (42%), Gaps = 32/208 (15%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVK----KVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGY 401
KG V R V ++ E A K K D E KL+H N+V+L
Sbjct: 39 KGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK--LEREARICRKLQHPNIVRLHDS 96
Query: 402 CRRKGELLLVYDYMPNGSL-DKIL----YSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWE 456
+ + LV+D + G L + I+ YS S I+ + + Y H
Sbjct: 97 IQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQILESIAYCH---S 146
Query: 457 QVVLHRDIKPANVLLDADLEG---KLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRN 513
++HR++KP N+LL + +G KL DFGLA + H GT GYL+PE+L+
Sbjct: 147 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG--FAGTPGYLSPEVLKK 204
Query: 514 GRGTTSTDVYAFGV---FMLEVACGRRP 538
+ D++A GV +L G P
Sbjct: 205 DPYSKPVDIWACGVILYILL---VGYPP 229
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-25
Identities = 52/187 (27%), Positives = 92/187 (49%), Gaps = 14/187 (7%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK 405
G G+V++ ++ ++A K + ++ +EI M +L H NL+QL K
Sbjct: 99 GGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESK 158
Query: 406 GELLLVYDYMPNGSL-DKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDI 464
+++LV +Y+ G L D+I+ + +L +K + G+ ++H + +LH D+
Sbjct: 159 NDIVLVMEYVDGGELFDRIIDESY--NLTELDTILFMKQICEGIRHMH---QMYILHLDL 213
Query: 465 KPANVLL----DADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTST 520
KP N+L + K+ DFGLAR Y L GT +LAPE++ + T
Sbjct: 214 KPENILCVNRDAKQI--KIIDFGLARRYKPREKLKV--NFGTPEFLAPEVVNYDFVSFPT 269
Query: 521 DVYAFGV 527
D+++ GV
Sbjct: 270 DMWSVGV 276
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 9e-25
Identities = 57/197 (28%), Positives = 87/197 (44%), Gaps = 13/197 (6%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK 405
+G G+V V + A KK+ + +F EI M L H N+++L
Sbjct: 19 RGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDN 78
Query: 406 GELLLVYDYMPNGSL-DKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDI 464
++ LV + G L ++++ + RI+K V + Y H + V HRD+
Sbjct: 79 TDIYLVMELCTGGELFERVV---HKRVFRESDAARIMKDVLSAVAYCH---KLNVAHRDL 132
Query: 465 KPANVLL---DADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTD 521
KP N L D KL DFGLA + G + T VGT Y++P++L G D
Sbjct: 133 KPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT--KVGTPYYVSPQVLEGLYG-PECD 189
Query: 522 VYAFGVFMLEVACGRRP 538
++ GV M + CG P
Sbjct: 190 EWSAGVMMYVLLCGYPP 206
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 53/243 (21%), Positives = 88/243 (36%), Gaps = 53/243 (21%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVK-----KVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRG 400
+G G V + + A A+K K+ + +++ +E+ M KL H N+ +L
Sbjct: 36 QGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYE 95
Query: 401 YCRRKGELLLVYDYMPNGSL-DKILYSNTRPSLNWFQRF--------------------- 438
+ + LV + G L DK+ +
Sbjct: 96 VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIH 155
Query: 439 ----------------RIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEG--KLG 480
I++ + L YLH Q + HRDIKP N L + KL
Sbjct: 156 GFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLV 212
Query: 481 DFGLARLY---DHGNDLHTTNVVGTVGYLAPELLRNGRG--TTSTDVYAFGVFMLEVACG 535
DFGL++ + ++G T GT ++APE+L D ++ GV + + G
Sbjct: 213 DFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMG 272
Query: 536 RRP 538
P
Sbjct: 273 AVP 275
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 68/223 (30%), Positives = 112/223 (50%), Gaps = 25/223 (11%)
Query: 337 SYKNLYKATKGGSGKVYRGVLPSSHAEI-AVKKVCHDS-DHGM-KQFVSEIVSMGKLRHR 393
Y+ L K +G G VY+ S I A+K++ D+ D G+ + EI + +L H
Sbjct: 22 KYQKLEKVGEGTYGVVYKAK--DSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHP 79
Query: 394 NLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAF----GLL 449
N+V L + L LV+++M L K+L N + IK + G+
Sbjct: 80 NIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQD-----SQIKIYLYQLLRGVA 133
Query: 450 YLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT-TNVVGTVGYLAP 508
+ H+ +LHRD+KP N+L+++D KL DFGLAR + G + + T+ V T+ Y AP
Sbjct: 134 HCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAF--GIPVRSYTHEVVTLWYRAP 188
Query: 509 ELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPG--ELDLLD 548
++L + +TS D+++ G E+ +P+ PG + D L
Sbjct: 189 DVLMGSKKYSTSVDIWSIGCIFAEMIT-GKPLFPGVTDDDQLP 230
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 49/211 (23%), Positives = 81/211 (38%), Gaps = 30/211 (14%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVK-----KVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRG 400
KG V R + + + AVK K + E L+H ++V+L
Sbjct: 34 KGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLE 93
Query: 401 YCRRKGELLLVYDYMPNGSL-DKILYSNTRPSLNWFQRF------RIIKGVAFGLLYLHE 453
G L +V+++M L +I+ + ++ + L Y H
Sbjct: 94 TYSSDGMLYMVFEFMDGADLCFEIVKRADAGF-----VYSEAVASHYMRQILEALRYCH- 147
Query: 454 EWEQVVLHRDIKPANVLLDADLEG---KLGDFGLARLYDHGNDLHTTNVVGTVGYLAPEL 510
+ ++HRD+KP VLL + KLG FG+A + VGT ++APE+
Sbjct: 148 --DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG-RVGTPHFMAPEV 204
Query: 511 LRNGRGTTSTDVYAFGV---FMLEVACGRRP 538
++ DV+ GV +L G P
Sbjct: 205 VKREPYGKPVDVWGCGVILFILL---SGCLP 232
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 37/204 (18%), Positives = 82/204 (40%), Gaps = 20/204 (9%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRR 404
G G + + + ++AVK++ + + E+ + + H N+++ +
Sbjct: 34 HGAEGTIVYRGMFDNR-DVAVKRILPECFSFADR---EVQLLRESDEHPNVIRYFCTEKD 89
Query: 405 KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDI 464
+ + + +L + + + + +++ GL +LH ++HRD+
Sbjct: 90 RQFQYIAIELCA-ATLQEYVEQK-DFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDL 144
Query: 465 KPANVLL-----DADLEGKLGDFGLARLYDHGNDL--HTTNVVGTVGYLAPELLR---NG 514
KP N+L+ ++ + DFGL + G + V GT G++APE+L
Sbjct: 145 KPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKE 204
Query: 515 RGTTSTDVYAFGVFMLEVACGRRP 538
T + D+++ G V
Sbjct: 205 NPTYTVDIFSAGCVFYYVISEGSH 228
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 68/211 (32%), Positives = 100/211 (47%), Gaps = 23/211 (10%)
Query: 350 GKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVS-----EIVSMGKLRHRNLVQLRGYCRR 404
VY+ +++ +A+KK+ K ++ EI + +L H N++ L
Sbjct: 24 ATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH 83
Query: 405 KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAF----GLLYLHEEWEQVVL 460
K + LV+D+M L+ I+ N+ IK GL YLH+ W +L
Sbjct: 84 KSNISLVFDFMET-DLEVIIKDNSLV----LTP-SHIKAYMLMTLQGLEYLHQHW---IL 134
Query: 461 HRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRG-TTS 519
HRD+KP N+LLD + KL DFGLA+ + N +T VV T Y APELL R
Sbjct: 135 HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TRWYRAPELLFGARMYGVG 193
Query: 520 TDVYAFGVFMLEVACGRRPVQPG--ELDLLD 548
D++A G + E+ R P PG +LD L
Sbjct: 194 VDMWAVGCILAEL-LLRVPFLPGDSDLDQLT 223
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 59/209 (28%), Positives = 90/209 (43%), Gaps = 33/209 (15%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVK-----KVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRG 400
KG V R V + E A K+ +++ E L+H N+V+L
Sbjct: 21 KGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLER---EARICRLLKHPNIVRLHD 77
Query: 401 YCRRKGELLLVYDYMPNGSL-DKIL----YSNTRPSLNWFQRFRIIKGVAFGLLYLHEEW 455
+G L++D + G L + I+ YS S I+ + +L+ H+
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS-------HCIQQILEAVLHCHQ-- 128
Query: 456 EQVVLHRDIKPANVLLDADLEG---KLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLR 512
V+HR++KP N+LL + L+G KL DFGLA + GT GYL+PE+LR
Sbjct: 129 -MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG-FAGTPGYLSPEVLR 186
Query: 513 NGRGTTSTDVYAFGV---FMLEVACGRRP 538
D++A GV +L G P
Sbjct: 187 KDPYGKPVDLWACGVILYILL---VGYPP 212
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-24
Identities = 38/238 (15%), Positives = 69/238 (28%), Gaps = 53/238 (22%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVK---KVCHDSDHGMKQFVSEIVSMGKLR----------- 391
+ + V + +KQ E++ + LR
Sbjct: 83 QEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 142
Query: 392 --------------HRNLVQLRGYCRRKGELLLVYDYM-PNGSLDKIL-----YSNTRPS 431
+ ++++R R L + Y +L +S+T S
Sbjct: 143 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS 202
Query: 432 LNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491
L R ++ V L LH ++H ++P +++LD L F
Sbjct: 203 LVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-- 257
Query: 492 NDLHTTNVVGTVGYLAPELL-----------RNGRGTTSTDVYAFGVFMLEVACGRRP 538
+ G+ PEL R T S D +A G+ + + C P
Sbjct: 258 ---ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-24
Identities = 72/288 (25%), Positives = 123/288 (42%), Gaps = 32/288 (11%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVC--HDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCR 403
KG G+V + + E AVK + + + E+ + KL H N+++L
Sbjct: 32 KGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE 91
Query: 404 RKGELLLVYDYMPNGSL-DKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHR 462
+V + G L D+I+ R + RIIK V G+ Y+H+ ++HR
Sbjct: 92 DSSSFYIVGELYTGGELFDEII---KRKRFSEHDAARIIKQVFSGITYMHK---HNIVHR 145
Query: 463 DIKPANVLLDADLEG---KLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTS 519
D+KP N+LL++ + K+ DFGL+ + + +GT Y+APE+LR G
Sbjct: 146 DLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYIAPEVLR-GTYDEK 202
Query: 520 TDVYAFGVFMLEVACGRRP-VQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEI 578
DV++ GV + + G P E D+L V + G P+ I ++ ++
Sbjct: 203 CDVWSAGVILYILLSGTPPFYGKNEYDILKRV----ETGK-YAFDLPQWRTI-SDDAKDL 256
Query: 579 VLKLGLFCSHSNPDTRPSMRQV------VQYLDGGALLPDIPLNSSVF 620
+ K+ L +P R + Q +Y + D+P S
Sbjct: 257 IRKM-L---TFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAM 300
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 17/213 (7%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKL-RHRNLV 396
++ + G G+VY+G + A+K + D ++ EI + K HRN+
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIA 84
Query: 397 QLRG------YCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLY 450
G +L LV ++ GS+ ++ + +L I + + GL +
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 144
Query: 451 LHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPEL 510
LH+ V+HRDIK NVLL + E KL DFG++ D T +GT ++APE+
Sbjct: 145 LHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEV 200
Query: 511 LRNGRGTTST-----DVYAFGVFMLEVACGRRP 538
+ +T D+++ G+ +E+A G P
Sbjct: 201 IACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 62/227 (27%), Positives = 112/227 (49%), Gaps = 28/227 (12%)
Query: 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-DHGM-KQFVSEIVSMGKLRHRN 394
Y+ + K +G G+VY+ + ++ +A+K++ + + G+ + E+ + +L+HRN
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRN 94
Query: 395 LVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAF----GLLY 450
+++L+ L L+++Y N L K + N S+ +IK + G+ +
Sbjct: 95 IIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMR------VIKSFLYQLINGVNF 147
Query: 451 LHEEWEQVVLHRDIKPANVLLDADLEG-----KLGDFGLARLYDHGNDLHT-TNVVGTVG 504
H LHRD+KP N+LL K+GDFGLAR + G + T+ + T+
Sbjct: 148 CHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF--GIPIRQFTHEIITLW 202
Query: 505 YLAPELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPG--ELDLLD 548
Y PE+L R +TS D+++ E+ + P+ PG E+D L
Sbjct: 203 YRPPEILLGSRHYSTSVDIWSIACIWAEMLM-KTPLFPGDSEIDQLF 248
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 47/209 (22%), Positives = 89/209 (42%), Gaps = 29/209 (13%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVK-----KVCHDSDHGMKQFV-SEIVSMGKLRHRNLVQLR 399
G V + S+ + A K + ++ + E+ + +++H N++ L
Sbjct: 21 SGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 80
Query: 400 GYCRRKGELLLVYDYMPNGSL-DKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQV 458
K +++L+ + + G L D + + SL + +K + G+ YLH
Sbjct: 81 EVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHS---LQ 134
Query: 459 VLHRDIKPANVLL------DADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLR 512
+ H D+KP N++L + K+ DFGLA D GN+ + GT ++APE++
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRI--KIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVN 190
Query: 513 NGRGTTSTDVYAFGV---FMLEVACGRRP 538
D+++ GV +L G P
Sbjct: 191 YEPLGLEADMWSIGVITYILL---SGASP 216
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 32/206 (15%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK 405
+G + VYR + A+K + D + + +EI + +L H N+++L+
Sbjct: 63 RGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR--TEIGVLLRLSHPNIIKLKEIFETP 120
Query: 406 GELLLVYDYMPNGSL-DKIL----YSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVL 460
E+ LV + + G L D+I+ YS + +K + + YLHE ++
Sbjct: 121 TEISLVLELVTGGELFDRIVEKGYYSERDAA-------DAVKQILEAVAYLHE---NGIV 170
Query: 461 HRDIKPANVLL-----DADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGR 515
HRD+KP N+L DA L K+ DFGL+++ +H + T V GT GY APE+LR
Sbjct: 171 HRDLKPENLLYATPAPDAPL--KIADFGLSKIVEHQVLMKT--VCGTPGYCAPEILRGCA 226
Query: 516 GTTSTDVYAFGV---FMLEVACGRRP 538
D+++ G+ +L CG P
Sbjct: 227 YGPEVDMWSVGIITYILL---CGFEP 249
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 46/207 (22%), Positives = 85/207 (41%), Gaps = 33/207 (15%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKV-CHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR 404
+G G V+R V SS K V +D EI + RHRN++ L
Sbjct: 15 RGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ--VLVKKEISILNIARHRNILHLHESFES 72
Query: 405 KGELLLVYDYMPNGSL-DKIL-----YSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQV 458
EL+++++++ + ++I + + V L +LH
Sbjct: 73 MEELVMIFEFISGLDIFERINTSAFELNEREIV-------SYVHQVCEALQFLH---SHN 122
Query: 459 VLHRDIKPANVLL----DADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNG 514
+ H DI+P N++ + + K+ +FG AR G++ + Y APE+ ++
Sbjct: 123 IGHFDIRPENIIYQTRRSSTI--KIIEFGQARQLKPGDNFRL--LFTAPEYYAPEVHQHD 178
Query: 515 RGTTSTDVYAFGV---FMLEVACGRRP 538
+T+TD+++ G +L G P
Sbjct: 179 VVSTATDMWSLGTLVYVLL---SGINP 202
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-24
Identities = 71/341 (20%), Positives = 129/341 (37%), Gaps = 76/341 (22%)
Query: 314 FVKKKKYEEVYEDWEKEYSPHRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKV---- 369
+V+KK+ + Y R K G G+V + H+E A+K +
Sbjct: 26 YVRKKE-----GKIGESYFKVR-------KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQ 73
Query: 370 ---------CHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSL 420
+ + ++ +EI + L H N+++L K LV ++ G L
Sbjct: 74 FDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL 133
Query: 421 -DKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLL---DADLE 476
++I+ R + I+K + G+ YLH+ ++HRDIKP N+LL ++ L
Sbjct: 134 FEQII---NRHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLN 187
Query: 477 GKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGR 536
K+ DFGL+ + L +GT Y+APE+L+ + DV++ GV M + CG
Sbjct: 188 IKIVDFGLSSFFSKDYKLRD--RLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGY 244
Query: 537 RP------------VQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGL 584
P V+ G+ + W+ +E E++ + L
Sbjct: 245 PPFGGQNDQDIIKKVEKGKYYFDF---NDWKNIS--------------DEAKELIKLM-L 286
Query: 585 FCSHSNPDTRPSMRQV-----VQYLDGGALLPDIPLNSSVF 620
+ + R + + ++ D
Sbjct: 287 ---TYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGAL 324
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 16/207 (7%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKV---CHDSDHGMKQFVSEIVSMGKLRHRN 394
+ +L + G G VY + +A+KK+ S+ + + E+ + KLRH N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 395 LVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEE 454
+Q RG R+ LV +Y + D L + L + + G GL YLH
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHGALQGLAYLHS- 172
Query: 455 WEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNG 514
++HRD+K N+LL KLGDFG A + VGT ++APE++
Sbjct: 173 --HNMIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANSFVGTPYWMAPEVILAM 225
Query: 515 RGTT---STDVYAFGVFMLEVACGRRP 538
DV++ G+ +E+A + P
Sbjct: 226 DEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 27/204 (13%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK 405
G +V+ + A+K + +EI + K++H N+V L
Sbjct: 19 SGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYEST 78
Query: 406 GELLLVYDYMPNGSL-DKIL----YSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVL 460
LV + G L D+IL Y+ S +I+ V + YLH E ++
Sbjct: 79 THYYLVMQLVSGGELFDRILERGVYTEKDAS-------LVIQQVLSAVKYLH---ENGIV 128
Query: 461 HRDIKPANVLL---DADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGT 517
HRD+KP N+L + + + + DFGL+++ +G + GT GY+APE+L +
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI---MSTACGTPGYVAPEVLAQKPYS 185
Query: 518 TSTDVYAFGV---FMLEVACGRRP 538
+ D ++ GV +L CG P
Sbjct: 186 KAVDCWSIGVITYILL---CGYPP 206
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 65/222 (29%), Positives = 109/222 (49%), Gaps = 25/222 (11%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEI-AVKKV-CHDSDHGM-KQFVSEIVSMGKLRHRN 394
Y L K +G G VY+ +++ E A+KK+ D G+ + EI + +L+H N
Sbjct: 4 YHGLEKIGEGTYGVVYKAQ--NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 395 LVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAF----GLLY 450
+V+L K L+LV++++ L K+L + K G+ Y
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLES-----VTAKSFLLQLLNGIAY 115
Query: 451 LHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT-TNVVGTVGYLAPE 509
H+ VLHRD+KP N+L++ + E K+ DFGLAR + G + T+ + T+ Y AP+
Sbjct: 116 CHDRR---VLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPD 170
Query: 510 LLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPG--ELDLLD 548
+L + +T+ D+++ G E+ P+ PG E D L
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVN-GTPLFPGVSEADQLM 211
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 6e-24
Identities = 74/244 (30%), Positives = 108/244 (44%), Gaps = 37/244 (15%)
Query: 318 KKYEEVYEDWEKEYSPHRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGM 377
K V + P SY + G G VY+ L S +A+KKV D
Sbjct: 36 KVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----- 90
Query: 378 KQFVS-EIVSMGKLRHRNLVQLRGYCRRKGE------LLLVYDYMPNGSLDKILYSNTRP 430
K+F + E+ M KL H N+V+LR + GE L LV DY+P ++ ++ +R
Sbjct: 91 KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRA 149
Query: 431 SLN---------WFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEG-KLG 480
+Q FR L Y+H + HRDIKP N+LLD D KL
Sbjct: 150 KQTLPVIYVKLYMYQLFR-------SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLC 199
Query: 481 DFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRG-TTSTDVYAFGVFMLEVACGRRPV 539
DFG A+ G + + + Y APEL+ T+S DV++ G + E+ +P+
Sbjct: 200 DFGSAKQLVRGEPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL-LLGQPI 256
Query: 540 QPGE 543
PG+
Sbjct: 257 FPGD 260
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 21/202 (10%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVK-----KVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRG 400
KG G+V + + E AVK + + + E+ + KL H N+++L
Sbjct: 32 KGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR---EVELLKKLDHPNIMKLFE 88
Query: 401 YCRRKGELLLVYDYMPNGSL-DKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVV 459
+V + G L D+I+ R + RIIK V G+ Y+H+ +
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEII---KRKRFSEHDAARIIKQVFSGITYMHK---HNI 142
Query: 460 LHRDIKPANVLLDADLEG---KLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRG 516
+HRD+KP N+LL++ + K+ DFGL+ + + +GT Y+APE+LR G
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYIAPEVLR-GTY 199
Query: 517 TTSTDVYAFGVFMLEVACGRRP 538
DV++ GV + + G P
Sbjct: 200 DEKCDVWSAGVILYILLSGTPP 221
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 7e-24
Identities = 57/205 (27%), Positives = 89/205 (43%), Gaps = 29/205 (14%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLR-HRNLVQLRGYCRR 404
+G + V S+ AVK + S EI ++ H N+V+L
Sbjct: 21 EGSFSICRKCVHKKSNQAFAVKII---SKRMEANTQKEITALKLCEGHPNIVKLHEVFHD 77
Query: 405 KGELLLVYDYMPNGSL-DKIL----YSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVV 459
+ LV + + G L ++I +S T S I++ + + ++H+ V
Sbjct: 78 QLHTFLVMELLNGGELFERIKKKKHFSETEAS-------YIMRKLVSAVSHMHD---VGV 127
Query: 460 LHRDIKPANVLL---DADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRG 516
+HRD+KP N+L + +LE K+ DFG ARL N T T+ Y APELL
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-PCFTLHYAAPELLNQNGY 186
Query: 517 TTSTDVYAFGV---FMLEVACGRRP 538
S D+++ GV ML G+ P
Sbjct: 187 DESCDLWSLGVILYTML---SGQVP 208
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 9e-24
Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 28/216 (12%)
Query: 350 GKVYRGVLPSSHAEI-AVKKV-CHDSDHGM-KQFVSEIVSMGKLR---HRNLVQLR---- 399
GKV++ + A+K+V + GM + E+ + L H N+V+L
Sbjct: 25 GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 84
Query: 400 -GYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAF----GLLYLHEE 454
R+ +L LV++++ L L P + IK + F GL +LH
Sbjct: 85 VSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTET----IKDMMFQLLRGLDFLHSH 139
Query: 455 WEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNG 514
V+HRD+KP N+L+ + + KL DFGLAR+Y + T+VV T+ Y APE+L
Sbjct: 140 R---VVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAPEVLLQS 194
Query: 515 RGTTSTDVYAFGVFMLEVACGRRPVQPG--ELDLLD 548
T D+++ G E+ R+P+ G ++D L
Sbjct: 195 SYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLG 229
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 9e-24
Identities = 70/304 (23%), Positives = 116/304 (38%), Gaps = 69/304 (22%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRR 404
G R + +++ E AVK + S + EI + + +H N++ L+
Sbjct: 32 VGSYSVCKRCIHKATNMEFAVKII-DKSKRDPTE---EIEILLRYGQHPNIITLKDVYDD 87
Query: 405 KGELLLVYDYMPNGSL-DKIL----YSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVV 459
+ +V + M G L DKIL +S S ++ + + YLH Q V
Sbjct: 88 GKYVYVVTELMKGGELLDKILRQKFFSEREAS-------AVLFTITKTVEYLHA---QGV 137
Query: 460 LHRDIKPANVLLDADLEG----KLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGR 515
+HRD+KP+N+L + ++ DFG A+ N L T T ++APE+L
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT-PCYTANFVAPEVLERQG 196
Query: 516 GTTSTDVYAFGV---FMLEVACGRRP---------------VQPGELDLLDWVIDYWQKG 557
+ D+++ GV ML G P + G+ L YW
Sbjct: 197 YDAACDIWSLGVLLYTML---TGYTPFANGPDDTPEEILARIGSGKFSLSG---GYWN-- 248
Query: 558 DVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY--LDGGALLPDIPL 615
SD ++V K+ L H +P R + V+++ + LP L
Sbjct: 249 ---SVSD---------TAKDLVSKM-L---HVDPHQRLTAALVLRHPWIVHWDQLPQYQL 292
Query: 616 NSSV 619
N
Sbjct: 293 NRQD 296
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 31/215 (14%)
Query: 350 GKVYRGV--LPSSHAEIAVKKVCHDSDHGMKQF-VSEIVSMGKLRHRNLVQLRGYCRRKG 406
G VY+ + A+K++ G+ EI + +L+H N++ L+
Sbjct: 35 GHVYKAKRKDGKDDKDYALKQIEGT---GISMSACREIALLRELKHPNVISLQKVFLSHA 91
Query: 407 E--LLLVYDYMPNGSLDKILYSNTRPSLNWFQRF---RIIKGVAF----GLLYLHEEWEQ 457
+ + L++DY + L I+ + N ++K + + G+ YLH W
Sbjct: 92 DRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW-- 148
Query: 458 VVLHRDIKPANVLLDADLEG----KLGDFGLARLYDHGNDL----HTTNVVGTVGYLAPE 509
VLHRD+KPAN+L+ + K+ D G ARL+ + L VV T Y APE
Sbjct: 149 -VLHRDLKPANILVMGEGPERGRVKIADMGFARLF--NSPLKPLADLDPVVVTFWYRAPE 205
Query: 510 LLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPGE 543
LL R T + D++A G E+ P+
Sbjct: 206 LLLGARHYTKAIDIWAIGCIFAEL-LTSEPIFHCR 239
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 51/209 (24%), Positives = 88/209 (42%), Gaps = 31/209 (14%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVK--KVCHDSDHGMKQFVSEIVSMGKLRHR-NLVQLRGYC 402
+G V + + S+ E A K K + + EI + + ++ L
Sbjct: 39 RGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98
Query: 403 RRKGELLLVYDYMPNGSL-DKILYSNTRPSLNWFQRF------RIIKGVAFGLLYLHEEW 455
E++L+ +Y G + L + R+IK + G+ YLH+
Sbjct: 99 ENTSEIILILEYAAGGEIFSLCLPEL-------AEMVSENDVIRLIKQILEGVYYLHQ-- 149
Query: 456 EQVVLHRDIKPANVLLDADLEG---KLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLR 512
++H D+KP N+LL + K+ DFG++R H +L ++GT YLAPE+L
Sbjct: 150 -NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE--IMGTPEYLAPEILN 206
Query: 513 NGRGTTSTDVYAFGV---FMLEVACGRRP 538
TT+TD++ G+ +L P
Sbjct: 207 YDPITTATDMWNIGIIAYMLL---THTSP 232
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 77/391 (19%), Positives = 139/391 (35%), Gaps = 74/391 (18%)
Query: 278 PLPPPPPTPGKKLNHTVIVSIVAAAVVLITIAAAVYFVKKKKYEEVYEDWEKEYSPHRFS 337
P PPP P + + +KK + Y+ +
Sbjct: 17 PAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLG----- 71
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKL-RHRNLV 396
G +GKV + + + A+K + D + E+ + + ++V
Sbjct: 72 --------LGINGKVLQIFNKRTQEKFALKML---QD--CPKARREVELHWRASQCPHIV 118
Query: 397 QLRGYC----RRKGELLLVYDYMPNGSL-DKIL------YSNTRPSLNWFQRFRIIKGVA 445
++ + LL+V + + G L +I ++ S I+K +
Sbjct: 119 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS-------EIMKSIG 171
Query: 446 FGLLYLHEEWEQVVLHRDIKPANVLL-----DADLEGKLGDFGLARLYDHGNDLHTTNVV 500
+ YLH + HRD+KP N+L +A L KL DFG A+ N L T
Sbjct: 172 EAIQYLHS---INIAHRDVKPENLLYTSKRPNAIL--KLTDFGFAKETTSHNSLTT--PC 224
Query: 501 GTVGYLAPELLRNGRGTTSTDVYAFGV---FMLEVACGRRP-----VQPGELDLLDWVID 552
T Y+APE+L + S D+++ GV +L CG P + +
Sbjct: 225 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL---CGYPPFYSNHGLAISPGMKTRI-- 279
Query: 553 YWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY--LDGGALL 610
+ G + +P + EE ++ L L + P R ++ + + + + +
Sbjct: 280 --RMGQ-YEFPNPEWSEV-SEEVKMLIRNL-L---KTEPTQRMTITEFMNHPWIMQSTKV 331
Query: 611 PDIPLNSSVFGVLTAKNEAPNNGMASFASLV 641
P PL++S VL E + S +
Sbjct: 332 PQTPLHTSR--VLKEDKERWEDVKEEMTSAL 360
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 62/228 (27%), Positives = 98/228 (42%), Gaps = 36/228 (15%)
Query: 333 PHRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRH 392
+Y N G G V++ L S E+A+KKV D + E+ M ++H
Sbjct: 37 QREIAYTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQDKRFKNR----ELQIMRIVKH 91
Query: 393 RNLVQLRGYCRRKGE------LLLVYDYMPNGSLDKILYSNTRPSLN---------WFQR 437
N+V L+ + G+ L LV +Y+P ++ + + +Q
Sbjct: 92 PNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQL 150
Query: 438 FRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEG-KLGDFGLARLYDHGNDLHT 496
R L Y+H + HRDIKP N+LLD KL DFG A++ G
Sbjct: 151 LR-------SLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN-- 198
Query: 497 TNVVGTVGYLAPELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPGE 543
+ + + Y APEL+ TT+ D+++ G M E+ +P+ PGE
Sbjct: 199 VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAEL-MQGQPLFPGE 245
|
| >1qmo_A Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 Length = 113 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 3e-23
Identities = 29/110 (26%), Positives = 44/110 (40%), Gaps = 10/110 (9%)
Query: 30 FIHHGFEGSK--LKLDGLAKIHPNGLLQLTNTSERI------SGHAFYPFPFKFNSSSSQ 81
F F+ ++ L G A N +LQ+T +G Y P + S+
Sbjct: 6 FSFTKFDPNQEDLIFQGHATST-NNVLQVTKLDSAGNPVSSSAGRVLYSAPLRLWEDSAV 64
Query: 82 SLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSN 131
SF T F + + G+AFFI+P D + G LG+F +N
Sbjct: 65 LTSFDTIINFEISTPYTSRIADGLAFFIAPP-DSVISYHGGFLGLFPNAN 113
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 69/220 (31%), Positives = 98/220 (44%), Gaps = 32/220 (14%)
Query: 350 GKVYRGVLPSSHAEIAVKKVCHDSDH-GMKQF-VSEIVSMGKLRHRNLVQLRG------- 400
G+V++ + ++A+KKV +++ G + EI + L+H N+V L
Sbjct: 31 GEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS 90
Query: 401 -YCRRKGELLLVYDYMPNGSLD-KILYSNTRPSLNWFQRFRIIKGVAF----GLLYLHEE 454
Y R KG + LV+D+ D L SN + IK V GL Y+H
Sbjct: 91 PYNRCKGSIYLVFDFC---EHDLAGLLSNVLVKFTLSE----IKRVMQMLLNGLYYIHRN 143
Query: 455 WEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT---TNVVGTVGYLAPELL 511
+LHRD+K ANVL+ D KL DFGLAR + + TN V T+ Y PELL
Sbjct: 144 K---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELL 200
Query: 512 RNGRG-TTSTDVYAFGVFMLEVACGRRPVQPG--ELDLLD 548
R D++ G M E+ R P+ G E L
Sbjct: 201 LGERDYGPPIDLWGAGCIMAEM-WTRSPIMQGNTEQHQLA 239
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 6e-23
Identities = 59/231 (25%), Positives = 94/231 (40%), Gaps = 52/231 (22%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVK-------------------------KVCHDSDHGMKQF 380
KG G V + + A+K G +
Sbjct: 23 KGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQ 82
Query: 381 VS-EIVSMGKLRHRNLVQLRGY----CRRKGELLLVYDYMPNGSLDKILYSNTRPS---- 431
V EI + KL H N+V+L + L +V++ + G + ++ + S
Sbjct: 83 VYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQA 139
Query: 432 LNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491
+FQ +IKG+ YLH Q ++HRDIKP+N+L+ D K+ DFG++ +
Sbjct: 140 RFYFQD--LIKGIE----YLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 492 ND-LHTTNVVGTVGYLAPELLRNGRGT---TSTDVYAFGVFMLEVACGRRP 538
+ L T VGT ++APE L R + DV+A GV + G+ P
Sbjct: 191 DALLSNT--VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 9e-23
Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 22/202 (10%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVK---KVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYC 402
KG KV + E+A+K K + +++ E+ M L H N+V+L
Sbjct: 25 KGNFAKVKLARHILTGREVAIKIIDKTQLNPT-SLQKLFREVRIMKILNHPNIVKLFEVI 83
Query: 403 RRKGELLLVYDYMPNGSL-DKILYS---NTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQV 458
+ L L+ +Y G + D ++ + + + F++ I+ V Y H+ +
Sbjct: 84 ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ--IVSAVQ----YCHQ---KR 134
Query: 459 VLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTT 518
++HRD+K N+LLDAD+ K+ DFG + + G L G Y APEL + G+
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF--CGAPPYAAPELFQ-GKKYD 191
Query: 519 --STDVYAFGVFMLEVACGRRP 538
DV++ GV + + G P
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLP 213
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 9e-23
Identities = 53/254 (20%), Positives = 101/254 (39%), Gaps = 47/254 (18%)
Query: 314 FVKKKKYEEVYEDWE-KEYSPHRFSYKNLYKATK----GGSGKVYRGVLPSSHAEIAVKK 368
+ V+ D + S + + ++ Y +K G G+V + ++A++
Sbjct: 108 LSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRI 167
Query: 369 V--------CHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSL 420
+ +EI + KL H +++++ + + + +V + M G L
Sbjct: 168 ISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGEL 226
Query: 421 -DKIL----YS--NTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDA 473
DK++ + + + YLHE ++HRD+KP NVLL +
Sbjct: 227 FDKVVGNKRLKEATCK---------LYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSS 274
Query: 474 DLEG---KLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRG---TTSTDVYAFGV 527
E K+ DFG +++ + + T + GT YLAPE+L + + D ++ GV
Sbjct: 275 QEEDCLIKITDFGHSKILGETSLMRT--LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 332
Query: 528 ---FMLEVACGRRP 538
L G P
Sbjct: 333 ILFICL---SGYPP 343
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 9e-23
Identities = 67/333 (20%), Positives = 133/333 (39%), Gaps = 55/333 (16%)
Query: 333 PHRFSYKNLYKATK-----GGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSM 387
P +++ + Y+ +K G +GKV + + A+K + +DS + E+
Sbjct: 21 PKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL-YDS----PKARQEVDHH 75
Query: 388 GKL-RHRNLVQLRGYC----RRKGELLLVYDYMPNGSL-DKIL------YSNTRPSLNWF 435
+ ++V + K LL++ + M G L +I ++ +
Sbjct: 76 WQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA---- 131
Query: 436 QRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLL---DADLEGKLGDFGLARLYDHGN 492
I++ + + +LH + HRD+KP N+L + D KL DFG A+
Sbjct: 132 ---EIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN- 184
Query: 493 DLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGV---FMLEVACGRRP-VQPGELDLLD 548
L T T Y+APE+L + S D+++ GV +L CG P +
Sbjct: 185 ALQT--PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL---CGFPPFYSNTGQAISP 239
Query: 549 WVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY--LDG 606
+ + G +P + E+ +++ L L ++P R ++ Q + + ++
Sbjct: 240 GMKRRIRLGQ-YGFPNPEWSEV-SEDAKQLIRLL-L---KTDPTERLTITQFMNHPWINQ 293
Query: 607 GALLPDIPLNSSVFGVLTAKNEAPNNGMASFAS 639
++P PL+++ VL + + S
Sbjct: 294 SMVVPQTPLHTAR--VLQEDKDHWDEVKEEMTS 324
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 21/202 (10%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVK---KVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYC 402
G GKV G + ++AVK + S + + EI ++ RH ++++L
Sbjct: 21 VGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI 80
Query: 403 RRKGELLLVYDYMPNGSL-DKILYS---NTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQV 458
+ +V +Y+ G L D I + FQ+ I+ V Y H +
Sbjct: 81 STPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQ--ILSAVD----YCHR---HM 131
Query: 459 VLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRG-- 516
V+HRD+KP NVLLDA + K+ DFGL+ + G L T+ G+ Y APE++ GR
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVIS-GRLYA 188
Query: 517 TTSTDVYAFGVFMLEVACGRRP 538
D+++ GV + + CG P
Sbjct: 189 GPEVDIWSCGVILYALLCGTLP 210
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 48/218 (22%), Positives = 88/218 (40%), Gaps = 40/218 (18%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLR-HRNLVQLRGYCRR 404
+G +V + + E AVK + H + E+ + + + HRN+++L +
Sbjct: 23 EGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE 82
Query: 405 KGELLLVYDYMPNGSL-DKIL----YSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVV 459
+ LV++ M GS+ I ++ S +++ VA L +LH + +
Sbjct: 83 EDRFYLVFEKMRGGSILSHIHKRRHFNELEAS-------VVVQDVASALDFLHN---KGI 132
Query: 460 LHRDIKPANVLL-----DADLEGKLGDFGLARLYDHGNDLHTTN------VVGTVGYLAP 508
HRD+KP N+L + + K+ DF L D + G+ Y+AP
Sbjct: 133 AHRDLKPENILCEHPNQVSPV--KICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190
Query: 509 ELLRNGRGTTST-----DVYAFGV---FMLEVACGRRP 538
E++ S D+++ GV +L G P
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVILYILL---SGYPP 225
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 62/229 (27%), Positives = 97/229 (42%), Gaps = 39/229 (17%)
Query: 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQF----VSEIVSMGKLRH 392
++ A +G G V G S+ +A+KKV D +F + + + L H
Sbjct: 24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-----PRFRNRELQIMQDLAVLHH 78
Query: 393 RNLVQLRGYCRRKGE-------LLLVYDYMPNGSLDKILYSNTRPSLN---------WFQ 436
N+VQL+ Y GE L +V +Y+P+ +L + + R + FQ
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQ 137
Query: 437 RFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLD-ADLEGKLGDFGLARLYDHGNDLH 495
R + LH V HRDIKP NVL++ AD KL DFG A+
Sbjct: 138 LIR-------SIGCLHLPSVNV-CHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN- 188
Query: 496 TTNVVGTVGYLAPELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPGE 543
+ + Y APEL+ + TT+ D+++ G E+ P+ G+
Sbjct: 189 -VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEM-MLGEPIFRGD 235
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 62/202 (30%), Positives = 92/202 (45%), Gaps = 20/202 (9%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVS-EIVSMGKLRHRNLVQLRGYCRR 404
+G G+V V + +AVK V + + EI L H N+V+ G+ R
Sbjct: 17 EGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE 76
Query: 405 KGELLLVYDYMPNGSL-DKILYSNTRPSLNWFQRF--RIIKGVAFGLLYLHEEWEQVVLH 461
L +Y G L D+I + QRF +++ GV YLH + H
Sbjct: 77 GNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVV----YLHG---IGITH 128
Query: 462 RDIKPANVLLDADLEGKLGDFGLARLYDHGND---LHTTNVVGTVGYLAPELLRNGRG-- 516
RDIKP N+LLD K+ DFGLA ++ + N L+ GT+ Y+APELL+ R
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--CGTLPYVAPELLK-RREFH 185
Query: 517 TTSTDVYAFGVFMLEVACGRRP 538
DV++ G+ + + G P
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELP 207
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 5e-22
Identities = 50/211 (23%), Positives = 87/211 (41%), Gaps = 33/211 (15%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVK--------KVCHDSDHGMKQFVSEIVSMGKLRHRNLVQ 397
G G V+ V + E+ VK + C D + + EI + ++ H N+++
Sbjct: 34 SGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIK 93
Query: 398 LRGYCRRKGELLLVYDYMPNGS--LDKILYSNTRPSLN------WFQRFRIIKGVAFGLL 449
+ +G LV + +G I P L+ F++ ++ V
Sbjct: 94 VLDIFENQGFFQLVMEKHGSGLDLFAFID---RHPRLDEPLASYIFRQ--LVSAVG---- 144
Query: 450 YLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPE 509
YL + ++HRDIK N+++ D KL DFG A + G +T GT+ Y APE
Sbjct: 145 YLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF--CGTIEYCAPE 199
Query: 510 LLRNGRGTT--STDVYAFGVFMLEVACGRRP 538
+L G ++++ GV + + P
Sbjct: 200 VLM-GNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 7e-22
Identities = 52/217 (23%), Positives = 91/217 (41%), Gaps = 42/217 (19%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVK-----KVCHDSDHGM---KQFVSEIVSMGKLRHRNLVQ 397
G G+V + ++A+K K S +EI + KL H +++
Sbjct: 20 SGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK 79
Query: 398 LRGYCRRKGELLLVYDYMPNGSL-DKILYSNTRPSLNWFQRF------RIIKGVAFGLLY 450
++ + + + +V + M G L DK++ + +R + + Y
Sbjct: 80 IKNFFDAE-DYYIVLELMEGGELFDKVVGN---------KRLKEATCKLYFYQMLLAVQY 129
Query: 451 LHEEWEQVVLHRDIKPANVLLDADLEG---KLGDFGLARLYDHGNDLHTTNVVGTVGYLA 507
LHE ++HRD+KP NVLL + E K+ DFG +++ + + T + GT YLA
Sbjct: 130 LHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--LCGTPTYLA 184
Query: 508 PELLRNGRG---TTSTDVYAFGV---FMLEVACGRRP 538
PE+L + + D ++ GV L G P
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICL---SGYPP 218
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 1e-21
Identities = 63/310 (20%), Positives = 115/310 (37%), Gaps = 70/310 (22%)
Query: 337 SYKNLYKATK----GGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKL-R 391
S KNL + K G SG V +AVK++ D EI + +
Sbjct: 12 SLKNLVVSEKILGYGSSGTVVFQGSFQGR-PVAVKRMLIDFCDIALM---EIKLLTESDD 67
Query: 392 HRNLVQLRGYCRRKGELLLVYDYMPNGSL-DKI----LYSNTRPSLNWFQRFRIIKGVAF 446
H N+++ L + + N +L D + + + +++ +A
Sbjct: 68 HPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 447 GLLYLHEEWEQVVLHRDIKPANVLLD-------------ADLEGKLGDFGLARLYDHGND 493
G+ +LH ++HRD+KP N+L+ +L + DFGL + D G
Sbjct: 127 GVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183
Query: 494 LHTTN---VVGTVGYLAPELLRNGRG-------TTSTDVYAFGVFMLEVAC-GRRP---- 538
TN GT G+ APELL T S D+++ G + G+ P
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243
Query: 539 ------VQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPD 592
+ G L + + + + +A+D ++ ++ + +P
Sbjct: 244 YSRESNIIRGIFSLDEMKCLHD-RSLIAEATD-------------LISQM-I---DHDPL 285
Query: 593 TRPSMRQVVQ 602
RP+ +V++
Sbjct: 286 KRPTAMKVLR 295
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 51/210 (24%), Positives = 86/210 (40%), Gaps = 29/210 (13%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVK-----KVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRG 400
+G GKV + + AVK K+ + G EI + +LRH+N++QL
Sbjct: 15 EGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPN-GEANVKKEIQLLRRLRHKNVIQLVD 73
Query: 401 --YCRRKGELLLVYDYMPNGS---LDKILYS--NTRPSLNWFQRFRIIKGVAFGLLYLHE 453
Y K ++ +V +Y G LD + + +F + +I G+ YLH
Sbjct: 74 VLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQ--LIDGLE----YLHS 127
Query: 454 EWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND---LHTTNVVGTVGYLAPEL 510
Q ++H+DIKP N+LL K+ G+A T+ G+ + PE+
Sbjct: 128 ---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS--QGSPAFQPPEI 182
Query: 511 LRNGRG--TTSTDVYAFGVFMLEVACGRRP 538
D+++ GV + + G P
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 62/202 (30%), Positives = 92/202 (45%), Gaps = 20/202 (9%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVS-EIVSMGKLRHRNLVQLRGYCRR 404
+G G+V V + +AVK V + + EI L H N+V+ G+ R
Sbjct: 17 EGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE 76
Query: 405 KGELLLVYDYMPNGSL-DKILYSNTRPSLNWFQRF--RIIKGVAFGLLYLHEEWEQVVLH 461
L +Y G L D+I + QRF +++ GV YLH + H
Sbjct: 77 GNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVV----YLHG---IGITH 128
Query: 462 RDIKPANVLLDADLEGKLGDFGLARLYDHGND---LHTTNVVGTVGYLAPELLRNGRG-- 516
RDIKP N+LLD K+ DFGLA ++ + N L+ GT+ Y+APELL+ R
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--CGTLPYVAPELLK-RREFH 185
Query: 517 TTSTDVYAFGVFMLEVACGRRP 538
DV++ G+ + + G P
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELP 207
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 95.0 bits (236), Expect = 3e-21
Identities = 33/271 (12%), Positives = 72/271 (26%), Gaps = 36/271 (13%)
Query: 313 YFVKKKKYEEVYEDWEKEYSPHRFSYKNLYKATKGGSGKVYRGVLPSSHA-----EIAVK 367
F + K + E + +L +G +VY + + +K
Sbjct: 44 TFEWQCKLPAIKPKTEFQLGSKLVYVHHLL--GEGAFAQVYEATQGDLNDAKNKQKFVLK 101
Query: 368 KVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSN 427
+ + + ++ + +LV + G+L +
Sbjct: 102 VQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLY 161
Query: 428 TRPSLNWF---QRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLL-----------DA 473
+ + + +H+ ++H DIKP N +L D
Sbjct: 162 KNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDL 218
Query: 474 DLEGKLGDFGLA---RLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFML 530
L D G + +L+ G T G+ E+L N D + +
Sbjct: 219 SAGLALIDLGQSIDMKLFPKGTIFTA--KCETSGFQCVEMLSNKPWNYQIDYFGVAATVY 276
Query: 531 EVACGRRPVQPGELDLLDWVID-----YWQK 556
+ G + + + +
Sbjct: 277 CMLFGTYM--KVKNEGGECKPEGLFRRLPHL 305
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 4e-21
Identities = 53/228 (23%), Positives = 98/228 (42%), Gaps = 27/228 (11%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGM--KQFVSEIVSMGKLRHRNL 395
Y+NL G G V +A+KK+ + K+ E+V M + H+N+
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 396 VQLR------GYCRRKGELLLVYDYMPNGSLDKILYSN-TRPSLNWF--QRFRIIKGVAF 446
+ L ++ +V + M +L +++ +++ Q
Sbjct: 87 IGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLC------- 138
Query: 447 GLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYL 506
G+ +LH ++HRD+KP+N+++ +D K+ DFGLAR + T V T Y
Sbjct: 139 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRYYR 193
Query: 507 APELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGE--LDLLDWVID 552
APE++ + D+++ G M E+ + PG +D + VI+
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIE 240
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 25/203 (12%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVS-EIVSMGKLRHRNLVQLRGYCRR 404
G G + +AVK + + + + V EI++ LRH N+V+ +
Sbjct: 30 SGNFGVARLMRDKLTKELVAVKYI--ERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87
Query: 405 KGELLLVYDYMPNGSL-DKILYSNTRPS----LNWFQRFRIIKGVAFGLLYLHEEWEQVV 459
L ++ +Y G L ++I + R S +FQ+ ++ GV+ Y H +
Sbjct: 88 PTHLAIIMEYASGGELYERIC-NAGRFSEDEARFFFQQ--LLSGVS----YCHS---MQI 137
Query: 460 LHRDIKPANVLLDADLEG--KLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRG- 516
HRD+K N LLD K+ DFG ++ + +T VGT Y+APE+L +
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLL-RQEY 194
Query: 517 -TTSTDVYAFGVFMLEVACGRRP 538
DV++ GV + + G P
Sbjct: 195 DGKIADVWSCGVTLYVMLVGAYP 217
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 6e-21
Identities = 53/225 (23%), Positives = 99/225 (44%), Gaps = 21/225 (9%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGM--KQFVSEIVSMGKLRHRNL 395
Y+NL G G V +A+KK+ + K+ E+V M + H+N+
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 396 VQLR------GYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLL 449
+ L ++ LV + M +L +++ + ++++ G +
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCG----IK 178
Query: 450 YLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPE 509
+LH ++HRD+KP+N+++ +D K+ DFGLAR T V T Y APE
Sbjct: 179 HLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPE 233
Query: 510 LLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGE--LDLLDWVID 552
++ + D+++ G M E+ + + PG +D + VI+
Sbjct: 234 VILGMGYKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIE 277
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 1e-20
Identities = 61/202 (30%), Positives = 99/202 (49%), Gaps = 21/202 (10%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVK---KVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYC 402
G GKV G + ++AVK + S + + EI ++ RH ++++L
Sbjct: 26 VGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI 85
Query: 403 RRKGELLLVYDYMPNGSL-DKILYS---NTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQV 458
++ +V +Y+ G L D I + + + S FQ+ I+ GV Y H +
Sbjct: 86 STPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQ--ILSGVD----YCHR---HM 136
Query: 459 VLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRG-- 516
V+HRD+KP NVLLDA + K+ DFGL+ + G L T+ G+ Y APE++ GR
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVIS-GRLYA 193
Query: 517 TTSTDVYAFGVFMLEVACGRRP 538
D+++ GV + + CG P
Sbjct: 194 GPEVDIWSSGVILYALLCGTLP 215
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-20
Identities = 57/229 (24%), Positives = 99/229 (43%), Gaps = 30/229 (13%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGM--KQFVSEIVSMGKLRHRNL 395
Y + G G V + S ++A+KK+ + K+ E++ + ++H N+
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV 85
Query: 396 VQLR------GYCRRKGELLLVYDYMPNGSLDKILYSN-TRPSLNWF--QRFRIIKGVAF 446
+ L R + LV +M L KI+ + + + Q +
Sbjct: 86 IGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQMLK------- 137
Query: 447 GLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYL 506
GL Y+H V+HRD+KP N+ ++ D E K+ DFGLAR D T V T Y
Sbjct: 138 GLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADA----EMTGYVVTRWYR 190
Query: 507 APELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPGE--LDLLDWVID 552
APE++ + + D+++ G M E+ + + G+ LD L ++
Sbjct: 191 APEVILSWMHYNQTVDIWSVGCIMAEML-TGKTLFKGKDYLDQLTQILK 238
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 2e-20
Identities = 60/198 (30%), Positives = 90/198 (45%), Gaps = 12/198 (6%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYC 402
KGG G+V + ++ A KK+ G ++E + K+ R +V L Y
Sbjct: 194 KGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA-YA 252
Query: 403 -RRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRI-IKGVAFGLLYLHEEWEQVVL 460
K L LV M G L +Y + R + GL LH + ++
Sbjct: 253 YETKDALCLVLTLMNGGDLKFHIYHMGQAGFP-EARAVFYAAEICCGLEDLHR---ERIV 308
Query: 461 HRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTST 520
+RD+KP N+LLD ++ D GLA G + VGTVGY+APE+++N R T S
Sbjct: 309 YRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG--RVGTVGYMAPEVVKNERYTFSP 366
Query: 521 DVYAFGVFMLEVACGRRP 538
D +A G + E+ G+ P
Sbjct: 367 DWWALGCLLYEMIAGQSP 384
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 64/218 (29%), Positives = 105/218 (48%), Gaps = 25/218 (11%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKV-CHDSDHGMKQFVSEIVSMGKLRHRNLV 396
Y NL +G G V + +A+KK+ + ++ + EI + + RH N++
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 397 QLR-----GYCRRKGELLLVYDYMPNGSLDKILYSN--TRPSLNWF--QRFRIIKGVAFG 447
+ + ++ +V D M L K+L + + + +F Q R G
Sbjct: 89 GINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILR-------G 140
Query: 448 LLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYD--HGNDLHTTNVVGTVGY 505
L Y+H VLHRD+KP+N+LL+ + K+ DFGLAR+ D H + T V T Y
Sbjct: 141 LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 506 LAPELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPG 542
APE++ N +G T S D+++ G + E+ RP+ PG
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPG 234
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 22/202 (10%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVK---KVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYC 402
+G GKV + ++A+K + + EI + LRH ++++L
Sbjct: 19 EGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI 78
Query: 403 RRKGELLLVYDYMPNGSL-DKILYS---NTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQV 458
++++V +Y G L D I+ +FQ+ II + Y H
Sbjct: 79 TTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQ--IICAIE----YCHR---HK 128
Query: 459 VLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRG-- 516
++HRD+KP N+LLD +L K+ DFGL+ + GN L T+ G+ Y APE++ G+
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVIN-GKLYA 185
Query: 517 TTSTDVYAFGVFMLEVACGRRP 538
DV++ G+ + + GR P
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLP 207
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-20
Identities = 59/230 (25%), Positives = 97/230 (42%), Gaps = 31/230 (13%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGM--KQFVSEIVSMGKLRHRNL 395
Y+NL G G V + +AVKK+ + K+ E+ + ++H N+
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 90
Query: 396 VQLR------GYCRRKGELLLVYDYMPNGSLDKILYSN--TRPSLNWF--QRFRIIKGVA 445
+ L ++ LV M L+ I+ T + + Q R
Sbjct: 91 IGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILR------ 143
Query: 446 FGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGY 505
GL Y+H ++HRD+KP+N+ ++ D E K+ DFGLAR T V T Y
Sbjct: 144 -GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTGYVATRWY 195
Query: 506 LAPELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPGE--LDLLDWVID 552
APE++ N + D+++ G M E+ R + PG +D L ++
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILR 244
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 4e-20
Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 21/203 (10%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVC-------HDSDHGM--KQFVSEIVSMGKLRHRNLV 396
+GG G+VY + A+K + + + +S + + +V
Sbjct: 199 RGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG---DCPFIV 255
Query: 397 QLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWE 456
+ +L + D M G L L + S RF + + GL ++H
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAD-MRFYAAE-IILGLEHMHN--- 310
Query: 457 QVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRG 516
+ V++RD+KPAN+LLD ++ D GLA + VGT GY+APE+L+ G
Sbjct: 311 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGVA 367
Query: 517 -TTSTDVYAFGVFMLEVACGRRP 538
+S D ++ G + ++ G P
Sbjct: 368 YDSSADWFSLGCMLFKLLRGHSP 390
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-20
Identities = 63/239 (26%), Positives = 104/239 (43%), Gaps = 36/239 (15%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQ 397
Y +L GG+G V+ V +A+KK+ +K + EI + +L H N+V+
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 398 LR--------------GYCRRKGELLLVYDYMPNGSLDKILYSN--TRPSLNWF--QRFR 439
+ G + +V +YM L +L F Q R
Sbjct: 73 VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARLFMYQLLR 131
Query: 440 IIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDA-DLEGKLGDFGLARLYD--HGNDLHT 496
GL Y+H VLHRD+KPAN+ ++ DL K+GDFGLAR+ D + + H
Sbjct: 132 -------GLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL 181
Query: 497 TNVVGTVGYLAPELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPGE--LDLLDWVID 552
+ + T Y +P LL + T + D++A G E+ + + G L+ + +++
Sbjct: 182 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML-TGKTLFAGAHELEQMQLILE 239
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 5e-20
Identities = 59/230 (25%), Positives = 99/230 (43%), Gaps = 31/230 (13%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGM--KQFVSEIVSMGKLRHRNL 395
Y++L G G V V + A++A+KK+ + K+ E+ + +RH N+
Sbjct: 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86
Query: 396 VQLR------GYCRRKGELLLVYDYMPNGSLDKILYSN--TRPSLNWF--QRFRIIKGVA 445
+ L + LV +M L K++ + + Q +
Sbjct: 87 IGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFLVYQMLK------ 139
Query: 446 FGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGY 505
GL Y+H ++HRD+KP N+ ++ D E K+ DFGLAR D T V T Y
Sbjct: 140 -GLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADS----EMTGYVVTRWY 191
Query: 506 LAPELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPGE--LDLLDWVID 552
APE++ N T + D+++ G M E+ + + G LD L ++
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMI-TGKTLFKGSDHLDQLKEIMK 240
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 8e-20
Identities = 48/212 (22%), Positives = 82/212 (38%), Gaps = 33/212 (15%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVK-----KVCHDSDHGMKQFV-SEIVSMGKLR----HRNL 395
KGG G V+ G + ++A+K +V S E+ + K+ H +
Sbjct: 41 KGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGV 100
Query: 396 VQLRGYCRRKGELLLVYDYMPNGS--LDKILYSNTR----PSLNWFQRFRIIKGVAFGLL 449
++L + + +LV + D I PS +F + ++ +
Sbjct: 101 IRLLDWFETQEGFMLVLERPLPAQDLFDYIT-EKGPLGEGPSRCFFGQ--VVAAIQ---- 153
Query: 450 YLHEEWEQVVLHRDIKPANVLLDAD-LEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAP 508
+ H + V+HRDIK N+L+D KL DFG L H GT Y P
Sbjct: 154 HCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALL-HDEPYTDF--DGTRVYSPP 207
Query: 509 ELLRNGR--GTTSTDVYAFGVFMLEVACGRRP 538
E + + V++ G+ + ++ CG P
Sbjct: 208 EWISRHQYHA-LPATVWSLGILLYDMVCGDIP 238
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 8e-20
Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 19/203 (9%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYC 402
+GG G+V+ + ++ A KK+ G + + E + K+ R +V L Y
Sbjct: 195 RGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA-YA 253
Query: 403 -RRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKG------VAFGLLYLHEEW 455
K +L LV M G + +Y+ + F+ + + GL +LH+
Sbjct: 254 FETKTDLCLVMTIMNGGDIRYHIYNVDEDN----PGFQEPRAIFYTAQIVSGLEHLHQ-- 307
Query: 456 EQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGR 515
+ +++RD+KP NVLLD D ++ D GLA G T GT G++APELL
Sbjct: 308 -RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGEE 365
Query: 516 GTTSTDVYAFGVFMLEVACGRRP 538
S D +A GV + E+ R P
Sbjct: 366 YDFSVDYFALGVTLYEMIAARGP 388
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 44/159 (27%), Positives = 70/159 (44%), Gaps = 18/159 (11%)
Query: 387 MGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKG--- 443
M +L H V+L + +L Y NG L K + F
Sbjct: 84 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--------GSFDETCTRFY 135
Query: 444 ---VAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTN-V 499
+ L YLH + ++HRD+KP N+LL+ D+ ++ DFG A++ + N
Sbjct: 136 TAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 192
Query: 500 VGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRP 538
VGT Y++PELL S+D++A G + ++ G P
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 54/208 (25%), Positives = 86/208 (41%), Gaps = 27/208 (12%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVK-----KVCHDSDHGMKQFVS-EIVSMGKLRHR--NLVQ 397
GG G VY G+ S + +A+K ++ + V E+V + K+ +++
Sbjct: 53 SGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 112
Query: 398 LRGYCRRKGELLLVYDY-MPNGSL-DKILYSNTRPSLNWFQR-FR-IIKGVAFGLLYLHE 453
L + R +L+ + P L D I + F +++ V + H
Sbjct: 113 LLDWFERPDSFVLILERPEPVQDLFDFIT-ERGALQEELARSFFWQVLEAVR----HCHN 167
Query: 454 EWEQVVLHRDIKPANVLLDAD-LEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLR 512
VLHRDIK N+L+D + E KL DFG L GT Y PE +R
Sbjct: 168 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDF--DGTRVYSPPEWIR 221
Query: 513 NGR--GTTSTDVYAFGVFMLEVACGRRP 538
R G S V++ G+ + ++ CG P
Sbjct: 222 YHRYHG-RSAAVWSLGILLYDMVCGDIP 248
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 4e-19
Identities = 45/169 (26%), Positives = 72/169 (42%), Gaps = 38/169 (22%)
Query: 387 MGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAF 446
M L H LV L + + ++ +V D + G L R+ + + V F
Sbjct: 69 MQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDL----------------RYHLQQNVHF 112
Query: 447 --------------GLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492
L YL Q ++HRD+KP N+LLD + DF +A +
Sbjct: 113 KEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169
Query: 493 DLHTTNVVGTVGYLAPELLRNGRG---TTSTDVYAFGVFMLEVACGRRP 538
+ T + GT Y+APE+ + +G + + D ++ GV E+ GRRP
Sbjct: 170 QITT--MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 57/225 (25%), Positives = 92/225 (40%), Gaps = 32/225 (14%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGM-----------KQFVSEIVS 386
Y + G G V GV +A+K+V + G K+ + EI
Sbjct: 24 YTVQRFISSGSYGAVCAGVDSEGI-PVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 387 MGKLRHRNLVQLR-----GYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRF--- 438
+ H N++ LR +L LV + M L ++++ ++
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMY 141
Query: 439 RIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTN 498
I+ G L LHE V+HRD+ P N+LL + + + DF LAR D + T+
Sbjct: 142 HILLG----LHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDT--ADANKTH 192
Query: 499 VVGTVGYLAPELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPG 542
V Y APEL+ +G T D+++ G M E+ R+ + G
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF-NRKALFRG 236
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 5e-19
Identities = 50/230 (21%), Positives = 101/230 (43%), Gaps = 23/230 (10%)
Query: 319 KYEEVYEDWEKEYSPHRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMK 378
YE +W + Y+ + K +G +V+ + +++ ++ VK + K
Sbjct: 24 DYESHVVEWG---NQDD--YQLVRKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKK 75
Query: 379 QFVSEIVSMGKLR-HRNLVQLRGYCR--RKGELLLVYDYMPNGSLDKILYSNTRPSLNWF 435
+ EI + LR N++ L + LV++++ N ++ + T + ++
Sbjct: 76 KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFY 135
Query: 436 QRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADL-EGKLGDFGLARLYDHGNDL 494
+ I+K L Y H ++HRD+KP NV++D + + +L D+GLA Y G +
Sbjct: 136 M-YEILKA----LDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 187
Query: 495 HTTNVVGTVGYLAPELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPGE 543
V + + PELL + + S D+++ G + + + P G
Sbjct: 188 --NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 235
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 58/257 (22%), Positives = 94/257 (36%), Gaps = 69/257 (26%)
Query: 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVS-EIVSMGKLRHRNL 395
Y G G V S A+KKV D ++ + E+ M L H N+
Sbjct: 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-----PRYKNRELDIMKVLDHVNI 62
Query: 396 VQLRGYCRRKGE--------------------------------------LLLVYDYMPN 417
++L Y G+ L ++ +Y+P+
Sbjct: 63 IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD 122
Query: 418 GSLDKILYSNTRPSLN---------WFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPAN 468
+L K+L S R + +Q FR + ++H + HRDIKP N
Sbjct: 123 -TLHKVLKSFIRSGRSIPMNLISIYIYQLFR-------AVGFIHS---LGICHRDIKPQN 171
Query: 469 VLLDA-DLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRG-TTSTDVYAFG 526
+L+++ D KL DFG A+ + + Y APEL+ T S D+++ G
Sbjct: 172 LLVNSKDNTLKLCDFGSAKKLIPSEPS--VAYICSRFYRAPELMLGATEYTPSIDLWSIG 229
Query: 527 VFMLEVACGRRPVQPGE 543
E+ +P+ GE
Sbjct: 230 CVFGEL-ILGKPLFSGE 245
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 7e-18
Identities = 51/226 (22%), Positives = 97/226 (42%), Gaps = 32/226 (14%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKV-CHDSDHGMKQFVSEIVSMGKLRHRNLV 396
++ +G G V + +A+KK+ D + + EI + +H N++
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENII 72
Query: 397 QLR-----GYCRRKGELLLVYDYMPNGSLDKILYSN--TRPSLNWF--QRFRIIKGVAFG 447
+ E+ ++ + M L +++ + + + +F Q R
Sbjct: 73 TIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTLR-------A 124
Query: 448 LLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYD---------HGNDLHTTN 498
+ LH V+HRD+KP+N+L++++ + K+ DFGLAR+ D G
Sbjct: 125 VKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 499 VVGTVGYLAPELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPGE 543
V T Y APE++ + + DV++ G + E+ RRP+ PG
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF-LRRPIFPGR 226
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 9e-18
Identities = 45/164 (27%), Positives = 68/164 (41%), Gaps = 26/164 (15%)
Query: 387 MGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVA- 445
M +VQL + L +V +YMP G L +N + + + A
Sbjct: 123 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL-----------VNLMSNYDVPEKWAR 171
Query: 446 F-------GLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTN 498
F L +H +HRD+KP N+LLD KL DFG + +
Sbjct: 172 FYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 228
Query: 499 VVGTVGYLAPELLRNGRG----TTSTDVYAFGVFMLEVACGRRP 538
VGT Y++PE+L++ G D ++ GVF+ E+ G P
Sbjct: 229 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 9e-18
Identities = 40/157 (25%), Positives = 66/157 (42%), Gaps = 9/157 (5%)
Query: 387 MGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAF 446
+ + + L + L LV DY G L +L RF + + +
Sbjct: 128 LVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAE-MVI 186
Query: 447 GLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYL 506
+ +H+ +HRDIKP N+L+D + +L DFG + ++ VGT Y+
Sbjct: 187 AIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 243
Query: 507 APELLRNGRG-----TTSTDVYAFGVFMLEVACGRRP 538
+PE+L+ G D ++ GV M E+ G P
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 3e-17
Identities = 54/251 (21%), Positives = 96/251 (38%), Gaps = 54/251 (21%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGM--KQFVSEIVSMGKLRHRNL 395
Y+ + G G V +A+KK+ + + K+ + EI + +L H ++
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV 114
Query: 396 VQLR-----GYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRF--RIIKGVAFGL 448
V++ + EL +V + + K+ + + + ++ G +
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVG----V 169
Query: 449 LYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT------------ 496
Y+H +LHRD+KPAN L++ D K+ DFGLAR D+ + ++
Sbjct: 170 KYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 497 --------------TNVVGTVGYLAPELLRNGRG-TTSTDVYAFG----------VFMLE 531
T V T Y APEL+ T + DV++ G +
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286
Query: 532 VACGRRPVQPG 542
R P+ PG
Sbjct: 287 YHADRGPLFPG 297
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 46/161 (28%), Positives = 68/161 (42%), Gaps = 15/161 (9%)
Query: 387 MGKLRHRNLVQLRGYC-RRKGELLLVYDYMPNGSLDKILY-SNTRPSLNWFQRFRIIKGV 444
+ R + QL + + + L LV +Y G L +L R RF + + +
Sbjct: 115 LVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM-ARFYLAE-I 171
Query: 445 AFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVG 504
+ +H +HRDIKP N+LLD +L DFG + + VGT
Sbjct: 172 VMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPD 228
Query: 505 YLAPELLRNGRGTTSTDVY-------AFGVFMLEVACGRRP 538
YL+PE+L+ G T Y A GVF E+ G+ P
Sbjct: 229 YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 4e-17
Identities = 58/268 (21%), Positives = 101/268 (37%), Gaps = 49/268 (18%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGM--KQFVSEIVSMGKLRHRNL 395
Y + +G G VY ++ +A+KKV + + K+ + EI + +L+ +
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYI 87
Query: 396 VQLR-----GYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRF--RIIKGVAFGL 448
++L + EL +V + + L K+ + + + ++ G
Sbjct: 88 IRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLG----E 142
Query: 449 LYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT------------ 496
++HE ++HRD+KPAN LL+ D K+ DFGLAR + D +
Sbjct: 143 NFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGP 199
Query: 497 ---------TNVVGTVGYLAPELLRNGRG-TTSTDVYAFG----------VFMLEVACGR 536
T+ V T Y APEL+ T S D+++ G + R
Sbjct: 200 HNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR 259
Query: 537 RPVQPGELDLLDWVIDYWQKGDVLDASD 564
P+ PG +K D
Sbjct: 260 FPLFPGSSCFPLSPDRNSKKVHEKSNRD 287
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 45/164 (27%), Positives = 79/164 (48%), Gaps = 16/164 (9%)
Query: 444 VAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLAR-LYDHGNDLHTTNVVGT 502
VA G+ +L + +HRD+ N+LL K+ DFGLAR +Y + + +
Sbjct: 202 VAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 503 VGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLD 561
+ ++APE + + T +DV++FGV + E+ G P PG + + + ++G +
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-PG-VKIDEEFCRRLKEGTRMR 316
Query: 562 ASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
A D +Y + M L C H P RP+ ++V++L
Sbjct: 317 APDYTTPEMY--QTM-------LDCWHGEPSQRPTFSELVEHLG 351
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 21/90 (23%), Positives = 41/90 (45%), Gaps = 8/90 (8%)
Query: 346 KGGSGKVYRGVL-----PSSHAEIAVKKVCHDSDHG-MKQFVSEIVSMGKL-RHRNLVQL 398
+G G+V ++ +AVK + + H + +SE+ + + H N+V L
Sbjct: 32 RGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91
Query: 399 RGYC-RRKGELLLVYDYMPNGSLDKILYSN 427
G C + G L+++ ++ G+L L S
Sbjct: 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSK 121
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 60/235 (25%), Positives = 103/235 (43%), Gaps = 42/235 (17%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGM--KQFVSEIVSMGKLR-HRN 394
Y+ + K KG G V++ + + +AVKK+ + ++ EI+ + +L H N
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 395 LVQLRGYCRRKG--ELLLVYDYMPNGSLDKILYSN--TRPSLNWF--QRFRIIKGVAFGL 448
+V L R ++ LV+DYM L ++ +N + Q + +
Sbjct: 71 IVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQYVVYQLIK-------VI 122
Query: 449 LYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLY-------------------- 488
YLH +LHRD+KP+N+LL+A+ K+ DFGL+R +
Sbjct: 123 KYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 489 DHGNDLHTTNVVGTVGYLAPELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPG 542
+ T+ V T Y APE+L T D+++ G + E+ +P+ PG
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL-CGKPIFPG 233
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 7e-16
Identities = 41/152 (26%), Positives = 67/152 (44%), Gaps = 9/152 (5%)
Query: 387 MGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAF 446
+ + LV+L + L +V +Y+ G + L R S RF +
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARF-YAAQIVL 152
Query: 447 GLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYL 506
YLH +++RD+KP N+L+D ++ DFG A+ T + GT L
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWTLCGTPEAL 205
Query: 507 APELLRNGRGTTSTDVYAFGVFMLEVACGRRP 538
APE++ + + D +A GV + E+A G P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 23/195 (11%), Positives = 59/195 (30%), Gaps = 38/195 (19%)
Query: 347 GGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQ-FVSEIVSMGKLRHRNLVQLRGYCR 403
+ ++ + + ++A+ V + Q +S + + ++ + ++
Sbjct: 42 VPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH 101
Query: 404 RKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRD 463
+ L+V +++ GSL ++ ++ P R ++ +A H V
Sbjct: 102 TRAGGLVVAEWIRGGSLQEVADTSPSPV----GAIRAMQSLAAAADAAHRAG---VALSI 154
Query: 464 IKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVY 523
P+ V + D G V+ + D+
Sbjct: 155 DHPSRVRVSID--------GDV-------------VLAYPATMPDA-------NPQDDIR 186
Query: 524 AFGVFMLEVACGRRP 538
G + + R P
Sbjct: 187 GIGASLYALLVNRWP 201
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 6e-15
Identities = 35/95 (36%), Positives = 49/95 (51%), Gaps = 3/95 (3%)
Query: 444 VAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTV 503
+ L YLH E + V++RD+K N++LD D K+ DFGL + GT
Sbjct: 257 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-MKTFCGTP 313
Query: 504 GYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRP 538
YLAPE+L + + D + GV M E+ CGR P
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 77.4 bits (190), Expect = 7e-15
Identities = 41/150 (27%), Positives = 66/150 (44%), Gaps = 10/150 (6%)
Query: 391 RHRNLVQLRGYC-RRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKG-VAFGL 448
+ L QL C + L V +Y+ G L + R +A GL
Sbjct: 400 KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP---HAVFYAAEIAIGL 455
Query: 449 LYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAP 508
+L + +++RD+K NV+LD++ K+ DFG+ + T GT Y+AP
Sbjct: 456 FFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV-TTKTFCGTPDYIAP 511
Query: 509 ELLRNGRGTTSTDVYAFGVFMLEVACGRRP 538
E++ S D +AFGV + E+ G+ P
Sbjct: 512 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 8e-15
Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 9/99 (9%)
Query: 444 VAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEG--KLGDFGLARLYDHGNDLHTTNVVG 501
+ L +LH+ +++RDIK N+LLD++ G L DFGL++ + + G
Sbjct: 168 IVLALEHLHK---LGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETERAYDFCG 222
Query: 502 TVGYLAPELLRNGRG--TTSTDVYAFGVFMLEVACGRRP 538
T+ Y+AP+++R G + D ++ GV M E+ G P
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 43/146 (29%), Positives = 68/146 (46%), Gaps = 10/146 (6%)
Query: 395 LVQLRGYC-RRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKG-VAFGLLYLH 452
L QL C + L V +++ G L + + R R R + L++LH
Sbjct: 86 LTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA---RARFYAAEIISALMFLH 141
Query: 453 EEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLR 512
+ + +++RD+K NVLLD + KL DFG+ + T GT Y+APE+L+
Sbjct: 142 D---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT-TATFCGTPDYIAPEILQ 197
Query: 513 NGRGTTSTDVYAFGVFMLEVACGRRP 538
+ D +A GV + E+ CG P
Sbjct: 198 EMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 37/95 (38%), Positives = 54/95 (56%), Gaps = 4/95 (4%)
Query: 444 VAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTV 503
++ L YLHE + +++RD+K NVLLD++ KL D+G+ + D T+ GT
Sbjct: 119 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TSTFCGTP 174
Query: 504 GYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRP 538
Y+APE+LR S D +A GV M E+ GR P
Sbjct: 175 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 1e-14
Identities = 36/97 (37%), Positives = 53/97 (54%), Gaps = 8/97 (8%)
Query: 444 VAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEG--KLGDFGLARLYDHGNDLHTTNVVG 501
+A L +LH +++RD+KP N+LLD + G KL DFGL++ + G
Sbjct: 135 LALALDHLHS---LGIIYRDLKPENILLDEE--GHIKLTDFGLSKESIDHEKK-AYSFCG 188
Query: 502 TVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRP 538
TV Y+APE++ T S D ++FGV M E+ G P
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 1e-14
Identities = 43/156 (27%), Positives = 76/156 (48%), Gaps = 21/156 (13%)
Query: 389 KLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQ----RFRIIKGV 444
+ H ++++ G + ++ ++ DY+ G L +L + R F +F + V
Sbjct: 62 IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR-----FPNPVAKFYAAE-V 115
Query: 445 AFGLLYLHEEWEQVVLHRDIKPANVLLDADLEG--KLGDFGLARLYDHGNDLHTTNVVGT 502
L YLH + +++RD+KP N+LLD + G K+ DFG A+ T + GT
Sbjct: 116 CLALEYLHS---KDIIYRDLKPENILLDKN--GHIKITDFGFAKYVPDV----TYTLCGT 166
Query: 503 VGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRP 538
Y+APE++ S D ++FG+ + E+ G P
Sbjct: 167 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 33/95 (34%), Positives = 47/95 (49%), Gaps = 4/95 (4%)
Query: 444 VAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTV 503
+A L YLH +++RD+KP N+LLD+ L DFGL + N T+ GT
Sbjct: 148 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST-TSTFCGTP 203
Query: 504 GYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRP 538
YLAPE+L + D + G + E+ G P
Sbjct: 204 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 2e-14
Identities = 30/97 (30%), Positives = 52/97 (53%), Gaps = 8/97 (8%)
Query: 444 VAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEG--KLGDFGLARLYDHGNDLHTTNVVG 501
++ L +LH+ + +++RD+KP N++L+ G KL DFGL + H + T G
Sbjct: 130 ISMALGHLHQ---KGIIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGTV-THTFCG 183
Query: 502 TVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRP 538
T+ Y+APE+L + D ++ G M ++ G P
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 35/95 (36%), Positives = 48/95 (50%), Gaps = 4/95 (4%)
Query: 444 VAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTV 503
+ L YLH + V++RDIK N++LD D K+ DFGL + GT
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTP 169
Query: 504 GYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRP 538
YLAPE+L + + D + GV M E+ CGR P
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 37/95 (38%), Positives = 54/95 (56%), Gaps = 4/95 (4%)
Query: 444 VAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTV 503
++ L YLHE + +++RD+K NVLLD++ KL D+G+ + D T+ GT
Sbjct: 162 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TSTFCGTP 217
Query: 504 GYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRP 538
Y+APE+LR S D +A GV M E+ GR P
Sbjct: 218 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 4/95 (4%)
Query: 444 VAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTV 503
+A GL +L + +++RD+K NV+LD++ K+ DFG+ + T GT
Sbjct: 130 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT-TKTFCGTP 185
Query: 504 GYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRP 538
Y+APE++ S D +AFGV + E+ G+ P
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 33/95 (34%), Positives = 53/95 (55%), Gaps = 4/95 (4%)
Query: 444 VAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTV 503
+ GL +LH + +++RD+K N+LLD D K+ DFG+ + G+ T GT
Sbjct: 127 IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNTFCGTP 182
Query: 504 GYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRP 538
Y+APE+L + S D ++FGV + E+ G+ P
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 61/336 (18%), Positives = 115/336 (34%), Gaps = 104/336 (30%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKL-RHRNLVQLRGYC-- 402
G +GKV + + + A+K + D + E+ + + ++V++
Sbjct: 28 LGINGKVLQIFNKRTQEKFALKML---QD--CPKARREVELHWRASQCPHIVRIVDVYEN 82
Query: 403 --RRKGELLLVYDYMPNGSL-DKIL------YSNTRPSLNWFQRFRIIKGVAFGLLYLHE 453
+ LL+V + + G L +I ++ S I+K + + YLH
Sbjct: 83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS-------EIMKSIGEAIQYLHS 135
Query: 454 EWEQVVLHRDIKPANVLL-----DADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAP 508
+ HRD+KP N+L +A L KL DFG A
Sbjct: 136 ---INIAHRDVKPENLLYTSKRPNAIL--KLTDFG----------------------FAK 168
Query: 509 ELLRNGRGTTSTDVYAFGV---FMLEVACGRRP----------------VQPGELDLLDW 549
E S D+++ GV +L CG P ++ G+ + +
Sbjct: 169 ETTGEKYD-KSCDMWSLGVIMYILL---CGYPPFYSNHGLAISPGMKTRIRMGQYEFPN- 223
Query: 550 VIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY--LDGG 607
W + S+ E ++ L L + P R ++ + + + +
Sbjct: 224 --PEWS-----EVSE---------EVKMLIRNL-L---KTEPTQRMTITEFMNHPWIMQS 263
Query: 608 ALLPDIPLNSSVFGVLTAKNEAPNNGMASFASLVRS 643
+P PL++S VL E + S + +
Sbjct: 264 TKVPQTPLHTSR--VLKEDKERWEDVKEEMTSALAT 297
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 61.4 bits (148), Expect = 2e-10
Identities = 37/254 (14%), Positives = 67/254 (26%), Gaps = 67/254 (26%)
Query: 330 EYSPHRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD--------HGMKQFV 381
+ + K +G G+V++ + H +A+K + + ++ +
Sbjct: 14 SHCLPTEKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEIL 71
Query: 382 SEIVSMGKL---------RHRNLVQLRGYCRRKG----ELLLVYDY-------------- 414
EI+ +L R + L +G LL +D+
Sbjct: 72 PEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDF 131
Query: 415 -----------MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRD 463
G +D L + I+ + L HRD
Sbjct: 132 FKDDQLFIVLEFEFGGID--LEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRD 187
Query: 464 IKPANVLLDADLEGKLGDFGLARLYDHGN--------------DLHTTNVVGTVGYLAPE 509
+ NVLL KL + + VV + +
Sbjct: 188 LHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDED 247
Query: 510 LLRNGRGTTSTDVY 523
L G G D+Y
Sbjct: 248 LFT-GDGDYQFDIY 260
|
| >2ltn_B PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1hkd_B 1rin_B* 1ofs_B* 1bqp_B* 1loe_B 1loa_B* 1loc_B* 1lod_B* 1lob_B 1lof_B* 1log_B* 1lof_D* 1les_B* 2b7y_B* 1lgc_B* 1lgb_B* 1len_B 1lem_B 2lal_B Length = 52 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 8e-10
Identities = 12/49 (24%), Positives = 24/49 (48%)
Query: 222 SRPLLSTSIDLSQILQDSMYVGLSAATGTRVSDYYILGWSFNKSGPAQN 270
+ LS + L ++ + + +G SA TG + + +L WSF+ +
Sbjct: 2 TSYTLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSFHSELSGTS 50
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 59.9 bits (144), Expect = 2e-09
Identities = 66/479 (13%), Positives = 134/479 (27%), Gaps = 170/479 (35%)
Query: 269 QNLDISKLPPLPPPPPTPGKKLNHTVIV-SIVAAAVVLITI-----AAAVY-FVK---KK 318
N D + +P + ++++H ++ V+ + L V FV+ +
Sbjct: 31 DNFDCKDVQDMPKSILS-KEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRI 89
Query: 319 KYEEVYEDWEKEY-------------------SPHRFS---------YKNLYKATK---- 346
Y+ + + E F+ Y L +A
Sbjct: 90 NYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRP 149
Query: 347 ---------GGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMK-QFVSEI--VSMGKLRHRN 394
GSGK + VC + ++ + +I +++
Sbjct: 150 AKNVLIDGVLGSGK---TWV--------ALDVC--LSYKVQCKMDFKIFWLNLKN----- 191
Query: 395 LVQLRGYCRRKGELL-----LVYDYMPNGSLDKILYSNTRPSLNWFQ----RFRIIKGVA 445
C +L L+Y PN + SN + ++ Q R K
Sbjct: 192 -------CNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYE 244
Query: 446 FGLLYLHEEWEQVVLHRDIKPANVLLDA-DLEGKLGDFGLARLYDHGNDLHTT------N 498
LL VL +++ A +A +L K+ L TT +
Sbjct: 245 NCLL---------VL-LNVQNAKA-WNAFNLSCKI--------------LLTTRFKQVTD 279
Query: 499 VVGTVGYLAPELLRNGRGTTSTDVYAFGVFM--LEVACGRRPVQ-----P------GELD 545
+ L + T + + + L+ P + P E
Sbjct: 280 FLSAATTTHISLDHHSMTLTPDE--VKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAES- 336
Query: 546 LLDWV--IDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603
+ D + D W+ +++ +++ L + P R++
Sbjct: 337 IRDGLATWDNWKH--------------VNCDKLTTIIESSL--NVLEPAE---YRKMFDR 377
Query: 604 LDGGALLPD---IPLNSSVFGVL--TAKNEAPNNGMASFA--SLVRSDSPHTMSTIDSI 655
L ++ P IP + + ++ + SLV + +I SI
Sbjct: 378 L---SVFPPSAHIP--TILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSI 431
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 3e-05
Identities = 87/524 (16%), Positives = 150/524 (28%), Gaps = 159/524 (30%)
Query: 134 QFTNHIFAIELDTVQSPE---------FNDIDGNHVG---IDVNGLQSNESASA---RYF 178
+ IF + L SPE ID N N S A R
Sbjct: 179 KMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLL 238
Query: 179 SDEKKEFESLVLESGKPIQIWIDYNGQEK-LV-----NVTLAPVPNPKPSRPLLSTSIDL 232
+ E LVL + + + W +N K L+ VT + + L
Sbjct: 239 KSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDF-LSAATTTHISL---DHH 294
Query: 233 SQILQDSMYVGLSA-ATGTRVSDYYILGWSFNKSGPAQNLDISKLPPLPPPPPTPGKKLN 291
S L L R D L P + L + P
Sbjct: 295 SMTLTPDEVKSLLLKYLDCRPQD---L--------PREVLTTN---PR------------ 328
Query: 292 HTVIVSIVAAAV--VLITIAAAVYF--VKKKKYEEVYEDWEKEYSPHRFSYKNLYKATKG 347
+SI+A ++ L T + V K + E P Y+ ++
Sbjct: 329 ---RLSIIAESIRDGLATWD---NWKHVNCDKLTTIIESSLNVLEPA--EYRKMFDRL-- 378
Query: 348 GSGKVYRGVLPSSHAEIAVKKVC---HDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR 404
V P S A I + D K V +V+ KL +LV+ +
Sbjct: 379 -------SVFPPS-AHIPTILLSLIWFDVI---KSDVMVVVN--KLHKYSLVE----KQP 421
Query: 405 KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDI 464
K + + +Y + L + LHR
Sbjct: 422 KESTISIPS----------IYLELKVKLE----------------------NEYALHR-- 447
Query: 465 KPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVG----TVGYLAPELLRNGRGTTST 520
++D + + + +D +DL + +G+ + R T
Sbjct: 448 ----SIVDH--------YNIPKTFDS-DDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFR 494
Query: 521 DVYA-FGVFM---LEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQM 576
V+ F F+ + L+ L + Y K + D +DP+ E V +
Sbjct: 495 MVFLDFR-FLEQKIRHDSTAWNASGSILNTLQQLKFY--KPYICD-NDPKYER-LVNAIL 549
Query: 577 EIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGALLPDIPLNSSVF 620
+ + K+ S T +++ AL+ + + ++F
Sbjct: 550 DFLPKIEENLICS-KYTD-----LLRI----ALMAE---DEAIF 580
|
| >1gv9_A P58/ergic-53; lectin, carbohydrate binding; 1.46A {Rattus norvegicus} SCOP: b.29.1.13 PDB: 1r1z_A 3a4u_A 3lcp_A Length = 260 | Back alignment and structure |
|---|
Score = 54.8 bits (131), Expect = 2e-08
Identities = 37/274 (13%), Positives = 78/274 (28%), Gaps = 43/274 (15%)
Query: 12 FLFKVTLIFSASAQEENQFIHHGFEGSKLKLDGLAKIHPNGLLQLTNTSERISGHAFYPF 71
F +K + Q + G+ + +I P+ Q G +
Sbjct: 30 FEYKYSFKGPHLVQSDGTVPFWAHAGNAIPSADQIRIAPSLKSQ--------RGSVWTKT 81
Query: 72 PFKFNSSSSQSLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSN 131
F + + F + + G G+A + + + V GS ++N
Sbjct: 82 KAAFEN-------WEVEVTFRVTGR-GRIGADGLAIWYTENQGLDGPVFGSA-DMWN--- 129
Query: 132 NGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLE 191
I D+ + + V + + + + + +
Sbjct: 130 -------GVGIFFDSFDNDGKKNNPAIVVVGNNGQINYDHQNDGATQALASCQRD--FRN 180
Query: 192 SGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTR 251
P++ I Y + V + P+ + ++ + G+SAATG
Sbjct: 181 KPYPVRAKITYYQKTLTVMINNGFTPDKNDYEFCAKVE---NMVIPTQGHFGISAATGGL 237
Query: 252 VSDYYILGWSFNKSGPAQNLDISKLPPLPPPPPT 285
D+ +L + +L PPT
Sbjct: 238 ADDHDVLSFLTF-----------QLTEPGKEPPT 260
|
| >2dur_A VIP36;, vesicular integral-membrane protein VIP36; beta sandwich, carbohydrate binding protein, cargo receptor, transport; HET: MAN; 1.65A {Canis lupus familiaris} PDB: 2dup_A 2duq_A* 2duo_A* 2e6v_A* Length = 253 | Back alignment and structure |
|---|
Score = 51.4 bits (122), Expect = 2e-07
Identities = 41/235 (17%), Positives = 73/235 (31%), Gaps = 32/235 (13%)
Query: 51 NGLLQLTNTSERISGHAFYPFPFKFNSSSSQSLSFSTSFVFAMF-PKLPNYGGHGMAFFI 109
+ ++LT G + P + F + N G G+A +
Sbjct: 37 SQYVRLTPDERSKEGSIWNHQPCFLKD-------WEMHVHFKVHGTGKKNLHGDGIALWY 89
Query: 110 SPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQS 169
+ V GS F+ AI LDT + E + ++ + VN
Sbjct: 90 TRDRLVPGPVFGS-KDNFH----------GLAIFLDTYPNDETTERVFPYISVMVNNGSL 138
Query: 170 NESASARYFSDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTS 229
+ S E + + + Y+ V L K
Sbjct: 139 SYDHSKDGRWTELAGCTADFRNRDHDTFLAVRYSRGRLTVMTDLEDKNEWK-------NC 191
Query: 230 IDLSQI-LQDSMYVGLSAATGTRVSDYYILGWSFNK-----SGPAQNLDISKLPP 278
ID++ + L Y G SA TG ++ I+ + + +N+D +K+ P
Sbjct: 192 IDITGVRLPTGYYFGASAGTGDLSDNHDIISMKLFQLMVEHTPDEENIDWTKIEP 246
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 7e-07
Identities = 44/226 (19%), Positives = 88/226 (38%), Gaps = 41/226 (18%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLR------ 391
Y + K G V+ ++ +A+K + + EI + ++
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRVNDADNTK 79
Query: 392 -----HRNLVQLRGYCRRKGE----LLLVYDYMPNGSLDKILYSNTRPSLNWFQRF---- 438
++++L + KG +++V++ + +L ++ +
Sbjct: 80 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYE------HRGIPLIY 132
Query: 439 --RIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLD------ADLEGKLGDFGLARLYDH 490
+I K + GL Y+H ++H DIKP NVL++ ++ K+ D G A YD
Sbjct: 133 VKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE 190
Query: 491 GNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGR 536
H TN + T Y +PE+L D+++ + E+ G
Sbjct: 191 ----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 33/152 (21%), Positives = 50/152 (32%), Gaps = 55/152 (36%)
Query: 439 RIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDAD------------------------ 474
+II+ V GL YLH + ++H DIKP N+LL +
Sbjct: 150 KIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207
Query: 475 -------------------------LEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPE 509
L+ K+ D G A H T + T Y + E
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK----HFTEDIQTRQYRSLE 263
Query: 510 LLRNGRGTTSTDVYAFGVFMLEVACGRRPVQP 541
+L T D+++ E+A G +P
Sbjct: 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEP 295
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 39/188 (20%), Positives = 69/188 (36%), Gaps = 35/188 (18%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRH-RNLV 396
++ K G G++ G ++ +A+K S Q E +L +
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIP 68
Query: 397 QLRGYCRRKGELLLVYDYMPNG-SLDKILYSNTRPSLNWFQRFRIIKGV---AFGLL--- 449
Q+ + +V + + G SL+ + R F + K V A L+
Sbjct: 69 QVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDR-------TFSL-KTVLMIAIQLISRM 118
Query: 450 -YLHEEWEQVVLHRDIKPANVLLDADLEGK-----LGDFGLARLY-DHGNDLH-----TT 497
Y+H + +++RD+KP N L+ + DF LA+ Y D H
Sbjct: 119 EYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHK 175
Query: 498 NVVGTVGY 505
++ GT Y
Sbjct: 176 SLTGTARY 183
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 42/187 (22%), Positives = 74/187 (39%), Gaps = 33/187 (17%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRH-RNLV 396
YK + +G G ++ G ++ ++A+K SD Q E + L +
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIP 69
Query: 397 QLRGYCRRKGELLLVYDYMPNG-SLDKILYSNTRPSLNWFQRFRI--IKGVAFGLL---- 449
+ + + +LV D + G SL+ +L R +F + + A +L
Sbjct: 70 NVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGR-------KFSVKTVAMAAKQMLARVQ 120
Query: 450 YLHEEWEQVVLHRDIKPANVLLDADLEGK-----LGDFGLARLY-DHGNDLH-----TTN 498
+HE + +++RDIKP N L+ + DFG+ + Y D H N
Sbjct: 121 SIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN 177
Query: 499 VVGTVGY 505
+ GT Y
Sbjct: 178 LSGTARY 184
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 42/185 (22%), Positives = 73/185 (39%), Gaps = 31/185 (16%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRH-RNLV 396
Y+ K G G +Y G ++ E+A+K C + H Q E ++ +
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIP 68
Query: 397 QLRGYCRRKGELLLVYDYMPNG-SLDKILYSNTRPSLNWFQRFRIIKGVAFG------LL 449
+R ++V + + G SL+ + +R +F + + +
Sbjct: 69 TIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSR-------KFSLKTVLLLADQMISRIE 119
Query: 450 YLHEEWEQVVLHRDIKPANVLLDADLEGK---LGDFGLARLY-DHGNDLH-----TTNVV 500
Y+H + +HRD+KP N L+ +G + DFGLA+ Y D H N+
Sbjct: 120 YIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 176
Query: 501 GTVGY 505
GT Y
Sbjct: 177 GTARY 181
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 8e-05
Identities = 19/64 (29%), Positives = 28/64 (43%), Gaps = 11/64 (17%)
Query: 450 YLHEEWEQVVLHRDIKPANVLLDADLEGK--LGDFGLARLY-DHGNDLH-----TTNVVG 501
Y+HE +H DIK +N+LL+ + L D+GLA Y G G
Sbjct: 167 YIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDG 223
Query: 502 TVGY 505
T+ +
Sbjct: 224 TIEF 227
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 9e-05
Identities = 20/64 (31%), Positives = 29/64 (45%), Gaps = 11/64 (17%)
Query: 450 YLHEEWEQVVLHRDIKPANVLLDADLEGK--LGDFGLARLY-DHGNDLH-----TTNVVG 501
Y+HE +H DIK AN+LL + L D+GL+ Y +GN G
Sbjct: 166 YIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNG 222
Query: 502 TVGY 505
T+ +
Sbjct: 223 TIEF 226
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 45/184 (24%), Positives = 76/184 (41%), Gaps = 29/184 (15%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLV- 396
++ K G G++Y G ++ E+A+K + H Q + E L+ +
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIP 66
Query: 397 QLRGYCRRKGELLLVYDYMPNG-SLDKILYSNTRP-SLNWFQRFRIIKGVAFGLL----Y 450
+R + +LV D + G SL+ + +R SL + + +A ++ +
Sbjct: 67 NVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSL------KTVLMLADQMINRVEF 118
Query: 451 LHEEWEQVVLHRDIKPANVLLDADLEGK---LGDFGLARLY-DHGNDLH-----TTNVVG 501
+H + LHRDIKP N L+ + DFGLA+ Y D H N+ G
Sbjct: 119 VHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175
Query: 502 TVGY 505
T Y
Sbjct: 176 TARY 179
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 48/214 (22%), Positives = 93/214 (43%), Gaps = 24/214 (11%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHR------NLVQLR 399
KG G+V + H +A+K + + +Q EI + LR + N++ +
Sbjct: 107 KGSFGQVVKAYDHKVHQHVALK-MVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHML 165
Query: 400 GYCRRKGELLLVYDYMPNGSL-DKILYSNTRP-SLNWFQRFRIIKGVAFGLLYLHEEWEQ 457
+ + + ++ + + +L + I + + SL ++F + L LH+
Sbjct: 166 ENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKF--AHSILQCLDALHK---N 219
Query: 458 VVLHRDIKPANVLL--DADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGR 515
++H D+KP N+LL K+ DFG + + + T + + Y APE++ R
Sbjct: 220 RIIHCDLKPENILLKQQGRSGIKVIDFGSSC---YEHQRVYTYIQ-SRFYRAPEVILGAR 275
Query: 516 GTTSTDVYAFGVFMLEVACGRRPVQPG--ELDLL 547
D+++ G + E+ G P+ PG E D L
Sbjct: 276 YGMPIDMWSLGCILAELLTG-YPLLPGEDEGDQL 308
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 10/41 (24%), Positives = 20/41 (48%), Gaps = 5/41 (12%)
Query: 450 YLHEEWEQVVLHRDIKPANVLLDADLEGK--LGDFGLARLY 488
+LHE +H ++ N+ +D + + + L +G A Y
Sbjct: 174 FLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 47/247 (19%), Positives = 100/247 (40%), Gaps = 23/247 (9%)
Query: 316 KKKKYEEVYEDWEKEYSPHR-----FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVC 370
++K Y + Y+D +Y Y+ KG G+V + +A+K +
Sbjct: 29 ERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIK-II 87
Query: 371 HDSDHGMKQFVSEIVSMGKLRHR------NLVQLRGYCRRKGELLLVYDYMPNGSLDKIL 424
+ + Q E+ + + +V L+ + + L LV++ + + +L +L
Sbjct: 88 KNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLL 146
Query: 425 YSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLL--DADLEGKLGDF 482
+ ++ + + + LL+L ++ H D+KP N+LL K+ DF
Sbjct: 147 RNTNFRGVSLNLTRKFAQQMCTALLFLATPELSII-HCDLKPENILLCNPKRSAIKIVDF 205
Query: 483 GLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPG 542
G + + + Y +PE+L + D+++ G ++E+ G P+ G
Sbjct: 206 GSSC---QLGQRIYQYIQ-SRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTG-EPLFSG 260
Query: 543 --ELDLL 547
E+D +
Sbjct: 261 ANEVDQM 267
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 660 | |||
| 3ujo_A | 281 | Legume lectin; carbohydrate-binding, galactose, ad | 100.0 | |
| 3ipv_A | 251 | Lectin alpha chain; galactose binding, SEED lectin | 100.0 | |
| 3zyr_A | 261 | Lectin; sugar binding protein, N-glycan; HET: NAG | 100.0 | |
| 1dbn_A | 239 | MAL, protein (leukoagglutinin); plant lectin, carb | 100.0 | |
| 1fny_A | 237 | BARK lectin, BARK agglutinin I,polypeptide A; legu | 100.0 | |
| 1v6i_A | 232 | Agglutinin, PNA, galactose-binding lectin; open qu | 100.0 | |
| 1fx5_A | 242 | UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HO | 100.0 | |
| 1hql_A | 257 | Lectin; xenograft antigen, sugar BI protein; HET: | 100.0 | |
| 1gzc_A | 239 | Erythrina crista-galli lectin; carbohydrate, sugar | 100.0 | |
| 1qnw_A | 242 | Chitin binding lectin, UEA-II; carbohydrate bindin | 100.0 | |
| 2eig_A | 234 | Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG bin | 100.0 | |
| 1sbf_A | 253 | Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {G | 100.0 | |
| 2fmd_A | 240 | Lectin, agglutinin, BMA; legume lectin, beta sandw | 100.0 | |
| 1g7y_A | 253 | Stem/LEAF lectin DB58; jelly roll fold, sugar bind | 100.0 | |
| 1n47_A | 233 | Isolectin B4; cancer antigen, vicia villosa lectin | 100.0 | |
| 1fat_A | 252 | Phytohemagglutinin-L; glycoprotein, plant defense | 100.0 | |
| 2bqp_A | 234 | Protein (PEA lectin); D-glucopyranose complex, sug | 100.0 | |
| 1gsl_A | 243 | Griffonia simplicifolia lectin 4; glycoprotein, ma | 100.0 | |
| 1wbf_A | 242 | Protein (agglutinin); lectin (agglutinin), legume | 100.0 | |
| 1f9k_A | 238 | Acidic lectin; legume lectin, glycosylated protein | 100.0 | |
| 1avb_A | 226 | Arcelin-1; lectin-like glycoprotein, plant defense | 100.0 | |
| 1ioa_A | 240 | Arcelin-5A, ARC5A; lectin-like proteins, plant def | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 1dhk_B | 223 | Bean lectin-like inhibitor, porcine pancreatic alp | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 2ltn_A | 181 | PEA lectin, alpha chain; 1.70A {Pisum sativum} SCO | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1qmo_E | 133 | Mannose binding lectin, FRIL; crosslink, hematopoi | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2dur_A | 253 | VIP36;, vesicular integral-membrane protein VIP36; | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1gv9_A | 260 | P58/ergic-53; lectin, carbohydrate binding; 1.46A | 100.0 | |
| 1nls_A | 237 | Concanavalin A; lectin, agglutinin; 0.94A {Canaval | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 1qmo_A | 113 | Mannose binding lectin, FRIL; crosslink, hematopoi | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 2a6y_A | 256 | EMP47P (FORM1); beta sandwich, carbohydrate bindin | 99.92 | |
| 1nls_A | 237 | Concanavalin A; lectin, agglutinin; 0.94A {Canaval | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 2a6z_A | 222 | EMP47P (FORM2); beta sandwich, carbohydrate bindin | 99.75 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.63 | |
| 2a6v_A | 226 | EMP46P; beta sandwich, carbohydrate binding protei | 99.48 | |
| 2ltn_B | 52 | PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP | 99.47 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.3 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.12 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.06 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.86 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.57 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.51 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.47 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.39 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.29 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.25 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.1 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.9 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.74 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.59 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.54 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.36 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.33 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.22 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.1 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.08 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.05 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.9 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.86 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.43 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.09 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.68 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.62 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.19 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 83.56 |
| >3ujo_A Legume lectin; carbohydrate-binding, galactose, adenine binding protein; HET: ADE GAL; 2.00A {Dolichos lablab} PDB: 3ujq_A* 3uk9_A* 3ul2_A* 1fat_A* 1g8w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-64 Score=504.71 Aligned_cols=230 Identities=28% Similarity=0.456 Sum_probs=204.5
Q ss_pred HHHhhccCCcceeeeCCCCCCCeeEecceeEcCCCcEEecCCCCC------eeEEEEeCCCeeeccCC-CCceeEEEEEE
Q 006112 18 LIFSASAQEENQFIHHGFEGSKLKLDGLAKIHPNGLLQLTNTSER------ISGHAFYPFPFKFNSSS-SQSLSFSTSFV 90 (660)
Q Consensus 18 ~~~~~~~~~~~~f~~~~f~~~~l~~~g~a~~~~~g~l~Lt~~~~~------~~G~~~y~~pv~~~~~~-~~~~sFst~F~ 90 (660)
|+..+.++..++|+|++|++.||+|+|||.+. +|.|+||+...+ ++|||+|++||++|+++ ++++||+|+|+
T Consensus 17 l~~~~~sa~~~sF~f~~F~~~nL~l~GdA~i~-~g~L~LT~~~~~~~p~~~s~Gra~Y~~Pi~l~d~~tg~vaSFsTsFs 95 (281)
T 3ujo_A 17 LLTKAASANLISFTFKKFNETNLILQRDATVS-SGKLRITKAAENGVPTAGSLGRAFYSTPIQIWDNTTGTVASWATSFT 95 (281)
T ss_dssp -------CEEEEEEESSCCSTTEEECSSCCCB-TTBEECSCCCSSCCCCSSCEEEEEESSCEECBCSSSCCBEEEEEEEE
T ss_pred HHcccCcCCcceEEcCCCCccCEEEecceEEe-CCEEEeCCCCCCCcccCCceEEEEECCCEEcccCCCCCceeEEEEEE
Confidence 33345567789999999998899999999998 999999998765 89999999999999987 89999999999
Q ss_pred EEEecCCCCCCCCceEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCeeEEEcCCcccc
Q 006112 91 FAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSN 170 (660)
Q Consensus 91 F~i~~~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~ 170 (660)
|.|.+++...+||||||||+|....|. +.||||||+|.+++ +..||+|||||||++|.+| ||++|||||||||+.|.
T Consensus 96 F~I~~~~~~~~gdGlAF~laP~~~~p~-~~gg~LGL~n~~~~-~~~n~~vAVEFDT~~N~e~-Dp~~nHVGIDvNSi~S~ 172 (281)
T 3ujo_A 96 FNLQAPNAASPADGLAFALVPVGSQPK-DKGGFLGLFDSKNY-ASSNQTVAVEFDTFYNGGW-DPTERHIGIDVNSIKSI 172 (281)
T ss_dssp EECCCSSTTSCCEEEEEEEEETTCCCC-CCGGGTTTCSCSSC-CTTSCCEEEEECCSCCCSS-CCSSSEEEEEESSSCCS
T ss_pred EEEecCCCCCCCCceEEEEecCCCCCC-CCcceeeeccccCC-CccCcEEEEEEeccccccC-CCCCCeEEEEcCCCCcc
Confidence 999988777899999999999876654 68999999999876 6789999999999999887 99999999999999998
Q ss_pred ccccccccccccccccccccCCCccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeecccCc
Q 006112 171 ESASARYFSDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGT 250 (660)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg~ 250 (660)
++++| .+.+|+.++|||+||+.+++|+|+|++.+. |..|+|++.|||+++|||+||||||||||.
T Consensus 173 ~t~~~-------------~l~~G~~~~vwI~Yd~~tk~L~V~l~~~~~--~~~~~lS~~vDL~~~L~e~v~VGFSAsTG~ 237 (281)
T 3ujo_A 173 KTTSW-------------DFANGENAEVLITYDSSTNLLVASLVHPSQ--KTSFIVSERVDLTSVLPEWVSVGFSATTGL 237 (281)
T ss_dssp CEEEC-------------CCCSSCCEEEEEEECTTTCEEEEEEECTTT--CCCEEEEEECCSTTTSCSEEEEEEEEEECS
T ss_pred ccccc-------------cccCCCEEEEEEEEeCCCCEEEEEEecCCC--CCCceEEEEechHHhccCcEEEEEEeecCC
Confidence 88865 356899999999999999999999997653 557899999999999999999999999996
Q ss_pred ---eeeeeeecCcccccCC
Q 006112 251 ---RVSDYYILGWSFNKSG 266 (660)
Q Consensus 251 ---~~~~h~i~~wsf~~~g 266 (660)
..|.|+|++|+|++..
T Consensus 238 ~~~~~e~H~IlsWSFss~l 256 (281)
T 3ujo_A 238 SKGYVETNEVLSWSFASKL 256 (281)
T ss_dssp STTSCCCCEEEEEEEEEEE
T ss_pred CCcccceeEEEEEEEEEEc
Confidence 5899999999999864
|
| >3ipv_A Lectin alpha chain; galactose binding, SEED lectin, hemagglutinin, legume lectin fungal, sugar binding protein; 2.04A {Spatholobus parviflorus} PDB: 3ipv_B 3usu_B* 3usu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-63 Score=492.44 Aligned_cols=224 Identities=31% Similarity=0.498 Sum_probs=204.8
Q ss_pred CcceeeeCCCC--CCCeeEecceeEcCCCcEEecCCCCC------eeEEEEeCCCeeeccCC-CCceeEEEEEEEEEecC
Q 006112 26 EENQFIHHGFE--GSKLKLDGLAKIHPNGLLQLTNTSER------ISGHAFYPFPFKFNSSS-SQSLSFSTSFVFAMFPK 96 (660)
Q Consensus 26 ~~~~f~~~~f~--~~~l~~~g~a~~~~~g~l~Lt~~~~~------~~G~~~y~~pv~~~~~~-~~~~sFst~F~F~i~~~ 96 (660)
..++|+|++|. ..||+|+|+|.+.++|.|+||+...+ ++|||+|++||+||+++ ++++||+|+|+|.|.+.
T Consensus 2 ~~~sF~f~~F~~~~~nl~l~GdA~v~~~g~L~LT~~~~~~~~~~~s~Gra~Y~~Pi~l~d~~tg~vaSFsT~F~F~I~~~ 81 (251)
T 3ipv_A 2 EETSFVFSKFKPLEPNLILQGDALVTVAGVLQLTNVDKNGVPEPSSLGRATYSAPINIWDSATGLVASFATSFRFTIYAP 81 (251)
T ss_dssp EEEEEEESSCCSSCTTEEEEETCEECTTSCEESSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCS
T ss_pred cceEEEeCCCCCCCCCeEEeccEEecCCCeEEcCCCCCCCcccCCcEEEEEECCCEEeecCCCCceeeEEEEEEEEEeCC
Confidence 45899999998 67999999999977999999998765 89999999999999987 89999999999999988
Q ss_pred CCCCCCCceEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCeeEEEcCCcccccccccc
Q 006112 97 LPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASAR 176 (660)
Q Consensus 97 ~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~ 176 (660)
+...+||||||||+|....|. ..||||||+|.+++ +..||+|||||||++|.+|+||++|||||||||+.|.++++|
T Consensus 82 ~~~~~gdGlAF~lap~~~~~~-~~gg~LGL~n~~~~-~~~n~~vAVEFDT~~n~~~~Dp~~nHVGIdvNsi~S~~t~~~- 158 (251)
T 3ipv_A 82 NIATIADGLAFFLAPVASAPD-SGGGFLGLFDSAVS-GSTYQTVAVEFDTYENTVFTDPPYTHIGFDVNSISSIKTVKW- 158 (251)
T ss_dssp STTSCCEEEEEEEEETTCCCC-CCGGGTTTCSSSSC-CTTSCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEEC-
T ss_pred CCCCCCCceEEEEecCCCCCC-CCCceeeeccccCC-CccCcEEEEEEecccccccCCCCCCeEEEEcCCCccccccee-
Confidence 778899999999999876655 57999999998876 678999999999999998889999999999999999888764
Q ss_pred ccccccccccccccCCCccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeecccCce---ee
Q 006112 177 YFSDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTR---VS 253 (660)
Q Consensus 177 ~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg~~---~~ 253 (660)
.+.+|+.++|||+||+.+++|+|+|++.+. |..|+|++.|||+++|+|+||||||||||.. .|
T Consensus 159 ------------~l~~G~~~~v~I~Yd~~tk~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~e 224 (251)
T 3ipv_A 159 ------------SLANGEAAKVLITYNSAVKLLVASLVYPSS--KTSFILADIVDLSSVLPEWVRVGFSAATGASGGKIE 224 (251)
T ss_dssp ------------CCCTTCEEEEEEEEETTTTEEEEEEECTTT--CCEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCC
T ss_pred ------------EecCCCEEEEEEEEeCCCCEEEEEEecCCC--CccceEEEEechHHhCCCcEEEEEEEecCCCccccc
Confidence 467999999999999999999999997553 5678999999999999999999999999998 89
Q ss_pred eeeecCcccccCC
Q 006112 254 DYYILGWSFNKSG 266 (660)
Q Consensus 254 ~h~i~~wsf~~~g 266 (660)
.|+|++|+|++..
T Consensus 225 ~h~IlsWsF~s~l 237 (251)
T 3ipv_A 225 THDVFSWSFASKL 237 (251)
T ss_dssp CCEEEEEEEEEEE
T ss_pred eeEEEEEEEEEEC
Confidence 9999999999864
|
| >3zyr_A Lectin; sugar binding protein, N-glycan; HET: NAG BMA MAN GOL; 1.65A {Platypodium elegans} SCOP: b.29.1.1 PDB: 3zvx_A* 1ukg_A* 1q8o_A* 1q8q_A* 1q8s_A* 1q8v_A* 1q8p_A* 2auy_A* 2gme_A 2gmm_A* 2gmp_A* 2gn3_A* 2gn7_A* 2gnb_A* 2gnd_A* 2gnm_A* 2gnt_A 2phf_A* 2phr_A* 2pht_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-62 Score=491.18 Aligned_cols=228 Identities=28% Similarity=0.448 Sum_probs=204.9
Q ss_pred hhccCCcceeeeCCCC--CCCeeEecceeEcCCCcEEecCCCC------CeeEEEEeCCCeeeccCC-CCceeEEEEEEE
Q 006112 21 SASAQEENQFIHHGFE--GSKLKLDGLAKIHPNGLLQLTNTSE------RISGHAFYPFPFKFNSSS-SQSLSFSTSFVF 91 (660)
Q Consensus 21 ~~~~~~~~~f~~~~f~--~~~l~~~g~a~~~~~g~l~Lt~~~~------~~~G~~~y~~pv~~~~~~-~~~~sFst~F~F 91 (660)
.+.++..++|+|++|+ ..||+|+|+|.+.++|.|+||+... +++|||+|++||+||+++ ++++||+|+|+|
T Consensus 5 ~~~sa~~~sF~f~~F~~~~~~l~l~GdA~i~~~g~L~LT~~~~~~~~~~~s~Gra~Y~~Pv~l~d~~tg~vaSFsT~F~F 84 (261)
T 3zyr_A 5 RANSTDSLSFSFINFDRDERNLIFQGDAHTSRNNILQLTRTDSNGAPVRSTVGRILHSAQVRLWEKSTNRVANLQTQFSF 84 (261)
T ss_dssp ---CCEEEEEEESSCCSCCTTEEEEETCEECTTSCEECSCBCTTSCBCSSEEEEEEESSCEECBCTTTCCBEEEEEEEEE
T ss_pred ccCcCcccEEEcCCCCCCCCCeEEeccEEecCCCeEEeCCCCCCCccccCCEEEEEECCCEEeecCCCCCceeEEEEEEE
Confidence 3456778999999998 5799999999997799999999875 799999999999999987 899999999999
Q ss_pred EEecCCCCCCCCceEEEEecCCC-CCCCCCCCcccccccCCCCC-CCccEEEEEeecc---cCCCCCCCCCCeeEEEcCC
Q 006112 92 AMFPKLPNYGGHGMAFFISPSTD-FSEAVAGSHLGIFNRSNNGQ-FTNHIFAIELDTV---QSPEFNDIDGNHVGIDVNG 166 (660)
Q Consensus 92 ~i~~~~~~~~g~GlaF~l~p~~~-~~~~~~g~~lGl~~~~~~~~-~~~~~vaVEFDt~---~n~~~~d~~~~Hvgid~ns 166 (660)
.|.+. ...+||||||||+|... +|.+++||||||+|.+++++ ..||+|||||||+ +|.+| ||++|||||||||
T Consensus 85 ~I~~~-~~~~gdGlAF~lap~~~~~p~~~~g~~LGL~n~~~~g~~~~n~~vAVEFDT~~~~~n~~~-Dp~~nHVGIdvNs 162 (261)
T 3zyr_A 85 FLSSP-LSNPADGIAFFIAPPDTTIPSGSAGGLLGLFNPRTALNESANQVLAVEFDTFFAQNSNTW-DPNYQHIGIDVNS 162 (261)
T ss_dssp EEECS-SSSCCCEEEEEEECTTCCCCTTCCGGGTTTCCTTTTTCGGGCCCEEEEEECCCCTTTCTT-SCSSCEEEEEESS
T ss_pred EEecC-CCCCCccEEEEEccCCCCCCCCCCCceeeeecccccCCCccCcEEEEEEeccccccCcCC-CCCCCeEEEEcCC
Confidence 99987 66689999999999875 48889999999999988754 5689999999999 99887 9999999999999
Q ss_pred ccccccccccccccccccccccccCCCccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeec
Q 006112 167 LQSNESASARYFSDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSA 246 (660)
Q Consensus 167 ~~s~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsa 246 (660)
+.|.++++| .+.+|+.++|||+||+.+++|+|+|++.+. ..|+|++.+||+++|||+|||||||
T Consensus 163 i~S~~s~~~-------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~---~~~~ls~~vdL~~~l~e~v~VGFSA 226 (261)
T 3zyr_A 163 IRSSKVVRW-------------ERREGKTLNVLVTYNPSTRTIDVVATYPDG---QRYQLSHVVDLTTILPEWVRVGFSA 226 (261)
T ss_dssp SSCSEEEEC-------------CCCTTCCEEEEEEEETTTTEEEEEEECTTC---CEEEEEEECCGGGTSCSEEEEEEEE
T ss_pred CCccccccc-------------cccCCceEEEEEEEcCCCCEEEEEEEcCCC---CCeEEEEEechHHhCcCcEEEEEEe
Confidence 999988865 456899999999999999999999997542 3789999999999999999999999
Q ss_pred ccCceeeeeeecCcccccCC
Q 006112 247 ATGTRVSDYYILGWSFNKSG 266 (660)
Q Consensus 247 stg~~~~~h~i~~wsf~~~g 266 (660)
|||...|.|+|++|+|++..
T Consensus 227 sTG~~~e~h~IlsWsF~s~l 246 (261)
T 3zyr_A 227 ASGEQFQTHNLESWSFTSTL 246 (261)
T ss_dssp EESSSCCEEEEEEEEEEEEE
T ss_pred cCCCccceEEEEEEEEEEEc
Confidence 99999999999999999864
|
| >1dbn_A MAL, protein (leukoagglutinin); plant lectin, carbohydrate binding, sialyllactose, sugar BIN protein; HET: NAG SIA GAL BGC; 2.75A {Maackia amurensis} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-61 Score=479.29 Aligned_cols=223 Identities=31% Similarity=0.479 Sum_probs=203.3
Q ss_pred CcceeeeCCCC--CCCeeEecceeEcCCCcEEecCCC-----CCeeEEEEeCCCeeeccCC-CCceeEEEEEEEEEecCC
Q 006112 26 EENQFIHHGFE--GSKLKLDGLAKIHPNGLLQLTNTS-----ERISGHAFYPFPFKFNSSS-SQSLSFSTSFVFAMFPKL 97 (660)
Q Consensus 26 ~~~~f~~~~f~--~~~l~~~g~a~~~~~g~l~Lt~~~-----~~~~G~~~y~~pv~~~~~~-~~~~sFst~F~F~i~~~~ 97 (660)
..++|+|++|+ ..||+|+|+|.+.++|.|+||++. .+++|||+|++||++|++. ++++||+|+|+|.|.+++
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pi~l~~~~tg~vaSFsT~F~F~I~~~~ 81 (239)
T 1dbn_A 2 DELSFTINNFVPNEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWGNTTGSVASFSTSFTFVVKAPN 81 (239)
T ss_dssp CEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSS
T ss_pred cceEEEcCCCCCCCCCeEEcccEEecCCCcEEeCCCCCCCcccCceEEEEeCCCEecccCCCCCccceEEEEEEEEeCCC
Confidence 46799999998 579999999999889999999876 6899999999999999987 889999999999999887
Q ss_pred CCCCCCceEEEEecCCC-CCCCCCCCcccccccCCCCCCCccEEEEEeecccC---CCCCCCCCCeeEEEcCCccccccc
Q 006112 98 PNYGGHGMAFFISPSTD-FSEAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQS---PEFNDIDGNHVGIDVNGLQSNESA 173 (660)
Q Consensus 98 ~~~~g~GlaF~l~p~~~-~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n---~~~~d~~~~Hvgid~ns~~s~~~~ 173 (660)
...+||||||||+|... +|.++.||||||+|.++ ++..+|+|||||||++| .+ +||++||||||+||+.|.+++
T Consensus 82 ~~~~gdGlAF~l~p~~~~~p~~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~n~~~~~-~Dp~~nHVGIdvNs~~S~~~~ 159 (239)
T 1dbn_A 82 PDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSN-SDSSNQIVAVEFDTYFAHSYDP-WDPNYRHIGIDVNGIESIKTV 159 (239)
T ss_dssp TTSCCEEEEEEEECTTCCCCSSSCGGGTTSCSSSC-CCTTSCCEEEEEECCCCTTTCT-TSCSSCEEEEEESSSSCSEEE
T ss_pred CCCCCCCEEEEEecCCCCCCcCCCCCcccccccCC-CCccccEEEEEEeccccCcccc-cCCCCCcEEEecCCccccceE
Confidence 77799999999999875 68889999999999764 46789999999999999 77 699999999999999998887
Q ss_pred cccccccccccccccccCCCccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeecccCce--
Q 006112 174 SARYFSDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTR-- 251 (660)
Q Consensus 174 ~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg~~-- 251 (660)
+| +|.+|+.++|||+||+.+++|+|+|.+.+ .|..|+|++.+||+++|+|+||||||||||..
T Consensus 160 ~~-------------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~ 224 (239)
T 1dbn_A 160 QW-------------DWINGGVAFATITYLAPNKTLIASLVYPS--NQTTFSVAASVDLKEILPEWVRVGFSAATGYPTE 224 (239)
T ss_dssp EC-------------CCCTTCCEEEEEEEEGGGTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEEEEEEEECSGGG
T ss_pred cc-------------cccCCCEEEEEEEEeCCCcEEEEEEccCC--CCCcceEEEEechHHhCCccEEEEEEeccCCCcc
Confidence 64 47799999999999999999999999764 35678999999999999999999999999998
Q ss_pred eeeeeecCcccccC
Q 006112 252 VSDYYILGWSFNKS 265 (660)
Q Consensus 252 ~~~h~i~~wsf~~~ 265 (660)
.|.|+|++|+|+++
T Consensus 225 ~~~h~IlsWsF~s~ 238 (239)
T 1dbn_A 225 VETHDVLSWSFTST 238 (239)
T ss_dssp CCCCEEEEEEEEEE
T ss_pred ceeeEEEEEEeEec
Confidence 99999999999863
|
| >1fny_A BARK lectin, BARK agglutinin I,polypeptide A; legume lectin, jelly roll, sugar binding protein; 1.81A {Robinia pseudoacacia} SCOP: b.29.1.1 PDB: 1fnz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-61 Score=477.20 Aligned_cols=221 Identities=29% Similarity=0.468 Sum_probs=199.5
Q ss_pred cceeeeCCCC--CCCeeEecceeEcCCCcEEecCCC-----CCeeEEEEeCCCeeeccCC-CCceeEEEEEEEEEecCCC
Q 006112 27 ENQFIHHGFE--GSKLKLDGLAKIHPNGLLQLTNTS-----ERISGHAFYPFPFKFNSSS-SQSLSFSTSFVFAMFPKLP 98 (660)
Q Consensus 27 ~~~f~~~~f~--~~~l~~~g~a~~~~~g~l~Lt~~~-----~~~~G~~~y~~pv~~~~~~-~~~~sFst~F~F~i~~~~~ 98 (660)
.++|+|++|+ ..||+|+|+|.+.++|.|+||++. .+++|||+|++||++|++. ++++||+|+|+|.|.+.+.
T Consensus 3 ~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pi~l~d~~tg~vaSFsT~F~F~I~~~~~ 82 (237)
T 1fny_A 3 SLSFSFPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDSTTGNVASFVTSFTFIIQAPNP 82 (237)
T ss_dssp EEEEEESSCCTTCTTEEEEETCEECTTSCEECSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSST
T ss_pred ceEEEcCCCCCCCCCeEEcccEEeccCCeEEecCCcCCCcccCceEEEEeCCCEecccCCCCCccceEEEEEEEEeCCCC
Confidence 5789999998 579999999999889999999876 6899999999999999987 8899999999999998877
Q ss_pred CCCCCceEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCeeEEEcCCcccccccccccc
Q 006112 99 NYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYF 178 (660)
Q Consensus 99 ~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~ 178 (660)
..+||||||||+|....| ++.||||||+|.++ ++..+|+|||||||++|.+ |||++|||||||||+.|.++++|
T Consensus 83 ~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~n~~-~Dp~~nHVGIdvNsi~S~~~~~~--- 156 (237)
T 1fny_A 83 ATTADGLAFFLAPVDTQP-LDLGGMLGIFKDGY-FNKSNQIVAVEFDTFSNGD-WDPKGRHLGINVNSIESIKTVPW--- 156 (237)
T ss_dssp TSCCEEEEEEEEETTCCC-CCCGGGTTTCC----CCTTSCCEEEEEECSCCTT-TCCSSSEEEEEESSSSCSEEEEC---
T ss_pred CCCCCCEEEEeccCCCCC-CCCCCcccccccCC-CCccccEEEEEeecccCcc-cCCCCCceEEecCCccccccccc---
Confidence 779999999999987655 48899999999764 4678999999999999988 69999999999999999888764
Q ss_pred ccccccccccccCCCccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeecccCce---eeee
Q 006112 179 SDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTR---VSDY 255 (660)
Q Consensus 179 ~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg~~---~~~h 255 (660)
+|.+|+.++|||+||+.+++|+|+|.+.+ .|..|+|++.+||+++|||+||||||||||.. .|.|
T Consensus 157 ----------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~~~h 224 (237)
T 1fny_A 157 ----------NWTNGEVANVFISYEASTKSLTASLVYPS--LETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQTN 224 (237)
T ss_dssp ----------CCCTTCCEEEEEEEEGGGTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCCCC
T ss_pred ----------cccCCCEEEEEEEEeCCCcEEEEEEecCC--CCCcceEEEEechHHhCCCcEEEEEEEeeCCCCccccee
Confidence 47799999999999999999999999764 35678999999999999999999999999998 9999
Q ss_pred eecCcccccC
Q 006112 256 YILGWSFNKS 265 (660)
Q Consensus 256 ~i~~wsf~~~ 265 (660)
+|++|+|++.
T Consensus 225 ~IlsWsF~s~ 234 (237)
T 1fny_A 225 DVLSWSFESN 234 (237)
T ss_dssp EEEEEEEEEE
T ss_pred EEEEEEEEEe
Confidence 9999999875
|
| >1v6i_A Agglutinin, PNA, galactose-binding lectin; open quaternary association, orthorhombic, carbohydrate specificity, protein crystallography; HET: GAL GLC; 2.15A {Arachis hypogaea} SCOP: b.29.1.1 PDB: 1bzw_A* 1v6j_A* 1v6k_A* 1v6l_A* 1v6m_A 1v6n_A 1v6o_A 2dva_A* 1cq9_A 1ciw_A* 1qf3_A* 1rir_A* 1rit_A* 2dh1_A 1cr7_A* 2dv9_A* 2dvb_A* 2dvd_A* 2dvf_A 2dvg_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-61 Score=472.60 Aligned_cols=220 Identities=28% Similarity=0.445 Sum_probs=201.9
Q ss_pred CcceeeeCCCC--CCCeeEecceeEcCCCcEEecCC-CCCeeEEEEeCCCeeeccCC-CCceeEEEEEEEEEecCCCCCC
Q 006112 26 EENQFIHHGFE--GSKLKLDGLAKIHPNGLLQLTNT-SERISGHAFYPFPFKFNSSS-SQSLSFSTSFVFAMFPKLPNYG 101 (660)
Q Consensus 26 ~~~~f~~~~f~--~~~l~~~g~a~~~~~g~l~Lt~~-~~~~~G~~~y~~pv~~~~~~-~~~~sFst~F~F~i~~~~~~~~ 101 (660)
..++|+|++|+ ..||+|+|+|.+.++|.|+||++ ..+++|||+|++||++|++. ++++||+|+|+|.|.+++...+
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~Gra~y~~Pi~l~~~~tg~vaSFsT~F~F~I~~~~~~~~ 81 (232)
T 1v6i_A 2 ETVSFNFNSFSEGNPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIWSSATGNVASFLTSFSFEMKDIKDYDP 81 (232)
T ss_dssp EEEEEEESSCCTTCTTEEEEESCEECTTSCEECSCTTSTTCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECCSSSBC
T ss_pred cceEEEcCCCCCCCCCeEEcccEEEccCCcEEeCCCCCCCceEEEEeCCCEEeecCCCCCccceEEEEEEEEecCCCCCC
Confidence 35799999998 57999999999988999999998 88999999999999999987 8899999999999998877778
Q ss_pred CCceEEEEecCC-CCCCCC-CCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCeeEEEcCCccccccccccccc
Q 006112 102 GHGMAFFISPST-DFSEAV-AGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFS 179 (660)
Q Consensus 102 g~GlaF~l~p~~-~~~~~~-~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~ 179 (660)
||||||||+|.. .+|.++ .||||||+|. ++.+|+|||||||++|.++|||++||||||+|++.|.++++|
T Consensus 82 gdGlAF~l~p~~~~~p~~~~~g~~LGl~n~----~~~~~~vAVEFDT~~n~~~~Dp~~nHVGIdvns~~S~~~~~~---- 153 (232)
T 1v6i_A 82 ADGIIFFIAPEDTQIPAGSIGGGTLGVSDT----KGAGHFVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVPW---- 153 (232)
T ss_dssp CCEEEEEEEETTCCCCTTCCCGGGTTTSCT----TSEEEEEEEEEECSCCGGGTCCSSCEEEEEEEESSCSEEEEC----
T ss_pred CCCEEEEEecCCCCCCCCcCCCcccccccC----CCcccEEEEEeecccccccCCCCCCeEEEEcCCccccccccc----
Confidence 999999999987 468778 8999999986 457999999999999999999999999999999999888764
Q ss_pred cccccccccccCCCccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeecccCc--eeeeeee
Q 006112 180 DEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGT--RVSDYYI 257 (660)
Q Consensus 180 ~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg~--~~~~h~i 257 (660)
+|.+|+.++|||+||+.+++|+|+|++ + +|..|+|++.+||+++|||+|||||| |||. ..|.|+|
T Consensus 154 ---------~l~~G~~~~v~I~Yd~~~~~L~V~l~~-~--~~~~~~ls~~vdL~~~l~e~v~VGFS-sTG~~~~~~~h~I 220 (232)
T 1v6i_A 154 ---------NSVSGAVVKVTVIYDSSTKTLSVAVTN-D--NGDITTIAQVVDLKAKLPERVKFGFS-ASGSLGGRQIHLI 220 (232)
T ss_dssp ---------CCCTTCEEEEEEEEETTTTEEEEEEEC-T--TSCEEEEEEECCHHHHSCSEEEEEEE-EECCSSBCCEEEE
T ss_pred ---------cccCCCEEEEEEEEeCCCcEEEEEEec-C--CCCcceEEEEechHHhCCccEEEEEE-ecCCCccccEEEE
Confidence 477999999999999999999999997 4 46789999999999999999999999 9998 6999999
Q ss_pred cCcccccCC
Q 006112 258 LGWSFNKSG 266 (660)
Q Consensus 258 ~~wsf~~~g 266 (660)
++|+|++..
T Consensus 221 lsWsF~s~l 229 (232)
T 1v6i_A 221 RSWSFTSTL 229 (232)
T ss_dssp EEEEEEEEE
T ss_pred EEEEEEeec
Confidence 999998764
|
| >1fx5_A UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HOMO-dimer, fucose specific lectin, SUG binding protein; HET: NAG FUC BMA MAN; 2.20A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1jxn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-60 Score=473.84 Aligned_cols=223 Identities=28% Similarity=0.425 Sum_probs=202.3
Q ss_pred CcceeeeCCCC--CCCeeEecceeEcCCCcEEecCCC---CCeeEE-EEeCCCeeeccCC-CCceeEEEEEEEEEecC-C
Q 006112 26 EENQFIHHGFE--GSKLKLDGLAKIHPNGLLQLTNTS---ERISGH-AFYPFPFKFNSSS-SQSLSFSTSFVFAMFPK-L 97 (660)
Q Consensus 26 ~~~~f~~~~f~--~~~l~~~g~a~~~~~g~l~Lt~~~---~~~~G~-~~y~~pv~~~~~~-~~~~sFst~F~F~i~~~-~ 97 (660)
..++|+|++|+ ..||+|+|+|.+.++|.|+||++. .+++|| |+|++||+||++. ++++||+|+|+|.|.+. +
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~Gr~a~y~~Pv~l~~~~tg~vaSFsT~F~F~I~~~~~ 81 (242)
T 1fx5_A 2 DDLSFKFKNFSQNGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWNCNTGELASFITSFSFFMETSAN 81 (242)
T ss_dssp CEEEEEESSCCTTCSSEEEEETCEECTTSCEESCCCSSSSCSEEEEEEEESSCEECEETTTTEECEEEEEEEEEEEESSC
T ss_pred cceEEEcCCCCCCCCCeEEcccEEeccCCcEEecCCCCcccCCccCEEEeCCCEEeecCCCCCccceEEEEEEEEecCCC
Confidence 46799999998 579999999999889999999986 689999 9999999999987 78999999999999987 5
Q ss_pred CCCCCCceEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCC-CCCCCCeeEEEcCCcccccccccc
Q 006112 98 PNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEF-NDIDGNHVGIDVNGLQSNESASAR 176 (660)
Q Consensus 98 ~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~-~d~~~~Hvgid~ns~~s~~~~~~~ 176 (660)
...+||||||||+|....| ++.||||||+|.++ ++..||+|||||||++|.++ |||++||||||+||+.|.++++|
T Consensus 82 ~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~-~~~~n~~vAVEFDT~~N~~~~~Dp~~nHVGIdvNs~~S~~~~~~- 158 (242)
T 1fx5_A 82 PKAATDGLTFFLAPPDSPL-RRAGGYFGLFNDTK-CDSSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAERW- 158 (242)
T ss_dssp GGGCCCEEEEEEECTTCCC-CBCGGGTTTBSSSC-CCGGGCCEEEEEECCCTTTSTTSCSSCEEEEEESSSSCSEEEEC-
T ss_pred CCCCCCcEEEEEecCCCCC-CCCCCcccccccCC-CCccCcEEEEEeccccCcccccCCCCCeEEEecCCccccceecc-
Confidence 6678999999999987654 48899999999765 46789999999999999997 89999999999999999888764
Q ss_pred ccccccccccccccCCC--ccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeeccc--Ccee
Q 006112 177 YFSDEKKEFESLVLESG--KPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAAT--GTRV 252 (660)
Q Consensus 177 ~~~~~~~~~~~~~l~~g--~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsast--g~~~ 252 (660)
+|.+| +.++|||+||+.+++|+|+|.+.+. |..|+|++.+||+++|||+||||||||| |..
T Consensus 159 ------------~l~~G~~~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGFSAsT~~G~~- 223 (242)
T 1fx5_A 159 ------------NKRYGLNNVANVEIIYEASSKTLTASLTYPSD--QTSISVTSIVDLKEILPEWVSVGFSGSTYIGRQ- 223 (242)
T ss_dssp ------------CCCCSGGGCEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCGGGTSCSEEEEEEEEEEETTSC-
T ss_pred ------------cccCCCceeEEEEEEEeCCCCEEEEEEecCCC--CccceeeEEechHHhCCccEEEEEEecccCCCc-
Confidence 46789 9999999999999999999997653 5578999999999999999999999999 998
Q ss_pred eeeeecCcccccCC
Q 006112 253 SDYYILGWSFNKSG 266 (660)
Q Consensus 253 ~~h~i~~wsf~~~g 266 (660)
|.|+|++|+|++..
T Consensus 224 ~~h~IlsWsF~s~l 237 (242)
T 1fx5_A 224 ATHEVLNWYFTSTF 237 (242)
T ss_dssp EEEEEEEEEEEEES
T ss_pred ceeEEEEEEeEeec
Confidence 99999999999864
|
| >1hql_A Lectin; xenograft antigen, sugar BI protein; HET: GLA MBG NAG; 2.20A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1gnz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-60 Score=478.17 Aligned_cols=239 Identities=30% Similarity=0.460 Sum_probs=202.6
Q ss_pred CcceeeeCCCC---CCCeeEecceeEcCCCcEEecCCC------CCeeEEEEeCCCeeeccCC-CCceeEEEEEEEEEec
Q 006112 26 EENQFIHHGFE---GSKLKLDGLAKIHPNGLLQLTNTS------ERISGHAFYPFPFKFNSSS-SQSLSFSTSFVFAMFP 95 (660)
Q Consensus 26 ~~~~f~~~~f~---~~~l~~~g~a~~~~~g~l~Lt~~~------~~~~G~~~y~~pv~~~~~~-~~~~sFst~F~F~i~~ 95 (660)
..++|+|++|. ..||+|+|+|.+. +|.|+||++. .+++|||||++||++|++. ++++||+|+|+|.|.+
T Consensus 3 ~~~~F~f~~F~~~~~~~l~l~GdA~v~-~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vasFsT~F~F~I~~ 81 (257)
T 1hql_A 3 DSVSFTFPNFWSDVEDSIIFQGDANTT-AGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWDNKTESVASFYTEFTFFLKI 81 (257)
T ss_dssp -CCEEEESCSCSCGGGTEEEEETCEEE-TTEEECSCBCTTSCBCSSCEEEEEESSCEECCCSTTCCCCEEEEEEEEEEEE
T ss_pred cceEEEcCCCCCCCCCCEEEccceEec-CCcEEecCCccCCcccCCCeEEEEECCCEecccCCCCCeeceEEEEEEEEec
Confidence 46899999998 5799999999998 9999999876 5789999999999999987 8899999999999998
Q ss_pred CCCCCCCCceEEEEecCCCCCCCCCCCcccccccCC-CCCCCccEEEEEeecccCCCCCCCCCCeeEEEcCCcccccccc
Q 006112 96 KLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSN-NGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESAS 174 (660)
Q Consensus 96 ~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~-~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~ 174 (660)
. ...+||||||||+|....| ++.||||||+|.++ +++..||+|||||||++|.+|.||++||||||+||+.|.++++
T Consensus 82 ~-~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~~~~~~~n~~vAVEFDT~~N~~~~Dp~~nHVGIdvNs~~S~~s~~ 159 (257)
T 1hql_A 82 T-GNGPADGLAFFLAPPDSDV-KDAGEYLGLFNKSTATQPSKNQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATKR 159 (257)
T ss_dssp C-SSCCCCEEEEEEECTTCCC-CCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCSSSCCCSSCEEEEEESSSSCSEEEE
T ss_pred C-CCCCCCcEEEEEecCCCCC-CCCCccccccccccccCCccCceEEEEecccccccccCCCCCceeeeeCCccccceec
Confidence 7 6778999999999987654 48899999999876 3677899999999999999988999999999999999998887
Q ss_pred ccccccccccccccccCCCccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeecccC-ceee
Q 006112 175 ARYFSDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATG-TRVS 253 (660)
Q Consensus 175 ~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg-~~~~ 253 (660)
|. + .+|.+|+.++|||+||+.+++|+|+|.+.+. ..|+|++.+||+.+||++|||||||||| ...|
T Consensus 160 ~~--------~--~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~---~~~~ls~~vdL~~~l~e~~~vGFSAsTG~~~~~ 226 (257)
T 1hql_A 160 WE--------D--SDIFSGKIATARISYDGSAEILTVVLSYPDG---SDYILSHSVDMRQNLPESVRVGISASTGNNQFL 226 (257)
T ss_dssp CC--------H--HHHTSCSCEEEEEEEETTTTEEEEEEEETTT---EEEEEEEECCGGGTSCSEEEEEEEEECCSCCCE
T ss_pred cC--------c--ccccCCceEEEEEEEeCCCCEEEEEEecCCC---CceeeEEeechHHhcCCceEEEEEeccCCCccc
Confidence 62 0 1366799999999999999999999997644 4689999999999999999999999999 8999
Q ss_pred eeeecCcccccCCCCCcCCCCCCCCCC
Q 006112 254 DYYILGWSFNKSGPAQNLDISKLPPLP 280 (660)
Q Consensus 254 ~h~i~~wsf~~~gp~~~l~~~~~p~~~ 280 (660)
.|+|++|+|++.++.+..+.+.+|..|
T Consensus 227 ~H~IlsWsF~s~~~~~~~~~~~~p~~~ 253 (257)
T 1hql_A 227 TVYILSWRFSSNLQSTSVKAAMEPEIT 253 (257)
T ss_dssp EEEEEEEEEEEEC--------------
T ss_pred eeEEEEEEeEecCCCCCcccccCCCCC
Confidence 999999999999888888887777654
|
| >1gzc_A Erythrina crista-galli lectin; carbohydrate, sugar binding protein, saccharide, protein-carbohydrate interactions, lactose, glycoprotein; HET: LAT; 1.58A {Erythrina crista-galli} SCOP: b.29.1.1 PDB: 1gz9_A* 1fyu_A* 1ax0_A* 1ax1_A* 1ax2_A* 1axy_A* 1axz_A* 1lte_A* 1sfy_A* 1v00_A* 1uzz_A 1uzy_A* 3n35_A* 3n36_A* 3n3h_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-60 Score=471.07 Aligned_cols=222 Identities=30% Similarity=0.488 Sum_probs=200.0
Q ss_pred CcceeeeCCCC--CCCeeEecceeEcCCCcEEecCCC------CCeeEEEEeCCCeeeccCC-CCceeEEEEEEEEEecC
Q 006112 26 EENQFIHHGFE--GSKLKLDGLAKIHPNGLLQLTNTS------ERISGHAFYPFPFKFNSSS-SQSLSFSTSFVFAMFPK 96 (660)
Q Consensus 26 ~~~~f~~~~f~--~~~l~~~g~a~~~~~g~l~Lt~~~------~~~~G~~~y~~pv~~~~~~-~~~~sFst~F~F~i~~~ 96 (660)
..++|+|++|+ ..||+|+|+|.+.++|.|+||++. .+++|||+|++||++|++. ++++||+|+|+|.|.+.
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pi~l~~~~tg~vaSFsT~F~F~I~~~ 81 (239)
T 1gzc_A 2 ETISFSFSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWDSTTGTVASFETRFSFSIEQP 81 (239)
T ss_dssp EEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCC
T ss_pred eeEEEEeCCCCCCCCCeEEcccEEEcCCCcEEeCCCCcCCcccCCceEEEEeCCCEecccCCCCCccceEEEEEEEEeCC
Confidence 35789999998 579999999999889999999876 5789999999999999987 88999999999999987
Q ss_pred C-CCCCCCceEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCeeEEEcCCccccccccc
Q 006112 97 L-PNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASA 175 (660)
Q Consensus 97 ~-~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~ 175 (660)
+ ...+||||||||+|....| ++.||||||+|.++ ++..+|+|||||||++|. |.||++||||||+||+.|.++++|
T Consensus 82 ~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~n~-~dDp~~nHVGIdvns~~S~~~~~~ 158 (239)
T 1gzc_A 82 YTRPLPADGLVFFMGPTKSKP-AQGYGYLGVFNNSK-QDNSYQTLAVEFDTFSNP-WDPPQVPHIGIDVNSIRSIKTQPF 158 (239)
T ss_dssp CSSSCCCEEEEEEEECSSCCC-CCCGGGTTTCSSSS-CCGGGCCEEEEEECSCCT-TSCSSSSEEEEEESSSSCSEEEEC
T ss_pred CCCCCCCCcEEEEEecCCCCC-CCCCCcccccccCC-CCccccEEEEEEeccccc-CCCCCCCeEEEecCCccccccccc
Confidence 6 6678999999999987655 48899999999764 467899999999999998 777999999999999999888764
Q ss_pred cccccccccccccccCCCccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeecccCc---ee
Q 006112 176 RYFSDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGT---RV 252 (660)
Q Consensus 176 ~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg~---~~ 252 (660)
+|.+|+.++|||+||+.+++|+|+|.+.+ .|..|+|++.+||+++|||+||||||||||. ..
T Consensus 159 -------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~ 223 (239)
T 1gzc_A 159 -------------QLDNGQVANVVIKYDAPSKILHVVLVYPS--SGAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDAA 223 (239)
T ss_dssp -------------CCCTTCEEEEEEEEETTTTEEEEEEECTT--TCCEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCC
T ss_pred -------------cccCCCEEEEEEEEeCCCcEEEEEEecCC--CCccceEEEEechHHhCCCceEEEEEeccCCCcccc
Confidence 47799999999999999999999998754 3567899999999999999999999999997 58
Q ss_pred eeeeecCcccccC
Q 006112 253 SDYYILGWSFNKS 265 (660)
Q Consensus 253 ~~h~i~~wsf~~~ 265 (660)
|.|+|++|+|++.
T Consensus 224 ~~h~IlsWsF~s~ 236 (239)
T 1gzc_A 224 ETHDVYSWSFQAS 236 (239)
T ss_dssp CCCEEEEEEEEEE
T ss_pred ceEEEEEEEeEEe
Confidence 9999999999875
|
| >1qnw_A Chitin binding lectin, UEA-II; carbohydrate binding; HET: NAG; 2.35A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1dzq_A* 1qoo_A* 1qos_A* 1qot_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-59 Score=468.17 Aligned_cols=223 Identities=28% Similarity=0.481 Sum_probs=203.2
Q ss_pred CCcceeeeCCCC--CCCeeEecceeEcCCCcEEecCCC---CCeeEEEEeCCCeeeccCC-CCceeEEEEEEEEEecCCC
Q 006112 25 QEENQFIHHGFE--GSKLKLDGLAKIHPNGLLQLTNTS---ERISGHAFYPFPFKFNSSS-SQSLSFSTSFVFAMFPKLP 98 (660)
Q Consensus 25 ~~~~~f~~~~f~--~~~l~~~g~a~~~~~g~l~Lt~~~---~~~~G~~~y~~pv~~~~~~-~~~~sFst~F~F~i~~~~~ 98 (660)
+..++|+|++|+ ..||+|+|+|.+.++|.|+||++. .+++|||+|++||++|++. ++++||+|+|+|.|.+. .
T Consensus 3 ~~~~~F~f~~F~~~~~~l~l~G~A~i~~~g~l~LT~~~~~~~~~~Gra~y~~Pv~l~~~~tg~vasFsT~F~F~I~~~-~ 81 (242)
T 1qnw_A 3 SDDLSFNFDKFVPNQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWDSITGKVASFATSFSFVVKAD-K 81 (242)
T ss_dssp CCSEEEEESSCCTTCTTEEEEETCEECTTSCEESSCCC--CCCEEEEEEESSCEECBCTTTCCBCEEEEEEEEECCBS-S
T ss_pred ccceEEEcCCCCCCCCCeEEccceEEccCCcEEecCCCCcccCCeEEEEeCCCEeeecCCCCCcccEEEEEEEEEecC-C
Confidence 456899999998 579999999999889999999987 7899999999999999987 88999999999999987 6
Q ss_pred CCCCCceEEEEecCC-CCCCCCCCCcccccccCCCCCCCccEEEEEeecc----cCCCCCCCCCCeeEEEcCCccccccc
Q 006112 99 NYGGHGMAFFISPST-DFSEAVAGSHLGIFNRSNNGQFTNHIFAIELDTV----QSPEFNDIDGNHVGIDVNGLQSNESA 173 (660)
Q Consensus 99 ~~~g~GlaF~l~p~~-~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~----~n~~~~d~~~~Hvgid~ns~~s~~~~ 173 (660)
..+||||||||+|.. .+|.++.||||||+|.++ ++..+|+|||||||+ +|. +||++||||||+|++.|.+++
T Consensus 82 ~~~gdGlAF~l~p~~~~~p~~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~~~~~N~--~Dp~~nHVGIdvNs~~S~~~~ 158 (242)
T 1qnw_A 82 SDGVDGLAFFLAPANSQIPSGSSAGMFGLFSSSD-SKSSNQIIAVEFDTYFGKAYNP--WDPDFKHIGIDVNSIKSIKTV 158 (242)
T ss_dssp SCCCCEEEEEEEETTCCCCTTCCGGGTTTCSSSS-CCTTSCCEEEEEECCCCTTTCT--TSCSSCEEEEEESSSSCSEEE
T ss_pred CCCCCCEEEEEecCCCCCCcCCCCCcccccccCC-CCccccEEEEEeecccccccCC--CCCCCCcEEEecCCcccccee
Confidence 778999999999987 468889999999999765 467899999999999 997 799999999999999998887
Q ss_pred cccccccccccccccccCCCccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeecccCce--
Q 006112 174 SARYFSDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTR-- 251 (660)
Q Consensus 174 ~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg~~-- 251 (660)
+| +|.+|+.++|||+||+.+++|+|+|.+.+ .|..|+|++.+||+.+|||+|||||||+||..
T Consensus 159 ~~-------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~ 223 (242)
T 1qnw_A 159 KW-------------DWRNGEVADVVITYRAPTKSLTVCLSYPS--DGTSNIITASVDLKAILPEWVSVGFSGGVGNAAE 223 (242)
T ss_dssp EC-------------CCCTTCCEEEEEEEEGGGTEEEEEEECTT--TCCEEEEEEECCHHHHSCSEEEEEEEEEESCGGG
T ss_pred cc-------------cccCCCEEEEEEEEeCCCcEEEEEEecCC--CCcceeEEEeechHHhcCCceEEEEEeccCCCcc
Confidence 64 47799999999999999999999998754 35678999999999999999999999999999
Q ss_pred eeeeeecCcccccCC
Q 006112 252 VSDYYILGWSFNKSG 266 (660)
Q Consensus 252 ~~~h~i~~wsf~~~g 266 (660)
.|.|+|++|+|++..
T Consensus 224 ~~~h~IlsWsF~s~l 238 (242)
T 1qnw_A 224 FETHDVLSWYFTSNL 238 (242)
T ss_dssp CBCCEEEEEEEEEEC
T ss_pred ceEEEEEEEEeEeec
Confidence 999999999999864
|
| >2eig_A Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG binding protein; HET: NAG; 2.00A {Lotus tetragonolobus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-59 Score=464.87 Aligned_cols=217 Identities=29% Similarity=0.414 Sum_probs=199.8
Q ss_pred ceeeeCCCC-CCCeeEecceeEcCCCcEEecCC--CCCeeEEEEeCCCeeeccCC-CCceeEEEEEEEEEecCCCCCCCC
Q 006112 28 NQFIHHGFE-GSKLKLDGLAKIHPNGLLQLTNT--SERISGHAFYPFPFKFNSSS-SQSLSFSTSFVFAMFPKLPNYGGH 103 (660)
Q Consensus 28 ~~f~~~~f~-~~~l~~~g~a~~~~~g~l~Lt~~--~~~~~G~~~y~~pv~~~~~~-~~~~sFst~F~F~i~~~~~~~~g~ 103 (660)
++|+|++|. ..||+|+|+|.+.++|.|+||++ ..+++|||+|++||++|++. ++++||+|+|+|.|.+.+...+||
T Consensus 1 ~sF~f~~F~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~Gra~y~~Pv~l~~~~tg~vaSFsT~F~F~I~~~~~~~~gd 80 (234)
T 2eig_A 1 VSFNYTRFKDDGSLIFQGDAKIWTDGRLAMPTDPLVNRTTSHALYATPVPIWDSATGNVASFITSFSFIVSNVQRYPPTD 80 (234)
T ss_dssp CEEEESSCCSSSSEEEEETCEEEGGGEEESSSCGGGSSEEEEEEESSCEECBCTTTCCBCEEEEEEEEEEEECTTSCCCC
T ss_pred CeEEcCCCCCCCCeEEcccEEEcCCCCeeeCCCCCccCceEEEEeCCCEEeecCCCCCccceEEEEEEEEeCCCCCCCCC
Confidence 479999998 78999999999987999999998 77899999999999999987 889999999999999887777999
Q ss_pred ceEEEEecCC-CCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCC---CeeEEEcCCccccccccccccc
Q 006112 104 GMAFFISPST-DFSEAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDG---NHVGIDVNGLQSNESASARYFS 179 (660)
Q Consensus 104 GlaF~l~p~~-~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~---~Hvgid~ns~~s~~~~~~~~~~ 179 (660)
||||||+|.. .+|.++.||||||+|.+ ++.+|+|||||||++|. |||++ ||||||+||+.|.++++|
T Consensus 81 GlAF~l~p~~~~~p~~~~g~~LGl~n~~---~~~~~~vAVEFDT~~N~--~Dp~~~~~nHVGIdvNsi~S~~~~~~---- 151 (234)
T 2eig_A 81 GVVFFLAPWGTEIPPNSQGGYLGITDSS---NSQNQFVAVEFDSHPNV--WDPKSLRSSHIGIDVNSIMSLKAVNW---- 151 (234)
T ss_dssp EEEEEEEETTCCCCTTCCGGGTTTCCTT---CSCCCCEEEEEECSCCT--TSCTTTCSSEEEEEESSSSCSEEEEC----
T ss_pred cEEEEEecCCCCCCcCCCCCccccccCC---CccccEEEEEeccccCc--cCCCCCCCCceEEecCCccccceecc----
Confidence 9999999987 47888899999999975 56799999999999998 69999 999999999999888764
Q ss_pred cccccccccccCCCccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeeccc--Cceeeeeee
Q 006112 180 DEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAAT--GTRVSDYYI 257 (660)
Q Consensus 180 ~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsast--g~~~~~h~i 257 (660)
+|.+|+.++|||+||+.+++|+|+|++ + .|..|+|++.+||+++|||+||||||||| |.. |.|+|
T Consensus 152 ---------~l~~g~~~~v~I~Yd~~~~~L~V~l~~-~--~~~~~~ls~~vdL~~~l~e~v~VGFSAsT~~G~~-~~h~I 218 (234)
T 2eig_A 152 ---------NRVSGSLEKATIIYDSDTKILTVVMTH-Q--NGQITTISQEIDLKTVLPEKVSVGFSATTWNPER-ERHDI 218 (234)
T ss_dssp ---------CCCTTCCEEEEEEEETTTTEEEEEEEE-T--TSCEEEEEEECCHHHHSCSEEEEEEEEEECSSCC-EEEEE
T ss_pred ---------cccCCCEEEEEEEEeCCCcEEEEEEec-C--CCCcceEeEeechHHhcCCceEEEEEeeecCCCc-ceeEE
Confidence 477999999999999999999999998 4 46678999999999999999999999999 988 99999
Q ss_pred cCcccccCC
Q 006112 258 LGWSFNKSG 266 (660)
Q Consensus 258 ~~wsf~~~g 266 (660)
++|+|++..
T Consensus 219 lsWsF~s~l 227 (234)
T 2eig_A 219 YSWSFTSTL 227 (234)
T ss_dssp EEEEEEEEC
T ss_pred EEEEEEecC
Confidence 999999864
|
| >1sbf_A Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {Glycine max} SCOP: b.29.1.1 PDB: 1sbd_A* 1sbe_A* 1g9f_A* 2sba_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-59 Score=467.99 Aligned_cols=220 Identities=28% Similarity=0.442 Sum_probs=200.0
Q ss_pred CcceeeeCCCC--CCCeeEecceeEcCCCcEEecCCC------CCeeEEEEeCCCeeeccCC-CCceeEEEEEEEEEecC
Q 006112 26 EENQFIHHGFE--GSKLKLDGLAKIHPNGLLQLTNTS------ERISGHAFYPFPFKFNSSS-SQSLSFSTSFVFAMFPK 96 (660)
Q Consensus 26 ~~~~f~~~~f~--~~~l~~~g~a~~~~~g~l~Lt~~~------~~~~G~~~y~~pv~~~~~~-~~~~sFst~F~F~i~~~ 96 (660)
..++|+|++|+ ..||+|+|+|.+.++|.|+||++. .+++|||||++||++|++. ++++||+|+|+|.|.+.
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~GdA~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~~ 81 (253)
T 1sbf_A 2 ETVSFSWNKFVPKQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIWDKETGSVASFAASFNFTFYAP 81 (253)
T ss_dssp EEEEEEESSCCTTCTTEEEEETCEECTTSCEECSCBCTTSCBCTTCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECS
T ss_pred cceEEEcCCCCCCCCCeEEcccEEEcCCCeEEeCCCccCCcccCCCeEEEEECCCEecccCCCCcccceEEEEEEEEeCC
Confidence 45799999998 579999999999889999999876 5789999999999999987 88999999999999988
Q ss_pred CCCCCCCceEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCeeEEEcCCcccccccccc
Q 006112 97 LPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASAR 176 (660)
Q Consensus 97 ~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~ 176 (660)
+...+||||||||+|....| ++.||||||+|.+ ++.+|+|||||||++|. |||++||||||+||+.|.++++|
T Consensus 82 ~~~~~gdGlAF~l~p~~~~~-~~~g~~LGL~n~~---~~~n~~vAVEFDT~~N~--~Dp~~nHVGIdvNs~~S~~t~~~- 154 (253)
T 1sbf_A 82 DTKRLADGLAFFLAPIDTKP-QTHAGYLGLFNEN---ESGDQVVAVEFDTFRNS--WDPPNPHIGINVNSIRSIKTTSW- 154 (253)
T ss_dssp STTSCCEEEEEEEEETTCCC-CCCGGGTTTCCTT---SCCCSCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEEEEC-
T ss_pred CCCCCCCcEEEEEecCCCCC-CCCCCccccccCC---CcccceEEEEeccccCC--CCCCCCcEEEEcCCccccceecc-
Confidence 77779999999999987655 4889999999976 56899999999999998 79999999999999999888764
Q ss_pred ccccccccccccccCCCccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeecccCce--eee
Q 006112 177 YFSDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTR--VSD 254 (660)
Q Consensus 177 ~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg~~--~~~ 254 (660)
+|.+|+.++|||+||+.+++|+|+|.+.+ .|..|+|++.+||+.+|||+||||||||||.. .|.
T Consensus 155 ------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~~ 220 (253)
T 1sbf_A 155 ------------DLANNKVAKVLITYDASTSLLVASLVYPS--QRTSNILSDVVDLKTSLPEWVRIGFSAATGLDIPGES 220 (253)
T ss_dssp ------------CCCTTCCEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEEEEEEEECSSSCCCE
T ss_pred ------------cccCCCeeEEEEEEeCCCcEEEEEEecCC--CCCcceEEEEechHHhCCCceEEEEEeccCCCcccee
Confidence 47789999999999999999999999764 35678999999999999999999999999998 999
Q ss_pred eeecCcccccCC
Q 006112 255 YYILGWSFNKSG 266 (660)
Q Consensus 255 h~i~~wsf~~~g 266 (660)
|+|++|+|++..
T Consensus 221 H~IlsWsF~s~l 232 (253)
T 1sbf_A 221 HDVLSWSFASNL 232 (253)
T ss_dssp EEEEEEEEEEEE
T ss_pred eEEEEEEeEeec
Confidence 999999999864
|
| >2fmd_A Lectin, agglutinin, BMA; legume lectin, beta sandwich, protein-carbohydrate complex, sugar binding protein; HET: MAN; 1.90A {Bowringia mildbraedii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-59 Score=465.62 Aligned_cols=224 Identities=30% Similarity=0.447 Sum_probs=201.5
Q ss_pred CcceeeeCCCC--CCCeeEecceeEcCCCcEEecCCCC------CeeEEEEeCCCeeeccCCCCceeEEEEEEEEEecCC
Q 006112 26 EENQFIHHGFE--GSKLKLDGLAKIHPNGLLQLTNTSE------RISGHAFYPFPFKFNSSSSQSLSFSTSFVFAMFPKL 97 (660)
Q Consensus 26 ~~~~f~~~~f~--~~~l~~~g~a~~~~~g~l~Lt~~~~------~~~G~~~y~~pv~~~~~~~~~~sFst~F~F~i~~~~ 97 (660)
..++|+|++|+ ..+|+|+|+|.+.++|.|+||++.. ++.|||||++||+||+++++++||+|+|+|.|.+.
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~G~a~y~~Pv~l~~~~g~~~sFst~F~F~I~~~- 80 (240)
T 2fmd_A 2 NSVCFTFTDFESGQQDLIFQGDASVGSNKALQLTKVDSKGNPQGGSVGRALYTAPIRLWQSSSLVASFETTFTFSISQG- 80 (240)
T ss_dssp CEEEEEESSCCTTCTTEEEEETCEECTTSCEECSCBCTTSCBCSSCEEEEEESSCEECCCTTCSEEEEEEEEEEECCBS-
T ss_pred cceEEEcCCCCCCCCCeEEccceEEcCCCCEEeCCCCcCCcccCCCeEEEEECCCEEeeCCCCCcCcEEEEEEEEEecC-
Confidence 46799999998 5799999999998789999999876 79999999999999988778899999999999987
Q ss_pred CCCCCCceEEEEecCCCCCCC-CCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCeeEEEcCCcccccccccc
Q 006112 98 PNYGGHGMAFFISPSTDFSEA-VAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASAR 176 (660)
Q Consensus 98 ~~~~g~GlaF~l~p~~~~~~~-~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~ 176 (660)
...+||||||||+|.+..|.+ +.|+||||+|.+++++..+|+|||||||++|.+++||++||||||+|++.|..+++|
T Consensus 81 ~~~~gdGlAF~l~p~~~~p~~g~~g~~LGl~n~~~~~~~~n~~vAVEfDT~~N~~~~Dp~~nHvgIdvns~~S~~s~~~- 159 (240)
T 2fmd_A 81 SSTPADALTFFIASPDTKIPSGSGGRLLGLFGSSNNAGSDNGVVSVEFDTYPNTDIGDPNYRHIGIDVNSIRSKAASKW- 159 (240)
T ss_dssp SSSCCCEEEEEEECTTCCCCTTCCGGGTTTCSCCC----CCCEEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEEC-
T ss_pred CCCCCCcEEEEEecCCCCCCccCCCCcccccccCcCCCCcCcEEEEEeccccccccCCCCCCceeeccccccccceeEE-
Confidence 677899999999998766665 889999999988777778999999999999999889999999999999999888764
Q ss_pred ccccccccccccccCCCccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeecccCceeeeee
Q 006112 177 YFSDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTRVSDYY 256 (660)
Q Consensus 177 ~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg~~~~~h~ 256 (660)
++.+|+.++|||+||+.+++|+|+|.+.+. ..|+|++.+||+.+||++||||||||||...|.|+
T Consensus 160 ------------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~---~~~~ls~~vdL~~~l~~~~yvGFSAsTG~~~~~H~ 224 (240)
T 2fmd_A 160 ------------DWQNGKTATAHISYNSASKRLSVVSSYPNS---SPVVVSFDVELNNVBPBWVRVGFSATTGQYTQTNN 224 (240)
T ss_dssp ------------CCCSSCEEEEEEEEETTTTEEEEEEECTTS---CCEEEEEECCGGGTSCSEEEEEEEEECCSSCBCCE
T ss_pred ------------EeeCCCEEEEEEEEeCCCCEEEEEEecCCC---CceEEEEEechHHhCCCceEEEEEeccCCccccEE
Confidence 366899999999999999999999997553 46899999999999999999999999999999999
Q ss_pred ecCcccccCC
Q 006112 257 ILGWSFNKSG 266 (660)
Q Consensus 257 i~~wsf~~~g 266 (660)
|++|+|++..
T Consensus 225 IlsWsF~s~~ 234 (240)
T 2fmd_A 225 ILAWSFRSSL 234 (240)
T ss_dssp EEEEEEEEEE
T ss_pred EEEEEeEecC
Confidence 9999998764
|
| >1g7y_A Stem/LEAF lectin DB58; jelly roll fold, sugar binding protein; HET: NAG FUC FUL; 2.50A {Vigna unguiculata subsp} SCOP: b.29.1.1 PDB: 1lul_A 1lu1_A* 1bjq_A* 1lu2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-59 Score=469.22 Aligned_cols=222 Identities=27% Similarity=0.435 Sum_probs=201.8
Q ss_pred CcceeeeCCCCCCCeeEecceeEcCCCcEEecCCC------CCeeEEEEeCCCeeeccCC-CCceeEEEEEEEEEecCCC
Q 006112 26 EENQFIHHGFEGSKLKLDGLAKIHPNGLLQLTNTS------ERISGHAFYPFPFKFNSSS-SQSLSFSTSFVFAMFPKLP 98 (660)
Q Consensus 26 ~~~~f~~~~f~~~~l~~~g~a~~~~~g~l~Lt~~~------~~~~G~~~y~~pv~~~~~~-~~~~sFst~F~F~i~~~~~ 98 (660)
..++|+|++|...||+|+|+|.+. +|.|+||++. .+++|||||++||++|++. ++++||+|+|+|.|.+++.
T Consensus 2 ~~~~F~f~~F~~~~l~l~GdA~v~-~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~~~~ 80 (253)
T 1g7y_A 2 DIQSFSFKNFNSSSFILQGDATVS-SSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIYDKSTGAVASWATSFTANIFAPNK 80 (253)
T ss_dssp EEEEEEESSCCSSCEEEEETCEEE-TTEEECSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSSG
T ss_pred cceEEEcCCCCcCCEEEecceEEe-CCEEEeCCCCCCCccccCCeEEEEECCCEEeecCCCCCccceEEEEEEEEecCCC
Confidence 457999999998899999999998 9999999876 5799999999999999987 8899999999999998766
Q ss_pred CCCCCceEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCeeEEEcCCcccccccccccc
Q 006112 99 NYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYF 178 (660)
Q Consensus 99 ~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~ 178 (660)
..+||||||||+|....| ++.||||||+|.++ ++..+|+|||||||++|.+ |||++||||||+||+.|.++++|
T Consensus 81 ~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~-~~~~n~~vAVEFDT~~N~~-~Dp~~nHVGIdvns~~S~~t~~~--- 154 (253)
T 1g7y_A 81 SSSADGIAFALVPVGSEP-KSNSGFLGVFDSDV-YDNSAQTVAVEFDTFSNTD-WDPTSRHIGIDVNSIKSIRTASW--- 154 (253)
T ss_dssp GGCCCEEEEEEEETTCCC-CCCGGGTTTCSCSS-CCGGGCCEEEEEECSCCTT-TCCSSCEEEEEESSSSCSEEEEC---
T ss_pred CCCCCcEEEEEecCCCCC-CCCCCcccccccCC-CCccCceEEEEecceeccC-cCCCCCcEeeccCCccccceecc---
Confidence 778999999999987655 48899999999874 3678999999999999998 69999999999999999888764
Q ss_pred ccccccccccccCCCccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeecccCce---eeee
Q 006112 179 SDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTR---VSDY 255 (660)
Q Consensus 179 ~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg~~---~~~h 255 (660)
+|.+|+.++|||+||+.+++|+|+|.+.+ .|..|+|++.+||+.+|||+||||||||||.. .|.|
T Consensus 155 ----------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~~~H 222 (253)
T 1g7y_A 155 ----------GLANGQNAEILITYNAATSLLVASLVHPS--RRTSYIVSERVDITNELPEYVSIGFSATTGLSEGYTETH 222 (253)
T ss_dssp ----------CCCTTSEEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEEEEEEECCSSSSCCCCC
T ss_pred ----------ccCCCCeEEEEEEEeCCCCEEEEEEecCC--CCCcceEEEEechHHhCCCceEEEEEeCcCCCCccccee
Confidence 47789999999999999999999998764 35678999999999999999999999999998 9999
Q ss_pred eecCcccccCC
Q 006112 256 YILGWSFNKSG 266 (660)
Q Consensus 256 ~i~~wsf~~~g 266 (660)
+|++|+|++..
T Consensus 223 ~IlsWsF~s~l 233 (253)
T 1g7y_A 223 DVLSWSFASKL 233 (253)
T ss_dssp EEEEEEEEEEE
T ss_pred EEEEEEEEeeC
Confidence 99999999864
|
| >1n47_A Isolectin B4; cancer antigen, vicia villosa lectin, glycoprotein TN-bindin protein, carbohydrate recognition, sugar binding protein; HET: NAG FUC TNR; 2.70A {Vicia villosa} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-59 Score=462.02 Aligned_cols=220 Identities=30% Similarity=0.470 Sum_probs=199.4
Q ss_pred CcceeeeCCCC--CCCeeEecceeEcCCCcEEecCCC-----CCeeEEEEeCCCeeeccCCCCceeEEEEEEEEEecCCC
Q 006112 26 EENQFIHHGFE--GSKLKLDGLAKIHPNGLLQLTNTS-----ERISGHAFYPFPFKFNSSSSQSLSFSTSFVFAMFPKLP 98 (660)
Q Consensus 26 ~~~~f~~~~f~--~~~l~~~g~a~~~~~g~l~Lt~~~-----~~~~G~~~y~~pv~~~~~~~~~~sFst~F~F~i~~~~~ 98 (660)
..++|+|++|+ +.||+|+|+|.+.++|.|+||++. .+++|||||++||++|++.+ ++||+|+|+|.|.+.+.
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pi~l~d~~~-~~sFsT~F~F~I~~~~~ 80 (233)
T 1n47_A 2 ESTSFSFTNFNPNQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIHDNTT-LASFTTSFSFVMAAPAA 80 (233)
T ss_dssp EEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCBSSSSBCTTCEEEEEESSCEECBCSSC-BCEEEEEEEEECCCSST
T ss_pred cceEEEcCCCCCCCCCeEEccceEEccCCcEEeccCcCCCccCCCeEEEEECCCEeccCCCC-cCCEEEEEEEEEeCCCC
Confidence 45799999998 579999999999879999999987 47999999999999999777 89999999999998877
Q ss_pred CCCCCceEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCeeEEEcCCcccccccccccc
Q 006112 99 NYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYF 178 (660)
Q Consensus 99 ~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~ 178 (660)
..+||||||||+|....|. +.||||||+|.++ ++..||+|||||||++|. +||++||||||+||+.|.++++|
T Consensus 81 ~~~gdGlAF~l~p~~~~p~-~~g~~LGl~n~~~-~~~~n~~vAVEFDT~~N~--~Dp~~nHvGIdvns~~S~~~~~~--- 153 (233)
T 1n47_A 81 AAVADGLAFFLAPPDTQPQ-ARGGFLGLFADRA-HDASYQTVAVEFDTYSNA--WDPNYTHIGIDTNGIESKKTTPF--- 153 (233)
T ss_dssp TSCCEEEEEEEECTTCCCC-CCGGGTTTCSSSS-CCGGGCCEEEEEECSCCT--TSCSSCEEEEEESSSSCSEEEEC---
T ss_pred CCCCCcEEEEEecCCCCCC-CCCCcccccccCC-CCccCceEEEEeccccCC--CCCCCCcEEEccCCccccccccc---
Confidence 7799999999999876665 8899999999874 467899999999999998 69999999999999999888764
Q ss_pred ccccccccccccCCCccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeecccCce---eeee
Q 006112 179 SDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTR---VSDY 255 (660)
Q Consensus 179 ~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg~~---~~~h 255 (660)
++.+|+.++|||+||+.+++|+|+|.+.+. +..|+|++.+||+.+|||+||||||||||.. .|.|
T Consensus 154 ----------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~~~~~vGFSAsTG~~~~~~~~h 221 (233)
T 1n47_A 154 ----------DMVYGEKANIVITYQASTKALAASLVFPVS--QTSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVETH 221 (233)
T ss_dssp ----------CCCTTSCEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCGGGTSCSEEEEEEEEEECSSTTCCCCC
T ss_pred ----------cccCCCEEEEEEEEeCCCCEEEEEEecCCC--CCcceEEEEechHHhCCCceEEEEEeccCCCcccccee
Confidence 467899999999999999999999997643 3478999999999999999999999999998 9999
Q ss_pred eecCcccccC
Q 006112 256 YILGWSFNKS 265 (660)
Q Consensus 256 ~i~~wsf~~~ 265 (660)
+|++|+|++.
T Consensus 222 ~IlsWsF~s~ 231 (233)
T 1n47_A 222 DIVSWSFAVS 231 (233)
T ss_dssp EEEEEEEEEE
T ss_pred EEEEEEEEee
Confidence 9999999864
|
| >1fat_A Phytohemagglutinin-L; glycoprotein, plant defense protein, lectin; HET: NAG; 2.80A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1g8w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-59 Score=468.82 Aligned_cols=221 Identities=29% Similarity=0.443 Sum_probs=201.2
Q ss_pred CcceeeeCCCCCCCeeEecceeEcCCCcEEecCCC------CCeeEEEEeCCCeeeccCC-CCceeEEEEEEEEEecCCC
Q 006112 26 EENQFIHHGFEGSKLKLDGLAKIHPNGLLQLTNTS------ERISGHAFYPFPFKFNSSS-SQSLSFSTSFVFAMFPKLP 98 (660)
Q Consensus 26 ~~~~f~~~~f~~~~l~~~g~a~~~~~g~l~Lt~~~------~~~~G~~~y~~pv~~~~~~-~~~~sFst~F~F~i~~~~~ 98 (660)
..++|+|++|...||+|+|+|.+.++|.|+||++. .+++|||||++||++|++. ++++||+|+|+|.|.+.+.
T Consensus 2 ~~~~F~f~~F~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~~~~ 81 (252)
T 1fat_A 2 NDIYFNFQRFNETNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDNTTGTVASFATSFTFNIQVPNN 81 (252)
T ss_dssp CCEEEEESSCCGGGEEEEETCEECTTSCEECSCCC-CCCCCTTCEEEEEEEEEEECEETTTTEEEEEEEEEEEECCCCSS
T ss_pred cceEEEcCCCCcCCEEEeccEEECCCCEEEeCCCCCCCccccCCEEEEEECCCEecccCCCCcccceEEEEEEEEeCCCC
Confidence 46899999999889999999999889999999986 5799999999999999987 7899999999999998877
Q ss_pred CCCCCceEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCeeEEEcCCcccccccccccc
Q 006112 99 NYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYF 178 (660)
Q Consensus 99 ~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~ 178 (660)
..+||||||||+|....| ++.||||||+|.+ ++.+|+|||||||++|.+ |||++||||||+|++.|.++++|
T Consensus 82 ~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~---~~~~~~vAVEFDT~~N~~-~Dp~~nHVGIdvNs~~S~~~~~~--- 153 (252)
T 1fat_A 82 AGPADGLAFALVPVGSQP-KDKGGFLGLFDGS---NSNFHTVAVEFDTLYNKD-WDPTERHIGIDVNSIRSIKTTRW--- 153 (252)
T ss_dssp CBCCEEEEEEEEETTCCC-CCSGGGTTTCCSS---CCCCCCEEEEEECSCCTT-TCCSSCEEEEEESSSSCSEEEEC---
T ss_pred CCCCCcEEEEEccCCCCC-CCCCccccccccC---CccCcEEEEEeecccCCC-CCCCCCeEEEecCCccccceecc---
Confidence 778999999999987655 4889999999976 558999999999999998 69999999999999999888764
Q ss_pred ccccccccccccCCCccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeecccCce---eeee
Q 006112 179 SDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTR---VSDY 255 (660)
Q Consensus 179 ~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg~~---~~~h 255 (660)
++.+|+.++|||+||+.+++|+|+|.+.+ .|..|+|++.+||+.+|||+||||||||||.. .|.|
T Consensus 154 ----------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~~~H 221 (252)
T 1fat_A 154 ----------DFVNGENAEVLITYDSSTNLLVASLVYPS--QKTSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNVETN 221 (252)
T ss_dssp ----------CCCTTCEEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTBCCCC
T ss_pred ----------cccCCCEEEEEEEEeCCCCEEEEEEecCC--CCCcceEEEEechHHhCCCceEEEEEeccCCCCcccceE
Confidence 46789999999999999999999999764 35678999999999999999999999999998 9999
Q ss_pred eecCcccccCC
Q 006112 256 YILGWSFNKSG 266 (660)
Q Consensus 256 ~i~~wsf~~~g 266 (660)
+|++|+|++..
T Consensus 222 ~IlsWsF~s~l 232 (252)
T 1fat_A 222 DVLSWSFASKL 232 (252)
T ss_dssp EEEEEEEEEEE
T ss_pred EEEEEEEEeeC
Confidence 99999999864
|
| >2bqp_A Protein (PEA lectin); D-glucopyranose complex, sugar binding protein; HET: GLC; 1.90A {Pisum sativum} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-59 Score=462.69 Aligned_cols=223 Identities=27% Similarity=0.442 Sum_probs=202.1
Q ss_pred CcceeeeCCCC--CCCeeEecceeEcCCCcEEecCCCCCeeEEEEeCCCeeeccCC-CCceeEEEEEEEEEecCCCCCCC
Q 006112 26 EENQFIHHGFE--GSKLKLDGLAKIHPNGLLQLTNTSERISGHAFYPFPFKFNSSS-SQSLSFSTSFVFAMFPKLPNYGG 102 (660)
Q Consensus 26 ~~~~f~~~~f~--~~~l~~~g~a~~~~~g~l~Lt~~~~~~~G~~~y~~pv~~~~~~-~~~~sFst~F~F~i~~~~~~~~g 102 (660)
..++|+|++|+ ..||+|+|+|. .++|.|+||++..++.|||||++||+||++. ++++||+|+|+|.|.+++...+|
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~-~~~g~l~LT~~~~~~~G~a~y~~Pv~l~~~~~~~~~sFst~F~F~I~~~~~~~~g 80 (234)
T 2bqp_A 2 ETTSFLITKFSPDQQNLIFQGDGY-TTKEKLTLTKAVKNTVGRALYSSPIHIWDRETGNVANFVTSFTFVINAPNSYNVA 80 (234)
T ss_dssp EEEEEEESSBCTTCTTEEEEETCE-EETBEEEEECSCTTCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECSSTTSCC
T ss_pred cceEEEcCCCCCCCCCEEEeecee-cCCCEEEeCCCCCCCEEEEEECCCEEcccCCCCceeeEEEEEEEEEeCCCCCCCC
Confidence 45789999998 57999999999 5689999999999999999999999999987 88999999999999988777899
Q ss_pred CceEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCC--CCeeEEEcCCcccccccccccccc
Q 006112 103 HGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDID--GNHVGIDVNGLQSNESASARYFSD 180 (660)
Q Consensus 103 ~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~--~~Hvgid~ns~~s~~~~~~~~~~~ 180 (660)
|||||+|+|.+..|. +.|+||||+|.++ ++..+|+|||||||++|.+ +||+ +||||||+|++.|..+++|
T Consensus 81 dGlAF~l~p~~~~p~-~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~N~~-~Dp~~~~nHVgIdvns~~S~~s~~~----- 152 (234)
T 2bqp_A 81 DGFTFFIAPVDTKPQ-TGGGYLGVFNSAE-YDKTTQTVAVEFDTFYNAA-WDPSNRDRHIGIDVNSIKSVNTKSW----- 152 (234)
T ss_dssp CEEEEEEEETTCCCC-CCGGGTTTCSCSS-CCGGGCCEEEEEECSCCTT-TSCTTCCCEEEEEESSSSCSEEEEC-----
T ss_pred CcEEEEEecCCCCCC-CCCCccccccccC-CCCCCcEEEEEEecccCcc-cCCCCCCCceeEeeCCccccceEee-----
Confidence 999999999876666 8899999999874 4678999999999999988 6999 9999999999999888764
Q ss_pred ccccccccccCCCccEEEEEEEeCcceeEEEEEeeCCCC---CCCCCcceeecCchhhhccceeeeeecccCceeeeeee
Q 006112 181 EKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNP---KPSRPLLSTSIDLSQILQDSMYVGLSAATGTRVSDYYI 257 (660)
Q Consensus 181 ~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~---~p~~~~l~~~~dL~~~l~~~~~vGFsastg~~~~~h~i 257 (660)
++.+|+.++|||+||+.+++|+|+|.+.+.. +|..|+|++.+||+.+||++||||||||||...|.|+|
T Consensus 153 --------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~p~~~~ls~~vdL~~~l~~~~yvGFSAsTG~~~~~H~I 224 (234)
T 2bqp_A 153 --------KLQNGEEANVVIAFNAATNVLTVSLTYPNNSLEEEVTSYTLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEV 224 (234)
T ss_dssp --------CCCTTCEEEEEEEEETTTTEEEEEEEECC------CEEEEEEEECCGGGTSCSEEEEEEEEECSSSCCEEEE
T ss_pred --------EEcCCCEEEEEEEEeCCCCEEEEEEecCCCCcccCCCcceEEEEechHHhCCCceEEEEEeccCCCcccEEE
Confidence 3678999999999999999999999987665 67889999999999999999999999999999999999
Q ss_pred cCcccccC
Q 006112 258 LGWSFNKS 265 (660)
Q Consensus 258 ~~wsf~~~ 265 (660)
++|+|++.
T Consensus 225 lsWsF~s~ 232 (234)
T 2bqp_A 225 LSWSFHSE 232 (234)
T ss_dssp EEEEEEEE
T ss_pred EEEEEEee
Confidence 99999864
|
| >1gsl_A Griffonia simplicifolia lectin 4; glycoprotein, manganese; HET: FUC GAL MAG NAG BMA; 2.00A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1lec_A* 1led_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-58 Score=461.66 Aligned_cols=221 Identities=29% Similarity=0.424 Sum_probs=199.0
Q ss_pred CcceeeeCCC----C--CCCeeEecceeEcCCCcEEecCCC------CCeeEEEEeCCCeeeccCCCCceeEEEEEEEEE
Q 006112 26 EENQFIHHGF----E--GSKLKLDGLAKIHPNGLLQLTNTS------ERISGHAFYPFPFKFNSSSSQSLSFSTSFVFAM 93 (660)
Q Consensus 26 ~~~~f~~~~f----~--~~~l~~~g~a~~~~~g~l~Lt~~~------~~~~G~~~y~~pv~~~~~~~~~~sFst~F~F~i 93 (660)
+.++|+|++| . ..||+|+|+|.+. +|.|+||++. .+++|||||++||+||+.+++++||+|+|+|.|
T Consensus 2 ~~~~F~f~~F~~~~~~~~~~l~l~GdA~i~-~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~~~tg~vasFsT~F~F~I 80 (243)
T 1gsl_A 2 NTVNFTYPDFWSYSLKNGTEITFLGDATRI-PGALQLTKTDANGNPVRSSAGQASYSEPVFLWDSTGKAASFYTSFTFLL 80 (243)
T ss_dssp CCCEEEESCCCCTTCCTTSSEEEEETCEEE-TTEEECSCBCTTSCBCSSEEEEEEESSCEECBCTTSCBCEEEEEEEEEE
T ss_pred cceEEEcCCCccccCCCCCCEEEccceEec-CCcEEecCCccCCcccCCCeEEEEECCCEEccCCCCCcCceEEEEEEEE
Confidence 4679999999 6 4799999999998 9999999976 579999999999999993388999999999999
Q ss_pred ecCCCCCCCCceEEEEecCCCCCCCCCCCcccccccCCC-CCCCccEEEEEeecccCCCCCCCCCCeeEEEcCCcccccc
Q 006112 94 FPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNN-GQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNES 172 (660)
Q Consensus 94 ~~~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~-~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~ 172 (660)
.++ ...+||||||||+|....| ++.||||||+|.+++ ++..||+|||||||++|.+|+||++||||||+|++.|.++
T Consensus 81 ~~~-~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~~~~~~~n~~vAVEFDT~~N~~~~Dp~~nHvGIdvns~~S~~~ 158 (243)
T 1gsl_A 81 KNY-GAPTADGLAFFLAPVDSSV-KDYGGFLGLFRHETAADPSKNQVVAVEFDTWINKDWNDPPYPHIGIDVNSIVSVAT 158 (243)
T ss_dssp EES-SSSCBCEEEEEEEETTCCC-CCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEE
T ss_pred ecC-CCCCCCCEEEEEecCCCCC-CCCCCcccccccccccCCccCcEEEEEeccccccccCCCCCCceeeccCCccccce
Confidence 987 6678999999999987654 488999999998764 6778999999999999999889999999999999999888
Q ss_pred ccccccccccccccccccCC---CccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeecccC
Q 006112 173 ASARYFSDEKKEFESLVLES---GKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATG 249 (660)
Q Consensus 173 ~~~~~~~~~~~~~~~~~l~~---g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg 249 (660)
++| ++.+ |+.++|||+||+.+++|+|+|.+.+. ..|+|++.+||+.+||++||||||||||
T Consensus 159 ~~~-------------~l~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~~---~~~~ls~~vdL~~~l~~~~~vGFSAsTG 222 (243)
T 1gsl_A 159 TRW-------------ENDDAYGSSIATAHITYDARSKILTVLLSYEHG---RDYILSHVVDLAKVLPQKVRIGFSAGVG 222 (243)
T ss_dssp EEC-------------CHHHHTSCCEEEEEEEEETTTTEEEEEEEETTS---CEEEEEEECCHHHHSCSEEEEEEEEEEC
T ss_pred eee-------------EEeccCCCcEEEEEEEEeCCCCEEEEEEecCCC---CceeEEEEechHHhCCCceEEEEEeccC
Confidence 765 2455 99999999999999999999997654 4689999999999999999999999999
Q ss_pred ceeeeeeecCcccccCC
Q 006112 250 TRVSDYYILGWSFNKSG 266 (660)
Q Consensus 250 ~~~~~h~i~~wsf~~~g 266 (660)
..|.|+|++|+|++..
T Consensus 223 -~~~~h~IlsWsF~s~l 238 (243)
T 1gsl_A 223 -YDEVTYILSWHFFSTL 238 (243)
T ss_dssp -BSEEEEEEEEEEEEEC
T ss_pred -CcceeEEEEEEEEeec
Confidence 9999999999999864
|
| >1wbf_A Protein (agglutinin); lectin (agglutinin), legume lectin, protein crystallography, group specificity, saccharide free form; HET: NAG; 2.30A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 2d3s_A* 2dtw_A* 1wbl_A* 2dty_A* 2du0_A* 2du1_A* 2e51_A* 2e53_A* 2zmk_A* 2zml_A* 2zmn_A* 2e7t_A* 2e7q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-58 Score=460.57 Aligned_cols=219 Identities=31% Similarity=0.457 Sum_probs=198.2
Q ss_pred CcceeeeCCCC--CCCeeEecceeEcCCCcEEecCCC-----CCeeEEEEeCCCeeeccCC-CCceeEEEEEEEEEecC-
Q 006112 26 EENQFIHHGFE--GSKLKLDGLAKIHPNGLLQLTNTS-----ERISGHAFYPFPFKFNSSS-SQSLSFSTSFVFAMFPK- 96 (660)
Q Consensus 26 ~~~~f~~~~f~--~~~l~~~g~a~~~~~g~l~Lt~~~-----~~~~G~~~y~~pv~~~~~~-~~~~sFst~F~F~i~~~- 96 (660)
+.++|+|++|+ ..||+|+|+|.+.++|.|+||++. .+++|||||++||+||++. ++++||+|+|+|.|.+.
T Consensus 2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~~~ 81 (242)
T 1wbf_A 2 KTISFNFNQFHQNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDSTTGNVASFETRFSFSIRQPF 81 (242)
T ss_dssp CEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSC
T ss_pred cceEEEcCCCCCCCCCeEEccceEEccCCcEEecCcccCCcccCCeEEEEECCCEecccCCCCCeeeEEEEEEEEEeCCC
Confidence 45799999998 579999999999889999999886 6899999999999999987 88999999999999987
Q ss_pred CCCCCCCceEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCeeEEEcCCcccccccccc
Q 006112 97 LPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASAR 176 (660)
Q Consensus 97 ~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~ 176 (660)
+...+||||||||+|....| ++.||||||+|.+ +.+|+|||||||++|. |||++||||||+|++.|.++++|
T Consensus 82 ~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~----~~~~~vAVEFDT~~N~--~Dp~~nHVGIdvNs~~S~~~~~~- 153 (242)
T 1wbf_A 82 PRPHPADGLVFFIAPPNTQT-GEGGGYFGIYNPL----SPYPFVAVEFDTFRNT--WDPQIPHIGIDVNSVISTKTVPF- 153 (242)
T ss_dssp CSSCCCEEEEEEEECSSCCC-CCCGGGTTTCCTT----SCCCCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEEEEC-
T ss_pred CCCCCCCcEEEEEecCCCCC-CCCCCccccccCC----CcCcEEEEEeccccCC--CCCCCCeEEEECCCccccceeee-
Confidence 56778999999999987554 4889999999865 5799999999999998 79999999999999999887764
Q ss_pred ccccccccccccccCCCccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeeccc----Cce-
Q 006112 177 YFSDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAAT----GTR- 251 (660)
Q Consensus 177 ~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsast----g~~- 251 (660)
+|.+|+.++|||+||+.+++|+|+|.+.+. |..|+|++.+||+.+|||+||||||||| |..
T Consensus 154 ------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGFSAsTg~~~G~~~ 219 (242)
T 1wbf_A 154 ------------TLDNGGIANVVIKYDASTKILHVVLVFPSL--GTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQR 219 (242)
T ss_dssp ------------CCCTTSCEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEEEEEEEEEECCGGGCCT
T ss_pred ------------EecCCCEEEEEEEEeCCCCEEEEEEccCCC--CCcceEEEEechHHhcCCceEEEEEEeecCcCCccc
Confidence 477999999999999999999999997643 5578999999999999999999999999 887
Q ss_pred --eeeeeecCcccccCC
Q 006112 252 --VSDYYILGWSFNKSG 266 (660)
Q Consensus 252 --~~~h~i~~wsf~~~g 266 (660)
.|.|+|++|+|++..
T Consensus 220 ~~~~~h~IlsWsF~s~l 236 (242)
T 1wbf_A 220 NATETHDILSWSFSASL 236 (242)
T ss_dssp TCCCCCEEEEEEEEEEC
T ss_pred cccceEEEEEEEeEecC
Confidence 899999999999864
|
| >1f9k_A Acidic lectin; legume lectin, glycosylated protein, H-antigenic specificity agglutinin, sugar binding protein; HET: NAG MAN AMG; 3.00A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 1fay_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-58 Score=458.29 Aligned_cols=218 Identities=33% Similarity=0.493 Sum_probs=198.0
Q ss_pred cceeeeCCCC--CCCeeEecceeEcCCCcEEecCCC------CCeeEEEEeCCCeeeccCC-CCceeEEEEEEEEEecC-
Q 006112 27 ENQFIHHGFE--GSKLKLDGLAKIHPNGLLQLTNTS------ERISGHAFYPFPFKFNSSS-SQSLSFSTSFVFAMFPK- 96 (660)
Q Consensus 27 ~~~f~~~~f~--~~~l~~~g~a~~~~~g~l~Lt~~~------~~~~G~~~y~~pv~~~~~~-~~~~sFst~F~F~i~~~- 96 (660)
.++|+|++|+ ..||+|+|+|.+.++|.|+||++. .+++|||||++||+||++. ++++||+|+|+|.|.+.
T Consensus 2 ~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~d~~~g~vasFsT~F~F~I~~~~ 81 (238)
T 1f9k_A 2 TQSFNFDHFEENSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWDSTTGNVASFETRFSFNITQPY 81 (238)
T ss_dssp EEEEEESSCCSSCTTEEEEETCEECTTSCEECSCSEETTEECCSCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECCC
T ss_pred CeEEEcCCCCCCCCCeEEccceEECcCCcEEecCccccCccccCCEEEEEECCCEEeecCCCCCeeeEEEEEEEEEecCC
Confidence 5789999998 579999999999888999999986 5799999999999999987 88999999999999987
Q ss_pred CCCCCCCceEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCeeEEEcCCcccccccccc
Q 006112 97 LPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASAR 176 (660)
Q Consensus 97 ~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~ 176 (660)
+...+||||||||+|....| ++.||||||+|.+ +. +|+|||||||++|. +||++||||||+|++.|..+++|
T Consensus 82 ~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~---~~-~~~vAVEFDT~~N~--~Dp~~nHVgIdvns~~S~~s~~~- 153 (238)
T 1f9k_A 82 AYPEPADGLTFFMVPPNSPQ-GEDGGNLGVFKPP---EG-DNAFAVEFDTFQNT--WDPQVPHIGIDVNSIVSSKTLHF- 153 (238)
T ss_dssp SSSCCCEEEEEEEECTTCCC-CCSGGGTTTCCSS---CC-SCCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEEEEC-
T ss_pred CCCCCCCcEEEEEccCCCCC-CCCCCcccccccC---CC-CcEEEEEEecccCC--CCCCCCeEEEecCCccccceEee-
Confidence 66778999999999987655 4889999999976 45 99999999999998 79999999999999999887764
Q ss_pred ccccccccccccccCCCccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhcc--ceeeeeecccCce---
Q 006112 177 YFSDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQD--SMYVGLSAATGTR--- 251 (660)
Q Consensus 177 ~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~--~~~vGFsastg~~--- 251 (660)
+|.+|+.++|||+||+.+++|+|+|.+.+ .|..|+|++.+||+.+||| +||||||||||..
T Consensus 154 ------------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~ls~~vdL~~~l~~~~~~~vGFSAsTG~~~~~ 219 (238)
T 1f9k_A 154 ------------QLENGGVANVVIKYDSPTKILNVVLAFHS--VGTVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQKNA 219 (238)
T ss_dssp ------------CCCTTCCEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCHHHHSTTCSEEEEEEEEEECSSTTC
T ss_pred ------------cccCCCEEEEEEEEeCCCCEEEEEEecCC--CCCceeEEEEechHHhCCCCceEEEEEEeCcCCCCcc
Confidence 47799999999999999999999999764 3567899999999999999 9999999999998
Q ss_pred eeeeeecCcccccCC
Q 006112 252 VSDYYILGWSFNKSG 266 (660)
Q Consensus 252 ~~~h~i~~wsf~~~g 266 (660)
.|.|+|++|+|++..
T Consensus 220 ~~~h~IlsWsF~s~~ 234 (238)
T 1f9k_A 220 VETHEIISWSFTSSL 234 (238)
T ss_dssp CCEEEEEEEEEEEEC
T ss_pred cceEEEEEeEeEeec
Confidence 999999999999864
|
| >1avb_A Arcelin-1; lectin-like glycoprotein, plant defense, insecticidal activi lectin; HET: NAG; 1.90A {Phaseolus vulgaris} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-58 Score=454.15 Aligned_cols=216 Identities=29% Similarity=0.481 Sum_probs=196.0
Q ss_pred CcceeeeCCCCCCCeeEecceeEcCCCcEEecCC---CCCeeEEEEeCCCeeeccCC-CCceeEEEEEEEEEecCCCCCC
Q 006112 26 EENQFIHHGFEGSKLKLDGLAKIHPNGLLQLTNT---SERISGHAFYPFPFKFNSSS-SQSLSFSTSFVFAMFPKLPNYG 101 (660)
Q Consensus 26 ~~~~f~~~~f~~~~l~~~g~a~~~~~g~l~Lt~~---~~~~~G~~~y~~pv~~~~~~-~~~~sFst~F~F~i~~~~~~~~ 101 (660)
..++|+|++|+..||+|+|+|.+.++|.|+||++ ..+++|||+|++||++|++. ++++||+|+|+|.|.+++...+
T Consensus 2 ~~~~F~f~~F~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~Gra~y~~Pv~l~~~~~g~vaSFsT~F~F~I~~~~~~~~ 81 (226)
T 1avb_A 2 NDASFNVETFNKTNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQINDRTIDNLASFSTNFTFRINAKNIENS 81 (226)
T ss_dssp EEEEEEESSCCGGGEEEEETCEECTTSCEECSCSSSCCTTCEEEEEESSCEECEEGGGTEEEEEEEEEEEEEEESSTTSC
T ss_pred cceEEEcCCCCccCEEEeccEEECCCCEEEeCCCCCCccCCeEEEEeCCCEEeecCCCCCcccEEEEEEEEEeCCCCCCC
Confidence 3578999999988999999999987999999998 77899999999999999977 8899999999999998877789
Q ss_pred CCceEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCeeEEEcCCccccccccccccccc
Q 006112 102 GHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDE 181 (660)
Q Consensus 102 g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~ 181 (660)
||||||||+|....|. +.||||||+|.+ +++..||+|||||||+ +||||||+|++.|.++++|
T Consensus 82 gdGlAF~l~p~~~~p~-~~g~~LGl~n~~-~~~~~~~~vAVEFDT~---------~nHVGIdvNs~~S~~t~~~------ 144 (226)
T 1avb_A 82 AYGLAFALVPVGSRPK-LKGRYLGLFNTT-NYDRDAHTVAVVFDTV---------SNRIEIDVNSIRPIATESC------ 144 (226)
T ss_dssp CEEEEEEEEETTCCCC-CCGGGTTTCSCS-SCCGGGCCEEEEEETT---------TTEEEEEESSSSCSEEEEC------
T ss_pred CCcEEEEEecCCCCCC-CCCCcccccccC-CCCCcccEEEEEecCc---------CCccceeecCcccCccccC------
Confidence 9999999999877666 889999999976 4467899999999998 6999999999999988875
Q ss_pred cccccccccCCCccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeecccCce---eeeeeec
Q 006112 182 KKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTR---VSDYYIL 258 (660)
Q Consensus 182 ~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg~~---~~~h~i~ 258 (660)
+..|.+|+.++|||+||+.+++|+|+|++.+. +..|+|++.+||+++|||+||||||||||.. .|.|+|+
T Consensus 145 -----~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~~~VGFSAsTG~~~~~~~~h~Il 217 (226)
T 1avb_A 145 -----NFGHNNGEKAEVRITYDSPKNDLRVSLLYPSS--EEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETHNVL 217 (226)
T ss_dssp -----CSGGGTTCEEEEEEEEEGGGTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEEEEEEEEEECSSGGGCEEEEEE
T ss_pred -----CccccCCCeEEEEEEEeCCCcEEEEEEeecCC--CccceEEEEechHHhCCCceEEEEEeccCCCCcccceeEEE
Confidence 24677999999999999999999999997654 3378999999999999999999999999998 9999999
Q ss_pred CcccccC
Q 006112 259 GWSFNKS 265 (660)
Q Consensus 259 ~wsf~~~ 265 (660)
+|+|++.
T Consensus 218 sWsF~s~ 224 (226)
T 1avb_A 218 SWSFSSN 224 (226)
T ss_dssp EEEEEEE
T ss_pred EEEEEee
Confidence 9999864
|
| >1ioa_A Arcelin-5A, ARC5A; lectin-like proteins, plant defense proteins, lectin; HET: NAG FUC; 2.70A {Phaseolus vulgaris} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-58 Score=453.61 Aligned_cols=216 Identities=25% Similarity=0.389 Sum_probs=196.1
Q ss_pred CcceeeeCCCCCCC-eeEecceeEcCCCcEEecCCCC------CeeEEEEeCCCeeeccCCCCceeEEEEEEEEEecCCC
Q 006112 26 EENQFIHHGFEGSK-LKLDGLAKIHPNGLLQLTNTSE------RISGHAFYPFPFKFNSSSSQSLSFSTSFVFAMFPKLP 98 (660)
Q Consensus 26 ~~~~f~~~~f~~~~-l~~~g~a~~~~~g~l~Lt~~~~------~~~G~~~y~~pv~~~~~~~~~~sFst~F~F~i~~~~~ 98 (660)
..++|+|++|.+.| |+|+|+|.+.++|.|+||++.. +++|||+|++||++|++. +++||+|+|+|.|.+++.
T Consensus 2 ~~~~F~f~~F~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~s~Gra~y~~Pi~l~d~~-~vaSFsT~F~F~I~~~~~ 80 (240)
T 1ioa_A 2 TETSFNFPNFHTDDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIKDSN-NVASFNTNFTFIIRAKNQ 80 (240)
T ss_dssp CCCEEEESSCCTTSSEEEEETCEECTTSCEETTCBCTTSSBCSSCBEEEEESSCEECBCSS-CBEEEEEEEEEECCBSCT
T ss_pred cceEEEcCCCCCCCcEEEccceEECCCCeEEeCCCCCCCccccCceEEEEECCCEEccCCC-ccccEEEEEEEEEeCCCC
Confidence 46799999999889 9999999998899999998875 799999999999999987 899999999999998877
Q ss_pred CCCCCceEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCeeEEEcCCcccccccccccc
Q 006112 99 NYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYF 178 (660)
Q Consensus 99 ~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~ 178 (660)
..+||||||||+|....|. +.||||||+|.+ +++..+|+|||||||+ +||||||+||+.|.++++|
T Consensus 81 ~~~gdGlAF~l~p~~~~p~-~~g~~LGL~n~~-~~~~~~~~vAVEFDT~---------~nHVGIdvNs~~S~~t~~~--- 146 (240)
T 1ioa_A 81 SISAYGLAFALVPVNSPPQ-KKQEFLGIFNTN-NPEPNARTVAVVFNTF---------KNRIDFDKNFIKPYVNENC--- 146 (240)
T ss_dssp TSCCEEEEEEEEETTCCCC-CCGGGTTTCCCS-SCCGGGCCEEEEEETT---------TTEEEEEESSSSCSEEEEC---
T ss_pred CCCCCcEEEEEecCCCCCC-CCCCcccccccC-CCCCcCcEEEEEecCc---------CCceeeeeCCccccccccC---
Confidence 7799999999999877666 889999999976 4467899999999998 6999999999999988875
Q ss_pred ccccccccccccCCCccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeecccCce---eeee
Q 006112 179 SDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTR---VSDY 255 (660)
Q Consensus 179 ~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg~~---~~~h 255 (660)
+..|.+|+.++|||+||+.+++|+|+|++.+. +..|+|++.+||+++|||+||||||||||.. .|.|
T Consensus 147 --------~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGFSAsTG~~~~~~~~H 216 (240)
T 1ioa_A 147 --------DFHKYNGEKTDVQITYDSSNNDLRVFLHFTVS--QVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDTTETH 216 (240)
T ss_dssp --------CHHHHCSSCEEEEEEEETTTTEEEEEEEETTT--CCEEEEEEECCGGGTSCSEEEEEEEEEECSSTTTCBCC
T ss_pred --------CccccCCCEEEEEEEEeCCCcEEEEEEecCCC--CccceeEEEechHHhCCCceEEEEEeccCCCCccccee
Confidence 24677999999999999999999999997653 3478999999999999999999999999998 9999
Q ss_pred eecCcccccCC
Q 006112 256 YILGWSFNKSG 266 (660)
Q Consensus 256 ~i~~wsf~~~g 266 (660)
+|++|+|++.+
T Consensus 217 ~IlsWsF~s~~ 227 (240)
T 1ioa_A 217 DVLSWSFSSKF 227 (240)
T ss_dssp EEEEEEEEEEE
T ss_pred EEEEEEEEeeC
Confidence 99999999865
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-55 Score=452.79 Aligned_cols=259 Identities=27% Similarity=0.413 Sum_probs=215.9
Q ss_pred CceeeecccccccCccEEEEEEEeC-----CCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCee
Q 006112 334 HRFSYKNLYKATKGGSGKVYRGVLP-----SSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGEL 408 (660)
Q Consensus 334 ~~~~~~~l~~lg~G~fg~Vy~g~~~-----~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 408 (660)
.+.+|...++||+|+||+||+|++. .++..||||++.....+..++|.+|+++|++++|||||+++|+|.+++.+
T Consensus 11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 3456788899999999999999975 35789999999877777788999999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhhhCC-----------CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCe
Q 006112 409 LLVYDYMPNGSLDKILYSNT-----------RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEG 477 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~ 477 (660)
+||||||++|+|.++|.... ...++|.++.+|+.|||+||+|||+ ++||||||||+||||++++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcE
Confidence 99999999999999997542 3469999999999999999999998 899999999999999999999
Q ss_pred EEeecccceeccCCCCce-eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHh
Q 006112 478 KLGDFGLARLYDHGNDLH-TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQ 555 (660)
Q Consensus 478 kl~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~ 555 (660)
||+|||+|+......... .....||+.|||||++.++.++.++|||||||+||||+| |+.||...... .+.....
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~~~i~ 244 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIECIT 244 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHHHH
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHH
Confidence 999999998765433222 234579999999999999999999999999999999998 89999864432 2333334
Q ss_pred cCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 556 KGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 556 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
.+..... .. .+...+.+|+..||+.||++||||+||++.|+..
T Consensus 245 ~~~~~~~-----p~----~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 245 QGRVLQR-----PR----TCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp HTCCCCC-----CT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCCC-----Cc----cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 4433221 11 2234577899999999999999999999999864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-54 Score=456.16 Aligned_cols=261 Identities=26% Similarity=0.368 Sum_probs=209.9
Q ss_pred ceeeecccccccCccEEEEEEEeCC-----CCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeE
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPS-----SHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELL 409 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~-----~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 409 (660)
+.++...++||+|+||+||+|++.. +++.||||++........++|.+|+++|++++|||||+++|+|.+++.++
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 3356667889999999999999753 57899999998777777889999999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhhhCC-------------CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCC
Q 006112 410 LVYDYMPNGSLDKILYSNT-------------RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLE 476 (660)
Q Consensus 410 lV~E~~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~ 476 (660)
||||||++|+|.++|+... ...++|.++++|+.|||+||+|||+ ++||||||||+||||++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCc
Confidence 9999999999999997542 2459999999999999999999998 89999999999999999999
Q ss_pred eEEeecccceeccCCCC-ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHH
Q 006112 477 GKLGDFGLARLYDHGND-LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYW 554 (660)
Q Consensus 477 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~ 554 (660)
+||+|||+|+....... ...+...||+.|||||++.+..++.++|||||||+||||+| |+.||...... .+....
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~~~i 273 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT---EAIDCI 273 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH---HHHHHH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH---HHHHHH
Confidence 99999999987654332 23345789999999999999999999999999999999999 89999764332 223333
Q ss_pred hcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCCCCC
Q 006112 555 QKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGALL 610 (660)
Q Consensus 555 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 610 (660)
..+.... .... +...+.+|+.+||+.||++||||+||+++|+.....
T Consensus 274 ~~g~~~~-----~p~~----~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 274 TQGRELE-----RPRA----CPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHTCCCC-----CCTT----CCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HcCCCCC-----Cccc----ccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 3333221 1122 234577889999999999999999999999875433
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-54 Score=449.19 Aligned_cols=255 Identities=24% Similarity=0.379 Sum_probs=212.0
Q ss_pred eeecccccccCccEEEEEEEeC-----CCCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLP-----SSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLL 410 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~-----~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 410 (660)
+++.+++||+|+||+||+|++. .+++.||||++.... ....++|.+|+.++++++|||||+++|+|.+++.++|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 5667789999999999999974 356899999996543 3446789999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhhCC--------------CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCC
Q 006112 411 VYDYMPNGSLDKILYSNT--------------RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLE 476 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~ 476 (660)
|||||++|+|.++|.... ...++|.++.+|+.|||+||+|||+ ++||||||||+||||+++++
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCCC
Confidence 999999999999996532 2358999999999999999999998 89999999999999999999
Q ss_pred eEEeecccceeccCCCC-ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHH
Q 006112 477 GKLGDFGLARLYDHGND-LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYW 554 (660)
Q Consensus 477 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~ 554 (660)
+||+|||+|+....... ...+...||++|||||++.++.++.++|||||||+||||+| |+.||...... .+....
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~---~~~~~i 260 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DVVEMI 260 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH---HHHHHH
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH---HHHHHH
Confidence 99999999987644322 23345689999999999999999999999999999999998 89999864432 233334
Q ss_pred hcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 555 QKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 555 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
..+..... . ..++..+.+|+..||+.||++||||.||++.|+.
T Consensus 261 ~~~~~~~~-----p----~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 261 RNRQVLPC-----P----DDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp HTTCCCCC-----C----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HcCCCCCC-----c----ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 44433221 1 1234557889999999999999999999999985
|
| >1dhk_B Bean lectin-like inhibitor, porcine pancreatic alpha-amylase; CO (hydrolase-inhibitor), complex (hydrolase-inhibitor) comple; HET: NAG; 1.85A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1viw_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-53 Score=416.29 Aligned_cols=200 Identities=28% Similarity=0.403 Sum_probs=175.1
Q ss_pred CcceeeeCCCCCCCeeEecceeEcCCCcEEecCCCCCeeEEEEeCCCeeeccCC-CCceeEEEEEEEEEecCCCCCCCCc
Q 006112 26 EENQFIHHGFEGSKLKLDGLAKIHPNGLLQLTNTSERISGHAFYPFPFKFNSSS-SQSLSFSTSFVFAMFPKLPNYGGHG 104 (660)
Q Consensus 26 ~~~~f~~~~f~~~~l~~~g~a~~~~~g~l~Lt~~~~~~~G~~~y~~pv~~~~~~-~~~~sFst~F~F~i~~~~~~~~g~G 104 (660)
..++|+|++|++.||+|+|+|.+.++|.|+||++..++.|||+|++||++|++. ++++||+|+|+|.|.+++...+|||
T Consensus 2 ~~~~F~f~~F~~~~l~l~G~A~v~~~g~l~LT~~~~~~~Gra~y~~Pi~l~~~~~g~vaSFsT~F~F~I~~~~~~~~gdG 81 (223)
T 1dhk_B 2 TETSFIIDAFNKTNLILQGDATVSSNGNLQLSYNSYDSMSRAFYSAPIQIRDSTTGNVASFDTNFTMNIRTHRQANSAVG 81 (223)
T ss_dssp CCCEEEESSCCGGGEEEESSEEECTTSCEEESSSCSSEEEEEEESSCEESEETTTTEECEEEEEEEEEEECCC---CCSE
T ss_pred cceEEEcCCCCcCCEEEeccEEECCCCEEEcCCCCCCCEEEEEECCCEEeecCCCCCccceEEEEEEEEeCCCCCCCCCc
Confidence 457999999998899999999998799999999989999999999999999977 7899999999999998877779999
Q ss_pred eEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCeeEEEcCCcccccccccccccccccc
Q 006112 105 MAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKE 184 (660)
Q Consensus 105 laF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~~~~ 184 (660)
|||||+|....|+ +++|||||||+ +||||||+|++ |.++++|
T Consensus 82 lAF~l~p~~~~p~-------------------~~~vAVEFDT~---------~nHVGIdvNsi-S~~~~~~--------- 123 (223)
T 1dhk_B 82 LDFVLVPVQPESK-------------------GDTVTVEFDTF---------LSRISIDVNNN-DIKSVPW--------- 123 (223)
T ss_dssp EEEEEEEC-------------------------CCEEEEEETT---------TTEEEEEETTE-EEEEEEC---------
T ss_pred eEEEEecCCCCCC-------------------ccEEEEEecCC---------CCcccccCCcc-ccccccC---------
Confidence 9999999765332 34899999998 69999999999 9888765
Q ss_pred ccccccCCCccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeecccCce---eeeeeecCcc
Q 006112 185 FESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTR---VSDYYILGWS 261 (660)
Q Consensus 185 ~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg~~---~~~h~i~~ws 261 (660)
+..|.+|+.++|||+||+.+++|+|+|++.+. ++.|+|++.+||+++|||+|||||||+||.. .|.|+|++|+
T Consensus 124 --~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdLs~~l~e~~~VGFSAsTG~~~~~~~~H~IlsWs 199 (223)
T 1dhk_B 124 --DVHDYDGQNAEVRITYNSSTKVFSVSLSNPST--GKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLSWS 199 (223)
T ss_dssp --CGGGTTTSCEEEEEEEETTTTEEEEEEECTTT--CCEEEEEEECCCCSGGGSEEEEEEEEEECSGGGSCCEEEEEEEE
T ss_pred --CccccCCCEEEEEEEEeCCCCEEEEEEecCCC--CccceEEEEechHHhCCCceEEEEEeccCCCccccceEEEEEEE
Confidence 25677999999999999999999999997643 3478999999999999999999999999998 9999999999
Q ss_pred cccCCC
Q 006112 262 FNKSGP 267 (660)
Q Consensus 262 f~~~gp 267 (660)
|++.++
T Consensus 200 F~s~~~ 205 (223)
T 1dhk_B 200 FSSKFI 205 (223)
T ss_dssp EEEEC-
T ss_pred EEeccc
Confidence 998753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-53 Score=441.77 Aligned_cols=256 Identities=26% Similarity=0.412 Sum_probs=202.1
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
+++..++||+|+||+||+|++.. .||||+++.. ..+..++|.+|++++++++|||||+++|+|.+ +.++|||||
T Consensus 37 ~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 37 EVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp SCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 56677899999999999999843 5999998643 34456789999999999999999999999865 568999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC-C
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN-D 493 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~-~ 493 (660)
|++|+|.++|.... ..++|.++.+|+.|||+||+|||+ ++||||||||+||||++++++||+|||+|+...... .
T Consensus 113 ~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 113 CEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp CSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred CCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 99999999997653 359999999999999999999998 899999999999999999999999999998765432 2
Q ss_pred ceeeccccCccccCcccccC---CCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCccccc
Q 006112 494 LHTTNVVGTVGYLAPELLRN---GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGI 570 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~---~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 570 (660)
......+||+.|||||++.. +.++.++|||||||+||||+||+.||...... ..+......+.. .|.+. .
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~--~~~~~~~~~~~~----~p~~~-~ 261 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR--DQIIFMVGRGYA----SPDLS-K 261 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHHHHTTCC----CCCST-T
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH--HHHHHHHhcCCC----CCCcc-c
Confidence 23455789999999999863 46899999999999999999999999763321 222222223221 11111 1
Q ss_pred CcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 571 YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
....+...+.+++..||+.||++||||.||++.|+..
T Consensus 262 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 262 LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1223345678889999999999999999999988753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=441.79 Aligned_cols=254 Identities=24% Similarity=0.327 Sum_probs=213.9
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
-.|+.+++||+|+||+||+|++..+|+.||||++........+.+.+|+++|++++|||||++++++.+++.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46999999999999999999999999999999997666666778999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 495 (660)
++|+|.+++... .+++.++..++.||+.||+|||+ ++||||||||+||||+.++.+||+|||+|+.+..... .
T Consensus 154 ~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~ 226 (346)
T 4fih_A 154 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R 226 (346)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-C
T ss_pred CCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-c
Confidence 999999999753 48999999999999999999998 9999999999999999999999999999987654332 3
Q ss_pred eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHH
Q 006112 496 TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQ 575 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 575 (660)
.+..+||+.|||||++.+..|+.++|||||||++|||++|+.||....... +......+. .+.+.. ....
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~i~~~~-----~~~~~~--~~~~ 296 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMKMIRDNL-----PPRLKN--LHKV 296 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHHSS-----CCCCSC--GGGS
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHHHHcCC-----CCCCCc--cccC
Confidence 345789999999999999999999999999999999999999998644321 122222221 111111 1122
Q ss_pred HHHHHHHhhhccCCCCCCCCCHHHHHH--HhhC
Q 006112 576 MEIVLKLGLFCSHSNPDTRPSMRQVVQ--YLDG 606 (660)
Q Consensus 576 ~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~ 606 (660)
...+.+++..||+.||++|||++|+++ ++..
T Consensus 297 s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~ 329 (346)
T 4fih_A 297 SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 329 (346)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcC
Confidence 234677888899999999999999987 3543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-53 Score=445.67 Aligned_cols=250 Identities=25% Similarity=0.372 Sum_probs=206.5
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
+|+.+++||+|+||+||+|++..+++.||||++... .....+.+.+|++++++++|||||++++++.+++.+||||||
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy 104 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY 104 (350)
T ss_dssp CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 699999999999999999999999999999999654 334567899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
|+||+|.++|.......+++.++..++.||+.||+|||+ ++||||||||+||||+.++.+||+|||+|+...... .
T Consensus 105 ~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~ 180 (350)
T 4b9d_A 105 CEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-E 180 (350)
T ss_dssp CTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-H
T ss_pred CCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-c
Confidence 999999999987666668999999999999999999998 999999999999999999999999999998754321 1
Q ss_pred eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHH
Q 006112 495 HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEE 574 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 574 (660)
..+..+||+.|||||++.+..|+.++|||||||++|||+||+.||....... +......+.. +.+...++
T Consensus 181 ~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~~i~~~~~-----~~~~~~~s-- 250 (350)
T 4b9d_A 181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN---LVLKIISGSF-----PPVSLHYS-- 250 (350)
T ss_dssp HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHTCC-----CCCCTTSC--
T ss_pred cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHHHHcCCC-----CCCCccCC--
Confidence 2345689999999999999999999999999999999999999998654321 2222222222 11222232
Q ss_pred HHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 575 QMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 575 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
..+.+|+..||+.||++|||++|+++
T Consensus 251 --~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 251 --YDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp --HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 34677888899999999999999987
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=433.94 Aligned_cols=249 Identities=22% Similarity=0.197 Sum_probs=204.9
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 416 (660)
.|+..++||+|+||+||+|++..+|+.||||++..... ..+|+.++++++|||||++++++.+++.++||||||+
T Consensus 59 ~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~ 133 (336)
T 4g3f_A 59 WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133 (336)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred heEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 57788899999999999999999999999999965422 2479999999999999999999999999999999999
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCC-CeEEeecccceeccCCCCc-
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADL-EGKLGDFGLARLYDHGNDL- 494 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~-~~kl~DFGla~~~~~~~~~- 494 (660)
||+|.++|.... .+++.++..++.||+.||+|||+ ++||||||||+||||+.++ .+||+|||+|+........
T Consensus 134 gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 134 GGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp TCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 999999997654 49999999999999999999998 9999999999999999987 6999999999977543221
Q ss_pred ---eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHHHHHHhcCCcccCCCCccccc
Q 006112 495 ---HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVIDYWQKGDVLDASDPRLEGI 570 (660)
Q Consensus 495 ---~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~ 570 (660)
.....+||+.|||||++.+..++.++|||||||++|||+||+.||..... .+...+.. ...... .
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~---~~~~~~--------~ 277 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS---EPPPIR--------E 277 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH---SCCGGG--------G
T ss_pred ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc---CCCCch--------h
Confidence 12346799999999999999999999999999999999999999976433 23322221 111100 1
Q ss_pred CcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 571 YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
..+.....+.+++..||+.||++|||+.|++++|..
T Consensus 278 ~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 278 IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 112233456778889999999999999999988764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=424.28 Aligned_cols=247 Identities=25% Similarity=0.359 Sum_probs=200.3
Q ss_pred eecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeee----cCeeEEE
Q 006112 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR----KGELLLV 411 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~lV 411 (660)
|+..++||+|+||+||+|++..++..||+|++... .....+.|.+|++++++++|||||+++++|.. ++.++||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 35556799999999999999999999999999643 34456789999999999999999999999865 3458999
Q ss_pred EecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCc--eeccCccCCcEEEcC-CCCeEEeecccceec
Q 006112 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQV--VLHRDIKPANVLLDA-DLEGKLGDFGLARLY 488 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDikp~NIll~~-~~~~kl~DFGla~~~ 488 (660)
||||++|+|.+++.... .+++..+..++.||+.||+|||+ ++ ||||||||+||||+. ++.+||+|||+|+..
T Consensus 108 mEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 99999999999997654 48999999999999999999998 66 999999999999984 789999999999864
Q ss_pred cCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCccc
Q 006112 489 DHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLE 568 (660)
Q Consensus 489 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 568 (660)
.. ......+||+.|||||++.+ +++.++|||||||++|||+||+.||..... ...+......+.. .+.+.
T Consensus 183 ~~---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~--~~~~~~~i~~~~~----~~~~~ 252 (290)
T 3fpq_A 183 RA---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTSGVK----PASFD 252 (290)
T ss_dssp CT---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHHTTTCC----CGGGG
T ss_pred CC---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc--HHHHHHHHHcCCC----CCCCC
Confidence 32 23345789999999999864 699999999999999999999999975332 1222222222211 11122
Q ss_pred ccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 569 GIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
...+ ..+.+++..||+.||++|||++|++++
T Consensus 253 ~~~~----~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 253 KVAI----PEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GCCC----HHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccCC----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2222 246778889999999999999999863
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=443.62 Aligned_cols=255 Identities=24% Similarity=0.288 Sum_probs=214.6
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
+-.|+.+++||+|+||.||+|++..+|+.||||++........+.+.+|+.+|++++|||||++++++.+++.+||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 34699999999999999999999999999999999876666678899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
|+||+|.+++... .+++.++..++.||+.||+|||+ ++||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 230 ~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~- 302 (423)
T 4fie_A 230 LEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 302 (423)
T ss_dssp CTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-
T ss_pred CCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-
Confidence 9999999999754 38999999999999999999998 9999999999999999999999999999987654332
Q ss_pred eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHH
Q 006112 495 HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEE 574 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 574 (660)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||........ ......+..... .....++
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~---~~~i~~~~~~~~---~~~~~~s-- 374 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MKMIRDNLPPRL---KNLHKVS-- 374 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHHHHSCCCCC---SCTTSSC--
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---HHHHHcCCCCCC---cccccCC--
Confidence 33457899999999999999999999999999999999999999976443221 222222211111 0111222
Q ss_pred HHHHHHHHhhhccCCCCCCCCCHHHHHH--HhhC
Q 006112 575 QMEIVLKLGLFCSHSNPDTRPSMRQVVQ--YLDG 606 (660)
Q Consensus 575 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~ 606 (660)
..+.+|+.+||+.||++|||++|+++ +|..
T Consensus 375 --~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~ 406 (423)
T 4fie_A 375 --PSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 406 (423)
T ss_dssp --HHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred --HHHHHHHHHHcCCChhHCcCHHHHhcCHHhcC
Confidence 34667888899999999999999987 3544
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=430.28 Aligned_cols=261 Identities=25% Similarity=0.278 Sum_probs=201.8
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecC----eeEEEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKG----ELLLVY 412 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~lV~ 412 (660)
+|...++||+|+||+||+|++ +|+.||||++..... ....+..|+..+.+++|||||+++|+|.+++ .++|||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 466778899999999999998 588999999854322 2223445677778899999999999998764 589999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcc-----cCceeccCccCCcEEEcCCCCeEEeeccccee
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEW-----EQVVLHRDIKPANVLLDADLEGKLGDFGLARL 487 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 487 (660)
|||++|+|.++|+.. .++|.++.+++.|+|+||+|||+.+ .++||||||||+||||+.++++||+|||+|+.
T Consensus 81 Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 999999999999764 4899999999999999999999742 35999999999999999999999999999998
Q ss_pred ccCCCCce---eeccccCccccCcccccCC------CCCcceeEEehHHHHHHHhhCCCCCCCCC------------cch
Q 006112 488 YDHGNDLH---TTNVVGTVGYLAPELLRNG------RGTTSTDVYAFGVFMLEVACGRRPVQPGE------------LDL 546 (660)
Q Consensus 488 ~~~~~~~~---~~~~~gt~~Y~aPE~~~~~------~~t~ksDV~S~Gvvl~elltG~~p~~~~~------------~~~ 546 (660)
........ ....+||+.|||||++.+. .++.++|||||||+||||+||+.|+.... ...
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 76544322 2346899999999998754 36789999999999999999987764211 111
Q ss_pred HHHHHHHHhcCCcccCCCCccccc-CcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 547 LDWVIDYWQKGDVLDASDPRLEGI-YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 547 ~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
.+.+......+ ..+|.+... ...+..+.+.+|+.+||+.||++||||.||++.|+..
T Consensus 238 ~~~~~~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 238 VEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp HHHHHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 22222222221 223333322 2345667889999999999999999999999999753
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=428.82 Aligned_cols=247 Identities=22% Similarity=0.294 Sum_probs=210.6
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
+|+.++.||+|+||+||+|++..+++.||||++... .....+.+.+|++++++++|||||++++++.+++.+|||||
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE 112 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 112 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 588999999999999999999999999999999643 23456789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC-
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN- 492 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~- 492 (660)
||+||+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+.+....
T Consensus 113 y~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 113 YAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp CCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred cCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 999999999997654 49999999999999999999998 999999999999999999999999999999875433
Q ss_pred CceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCc
Q 006112 493 DLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 493 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
.......+||+.|||||++.+..++.++||||+||++|||+||+.||....... +......+.. .+...++
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~i~~~~~------~~p~~~s 258 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL---IFAKIIKLEY------DFPEKFF 258 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHTCC------CCCTTCC
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHcCCC------CCCcccC
Confidence 233456789999999999999999999999999999999999999998654322 2222223321 1222333
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCCHHHHH
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRPSMRQVV 601 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 601 (660)
+ .+.+++..|++.||++|||++|++
T Consensus 259 ~----~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 259 P----KARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp H----HHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred H----HHHHHHHHHccCCHhHCcChHHHc
Confidence 3 466788889999999999999874
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-51 Score=433.34 Aligned_cols=258 Identities=25% Similarity=0.351 Sum_probs=212.7
Q ss_pred ceeeecccccccCccEEEEEEEeCCC-----CeEEEEEEeccCCC-hhhHHHHHHHHHHhccCC-CCceeEeeeeeec-C
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSS-----HAEIAVKKVCHDSD-HGMKQFVSEIVSMGKLRH-RNLVQLRGYCRRK-G 406 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~-----~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H-~nIv~l~g~~~~~-~ 406 (660)
+-+|+..+.||+|+||+||+|++... ++.||||++..... ...++|.+|+++|.+++| ||||+++|+|.+. +
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~ 142 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 142 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence 44788899999999999999997543 36899999976543 346789999999999965 9999999999765 5
Q ss_pred eeEEEEecCCCCChhhhhhhCC--------------CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEc
Q 006112 407 ELLLVYDYMPNGSLDKILYSNT--------------RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLD 472 (660)
Q Consensus 407 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~ 472 (660)
.++||||||++|+|.++|+... +..++|.++..++.|||+||+|||+ ++||||||||+||||+
T Consensus 143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NILl~ 219 (353)
T 4ase_A 143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLS 219 (353)
T ss_dssp CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccceeeC
Confidence 6899999999999999997532 2458999999999999999999998 9999999999999999
Q ss_pred CCCCeEEeecccceeccCCCCc-eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHH
Q 006112 473 ADLEGKLGDFGLARLYDHGNDL-HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWV 550 (660)
Q Consensus 473 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~ 550 (660)
+++.+||+|||+|+........ ......||+.|||||++.++.++.++|||||||+||||+| |+.||...... +.+
T Consensus 220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~--~~~ 297 (353)
T 4ase_A 220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEF 297 (353)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS--HHH
T ss_pred CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH--HHH
Confidence 9999999999999976554333 3445789999999999999999999999999999999998 99999764322 223
Q ss_pred HHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 551 IDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 551 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
......+..... .... ...+.+++..||+.||++|||+.||+++|+.
T Consensus 298 ~~~i~~g~~~~~-----p~~~----~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ 344 (353)
T 4ase_A 298 CRRLKEGTRMRA-----PDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 344 (353)
T ss_dssp HHHHHHTCCCCC-----CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHcCCCCCC-----CccC----CHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 333344433221 1222 3457788899999999999999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=414.08 Aligned_cols=249 Identities=23% Similarity=0.373 Sum_probs=196.5
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
.|+.++.||+|+||+||+|++..+++.||||++... .....+.+.+|++++++++|||||++++++.+++.+++|||
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 93 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 93 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence 689999999999999999999999999999999654 23345689999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
|| +|+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||+++++++||+|||+|+......
T Consensus 94 y~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 166 (275)
T 3hyh_A 94 YA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN- 166 (275)
T ss_dssp CC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred CC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence 99 789999997654 49999999999999999999998 999999999999999999999999999998754332
Q ss_pred ceeeccccCccccCcccccCCCC-CcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCc
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
.....+||+.|||||++.+..+ +.++||||+||++|||+||+.||...... ...+....+.. .+....+
T Consensus 167 -~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~---~~~~~i~~~~~------~~p~~~s 236 (275)
T 3hyh_A 167 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP---VLFKNISNGVY------TLPKFLS 236 (275)
T ss_dssp ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHTCC------CCCTTSC
T ss_pred -ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHcCCC------CCCCCCC
Confidence 2345689999999999988776 57999999999999999999999864432 22222233321 1222233
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCCHHHHHH--HhhC
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ--YLDG 606 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~ 606 (660)
..+.+++.+||+.||++|||++|+++ +++.
T Consensus 237 ----~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 237 ----PGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp ----HHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred ----HHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 34667888899999999999999997 5654
|
| >2ltn_A PEA lectin, alpha chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1bqp_A* 1hkd_A 1ofs_A* 1rin_A* 1lof_C* 1len_A 1lem_A 1les_A* 2lal_A 1loe_A 1loa_A* 1loc_A* 1lod_A* 1lob_A 1lof_A* 1log_A* 1lgc_A* 1lgb_A* 2b7y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=373.26 Aligned_cols=173 Identities=27% Similarity=0.435 Sum_probs=158.0
Q ss_pred CcceeeeCCCC--CCCeeEecceeEcCCCcEEecCCCCCeeEEEEeCCCeeeccCC-CCceeEEEEEEEEEecCCCCCCC
Q 006112 26 EENQFIHHGFE--GSKLKLDGLAKIHPNGLLQLTNTSERISGHAFYPFPFKFNSSS-SQSLSFSTSFVFAMFPKLPNYGG 102 (660)
Q Consensus 26 ~~~~f~~~~f~--~~~l~~~g~a~~~~~g~l~Lt~~~~~~~G~~~y~~pv~~~~~~-~~~~sFst~F~F~i~~~~~~~~g 102 (660)
..++|+|++|. +.||+|+|+|. .++|.|+||+...+++|||+|++||+||++. ++++||+|+|+|.|.+.+...+|
T Consensus 2 ~~~sF~f~~F~~~~~~l~l~G~A~-~~~g~l~LT~~~~~~~Gra~y~~Pv~l~d~~tg~vaSFsT~F~F~I~~~~~~~~g 80 (181)
T 2ltn_A 2 ETTSFLITKFSPDQQNLIFQGDGY-TTKEKLTLTKAVKNTVGRALYSSPIHIWDRETGNVANFVTSFTFVINAPNSYNVA 80 (181)
T ss_dssp EEEEEEESSCCSSCTTEEEEETCE-ECSSSEEEECSCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECSSTTSCC
T ss_pred cceEEEcCCCCCCCCCEEEecccc-CCCCCeEcCCCCCCCEEEEEECCCEEeecCCCCCccceEEEEEEEEecCCCCCCC
Confidence 45799999998 57999999999 6789999999999999999999999999977 88999999999999988777799
Q ss_pred CceEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCC--CCeeEEEcCCcccccccccccccc
Q 006112 103 HGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDID--GNHVGIDVNGLQSNESASARYFSD 180 (660)
Q Consensus 103 ~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~--~~Hvgid~ns~~s~~~~~~~~~~~ 180 (660)
|||||||+|....|. +.||||||+|.++ ++..+|+|||||||++|.+ |||+ +|||||||||+.|.++++|
T Consensus 81 dGlAF~l~p~~~~p~-~~g~~LGL~n~~~-~~~~n~~vAVEFDT~~n~~-~Dp~~~~nHVGIdvNs~~S~~t~~~----- 152 (181)
T 2ltn_A 81 DGFTFFIAPVDTKPQ-TGGGYLGVFNSAE-YDKTTQTVAVEFDTFYNAA-WDPSNRDRHIGIDVNSIKSVNTKSW----- 152 (181)
T ss_dssp CEEEEEEEETTCCCC-CCGGGTTTCSCSS-CCTTSCCEEEEEECSCCTT-TSCTTCCCEEEEEESSSSCSEEEEC-----
T ss_pred CceEEEEecCCCCCC-CCCccccccccCC-CCccccEEEEEeccccccc-cCCCCCCCEEEEEcCCccccceecc-----
Confidence 999999999876666 8899999999874 4678999999999999998 6999 9999999999999988764
Q ss_pred ccccccccccCCCccEEEEEEEeCcceeEEEEEee
Q 006112 181 EKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAP 215 (660)
Q Consensus 181 ~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~ 215 (660)
+|.+|+.++|||+||+.+++|+|+|++
T Consensus 153 --------~l~~G~~~~v~I~Yd~~~~~L~V~l~~ 179 (181)
T 2ltn_A 153 --------KLQNGEEANVVIAFNAATNVLTVSLTY 179 (181)
T ss_dssp --------CCCTTCCEEEEEEEETTTTEEEEEEEE
T ss_pred --------ccCCCCEEEEEEEEECCCCEEEEEEec
Confidence 367999999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=420.04 Aligned_cols=247 Identities=24% Similarity=0.301 Sum_probs=197.9
Q ss_pred eeecccccccCccEEEEEEEeC---CCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLP---SSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~---~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 411 (660)
+|+.++.||+|+||+||+|+.. .+++.||||++.... .....++.+|++++++++|||||++++++.+++.+++|
T Consensus 25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 104 (304)
T 3ubd_A 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLI 104 (304)
T ss_dssp GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEE
T ss_pred ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 6899999999999999999874 457899999986532 23345788999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCC
Q 006112 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 491 (660)
||||+||+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 105 mEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 105 LDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp ECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 99999999999997654 48999999999999999999998 99999999999999999999999999999865433
Q ss_pred CCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccC
Q 006112 492 NDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIY 571 (660)
Q Consensus 492 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 571 (660)
.. .....+||+.|||||++.+..++.++||||+||++|||+||+.||....... +......+.. .+....
T Consensus 180 ~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~~i~~~~~------~~p~~~ 249 (304)
T 3ubd_A 180 EK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE---TMTMILKAKL------GMPQFL 249 (304)
T ss_dssp -C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHCCC------CCCTTS
T ss_pred Cc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH---HHHHHHcCCC------CCCCcC
Confidence 22 2345789999999999999999999999999999999999999998654322 2222222221 112223
Q ss_pred cHHHHHHHHHHhhhccCCCCCCCCC-----HHHHHH
Q 006112 572 VEEQMEIVLKLGLFCSHSNPDTRPS-----MRQVVQ 602 (660)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 602 (660)
+ ..+.+++..||+.||++||| ++|+++
T Consensus 250 s----~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 250 S----PEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp C----HHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred C----HHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 3 34667888899999999998 467764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=411.81 Aligned_cols=249 Identities=19% Similarity=0.323 Sum_probs=190.9
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHhccCCCCceeEeeeeeecC---------
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD-HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKG--------- 406 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~--------- 406 (660)
+|+.++.||+|+||+||+|++..+++.||||++..... ...+++.+|+++|++++|||||++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 58899999999999999999999999999999976544 34578999999999999999999999987554
Q ss_pred ---eeEEEEecCCCCChhhhhhhCCC-CCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeec
Q 006112 407 ---ELLLVYDYMPNGSLDKILYSNTR-PSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDF 482 (660)
Q Consensus 407 ---~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DF 482 (660)
.+++|||||++|+|.+++..... ...++..+..++.||++||+|||+ ++|+||||||+||||+.++.+||+||
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEccC
Confidence 37999999999999999976543 224556688999999999999998 99999999999999999999999999
Q ss_pred ccceeccCCCCc-----------eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHH
Q 006112 483 GLARLYDHGNDL-----------HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVI 551 (660)
Q Consensus 483 Gla~~~~~~~~~-----------~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~ 551 (660)
|+|+........ ..+..+||+.|||||++.+..++.++|||||||++|||++ ||.... +.... .
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-~~~~~-~ 237 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-ERVRT-L 237 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-HHHHH-H
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-HHHHH-H
Confidence 999876543221 1234679999999999999999999999999999999996 775321 11111 1
Q ss_pred HHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 552 DYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 552 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
....... .|.. .......+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~-----~p~~----~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 238 TDVRNLK-----FPPL----FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHTTC-----CCHH----HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHhcCC-----CCCC----CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111111 1111 1222334567889999999999999999987
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=405.77 Aligned_cols=264 Identities=23% Similarity=0.291 Sum_probs=205.0
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeee------cCee
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR------KGEL 408 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~------~~~~ 408 (660)
.|+.++.||+|+||+||+|++..+|+.||||++.... ....+.+.+|+++|++++|||||++++++.. .+.+
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~ 134 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV 134 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence 5899999999999999999999999999999996543 2345678999999999999999999998754 3678
Q ss_pred EEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceec
Q 006112 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLY 488 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 488 (660)
|||||||+ |+|.+++.... .+++.++..++.||+.||.|||+ ++||||||||+|||++.++.+||+|||+|+.+
T Consensus 135 ~ivmE~~~-g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 135 YVVLDLME-SDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp EEEEECCS-EEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EEEEeCCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 99999995 78999997643 59999999999999999999998 99999999999999999999999999999876
Q ss_pred cCCC---CceeeccccCccccCcccccCC-CCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHHHHHHhcCCcccC-
Q 006112 489 DHGN---DLHTTNVVGTVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVIDYWQKGDVLDA- 562 (660)
Q Consensus 489 ~~~~---~~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~~~~~~~~~~- 562 (660)
.... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||.+... +....+............
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~ 288 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ 288 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 4332 2234467899999999998765 569999999999999999999999986443 223333222211110000
Q ss_pred -------------CCCccccc---CcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH--HhhC
Q 006112 563 -------------SDPRLEGI---YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ--YLDG 606 (660)
Q Consensus 563 -------------~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~ 606 (660)
..+..... ..+.....+.+|+..||+.||++|||++|+++ +|+.
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 350 (398)
T 4b99_A 289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK 350 (398)
T ss_dssp -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTT
T ss_pred hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCc
Confidence 00000000 00011235678888999999999999999997 4543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=415.08 Aligned_cols=252 Identities=23% Similarity=0.277 Sum_probs=211.2
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 416 (660)
.|+.++.||+|+||.||+|++..+|+.||+|++........+.+.+|+++|++++|||||++++++.+++.++||||||+
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~ 237 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecC
Confidence 58899999999999999999999999999999977666667789999999999999999999999999999999999999
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCC--CCeEEeecccceeccCCCCc
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDAD--LEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~--~~~kl~DFGla~~~~~~~~~ 494 (660)
||+|.++|.... ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 238 gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~-- 311 (573)
T 3uto_A 238 GGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-- 311 (573)
T ss_dssp CCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS--
T ss_pred CCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC--
Confidence 999999986443 359999999999999999999998 999999999999999854 899999999999875433
Q ss_pred eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHH
Q 006112 495 HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEE 574 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 574 (660)
.....+||+.|||||++.+..++.++||||+||++|||++|+.||....... .......+... ..+......
T Consensus 312 ~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~---~~~~i~~~~~~--~~~~~~~~~--- 383 (573)
T 3uto_A 312 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE---TLRNVKSCDWN--MDDSAFSGI--- 383 (573)
T ss_dssp EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHHTTCCC--CCSGGGTTS---
T ss_pred ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHHHHhCCCC--CCcccccCC---
Confidence 3345689999999999999999999999999999999999999998654322 12222222110 111111122
Q ss_pred HHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 575 QMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 575 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
...+.+|+..||+.||++|||+.|++++
T Consensus 384 -s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 384 -SEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp -CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2346678889999999999999999983
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=391.11 Aligned_cols=197 Identities=25% Similarity=0.357 Sum_probs=170.1
Q ss_pred eeecccccccCccEEEEEEEeC---CCCeEEEEEEeccCCChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCeeEEEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLP---SSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~---~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
.|+..++||+|+||+||+|+.+ .+++.||||++.... ...++.+|+++++++ +||||+++++++.+++.+++||
T Consensus 22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm 99 (361)
T 4f9c_A 22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM 99 (361)
T ss_dssp TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence 5889999999999999999864 457899999986543 345788999999998 6999999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCC-CCeEEeecccceeccCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDAD-LEGKLGDFGLARLYDHG 491 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~-~~~kl~DFGla~~~~~~ 491 (660)
|||++|+|.+++. .+++.++..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 100 E~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~ 171 (361)
T 4f9c_A 100 PYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171 (361)
T ss_dssp ECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred eCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence 9999999999983 38899999999999999999998 999999999999999877 79999999999865432
Q ss_pred CC---------------------------ceeeccccCccccCcccccCC-CCCcceeEEehHHHHHHHhhCCCCCCCCC
Q 006112 492 ND---------------------------LHTTNVVGTVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQPGE 543 (660)
Q Consensus 492 ~~---------------------------~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~ 543 (660)
.. ...+..+||+.|||||++.+. .++.++||||+||++|||+||+.||....
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251 (361)
T ss_dssp SCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence 21 112345799999999998765 58999999999999999999999997644
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=380.92 Aligned_cols=268 Identities=34% Similarity=0.635 Sum_probs=235.3
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
-.|+..+.||+|+||.||+|++. +++.||||++........+.+.+|++++++++||||++++++|.+.+..++||||+
T Consensus 39 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 117 (321)
T 2qkw_B 39 NNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM 117 (321)
T ss_dssp CCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECC
T ss_pred hccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcC
Confidence 36888899999999999999974 68899999998777777889999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCC--CCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC-
Q 006112 416 PNGSLDKILYSNTR--PSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN- 492 (660)
Q Consensus 416 ~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~- 492 (660)
++|+|.+++..... ..++|.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 118 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 194 (321)
T 2qkw_B 118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ 194 (321)
T ss_dssp TTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSC
T ss_pred CCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 99999999976532 358999999999999999999998 899999999999999999999999999998754322
Q ss_pred CceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCC----CcchHHHHHHHHhcCCcccCCCCccc
Q 006112 493 DLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPG----ELDLLDWVIDYWQKGDVLDASDPRLE 568 (660)
Q Consensus 493 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~----~~~~~~~~~~~~~~~~~~~~~d~~l~ 568 (660)
........||+.|+|||.+.+..++.++|||||||++|||++|+.||... ......|.......+......++.+.
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (321)
T 2qkw_B 195 THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLA 274 (321)
T ss_dssp CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCT
T ss_pred cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhc
Confidence 22234456899999999999889999999999999999999999999752 23456666666667777777788777
Q ss_pred ccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 569 GIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
.....+....+.+++..||+.||++|||+.|+++.|+..
T Consensus 275 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 275 DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 778888999999999999999999999999999999864
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=383.87 Aligned_cols=274 Identities=40% Similarity=0.712 Sum_probs=236.5
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD-HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
.|+..+.||+|+||.||+|++. +++.||||++..... .....+.+|++++++++||||++++++|...+..++||||+
T Consensus 31 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 109 (326)
T 3uim_A 31 NFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 109 (326)
T ss_dssp SSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECC
T ss_pred ccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEec
Confidence 6888899999999999999864 588999999865432 23447999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCC--CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 416 PNGSLDKILYSNT--RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 416 ~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
++|+|.+++.... ...++|..+..++.|++.||+|||+.+..+|+||||||+|||++.++.+||+|||+++.......
T Consensus 110 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 189 (326)
T 3uim_A 110 ANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 189 (326)
T ss_dssp TTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSS
T ss_pred cCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccc
Confidence 9999999997653 34599999999999999999999993333999999999999999999999999999998765555
Q ss_pred ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCC------CCcchHHHHHHHHhcCCcccCCCCcc
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQP------GELDLLDWVIDYWQKGDVLDASDPRL 567 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~------~~~~~~~~~~~~~~~~~~~~~~d~~l 567 (660)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||.. ......+|+.............+..+
T Consensus 190 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (326)
T 3uim_A 190 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDL 269 (326)
T ss_dssp CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTC
T ss_pred cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhh
Confidence 555667799999999999888899999999999999999999999952 34456677666666666677777777
Q ss_pred cccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCCCCCC
Q 006112 568 EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGALLP 611 (660)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p 611 (660)
...+..+....+.+++.+||+.||.+|||+.||+++|++.....
T Consensus 270 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~ 313 (326)
T 3uim_A 270 QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAE 313 (326)
T ss_dssp TTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSS
T ss_pred ccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhh
Confidence 78888999999999999999999999999999999999865443
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=409.40 Aligned_cols=252 Identities=20% Similarity=0.229 Sum_probs=204.6
Q ss_pred CCceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhH---HHHHHHHHHhccCCCCceeEeeeeeecC
Q 006112 333 PHRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMK---QFVSEIVSMGKLRHRNLVQLRGYCRRKG 406 (660)
Q Consensus 333 ~~~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~---~~~~Ei~~l~~l~H~nIv~l~g~~~~~~ 406 (660)
..--+|+.++.||+|+||+||+|+...+|+.||||++.+.. ..... ....++.+++.++|||||++++++.+++
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 34457999999999999999999999999999999996431 12222 3334567788889999999999999999
Q ss_pred eeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccce
Q 006112 407 ELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLAR 486 (660)
Q Consensus 407 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 486 (660)
.+|||||||+||+|.++|.... .+++..+..++.||+.||+|||+ ++||||||||+||||+.++.+||+|||+|+
T Consensus 266 ~lylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceee
Confidence 9999999999999999998654 48999999999999999999998 999999999999999999999999999998
Q ss_pred eccCCCCceeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCC
Q 006112 487 LYDHGNDLHTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDP 565 (660)
Q Consensus 487 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 565 (660)
.+.... ....+||+.|||||++.. ..|+.++||||+||++|||++|+.||..........+.........
T Consensus 341 ~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~------ 411 (689)
T 3v5w_A 341 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV------ 411 (689)
T ss_dssp ECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCC------
T ss_pred ecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCC------
Confidence 765432 345689999999999965 5789999999999999999999999976433222222322222221
Q ss_pred cccccCcHHHHHHHHHHhhhccCCCCCCCCC-----HHHHHH
Q 006112 566 RLEGIYVEEQMEIVLKLGLFCSHSNPDTRPS-----MRQVVQ 602 (660)
Q Consensus 566 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 602 (660)
.+...+++ .+.+|+..||+.||.+|++ ++||++
T Consensus 412 ~~p~~~S~----~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 412 ELPDSFSP----ELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp CCCTTSCH----HHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred CCCccCCH----HHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 12223333 3567888899999999998 788875
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=373.12 Aligned_cols=255 Identities=22% Similarity=0.351 Sum_probs=211.3
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
-+|+..+.||+|+||.||+|++..+++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 36888899999999999999999999999999997767777889999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 495 (660)
++|+|.+++.... ..+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 90 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 90 KGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp TTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred CCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 9999999998753 359999999999999999999998 899999999999999999999999999998764432211
Q ss_pred -------------eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchH---HHHHHHHhcCCc
Q 006112 496 -------------TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLL---DWVIDYWQKGDV 559 (660)
Q Consensus 496 -------------~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~---~~~~~~~~~~~~ 559 (660)
.....||+.|+|||.+.+..++.++||||||+++|||++|..|+........ .........
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~--- 242 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR--- 242 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH---
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc---
Confidence 1145799999999999999999999999999999999999999865221100 000000000
Q ss_pred ccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 560 LDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 560 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
.........+.+++..||+.||++|||+.|+++.|+..
T Consensus 243 ----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 243 ----------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp ----------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00111223477889999999999999999999999864
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=368.70 Aligned_cols=252 Identities=23% Similarity=0.335 Sum_probs=212.3
Q ss_pred CceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 334 HRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 334 ~~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
..-.|+.++.||+|+||.||+|.+..+++.||||++........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 34579999999999999999999999999999999976666667789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
||++|+|.+++... .+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 98 ~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 98 YLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 99999999999764 38899999999999999999998 8999999999999999999999999999987654332
Q ss_pred ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ .......+... . .. ..
T Consensus 172 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~-~---~~----~~ 240 (297)
T 3fxz_A 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYLIATNGTPE-L---QN----PE 240 (297)
T ss_dssp -CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHHCSCC-C---SC----GG
T ss_pred -ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhCCCCC-C---CC----cc
Confidence 23456799999999999999999999999999999999999999976443221 22222222110 0 01 11
Q ss_pred HHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
.....+.+++..||+.||++|||++|+++
T Consensus 241 ~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 241 KLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 22345778888999999999999999987
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=369.83 Aligned_cols=257 Identities=27% Similarity=0.385 Sum_probs=202.0
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEE
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
..+|+..+.||+|+||.||+|++ .++.||||++.... ....+++.+|++++++++||||+++++++...+..++||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 45788999999999999999988 57899999986543 334578999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhhCCC-CCcchhHHHHHHHHHHHHHHHhhhcccCc--eeccCccCCcEEEcCCCCeEEeecccceecc
Q 006112 413 DYMPNGSLDKILYSNTR-PSLNWFQRFRIIKGVAFGLLYLHEEWEQV--VLHRDIKPANVLLDADLEGKLGDFGLARLYD 489 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 489 (660)
||+++|+|.+++..... ..+++..++.++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++...
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 99999999999976432 238899999999999999999998 78 9999999999999999999999999998644
Q ss_pred CCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccc
Q 006112 490 HGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEG 569 (660)
Q Consensus 490 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 569 (660)
... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......... ......... ..+..
T Consensus 191 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~--~~~~~~~~~-----~~~~~ 262 (309)
T 3p86_A 191 STF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV--AAVGFKCKR-----LEIPR 262 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHH--HHHHHSCCC-----CCCCT
T ss_pred ccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhcCCC-----CCCCc
Confidence 322 2234467999999999999999999999999999999999999999864432221 111111111 11112
Q ss_pred cCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCCC
Q 006112 570 IYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGA 608 (660)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (660)
.+ ...+.+++..||+.||++|||++|+++.|+...
T Consensus 263 ~~----~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~ 297 (309)
T 3p86_A 263 NL----NPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297 (309)
T ss_dssp TS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 22 234778888999999999999999999998653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=363.34 Aligned_cols=259 Identities=23% Similarity=0.350 Sum_probs=208.9
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
.|+.++.||+|+||.||++++..+++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 91 (294)
T 4eqm_A 12 RYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVME 91 (294)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEe
Confidence 6899999999999999999999999999999985432 3345789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
|+++++|.+++.... .+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 92 ~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 92 YIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp CCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred CCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 999999999997654 48999999999999999999998 8999999999999999999999999999987654443
Q ss_pred ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... +......... .+........
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~--~~~~~~~~~~------~~~~~~~~~~ 238 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV--SIAIKHIQDS------VPNVTTDVRK 238 (294)
T ss_dssp --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH--HHHHHHHSSC------CCCHHHHSCT
T ss_pred cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHhhcc------CCCcchhccc
Confidence 3444567999999999999999999999999999999999999999764432 1122222211 1111111222
Q ss_pred HHHHHHHHHhhhccCCCCCCCC-CHHHHHHHhhCCC
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRP-SMRQVVQYLDGGA 608 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~~~ 608 (660)
.....+.+++.+|++.||++|| +++++.+.|+...
T Consensus 239 ~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 239 DIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred CCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 3345678888999999999998 9999999998753
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=369.51 Aligned_cols=249 Identities=24% Similarity=0.342 Sum_probs=209.1
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEE
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
--.|+.++.||+|+||.||+|++..+++.||||++... .....+.+.+|++++++++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 34699999999999999999999999999999999654 3345678899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
|||++|+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 94 e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp CCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred ECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 9999999999997654 48999999999999999999998 899999999999999999999999999998765432
Q ss_pred CceeeccccCccccCcccccCCCCC-cceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccC
Q 006112 493 DLHTTNVVGTVGYLAPELLRNGRGT-TSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIY 571 (660)
Q Consensus 493 ~~~~~~~~gt~~Y~aPE~~~~~~~t-~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 571 (660)
......||+.|+|||++.+..+. .++||||+||++|||++|+.||........ ......+.. .+....
T Consensus 169 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~------~~p~~~ 237 (328)
T 3fe3_A 169 --KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL---RERVLRGKY------RIPFYM 237 (328)
T ss_dssp --GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHCCC------CCCTTS
T ss_pred --ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH---HHHHHhCCC------CCCCCC
Confidence 23456899999999999887764 799999999999999999999987543322 222222221 111112
Q ss_pred cHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 572 VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
...+.+++..||+.||.+|||++|++++
T Consensus 238 ----s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 238 ----STDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ----CHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ----CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 2346678888999999999999999974
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=373.24 Aligned_cols=258 Identities=28% Similarity=0.392 Sum_probs=212.3
Q ss_pred ceeeecccccccCccEEEEEEEeC-------CCCeEEEEEEeccCCC-hhhHHHHHHHHHHhcc-CCCCceeEeeeeeec
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLP-------SSHAEIAVKKVCHDSD-HGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRK 405 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~-------~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~ 405 (660)
.-.|+..+.||+|+||.||+|++. .++..||||++..... ...+++.+|+++++++ +||||++++++|..+
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 346888999999999999999863 3456899999976533 3467899999999999 899999999999999
Q ss_pred CeeEEEEecCCCCChhhhhhhCCC--------------CCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEE
Q 006112 406 GELLLVYDYMPNGSLDKILYSNTR--------------PSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLL 471 (660)
Q Consensus 406 ~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll 471 (660)
+.+++||||+++|+|.+++..... ..+++.+++.++.||+.||+|||+ ++|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEE
Confidence 999999999999999999976532 348899999999999999999998 899999999999999
Q ss_pred cCCCCeEEeecccceeccCCCCc-eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHH
Q 006112 472 DADLEGKLGDFGLARLYDHGNDL-HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDW 549 (660)
Q Consensus 472 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~ 549 (660)
+.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.........
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~- 315 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF- 315 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-
Confidence 99999999999999876543322 2334567899999999999999999999999999999999 99999765443222
Q ss_pred HHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 550 VIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 550 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
.....+.... ... .....+.+++..||+.||++||++.|+++.|+..
T Consensus 316 --~~~~~~~~~~-----~~~----~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 316 --KLLKEGHRMD-----KPA----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp --HHHHTTCCCC-----CCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHhcCCCCC-----CCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 2222222111 111 2234577888899999999999999999999863
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=364.47 Aligned_cols=263 Identities=27% Similarity=0.384 Sum_probs=207.0
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecC----eeEE
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKG----ELLL 410 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~l 410 (660)
..+|+.++.||+|+||.||+|++. ++.||||++.... ....++.+|+.++++++||||+++++++.... .+++
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 457999999999999999999984 7899999996443 33456677999999999999999999998754 4799
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhc-------ccCceeccCccCCcEEEcCCCCeEEeecc
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEE-------WEQVVLHRDIKPANVLLDADLEGKLGDFG 483 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------~~~~ivHrDikp~NIll~~~~~~kl~DFG 483 (660)
|||||++|+|.+++... .++|..+..++.|++.||+|||+. +.++|+||||||+|||++.++.+||+|||
T Consensus 100 v~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 99999999999999764 389999999999999999999982 11299999999999999999999999999
Q ss_pred cceeccCCCCc-eeeccccCccccCcccccCC-----CCCcceeEEehHHHHHHHhhCCCCCCCCCcc------------
Q 006112 484 LARLYDHGNDL-HTTNVVGTVGYLAPELLRNG-----RGTTSTDVYAFGVFMLEVACGRRPVQPGELD------------ 545 (660)
Q Consensus 484 la~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~-----~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~------------ 545 (660)
+++........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 256 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence 99876554332 23346799999999998763 4567899999999999999999999752211
Q ss_pred -hHHHHHHHHhcCCcccCCCCcccccC-cHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 546 -LLDWVIDYWQKGDVLDASDPRLEGIY-VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 546 -~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
............. ..+.+.... .......+.+++.+||+.||++|||+.||++.|+..
T Consensus 257 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 257 PSLEDMQEVVVHKK----KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp CCHHHHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred Cchhhhhhhhhccc----CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111111111111 122222211 234556789999999999999999999999999753
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=366.38 Aligned_cols=257 Identities=30% Similarity=0.436 Sum_probs=209.1
Q ss_pred ceeeecccccccCccEEEEEEEeCCCC---eEEEEEEeccC-CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEE
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSH---AEIAVKKVCHD-SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLL 410 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~---~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 410 (660)
.-.|+..+.||+|+||.||+|++..++ ..||||++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 346888999999999999999997544 46999999765 33456789999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccC
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDH 490 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 490 (660)
||||+++|+|.+++.... ..+++.+++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 128 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred EeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 999999999999997543 359999999999999999999998 8999999999999999999999999999987654
Q ss_pred CCCc--eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcc
Q 006112 491 GNDL--HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL 567 (660)
Q Consensus 491 ~~~~--~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 567 (660)
.... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... .......+.... .
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~~~~~~~~~-----~ 275 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD---VISSVEEGYRLP-----A 275 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HHHHHHTTCCCC-----C
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHHcCCCCC-----C
Confidence 4322 2233456889999999998899999999999999999999 999997643322 222222221111 1
Q ss_pred cccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 568 EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
. ......+.+++..||+.||++||++.||++.|+..
T Consensus 276 ~----~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l 311 (325)
T 3kul_A 276 P----MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311 (325)
T ss_dssp C----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C----CCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1 12234577888999999999999999999999874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=389.59 Aligned_cols=257 Identities=27% Similarity=0.404 Sum_probs=216.6
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
+.+|+..+.||+|+||.||+|++..++..||||.+.... ...++|.+|+.++++++||||++++++|...+.+++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 446888999999999999999998889999999996543 3467899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
|++|+|.+++.......+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 374 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 374 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCcee
Confidence 999999999987666679999999999999999999998 89999999999999999999999999999876543322
Q ss_pred eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 495 HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
......+++.|+|||.+..+.++.++|||||||++|||++ |+.||........ .+....+.... . ..
T Consensus 375 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~---~~~~~~~~~~~-----~----~~ 442 (495)
T 1opk_A 375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YELLEKDYRME-----R----PE 442 (495)
T ss_dssp CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHHHHTTCCCC-----C----CT
T ss_pred ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHcCCCCC-----C----CC
Confidence 2334456789999999998899999999999999999999 9999976544322 22222221111 1 11
Q ss_pred HHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
.....+.+++..||+.||++|||+.+|++.|+..
T Consensus 443 ~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 443 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 2334577888999999999999999999999875
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=362.51 Aligned_cols=251 Identities=23% Similarity=0.338 Sum_probs=210.0
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
..|+..+.||+|+||.||+|++..+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 124 (321)
T 2c30_A 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFL 124 (321)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecC
Confidence 35777789999999999999998889999999998776667788999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 495 (660)
++++|.+++... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 125 ~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~ 197 (321)
T 2c30_A 125 QGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-K 197 (321)
T ss_dssp CSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-C
T ss_pred CCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-c
Confidence 999999998643 48999999999999999999998 8999999999999999999999999999987654322 2
Q ss_pred eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHH
Q 006112 496 TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQ 575 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 575 (660)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ......... .+.+.. ....
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~---~~~~~~~~~-----~~~~~~--~~~~ 267 (321)
T 2c30_A 198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---AMKRLRDSP-----PPKLKN--SHKV 267 (321)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHHSS-----CCCCTT--GGGS
T ss_pred cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHhcCC-----CCCcCc--cccC
Confidence 345679999999999999999999999999999999999999997643321 111222211 111111 1112
Q ss_pred HHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 576 MEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 576 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
...+.+++..||+.||++|||++|++++
T Consensus 268 ~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 268 SPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 3457788889999999999999999974
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=358.21 Aligned_cols=259 Identities=24% Similarity=0.401 Sum_probs=207.3
Q ss_pred ceeeecccccccCccEEEEEEE----eCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeec--Cee
Q 006112 335 RFSYKNLYKATKGGSGKVYRGV----LPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK--GEL 408 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~----~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~ 408 (660)
.-.|+.++.||+|+||.||+|+ ...+++.||||++........+.+.+|++++++++||||++++++|... ..+
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 3478999999999999999998 4567899999999877777778999999999999999999999998653 568
Q ss_pred EEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceec
Q 006112 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLY 488 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 488 (660)
++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred EEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 99999999999999997654 348999999999999999999998 99999999999999999999999999999876
Q ss_pred cCCCCc--eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcch-------------HHHHHHH
Q 006112 489 DHGNDL--HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDL-------------LDWVIDY 553 (660)
Q Consensus 489 ~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~-------------~~~~~~~ 553 (660)
...... ......++..|+|||.+.+..++.++||||||+++|||++|..|+....... .....+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence 543321 2234457888999999999999999999999999999999999986422111 1112222
Q ss_pred HhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 554 WQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 554 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
...+.... . .......+.+++..||+.||++|||++|+++.|+.
T Consensus 245 ~~~~~~~~-----~----~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~ 288 (295)
T 3ugc_A 245 LKNNGRLP-----R----PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288 (295)
T ss_dssp HHTTCCCC-----C----CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HhccCcCC-----C----CcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 22221111 1 11223557788999999999999999999999875
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=359.11 Aligned_cols=268 Identities=21% Similarity=0.259 Sum_probs=216.5
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecC--eeEEE
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKG--ELLLV 411 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~lV 411 (660)
.-.|+..+.||+|+||.||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 457899999999999999999999999999999996543 234677889999999999999999999988665 78999
Q ss_pred EecCCCCChhhhhhhCCC-CCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEE----cCCCCeEEeecccce
Q 006112 412 YDYMPNGSLDKILYSNTR-PSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLL----DADLEGKLGDFGLAR 486 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll----~~~~~~kl~DFGla~ 486 (660)
|||+++++|.+++..... ..+++.+++.++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999976432 348999999999999999999998 899999999999999 788889999999998
Q ss_pred eccCCCCceeeccccCccccCccccc--------CCCCCcceeEEehHHHHHHHhhCCCCCCCCC--cchHHHHHHHHhc
Q 006112 487 LYDHGNDLHTTNVVGTVGYLAPELLR--------NGRGTTSTDVYAFGVFMLEVACGRRPVQPGE--LDLLDWVIDYWQK 556 (660)
Q Consensus 487 ~~~~~~~~~~~~~~gt~~Y~aPE~~~--------~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~--~~~~~~~~~~~~~ 556 (660)
....... .....||+.|+|||++. +..++.++|||||||++|||++|+.||.... ....+.......
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~- 241 (319)
T 4euu_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT- 241 (319)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH-
T ss_pred ecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc-
Confidence 7654432 23457999999999986 5678999999999999999999999997522 122222222222
Q ss_pred CCcccC-------C--------CCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCCC
Q 006112 557 GDVLDA-------S--------DPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGA 608 (660)
Q Consensus 557 ~~~~~~-------~--------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (660)
+..... . +..............+..++..||+.||++|||++|++++...++
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 111100 0 011122445677788999999999999999999999999988654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=364.70 Aligned_cols=248 Identities=25% Similarity=0.285 Sum_probs=207.5
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
+|+.++.||+|+||.||+++...+++.||+|++... .....+.+.+|+.++++++||||+++++++...+.+++|||
T Consensus 6 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E 85 (337)
T 1o6l_A 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEe
Confidence 688899999999999999999999999999999653 23456788999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
|+++|+|..++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 159 (337)
T 1o6l_A 86 YANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG- 159 (337)
T ss_dssp CCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC-
Confidence 999999999997643 48899999999999999999998 899999999999999999999999999998543222
Q ss_pred ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||........ .+....+.. .+...++
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~i~~~~~------~~p~~~s- 229 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---FELILMEEI------RFPRTLS- 229 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHCCC------CCCTTSC-
T ss_pred CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH---HHHHHcCCC------CCCCCCC-
Confidence 223456899999999999999999999999999999999999999986543222 222222211 1122222
Q ss_pred HHHHHHHHHhhhccCCCCCCCC-----CHHHHHHH
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRP-----SMRQVVQY 603 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 603 (660)
..+.+++..||+.||++|| +++|++++
T Consensus 230 ---~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 230 ---PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ---HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---HHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 3467788889999999999 89999863
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=366.66 Aligned_cols=250 Identities=20% Similarity=0.254 Sum_probs=207.2
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCCh------hhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDH------GMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLL 410 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 410 (660)
.|+..+.||+|+||.||+++...+++.||+|.+...... ..+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 13 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 92 (361)
T 2yab_A 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVL 92 (361)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEE
Confidence 588899999999999999999999999999999754322 35789999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCC----CeEEeecccce
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADL----EGKLGDFGLAR 486 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~----~~kl~DFGla~ 486 (660)
||||+++|+|.+++... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++.++ .+||+|||+++
T Consensus 93 v~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 93 ILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp EEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred EEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 99999999999999654 359999999999999999999998 8999999999999998877 79999999998
Q ss_pred eccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCc
Q 006112 487 LYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPR 566 (660)
Q Consensus 487 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 566 (660)
...... ......||+.|+|||++.+..++.++|||||||++|||++|..||....... .......+... .++.
T Consensus 168 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~---~~~~i~~~~~~--~~~~ 240 (361)
T 2yab_A 168 EIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLANITAVSYD--FDEE 240 (361)
T ss_dssp ECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHHTTCCC--CCHH
T ss_pred EcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhcCCC--CCch
Confidence 765432 2344679999999999998899999999999999999999999997644321 12222222110 0111
Q ss_pred ccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 567 LEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 567 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
... .....+.+++..||+.||++|||+.|+++
T Consensus 241 ~~~----~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 241 FFS----QTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hcc----CCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111 12345678888999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=354.77 Aligned_cols=258 Identities=26% Similarity=0.345 Sum_probs=202.5
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhc--cCCCCceeEeeeeeec----CeeEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGK--LRHRNLVQLRGYCRRK----GELLL 410 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~H~nIv~l~g~~~~~----~~~~l 410 (660)
.|+.++.||+|+||.||+|++ +++.||||++... ..+.+..|.+++.. ++||||+++++++... ...++
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 9 DITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp GCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred cEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 688899999999999999998 6889999998543 34556667666665 7999999999987543 45899
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcc-----cCceeccCccCCcEEEcCCCCeEEeecccc
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEW-----EQVVLHRDIKPANVLLDADLEGKLGDFGLA 485 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDikp~NIll~~~~~~kl~DFGla 485 (660)
||||+++|+|.+++.. ..+++..+++++.|++.||+|||... +++|+||||||+|||++.++.+||+|||++
T Consensus 84 v~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 160 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA 160 (301)
T ss_dssp EECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred ehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence 9999999999999954 35999999999999999999999211 289999999999999999999999999999
Q ss_pred eeccCCCCce---eeccccCccccCcccccCC------CCCcceeEEehHHHHHHHhhC----------CCCCCCCC--c
Q 006112 486 RLYDHGNDLH---TTNVVGTVGYLAPELLRNG------RGTTSTDVYAFGVFMLEVACG----------RRPVQPGE--L 544 (660)
Q Consensus 486 ~~~~~~~~~~---~~~~~gt~~Y~aPE~~~~~------~~t~ksDV~S~Gvvl~elltG----------~~p~~~~~--~ 544 (660)
+......... .....||+.|+|||++.+. .++.++|||||||++|||++| +.||.... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~ 240 (301)
T 3q4u_A 161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240 (301)
T ss_dssp EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence 8765543322 2335799999999999876 445799999999999999999 88886521 1
Q ss_pred chHHHHHHHHhcCCcccCCCCccc-ccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 545 DLLDWVIDYWQKGDVLDASDPRLE-GIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
.............. ..+.+. ..+.......+.+++..||+.||++|||+.||++.|+.
T Consensus 241 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 241 PSFEDMRKVVCVDQ----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp CCHHHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred cchhhhhHHHhccC----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 12222222222111 112221 22344567789999999999999999999999999975
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=375.23 Aligned_cols=256 Identities=24% Similarity=0.358 Sum_probs=210.7
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
.-+|+..+.||+|+||.||+|++..+++.||||.+.... ....++|.+|++++++++||||++++++|..++..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 346888899999999999999998889999999986543 3345679999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
||++|+|.+++.... ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 193 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp CCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 999999999997543 348899999999999999999998 8999999999999999999999999999986543211
Q ss_pred cee-eccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccC
Q 006112 494 LHT-TNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIY 571 (660)
Q Consensus 494 ~~~-~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 571 (660)
... ....+++.|+|||.+..+.++.++|||||||++|||++ |+.||...... .+.+....+.... ...
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~---~~~~~~~~~~~~~-----~~~-- 338 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ---QTREFVEKGGRLP-----CPE-- 338 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH---HHHHHHHTTCCCC-----CCT--
T ss_pred eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcCCCCC-----CCC--
Confidence 111 12345778999999998899999999999999999998 99999764432 2233333332211 111
Q ss_pred cHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 572 VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
.....+.+++..||+.||++|||++++++.|+.
T Consensus 339 --~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 371 (377)
T 3cbl_A 339 --LCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQS 371 (377)
T ss_dssp --TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 123457788899999999999999999999975
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=361.44 Aligned_cols=251 Identities=21% Similarity=0.298 Sum_probs=207.3
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCCh------hhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDH------GMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLL 410 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 410 (660)
.|+..+.||+|+||.||+++...+++.||+|.+...... ..+.+.+|+.++++++||||+++++++...+..++
T Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 91 (326)
T 2y0a_A 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 91 (326)
T ss_dssp HEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 588899999999999999999999999999998654321 35789999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCC----CeEEeecccce
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADL----EGKLGDFGLAR 486 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~----~~kl~DFGla~ 486 (660)
||||+++|+|.+++... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++.++ .+||+|||+++
T Consensus 92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 92 ILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 99999999999999654 359999999999999999999998 9999999999999998887 79999999998
Q ss_pred eccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCc
Q 006112 487 LYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPR 566 (660)
Q Consensus 487 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 566 (660)
....... .....||+.|+|||++....++.++|||||||++|||++|+.||........ ......... .
T Consensus 167 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~~~~~~~------~ 235 (326)
T 2y0a_A 167 KIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---LANVSAVNY------E 235 (326)
T ss_dssp ECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHHHHTCC------C
T ss_pred ECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---HHHHHhcCC------C
Confidence 7654322 2346799999999999988999999999999999999999999976443211 111111111 0
Q ss_pred ccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 567 LEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 567 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
............+.+++..||+.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 236 FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111111123457788889999999999999999974
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=351.95 Aligned_cols=254 Identities=25% Similarity=0.376 Sum_probs=209.7
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
.-.|+.++.+|+|+||.||+|++. ++..||+|++.... ...+++.+|++++++++||||+++++++.+++..++||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 346888999999999999999996 46789999996543 3346799999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
+++++|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 87 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 87 MEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp CTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 99999999997543 358999999999999999999998 99999999999999999999999999999865443322
Q ss_pred eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 495 HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||....... .......+.. +......
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~---~~~~~~~~~~-----~~~~~~~-- 232 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDISTGFR-----LYKPRLA-- 232 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHTTCC-----CCCCTTS--
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH---HHHHHhcCcc-----CCCCCcC--
Confidence 3334567889999999998999999999999999999999 999997644322 2222222211 1111112
Q ss_pred HHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
...+.+++..||+.||++||+++|++++|+.
T Consensus 233 --~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~ 263 (269)
T 4hcu_A 233 --STHVYQIMNHCWRERPEDRPAFSRLLRQLAE 263 (269)
T ss_dssp --CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CHHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence 2447788889999999999999999999975
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=372.32 Aligned_cols=256 Identities=26% Similarity=0.429 Sum_probs=198.5
Q ss_pred eeeecccccccCccEEEEEEEeC---CCCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLP---SSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~---~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 411 (660)
..|+..+.||+|+||.||+|++. .++..||||++.... ....++|.+|+.++++++||||++++++|.+.+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 36888899999999999999886 456789999997653 34567899999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCC
Q 006112 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 491 (660)
||||++|+|.+++.... ..+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 125 ~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 99999999999997653 358999999999999999999998 89999999999999999999999999999876543
Q ss_pred CCce--eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCccc
Q 006112 492 NDLH--TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLE 568 (660)
Q Consensus 492 ~~~~--~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 568 (660)
.... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... +......+....
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~---~~~~i~~~~~~~------- 270 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---VIKAVDEGYRLP------- 270 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH---HHHHHHTTEECC-------
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCCCCC-------
Confidence 2221 122345788999999999999999999999999999998 999997644322 222222221111
Q ss_pred ccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 569 GIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
........+.+++..||+.||++||+++||++.|+..
T Consensus 271 --~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 271 --PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp --CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 0112335578899999999999999999999999764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=353.39 Aligned_cols=259 Identities=27% Similarity=0.341 Sum_probs=203.7
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
+|+.++.||+|+||+||+|++..+++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 82 (292)
T 3o0g_A 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEec
Confidence 5889999999999999999999999999999997543 33457889999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
+++ +|.+++.... ..+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 156 (292)
T 3o0g_A 83 CDQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp CSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-
T ss_pred CCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc-
Confidence 965 6666555433 359999999999999999999998 8999999999999999999999999999987653322
Q ss_pred eeeccccCccccCcccccCCC-CCcceeEEehHHHHHHHhhCCCCCCCCCc--chHHHHHHHHhcCCcccCCCCc-----
Q 006112 495 HTTNVVGTVGYLAPELLRNGR-GTTSTDVYAFGVFMLEVACGRRPVQPGEL--DLLDWVIDYWQKGDVLDASDPR----- 566 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~-~t~ksDV~S~Gvvl~elltG~~p~~~~~~--~~~~~~~~~~~~~~~~~~~d~~----- 566 (660)
......||+.|+|||.+.+.. ++.++|||||||++|||++|..|+..... .....+.+..... .....+.
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~~~ 234 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP--TEEQWPSMTKLP 234 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCC--CTTTCTTGGGST
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCC--Chhhhhhhcccc
Confidence 234467899999999997765 79999999999999999999998654332 1222222221111 0000000
Q ss_pred ------------ccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 567 ------------LEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 567 ------------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
............+.+++..|++.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0001112233456788889999999999999999973
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=361.02 Aligned_cols=253 Identities=25% Similarity=0.322 Sum_probs=204.5
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
-.|+.++.||+|+||.||+|++..+++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 36899999999999999999999899999999986543 23346789999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC-
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND- 493 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~- 493 (660)
|++|+|.+++.... .+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 87 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 87 CSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp CTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred CCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 99999999996543 48999999999999999999998 9999999999999999999999999999987643322
Q ss_pred ceeeccccCccccCcccccCCCC-CcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCc
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
.......||+.|+|||++.+..+ +.++|||||||++|||++|+.||............ ........ .+ ..
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~-~~~~~~~~---~~--~~--- 232 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-WKEKKTYL---NP--WK--- 232 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHH-HHTTCTTS---TT--GG---
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH-HhcccccC---Cc--cc---
Confidence 22345689999999999987765 77999999999999999999999764433222111 11111110 00 11
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.....+.+++..||+.||++|||++|++++
T Consensus 233 -~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 233 -KIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp -GSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -cCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 123446678889999999999999999874
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=367.20 Aligned_cols=258 Identities=24% Similarity=0.349 Sum_probs=209.6
Q ss_pred ceeeecccccccCccEEEEEEE-----eCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCe
Q 006112 335 RFSYKNLYKATKGGSGKVYRGV-----LPSSHAEIAVKKVCHDSD-HGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGE 407 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~-----~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 407 (660)
+-.|+..+.||+|+||.||+|+ ...+++.||||++..... ...+.+.+|++++.++ +||||++++++|.+.+.
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 100 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 100 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCC
Confidence 4478899999999999999998 455678999999976433 3457899999999999 79999999999987654
Q ss_pred -eEEEEecCCCCChhhhhhhCCC---------------------------------------------------------
Q 006112 408 -LLLVYDYMPNGSLDKILYSNTR--------------------------------------------------------- 429 (660)
Q Consensus 408 -~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 429 (660)
.++|||||++|+|.+++.....
T Consensus 101 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (359)
T 3vhe_A 101 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 180 (359)
T ss_dssp CCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------------
T ss_pred ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcc
Confidence 8999999999999999976432
Q ss_pred -------CCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC-ceeecccc
Q 006112 430 -------PSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND-LHTTNVVG 501 (660)
Q Consensus 430 -------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~-~~~~~~~g 501 (660)
..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....... .......|
T Consensus 181 ~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 257 (359)
T 3vhe_A 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257 (359)
T ss_dssp ---CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred cccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCC
Confidence 128899999999999999999998 8999999999999999999999999999987644332 23345678
Q ss_pred CccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHH
Q 006112 502 TVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVL 580 (660)
Q Consensus 502 t~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 580 (660)
|+.|+|||++.+..++.++|||||||++|||++ |+.||....... .+......+.... ..... ...+.
T Consensus 258 t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~~~~~~~~-----~~~~~----~~~l~ 326 (359)
T 3vhe_A 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLKEGTRMR-----APDYT----TPEMY 326 (359)
T ss_dssp CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHHHHHHTCCCC-----CCTTC----CHHHH
T ss_pred CceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HHHHHHHcCCCCC-----CCCCC----CHHHH
Confidence 999999999999999999999999999999998 999997644321 1222223322211 11122 23477
Q ss_pred HHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 581 KLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 581 ~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
+++..||+.||++|||++|++++|+.
T Consensus 327 ~li~~~l~~dP~~Rps~~ell~~L~~ 352 (359)
T 3vhe_A 327 QTMLDCWHGEPSQRPTFSELVEHLGN 352 (359)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHccCChhhCCCHHHHHHHHHH
Confidence 88889999999999999999999975
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=360.73 Aligned_cols=254 Identities=20% Similarity=0.261 Sum_probs=209.7
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 416 (660)
.|+..+.||+|+||.||+|++..+++.+|+|.+... ....+.+.+|+.++++++||||+++++++.+.+..++|||||+
T Consensus 6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 84 (321)
T 1tki_A 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred ceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCC
Confidence 588899999999999999999999999999998643 3445678999999999999999999999999999999999999
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcC--CCCeEEeecccceeccCCCCc
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDA--DLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~--~~~~kl~DFGla~~~~~~~~~ 494 (660)
+|+|.+++.... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++. ++.+||+|||+++......
T Consensus 85 g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~-- 158 (321)
T 1tki_A 85 GLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-- 158 (321)
T ss_dssp CCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--
T ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC--
Confidence 999999996543 358999999999999999999998 89999999999999987 7899999999998765433
Q ss_pred eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHH
Q 006112 495 HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEE 574 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 574 (660)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......+... +.......
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~~~~------~~~~~~~~ 229 (321)
T 1tki_A 159 NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---IIENIMNAEYT------FDEEAFKE 229 (321)
T ss_dssp EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHHTCCC------CCHHHHTT
T ss_pred ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH---HHHHHHcCCCC------CChhhhcc
Confidence 2345679999999999998888999999999999999999999997644321 12222222111 00000011
Q ss_pred HHHHHHHHhhhccCCCCCCCCCHHHHHH--HhhC
Q 006112 575 QMEIVLKLGLFCSHSNPDTRPSMRQVVQ--YLDG 606 (660)
Q Consensus 575 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~ 606 (660)
....+.+++..|++.||++|||+.|+++ +++.
T Consensus 230 ~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 263 (321)
T 1tki_A 230 ISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcChhhcc
Confidence 2345778899999999999999999997 4544
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=349.37 Aligned_cols=256 Identities=27% Similarity=0.394 Sum_probs=212.0
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
.-+|+.++.||+|+||.||+|.+. ++..||+|++..... ..+++.+|++++++++||||+++++++.+++..++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 447899999999999999999885 567899999965432 346799999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
+++++|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 85 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 85 ISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp CTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred cCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 99999999997643 348999999999999999999998 89999999999999999999999999999876655444
Q ss_pred eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 495 HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........ ......+... ..+ ...
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~~~~~~~~--~~~---~~~-- 230 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV---VLKVSQGHRL--YRP---HLA-- 230 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---HHHHHTTCCC--CCC---TTS--
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH---HHHHHcCCCC--CCC---CcC--
Confidence 4445567888999999998889999999999999999999 9999976443221 1122222211 111 111
Q ss_pred HHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCCC
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGA 608 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (660)
...+.+++..||+.||++|||+.|+++.|+...
T Consensus 231 --~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 231 --SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp --CHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred --hHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 235778888999999999999999999998754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=353.04 Aligned_cols=257 Identities=27% Similarity=0.391 Sum_probs=218.0
Q ss_pred CceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 334 HRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 334 ~~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
...+|+..+.||+|+||.||+|.+..++..||+|.+... ....+++.+|++++++++||||+++++++.+++..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 345788999999999999999999888999999999653 3456789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
|+++++|.+++.......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence 9999999999988766679999999999999999999998 8999999999999999999999999999987765544
Q ss_pred ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCc
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
.......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||............ ..... +....
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~---~~~~~-----~~~~~--- 235 (288)
T 3kfa_A 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL---EKDYR-----MERPE--- 235 (288)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH---HTTCC-----CCCCT---
T ss_pred ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---hccCC-----CCCCC---
Confidence 44455677889999999998999999999999999999999 99999765543332222 22111 11111
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
.....+.+++..|++.||.+|||+.|+++.|+.
T Consensus 236 -~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~ 268 (288)
T 3kfa_A 236 -GCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 268 (288)
T ss_dssp -TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHH
Confidence 223457788889999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=363.45 Aligned_cols=257 Identities=23% Similarity=0.351 Sum_probs=203.4
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeE----EEEEEeccC-CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeE
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAE----IAVKKVCHD-SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELL 409 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~----vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 409 (660)
..+|+.++.||+|+||.||+|++..+++. ||+|.+... .....+++.+|+.++++++||||++++++|... ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeE
Confidence 34688999999999999999998776654 588877543 334567899999999999999999999999875 478
Q ss_pred EEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceecc
Q 006112 410 LVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYD 489 (660)
Q Consensus 410 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 489 (660)
+|+||+++|+|.+++.... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 9999999999999998754 358999999999999999999998 899999999999999999999999999998765
Q ss_pred CCCCc-eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcc
Q 006112 490 HGNDL-HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL 567 (660)
Q Consensus 490 ~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 567 (660)
..... ......||+.|+|||++.+..++.++|||||||++|||++ |+.||............ ..+.... .
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~---~~~~~~~-----~ 240 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL---EKGERLP-----Q 240 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH---HTTCCCC-----C
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHH---HcCCCCC-----C
Confidence 44322 2334567889999999999999999999999999999999 99999875544333222 2222111 1
Q ss_pred cccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCCC
Q 006112 568 EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGA 608 (660)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (660)
.......+.+++..||+.||++||+++|+++.|+...
T Consensus 241 ----~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 241 ----PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp ----CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred ----CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1112345778889999999999999999999997643
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=380.25 Aligned_cols=256 Identities=27% Similarity=0.409 Sum_probs=210.0
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
+-+|+..+.||+|+||.||+|.+. ++..||||++.... ...++|.+|+.++++++||||+++++++. .+..++||||
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred hHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 346888899999999999999995 46789999997543 45688999999999999999999999986 5678999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
|++|+|.+++.......+++.++.+++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 340 (454)
T 1qcf_A 264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 340 (454)
T ss_dssp CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH
T ss_pred cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee
Confidence 999999999975443458889999999999999999998 89999999999999999999999999999876432212
Q ss_pred eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 495 HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
......+|+.|+|||.+..+.++.++|||||||++|||++ |+.||....... +......+.... . . .
T Consensus 341 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~---~~~~i~~~~~~~--~---~----~ 408 (454)
T 1qcf_A 341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRALERGYRMP--R---P----E 408 (454)
T ss_dssp TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHHHHHTCCCC--C---C----T
T ss_pred ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCCCCC--C---C----C
Confidence 2233456889999999998999999999999999999999 999997643322 222223332111 1 1 1
Q ss_pred HHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCCC
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGA 608 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (660)
.....+.+++..||+.||++|||+++|++.|+...
T Consensus 409 ~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 409 NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 23345788899999999999999999999999753
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=371.18 Aligned_cols=258 Identities=25% Similarity=0.396 Sum_probs=209.3
Q ss_pred ceeeecccccccCccEEEEEEEeC-----CCCeEEEEEEeccC-CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCee
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLP-----SSHAEIAVKKVCHD-SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGEL 408 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~-----~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 408 (660)
+-+|+.++.||+|+||.||+|++. .+++.||||++... ......++.+|+.++++++||||+++++++...+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 346888999999999999999953 46779999999654 344566899999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhhhCC-----CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCC---CeEEe
Q 006112 409 LLVYDYMPNGSLDKILYSNT-----RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADL---EGKLG 480 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~---~~kl~ 480 (660)
++|||||++|+|.+++.... ...+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999997542 2458999999999999999999998 8999999999999999554 59999
Q ss_pred ecccceeccCCC-CceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCC
Q 006112 481 DFGLARLYDHGN-DLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGD 558 (660)
Q Consensus 481 DFGla~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 558 (660)
|||+++...... ........||+.|+|||.+.+..++.++|||||||++|||++ |+.||....... +......+.
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~---~~~~i~~~~ 303 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VLEFVTSGG 303 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHHHHTTC
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCC
Confidence 999997553222 222334578999999999999999999999999999999998 999997654322 222223322
Q ss_pred cccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 559 VLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 559 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
... ... .....+.+++..||+.||++||++.||++.|+..
T Consensus 304 ~~~-----~~~----~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 304 RMD-----PPK----NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp CCC-----CCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC-----CCc----cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 211 111 1234577888999999999999999999999764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=363.70 Aligned_cols=252 Identities=23% Similarity=0.278 Sum_probs=206.0
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC-----CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD-----SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 411 (660)
.|+.++.||+|+||.||+|++..+++.||||++... .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 104 (351)
T 3c0i_A 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMV 104 (351)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 588899999999999999999999999999998532 122467899999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhhC--CCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCC---eEEeecccce
Q 006112 412 YDYMPNGSLDKILYSN--TRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLE---GKLGDFGLAR 486 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~---~kl~DFGla~ 486 (660)
||||++|+|.+++... ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++. +||+|||+++
T Consensus 105 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 105 FEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 9999999998887543 23358899999999999999999998 89999999999999987655 9999999998
Q ss_pred eccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCc
Q 006112 487 LYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPR 566 (660)
Q Consensus 487 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 566 (660)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .....+... ..+.
T Consensus 182 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----~~i~~~~~~--~~~~ 254 (351)
T 3c0i_A 182 QLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLF----EGIIKGKYK--MNPR 254 (351)
T ss_dssp ECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHH----HHHHHTCCC--CCHH
T ss_pred EecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHH----HHHHcCCCC--CCcc
Confidence 765432 223446799999999999988999999999999999999999999986433222 222222211 0110
Q ss_pred ccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 567 LEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 567 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
... .....+.+++..||+.||++|||+.|+++
T Consensus 255 ~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 255 QWS----HISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 001 12345778888999999999999999996
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=361.44 Aligned_cols=257 Identities=16% Similarity=0.120 Sum_probs=209.2
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCeeEEEEecC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
.|+..+.||+|+||.||+|+...+++.||||.+.... ..+++.+|+.+++++ +||||+++++++...+..++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (330)
T 2izr_A 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL 87 (330)
T ss_dssp TEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred CeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence 5888999999999999999998899999999986543 235789999999999 9999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCC-----eEEeecccceeccC
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLE-----GKLGDFGLARLYDH 490 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~-----~kl~DFGla~~~~~ 490 (660)
+++|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++. +||+|||+++.+..
T Consensus 88 -~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 88 -GPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp -CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred -CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence 999999998653 469999999999999999999998 89999999999999998887 99999999987654
Q ss_pred CCCc------eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCC
Q 006112 491 GNDL------HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASD 564 (660)
Q Consensus 491 ~~~~------~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d 564 (660)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....................... .
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~-~ 241 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP-I 241 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC-H
T ss_pred CCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC-H
Confidence 3321 12456899999999999999999999999999999999999999987443322222222211111000 0
Q ss_pred CcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 565 PRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 565 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
..+... .+ .+.+++..||+.||.+||++.+|++.|+.
T Consensus 242 ~~~~~~----~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~ 278 (330)
T 2izr_A 242 EVLCEN----FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTD 278 (330)
T ss_dssp HHHTTT----CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred HHHhcc----Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence 000011 12 67888889999999999999999998874
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=349.50 Aligned_cols=252 Identities=24% Similarity=0.460 Sum_probs=205.9
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChh-------hHHHHHHHHHHhccCCCCceeEeeeeeecCee
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHG-------MKQFVSEIVSMGKLRHRNLVQLRGYCRRKGEL 408 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~-------~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 408 (660)
-.|+..+.||+|+||.||+|++..+++.||+|++....... .+.+.+|+.++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 36888899999999999999999999999999986543221 267999999999999999999999987665
Q ss_pred EEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCc--eeccCccCCcEEEcCCCC-----eEEee
Q 006112 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQV--VLHRDIKPANVLLDADLE-----GKLGD 481 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDikp~NIll~~~~~-----~kl~D 481 (660)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+ .+ |+||||||+|||++.++. +||+|
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 69999999999999887543 369999999999999999999998 78 999999999999988776 99999
Q ss_pred cccceeccCCCCceeeccccCccccCccccc--CCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCc
Q 006112 482 FGLARLYDHGNDLHTTNVVGTVGYLAPELLR--NGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDV 559 (660)
Q Consensus 482 FGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 559 (660)
||+++.... ......||+.|+|||.+. ...++.++|||||||++|||++|+.||.................+.
T Consensus 173 fg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~- 247 (287)
T 4f0f_A 173 FGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL- 247 (287)
T ss_dssp CTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC-
T ss_pred CCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC-
Confidence 999975332 234567999999999984 4557889999999999999999999998755444433333322221
Q ss_pred ccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 560 LDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 560 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
.+.+... ....+.+++..||+.||++|||++|+++.|+.
T Consensus 248 ----~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 248 ----RPTIPED----CPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp ----CCCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ----CCCCCcc----cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 1112222 23457788889999999999999999999975
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=351.08 Aligned_cols=248 Identities=25% Similarity=0.319 Sum_probs=198.6
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC--------------------------hhhHHHHHHHHHHhcc
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD--------------------------HGMKQFVSEIVSMGKL 390 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~Ei~~l~~l 390 (660)
.|+..+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+++++++
T Consensus 14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 93 (298)
T 2zv2_A 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL 93 (298)
T ss_dssp TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence 68889999999999999999999999999999865421 1246789999999999
Q ss_pred CCCCceeEeeeeee--cCeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCc
Q 006112 391 RHRNLVQLRGYCRR--KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPAN 468 (660)
Q Consensus 391 ~H~nIv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~N 468 (660)
+||||+++++++.+ .+..++||||+++++|.+++.. ..+++.++..++.||+.||+|||+ .+|+||||||+|
T Consensus 94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~N 167 (298)
T 2zv2_A 94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSN 167 (298)
T ss_dssp CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGG
T ss_pred CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHH
Confidence 99999999999986 5679999999999999887643 358999999999999999999998 899999999999
Q ss_pred EEEcCCCCeEEeecccceeccCCCCceeeccccCccccCcccccCCC---CCcceeEEehHHHHHHHhhCCCCCCCCCcc
Q 006112 469 VLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGR---GTTSTDVYAFGVFMLEVACGRRPVQPGELD 545 (660)
Q Consensus 469 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~t~ksDV~S~Gvvl~elltG~~p~~~~~~~ 545 (660)
||++.++.+||+|||+++....... ......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||......
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 246 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence 9999999999999999987654322 234567999999999997655 378899999999999999999999764432
Q ss_pred hHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 546 LLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
. .......+.... +. .... ...+.+++.+||+.||++||++.|+++
T Consensus 247 ~---~~~~~~~~~~~~---~~-~~~~----~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 247 C---LHSKIKSQALEF---PD-QPDI----AEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp H---HHHHHHHCCCCC---CS-SSCC----CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred H---HHHHHhcccCCC---CC-cccc----CHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 2 122222221111 10 1112 234778888999999999999999985
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=374.06 Aligned_cols=249 Identities=31% Similarity=0.392 Sum_probs=206.5
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecC-eeEEEEe
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKG-ELLLVYD 413 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-~~~lV~E 413 (660)
.-+|+.++.||+|+||.||+|.+. ++.||||++.... ..+.|.+|+.++++++||||++++++|.+.. .+++|||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 346888999999999999999984 7899999996543 5678999999999999999999999987665 7999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
||++|+|.+++.......+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 342 (450)
T ss_dssp CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence 9999999999987665568999999999999999999998 89999999999999999999999999999854322
Q ss_pred ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCc
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
.....+++.|+|||.+.+..++.++|||||||++|||++ |+.||........ ......+.... ..
T Consensus 343 --~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~~~i~~~~~~~-----~p---- 408 (450)
T 1k9a_A 343 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRVEKGYKMD-----AP---- 408 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH---HHHHHTTCCCC-----CC----
T ss_pred --ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHcCCCCC-----CC----
Confidence 122367889999999999999999999999999999998 9999976433222 22223332211 11
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
......+.+++..||+.||++|||+.++++.|+.
T Consensus 409 ~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~ 442 (450)
T 1k9a_A 409 DGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH 442 (450)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1233457788899999999999999999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=350.57 Aligned_cols=254 Identities=25% Similarity=0.346 Sum_probs=206.2
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
.-+|+.++.||+|+||.||++.+. ++..||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 347889999999999999999986 577899999965432 346799999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
+++++|.+++.... ..+++.++..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++........
T Consensus 101 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 101 MANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp CTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred cCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence 99999999997533 358999999999999999999998 89999999999999999999999999999865443222
Q ss_pred eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 495 HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........ ......+.. .......
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~---~~~~~~~~~-----~~~~~~~-- 246 (283)
T 3gen_A 177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET---AEHIAQGLR-----LYRPHLA-- 246 (283)
T ss_dssp STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---HHHHHTTCC-----CCCCTTC--
T ss_pred cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH---HHHHhcccC-----CCCCCcC--
Confidence 2334567889999999998899999999999999999998 9999976443222 122222211 1111111
Q ss_pred HHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
...+.+++..||+.||++|||++|++++|+.
T Consensus 247 --~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 277 (283)
T 3gen_A 247 --SEKVYTIMYSCWHEKADERPTFKILLSNILD 277 (283)
T ss_dssp --CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred --CHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 2457788899999999999999999999975
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=366.12 Aligned_cols=257 Identities=22% Similarity=0.272 Sum_probs=205.9
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
.+.+...+.||+|+||.||+|+...+++.||+|++........+++.+|++++++++||||++++++|...+..++||||
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~ 167 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY 167 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 35666678899999999999999999999999999876666678899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEE--cCCCCeEEeecccceeccCCC
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLL--DADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll--~~~~~~kl~DFGla~~~~~~~ 492 (660)
|++|+|.+++.... ..+++.++..++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++.+....
T Consensus 168 ~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 168 VDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp CTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 99999999887543 358999999999999999999998 899999999999999 567889999999998765433
Q ss_pred CceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCc
Q 006112 493 DLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 493 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
. .....||+.|+|||++....++.++|||||||++|||++|+.||...... +........ .. .. .+....
T Consensus 244 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~~~~i~~~-~~-~~-~~~~~~--- 313 (373)
T 2x4f_A 244 K--LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA--ETLNNILAC-RW-DL-EDEEFQ--- 313 (373)
T ss_dssp B--CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHHT-CC-CS-CSGGGT---
T ss_pred c--cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhc-cC-CC-Chhhhc---
Confidence 2 23457999999999999889999999999999999999999999864432 111211111 11 00 011111
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCCHHHHHH--HhhC
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ--YLDG 606 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~ 606 (660)
.....+.+++..||+.||.+||+++|+++ ++..
T Consensus 314 -~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 314 -DISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp -TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred -cCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 12345778889999999999999999997 4543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=364.53 Aligned_cols=251 Identities=24% Similarity=0.307 Sum_probs=207.2
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
.|+..+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 30 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~ 109 (362)
T 2bdw_A 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 109 (362)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 5888999999999999999999999999999996543 34557899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCC---CeEEeecccceeccCC
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADL---EGKLGDFGLARLYDHG 491 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~---~~kl~DFGla~~~~~~ 491 (660)
|++|+|.+++.... .+++.++..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+++.....
T Consensus 110 ~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 110 VTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp CCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 99999999986543 58999999999999999999998 8999999999999998654 5999999999876533
Q ss_pred CCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccC
Q 006112 492 NDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIY 571 (660)
Q Consensus 492 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 571 (660)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........+... ...+.
T Consensus 185 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---~~~~~i~~~~~~-~~~~~----- 253 (362)
T 2bdw_A 185 E--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYAQIKAGAYD-YPSPE----- 253 (362)
T ss_dssp C--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHTCCC-CCTTG-----
T ss_pred c--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHhCCCC-CCccc-----
Confidence 2 223467999999999999889999999999999999999999999764432 122222232211 11111
Q ss_pred cHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 572 VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.......+.+++..||+.||++||++.|++++
T Consensus 254 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 254 WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11123456788889999999999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=363.72 Aligned_cols=259 Identities=27% Similarity=0.417 Sum_probs=212.4
Q ss_pred ceeeecccccccCccEEEEEEEeCC-----CCeEEEEEEeccCCC-hhhHHHHHHHHHHhccCCCCceeEeeeeeecCee
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPS-----SHAEIAVKKVCHDSD-HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGEL 408 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~-----~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 408 (660)
.-.|+.++.||+|+||.||+|++.. +++.||||++..... ...+.+.+|+.++++++||||++++++|...+..
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 125 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 125 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCce
Confidence 3468889999999999999999863 458999999976533 3467899999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhhhCC----------------------CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccC
Q 006112 409 LLVYDYMPNGSLDKILYSNT----------------------RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKP 466 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp 466 (660)
++||||+++|+|.+++.... ...+++.+++.++.||+.||.|||+ ++|+||||||
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp 202 (343)
T 1luf_A 126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLAT 202 (343)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSG
T ss_pred EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCc
Confidence 99999999999999997642 1468999999999999999999998 8999999999
Q ss_pred CcEEEcCCCCeEEeecccceeccCCCC-ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCc
Q 006112 467 ANVLLDADLEGKLGDFGLARLYDHGND-LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGEL 544 (660)
Q Consensus 467 ~NIll~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~ 544 (660)
+|||++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 282 (343)
T 1luf_A 203 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 282 (343)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh
Confidence 999999999999999999986543221 22334578999999999998899999999999999999999 9999976443
Q ss_pred chHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCCC
Q 006112 545 DLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGA 608 (660)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (660)
. ........+.... .... ....+.+++..||+.||++||++.++++.|+...
T Consensus 283 ~---~~~~~~~~~~~~~-----~~~~----~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~ 334 (343)
T 1luf_A 283 E---EVIYYVRDGNILA-----CPEN----CPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 334 (343)
T ss_dssp H---HHHHHHHTTCCCC-----CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred H---HHHHHHhCCCcCC-----CCCC----CCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence 2 2222333333211 1112 2345778889999999999999999999998753
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=365.71 Aligned_cols=252 Identities=20% Similarity=0.237 Sum_probs=209.3
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 416 (660)
.|+.++.||+|+||.||+|....+++.||+|.+..........+.+|+.++++++||||+++++++.+.+..++|||||+
T Consensus 52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 131 (387)
T 1kob_A 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131 (387)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCC
Confidence 68899999999999999999999999999999976655566789999999999999999999999999999999999999
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcC--CCCeEEeecccceeccCCCCc
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDA--DLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~--~~~~kl~DFGla~~~~~~~~~ 494 (660)
+|+|.+++.... ..+++.++..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.......
T Consensus 132 gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~- 206 (387)
T 1kob_A 132 GGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI- 206 (387)
T ss_dssp CCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC-
T ss_pred CCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCCcc-
Confidence 999999987543 358999999999999999999998 89999999999999974 46799999999987654332
Q ss_pred eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHH
Q 006112 495 HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEE 574 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 574 (660)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.. ......... .++.... .
T Consensus 207 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~~~-~~i~~~~~~--~~~~~~~----~ 276 (387)
T 1kob_A 207 -VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--ETL-QNVKRCDWE--FDEDAFS----S 276 (387)
T ss_dssp -EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHH-HHHHHCCCC--CCSSTTT----T
T ss_pred -eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH--HHH-HHHHhCCCC--CCccccc----c
Confidence 33457999999999999989999999999999999999999999864432 111 112222111 1111111 2
Q ss_pred HHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 575 QMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 575 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
....+.+++..||+.||++|||+.|++++
T Consensus 277 ~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 277 VSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 23457788899999999999999999974
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=367.21 Aligned_cols=269 Identities=20% Similarity=0.266 Sum_probs=211.4
Q ss_pred cCCCceeeecccccccC--ccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeeecC
Q 006112 331 YSPHRFSYKNLYKATKG--GSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKG 406 (660)
Q Consensus 331 ~~~~~~~~~~l~~lg~G--~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~ 406 (660)
+.+..-.|+.++.||+| +||.||+|++..+++.||||++.... ....+.+.+|+.++++++||||+++++++.+++
T Consensus 20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 99 (389)
T 3gni_B 20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 99 (389)
T ss_dssp CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC
Confidence 34556689999999999 99999999999999999999996542 344677889999999999999999999999999
Q ss_pred eeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccce
Q 006112 407 ELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLAR 486 (660)
Q Consensus 407 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 486 (660)
.+++|||||++|+|.+++.......+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~ 176 (389)
T 3gni_B 100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNL 176 (389)
T ss_dssp EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccce
Confidence 99999999999999999987655669999999999999999999998 899999999999999999999999999986
Q ss_pred eccCCCC------ceeeccccCccccCcccccC--CCCCcceeEEehHHHHHHHhhCCCCCCCCCcchH-HHHHHHHhcC
Q 006112 487 LYDHGND------LHTTNVVGTVGYLAPELLRN--GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLL-DWVIDYWQKG 557 (660)
Q Consensus 487 ~~~~~~~------~~~~~~~gt~~Y~aPE~~~~--~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~-~~~~~~~~~~ 557 (660)
....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .... .+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~----~~ 252 (389)
T 3gni_B 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL----NG 252 (389)
T ss_dssp ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------
T ss_pred eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh----cC
Confidence 5432211 11123478999999999987 5789999999999999999999999976332211 1100 00
Q ss_pred CcccCC------------------------------CCcc------cccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHH
Q 006112 558 DVLDAS------------------------------DPRL------EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVV 601 (660)
Q Consensus 558 ~~~~~~------------------------------d~~l------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 601 (660)
...... .++. ...+.......+.+++..||+.||++|||++|++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell 332 (389)
T 3gni_B 253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL 332 (389)
T ss_dssp -----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred CCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 000000 0000 0001122234588899999999999999999999
Q ss_pred HH--hhC
Q 006112 602 QY--LDG 606 (660)
Q Consensus 602 ~~--L~~ 606 (660)
++ ++.
T Consensus 333 ~hp~f~~ 339 (389)
T 3gni_B 333 NHSFFKQ 339 (389)
T ss_dssp TSGGGGG
T ss_pred cCHHHHH
Confidence 64 554
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=370.72 Aligned_cols=256 Identities=22% Similarity=0.233 Sum_probs=207.4
Q ss_pred CceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEE
Q 006112 334 HRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLL 410 (660)
Q Consensus 334 ~~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 410 (660)
..-+|+.++.||+|+||+||+|++..+++.||+|++... .....+.+.+|+.++.+++||||++++++|.+++.+++
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 151 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYL 151 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEE
Confidence 345789999999999999999999999999999999642 22234458999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccC
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDH 490 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 490 (660)
|||||++|+|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 152 V~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 152 VMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227 (437)
T ss_dssp EECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence 999999999999997643 358999999999999999999998 9999999999999999999999999999987665
Q ss_pred CCCceeeccccCccccCccccc-----CCCCCcceeEEehHHHHHHHhhCCCCCCCCCcch-HHHHHHHHhcCCcccCCC
Q 006112 491 GNDLHTTNVVGTVGYLAPELLR-----NGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDL-LDWVIDYWQKGDVLDASD 564 (660)
Q Consensus 491 ~~~~~~~~~~gt~~Y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~d 564 (660)
.........+||+.|+|||++. .+.++.++|||||||++|||++|+.||....... ...+......- ..
T Consensus 228 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-----~~ 302 (437)
T 4aw2_A 228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF-----QF 302 (437)
T ss_dssp TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC-----CC
T ss_pred CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccc-----cC
Confidence 5444455578999999999987 5678999999999999999999999998654322 22221111111 11
Q ss_pred CcccccCcHHHHHHHHHHhhhccCCCCCC--CCCHHHHHH
Q 006112 565 PRLEGIYVEEQMEIVLKLGLFCSHSNPDT--RPSMRQVVQ 602 (660)
Q Consensus 565 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~ 602 (660)
|......+. .+.+++..|+..+|++ ||+++|+++
T Consensus 303 p~~~~~~s~----~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 303 PTQVTDVSE----NAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp CSSCCCSCH----HHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred CcccccCCH----HHHHHHHHHhcccccccCCCCHHHHhC
Confidence 111112233 3556667778777777 999999997
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=359.48 Aligned_cols=257 Identities=24% Similarity=0.365 Sum_probs=206.5
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeE----EEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAE----IAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLL 410 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~----vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 410 (660)
..|+.++.||+|+||.||+|++..+++. ||+|.+.... ....+.+.+|+.++++++||||++++++|. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 4688999999999999999999777654 7888775432 344567889999999999999999999986 567899
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccC
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDH 490 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 490 (660)
||||+++|+|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 92 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 999999999999997642 358999999999999999999998 8999999999999999999999999999987654
Q ss_pred CCC-ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCccc
Q 006112 491 GND-LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLE 568 (660)
Q Consensus 491 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 568 (660)
... .......||..|+|||.+.++.++.++|||||||++|||++ |+.||.......... ....+.......
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~---- 240 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD---LLEKGERLAQPQ---- 240 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHH---HHHTTCBCCCCT----
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHH---HHHcCCCCCCCC----
Confidence 432 22345678889999999999999999999999999999999 999998754433222 222222111111
Q ss_pred ccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCCCC
Q 006112 569 GIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGAL 609 (660)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 609 (660)
. ....+.+++..||+.||++||+++|+++.|+....
T Consensus 241 -~----~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 241 -I----CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp -T----BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred -c----CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1 11235678889999999999999999999987543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=371.53 Aligned_cols=252 Identities=23% Similarity=0.274 Sum_probs=206.8
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD--HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
.|+.++.||+|+||.||+|....+++.+|+|++..... ...+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 12 ~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~ 91 (444)
T 3soa_A 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDL 91 (444)
T ss_dssp HEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred CeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEe
Confidence 68889999999999999999999999999999965432 3456789999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEc---CCCCeEEeecccceeccCC
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLD---ADLEGKLGDFGLARLYDHG 491 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~---~~~~~kl~DFGla~~~~~~ 491 (660)
|++|+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||++ .++.+||+|||+++.....
T Consensus 92 ~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 92 VTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp CBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 99999999997754 48999999999999999999998 8999999999999998 4578999999999876543
Q ss_pred CCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccC
Q 006112 492 NDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIY 571 (660)
Q Consensus 492 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 571 (660)
.. ......||+.|+|||++.+..++.++||||+||++|||++|+.||....... .......+... ...+.. ...
T Consensus 167 ~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~---~~~~i~~~~~~-~~~~~~-~~~ 240 (444)
T 3soa_A 167 QQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR---LYQQIKAGAYD-FPSPEW-DTV 240 (444)
T ss_dssp CC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHTCCC-CCTTTT-TTS
T ss_pred Cc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH---HHHHHHhCCCC-CCcccc-ccC
Confidence 22 2345689999999999998899999999999999999999999997644322 22222333221 111111 112
Q ss_pred cHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 572 VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
...+.+++..||+.||++|||+.|++++
T Consensus 241 ----s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 241 ----TPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp ----CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ----CHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 2346788888999999999999999974
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=366.39 Aligned_cols=251 Identities=24% Similarity=0.295 Sum_probs=204.6
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCeeEEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 411 (660)
-.|+.++.||+|+||+||++++..+++.||+|++... .....+.+.+|..++.++ +||||+++++++.+++.+++|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 4688999999999999999999999999999999754 233456788999999887 899999999999999999999
Q ss_pred EecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCC
Q 006112 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 491 (660)
||||++|+|..++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 132 ~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 99999999999997654 48999999999999999999998 89999999999999999999999999999853322
Q ss_pred CCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCC------cchHHHHHHHHhcCCcccCCCC
Q 006112 492 NDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGE------LDLLDWVIDYWQKGDVLDASDP 565 (660)
Q Consensus 492 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~------~~~~~~~~~~~~~~~~~~~~d~ 565 (660)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....+...+....+..
T Consensus 207 -~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------ 279 (396)
T 4dc2_A 207 -GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------ 279 (396)
T ss_dssp -TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC------
T ss_pred -CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc------
Confidence 223445789999999999999999999999999999999999999996421 1122223333333221
Q ss_pred cccccCcHHHHHHHHHHhhhccCCCCCCCCCH------HHHHH
Q 006112 566 RLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSM------RQVVQ 602 (660)
Q Consensus 566 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~ 602 (660)
.+...++ ..+.+++..||+.||++||++ +||++
T Consensus 280 ~~p~~~s----~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 280 RIPRSLS----VKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp CCCTTSC----HHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred CCCCcCC----HHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 1222222 346678888999999999985 67765
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=365.95 Aligned_cols=258 Identities=28% Similarity=0.390 Sum_probs=213.0
Q ss_pred ceeeecccccccCccEEEEEEEeCC-------CCeEEEEEEeccCC-ChhhHHHHHHHHHHhcc-CCCCceeEeeeeeec
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPS-------SHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRK 405 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~-------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~ 405 (660)
+-.|+..+.||+|+||.||+|++.. .+..||||++.... ....+++.+|+++++++ +||||++++++|..+
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 3478889999999999999999642 34689999997653 34567899999999999 999999999999999
Q ss_pred CeeEEEEecCCCCChhhhhhhCC--------------CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEE
Q 006112 406 GELLLVYDYMPNGSLDKILYSNT--------------RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLL 471 (660)
Q Consensus 406 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll 471 (660)
+..++||||+++|+|.+++.... ...+++.++++++.||+.||+|||+ .+|+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEEE
Confidence 99999999999999999997654 2358999999999999999999998 899999999999999
Q ss_pred cCCCCeEEeecccceeccCCCC-ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHH
Q 006112 472 DADLEGKLGDFGLARLYDHGND-LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDW 549 (660)
Q Consensus 472 ~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~ 549 (660)
+.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||...... .
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~---~ 301 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---E 301 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---H
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---H
Confidence 9999999999999987654332 22334567899999999999999999999999999999999 99999764432 2
Q ss_pred HHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 550 VIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 550 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
+.+....+.... .... ....+.+++..||+.||++|||++||++.|+..
T Consensus 302 ~~~~~~~~~~~~-----~~~~----~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 350 (382)
T 3tt0_A 302 LFKLLKEGHRMD-----KPSN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350 (382)
T ss_dssp HHHHHHTTCCCC-----CCSS----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHcCCCCC-----CCcc----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 233333332211 1112 234577888899999999999999999999865
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=376.51 Aligned_cols=256 Identities=29% Similarity=0.403 Sum_probs=204.7
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
+-+|+..+.||+|+||.||+|.+.. +..||||++.... ...++|.+|++++++++||||++++++|.+ +..++||||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 3468888999999999999999964 5679999997543 345789999999999999999999999876 678999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
|++|+|.+++.......+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 336 (452)
T 1fmk_A 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336 (452)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence 999999999975443458999999999999999999998 89999999999999999999999999999876543322
Q ss_pred eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 495 HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
......+|..|+|||.+..+.++.++|||||||++|||++ |+.||...... .+......+.... . ..
T Consensus 337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~~~~i~~~~~~~-----~----~~ 404 (452)
T 1fmk_A 337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQVERGYRMP-----C----PP 404 (452)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHHHTTCCCC-----C----CT
T ss_pred cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcCCCCC-----C----CC
Confidence 3334567889999999999999999999999999999999 99999764332 2222333332111 1 11
Q ss_pred HHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCCC
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGA 608 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (660)
.....+.+++..||+.||++|||++++++.|+...
T Consensus 405 ~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 405 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 23346778899999999999999999999999754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=366.72 Aligned_cols=247 Identities=23% Similarity=0.309 Sum_probs=202.0
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCeeEEEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
.|+.++.||+|+||.||++++..+++.||||++... .....+.+.+|..++..+ +||||+++++++.+.+.+++||
T Consensus 24 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~ 103 (353)
T 3txo_A 24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVM 103 (353)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEE
Confidence 688999999999999999999999999999999653 233456788999999988 6999999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
|||++|+|..++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 104 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~- 177 (353)
T 3txo_A 104 EFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN- 177 (353)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeecccC-
Confidence 9999999999997654 48999999999999999999998 89999999999999999999999999999853322
Q ss_pred CceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCc
Q 006112 493 DLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 493 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......+.. .+....
T Consensus 178 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~~~i~~~~~------~~p~~~- 247 (353)
T 3txo_A 178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD---LFEAILNDEV------VYPTWL- 247 (353)
T ss_dssp --------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHCCC------CCCTTS-
T ss_pred CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH---HHHHHHcCCC------CCCCCC-
Confidence 223345689999999999998889999999999999999999999998654322 2222222221 111122
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCCH------HHHHH
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRPSM------RQVVQ 602 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~ 602 (660)
...+.+++..|++.||.+||++ +|+++
T Consensus 248 ---~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 248 ---HEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ---CHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 2346678888999999999998 77875
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=353.62 Aligned_cols=260 Identities=25% Similarity=0.310 Sum_probs=202.8
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
-.|+.++.||+|+||.||+|++. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred hhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 37999999999999999999995 58899999986543 2335788999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
||+ |+|.+++.... ..+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 100 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 100 FME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174 (311)
T ss_dssp CCS-EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred CCC-CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence 997 58888886543 358999999999999999999998 8999999999999999999999999999987653322
Q ss_pred ceeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCC-cchHHHHHHHHhcCCccc----------
Q 006112 494 LHTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGE-LDLLDWVIDYWQKGDVLD---------- 561 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~-~~~~~~~~~~~~~~~~~~---------- 561 (660)
......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.... ......+...........
T Consensus 175 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 253 (311)
T 3niz_A 175 -SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253 (311)
T ss_dssp ----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred -cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence 2334578999999999876 568999999999999999999999997633 233333333322211100
Q ss_pred ------CCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 562 ------ASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 562 ------~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
...........+.....+.+++..|++.||++|||++|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000000001112245778899999999999999999997
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=349.88 Aligned_cols=263 Identities=37% Similarity=0.567 Sum_probs=212.2
Q ss_pred eecccccccCccEEEEEEEeCCCCeEEEEEEeccC----CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD----SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~----~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
|...+.||+|+||.||+|+. +++.||||++... .....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 44457899999999999997 5789999998643 23446789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCC-CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 414 YMPNGSLDKILYSNT-RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
|+++++|.+++.... ...++|..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 187 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCS
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEEcCCCcEEEeeccccccccccc
Confidence 999999999986432 3458999999999999999999998 899999999999999999999999999998765433
Q ss_pred Cc-eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCc-c-hHHHHHHHHhcC-CcccCCCCccc
Q 006112 493 DL-HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGEL-D-LLDWVIDYWQKG-DVLDASDPRLE 568 (660)
Q Consensus 493 ~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~-~~~~~~~~~~~~-~~~~~~d~~l~ 568 (660)
.. ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||..... . ...+........ ...+..++.+
T Consensus 188 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 265 (307)
T 2nru_A 188 QTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM- 265 (307)
T ss_dssp SCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSC-
T ss_pred ccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccc-
Confidence 22 2334679999999998864 578999999999999999999999976332 1 222222211111 1122233332
Q ss_pred ccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 569 GIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
........+.+.+++..||+.||.+||++++|++.|+..
T Consensus 266 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 266 NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 234566778899999999999999999999999999863
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=364.99 Aligned_cols=250 Identities=24% Similarity=0.320 Sum_probs=208.3
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
-.|+.++.||+|+||.||++....+++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+.+++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 4688999999999999999999999999999998643 2344678899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
|||++|+|..++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 95 e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp CCCTTEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred ecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence 9999999999997643 48999999999999999999998 899999999999999999999999999998765432
Q ss_pred CceeeccccCccccCcccccC---CCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccc
Q 006112 493 DLHTTNVVGTVGYLAPELLRN---GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEG 569 (660)
Q Consensus 493 ~~~~~~~~gt~~Y~aPE~~~~---~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 569 (660)
......||+.|+|||++.. ..++.++|||||||++|||++|+.||.................... ....
T Consensus 170 --~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~------~~p~ 241 (384)
T 4fr4_A 170 --QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV------TYPS 241 (384)
T ss_dssp --CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCC------CCCT
T ss_pred --ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhccc------CCCC
Confidence 2345689999999999864 4588999999999999999999999976443333333333332211 1111
Q ss_pred cCcHHHHHHHHHHhhhccCCCCCCCCC-HHHHHH
Q 006112 570 IYVEEQMEIVLKLGLFCSHSNPDTRPS-MRQVVQ 602 (660)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~ 602 (660)
.+ ...+.+++..||+.||.+||+ ++++++
T Consensus 242 ~~----s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 242 AW----SQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp TS----CHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred cC----CHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 22 245778888899999999998 788774
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=350.81 Aligned_cols=253 Identities=22% Similarity=0.310 Sum_probs=205.9
Q ss_pred ceeeecccccccCccEEEEEEEeCCCC-------eEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCe
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSH-------AEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGE 407 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~-------~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 407 (660)
.-+|+..+.||+|+||.||+|++..++ ..||+|.+........+.+.+|++++++++||||+++++++..++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 346888999999999999999987655 5799999977666777889999999999999999999999999999
Q ss_pred eEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCC--------eEE
Q 006112 408 LLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLE--------GKL 479 (660)
Q Consensus 408 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~--------~kl 479 (660)
.++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++. +||
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred CEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceeee
Confidence 999999999999999998654 348899999999999999999998 89999999999999998887 999
Q ss_pred eecccceeccCCCCceeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCC
Q 006112 480 GDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGD 558 (660)
Q Consensus 480 ~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~ 558 (660)
+|||+++.... .....||+.|+|||.+.+ ..++.++|||||||++|||++|..|+........ .........
T Consensus 163 ~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~--~~~~~~~~~ 235 (289)
T 4fvq_A 163 SDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR--KLQFYEDRH 235 (289)
T ss_dssp CCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHHHHHTTC
T ss_pred ccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH--HHHHhhccC
Confidence 99999865422 223568999999999987 6789999999999999999996655543222111 111111111
Q ss_pred cccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCCCC
Q 006112 559 VLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGAL 609 (660)
Q Consensus 559 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 609 (660)
.. .... ...+.+++..||+.||++|||++|+++.|+....
T Consensus 236 ~~-------~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 236 QL-------PAPK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp CC-------CCCS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred CC-------CCCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11 1111 1236788889999999999999999999997643
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=354.12 Aligned_cols=258 Identities=25% Similarity=0.378 Sum_probs=212.5
Q ss_pred CceeeecccccccCccEEEEEEEe-----CCCCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCe
Q 006112 334 HRFSYKNLYKATKGGSGKVYRGVL-----PSSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGE 407 (660)
Q Consensus 334 ~~~~~~~l~~lg~G~fg~Vy~g~~-----~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 407 (660)
..-.|+..+.||+|+||.||+|++ ..++..||||++.... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 345788899999999999999987 3456899999997543 3456789999999999999999999999999999
Q ss_pred eEEEEecCCCCChhhhhhhCCC----------------------CCcchhHHHHHHHHHHHHHHHhhhcccCceeccCcc
Q 006112 408 LLLVYDYMPNGSLDKILYSNTR----------------------PSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIK 465 (660)
Q Consensus 408 ~~lV~E~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDik 465 (660)
.++||||+++|+|.+++..... ..+++.+++.++.||+.||+|||+ ++|+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccc
Confidence 9999999999999999976432 348899999999999999999998 899999999
Q ss_pred CCcEEEcCCCCeEEeecccceeccCCCCc-eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCC
Q 006112 466 PANVLLDADLEGKLGDFGLARLYDHGNDL-HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGE 543 (660)
Q Consensus 466 p~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~ 543 (660)
|+|||++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999876543322 2234567889999999998889999999999999999999 999997654
Q ss_pred cchHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 544 LDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 544 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
..... .....+... .... .....+.+++..||+.||++||++.|+++.|+.
T Consensus 258 ~~~~~---~~~~~~~~~-----~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~ 308 (314)
T 2ivs_A 258 PERLF---NLLKTGHRM-----ERPD----NCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK 308 (314)
T ss_dssp GGGHH---HHHHTTCCC-----CCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHH---HHhhcCCcC-----CCCc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 43322 222222211 1111 223457788889999999999999999999975
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=354.23 Aligned_cols=250 Identities=18% Similarity=0.298 Sum_probs=199.5
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecC---------
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKG--------- 406 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~--------- 406 (660)
.|+.++.||+|+||.||+|++..+++.||||++.... ....+.+.+|++++++++||||++++++|.+..
T Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~ 86 (332)
T 3qd2_B 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMD 86 (332)
T ss_dssp HEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHH
T ss_pred cCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhh
Confidence 5888999999999999999999899999999997543 345678999999999999999999999986543
Q ss_pred ------------------------------------------------eeEEEEecCCCCChhhhhhhCCC-CCcchhHH
Q 006112 407 ------------------------------------------------ELLLVYDYMPNGSLDKILYSNTR-PSLNWFQR 437 (660)
Q Consensus 407 ------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~ 437 (660)
..++|||||++|+|.+++..... ...++..+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~ 166 (332)
T 3qd2_B 87 EIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC 166 (332)
T ss_dssp C--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHH
T ss_pred hhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHH
Confidence 28999999999999999976543 23556678
Q ss_pred HHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC-----------ceeeccccCcccc
Q 006112 438 FRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND-----------LHTTNVVGTVGYL 506 (660)
Q Consensus 438 ~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~-----------~~~~~~~gt~~Y~ 506 (660)
+.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....... .......||+.|+
T Consensus 167 ~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 167 LHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 9999999999999998 8999999999999999999999999999987655421 1223457999999
Q ss_pred CcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhc
Q 006112 507 APELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFC 586 (660)
Q Consensus 507 aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C 586 (660)
|||.+.+..++.++|||||||++|||++|..|+.. ..........+. .+. ........+.+++..|
T Consensus 244 aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~-----~~~----~~~~~~~~~~~li~~~ 309 (332)
T 3qd2_B 244 SPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLK-----FPL----LFTQKYPQEHMMVQDM 309 (332)
T ss_dssp CHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTC-----CCH----HHHHHCHHHHHHHHHH
T ss_pred ChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccC-----CCc----ccccCChhHHHHHHHH
Confidence 99999999999999999999999999998766421 111111111211 111 1123334567889999
Q ss_pred cCCCCCCCCCHHHHHHH
Q 006112 587 SHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 587 l~~dP~~RPs~~evl~~ 603 (660)
|+.||++|||++|++++
T Consensus 310 l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 310 LSPSPTERPEATDIIEN 326 (332)
T ss_dssp HCSSGGGSCCHHHHHHS
T ss_pred ccCCCCcCCCHHHHhhc
Confidence 99999999999999974
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=350.64 Aligned_cols=256 Identities=24% Similarity=0.341 Sum_probs=197.3
Q ss_pred CceeeecccccccCccEEEEEEEeCCC---CeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeE
Q 006112 334 HRFSYKNLYKATKGGSGKVYRGVLPSS---HAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELL 409 (660)
Q Consensus 334 ~~~~~~~l~~lg~G~fg~Vy~g~~~~~---~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 409 (660)
..-.|+..+.||+|+||.||+|.+..+ +..||+|++.... ....+.+.+|+.++++++||||+++++++. ++..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 345788999999999999999998643 4679999986543 344678999999999999999999999984 56789
Q ss_pred EEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceecc
Q 006112 410 LVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYD 489 (660)
Q Consensus 410 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 489 (660)
+||||+++|+|.+++.... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 92 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccC
Confidence 9999999999999997653 358999999999999999999998 899999999999999999999999999998765
Q ss_pred CCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCccc
Q 006112 490 HGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLE 568 (660)
Q Consensus 490 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 568 (660)
...........+|+.|+|||.+....++.++||||||+++|||++ |+.||......... .....+... .+.
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~---~~i~~~~~~-----~~~ 239 (281)
T 1mp8_A 168 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GRIENGERL-----PMP 239 (281)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HHHHTTCCC-----CCC
T ss_pred cccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH---HHHHcCCCC-----CCC
Confidence 544333444567889999999998899999999999999999996 99999764433221 112222211 111
Q ss_pred ccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 569 GIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
. .....+.+++..||+.||++|||+.|+++.|+.
T Consensus 240 ~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 273 (281)
T 1mp8_A 240 P----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 273 (281)
T ss_dssp T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 1 223457788889999999999999999999975
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=349.93 Aligned_cols=259 Identities=18% Similarity=0.159 Sum_probs=210.2
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCeeEEEEecC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
.|+..+.||+|+||.||+|+...+++.||||++.... ..+.+.+|+.+++++ +|+|++++++++......++||||+
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (298)
T 1csn_A 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 88 (298)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence 5888999999999999999998899999999985432 345788999999999 7999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCC-----eEEeecccceeccC
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLE-----GKLGDFGLARLYDH 490 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~-----~kl~DFGla~~~~~ 490 (660)
+++|.+++.... ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.++. +||+|||+++....
T Consensus 89 -~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~ 163 (298)
T 1csn_A 89 -GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163 (298)
T ss_dssp -CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred -CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence 999999998654 358999999999999999999998 89999999999999987776 99999999987765
Q ss_pred CCCc------eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCC
Q 006112 491 GNDL------HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASD 564 (660)
Q Consensus 491 ~~~~------~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d 564 (660)
.... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.................+.... ..
T Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~ 242 (298)
T 1csn_A 164 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST-PL 242 (298)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS-CH
T ss_pred ccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc-cH
Confidence 4321 2345679999999999999999999999999999999999999998643222222222111110000 00
Q ss_pred CcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 565 PRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 565 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
+.+. ......+.+++..||+.||++||++++|++.|+..
T Consensus 243 ~~~~----~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 243 RELC----AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp HHHT----TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred HHHH----hhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 0001 11234678888999999999999999999998864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=346.43 Aligned_cols=249 Identities=27% Similarity=0.437 Sum_probs=194.4
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC----hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD----HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~----~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 411 (660)
-+|+..+.+|+|+||.||+|++ .++.||||++..... ...+.+.+|++++++++||||+++++++..++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 3688889999999999999998 478999999865432 3357899999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCc---eeccCccCCcEEEcC--------CCCeEEe
Q 006112 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQV---VLHRDIKPANVLLDA--------DLEGKLG 480 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~---ivHrDikp~NIll~~--------~~~~kl~ 480 (660)
|||+++++|.+++.. ..+++.+++.++.|++.||+|||+ ++ |+||||||+|||++. ++.+||+
T Consensus 85 ~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 999999999999853 358999999999999999999998 66 999999999999986 6789999
Q ss_pred ecccceeccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcc
Q 006112 481 DFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVL 560 (660)
Q Consensus 481 DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 560 (660)
|||+++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.........+ .. ......
T Consensus 159 Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~--~~-~~~~~~ 232 (271)
T 3dtc_A 159 DFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY--GV-AMNKLA 232 (271)
T ss_dssp CCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH--HH-HTSCCC
T ss_pred cCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--hh-hcCCCC
Confidence 999998654332 224578999999999999999999999999999999999999998644322221 11 111111
Q ss_pred cCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 561 DASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 561 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
..... .....+.+++..||+.||++|||+.|++++|+.
T Consensus 233 ----~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 233 ----LPIPS----TCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp ----CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred ----CCCCc----ccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 11111 223457788899999999999999999999975
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=351.65 Aligned_cols=252 Identities=25% Similarity=0.388 Sum_probs=199.3
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
-.|+..+.||+|+||.||+|++ .++.||||++.. ....+.|.+|++++++++||||+++++++.+ ..++||||+
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~ 81 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA 81 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred hHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence 3688889999999999999998 468899999853 3456789999999999999999999999873 489999999
Q ss_pred CCCChhhhhhhCCC-CCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCC-eEEeecccceeccCCCC
Q 006112 416 PNGSLDKILYSNTR-PSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLE-GKLGDFGLARLYDHGND 493 (660)
Q Consensus 416 ~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~-~kl~DFGla~~~~~~~~ 493 (660)
++|+|.+++..... ..+++..++.++.|+++||+|||+.+.++|+||||||+|||++.++. +||+|||+++.....
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 99999999976542 24788899999999999999999855579999999999999998886 799999999765332
Q ss_pred ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+... .+.. +......
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~-----~~~~~~~-- 229 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVH-NGTR-----PPLIKNL-- 229 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHH-TTCC-----CCCBTTC--
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHh-cCCC-----CCccccc--
Confidence 23346899999999999989999999999999999999999999864433332222222 2111 1111222
Q ss_pred HHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
...+.+++..||+.||++|||++|+++.|+..
T Consensus 230 --~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 261 (307)
T 2eva_A 230 --PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261 (307)
T ss_dssp --CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 34577888899999999999999999999864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=355.07 Aligned_cols=244 Identities=21% Similarity=0.289 Sum_probs=205.8
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
+|+.++.||+|+||.||+++...+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus 7 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e 86 (318)
T 1fot_A 7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 86 (318)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEe
Confidence 688899999999999999999999999999999653 22345678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
|+++|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 87 ~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-- 159 (318)
T 1fot_A 87 YIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 159 (318)
T ss_dssp CCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred CCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence 999999999998754 48899999999999999999998 89999999999999999999999999999875432
Q ss_pred ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .... ...+.. .+...++
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~-i~~~~~------~~p~~~~- 227 (318)
T 1fot_A 160 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK--TYEK-ILNAEL------RFPPFFN- 227 (318)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHH-HHHCCC------CCCTTSC-
T ss_pred --cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--HHHH-HHhCCC------CCCCCCC-
Confidence 234679999999999999999999999999999999999999997644321 1111 222211 1122222
Q ss_pred HHHHHHHHHhhhccCCCCCCCC-----CHHHHHH
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRP-----SMRQVVQ 602 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 602 (660)
..+.+++..|++.||++|| +++|+++
T Consensus 228 ---~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 228 ---EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp ---HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ---HHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 3466788889999999999 8999985
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=353.56 Aligned_cols=261 Identities=28% Similarity=0.314 Sum_probs=205.1
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC-----ChhhHHHHHHHHHHhccC---CCCceeEeeeeeecC--
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-----DHGMKQFVSEIVSMGKLR---HRNLVQLRGYCRRKG-- 406 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~---H~nIv~l~g~~~~~~-- 406 (660)
.|+.++.||+|+||.||+|++..+++.||||++.... ......+.+|+.++++++ ||||++++++|....
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~ 89 (308)
T 3g33_A 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTD 89 (308)
T ss_dssp CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSS
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCC
Confidence 6889999999999999999998899999999986432 122356778888777765 999999999998765
Q ss_pred ---eeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecc
Q 006112 407 ---ELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFG 483 (660)
Q Consensus 407 ---~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG 483 (660)
..++||||+. |+|.+++.......+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 165 (308)
T 3g33_A 90 REIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFG 165 (308)
T ss_dssp SEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred CceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEEeeCc
Confidence 5899999996 699999987766669999999999999999999998 899999999999999999999999999
Q ss_pred cceeccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcc-hHHHHHHHHhcCCcccC
Q 006112 484 LARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELD-LLDWVIDYWQKGDVLDA 562 (660)
Q Consensus 484 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~ 562 (660)
+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ....+.+..........
T Consensus 166 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (308)
T 3g33_A 166 LARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 243 (308)
T ss_dssp CTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 998654332 234568999999999999999999999999999999999999999764432 22222222211110000
Q ss_pred -------------CCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 563 -------------SDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 563 -------------~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
..+.......++..+.+.+++..|++.||++|||+.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 244 PRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 00000000011223567788899999999999999999863
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=349.09 Aligned_cols=258 Identities=25% Similarity=0.339 Sum_probs=212.2
Q ss_pred ceeeecccccccCccEEEEEEEe-----CCCCeEEEEEEeccCCC-hhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCe
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVL-----PSSHAEIAVKKVCHDSD-HGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGE 407 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~-----~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 407 (660)
.-.|+..+.||+|+||.||+|++ ..+++.||||++..... ...+.+.+|+.+++++ +||||++++++|..++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 44788899999999999999985 45678999999975543 3467899999999999 99999999999999999
Q ss_pred eEEEEecCCCCChhhhhhhCCC----------------CCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEE
Q 006112 408 LLLVYDYMPNGSLDKILYSNTR----------------PSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLL 471 (660)
Q Consensus 408 ~~lV~E~~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll 471 (660)
.++||||+++|+|.+++..... ..+++.+++.++.||+.||+|||+ ++|+||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEE
Confidence 9999999999999999976542 248999999999999999999998 899999999999999
Q ss_pred cCCCCeEEeecccceeccCCCCc-eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHH
Q 006112 472 DADLEGKLGDFGLARLYDHGNDL-HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDW 549 (660)
Q Consensus 472 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~ 549 (660)
+.++.+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-- 256 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-- 256 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH--
Confidence 99999999999999876654332 2234567889999999999999999999999999999999 9999976443221
Q ss_pred HHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 550 VIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 550 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
.......+.. +.... .....+.+++..||+.||.+|||+.|+++.|+.
T Consensus 257 ~~~~~~~~~~-----~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 304 (313)
T 1t46_A 257 FYKMIKEGFR-----MLSPE----HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (313)
T ss_dssp HHHHHHHTCC-----CCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHhccCCC-----CCCcc----cCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 1222222211 11111 123457788889999999999999999999975
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=357.38 Aligned_cols=259 Identities=25% Similarity=0.331 Sum_probs=209.8
Q ss_pred ceeeecccccccCccEEEEEEEe-----CCCCeEEEEEEeccC-CChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCe
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVL-----PSSHAEIAVKKVCHD-SDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGE 407 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~-----~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 407 (660)
.-.|+..+.||+|+||.||+|++ ..++..||||.+... .....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 44788899999999999999997 345678999999654 334567899999999999 89999999999999999
Q ss_pred eEEEEecCCCCChhhhhhhCCC---------------------CCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccC
Q 006112 408 LLLVYDYMPNGSLDKILYSNTR---------------------PSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKP 466 (660)
Q Consensus 408 ~~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp 466 (660)
.++||||+++|+|.+++..... ..+++..++.++.||+.||+|||+ ++|+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCh
Confidence 9999999999999999976532 237899999999999999999998 8999999999
Q ss_pred CcEEEcCCCCeEEeecccceeccCCCCc-eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCc
Q 006112 467 ANVLLDADLEGKLGDFGLARLYDHGNDL-HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGEL 544 (660)
Q Consensus 467 ~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~ 544 (660)
+|||++.++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.....
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 9999999999999999999876544332 2334567899999999999999999999999999999998 9999976443
Q ss_pred chHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 545 DLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
.. ........+... .... .....+.+++..||+.||.+||++.|++++|+..
T Consensus 281 ~~--~~~~~~~~~~~~-----~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 332 (344)
T 1rjb_A 281 DA--NFYKLIQNGFKM-----DQPF----YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332 (344)
T ss_dssp SH--HHHHHHHTTCCC-----CCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH--HHHHHHhcCCCC-----CCCC----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 21 122222222111 1111 1234577888899999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=356.63 Aligned_cols=244 Identities=25% Similarity=0.334 Sum_probs=196.3
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD--HGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
.|+.+++||+|+||+||+|++..+++.||||++..... ....++..|+..+.++ +||||++++++|.+++.+++|||
T Consensus 58 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e 137 (311)
T 3p1a_A 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTE 137 (311)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred heeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEe
Confidence 58889999999999999999998999999999865432 3344566677666665 89999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
|+ +++|.+++.... ..++|.+++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 138 ~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~- 211 (311)
T 3p1a_A 138 LC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG- 211 (311)
T ss_dssp CC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred cc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeecccCC-
Confidence 99 789999887654 359999999999999999999998 899999999999999999999999999998764332
Q ss_pred ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
......||+.|+|||++.+ .++.++|||||||++|||++|..|+.... .+.....+.. .+ .+..
T Consensus 212 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~------~~~~~~~~~~----~~----~~~~ 275 (311)
T 3p1a_A 212 -AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE------GWQQLRQGYL----PP----EFTA 275 (311)
T ss_dssp ----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH------HHHHHTTTCC----CH----HHHT
T ss_pred -CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHhccCC----Cc----cccc
Confidence 2344579999999999875 78999999999999999999987765421 1122222211 11 1111
Q ss_pred HHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
.....+.+++..||+.||++|||++|+++
T Consensus 276 ~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 276 GLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 22356788889999999999999999996
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=355.87 Aligned_cols=261 Identities=28% Similarity=0.379 Sum_probs=193.6
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD-HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
.|+.++.||+|+||.||+|....+++.||+|++..... ...+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 85 (317)
T 2pmi_A 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM 85 (317)
T ss_dssp -------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECC
T ss_pred ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEec
Confidence 68889999999999999999998999999999975433 34578899999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCC----CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCC
Q 006112 416 PNGSLDKILYSNT----RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491 (660)
Q Consensus 416 ~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 491 (660)
+ |+|.+++.... ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 86 D-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp C-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred C-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 7 69999886432 2358899999999999999999998 89999999999999999999999999999876533
Q ss_pred CCceeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCcc-hHHHHHHHHhcCCc--------cc
Q 006112 492 NDLHTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGELD-LLDWVIDYWQKGDV--------LD 561 (660)
Q Consensus 492 ~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~~~--------~~ 561 (660)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ....+.+....... ..
T Consensus 162 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (317)
T 2pmi_A 162 VN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP 240 (317)
T ss_dssp CC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCT
T ss_pred cc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhh
Confidence 22 2234578999999999876 46899999999999999999999999864432 22222222111000 00
Q ss_pred CCCCccc----cc--------CcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 562 ASDPRLE----GI--------YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 562 ~~d~~l~----~~--------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
...+.+. .. ........+.+++..||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0000000 00 00112245788899999999999999999986
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=357.77 Aligned_cols=251 Identities=24% Similarity=0.296 Sum_probs=205.7
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCeeEEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 411 (660)
-.|+.++.||+|+||.||++++..+++.||+|++... .....+.+.+|..++.++ +||||+++++++.+.+.+++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 3688999999999999999999999999999999754 233456788999999988 899999999999999999999
Q ss_pred EecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCC
Q 006112 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 491 (660)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999999997643 48999999999999999999998 89999999999999999999999999999854322
Q ss_pred CCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCc------chHHHHHHHHhcCCcccCCCC
Q 006112 492 NDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGEL------DLLDWVIDYWQKGDVLDASDP 565 (660)
Q Consensus 492 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~------~~~~~~~~~~~~~~~~~~~d~ 565 (660)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+...+....+..
T Consensus 164 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~------ 236 (345)
T 3a8x_A 164 G-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------ 236 (345)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC------
T ss_pred C-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC------
Confidence 2 223456899999999999998999999999999999999999999964211 112222332222221
Q ss_pred cccccCcHHHHHHHHHHhhhccCCCCCCCCCH------HHHHH
Q 006112 566 RLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSM------RQVVQ 602 (660)
Q Consensus 566 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~ 602 (660)
.+...++ ..+.+++..||+.||++||++ +|+++
T Consensus 237 ~~p~~~s----~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 237 RIPRSLS----VKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp CCCTTSC----HHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred CCCCCCC----HHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 1222222 346678888999999999995 67765
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=370.42 Aligned_cols=254 Identities=22% Similarity=0.236 Sum_probs=207.1
Q ss_pred CceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEE
Q 006112 334 HRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLL 410 (660)
Q Consensus 334 ~~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 410 (660)
..-.|+.++.||+|+||.||+|++..+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+++.+++
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 146 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 146 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 344789999999999999999999999999999998642 22234568899999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccC
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDH 490 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 490 (660)
|||||++|+|.+++... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 147 V~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 147 VMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp EECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 99999999999999754 38899999999999999999998 8999999999999999999999999999987655
Q ss_pred CCCceeeccccCccccCcccccCCC----CCcceeEEehHHHHHHHhhCCCCCCCCCcch-HHHHHHHHhcCCcccCCCC
Q 006112 491 GNDLHTTNVVGTVGYLAPELLRNGR----GTTSTDVYAFGVFMLEVACGRRPVQPGELDL-LDWVIDYWQKGDVLDASDP 565 (660)
Q Consensus 491 ~~~~~~~~~~gt~~Y~aPE~~~~~~----~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~d~ 565 (660)
.........+||+.|+|||++.... ++.++|||||||++|||++|+.||....... ...+...... .. .|
T Consensus 221 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~---~~--~p 295 (410)
T 3v8s_A 221 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS---LT--FP 295 (410)
T ss_dssp TSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH---CC--CC
T ss_pred CCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccc---cc--CC
Confidence 4433445678999999999998655 7889999999999999999999998654322 1211111000 00 11
Q ss_pred cccccCcHHHHHHHHHHhhhccCCCCCC--CCCHHHHHHH
Q 006112 566 RLEGIYVEEQMEIVLKLGLFCSHSNPDT--RPSMRQVVQY 603 (660)
Q Consensus 566 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~ 603 (660)
. ...++ ..+.+++..|++.+|.+ ||+++||+++
T Consensus 296 ~-~~~~s----~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 296 D-DNDIS----KEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp T-TCCCC----HHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred C-ccccc----HHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 0 01122 34667778899989988 9999999974
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=358.18 Aligned_cols=252 Identities=23% Similarity=0.295 Sum_probs=196.3
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCe----eE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGE----LL 409 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~----~~ 409 (660)
.|+.++.||+|+||.||++++..+++.||||++.... ....+.+.+|++++++++||||+++++++..... .+
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 92 (311)
T 3ork_A 13 RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 92 (311)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccE
Confidence 5889999999999999999999999999999997542 2345678999999999999999999999876543 49
Q ss_pred EEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceecc
Q 006112 410 LVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYD 489 (660)
Q Consensus 410 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 489 (660)
+||||+++++|.+++.... .+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 93 lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 93 IVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred EEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 9999999999999997654 48999999999999999999998 899999999999999999999999999998765
Q ss_pred CCCC--ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcc
Q 006112 490 HGND--LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL 567 (660)
Q Consensus 490 ~~~~--~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 567 (660)
.... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ...........
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~--~~~~~~~~~~~------- 238 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--AYQHVREDPIP------- 238 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHCCCCC-------
T ss_pred ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHhcCCCCC-------
Confidence 4322 223346799999999999999999999999999999999999999986543322 22222221110
Q ss_pred cccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 568 EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
...........+.+++..||+.||++||+..++++
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 239 PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 00001112345778888999999999997766654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=347.65 Aligned_cols=258 Identities=26% Similarity=0.402 Sum_probs=209.8
Q ss_pred CCCceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEE
Q 006112 332 SPHRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 332 ~~~~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 411 (660)
....-+|+.++.||+|+||.||+|.+. ++..||||.+.... ...+.+.+|++++++++||||+++++++. .+..++|
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 85 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYII 85 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEE
Confidence 344557999999999999999999985 56789999986543 34678999999999999999999999986 4568999
Q ss_pred EecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCC
Q 006112 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 491 (660)
|||+++++|.+++.......+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.....
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 999999999999975433358999999999999999999998 89999999999999999999999999999877554
Q ss_pred CCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCccccc
Q 006112 492 NDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGI 570 (660)
Q Consensus 492 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 570 (660)
.........++..|+|||.+.++.++.++||||||+++|||++ |+.||....... .......+.. +.....
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~~~~~~~-----~~~~~~ 234 (279)
T 1qpc_A 163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---VIQNLERGYR-----MVRPDN 234 (279)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHTTCC-----CCCCTT
T ss_pred ccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH---HHHHHhcccC-----CCCccc
Confidence 3333334567889999999988889999999999999999999 899997643321 2222222211 111112
Q ss_pred CcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 571 YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
....+.+++..|++.||++|||+.++++.|+..
T Consensus 235 ----~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 235 ----CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp ----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----ccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 234577888899999999999999999998753
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=357.37 Aligned_cols=255 Identities=24% Similarity=0.297 Sum_probs=187.6
Q ss_pred cccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccC-CCCceeEeeeeeecCeeEEEEecCCCCCh
Q 006112 342 YKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLR-HRNLVQLRGYCRRKGELLLVYDYMPNGSL 420 (660)
Q Consensus 342 ~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 420 (660)
+.||+|+||.||+|++..+++.||||++.. .....+.+|+.+++++. ||||+++++++.+++..++|||||++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 679999999999999999999999999854 34567889999999997 99999999999999999999999999999
Q ss_pred hhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCC---CeEEeecccceeccCCCCceee
Q 006112 421 DKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADL---EGKLGDFGLARLYDHGNDLHTT 497 (660)
Q Consensus 421 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~---~~kl~DFGla~~~~~~~~~~~~ 497 (660)
.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+++....... ...
T Consensus 94 ~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~ 167 (325)
T 3kn6_A 94 FERIKKKK--HFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PLK 167 (325)
T ss_dssp HHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-ccc
Confidence 99998754 58999999999999999999998 8999999999999997665 799999999987544322 233
Q ss_pred ccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCc----chHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 498 NVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGEL----DLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 498 ~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~----~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
...||+.|+|||++.+..++.++|||||||++|||++|+.||..... ............+... +......
T Consensus 168 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~------~~~~~~~ 241 (325)
T 3kn6_A 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS------FEGEAWK 241 (325)
T ss_dssp ----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC------CCSHHHH
T ss_pred ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC------CCccccc
Confidence 46789999999999999999999999999999999999999976332 1222333333333221 1111112
Q ss_pred HHHHHHHHHhhhccCCCCCCCCCHHHHHH--HhhCCCCCC
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQ--YLDGGALLP 611 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~~~p 611 (660)
.....+.+++..||+.||++|||++|+++ +++.....+
T Consensus 242 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~ 281 (325)
T 3kn6_A 242 NVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLS 281 (325)
T ss_dssp TSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCC
T ss_pred CCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCC
Confidence 23345778888999999999999999985 454443333
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=359.49 Aligned_cols=246 Identities=20% Similarity=0.234 Sum_probs=208.1
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEE
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 411 (660)
.-.|+.++.||+|+||.||+++...+++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+.+++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 34789999999999999999999999999999998643 223457889999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCC
Q 006112 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 491 (660)
|||+++|+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 120 ~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence 99999999999997654 48999999999999999999998 99999999999999999999999999999876432
Q ss_pred CCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccC
Q 006112 492 NDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIY 571 (660)
Q Consensus 492 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 571 (660)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+....+.. .+...+
T Consensus 195 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~i~~~~~------~~p~~~ 261 (350)
T 1rdq_E 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ---IYEKIVSGKV------RFPSHF 261 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHCCC------CCCTTC
T ss_pred ----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH---HHHHHHcCCC------CCCCCC
Confidence 234679999999999999999999999999999999999999998654321 2222223321 112222
Q ss_pred cHHHHHHHHHHhhhccCCCCCCCCC-----HHHHHH
Q 006112 572 VEEQMEIVLKLGLFCSHSNPDTRPS-----MRQVVQ 602 (660)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 602 (660)
...+.+++..||+.||.+||+ ++||++
T Consensus 262 ----~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 262 ----SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 234678888899999999998 899885
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=344.03 Aligned_cols=251 Identities=21% Similarity=0.304 Sum_probs=205.9
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeeec--CeeEE
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK--GELLL 410 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~l 410 (660)
.-+|+.++.+|+|+||.||+|++ .++.||||++.... ....+.+.+|+.++++++||||+++++++... +..++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 34788899999999999999999 47899999997543 34567899999999999999999999999877 78899
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCc--eeccCccCCcEEEcCCCCeEEeecccceec
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQV--VLHRDIKPANVLLDADLEGKLGDFGLARLY 488 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDikp~NIll~~~~~~kl~DFGla~~~ 488 (660)
||||+++|+|.+++.......+++.++..++.|++.||+|||+ .+ |+||||||+||+++.++.+||+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 9999999999999987665569999999999999999999998 77 999999999999999999999999987643
Q ss_pred cCCCCceeeccccCccccCcccccCCCCCc---ceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCC
Q 006112 489 DHGNDLHTTNVVGTVGYLAPELLRNGRGTT---STDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDP 565 (660)
Q Consensus 489 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~---ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 565 (660)
.. ....||+.|+|||.+.+..++. ++||||||+++|||++|+.||....... ........+.. +
T Consensus 164 ~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~~~~~-----~ 230 (271)
T 3kmu_A 164 QS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME--IGMKVALEGLR-----P 230 (271)
T ss_dssp SC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH--HHHHHHHSCCC-----C
T ss_pred cc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH--HHHHHHhcCCC-----C
Confidence 22 2356899999999998765444 8999999999999999999997643322 12222222211 1
Q ss_pred cccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 566 RLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 566 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
.+.... ...+.+++..||+.||++|||++|+++.|+..
T Consensus 231 ~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 231 TIPPGI----SPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp CCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 122222 34577888889999999999999999999863
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=357.81 Aligned_cols=250 Identities=24% Similarity=0.327 Sum_probs=190.9
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 416 (660)
.|+..+.||+|+||.||+|++..+++.||||++.... ..+.+.+|++++++++||||++++++|...+..++||||++
T Consensus 54 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 131 (349)
T 2w4o_A 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT 131 (349)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred cEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence 5888899999999999999999889999999996543 34678899999999999999999999999999999999999
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcC---CCCeEEeecccceeccCCCC
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDA---DLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~---~~~~kl~DFGla~~~~~~~~ 493 (660)
+|+|.+++.... .+++.++..++.||+.||.|||+ .+|+||||||+|||++. ++.+||+|||+++......
T Consensus 132 ~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~- 205 (349)
T 2w4o_A 132 GGELFDRIVEKG--YYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV- 205 (349)
T ss_dssp SCBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc-
Confidence 999999997543 48999999999999999999998 89999999999999975 8899999999998754322
Q ss_pred ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........+... ...+ . ..
T Consensus 206 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~i~~~~~~-~~~~-~----~~ 276 (349)
T 2w4o_A 206 -LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--FMFRRILNCEYY-FISP-W----WD 276 (349)
T ss_dssp --------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH--HHHHHHHTTCCC-CCTT-T----TT
T ss_pred -ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH--HHHHHHHhCCCc-cCCc-h----hh
Confidence 2234679999999999999899999999999999999999999997644321 122222222111 1111 1 11
Q ss_pred HHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.....+.+++..||+.||++|||+.|++++
T Consensus 277 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 277 EVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 223457788899999999999999999973
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=352.16 Aligned_cols=258 Identities=21% Similarity=0.239 Sum_probs=202.1
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
-.|+..+.+|+|+||.||+|++..+++.||+|++.... ....+.+.+|+.++++++||||+++++++..++..++||
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM 113 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence 36899999999999999999998899999999986542 233578999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
||+++++|.+++.... .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 114 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 114 RLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp ECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred EecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 9999999999997643 48999999999999999999998 899999999999999999999999999998765443
Q ss_pred CceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCc
Q 006112 493 DLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 493 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
........||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .......... .....
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~-------~~~~~ 258 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM---GAHINQAIPR-------PSTVR 258 (309)
T ss_dssp --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH---HHHHHSCCCC-------GGGTS
T ss_pred cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH---HHHhccCCCC-------ccccC
Confidence 3334456799999999999988999999999999999999999999986543322 2222211110 00111
Q ss_pred HHHHHHHHHHhhhccCCCCCCCC-CHHHHHHHhhCCC
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRP-SMRQVVQYLDGGA 608 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~~~ 608 (660)
......+.+++..||+.||++|| +++++++.|+...
T Consensus 259 ~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 259 PGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp TTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred CCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 22234577888899999999999 9999999998754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=350.61 Aligned_cols=261 Identities=25% Similarity=0.278 Sum_probs=201.3
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD--HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
.|+.++.||+|+||.||+|++..+++.||||++..... ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus 4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (311)
T 4agu_A 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY 83 (311)
T ss_dssp CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEe
Confidence 58899999999999999999999999999999865433 2356788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
+++++|..++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~~~~l~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 157 (311)
T 4agu_A 84 CDHTVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD- 157 (311)
T ss_dssp CSEEHHHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred CCCchHHHHHhhhc--CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-
Confidence 99999999886543 48999999999999999999998 8999999999999999999999999999987653322
Q ss_pred eeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCcchH-HHHHHHH-----------hcCCcc-
Q 006112 495 HTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLL-DWVIDYW-----------QKGDVL- 560 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~-~~~~~~~-----------~~~~~~- 560 (660)
......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........ ..+.... ......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
T 4agu_A 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence 2234578999999999876 6679999999999999999999999976443221 1111111 111100
Q ss_pred --cCCCCccccc---CcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 561 --DASDPRLEGI---YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 561 --~~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
...++..... ..+.....+.+++..||+.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0111100000 001223457789999999999999999999963
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=347.56 Aligned_cols=260 Identities=25% Similarity=0.342 Sum_probs=200.4
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD--HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
.|+.++.||+|+||.||+|+. .+++.||+|++..... ...+.+.+|++++++++||||+++++++..++..++||||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp SEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred cchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 588899999999999999998 5788999999965432 2346789999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
++ ++|.+++.... ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 155 (288)
T 1ob3_A 82 LD-QDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-R 155 (288)
T ss_dssp CS-EEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred cC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCccc-c
Confidence 96 59999887543 358999999999999999999998 899999999999999999999999999998664322 1
Q ss_pred eeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHHHHHHhcCCcc--------cCCC
Q 006112 495 HTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVIDYWQKGDVL--------DASD 564 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~~~~~~~~--------~~~d 564 (660)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .....+.......... ...+
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence 2234578999999999875 4589999999999999999999999976432 2222222221111000 0011
Q ss_pred Ccc-------cccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 565 PRL-------EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 565 ~~l-------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
+.+ ...+.......+.+++..||+.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 111 011112233457788899999999999999999863
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=351.08 Aligned_cols=251 Identities=20% Similarity=0.261 Sum_probs=207.7
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCCh------hhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDH------GMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLL 410 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 410 (660)
.|+..+.||+|+||.||+++...+++.||+|.+...... ..+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (321)
T 2a2a_A 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVL 92 (321)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 588899999999999999999989999999998654321 35789999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCC----CeEEeecccce
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADL----EGKLGDFGLAR 486 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~----~~kl~DFGla~ 486 (660)
||||+++++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||+++
T Consensus 93 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 93 ILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 999999999999997643 58999999999999999999998 8999999999999999887 79999999998
Q ss_pred eccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCc
Q 006112 487 LYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPR 566 (660)
Q Consensus 487 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 566 (660)
....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .......... ..++.
T Consensus 168 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~--~~~~~ 240 (321)
T 2a2a_A 168 EIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLANITSVSY--DFDEE 240 (321)
T ss_dssp ECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHHTTCC--CCCHH
T ss_pred ecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHhccc--ccChh
Confidence 7654322 234579999999999998899999999999999999999999997643321 1111222111 01111
Q ss_pred ccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 567 LEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 567 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.. ......+.+++..||+.||++|||++|++++
T Consensus 241 ~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 241 FF----SHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HH----TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred hh----cccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11 1123457788999999999999999999974
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=362.40 Aligned_cols=247 Identities=23% Similarity=0.337 Sum_probs=205.6
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCeeEEEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
.|+.++.||+|+||.||+|++..+++.||+|++.... ....+.+..|..++.++ +||||+++++++.+.+.+++||
T Consensus 18 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~ 97 (345)
T 1xjd_A 18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 97 (345)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEE
Confidence 6888999999999999999999999999999996532 33456788999999887 8999999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
||+++|+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 98 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 172 (345)
T 1xjd_A 98 EYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 172 (345)
T ss_dssp ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence 9999999999997643 48999999999999999999998 899999999999999999999999999998643222
Q ss_pred CceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCc
Q 006112 493 DLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 493 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......+. +.+...++
T Consensus 173 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~i~~~~------~~~p~~~s 242 (345)
T 1xjd_A 173 -AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFHSIRMDN------PFYPRWLE 242 (345)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHCC------CCCCTTSC
T ss_pred -CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHhCC------CCCCcccC
Confidence 22345789999999999999899999999999999999999999998654322 222222222 11222222
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCCHH-HHHH
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRPSMR-QVVQ 602 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl~ 602 (660)
..+.+++..||+.||++||++. ++++
T Consensus 243 ----~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 243 ----KEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp ----HHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ----HHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 3466788889999999999997 7763
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=359.64 Aligned_cols=249 Identities=21% Similarity=0.332 Sum_probs=204.6
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
.|+.++.||+|+||.||+|++..+++.||||++... .....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 89 (336)
T 3h4j_B 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE 89 (336)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence 689999999999999999999999999999998643 22334678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
|+ +|+|.+++.... .+++.++..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 90 ~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~ 163 (336)
T 3h4j_B 90 YA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163 (336)
T ss_dssp CC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT
T ss_pred CC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc
Confidence 99 789999887654 48999999999999999999998 8999999999999999999999999999987644322
Q ss_pred ceeeccccCccccCcccccCCCC-CcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCc
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
.....||+.|+|||.+.+..+ +.++|||||||++|||++|+.||........ .... ......+....
T Consensus 164 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~--------~~~i-~~~~~~~p~~~- 231 (336)
T 3h4j_B 164 --LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL--------FKKV-NSCVYVMPDFL- 231 (336)
T ss_dssp --TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC--------BCCC-CSSCCCCCTTS-
T ss_pred --cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH--------HHHH-HcCCCCCcccC-
Confidence 234579999999999987765 6899999999999999999999975332110 0000 01111112222
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCCHHHHHH--HhhC
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ--YLDG 606 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~ 606 (660)
...+.+++..||+.||.+|||++|+++ +++.
T Consensus 232 ---s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 232 ---SPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp ---CHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred ---CHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence 344678888999999999999999996 4554
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=368.13 Aligned_cols=255 Identities=22% Similarity=0.228 Sum_probs=206.6
Q ss_pred CceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEE
Q 006112 334 HRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLL 410 (660)
Q Consensus 334 ~~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 410 (660)
..-.|+.++.||+|+||.||+++...+++.||+|++... .....+.+.+|..++.+++||||+++++++.+.+.+++
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 138 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL 138 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 345789999999999999999999999999999999643 22334568999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccC
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDH 490 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 490 (660)
|||||++|+|.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 139 VmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 139 VMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRA 214 (412)
T ss_dssp EECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeechhheeccC
Confidence 999999999999997643 258999999999999999999998 9999999999999999999999999999987765
Q ss_pred CCCceeeccccCccccCccccc-------CCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchH-HHHHHHHhcCCcccC
Q 006112 491 GNDLHTTNVVGTVGYLAPELLR-------NGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLL-DWVIDYWQKGDVLDA 562 (660)
Q Consensus 491 ~~~~~~~~~~gt~~Y~aPE~~~-------~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~ 562 (660)
.........+||+.|+|||++. ...++.++|||||||++|||++|+.||........ ..+...... .
T Consensus 215 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~-----~ 289 (412)
T 2vd5_A 215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH-----L 289 (412)
T ss_dssp TSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH-----C
T ss_pred CCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC-----c
Confidence 4443444568999999999987 35689999999999999999999999986543221 111111111 0
Q ss_pred CCCcccccCcHHHHHHHHHHhhhccCCCCCCC---CCHHHHHH
Q 006112 563 SDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTR---PSMRQVVQ 602 (660)
Q Consensus 563 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps~~evl~ 602 (660)
..|.....+ ...+.+++..||. +|.+| |+++|+++
T Consensus 290 ~~p~~~~~~----s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 290 SLPLVDEGV----PEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp CCC----CC----CHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred CCCccccCC----CHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 111111222 2346778888999 99998 69999986
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=344.81 Aligned_cols=249 Identities=25% Similarity=0.292 Sum_probs=207.3
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 416 (660)
.|+..+.||+|+||.||+|++..++..+|+|++........+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (277)
T 3f3z_A 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCT 89 (277)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred hEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccC
Confidence 58888999999999999999999999999999977666667889999999999999999999999999999999999999
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEE---cCCCCeEEeecccceeccCCCC
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLL---DADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll---~~~~~~kl~DFGla~~~~~~~~ 493 (660)
+++|.+++.... .+++.++..++.|++.||+|||+ ++|+||||||+|||+ +.++.+||+|||++.......
T Consensus 90 ~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~- 163 (277)
T 3f3z_A 90 GGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK- 163 (277)
T ss_dssp SCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS-
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc-
Confidence 999999987643 48999999999999999999998 899999999999999 788999999999998765433
Q ss_pred ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
......||+.|+|||.+.+ .++.++||||||+++|||++|+.||....... .......+.... + .....
T Consensus 164 -~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~---~---~~~~~ 232 (277)
T 3f3z_A 164 -MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE---VMLKIREGTFTF---P---EKDWL 232 (277)
T ss_dssp -CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHCCCCC---C---HHHHT
T ss_pred -chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHhCCCCC---C---chhhh
Confidence 2234579999999999865 48999999999999999999999997644322 222222222110 0 00000
Q ss_pred HHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
.....+.+++..|++.||++||++.|+++
T Consensus 233 ~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 233 NVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 12345778888999999999999999986
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=356.76 Aligned_cols=254 Identities=24% Similarity=0.257 Sum_probs=201.0
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC-----CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD-----SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 411 (660)
.|+.++.||+|+||.||+|+...+++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 27 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 106 (345)
T 3hko_A 27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLV 106 (345)
T ss_dssp HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred heeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEE
Confidence 688899999999999999999999999999998643 345567899999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhhC--------------------------------------CCCCcchhHHHHHHHHHHHHHHHhhh
Q 006112 412 YDYMPNGSLDKILYSN--------------------------------------TRPSLNWFQRFRIIKGVAFGLLYLHE 453 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~--------------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~ 453 (660)
||||++|+|.+++... ....+++..+..++.||+.||+|||+
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~ 186 (345)
T 3hko_A 107 MELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN 186 (345)
T ss_dssp EECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999998521 01124677888999999999999998
Q ss_pred cccCceeccCccCCcEEEcCCC--CeEEeecccceeccCCCC---ceeeccccCccccCcccccC--CCCCcceeEEehH
Q 006112 454 EWEQVVLHRDIKPANVLLDADL--EGKLGDFGLARLYDHGND---LHTTNVVGTVGYLAPELLRN--GRGTTSTDVYAFG 526 (660)
Q Consensus 454 ~~~~~ivHrDikp~NIll~~~~--~~kl~DFGla~~~~~~~~---~~~~~~~gt~~Y~aPE~~~~--~~~t~ksDV~S~G 526 (660)
.+|+||||||+|||++.++ .+||+|||+++.+..... .......||+.|+|||.+.. ..++.++||||||
T Consensus 187 ---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG 263 (345)
T 3hko_A 187 ---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263 (345)
T ss_dssp ---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHH
T ss_pred ---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHH
Confidence 8999999999999998776 899999999987643221 22345679999999999875 6788999999999
Q ss_pred HHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 527 VFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 527 vvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
|++|||++|+.||...... +............ ..+. .......+.+++..||+.||++||++.|+++
T Consensus 264 ~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~--~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 264 VLLHLLLMGAVPFPGVNDA--DTISQVLNKKLCF--ENPN-----YNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHHHHSSCSSCCSSHH--HHHHHHHHCCCCT--TSGG-----GGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHHHHHCCCCCCCCChH--HHHHHHHhccccc--CCcc-----cccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 9999999999999764432 2222222221111 1111 1112345778888999999999999999997
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=357.73 Aligned_cols=252 Identities=21% Similarity=0.216 Sum_probs=195.2
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
-.|+.++.||+|+||.||+++...+++.||||++.... ...+.+.+|+.++++++||||+++++++...+..++|||||
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 36889999999999999999999999999999996543 33467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCC--eEEeecccceeccCCCC
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLE--GKLGDFGLARLYDHGND 493 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~--~kl~DFGla~~~~~~~~ 493 (660)
++|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++. +||+|||+++......
T Consensus 99 ~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~- 172 (361)
T 3uc3_A 99 SGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 172 (361)
T ss_dssp CSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC-
Confidence 9999999997644 48999999999999999999998 99999999999999987765 9999999997533222
Q ss_pred ceeeccccCccccCcccccCCCCCcc-eeEEehHHHHHHHhhCCCCCCCCCc-chHHHHHHHHhcCCcccCCCCcccccC
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTS-TDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVIDYWQKGDVLDASDPRLEGIY 571 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~k-sDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~ 571 (660)
......||+.|+|||++.+..++.+ +|||||||++|||++|+.||..... ...................+ ...
T Consensus 173 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~ 247 (361)
T 3uc3_A 173 -QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDD----IRI 247 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTT----SCC
T ss_pred -CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCc----CCC
Confidence 2234579999999999988777655 9999999999999999999976322 22222222222211111101 111
Q ss_pred cHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 572 VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
...+.+++.+||+.||++|||+.|++++
T Consensus 248 ----s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 248 ----SPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ----CHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ----CHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 2346788889999999999999999973
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=354.96 Aligned_cols=259 Identities=27% Similarity=0.373 Sum_probs=194.5
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCe---EEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCee-
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHA---EIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGEL- 408 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~---~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~- 408 (660)
.-.|+..+.||+|+||.||+|++..++. .||||++... .....+++.+|++++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 3478899999999999999999876664 8999998654 445678899999999999999999999999877654
Q ss_pred -----EEEEecCCCCChhhhhhhCC----CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEE
Q 006112 409 -----LLVYDYMPNGSLDKILYSNT----RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKL 479 (660)
Q Consensus 409 -----~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl 479 (660)
++||||+++|+|.+++.... ...+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEEE
Confidence 99999999999999986432 2258999999999999999999998 89999999999999999999999
Q ss_pred eecccceeccCCCC-ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcC
Q 006112 480 GDFGLARLYDHGND-LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKG 557 (660)
Q Consensus 480 ~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 557 (660)
+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||......... .....+
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~---~~~~~~ 255 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY---NYLIGG 255 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HHHHTT
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH---HHHhcC
Confidence 99999987644332 22234567889999999999999999999999999999999 99999864433221 111222
Q ss_pred CcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCCC
Q 006112 558 DVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGA 608 (660)
Q Consensus 558 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (660)
.... .. ......+.+++..||+.||++|||+.++++.|+...
T Consensus 256 ~~~~-----~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 256 NRLK-----QP----PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp CCCC-----CC----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCC-----CC----CccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1111 11 122345778899999999999999999999998653
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=356.86 Aligned_cols=254 Identities=21% Similarity=0.288 Sum_probs=206.7
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCeeEEEEecC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
.|+.++.||+|+||.||++++..+++.||||.+..... ...+|++++.++ +||||+++++++.+++..++|||||
T Consensus 23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~ 98 (342)
T 2qr7_A 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELM 98 (342)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCC
Confidence 58888999999999999999999999999999965432 345788888888 7999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCC----CCeEEeecccceeccCC
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDAD----LEGKLGDFGLARLYDHG 491 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~----~~~kl~DFGla~~~~~~ 491 (660)
++|+|.+++.... .+++.++..++.||+.||+|||+ .+|+||||||+|||+..+ +.+||+|||+++.....
T Consensus 99 ~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 99 KGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp CSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 9999999997653 48999999999999999999998 899999999999998543 34999999999876543
Q ss_pred CCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccC
Q 006112 492 NDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIY 571 (660)
Q Consensus 492 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 571 (660)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........+......+.... ...+
T Consensus 174 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~------~~~~ 246 (342)
T 2qr7_A 174 NG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSL------SGGY 246 (342)
T ss_dssp TC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCC------CSTT
T ss_pred CC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCccc------Cccc
Confidence 32 2334678999999999988788999999999999999999999998644333444444444443321 1111
Q ss_pred cHHHHHHHHHHhhhccCCCCCCCCCHHHHHH--HhhC
Q 006112 572 VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ--YLDG 606 (660)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~ 606 (660)
.......+.+++..||+.||++||++.|+++ ++..
T Consensus 247 ~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 247 WNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp TTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 1122345678888899999999999999996 4544
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=348.06 Aligned_cols=257 Identities=23% Similarity=0.370 Sum_probs=206.9
Q ss_pred eeecccccccCccEEEEEEE----eCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeec--CeeE
Q 006112 337 SYKNLYKATKGGSGKVYRGV----LPSSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK--GELL 409 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~----~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~ 409 (660)
.|+.++.||+|+||.||+|+ ...+++.||||++.... ....+.+.+|++++++++||||+++++++... ..++
T Consensus 22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 101 (302)
T 4e5w_A 22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 101 (302)
T ss_dssp GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEE
T ss_pred hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEE
Confidence 58899999999999999999 45678999999997543 34567899999999999999999999999876 6689
Q ss_pred EEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceecc
Q 006112 410 LVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYD 489 (660)
Q Consensus 410 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 489 (660)
+||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 102 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 102 LIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp EEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECccccccccc
Confidence 9999999999999996543 358999999999999999999998 999999999999999999999999999998876
Q ss_pred CCCCc--eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCC------------CcchHHHHHHHHh
Q 006112 490 HGNDL--HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPG------------ELDLLDWVIDYWQ 555 (660)
Q Consensus 490 ~~~~~--~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~------------~~~~~~~~~~~~~ 555 (660)
..... ......||..|+|||.+.+..++.++||||||+++|||++|+.|+... .............
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK 257 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh
Confidence 54432 223457889999999999888999999999999999999999986431 1111122222222
Q ss_pred cCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 556 KGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 556 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
.+.... . .......+.+++..||+.||.+|||+.|+++.|+.
T Consensus 258 ~~~~~~-----~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 258 EGKRLP-----C----PPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp TTCCCC-----C----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ccCCCC-----C----CCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 222111 1 11223457788999999999999999999999974
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=352.63 Aligned_cols=256 Identities=21% Similarity=0.256 Sum_probs=200.4
Q ss_pred eeecc-cccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCeeEEEEec
Q 006112 337 SYKNL-YKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l-~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
.|+.. +.||+|+||.||+|+...+++.||||++........+.+.+|++++.++ +||||+++++++.+++..++||||
T Consensus 13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 92 (316)
T 2ac3_A 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEK 92 (316)
T ss_dssp SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEc
Confidence 46664 6799999999999999889999999999776666678899999999985 799999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCC---eEEeecccceeccCC
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLE---GKLGDFGLARLYDHG 491 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~---~kl~DFGla~~~~~~ 491 (660)
+++|+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++. +||+|||+++.....
T Consensus 93 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 93 MRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp CTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred CCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 99999999997653 48899999999999999999998 89999999999999988776 999999999765432
Q ss_pred CC------ceeeccccCccccCcccccC-----CCCCcceeEEehHHHHHHHhhCCCCCCCCCcch------------HH
Q 006112 492 ND------LHTTNVVGTVGYLAPELLRN-----GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDL------------LD 548 (660)
Q Consensus 492 ~~------~~~~~~~gt~~Y~aPE~~~~-----~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~------------~~ 548 (660)
.. .......||+.|+|||++.. ..++.++|||||||++|||++|+.||....... ..
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 247 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence 11 11224569999999999875 457889999999999999999999997643211 11
Q ss_pred HHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 549 WVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 549 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
...+....+... +...........+.+++.+||+.||++|||++|++++
T Consensus 248 ~~~~~i~~~~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 248 MLFESIQEGKYE------FPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHCCCC------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHhccCcc------cCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 122222222210 0000001123457788999999999999999999984
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=343.01 Aligned_cols=255 Identities=25% Similarity=0.368 Sum_probs=209.5
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
.-.|+..+.+|+|+||.||++.+. ++..||+|++..... ..+++.+|++++++++||||+++++++.+++..++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 346888999999999999999996 577899999965433 346899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
+++++|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++........
T Consensus 85 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 85 MEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp CTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 99999999997653 358999999999999999999998 89999999999999999999999999999865432222
Q ss_pred eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 495 HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... .......+... . ....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~i~~~~~~--~---~~~~--- 229 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDISTGFRL--Y---KPRL--- 229 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHTTCCC--C---CCTT---
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH---HHHHHhcCCcC--C---CCcc---
Confidence 2234567889999999998899999999999999999999 899997643321 22222222111 1 1111
Q ss_pred HHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
....+.+++..||+.||++||+++|+++.|+..
T Consensus 230 -~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 230 -ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp -SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 234577888899999999999999999999753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=358.77 Aligned_cols=248 Identities=23% Similarity=0.299 Sum_probs=205.8
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCeeEEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 411 (660)
-.|+.++.||+|+||.||+++...+++.||+|++... .....+.+..|..++..+ +||||+++++++...+.+++|
T Consensus 20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 99 (353)
T 2i0e_A 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 99 (353)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence 3688899999999999999999988999999999654 234467788999999988 799999999999999999999
Q ss_pred EecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCC
Q 006112 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 491 (660)
|||+++|+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 100 ~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 100 MEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 99999999999997654 48999999999999999999998 89999999999999999999999999999854322
Q ss_pred CCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccC
Q 006112 492 NDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIY 571 (660)
Q Consensus 492 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 571 (660)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+....+.. .+....
T Consensus 175 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~~~i~~~~~------~~p~~~ 244 (353)
T 2i0e_A 175 G-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQSIMEHNV------AYPKSM 244 (353)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHCCC------CCCTTS
T ss_pred C-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH---HHHHHHhCCC------CCCCCC
Confidence 2 22345689999999999999999999999999999999999999998654322 1222222221 111222
Q ss_pred cHHHHHHHHHHhhhccCCCCCCCCC-----HHHHHH
Q 006112 572 VEEQMEIVLKLGLFCSHSNPDTRPS-----MRQVVQ 602 (660)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 602 (660)
...+.+++..||+.||.+||+ ++|+++
T Consensus 245 ----s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 245 ----SKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ----CHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ----CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 234677888899999999995 688875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=361.11 Aligned_cols=260 Identities=25% Similarity=0.337 Sum_probs=213.6
Q ss_pred ceeeecccccccCccEEEEEEE----eCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeee--ecCee
Q 006112 335 RFSYKNLYKATKGGSGKVYRGV----LPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCR--RKGEL 408 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~----~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~--~~~~~ 408 (660)
...|+.++.||+|+||.||+++ ...+++.||||++........+.+.+|++++++++||||+++++++. +.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 4478899999999999999999 45678999999998777777788999999999999999999999886 45678
Q ss_pred EEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceec
Q 006112 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLY 488 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 488 (660)
++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceec
Confidence 99999999999999997643 248999999999999999999998 99999999999999999999999999999877
Q ss_pred cCCCCc--eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcc------------hHHHHHHHH
Q 006112 489 DHGNDL--HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELD------------LLDWVIDYW 554 (660)
Q Consensus 489 ~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~------------~~~~~~~~~ 554 (660)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .........
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 544332 223456888999999999888999999999999999999999998642211 112222222
Q ss_pred hcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 555 QKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 555 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
..+.... ........+.+++..||+.||++|||++|+++.|+..
T Consensus 258 ~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 301 (327)
T 3lxl_A 258 EEGQRLP---------APPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301 (327)
T ss_dssp HTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC
T ss_pred hcccCCC---------CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 2222111 1122334577888999999999999999999999875
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=354.04 Aligned_cols=258 Identities=22% Similarity=0.242 Sum_probs=205.6
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccC-----CCCceeEeeeeeecCeeEEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLR-----HRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----H~nIv~l~g~~~~~~~~~lV 411 (660)
.|+.++.||+|+||.||+|++..+++.||||++.. .....+.+..|+.++++++ ||||+++++++...+..++|
T Consensus 36 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv 114 (360)
T 3llt_A 36 AFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLI 114 (360)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEE
T ss_pred EEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEE
Confidence 68999999999999999999999999999999853 2344567888999999986 99999999999999999999
Q ss_pred EecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcC------------------
Q 006112 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDA------------------ 473 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~------------------ 473 (660)
|||+ +++|.+++.......+++.++..++.||+.||+|||+ ++|+||||||+|||++.
T Consensus 115 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~ 190 (360)
T 3llt_A 115 FEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK 190 (360)
T ss_dssp ECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCE
T ss_pred EcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccccccchhccccccc
Confidence 9999 9999999987766679999999999999999999998 99999999999999975
Q ss_pred -------CCCeEEeecccceeccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcch
Q 006112 474 -------DLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDL 546 (660)
Q Consensus 474 -------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~ 546 (660)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 191 ~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 266 (360)
T 3llt_A 191 IQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHME 266 (360)
T ss_dssp EEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHH
Confidence 788999999999864432 234678999999999999999999999999999999999999997644321
Q ss_pred -HHHHHHHHhc-----------CCc--------ccCCCCccccc-------------CcHHHHHHHHHHhhhccCCCCCC
Q 006112 547 -LDWVIDYWQK-----------GDV--------LDASDPRLEGI-------------YVEEQMEIVLKLGLFCSHSNPDT 593 (660)
Q Consensus 547 -~~~~~~~~~~-----------~~~--------~~~~d~~l~~~-------------~~~~~~~~l~~l~~~Cl~~dP~~ 593 (660)
...+...... ... .....|..... +.....+.+.+++..||+.||++
T Consensus 267 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 346 (360)
T 3llt_A 267 HLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTL 346 (360)
T ss_dssp HHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhh
Confidence 1111111000 000 00000000000 00001145778999999999999
Q ss_pred CCCHHHHHHH
Q 006112 594 RPSMRQVVQY 603 (660)
Q Consensus 594 RPs~~evl~~ 603 (660)
|||++|++++
T Consensus 347 Rpta~elL~h 356 (360)
T 3llt_A 347 RPSPAELLKH 356 (360)
T ss_dssp SCCHHHHTTS
T ss_pred CCCHHHHhcC
Confidence 9999999863
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=347.72 Aligned_cols=259 Identities=23% Similarity=0.342 Sum_probs=200.7
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
.|+..+.||+|+||.||+|....+++.||||++... .....+++.+|+.++++++||||+++++++..++..++|||
T Consensus 33 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 112 (310)
T 2wqm_A 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 112 (310)
T ss_dssp GEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEe
Confidence 688999999999999999999889999999999653 23456789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhC--CCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCC
Q 006112 414 YMPNGSLDKILYSN--TRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491 (660)
Q Consensus 414 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 491 (660)
|+++++|.+++... ....+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp CCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred cCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 99999999998642 23458999999999999999999998 89999999999999999999999999999865433
Q ss_pred CCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccC
Q 006112 492 NDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIY 571 (660)
Q Consensus 492 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 571 (660)
.. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||............. ...+..... ....
T Consensus 190 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~----~~~~- 262 (310)
T 2wqm_A 190 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK-IEQCDYPPL----PSDH- 262 (310)
T ss_dssp ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHH-HHTTCSCCC----CTTT-
T ss_pred Cc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHH-hhcccCCCC----cccc-
Confidence 22 2234578999999999999999999999999999999999999997654443333222 222221111 1111
Q ss_pred cHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCCC
Q 006112 572 VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGA 608 (660)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (660)
....+.+++..||+.||++||++++|++.|+...
T Consensus 263 ---~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~ 296 (310)
T 2wqm_A 263 ---YSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296 (310)
T ss_dssp ---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---cCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 2345778888999999999999999999998754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=372.28 Aligned_cols=249 Identities=24% Similarity=0.279 Sum_probs=197.2
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
-.|+.++.||+|+||.||+++...+++.||||++... .......+.+|+.++++++||||++++++|...+.+++||
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 3688999999999999999999999999999999653 3445567889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
|||++|+|.+++.... .+++..+..++.||+.||+|||+ .++|+||||||+|||++.++.+||+|||+++......
T Consensus 228 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 228 EYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303 (446)
T ss_dssp CCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred eeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence 9999999999997654 48999999999999999999996 3789999999999999999999999999998543222
Q ss_pred CceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCc
Q 006112 493 DLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 493 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......... .+....
T Consensus 304 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~i~~~~~------~~p~~~- 372 (446)
T 4ejn_A 304 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FELILMEEI------RFPRTL- 372 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHCCC------CCCTTS-
T ss_pred -cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH---HHHHHhCCC------CCCccC-
Confidence 223457899999999999999999999999999999999999999976543222 111112111 111222
Q ss_pred HHHHHHHHHHhhhccCCCCCCCC-----CHHHHHH
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRP-----SMRQVVQ 602 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 602 (660)
...+.+++..||+.||++|| +++|+++
T Consensus 373 ---~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 373 ---GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ---CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 23467888889999999999 9999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=347.25 Aligned_cols=259 Identities=24% Similarity=0.305 Sum_probs=199.8
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhcc--CCCCceeEeeeeeec----CeeEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKL--RHRNLVQLRGYCRRK----GELLL 410 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l--~H~nIv~l~g~~~~~----~~~~l 410 (660)
.|+.++.||+|+||.||+|++. ++.||||++... ....+..|.+++..+ +||||+++++++... ...++
T Consensus 38 ~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 112 (337)
T 3mdy_A 38 QIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYL 112 (337)
T ss_dssp HCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEE
T ss_pred ceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEE
Confidence 6889999999999999999984 899999998543 234455566665554 899999999999877 78999
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcc-----cCceeccCccCCcEEEcCCCCeEEeecccc
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEW-----EQVVLHRDIKPANVLLDADLEGKLGDFGLA 485 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDikp~NIll~~~~~~kl~DFGla 485 (660)
||||+++|+|.+++... .+++.+++.++.|++.||+|||+.+ +++|+||||||+|||++.++.+||+|||++
T Consensus 113 v~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a 189 (337)
T 3mdy_A 113 ITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 189 (337)
T ss_dssp EECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCc
Confidence 99999999999999764 4899999999999999999999821 129999999999999999999999999999
Q ss_pred eeccCCCCce---eeccccCccccCcccccCCCCCcc------eeEEehHHHHHHHhhC----------CCCCCCCC--c
Q 006112 486 RLYDHGNDLH---TTNVVGTVGYLAPELLRNGRGTTS------TDVYAFGVFMLEVACG----------RRPVQPGE--L 544 (660)
Q Consensus 486 ~~~~~~~~~~---~~~~~gt~~Y~aPE~~~~~~~t~k------sDV~S~Gvvl~elltG----------~~p~~~~~--~ 544 (660)
+.+....... .....||+.|+|||++.+.....+ +|||||||++|||++| +.||.... .
T Consensus 190 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~ 269 (337)
T 3mdy_A 190 VKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD 269 (337)
T ss_dssp EECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCC
Confidence 8765433221 224579999999999987766654 9999999999999999 66665421 1
Q ss_pred chHHHHHHHHhcCCcccCCCCccccc-CcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 545 DLLDWVIDYWQKGDVLDASDPRLEGI-YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
.............. ..+.+... ...+....+.+++..||+.||++|||+.||+++|+..
T Consensus 270 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 270 PSYEDMREIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp CCHHHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred CchhhhHHHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 12222222222211 12222221 1236677899999999999999999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=358.33 Aligned_cols=259 Identities=24% Similarity=0.377 Sum_probs=206.8
Q ss_pred CceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEE
Q 006112 334 HRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 334 ~~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
..-.|+.++.||+|+||.||++.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++..++..++||
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 3447999999999999999999999899999999997653 344678999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
||+++++|.+++.... .+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++.+||+|||+++.....
T Consensus 111 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 185 (360)
T ss_dssp CCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred ECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH--hCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence 9999999999997654 48899999999999999999998 238999999999999999999999999999754322
Q ss_pred CceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCccc-----------
Q 006112 493 DLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLD----------- 561 (660)
Q Consensus 493 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 561 (660)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.................+....
T Consensus 186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence 2234579999999999999999999999999999999999999998654433322221110000000
Q ss_pred -----------------------CCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 562 -----------------------ASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 562 -----------------------~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
...+.+. .......+.+++..||+.||++|||++|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLP---SGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCCCCCC---TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccccccCCCCcccchhhhhHHhccCCCCCC---cccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0000000 0112335778889999999999999999996
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=342.73 Aligned_cols=255 Identities=24% Similarity=0.314 Sum_probs=208.9
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
.|+.++.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 86 (284)
T 3kk8_A 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 86 (284)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEec
Confidence 688899999999999999999999999999998654 334567889999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCC---eEEeecccceeccCC
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLE---GKLGDFGLARLYDHG 491 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~---~kl~DFGla~~~~~~ 491 (660)
+++++|.+++.... .+++.++..++.|++.||.|||+ .+|+||||||+||+++.++. +||+|||++......
T Consensus 87 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 87 VTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp CCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 99999999887653 48999999999999999999998 89999999999999987655 999999999876543
Q ss_pred CCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccC
Q 006112 492 NDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIY 571 (660)
Q Consensus 492 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 571 (660)
.. .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ......+... ...+.. ...
T Consensus 162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~~-~~~~~~-~~~ 234 (284)
T 3kk8_A 162 EA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL---YAQIKAGAYD-YPSPEW-DTV 234 (284)
T ss_dssp CB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHTCCC-CCTTTT-TTS
T ss_pred cc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH---HHHHHhcccc-CCchhh-ccc
Confidence 22 2346799999999999999999999999999999999999999976443222 2222222211 111111 112
Q ss_pred cHHHHHHHHHHhhhccCCCCCCCCCHHHHHH--HhhCC
Q 006112 572 VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ--YLDGG 607 (660)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~ 607 (660)
...+.+++..|++.||++|||++|+++ +++..
T Consensus 235 ----~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (284)
T 3kk8_A 235 ----TPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 268 (284)
T ss_dssp ----CHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred ----CHHHHHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence 234678888999999999999999997 45543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=353.25 Aligned_cols=259 Identities=27% Similarity=0.396 Sum_probs=210.8
Q ss_pred CceeeecccccccCccEEEEEEEeC-------CCCeEEEEEEeccCC-ChhhHHHHHHHHHHhcc-CCCCceeEeeeeee
Q 006112 334 HRFSYKNLYKATKGGSGKVYRGVLP-------SSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRR 404 (660)
Q Consensus 334 ~~~~~~~l~~lg~G~fg~Vy~g~~~-------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~ 404 (660)
..-.|+..+.||+|+||.||+|++. .++..||||++.... ....+.+.+|+++++++ +||||++++++|..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3457889999999999999999975 356789999997553 34567899999999999 89999999999999
Q ss_pred cCeeEEEEecCCCCChhhhhhhCCC--------------CCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEE
Q 006112 405 KGELLLVYDYMPNGSLDKILYSNTR--------------PSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVL 470 (660)
Q Consensus 405 ~~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIl 470 (660)
.+..++||||+++|+|.+++..... ..+++.+++.++.||+.||+|||+ .+|+||||||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEE
Confidence 9999999999999999999976532 248899999999999999999998 89999999999999
Q ss_pred EcCCCCeEEeecccceeccCCCCc-eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHH
Q 006112 471 LDADLEGKLGDFGLARLYDHGNDL-HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLD 548 (660)
Q Consensus 471 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~ 548 (660)
++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.......
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-- 267 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-- 267 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH--
Confidence 999999999999999876543322 2234567889999999988889999999999999999999 999997644322
Q ss_pred HHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 549 WVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 549 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
.......+.... .... ....+.+++..||+.||.+||+++|+++.|+..
T Consensus 268 -~~~~~~~~~~~~-----~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 268 -LFKLLKEGHRMD-----KPAN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp -HHHHHHHTCCCC-----CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHHHhcCCCCC-----CCcc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 222222322111 1112 234577888899999999999999999999864
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=352.80 Aligned_cols=258 Identities=21% Similarity=0.228 Sum_probs=205.8
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeee----cCeeEE
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR----KGELLL 410 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~l 410 (660)
.-.|+.++.||+|+||.||+++...+++.||||++........+.+.+|++++++++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 3479999999999999999999988999999999977666677889999999999999999999999873 347899
Q ss_pred EEecCCCCChhhhhhhC--CCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceec
Q 006112 411 VYDYMPNGSLDKILYSN--TRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLY 488 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 488 (660)
||||+++|+|.+++... ....+++.+++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999998752 23468999999999999999999998 89999999999999999999999999998764
Q ss_pred cCCCCc--------eeeccccCccccCcccccCCC---CCcceeEEehHHHHHHHhhCCCCCCC---CCcchHHHHHHHH
Q 006112 489 DHGNDL--------HTTNVVGTVGYLAPELLRNGR---GTTSTDVYAFGVFMLEVACGRRPVQP---GELDLLDWVIDYW 554 (660)
Q Consensus 489 ~~~~~~--------~~~~~~gt~~Y~aPE~~~~~~---~t~ksDV~S~Gvvl~elltG~~p~~~---~~~~~~~~~~~~~ 554 (660)
...... ......||+.|+|||.+.... ++.++||||||+++|||++|+.||.. ....... . .
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~-~---~ 260 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL-A---V 260 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH-H---H
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH-H---h
Confidence 321110 012345799999999987544 68899999999999999999999853 1111111 1 1
Q ss_pred hcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCCC
Q 006112 555 QKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGA 608 (660)
Q Consensus 555 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (660)
... . .. + .. ......+.+++..||+.||++||+++|+++.|+...
T Consensus 261 ~~~-~-~~--~-~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 261 QNQ-L-SI--P-QS----PRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp HCC----C--C-CC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred hcc-C-CC--C-cc----ccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 111 0 00 0 01 112345778888999999999999999999999764
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=344.35 Aligned_cols=250 Identities=26% Similarity=0.318 Sum_probs=199.7
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
.|...+.||+|+||.||+++...++..+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 102 (285)
T 3is5_A 23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETC 102 (285)
T ss_dssp HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeC
Confidence 5888999999999999999999999999999986543 345678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhC--CCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEE---cCCCCeEEeecccceeccC
Q 006112 416 PNGSLDKILYSN--TRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLL---DADLEGKLGDFGLARLYDH 490 (660)
Q Consensus 416 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll---~~~~~~kl~DFGla~~~~~ 490 (660)
++|+|.+++... ....+++..+..++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++....
T Consensus 103 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 179 (285)
T 3is5_A 103 EGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179 (285)
T ss_dssp SCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred CCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence 999999988543 23458999999999999999999998 899999999999999 4567899999999986544
Q ss_pred CCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCccccc
Q 006112 491 GNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGI 570 (660)
Q Consensus 491 ~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 570 (660)
.. ......||+.|+|||.+. +.++.++||||||+++|||++|+.||............ .......... ...
T Consensus 180 ~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~---~~~~~~~~~~---~~~ 250 (285)
T 3is5_A 180 DE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA---TYKEPNYAVE---CRP 250 (285)
T ss_dssp ---------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHCCCCCCC-----CC
T ss_pred cc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhh---ccCCcccccc---cCc
Confidence 32 234467999999999985 56899999999999999999999999865433222111 1111110000 011
Q ss_pred CcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 571 YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
. ...+.+++..||+.||++|||++|+++
T Consensus 251 ~----~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 251 L----TPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp C----CHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred C----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 234668888999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=342.34 Aligned_cols=256 Identities=27% Similarity=0.352 Sum_probs=204.5
Q ss_pred CceeeecccccccCccEEEEEEEeCC---CCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeE
Q 006112 334 HRFSYKNLYKATKGGSGKVYRGVLPS---SHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELL 409 (660)
Q Consensus 334 ~~~~~~~l~~lg~G~fg~Vy~g~~~~---~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 409 (660)
..-.|+..+.+|+|+||.||+|++.. .+..||+|.+.... ....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 34578889999999999999998643 34569999987653 3456789999999999999999999999865 4578
Q ss_pred EEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceecc
Q 006112 410 LVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYD 489 (660)
Q Consensus 410 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 489 (660)
+||||+++++|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 89 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 9999999999999997643 358999999999999999999998 999999999999999999999999999998765
Q ss_pred CCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCccc
Q 006112 490 HGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLE 568 (660)
Q Consensus 490 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 568 (660)
...........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......... ....+.... ..
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~---~~~~~~~~~-----~~ 236 (281)
T 3cc6_A 165 DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIG---VLEKGDRLP-----KP 236 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHH---HHHHTCCCC-----CC
T ss_pred cccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHH---HHhcCCCCC-----CC
Confidence 544333445567899999999998899999999999999999998 999997644332221 122222111 11
Q ss_pred ccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 569 GIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
.. ....+.+++..||+.||++||++.|+++.|+.
T Consensus 237 ~~----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 270 (281)
T 3cc6_A 237 DL----CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD 270 (281)
T ss_dssp TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CC----CCHHHHHHHHHHccCCchhCcCHHHHHHHHHH
Confidence 11 22457788889999999999999999999975
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=355.56 Aligned_cols=262 Identities=18% Similarity=0.180 Sum_probs=201.2
Q ss_pred eeeecccccccCccEEEEEEEeCC---CCeEEEEEEeccCCCh-----------hhHHHHHHHHHHhccCCCCceeEeee
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPS---SHAEIAVKKVCHDSDH-----------GMKQFVSEIVSMGKLRHRNLVQLRGY 401 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~---~~~~vavK~~~~~~~~-----------~~~~~~~Ei~~l~~l~H~nIv~l~g~ 401 (660)
-.|+..+.||+|+||.||+|++.. ++..+|||++...... ..+.+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 478999999999999999999976 7789999998765432 12347788999999999999999999
Q ss_pred eee----cCeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCC--
Q 006112 402 CRR----KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADL-- 475 (660)
Q Consensus 402 ~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~-- 475 (660)
+.. ....++||||+ +++|.+++.... .+++.+++.++.||+.||+|||+ .+|+||||||+|||++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSSTT
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCCCC
Confidence 987 67899999999 999999997654 58999999999999999999998 8999999999999998887
Q ss_pred CeEEeecccceeccCCCC------ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCC--CcchH
Q 006112 476 EGKLGDFGLARLYDHGND------LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPG--ELDLL 547 (660)
Q Consensus 476 ~~kl~DFGla~~~~~~~~------~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~--~~~~~ 547 (660)
.+||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||... .....
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 270 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV 270 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence 999999999987643221 1123457999999999999989999999999999999999999999642 22222
Q ss_pred HHHHHHHhcCCcccCCCCcccccC-cHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCCC
Q 006112 548 DWVIDYWQKGDVLDASDPRLEGIY-VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGA 608 (660)
Q Consensus 548 ~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (660)
.......... ..+.+.... .......+.+++..||+.||++||++++|++.|+...
T Consensus 271 ~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 271 QTAKTNLLDE-----LPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHHHT-----TTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHHhhccc-----ccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 2222111111 000000000 0022345788888999999999999999999998754
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=358.71 Aligned_cols=263 Identities=18% Similarity=0.181 Sum_probs=202.5
Q ss_pred eeeecccccccCccEEEEEEEeCCC-----CeEEEEEEeccCCChh-----------hHHHHHHHHHHhccCCCCceeEe
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSS-----HAEIAVKKVCHDSDHG-----------MKQFVSEIVSMGKLRHRNLVQLR 399 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~-----~~~vavK~~~~~~~~~-----------~~~~~~Ei~~l~~l~H~nIv~l~ 399 (660)
-.|+..+.||+|+||.||+|.+..+ ++.||||++....... ...+..|+..+..++||||++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 3799999999999999999998764 5789999986554221 12345566778888999999999
Q ss_pred eeeeec----CeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEc--C
Q 006112 400 GYCRRK----GELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLD--A 473 (660)
Q Consensus 400 g~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~--~ 473 (660)
+++... ...++||||| +++|.+++.... ..+++.++..++.||+.||+|||+ ++|+||||||+|||++ .
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEESSC
T ss_pred eeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEecCC
Confidence 998765 4589999999 999999998753 359999999999999999999998 8999999999999999 8
Q ss_pred CCCeEEeecccceeccCCCCc------eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCC--Ccc
Q 006112 474 DLEGKLGDFGLARLYDHGNDL------HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPG--ELD 545 (660)
Q Consensus 474 ~~~~kl~DFGla~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~--~~~ 545 (660)
++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||... ...
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 899999999999876433211 113356999999999999999999999999999999999999999852 222
Q ss_pred hHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 546 LLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
........... ...+..++.+.. ......+.+++..||+.||++||++++|++.|+..
T Consensus 270 ~~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 270 YVRDSKIRYRE-NIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp HHHHHHHHHHH-CHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHHHhhh-hHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 22222211111 111111111110 11234577888899999999999999999988753
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=354.65 Aligned_cols=245 Identities=27% Similarity=0.414 Sum_probs=202.3
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC---hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD---HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
.|+.++.||+|+||.||+|+...+++.||||++..... ...+++.+|++++++++||||+++++++..++..++|||
T Consensus 55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 134 (348)
T 1u5q_A 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 134 (348)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence 58889999999999999999988999999999975432 234678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
|+. |+|.+++.... ..+++.++..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 135 ~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-- 207 (348)
T 1u5q_A 135 YCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 207 (348)
T ss_dssp CCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred cCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence 996 78888875433 358999999999999999999998 89999999999999999999999999999865432
Q ss_pred ceeeccccCccccCccccc---CCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcc-cc
Q 006112 494 LHTTNVVGTVGYLAPELLR---NGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL-EG 569 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l-~~ 569 (660)
....||+.|+|||++. .+.++.++|||||||++|||++|+.||...... +.......... +.+ ..
T Consensus 208 ---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~--~~~~~~~~~~~------~~~~~~ 276 (348)
T 1u5q_A 208 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIAQNES------PALQSG 276 (348)
T ss_dssp ---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSCC------CCCCCT
T ss_pred ---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHhcCC------CCCCCC
Confidence 2457999999999984 567899999999999999999999999764322 22222222211 111 11
Q ss_pred cCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 570 IYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.+ .+.+.+++..||+.||++|||+++++++
T Consensus 277 ~~----~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 277 HW----SEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp TS----CHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CC----CHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 12 2346788889999999999999999974
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=361.99 Aligned_cols=267 Identities=21% Similarity=0.258 Sum_probs=213.9
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecC--eeEEE
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKG--ELLLV 411 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~lV 411 (660)
...|+..+.||+|+||.||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 457999999999999999999999999999999996543 234577889999999999999999999998765 78999
Q ss_pred EecCCCCChhhhhhhCCC-CCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEE----cCCCCeEEeecccce
Q 006112 412 YDYMPNGSLDKILYSNTR-PSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLL----DADLEGKLGDFGLAR 486 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll----~~~~~~kl~DFGla~ 486 (660)
||||++|+|.+++..... ..+++..++.++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999975432 338999999999999999999998 899999999999999 778889999999998
Q ss_pred eccCCCCceeeccccCccccCcccccC--------CCCCcceeEEehHHHHHHHhhCCCCCCCCC--cchHHHHHHHHhc
Q 006112 487 LYDHGNDLHTTNVVGTVGYLAPELLRN--------GRGTTSTDVYAFGVFMLEVACGRRPVQPGE--LDLLDWVIDYWQK 556 (660)
Q Consensus 487 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~t~ksDV~S~Gvvl~elltG~~p~~~~~--~~~~~~~~~~~~~ 556 (660)
...... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||.+.. ....+..... ..
T Consensus 165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~-~~ 241 (396)
T 4eut_A 165 ELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI-IT 241 (396)
T ss_dssp ECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHH-HH
T ss_pred EccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHH-hc
Confidence 764432 2234679999999999864 466789999999999999999999997522 1222222222 22
Q ss_pred CCcccCC---------------CCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 557 GDVLDAS---------------DPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 557 ~~~~~~~---------------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
+...... +..............+..++..||+.||++||++.|+++.|+..
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 2211100 01112234567778899999999999999999999999887653
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=351.57 Aligned_cols=257 Identities=24% Similarity=0.372 Sum_probs=209.4
Q ss_pred eeeecccccccCccEEEEEEEeCCCC-----eEEEEEEeccCCC-hhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCee
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSH-----AEIAVKKVCHDSD-HGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGEL 408 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~-----~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 408 (660)
..|+..+.||+|+||.||+|.+..++ ..||+|.+..... ...+.+.+|+.+++++ +||||++++++|...+..
T Consensus 46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 125 (333)
T 2i1m_A 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV 125 (333)
T ss_dssp TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCce
Confidence 46888899999999999999986655 3799999975533 3567899999999999 899999999999999999
Q ss_pred EEEEecCCCCChhhhhhhCC------------CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCC
Q 006112 409 LLVYDYMPNGSLDKILYSNT------------RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLE 476 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~ 476 (660)
++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.
T Consensus 126 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~ 202 (333)
T 2i1m_A 126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHV 202 (333)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGGGE
T ss_pred EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCCCe
Confidence 99999999999999986532 2357899999999999999999998 89999999999999999999
Q ss_pred eEEeecccceeccCCCCc-eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHH
Q 006112 477 GKLGDFGLARLYDHGNDL-HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYW 554 (660)
Q Consensus 477 ~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~ 554 (660)
+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++ |..||........ .....
T Consensus 203 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~~~~~ 280 (333)
T 2i1m_A 203 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK--FYKLV 280 (333)
T ss_dssp EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH--HHHHH
T ss_pred EEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH--HHHHH
Confidence 999999999876544322 2334567889999999998899999999999999999998 9999976433221 22222
Q ss_pred hcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 555 QKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 555 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
..+... ..+ .. ....+.+++..||+.||.+|||+.|+++.|+.
T Consensus 281 ~~~~~~--~~~---~~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 323 (333)
T 2i1m_A 281 KDGYQM--AQP---AF----APKNIYSIMQACWALEPTHRPTFQQICSFLQE 323 (333)
T ss_dssp HHTCCC--CCC---TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hcCCCC--CCC---CC----CCHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence 222111 111 11 13457788889999999999999999999975
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=360.05 Aligned_cols=261 Identities=22% Similarity=0.273 Sum_probs=197.6
Q ss_pred eeecc-cccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhc-cCCCCceeEeeeeee----cCeeEE
Q 006112 337 SYKNL-YKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGK-LRHRNLVQLRGYCRR----KGELLL 410 (660)
Q Consensus 337 ~~~~l-~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~-l~H~nIv~l~g~~~~----~~~~~l 410 (660)
.|..+ +.||+|+||+||++.+..+++.||||++.. ...+.+|+.++.+ .+||||+++++++.. .+.+++
T Consensus 62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l 136 (400)
T 1nxk_A 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136 (400)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence 46665 679999999999999999999999999853 2467788888744 589999999998875 567899
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcC---CCCeEEeeccccee
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDA---DLEGKLGDFGLARL 487 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~---~~~~kl~DFGla~~ 487 (660)
|||||++|+|.+++.......+++.++..++.||+.||.|||+ .+|+||||||+|||++. ++.+||+|||+++.
T Consensus 137 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~ 213 (400)
T 1nxk_A 137 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213 (400)
T ss_dssp EEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccccc
Confidence 9999999999999987655569999999999999999999998 89999999999999988 78899999999986
Q ss_pred ccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcch-HHHHHHHHhcCCcccCCCCc
Q 006112 488 YDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDL-LDWVIDYWQKGDVLDASDPR 566 (660)
Q Consensus 488 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~d~~ 566 (660)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..........+... ...+.
T Consensus 214 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~-~~~~~ 290 (400)
T 1nxk_A 214 TTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE-FPNPE 290 (400)
T ss_dssp CC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCC-CCTTT
T ss_pred cCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCccc-CCCcc
Confidence 54322 2345678999999999999999999999999999999999999997633211 00111112222211 11111
Q ss_pred ccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH--HhhCCCCCCCC
Q 006112 567 LEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ--YLDGGALLPDI 613 (660)
Q Consensus 567 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~~~p~~ 613 (660)
. ......+.+++..||+.||++|||+.|+++ ++......+..
T Consensus 291 ~-----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~ 334 (400)
T 1nxk_A 291 W-----SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 334 (400)
T ss_dssp T-----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTTSCCC
T ss_pred c-----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCCCCCC
Confidence 1 112345778889999999999999999998 45544434433
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=342.21 Aligned_cols=248 Identities=21% Similarity=0.356 Sum_probs=206.2
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeee------------
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR------------ 404 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~------------ 404 (660)
.|+.++.||+|+||.||+|++..+++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 87 (284)
T 2a19_B 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNS 87 (284)
T ss_dssp HEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--------
T ss_pred ccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccc
Confidence 6888999999999999999998889999999996543 467889999999999999999998854
Q ss_pred ----cCeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEe
Q 006112 405 ----KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLG 480 (660)
Q Consensus 405 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~ 480 (660)
....++||||+++|+|.+++.......+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 88 SRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp -CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEEC
T ss_pred cccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCCEEEC
Confidence 4558999999999999999976554569999999999999999999998 899999999999999999999999
Q ss_pred ecccceeccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcc
Q 006112 481 DFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVL 560 (660)
Q Consensus 481 DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 560 (660)
|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|..|+... .........+..
T Consensus 165 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~~~~~~~~~~~~- 236 (284)
T 2a19_B 165 DFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----SKFFTDLRDGII- 236 (284)
T ss_dssp CCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----HHHHHHHHTTCC-
T ss_pred cchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----HHHHHHhhcccc-
Confidence 999998765432 223457999999999999989999999999999999999999886421 111222222211
Q ss_pred cCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCCCCC
Q 006112 561 DASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGALL 610 (660)
Q Consensus 561 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 610 (660)
...++ ..+.+++..||+.||++||++.|+++.|+.....
T Consensus 237 -------~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 237 -------SDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp -------CTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred -------cccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 12222 3466788899999999999999999999865433
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=378.92 Aligned_cols=256 Identities=29% Similarity=0.403 Sum_probs=209.6
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
+-+|+..+.||+|+||.||+|++.. +..||||++.... ...++|.+|+++|++++||||++++++|.+ +..++||||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 3468888999999999999999964 5679999997543 345789999999999999999999999876 678999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
|++|+|.++|.......+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 419 (535)
T 2h8h_A 343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 419 (535)
T ss_dssp CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH
T ss_pred hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee
Confidence 999999999975433458999999999999999999998 89999999999999999999999999999865432211
Q ss_pred eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 495 HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
......++..|+|||.+..+.++.++|||||||++|||++ |+.||...... .+......+.... . ..
T Consensus 420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~---~~~~~i~~~~~~~-----~----~~ 487 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQVERGYRMP-----C----PP 487 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH---HHHHHHHTTCCCC-----C----CT
T ss_pred cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcCCCCC-----C----CC
Confidence 2233457889999999999999999999999999999999 99999764322 2223333332211 1 11
Q ss_pred HHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCCC
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGA 608 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (660)
.....+.+++..||+.||++|||+++|++.|+...
T Consensus 488 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 488 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 23345778899999999999999999999999753
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=352.84 Aligned_cols=258 Identities=23% Similarity=0.353 Sum_probs=203.2
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeE----EEEEEeccC-CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeE
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAE----IAVKKVCHD-SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELL 409 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~----vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 409 (660)
...|+.++.||+|+||.||+|++..+++. ||+|.+... .....+++.+|+.++++++||||++++++|.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 34689999999999999999998777654 577777543 3445678999999999999999999999998654 88
Q ss_pred EEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceecc
Q 006112 410 LVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYD 489 (660)
Q Consensus 410 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 489 (660)
+|+||+.+|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 9999999999999997654 358999999999999999999998 899999999999999999999999999998765
Q ss_pred CCCC-ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcc
Q 006112 490 HGND-LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL 567 (660)
Q Consensus 490 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 567 (660)
.... .......||+.|+|||.+.+..++.++|||||||++|||++ |+.||............ ..+.... .
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~---~~~~~~~-----~ 240 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL---EKGERLP-----Q 240 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH---HTTCCCC-----C
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH---HcCCCCC-----C
Confidence 4322 22234567889999999999999999999999999999999 99999875544333222 2222111 1
Q ss_pred cccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCCCC
Q 006112 568 EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGAL 609 (660)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 609 (660)
... ....+.+++..||+.||.+||+++|+++.|+....
T Consensus 241 ~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 241 PPI----CTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CTT----BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred Ccc----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 111 22347788889999999999999999999987543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=359.63 Aligned_cols=260 Identities=27% Similarity=0.375 Sum_probs=198.9
Q ss_pred CCCceeeecccccccCccEEEEEEEeCCC---CeEEEEEEeccC-CChhhHHHHHHHHHHhccCCCCceeEeeeeee-cC
Q 006112 332 SPHRFSYKNLYKATKGGSGKVYRGVLPSS---HAEIAVKKVCHD-SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR-KG 406 (660)
Q Consensus 332 ~~~~~~~~~l~~lg~G~fg~Vy~g~~~~~---~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-~~ 406 (660)
.+....|+..+.||+|+||.||+|++..+ +..||||.+... .....++|.+|+.++++++||||++++++|.+ ++
T Consensus 85 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 164 (373)
T 3c1x_A 85 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 164 (373)
T ss_dssp CSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSS
T ss_pred ChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCC
Confidence 35667788899999999999999997533 346899998654 34567889999999999999999999998754 46
Q ss_pred eeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccce
Q 006112 407 ELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLAR 486 (660)
Q Consensus 407 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 486 (660)
..++||||+++|+|.+++.... ..+++.++..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 240 (373)
T 3c1x_A 165 SPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLAR 240 (373)
T ss_dssp CCEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred CeEEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeeccccc
Confidence 7899999999999999997543 458999999999999999999998 899999999999999999999999999998
Q ss_pred eccCCCC---ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccC
Q 006112 487 LYDHGND---LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDA 562 (660)
Q Consensus 487 ~~~~~~~---~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 562 (660)
....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |..||.......... ....+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~---~~~~~~~~-- 315 (373)
T 3c1x_A 241 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV---YLLQGRRL-- 315 (373)
T ss_dssp -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH---HHHTTCCC--
T ss_pred cccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH---HHHcCCCC--
Confidence 6543321 12234567889999999999999999999999999999999 666776533222211 11222211
Q ss_pred CCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 563 SDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 563 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
..| . .....+.+++..||+.||++||++.|+++.|+..
T Consensus 316 ~~p---~----~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 316 LQP---E----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp CCC---T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC---C----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111 1 1234577888999999999999999999999864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=352.28 Aligned_cols=249 Identities=23% Similarity=0.281 Sum_probs=195.5
Q ss_pred ceeeecccccccCccEEEEEEEeC---CCCeEEEEEEeccCC----ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCe
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLP---SSHAEIAVKKVCHDS----DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGE 407 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~---~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 407 (660)
.-.|+.++.||+|+||.||+++.. .+++.||+|++.... ......+.+|+.++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 346889999999999999999985 578999999996542 2345678899999999999999999999999999
Q ss_pred eEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeeccccee
Q 006112 408 LLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARL 487 (660)
Q Consensus 408 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 487 (660)
.++|||||++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 999999999999999997643 48889999999999999999998 8999999999999999999999999999975
Q ss_pred ccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcc
Q 006112 488 YDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL 567 (660)
Q Consensus 488 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 567 (660)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......+.. .+
T Consensus 171 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~------~~ 240 (327)
T 3a62_A 171 SIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT---IDKILKCKL------NL 240 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHTCC------CC
T ss_pred cccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHhCCC------CC
Confidence 43322 223346799999999999988999999999999999999999999986443211 111122111 11
Q ss_pred cccCcHHHHHHHHHHhhhccCCCCCCCC-----CHHHHHH
Q 006112 568 EGIYVEEQMEIVLKLGLFCSHSNPDTRP-----SMRQVVQ 602 (660)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 602 (660)
.... ...+.+++..||+.||++|| +++|+++
T Consensus 241 p~~~----~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 241 PPYL----TQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp CTTS----CHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred CCCC----CHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 1122 24567888889999999999 7888886
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=341.57 Aligned_cols=250 Identities=21% Similarity=0.300 Sum_probs=203.6
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC------hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD------HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLL 410 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 410 (660)
.|+.++.||+|+||.||+++...+++.||+|.+..... ...+.+.+|+.++++++||||+++++++...+..++
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (283)
T 3bhy_A 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVL 85 (283)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEE
Confidence 58889999999999999999998999999999865422 136789999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCC----CeEEeecccce
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADL----EGKLGDFGLAR 486 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~----~~kl~DFGla~ 486 (660)
||||+++++|.+++.... .+++.++..++.||+.||.|||+ .+|+||||||+||+++.++ .+||+|||+++
T Consensus 86 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 86 ILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 999999999999997643 48999999999999999999998 8999999999999998877 79999999998
Q ss_pred eccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCc
Q 006112 487 LYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPR 566 (660)
Q Consensus 487 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 566 (660)
....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .......... .
T Consensus 161 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~------~ 229 (283)
T 3bhy_A 161 KIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE---TLTNISAVNY------D 229 (283)
T ss_dssp ECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHTTCC------C
T ss_pred eccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH---HHHHhHhccc------C
Confidence 7644322 234578999999999998899999999999999999999999997644321 1111222111 0
Q ss_pred ccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 567 LEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 567 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
............+.+++..||+.||++||++.|+++
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 230 FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 110111122345788899999999999999999997
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=342.86 Aligned_cols=246 Identities=26% Similarity=0.378 Sum_probs=202.6
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
.|+.++.||+|+||.||+|++..++..||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (279)
T 3fdn_A 10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 89 (279)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEe
Confidence 6888999999999999999999999999999985432 2235678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
|+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 90 ~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-- 162 (279)
T 3fdn_A 90 YAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-- 162 (279)
T ss_dssp CCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCcc--
Confidence 999999999997654 48999999999999999999998 89999999999999999999999999998654332
Q ss_pred ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ......... .+...
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~------~~~~~--- 229 (279)
T 3fdn_A 163 -RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET---YKRISRVEF------TFPDF--- 229 (279)
T ss_dssp ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHHTCC------CCCTT---
T ss_pred -cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH---HHHHHhCCC------CCCCc---
Confidence 22345789999999999998999999999999999999999999986443222 111122111 11111
Q ss_pred HHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
....+.+++..||+.||++||+++|++++
T Consensus 230 -~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 230 -VTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp -SCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred -CCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 22346788888999999999999999973
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=349.00 Aligned_cols=259 Identities=25% Similarity=0.304 Sum_probs=206.5
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhc--cCCCCceeEeeeeeecC----eeEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGK--LRHRNLVQLRGYCRRKG----ELLL 410 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~H~nIv~l~g~~~~~~----~~~l 410 (660)
.|+..+.||+|+||.||+|++ +++.||||++.. ...+.+.+|++++.. ++||||+++++++.... ..++
T Consensus 43 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~l 117 (342)
T 1b6c_B 43 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 117 (342)
T ss_dssp HCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEE
T ss_pred cEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEE
Confidence 578889999999999999998 588999999853 334678888888877 78999999999998776 7899
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcc-----cCceeccCccCCcEEEcCCCCeEEeecccc
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEW-----EQVVLHRDIKPANVLLDADLEGKLGDFGLA 485 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDikp~NIll~~~~~~kl~DFGla 485 (660)
||||+++|+|.+++... .+++.+++.++.|++.||+|||... +++|+||||||+|||++.++.+||+|||++
T Consensus 118 v~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~ 194 (342)
T 1b6c_B 118 VSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 194 (342)
T ss_dssp EECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCc
Confidence 99999999999999764 4899999999999999999999211 289999999999999999999999999999
Q ss_pred eeccCCCCc---eeeccccCccccCcccccCCC------CCcceeEEehHHHHHHHhhC----------CCCCCCCCc--
Q 006112 486 RLYDHGNDL---HTTNVVGTVGYLAPELLRNGR------GTTSTDVYAFGVFMLEVACG----------RRPVQPGEL-- 544 (660)
Q Consensus 486 ~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~------~t~ksDV~S~Gvvl~elltG----------~~p~~~~~~-- 544 (660)
+........ ......||+.|+|||++.+.. ++.++|||||||++|||++| +.||.....
T Consensus 195 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~ 274 (342)
T 1b6c_B 195 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 274 (342)
T ss_dssp EEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCc
Confidence 876654432 223457999999999987652 33689999999999999999 778865321
Q ss_pred chHHHHHHHHhcCCcccCCCCccccc-CcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 545 DLLDWVIDYWQKGDVLDASDPRLEGI-YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
...+.......... ..+.+... ...+..+.+.+++.+||+.||++|||++||+++|+..
T Consensus 275 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 275 PSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp CCHHHHHHHHTTSC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHHH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 12222222222221 12222221 2346677899999999999999999999999999864
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=356.02 Aligned_cols=256 Identities=25% Similarity=0.299 Sum_probs=190.4
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccC-CCCceeEeeeee--------ec
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLR-HRNLVQLRGYCR--------RK 405 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~--------~~ 405 (660)
...|+..+.||+|+||.||+|++..+++.||||++........+.+.+|+.++.++. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 447899999999999999999999899999999997776667788999999999996 999999999983 34
Q ss_pred CeeEEEEecCCCCChhhhhhhC-CCCCcchhHHHHHHHHHHHHHHHhhhcccCc--eeccCccCCcEEEcCCCCeEEeec
Q 006112 406 GELLLVYDYMPNGSLDKILYSN-TRPSLNWFQRFRIIKGVAFGLLYLHEEWEQV--VLHRDIKPANVLLDADLEGKLGDF 482 (660)
Q Consensus 406 ~~~~lV~E~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDikp~NIll~~~~~~kl~DF 482 (660)
...++||||+ +|+|.+++... ....+++.+++.++.||+.||+|||+ .+ |+||||||+|||++.++.+||+||
T Consensus 107 ~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 107 AEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred ceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEecC
Confidence 4589999999 48999988652 23459999999999999999999998 77 999999999999999999999999
Q ss_pred ccceeccCCCCc-----------eeeccccCccccCcccc---cCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHH
Q 006112 483 GLARLYDHGNDL-----------HTTNVVGTVGYLAPELL---RNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLD 548 (660)
Q Consensus 483 Gla~~~~~~~~~-----------~~~~~~gt~~Y~aPE~~---~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~ 548 (660)
|+++........ ......||+.|+|||.+ .+..++.++|||||||++|||++|+.||.......
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-- 260 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR-- 260 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH--
Confidence 999876543221 11235689999999998 56678999999999999999999999997532211
Q ss_pred HHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCCCC
Q 006112 549 WVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGAL 609 (660)
Q Consensus 549 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 609 (660)
.. .+...... .... ...+.+++..||+.||++||++.|++++|+....
T Consensus 261 ~~-----~~~~~~~~----~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 261 IV-----NGKYSIPP----HDTQ----YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp ----------CCCCT----TCCS----SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hh-----cCcccCCc----cccc----chHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 00 01110000 1111 1236678889999999999999999999986543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=373.84 Aligned_cols=255 Identities=26% Similarity=0.328 Sum_probs=212.0
Q ss_pred CCceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeE
Q 006112 333 PHRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELL 409 (660)
Q Consensus 333 ~~~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 409 (660)
...-.|+.++.||+|+||.||+|+...+++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+.++
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 3445689999999999999999999999999999999643 2334567899999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceecc
Q 006112 410 LVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYD 489 (660)
Q Consensus 410 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 489 (660)
+|||||++|+|.+++.......+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 99999999999999987665669999999999999999999998 899999999999999999999999999998765
Q ss_pred CCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcc-hHHHHHHHHhcCCcccCCCCccc
Q 006112 490 HGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELD-LLDWVIDYWQKGDVLDASDPRLE 568 (660)
Q Consensus 490 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~d~~l~ 568 (660)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....+........ ..+.
T Consensus 338 ~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~------~~~p 409 (576)
T 2acx_A 338 EGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP------EEYS 409 (576)
T ss_dssp TTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCC------CCCC
T ss_pred cCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccc------ccCC
Confidence 433 233468999999999999888999999999999999999999999864321 2222222222211 1111
Q ss_pred ccCcHHHHHHHHHHhhhccCCCCCCCC-----CHHHHHH
Q 006112 569 GIYVEEQMEIVLKLGLFCSHSNPDTRP-----SMRQVVQ 602 (660)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 602 (660)
..+ ...+.+++..||+.||.+|| +++||++
T Consensus 410 ~~~----s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 410 ERF----SPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp TTS----CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ccC----CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 222 23467788889999999999 7899986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=353.19 Aligned_cols=241 Identities=21% Similarity=0.294 Sum_probs=202.9
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC--------hhhHHHHHHHHHHhccCCCCceeEeeeeeecCee
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD--------HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGEL 408 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 408 (660)
.|+.++.||+|+||.||+|++..+++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 25 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 104 (335)
T 3dls_A 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFF 104 (335)
T ss_dssp HEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEE
Confidence 68899999999999999999999999999999975431 2345788999999999999999999999999999
Q ss_pred EEEEecCCCC-ChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeeccccee
Q 006112 409 LLVYDYMPNG-SLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARL 487 (660)
Q Consensus 409 ~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 487 (660)
++||||+.+| +|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 105 ~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 105 QLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp EEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 9999999777 9999997654 48999999999999999999998 8999999999999999999999999999987
Q ss_pred ccCCCCceeeccccCccccCcccccCCCC-CcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCc
Q 006112 488 YDHGNDLHTTNVVGTVGYLAPELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPR 566 (660)
Q Consensus 488 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 566 (660)
...... .....||+.|+|||.+.+..+ +.++|||||||++|||++|+.||...... .. ....
T Consensus 180 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------~~----~~~~-- 242 (335)
T 3dls_A 180 LERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------VE----AAIH-- 242 (335)
T ss_dssp CCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------TT----TCCC--
T ss_pred CCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------Hh----hccC--
Confidence 654432 234679999999999988776 88999999999999999999999742110 00 0000
Q ss_pred ccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 567 LEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 567 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
....+ ...+.+++..||+.||++|||++|++++
T Consensus 243 ~~~~~----~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 243 PPYLV----SKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp CSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred CCccc----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11112 2347788889999999999999999985
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=354.84 Aligned_cols=250 Identities=22% Similarity=0.335 Sum_probs=196.0
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCC--CCceeEeeeeeecCeeEEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRH--RNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H--~nIv~l~g~~~~~~~~~lV 411 (660)
-.|+.++.||+|+||.||++... +++.||||++... .....+.+.+|+.++.+++| +||+++++++..++..++|
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 46899999999999999999984 5889999998654 33446789999999999986 9999999999999999999
Q ss_pred EecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCC
Q 006112 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 491 (660)
|| +.+++|.+++.... .+++.++..++.||+.||.|||+ ++|+||||||+|||++ ++.+||+|||+++.....
T Consensus 88 ~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EC-CCSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred Ee-CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 99 55899999998754 58999999999999999999998 8999999999999997 578999999999876543
Q ss_pred CCc-eeeccccCccccCcccccC-----------CCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCc
Q 006112 492 NDL-HTTNVVGTVGYLAPELLRN-----------GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDV 559 (660)
Q Consensus 492 ~~~-~~~~~~gt~~Y~aPE~~~~-----------~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 559 (660)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ............
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~ 239 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-SKLHAIIDPNHE 239 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-HHHHHHHCTTSC
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH-HHHHHHhcCCcc
Confidence 322 2345679999999999864 678899999999999999999999997533222 222222111111
Q ss_pred ccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 560 LDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 560 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
....... ...+.+++..||+.||++|||+.|++++
T Consensus 240 -----~~~~~~~----~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 240 -----IEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp -----CCCCCCS----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -----cCCcccC----CHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1111111 2356788889999999999999999974
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=350.09 Aligned_cols=263 Identities=24% Similarity=0.312 Sum_probs=200.3
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCCh-hhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDH-GMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
.|+.++.||+|+||.||+|+...+++.||||++...... ....+.+|++++++++||||+++++++..++..++||||+
T Consensus 3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (324)
T 3mtl_A 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 82 (324)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccc
Confidence 588999999999999999999989999999999654332 2335668999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 495 (660)
+ |+|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 83 ~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~ 156 (324)
T 3mtl_A 83 D-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KT 156 (324)
T ss_dssp S-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred c-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCc-cc
Confidence 6 69999887654 358999999999999999999998 899999999999999999999999999998654322 22
Q ss_pred eeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCcc-hHHHHHHHHhcCCcccCCCCcc------
Q 006112 496 TTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGELD-LLDWVIDYWQKGDVLDASDPRL------ 567 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~d~~l------ 567 (660)
.....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...... ....+....... .....+..
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTP--TEETWPGILSNEEF 234 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC--CTTTSTTGGGCHHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC--ChHhchhhhcchhh
Confidence 234578999999999876 56899999999999999999999999864432 223333222211 11100100
Q ss_pred --------ccc----CcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH--HhhCC
Q 006112 568 --------EGI----YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ--YLDGG 607 (660)
Q Consensus 568 --------~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~ 607 (660)
... ........+.+++..|++.||++|||++|+++ ++...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 000 00112245678899999999999999999997 45543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=338.98 Aligned_cols=252 Identities=24% Similarity=0.323 Sum_probs=206.0
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC-CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD-SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
.|+.++.||+|+||.||+|+...+++.||||.+... .....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (276)
T 2yex_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 87 (276)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEec
Confidence 588889999999999999999989999999998644 3345678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC-c
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND-L 494 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~-~ 494 (660)
++++|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........ .
T Consensus 88 ~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 88 SGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp TTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred CCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 999999998654 348999999999999999999998 8999999999999999999999999999987643321 2
Q ss_pred eeeccccCccccCcccccCCCC-CcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 495 HTTNVVGTVGYLAPELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.........+ ..+...... . + ...
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~~~~~~--~-~-~~~---- 232 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY--SDWKEKKTY--L-N-PWK---- 232 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHH--HHHHTTCTT--S-T-TGG----
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH--HHhhhcccc--c-C-chh----
Confidence 2334678999999999987665 779999999999999999999998644322221 111111110 0 0 011
Q ss_pred HHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.....+.+++..||+.||++|||++|++++
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 233 KIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred hcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 123456788889999999999999999863
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=347.92 Aligned_cols=258 Identities=24% Similarity=0.351 Sum_probs=209.9
Q ss_pred ceeeecccccccCccEEEEEEEe-----CCCCeEEEEEEeccCCC-hhhHHHHHHHHHHhcc-CCCCceeEeeeeeecC-
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVL-----PSSHAEIAVKKVCHDSD-HGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKG- 406 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~-----~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~- 406 (660)
.-.|+..+.||+|+||.||+|++ ..+++.||||++..... ...+.+.+|+.++.++ +||||++++++|...+
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 105 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 105 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence 34788999999999999999985 34678999999976543 3456899999999999 7999999999988765
Q ss_pred eeEEEEecCCCCChhhhhhhCCC--------------CCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEc
Q 006112 407 ELLLVYDYMPNGSLDKILYSNTR--------------PSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLD 472 (660)
Q Consensus 407 ~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~ 472 (660)
..++||||+++|+|.+++..... ..+++.++..++.|++.||.|||+ .+|+||||||+||+++
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~ 182 (316)
T 2xir_A 106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLS 182 (316)
T ss_dssp CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEEC
Confidence 58999999999999999976542 228999999999999999999998 8999999999999999
Q ss_pred CCCCeEEeecccceeccCCCC-ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHH
Q 006112 473 ADLEGKLGDFGLARLYDHGND-LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWV 550 (660)
Q Consensus 473 ~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~ 550 (660)
.++.+||+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++ |+.||....... ..
T Consensus 183 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~ 260 (316)
T 2xir_A 183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EF 260 (316)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH--HH
T ss_pred CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH--HH
Confidence 999999999999987654433 23345678999999999999999999999999999999998 999997643321 22
Q ss_pred HHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 551 IDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 551 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
......+.... ..... ...+.+++..||+.||.+|||+.|++++|+.
T Consensus 261 ~~~~~~~~~~~-----~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 307 (316)
T 2xir_A 261 CRRLKEGTRMR-----APDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 307 (316)
T ss_dssp HHHHHHTCCCC-----CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhccCccCC-----CCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 22223322211 11112 2347788889999999999999999999975
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=350.57 Aligned_cols=256 Identities=27% Similarity=0.442 Sum_probs=202.0
Q ss_pred eeeecccccccCccEEEEEEEeCCC----CeEEEEEEeccCCC-hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSS----HAEIAVKKVCHDSD-HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLL 410 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~----~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 410 (660)
..|+..+.||+|+||.||+|.+..+ +..||||.+..... .....+.+|+.++++++||||+++++++...+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 3577788999999999999988644 34699999975533 345679999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccC
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDH 490 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 490 (660)
||||+++|+|.+++.... ..+++.+++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 124 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 999999999999997653 358999999999999999999998 8999999999999999999999999999987654
Q ss_pred CCCc--eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcc
Q 006112 491 GNDL--HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL 567 (660)
Q Consensus 491 ~~~~--~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 567 (660)
.... ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...... .+......+.... .
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~~~~~~~~~~~-----~ 271 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---EVMKAINDGFRLP-----T 271 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHHTTCCCC-----C
T ss_pred ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHHCCCcCC-----C
Confidence 3221 1223456889999999999999999999999999999998 99999764332 1222223322111 1
Q ss_pred cccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 568 EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
.. .....+.+++..||+.||++||++.++++.|+..
T Consensus 272 ~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 272 PM----DCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp CT----TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred cc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11 2234577888999999999999999999999764
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=342.14 Aligned_cols=258 Identities=25% Similarity=0.402 Sum_probs=196.6
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
-+|+..+.||+|+||.||+|++.. .||||++.... ....+.+.+|++++++++||||+++++++ ..+..++|||
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 24 GQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred cceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 368889999999999999998743 59999986543 34567899999999999999999999976 4556899999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC-
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN- 492 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~- 492 (660)
|+++++|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 100 WCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp CCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred ecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 999999999996543 458999999999999999999998 899999999999999999999999999998654322
Q ss_pred CceeeccccCccccCccccc---CCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccc
Q 006112 493 DLHTTNVVGTVGYLAPELLR---NGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEG 569 (660)
Q Consensus 493 ~~~~~~~~gt~~Y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 569 (660)
........||+.|+|||.+. ...++.++||||||+++|||++|+.||..... .+.+.+....+....... .+
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~-~~-- 250 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIEMVGRGSLSPDLS-KV-- 250 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC--HHHHHHHHHHTSCCCCTT-SS--
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch--HHHHHHHhcccccCcchh-hc--
Confidence 22234467999999999986 56788899999999999999999999976332 222333333333221111 11
Q ss_pred cCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCCC
Q 006112 570 IYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGA 608 (660)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (660)
.......+.+++..||+.||++|||+.|+++.|+...
T Consensus 251 --~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 251 --RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred --cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 1223356788889999999999999999999998653
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=346.58 Aligned_cols=257 Identities=25% Similarity=0.351 Sum_probs=208.1
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeee--ecCeeEEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCR--RKGELLLV 411 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~--~~~~~~lV 411 (660)
-.|+.++.||+|+||.||+++...+++.||+|++.... ....+.+.+|++++++++||||+++++++. ..+..++|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence 36889999999999999999999899999999996543 345678999999999999999999999875 45789999
Q ss_pred EecCCCCChhhhhhhC--CCCCcchhHHHHHHHHHHHHHHHhhhcccCc-----eeccCccCCcEEEcCCCCeEEeeccc
Q 006112 412 YDYMPNGSLDKILYSN--TRPSLNWFQRFRIIKGVAFGLLYLHEEWEQV-----VLHRDIKPANVLLDADLEGKLGDFGL 484 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-----ivHrDikp~NIll~~~~~~kl~DFGl 484 (660)
|||+++++|.+++... ....+++.+++.++.|++.||+|||+ .+ |+||||||+||+++.++.+||+|||+
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 9999999999999753 23458999999999999999999998 66 99999999999999999999999999
Q ss_pred ceeccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCC
Q 006112 485 ARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASD 564 (660)
Q Consensus 485 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d 564 (660)
++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .......+...
T Consensus 163 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~i~~~~~~---- 234 (279)
T 2w5a_A 163 ARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAGKIREGKFR---- 234 (279)
T ss_dssp HHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHTCCC----
T ss_pred heeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH---HHHHHhhcccc----
Confidence 986543321 1234578999999999998899999999999999999999999998654322 22223333221
Q ss_pred CcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCCC
Q 006112 565 PRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGA 608 (660)
Q Consensus 565 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (660)
.+...+ ...+.+++..||+.||++||++.|+++++....
T Consensus 235 -~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 235 -RIPYRY----SDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp -CCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred -cCCccc----CHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 111222 345778888999999999999999998876543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=343.19 Aligned_cols=250 Identities=26% Similarity=0.337 Sum_probs=200.4
Q ss_pred ecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCCCC
Q 006112 339 KNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNG 418 (660)
Q Consensus 339 ~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g 418 (660)
.....||+|+||.||+|++..+++.||||.+........+.+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 25 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 104 (295)
T 2clq_A 25 GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGG 104 (295)
T ss_dssp SSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred CCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCC
Confidence 33458999999999999999999999999998776667788999999999999999999999999999999999999999
Q ss_pred ChhhhhhhCC-CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcC-CCCeEEeecccceeccCCCCcee
Q 006112 419 SLDKILYSNT-RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDA-DLEGKLGDFGLARLYDHGNDLHT 496 (660)
Q Consensus 419 sL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~-~~~~kl~DFGla~~~~~~~~~~~ 496 (660)
+|.+++.... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++...... ...
T Consensus 105 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~~~ 180 (295)
T 2clq_A 105 SLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCT 180 (295)
T ss_dssp EHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------
T ss_pred CHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCC-Ccc
Confidence 9999997653 2346788899999999999999998 89999999999999987 8999999999998764322 223
Q ss_pred eccccCccccCcccccCCC--CCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHH
Q 006112 497 TNVVGTVGYLAPELLRNGR--GTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEE 574 (660)
Q Consensus 497 ~~~~gt~~Y~aPE~~~~~~--~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 574 (660)
....||+.|+|||.+.... ++.++||||||+++|||++|+.||.............. .. ...+.+...+
T Consensus 181 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~-----~~~~~~~~~~--- 251 (295)
T 2clq_A 181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVG-MF-----KVHPEIPESM--- 251 (295)
T ss_dssp CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHH-HH-----CCCCCCCTTS---
T ss_pred cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhc-cc-----cccccccccC---
Confidence 3467899999999987643 78999999999999999999999975322211111111 11 1112222222
Q ss_pred HHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 575 QMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 575 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
...+.+++..||+.||++||++.|+++
T Consensus 252 -~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 252 -SAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp -CHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred -CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 345678888999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=343.24 Aligned_cols=254 Identities=24% Similarity=0.342 Sum_probs=206.1
Q ss_pred ceeeeccc-ccccCccEEEEEEEe--CCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeE
Q 006112 335 RFSYKNLY-KATKGGSGKVYRGVL--PSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELL 409 (660)
Q Consensus 335 ~~~~~~l~-~lg~G~fg~Vy~g~~--~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 409 (660)
+..|+..+ .||+|+||.||+|.+ ...++.||||++.... ....+++.+|++++++++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 44677777 899999999999954 5567899999996543 33467899999999999999999999999 567789
Q ss_pred EEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceecc
Q 006112 410 LVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYD 489 (660)
Q Consensus 410 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 489 (660)
+||||+++++|.+++.... .+++.++..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 94 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 9999999999999998754 48999999999999999999998 899999999999999999999999999998775
Q ss_pred CCCCcee--eccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCc
Q 006112 490 HGNDLHT--TNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPR 566 (660)
Q Consensus 490 ~~~~~~~--~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 566 (660)
....... ....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... +......+... .
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~~~~~-----~ 240 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAMLEKGERM-----G 240 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHTTCCC-----C
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHcCCCC-----C
Confidence 5443222 23456789999999988889999999999999999999 999998644322 22223333221 1
Q ss_pred ccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 567 LEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 567 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
... .....+.+++..||+.||++||++.++++.|+.
T Consensus 241 ~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 276 (291)
T 1xbb_A 241 CPA----GCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 276 (291)
T ss_dssp CCT----TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 111 223457788899999999999999999999975
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=342.31 Aligned_cols=256 Identities=23% Similarity=0.341 Sum_probs=208.3
Q ss_pred ceeeeccc-ccccCccEEEEEEEeC--CCCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEE
Q 006112 335 RFSYKNLY-KATKGGSGKVYRGVLP--SSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLL 410 (660)
Q Consensus 335 ~~~~~~l~-~lg~G~fg~Vy~g~~~--~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 410 (660)
+-+|..+. .||+|+||.||+|++. .++..||||++.... ....+++.+|++++++++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 34677776 8999999999999864 467889999997653 34567899999999999999999999999 5567999
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccC
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDH 490 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 490 (660)
||||+++++|.+++.... ..+++.++..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 87 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999999997543 458999999999999999999998 8999999999999999999999999999987754
Q ss_pred CCCce--eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcc
Q 006112 491 GNDLH--TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL 567 (660)
Q Consensus 491 ~~~~~--~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 567 (660)
..... .....||+.|+|||.+.+..++.++||||||+++|||++ |+.||....... .......+... ..
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~i~~~~~~-----~~ 234 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFIEQGKRM-----EC 234 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHHHHHTTCCC-----CC
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHhcCCcC-----CC
Confidence 43322 223457899999999988889999999999999999998 999997644322 22222232211 11
Q ss_pred cccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 568 EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
. ......+.+++..||+.||++||++.++++.|+..
T Consensus 235 ~----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 235 P----PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp C----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred C----CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1 12234577888999999999999999999999763
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=339.36 Aligned_cols=260 Identities=25% Similarity=0.303 Sum_probs=207.9
Q ss_pred CCCceeeecccccccCccEEEEEEEeCCCC---eEEEEEEeccCCC-hhhHHHHHHHHHHhccCCCCceeEeeeeeecCe
Q 006112 332 SPHRFSYKNLYKATKGGSGKVYRGVLPSSH---AEIAVKKVCHDSD-HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGE 407 (660)
Q Consensus 332 ~~~~~~~~~l~~lg~G~fg~Vy~g~~~~~~---~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 407 (660)
...+..|+..+.||+|+||.||+|++..++ ..||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 96 (298)
T 3pls_A 17 PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEG 96 (298)
T ss_dssp CGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred cccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCC
Confidence 345678888899999999999999975443 3799999975443 456789999999999999999999999987665
Q ss_pred e-EEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccce
Q 006112 408 L-LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLAR 486 (660)
Q Consensus 408 ~-~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 486 (660)
. ++||||+.+|+|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 97 ~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 172 (298)
T 3pls_A 97 LPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLAR 172 (298)
T ss_dssp CCEEEECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSC
T ss_pred CcEEEEecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcc
Confidence 5 99999999999999997643 458999999999999999999998 899999999999999999999999999998
Q ss_pred eccCCC---CceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCC-CCcchHHHHHHHHhcCCcccC
Q 006112 487 LYDHGN---DLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQP-GELDLLDWVIDYWQKGDVLDA 562 (660)
Q Consensus 487 ~~~~~~---~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~-~~~~~~~~~~~~~~~~~~~~~ 562 (660)
...... ........+|+.|+|||.+.+..++.++||||||+++|||++|..|+.. ....... .....+....
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~---~~~~~~~~~~- 248 (298)
T 3pls_A 173 DILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLT---HFLAQGRRLP- 248 (298)
T ss_dssp TTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHH---HHHHTTCCCC-
T ss_pred cccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHH---HHhhcCCCCC-
Confidence 654322 1222345788999999999999999999999999999999996666543 3222221 1122222111
Q ss_pred CCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 563 SDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 563 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
.... ....+.+++..||+.||.+|||++++++.|+..
T Consensus 249 ----~~~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 249 ----QPEY----CPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp ----CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCcc----chHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111 224577888999999999999999999999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=348.43 Aligned_cols=253 Identities=22% Similarity=0.308 Sum_probs=202.9
Q ss_pred eeecc-cccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccC-CCCceeEeeeeeecCeeEEEE
Q 006112 337 SYKNL-YKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLR-HRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 337 ~~~~l-~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~ 412 (660)
.|... +.||+|+||.||+|+...+++.||+|++.... ....+.+.+|+.++.+++ ||||+++++++...+..++||
T Consensus 29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~ 108 (327)
T 3lm5_A 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILIL 108 (327)
T ss_dssp HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEE
Confidence 35555 78999999999999999999999999986542 334678999999999995 699999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcC---CCCeEEeecccceecc
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDA---DLEGKLGDFGLARLYD 489 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~---~~~~kl~DFGla~~~~ 489 (660)
||+++|+|.+++.......+++.++..++.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||+++...
T Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 185 (327)
T 3lm5_A 109 EYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185 (327)
T ss_dssp ECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence 99999999999976655679999999999999999999998 89999999999999988 7899999999998765
Q ss_pred CCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccc
Q 006112 490 HGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEG 569 (660)
Q Consensus 490 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 569 (660)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||............ ..... ... .
T Consensus 186 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i---~~~~~-~~~-----~ 254 (327)
T 3lm5_A 186 HAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI---SQVNV-DYS-----E 254 (327)
T ss_dssp ----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHTCC-CCC-----T
T ss_pred Ccc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHH---Hhccc-ccC-----c
Confidence 432 223467999999999999999999999999999999999999999765432221111 11111 000 1
Q ss_pred cCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 570 IYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.........+.+++..||+.||++|||++|++++
T Consensus 255 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 255 ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 1111223457788889999999999999999874
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=351.79 Aligned_cols=259 Identities=23% Similarity=0.326 Sum_probs=195.5
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD--HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
.|+.++.||+|+||.||+|++..+++.||||++..... ...+.+.+|++++++++||||+++++++..++..++||||
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 114 (329)
T 3gbz_A 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY 114 (329)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEec
Confidence 68999999999999999999999999999999965432 2356788999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEc-----CCCCeEEeecccceecc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLD-----ADLEGKLGDFGLARLYD 489 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~-----~~~~~kl~DFGla~~~~ 489 (660)
++ |+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||++ .++.+||+|||+++...
T Consensus 115 ~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 115 AE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp CS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred CC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 96 69999998764 48999999999999999999998 8999999999999994 45569999999998764
Q ss_pred CCCCceeeccccCccccCcccccCC-CCCcceeEEehHHHHHHHhhCCCCCCCCCcc-hHHHHHHHHhcCCccc------
Q 006112 490 HGNDLHTTNVVGTVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQPGELD-LLDWVIDYWQKGDVLD------ 561 (660)
Q Consensus 490 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~------ 561 (660)
.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ....+...........
T Consensus 189 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (329)
T 3gbz_A 189 IPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA 267 (329)
T ss_dssp ------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred Cccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhh
Confidence 3322 23345789999999999874 4899999999999999999999999764432 2222222111110000
Q ss_pred -----CCCCcccccCcH-----HHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 562 -----ASDPRLEGIYVE-----EQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 562 -----~~d~~l~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
...+........ .....+.+++..||+.||++|||++|+++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000111111111 12346778899999999999999999997
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=338.72 Aligned_cols=249 Identities=22% Similarity=0.352 Sum_probs=185.2
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
-.|+..+.||+|+||.||+|+...+++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 36888999999999999999998899999999986432 233578999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
||+++++|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 91 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp ECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred ecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 9999999999997643 358999999999999999999998 899999999999999999999999999998765332
Q ss_pred CceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCc
Q 006112 493 DLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 493 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ..... ..+......+
T Consensus 167 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~------~~~~~~~~~~- 235 (278)
T 3cok_A 167 E-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT---LNKVV------LADYEMPSFL- 235 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------CC------SSCCCCCTTS-
T ss_pred C-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH---HHHHh------hcccCCcccc-
Confidence 2 12345789999999999988899999999999999999999999976433211 00000 0111112222
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
...+.+++.+||+.||++||+++++++
T Consensus 236 ---~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 236 ---SIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ---CHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ---CHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 235678888999999999999999986
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=365.06 Aligned_cols=252 Identities=23% Similarity=0.379 Sum_probs=209.6
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
-.|...+.||+|+||.||+|++..+++.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 36889999999999999999999899999999996432 234567899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
|||++|+|.+++.... .+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 96 E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 96 EYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp ECCSSEEHHHHTTSSS--SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 9999999999997543 48999999999999999999998 899999999999999999999999999998765432
Q ss_pred CceeeccccCccccCcccccCCCC-CcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccC
Q 006112 493 DLHTTNVVGTVGYLAPELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIY 571 (660)
Q Consensus 493 ~~~~~~~~gt~~Y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 571 (660)
.....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||....... .......+... .....
T Consensus 171 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~---~~~~i~~~~~~------~p~~~ 239 (476)
T 2y94_A 171 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT---LFKKICDGIFY------TPQYL 239 (476)
T ss_dssp --CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH---HHHHHHTTCCC------CCTTC
T ss_pred --cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH---HHHHHhcCCcC------CCccC
Confidence 2334679999999999987765 789999999999999999999998654322 12222222211 11122
Q ss_pred cHHHHHHHHHHhhhccCCCCCCCCCHHHHHH--HhhCC
Q 006112 572 VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ--YLDGG 607 (660)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~ 607 (660)
+ ..+.+++..||+.||++|||++|+++ +++..
T Consensus 240 s----~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 240 N----PSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp C----HHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred C----HHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 2 34677888899999999999999997 56554
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=349.78 Aligned_cols=263 Identities=26% Similarity=0.359 Sum_probs=195.8
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHH--HhccCCCCceeEeeeeee-----cCe
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVS--MGKLRHRNLVQLRGYCRR-----KGE 407 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~--l~~l~H~nIv~l~g~~~~-----~~~ 407 (660)
.-+|+.++.||+|+||.||+|++ +++.||||++.... .+.+..|.++ +..++||||+++++++.. ...
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 34789999999999999999988 67999999986432 3344444444 556899999999985532 336
Q ss_pred eEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcc------cCceeccCccCCcEEEcCCCCeEEee
Q 006112 408 LLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEW------EQVVLHRDIKPANVLLDADLEGKLGD 481 (660)
Q Consensus 408 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~ivHrDikp~NIll~~~~~~kl~D 481 (660)
.++|||||++|+|.+++.... .++..+.+++.||+.||+|||+.+ .++|+||||||+|||++.++.+||+|
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred EEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 799999999999999997653 588999999999999999999821 12999999999999999999999999
Q ss_pred cccceeccCCC-------CceeeccccCccccCcccccC-------CCCCcceeEEehHHHHHHHhhCCCCCCCCCc---
Q 006112 482 FGLARLYDHGN-------DLHTTNVVGTVGYLAPELLRN-------GRGTTSTDVYAFGVFMLEVACGRRPVQPGEL--- 544 (660)
Q Consensus 482 FGla~~~~~~~-------~~~~~~~~gt~~Y~aPE~~~~-------~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~--- 544 (660)
||+++.+.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.|+.....
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 243 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence 99998765422 112234579999999999876 3456789999999999999999888754211
Q ss_pred ------------chHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 545 ------------DLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 545 ------------~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
...+.................... ........+.+++..||+.||++|||++|+++.|+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWK--ENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCC--CCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhhhcccCCCchHHHHHhhhcccccCCCCCcccc--cccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 001111111111111111111111 1234566789999999999999999999999999863
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=341.24 Aligned_cols=261 Identities=27% Similarity=0.363 Sum_probs=205.2
Q ss_pred cCCCceeeecccccccCccEEEEEEEeCCC---CeEEEEEEeccCCC-hhhHHHHHHHHHHhccCCCCceeEeeeee-ec
Q 006112 331 YSPHRFSYKNLYKATKGGSGKVYRGVLPSS---HAEIAVKKVCHDSD-HGMKQFVSEIVSMGKLRHRNLVQLRGYCR-RK 405 (660)
Q Consensus 331 ~~~~~~~~~~l~~lg~G~fg~Vy~g~~~~~---~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~-~~ 405 (660)
.++....|+..+.||+|+||.||+|++..+ ...+|+|.+..... ...+++.+|+.++++++||||++++++|. .+
T Consensus 20 i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 99 (298)
T 3f66_A 20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 99 (298)
T ss_dssp CCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred cCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC
Confidence 456678899999999999999999997543 34689999876443 45678999999999999999999999865 45
Q ss_pred CeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccc
Q 006112 406 GELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLA 485 (660)
Q Consensus 406 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla 485 (660)
+..++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a 175 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLA 175 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGG
T ss_pred CceEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECccccc
Confidence 67899999999999999997543 458899999999999999999998 89999999999999999999999999999
Q ss_pred eeccCCCC---ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCC-CCCCCCCcchHHHHHHHHhcCCccc
Q 006112 486 RLYDHGND---LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGR-RPVQPGELDLLDWVIDYWQKGDVLD 561 (660)
Q Consensus 486 ~~~~~~~~---~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~ 561 (660)
+....... .......||+.|+|||.+.+..++.++||||||+++|||++|. .||.......... ....+...
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~---~~~~~~~~- 251 (298)
T 3f66_A 176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV---YLLQGRRL- 251 (298)
T ss_dssp CCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHH---HHHTTCCC-
T ss_pred ccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHH---HHhcCCCC-
Confidence 86643321 1233456788999999999999999999999999999999954 4554433222111 11121111
Q ss_pred CCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 562 ASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 562 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
..... ....+.+++..||+.||++||+++|+++.|+..
T Consensus 252 ----~~~~~----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 252 ----LQPEY----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp ----CCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCcc----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 01111 224577888899999999999999999999863
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=365.32 Aligned_cols=193 Identities=27% Similarity=0.376 Sum_probs=156.0
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeec-----CeeE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK-----GELL 409 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~~ 409 (660)
.|+.++.||+|+||.||+|++..+++.||||++... .....+++.+|++++++++||||+++++++... ..++
T Consensus 54 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 133 (458)
T 3rp9_A 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY 133 (458)
T ss_dssp TEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEE
Confidence 588999999999999999999999999999999653 233467899999999999999999999998433 5789
Q ss_pred EEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceecc
Q 006112 410 LVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYD 489 (660)
Q Consensus 410 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 489 (660)
+||||+ +|+|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+++...
T Consensus 134 lv~e~~-~~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 134 VVLEIA-DSDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp EEECCC-SEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred EEEecc-ccchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 999998 689999987643 48999999999999999999998 899999999999999999999999999998764
Q ss_pred CCCC--------------------------ceeeccccCccccCcccc-cCCCCCcceeEEehHHHHHHHhhC
Q 006112 490 HGND--------------------------LHTTNVVGTVGYLAPELL-RNGRGTTSTDVYAFGVFMLEVACG 535 (660)
Q Consensus 490 ~~~~--------------------------~~~~~~~gt~~Y~aPE~~-~~~~~t~ksDV~S~Gvvl~elltG 535 (660)
.... ...+..+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 3221 123456789999999976 456799999999999999999993
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=348.73 Aligned_cols=254 Identities=24% Similarity=0.369 Sum_probs=211.4
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEE
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 411 (660)
...|+..+.||+|+||.||++++..+++.+|+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 45789999999999999999999999999999998654 234567889999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCC
Q 006112 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 491 (660)
|||+++++|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 120 ~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp ECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 99999999999987643 48999999999999999999998 89999999999999999999999999999876533
Q ss_pred CCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccC
Q 006112 492 NDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIY 571 (660)
Q Consensus 492 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 571 (660)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... . ......+.. .+...+
T Consensus 195 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~-~~~~~~~~~------~~~~~~ 264 (335)
T 2owb_A 195 GE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE--T-YLRIKKNEY------SIPKHI 264 (335)
T ss_dssp TC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--H-HHHHHHTCC------CCCTTS
T ss_pred cc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH--H-HHHHhcCCC------CCCccC
Confidence 22 2334679999999999998889999999999999999999999997644321 1 111222211 111222
Q ss_pred cHHHHHHHHHHhhhccCCCCCCCCCHHHHHH--HhhCC
Q 006112 572 VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ--YLDGG 607 (660)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~ 607 (660)
+ ..+.+++..||+.||++||+++|+++ ++...
T Consensus 265 ~----~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 265 N----PVAASLIQKMLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp C----HHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred C----HHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 2 34677888999999999999999997 55543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=358.99 Aligned_cols=250 Identities=22% Similarity=0.337 Sum_probs=197.6
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccC--CCCceeEeeeeeecCeeEEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLR--HRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~--H~nIv~l~g~~~~~~~~~lV 411 (660)
..|+.++.||+|+||.||++.... ++.||||++.... ....+.+.+|+.++++++ ||||+++++++..++.+++|
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 359999999999999999999865 8899999986543 345678999999999996 59999999999999999999
Q ss_pred EecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCC
Q 006112 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 491 (660)
|| +.+++|.+++.... .+++.++..++.||+.||.|||+ .+|+||||||+|||++ ++.+||+|||+++.+...
T Consensus 135 ~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp EE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred Ee-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 99 56899999998754 58888999999999999999998 8999999999999996 578999999999876543
Q ss_pred CCc-eeeccccCccccCcccccC-----------CCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCc
Q 006112 492 NDL-HTTNVVGTVGYLAPELLRN-----------GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDV 559 (660)
Q Consensus 492 ~~~-~~~~~~gt~~Y~aPE~~~~-----------~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 559 (660)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .............
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-~~~~~~~~~~~~~ 286 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-ISKLHAIIDPNHE 286 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-HHHHHHHHCTTSC
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-HHHHHHHhCcccc
Confidence 322 2345679999999999865 46889999999999999999999999753322 2222222211111
Q ss_pred ccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 560 LDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 560 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
. ...... ...+.+++..||+.||++||++.|++++
T Consensus 287 ~-----~~~~~~----~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 287 I-----EFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp C-----CCCCCS----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred C-----CCCccc----hHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1 111111 2356788889999999999999999973
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=345.39 Aligned_cols=255 Identities=21% Similarity=0.334 Sum_probs=207.2
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 416 (660)
.|+.++.||+|+||.||+++...+++.||+|.+........+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (304)
T 2jam_A 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVS 89 (304)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred cceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCC
Confidence 68889999999999999999998999999999976655556778999999999999999999999999999999999999
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEE---cCCCCeEEeecccceeccCCCC
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLL---DADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll---~~~~~~kl~DFGla~~~~~~~~ 493 (660)
+++|.+++.... .+++.++..++.|++.||.|||+ .+|+||||||+||++ +.++.+||+|||+++.....
T Consensus 90 ~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-- 162 (304)
T 2jam_A 90 GGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-- 162 (304)
T ss_dssp SCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB--
T ss_pred CccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC--
Confidence 999999987643 48899999999999999999998 899999999999999 78899999999999764332
Q ss_pred ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ........+... . .... ..
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~-~-~~~~----~~ 232 (304)
T 2jam_A 163 -IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---KLFEKIKEGYYE-F-ESPF----WD 232 (304)
T ss_dssp -TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHCCCC-C-CTTT----TT
T ss_pred -ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHcCCCC-C-Cccc----cc
Confidence 123456899999999999999999999999999999999999999764332 122222222211 0 1111 11
Q ss_pred HHHHHHHHHhhhccCCCCCCCCCHHHHHH--HhhCCC
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQ--YLDGGA 608 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~ 608 (660)
.....+.+++..|++.||++||+++|+++ ++++..
T Consensus 233 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 233 DISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp TSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 22345778888999999999999999997 566543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=357.87 Aligned_cols=260 Identities=27% Similarity=0.394 Sum_probs=193.4
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccC-CCCceeEeeeeeecC--eeEEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLR-HRNLVQLRGYCRRKG--ELLLV 411 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~--~~~lV 411 (660)
.|+.++.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.+++++. ||||+++++++...+ .+++|
T Consensus 10 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 89 (388)
T 3oz6_A 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLV 89 (388)
T ss_dssp TEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEE
T ss_pred ceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEE
Confidence 588999999999999999999999999999998643 3345677889999999997 999999999997544 68999
Q ss_pred EecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCC
Q 006112 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 491 (660)
||||+ |+|..++... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+...
T Consensus 90 ~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 90 FDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp EECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred ecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 99996 7999999763 48899999999999999999998 89999999999999999999999999999875431
Q ss_pred C--------------------CceeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHH
Q 006112 492 N--------------------DLHTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDW 549 (660)
Q Consensus 492 ~--------------------~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~ 549 (660)
. ....+..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 1 112344689999999999876 6789999999999999999999999976432 22222
Q ss_pred HHHHHhcCCcc--cCC-------------------CCcccccCc------------HHHHHHHHHHhhhccCCCCCCCCC
Q 006112 550 VIDYWQKGDVL--DAS-------------------DPRLEGIYV------------EEQMEIVLKLGLFCSHSNPDTRPS 596 (660)
Q Consensus 550 ~~~~~~~~~~~--~~~-------------------d~~l~~~~~------------~~~~~~l~~l~~~Cl~~dP~~RPs 596 (660)
+.......... ... .......+. ......+.+++..||+.||++|||
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 22111110000 000 000000000 011245778899999999999999
Q ss_pred HHHHHHH
Q 006112 597 MRQVVQY 603 (660)
Q Consensus 597 ~~evl~~ 603 (660)
++|++++
T Consensus 323 ~~e~l~H 329 (388)
T 3oz6_A 323 ANDALKH 329 (388)
T ss_dssp HHHHTTS
T ss_pred HHHHhCC
Confidence 9999975
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=354.61 Aligned_cols=260 Identities=15% Similarity=0.147 Sum_probs=204.8
Q ss_pred ceeeecccccccCccEEEEEEEeCC--------CCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCcee---------
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPS--------SHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQ--------- 397 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~--------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~--------- 397 (660)
.-.|+..+.||+|+||.||+|++.. .++.||||.+... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3479999999999999999999976 4789999998643 47889999999999999998
Q ss_pred ------Eeeeeee-cCeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEE
Q 006112 398 ------LRGYCRR-KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVL 470 (660)
Q Consensus 398 ------l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIl 470 (660)
+++++.. ++..++||||+ +++|.+++.......+++.+++.++.||+.||+|||+ ++|+||||||+|||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl 191 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIF 191 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEE
Confidence 5667765 67899999999 9999999987644569999999999999999999998 89999999999999
Q ss_pred EcCCC--CeEEeecccceeccCCCCc------eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCC
Q 006112 471 LDADL--EGKLGDFGLARLYDHGNDL------HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPG 542 (660)
Q Consensus 471 l~~~~--~~kl~DFGla~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~ 542 (660)
++.++ .+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 8999999999876432211 123457999999999999989999999999999999999999999764
Q ss_pred C--cchHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 543 E--LDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 543 ~--~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
. ..........+.. ......++.... ......+.+++..||+.||++||+++++++.|+..
T Consensus 272 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 334 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVD-KPGPFVGPCGHW---IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL 334 (352)
T ss_dssp TTCHHHHHHHHHHHHH-SCCCEECTTSCE---ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHhccC-Chhhhhhhcccc---CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence 2 2222222221111 111111111100 11124577888889999999999999999998764
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=353.99 Aligned_cols=259 Identities=24% Similarity=0.411 Sum_probs=210.2
Q ss_pred ceeeecccccccCccEEEEEEEe----CCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecC--ee
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVL----PSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKG--EL 408 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~----~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~ 408 (660)
.-.|+.++.||+|+||.||++++ ..+++.||||++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 34688899999999999999984 5578999999998777777889999999999999999999999987654 78
Q ss_pred EEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceec
Q 006112 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLY 488 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 488 (660)
++||||+++++|.+++.... ..+++.+++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 99999999999999998754 358999999999999999999998 89999999999999999999999999999877
Q ss_pred cCCCCce--eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcch-------------HHHHHHH
Q 006112 489 DHGNDLH--TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDL-------------LDWVIDY 553 (660)
Q Consensus 489 ~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~-------------~~~~~~~ 553 (660)
....... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+....... .....+.
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence 5543322 223457888999999998889999999999999999999999876421111 1111222
Q ss_pred HhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 554 WQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 554 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
...+... ... ......+.+++..||+.||++||++.|+++.|+.
T Consensus 276 ~~~~~~~-----~~~----~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~ 319 (326)
T 2w1i_A 276 LKNNGRL-----PRP----DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 319 (326)
T ss_dssp HHTTCCC-----CCC----TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred hhcCCCC-----CCC----CcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 2222111 111 1223457788899999999999999999999875
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=351.85 Aligned_cols=261 Identities=27% Similarity=0.382 Sum_probs=202.2
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC--hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD--HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
-.|+.++.||+|+||.||+|++..+++.||||++..... ...+.+.+|++++++++||||++++++|.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 368999999999999999999999999999999865433 335668899999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
|+++++|..++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 105 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 105 FVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp CCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred cCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 999999998876543 48999999999999999999998 8999999999999999999999999999986544322
Q ss_pred ceeeccccCccccCcccccCC-CCCcceeEEehHHHHHHHhhCCCCCCCCCcc-hHHHHHHH-----------HhcCCc-
Q 006112 494 LHTTNVVGTVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQPGELD-LLDWVIDY-----------WQKGDV- 559 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~~-----------~~~~~~- 559 (660)
......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...... ....+... +.....
T Consensus 180 -~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 180 -VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred -ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 22345789999999998765 7899999999999999999999999764432 11111111 111110
Q ss_pred ccCCCCcccccCc-----HHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 560 LDASDPRLEGIYV-----EEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 560 ~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
.....+.+..... +...+.+.+++..||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1111111111111 122456888999999999999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=355.32 Aligned_cols=255 Identities=26% Similarity=0.390 Sum_probs=205.3
Q ss_pred eecccccccCccEEEEEEEe----CCCCeEEEEEEeccCCC-hhhHHHHHHHHHHhccCCCCceeEeeeeeec--CeeEE
Q 006112 338 YKNLYKATKGGSGKVYRGVL----PSSHAEIAVKKVCHDSD-HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK--GELLL 410 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~----~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~l 410 (660)
|+.++.||+|+||.||++.+ ..+++.||||++..... ...+.+.+|++++++++||||+++++++.+. ..+++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 58899999999999988865 34688999999976543 4467899999999999999999999999874 57899
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccC
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDH 490 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 490 (660)
||||+++|+|.+++.... +++.+++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 113 v~e~~~~~~L~~~l~~~~---~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EECCCTTCBHHHHGGGSC---CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEecccCCcHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 999999999999997643 8999999999999999999998 8999999999999999999999999999988765
Q ss_pred CCCc--eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcch------------HHHHHHHHhc
Q 006112 491 GNDL--HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDL------------LDWVIDYWQK 556 (660)
Q Consensus 491 ~~~~--~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~------------~~~~~~~~~~ 556 (660)
.... ......||..|+|||.+.+..++.++||||||+++|||++|+.||....... .....+....
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc
Confidence 4332 2234568889999999998889999999999999999999999987522111 1111222222
Q ss_pred CCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 557 GDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 557 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
+... .. .......+.+++.+||+.||++|||++|+++.|+..
T Consensus 267 ~~~~-----~~----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 267 GERL-----PR----PDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp TCCC-----CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCC-----CC----CccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 2111 11 122234578888999999999999999999999753
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=357.88 Aligned_cols=244 Identities=25% Similarity=0.258 Sum_probs=193.2
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHH-HhccCCCCceeEeeeeeecCeeEEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVS-MGKLRHRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~-l~~l~H~nIv~l~g~~~~~~~~~lV 411 (660)
-+|+.++.||+|+||.||+++...+++.||+|++.... ....+.+.+|..+ ++.++||||+++++++.+.+.+++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 36889999999999999999999999999999996542 2344567778777 5778999999999999999999999
Q ss_pred EecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCC
Q 006112 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 491 (660)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 118 ~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 118 LDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 99999999999997643 48888999999999999999998 99999999999999999999999999999864322
Q ss_pred CCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccC
Q 006112 492 NDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIY 571 (660)
Q Consensus 492 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 571 (660)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+....+.. .+...+
T Consensus 193 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~~~i~~~~~------~~~~~~ 262 (373)
T 2r5t_A 193 N-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYDNILNKPL------QLKPNI 262 (373)
T ss_dssp C-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH---HHHHHHHSCC------CCCSSS
T ss_pred C-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHhccc------CCCCCC
Confidence 2 23345789999999999999999999999999999999999999998644322 1222222211 111222
Q ss_pred cHHHHHHHHHHhhhccCCCCCCCCCHH
Q 006112 572 VEEQMEIVLKLGLFCSHSNPDTRPSMR 598 (660)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 598 (660)
. ..+.+++..||+.||.+||++.
T Consensus 263 ~----~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 263 T----NSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp C----HHHHHHHHHHTCSSGGGSTTTT
T ss_pred C----HHHHHHHHHHcccCHHhCCCCC
Confidence 2 3467788889999999999975
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=350.81 Aligned_cols=259 Identities=25% Similarity=0.404 Sum_probs=210.6
Q ss_pred ceeeecccccccCccEEEEEEEeC-----CCCeEEEEEEeccCCC-hhhHHHHHHHHHHhccCCCCceeEeeeeeecCee
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLP-----SSHAEIAVKKVCHDSD-HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGEL 408 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~-----~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 408 (660)
.-.|+..+.||+|+||.||+|++. .+++.||||.+..... ....++.+|+.++++++||||+++++++.+.+..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 103 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 103 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCcc
Confidence 346888999999999999999875 3468899999865433 3456799999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhhhCC--------CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEe
Q 006112 409 LLVYDYMPNGSLDKILYSNT--------RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLG 480 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~ 480 (660)
++||||+++|+|.+++.... ...+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+
T Consensus 104 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~~~kl~ 180 (322)
T 1p4o_A 104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIG 180 (322)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCCeEEEC
Confidence 99999999999999986531 1347899999999999999999998 899999999999999999999999
Q ss_pred ecccceeccCCCCc-eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCC
Q 006112 481 DFGLARLYDHGNDL-HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGD 558 (660)
Q Consensus 481 DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 558 (660)
|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++ |+.||...... ........+.
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~~~~~ 257 (322)
T 1p4o_A 181 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---QVLRFVMEGG 257 (322)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---HHHHHHHTTC
T ss_pred cCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH---HHHHHHHcCC
Confidence 99999865433221 2233467899999999999999999999999999999999 88898764332 2222223332
Q ss_pred cccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCCC
Q 006112 559 VLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGA 608 (660)
Q Consensus 559 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (660)
... ... .....+.+++..||+.||.+|||+.|+++.|+...
T Consensus 258 ~~~-----~~~----~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 258 LLD-----KPD----NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp CCC-----CCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred cCC-----CCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 211 111 22345778888999999999999999999998753
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=343.13 Aligned_cols=255 Identities=24% Similarity=0.367 Sum_probs=211.3
Q ss_pred CceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEE
Q 006112 334 HRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLL 410 (660)
Q Consensus 334 ~~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 410 (660)
....|+..+.||+|+||.||++.+..+++.+|+|.+... .....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 345799999999999999999999999999999998654 23456788999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccC
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDH 490 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 490 (660)
||||+++++|.+++.... .+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 93 v~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 93 VLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EEECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 999999999999987643 48999999999999999999998 8999999999999999999999999999987653
Q ss_pred CCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCccccc
Q 006112 491 GNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGI 570 (660)
Q Consensus 491 ~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 570 (660)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... . ......+.. .+...
T Consensus 168 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~-~~~~~~~~~------~~~~~ 237 (294)
T 2rku_A 168 DGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE--T-YLRIKKNEY------SIPKH 237 (294)
T ss_dssp TTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--H-HHHHHTTCC------CCCTT
T ss_pred Ccc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--H-HHHHhhccC------CCccc
Confidence 322 2334678999999999998889999999999999999999999997644321 1 111222211 11122
Q ss_pred CcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH--HhhCC
Q 006112 571 YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ--YLDGG 607 (660)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~ 607 (660)
. ...+.+++..||+.||++|||++|+++ ++...
T Consensus 238 ~----~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 238 I----NPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp S----CHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred c----CHHHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence 2 234677888999999999999999997 45543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=365.82 Aligned_cols=257 Identities=23% Similarity=0.283 Sum_probs=196.8
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeec------Cee
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK------GEL 408 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~ 408 (660)
.|+.++.||+|+||.||+|++..+++.||||++... .....+++.+|+.++++++||||+++++++... ..+
T Consensus 63 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 142 (464)
T 3ttj_A 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 142 (464)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeE
Confidence 588999999999999999999999999999999654 334567889999999999999999999998654 457
Q ss_pred EEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceec
Q 006112 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLY 488 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 488 (660)
++|||||++ +|.+.+.. .+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 143 ~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 143 YLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp EEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred EEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 999999965 56666632 38899999999999999999998 89999999999999999999999999999876
Q ss_pred cCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHHHHHHhcCCc--ccC---
Q 006112 489 DHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVIDYWQKGDV--LDA--- 562 (660)
Q Consensus 489 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~~~~~~~--~~~--- 562 (660)
... ...+...||+.|+|||++.+..++.++|||||||++|||++|+.||.+... +....+.+....... ...
T Consensus 215 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~ 292 (464)
T 3ttj_A 215 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292 (464)
T ss_dssp --C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCH
T ss_pred CCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcch
Confidence 443 223456899999999999999999999999999999999999999986432 122222211111000 000
Q ss_pred -------CCCccc----------------ccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 563 -------SDPRLE----------------GIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 563 -------~d~~l~----------------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
..+... ..........+.+|+..||+.||++|||++|++++
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 00111224568899999999999999999999973
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=378.35 Aligned_cols=247 Identities=23% Similarity=0.374 Sum_probs=200.0
Q ss_pred ccccCccEEEEEEEeC--CCCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCCCCC
Q 006112 343 KATKGGSGKVYRGVLP--SSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGS 419 (660)
Q Consensus 343 ~lg~G~fg~Vy~g~~~--~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gs 419 (660)
.||+|+||.||+|.+. .++..||||++.... ....++|.+|++++++++||||++++++|.. +.+++|||||++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999875 356789999997653 3457889999999999999999999999976 56999999999999
Q ss_pred hhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce--ee
Q 006112 420 LDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH--TT 497 (660)
Q Consensus 420 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~--~~ 497 (660)
|.+++... ...+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......... ..
T Consensus 422 L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 497 (613)
T 2ozo_A 422 LHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 497 (613)
T ss_dssp HHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred HHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeecc
Confidence 99999754 3459999999999999999999998 899999999999999999999999999998764433221 12
Q ss_pred ccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHH
Q 006112 498 NVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQM 576 (660)
Q Consensus 498 ~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 576 (660)
...+|+.|+|||++.++.++.++|||||||++|||++ |+.||....... +......+..... .....
T Consensus 498 ~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~~~i~~~~~~~~---------p~~~~ 565 (613)
T 2ozo_A 498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFIEQGKRMEC---------PPECP 565 (613)
T ss_dssp ----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---HHHHHHTTCCCCC---------CTTCC
T ss_pred CCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHHHHcCCCCCC---------CCcCC
Confidence 3346789999999999999999999999999999998 999998644322 2233333332211 12234
Q ss_pred HHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 577 EIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 577 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
..+.+++..||+.||++||++.+|++.|+.
T Consensus 566 ~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 595 (613)
T 2ozo_A 566 PELYALMSDCWIYKWEDRPDFLTVEQRMRA 595 (613)
T ss_dssp HHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 567889999999999999999999999875
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=340.59 Aligned_cols=248 Identities=26% Similarity=0.430 Sum_probs=208.4
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
.|+.++.||+|+||.||+|+...+++.||||.+.... ....+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 102 (303)
T 3a7i_A 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 102 (303)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeC
Confidence 5888999999999999999998899999999996543 445688999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 495 (660)
++++|.+++.. ..+++.++..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++....... ..
T Consensus 103 ~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 175 (303)
T 3a7i_A 103 GGGSALDLLEP---GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IK 175 (303)
T ss_dssp TTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-CC
T ss_pred CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCccc-cc
Confidence 99999999864 348999999999999999999998 899999999999999999999999999998765432 22
Q ss_pred eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHH
Q 006112 496 TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQ 575 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 575 (660)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ......+. .+.+...++
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~-----~~~~~~~~~--- 244 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV---LFLIPKNN-----PPTLEGNYS--- 244 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHHHHSC-----CCCCCSSCC---
T ss_pred cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH---HHHhhcCC-----CCCCccccC---
Confidence 3346789999999999998999999999999999999999999976433221 11112221 122222332
Q ss_pred HHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 576 MEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 576 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
..+.+++..||+.||++|||+.|++++
T Consensus 245 -~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 245 -KPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp -HHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred -HHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 347788889999999999999999974
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=356.10 Aligned_cols=254 Identities=21% Similarity=0.265 Sum_probs=204.8
Q ss_pred eeeecccccccCccEEEEEEEeC---CCCeEEEEEEeccCC----ChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCe
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLP---SSHAEIAVKKVCHDS----DHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGE 407 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~---~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 407 (660)
..|+.++.||+|+||.||+++.. .+++.||||++.... ....+.+.+|+++++++ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 47899999999999999999984 478999999986432 23456788899999999 69999999999999999
Q ss_pred eEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeeccccee
Q 006112 408 LLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARL 487 (660)
Q Consensus 408 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 487 (660)
.++|||||++|+|.+++.... .+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred EEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 999999999999999997654 48999999999999999999998 8999999999999999999999999999987
Q ss_pred ccCCCCceeeccccCccccCcccccC--CCCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHHHHHHhcCCcccCCC
Q 006112 488 YDHGNDLHTTNVVGTVGYLAPELLRN--GRGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVIDYWQKGDVLDASD 564 (660)
Q Consensus 488 ~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~~~~~~~~~~~d 564 (660)
+............||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .....+........
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~------ 282 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE------ 282 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC------
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC------
Confidence 65443334445689999999999985 3478899999999999999999999975322 12222222221111
Q ss_pred CcccccCcHHHHHHHHHHhhhccCCCCCCCC-----CHHHHHHHh
Q 006112 565 PRLEGIYVEEQMEIVLKLGLFCSHSNPDTRP-----SMRQVVQYL 604 (660)
Q Consensus 565 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L 604 (660)
+.+... ....+.+++..||+.||++|| +++|++++.
T Consensus 283 ~~~~~~----~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 283 PPYPQE----MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp CCCCTT----SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred CCCCcc----cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 111122 234567888899999999999 999999754
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=339.72 Aligned_cols=255 Identities=24% Similarity=0.292 Sum_probs=205.6
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC----ChhhHHHHHHHHHHhccCCCCceeEeeee--eecCeeEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS----DHGMKQFVSEIVSMGKLRHRNLVQLRGYC--RRKGELLL 410 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~--~~~~~~~l 410 (660)
.|+..+.||+|+||.||++.+..+++.||+|.+.... ....+.+.+|++++++++||||+++++++ .+.+..++
T Consensus 6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (305)
T 2wtk_C 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM 85 (305)
T ss_dssp CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEE
T ss_pred ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEE
Confidence 6888999999999999999999999999999986432 34567899999999999999999999998 44567899
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccC
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDH 490 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 490 (660)
||||++++ |.+++.......+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 86 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 86 VMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 99999766 7787776655679999999999999999999998 8999999999999999999999999999987654
Q ss_pred CC-CceeeccccCccccCcccccCCCC--CcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcc
Q 006112 491 GN-DLHTTNVVGTVGYLAPELLRNGRG--TTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL 567 (660)
Q Consensus 491 ~~-~~~~~~~~gt~~Y~aPE~~~~~~~--t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 567 (660)
.. ........||+.|+|||++.+... +.++||||||+++|||++|+.||...... ...+....+.. .+
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~i~~~~~------~~ 232 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY---KLFENIGKGSY------AI 232 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHCCC------CC
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH---HHHHHHhcCCC------CC
Confidence 32 223345679999999999876443 77999999999999999999999864432 22222223221 11
Q ss_pred cccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH--HhhCCC
Q 006112 568 EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ--YLDGGA 608 (660)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~ 608 (660)
...+ ...+.+++.+||+.||++|||++|+++ +++...
T Consensus 233 ~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 233 PGDC----GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp CSSS----CHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred CCcc----CHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence 2222 235678888999999999999999997 566543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=342.56 Aligned_cols=255 Identities=18% Similarity=0.215 Sum_probs=203.6
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeee-eecCeeEEEEecC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYC-RRKGELLLVYDYM 415 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~-~~~~~~~lV~E~~ 415 (660)
.|+..+.||+|+||.||+|++..+++.||||++.... ..+++.+|++++++++|++++..+++| ...+..++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 4hgt_A 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp -CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred ceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc
Confidence 6888999999999999999998899999999875433 235688999999999998888777766 5667789999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEE---cCCCCeEEeecccceeccCCC
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLL---DADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll---~~~~~~kl~DFGla~~~~~~~ 492 (660)
+++|.+++.... ..+++.++..++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++......
T Consensus 88 -~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 88 -GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp -CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred -CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 999999997543 358999999999999999999998 899999999999999 788999999999998765543
Q ss_pred Cc------eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCc----chHHHHHHHHhcCCcccC
Q 006112 493 DL------HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGEL----DLLDWVIDYWQKGDVLDA 562 (660)
Q Consensus 493 ~~------~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~----~~~~~~~~~~~~~~~~~~ 562 (660)
.. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .....+........
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---- 238 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP---- 238 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC----
T ss_pred cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch----
Confidence 21 22356799999999999999999999999999999999999999975221 12222211111100
Q ss_pred CCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 563 SDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 563 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
.+.+... ....+.+++..||+.||++||+++++++.|+..
T Consensus 239 -~~~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 239 -IEVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp -HHHHTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred -hhhhhcc----CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 0000011 134578888999999999999999999998764
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=338.63 Aligned_cols=251 Identities=24% Similarity=0.344 Sum_probs=202.7
Q ss_pred CceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeee----cCe
Q 006112 334 HRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR----KGE 407 (660)
Q Consensus 334 ~~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~----~~~ 407 (660)
....|+..+.||+|+||.||+|.+..++..||+|.+... .....+.+.+|+.++++++||||+++++++.. ...
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 344578888999999999999999999999999998654 34456789999999999999999999998865 355
Q ss_pred eEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCc--eeccCccCCcEEEc-CCCCeEEeeccc
Q 006112 408 LLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQV--VLHRDIKPANVLLD-ADLEGKLGDFGL 484 (660)
Q Consensus 408 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDikp~NIll~-~~~~~kl~DFGl 484 (660)
+++||||+++++|.+++.... .+++..+..++.||+.||.|||+ .+ |+||||||+|||++ .++.+||+|||+
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEEEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 899999999999999997643 48899999999999999999998 77 99999999999997 789999999999
Q ss_pred ceeccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCC
Q 006112 485 ARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASD 564 (660)
Q Consensus 485 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d 564 (660)
+...... ......||+.|+|||.+. +.++.++||||||+++|||++|+.||...... .........+...
T Consensus 179 ~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~---- 248 (290)
T 1t4h_A 179 ATLKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYRRVTSGVKP---- 248 (290)
T ss_dssp GGGCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHHHHTTTCCC----
T ss_pred ccccccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH--HHHHHHHhccCCc----
Confidence 9754332 233467999999999886 46899999999999999999999999753321 1222222222111
Q ss_pred CcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 565 PRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 565 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
..+.... ...+.+++..||+.||++|||++|++++
T Consensus 249 ~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 249 ASFDKVA----IPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GGGGGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccCCCC----CHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1111112 2357788889999999999999999963
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=337.79 Aligned_cols=250 Identities=23% Similarity=0.317 Sum_probs=208.1
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
-.|+..+.||+|+||.||+|+...+++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888999999999999999999899999999985432 233567899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
||+++|+|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~- 167 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL- 167 (284)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred EeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence 9999999999997654 48899999999999999999998 89999999999999999999999999999765432
Q ss_pred CceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCc
Q 006112 493 DLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 493 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||........ ........ ..+...+
T Consensus 168 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~------~~~~~~~- 235 (284)
T 2vgo_A 168 --RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET---HRRIVNVD------LKFPPFL- 235 (284)
T ss_dssp --CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHTTC------CCCCTTS-
T ss_pred --ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH---HHHHhccc------cCCCCcC-
Confidence 22345789999999999998899999999999999999999999976443211 11112211 1112222
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCCHHHHHH--HhhC
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ--YLDG 606 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~ 606 (660)
...+.+++..|++.||.+||+++|+++ +++.
T Consensus 236 ---~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~ 268 (284)
T 2vgo_A 236 ---SDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 268 (284)
T ss_dssp ---CHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHH
T ss_pred ---CHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHh
Confidence 234678888999999999999999996 4543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=342.53 Aligned_cols=244 Identities=21% Similarity=0.330 Sum_probs=200.7
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
.|+.++.+|+|+||.||+|++..+++.||||++... ......++.+|+..+.++ +||||+++++++.+++..++|||
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e 91 (289)
T 1x8b_A 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNE 91 (289)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEE
Confidence 688899999999999999999989999999998754 344567889999999999 99999999999999999999999
Q ss_pred cCCCCChhhhhhhCC--CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcC------------------
Q 006112 414 YMPNGSLDKILYSNT--RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDA------------------ 473 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~------------------ 473 (660)
|+++++|.+++.... ...+++.++..++.||+.||+|||+ ++|+||||||+|||++.
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 168 (289)
T 1x8b_A 92 YCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168 (289)
T ss_dssp CCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC-------------------
T ss_pred ecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence 999999999997542 2458999999999999999999998 89999999999999984
Q ss_pred -CCCeEEeecccceeccCCCCceeeccccCccccCcccccCC-CCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHH
Q 006112 474 -DLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVI 551 (660)
Q Consensus 474 -~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~ 551 (660)
...+||+|||++....... ...||+.|+|||.+.+. .++.++|||||||++|||++|..++.... . +
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~----~ 237 (289)
T 1x8b_A 169 NKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD--Q----W 237 (289)
T ss_dssp -CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH--H----H
T ss_pred CceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh--H----H
Confidence 4479999999998765432 23589999999999765 56789999999999999999987765322 1 1
Q ss_pred HHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 552 DYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 552 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.....+.. +.+...++ ..+.+++..||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~-----~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 238 HEIRQGRL-----PRIPQVLS----QEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HHHHTTCC-----CCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHHHcCCC-----CCCCcccC----HHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 12222222 22222222 346788888999999999999999864
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=340.96 Aligned_cols=255 Identities=18% Similarity=0.215 Sum_probs=205.4
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeee-eecCeeEEEEecC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYC-RRKGELLLVYDYM 415 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~-~~~~~~~lV~E~~ 415 (660)
.|+..+.||+|+||.||+|++..+++.||||++.... ..+++.+|+.++++++|++++..+.++ ...+..++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 3uzp_A 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence 5888999999999999999998899999999986543 235789999999999998877777766 5567789999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEE---cCCCCeEEeecccceeccCCC
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLL---DADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll---~~~~~~kl~DFGla~~~~~~~ 492 (660)
+++|.+++.... ..+++.++..++.||+.||+|||+ ++|+||||||+|||+ +.++.+||+|||+++......
T Consensus 88 -~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 88 -GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp -CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred -CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 999999997543 358999999999999999999998 899999999999999 488899999999998766543
Q ss_pred Cc------eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCc----chHHHHHHHHhcCCcccC
Q 006112 493 DL------HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGEL----DLLDWVIDYWQKGDVLDA 562 (660)
Q Consensus 493 ~~------~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~----~~~~~~~~~~~~~~~~~~ 562 (660)
.. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .....+........
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---- 238 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP---- 238 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC----
T ss_pred cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc----
Confidence 21 12456799999999999999999999999999999999999999975221 22222222111100
Q ss_pred CCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 563 SDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 563 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
.+.+... ....+.+++..||+.||++||+++++++.|+..
T Consensus 239 -~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 239 -IEVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp -HHHHTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred -hHHHHhh----CCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 0001111 224577888999999999999999999999864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=379.75 Aligned_cols=247 Identities=24% Similarity=0.362 Sum_probs=199.6
Q ss_pred cccccCccEEEEEEEe--CCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCCC
Q 006112 342 YKATKGGSGKVYRGVL--PSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPN 417 (660)
Q Consensus 342 ~~lg~G~fg~Vy~g~~--~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 417 (660)
+.||+|+||.||+|.+ ...++.||||++.... ....+++.+|++++++++|||||+++++|.. +..++|||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999965 4566899999997543 3346789999999999999999999999964 568999999999
Q ss_pred CChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC--ce
Q 006112 418 GSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND--LH 495 (660)
Q Consensus 418 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~--~~ 495 (660)
|+|.+++.... .+++.++..|+.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++.+..... ..
T Consensus 454 g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 454 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 99999997654 48999999999999999999998 8999999999999999999999999999987654332 22
Q ss_pred eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHH
Q 006112 496 TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEE 574 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 574 (660)
.....+|+.|+|||++....++.++|||||||++|||++ |+.||....... +......+.... ... .
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~~~i~~~~~~~-----~p~----~ 596 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAMLEKGERMG-----CPA----G 596 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHTTCCCC-----CCT----T
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCCCCC-----CCC----C
Confidence 234467889999999999999999999999999999998 999998654332 233333333221 111 2
Q ss_pred HHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 575 QMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 575 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
....+.+++..||+.||++||++.+|++.|+.
T Consensus 597 ~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 597 CPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 23557788899999999999999999999974
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=348.59 Aligned_cols=255 Identities=26% Similarity=0.360 Sum_probs=204.9
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEE--EEEEeccC-CChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCeeEEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEI--AVKKVCHD-SDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~v--avK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 411 (660)
-.|+..+.||+|+||.||+|++..++..+ |+|++... .....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 36888899999999999999998888755 99988653 344567899999999999 899999999999999999999
Q ss_pred EecCCCCChhhhhhhCC--------------CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCe
Q 006112 412 YDYMPNGSLDKILYSNT--------------RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEG 477 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~ 477 (660)
|||+++|+|.+++.... ...+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeE
Confidence 99999999999997643 2468999999999999999999998 999999999999999999999
Q ss_pred EEeecccceeccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhc
Q 006112 478 KLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQK 556 (660)
Q Consensus 478 kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~ 556 (660)
||+|||+++..... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||...... ........
T Consensus 182 kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~~~~~~ 256 (327)
T 1fvr_A 182 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEKLPQ 256 (327)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHGGG
T ss_pred EEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH---HHHHHhhc
Confidence 99999999743221 11233467889999999988889999999999999999998 99999764432 12222222
Q ss_pred CCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 557 GDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 557 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
+.. +..... ....+.+++..||+.||++||+++|+++.|+..
T Consensus 257 ~~~-----~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 257 GYR-----LEKPLN----CDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp TCC-----CCCCTT----BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC-----CCCCCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 211 111112 234577888899999999999999999988753
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=367.49 Aligned_cols=256 Identities=23% Similarity=0.301 Sum_probs=209.4
Q ss_pred CCceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeE
Q 006112 333 PHRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELL 409 (660)
Q Consensus 333 ~~~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 409 (660)
...-.|+.++.||+|+||.||++++..+++.||+|++.... ....+.+.+|++++++++||||+++++++...+.++
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 34457888999999999999999999999999999996432 234567899999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhhhCC--CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeeccccee
Q 006112 410 LVYDYMPNGSLDKILYSNT--RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARL 487 (660)
Q Consensus 410 lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 487 (660)
+|||||++|+|..++.... ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeee
Confidence 9999999999999997643 3469999999999999999999998 8999999999999999999999999999987
Q ss_pred ccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHHHHHHhcCCcccCCCCc
Q 006112 488 YDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVIDYWQKGDVLDASDPR 566 (660)
Q Consensus 488 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~~~~~~~~~~~d~~ 566 (660)
...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .....+.+....+.. .
T Consensus 339 ~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~------~ 411 (543)
T 3c4z_A 339 LKAGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV------T 411 (543)
T ss_dssp CCTTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC------C
T ss_pred ccCCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc------C
Confidence 654332 23345899999999999999999999999999999999999999976432 112222222222211 1
Q ss_pred ccccCcHHHHHHHHHHhhhccCCCCCCCCCH-----HHHHH
Q 006112 567 LEGIYVEEQMEIVLKLGLFCSHSNPDTRPSM-----RQVVQ 602 (660)
Q Consensus 567 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~ 602 (660)
+...+ ...+.+++..||+.||++||++ ++|++
T Consensus 412 ~p~~~----s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 412 YPDKF----SPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp CCTTS----CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred CCccc----CHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 11222 2346678888999999999965 67764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=349.34 Aligned_cols=258 Identities=25% Similarity=0.393 Sum_probs=205.1
Q ss_pred ceeeecccccccCccEEEEEEEe-----CCCCeEEEEEEeccC-CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCee
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVL-----PSSHAEIAVKKVCHD-SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGEL 408 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~-----~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 408 (660)
.-.|+.++.||+|+||.||+|++ ..++..||||++... ......++.+|+.++++++||||+++++++...+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 34788999999999999999994 456789999999654 334567899999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhhhCCC-----CCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcC---CCCeEEe
Q 006112 409 LLVYDYMPNGSLDKILYSNTR-----PSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDA---DLEGKLG 480 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~---~~~~kl~ 480 (660)
++||||+++|+|.+++..... ..+++.+++.++.||+.||.|||+ .+|+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999986532 348899999999999999999998 89999999999999984 4569999
Q ss_pred ecccceeccCCCC-ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCC
Q 006112 481 DFGLARLYDHGND-LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGD 558 (660)
Q Consensus 481 DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 558 (660)
|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++ |+.||...... ........+.
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~~~~~~ 262 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLEFVTSGG 262 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHHHTTC
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---HHHHHHhcCC
Confidence 9999976543322 22334578999999999998999999999999999999998 99999764432 1222223322
Q ss_pred cccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 559 VLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 559 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
... .... ....+.+++..||+.||.+||++.+++++|+..
T Consensus 263 ~~~-----~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 263 RMD-----PPKN----CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp CCC-----CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC-----CCCC----CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 111 1112 234577888999999999999999999998864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=359.57 Aligned_cols=199 Identities=20% Similarity=0.291 Sum_probs=176.5
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhcc------CCCCceeEeeeeeecCeeE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKL------RHRNLVQLRGYCRRKGELL 409 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l------~H~nIv~l~g~~~~~~~~~ 409 (660)
..|+.++.||+|+||.||+|++..+++.||||++... ....+++.+|+.+++.+ .|+||+++++++...+.++
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 3588999999999999999999999999999999643 33456788888888877 5779999999999999999
Q ss_pred EEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCC--eEEeeccccee
Q 006112 410 LVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLE--GKLGDFGLARL 487 (660)
Q Consensus 410 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~--~kl~DFGla~~ 487 (660)
+||||+. ++|.+++.......+++..+..++.||+.||+|||+ ++|+||||||+|||++.++. +||+|||+++.
T Consensus 176 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251 (429)
T ss_dssp EEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence 9999995 799999987766679999999999999999999998 89999999999999999887 99999999976
Q ss_pred ccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCC
Q 006112 488 YDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGE 543 (660)
Q Consensus 488 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~ 543 (660)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 252 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 252 EHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp TTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 4332 234678999999999999999999999999999999999999997643
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=340.76 Aligned_cols=249 Identities=31% Similarity=0.377 Sum_probs=197.9
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeec-CeeEEEEe
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK-GELLLVYD 413 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-~~~~lV~E 413 (660)
.-.|+.++.||+|+||.||++++ .++.||||.+... ...+.+.+|++++++++||||+++++++.+. +..++|||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 44789999999999999999998 4789999998643 3457899999999999999999999987654 57899999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
|+++++|.+++.......+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence 9999999999976543347889999999999999999998 89999999999999999999999999999764432
Q ss_pred ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCc
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||........ ......+.. +.....
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~~~~~~~~-----~~~~~~-- 238 (278)
T 1byg_A 171 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRVEKGYK-----MDAPDG-- 238 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HHHHTTTCC-----CCCCTT--
T ss_pred --ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHhcCCC-----CCCccc--
Confidence 123467889999999998899999999999999999998 9999976443322 122222211 111122
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
....+.+++..||+.||++||++.|+++.|+.
T Consensus 239 --~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 270 (278)
T 1byg_A 239 --CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 270 (278)
T ss_dssp --CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCHHHHHHHHHHhcCChhhCCCHHHHHHHHHH
Confidence 23457788889999999999999999999875
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=360.15 Aligned_cols=249 Identities=22% Similarity=0.318 Sum_probs=192.1
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--------ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCee
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--------DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGEL 408 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 408 (660)
.|+..+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.++++++||||+++++++. .+..
T Consensus 136 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~ 214 (419)
T 3i6u_A 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDY 214 (419)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEE
T ss_pred cEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCce
Confidence 5888999999999999999999999999999986431 122346899999999999999999999975 4568
Q ss_pred EEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCC---CeEEeecccc
Q 006112 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADL---EGKLGDFGLA 485 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~---~~kl~DFGla 485 (660)
++|||||++|+|.+++.... .+++.++..++.|++.||+|||+ ++|+||||||+|||++.++ .+||+|||++
T Consensus 215 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 215 YIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp EEEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred EEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 99999999999999987543 58999999999999999999998 8999999999999997544 5999999999
Q ss_pred eeccCCCCceeeccccCccccCccccc---CCCCCcceeEEehHHHHHHHhhCCCCCCCCCc--chHHHHHHHHhcCCcc
Q 006112 486 RLYDHGNDLHTTNVVGTVGYLAPELLR---NGRGTTSTDVYAFGVFMLEVACGRRPVQPGEL--DLLDWVIDYWQKGDVL 560 (660)
Q Consensus 486 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~--~~~~~~~~~~~~~~~~ 560 (660)
+..... .......||+.|+|||++. ...++.++|||||||++|||++|+.||..... .+.+. ...+...
T Consensus 290 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~----i~~~~~~ 363 (419)
T 3i6u_A 290 KILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ----ITSGKYN 363 (419)
T ss_dssp TSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHH----HHTTCCC
T ss_pred eecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHH----HhcCCCC
Confidence 876432 2234567999999999985 36778899999999999999999999975332 22221 1222110
Q ss_pred cCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 561 DASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 561 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
..+.. .......+.+++..||+.||++||+++|++++
T Consensus 364 --~~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 364 --FIPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp --CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --CCchh----hcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000 01123457888999999999999999999974
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=361.92 Aligned_cols=242 Identities=15% Similarity=0.089 Sum_probs=191.1
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHH---HHHhccCCCCceeEe-------ee
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEI---VSMGKLRHRNLVQLR-------GY 401 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei---~~l~~l~H~nIv~l~-------g~ 401 (660)
.-.|+..+.||+|+||.||+|++..+++.||||++... .....+.+.+|+ +++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 45789999999999999999999888999999999743 344567899999 556666899999998 55
Q ss_pred eeecC-----------------eeEEEEecCCCCChhhhhhhCC-----CCCcchhHHHHHHHHHHHHHHHhhhcccCce
Q 006112 402 CRRKG-----------------ELLLVYDYMPNGSLDKILYSNT-----RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVV 459 (660)
Q Consensus 402 ~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 459 (660)
+..++ ..++||||+ +|+|.+++.... ...+++..++.|+.||+.||+|||+ ++|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 55443 278999999 789999997532 1235578899999999999999998 899
Q ss_pred eccCccCCcEEEcCCCCeEEeecccceeccCCCCceeeccccCccccCcccccCC-----------CCCcceeEEehHHH
Q 006112 460 LHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNG-----------RGTTSTDVYAFGVF 528 (660)
Q Consensus 460 vHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----------~~t~ksDV~S~Gvv 528 (660)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999986322 3345677 999999999877 89999999999999
Q ss_pred HHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 529 MLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 529 l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
+|||++|+.||....... ......... ..+ ...+.+++..||+.||++||++.|+++
T Consensus 303 l~elltg~~Pf~~~~~~~------------~~~~~~~~~-~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 303 IYWIWCADLPITKDAALG------------GSEWIFRSC-KNI----PQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHSSCCC------C------------CSGGGGSSC-CCC----CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHCCCCCccccccc------------chhhhhhhc-cCC----CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999996532110 000000000 112 245778888999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=348.07 Aligned_cols=262 Identities=27% Similarity=0.352 Sum_probs=204.0
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeee--------
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR-------- 404 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-------- 404 (660)
.-.|+.++.||+|+||.||+|++..+++.||||++.... ......+.+|++++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 347999999999999999999999999999999986543 2335678899999999999999999999877
Q ss_pred cCeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeeccc
Q 006112 405 KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGL 484 (660)
Q Consensus 405 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGl 484 (660)
.+..++||||++ |+|.+.+.... ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 96 KGSIYLVFDFCE-HDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp -CEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccC-CCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 456899999996 57777776543 358999999999999999999998 8999999999999999999999999999
Q ss_pred ceeccCCCC---ceeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCcch-HHHHHHHHhcCCc
Q 006112 485 ARLYDHGND---LHTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDL-LDWVIDYWQKGDV 559 (660)
Q Consensus 485 a~~~~~~~~---~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~-~~~~~~~~~~~~~ 559 (660)
++.+..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ...+.... +..
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~ 248 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC--GSI 248 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH--CCC
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh--CCC
Confidence 987653321 22345678999999999876 457999999999999999999999998754322 22222221 111
Q ss_pred ccCCCCccc--------------ccCcHHH------HHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 560 LDASDPRLE--------------GIYVEEQ------MEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 560 ~~~~d~~l~--------------~~~~~~~------~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.....+... .....+. ...+.+++..||+.||++|||++|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 111111100 0000111 2347789999999999999999999973
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=343.00 Aligned_cols=259 Identities=25% Similarity=0.371 Sum_probs=198.4
Q ss_pred CceeeecccccccCccEEEEEEEeCC---CCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeecC--
Q 006112 334 HRFSYKNLYKATKGGSGKVYRGVLPS---SHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKG-- 406 (660)
Q Consensus 334 ~~~~~~~l~~lg~G~fg~Vy~g~~~~---~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~-- 406 (660)
..-.|+..+.||+|+||.||+|.+.. ++..||+|++... .....+.+.+|+.++++++||||+++++++.+.+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 34578899999999999999998754 4568999998654 3345678999999999999999999999997655
Q ss_pred ---eeEEEEecCCCCChhhhhhhC----CCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEE
Q 006112 407 ---ELLLVYDYMPNGSLDKILYSN----TRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKL 479 (660)
Q Consensus 407 ---~~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl 479 (660)
..++||||+++|+|.+++... ....+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEE
Confidence 359999999999999998532 23469999999999999999999998 89999999999999999999999
Q ss_pred eecccceeccCCCC-ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcC
Q 006112 480 GDFGLARLYDHGND-LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKG 557 (660)
Q Consensus 480 ~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 557 (660)
+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......... .....+
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~~~~~~ 265 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY---DYLLHG 265 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH---HHHHTT
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH---HHHHcC
Confidence 99999987644322 22234567889999999999999999999999999999999 88898764433221 111222
Q ss_pred CcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 558 DVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 558 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
.. +.... .....+.+++..||+.||.+||++.++++.|+..
T Consensus 266 ~~-----~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 266 HR-----LKQPE----DCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp CC-----CCCBT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC-----CCCCc----cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11 11111 2234577888999999999999999999999863
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=346.38 Aligned_cols=259 Identities=25% Similarity=0.379 Sum_probs=186.4
Q ss_pred CceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEE
Q 006112 334 HRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 334 ~~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
..-.|+..+.||+|+||.||+|....+++.||||++.... ....+++.+|+.++++++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 3447889999999999999999998889999999986443 344678899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhh------CCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccce
Q 006112 413 DYMPNGSLDKILYS------NTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLAR 486 (660)
Q Consensus 413 E~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 486 (660)
||+++++|.+++.. .....+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 99999999999864 123458999999999999999999998 899999999999999999999999999997
Q ss_pred eccCCCC----ceeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCccc
Q 006112 487 LYDHGND----LHTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLD 561 (660)
Q Consensus 487 ~~~~~~~----~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 561 (660)
....... .......||+.|+|||.+.. ..++.++||||||+++|||++|+.||......... ...... ....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~-~~~~ 246 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL--MLTLQN-DPPS 246 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH--HHHHTS-SCCC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH--HHHhcc-CCCc
Confidence 6543321 12234579999999999875 56899999999999999999999999864432211 111111 1111
Q ss_pred ----CCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 562 ----ASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 562 ----~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
..++.....+ ...+.+++..||+.||.+||++.|+++
T Consensus 247 ~~~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 247 LETGVQDKEMLKKY----GKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TTC-----CCCCCC----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cccccccchhhhhh----hHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 1111111222 245778888999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=348.90 Aligned_cols=262 Identities=27% Similarity=0.290 Sum_probs=201.1
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC-----hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD-----HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLL 410 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~-----~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 410 (660)
-.|+.++.||+|+||.||+|++..+++.||||++..... ...+.+.+|++++++++||||+++++++...+..++
T Consensus 10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (346)
T 1ua2_A 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL 89 (346)
T ss_dssp ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence 468899999999999999999998899999999864322 123578899999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccC
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDH 490 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 490 (660)
||||+++ +|..++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 90 v~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 90 VFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp EEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred EEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 9999975 8988886543 458999999999999999999998 8999999999999999999999999999987643
Q ss_pred CCCceeeccccCccccCcccccCC-CCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHHHHHHhcCCcccCC-----
Q 006112 491 GNDLHTTNVVGTVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVIDYWQKGDVLDAS----- 563 (660)
Q Consensus 491 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~~~~~~~~~~~----- 563 (660)
.. .......||+.|+|||.+.+. .++.++|||||||++|||++|..||..... .....+.+...........
T Consensus 165 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 243 (346)
T 1ua2_A 165 PN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 243 (346)
T ss_dssp CC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred Cc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccC
Confidence 32 223446789999999998754 578999999999999999999999876432 2222222221111100000
Q ss_pred -CC----ccccc----CcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 564 -DP----RLEGI----YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 564 -d~----~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
+. ..... ........+.+++..||+.||++|||++|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 244 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00 00000 001223568889999999999999999999974
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=364.26 Aligned_cols=249 Identities=26% Similarity=0.372 Sum_probs=200.9
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
.|+.++.||+|+||.||+|+...++..||+|++.... ....+.+.+|+.++++++||||++++++|.+.+..++||||
T Consensus 38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 117 (494)
T 3lij_A 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMEC 117 (494)
T ss_dssp HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 6889999999999999999999999999999986543 33467899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCC---CCeEEeecccceeccCC
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDAD---LEGKLGDFGLARLYDHG 491 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~---~~~kl~DFGla~~~~~~ 491 (660)
|++|+|.+++.... .+++.++..++.||+.||.|||+ ++|+||||||+|||++.. +.+||+|||+++.....
T Consensus 118 ~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 118 YKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp CCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 99999999887653 48999999999999999999998 899999999999999764 45999999999876543
Q ss_pred CCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccC
Q 006112 492 NDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIY 571 (660)
Q Consensus 492 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 571 (660)
. ......||+.|+|||++. +.++.++||||+||++|||++|+.||....... +......+... ...+. ..
T Consensus 193 ~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~~~~-~~~~~-~~-- 262 (494)
T 3lij_A 193 K--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE---ILRKVEKGKYT-FDSPE-WK-- 262 (494)
T ss_dssp B--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHTCCC-CCSGG-GT--
T ss_pred c--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhCCCC-CCchh-cc--
Confidence 2 234467999999999986 568999999999999999999999998654322 22222232211 11111 11
Q ss_pred cHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 572 VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
.....+.+++..||+.||.+|||+.|+++
T Consensus 263 --~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 263 --NVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp --TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --cCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 12234678888899999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=349.18 Aligned_cols=249 Identities=14% Similarity=0.067 Sum_probs=199.3
Q ss_pred ceeeecccccccCccEEEEEEE-----eCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccC---CCCceeEeeeeeecC
Q 006112 335 RFSYKNLYKATKGGSGKVYRGV-----LPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLR---HRNLVQLRGYCRRKG 406 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~-----~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---H~nIv~l~g~~~~~~ 406 (660)
...|+..+.||+|+||.||+|+ ...+++.||||++... ...++..|++++.+++ |+||+++++++..++
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 3468889999999999999994 5567889999999654 3456777888877776 999999999999999
Q ss_pred eeEEEEecCCCCChhhhhhhC---CCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcC----------
Q 006112 407 ELLLVYDYMPNGSLDKILYSN---TRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDA---------- 473 (660)
Q Consensus 407 ~~~lV~E~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~---------- 473 (660)
..++|||||++|+|.+++... ....++|.++..++.||+.||+|||+ ++|+||||||+|||++.
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC-----
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCcccccc
Confidence 999999999999999999742 23469999999999999999999998 89999999999999998
Q ss_pred -CCCeEEeecccceeccCC-CCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHH
Q 006112 474 -DLEGKLGDFGLARLYDHG-NDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVI 551 (660)
Q Consensus 474 -~~~~kl~DFGla~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~ 551 (660)
++.+||+|||+++.+... .........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----- 292 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE----- 292 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-----
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-----
Confidence 899999999999875432 2334456789999999999999999999999999999999999999986422110
Q ss_pred HHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCC-CCHHHHHHHhhC
Q 006112 552 DYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTR-PSMRQVVQYLDG 606 (660)
Q Consensus 552 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Ps~~evl~~L~~ 606 (660)
......+...... +.+.+++..|++.+|.+| |+++++.+.|+.
T Consensus 293 ---------~~~~~~~~~~~~~---~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~ 336 (365)
T 3e7e_A 293 ---------CKPEGLFRRLPHL---DMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK 336 (365)
T ss_dssp ---------EEECSCCTTCSSH---HHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred ---------eeechhccccCcH---HHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence 0011111111222 334566667999999999 678888877764
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=351.56 Aligned_cols=258 Identities=24% Similarity=0.345 Sum_probs=198.5
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeecC------ee
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKG------EL 408 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------~~ 408 (660)
.|+.++.||+|+||.||+|.+..+++.||||++... .....+++.+|++++++++||||+++++++...+ .+
T Consensus 26 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 105 (367)
T 1cm8_A 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 105 (367)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred eEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceE
Confidence 689999999999999999999999999999998543 2334578899999999999999999999987653 46
Q ss_pred EEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceec
Q 006112 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLY 488 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 488 (660)
++||||+ +++|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 106 ~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 106 YLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp EEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 9999999 89999999763 48899999999999999999998 89999999999999999999999999999875
Q ss_pred cCCCCceeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHHHHHHhcCC--------
Q 006112 489 DHGNDLHTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVIDYWQKGD-------- 558 (660)
Q Consensus 489 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~~~~~~-------- 558 (660)
... .+...||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... .....+........
T Consensus 179 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 254 (367)
T 1cm8_A 179 DSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254 (367)
T ss_dssp CSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred ccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 432 334678999999999877 6789999999999999999999999986432 22222221111000
Q ss_pred ----------cccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH--HhhC
Q 006112 559 ----------VLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ--YLDG 606 (660)
Q Consensus 559 ----------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~ 606 (660)
........+. .........+.+++.+|++.||++|||++|+++ +++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~ 313 (367)
T 1cm8_A 255 SDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313 (367)
T ss_dssp CHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred hHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHh
Confidence 0000000011 111122345778888999999999999999998 4544
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=354.77 Aligned_cols=257 Identities=12% Similarity=0.072 Sum_probs=185.4
Q ss_pred CCceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC---hhhHHHHHHHHHHhcc--CCCCceeEe-------e
Q 006112 333 PHRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD---HGMKQFVSEIVSMGKL--RHRNLVQLR-------G 400 (660)
Q Consensus 333 ~~~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l--~H~nIv~l~-------g 400 (660)
....+|+.++.||+|+||.||+|++..+++.||||++..... ...+.+.+|+.+++.+ +||||++++ +
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d 138 (371)
T 3q60_A 59 QGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSD 138 (371)
T ss_dssp CCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCE
T ss_pred CCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeeh
Confidence 345569999999999999999999998999999999976543 3355677885444444 699988755 3
Q ss_pred eeeec-----------------CeeEEEEecCCCCChhhhhhhCCCCCcchhHH------HHHHHHHHHHHHHhhhcccC
Q 006112 401 YCRRK-----------------GELLLVYDYMPNGSLDKILYSNTRPSLNWFQR------FRIIKGVAFGLLYLHEEWEQ 457 (660)
Q Consensus 401 ~~~~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~ 457 (660)
++... ..+++|||||+ |+|.+++..... .+.+..+ ..++.||+.||+|||+ +
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~ 213 (371)
T 3q60_A 139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQS---K 213 (371)
T ss_dssp EEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHH---T
T ss_pred heecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHH---C
Confidence 43332 33899999998 999999976432 3466666 7888999999999998 8
Q ss_pred ceeccCccCCcEEEcCCCCeEEeecccceeccCCCCceeeccccCccccCcccccC--CCCCcceeEEehHHHHHHHhhC
Q 006112 458 VVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRN--GRGTTSTDVYAFGVFMLEVACG 535 (660)
Q Consensus 458 ~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~t~ksDV~S~Gvvl~elltG 535 (660)
+|+||||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 999999999999999999999999999986532 2224567899999999987 6789999999999999999999
Q ss_pred CCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 536 RRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 536 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
+.||......... .+............+...........+.+++..||+.||++|||+.|+++
T Consensus 290 ~~Pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 290 FLPFGLVTPGIKG----SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SCSTTBCCTTCTT----CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCcCccccc----chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9999764321110 00000000001111111111123456778888999999999999999985
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=344.09 Aligned_cols=253 Identities=22% Similarity=0.319 Sum_probs=201.2
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
-.|+.++.||+|+||.||+|++..+++.||+|.+........+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC 98 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECC
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeC
Confidence 46899999999999999999999889999999997776667789999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 495 (660)
++++|.+++.... ..+++.++..++.||+.||.|||+ .+++||||||+||+++.++.+||+|||++....... ..
T Consensus 99 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 173 (302)
T 2j7t_A 99 PGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-QK 173 (302)
T ss_dssp TTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-HC
T ss_pred CCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-cc
Confidence 9999999987543 348999999999999999999998 899999999999999999999999999985432111 11
Q ss_pred eeccccCccccCcccc-----cCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCccccc
Q 006112 496 TTNVVGTVGYLAPELL-----RNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGI 570 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~-----~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 570 (660)
.....||+.|+|||++ ....++.++||||||+++|||++|+.||...... +....... +...... ...
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~-~~~~~~~---~~~- 246 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVLLKIAK-SDPPTLL---TPS- 246 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHH-SCCCCCS---SGG-
T ss_pred cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH--HHHHHHhc-cCCcccC---Ccc-
Confidence 2235789999999998 3667899999999999999999999999764332 22222222 1111100 111
Q ss_pred CcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 571 YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.....+.+++..||+.||++|||+.|++++
T Consensus 247 ---~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 247 ---KWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp ---GSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred ---ccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 223457788889999999999999999863
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=352.74 Aligned_cols=258 Identities=22% Similarity=0.260 Sum_probs=204.8
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccC--------CCCceeEeeeee----e
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLR--------HRNLVQLRGYCR----R 404 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~--------H~nIv~l~g~~~----~ 404 (660)
.|+.++.||+|+||.||+|+...+++.||||++... ....+.+.+|+.++++++ |+||+++++++. .
T Consensus 38 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~ 116 (397)
T 1wak_A 38 RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVN 116 (397)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETT
T ss_pred eEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCC
Confidence 589999999999999999999999999999999643 345678899999999986 788999999987 4
Q ss_pred cCeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccC-ceeccCccCCcEEEcCCC--------
Q 006112 405 KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQ-VVLHRDIKPANVLLDADL-------- 475 (660)
Q Consensus 405 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDikp~NIll~~~~-------- 475 (660)
....++||||+ +++|.+++.......+++.++..++.||+.||+|||+ + +|+||||||+|||++.++
T Consensus 117 ~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 117 GTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp EEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred CceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhhhhhh
Confidence 56799999999 6777777766554569999999999999999999998 7 999999999999998775
Q ss_pred -----------------------------------------CeEEeecccceeccCCCCceeeccccCccccCcccccCC
Q 006112 476 -----------------------------------------EGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNG 514 (660)
Q Consensus 476 -----------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 514 (660)
.+||+|||+++..... .....||+.|+|||++.+.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~~ 268 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIGS 268 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHTS
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcCC
Confidence 7999999999876432 2345789999999999999
Q ss_pred CCCcceeEEehHHHHHHHhhCCCCCCCCCcc-------hHHHHHHHHhc--------CCc-----------ccCCCCcc-
Q 006112 515 RGTTSTDVYAFGVFMLEVACGRRPVQPGELD-------LLDWVIDYWQK--------GDV-----------LDASDPRL- 567 (660)
Q Consensus 515 ~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-------~~~~~~~~~~~--------~~~-----------~~~~d~~l- 567 (660)
.++.++|||||||++|||++|+.||...... ....+.+.... +.. ....+...
T Consensus 269 ~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (397)
T 1wak_A 269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPW 348 (397)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCC
T ss_pred CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCc
Confidence 9999999999999999999999999763211 11111111110 000 00000000
Q ss_pred --------cccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 568 --------EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 568 --------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
...........+.+|+.+||+.||++|||++|++++
T Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 349 GLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred chhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 012345667789999999999999999999999863
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=335.84 Aligned_cols=251 Identities=22% Similarity=0.372 Sum_probs=199.7
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
-.|+..+.+|+|+||.||+|++..+++.||||.+... .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 3688899999999999999999888999999998643 2334568899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
||+++++|.+++.... .+++.++..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 91 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 91 EYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp ECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred eccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 9999999999997654 48899999999999999999998 899999999999999999999999999998754432
Q ss_pred CceeeccccCccccCcccccCCCC-CcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccC
Q 006112 493 DLHTTNVVGTVGYLAPELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIY 571 (660)
Q Consensus 493 ~~~~~~~~gt~~Y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 571 (660)
......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||....... ..+....+.. .+....
T Consensus 166 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~------~~~~~~ 234 (276)
T 2h6d_A 166 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT---LFKKIRGGVF------YIPEYL 234 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHCCC------CCCTTS
T ss_pred --ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---HHHHhhcCcc------cCchhc
Confidence 2234578999999999987665 689999999999999999999997644321 2222222211 111122
Q ss_pred cHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH--hhC
Q 006112 572 VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY--LDG 606 (660)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~ 606 (660)
...+.+++..|++.||++|||++|++++ ++.
T Consensus 235 ----~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~ 267 (276)
T 2h6d_A 235 ----NRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ 267 (276)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHT
T ss_pred ----CHHHHHHHHHHccCChhhCCCHHHHHhChhhcc
Confidence 2346788889999999999999999973 554
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=339.93 Aligned_cols=254 Identities=24% Similarity=0.367 Sum_probs=204.5
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
-.|+.++.+|+|+||.||+|++..+++.||||.+.... ..+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (314)
T 3com_A 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC 106 (314)
T ss_dssp -CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence 36889999999999999999999889999999996543 4578999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 495 (660)
++++|.+++.... ..+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++........ .
T Consensus 107 ~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~ 181 (314)
T 3com_A 107 GAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-K 181 (314)
T ss_dssp TTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-C
T ss_pred CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-c
Confidence 9999999986432 358999999999999999999998 8999999999999999999999999999987654322 2
Q ss_pred eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHH
Q 006112 496 TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQ 575 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 575 (660)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .... ..... +.+. .....
T Consensus 182 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~-~~~~~-----~~~~--~~~~~ 251 (314)
T 3com_A 182 RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA--IFMI-PTNPP-----PTFR--KPELW 251 (314)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHH-HHSCC-----CCCS--SGGGS
T ss_pred cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH--HHHH-hcCCC-----cccC--CcccC
Confidence 3345789999999999988899999999999999999999999976433221 1111 11111 1110 01112
Q ss_pred HHHHHHHhhhccCCCCCCCCCHHHHHH--HhhC
Q 006112 576 MEIVLKLGLFCSHSNPDTRPSMRQVVQ--YLDG 606 (660)
Q Consensus 576 ~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~ 606 (660)
...+.+++..||+.||.+|||+.++++ +++.
T Consensus 252 ~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~ 284 (314)
T 3com_A 252 SDNFTDFVKQCLVKSPEQRATATQLLQHPFVRS 284 (314)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHT
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHhCHHHhc
Confidence 345778888999999999999999986 4444
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=364.19 Aligned_cols=249 Identities=26% Similarity=0.362 Sum_probs=206.4
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
.|+.++.||+|+||.||+|+...+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 106 (484)
T 3nyv_A 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGE 106 (484)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 6888999999999999999999999999999986542 3456789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEE---cCCCCeEEeecccceeccC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLL---DADLEGKLGDFGLARLYDH 490 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll---~~~~~~kl~DFGla~~~~~ 490 (660)
||.+|+|.+++.... .+++.++..++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++.+..
T Consensus 107 ~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 107 VYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp CCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred cCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 999999999987654 48999999999999999999998 899999999999999 5678999999999987654
Q ss_pred CCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCccccc
Q 006112 491 GNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGI 570 (660)
Q Consensus 491 ~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 570 (660)
... .....||+.|+|||++.+ .++.++||||+||++|||++|+.||....... .......+.... ..+.
T Consensus 182 ~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~~~~~-~~~~---- 250 (484)
T 3nyv_A 182 SKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD---ILKKVEKGKYTF-ELPQ---- 250 (484)
T ss_dssp CCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHCCCCC-CSGG----
T ss_pred ccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHcCCCCC-CCcc----
Confidence 332 334579999999999865 68999999999999999999999998654322 222223332211 0111
Q ss_pred CcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 571 YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
.......+.+++..||+.||.+|||+.|+++
T Consensus 251 -~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 251 -WKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp -GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -cccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 1122345778888999999999999999996
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=336.57 Aligned_cols=251 Identities=25% Similarity=0.357 Sum_probs=205.9
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC---------ChhhHHHHHHHHHHhccC-CCCceeEeeeeeec
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---------DHGMKQFVSEIVSMGKLR-HRNLVQLRGYCRRK 405 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---------~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~ 405 (660)
-.|+..+.+|+|+||.||+|++..+++.||||.+.... ....+.+.+|+++++++. ||||+++++++..+
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (298)
T 1phk_A 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 96 (298)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred hccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccC
Confidence 36888999999999999999999999999999996543 123467889999999996 99999999999999
Q ss_pred CeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccc
Q 006112 406 GELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLA 485 (660)
Q Consensus 406 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla 485 (660)
+..++||||+++++|.+++.... .+++.++..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 97 TFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccch
Confidence 99999999999999999997643 48999999999999999999998 89999999999999999999999999999
Q ss_pred eeccCCCCceeeccccCccccCccccc------CCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCc
Q 006112 486 RLYDHGNDLHTTNVVGTVGYLAPELLR------NGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDV 559 (660)
Q Consensus 486 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 559 (660)
+...... ......||+.|+|||.+. ...++.++||||||+++|||++|+.||....... .......+..
T Consensus 172 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~ 246 (298)
T 1phk_A 172 CQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---MLRMIMSGNY 246 (298)
T ss_dssp EECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHTCC
T ss_pred hhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH---HHHHHhcCCc
Confidence 8765433 233467899999999985 4567899999999999999999999997644322 1222222221
Q ss_pred ccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 560 LDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 560 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
. ...+. .......+.+++..||+.||++|||+.|+++
T Consensus 247 ~-~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 247 Q-FGSPE-----WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp C-CCTTT-----GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred c-cCccc-----ccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1 11111 1122345778889999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=348.58 Aligned_cols=251 Identities=25% Similarity=0.369 Sum_probs=204.1
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC--------hhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD--------HGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGE 407 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 407 (660)
.|+..+.||+|+||.||+|++..+|+.||||++..... ...+.+.+|+.+++++ +||||+++++++...+.
T Consensus 95 ~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 174 (365)
T 2y7j_A 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF 174 (365)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSE
T ss_pred hcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCE
Confidence 48888999999999999999988899999999865432 1245688999999999 79999999999999999
Q ss_pred eEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeeccccee
Q 006112 408 LLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARL 487 (660)
Q Consensus 408 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 487 (660)
.++||||+++++|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++..
T Consensus 175 ~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~ 249 (365)
T 2y7j_A 175 MFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCH 249 (365)
T ss_dssp EEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEecCcccc
Confidence 999999999999999997643 48999999999999999999998 8999999999999999999999999999987
Q ss_pred ccCCCCceeeccccCccccCcccccC------CCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCccc
Q 006112 488 YDHGNDLHTTNVVGTVGYLAPELLRN------GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLD 561 (660)
Q Consensus 488 ~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 561 (660)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .......+...
T Consensus 250 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~- 323 (365)
T 2y7j_A 250 LEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL---MLRMIMEGQYQ- 323 (365)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHTCCC-
T ss_pred cCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHhCCCC-
Confidence 65433 2344689999999999863 357889999999999999999999997643321 12222222111
Q ss_pred CCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 562 ASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 562 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
...+.. . .....+.+++..||+.||++||+++|++++
T Consensus 324 ~~~~~~-~----~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 324 FSSPEW-D----DRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp CCHHHH-S----SSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCccc-c----cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 000000 1 112357788889999999999999999973
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=338.86 Aligned_cols=251 Identities=21% Similarity=0.275 Sum_probs=188.4
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC-hh-hHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD-HG-MKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~-~~-~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
-+|+.++.||+|+||.||+++...+++.||||++..... .. .+.+.++...++.++||||+++++++.+++..++|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e 86 (290)
T 3fme_A 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME 86 (290)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence 468899999999999999999999999999999965432 22 3334455566888999999999999999999999999
Q ss_pred cCCCCChhhhhhh--CCCCCcchhHHHHHHHHHHHHHHHhhhcccC-ceeccCccCCcEEEcCCCCeEEeecccceeccC
Q 006112 414 YMPNGSLDKILYS--NTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQ-VVLHRDIKPANVLLDADLEGKLGDFGLARLYDH 490 (660)
Q Consensus 414 ~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 490 (660)
|++ |+|.+++.. .....+++..+..++.|++.||+|||+ + +|+||||||+||+++.++.+||+|||+++....
T Consensus 87 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 87 LMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp CCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred hhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 996 688887754 123469999999999999999999998 6 999999999999999999999999999986644
Q ss_pred CCCceeeccccCccccCcccc----cCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCc
Q 006112 491 GNDLHTTNVVGTVGYLAPELL----RNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPR 566 (660)
Q Consensus 491 ~~~~~~~~~~gt~~Y~aPE~~----~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 566 (660)
.. ......||+.|+|||.+ .+..++.++||||||+++|||++|+.||........ ............ ..
T Consensus 163 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~-~~--- 235 (290)
T 3fme_A 163 DV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-QLKQVVEEPSPQ-LP--- 235 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-HHHHHHHSCCCC-CC---
T ss_pred cc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-HHHHHhccCCCC-cc---
Confidence 32 22334799999999996 556789999999999999999999999975333222 222222222111 00
Q ss_pred ccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 567 LEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 567 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
...+ ...+.+++..||+.||++|||+.|+++
T Consensus 236 -~~~~----~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 236 -ADKF----SAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -TTTS----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -cccC----CHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1112 234778888999999999999999987
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=362.28 Aligned_cols=254 Identities=24% Similarity=0.347 Sum_probs=205.7
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
.|+.++.||+|+||.||+|+...+++.||||++... .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 102 (486)
T 3mwu_A 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL 102 (486)
T ss_dssp HEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEc
Confidence 688899999999999999999989999999998543 233467899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEc---CCCCeEEeecccceeccCC
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLD---ADLEGKLGDFGLARLYDHG 491 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~---~~~~~kl~DFGla~~~~~~ 491 (660)
|++|+|.+++.... .+++.++..++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||+++.....
T Consensus 103 ~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 103 YTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp CCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 99999999887653 48999999999999999999998 8999999999999995 4567999999999866443
Q ss_pred CCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccC
Q 006112 492 NDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIY 571 (660)
Q Consensus 492 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 571 (660)
. ......||+.|+|||++.+ .++.++||||+||++|||++|+.||....... .......+.... ..+..
T Consensus 178 ~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~~~~~-~~~~~---- 246 (486)
T 3mwu_A 178 T--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD---ILKRVETGKYAF-DLPQW---- 246 (486)
T ss_dssp ------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHTCCCS-CSGGG----
T ss_pred C--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhCCCCC-CCccc----
Confidence 2 2334679999999999875 58999999999999999999999998654322 222222322211 01111
Q ss_pred cHHHHHHHHHHhhhccCCCCCCCCCHHHHHH--HhhCC
Q 006112 572 VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ--YLDGG 607 (660)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~ 607 (660)
......+.+++..||+.||.+|||+.|+++ +++..
T Consensus 247 -~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 247 -RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp -GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred -CCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence 112345678888999999999999999997 35543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=356.66 Aligned_cols=197 Identities=28% Similarity=0.362 Sum_probs=168.1
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeec-----CeeE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK-----GELL 409 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~~ 409 (660)
.|+.++.||+|+||.||+|++..+++.||||++... .....+++.+|++++++++||||+++++++... +.++
T Consensus 27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 106 (432)
T 3n9x_A 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY 106 (432)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEE
Confidence 688999999999999999999999999999999654 233457899999999999999999999999766 5789
Q ss_pred EEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceecc
Q 006112 410 LVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYD 489 (660)
Q Consensus 410 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 489 (660)
+||||+. |+|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 107 lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 107 IVLEIAD-SDLKKLFKTPI--FLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp EEEECCS-EEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred EEEecCC-cCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 9999995 69999997643 48999999999999999999998 899999999999999999999999999998765
Q ss_pred CCCC---------------------ceeeccccCccccCcccc-cCCCCCcceeEEehHHHHHHHhhCCCCC
Q 006112 490 HGND---------------------LHTTNVVGTVGYLAPELL-RNGRGTTSTDVYAFGVFMLEVACGRRPV 539 (660)
Q Consensus 490 ~~~~---------------------~~~~~~~gt~~Y~aPE~~-~~~~~t~ksDV~S~Gvvl~elltG~~p~ 539 (660)
.... ...+..+||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 4321 123567899999999986 5567999999999999999999865444
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=362.13 Aligned_cols=258 Identities=19% Similarity=0.222 Sum_probs=204.9
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCC-CCceeEeeeeeecCeeEEEEecC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRH-RNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
.|+.++.||+|+||.||+|++..+++.||||++..... .+++.+|+++++.++| +++..+..++...+..+|||||+
T Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp TEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 58899999999999999999988999999998765433 3468899999999987 55556666667778899999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEE---cCCCCeEEeecccceeccCCC
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLL---DADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll---~~~~~~kl~DFGla~~~~~~~ 492 (660)
+++|.+++.... ..+++.+++.|+.||+.||+|||+ ++|+||||||+|||| +.++.+||+|||+++.+....
T Consensus 86 -g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 86 -GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp -CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred -CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 999999997543 359999999999999999999998 899999999999999 688999999999998776543
Q ss_pred Cc------eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCc
Q 006112 493 DL------HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPR 566 (660)
Q Consensus 493 ~~------~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 566 (660)
.. ......||+.|+|||++.+..++.++|||||||+||||++|+.||........................ +.
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~-~~ 239 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI-EA 239 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH-HH
T ss_pred cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH-HH
Confidence 21 123568999999999999999999999999999999999999999864332222222111111110000 00
Q ss_pred ccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 567 LEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 567 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
+.. .....+.+++..||+.||++||++.+|++.|+.
T Consensus 240 l~~----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~ 275 (483)
T 3sv0_A 240 LCR----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRD 275 (483)
T ss_dssp HHT----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred Hhc----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 111 123467888999999999999999999998865
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=355.93 Aligned_cols=260 Identities=27% Similarity=0.334 Sum_probs=198.8
Q ss_pred CCceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeec------C
Q 006112 333 PHRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK------G 406 (660)
Q Consensus 333 ~~~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------~ 406 (660)
+....|+.++.||+|+||.||+|++..+++.||||++.... +.+.+|++++++++||||++++++|... .
T Consensus 51 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp CEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred cccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 55678999999999999999999999899999999986543 2334799999999999999999988542 2
Q ss_pred eeEEEEecCCCCChhhhhhh--CCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCC-CCeEEeecc
Q 006112 407 ELLLVYDYMPNGSLDKILYS--NTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDAD-LEGKLGDFG 483 (660)
Q Consensus 407 ~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~-~~~kl~DFG 483 (660)
.+++||||+++ +|.+.+.. .....+++..+..++.||++||+|||+ ++|+||||||+|||++.+ +.+||+|||
T Consensus 127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccch
Confidence 36799999975 66665542 223469999999999999999999998 999999999999999965 568999999
Q ss_pred cceeccCCCCceeeccccCccccCcccccCC-CCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHHHHHHhc-----
Q 006112 484 LARLYDHGNDLHTTNVVGTVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVIDYWQK----- 556 (660)
Q Consensus 484 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~~~~----- 556 (660)
+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... +....+.+....
T Consensus 203 ~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 203 SAKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280 (420)
T ss_dssp TCEECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred hhhhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9987654322 2346789999999998764 789999999999999999999999986432 222222221110
Q ss_pred -----CCcccCCCCcccc-----cCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 557 -----GDVLDASDPRLEG-----IYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 557 -----~~~~~~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
....+...+.+.. .+.......+.+|+.+||+.||++||++.|+++
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 1111111111111 111222356788999999999999999999996
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=340.32 Aligned_cols=253 Identities=21% Similarity=0.309 Sum_probs=201.2
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccC-CCCceeEeeeeee--cCeeEEEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLR-HRNLVQLRGYCRR--KGELLLVY 412 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~--~~~~~lV~ 412 (660)
-.|+.++.||+|+||.||+|++..+++.||||++... ..+.+.+|++++++++ ||||+++++++.. ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 4789999999999999999999999999999998643 3567899999999997 9999999999987 56789999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCC-CeEEeecccceeccCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADL-EGKLGDFGLARLYDHG 491 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~-~~kl~DFGla~~~~~~ 491 (660)
||+++++|.+++.. +++.++..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+++.....
T Consensus 113 e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp ECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred eccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 99999999998853 7888999999999999999998 8999999999999999776 8999999999876543
Q ss_pred CCceeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCcch--HHHHHH---------HHhcCCc
Q 006112 492 NDLHTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDL--LDWVID---------YWQKGDV 559 (660)
Q Consensus 492 ~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~--~~~~~~---------~~~~~~~ 559 (660)
.. .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||....... ...... .......
T Consensus 185 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 185 QE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp CC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred Cc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 32 234578999999999877 678999999999999999999999996533221 111111 1111000
Q ss_pred ccCCCCc----------------ccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 560 LDASDPR----------------LEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 560 ~~~~d~~----------------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
..++. ............+.+++..||+.||++|||++|++++
T Consensus 263 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 263 --ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp --CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred --ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000 0011111124567888999999999999999999973
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=363.33 Aligned_cols=254 Identities=24% Similarity=0.347 Sum_probs=204.9
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC-------------hhhHHHHHHHHHHhccCCCCceeEeeee
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD-------------HGMKQFVSEIVSMGKLRHRNLVQLRGYC 402 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~-------------~~~~~~~~Ei~~l~~l~H~nIv~l~g~~ 402 (660)
-.|+.++.||+|+||.||+|+...+++.||||++..... ...+.+.+|+.++++++||||++++++|
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 368899999999999999999999999999999865321 3356799999999999999999999999
Q ss_pred eecCeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCC---CeEE
Q 006112 403 RRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADL---EGKL 479 (660)
Q Consensus 403 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~---~~kl 479 (660)
.+.+..++|||||++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccEEE
Confidence 99999999999999999999987643 48999999999999999999998 8999999999999998775 6999
Q ss_pred eecccceeccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCc
Q 006112 480 GDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDV 559 (660)
Q Consensus 480 ~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 559 (660)
+|||+++...... ......||+.|+|||++. +.++.++||||+||++|||++|+.||...... .+......+..
T Consensus 191 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~ 264 (504)
T 3q5i_A 191 VDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ---DIIKKVEKGKY 264 (504)
T ss_dssp CCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCC
T ss_pred EECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHcCCC
Confidence 9999998765432 234467999999999986 56899999999999999999999999864432 22222233321
Q ss_pred ccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH--HhhC
Q 006112 560 LDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ--YLDG 606 (660)
Q Consensus 560 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~ 606 (660)
.. +..... .....+.+++..||+.||.+|||++|+++ +++.
T Consensus 265 ~~--~~~~~~----~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 307 (504)
T 3q5i_A 265 YF--DFNDWK----NISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK 307 (504)
T ss_dssp CC--CHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred CC--CccccC----CCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhh
Confidence 10 000001 12245778888999999999999999996 4544
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=342.14 Aligned_cols=258 Identities=20% Similarity=0.226 Sum_probs=206.0
Q ss_pred eeecccccccCccEEEEEEEe-CCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCC------ceeEeeeeeecCeeE
Q 006112 337 SYKNLYKATKGGSGKVYRGVL-PSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRN------LVQLRGYCRRKGELL 409 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n------Iv~l~g~~~~~~~~~ 409 (660)
.|+.++.||+|+||.||+|.+ ..+++.||||++... ....+.+.+|++++++++|+| ++++++++...+..+
T Consensus 15 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~ 93 (339)
T 1z57_A 15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC 93 (339)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEE
T ss_pred ceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEE
Confidence 689999999999999999998 557899999998543 344677899999999987665 999999999999999
Q ss_pred EEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcC----------------
Q 006112 410 LVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDA---------------- 473 (660)
Q Consensus 410 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~---------------- 473 (660)
+||||+ +++|.+++.......+++.++..++.||+.||+|||+ ++|+||||||+|||++.
T Consensus 94 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~ 169 (339)
T 1z57_A 94 IVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDER 169 (339)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----CEEE
T ss_pred EEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCccccccc
Confidence 999999 9999999987765678999999999999999999998 89999999999999987
Q ss_pred ---CCCeEEeecccceeccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHH
Q 006112 474 ---DLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWV 550 (660)
Q Consensus 474 ---~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~ 550 (660)
++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...........
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 245 (339)
T 1z57_A 170 TLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAM 245 (339)
T ss_dssp EESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHH
T ss_pred cccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 668999999999864432 2345789999999999998999999999999999999999999986443222111
Q ss_pred HHHHhcCCcc------------c------------------CCCCcc-cccCcHHHHHHHHHHhhhccCCCCCCCCCHHH
Q 006112 551 IDYWQKGDVL------------D------------------ASDPRL-EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQ 599 (660)
Q Consensus 551 ~~~~~~~~~~------------~------------------~~d~~l-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 599 (660)
.......... . ...+.. .........+.+.+++..||+.||++|||++|
T Consensus 246 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e 325 (339)
T 1z57_A 246 MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLRE 325 (339)
T ss_dssp HHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHH
Confidence 1111100000 0 000000 00112345667889999999999999999999
Q ss_pred HHHH
Q 006112 600 VVQY 603 (660)
Q Consensus 600 vl~~ 603 (660)
++++
T Consensus 326 ll~h 329 (339)
T 1z57_A 326 ALKH 329 (339)
T ss_dssp HTTS
T ss_pred HhcC
Confidence 9853
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=340.37 Aligned_cols=255 Identities=23% Similarity=0.311 Sum_probs=199.7
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhcc-CCCCceeEeeeeee------cCee
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRR------KGEL 408 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~------~~~~ 408 (660)
-.|+.++.||+|+||.||+|++..+++.||||++.... ...+.+.+|+.+++++ +||||+++++++.. .+..
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 102 (326)
T 2x7f_A 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 102 (326)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEE
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceE
Confidence 46889999999999999999998899999999986543 3457889999999999 79999999999976 4678
Q ss_pred EEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceec
Q 006112 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLY 488 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 488 (660)
++||||+++|+|.+++.......+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++...
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 179 (326)
T 2x7f_A 103 WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179 (326)
T ss_dssp EEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred EEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence 999999999999999987655568999999999999999999998 89999999999999999999999999999865
Q ss_pred cCCCCceeeccccCccccCccccc-----CCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCC
Q 006112 489 DHGNDLHTTNVVGTVGYLAPELLR-----NGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDAS 563 (660)
Q Consensus 489 ~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (660)
..... ......||+.|+|||.+. ...++.++|||||||++|||++|+.||........ ....... ......
T Consensus 180 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~-~~~~~~ 255 (326)
T 2x7f_A 180 DRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA--LFLIPRN-PAPRLK 255 (326)
T ss_dssp ------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHS-CCCCCS
T ss_pred CcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH--HHHhhcC-ccccCC
Confidence 43221 223457899999999987 56788999999999999999999999976443211 1111111 111110
Q ss_pred CCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH--HhhC
Q 006112 564 DPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ--YLDG 606 (660)
Q Consensus 564 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~ 606 (660)
...+ ...+.+++..||+.||.+||+++|+++ +++.
T Consensus 256 ----~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~ 292 (326)
T 2x7f_A 256 ----SKKW----SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292 (326)
T ss_dssp ----CSCS----CHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHC
T ss_pred ----cccc----CHHHHHHHHHHhccChhhCCCHHHHhhChHHhh
Confidence 1112 245778888999999999999999997 4543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=346.96 Aligned_cols=259 Identities=26% Similarity=0.329 Sum_probs=203.0
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHhccCCCCceeEeeeeeec-----CeeEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD-HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK-----GELLL 410 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~~l 410 (660)
.|+.++.||+|+||.||+|++..+++.||||++..... ...+.+.+|++++++++||||+++++++... ...++
T Consensus 28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i 107 (364)
T 3qyz_A 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 107 (364)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence 59999999999999999999999999999999975433 3457899999999999999999999998654 36899
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccC
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDH 490 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 490 (660)
||||+. |+|.+++... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 108 v~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 108 VQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp EEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 999996 6999998764 48999999999999999999998 8999999999999999999999999999987654
Q ss_pred CCCc--eeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHHHHHHhcCCcc------
Q 006112 491 GNDL--HTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVIDYWQKGDVL------ 560 (660)
Q Consensus 491 ~~~~--~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~~~~~~~~------ 560 (660)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... +....+..........
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 260 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 3221 1244689999999998754 4589999999999999999999999976432 2333322221111000
Q ss_pred ---------cCCCCc-c-cccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 561 ---------DASDPR-L-EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 561 ---------~~~d~~-l-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
....+. . ...........+.+++..||+.||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 0 00000112345778899999999999999999997
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=350.78 Aligned_cols=257 Identities=25% Similarity=0.261 Sum_probs=197.2
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeec----------
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK---------- 405 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~---------- 405 (660)
.+|+.++.||+|+||.||+|++..+++.||||++..+.. ...+|++++++++||||+++++++...
T Consensus 7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 82 (383)
T 3eb0_A 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQP 82 (383)
T ss_dssp TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC----------
T ss_pred ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccccccc
Confidence 368999999999999999999999999999999865432 234799999999999999999998443
Q ss_pred ----------------------------CeeEEEEecCCCCChhhhhhh--CCCCCcchhHHHHHHHHHHHHHHHhhhcc
Q 006112 406 ----------------------------GELLLVYDYMPNGSLDKILYS--NTRPSLNWFQRFRIIKGVAFGLLYLHEEW 455 (660)
Q Consensus 406 ----------------------------~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 455 (660)
..+++|||||+ |+|.+.+.. .....+++..+..++.||+.||+|||+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-- 159 (383)
T 3eb0_A 83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-- 159 (383)
T ss_dssp ---------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT--
T ss_pred ccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--
Confidence 34889999997 688777753 223469999999999999999999998
Q ss_pred cCceeccCccCCcEEEc-CCCCeEEeecccceeccCCCCceeeccccCccccCcccccCC-CCCcceeEEehHHHHHHHh
Q 006112 456 EQVVLHRDIKPANVLLD-ADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVA 533 (660)
Q Consensus 456 ~~~ivHrDikp~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~ell 533 (660)
.+|+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||.+.+. .++.++||||+||++|||+
T Consensus 160 -~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 236 (383)
T 3eb0_A 160 -LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236 (383)
T ss_dssp -TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred -CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHH
Confidence 9999999999999998 68899999999998764433 23345789999999998764 4899999999999999999
Q ss_pred hCCCCCCCCCc-chHHHHHHHHhcC----------CcccCCCCcc-----cccCcHHHHHHHHHHhhhccCCCCCCCCCH
Q 006112 534 CGRRPVQPGEL-DLLDWVIDYWQKG----------DVLDASDPRL-----EGIYVEEQMEIVLKLGLFCSHSNPDTRPSM 597 (660)
Q Consensus 534 tG~~p~~~~~~-~~~~~~~~~~~~~----------~~~~~~d~~l-----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 597 (660)
+|+.||..... +....+....... ...+..-+.. ...+.......+.+++..||+.||++|||+
T Consensus 237 ~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 316 (383)
T 3eb0_A 237 LGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINP 316 (383)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence 99999986432 2222222211110 0011111111 111222234557889999999999999999
Q ss_pred HHHHH
Q 006112 598 RQVVQ 602 (660)
Q Consensus 598 ~evl~ 602 (660)
.|+++
T Consensus 317 ~e~l~ 321 (383)
T 3eb0_A 317 YEAMA 321 (383)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99985
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=341.27 Aligned_cols=248 Identities=23% Similarity=0.335 Sum_probs=197.0
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--------ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCee
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--------DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGEL 408 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 408 (660)
.|+.++.||+|+||.||+|++..+++.||||.+.... ......+.+|++++++++||||+++++++..++ .
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~ 89 (322)
T 2ycf_A 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-Y 89 (322)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-E
T ss_pred ceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-e
Confidence 5888999999999999999999999999999986432 123456889999999999999999999987654 8
Q ss_pred EEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCC---eEEeecccc
Q 006112 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLE---GKLGDFGLA 485 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~---~kl~DFGla 485 (660)
++||||+++++|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++. +||+|||++
T Consensus 90 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 90 YIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp EEEEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred EEEEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 99999999999999986543 58999999999999999999998 89999999999999987664 999999999
Q ss_pred eeccCCCCceeeccccCccccCccccc---CCCCCcceeEEehHHHHHHHhhCCCCCCCCCc--chHHHHHHHHhcCCcc
Q 006112 486 RLYDHGNDLHTTNVVGTVGYLAPELLR---NGRGTTSTDVYAFGVFMLEVACGRRPVQPGEL--DLLDWVIDYWQKGDVL 560 (660)
Q Consensus 486 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~--~~~~~~~~~~~~~~~~ 560 (660)
+..... .......||+.|+|||++. ...++.++|||||||++|||++|+.||..... .+.+.+ ..+...
T Consensus 165 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~----~~~~~~ 238 (322)
T 2ycf_A 165 KILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI----TSGKYN 238 (322)
T ss_dssp EECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHH----HHTCCC
T ss_pred eecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHH----HhCccc
Confidence 876432 1223457899999999974 56788999999999999999999999975332 222222 122110
Q ss_pred cCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 561 DASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 561 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
..+... ......+.+++..||+.||++||++.|+++
T Consensus 239 --~~~~~~----~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 239 --FIPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp --CCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --cCchhh----hhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 001111 112345778889999999999999999985
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=347.02 Aligned_cols=254 Identities=22% Similarity=0.264 Sum_probs=193.3
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeecC------ee
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKG------EL 408 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------~~ 408 (660)
.|+.++.||+|+||.||+|....+++.||||++... .....+.+.+|+.++++++||||+++++++...+ ..
T Consensus 26 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 105 (371)
T 2xrw_A 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 105 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEE
T ss_pred heeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccce
Confidence 688999999999999999999999999999999653 2334567899999999999999999999987654 78
Q ss_pred EEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceec
Q 006112 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLY 488 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 488 (660)
++|||||+ |+|.+++.. .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 106 ~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 106 YIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp EEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred EEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 99999996 578888852 38899999999999999999998 89999999999999999999999999999865
Q ss_pred cCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhc-CCcc----cC-
Q 006112 489 DHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQK-GDVL----DA- 562 (660)
Q Consensus 489 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~-~~~~----~~- 562 (660)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +........ +... ..
T Consensus 178 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 178 GTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI--DQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp --------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHC-CCCCCHHHHTTS
T ss_pred cccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHHHHh
Confidence 4322 233467999999999999989999999999999999999999999764321 111111110 0000 00
Q ss_pred ---------CCCccc----------------ccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 563 ---------SDPRLE----------------GIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 563 ---------~d~~l~----------------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
..+... ..........+.+++.+||+.||++|||++|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 000000 0011223567889999999999999999999997
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=344.38 Aligned_cols=257 Identities=19% Similarity=0.256 Sum_probs=205.6
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCCh---h--------------hHHHHHHHHHHhccCCCCceeEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDH---G--------------MKQFVSEIVSMGKLRHRNLVQLR 399 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~---~--------------~~~~~~Ei~~l~~l~H~nIv~l~ 399 (660)
.|+.++.+|+|+||.||+|+. +++.||||++...... . .+.+.+|+.++++++||||++++
T Consensus 32 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 32 DYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp TEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred ceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 689999999999999999999 7899999998643211 1 17899999999999999999999
Q ss_pred eeeeecCeeEEEEecCCCCChhhh------hhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcC
Q 006112 400 GYCRRKGELLLVYDYMPNGSLDKI------LYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDA 473 (660)
Q Consensus 400 g~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~ 473 (660)
+++.+.+..++||||+++|+|.++ +.......+++..+..++.||+.||.|||+ .++|+||||||+||+++.
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDK 187 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEECT
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEcC
Confidence 999999999999999999999999 655445679999999999999999999996 379999999999999999
Q ss_pred CCCeEEeecccceeccCCCCceeeccccCccccCcccccCC-CCCc-ceeEEehHHHHHHHhhCCCCCCCCCcchHHHHH
Q 006112 474 DLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNG-RGTT-STDVYAFGVFMLEVACGRRPVQPGELDLLDWVI 551 (660)
Q Consensus 474 ~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~t~-ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~ 551 (660)
++.+||+|||+++..... ......||+.|+|||.+.+. .++. ++||||||+++|||++|+.||...... ....
T Consensus 188 ~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~ 262 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--VELF 262 (348)
T ss_dssp TSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--HHHH
T ss_pred CCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHH
Confidence 999999999999876443 34456799999999999877 5666 999999999999999999999864431 1122
Q ss_pred HHHhcCCcccCCCC-cc-----c---ccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 552 DYWQKGDVLDASDP-RL-----E---GIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 552 ~~~~~~~~~~~~d~-~l-----~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
.....+......+. .. . ..........+.+++..||+.||.+||+++|+++
T Consensus 263 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 22233322111000 00 0 0001223346788889999999999999999997
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=373.42 Aligned_cols=247 Identities=23% Similarity=0.305 Sum_probs=207.0
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCeeEEEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
+|+.++.||+|+||.||++++..+++.||||++... .....+.+..|..++..+ +||||+++++++.+.+.++|||
T Consensus 342 ~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~ 421 (674)
T 3pfq_A 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 421 (674)
T ss_dssp TEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEE
T ss_pred ceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEE
Confidence 688899999999999999999999999999999643 234567788999999988 7999999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
||+++|+|..++.... .+++.++..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++......
T Consensus 422 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 422 EYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496 (674)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred eCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence 9999999999998654 48999999999999999999998 899999999999999999999999999998643322
Q ss_pred CceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCc
Q 006112 493 DLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 493 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....... +.+....+.. .+...+
T Consensus 497 -~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~---~~~~i~~~~~------~~p~~~- 565 (674)
T 3pfq_A 497 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQSIMEHNV------AYPKSM- 565 (674)
T ss_dssp -CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHSSCC------CCCTTS-
T ss_pred -cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH---HHHHHHhCCC------CCCccC-
Confidence 23445789999999999999999999999999999999999999998654322 2222222221 112222
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCCH-----HHHHH
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRPSM-----RQVVQ 602 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~ 602 (660)
...+.+|+..||+.||++||++ +||++
T Consensus 566 ---s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 566 ---SKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ---CHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ---CHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 2346778888999999999997 78874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=336.04 Aligned_cols=251 Identities=23% Similarity=0.414 Sum_probs=195.3
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeee------------
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR------------ 404 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~------------ 404 (660)
.|+.++.+|+|+||.||+|+...+++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (303)
T 1zy4_A 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK 85 (303)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred cchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence 588899999999999999999889999999998543 3456789999999999999999999998865
Q ss_pred -cCeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecc
Q 006112 405 -KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFG 483 (660)
Q Consensus 405 -~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG 483 (660)
.+..++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 86 KKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 456899999999999999997643 357888999999999999999998 899999999999999999999999999
Q ss_pred cceeccCCC-------------CceeeccccCccccCcccccCC-CCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHH
Q 006112 484 LARLYDHGN-------------DLHTTNVVGTVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDW 549 (660)
Q Consensus 484 la~~~~~~~-------------~~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~ 549 (660)
+++...... ........||+.|+|||.+.+. .++.++|||||||++|||++ ||.... . ...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~-~-~~~ 236 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-E-RVN 236 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH-H-HHH
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch-h-HHH
Confidence 998654321 1122345789999999998754 68999999999999999998 554321 1 111
Q ss_pred HHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 550 VIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 550 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
......... ..+...+.......+.+++..||+.||++|||++|++++
T Consensus 237 ~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 237 ILKKLRSVS------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHSTT------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHhccccc------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 222222211 111222333344567788999999999999999999974
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=339.24 Aligned_cols=261 Identities=26% Similarity=0.339 Sum_probs=204.2
Q ss_pred eeeecccccccCccEEEEEEEeC-CCCeEEEEEEeccCC--ChhhHHHHHHHHHHhcc---CCCCceeEeeeee-----e
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLP-SSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKL---RHRNLVQLRGYCR-----R 404 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l---~H~nIv~l~g~~~-----~ 404 (660)
-.|+.++.||+|+||.||+|++. .+++.||+|++.... ......+.+|+.+++++ +||||++++++|. .
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 90 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 90 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence 36899999999999999999995 678999999986432 22345677888877766 8999999999987 5
Q ss_pred cCeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeeccc
Q 006112 405 KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGL 484 (660)
Q Consensus 405 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGl 484 (660)
....++||||++ |+|.+++.......+++.++..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 91 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp EEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred CceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecCcc
Confidence 567899999997 799999987766669999999999999999999998 8999999999999999999999999999
Q ss_pred ceeccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHHHHHHhcCCcccC-
Q 006112 485 ARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVIDYWQKGDVLDA- 562 (660)
Q Consensus 485 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~~~~~~~~~~- 562 (660)
++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .....+............
T Consensus 167 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (326)
T 1blx_A 167 ARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 244 (326)
T ss_dssp CCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred cccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCc
Confidence 98654322 23346789999999999999999999999999999999999999986443 222222222111100000
Q ss_pred ------------CCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 563 ------------SDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 563 ------------~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
........+.......+.+++..||+.||++||++.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 245 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000001111223455778889999999999999999995
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=350.60 Aligned_cols=256 Identities=25% Similarity=0.315 Sum_probs=185.1
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeec------Cee
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK------GEL 408 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~ 408 (660)
.|+.++.||+|+||.||+|.+..+++.||||++... .....+.+.+|++++++++||||+++++++... ...
T Consensus 30 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 109 (367)
T 2fst_X 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 109 (367)
T ss_dssp TEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred ceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeE
Confidence 588999999999999999999999999999998653 233467889999999999999999999998654 568
Q ss_pred EEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceec
Q 006112 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLY 488 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 488 (660)
++|+||+ +++|.+++.. ..+++..+..++.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 110 ~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 110 YLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp EEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred EEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 9999999 7999998865 348999999999999999999998 99999999999999999999999999999865
Q ss_pred cCCCCceeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHHHHHHhcCCc--ccCCC
Q 006112 489 DHGNDLHTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVIDYWQKGDV--LDASD 564 (660)
Q Consensus 489 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~~~~~~~--~~~~d 564 (660)
... .+...||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .....+.+....... .....
T Consensus 183 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 258 (367)
T 2fst_X 183 ADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred ccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 432 334679999999999876 6789999999999999999999999976442 222222222111100 00000
Q ss_pred -----------CcccccC----cHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 565 -----------PRLEGIY----VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 565 -----------~~l~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
+...... .......+.+|+.+||+.||++|||++|++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000000 01112457788899999999999999999974
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=338.75 Aligned_cols=264 Identities=24% Similarity=0.334 Sum_probs=197.9
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeee-------------
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCR------------- 403 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~------------- 403 (660)
.|+.++.||+|+||.||+|++..+++.||||++........+++.+|++++++++||||+++++++.
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 91 (320)
T 2i6l_A 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSL 91 (320)
T ss_dssp TEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----C
T ss_pred ceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccc
Confidence 6889999999999999999999889999999998776677789999999999999999999999873
Q ss_pred -ecCeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEc-CCCCeEEee
Q 006112 404 -RKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLD-ADLEGKLGD 481 (660)
Q Consensus 404 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~-~~~~~kl~D 481 (660)
+....++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+ ++|+||||||+|||++ +++.+||+|
T Consensus 92 ~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 92 TELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp CSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred cccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEEcc
Confidence 3467899999997 799999864 348899999999999999999998 8999999999999997 567999999
Q ss_pred cccceeccCCCC--ceeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCcc-hHHHHHHHHhcC
Q 006112 482 FGLARLYDHGND--LHTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGELD-LLDWVIDYWQKG 557 (660)
Q Consensus 482 FGla~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~ 557 (660)
||+++....... .......+|..|+|||.+.. ..++.++|||||||++|||++|+.||...... ....+.......
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 244 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999987643221 12234567999999998865 67899999999999999999999999864421 111111100000
Q ss_pred ------Cccc---------CCCCcc-cccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH--HhhCC
Q 006112 558 ------DVLD---------ASDPRL-EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ--YLDGG 607 (660)
Q Consensus 558 ------~~~~---------~~d~~l-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~ 607 (660)
.... ...+.. ...........+.+++..||+.||++|||++|+++ +++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence 0000 000000 00001112356788999999999999999999987 55543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=338.13 Aligned_cols=258 Identities=26% Similarity=0.338 Sum_probs=198.6
Q ss_pred ceeeecccccccCccEEEEEEEeCC-CC--eEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCee
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPS-SH--AEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGEL 408 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~-~~--~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 408 (660)
...|+.++.||+|+||.||+|++.. ++ ..||||++... .....+.+.+|++++++++||||+++++++..+. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 3468899999999999999998643 22 36899998654 3455778999999999999999999999998764 8
Q ss_pred EEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceec
Q 006112 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLY 488 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 488 (660)
++||||+++++|.+++.... ..+++.++..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 99999999999999997643 348899999999999999999998 89999999999999999999999999999876
Q ss_pred cCCCCce--eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCC
Q 006112 489 DHGNDLH--TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDP 565 (660)
Q Consensus 489 ~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 565 (660)
....... .....+|..|+|||.+.+..++.++||||||+++|||++ |+.||...... +........+...
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~~----- 244 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QILHKIDKEGERL----- 244 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTSCCCC-----
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH--HHHHHHHccCCCC-----
Confidence 5443321 234567889999999988889999999999999999999 99999764432 1122221221111
Q ss_pred cccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCCC
Q 006112 566 RLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGA 608 (660)
Q Consensus 566 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (660)
.... .....+.+++..||+.||++||++.++++.|+...
T Consensus 245 ~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 245 PRPE----DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp CCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCc----CcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 1111 22345778888999999999999999999998653
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=339.70 Aligned_cols=263 Identities=20% Similarity=0.257 Sum_probs=202.5
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHhccCCCCceeEeeeeeec-----CeeEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD-HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK-----GELLL 410 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~~l 410 (660)
.|+..+.||+|+||.||+|++..+++.||||++..... .....+.+|++++++++||||+++++++... ...++
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 91 (353)
T 2b9h_A 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYI 91 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEE
T ss_pred ceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEE
Confidence 68889999999999999999998999999999965433 3456788999999999999999999988754 67899
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccC
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDH 490 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 490 (660)
||||+. |+|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 92 v~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 92 IQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp EECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 999996 7999998763 48999999999999999999998 8999999999999999999999999999987653
Q ss_pred CCCc---------eeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCcc-hHHHHHHHHhcCCc
Q 006112 491 GNDL---------HTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGELD-LLDWVIDYWQKGDV 559 (660)
Q Consensus 491 ~~~~---------~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~~~ 559 (660)
.... ......||+.|+|||.+.. ..++.++|||||||++|||++|+.||...... ....+.........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCS
T ss_pred ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCch
Confidence 3211 1223578999999998764 67899999999999999999999999865432 11112211111100
Q ss_pred cc---CCC-----------Ccccc----cCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH--HhhC
Q 006112 560 LD---ASD-----------PRLEG----IYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ--YLDG 606 (660)
Q Consensus 560 ~~---~~d-----------~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~ 606 (660)
.. ... +.... .........+.+++..||+.||++|||++|+++ +++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 311 (353)
T 2b9h_A 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT 311 (353)
T ss_dssp TTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred hccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 00 000 00000 000122345778899999999999999999997 4544
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=343.64 Aligned_cols=259 Identities=19% Similarity=0.227 Sum_probs=204.6
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccC-CC-----CceeEeeeeeecCeeEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLR-HR-----NLVQLRGYCRRKGELLL 410 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~-----nIv~l~g~~~~~~~~~l 410 (660)
.|+.++.||+|+||.||+|++..+++.||||++... ....+++..|+.+++.++ |+ +|+++++++...+..++
T Consensus 55 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 133 (382)
T 2vx3_A 55 RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCL 133 (382)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEE
T ss_pred eEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEE
Confidence 688899999999999999999999999999999643 344567888999988885 44 49999999999999999
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEc--CCCCeEEeecccceec
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLD--ADLEGKLGDFGLARLY 488 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~--~~~~~kl~DFGla~~~ 488 (660)
||||++ |+|.+++.......+++..+..++.|++.||.|||.. +.+|+||||||+|||++ .++.+||+|||+++..
T Consensus 134 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~ 211 (382)
T 2vx3_A 134 VFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 211 (382)
T ss_dssp EEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence 999995 6999999877655699999999999999999999941 37999999999999994 4778999999999876
Q ss_pred cCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHHHHHHhcCCc--------
Q 006112 489 DHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVIDYWQKGDV-------- 559 (660)
Q Consensus 489 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~~~~~~~-------- 559 (660)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .....+.+.......
T Consensus 212 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 287 (382)
T 2vx3_A 212 GQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPK 287 (382)
T ss_dssp TCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTT
T ss_pred ccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHH
Confidence 432 2346789999999999999999999999999999999999999986432 222222222110000
Q ss_pred ----cc-CCC-----------------Ccc--------------------cccCcHHHHHHHHHHhhhccCCCCCCCCCH
Q 006112 560 ----LD-ASD-----------------PRL--------------------EGIYVEEQMEIVLKLGLFCSHSNPDTRPSM 597 (660)
Q Consensus 560 ----~~-~~d-----------------~~l--------------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 597 (660)
.+ ..+ +.. .......+...+.+|+.+||+.||++|||+
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta 367 (382)
T 2vx3_A 288 ARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQP 367 (382)
T ss_dssp HHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCH
T ss_pred HHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCH
Confidence 00 000 000 001123344578899999999999999999
Q ss_pred HHHHH
Q 006112 598 RQVVQ 602 (660)
Q Consensus 598 ~evl~ 602 (660)
+|+++
T Consensus 368 ~e~L~ 372 (382)
T 2vx3_A 368 YYALQ 372 (382)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=339.59 Aligned_cols=261 Identities=21% Similarity=0.303 Sum_probs=178.6
Q ss_pred eeeccc-ccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHH-HHHhccCCCCceeEeeeeee----cCeeEE
Q 006112 337 SYKNLY-KATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEI-VSMGKLRHRNLVQLRGYCRR----KGELLL 410 (660)
Q Consensus 337 ~~~~l~-~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei-~~l~~l~H~nIv~l~g~~~~----~~~~~l 410 (660)
.|+.++ .||+|+||.||+|++..+++.||||++... . ...+|+ ..++.++||||+++++++.. +...++
T Consensus 29 ~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 103 (336)
T 3fhr_A 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-P----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLI 103 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-H----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred eeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-H----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEE
Confidence 577765 499999999999999989999999998542 1 222333 34566799999999999876 455899
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcC---CCCeEEeeccccee
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDA---DLEGKLGDFGLARL 487 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~---~~~~kl~DFGla~~ 487 (660)
|||||++|+|.+++.......+++.++..++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+++.
T Consensus 104 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 104 IMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp EEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 9999999999999987765679999999999999999999998 89999999999999976 45599999999986
Q ss_pred ccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHH-HHHHHHhcCCcccCCCCc
Q 006112 488 YDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLD-WVIDYWQKGDVLDASDPR 566 (660)
Q Consensus 488 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~d~~ 566 (660)
.... ......||+.|+|||++....++.++|||||||++|||++|+.||......... ........+.. ....+
T Consensus 181 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~- 255 (336)
T 3fhr_A 181 TTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY-GFPNP- 255 (336)
T ss_dssp C-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------CCCTT-
T ss_pred cccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccc-ccCch-
Confidence 5432 223457899999999998888999999999999999999999999764322111 11111111110 00111
Q ss_pred ccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH--HhhCCCCCCCCC
Q 006112 567 LEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ--YLDGGALLPDIP 614 (660)
Q Consensus 567 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~~~p~~p 614 (660)
........+.+++..||+.||++|||++|+++ +++.....|..|
T Consensus 256 ----~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~ 301 (336)
T 3fhr_A 256 ----EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTP 301 (336)
T ss_dssp ----TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSCCCB
T ss_pred ----hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCCCCc
Confidence 11122345778888999999999999999998 666554444433
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=338.96 Aligned_cols=256 Identities=25% Similarity=0.323 Sum_probs=182.3
Q ss_pred CceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHH-HHhccCCCCceeEeeeeeecCeeEEE
Q 006112 334 HRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD-HGMKQFVSEIV-SMGKLRHRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 334 ~~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~lV 411 (660)
..-+|+.++.||+|+||.||+|.+..+++.||||++..... ...+++..|+. +++.++||||+++++++..++..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 34478899999999999999999998999999999976533 34456667776 77888999999999999999999999
Q ss_pred EecCCCCChhhhhhh---CCCCCcchhHHHHHHHHHHHHHHHhhhcccC-ceeccCccCCcEEEcCCCCeEEeeccccee
Q 006112 412 YDYMPNGSLDKILYS---NTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQ-VVLHRDIKPANVLLDADLEGKLGDFGLARL 487 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDikp~NIll~~~~~~kl~DFGla~~ 487 (660)
|||++ |+|.+++.. .....+++..+..++.|++.||.|||+ . +|+||||||+|||++.++.+||+|||+++.
T Consensus 100 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 100 MELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp ECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 99997 588877753 224568999999999999999999998 6 999999999999999999999999999986
Q ss_pred ccCCCCceeeccccCccccCcccc----cCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCC
Q 006112 488 YDHGNDLHTTNVVGTVGYLAPELL----RNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDAS 563 (660)
Q Consensus 488 ~~~~~~~~~~~~~gt~~Y~aPE~~----~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (660)
..... ......||+.|+|||.+ .+..++.++|||||||++|||++|+.||...... .+.. .......
T Consensus 176 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~------~~~~~~~ 246 (327)
T 3aln_A 176 LVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV-FDQL------TQVVKGD 246 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CCCCCSC
T ss_pred ccccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH-HHHH------HHHhcCC
Confidence 64332 22334799999999998 4567899999999999999999999999753211 0100 1111111
Q ss_pred CCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 564 DPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 564 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
.+.+...........+.+++..||+.||++||++.|+++
T Consensus 247 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 122221111223345778888999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=337.17 Aligned_cols=255 Identities=22% Similarity=0.327 Sum_probs=200.7
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEE
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
.-+|+..+.||+|+||.||+|++.. .+|+|.+... .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 4478899999999999999999853 4999998643 2334567889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
||+++++|.+++.... ..+++.++..++.||+.||+|||+ .+|+||||||+|||++ ++.+||+|||+++......
T Consensus 109 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp BCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred ecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 9999999999997643 358999999999999999999998 8999999999999998 6799999999987653221
Q ss_pred ----CceeeccccCccccCcccccC---------CCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCc
Q 006112 493 ----DLHTTNVVGTVGYLAPELLRN---------GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDV 559 (660)
Q Consensus 493 ----~~~~~~~~gt~~Y~aPE~~~~---------~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 559 (660)
........||+.|+|||.+.. ..++.++||||||+++|||++|+.||.........+ ....+..
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~---~~~~~~~ 260 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW---QMGTGMK 260 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH---HHHTTCC
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HhccCCC
Confidence 112234568999999999864 457889999999999999999999998654332222 2222221
Q ss_pred ccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCCC
Q 006112 560 LDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGA 608 (660)
Q Consensus 560 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (660)
...... . ....+.+++..||+.||++|||+.++++.|+...
T Consensus 261 ~~~~~~----~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~ 301 (319)
T 2y4i_B 261 PNLSQI----G----MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301 (319)
T ss_dssp CCCCCS----S----CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred CCCCcC----C----CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 111111 1 1234678888999999999999999999998764
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=336.48 Aligned_cols=257 Identities=18% Similarity=0.214 Sum_probs=203.1
Q ss_pred eeecccccccCccEEEEEEEeCCCC-eEEEEEEeccCCChhhHHHHHHHHHHhccCCCC------ceeEeeeeeecCeeE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSH-AEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRN------LVQLRGYCRRKGELL 409 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~-~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n------Iv~l~g~~~~~~~~~ 409 (660)
.|+.++.||+|+||.||+|+...++ +.||+|++... ....+.+.+|+.++++++|++ ++.+++++...+..+
T Consensus 20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (355)
T 2eu9_A 20 RYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMC 98 (355)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEE
T ss_pred cEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEE
Confidence 6889999999999999999997666 78999998643 344577889999999998766 999999999999999
Q ss_pred EEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEE------------------
Q 006112 410 LVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLL------------------ 471 (660)
Q Consensus 410 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll------------------ 471 (660)
+||||+ +++|.+++.......+++.++..++.||+.||+|||+ ++|+||||||+|||+
T Consensus 99 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~ 174 (355)
T 2eu9_A 99 IAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174 (355)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred EEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeccccccccccccccccc
Confidence 999999 7778777776655569999999999999999999998 899999999999999
Q ss_pred -cCCCCeEEeecccceeccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcch-HHH
Q 006112 472 -DADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDL-LDW 549 (660)
Q Consensus 472 -~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~-~~~ 549 (660)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...
T Consensus 175 ~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 250 (355)
T 2eu9_A 175 SVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVM 250 (355)
T ss_dssp EESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 66789999999999864432 234679999999999999999999999999999999999999998644322 111
Q ss_pred HHHHHhc-----------CCcccC----CC-------------Ccc--cccCcHHHHHHHHHHhhhccCCCCCCCCCHHH
Q 006112 550 VIDYWQK-----------GDVLDA----SD-------------PRL--EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQ 599 (660)
Q Consensus 550 ~~~~~~~-----------~~~~~~----~d-------------~~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 599 (660)
+...... ...... .+ +.+ .......+...+.+++..||+.||++|||++|
T Consensus 251 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e 330 (355)
T 2eu9_A 251 MEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAE 330 (355)
T ss_dssp HHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHH
Confidence 1111100 000000 00 000 00112234557889999999999999999999
Q ss_pred HHH
Q 006112 600 VVQ 602 (660)
Q Consensus 600 vl~ 602 (660)
+++
T Consensus 331 ~l~ 333 (355)
T 2eu9_A 331 ALL 333 (355)
T ss_dssp HTT
T ss_pred Hhc
Confidence 985
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=343.89 Aligned_cols=260 Identities=24% Similarity=0.282 Sum_probs=192.9
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCCh-----------hhHHHHHHHHHHhccCCCCceeEeeeeee
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDH-----------GMKQFVSEIVSMGKLRHRNLVQLRGYCRR 404 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~-----------~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~ 404 (660)
-.|+.++.||+|+||.||+|.... ++.||||++...... ..+.+.+|++++++++||||+++++++..
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 100 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH 100 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred cceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence 368889999999999999999865 889999998643221 23789999999999999999999999843
Q ss_pred -----cCeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEE
Q 006112 405 -----KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKL 479 (660)
Q Consensus 405 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl 479 (660)
...+++||||++ |+|.+++.... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||
T Consensus 101 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl 175 (362)
T 3pg1_A 101 FEEPAMHKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITI 175 (362)
T ss_dssp CCTTTCCEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEE
T ss_pred ccCCCcceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEEcCCCCEEE
Confidence 346899999996 78888887543 458999999999999999999998 89999999999999999999999
Q ss_pred eecccceeccCCCCceeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHHHHHHhcC
Q 006112 480 GDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVIDYWQKG 557 (660)
Q Consensus 480 ~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~~~~~ 557 (660)
+|||+++...... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||..... .....+.+.....
T Consensus 176 ~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 253 (362)
T 3pg1_A 176 CDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253 (362)
T ss_dssp CCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred EecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 9999997543322 2344678999999999876 6789999999999999999999999986432 2222222211111
Q ss_pred Cc------------------ccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 558 DV------------------LDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 558 ~~------------------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.. ...................+.+++..||+.||++|||++|++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 00 00000000000111223457889999999999999999999973
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=347.28 Aligned_cols=260 Identities=24% Similarity=0.307 Sum_probs=195.7
Q ss_pred CceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCe------
Q 006112 334 HRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGE------ 407 (660)
Q Consensus 334 ~~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~------ 407 (660)
...+|+.++.||+|+||.||+|++..++. +|+|++..... ...+|+++++.++||||+++++++...+.
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 34579999999999999999999976655 99998864432 22379999999999999999999865443
Q ss_pred eEEEEecCCCCChhhhhh-hCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEc-CCCCeEEeecccc
Q 006112 408 LLLVYDYMPNGSLDKILY-SNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLD-ADLEGKLGDFGLA 485 (660)
Q Consensus 408 ~~lV~E~~~~gsL~~~l~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~-~~~~~kl~DFGla 485 (660)
+++|||||+++.+..... ......+++..+..++.||+.||+|||+ .+|+||||||+|||++ .++.+||+|||++
T Consensus 113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 789999997654443332 1123458999999999999999999998 8999999999999999 7899999999999
Q ss_pred eeccCCCCceeeccccCccccCcccccCC-CCCcceeEEehHHHHHHHhhCCCCCCCCCcc-hHHHHHHHHhcC------
Q 006112 486 RLYDHGNDLHTTNVVGTVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQPGELD-LLDWVIDYWQKG------ 557 (660)
Q Consensus 486 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~------ 557 (660)
+....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ....+.......
T Consensus 190 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 190 KILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK 267 (394)
T ss_dssp EECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred ccccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 87644332 2346789999999998764 5899999999999999999999999864421 222222211110
Q ss_pred ----CcccCCCCcc-----cccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 558 ----DVLDASDPRL-----EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 558 ----~~~~~~d~~l-----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
...+..-+.. ...+.......+.+++..||+.||++|||+.|++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0111111111 111122233567889999999999999999999974
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=367.45 Aligned_cols=255 Identities=25% Similarity=0.348 Sum_probs=204.5
Q ss_pred ceeeecccccccCccEEEEEEEeCC---CCeEEEEEEeccCCC-hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEE
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPS---SHAEIAVKKVCHDSD-HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLL 410 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~---~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 410 (660)
+..|+..+.||+|+||.||+|++.. .+..||||++..... ...+.+.+|+.++++++||||+++++++. ++..++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence 4468889999999999999999854 356899999865433 34578999999999999999999999985 457899
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccC
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDH 490 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 490 (660)
||||+++|+|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 468 v~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp EEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred EEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 999999999999997653 358999999999999999999998 8999999999999999999999999999987655
Q ss_pred CCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccc
Q 006112 491 GNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEG 569 (660)
Q Consensus 491 ~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 569 (660)
..........+|+.|+|||.+....++.++|||||||++|||++ |..||....... .......+.... +..
T Consensus 544 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~~~~i~~~~~~~-----~~~ 615 (656)
T 2j0j_A 544 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIENGERLP-----MPP 615 (656)
T ss_dssp ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHHTCCCC-----CCT
T ss_pred CcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHcCCCCC-----CCc
Confidence 44333445567889999999998899999999999999999997 999997644322 222222222211 111
Q ss_pred cCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 570 IYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
.....+.+++..||+.||++||++.|+++.|+.
T Consensus 616 ----~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~ 648 (656)
T 2j0j_A 616 ----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 648 (656)
T ss_dssp ----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 223457788899999999999999999999875
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=341.06 Aligned_cols=262 Identities=21% Similarity=0.318 Sum_probs=205.5
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccC-----------CCCceeEeeeeee
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLR-----------HRNLVQLRGYCRR 404 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----------H~nIv~l~g~~~~ 404 (660)
..|+.++.||+|+||.||+|++..+++.||||++... ....+.+.+|+.++++++ ||||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 3688999999999999999999999999999998642 334567889999999886 8999999999886
Q ss_pred cC----eeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccC-ceeccCccCCcEEEc------C
Q 006112 405 KG----ELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQ-VVLHRDIKPANVLLD------A 473 (660)
Q Consensus 405 ~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDikp~NIll~------~ 473 (660)
.+ ..++||||+ +++|.+++.......+++..+..++.||+.||+|||+ + +|+||||||+|||++ .
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCCcC
Confidence 54 789999999 9999999987665669999999999999999999998 7 999999999999994 3
Q ss_pred CCCeEEeecccceeccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCc-------ch
Q 006112 474 DLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGEL-------DL 546 (660)
Q Consensus 474 ~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-------~~ 546 (660)
.+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..
T Consensus 174 ~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 447999999999876432 2345789999999999999999999999999999999999999975331 11
Q ss_pred HHHHHHHHhc--------C----------CcccCCCC-cc---------cccCcHHHHHHHHHHhhhccCCCCCCCCCHH
Q 006112 547 LDWVIDYWQK--------G----------DVLDASDP-RL---------EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMR 598 (660)
Q Consensus 547 ~~~~~~~~~~--------~----------~~~~~~d~-~l---------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 598 (660)
...+.+.... + ........ .. ...+.......+.+++..||+.||++|||++
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 329 (373)
T 1q8y_A 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329 (373)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence 1111111100 0 00000000 00 0123456677899999999999999999999
Q ss_pred HHHH--HhhC
Q 006112 599 QVVQ--YLDG 606 (660)
Q Consensus 599 evl~--~L~~ 606 (660)
|+++ +++.
T Consensus 330 ell~hp~f~~ 339 (373)
T 1q8y_A 330 GLVNHPWLKD 339 (373)
T ss_dssp HHHTCGGGTT
T ss_pred HHhhChhhhc
Confidence 9997 4444
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=328.99 Aligned_cols=249 Identities=24% Similarity=0.338 Sum_probs=203.5
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
.|+.++.||+|+||.||+|+...+++.||+|++... .....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 23 ~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 102 (287)
T 2wei_A 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL 102 (287)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEc
Confidence 688899999999999999999888999999998653 234567899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCC---CCeEEeecccceeccCC
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDAD---LEGKLGDFGLARLYDHG 491 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~---~~~kl~DFGla~~~~~~ 491 (660)
+++++|.+++.... .+++.++..++.||+.||.|||+ .+|+||||||+||+++.+ +.+||+|||+++.....
T Consensus 103 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 103 YTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp CCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 99999999887643 48999999999999999999998 899999999999999764 46999999999866443
Q ss_pred CCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccC
Q 006112 492 NDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIY 571 (660)
Q Consensus 492 ~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 571 (660)
.. .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||....... .......+..... .+. ...
T Consensus 178 ~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~-~~~-~~~- 248 (287)
T 2wei_A 178 TK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD---ILKRVETGKYAFD-LPQ-WRT- 248 (287)
T ss_dssp SS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHCCCCCC-SGG-GTT-
T ss_pred Cc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH---HHHHHHcCCCCCC-chh-hhh-
Confidence 22 233468999999999865 58999999999999999999999998644321 2222233322110 010 011
Q ss_pred cHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 572 VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
....+.+++..||+.||++|||+.|+++
T Consensus 249 ---~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 249 ---ISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp ---SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---cCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 2345778888999999999999999997
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=341.88 Aligned_cols=255 Identities=23% Similarity=0.264 Sum_probs=197.1
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCee------
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGEL------ 408 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~------ 408 (660)
.|...+.||+|+||.||+|++..+++.||||++.... ....+.+.+|+.++++++||||+++++++...+..
T Consensus 43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 122 (371)
T 4exu_A 43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 122 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCC
T ss_pred cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeE
Confidence 6888899999999999999999999999999996543 23457889999999999999999999999877654
Q ss_pred EEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceec
Q 006112 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLY 488 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 488 (660)
++||||+. ++|.+++. ..+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 123 ~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 123 YLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp EEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred EEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 99999996 78888873 238999999999999999999998 89999999999999999999999999999865
Q ss_pred cCCCCceeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCcc-hHHHHHHHHhcCCc--ccC--
Q 006112 489 DHGNDLHTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGELD-LLDWVIDYWQKGDV--LDA-- 562 (660)
Q Consensus 489 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~~~--~~~-- 562 (660)
... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...... ....+......... ...
T Consensus 195 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 270 (371)
T 4exu_A 195 DAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 270 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred ccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhh
Confidence 332 334678999999999877 67899999999999999999999999864321 12222111110000 000
Q ss_pred ----------CCCccccc---CcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 563 ----------SDPRLEGI---YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 563 ----------~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
........ ........+.+++..||+.||++|||++|++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 271 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00000000 001123567888999999999999999999973
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=341.34 Aligned_cols=260 Identities=23% Similarity=0.241 Sum_probs=188.2
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCe-------eE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGE-------LL 409 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~-------~~ 409 (660)
.|+..+.||+|+||.||+|++..+++.||||++... ....+.+.+|++.++.++||||+++++++...+. ++
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~ 102 (360)
T 3e3p_A 24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLN 102 (360)
T ss_dssp TEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEE
Confidence 588889999999999999999989999999998554 3334567888999999999999999999976443 88
Q ss_pred EEEecCCCCChhhhhhh--CCCCCcchhHHHHHHHHHHHHHHHhh--hcccCceeccCccCCcEEEcC-CCCeEEeeccc
Q 006112 410 LVYDYMPNGSLDKILYS--NTRPSLNWFQRFRIIKGVAFGLLYLH--EEWEQVVLHRDIKPANVLLDA-DLEGKLGDFGL 484 (660)
Q Consensus 410 lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~ivHrDikp~NIll~~-~~~~kl~DFGl 484 (660)
+||||+++ +|...+.. .....+++..+..++.|++.||.||| + ++|+||||||+|||++. ++.+||+|||+
T Consensus 103 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 103 VVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred EEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 99999975 55444432 23345889999999999999999999 6 99999999999999997 89999999999
Q ss_pred ceeccCCCCceeeccccCccccCcccccCC-CCCcceeEEehHHHHHHHhhCCCCCCCCCcc-hHHHHHHHHhcC-----
Q 006112 485 ARLYDHGNDLHTTNVVGTVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQPGELD-LLDWVIDYWQKG----- 557 (660)
Q Consensus 485 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~----- 557 (660)
++...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ....+.+.....
T Consensus 179 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3e3p_A 179 AKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256 (360)
T ss_dssp CBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHH
Confidence 98765432 23346789999999998654 4899999999999999999999999864432 222222111110
Q ss_pred -------CcccCCCC---cc---cccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 558 -------DVLDASDP---RL---EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 558 -------~~~~~~d~---~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
......+. .. ...........+.+++..||+.||++|||+.|++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000000 00 000111234568899999999999999999999973
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=345.36 Aligned_cols=254 Identities=24% Similarity=0.294 Sum_probs=180.8
Q ss_pred ccccccCccEEEEEEEeC--CCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeee--cCeeEEEEecCC
Q 006112 341 LYKATKGGSGKVYRGVLP--SSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR--KGELLLVYDYMP 416 (660)
Q Consensus 341 l~~lg~G~fg~Vy~g~~~--~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV~E~~~ 416 (660)
.++||+|+||.||+|++. .+++.||||++.... ..+.+.+|+.++++++||||+++++++.. ...+++||||+.
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 347999999999999975 467899999986432 33578899999999999999999999954 678999999995
Q ss_pred CCChhhhhhhC-------CCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEE----cCCCCeEEeecccc
Q 006112 417 NGSLDKILYSN-------TRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLL----DADLEGKLGDFGLA 485 (660)
Q Consensus 417 ~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll----~~~~~~kl~DFGla 485 (660)
|+|.+++... ....+++..+..++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||++
T Consensus 104 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 179 (405)
T 3rgf_A 104 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 179 (405)
T ss_dssp -EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred -CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence 6888877522 12348999999999999999999998 899999999999999 77889999999999
Q ss_pred eeccCCCC--ceeeccccCccccCcccccCC-CCCcceeEEehHHHHHHHhhCCCCCCCCCc----------chHHHHHH
Q 006112 486 RLYDHGND--LHTTNVVGTVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQPGEL----------DLLDWVID 552 (660)
Q Consensus 486 ~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~----------~~~~~~~~ 552 (660)
+....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... .....+..
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~ 259 (405)
T 3rgf_A 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 259 (405)
T ss_dssp C----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHH
T ss_pred eecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHH
Confidence 87654322 223456899999999998874 589999999999999999999999975332 12222222
Q ss_pred HHhcCCcccCCCCccccc-----------------Cc-H--------HHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 553 YWQKGDVLDASDPRLEGI-----------------YV-E--------EQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 553 ~~~~~~~~~~~d~~l~~~-----------------~~-~--------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
..... .....+.+... .. . .....+.+|+..||+.||.+|||++|+++
T Consensus 260 ~~g~p--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 260 VMGFP--ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHCCC--CTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhCCC--ChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 21111 00000000000 00 0 00235678999999999999999999997
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=332.54 Aligned_cols=249 Identities=22% Similarity=0.331 Sum_probs=194.8
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccC--CCCceeEeeeeeecCeeEEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLR--HRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~--H~nIv~l~g~~~~~~~~~lV 411 (660)
-.|+.++.||+|+||.||++.+. +++.||||++... .....+.+.+|+.++.+++ |+||+++++++..++..++|
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 106 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 106 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred ceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence 46999999999999999999985 4888999998654 3345678999999999997 59999999999999999999
Q ss_pred EecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCC
Q 006112 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 491 (660)
|| +.+++|.+++.... .+++.++..++.|++.||.|||+ .+|+||||||+|||+++ +.+||+|||+++.....
T Consensus 107 ~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 107 ME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPD 179 (313)
T ss_dssp EC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCSSSCC----
T ss_pred Ee-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeeccccccccCc
Confidence 99 56899999998754 58899999999999999999998 89999999999999965 78999999999876543
Q ss_pred CCc-eeeccccCccccCcccccC-----------CCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCc
Q 006112 492 NDL-HTTNVVGTVGYLAPELLRN-----------GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDV 559 (660)
Q Consensus 492 ~~~-~~~~~~gt~~Y~aPE~~~~-----------~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 559 (660)
... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||....... ............
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~ 258 (313)
T 3cek_A 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-SKLHAIIDPNHE 258 (313)
T ss_dssp ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-HHHHHHHCTTSC
T ss_pred cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-HHHHHHHhcccc
Confidence 221 2234579999999999875 467889999999999999999999997543222 222222211111
Q ss_pred ccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 560 LDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 560 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
..+.... ...+.+++..||+.||++||++.|+++
T Consensus 259 -----~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 259 -----IEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp -----CCCCCCS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----cCCcccc----hHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 1111111 245778888999999999999999996
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=337.49 Aligned_cols=254 Identities=22% Similarity=0.273 Sum_probs=197.1
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCe------e
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGE------L 408 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~------~ 408 (660)
.|...+.||+|+||.||+|++..+++.||||++.... ....+.+.+|+.++++++||||+++++++...+. .
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 104 (353)
T 3coi_A 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 104 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeE
Confidence 5888999999999999999999999999999996542 2345788999999999999999999999987654 4
Q ss_pred EEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceec
Q 006112 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLY 488 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 488 (660)
++||||+. ++|.+++.. .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 105 ~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 105 YLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp EEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred EEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 99999996 799888742 38999999999999999999998 89999999999999999999999999999865
Q ss_pred cCCCCceeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCcc-hHHHHHHHHhcC---------
Q 006112 489 DHGNDLHTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGELD-LLDWVIDYWQKG--------- 557 (660)
Q Consensus 489 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~--------- 557 (660)
... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...... ....+.......
T Consensus 177 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 252 (353)
T 3coi_A 177 DAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252 (353)
T ss_dssp -----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred CCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHh
Confidence 322 234578999999999876 67899999999999999999999999764421 122221111100
Q ss_pred ---------CcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 558 ---------DVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 558 ---------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.......+.+. .........+.+++..|++.||++|||++|++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 253 DKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp CHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000001111 1112234567788889999999999999999963
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=337.00 Aligned_cols=242 Identities=25% Similarity=0.337 Sum_probs=200.4
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC------hhhHHHHHHHHHHhccC--CCCceeEeeeeeecC
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD------HGMKQFVSEIVSMGKLR--HRNLVQLRGYCRRKG 406 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~--H~nIv~l~g~~~~~~ 406 (660)
...|+..+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+.++++++ |+||+++++++..++
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~ 121 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 121 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence 3468899999999999999999999999999999965422 12356788999999996 599999999999999
Q ss_pred eeEEEEecCCC-CChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEc-CCCCeEEeeccc
Q 006112 407 ELLLVYDYMPN-GSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLD-ADLEGKLGDFGL 484 (660)
Q Consensus 407 ~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~-~~~~~kl~DFGl 484 (660)
..++|||++.+ ++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++ +++.+||+|||+
T Consensus 122 ~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 122 SFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred cEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 99999999976 89999997643 48999999999999999999998 8999999999999999 778999999999
Q ss_pred ceeccCCCCceeeccccCccccCcccccCCCC-CcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCC
Q 006112 485 ARLYDHGNDLHTTNVVGTVGYLAPELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDAS 563 (660)
Q Consensus 485 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (660)
++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||..... . ..+..
T Consensus 197 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~----~~~~~---- 260 (320)
T 3a99_A 197 GALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----I----IRGQV---- 260 (320)
T ss_dssp CEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H----HHCCC----
T ss_pred cccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----h----hcccc----
Confidence 98765332 234579999999999887665 6889999999999999999999974211 1 11111
Q ss_pred CCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 564 DPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 564 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.....+ ...+.+++.+||+.||++|||++|++++
T Consensus 261 --~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 261 --FFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp --CCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --cccccC----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011122 2356788889999999999999999973
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=333.41 Aligned_cols=240 Identities=22% Similarity=0.325 Sum_probs=193.3
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC------hhhHHHHHHHHHHhcc----CCCCceeEeeeeeecC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD------HGMKQFVSEIVSMGKL----RHRNLVQLRGYCRRKG 406 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l----~H~nIv~l~g~~~~~~ 406 (660)
.|+..+.||+|+||.||+|++..+++.||||++..... .....+.+|+.++.++ +||||+++++++...+
T Consensus 32 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~ 111 (312)
T 2iwi_A 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQE 111 (312)
T ss_dssp -CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC----
T ss_pred ceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCC
Confidence 58889999999999999999988999999999865432 2234567899999988 8999999999999999
Q ss_pred eeEEEEec-CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEc-CCCCeEEeeccc
Q 006112 407 ELLLVYDY-MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLD-ADLEGKLGDFGL 484 (660)
Q Consensus 407 ~~~lV~E~-~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~-~~~~~kl~DFGl 484 (660)
..++|||| +.+++|.+++.... .+++.++..++.||+.||+|||+ .+|+||||||+||+++ .++.+||+|||+
T Consensus 112 ~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 112 GFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp -CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred eEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence 99999999 78999999997643 48999999999999999999998 8999999999999999 889999999999
Q ss_pred ceeccCCCCceeeccccCccccCcccccCCCC-CcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCC
Q 006112 485 ARLYDHGNDLHTTNVVGTVGYLAPELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDAS 563 (660)
Q Consensus 485 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (660)
++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... ... ...
T Consensus 187 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~----~~~----- 249 (312)
T 2iwi_A 187 GALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----EIL----EAE----- 249 (312)
T ss_dssp CEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHH----HTC-----
T ss_pred hhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----HHh----hhc-----
Confidence 98765432 234579999999999877665 458999999999999999999997421 111 111
Q ss_pred CCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 564 DPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 564 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
..+...+ ...+.+++..||+.||++||+++|++++
T Consensus 250 -~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 250 -LHFPAHV----SPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -CCCCTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -cCCcccC----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111222 3356788889999999999999999984
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=328.38 Aligned_cols=251 Identities=22% Similarity=0.311 Sum_probs=181.2
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCCh-hh-HHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDH-GM-KQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~-~~-~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
-.|+.++.||+|+||.||+|++..+++.||||++...... .. +.+.++..+++.++||||+++++++..++..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 3688899999999999999999989999999999755332 23 334455567888899999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccC-ceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQ-VVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
|+ ++.+..+.... ...+++..+..++.|++.||.|||+ + +|+||||||+||+++.++.+||+|||+++......
T Consensus 105 ~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 105 LM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp CC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred cc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 99 55666555432 3458999999999999999999997 5 99999999999999999999999999997654432
Q ss_pred CceeeccccCccccCccccc-----CCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcc
Q 006112 493 DLHTTNVVGTVGYLAPELLR-----NGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL 567 (660)
Q Consensus 493 ~~~~~~~~gt~~Y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 567 (660)
......||+.|+|||.+. ...++.++|||||||++|||++|+.||....... +........ .. +.+
T Consensus 180 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~-~~-----~~~ 250 (318)
T 2dyl_A 180 --AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF-EVLTKVLQE-EP-----PLL 250 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH-HHHHHHHHS-CC-----CCC
T ss_pred --cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH-HHHHHHhcc-CC-----CCC
Confidence 223457899999999984 4568899999999999999999999997633221 112222222 11 111
Q ss_pred cccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 568 EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
... ......+.+++..||+.||.+||+++|+++
T Consensus 251 ~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 251 PGH--MGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CSS--SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred Ccc--CCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 110 012234678888999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=341.43 Aligned_cols=249 Identities=22% Similarity=0.290 Sum_probs=186.9
Q ss_pred eecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCeeEEEEecCC
Q 006112 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~ 416 (660)
|...+.||+|+||+||.+.. .+++.||||++... ..+.+.+|+++++++ +||||+++++++.+++.+++|||||.
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 45567899999999976543 46889999998543 345678999999886 89999999999999999999999995
Q ss_pred CCChhhhhhhCCCCC-----cchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCC-------------CCeE
Q 006112 417 NGSLDKILYSNTRPS-----LNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDAD-------------LEGK 478 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~-----l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~-------------~~~k 478 (660)
|+|.+++....... .++..++.++.||+.||+|||+ ++|+||||||+|||++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 79999997653211 2445668899999999999998 899999999999999754 4899
Q ss_pred EeecccceeccCCCCc---eeeccccCccccCcccccC-------CCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchH
Q 006112 479 LGDFGLARLYDHGNDL---HTTNVVGTVGYLAPELLRN-------GRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLL 547 (660)
Q Consensus 479 l~DFGla~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~-------~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~ 547 (660)
|+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||........
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~ 248 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 248 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH
Confidence 9999999887554322 1234679999999999865 568999999999999999999 9999975433221
Q ss_pred HHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 548 DWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 548 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
.. . .+... .+.+...........+.+++.+||+.||++|||+.||++
T Consensus 249 ~i-~----~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 249 NI-I----RGIFS---LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HH-H----HTCCC---CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH-h----cCCCC---cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11 1 11110 011112223455677889999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=339.82 Aligned_cols=248 Identities=21% Similarity=0.361 Sum_probs=187.6
Q ss_pred ceeeecccccccCccEEE-EEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCeeEEEE
Q 006112 335 RFSYKNLYKATKGGSGKV-YRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~V-y~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
..+|+..+.||+|+||+| |++.. +++.||||++.... .+.+.+|+++++++ +||||+++++++.+.+..++||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~--~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMF--DNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEES--SSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEe--CCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 457888999999999985 44443 67899999995432 34567899999999 7999999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcC-----CCCeEEeeccccee
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDA-----DLEGKLGDFGLARL 487 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~-----~~~~kl~DFGla~~ 487 (660)
|||. |+|.+++..... .+.+.++..++.||+.||+|||+ .+|+||||||+|||++. ...+||+|||+++.
T Consensus 98 E~~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp ECCS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred ECCC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 9995 799999976543 35566778999999999999998 89999999999999943 34688999999987
Q ss_pred ccCCCC--ceeeccccCccccCccccc---CCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCccc
Q 006112 488 YDHGND--LHTTNVVGTVGYLAPELLR---NGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLD 561 (660)
Q Consensus 488 ~~~~~~--~~~~~~~gt~~Y~aPE~~~---~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 561 (660)
...... .......||+.|+|||++. ...++.++|||||||++|||++ |..||.......... ........
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~----~~~~~~~~ 248 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI----LLGACSLD 248 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH----HTTCCCCT
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH----HhccCCcc
Confidence 654322 2234567999999999997 4567889999999999999999 899986543322211 11111111
Q ss_pred CCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 562 ASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 562 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
...+ .......+.+++..||+.||++|||++||++
T Consensus 249 ~~~~------~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 249 CLHP------EKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TSCT------TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCc------cccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1111 1223445778899999999999999999985
|
| >1qmo_E Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=277.15 Aligned_cols=114 Identities=34% Similarity=0.478 Sum_probs=105.4
Q ss_pred ccEEEEEeecccCCCCCCCCCCeeEEEcCCccccccccccccccccccccccccCCCccEEEEEEEeCcceeEEEEEeeC
Q 006112 137 NHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPV 216 (660)
Q Consensus 137 ~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~ 216 (660)
||+|||||||++|.+++||++||||||+||+.|.++++| ++.+|+.++|||+||+.+++|+|+|++.
T Consensus 1 n~~vAVEFDT~~N~e~~Dp~~nHVGIdvNsi~S~~s~~~-------------~l~sG~~~~v~I~Yd~~~~~L~V~l~~~ 67 (133)
T 1qmo_E 1 SNVVAVEFDTYLNPDYGDPNYIHIGIDVNSIRSKVTAKW-------------DWQNGKIATAHISYNSVSKRLSVTSYYA 67 (133)
T ss_dssp CCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEEC-------------CCCTTSCEEEEEEEETTTTEEEEEEECS
T ss_pred CCEEEEEEeCCcCccccCCCCCeeEEecccccccceeee-------------EEcCCCEEEEEEEEeCCCcEEEEEEccC
Confidence 689999999999999899999999999999999888764 3679999999999999999999999876
Q ss_pred CCCCCCCCcceeecCchhhhccceeeeeecccCceeeeeeecCcccccCC
Q 006112 217 PNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTRVSDYYILGWSFNKSG 266 (660)
Q Consensus 217 ~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg~~~~~h~i~~wsf~~~g 266 (660)
+. + .|+|++.+||+++|+|+||||||||||...|.|+|++|+|++..
T Consensus 68 ~~-~--~p~ls~~vdLs~~l~e~v~VGFSAsTG~~~~~h~IlsWsF~s~l 114 (133)
T 1qmo_E 68 GS-K--PATLSYDIELHTVLPEWVRVGLSASTGQDKERNTVHSWSFTSSL 114 (133)
T ss_dssp SS-C--CEEEEEECCGGGTSCSEEEEEEEEECSSSCCEEEEEEEEEEEEE
T ss_pred CC-c--cceEEEeechHHhccccEEEEEEeccCCCcceeEEEEEEEEeeC
Confidence 43 2 78999999999999999999999999999999999999999863
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=356.35 Aligned_cols=259 Identities=27% Similarity=0.332 Sum_probs=201.0
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccC-CChhhHHHHHHHHHHhccCCCCceeEeeeeee------cCee
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD-SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR------KGEL 408 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~------~~~~ 408 (660)
..|+..+.||+|+||.||+|.+..+++.||||++... .....+.+.+|++++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 3688999999999999999999889999999998654 33456789999999999999999999998765 6678
Q ss_pred EEEEecCCCCChhhhhhhCC-CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCC---eEEeeccc
Q 006112 409 LLVYDYMPNGSLDKILYSNT-RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLE---GKLGDFGL 484 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~---~kl~DFGl 484 (660)
++|||||++|+|.+++.... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999997643 2358999999999999999999998 89999999999999987765 99999999
Q ss_pred ceeccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcC-------
Q 006112 485 ARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKG------- 557 (660)
Q Consensus 485 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~------- 557 (660)
++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.+.... ..|.......+
T Consensus 171 a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-~~~~~~i~~~~~~~~~~~ 247 (676)
T 3qa8_A 171 AKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-VQWHGKVREKSNEHIVVY 247 (676)
T ss_dssp CCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-HHSSTTCC------CCSC
T ss_pred cccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-hhhhhhhhcccchhhhhh
Confidence 98765433 234467999999999999999999999999999999999999999753211 11110000000
Q ss_pred -----CcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHH
Q 006112 558 -----DVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQV 600 (660)
Q Consensus 558 -----~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev 600 (660)
...-.................+.+++..|++.||++|||++|+
T Consensus 248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 0000000011122344456778899999999999999999763
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=315.59 Aligned_cols=241 Identities=20% Similarity=0.248 Sum_probs=186.0
Q ss_pred eeecc-cccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHH-hccCCCCceeEeeeeee----cCeeEE
Q 006112 337 SYKNL-YKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSM-GKLRHRNLVQLRGYCRR----KGELLL 410 (660)
Q Consensus 337 ~~~~l-~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l-~~l~H~nIv~l~g~~~~----~~~~~l 410 (660)
.|..+ +.||+|+||.||++....+++.||+|++.. ...+.+|+.++ +.++||||+++++++.. ....++
T Consensus 18 ~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 92 (299)
T 3m2w_A 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 92 (299)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred chhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEE
Confidence 57776 679999999999999999999999999853 24677899888 55689999999999877 677999
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcC---CCCeEEeeccccee
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDA---DLEGKLGDFGLARL 487 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~---~~~~kl~DFGla~~ 487 (660)
||||+++|+|.+++.......+++.++..++.|++.||.|||+ .+|+||||||+|||++. ++.+||+|||+++.
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 169 (299)
T 3m2w_A 93 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169 (299)
T ss_dssp EECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence 9999999999999988765679999999999999999999998 89999999999999998 78899999999875
Q ss_pred ccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcc
Q 006112 488 YDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL 567 (660)
Q Consensus 488 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 567 (660)
.. +..++.++|||||||++|||++|+.||......... .............+
T Consensus 170 ~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----~~~~~~~~~~~~~~ 221 (299)
T 3m2w_A 170 TT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----PGMKTRIRMGQYEF 221 (299)
T ss_dssp CT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------CCSCCSSCTTCCSS
T ss_pred cc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----HHHHHHHhhccccC
Confidence 32 234678999999999999999999999753221100 00000000001111
Q ss_pred cccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH--HhhCCCCCCCC
Q 006112 568 EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ--YLDGGALLPDI 613 (660)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~~~p~~ 613 (660)
...........+.+++..||+.||++|||+.|+++ ++......|..
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~~ 269 (299)
T 3m2w_A 222 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 269 (299)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCCC
T ss_pred CchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCCC
Confidence 10000122356788889999999999999999997 55554434433
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=353.20 Aligned_cols=236 Identities=21% Similarity=0.290 Sum_probs=191.9
Q ss_pred eeecccccccCccEEEEEEEeCC-CCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCe-----eE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPS-SHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGE-----LL 409 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~-----~~ 409 (660)
.|+.++.||+|+||.||+|.+.. +++.||||++.... ....+.+.+|++++++++||||++++++|...+. .+
T Consensus 81 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~ 160 (681)
T 2pzi_A 81 QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGY 160 (681)
T ss_dssp TEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred ceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeE
Confidence 68899999999999999999975 68999999986543 3456688999999999999999999999987765 79
Q ss_pred EEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceecc
Q 006112 410 LVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYD 489 (660)
Q Consensus 410 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 489 (660)
||||||++++|.+++.. .++|.+++.++.||+.||.|||+ ++|+||||||+|||++.+ .+||+|||+++...
T Consensus 161 lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 161 IVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN 232 (681)
T ss_dssp EEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred EEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence 99999999999987753 58999999999999999999998 899999999999999986 89999999998764
Q ss_pred CCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccc
Q 006112 490 HGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEG 569 (660)
Q Consensus 490 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 569 (660)
.. ....||+.|+|||++.++. +.++|||||||++|||++|..|+...... .. + ..
T Consensus 233 ~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------------~~-~--~~ 287 (681)
T 2pzi_A 233 SF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD----------------GL-P--ED 287 (681)
T ss_dssp CC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS----------------SC-C--TT
T ss_pred cC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc----------------cc-c--cc
Confidence 33 3457999999999987654 89999999999999999998887641110 00 0 01
Q ss_pred cCcHHHHHHHHHHhhhccCCCCCCCCC-HHHHHHHhh
Q 006112 570 IYVEEQMEIVLKLGLFCSHSNPDTRPS-MRQVVQYLD 605 (660)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~L~ 605 (660)
.........+.+++..||+.||++||+ ++++.+.|.
T Consensus 288 ~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 288 DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 111223356788999999999999995 555555554
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=312.57 Aligned_cols=230 Identities=11% Similarity=0.104 Sum_probs=182.6
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
.|+.++.||+|+||.||+|++..+++.||||++.... ....+.+.+|+.++.+++||||+++++++.+++..++|||
T Consensus 32 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 111 (286)
T 3uqc_A 32 RYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAE 111 (286)
T ss_dssp TEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEE
Confidence 5888899999999999999999889999999997543 2345789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
|+++++|.+++... ....++.+++.||+.||+|||+ ++|+||||||+|||++.++.+||+++
T Consensus 112 ~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~----------- 173 (286)
T 3uqc_A 112 WIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYP----------- 173 (286)
T ss_dssp CCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSC-----------
T ss_pred ecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEec-----------
Confidence 99999999999542 2445688999999999999998 89999999999999999999999744
Q ss_pred ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
+|++| ++.++|||||||++|||++|+.||........- ......... .+........
T Consensus 174 ----------~~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~-----~~~~~~~~~-~~~~~~~~~~ 230 (286)
T 3uqc_A 174 ----------ATMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL-----APAERDTAG-QPIEPADIDR 230 (286)
T ss_dssp ----------CCCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS-----EECCBCTTS-CBCCHHHHCT
T ss_pred ----------cccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh-----HHHHHHhcc-CCCChhhccc
Confidence 34443 688999999999999999999999864321000 000000000 0000001112
Q ss_pred HHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCCC
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGA 608 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (660)
.....+.+++.+||+.||++| |+.|+++.|+...
T Consensus 231 ~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 231 DIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp TSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 233457888999999999999 9999999998643
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=331.19 Aligned_cols=241 Identities=16% Similarity=0.080 Sum_probs=183.5
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC---hhhHHHHHHHHHHhccCC-CCceeEeee----------
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD---HGMKQFVSEIVSMGKLRH-RNLVQLRGY---------- 401 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~H-~nIv~l~g~---------- 401 (660)
..|+..+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+.+++.++| +|...+..+
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 357788899999999999999999999999999874332 336789999999999987 332111111
Q ss_pred -----------eee-----cCeeEEEEecCCCCChhhhhh-----hCCCCCcchhHHHHHHHHHHHHHHHhhhcccCcee
Q 006112 402 -----------CRR-----KGELLLVYDYMPNGSLDKILY-----SNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVL 460 (660)
Q Consensus 402 -----------~~~-----~~~~~lV~E~~~~gsL~~~l~-----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv 460 (660)
+.. ....+++|+++ +++|.+++. ......+++..++.++.||++||+|||+ ++|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcc
Confidence 111 12357778876 799999885 2233458899999999999999999998 9999
Q ss_pred ccCccCCcEEEcCCCCeEEeecccceeccCCCCceeeccccCccccCcccc----------cCCCCCcceeEEehHHHHH
Q 006112 461 HRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELL----------RNGRGTTSTDVYAFGVFML 530 (660)
Q Consensus 461 HrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~----------~~~~~t~ksDV~S~Gvvl~ 530 (660)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||++|
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999999999864332 445677 999999999 5556788999999999999
Q ss_pred HHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 531 EVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 531 elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
||++|+.||........ .+..-... ..+ .+.+.+++..||+.||++||++.|+++
T Consensus 309 elltg~~Pf~~~~~~~~------------~~~~~~~~-~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGG------------SEWIFRSC-KNI----PQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHSSCCCCTTGGGSC------------SGGGGSSC-CCC----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHCCCCCCCcchhhh------------HHHHHhhc-ccC----CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999976432110 00000000 111 245778888999999999999877754
|
| >2dur_A VIP36;, vesicular integral-membrane protein VIP36; beta sandwich, carbohydrate binding protein, cargo receptor, transport; HET: MAN; 1.65A {Canis lupus familiaris} PDB: 2dup_A 2duq_A* 2duo_A* 2e6v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=298.18 Aligned_cols=199 Identities=19% Similarity=0.195 Sum_probs=149.6
Q ss_pred CCeeEecceeEcCCCcEEecCCCCCeeEEEEeCCCeeeccCCCCceeEEEEEEEEEecCCC-CCCCCceEEEEecCCCCC
Q 006112 38 SKLKLDGLAKIHPNGLLQLTNTSERISGHAFYPFPFKFNSSSSQSLSFSTSFVFAMFPKLP-NYGGHGMAFFISPSTDFS 116 (660)
Q Consensus 38 ~~l~~~g~a~~~~~g~l~Lt~~~~~~~G~~~y~~pv~~~~~~~~~~sFst~F~F~i~~~~~-~~~g~GlaF~l~p~~~~~ 116 (660)
+++.++|+|.+. +|.|+||++..++.|||||+.|+++ +||+|+|+|.|.+... ..+||||||+|+|...
T Consensus 25 ~~~~l~G~a~i~-~g~l~LT~~~~~~~G~~w~~~pi~~-------~sF~t~F~F~I~~~~~~~~~gdGlAF~l~~~~~-- 94 (253)
T 2dur_A 25 PLWDFQGSTILT-SQYVRLTPDERSKEGSIWNHQPCFL-------KDWEMHVHFKVHGTGKKNLHGDGIALWYTRDRL-- 94 (253)
T ss_dssp CSEEEEETCEEC-SSCEEEECSSSSEEEEEEESSCBCC-------SSEEEEEEEEEECCCCTTCCCCEEEEEEESCCS--
T ss_pred CCEEEccceEEE-CCEEEECCCCCCCEEEEEeCCCCcc-------CcEEEEEEEEEecCCCCCcCCCcEEEEEECCCC--
Confidence 689999999996 9999999999999999999999997 5799999999998765 5689999999999754
Q ss_pred CCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCeeEEEcCCcccccccccccccccc-ccc--ccccc-CC
Q 006112 117 EAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEK-KEF--ESLVL-ES 192 (660)
Q Consensus 117 ~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~~-~~~--~~~~l-~~ 192 (660)
..|++||+.+ .++.|||||||++|.++.| |+++|||++.+..++.+....+.. ... ....+ +.
T Consensus 95 --~~G~~lG~~~-------~~~gvAVefDT~~n~~~~~----~~~~~I~~~~n~gs~~~d~~~dg~~~~~~~c~~~~~n~ 161 (253)
T 2dur_A 95 --VPGPVFGSKD-------NFHGLAIFLDTYPNDETTE----RVFPYISVMVNNGSLSYDHSKDGRWTELAGCTADFRNR 161 (253)
T ss_dssp --CEETBTEECS-------SCEEEEEEEECSCCCTTCC----SCSSEEEEEEEESCCCCCGGGTTGGGCCEEEECCCBTC
T ss_pred --CCCcccCcCC-------CCCEEEEEEECCCCCCCCC----CCCcEEEEEecCCceeeeccCCCcccccccccHhhccC
Confidence 2578999632 3678999999999975433 555555555554444321100100 000 01133 34
Q ss_pred CccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeecccCceeeeeeecCcccccC
Q 006112 193 GKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTRVSDYYILGWSFNKS 265 (660)
Q Consensus 193 g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg~~~~~h~i~~wsf~~~ 265 (660)
|+.++|||+|++. +|+|++++.+. .+..++ ..+| ..+||++|||||||+||...+.|+|++|+|..-
T Consensus 162 g~~~~v~I~Y~~~--~L~V~l~~~~~-~~~~~~--~~~~-~v~Lp~~~yvGfSAaTG~~~~~h~Ilswsf~sl 228 (253)
T 2dur_A 162 DHDTFLAVRYSRG--RLTVMTDLEDK-NEWKNC--IDIT-GVRLPTGYYFGASAGTGDLSDNHDIISMKLFQL 228 (253)
T ss_dssp SSCEEEEEEEETT--EEEEEEECSSS-SCCEEE--EEEC-CEECCSSBEEEEEEEESSSCCEEEEEEEEEEEC
T ss_pred CCCeEEEEEEECC--EEEEEEeCCCC-CCceEE--EEeC-CcccCCCcEEEEEeccCCCcceEEEEEEEEEec
Confidence 8899999999976 89999986543 233333 3444 345999999999999999999999999999864
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=319.32 Aligned_cols=242 Identities=16% Similarity=0.169 Sum_probs=183.9
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--------ChhhHHHHHHHHHHhccC---------CCCceeE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--------DHGMKQFVSEIVSMGKLR---------HRNLVQL 398 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~---------H~nIv~l 398 (660)
-.|+.++.||+|+||+||+|++ +++.||||++.... ....+.+.+|+.++++++ ||||+++
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 3688899999999999999998 67999999997543 223478899999998886 6666666
Q ss_pred eee-----------------eee-------------cCeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHH
Q 006112 399 RGY-----------------CRR-------------KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGL 448 (660)
Q Consensus 399 ~g~-----------------~~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL 448 (660)
.+. +.+ .+.+++|||||++|++.+.+.+ ..+++.++..++.||+.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence 554 332 6789999999999977666643 3489999999999999999
Q ss_pred HHhh-hcccCceeccCccCCcEEEcCCC--------------------CeEEeecccceeccCCCCceeeccccCccccC
Q 006112 449 LYLH-EEWEQVVLHRDIKPANVLLDADL--------------------EGKLGDFGLARLYDHGNDLHTTNVVGTVGYLA 507 (660)
Q Consensus 449 ~yLH-~~~~~~ivHrDikp~NIll~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~a 507 (660)
+||| + ++|+||||||+|||++.++ .+||+|||+|+..... ...||+.|+|
T Consensus 175 ~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~a 245 (336)
T 2vuw_A 175 AVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMD 245 (336)
T ss_dssp HHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTC
T ss_pred HHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccC
Confidence 9999 7 8999999999999999887 8999999999876532 3479999999
Q ss_pred cccccCCCCCcceeEEehHHH-HHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhc
Q 006112 508 PELLRNGRGTTSTDVYAFGVF-MLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFC 586 (660)
Q Consensus 508 PE~~~~~~~t~ksDV~S~Gvv-l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C 586 (660)
||++.+.. +.++||||++++ .+++++|..||.... ......+......... ..............+.+++..|
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~--~~~~~~~~~~~~~~~~---~~~~~~~~~~~s~~~~dli~~~ 319 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL--WLHYLTDKMLKQMTFK---TKCNTPAMKQIKRKIQEFHRTM 319 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH--HHHHHHHHHHHTCCCS---SCCCSHHHHHHHHHHHHHHHHG
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh--hhhHHHHhhhhhhccC---cccchhhhhhcCHHHHHHHHHH
Confidence 99998665 899999998777 777889999874210 0011111111111111 1111122345667789999999
Q ss_pred cCCCCCCCCCHHHHH-H
Q 006112 587 SHSNPDTRPSMRQVV-Q 602 (660)
Q Consensus 587 l~~dP~~RPs~~evl-~ 602 (660)
|+.| |++|++ +
T Consensus 320 L~~d-----sa~e~l~~ 331 (336)
T 2vuw_A 320 LNFS-----SATDLLCQ 331 (336)
T ss_dssp GGSS-----SHHHHHHH
T ss_pred hccC-----CHHHHHhc
Confidence 9976 999998 5
|
| >1gv9_A P58/ergic-53; lectin, carbohydrate binding; 1.46A {Rattus norvegicus} SCOP: b.29.1.13 PDB: 1r1z_A 3a4u_A 3lcp_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=295.33 Aligned_cols=204 Identities=14% Similarity=0.175 Sum_probs=154.8
Q ss_pred cceeeeCCCCC-----CCeeEecceeEcCCCcEEecCCCCCeeEEEEeCCCeeeccCCCCceeEEEEEEEEEecCCCCCC
Q 006112 27 ENQFIHHGFEG-----SKLKLDGLAKIHPNGLLQLTNTSERISGHAFYPFPFKFNSSSSQSLSFSTSFVFAMFPKLPNYG 101 (660)
Q Consensus 27 ~~~f~~~~f~~-----~~l~~~g~a~~~~~g~l~Lt~~~~~~~G~~~y~~pv~~~~~~~~~~sFst~F~F~i~~~~~~~~ 101 (660)
..||..+.+.. +++.++|+|.+. +|.|+||++..++.||+||+.|+++ +||+|+|+|.|.+.. ..+
T Consensus 33 ~~Sf~~P~~~~~~~~i~~w~~~G~a~i~-~~~IrLT~~~~~~~G~~w~~~p~~~-------~sF~t~F~F~I~~~~-~~~ 103 (260)
T 1gv9_A 33 KYSFKGPHLVQSDGTVPFWAHAGNAIPS-ADQIRIAPSLKSQRGSVWTKTKAAF-------ENWEVEVTFRVTGRG-RIG 103 (260)
T ss_dssp GGCEECSSCSCTTSCBTTEEEEETCEEC-SSCEEEECSSTTCEEEEEESSCBCC-------SSEEEEEEEEEECSS-SCC
T ss_pred ceeEcCccccCCCCccCCeEEcccEEee-CCEEEeCCCCCCCEEEEEECCCccc-------cCEEEEEEEEEecCC-CCC
Confidence 34565444431 689999999995 8999999999999999999999965 689999999999864 368
Q ss_pred CCceEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCC-CC------CCCeeEEEcCC-ccccccc
Q 006112 102 GHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFN-DI------DGNHVGIDVNG-LQSNESA 173 (660)
Q Consensus 102 g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~-d~------~~~Hvgid~ns-~~s~~~~ 173 (660)
||||||+|+|... ..|+++|+. ..++.|||||||+.|.++. +| +++|||||+|+ +.|...+
T Consensus 104 gdGlAF~l~~~~~----~~g~~~G~~-------~~~~gvaVefDT~~N~~~~~~p~I~~~indg~~~~d~~~d~~s~~~~ 172 (260)
T 1gv9_A 104 ADGLAIWYTENQG----LDGPVFGSA-------DMWNGVGIFFDSFDNDGKKNNPAIVVVGNNGQINYDHQNDGATQALA 172 (260)
T ss_dssp CCEEEEEEESSCC----CEEEETTEC-------SCCEEEEEEEECCCC-----CCEEEEEEEESCCCCCHHHHHHHHCSE
T ss_pred CCeEEEEEecCCC----CCCCccCCC-------CCCCEEEEEEECCCCCCCCCCCceEEEeCCCceEeecCCCcccceee
Confidence 9999999999654 257888883 2467899999999997431 22 46677777775 5443333
Q ss_pred ccccccccccccccccc-CCCccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeecccCcee
Q 006112 174 SARYFSDEKKEFESLVL-ESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTRV 252 (660)
Q Consensus 174 ~~~~~~~~~~~~~~~~l-~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg~~~ 252 (660)
.+. ..+ ++|+.++|||+|++. +|+|.+.+...+......++..+| ..+||+++||||||+||...
T Consensus 173 ~c~-----------~~~~n~g~~~~~~I~Y~~~--~L~V~l~~~~~~~~~~~~~~~~vd-~~~LP~~~~vGfSAaTG~~~ 238 (260)
T 1gv9_A 173 SCQ-----------RDFRNKPYPVRAKITYYQK--TLTVMINNGFTPDKNDYEFCAKVE-NMVIPTQGHFGISAATGGLA 238 (260)
T ss_dssp EEC-----------CCCBSCSSCEEEEEEEETT--EEEEEEECSSCCCTTCCEEEEEET-TCCCCSSBEEEEEEECCSSC
T ss_pred ccC-----------hhhccCCCcEEEEEEEECC--EEEEEEeeccCCCCCcceEEEEEc-ccccCCCcEEEEEEeCCCCc
Confidence 211 122 358899999999986 799999863211111235788888 67799999999999999999
Q ss_pred eeeeecCccccc
Q 006112 253 SDYYILGWSFNK 264 (660)
Q Consensus 253 ~~h~i~~wsf~~ 264 (660)
+.|+|++|+|..
T Consensus 239 e~hdIlsw~~~~ 250 (260)
T 1gv9_A 239 DDHDVLSFLTFQ 250 (260)
T ss_dssp CEEEEEEEEEEE
T ss_pred ceEEEEEEEEEE
Confidence 999999999975
|
| >1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-34 Score=279.52 Aligned_cols=116 Identities=30% Similarity=0.442 Sum_probs=106.7
Q ss_pred CccEEEEEeecccCCCCCCCCCCeeEEEcCCccccccccccccccccccccccccCCCccEEEEEEEeCcceeEEEEEee
Q 006112 136 TNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAP 215 (660)
Q Consensus 136 ~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~ 215 (660)
+||+|||||||++|.+|+||++|||||||||+.|.++++| ++.+|+.++|||+||+.+++|+|+|++
T Consensus 1 ~n~~vAVEFDT~~n~~~~Dp~~nHVGIdvNs~~S~~~~~~-------------~l~~g~~~~v~I~Yd~~~~~L~V~l~~ 67 (237)
T 1nls_A 1 ADTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAKW-------------NMQNGKVGTAHIIYNSVDKRLSAVVSY 67 (237)
T ss_dssp CCCEEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEEC-------------CCCTTCEEEEEEEEETTTTEEEEEEEC
T ss_pred CCCEEEEEEeCCCCcccCCCCCCeeeEecCCccccccccc-------------cccCCCEEEEEEEEeCCCCEEEEEEec
Confidence 4799999999999999889999999999999999988764 367999999999999999999999987
Q ss_pred CCCCCCCCCcceeecCchhhhccceeeeeecccCceeeeeeecCcccccCCC
Q 006112 216 VPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTRVSDYYILGWSFNKSGP 267 (660)
Q Consensus 216 ~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg~~~~~h~i~~wsf~~~gp 267 (660)
.+. ..|+|++.+||+++|+|+||||||||||...|.|+|++|+|++.++
T Consensus 68 ~~~---~~~~ls~~vdLs~~l~e~~~VGFSAsTG~~~~~h~IlsWsF~s~~~ 116 (237)
T 1nls_A 68 PNA---DSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSKLK 116 (237)
T ss_dssp TTS---CCEEEEEECCGGGTSCSEEEEEEEEECSSSCCCCEEEEEEEEEEEE
T ss_pred CCC---CcceEEEeeChHHhCccccEEEEEeccCCcceeeeeEEEEEEeccc
Confidence 543 5789999999999999999999999999999999999999998653
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-30 Score=290.13 Aligned_cols=185 Identities=17% Similarity=0.124 Sum_probs=131.1
Q ss_pred cccCccEEEEEEEeCCCCeEEEEEEeccCC----------ChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCeeEEEE
Q 006112 344 ATKGGSGKVYRGVLPSSHAEIAVKKVCHDS----------DHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 344 lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~----------~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
...|+.|.+..++..-.|+.+|+|.+.... ....++|.+|+++|+++ .|+||++++++++++++.||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 445666666555544467889999986542 12356799999999999 7999999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
||++|++|.++|..... ++. .+|+.||+.||+|||+ ++||||||||+||||++++++||+|||+|+......
T Consensus 322 Eyv~G~~L~d~i~~~~~--l~~---~~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEE--IDR---EKILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp ECCCSEEHHHHHHTTCC--CCH---HHHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred ecCCCCcHHHHHHhCCC--CCH---HHHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 99999999999986543 543 3589999999999998 999999999999999999999999999998765432
Q ss_pred CceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCC
Q 006112 493 DLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRP 538 (660)
Q Consensus 493 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p 538 (660)
. .....+||++|||||++.+ .+..++|+||+|++++++.++..+
T Consensus 394 ~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 394 S-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred c-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 2 2345789999999999864 567789999999998887665443
|
| >1qmo_A Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-28 Score=212.06 Aligned_cols=103 Identities=25% Similarity=0.433 Sum_probs=93.0
Q ss_pred CcceeeeCCCC--CCCeeEecceeEcCCCcEEecCCCC------CeeEEEEeCCCeeeccCCCCceeEEEEEEEEEecCC
Q 006112 26 EENQFIHHGFE--GSKLKLDGLAKIHPNGLLQLTNTSE------RISGHAFYPFPFKFNSSSSQSLSFSTSFVFAMFPKL 97 (660)
Q Consensus 26 ~~~~f~~~~f~--~~~l~~~g~a~~~~~g~l~Lt~~~~------~~~G~~~y~~pv~~~~~~~~~~sFst~F~F~i~~~~ 97 (660)
..++|+|++|+ ..||+|+|||.+.+ |.|+||+... +++|||+|++||+||+++++++||+|+|+|.|.+.+
T Consensus 2 ~~~~F~f~~F~~~~~nl~l~G~A~v~~-g~l~LT~~~~~g~~~~~s~Gra~Y~~Pv~l~d~tg~vaSFsT~F~F~I~~~~ 80 (113)
T 1qmo_A 2 QSLSFSFTKFDPNQEDLIFQGHATSTN-NVLQVTKLDSAGNPVSSSAGRVLYSAPLRLWEDSAVLTSFDTIINFEISTPY 80 (113)
T ss_dssp EEEEEEESSCCSSCTTEEEEETCEEET-TEEECSCBCTTSCBCSSCEEEEEESSCEECCCTTEEEEEEEEEEEEEEECSS
T ss_pred cceEEEcCCCCCCCCCeEEecceEcCC-CceEeCCCCCCCcccCCcEEEEEeCCCEEeeCCCCCEEeeEEEEEEEEecCC
Confidence 35789999998 57999999999986 9999998865 789999999999999986678999999999999887
Q ss_pred CCCCCCceEEEEecCCCCCCCCCCCcccccccC
Q 006112 98 PNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRS 130 (660)
Q Consensus 98 ~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~ 130 (660)
...+||||||||+|....|. +.||||||+|.+
T Consensus 81 ~~~~gdGlAF~lap~~~~p~-s~g~~LGL~n~~ 112 (113)
T 1qmo_A 81 TSRIADGLAFFIAPPDSVIS-YHGGFLGLFPNA 112 (113)
T ss_dssp SSCCCCEEEEEEECTTCCCC-CCGGGTTTCSSC
T ss_pred CCCCCCeEEEEecCCCCCCC-CCccccccccCC
Confidence 77799999999999877777 999999999864
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.6e-27 Score=263.82 Aligned_cols=183 Identities=13% Similarity=0.131 Sum_probs=147.6
Q ss_pred ccccccCccEEEEEEEeCCCCeEEEEEEeccCCC--h------hhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEE
Q 006112 341 LYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD--H------GMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 341 l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~--~------~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
.+.||+|+||.||+|.. .+..+++|+...... . ..+++.+|++++++++||||+++..++...+..++||
T Consensus 341 ~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp -------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 45799999999999965 567899998744221 1 1356899999999999999997777777888889999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
|||++++|.+++.. +..++.|+++||+|||+ ++|+||||||+|||++. ++||+|||+++......
T Consensus 419 E~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 419 SYINGKLAKDVIED----------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp ECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred ECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 99999999999865 45899999999999998 89999999999999998 99999999999875432
Q ss_pred Cce------eeccccCccccCcccccC--CCCCcceeEEehHHHHHHHhhCCCCCC
Q 006112 493 DLH------TTNVVGTVGYLAPELLRN--GRGTTSTDVYAFGVFMLEVACGRRPVQ 540 (660)
Q Consensus 493 ~~~------~~~~~gt~~Y~aPE~~~~--~~~t~ksDV~S~Gvvl~elltG~~p~~ 540 (660)
... .....||+.|||||++.. ..|+..+|+|+..+-.++.+.++.+|.
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 211 235689999999999976 567888999999999999888777663
|
| >2a6y_A EMP47P (FORM1); beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.42A {Saccharomyces cerevisiae} SCOP: b.29.1.13 | Back alignment and structure |
|---|
Probab=99.92 E-value=4.2e-25 Score=221.86 Aligned_cols=186 Identities=14% Similarity=0.238 Sum_probs=142.6
Q ss_pred CCeeEecceeEcCCCcEEecCCCCCeeEEEEeCCCeeeccCCCCceeEEEEEEEEEecCCCCCCCCceEEEEecCCCCCC
Q 006112 38 SKLKLDGLAKIHPNGLLQLTNTSERISGHAFYPFPFKFNSSSSQSLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSE 117 (660)
Q Consensus 38 ~~l~~~g~a~~~~~g~l~Lt~~~~~~~G~~~y~~pv~~~~~~~~~~sFst~F~F~i~~~~~~~~g~GlaF~l~p~~~~~~ 117 (660)
+++.++|+|.+. ++.|+||++ .++.|++|.+.|+.+. .+|+++|+|.|.+.. ..+||||||+++|....|
T Consensus 31 ~~w~~~G~a~v~-~~~IrLTp~-~~s~G~iW~~~p~~~~------~~f~~~f~FrI~g~~-~~~gdGlAfwlt~~~~~~- 100 (256)
T 2a6y_A 31 NNWQTGEQASLE-EGRIVLTSN-QNSKGSLWLKQGFDLK------DSFTMEWTFRSVGYS-GQTDGGISFWFVQDSNIP- 100 (256)
T ss_dssp TTEEEEETCEEE-TBEEECCCS-TTCEEEEEESSCEEES------SCEEEEEEEEEESCC-SCCSCEEEEEEEECSSSC-
T ss_pred CCeEEccceEEe-CCEEEECCC-CCceEEEeeCCCCccc------CCEEEEEEEEEecCC-CCCCCeEEEEEeCCCCcc-
Confidence 689999999995 999999999 6789999999999842 479999999998764 338999999999975432
Q ss_pred CCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCC------CCeeEEEcCCccccccccccccccccccccccccC
Q 006112 118 AVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDID------GNHVGIDVNGLQSNESASARYFSDEKKEFESLVLE 191 (660)
Q Consensus 118 ~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~------~~Hvgid~ns~~s~~~~~~~~~~~~~~~~~~~~l~ 191 (660)
..|+.+|..+ ...-+||||||+.|. .|. +.|+++|.+++.+...+.+. ..+ .+
T Consensus 101 -~~g~~~G~~~-------~f~GlaV~fDT~~n~---~p~i~~~~Ndg~~~~d~~~~~~~~~~~c~---------~~~-rn 159 (256)
T 2a6y_A 101 -RDKQLYNGPV-------NYDGLQLLVDNNGPL---GPTLRGQLNDGQKPVDKTKIYDQSFASCL---------MGY-QD 159 (256)
T ss_dssp -CCCTBTTBCT-------TCEEEEEEEESCSTT---CSEEEEEEEESSSCCCGGGHHHHCSEEEE---------CCC-TT
T ss_pred -cCCcccCcCC-------CCCEEEEEEECCCCC---CceEEEEECCCceecccCCCcccceecce---------eec-cc
Confidence 5677888753 234589999999873 343 66778877764343333221 011 13
Q ss_pred CCccEEEEEEEe-CcceeEEEEEeeCCCCCCCCCcceeecCchhh-hccce-eeeeecccC---ceeeeeeecCcccccC
Q 006112 192 SGKPIQIWIDYN-GQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQI-LQDSM-YVGLSAATG---TRVSDYYILGWSFNKS 265 (660)
Q Consensus 192 ~g~~~~~~I~Y~-~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~-l~~~~-~vGFsastg---~~~~~h~i~~wsf~~~ 265 (660)
+|.+.++||+|+ +..+.|+|.+.. . .-+++..+ ||+.+ ||||||+|| ...+.|.|++|+|...
T Consensus 160 ~~~~~~v~I~Y~~~~~~~L~V~i~~-------~----~c~~~~~v~LP~~~~~~GfSAaTG~~~~~~d~hdIls~~~~~~ 228 (256)
T 2a6y_A 160 SSVPSTIRVTYDLEDDNLLKVQVDN-------K----VCFQTRKVRFPSGSYRIGVTAQNGAVNNNAESFEIFKMQFFNG 228 (256)
T ss_dssp CSSCEEEEEEEEGGGTSEEEEEETT-------E----EEEEESCEECCSEEEEEEEEEECCSGGGCCCEEEEEEEEEEES
T ss_pred CCCcEEEEEEEecCCCcEEEEEEcC-------E----EEEEECcEEeCCCCeEEEEEEeCCCCCCCcceEEEEEEEEEec
Confidence 788999999999 888899999964 1 12334444 88887 699999999 8899999999999984
|
| >1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-24 Score=214.21 Aligned_cols=104 Identities=29% Similarity=0.446 Sum_probs=93.2
Q ss_pred CcceeeeCCCCC--CCeeEecceeEcCCCcEEecCCCC------CeeEEEEeCCCeeeccCCCCceeEEEEEEEEEecCC
Q 006112 26 EENQFIHHGFEG--SKLKLDGLAKIHPNGLLQLTNTSE------RISGHAFYPFPFKFNSSSSQSLSFSTSFVFAMFPKL 97 (660)
Q Consensus 26 ~~~~f~~~~f~~--~~l~~~g~a~~~~~g~l~Lt~~~~------~~~G~~~y~~pv~~~~~~~~~~sFst~F~F~i~~~~ 97 (660)
..++|.|++|.. .||+|+|+|.+.++|.|+||++.. +++|||+|++||+||+++++++||+|+|+|.|.+.
T Consensus 124 ~~~~F~~~~F~~~~~nl~l~G~A~v~~~g~l~LT~~~~n~~~~~~~~Gra~Y~~Pv~lwd~~~~vaSFsT~F~F~I~~~- 202 (237)
T 1nls_A 124 NALHFMFNQFSKDQKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHIWESSAVVASFEATFTFLIKSP- 202 (237)
T ss_dssp EEEEEEESCCCTTCTTEEEEETCEEEETTEEESSCBCTTSCBCSSCEEEEEESSCEECCCTTEEEEEEEEEEEEECCCS-
T ss_pred ccchhhhccccccCCCeEEccceEecCCCceEecCCccCCccccCceEEEEeCCCEEeecCCCCEeeeEEEEEEEEecC-
Confidence 457999999984 599999999998799999998763 68999999999999998778999999999999986
Q ss_pred CCCCCCceEEEEecCC-CCCCCCCCCcccccccC
Q 006112 98 PNYGGHGMAFFISPST-DFSEAVAGSHLGIFNRS 130 (660)
Q Consensus 98 ~~~~g~GlaF~l~p~~-~~~~~~~g~~lGl~~~~ 130 (660)
...+||||||||+|.. .+|.+++||||||||.+
T Consensus 203 ~~~~g~GlAF~lap~~~~~p~~~~g~~LGL~n~~ 236 (237)
T 1nls_A 203 DSHPADGIAFFISNIDSSIPSGSTGRLLGLFPDA 236 (237)
T ss_dssp SSSCCCEEEEEEECTTCCCCTTCCGGGTTTCSSC
T ss_pred CCCCCccEEEEECCCCCCCCCCCCcCeeccccCC
Confidence 4458999999999987 58889999999999975
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.9e-23 Score=215.23 Aligned_cols=143 Identities=13% Similarity=0.038 Sum_probs=117.5
Q ss_pred eecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC------------------hhhHHHHHHHHHHhccCCCCceeEe
Q 006112 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD------------------HGMKQFVSEIVSMGKLRHRNLVQLR 399 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~------------------~~~~~~~~Ei~~l~~l~H~nIv~l~ 399 (660)
|+..+.||+|+||.||+|.+ .+++.||||.+..... .....+.+|++++++++ | +++.
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 44558999999999999999 7899999999864321 13457899999999999 5 6666
Q ss_pred eeeeecCeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEE
Q 006112 400 GYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKL 479 (660)
Q Consensus 400 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl 479 (660)
+++. .+..++|||||++|+|.+ +.. .....++.|++.||.|||+ .+|+||||||+|||++ ++.+||
T Consensus 168 ~~~~-~~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-~~~vkl 233 (282)
T 1zar_A 168 KVYA-WEGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EEGIWI 233 (282)
T ss_dssp CEEE-EETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-TTEEEE
T ss_pred eEEe-ccceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-CCcEEE
Confidence 6553 356799999999999988 421 2345799999999999998 9999999999999999 999999
Q ss_pred eecccceeccCCCCceeeccccCccccCccccc
Q 006112 480 GDFGLARLYDHGNDLHTTNVVGTVGYLAPELLR 512 (660)
Q Consensus 480 ~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 512 (660)
+|||+++. +..|+|||++.
T Consensus 234 ~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 234 IDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp CCCTTCEE--------------TTSTTHHHHHH
T ss_pred EECCCCeE--------------CCCCCHHHHHH
Confidence 99999974 34578999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=2.2e-19 Score=182.37 Aligned_cols=139 Identities=15% Similarity=0.090 Sum_probs=109.3
Q ss_pred eeecccccccCccEEEEEEEeCCCCeE--EEEEEeccCCCh------------------------hhHHHHHHHHHHhcc
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAE--IAVKKVCHDSDH------------------------GMKQFVSEIVSMGKL 390 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~Ei~~l~~l 390 (660)
-|+....||+|+||.||+|.+..+|+. ||||+++..... ....+.+|+.++.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 467778999999999999998667888 999987543111 113678999999999
Q ss_pred CCCCc--eeEeeeeeecCeeEEEEecCCC-C----ChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhh-hcccCceecc
Q 006112 391 RHRNL--VQLRGYCRRKGELLLVYDYMPN-G----SLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLH-EEWEQVVLHR 462 (660)
Q Consensus 391 ~H~nI--v~l~g~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivHr 462 (660)
+|+++ ..++.+ +..+|||||+.+ | +|.++... .++..+..++.|++.+|.||| + .+|+||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~---~givHr 195 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQE---AELVHA 195 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHT---SCEECS
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHH---CCEEeC
Confidence 98864 344432 356899999942 4 66665432 345678899999999999999 7 899999
Q ss_pred CccCCcEEEcCCCCeEEeecccceecc
Q 006112 463 DIKPANVLLDADLEGKLGDFGLARLYD 489 (660)
Q Consensus 463 Dikp~NIll~~~~~~kl~DFGla~~~~ 489 (660)
||||+|||++. .++|+|||+|....
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEETT
T ss_pred CCCHHHEEEcC--cEEEEECcccccCC
Confidence 99999999998 99999999997643
|
| >2a6z_A EMP47P (FORM2); beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.00A {Saccharomyces cerevisiae} SCOP: b.29.1.13 PDB: 2a70_A 2a71_A | Back alignment and structure |
|---|
Probab=99.75 E-value=1.3e-17 Score=163.66 Aligned_cols=189 Identities=14% Similarity=0.229 Sum_probs=125.2
Q ss_pred CCeeEecceeEcCCCcEEecCCCCCeeEEEEeCCCeeeccCCCCceeEEEEEEEEEecCCCCCCCCceEEEEecCCCCCC
Q 006112 38 SKLKLDGLAKIHPNGLLQLTNTSERISGHAFYPFPFKFNSSSSQSLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSE 117 (660)
Q Consensus 38 ~~l~~~g~a~~~~~g~l~Lt~~~~~~~G~~~y~~pv~~~~~~~~~~sFst~F~F~i~~~~~~~~g~GlaF~l~p~~~~~~ 117 (660)
++..+.|+|.+. ++.|+||++ .++.|.+|.+.|+++. .+|+++|+|.|.+.. ..+||||||++++.+..+
T Consensus 24 ~~W~~~G~a~i~-~~~IrLTp~-~~~~G~iWs~~p~~~~------~~weie~~Fri~g~~-~~~gdGlA~W~t~~~~~~- 93 (222)
T 2a6z_A 24 NNWQTGEQASLE-EGRIVLTSN-QNSKGSLWLKQGFDLK------DSFTMEWTFRSVGYS-GQTDGGISFWFVQDSNIP- 93 (222)
T ss_dssp TTEEEEETCEEE-TTEEESCCS-TTCEEEEEESSCEECC------SCEEEEEEEEEESCC-SCCSCEEEEEEEECSSSC-
T ss_pred CCcEEcccEEEc-CCEEEECCC-CCCeEEEEeCCCCCCC------CCEEEEEEEEEeCCC-CCCCCEEEEEEECCCccc-
Confidence 689999999996 799999999 5779999999999853 259999999998763 347999999999865411
Q ss_pred CCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCeeEEEcCCc-cccccccccccccccccccccccCCCccE
Q 006112 118 AVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGL-QSNESASARYFSDEKKEFESLVLESGKPI 196 (660)
Q Consensus 118 ~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~-~s~~~~~~~~~~~~~~~~~~~~l~~g~~~ 196 (660)
..|..+|..+. -.=+||+|||+.|. .++|.+.+|.= .+..... +.-....++...+ .+.+.+.
T Consensus 94 -~~g~~~G~~~~-------f~GL~I~~Dt~~n~------~p~i~~~~ndG~~~yd~~~-~~~~~~~~C~~~~-rn~~~~~ 157 (222)
T 2a6z_A 94 -RDKQLYNGPVN-------YDGLQLLVDNNGPL------GPTLRGQLNDGQKPVDKTK-IYDQSFASCLMGY-QDSSVPS 157 (222)
T ss_dssp -CCCTBTTBCTT-------CEEEEEEEESCSTT------SSEEEEEEEESSSCCCGGG-HHHHCSEEEECCC-TTEEEEE
T ss_pred -CCCcccCCCCC-------CCEEEEEEECCCCC------CceEEEEECCCCeeeccCC-Cccccccccceec-cCCCCcE
Confidence 22333333111 11159999998873 35666555421 1110000 0000000111111 1356789
Q ss_pred EEEEEEe-CcceeEEEEEeeCCCCCCCCCcc-eeecCchhhhccc-eeeeeecccC---ceeeeeeecCcccc
Q 006112 197 QIWIDYN-GQEKLVNVTLAPVPNPKPSRPLL-STSIDLSQILQDS-MYVGLSAATG---TRVSDYYILGWSFN 263 (660)
Q Consensus 197 ~~~I~Y~-~~~~~l~v~~~~~~~~~p~~~~l-~~~~dL~~~l~~~-~~vGFsastg---~~~~~h~i~~wsf~ 263 (660)
++||+|+ ...+.|+|.+.. ...+ ...|+ ||+. .|+||||+|| ...+.|.|++|++.
T Consensus 158 ~~rI~Y~~~~~~~l~v~id~-------~~C~~~~~v~----LP~~~~y~G~SA~TG~l~~~~d~hdil~~~~~ 219 (222)
T 2a6z_A 158 TIRVTYDLEDDNLLKVQVDN-------KVCFQTRKVR----FPSGSYRIGVTAQNGAVNNNAESFEIFKMQFF 219 (222)
T ss_dssp EEEEEEEGGGTSEEEEEETT-------EEEEEESCCC----CCSSEEEEEEEEECCSGGGCCCEEEEEEEEEE
T ss_pred EEEEEEEcCCCcEEEEEEcC-------eEEEEeCCee----cCCCCcEEEEEEcCCCCCCCCccEEEEEEEEE
Confidence 9999999 667789999853 1111 12233 5655 4799999999 88899999999875
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.63 E-value=2.3e-16 Score=167.37 Aligned_cols=142 Identities=10% Similarity=0.008 Sum_probs=98.4
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC--------------hhhHHHHHHHHHHhccCCCCceeEeeee
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD--------------HGMKQFVSEIVSMGKLRHRNLVQLRGYC 402 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~--------------~~~~~~~~Ei~~l~~l~H~nIv~l~g~~ 402 (660)
-|+....||.|++|.||+|... +|+.||||.++.... ........+.++.....|+|+++++...
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 4788899999999999999985 688999998753210 0111222333333333344444433211
Q ss_pred e------ecCeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCC
Q 006112 403 R------RKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLE 476 (660)
Q Consensus 403 ~------~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~ 476 (660)
. .....+|||||++|++|.++.. ......++.||+.+|.|||+ .+||||||||.|||+++++.
T Consensus 175 v~vp~p~~~~~~~LVME~i~G~~L~~l~~--------~~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 175 FPVPEPIAQSRHTIVMSLVDALPMRQVSS--------VPDPASLYADLIALILRLAK---HGLIHGDFNEFNILIREEKD 243 (397)
T ss_dssp CSCCCEEEEETTEEEEECCSCEEGGGCCC--------CSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEEEC
T ss_pred CCCCeeeeccCceEEEEecCCccHhhhcc--------cHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCCCC
Confidence 1 1112379999999999876542 12346788999999999998 89999999999999988763
Q ss_pred ----------eEEeecccceeccC
Q 006112 477 ----------GKLGDFGLARLYDH 490 (660)
Q Consensus 477 ----------~kl~DFGla~~~~~ 490 (660)
+.|+||+-+....+
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~~~h 267 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVSMDH 267 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEETTS
T ss_pred cccccccccceEEEEeCCcccCCC
Confidence 88999998765443
|
| >2a6v_A EMP46P; beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.52A {Saccharomyces cerevisiae} SCOP: b.29.1.13 PDB: 2a6w_A 2a6x_A | Back alignment and structure |
|---|
Probab=99.48 E-value=8.2e-13 Score=129.06 Aligned_cols=186 Identities=18% Similarity=0.238 Sum_probs=119.3
Q ss_pred CCeeEecceeEcCCCcEEecCCCCCeeEEEEeCCCeeeccCCCCceeEEEEEEEEEecCCCCCCCCceEEEEecCCCC-C
Q 006112 38 SKLKLDGLAKIHPNGLLQLTNTSERISGHAFYPFPFKFNSSSSQSLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDF-S 116 (660)
Q Consensus 38 ~~l~~~g~a~~~~~g~l~Lt~~~~~~~G~~~y~~pv~~~~~~~~~~sFst~F~F~i~~~~~~~~g~GlaF~l~p~~~~-~ 116 (660)
++..+.|+|.+. ++.|+||++ +++.|.+|-+.|+.+. ..|+.+|+|.|.+.... +||||||+++..+.. +
T Consensus 27 ~~W~~~G~t~v~-~~~IrLTp~-~s~~G~lWs~~p~~~~------~~weiev~Fri~G~~~~-~gdGlA~Wyt~~~~~~~ 97 (226)
T 2a6v_A 27 SQWTLGDKVKLE-EGRFVLTPG-KNTKGSLWLKPEYSIK------DAMTIEWTFRSFGFRGS-TKGGLAFWLKQGNEGDS 97 (226)
T ss_dssp TTEEEEETCEEE-TTEEESCCS-TTCEEEEEESSCBCCS------SCEEEEEEEEEESCCSC-CSCEEEEEEECSCCCCC
T ss_pred CCcEEcCCeEEe-CCEEEECCC-CCceEEEeeCCCCCCC------CCeEEEEEEEEecCCCC-CCCEEEEEEECCCCCCC
Confidence 578999999997 778999999 9999999999999851 24999999999986433 799999999975431 2
Q ss_pred CCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCeeEEEcC-CccccccccccccccccccccccccCCCcc
Q 006112 117 EAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVN-GLQSNESASARYFSDEKKEFESLVLESGKP 195 (660)
Q Consensus 117 ~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~n-s~~s~~~~~~~~~~~~~~~~~~~~l~~g~~ 195 (660)
+.-.||+..-| .=+||.|||+.|. ...|-+-+| +..+..... .....++... -.+.+.+
T Consensus 98 g~vfGg~~d~f----------~GlgI~~Dt~~n~------~p~i~~~~NDGt~~yd~~~---~~~~g~C~~~-~rn~~~~ 157 (226)
T 2a6v_A 98 TELFGGSSKKF----------NGLMILLRLDDKL------GESVTAYLNDGTKDLDIES---SPYFASCLFQ-YQDSMVP 157 (226)
T ss_dssp CTBTTTBCSSC----------EEEEEEEEEETTT------EEEEEEEEEESSSCCCTTT---SCCSEEEECC-CSSCSSC
T ss_pred cccccccCCCc----------cEEEEEEECCCCC------CceEEEEECCCCcccCCCC---CcccceEeEe-ccCCCCC
Confidence 11112111111 1159999999762 122322222 222111100 0000111111 1245678
Q ss_pred EEEEEEEe-CcceeEEEEEeeCCCCCCCCCcce-eecCchhhhccc--eeeeeecccCceeeeeeecCcccc
Q 006112 196 IQIWIDYN-GQEKLVNVTLAPVPNPKPSRPLLS-TSIDLSQILQDS--MYVGLSAATGTRVSDYYILGWSFN 263 (660)
Q Consensus 196 ~~~~I~Y~-~~~~~l~v~~~~~~~~~p~~~~l~-~~~dL~~~l~~~--~~vGFsastg~~~~~h~i~~wsf~ 263 (660)
.+++|.|. ...+.|+|.+.. +..+. ..|+ ||.. +|+||||+||...+.|.|++..+.
T Consensus 158 t~~ri~Y~~~~~~~l~v~id~-------~~Cf~~~~v~----LP~g~~~yfGiSAaTg~~~D~hdils~~~~ 218 (226)
T 2a6v_A 158 STLRLTYNPLDNHLLKLQMDN-------RVCFQTRKVK----FMGSSPFRIGTSAINDASKESFEILKMKLY 218 (226)
T ss_dssp EEEEEEEEGGGTSEEEEEETT-------EEEEEESCCC----GGGTSCBEEEEEEECCTTCCEEEEEEEEEE
T ss_pred EEEEEEEEccCCCEEEEEEcC-------CeeEEECCee----cCCCCccEEEEEEcCCCCcccEEEEEEEEE
Confidence 89999998 456789998852 11121 1233 4543 499999999999999999986543
|
| >2ltn_B PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1hkd_B 1rin_B* 1ofs_B* 1bqp_B* 1loe_B 1loa_B* 1loc_B* 1lod_B* 1lob_B 1lof_B* 1log_B* 1lof_D* 1les_B* 2b7y_B* 1lgc_B* 1lgb_B* 1len_B 1lem_B 2lal_B | Back alignment and structure |
|---|
Probab=99.47 E-value=4.7e-15 Score=108.86 Aligned_cols=45 Identities=27% Similarity=0.470 Sum_probs=41.9
Q ss_pred CCcceeecCchhhhccceeeeeecccCceeeeeeecCcccccCCC
Q 006112 223 RPLLSTSIDLSQILQDSMYVGLSAATGTRVSDYYILGWSFNKSGP 267 (660)
Q Consensus 223 ~~~l~~~~dL~~~l~~~~~vGFsastg~~~~~h~i~~wsf~~~gp 267 (660)
+|+|+..+||+++|+|+|||||||+||...+.|+|++|+|+..++
T Consensus 3 ~p~ls~~vdLs~~l~e~v~VGFSAsTG~~~~~h~IlsWsF~s~~~ 47 (52)
T 2ltn_B 3 SYTLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSFHSELS 47 (52)
T ss_dssp EEEEEEECCHHHHSCSEEEEEEEEECCSSCCEEEEEEEEEEEEEC
T ss_pred eeeEEEEEcHHHhcCceEEEEEEeccCCcceeEEEEEeEEEeecc
Confidence 478999999999999999999999999999999999999988653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=1.1e-11 Score=125.25 Aligned_cols=141 Identities=16% Similarity=0.070 Sum_probs=110.9
Q ss_pred eecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccC-CCCceeEeeeeeecCeeEEEEecCC
Q 006112 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLR-HRNLVQLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~ 416 (660)
|+.....+.|+.+.||+... .+..+++|............+.+|+.+++.+. |..+.++++++...+..++||||++
T Consensus 16 ~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~ 93 (263)
T 3tm0_A 16 YRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEAD 93 (263)
T ss_dssp SEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCS
T ss_pred ceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecC
Confidence 55566677788899999876 35789999986532233456889999999884 6778899999998889999999999
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhc------------------------------------------
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEE------------------------------------------ 454 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------ 454 (660)
|.+|.+.+. +..+...++.+++++|..||+.
T Consensus 94 G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T 3tm0_A 94 GVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp SEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred CeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence 999987632 1223457889999999999981
Q ss_pred --------------ccCceeccCccCCcEEEcCCCCeEEeeccccee
Q 006112 455 --------------WEQVVLHRDIKPANVLLDADLEGKLGDFGLARL 487 (660)
Q Consensus 455 --------------~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 487 (660)
....++|+|++|.|||++++..+.|+||+.+..
T Consensus 167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 115699999999999998766667999998753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.12 E-value=1.7e-10 Score=115.81 Aligned_cols=128 Identities=16% Similarity=0.127 Sum_probs=96.9
Q ss_pred cCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCC--ceeEeeeeeecCeeEEEEecCCCCChhhh
Q 006112 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRN--LVQLRGYCRRKGELLLVYDYMPNGSLDKI 423 (660)
Q Consensus 346 ~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~ 423 (660)
.|..+.||+... .+|..+++|..... ....+.+|+.+++.+.+.+ +.++++++..++..++||||++|.+|.
T Consensus 30 gg~~~~v~~~~~-~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 30 GCSDAAVFRLSA-QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp TTSSCEEEEEEC-TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred CCCCceEEEEec-CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 455699999976 45677999987543 3356889999999886545 456888888778899999999999884
Q ss_pred hhhCCCCCcchhHHHHHHHHHHHHHHHhhhcc------------------------------------------------
Q 006112 424 LYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEW------------------------------------------------ 455 (660)
Q Consensus 424 l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------------------ 455 (660)
... . ....++.++++.|..||+..
T Consensus 104 ~~~-----~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (264)
T 1nd4_A 104 SSH-----L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK 175 (264)
T ss_dssp TSC-----C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred cCc-----C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence 211 1 12367788888888888631
Q ss_pred -------cCceeccCccCCcEEEcCCCCeEEeeccccee
Q 006112 456 -------EQVVLHRDIKPANVLLDADLEGKLGDFGLARL 487 (660)
Q Consensus 456 -------~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 487 (660)
...++|+|++|.|||++++..++|+||+.+..
T Consensus 176 ~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 176 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998876677999998864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.06 E-value=7.6e-10 Score=117.30 Aligned_cols=142 Identities=14% Similarity=0.188 Sum_probs=107.3
Q ss_pred cccccccCccEEEEEEEeCCCCeEEEEEEec--cCC-ChhhHHHHHHHHHHhccC--CCCceeEeeeeeec---CeeEEE
Q 006112 340 NLYKATKGGSGKVYRGVLPSSHAEIAVKKVC--HDS-DHGMKQFVSEIVSMGKLR--HRNLVQLRGYCRRK---GELLLV 411 (660)
Q Consensus 340 ~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~--~~~-~~~~~~~~~Ei~~l~~l~--H~nIv~l~g~~~~~---~~~~lV 411 (660)
.++.++.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.+. +..+.+++.+|.+. +..++|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 4667889999999998874 4578888765 322 123457888999999987 45678899988776 458999
Q ss_pred EecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcc------------------------------------
Q 006112 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEW------------------------------------ 455 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------ 455 (660)
|||++|..+.+.. ...++..++..++.++++.|..||...
T Consensus 120 me~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 120 MEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 9999998885421 123677888899999999999999720
Q ss_pred -------------------cCceeccCccCCcEEEcCCCC--eEEeeccccee
Q 006112 456 -------------------EQVVLHRDIKPANVLLDADLE--GKLGDFGLARL 487 (660)
Q Consensus 456 -------------------~~~ivHrDikp~NIll~~~~~--~kl~DFGla~~ 487 (660)
...++|+|+++.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 268999999999999987753 68999999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.86 E-value=8e-10 Score=114.33 Aligned_cols=188 Identities=15% Similarity=0.175 Sum_probs=122.8
Q ss_pred ecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccC-CCC--ceeEeeeeeecC---eeEEEE
Q 006112 339 KNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLR-HRN--LVQLRGYCRRKG---ELLLVY 412 (660)
Q Consensus 339 ~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~n--Iv~l~g~~~~~~---~~~lV~ 412 (660)
..++.++.|....||+.. ..+++|..... .....+.+|..+++.+. +.. +.+++..+...+ ..++||
T Consensus 23 ~~i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 23 NTIEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CCCCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred eeeEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 345568899999999853 35888875322 34567899999998883 333 345555544333 348899
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhc--------------------------------------
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEE-------------------------------------- 454 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------------------------------------- 454 (660)
|+++|.+|...... .++..++..++.++++.|+.||..
T Consensus 96 ~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 96 TKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp ECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred cccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 99999998754321 256677788888888888888851
Q ss_pred -----------------ccCceeccCccCCcEEEcC--CCCeEEeecccceeccCCCCceeec-------------cccC
Q 006112 455 -----------------WEQVVLHRDIKPANVLLDA--DLEGKLGDFGLARLYDHGNDLHTTN-------------VVGT 502 (660)
Q Consensus 455 -----------------~~~~ivHrDikp~NIll~~--~~~~kl~DFGla~~~~~~~~~~~~~-------------~~gt 502 (660)
....++|+|++|.||++++ ...+.|+||+.+...+...+..... ....
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence 1246899999999999998 4568899999987643221110000 0000
Q ss_pred ccccC-cccccCCCCCcceeEEehHHHHHHHhhCCCCC
Q 006112 503 VGYLA-PELLRNGRGTTSTDVYAFGVFMLEVACGRRPV 539 (660)
Q Consensus 503 ~~Y~a-PE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~ 539 (660)
.++.. |+.... .....+.|+++.++|++.+|..+|
T Consensus 252 Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 252 YKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 01112 222111 112357899999999999998664
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.47 E-value=1.1e-06 Score=88.79 Aligned_cols=135 Identities=21% Similarity=0.195 Sum_probs=99.7
Q ss_pred cccCccE-EEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccC-CCCceeEeeeeeecCeeEEEEecCCCCChh
Q 006112 344 ATKGGSG-KVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLR-HRNLVQLRGYCRRKGELLLVYDYMPNGSLD 421 (660)
Q Consensus 344 lg~G~fg-~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~ 421 (660)
++.|..| .||+.....++..+++|+-.. .....+.+|...|+.+. +--+.++++++.+.+..++|||+++|.++.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 4445555 689988777777899998643 23456788999988874 333678889999999999999999998887
Q ss_pred hhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhc-----------------------------------------------
Q 006112 422 KILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEE----------------------------------------------- 454 (660)
Q Consensus 422 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------------------- 454 (660)
+..... ......+..+++..|.-||..
T Consensus 109 ~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 109 QVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp HHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred ccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 765322 123445667777777777741
Q ss_pred --------ccCceeccCccCCcEEEcCCCCeEEeeccccee
Q 006112 455 --------WEQVVLHRDIKPANVLLDADLEGKLGDFGLARL 487 (660)
Q Consensus 455 --------~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 487 (660)
....++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 022489999999999999877777999998864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=1.7e-06 Score=89.37 Aligned_cols=138 Identities=17% Similarity=0.115 Sum_probs=95.5
Q ss_pred ecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCC---CceeEeeeee-ecCeeEEEEec
Q 006112 339 KNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHR---NLVQLRGYCR-RKGELLLVYDY 414 (660)
Q Consensus 339 ~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~---nIv~l~g~~~-~~~~~~lV~E~ 414 (660)
..++.++.|....||+. +..+++|.-. .......+.+|..+++.+.+. .+.+.+.++. ..+..++||||
T Consensus 22 ~~v~~l~~G~~n~v~~v-----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~ 94 (306)
T 3tdw_A 22 QSVESLGEGFRNYAILV-----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK 94 (306)
T ss_dssp SCEEEEEECSSEEEEEE-----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred eeeeecCCCcceeEEEE-----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence 34556788888899987 3457888742 233456889999999999753 2556676664 34567899999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhc----------------------------------------
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEE---------------------------------------- 454 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------------------------------------- 454 (660)
++|..|...... .++..++..++.++++.|..||+.
T Consensus 95 i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 95 VQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp CCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred cCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 999888763211 133444555555555555555541
Q ss_pred -----------------ccCceeccCccCCcEEEcC---CCC-eEEeeccccee
Q 006112 455 -----------------WEQVVLHRDIKPANVLLDA---DLE-GKLGDFGLARL 487 (660)
Q Consensus 455 -----------------~~~~ivHrDikp~NIll~~---~~~-~kl~DFGla~~ 487 (660)
....++|+|+++.|||++. ++. +.|+||+.+..
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1246799999999999987 455 48999998865
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=2e-06 Score=90.55 Aligned_cols=85 Identities=7% Similarity=-0.008 Sum_probs=58.3
Q ss_pred eeccccc-ccCccEEEEEEEeC---C---CCeEEEEEEeccCC---ChhhHHHHHHHHHHhccCC---CCceeEeeeeee
Q 006112 338 YKNLYKA-TKGGSGKVYRGVLP---S---SHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKLRH---RNLVQLRGYCRR 404 (660)
Q Consensus 338 ~~~l~~l-g~G~fg~Vy~g~~~---~---~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H---~nIv~l~g~~~~ 404 (660)
...++.+ +.|....+|+.... . ++..+++|...... ......+.+|+.+++.+.. -.+.+++.++.+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 4456677 88889999988763 0 15678888754322 1112567889988888853 346778888766
Q ss_pred c---CeeEEEEecCCCCChhh
Q 006112 405 K---GELLLVYDYMPNGSLDK 422 (660)
Q Consensus 405 ~---~~~~lV~E~~~~gsL~~ 422 (660)
. +..++||||++|..+.+
T Consensus 102 ~~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp STTTSSCEEEEECCCCBCCCB
T ss_pred CCccCCceEEEEecCCCChhh
Confidence 5 35689999999877653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.10 E-value=1.3e-05 Score=85.80 Aligned_cols=77 Identities=6% Similarity=-0.010 Sum_probs=50.3
Q ss_pred cccccccCccEEEEEEEeCCCCeEEEEEEeccCCC-------hhhHHHHHHHHHHhccCC--CC-ceeEeeeeeecCeeE
Q 006112 340 NLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD-------HGMKQFVSEIVSMGKLRH--RN-LVQLRGYCRRKGELL 409 (660)
Q Consensus 340 ~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~-------~~~~~~~~Ei~~l~~l~H--~n-Iv~l~g~~~~~~~~~ 409 (660)
.++.+|.|..+.||++....++..++||....... ...+.+..|.++++.+.. +. +.+++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 35578999999999998765677899998643211 224567788888887742 33 4455544 344568
Q ss_pred EEEecCCCC
Q 006112 410 LVYDYMPNG 418 (660)
Q Consensus 410 lV~E~~~~g 418 (660)
+||||+++.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.90 E-value=7.7e-05 Score=77.47 Aligned_cols=142 Identities=15% Similarity=0.178 Sum_probs=81.0
Q ss_pred cccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCC--CCceeEee------eeeecCeeEEE
Q 006112 340 NLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRH--RNLVQLRG------YCRRKGELLLV 411 (660)
Q Consensus 340 ~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H--~nIv~l~g------~~~~~~~~~lV 411 (660)
.++.++.|..+.||+.... +..+++|+.... ..++..|..+++.|.. -.+.+++. +....+..++|
T Consensus 36 ~~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l 109 (346)
T 2q83_A 36 KIDVIQGNQMALVWKVHTD--SGAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVV 109 (346)
T ss_dssp EEEECC----CEEEEEEET--TEEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEE
T ss_pred EeeeccccccCcEEEEEeC--CCCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEE
Confidence 3445655678899998873 345899988642 2334445555554431 12333332 12345678999
Q ss_pred EecCCCCChh-----------hh---hhh--CCC--C--------CcchhHHH---------------------------
Q 006112 412 YDYMPNGSLD-----------KI---LYS--NTR--P--------SLNWFQRF--------------------------- 438 (660)
Q Consensus 412 ~E~~~~gsL~-----------~~---l~~--~~~--~--------~l~~~~~~--------------------------- 438 (660)
|||++|..+. .. ++. ... + .-.|...+
T Consensus 110 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 189 (346)
T 2q83_A 110 YDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYL 189 (346)
T ss_dssp EECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHH
T ss_pred EEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHH
Confidence 9999986543 01 111 000 0 01232111
Q ss_pred ----HHHHHHHHHHHHhhh----------cccCceeccCccCCcEEEcCCCCeEEeeccccee
Q 006112 439 ----RIIKGVAFGLLYLHE----------EWEQVVLHRDIKPANVLLDADLEGKLGDFGLARL 487 (660)
Q Consensus 439 ----~i~~~ia~gL~yLH~----------~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 487 (660)
.+...+..++.+|++ .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus 190 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 190 QEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 111223445666763 1357899999999999998888999999998753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00013 Score=75.23 Aligned_cols=141 Identities=16% Similarity=0.063 Sum_probs=93.8
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccC---CCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLR---HRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~lV~E 413 (660)
....++.++.|....+|+... ++..+++|+.... ....+..|...|+.|. ...+.+++.++...+..++|||
T Consensus 37 ~i~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 37 FIKHKEKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp CCCEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred ceeeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 345567788999999999876 4567889986532 3567889999888884 3568889998888888999999
Q ss_pred cCCCCChhh-----------hhhhCCC-C-------------------CcchhHHH---HHHH----------------H
Q 006112 414 YMPNGSLDK-----------ILYSNTR-P-------------------SLNWFQRF---RIIK----------------G 443 (660)
Q Consensus 414 ~~~~gsL~~-----------~l~~~~~-~-------------------~l~~~~~~---~i~~----------------~ 443 (660)
|+++..+.. .|+.... . .-+|...+ ++.. .
T Consensus 112 ~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~ 191 (312)
T 3jr1_A 112 ALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDL 191 (312)
T ss_dssp CCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHH
T ss_pred eccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHH
Confidence 999886521 1222111 0 01343221 1111 1
Q ss_pred HHHH-HHHhhh-cccCceeccCccCCcEEEcCCCCeEEeecc
Q 006112 444 VAFG-LLYLHE-EWEQVVLHRDIKPANVLLDADLEGKLGDFG 483 (660)
Q Consensus 444 ia~g-L~yLH~-~~~~~ivHrDikp~NIll~~~~~~kl~DFG 483 (660)
+..- ...|.. .....+||+|+.+.|++++.++ +.|.|+.
T Consensus 192 l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 192 IVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1111 123321 2257899999999999999887 8899973
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00027 Score=76.08 Aligned_cols=79 Identities=13% Similarity=0.044 Sum_probs=46.8
Q ss_pred cCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCceeeccccCccccCcccccCC---CCCcceeEEehHHHHHHH
Q 006112 456 EQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNG---RGTTSTDVYAFGVFMLEV 532 (660)
Q Consensus 456 ~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~~t~ksDV~S~Gvvl~el 532 (660)
...++|+|++|.|||++.++ ++|+||+.+..-....+....-..-...|++|+..... ......++......+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 48999999999999998876 99999999875332111110000002346666654311 111234445666677766
Q ss_pred hhC
Q 006112 533 ACG 535 (660)
Q Consensus 533 ltG 535 (660)
+++
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 553
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00034 Score=71.13 Aligned_cols=78 Identities=15% Similarity=0.169 Sum_probs=56.1
Q ss_pred eecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCC---CceeEeeeeeecCeeEEEEec
Q 006112 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHR---NLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~---nIv~l~g~~~~~~~~~lV~E~ 414 (660)
...+..+|.|..+.||+.+.. +|+.+++|+-..........|..|...|+.|.-. -+.+++++. .-++||||
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred eEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 455678899999999999984 5788999987555444455688999988887422 244555542 24789999
Q ss_pred CCCCCh
Q 006112 415 MPNGSL 420 (660)
Q Consensus 415 ~~~gsL 420 (660)
++++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987654
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.36 E-value=0.0005 Score=74.25 Aligned_cols=74 Identities=19% Similarity=0.267 Sum_probs=50.3
Q ss_pred ccccccCccEEEEEEEeCC-------CCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCc-eeEeeeeeecCeeEEEE
Q 006112 341 LYKATKGGSGKVYRGVLPS-------SHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNL-VQLRGYCRRKGELLLVY 412 (660)
Q Consensus 341 l~~lg~G~fg~Vy~g~~~~-------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~ 412 (660)
++.++.|-...+|+..... .+..+.+|+.... ...+.+..|..+++.+...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4567788889999998753 2467888887331 112456689998888854444 567765542 2899
Q ss_pred ecCCCCCh
Q 006112 413 DYMPNGSL 420 (660)
Q Consensus 413 E~~~~gsL 420 (660)
||++|.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987554
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00096 Score=68.68 Aligned_cols=145 Identities=14% Similarity=0.054 Sum_probs=82.2
Q ss_pred ecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCC--ceeEeee------eeecCeeEE
Q 006112 339 KNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRN--LVQLRGY------CRRKGELLL 410 (660)
Q Consensus 339 ~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~g~------~~~~~~~~l 410 (660)
..++.++.|....+|+....+ + .+++|..... ...+++..|+.++..+...+ +.+++.. ....+..++
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~ 100 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAA 100 (322)
T ss_dssp EEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEE
T ss_pred eEeeccCCCcccceEEEEeCC-c-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEE
Confidence 345667778889999988743 3 5888987542 12245566777777664322 2333321 123456789
Q ss_pred EEecCCCCChhh-----------h---hhhC----CCC-----C-cchhHHHH------------HHHHHHHHHHHhhhc
Q 006112 411 VYDYMPNGSLDK-----------I---LYSN----TRP-----S-LNWFQRFR------------IIKGVAFGLLYLHEE 454 (660)
Q Consensus 411 V~E~~~~gsL~~-----------~---l~~~----~~~-----~-l~~~~~~~------------i~~~ia~gL~yLH~~ 454 (660)
+|||++|..+.. . ++.. ..+ . ..|...+. +...+...+++|++.
T Consensus 101 l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~ 180 (322)
T 2ppq_A 101 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH 180 (322)
T ss_dssp EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred EEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhh
Confidence 999998865421 0 1110 111 0 12332111 011234455555532
Q ss_pred ----ccCceeccCccCCcEEEcCCCCeEEeeccccee
Q 006112 455 ----WEQVVLHRDIKPANVLLDADLEGKLGDFGLARL 487 (660)
Q Consensus 455 ----~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 487 (660)
...+++|+|+.+.|||++++..+.|+||+.+..
T Consensus 181 ~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 181 WPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp CCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 246899999999999998876568999997753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0016 Score=70.76 Aligned_cols=76 Identities=12% Similarity=0.031 Sum_probs=49.1
Q ss_pred cccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCc-eeEeeeeeecCeeEEEEecCCCC
Q 006112 340 NLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNL-VQLRGYCRRKGELLLVYDYMPNG 418 (660)
Q Consensus 340 ~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~E~~~~g 418 (660)
.++.++.|-...+|+......+..+++|+........ -.-.+|..+++.|...++ .++++.+. + .+||||++|.
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~ 186 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGY 186 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSE
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCc
Confidence 3556777888999999885445778888764332221 122578888888865555 46777663 2 2599999876
Q ss_pred Ch
Q 006112 419 SL 420 (660)
Q Consensus 419 sL 420 (660)
+|
T Consensus 187 ~l 188 (458)
T 2qg7_A 187 AL 188 (458)
T ss_dssp EC
T ss_pred cC
Confidence 55
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0019 Score=68.28 Aligned_cols=142 Identities=23% Similarity=0.235 Sum_probs=84.4
Q ss_pred ccccccCccEEEEEEEeCC-------CCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCC-ceeEeeeeeecCeeEEEE
Q 006112 341 LYKATKGGSGKVYRGVLPS-------SHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRN-LVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 341 l~~lg~G~fg~Vy~g~~~~-------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~ 412 (660)
++.++.|-...+|+..... ++..+.+|+.... ........+|..+++.+.-.+ ..++++.+.+ .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 4456678788899988753 3467888875322 223456678999988874322 3566766643 2999
Q ss_pred ecCCCCChhhh-----------------hhhCC----CCCc-chhHHHHHHHHHHH-------------------HHHHh
Q 006112 413 DYMPNGSLDKI-----------------LYSNT----RPSL-NWFQRFRIIKGVAF-------------------GLLYL 451 (660)
Q Consensus 413 E~~~~gsL~~~-----------------l~~~~----~~~l-~~~~~~~i~~~ia~-------------------gL~yL 451 (660)
||++|..|..- |+... +... -|.+..++..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99998665421 11111 1111 24455555444322 23333
Q ss_pred hh-----cccCceeccCccCCcEEEcCC----CCeEEeeccccee
Q 006112 452 HE-----EWEQVVLHRDIKPANVLLDAD----LEGKLGDFGLARL 487 (660)
Q Consensus 452 H~-----~~~~~ivHrDikp~NIll~~~----~~~kl~DFGla~~ 487 (660)
.+ .....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 22 124689999999999999876 6899999998864
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0038 Score=64.60 Aligned_cols=142 Identities=16% Similarity=0.154 Sum_probs=72.8
Q ss_pred ccccccCccEE-EEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCC--CCceeEeeeeeecCeeEEEEecCCC
Q 006112 341 LYKATKGGSGK-VYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRH--RNLVQLRGYCRRKGELLLVYDYMPN 417 (660)
Q Consensus 341 l~~lg~G~fg~-Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H--~nIv~l~g~~~~~~~~~lV~E~~~~ 417 (660)
++.++.|+... +|+.... ++..+++|....... .++..|+.+++.+.. -.+.+++.++.+.+ +++||++.+
T Consensus 23 ~~~l~gg~s~~~~~r~~~~-~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~ 96 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSP-TGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGD 96 (333)
T ss_dssp ECC--------CCEEEECT-TCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCS
T ss_pred eeECCCCCCCceEEEEEcC-CCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCC
Confidence 34555555554 6676542 255677775433211 344556666666642 23456676654444 689999977
Q ss_pred CChhhhhhhCC---------------------CCCcc-hhH--H----------H----------HHHHHHHHHHHHhhh
Q 006112 418 GSLDKILYSNT---------------------RPSLN-WFQ--R----------F----------RIIKGVAFGLLYLHE 453 (660)
Q Consensus 418 gsL~~~l~~~~---------------------~~~l~-~~~--~----------~----------~i~~~ia~gL~yLH~ 453 (660)
..+.+++.... ...++ |.. . + .....+...+..|.+
T Consensus 97 ~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~ 176 (333)
T 3csv_A 97 ALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILS 176 (333)
T ss_dssp CBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHH
T ss_pred cchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHH
Confidence 66654432110 00111 100 0 0 000111112222211
Q ss_pred ---cccCceeccCccCCcEEEcCC----CCeEEeecccceec
Q 006112 454 ---EWEQVVLHRDIKPANVLLDAD----LEGKLGDFGLARLY 488 (660)
Q Consensus 454 ---~~~~~ivHrDikp~NIll~~~----~~~kl~DFGla~~~ 488 (660)
.....++|+|+.+.|||++.+ ..+.|+||+.+..-
T Consensus 177 ~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 177 AQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred hcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 124689999999999999874 67899999988753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.05 E-value=0.00064 Score=69.48 Aligned_cols=136 Identities=12% Similarity=0.082 Sum_probs=75.6
Q ss_pred ccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCc-eeEeeeeeecCeeEEEEecC-CCC
Q 006112 341 LYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNL-VQLRGYCRRKGELLLVYDYM-PNG 418 (660)
Q Consensus 341 l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~E~~-~~g 418 (660)
++.++.|....+|+. ..+++|+....... .-...+|+.+++.+...++ .++++.+. +.-++|+||+ ++.
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCCCc
Confidence 677888999999998 34788877543221 2233568877777643333 45665443 3346899999 665
Q ss_pred Chhhh------------------hhhCCCCCcc-----hhHHHHHHH--------------HHHHHHHHhh-----hccc
Q 006112 419 SLDKI------------------LYSNTRPSLN-----WFQRFRIIK--------------GVAFGLLYLH-----EEWE 456 (660)
Q Consensus 419 sL~~~------------------l~~~~~~~l~-----~~~~~~i~~--------------~ia~gL~yLH-----~~~~ 456 (660)
+|... ++... ..+. +.....+.. .+...+..|. ....
T Consensus 94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~ 172 (301)
T 3dxq_A 94 TMSPEKFKTRPGSPARAGEAFRKLHGSG-AVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLP 172 (301)
T ss_dssp ECCHHHHHHSTTHHHHHHHHHHHHHTSC-CCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCC
T ss_pred cCCHhhHhhhHHHHHHHHHHHHHHhCCC-CCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCC
Confidence 55321 11111 0010 111111110 0111111111 1124
Q ss_pred CceeccCccCCcEEEcCCCCeEEeeccccee
Q 006112 457 QVVLHRDIKPANVLLDADLEGKLGDFGLARL 487 (660)
Q Consensus 457 ~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 487 (660)
..++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 57999999999999 5666789999998865
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0062 Score=62.70 Aligned_cols=141 Identities=15% Similarity=0.163 Sum_probs=80.0
Q ss_pred cccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCC--ceeEeee-----eeecCeeEEEEec
Q 006112 342 YKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRN--LVQLRGY-----CRRKGELLLVYDY 414 (660)
Q Consensus 342 ~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--Iv~l~g~-----~~~~~~~~lV~E~ 414 (660)
..++ |....||+.... +|+.+++|...... .....+..|..++..+.... +.+++.. ....+..++||||
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 3445 778899987653 45578999885332 13456677888877774222 3444432 2234566889999
Q ss_pred CCCCChhh-----------h---hhh----CC---CCCcchhHH----HHH---------------HHHHHHHHHHhhh-
Q 006112 415 MPNGSLDK-----------I---LYS----NT---RPSLNWFQR----FRI---------------IKGVAFGLLYLHE- 453 (660)
Q Consensus 415 ~~~gsL~~-----------~---l~~----~~---~~~l~~~~~----~~i---------------~~~ia~gL~yLH~- 453 (660)
++|..+.. . ++. .. +...++... ..+ ...+...++.+..
T Consensus 109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 188 (328)
T 1zyl_A 109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 188 (328)
T ss_dssp CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence 98765421 0 111 00 111222111 001 1111112222222
Q ss_pred ---cccCceeccCccCCcEEEcCCCCeEEeeccccee
Q 006112 454 ---EWEQVVLHRDIKPANVLLDADLEGKLGDFGLARL 487 (660)
Q Consensus 454 ---~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 487 (660)
.....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1246799999999999999 4 899999998764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0029 Score=66.63 Aligned_cols=75 Identities=9% Similarity=0.100 Sum_probs=44.0
Q ss_pred ccccccCccEEEEEEEeCCC--------CeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCc-eeEeeeeeecCeeEEE
Q 006112 341 LYKATKGGSGKVYRGVLPSS--------HAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNL-VQLRGYCRRKGELLLV 411 (660)
Q Consensus 341 l~~lg~G~fg~Vy~g~~~~~--------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV 411 (660)
++.++.|-...+|+...... +..+++|...... ........|..+++.+...++ .++++.. . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 45667788889999887431 2577777754322 222234678888887754443 4666543 2 2689
Q ss_pred EecCCCCCh
Q 006112 412 YDYMPNGSL 420 (660)
Q Consensus 412 ~E~~~~gsL 420 (660)
|||++|..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.09 E-value=0.044 Score=56.85 Aligned_cols=32 Identities=28% Similarity=0.334 Sum_probs=28.6
Q ss_pred cCceeccCccCCcEEEcCCCCeEEeeccccee
Q 006112 456 EQVVLHRDIKPANVLLDADLEGKLGDFGLARL 487 (660)
Q Consensus 456 ~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 487 (660)
...++|+|+.+.||++++++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 46899999999999999888899999988764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.68 E-value=0.053 Score=52.06 Aligned_cols=103 Identities=16% Similarity=0.047 Sum_probs=66.1
Q ss_pred CChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCceee
Q 006112 418 GSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTT 497 (660)
Q Consensus 418 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 497 (660)
-||.+.|..... +++++++|.++.|.+..|.-+-. ++.-..+=+.|..|++..+|++.+.+ ..+.
T Consensus 33 vSL~eIL~~~~~-PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQ-PINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHHHcCC-CcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc-----------
Confidence 478898876553 69999999999999999876621 01111333457899999999888764 1110
Q ss_pred ccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCC
Q 006112 498 NVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRP 538 (660)
Q Consensus 498 ~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p 538 (660)
.....+.+||... ...+.+.=|||+|+++|.-+--..|
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1122456888763 3456788899999999998864433
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.62 E-value=0.06 Score=57.66 Aligned_cols=141 Identities=11% Similarity=0.126 Sum_probs=83.5
Q ss_pred ccccccCccEEEEEEEeCCC-------CeEEEEEEeccCCChhhHHHHHHHHHHhccCCCC-ceeEeeeeeecCeeEEEE
Q 006112 341 LYKATKGGSGKVYRGVLPSS-------HAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRN-LVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 341 l~~lg~G~fg~Vy~g~~~~~-------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~ 412 (660)
++.+..|-...+|+...... +..+++++..... ...-.-.+|..+++.+...+ ..++++.+ . -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence 44566777889999987531 4678888754332 22223467888887775333 34555533 2 26899
Q ss_pred ecCCCCChhh-------h-------h---hh--------C---CCCCcchhHHHHHHHHH-------------------H
Q 006112 413 DYMPNGSLDK-------I-------L---YS--------N---TRPSLNWFQRFRIIKGV-------------------A 445 (660)
Q Consensus 413 E~~~~gsL~~-------~-------l---~~--------~---~~~~l~~~~~~~i~~~i-------------------a 445 (660)
||++|..|.. . | +. . .+.+.-|.++.++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 9999876421 0 0 00 0 11112244443333222 2
Q ss_pred HHHHHhhh---------------------cccCceeccCccCCcEEEcCCCCeEEeeccccee
Q 006112 446 FGLLYLHE---------------------EWEQVVLHRDIKPANVLLDADLEGKLGDFGLARL 487 (660)
Q Consensus 446 ~gL~yLH~---------------------~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 487 (660)
..+..|.+ .....++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 22333321 12357999999999999 7788999999998864
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.19 E-value=0.41 Score=50.68 Aligned_cols=31 Identities=29% Similarity=0.355 Sum_probs=25.9
Q ss_pred CceeccCccCCcEEE------cCCCCeEEeeccccee
Q 006112 457 QVVLHRDIKPANVLL------DADLEGKLGDFGLARL 487 (660)
Q Consensus 457 ~~ivHrDikp~NIll------~~~~~~kl~DFGla~~ 487 (660)
..++|+|+.+.|||+ +++..++++||.+|..
T Consensus 244 ~vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 244 VVFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 357899999999999 4567799999998864
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=83.56 E-value=0.11 Score=56.17 Aligned_cols=61 Identities=8% Similarity=0.047 Sum_probs=17.2
Q ss_pred cccccccCccEEEEEEEeCCCCeEEEE------EEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeee
Q 006112 340 NLYKATKGGSGKVYRGVLPSSHAEIAV------KKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCR 403 (660)
Q Consensus 340 ~l~~lg~G~fg~Vy~g~~~~~~~~vav------K~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~ 403 (660)
..+++| ||.||+|.+.....+||| |..... ..+....|.+|..+++.++|||+++.+++..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 344555 999999999765568888 766432 2334567899999999999999999988653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 660 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-65 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-62 | |
| d1gzca_ | 239 | b.29.1.1 (A:) Legume lectin {Cockspur coral tree ( | 1e-60 | |
| d1hqla_ | 236 | b.29.1.1 (A:) Legume lectin {Griffonia simplicifol | 2e-60 | |
| d1qnwa_ | 237 | b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus | 5e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-59 | |
| d1g9fa_ | 251 | b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) | 2e-59 | |
| d1g7ya_ | 253 | b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos | 5e-59 | |
| d1g8wa_ | 233 | b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar | 1e-58 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-58 | |
| d2d3sa1 | 237 | b.29.1.1 (A:1-237) Legume lectin {Winged bean (Pso | 2e-58 | |
| d1dbna_ | 239 | b.29.1.1 (A:) Legume lectin {Maackia amurensis, le | 2e-58 | |
| d1fx5a_ | 240 | b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus | 3e-58 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-58 | |
| d1leda_ | 243 | b.29.1.1 (A:) Legume lectin {West-central african | 8e-58 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-57 | |
| d1avba_ | 226 | b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar | 3e-57 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-57 | |
| d1f9ka_ | 234 | b.29.1.1 (A:) Legume lectin {Winged bean (Psophoca | 4e-57 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-57 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-56 | |
| d1v6ia_ | 232 | b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypog | 3e-56 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-56 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-55 | |
| g1qmo.1 | 230 | b.29.1.1 (A:,E:) Legume lectin {Field bean (Dolich | 7e-55 | |
| d1ukga_ | 241 | b.29.1.1 (A:) Legume lectin {Bloodwood tree (Ptero | 2e-54 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-54 | |
| d1n47a_ | 233 | b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia vi | 4e-54 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-54 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-53 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-53 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-53 | |
| d1fnya_ | 237 | b.29.1.1 (A:) Legume lectin {Black locust (Robinia | 3e-53 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-53 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 8e-53 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-53 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-52 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-52 | |
| g2ltn.1 | 229 | b.29.1.1 (A:,B:) Legume lectin {Garden pea (Pisum | 4e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-51 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-51 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-51 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-50 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-50 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-49 | |
| d1ioaa_ | 228 | b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar | 2e-49 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-49 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-48 | |
| d1dhkb_ | 204 | b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also ar | 2e-47 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-47 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-47 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-46 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-43 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-42 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-40 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 9e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-39 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-38 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-38 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-38 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-37 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-37 | |
| d1nlsa_ | 237 | b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia | 3e-37 | |
| d1nlsa_ | 237 | b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia | 7e-27 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-37 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-36 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-36 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-30 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-30 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-26 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-24 | |
| d1gv9a_ | 228 | b.29.1.13 (A:) Carbohydrate-recognition domain of | 6e-22 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-19 | |
| d2a6va1 | 218 | b.29.1.13 (A:9-226) Emp46p N-terminal domain {Bake | 5e-04 | |
| d2a6za1 | 221 | b.29.1.13 (A:7-227) Emp47p N-terminal domain {Bake | 7e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 1e-65
Identities = 70/294 (23%), Positives = 126/294 (42%), Gaps = 23/294 (7%)
Query: 325 EDWEKEYSPHRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEI 384
+DWE + G G VY+G A + + V + ++ F +E+
Sbjct: 1 DDWEIPDG----QITVGQRIGSGSFGTVYKGKWHGDVA-VKMLNVTAPTPQQLQAFKNEV 55
Query: 385 VSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGV 444
+ K RH N++ GY +L +V + SL L+ + I +
Sbjct: 56 GVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQT 113
Query: 445 AFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH-TTNVVGTV 503
A G+ YLH + ++HRD+K N+ L DL K+GDFGLA + + H + G++
Sbjct: 114 AQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 170
Query: 504 GYLAPELLRNGRG---TTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVL 560
++APE++R + +DVYAFG+ + E+ G+ P ++ D +I +G L
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS--NINNRDQIIFMVGRG-YL 227
Query: 561 DASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGALLPDIP 614
++ + ++ + C D RP Q++ ++ L +P
Sbjct: 228 SPDLSKVRSNCPKAMKRLMAE----CLKKKRDERPLFPQILASIE--LLARSLP 275
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 2e-62
Identities = 70/281 (24%), Positives = 125/281 (44%), Gaps = 21/281 (7%)
Query: 325 EDWEKEYSPHRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEI 384
++WE + K + + G G+V+ G H ++AVK + F++E
Sbjct: 6 DEWEVPRE----TLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEA 59
Query: 385 VSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGV 444
M +L+H+ LV+L + + ++ +YM NGSL L + + L + + +
Sbjct: 60 NLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 445 AFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVG 504
A G+ ++ E +HRD++ AN+L+ L K+ DFGLARL + +
Sbjct: 119 AEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 175
Query: 505 YLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASD 564
+ APE + G T +DV++FG+ + E+ R PG + VI ++G + D
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEVIQNLERGYRMVRPD 233
Query: 565 PRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
E +Y +L C P+ RP+ + L+
Sbjct: 234 NCPEELY---------QLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1gzca_ b.29.1.1 (A:) Legume lectin {Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]} Length = 239 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]
Score = 200 bits (510), Expect = 1e-60
Identities = 65/250 (26%), Positives = 107/250 (42%), Gaps = 29/250 (11%)
Query: 30 FIHHGFE--GSKLKLDGLAKIHPNGLLQLTNTSE------RISGHAFYPFPFKFNSSSSQ 81
F FE L L G A I +G+LQLT ++ +G Y P S++
Sbjct: 6 FSFSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWDSTTG 65
Query: 82 SL-SFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIF 140
++ SF T F F++ F T A +LG+FN S +
Sbjct: 66 TVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPAQGYGYLGVFNNSKQDN-SYQTL 124
Query: 141 AIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPIQIWI 200
A+E DT +P ++ H+GIDVN ++S ++ + L++G+ + I
Sbjct: 125 AVEFDTFSNP-WDPPQVPHIGIDVNSIRSIKTQPFQ-------------LDNGQVANVVI 170
Query: 201 DYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTR---VSDYYI 257
Y+ K+++V L + ++ +D+ Q+L D + VGLS ATG + + +
Sbjct: 171 KYDAPSKILHVVLVYPS--SGAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDAAETHDV 228
Query: 258 LGWSFNKSGP 267
WSF S P
Sbjct: 229 YSWSFQASLP 238
|
| >d1hqla_ b.29.1.1 (A:) Legume lectin {Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]} Length = 236 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]
Score = 199 bits (508), Expect = 2e-60
Identities = 75/248 (30%), Positives = 116/248 (46%), Gaps = 28/248 (11%)
Query: 30 FIHHGFEG---SKLKLDGLAKIHPNGLLQLTNTSERI------SGHAFYPFPFKF-NSSS 79
F F + G A G LQL T++ +G A Y P + ++ +
Sbjct: 4 FTFPNFWSDVEDSIIFQGDANT-TAGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWDNKT 62
Query: 80 SQSLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFT-NH 138
SF T F F + N G+AFF++P D AG +LG+FN+S Q + N
Sbjct: 63 ESVASFYTEFTFFLKIT-GNGPADGLAFFLAPP-DSDVKDAGEYLGLFNKSTATQPSKNQ 120
Query: 139 IFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPIQI 198
+ A+E DT +P F + H+GI+VN + S + +E + SGK
Sbjct: 121 VVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATKR----------WEDSDIFSGKIATA 170
Query: 199 WIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGT-RVSDYYI 257
I Y+G +++ V L+ P S +LS S+D+ Q L +S+ VG+SA+TG + YI
Sbjct: 171 RISYDGSAEILTVVLSY---PDGSDYILSHSVDMRQNLPESVRVGISASTGNNQFLTVYI 227
Query: 258 LGWSFNKS 265
L W F+ +
Sbjct: 228 LSWRFSSN 235
|
| >d1qnwa_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-II [TaxId: 3902]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Furze (Ulex europaeus), UEA-II [TaxId: 3902]
Score = 199 bits (506), Expect = 5e-60
Identities = 61/248 (24%), Positives = 107/248 (43%), Gaps = 26/248 (10%)
Query: 26 EENQFIHHGFE--GSKLKLDGLAKIHPNGLLQLTNTSERIS---GHAFYPFPFKFNSSSS 80
++ F F + G A + G+LQ+T S+ + G A Y P + S +
Sbjct: 2 DDLSFNFDKFVPNQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWDSIT 61
Query: 81 QSL-SFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHI 139
+ SF+TSF F + + G G+AFF++P+ + + + + S++ + +N I
Sbjct: 62 GKVASFATSFSFVVKAD-KSDGVDGLAFFLAPANSQIPSGSSAGMFGLFSSSDSKSSNQI 120
Query: 140 FAIELDTVQSPEFN--DIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPIQ 197
A+E DT +N D D H+GIDVN ++S + +G+
Sbjct: 121 IAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSI-------------KTVKWDWRNGEVAD 167
Query: 198 IWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATG--TRVSDY 255
+ I Y K + V L+ + +++ S+DL IL + + VG S G +
Sbjct: 168 VVITYRAPTKSLTVCLSYPSDGT--SNIITASVDLKAILPEWVSVGFSGGVGNAAEFETH 225
Query: 256 YILGWSFN 263
+L W F
Sbjct: 226 DVLSWYFT 233
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 1e-59
Identities = 74/282 (26%), Positives = 118/282 (41%), Gaps = 21/282 (7%)
Query: 324 YEDWEKEYSPHRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSE 383
+ WE S + K +G G+V+ G + +A+K + + F+ E
Sbjct: 9 KDAWEIPRE----SLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTL-KPGTMSPEAFLQE 62
Query: 384 IVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKG 443
M KLRH LVQL + +V +YM GSL L T L Q +
Sbjct: 63 AQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 121
Query: 444 VAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTV 503
+A G+ Y+ +HRD++ AN+L+ +L K+ DFGLARL + +
Sbjct: 122 IASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 178
Query: 504 GYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDAS 563
+ APE GR T +DV++FG+ + E+ R PG ++ +VLD
Sbjct: 179 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----------EVLDQV 227
Query: 564 DPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
+ E E + L C P+ RP+ + +L+
Sbjct: 228 ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1g9fa_ b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) [TaxId: 3847]} Length = 251 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Soybean (Glycine max) [TaxId: 3847]
Score = 197 bits (502), Expect = 2e-59
Identities = 64/260 (24%), Positives = 107/260 (41%), Gaps = 32/260 (12%)
Query: 30 FIHHGF--EGSKLKLDGLAKIHPNGLLQLTNTSE------RISGHAFYPFPFKFNSSSSQ 81
F + F + + L G A + +G LQL E G A Y P +
Sbjct: 6 FSWNKFVPKQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIWDKETG 65
Query: 82 SL-SFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIF 140
S+ SF+ SF F + G+AFF++P +H G N + + +
Sbjct: 66 SVASFAASFNFTFYAPDTKRLADGLAFFLAPIDTK----PQTHAGYLGLFNENESGDQVV 121
Query: 141 AIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPIQIWI 200
A+E DT ++ D H+GI+VN ++S ++ S L + K ++ I
Sbjct: 122 AVEFDTFRNS--WDPPNPHIGINVNSIRSIKTTS-------------WDLANNKVAKVLI 166
Query: 201 DYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATG--TRVSDYYIL 258
Y+ L+ +L + + +LS +DL L + + +G SAATG + +L
Sbjct: 167 TYDASTSLLVASLVYPS--QRTSNILSDVVDLKTSLPEWVRIGFSAATGLDIPGESHDVL 224
Query: 259 GWSFNKSGPAQNLDISKLPP 278
WSF + P + +I L
Sbjct: 225 SWSFASNLPHASSNIDPLDL 244
|
| >d1g7ya_ b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]} Length = 253 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]
Score = 196 bits (500), Expect = 5e-59
Identities = 65/267 (24%), Positives = 109/267 (40%), Gaps = 33/267 (12%)
Query: 26 EENQFIHHGFEGSKLKLDGLAKIHPNGLLQLTNTSE------RISGHAFYPFPFKF-NSS 78
+ F F S L G A + + L+LT G AFY P + + S
Sbjct: 2 DIQSFSFKNFNSSSFILQGDATV-SSSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIYDKS 60
Query: 79 SSQSLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNH 138
+ S++TSF +F + G+AF + P ++ +G LG+F+ +
Sbjct: 61 TGAVASWATSFTANIFAPNKSSSADGIAFALVPVGSEPKSNSGF-LGVFDSDVYDN-SAQ 118
Query: 139 IFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPIQI 198
A+E DT + ++ D H+GIDVN ++S +AS L +G+ +I
Sbjct: 119 TVAVEFDTFSNTDW-DPTSRHIGIDVNSIKSIRTASWG-------------LANGQNAEI 164
Query: 199 WIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGT---RVSDY 255
I YN L+ +L ++S +D++ L + + +G SA TG +
Sbjct: 165 LITYNAATSLLVASLVHPSRRT--SYIVSERVDITNELPEYVSIGFSATTGLSEGYTETH 222
Query: 256 YILGWSFN----KSGPAQNLDISKLPP 278
+L WSF + LDI+
Sbjct: 223 DVLSWSFASKLPDDSTTEPLDIASYLV 249
|
| >d1g8wa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 233 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 194 bits (495), Expect = 1e-58
Identities = 64/247 (25%), Positives = 110/247 (44%), Gaps = 30/247 (12%)
Query: 29 QFIHHGFEGSKLKLDGLAKIHPNGLLQLTNTSERI------SGHAFYPFPFKF-NSSSSQ 81
F F + L L A + +G L+LTN + G AFY P + ++++
Sbjct: 5 YFNFQRFNETNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDNTTGT 64
Query: 82 SLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFA 141
SF+TSF F + G+AF + P + G LG+F+ SN+ H A
Sbjct: 65 VASFATSFTFNIQVPNNAGPADGLAFALVPVGSQPKD-KGGFLGLFDGSNS---NFHTVA 120
Query: 142 IELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPIQIWID 201
+E DT+ + ++ D H+GIDVN ++S ++ + +G+ ++ I
Sbjct: 121 VEFDTLYNKDW-DPTERHIGIDVNSIRSIKTTRWDF-------------VNGENAEVLIT 166
Query: 202 YNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGT---RVSDYYIL 258
Y+ L+ +L + + ++S ++DL +L + + VG SA TG V +L
Sbjct: 167 YDSSTNLLVASLVYPS--QKTSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNVETNDVL 224
Query: 259 GWSFNKS 265
WSF
Sbjct: 225 SWSFASK 231
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 196 bits (499), Expect = 2e-58
Identities = 72/282 (25%), Positives = 120/282 (42%), Gaps = 19/282 (6%)
Query: 324 YEDWEKEYSPHRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSE 383
Y+ WE + K+ K G G+VY GV +AVK + D+ +++F+ E
Sbjct: 9 YDKWE--MERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKE 63
Query: 384 IVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKG 443
M +++H NLVQL G C R+ ++ ++M G+L L R ++ +
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123
Query: 444 VAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTV 503
++ + YL + + +HRD+ N L+ + K+ DFGL+RL +
Sbjct: 124 ISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 180
Query: 504 GYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDAS 563
+ APE L + + +DV+AFGV + E+A PG V +
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-----------IDLSQVYELL 229
Query: 564 DPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
+ E E V +L C NP RPS ++ Q +
Sbjct: 230 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d2d3sa1 b.29.1.1 (A:1-237) Legume lectin {Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]
Score = 194 bits (494), Expect = 2e-58
Identities = 65/253 (25%), Positives = 103/253 (40%), Gaps = 36/253 (14%)
Query: 30 FIHHGFE--GSKLKLDGLAKIHPNGLLQLTNT-----SERISGHAFYPFPFKF-NSSSSQ 81
F + F +LKL A+I N +L+LT + +G A Y P + +S++
Sbjct: 5 FNFNQFHQNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDSTTGN 64
Query: 82 SLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFA 141
SF T F F++ P F + G + GI+N + A
Sbjct: 65 VASFETRFSFSIRQPFPRPHPADGLVFFIAPPNTQTGEGGGYFGIYNPLSP----YPFVA 120
Query: 142 IELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPIQIWID 201
+E DT ++ D H+GIDVN + S + L++G + I
Sbjct: 121 VEFDTFRNTW--DPQIPHIGIDVNSVIST-------------KTVPFTLDNGGIANVVIK 165
Query: 202 YNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATG-------TRVSD 254
Y+ K+++V L ++ +DL Q+L +S+ VG SAATG
Sbjct: 166 YDASTKILHVVLVFPSLGTI--YTIADIVDLKQVLPESVNVGFSAATGDPSGKQRNATET 223
Query: 255 YYILGWSFNKSGP 267
+ IL WSF+ S P
Sbjct: 224 HDILSWSFSASLP 236
|
| >d1dbna_ b.29.1.1 (A:) Legume lectin {Maackia amurensis, leukoagglutinin [TaxId: 37501]} Length = 239 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Maackia amurensis, leukoagglutinin [TaxId: 37501]
Score = 194 bits (494), Expect = 2e-58
Identities = 65/252 (25%), Positives = 108/252 (42%), Gaps = 27/252 (10%)
Query: 26 EENQFIHHGFE--GSKLKLDGLAKIHPNGLLQLTNTSE-----RISGHAFYPFPFKF-NS 77
+E F + F + L G A + G+LQLT G A Y P + +
Sbjct: 2 DELSFTINNFVPNEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWGN 61
Query: 78 SSSQSLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTN 137
++ SFSTSF F + P+ G+AF+++P + + S ++N +N
Sbjct: 62 TTGSVASFSTSFTFVVKAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSNSDSSN 121
Query: 138 HIFAIELDTVQSPEFNDID--GNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKP 195
I A+E DT + ++ D H+GIDVNG++S ++ + + L K
Sbjct: 122 QIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIKTVQWDWINGGVAFATITYLAPNKT 181
Query: 196 IQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATG--TRVS 253
+ + Y + ++ S+DL +IL + + VG SAATG T V
Sbjct: 182 LIASLVY---------------PSNQTTFSVAASVDLKEILPEWVRVGFSAATGYPTEVE 226
Query: 254 DYYILGWSFNKS 265
+ +L WSF +
Sbjct: 227 THDVLSWSFTST 238
|
| >d1fx5a_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-I [TaxId: 3902]} Length = 240 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Furze (Ulex europaeus), UEA-I [TaxId: 3902]
Score = 194 bits (493), Expect = 3e-58
Identities = 65/250 (26%), Positives = 102/250 (40%), Gaps = 25/250 (10%)
Query: 26 EENQFIHHGF--EGSKLKLDGLAKIHPNGLLQLT----NTSERISGHAFYPFPFKF-NSS 78
++ F F G L G A + G+LQL N + G A Y P N +
Sbjct: 2 DDLSFKFKNFSQNGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWNCN 61
Query: 79 SSQSLSFSTSFVFAMF-PKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTN 137
+ + SF TSF F M P G+ FF++P D AG + G+FN +
Sbjct: 62 TGELASFITSFSFFMETSANPKAATDGLTFFLAPP-DSPLRRAGGYFGLFN-DTKCDSSY 119
Query: 138 HIFAIELDTVQSP-EFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPI 196
A+E DT+ SP F D H+GIDVN ++S + +
Sbjct: 120 QTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAERW-----------NKRYGLNNVA 168
Query: 197 QIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGT-RVSDY 255
+ I Y K + +L + +++ +DL +IL + + VG S +T R + +
Sbjct: 169 NVEIIYEASSKTLTASLT--YPSDQTSISVTSIVDLKEILPEWVSVGFSGSTYIGRQATH 226
Query: 256 YILGWSFNKS 265
+L W F +
Sbjct: 227 EVLNWYFTST 236
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 7e-58
Identities = 65/260 (25%), Positives = 110/260 (42%), Gaps = 17/260 (6%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK 405
G G V+ G + ++A+K + + + F+ E M KL H LVQL G C +
Sbjct: 15 SGQFGLVHLGYWLNKD-KVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 72
Query: 406 GELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIK 465
+ LV+++M +G L L + + V G+ E V+HRD+
Sbjct: 73 APICLVFEFMEHGCLSDYLRTQRGLF-AAETLLGMCLDVCEGM---AYLEEACVIHRDLA 128
Query: 466 PANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAF 525
N L+ + K+ DFG+ R +T V + +PE+ R ++ +DV++F
Sbjct: 129 ARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSF 188
Query: 526 GVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLF 585
GV M EV + P E V++ G L PRL +V + +
Sbjct: 189 GVLMWEVFSEGKI--PYENRSNSEVVEDISTGFRLY--KPRLASTHVYQ-------IMNH 237
Query: 586 CSHSNPDTRPSMRQVVQYLD 605
C P+ RP+ ++++ L
Sbjct: 238 CWKERPEDRPAFSRLLRQLA 257
|
| >d1leda_ b.29.1.1 (A:) Legume lectin {West-central african legume (Griffonia simplicifolia) [TaxId: 3850]} Length = 243 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: West-central african legume (Griffonia simplicifolia) [TaxId: 3850]
Score = 193 bits (491), Expect = 8e-58
Identities = 65/241 (26%), Positives = 99/241 (41%), Gaps = 24/241 (9%)
Query: 37 GSKLKLDGLAKIHPNGLLQLTNTSE------RISGHAFYPFPFKFNSSSSQSLSFSTSFV 90
G+++ G A G LQLT T +G A Y P S+ ++ SF TSF
Sbjct: 19 GTEITFLGDATRI-PGALQLTKTDANGNPVRSSAGQASYSEPVFLWDSTGKAASFYTSFT 77
Query: 91 FAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFT-NHIFAIELDTVQS 149
F + G+AFF++P D S G LG+F + N + A+E DT +
Sbjct: 78 F-LLKNYGAPTADGLAFFLAP-VDSSVKDYGGFLGLFRHETAADPSKNQVVAVEFDTWIN 135
Query: 150 PEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPIQIWIDYNGQEKLV 209
++ND H+GIDVN + S + I Y+ + K++
Sbjct: 136 KDWNDPPYPHIGIDVNSIVSVATTRWENDD----------AYGSSIATAHITYDARSKIL 185
Query: 210 NVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTRVSDYYILGWSFNKSGPAQ 269
V L+ +LS +DL+++L + +G SA G YIL W F +
Sbjct: 186 TVLLSY---EHGRDYILSHVVDLAKVLPQKVRIGFSAGVG-YDEVTYILSWHFFSTLDGT 241
Query: 270 N 270
N
Sbjct: 242 N 242
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 1e-57
Identities = 56/225 (24%), Positives = 110/225 (48%), Gaps = 8/225 (3%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGM-KQFVSEIVSMGKLRHRNLV 396
++ + + G G V++ S +A K + + + Q + E+ + + +V
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 397 QLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWE 456
G GE+ + ++M GSLD++L R + ++ V GL YL E +
Sbjct: 68 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLRE--K 123
Query: 457 QVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRG 516
++HRD+KP+N+L+++ E KL DFG++ + VGT Y++PE L+
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHY 180
Query: 517 TTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLD 561
+ +D+++ G+ ++E+A GR P+ P + L+ + +GD +
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225
|
| >d1avba_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 226 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 191 bits (485), Expect = 3e-57
Identities = 58/245 (23%), Positives = 101/245 (41%), Gaps = 31/245 (12%)
Query: 26 EENQFIHHGFEGSKLKLDGLAKIHPNGLLQLTNTSERIS---GHAFYPFPFKF-NSSSSQ 81
+ F F + L L G A + G L LTN G AFY P + + +
Sbjct: 2 NDASFNVETFNKTNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQINDRTIDN 61
Query: 82 SLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFA 141
SFST+F F + K +G+AF + P + G +LG+FN +N
Sbjct: 62 LASFSTNFTFRINAKNIENSAYGLAFALVPVGSRP-KLKGRYLGLFNTTNY--------- 111
Query: 142 IELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPIQIWID 201
+ D D N + IDVN ++ + S + +G+ ++ I
Sbjct: 112 -DRDAHTVAVVFDTVSNRIEIDVNSIRPIATESCNFG-----------HNNGEKAEVRIT 159
Query: 202 YNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTR---VSDYYIL 258
Y+ + + V+L + +S ++ L + ++D + VG SA +G++ + +L
Sbjct: 160 YDSPKNDLRVSLLY--PSSEEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETHNVL 217
Query: 259 GWSFN 263
WSF+
Sbjct: 218 SWSFS 222
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 4e-57
Identities = 69/287 (24%), Positives = 116/287 (40%), Gaps = 33/287 (11%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK 405
KG G+V+RG E+AVK + +EI LRH N++ +
Sbjct: 13 KGRFGEVWRGKW--RGEEVAVKIF-SSREERSWFREAEIYQTVMLRHENILGFIAADNKD 69
Query: 406 G----ELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEE-----WE 456
+L LV DY +GSL L R ++ ++ A GL +LH E +
Sbjct: 70 NGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126
Query: 457 QVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND---LHTTNVVGTVGYLAPELL-- 511
+ HRD+K N+L+ + + D GLA +D D + + VGT Y+APE+L
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186
Query: 512 ----RNGRGTTSTDVYAFGVFMLEVACGRRPVQPGE--------LDLLDWVIDYWQKGDV 559
++ D+YA G+ E+A E L D ++ +K
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 246
Query: 560 LDASDPRLEGIYVE-EQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
P + + E + ++ K+ C ++N R + ++ + L
Sbjct: 247 EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1f9ka_ b.29.1.1 (A:) Legume lectin {Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]} Length = 234 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]
Score = 191 bits (485), Expect = 4e-57
Identities = 72/255 (28%), Positives = 105/255 (41%), Gaps = 37/255 (14%)
Query: 26 EENQFIHHGFE--GSKLKLDGLAKIHPNGLLQLTNTSE------RISGHAFYPFPFKFNS 77
E F FE +L L A I NG+L+LT ++ + +G A Y P K
Sbjct: 1 ETQSFNFDHFEENSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWD 60
Query: 78 SSSQSL-SFSTSFVFAMFPKLPN-YGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQF 135
S++ ++ SF T F F + G+ FF+ P G
Sbjct: 61 STTGNVASFETRFSFNITQPYAYPEPADGLTFFMVPPNSPQGE-----DGGNLGVFKPPE 115
Query: 136 TNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKP 195
++ FA+E DT Q+ D H+GIDVN + S+ + LE+G
Sbjct: 116 GDNAFAVEFDTFQNTW--DPQVPHIGIDVNSIVSS-------------KTLHFQLENGGV 160
Query: 196 IQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDS--MYVGLSAATGTR-- 251
+ I Y+ K++NV LA LS +DL Q +S + VGLSA TG +
Sbjct: 161 ANVVIKYDSPTKILNVVLAFHSVGTV--YTLSNIVDLKQEFPNSEWVNVGLSATTGYQKN 218
Query: 252 -VSDYYILGWSFNKS 265
V + I+ WSF S
Sbjct: 219 AVETHEIISWSFTSS 233
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 8e-57
Identities = 78/261 (29%), Positives = 115/261 (44%), Gaps = 23/261 (8%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYC-RR 404
KG G V G + ++AVK + +D + F++E M +LRH NLVQL G
Sbjct: 17 KGEFGDVMLGDYRGN--KVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 72
Query: 405 KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDI 464
KG L +V +YM GSL L S R L + V + YL +HRD+
Sbjct: 73 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDL 129
Query: 465 KPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYA 524
NVL+ D K+ DFGL + V + APE LR + +T +DV++
Sbjct: 130 AARNVLVSEDNVAKVSDFGLTKEASS----TQDTGKLPVKWTAPEALREKKFSTKSDVWS 185
Query: 525 FGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGL 584
FG+ + E+ R P L V+ +KG +DA D +Y ++
Sbjct: 186 FGILLWEIYSFGRV--PYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY---------EVMK 234
Query: 585 FCSHSNPDTRPSMRQVVQYLD 605
C H + RPS Q+ + L+
Sbjct: 235 NCWHLDAAMRPSFLQLREQLE 255
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 1e-56
Identities = 65/259 (25%), Positives = 107/259 (41%), Gaps = 17/259 (6%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK 405
G G V G + ++A+K + + +F+ E M L H LVQL G C ++
Sbjct: 14 TGQFGVVKYGKWRGQY-DVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 71
Query: 406 GELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIK 465
+ ++ +YM NG L L R Q + K V + YL + LHRD+
Sbjct: 72 RPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLA 127
Query: 466 PANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAF 525
N L++ K+ DFGL+R + V + PE+L + ++ +D++AF
Sbjct: 128 ARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAF 187
Query: 526 GVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLF 585
GV M E+ + P E ++ +G L P L E V +
Sbjct: 188 GVLMWEIYSLGKM--PYERFTNSETAEHIAQGLRLY--RPHLAS-------EKVYTIMYS 236
Query: 586 CSHSNPDTRPSMRQVVQYL 604
C H D RP+ + ++ +
Sbjct: 237 CWHEKADERPTFKILLSNI 255
|
| >d1v6ia_ b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3818]} Length = 232 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Peanut (Arachis hypogaea) [TaxId: 3818]
Score = 188 bits (479), Expect = 3e-56
Identities = 59/241 (24%), Positives = 96/241 (39%), Gaps = 23/241 (9%)
Query: 30 FIHHGFEGS--KLKLDGLAKIHPNGLLQLTN-TSERISGHAFYPFPFKF-NSSSSQSLSF 85
F + F + G + NG +QLTN G Y P + +S++ SF
Sbjct: 6 FNFNSFSEGNPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIWSSATGNVASF 65
Query: 86 STSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIELD 145
TSF F M G+ FFI+P ++ AGS G ++ + H +E D
Sbjct: 66 LTSFSFEMKDIKDYDPADGIIFFIAPED--TQIPAGSIGGGTLGVSDTKGAGHFVGVEFD 123
Query: 146 TVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPIQIWIDYNGQ 205
T + E+ND +HVGIDVN + S + SG +++ + Y+
Sbjct: 124 TYSNSEYNDPPTDHVGIDVNSVDSV-------------KTVPWNSVSGAVVKVTVIYDSS 170
Query: 206 EKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGT-RVSDYYILGWSFNK 264
K ++V + ++ +DL L + + G SA+ + I WSF
Sbjct: 171 TKTLSVAVTN---DNGDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIRSWSFTS 227
Query: 265 S 265
+
Sbjct: 228 T 228
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 4e-56
Identities = 68/273 (24%), Positives = 116/273 (42%), Gaps = 21/273 (7%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNL 395
Y+ LY G G+ + S + K++ + S + + VSE+ + +L+H N+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 396 VQLRGYC--RRKGELLLVYDYMPNGSLDKILYSNT--RPSLNWFQRFRIIKGVAFGLLYL 451
V+ R L +V +Y G L ++ T R L+ R++ + L
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 452 HE--EWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPE 509
H + VLHRD+KPANV LD KLGDFGLAR+ +H VGT Y++PE
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSPE 184
Query: 510 LLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEG 569
+ +D+++ G + E+ P G + + R+
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--------QKELAGKIREGKFRRIPY 236
Query: 570 IYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602
Y +E EI+ + + RPS+ ++++
Sbjct: 237 RYSDELNEIITR----MLNLKDYHRPSVEEILE 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 1e-55
Identities = 63/284 (22%), Positives = 120/284 (42%), Gaps = 21/284 (7%)
Query: 324 YEDWEKEYSPHRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSE 383
YE ++ +P F ++ + + G GKVY+ + A K + S+ ++ ++ E
Sbjct: 1 YEHVTRDLNPEDF-WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVE 59
Query: 384 IVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKG 443
I + H N+V+L + L ++ ++ G++D ++ RP L Q + K
Sbjct: 60 IDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP-LTESQIQVVCKQ 118
Query: 444 VAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTV 503
L YLH+ ++HRD+K N+L D + KL DFG++ + +GT
Sbjct: 119 TLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-FIGTP 174
Query: 504 GYLAPELLRNGRG-----TTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGD 558
++APE++ DV++ G+ ++E+A P V+ K +
Sbjct: 175 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN---PMRVLLKIAKSE 231
Query: 559 VLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602
+ P + + + K C N D R + Q++Q
Sbjct: 232 PPTLAQPS---RWSSNFKDFLKK----CLEKNVDARWTTSQLLQ 268
|
| >d1ukga_ b.29.1.1 (A:) Legume lectin {Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]} Length = 241 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]
Score = 184 bits (467), Expect = 2e-54
Identities = 57/248 (22%), Positives = 94/248 (37%), Gaps = 29/248 (11%)
Query: 30 FIHHGFE--GSKLKLDGLAKIHPNGLLQLTNTSE------RISGHAFYPFPFKF-NSSSS 80
F F L G A+I N +QLT T G + SSS
Sbjct: 6 FGFPTFPSDQKNLIFQGDAQIK-NNAVQLTKTDSNGNPVASTVGRILFSAQVHLWEKSSS 64
Query: 81 QSLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNG-QFTNHI 139
+ +F + F F++ L N F P T G LG+F N +
Sbjct: 65 RVANFQSQFSFSLKSPLSNGADGIAFFIAPPDTTIPSGSGGGLLGLFAPGTAQNTSANQV 124
Query: 140 FAIELDTVQSPEFNDID--GNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPIQ 197
A+E DT + + N D H+GIDVN ++S + G+ +
Sbjct: 125 IAVEFDTFYAQDSNTWDPNYPHIGIDVNSIRSVK-------------TVKWDRRDGQSLN 171
Query: 198 IWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTRVSDYYI 257
+ + +N + ++V +R +S +D+ +L + + VG SAA+G + + +
Sbjct: 172 VLVTFNPSTRNLDVVATY---SDGTRYEVSYEVDVRSVLPEWVRVGFSAASGEQYQTHTL 228
Query: 258 LGWSFNKS 265
WSF +
Sbjct: 229 ESWSFTST 236
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 185 bits (470), Expect = 4e-54
Identities = 70/298 (23%), Positives = 131/298 (43%), Gaps = 44/298 (14%)
Query: 336 FSYKNLYKAT-------------------KGGSGKVYRGVLPSS---HAEIAVKKVCHD- 372
F++++ +A G G+V G L +A+K +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 373 SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSL 432
++ + F+SE MG+ H N++ L G + ++++ ++M NGSLD L N
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 433 NWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492
Q +++G+A G+ YL + +HRD+ N+L++++L K+ DFGL+R +
Sbjct: 126 TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 493 DLHTTN----VVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLE-VACGRRPVQPGELDLL 547
T + + APE ++ + T+++DV+++G+ M E ++ G RP +
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV 242
Query: 548 DWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
I+ D RL + + +L L C + + RP Q+V LD
Sbjct: 243 INAIE----------QDYRLP--PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288
|
| >d1n47a_ b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]} Length = 233 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]
Score = 183 bits (464), Expect = 4e-54
Identities = 67/250 (26%), Positives = 104/250 (41%), Gaps = 30/250 (12%)
Query: 26 EENQFIHHGFE--GSKLKLDGLAKIHPNGLLQLTNTSE-----RISGHAFYPFPFKFNSS 78
E F F + L L A ++ G L+LT + G A Y P + +
Sbjct: 2 ESTSFSFTNFNPNQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIHDN 61
Query: 79 SSQSLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNH 138
++ + SF+TSF F M G+AFF++P +A G LG+F + +
Sbjct: 62 TTLA-SFTTSFSFVMAAPAAAAVADGLAFFLAPPDTQPQAR-GGFLGLFADRAHDA-SYQ 118
Query: 139 IFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPIQI 198
A+E DT + D + H+GID NG++S ++ + G+ I
Sbjct: 119 TVAVEFDTYSNAW--DPNYTHIGIDTNGIESKKT-------------TPFDMVYGEKANI 163
Query: 199 WIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGT---RVSDY 255
I Y K + +L V + +S +DL IL + + VG SA TG V +
Sbjct: 164 VITYQASTKALAASL--VFPVSQTSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVETH 221
Query: 256 YILGWSFNKS 265
I+ WSF S
Sbjct: 222 DIVSWSFAVS 231
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 6e-54
Identities = 67/290 (23%), Positives = 128/290 (44%), Gaps = 24/290 (8%)
Query: 330 EYSPHRFSYKNLYKATKGGSGKVYRGVLPSSHAE----IAVKKVCHDSDHGMK-QFVSEI 384
E P + + + G G+VY+G+L +S + +A+K + + F+ E
Sbjct: 3 EIHPSCVTRQKVIG--AGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60
Query: 385 VSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGV 444
MG+ H N+++L G + ++++ +YM NG+LDK + Q +++G+
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF-LREKDGEFSVLQLVGMLRGI 119
Query: 445 AFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND--LHTTNVVGT 502
A G+ YL +HRD+ N+L++++L K+ DFGL+R+ + + T+
Sbjct: 120 AAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176
Query: 503 VGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDA 562
+ + APE + + T+++DV++FG+ M EV +V+ A
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE-----------LSNHEVMKA 225
Query: 563 SDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGALLPD 612
+ + + +L + C RP +V LD PD
Sbjct: 226 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 1e-53
Identities = 63/264 (23%), Positives = 109/264 (41%), Gaps = 24/264 (9%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVC--HDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYC- 402
+G VY+G+ + E+A ++ + ++F E + L+H N+V+
Sbjct: 19 RGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWE 78
Query: 403 ---RRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVV 459
+ K ++LV + M +G+L L + + + GL +LH ++
Sbjct: 79 STVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTRTPPII 136
Query: 460 LHRDIKPANVLLDA-DLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTT 518
HRD+K N+ + K+GD GLA L V+GT ++APE+ +
Sbjct: 137 -HRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---FAKAVIGTPEFMAPEMYE-EKYDE 191
Query: 519 STDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEI 578
S DVYAFG+ MLE+A P E + G + + + E EI
Sbjct: 192 SVDVYAFGMCMLEMATSEYPYS--ECQNAAQIYRRVTSGV----KPASFDKVAIPEVKEI 245
Query: 579 VLKLGLFCSHSNPDTRPSMRQVVQ 602
+ C N D R S++ ++
Sbjct: 246 IEG----CIRQNKDERYSIKDLLN 265
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 184 bits (468), Expect = 1e-53
Identities = 64/271 (23%), Positives = 110/271 (40%), Gaps = 27/271 (9%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRN 394
+ +L + G G VY + +A+KK+ + S+ + + E+ + KLRH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 395 LVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEE 454
+Q RG R+ LV +Y + D + L + + G GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLHSH 134
Query: 455 WEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLR-- 512
++HRD+K N+LL KLGDFG A + + VGT ++APE++
Sbjct: 135 N---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANSFVGTPYWMAPEVILAM 186
Query: 513 -NGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIY 571
G+ DV++ G+ +E+A + P+ + P L+ +
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNESPALQSGH 238
Query: 572 VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602
E + C P RP+ +++
Sbjct: 239 WSEYFRNFVDS---CLQKIPQDRPTSEVLLK 266
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 183 bits (464), Expect = 3e-53
Identities = 71/311 (22%), Positives = 122/311 (39%), Gaps = 47/311 (15%)
Query: 324 YEDWEKEYSPHRFSYKNLYKATKGGSGKVYRGVLPS-----SHAEIAVKKVCHDSDHGM- 377
E R + + + +G G+V++ P +AVK + ++ M
Sbjct: 5 LLSLEYP----RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 60
Query: 378 KQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTR-------- 429
F E M + + N+V+L G C + L+++YM G L++ L S +
Sbjct: 61 ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120
Query: 430 --------------PSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADL 475
P L+ ++ I + VA G+ YL E +HRD+ N L+ ++
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENM 177
Query: 476 EGKLGDFGLARLYDHGNDLH-TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC 534
K+ DFGL+R + N + ++ PE + R TT +DV+A+GV + E+
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237
Query: 535 GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTR 594
P + VI Y + G++L E + L C P R
Sbjct: 238 YGLQ--PYYGMAHEEVIYYVRDGNILA---------CPENCPLELYNLMRLCWSKLPADR 286
Query: 595 PSMRQVVQYLD 605
PS + + L
Sbjct: 287 PSFCSIHRILQ 297
|
| >d1fnya_ b.29.1.1 (A:) Legume lectin {Black locust (Robinia pseudoacacia) [TaxId: 35938]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Black locust (Robinia pseudoacacia) [TaxId: 35938]
Score = 180 bits (458), Expect = 3e-53
Identities = 67/249 (26%), Positives = 108/249 (43%), Gaps = 29/249 (11%)
Query: 30 FIHHGFE--GSKLKLDGLAKIHPNGLLQLTNT-----SERISGHAFYPFPFKFNSSSSQS 82
F F L G A + G+LQLTN S + G A Y PF+ S++ +
Sbjct: 6 FSFPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDSTTGN 65
Query: 83 L-SFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFA 141
+ SF TSF F + P G+AFF++P + G LGIF +N I A
Sbjct: 66 VASFVTSFTFIIQAPNPATTADGLAFFLAPVDTQPLDLGGM-LGIFK-DGYFNKSNQIVA 123
Query: 142 IELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPIQIWID 201
+E DT + ++ D G H+GI+VN ++S ++ + +G+ ++I
Sbjct: 124 VEFDTFSNGDW-DPKGRHLGINVNSIESIKTVPWNW-------------TNGEVANVFIS 169
Query: 202 YNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGT---RVSDYYIL 258
Y K + +L + ++ +D+ +L + + G SA TG V +L
Sbjct: 170 YEASTKSLTASLV--YPSLETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQTNDVL 227
Query: 259 GWSFNKSGP 267
WSF + P
Sbjct: 228 SWSFESNLP 236
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 8e-53
Identities = 71/268 (26%), Positives = 113/268 (42%), Gaps = 23/268 (8%)
Query: 346 KGGSGKVYRGVLPSSHAE---IAVKKVCHDSDHG-MKQFVSEIVSMGKLRHRNLVQLRGY 401
+G G VY G L + + AVK + +D G + QF++E + M H N++ L G
Sbjct: 37 RGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGI 96
Query: 402 C-RRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVL 460
C R +G L+V YM +G L N + VA G+ + +
Sbjct: 97 CLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGM---KFLASKKFV 152
Query: 461 HRDIKPANVLLDADLEGKLGDFGLARLYDHGND---LHTTNVVGTVGYLAPELLRNGRGT 517
HRD+ N +LD K+ DFGLAR + T V ++A E L+ + T
Sbjct: 153 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT 212
Query: 518 TSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQME 577
T +DV++FGV + E+ P P + D + Q +L E +
Sbjct: 213 TKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGRRLLQP----------EYCPD 261
Query: 578 IVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
+ ++ L C H + RPS ++V +
Sbjct: 262 PLYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 8e-53
Identities = 63/260 (24%), Positives = 103/260 (39%), Gaps = 18/260 (6%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGM-KQFVSEIVSMGKLRHRNLVQLRGYCRR 404
+G G+V V + +AVK V + EI L H N+V+ G+ R
Sbjct: 15 EGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE 74
Query: 405 KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDI 464
L +Y G L + + + R + G++YLH + HRDI
Sbjct: 75 GNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIG---ITHRDI 129
Query: 465 KPANVLLDADLEGKLGDFGLARLYDHGNDLHTTN-VVGTVGYLAPELLRNGRG-TTSTDV 522
KP N+LLD K+ DFGLA ++ + N N + GT+ Y+APELL+ DV
Sbjct: 130 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 189
Query: 523 YAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKL 582
++ G+ + + G D D+ +K L+ + ++ K
Sbjct: 190 WSCGIVLTAMLAG-ELPWDQPSDSCQEYSDWKEKKTYLNPWKK-----IDSAPLALLHK- 242
Query: 583 GLFCSHSNPDTRPSMRQVVQ 602
NP R ++ + +
Sbjct: 243 ---ILVENPSARITIPDIKK 259
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 9e-53
Identities = 57/264 (21%), Positives = 111/264 (42%), Gaps = 21/264 (7%)
Query: 346 KGGSGKVYRGVLPS--SHAEIAVKKVCHDSDHG-MKQFVSEIVSMGKLRHRNLVQLRGYC 402
G G V +GV ++A+K + ++ ++ + E M +L + +V+L G C
Sbjct: 19 CGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC 78
Query: 403 RRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHR 462
+ + L+LV + G L K L R + ++ V+ G+ YL E+ +HR
Sbjct: 79 QAEA-LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FVHR 133
Query: 463 DIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT--TNVVGTVGYLAPELLRNGRGTTST 520
D+ NVLL K+ DFGL++ + +T + + + APE + + ++ +
Sbjct: 134 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRS 193
Query: 521 DVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVL 580
DV+++GV M E + V+ + ++G ++ +Y ++
Sbjct: 194 DVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQGKRMECPPECPPELY-----ALMS 246
Query: 581 KLGLFCSHSNPDTRPSMRQVVQYL 604
C + RP V Q +
Sbjct: 247 D----CWIYKWEDRPDFLTVEQRM 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 2e-52
Identities = 64/261 (24%), Positives = 108/261 (41%), Gaps = 26/261 (9%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVK---KVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYC 402
KG G VY S +A+K K + Q E+ LRH N+++L GY
Sbjct: 16 KGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 75
Query: 403 RRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHR 462
+ L+ +Y P G++ + L ++ + + I +A L Y H + V+HR
Sbjct: 76 HDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH---SKRVIHR 130
Query: 463 DIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDV 522
DIKP N+LL + E K+ DFG + H T + GT+ YL PE++ D+
Sbjct: 131 DIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDL 187
Query: 523 YAFGVFMLEVACGRRPVQ-PGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLK 581
++ GV E G+ P + + + + E +++ +
Sbjct: 188 WSLGVLCYEFLVGKPPFEANTYQETYKRISR----------VEFTFPDFVTEGARDLISR 237
Query: 582 LGLFCSHSNPDTRPSMRQVVQ 602
NP RP +R+V++
Sbjct: 238 ----LLKHNPSQRPMLREVLE 254
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 3e-52
Identities = 67/305 (21%), Positives = 117/305 (38%), Gaps = 39/305 (12%)
Query: 326 DWEKEYSPHRFSYKNLYKATKGGSGKVYRGVLP-----SSHAEIAVKKVCHDSDHGMKQ- 379
D + E+ +R S+ G GKV + +AVK + + ++
Sbjct: 15 DHKWEFPRNRLSFGK--TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA 72
Query: 380 FVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILY------------- 425
+SE+ + L H N+V L G C G L++ +Y G L L
Sbjct: 73 LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 132
Query: 426 ---SNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDF 482
+ +L+ VA G+ +L + +HRD+ N+LL K+ DF
Sbjct: 133 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDF 189
Query: 483 GLAR-LYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQP 541
GLAR + + N + N V ++APE + N T +DV+++G+F+ E+ P
Sbjct: 190 GLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249
Query: 542 GELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVV 601
G + E + + C ++P RP+ +Q+V
Sbjct: 250 GM----------PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299
Query: 602 QYLDG 606
Q ++
Sbjct: 300 QLIEK 304
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 2e-51
Identities = 58/265 (21%), Positives = 106/265 (40%), Gaps = 23/265 (8%)
Query: 346 KGGSGKVYRGVLPSSHA--EIAVKKVCHDSDHG--MKQFVSEIVSMGKLRHRNLVQLRGY 401
G G V +G +AVK + ++++ + ++E M +L + +V++ G
Sbjct: 17 SGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGI 76
Query: 402 CRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLH 461
C + +LV + G L+K L N + ++ V+ G+ YL E +H
Sbjct: 77 CEAE-SWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESN---FVH 130
Query: 462 RDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTN--VVGTVGYLAPELLRNGRGTTS 519
RD+ NVLL K+ DFGL++ + + V + APE + + ++
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 190
Query: 520 TDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIV 579
+DV++FGV M E + G V +KG+ + E +++
Sbjct: 191 SDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKGERMGCPAG-----CPREMYDLM 243
Query: 580 LKLGLFCSHSNPDTRPSMRQVVQYL 604
C + + RP V L
Sbjct: 244 NL----CWTYDVENRPGFAAVELRL 264
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 4e-51
Identities = 66/278 (23%), Positives = 117/278 (42%), Gaps = 34/278 (12%)
Query: 346 KGGSGKVYRGVLPSS--HAEIAVKKV-CHDSDHGMKQFVSEIVSMGKL-RHRNLVQLRGY 401
+G G+V + + + A+K++ + S + F E+ + KL H N++ L G
Sbjct: 20 EGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGA 79
Query: 402 CRRKGELLLVYDYMPNGSLDKILY--------------SNTRPSLNWFQRFRIIKGVAFG 447
C +G L L +Y P+G+L L ++T +L+ Q VA G
Sbjct: 80 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARG 139
Query: 448 LLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLA 507
+ YL ++ +HRD+ N+L+ + K+ DFGL+R + + T V ++A
Sbjct: 140 MDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV--YVKKTMGRLPVRWMA 194
Query: 508 PELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL 567
E L TT++DV+++GV + E+ P + + +G L+
Sbjct: 195 IESLNYSVYTTNSDVWSYGVLLWEIVSLGGT--PYCGMTCAELYEKLPQGYRLE------ 246
Query: 568 EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
+ V L C P RPS Q++ L+
Sbjct: 247 ---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 8e-51
Identities = 58/265 (21%), Positives = 109/265 (41%), Gaps = 17/265 (6%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQ 397
Y K +G SG VY + ++ E+A++++ + ++EI+ M + ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 398 LRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQ 457
EL +V +Y+ GSL ++ Q + + L +LH
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD---EGQIAAVCRECLQALEFLHSNQ-- 136
Query: 458 VVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGT 517
V+HRDIK N+LL D KL DFG + +VGT ++APE++
Sbjct: 137 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYG 194
Query: 518 TSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQME 577
D+++ G+ +E+ G P E L + + +P +
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPY-LNENPL--RALYLIATNGTPELQNPE---KLSAIFRD 248
Query: 578 IVLKLGLFCSHSNPDTRPSMRQVVQ 602
+ + C + + R S ++++Q
Sbjct: 249 FLNR----CLDMDVEKRGSAKELLQ 269
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 3e-50
Identities = 66/269 (24%), Positives = 107/269 (39%), Gaps = 27/269 (10%)
Query: 346 KGGSGKVYRGVLPSSH---AEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLR 399
G G V RG + +AVK + D M F+ E+ +M L HRNL++L
Sbjct: 18 DGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLY 77
Query: 400 GYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVV 459
G + +V + P GSL L + R VA G+ YL +
Sbjct: 78 GVV-LTPPMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGYLESKR---F 132
Query: 460 LHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH--TTNVVGTVGYLAPELLRNGRGT 517
+HRD+ N+LL K+GDFGL R +D + + + APE L+ +
Sbjct: 133 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFS 192
Query: 518 TSTDVYAFGVFMLEVACGRRPVQPGE--LDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQ 575
++D + FGV + E+ + G +L + D RL E+
Sbjct: 193 HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI----------DKEGERLP--RPEDC 240
Query: 576 MEIVLKLGLFCSHSNPDTRPSMRQVVQYL 604
+ + + + C P+ RP+ + +L
Sbjct: 241 PQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 4e-50
Identities = 60/284 (21%), Positives = 116/284 (40%), Gaps = 24/284 (8%)
Query: 326 DWEKEYSPHRFSYKNLYKATKGGSGKVYRGVLPSSH---AEIAVKKVCHDSDHGMKQ-FV 381
D+E + + +G G V++G+ S +A+K + + +++ F+
Sbjct: 1 DYEIQRE----RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL 56
Query: 382 SEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRII 441
E ++M + H ++V+L G + + ++ + G L L L+
Sbjct: 57 QEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYA 114
Query: 442 KGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVG 501
++ L YL + +HRDI NVL+ ++ KLGDFGL+R + +
Sbjct: 115 YQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 171
Query: 502 TVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLD 561
+ ++APE + R T+++DV+ FGV M E+ P + + VI + G+
Sbjct: 172 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK--PFQGVKNNDVIGRIENGE--- 226
Query: 562 ASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
+ ++ K C +P RP ++ L
Sbjct: 227 --RLPMPPNCPPTLYSLMTK----CWAYDPSRRPRFTELKAQLS 264
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 5e-50
Identities = 68/289 (23%), Positives = 111/289 (38%), Gaps = 42/289 (14%)
Query: 346 KGGSGKVYRGVLPSSH-----AEIAVKKVCHDSDHG-MKQFVSEIVSMGKL-RHRNLVQL 398
G GKV ++AVK + +D + +SE+ M +L H N+V L
Sbjct: 47 SGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNL 106
Query: 399 RGYCRRKGELLLVYDYMPNGSLDKILYSNTRP---------------------SLNWFQR 437
G C G + L+++Y G L L S L +
Sbjct: 107 LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDL 166
Query: 438 FRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT- 496
VA G+ +L + +HRD+ NVL+ K+ DFGLAR ++
Sbjct: 167 LCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVR 223
Query: 497 TNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQK 556
N V ++APE L G T +DV+++G+ + E+ PG + + Q
Sbjct: 224 GNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG-IPVDANFYKLIQN 282
Query: 557 GDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
G +D Y E++ I+++ C + RPS + +L
Sbjct: 283 GFKMDQPF------YATEEIYIIMQS---CWAFDSRKRPSFPNLTSFLG 322
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 174 bits (441), Expect = 2e-49
Identities = 65/295 (22%), Positives = 117/295 (39%), Gaps = 28/295 (9%)
Query: 320 YEEVYEDWEKEYSPHRFS---------YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVC 370
Y+ D K+Y P Y + G G V+R ++ A K V
Sbjct: 1 YDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM 60
Query: 371 HDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRP 430
+ + EI +M LRH LV L E++++Y++M G L + +
Sbjct: 61 TPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK 120
Query: 431 SLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEG--KLGDFGLARLY 488
++ + ++ V GL ++HE +H D+KP N++ KL DFGL
Sbjct: 121 -MSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176
Query: 489 DHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQ-PGELDLL 547
D + T GT + APE+ TD+++ GV + G P + + L
Sbjct: 177 DPKQSVKVT--TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL 234
Query: 548 DWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602
V ++ D++ + E+ + + K ++P+TR ++ Q ++
Sbjct: 235 RNVKS--CDWNMDDSAFSGIS----EDGKDFIRK----LLLADPNTRMTIHQALE 279
|
| >d1ioaa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]} Length = 228 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]
Score = 169 bits (430), Expect = 2e-49
Identities = 59/248 (23%), Positives = 94/248 (37%), Gaps = 35/248 (14%)
Query: 26 EENQFIHHGFE-GSKLKLDGLAKIHPNGLLQLTNTSE------RISGHAFYPFPFKFNSS 78
E F F KL L G A I G LQLT G AFY P + S
Sbjct: 2 TETSFNFPNFHTDDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIKDS 61
Query: 79 SSQSLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNH 138
++ + SF+T+F F + K + +G+AF + P + LGIFN +NN +
Sbjct: 62 NNVA-SFNTNFTFIIRAKNQSISAYGLAFALVPV-NSPPQKKQEFLGIFN-TNNPEPNAR 118
Query: 139 IFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPIQI 198
A+ +T + D D N + VN +G+ +
Sbjct: 119 TVAVVFNTFK--NRIDFDKNFIKPYVNENCDFH------------------KYNGEKTDV 158
Query: 199 WIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATG---TRVSDY 255
I Y+ + V L + +S ++ L + + + + VG S +G +
Sbjct: 159 QITYDSSNNDLRVFLHF--TVSQVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDTTETH 216
Query: 256 YILGWSFN 263
+L WSF+
Sbjct: 217 DVLSWSFS 224
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 173 bits (439), Expect = 4e-49
Identities = 61/297 (20%), Positives = 113/297 (38%), Gaps = 28/297 (9%)
Query: 318 KKYEEVYEDWEKEYSPHRFS---------YKNLYKATKGGSGKVYRGVLPSSHAEIAVKK 368
Y++ YED K+Y P Y L + G G V+R V ++ K
Sbjct: 2 NDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKF 61
Query: 369 VCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNT 428
+ +EI M +L H L+ L K E++L+ +++ G L + +
Sbjct: 62 INTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED 121
Query: 429 RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEG--KLGDFGLAR 486
++ + ++ GL ++HE ++H DIKP N++ + K+ DFGLA
Sbjct: 122 YK-MSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLAT 177
Query: 487 LYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQ-PGELD 545
+ + T T + APE++ TD++A GV + G P +L+
Sbjct: 178 KLNPDEIVKVT--TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE 235
Query: 546 LLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602
L V + + + + E + + P R ++ ++
Sbjct: 236 TLQNVKR--CDWEFDEDAFSSVS----PEAKDFIKN----LLQKEPRKRLTVHDALE 282
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (430), Expect = 2e-48
Identities = 69/309 (22%), Positives = 129/309 (41%), Gaps = 35/309 (11%)
Query: 313 YFVKKKKYEEVYEDWEKEYSPHRFSYKNLYKATKGGSGKVYRGVLPS-----SHAEIAVK 367
YF Y V ++WE + + + + +G G VY GV +A+K
Sbjct: 3 YFSAADVY--VPDEWE--VAREKITMSR--ELGQGSFGMVYEGVAKGVVKDEPETRVAIK 56
Query: 368 KVCHDSDHG-MKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYS 426
V + +F++E M + ++V+L G + L++ + M G L L S
Sbjct: 57 TVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS 116
Query: 427 N--------TRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGK 478
+ + ++ +A G+ YL+ +HRD+ N ++ D K
Sbjct: 117 LRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 173
Query: 479 LGDFGLARLYDHGNDLH-TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRR 537
+GDFG+ R + + V +++PE L++G TT +DV++FGV + E+A
Sbjct: 174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 233
Query: 538 PVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSM 597
G + + V+ + +G +LD D + ++ +L C NP RPS
Sbjct: 234 QPYQGLSN--EQVLRFVMEGGLLDKPDNCPDMLF---------ELMRMCWQYNPKMRPSF 282
Query: 598 RQVVQYLDG 606
+++ +
Sbjct: 283 LEIISSIKE 291
|
| >d1dhkb_ b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 204 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 164 bits (415), Expect = 2e-47
Identities = 54/244 (22%), Positives = 89/244 (36%), Gaps = 46/244 (18%)
Query: 26 EENQFIHHGFEGSKLKLDGLAKIHPNGLLQLTNTSERISGHAFYPFPFKFNSSSSQSL-S 84
E FI F + L L G A + NG LQL+ S AFY P + S++ ++ S
Sbjct: 2 TETSFIIDAFNKTNLILQGDATVSSNGNLQLSYNSYDSMSRAFYSAPIQIRDSTTGNVAS 61
Query: 85 FSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIEL 144
F T+F + G+ F + P S +E
Sbjct: 62 FDTNFTMNIRTHRQANSAVGLDFVLVPVQPES-------------------KGDTVTVEF 102
Query: 145 DTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPIQIWIDYNG 204
DT S D++ N + + G+ ++ I YN
Sbjct: 103 DTFLSRISIDVNNNDIKSVPWDVHDY---------------------DGQNAEVRITYNS 141
Query: 205 QEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGT---RVSDYYILGWS 261
K+ +V+L+ K +ST+++L + + D + VG SA +G + +L WS
Sbjct: 142 STKVFSVSLSNPSTGKS--NNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLSWS 199
Query: 262 FNKS 265
F+
Sbjct: 200 FSSK 203
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 2e-47
Identities = 60/308 (19%), Positives = 116/308 (37%), Gaps = 22/308 (7%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAE----IAVKKVCH-DSDHGMKQFVSEIVSMGKLRH 392
+K + G G VY+G+ + +A+K++ S K+ + E M + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 393 RNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLH 452
++ +L G C + L+ MP G L + + +A G+ YL
Sbjct: 71 PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQIAKGMNYLE 128
Query: 453 EEWEQVVLHRDIKPANVLLDADLEGKLGDFGLAR-LYDHGNDLHTTNVVGTVGYLAPELL 511
+ ++HRD+ NVL+ K+ DFGLA+ L + H + ++A E +
Sbjct: 129 DRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 512 RNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIY 571
+ T +DV+++GV + E+ P + + +KG+ L
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSK--PYDGIPASEISSILEKGERLP---------Q 234
Query: 572 VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGALLPDIPLNSSVFGVLTAKNEAPN 631
V + + C + D+RP R+++ A P L + + +
Sbjct: 235 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDS 294
Query: 632 NGMASFAS 639
N +
Sbjct: 295 NFYRALMD 302
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 4e-47
Identities = 74/305 (24%), Positives = 126/305 (41%), Gaps = 40/305 (13%)
Query: 325 EDWEKEYSPHRFSYKNLYKATKGGSGKVYRGVL-------PSSHAEIAVKKVCHD-SDHG 376
ED E R +G G+V P+ ++AVK + D ++
Sbjct: 4 EDPRWELPRDRLVLGK--PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD 61
Query: 377 MKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPS---- 431
+ +SE+ M + +H+N++ L G C + G L ++ +Y G+L + L + P
Sbjct: 62 LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYS 121
Query: 432 ----------LNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGD 481
L+ VA G+ YL + +HRD+ NVL+ D K+ D
Sbjct: 122 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIAD 178
Query: 482 FGLARLYDHGNDLHTTNV-VGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQ 540
FGLAR H + T V ++APE L + T +DV++FGV + E+
Sbjct: 179 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 238
Query: 541 PGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQV 600
PG ++ + ++G +D + + C H+ P RP+ +Q+
Sbjct: 239 PGV--PVEELFKLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQL 287
Query: 601 VQYLD 605
V+ LD
Sbjct: 288 VEDLD 292
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 3e-46
Identities = 55/265 (20%), Positives = 102/265 (38%), Gaps = 24/265 (9%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYC 402
+G V ++ E A+K + ++ + E M +L H V+L
Sbjct: 18 EGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF 77
Query: 403 RRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHR 462
+ +L Y NG L K + + + L YLH + ++HR
Sbjct: 78 QDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHGKG---IIHR 132
Query: 463 DIKPANVLLDADLEGKLGDFGLARLYDHGNDLH-TTNVVGTVGYLAPELLRNGRGTTSTD 521
D+KP N+LL+ D+ ++ DFG A++ + + VGT Y++PELL S+D
Sbjct: 133 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSD 192
Query: 522 VYAFGVFMLEVACGRRPVQPG-ELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVL 580
++A G + ++ G P + G E + +I + + + ++V
Sbjct: 193 LWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK----------LEYDFPEKFFPKARDLVE 242
Query: 581 KLGLFCSHSNPDTRPSMRQVVQYLD 605
K + R ++ Y
Sbjct: 243 K----LLVLDATKRLGCEEMEGYGP 263
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 9e-45
Identities = 64/283 (22%), Positives = 114/283 (40%), Gaps = 36/283 (12%)
Query: 346 KGGSGKVYRGVLPSSHA-----EIAVKKVCHDSDHG-MKQFVSEIVSMGK-LRHRNLVQL 398
+G G+V +AVK + + H + +SE+ + H N+V L
Sbjct: 23 RGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 82
Query: 399 RGYCRRKGE-LLLVYDYMPNGSLDKILYSN--------------TRPSLNWFQRFRIIKG 443
G C + G L+++ ++ G+L L S + L
Sbjct: 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQ 142
Query: 444 VAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLAR-LYDHGNDLHTTNVVGT 502
VA G+ +L +HRD+ N+LL K+ DFGLAR +Y + + +
Sbjct: 143 VAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 199
Query: 503 VGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDA 562
+ ++APE + + T +DV++FGV + E+ PG + + ++G + A
Sbjct: 200 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV-KIDEEFCRRLKEGTRMRA 258
Query: 563 SDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
D +Y + L C H P RP+ ++V++L
Sbjct: 259 PDYTTPEMY---------QTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (401), Expect = 3e-44
Identities = 62/261 (23%), Positives = 105/261 (40%), Gaps = 20/261 (7%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGM-KQFVSEIVSMGKLRHRNLVQLRGYCRR 404
G +V + +A+K + + G +EI + K++H N+V L
Sbjct: 19 TGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES 78
Query: 405 KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDI 464
G L L+ + G L + R+I V + YLH+ ++HRD+
Sbjct: 79 GGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQVLDAVKYLHDLG---IVHRDL 133
Query: 465 KPANVLL---DADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTD 521
KP N+L D D + + DFGL+++ D G+ L T GT GY+APE+L + + D
Sbjct: 134 KPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST--ACGTPGYVAPEVLAQKPYSKAVD 191
Query: 522 VYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLK 581
++ GV + CG P L I + P + I + + +
Sbjct: 192 CWSIGVIAYILLCGYPPFYDENDAKLFEQI----LKAEYEFDSPYWDDI-SDSAKDFIRH 246
Query: 582 LGLFCSHSNPDTRPSMRQVVQ 602
+P+ R + Q +Q
Sbjct: 247 ----LMEKDPEKRFTCEQALQ 263
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 3e-43
Identities = 50/260 (19%), Positives = 104/260 (40%), Gaps = 20/260 (7%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK 405
+G G V+R V SS K V EI + RHRN++ L
Sbjct: 15 RGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLHESFESM 73
Query: 406 GELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIK 465
EL+++++++ + + + ++ LN + + V L +LH + H DI+
Sbjct: 74 EELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLHSHN---IGHFDIR 129
Query: 466 PANVLLDADLEG--KLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVY 523
P N++ K+ +FG AR G++ Y APE+ ++ +T+TD++
Sbjct: 130 PENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQHDVVSTATDMW 187
Query: 524 AFGVFMLEVACGRRPVQ-PGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKL 582
+ G + + G P +++ +++ + + + + E M+ V +
Sbjct: 188 SLGTLVYVLLSGINPFLAETNQQIIENIMN--AEYTFDEEAFKEIS----IEAMDFVDR- 240
Query: 583 GLFCSHSNPDTRPSMRQVVQ 602
+R + + +Q
Sbjct: 241 ---LLVKERKSRMTASEALQ 257
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 3e-42
Identities = 57/283 (20%), Positives = 111/283 (39%), Gaps = 25/283 (8%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCR- 403
G +GKV + + + A+K + + E+ + + ++V++
Sbjct: 22 LGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDVYEN 76
Query: 404 ---RKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVL 460
+ LL+V + + G L + + + I+K + + YLH +
Sbjct: 77 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIA 133
Query: 461 HRDIKPANVLLDADLEG---KLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGT 517
HRD+KP N+L + KL DFG A+ N L T T Y+APE+L +
Sbjct: 134 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPEKYD 191
Query: 518 TSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQME 577
S D+++ GV M + CG P + + + + +P + EE
Sbjct: 192 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS-EEVKM 250
Query: 578 IVLKLGLFCSHSNPDTRPSMRQVVQ--YLDGGALLPDIPLNSS 618
++ + P R ++ + + ++ +P PL++S
Sbjct: 251 LIRN----LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 289
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 151 bits (383), Expect = 3e-42
Identities = 62/273 (22%), Positives = 106/273 (38%), Gaps = 32/273 (11%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGM---------KQFVSEIVSMGKLR-HRNL 395
+G S V R + + E AVK + + + E+ + K+ H N+
Sbjct: 13 RGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 72
Query: 396 VQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEW 455
+QL+ LV+D M G L L L+ + +I++ + + LH+
Sbjct: 73 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICALHKLN 130
Query: 456 EQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGR 515
++HRD+KP N+LLD D+ KL DFG + D G V GT YLAPE++
Sbjct: 131 ---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSM 185
Query: 516 G------TTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEG 569
D+++ GV M + G P + L+ +I P +
Sbjct: 186 NDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI----MSGNYQFGSPEWDD 241
Query: 570 IYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602
+ ++V + P R + + +
Sbjct: 242 YS-DTVKDLVSR----FLVVQPQKRYTAEEALA 269
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 146 bits (370), Expect = 3e-40
Identities = 62/270 (22%), Positives = 110/270 (40%), Gaps = 26/270 (9%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYC 402
GG +V+ H ++AVK + D +F E + L H +V +
Sbjct: 17 FGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG 76
Query: 403 RRKGE----LLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQV 458
+ +V +Y+ +L I+++ + + +I L + +
Sbjct: 77 EAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFS---HQNG 131
Query: 459 VLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND--LHTTNVVGTVGYLAPELLRNGRG 516
++HRD+KPAN+++ A K+ DFG+AR + T V+GT YL+PE R
Sbjct: 132 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSV 191
Query: 517 TTSTDVYAFGVFMLEVACGRRPVQ-PGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQ 575
+DVY+ G + EV G P + + + + D + S R EG+ +
Sbjct: 192 DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV----REDPIPPS-ARHEGLS-ADL 245
Query: 576 MEIVLKLGLFCSHSNPDTRP-SMRQVVQYL 604
+VLK NP+ R + ++ L
Sbjct: 246 DAVVLK----ALAKNPENRYQTAAEMRADL 271
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 146 bits (369), Expect = 6e-40
Identities = 49/269 (18%), Positives = 92/269 (34%), Gaps = 20/269 (7%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK 405
G G +Y G ++ E+A+K C + H Q E ++ + +C +
Sbjct: 17 SGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAE 74
Query: 406 GELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIK 465
G+ ++ + SL+ + +R + + + + Y+H + +HRD+K
Sbjct: 75 GDYNVMVMELLGPSLEDLFNFCSRK-FSLKTVLLLADQMISRIEYIHSKN---FIHRDVK 130
Query: 466 PANVLLDADLEGKL---GDFGLARLYDHGNDL------HTTNVVGTVGYLAPELLRNGRG 516
P N L+ +G L DFGLA+ Y N+ GT Y +
Sbjct: 131 PDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQ 190
Query: 517 TTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQM 576
+ D+ + G ++ G P Q + + + + L Y E
Sbjct: 191 SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK-MSTPIEVLCKGYPSEFA 249
Query: 577 EIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
+ C D +P + Q
Sbjct: 250 TYLNF----CRSLRFDDKPDYSYLRQLFR 274
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 8e-40
Identities = 59/259 (22%), Positives = 106/259 (40%), Gaps = 25/259 (9%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGK-LRHRNLVQLRGY 401
KG GKV+ ++ A+K + D D ++ + E + H L +
Sbjct: 12 KGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCT 71
Query: 402 CRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLH 461
+ K L V +Y+ G L + S + + + + GL +L + +++
Sbjct: 72 FQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFL---HSKGIVY 126
Query: 462 RDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTD 521
RD+K N+LLD D K+ DFG+ + G+ T GT Y+APE+L + S D
Sbjct: 127 RDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEILLGQKYNHSVD 185
Query: 522 VYAFGVFMLEVACGRRPVQ-PGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVL 580
++FGV + E+ G+ P E +L + +P +E ++++
Sbjct: 186 WWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM----------DNPFYPRWLEKEAKDLLV 235
Query: 581 KLGLFCSHSNPDTRPSMRQ 599
K P+ R +R
Sbjct: 236 K----LFVREPEKRLGVRG 250
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 9e-40
Identities = 73/308 (23%), Positives = 116/308 (37%), Gaps = 28/308 (9%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGM-KQFVSEIVSMGKLRHRNLV 396
Y NL +G G V + +A+KK+ ++ + EI + + RH N++
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69
Query: 397 QLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRP-SLNWFQRFRIIKGVAFGLLYLHEEW 455
+ R + Y+ + LY + L+ + + GL Y+H
Sbjct: 70 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 129
Query: 456 EQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT--TNVVGTVGYLAPELLRN 513
VLHRD+KP+N+LL+ + K+ DFGLAR+ D +D T V T Y APE++ N
Sbjct: 130 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 186
Query: 514 GRGTT-STDVYAFGVFMLEVACGRRPVQ--------------PGELDLLDWVIDYWQKGD 558
+G T S D+++ G + E+ R G D K
Sbjct: 187 SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246
Query: 559 VLDASDPRLEGIYVEEQMEIV----LKLGLFCSHSNPDTRPSMRQVVQ--YLDGGALLPD 612
S P + L L NP R + Q + YL+ D
Sbjct: 247 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 306
Query: 613 IPLNSSVF 620
P+ + F
Sbjct: 307 EPIAEAPF 314
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 5e-39
Identities = 62/283 (21%), Positives = 116/283 (40%), Gaps = 22/283 (7%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNL 395
++ + K +G G VY+ + +A+KK+ D ++ + EI + +L H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 396 VQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEW 455
V+L + +L LV++++ + L K + ++ + + + GL + H
Sbjct: 64 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 456 EQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGR 515
VLHRD+KP N+L++ + KL DFGLAR + +T VV LL
Sbjct: 123 ---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 516 GTTSTDVYAFGVFMLEVACGRRPVQPG-ELDLLDWVI--------DYWQKGDVLDASDPR 566
+T+ D+++ G E+ R E+D L + W + P
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 567 LEGIYVEEQMEIVLKLGLF-------CSHSNPDTRPSMRQVVQ 602
++ ++V L H +P+ R S + +
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 1e-38
Identities = 69/278 (24%), Positives = 112/278 (40%), Gaps = 27/278 (9%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDS-----DHGMKQFVSEIVSMGKLRHRNLVQLRG 400
+G VY+ +++ +A+KK+ D + + EI + +L H N++ L
Sbjct: 8 EGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLD 67
Query: 401 YCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVL 460
K + LV+D+M + + L + GL YLH+ W +L
Sbjct: 68 AFGHKSNISLVFDFMETDLEV--IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---IL 122
Query: 461 HRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRG-TTS 519
HRD+KP N+LLD + KL DFGLA+ + N + T+ V T Y APELL R
Sbjct: 123 HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-THQVVTRWYRAPELLFGARMYGVG 181
Query: 520 TDVYAFGVFMLEVACGRRPVQP-GELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEI 578
D++A G + E+ + +LD L + + D YV +
Sbjct: 182 VDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP 241
Query: 579 VLKLGLFCSHS--------------NPDTRPSMRQVVQ 602
+ L S + NP R + Q ++
Sbjct: 242 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 144 bits (364), Expect = 1e-38
Identities = 49/261 (18%), Positives = 91/261 (34%), Gaps = 25/261 (9%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKV------CHDSDHGMKQFVSEIVSMGKLRHRNLVQLR 399
+GG G+VY + A+K + + + + +V +
Sbjct: 14 RGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS 73
Query: 400 GYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVV 459
+L + D M G L L + + + GL ++H + V
Sbjct: 74 YAFHTPDKLSFILDLMNGGDLHYHLSQHGVF--SEADMRFYAAEIILGLEHMHNRF---V 128
Query: 460 LHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRG-TT 518
++RD+KPAN+LLD ++ D GLA + VGT GY+APE+L+ G +
Sbjct: 129 VYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMAPEVLQKGVAYDS 185
Query: 519 STDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEI 578
S D ++ G + ++ G P + + + L + E +
Sbjct: 186 SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM------AVELPDSFSPELRSL 239
Query: 579 VLKLGLFCSHSNPDTRPSMRQ 599
+ + + R
Sbjct: 240 LEG----LLQRDVNRRLGCLG 256
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 2e-38
Identities = 76/319 (23%), Positives = 119/319 (37%), Gaps = 40/319 (12%)
Query: 333 PHRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRH 392
P SY + G G VY+ L S +A+KKV D + E+ M KL H
Sbjct: 17 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDH 72
Query: 393 RNLVQLRGYCRRKGE------LLLVYDYMPNGSLDKIL-YSNTRPSLNWFQRFRIIKGVA 445
N+V+LR + GE L LV DY+P YS + +L + +
Sbjct: 73 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 446 FGLLYLHEEWEQVVLHRDIKPANVLLDAD-LEGKLGDFGLARLYDHGNDLHTTNVVGTVG 504
L Y+H + HRDIKP N+LLD D KL DFG A+ G + + +
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY--ICSRY 187
Query: 505 YLAPELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPGE--------LDLLDWVIDYWQ 555
Y APEL+ T+S DV++ G + E+ G+ + +L
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247
Query: 556 KGDVLDASDPRLEGIYVEEQMEIV--------LKLGLFCSHSNPDTRPSMRQVVQ----- 602
+ + ++ + I ++ + L P R + +
Sbjct: 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 307
Query: 603 -YLDGGALLPDIPLNSSVF 620
D LP+ ++F
Sbjct: 308 ELRDPNVKLPNGRDTPALF 326
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 8e-38
Identities = 47/267 (17%), Positives = 95/267 (35%), Gaps = 26/267 (9%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKV------CHDSDHGMKQFVSEIVSMGKLRHRNLVQLR 399
G V + S+ + A K + + E+ + +++H N++ L
Sbjct: 20 SGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 79
Query: 400 GYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVV 459
K +++L+ + + G L L + F + L ++ +
Sbjct: 80 EVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-----LKQILNGVYYLHSLQI 134
Query: 460 LHRDIKPANVLLDADLEG----KLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGR 515
H D+KP N++L K+ DFGLA D GN+ N+ GT ++APE++
Sbjct: 135 AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEP 192
Query: 516 GTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQ 575
D+++ GV + G P D + + + D
Sbjct: 193 LGLEADMWSIGVITYILLSGASPFLG---DTKQETLANVSAVN-YEFEDEYFSNT-SALA 247
Query: 576 MEIVLKLGLFCSHSNPDTRPSMRQVVQ 602
+ + + +P R +++ +Q
Sbjct: 248 KDFIRR----LLVKDPKKRMTIQDSLQ 270
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 139 bits (351), Expect = 2e-37
Identities = 43/196 (21%), Positives = 86/196 (43%), Gaps = 12/196 (6%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYC 402
G G+V+ + A+K + + ++ E + + + H ++++ G
Sbjct: 14 TGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF 73
Query: 403 RRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHR 462
+ ++ ++ DY+ G L +L + R + + L L + +++R
Sbjct: 74 QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE-----VCLALEYLHSKDIIYR 128
Query: 463 DIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDV 522
D+KP N+LLD + K+ DFG A+ T + GT Y+APE++ S D
Sbjct: 129 DLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLCGTPDYIAPEVVSTKPYNKSIDW 184
Query: 523 YAFGVFMLEVACGRRP 538
++FG+ + E+ G P
Sbjct: 185 WSFGILIYEMLAGYTP 200
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 2e-37
Identities = 57/267 (21%), Positives = 100/267 (37%), Gaps = 36/267 (13%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDS------DHGMKQFVSEIVSMGKLR--HRNLVQ 397
GG G VY G+ S + +A+K V D + E+V + K+ +++
Sbjct: 14 SGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 73
Query: 398 LRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQ 457
L + R +L+ + + R +L V + +
Sbjct: 74 LLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHC---HNC 129
Query: 458 VVLHRDIKPANVLLDAD-LEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRG 516
VLHRDIK N+L+D + E KL DFG L T+ GT Y PE +R R
Sbjct: 130 GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRY 186
Query: 517 -TTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQ 575
S V++ G+ + ++ CG P + + +++ + + Q+ E
Sbjct: 187 HGRSAAVWSLGILLYDMVCGDIPFE-HDEEIIRGQVFFRQR--------------VSSEC 231
Query: 576 MEIVLKLGLFCSHSNPDTRPSMRQVVQ 602
++ C P RP+ ++
Sbjct: 232 QHLIRW----CLALRPSDRPTFEEIQN 254
|
| >d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Concanavalin A species: Jack bean (Canavalia ensiformis) [TaxId: 3823]
Score = 136 bits (344), Expect = 3e-37
Identities = 36/129 (27%), Positives = 60/129 (46%), Gaps = 16/129 (12%)
Query: 137 NHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPI 196
+ I A+ELDT + + D H+GID+ ++S ++A +++GK
Sbjct: 2 DTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTA-------------KWNMQNGKVG 48
Query: 197 QIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTRVSDYY 256
I YN +K ++ ++ P +S +DL +L + + VGLSA+TG
Sbjct: 49 TAHIIYNSVDKRLSAVVSY---PNADSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNT 105
Query: 257 ILGWSFNKS 265
IL WSF
Sbjct: 106 ILSWSFTSK 114
|
| >d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} Length = 237 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Concanavalin A species: Jack bean (Canavalia ensiformis) [TaxId: 3823]
Score = 107 bits (268), Expect = 7e-27
Identities = 31/110 (28%), Positives = 43/110 (39%), Gaps = 8/110 (7%)
Query: 29 QFIHHGFEGSKLKLDGLAKIHPNGLLQLTNTSERIS------GHAFYPFPFKFNSSSSQS 82
F + L L G A +G L+LT S S G A + P SS+
Sbjct: 129 MFNQFSKDQKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHIWESSAVV 188
Query: 83 LSFSTSFVFAMFPKLPNYGGHGMAFFISP-STDFSEAVAGSHLGIFNRSN 131
SF +F F + + G+AFFIS + G LG+F +N
Sbjct: 189 ASFEATFTFLIKSPDSH-PADGIAFFISNIDSSIPSGSTGRLLGLFPDAN 237
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 138 bits (347), Expect = 4e-37
Identities = 61/283 (21%), Positives = 109/283 (38%), Gaps = 24/283 (8%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKV--CHDSDHGMKQFVSEIVSMGKLRHRNL 395
Y L K +G G VY+ A+KK+ + + + EI + +L+H N+
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGE-TFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 396 VQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEW 455
V+L K L+LV++++ + L + + G+ Y H+
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHDRR 120
Query: 456 EQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGR 515
VLHRD+KP N+L++ + E K+ DFGLAR + +T +V L+ + +
Sbjct: 121 ---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177
Query: 516 GTTSTDVYAFGVFMLEVACGRRPVQ-PGELDLLDWVI--------DYWQKGDVLDASDPR 566
+T+ D+++ G E+ G E D L + W L DP
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 567 LEGIYVEEQMEIVLKLGLF-------CSHSNPDTRPSMRQVVQ 602
+ L +P+ R + +Q ++
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 137 bits (346), Expect = 7e-37
Identities = 45/272 (16%), Positives = 85/272 (31%), Gaps = 24/272 (8%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRN-LVQLRGYCRR 404
+G G ++ G ++ ++A+K SD Q E + L + + + +
Sbjct: 15 EGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFGQE 72
Query: 405 KGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDI 464
+LV D + D L + K + + +HE + +++RDI
Sbjct: 73 GLHNVLVIDLLGPSLED--LLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDI 127
Query: 465 KPANVLLDADLEG-----KLGDFGLARLYD------HGNDLHTTNVVGTVGYLAPELLRN 513
KP N L+ + DFG+ + Y H N+ GT Y++
Sbjct: 128 KPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG 187
Query: 514 GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573
+ D+ A G + G P Q + + + G E
Sbjct: 188 REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGF-PE 246
Query: 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605
E + + + D P +
Sbjct: 247 EFYKYMHY----ARNLAFDATPDYDYLQGLFS 274
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 1e-36
Identities = 69/290 (23%), Positives = 119/290 (41%), Gaps = 31/290 (10%)
Query: 338 YKNLYKATKGGSGKVYRGV-LPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKL---R 391
Y+ + + +G GKV++ L + +A+K+V + + + E+ + L
Sbjct: 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68
Query: 392 HRNLVQLRGYC-----RRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAF 446
H N+V+L C R+ +L LV++++ L P + ++ +
Sbjct: 69 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT-YLDKVPEPGVPTETIKDMMFQLLR 127
Query: 447 GLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYL 506
GL +LH V+HRD+KP N+L+ + + KL DFGLAR+Y T+VV T+ Y
Sbjct: 128 GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYR 182
Query: 507 APELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQP--------------GELDLLDWVID 552
APE+L T D+++ G E+ + + G DW D
Sbjct: 183 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242
Query: 553 YWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602
+ + +V + E+ L L C NP R S +
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 1e-36
Identities = 68/284 (23%), Positives = 112/284 (39%), Gaps = 24/284 (8%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKV--CHDSDHGMKQFVSEIVSMGKLRHRNL 395
Y+ L K +G G V++ +H +A+K+V D + + EI + +L+H+N+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 396 VQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEW 455
V+L +L LV+++ N + F + L L
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF-----LFQLLKGLGFCH 118
Query: 456 EQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGR 515
+ VLHRD+KP N+L++ + E KL +FGLAR + ++ VV L
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 516 GTTSTDVYAFGVFMLEVACGRRPVQPG--ELDLLDWVI--------DYWQKGDVLDASDP 565
+TS D+++ G E+A RP+ PG D L + + W L P
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 566 RLEGIYVEEQMEIVLKLGLF-------CSHSNPDTRPSMRQVVQ 602
+ +V KL NP R S + +Q
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 3e-36
Identities = 70/299 (23%), Positives = 116/299 (38%), Gaps = 40/299 (13%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNL 395
Y+ L K +G G+V++ + ++A+KKV ++ + + EI + L+H N+
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 396 VQLRGYC--------RRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFG 447
V L C R KG + LV+D+ + L SN + R+++ +
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNVLVKFTLSEIKRVMQML--- 126
Query: 448 LLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL---HTTNVVGTVG 504
L L+ +LHRD+K ANVL+ D KL DFGLAR + + TN V T+
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 505 YLAPELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDAS 563
Y PELL R D++ G M E+ G + + G +
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI-MQGNTEQHQLALISQLCGSITPEV 245
Query: 564 DPRLEGIYVEEQMEIVLKLGLFCSHS--------------------NPDTRPSMRQVVQ 602
P ++ + E++E+V +P R +
Sbjct: 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 9e-34
Identities = 52/196 (26%), Positives = 80/196 (40%), Gaps = 9/196 (4%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYC 402
KG GKV ++ A+K + + + + V+E + RH L L+
Sbjct: 15 KGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF 74
Query: 403 RRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHR 462
+ L V +Y G L L + + + A + L + V++R
Sbjct: 75 QTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY-----GAEIVSALEYLHSRDVVYR 129
Query: 463 DIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDV 522
DIK N++LD D K+ DFGL + GT YLAPE+L + + D
Sbjct: 130 DIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDW 188
Query: 523 YAFGVFMLEVACGRRP 538
+ GV M E+ CGR P
Sbjct: 189 WGLGVVMYEMMCGRLP 204
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 4e-33
Identities = 63/292 (21%), Positives = 111/292 (38%), Gaps = 38/292 (13%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVC--HDSDHGMKQFVSEIVSMGKLRHRNL 395
Y++L G G V V + A++A+KK+ S+ K+ E+ + +RH N+
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 396 VQLRGYCRRKG------ELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLL 449
+ L + LV +M + L + ++ + GL
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM----KHEKLGEDRIQFLVYQMLKGLR 135
Query: 450 YLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPE 509
Y+H HRD+KP N+ ++ D E K+ DFGLAR D T V T Y APE
Sbjct: 136 YIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADS----EMTGYVVTRWYRAPE 188
Query: 510 LLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVI---------DYWQKGDV 559
++ N T + D+++ G M E+ G+ + + I ++ Q+
Sbjct: 189 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248
Query: 560 LDA-----SDPRLEGIYVEEQMEIVLKLGL----FCSHSNPDTRPSMRQVVQ 602
+A P LE + L + + + R + + +
Sbjct: 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 124 bits (312), Expect = 9e-32
Identities = 49/227 (21%), Positives = 87/227 (38%), Gaps = 14/227 (6%)
Query: 317 KKKYEEVYEDWEKEYSPHRF--SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD-- 372
K E+ + WE + + G G+V S A+K +
Sbjct: 20 AKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 373 -SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPS 431
++ ++E + + LV+L + L +V +Y+ G + L R
Sbjct: 80 VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-- 137
Query: 432 LNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491
+ + YLH +++RD+KP N+L+D ++ DFG A+
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG- 193
Query: 492 NDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRP 538
T + GT LAPE++ + + D +A GV + E+A G P
Sbjct: 194 ---RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 5e-30
Identities = 48/209 (22%), Positives = 86/209 (41%), Gaps = 18/209 (8%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKV--CHDSDHGMKQFVSEIVSMGKLRHRNL 395
Y+NL G G V +A+KK+ + K+ E+V M + H+N+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 396 VQLRGYCRRKG------ELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLL 449
+ L + ++ LV + M I + ++ + G+
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-----HERMSYLLYQMLCGIK 133
Query: 450 YLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPE 509
+LH ++HRD+KP+N+++ +D K+ DFGLAR T V T Y APE
Sbjct: 134 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPE 188
Query: 510 LLRNGRGTTSTDVYAFGVFMLEVACGRRP 538
++ + D+++ G M E+ +
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 118 bits (295), Expect = 8e-30
Identities = 63/326 (19%), Positives = 130/326 (39%), Gaps = 47/326 (14%)
Query: 310 AAVYF-VKKKKYEEV--YEDWEKEYSPHRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAV 366
A VY V + E YE E+ ++ Y+ + K +G +V+ + +++ ++ V
Sbjct: 7 ARVYTDVNTHRPREYWDYESHVVEWG-NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVV 65
Query: 367 KKVCHDSDHGMKQFVSEIVSMGKLR-HRNLVQLRGYCRRKGE--LLLVYDYMPNGSLDKI 423
K + K+ EI + LR N++ L + LV++++ N ++
Sbjct: 66 KILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 122
Query: 424 LYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDAD-LEGKLGDF 482
+L + + + L Y H ++HRD+KP NV++D + + +L D+
Sbjct: 123 Y-----QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDW 174
Query: 483 GLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQP 541
GLA Y G + V + + PELL + + S D+++ G + + + P
Sbjct: 175 GLAEFYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 232
Query: 542 GELDL-----------LDWVIDYWQKGDV-LDASDPRLEGIYVEEQMEIVLKLGLFCSHS 589
G + + + DY K ++ LD + G + ++ E + S
Sbjct: 233 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVS 292
Query: 590 -------------NPDTRPSMRQVVQ 602
+ +R + R+ ++
Sbjct: 293 PEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 6e-29
Identities = 58/265 (21%), Positives = 102/265 (38%), Gaps = 26/265 (9%)
Query: 346 KGGSGKVYRGVLPSSH---AEIAVKKV----CHDSDHGMKQFVSEIVSMGKLRHR-NLVQ 397
G GKV+ S H A+K + + +E + +R LV
Sbjct: 34 TGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVT 93
Query: 398 LRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQ 457
L + + +L L+ DY+ G L L R + + Q + V +L L +
Sbjct: 94 LHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY-----VGEIVLALEHLHKL 148
Query: 458 VVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRG- 516
+++RDIK N+LLD++ L DFGL++ + + GT+ Y+AP+++R G
Sbjct: 149 GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSG 208
Query: 517 -TTSTDVYAFGVFMLEVACGRRPVQ-PGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEE 574
+ D ++ GV M E+ G P GE + + K +P
Sbjct: 209 HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS------EPPYPQEMSAL 262
Query: 575 QMEIVLKLGLFCSHSNPDTRPSMRQ 599
+++ + +P R
Sbjct: 263 AKDLIQR----LLMKDPKKRLGCGP 283
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 1e-26
Identities = 50/208 (24%), Positives = 83/208 (39%), Gaps = 16/208 (7%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKV--CHDSDHGMKQFVSEIVSMGKLRHRNL 395
Y+NL G G V + +AVKK+ S K+ E+ + ++H N+
Sbjct: 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 396 VQLRGYCRRKGEL-----LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLY 450
+ L L + + ++ L+ I L +I + GL Y
Sbjct: 80 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKY 136
Query: 451 LHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPEL 510
+H ++HRD+KP+N+ ++ D E K+ DFGLAR D T V +
Sbjct: 137 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIM 190
Query: 511 LRNGRGTTSTDVYAFGVFMLEVACGRRP 538
L + D+++ G M E+ GR
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 102 bits (253), Expect = 5e-24
Identities = 49/274 (17%), Positives = 86/274 (31%), Gaps = 19/274 (6%)
Query: 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQ 397
Y + K G V+ ++ +A+K V + EI + ++ + +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 398 LRGYCRRKGELLLVY--DYMPNGSL------------DKILYSNTRPSLNWFQRFRIIKG 443
LL + PNG ++ + +I K
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 444 VAFGLLYLHEEWEQVVLHRDIKPANVLLDA-DLEGKLGDFGLARLYDHGNDLHTTNVV-G 501
+ GL Y+H ++H DIKP NVL++ D L +A L +
Sbjct: 134 LLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 502 TVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLD 561
T Y +PE+L D+++ + E+ G +P E D+ + L
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 251
Query: 562 ASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRP 595
P + GL + S P
Sbjct: 252 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWP 285
|
| >d1gv9a_ b.29.1.13 (A:) Carbohydrate-recognition domain of P58/ERGIC-53 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 228 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Carbohydrate-recognition domain of P58/ERGIC-53 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 92.9 bits (230), Expect = 6e-22
Identities = 26/212 (12%), Positives = 63/212 (29%), Gaps = 24/212 (11%)
Query: 51 NGLLQLTNTSERISGHAFYPFPFKFNSSSSQSLSFSTSFVFAMFPKLPNYGGHGMAFFIS 110
+++ + + G + F + + F + + G G+A + +
Sbjct: 36 ADQIRIAPSLKSQRGSVWTKTKAAFEN-------WEVEVTFRVTGRGRI-GADGLAIWYT 87
Query: 111 PSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSN 170
+ G G + + I D+ + + + + N Q N
Sbjct: 88 ENQGLD----GPVFGSADM-------WNGVGIFFDSFDND--GKKNNPAIVVVGNNGQIN 134
Query: 171 ESASARYFSDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSI 230
+ + P++ I Y + V + P+ +
Sbjct: 135 YDHQNDGATQALASCQRDFRNKPYPVRAKITYYQKTLTVMINNGFTPDKND---YEFCAK 191
Query: 231 DLSQILQDSMYVGLSAATGTRVSDYYILGWSF 262
+ ++ + G+SAATG D+ +L +
Sbjct: 192 VENMVIPTQGHFGISAATGGLADDHDVLSFLT 223
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 84.4 bits (208), Expect = 2e-19
Identities = 26/159 (16%), Positives = 51/159 (32%), Gaps = 20/159 (12%)
Query: 346 KGGSGKVYRGVLPSSHAEIAVK----------KVCHDSDHGMKQFVSEIVSMGKLRHRNL 395
+G V+ E VK KV D+G F + + R L
Sbjct: 10 EGKESAVFNCYSEKFG-ECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRAL 68
Query: 396 VQLRGYCRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEW 455
+L+G K VY + N L +++ + + ++ + + +
Sbjct: 69 QKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRG 123
Query: 456 EQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494
++H D+ NVL+ + + DF +
Sbjct: 124 ---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWR 158
|
| >d2a6va1 b.29.1.13 (A:9-226) Emp46p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 218 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Emp46p N-terminal domain species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 39.6 bits (92), Expect = 5e-04
Identities = 31/214 (14%), Positives = 63/214 (29%), Gaps = 37/214 (17%)
Query: 51 NGLLQLTNTSERISGHAFYPFPFKFNSSSSQSLSFSTSFVFAMFPKLPNYGGHGMAFFIS 110
G LT + G + + + + +F + G+AF++
Sbjct: 34 EGRFVLT-PGKNTKGSLWLKPEYSIKDAMTIEWTFRSF-------GFRGSTKGGLAFWLK 85
Query: 111 PSTDFSEAVA-GSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVN-GLQ 168
+ G FN I L +D G V +N G +
Sbjct: 86 QGNEGDSTELFGGSSKKFNG----------LMILLRL------DDKLGESVTAYLNDGTK 129
Query: 169 SNESASARYFSDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLST 228
+ S+ YF+ ++ +S P + + YN + + L + + +
Sbjct: 130 DLDIESSPYFASCLFQY----QDSMVPSTLRLTYNPLDNHL---LKLQMDNR----VCFQ 178
Query: 229 SIDLSQILQDSMYVGLSAATGTRVSDYYILGWSF 262
+ + + +G SA + IL
Sbjct: 179 TRKVKFMGSSPFRIGTSAINDASKESFEILKMKL 212
|
| >d2a6za1 b.29.1.13 (A:7-227) Emp47p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 221 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Emp47p N-terminal domain species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 39.2 bits (91), Expect = 7e-04
Identities = 28/204 (13%), Positives = 61/204 (29%), Gaps = 40/204 (19%)
Query: 51 NGLLQLTNTSERISGHAFYPFPFKFNSSSSQSLSFSTSFVFAMFPKLPNYGGHGMAFFIS 110
G + LT+ ++ G + F S F+ + F G++F+
Sbjct: 35 EGRIVLTS-NQNSKGSLWLKQGFDLKDS------FTMEWTFRSVGY-SGQTDGGISFWFV 86
Query: 111 PSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSN 170
S++ + NG + +D N G + +N +
Sbjct: 87 QD---------SNIPRDKQLYNGPVNYDGLQLLVDN------NGPLGPTLRGQLN----D 127
Query: 171 ESASARYFSDEKKEFESLVL---ESGKPIQIWIDYNGQEKLV-NVTLAPVPNPKPSRPLL 226
+ F S ++ +S P I + Y+ ++ + V + +
Sbjct: 128 GQKPVDKTKIYDQSFASCLMGYQDSSVPSTIRVTYDLEDDNLLKVQVDNK---------V 178
Query: 227 STSIDLSQILQDSMYVGLSAATGT 250
+ S +G++A G
Sbjct: 179 CFQTRKVRFPSGSYRIGVTAQNGA 202
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 660 | |||
| d1hqla_ | 236 | Legume lectin {Griffonia simplicifolia, lectin I-b | 100.0 | |
| d1leda_ | 243 | Legume lectin {West-central african legume (Griffo | 100.0 | |
| d1fx5a_ | 240 | Legume lectin {Furze (Ulex europaeus), UEA-I [TaxI | 100.0 | |
| d1qnwa_ | 237 | Legume lectin {Furze (Ulex europaeus), UEA-II [Tax | 100.0 | |
| d1gzca_ | 239 | Legume lectin {Cockspur coral tree (Erythrina cris | 100.0 | |
| d2d3sa1 | 237 | Legume lectin {Winged bean (Psophocarpus tetragono | 100.0 | |
| d1g9fa_ | 251 | Legume lectin {Soybean (Glycine max) [TaxId: 3847] | 100.0 | |
| d1f9ka_ | 234 | Legume lectin {Winged bean (Psophocarpus tetragono | 100.0 | |
| d1g8wa_ | 233 | Phytohemagglutinin-L, PHA-L, also arcelin {Kidney | 100.0 | |
| d1g7ya_ | 253 | Legume lectin {Horse gram (Dolichos biflorus), dif | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1dbna_ | 239 | Legume lectin {Maackia amurensis, leukoagglutinin | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1v6ia_ | 232 | Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3 | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1n47a_ | 233 | Legume lectin {Hairy vetch (Vicia villosa), isolec | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fnya_ | 237 | Legume lectin {Black locust (Robinia pseudoacacia) | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| g1qmo.1 | 230 | Legume lectin {Field bean (Dolichos lablab), Fril | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1ukga_ | 241 | Legume lectin {Bloodwood tree (Pterocarpus angolen | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| g2ltn.1 | 229 | Legume lectin {Garden pea (Pisum sativum) [TaxId: | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ioaa_ | 228 | Phytohemagglutinin-L, PHA-L, also arcelin {Kidney | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1avba_ | 226 | Phytohemagglutinin-L, PHA-L, also arcelin {Kidney | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1dhkb_ | 204 | Phytohemagglutinin-L, PHA-L, also arcelin {Kidney | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1nlsa_ | 237 | Concanavalin A {Jack bean (Canavalia ensiformis) [ | 99.97 | |
| d1gv9a_ | 228 | Carbohydrate-recognition domain of P58/ERGIC-53 {R | 99.95 | |
| d1nlsa_ | 237 | Concanavalin A {Jack bean (Canavalia ensiformis) [ | 99.9 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d2a6za1 | 221 | Emp47p N-terminal domain {Baker's yeast (Saccharom | 99.81 | |
| d2a6va1 | 218 | Emp46p N-terminal domain {Baker's yeast (Saccharom | 99.81 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.43 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.92 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.67 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.73 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.45 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.72 |
| >d1hqla_ b.29.1.1 (A:) Legume lectin {Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]
Probab=100.00 E-value=9.6e-56 Score=438.01 Aligned_cols=223 Identities=33% Similarity=0.500 Sum_probs=197.3
Q ss_pred cceeeeCCCCC---CCeeEecceeEcCCCcEEecCCC------CCeeEEEEeCCCeeeccCC-CCceeEEEEEEEEEecC
Q 006112 27 ENQFIHHGFEG---SKLKLDGLAKIHPNGLLQLTNTS------ERISGHAFYPFPFKFNSSS-SQSLSFSTSFVFAMFPK 96 (660)
Q Consensus 27 ~~~f~~~~f~~---~~l~~~g~a~~~~~g~l~Lt~~~------~~~~G~~~y~~pv~~~~~~-~~~~sFst~F~F~i~~~ 96 (660)
+++|+|++|+. .+|+|+|||.+. +|.|+||+.. ..++|||+|++||+||++. +.++||+|+|+|.|...
T Consensus 1 ~~sF~f~~F~~~~~~~l~l~G~A~~~-~~~l~LT~~~~~~~~~~~s~Gra~y~~Pv~l~~~~t~~~asFsT~F~F~i~~~ 79 (236)
T d1hqla_ 1 SVSFTFPNFWSDVEDSIIFQGDANTT-AGTLQLCKTNQYGTPLQWSAGRALYSDPVQLWDNKTESVASFYTEFTFFLKIT 79 (236)
T ss_dssp CCEEEESCSCSCGGGTEEEEETCEEE-TTEEECSCBCTTSCBCSSCEEEEEESSCEECCCSTTCCCCEEEEEEEEEEEEC
T ss_pred CEEEEeCCCCCCCcCCEEEeccEEec-CCEEEEecCCCCCcccccceEEEEECCCEEeecCCCCceeEEEEEEEEEEeCC
Confidence 47999999974 579999999986 8999999764 4578999999999999987 88999999999999875
Q ss_pred CCCCCCCceEEEEecCCCCCCCCCCCcccccccCCCCC-CCccEEEEEeecccCCCCCCCCCCeeEEEcCCccccccccc
Q 006112 97 LPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQ-FTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASA 175 (660)
Q Consensus 97 ~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~-~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~ 175 (660)
...+||||||+|+|... +.+..|++||+++..+.+. +.+++|||||||++|.+++||++||||||+|++.|..+.++
T Consensus 80 -~~~~gDGlAFvl~p~~~-~~~~~G~~lGl~~~~~~~~~~~~~~vAVEFDT~~n~~~~D~~~nHIgIdvns~~s~~~~~~ 157 (236)
T d1hqla_ 80 -GNGPADGLAFFLAPPDS-DVKDAGEYLGLFNKSTATQPSKNQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATKRW 157 (236)
T ss_dssp -SSCCCCEEEEEEECTTC-CCCCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCSSSCCCSSCEEEEEESSSSCSEEEEC
T ss_pred -CCCCCceEEEEEeCCCC-CCCCCccccccccccccCCcccCceEEEEeeCccCCCCCCCCCCEEEEEcCCccccccccc
Confidence 45689999999999764 3457899999999877643 57899999999999999999999999999999999887764
Q ss_pred cccccccccccccccCCCccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeecccCce-eee
Q 006112 176 RYFSDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTR-VSD 254 (660)
Q Consensus 176 ~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg~~-~~~ 254 (660)
...++.+|+.++|||+||+.+++|+|+|++. +|..|+|++.|||+++|+++||||||||||.. .+.
T Consensus 158 ----------~~~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~---~~~~~~ls~~vdL~~~l~~~v~vGFSasTG~~~~~~ 224 (236)
T d1hqla_ 158 ----------EDSDIFSGKIATARISYDGSAEILTVVLSYP---DGSDYILSHSVDMRQNLPESVRVGISASTGNNQFLT 224 (236)
T ss_dssp ----------CHHHHTSCSCEEEEEEEETTTTEEEEEEEET---TTEEEEEEEECCGGGTSCSEEEEEEEEECCSCCCEE
T ss_pred ----------ccccccCCCEEEEEEEEeCCCcEEEEEEecC---CCCCeeEEEEeCHHHhCCCcEEEEEEeECCCCCceE
Confidence 2467889999999999999999999999864 56778999999999999999999999999975 678
Q ss_pred eeecCcccccC
Q 006112 255 YYILGWSFNKS 265 (660)
Q Consensus 255 h~i~~wsf~~~ 265 (660)
|+|++|+|+++
T Consensus 225 h~I~sWsF~s~ 235 (236)
T d1hqla_ 225 VYILSWRFSSN 235 (236)
T ss_dssp EEEEEEEEEEE
T ss_pred EEEEEeEeEec
Confidence 99999999874
|
| >d1leda_ b.29.1.1 (A:) Legume lectin {West-central african legume (Griffonia simplicifolia) [TaxId: 3850]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: West-central african legume (Griffonia simplicifolia) [TaxId: 3850]
Probab=100.00 E-value=1.1e-55 Score=439.16 Aligned_cols=224 Identities=29% Similarity=0.413 Sum_probs=198.6
Q ss_pred CcceeeeCCCC------CCCeeEecceeEcCCCcEEecCCC------CCeeEEEEeCCCeeeccCCCCceeEEEEEEEEE
Q 006112 26 EENQFIHHGFE------GSKLKLDGLAKIHPNGLLQLTNTS------ERISGHAFYPFPFKFNSSSSQSLSFSTSFVFAM 93 (660)
Q Consensus 26 ~~~~f~~~~f~------~~~l~~~g~a~~~~~g~l~Lt~~~------~~~~G~~~y~~pv~~~~~~~~~~sFst~F~F~i 93 (660)
++++|+|++|. ..||+|+|+|.+. +|.|+||+.. .+++|||+|++||+||+++++++||+|+|+|.|
T Consensus 2 ~s~sF~f~~F~~~~~~~~~~l~l~G~A~~~-~g~l~LT~~~~~~~~~~~s~Gra~y~~Pv~l~~~t~~~asFsT~F~f~i 80 (243)
T d1leda_ 2 NTVNFTYPDFWSYSLKNGTEITFLGDATRI-PGALQLTKTDANGNPVRSSAGQASYSEPVFLWDSTGKAASFYTSFTFLL 80 (243)
T ss_dssp CCCEEEESCBCCTTSCTTTSEEEEETCEEE-TBEEECSCBCTTSCBCSSEEEEEEESSCEECBCTTSCBCEEEEEEEEEE
T ss_pred CceEEEcCCCCCCCCCCCCcEEEeeeeEEc-CCEEEeccCCCCCCccccceEEEEeCCCeEecCCCCcEeeEEEEEEEEc
Confidence 57999999995 3589999999997 8999999654 358999999999999998789999999999988
Q ss_pred ecCCCCCCCCceEEEEecCCCCCCCCCCCcccccccCCCCC-CCccEEEEEeecccCCCCCCCCCCeeEEEcCCcccccc
Q 006112 94 FPKLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQ-FTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNES 172 (660)
Q Consensus 94 ~~~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~-~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~ 172 (660)
.+. ...+||||||+|+|... +.+..|++|||++..+.++ +.+++|||||||++|.+++||++||||||+|++.|..+
T Consensus 81 ~~~-~~~~gdGlAF~l~p~~~-~~~~~g~~lGl~~~~~~~~~~~~~~vAVEFDT~~n~~~~d~~~nHVgIdvns~~s~~~ 158 (243)
T d1leda_ 81 KNY-GAPTADGLAFFLAPVDS-SVKDYGGFLGLFRHETAADPSKNQVVAVEFDTWINKDWNDPPYPHIGIDVNSIVSVAT 158 (243)
T ss_dssp EES-SSSCBCEEEEEEEETTC-CCCCCGGGTTTCCTTTTTCGGGCCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEE
T ss_pred CCC-CCCCCCceEEEEcCCCC-CCCCCccccccccccccCCCccCcEEEEEEeCccccccCCCCCCceEEEecCcccccc
Confidence 765 44589999999999764 4457899999999887654 57899999999999999999999999999999999888
Q ss_pred ccccccccccccccccccCCCccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeecccCcee
Q 006112 173 ASARYFSDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTRV 252 (660)
Q Consensus 173 ~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg~~~ 252 (660)
.++. ..++.+|+.++|||+||+.+++|+|+|++. +|..|+|++.|||+++|+++||||||||||. .
T Consensus 159 ~~~~----------~~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~---~~~~p~ls~~idL~~~l~~~vyvGFSAsTG~-~ 224 (243)
T d1leda_ 159 TRWE----------NDDAYGSSIATAHITYDARSKILTVLLSYE---HGRDYILSHVVDLAKVLPQKVRIGFSAGVGY-D 224 (243)
T ss_dssp EECC----------HHHHTSCCEEEEEEEEETTTTEEEEEEEET---TSCEEEEEEECCHHHHSCSEEEEEEEEEECB-S
T ss_pred cccc----------cCCcccCceeEEEEEEECCCCEEEEEEeeC---CCCCceEEEecCHHHhcCCcEEEEEEcccCC-c
Confidence 7653 346889999999999999999999999864 5677899999999999999999999999995 6
Q ss_pred eeeeecCcccccCC
Q 006112 253 SDYYILGWSFNKSG 266 (660)
Q Consensus 253 ~~h~i~~wsf~~~g 266 (660)
|.|+|++|+|++..
T Consensus 225 ~~h~I~sWsF~s~l 238 (243)
T d1leda_ 225 EVTYILSWHFFSTL 238 (243)
T ss_dssp EEEEEEEEEEEEEC
T ss_pred ceeeEEEEEEEeeC
Confidence 99999999999764
|
| >d1fx5a_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-I [TaxId: 3902]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Furze (Ulex europaeus), UEA-I [TaxId: 3902]
Probab=100.00 E-value=5.6e-54 Score=427.88 Aligned_cols=226 Identities=27% Similarity=0.407 Sum_probs=198.3
Q ss_pred CcceeeeCCCCC--CCeeEecceeEcCCCcEEecCCC----CCeeEEEEeCCCeeeccCC-CCceeEEEEEEEEEecC-C
Q 006112 26 EENQFIHHGFEG--SKLKLDGLAKIHPNGLLQLTNTS----ERISGHAFYPFPFKFNSSS-SQSLSFSTSFVFAMFPK-L 97 (660)
Q Consensus 26 ~~~~f~~~~f~~--~~l~~~g~a~~~~~g~l~Lt~~~----~~~~G~~~y~~pv~~~~~~-~~~~sFst~F~F~i~~~-~ 97 (660)
++++|+|++|+. +||+|+|+|.+.++|.|+||+.. .+++|||+|++||++|++. +.++||+|+|+|.|... +
T Consensus 2 ~~~sF~f~~F~~~~~~l~l~G~A~~~~~g~l~LT~~~~~~~~~~~G~a~y~~Pv~l~~~~t~~~~sF~t~F~f~i~~~~~ 81 (240)
T d1fx5a_ 2 DDLSFKFKNFSQNGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWNCNTGELASFITSFSFFMETSAN 81 (240)
T ss_dssp CEEEEEESSCCTTCSSEEEEETCEECTTSCEESCCCSSSSCSEEEEEEEESSCEECEETTTTEECEEEEEEEEEEEESSC
T ss_pred CceEEECCCCCCCCCCEEEeeeeEecCCCEEEccCCCCCCccceeEEEecCCCceeecCCCCceeeeEEEEEEEEeCCCC
Confidence 578999999974 68999999999889999999775 3578999999999999987 88999999999999755 3
Q ss_pred CCCCCCceEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCC-CCCCCCCCeeEEEcCCcccccccccc
Q 006112 98 PNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSP-EFNDIDGNHVGIDVNGLQSNESASAR 176 (660)
Q Consensus 98 ~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~-~~~d~~~~Hvgid~ns~~s~~~~~~~ 176 (660)
...+||||||+|+|.. .|.+..|++|||+|.++. ++.+++|||||||++|. +++||++||||||+|++.+..+.++.
T Consensus 82 ~~~ggdG~AFvl~p~~-~~~~~~g~~lGl~~~~~~-~~~~~~vAVEFDT~~n~~~~~D~~~nHIgid~ns~~s~~~~~~~ 159 (240)
T d1fx5a_ 82 PKAATDGLTFFLAPPD-SPLRRAGGYFGLFNDTKC-DSSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAERWN 159 (240)
T ss_dssp GGGCCCEEEEEEECTT-CCCCBCGGGTTTBSSSCC-CGGGCCEEEEEECCCTTTSTTSCSSCEEEEEESSSSCSEEEECC
T ss_pred CCCCCCcEEEEECCCC-CCCCCCCccccccccCCC-CccCceEEEEeeccccccccCCCCCCceEEccCCcccccccccc
Confidence 4568999999999975 466789999999997654 45789999999999985 67999999999999999987777543
Q ss_pred ccccccccccccccCCCccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeecccCc-eeeee
Q 006112 177 YFSDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGT-RVSDY 255 (660)
Q Consensus 177 ~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg~-~~~~h 255 (660)
..+.+|+.++|||+||+.+++|+|+|.+.+ +|..|+|+..|||+++|+++||||||||||. ..|.|
T Consensus 160 -----------~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~ls~~vdLs~~l~~~v~vGFSasTG~~~~~~H 226 (240)
T d1fx5a_ 160 -----------KRYGLNNVANVEIIYEASSKTLTASLTYPS--DQTSISVTSIVDLKEILPEWVSVGFSGSTYIGRQATH 226 (240)
T ss_dssp -----------CCCSGGGCEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCGGGTSCSEEEEEEEEEEETTSCEEE
T ss_pred -----------cccCCCCeEEEEEEEcCCCCEEEEEEecCC--CceeeEEeEEEchHHhCCCcEEEEEEeECCCCCCceE
Confidence 456789999999999999999999998654 6778899999999999999999999999995 67999
Q ss_pred eecCcccccCC
Q 006112 256 YILGWSFNKSG 266 (660)
Q Consensus 256 ~i~~wsf~~~g 266 (660)
+|++|+|+++.
T Consensus 227 ~I~sWsFsst~ 237 (240)
T d1fx5a_ 227 EVLNWYFTSTF 237 (240)
T ss_dssp EEEEEEEEEES
T ss_pred EEEEEEeEEec
Confidence 99999998753
|
| >d1qnwa_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-II [TaxId: 3902]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Furze (Ulex europaeus), UEA-II [TaxId: 3902]
Probab=100.00 E-value=2.7e-53 Score=422.52 Aligned_cols=223 Identities=28% Similarity=0.495 Sum_probs=196.4
Q ss_pred CcceeeeCCCCC--CCeeEecceeEcCCCcEEecCCC---CCeeEEEEeCCCeeeccCC-CCceeEEEEEEEEEecCCCC
Q 006112 26 EENQFIHHGFEG--SKLKLDGLAKIHPNGLLQLTNTS---ERISGHAFYPFPFKFNSSS-SQSLSFSTSFVFAMFPKLPN 99 (660)
Q Consensus 26 ~~~~f~~~~f~~--~~l~~~g~a~~~~~g~l~Lt~~~---~~~~G~~~y~~pv~~~~~~-~~~~sFst~F~F~i~~~~~~ 99 (660)
++++|+|++|++ +||+|+|||.+.++|.|+||+.. .+++|||||++||+||++. ++++||+|+|+|.|.++ ..
T Consensus 2 ~~lsF~f~~F~~~~~~l~l~GdA~i~~~g~l~LT~~~~~~~~~~G~a~y~~Pi~l~~~~~~~~~sF~t~F~f~i~~~-~~ 80 (237)
T d1qnwa_ 2 DDLSFNFDKFVPNQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIWDSITGKVASFATSFSFVVKAD-KS 80 (237)
T ss_dssp CSEEEEESSCCTTCTTEEEEETCEECTTSCEESSCCC--CCCEEEEEEESSCEECBCTTTCCBCEEEEEEEEECCBS-SS
T ss_pred CcEEEEcCCCCCCCCCEEEeeceEEcCCCeEEeccCCCCccccEEEEEECCCEEecCCCCcceeeEEEEEEEEEecC-CC
Confidence 578999999964 68999999999889999999875 4689999999999999987 88999999999999875 44
Q ss_pred CCCCceEEEEecCCC-CCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCC--CCCCCeeEEEcCCcccccccccc
Q 006112 100 YGGHGMAFFISPSTD-FSEAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFN--DIDGNHVGIDVNGLQSNESASAR 176 (660)
Q Consensus 100 ~~g~GlaF~l~p~~~-~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~--d~~~~Hvgid~ns~~s~~~~~~~ 176 (660)
.+||||||+|+|... .+.++.++++|+.+..+ ..+.+++|||||||++|.+++ ||++||||||+|++.|..+++
T Consensus 81 ~ggdG~aF~l~p~~~~~~~~~~~~~~g~~~~~~-~~~~~~~vAVEFDT~~n~~~~~~d~~~nHvgid~ns~~s~~~~~-- 157 (237)
T d1qnwa_ 81 DGVDGLAFFLAPANSQIPSGSSAGMFGLFSSSD-SKSSNQIIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKTVK-- 157 (237)
T ss_dssp CCCCEEEEEEEETTCCCCTTCCGGGTTTCSSSS-CCTTSCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSCSEEEE--
T ss_pred CCcceeEEEEeCCCCCCCCCCccccccccCCCC-CCCcccEEEEEeeceecCCcCCCCCCCCeEEEECCCCCcccccc--
Confidence 589999999999764 56778889999988654 456799999999999998754 699999999999999876664
Q ss_pred ccccccccccccccCCCccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeecccCcee--ee
Q 006112 177 YFSDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTRV--SD 254 (660)
Q Consensus 177 ~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg~~~--~~ 254 (660)
..+.+|+.++|||+||+.+++|+|+|++.+ +|..|+|++.|||+++|+++||||||||||... |.
T Consensus 158 -----------~~~~~G~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~p~ls~~vDLs~~l~~~vyvGFSasTG~~~~~q~ 224 (237)
T d1qnwa_ 158 -----------WDWRNGEVADVVITYRAPTKSLTVCLSYPS--DGTSNIITASVDLKAILPEWVSVGFSGGVGNAAEFET 224 (237)
T ss_dssp -----------CCCCTTCCEEEEEEEEGGGTEEEEEEECTT--TCCEEEEEEECCHHHHSCSEEEEEEEEEESCGGGCBC
T ss_pred -----------cccCCCcEEEEEEEEcCCCcEEEEEEecCC--CCccceEEEEEChHHhCCCcEEEEEEeECCCCCCccE
Confidence 356799999999999999999999998643 788899999999999999999999999999754 89
Q ss_pred eeecCcccccC
Q 006112 255 YYILGWSFNKS 265 (660)
Q Consensus 255 h~i~~wsf~~~ 265 (660)
|+|++|+|+++
T Consensus 225 h~I~sWsF~s~ 235 (237)
T d1qnwa_ 225 HDVLSWYFTSN 235 (237)
T ss_dssp CEEEEEEEEEE
T ss_pred eEEEEeEeEEe
Confidence 99999999875
|
| >d1gzca_ b.29.1.1 (A:) Legume lectin {Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]
Probab=100.00 E-value=1.6e-53 Score=424.29 Aligned_cols=224 Identities=30% Similarity=0.488 Sum_probs=196.9
Q ss_pred CcceeeeCCCCC--CCeeEecceeEcCCCcEEecCCCC------CeeEEEEeCCCeeeccCC-CCceeEEEEEEEEEecC
Q 006112 26 EENQFIHHGFEG--SKLKLDGLAKIHPNGLLQLTNTSE------RISGHAFYPFPFKFNSSS-SQSLSFSTSFVFAMFPK 96 (660)
Q Consensus 26 ~~~~f~~~~f~~--~~l~~~g~a~~~~~g~l~Lt~~~~------~~~G~~~y~~pv~~~~~~-~~~~sFst~F~F~i~~~ 96 (660)
++++|+|++|+. +||+|+|+|.+.++|.|+||+... +++|||+|++||+||++. ++++||+|+|+|.|...
T Consensus 2 ~~~sF~f~~F~~~~~nl~l~G~A~i~~~g~l~LT~~~~~~~~~~~~~Gr~~y~~Pv~l~~~~~~~~~sFst~F~f~i~~~ 81 (239)
T d1gzca_ 2 ETISFSFSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMWDSTTGTVASFETRFSFSIEQP 81 (239)
T ss_dssp EEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCC
T ss_pred eeEEEEeCCCCCCCCCeEEeeeeEECCCCeEEccCCCCCCcccccceEEEEeCCCeEecCCCCCceeeEEEEEEEEEecC
Confidence 468999999974 689999999998899999998753 578999999999999987 88999999999999755
Q ss_pred C-CCCCCCceEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCeeEEEcCCccccccccc
Q 006112 97 L-PNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASA 175 (660)
Q Consensus 97 ~-~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~ 175 (660)
. ...+||||||+|+|.... .+..+|+||+++..+.+ +.++.|||||||++| +++||++||||||+|++.|..+.+
T Consensus 82 ~~~~~g~dG~aF~l~p~~~~-~~~~~g~lg~~~~~~~~-~~~~~vaVEFDT~~n-~~~d~~~~HvgI~vn~~~s~~t~~- 157 (239)
T d1gzca_ 82 YTRPLPADGLVFFMGPTKSK-PAQGYGYLGVFNNSKQD-NSYQTLAVEFDTFSN-PWDPPQVPHIGIDVNSIRSIKTQP- 157 (239)
T ss_dssp CSSSCCCEEEEEEEECSSCC-CCCCGGGTTTCSSSSCC-GGGCCEEEEEECSCC-TTSCSSSSEEEEEESSSSCSEEEE-
T ss_pred CCCCCCCCeEEEEECCCCCC-CCCCcccccccccCCCC-CccceEEEEEEcccc-CCCCCCCCEEEEEECCccccccCC-
Confidence 3 356899999999998754 35688999998876553 468899999999999 478999999999999999887765
Q ss_pred cccccccccccccccCCCccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeecccCc---ee
Q 006112 176 RYFSDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGT---RV 252 (660)
Q Consensus 176 ~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg~---~~ 252 (660)
.++.+|+.++|||+||+.+++|+|+|.+.. +|..|+|++.|||+++|+++|||||||+||. ..
T Consensus 158 ------------~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~~ 223 (239)
T d1gzca_ 158 ------------FQLDNGQVANVVIKYDAPSKILHVVLVYPS--SGAIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDAA 223 (239)
T ss_dssp ------------CCCCTTCEEEEEEEEETTTTEEEEEEECTT--TCCEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCC
T ss_pred ------------ccccCCCEEEEEEEEeCCCcEEEEEEecCC--CCcceeeeeEechHHhcCCcEEEEEEEEcCCCCCCc
Confidence 357899999999999999999999998643 7888999999999999999999999999994 56
Q ss_pred eeeeecCcccccCCC
Q 006112 253 SDYYILGWSFNKSGP 267 (660)
Q Consensus 253 ~~h~i~~wsf~~~gp 267 (660)
|.|+|++|+|+++.|
T Consensus 224 ~~H~V~sWsF~s~lp 238 (239)
T d1gzca_ 224 ETHDVYSWSFQASLP 238 (239)
T ss_dssp CCCEEEEEEEEEEEC
T ss_pred eeeEEEEEEeEeeCC
Confidence 899999999998754
|
| >d2d3sa1 b.29.1.1 (A:1-237) Legume lectin {Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]
Probab=100.00 E-value=9.3e-53 Score=417.91 Aligned_cols=219 Identities=31% Similarity=0.473 Sum_probs=192.5
Q ss_pred cceeeeCCCCC--CCeeEecceeEcCCCcEEecCCC-----CCeeEEEEeCCCeeeccCC-CCceeEEEEEEEEEecC-C
Q 006112 27 ENQFIHHGFEG--SKLKLDGLAKIHPNGLLQLTNTS-----ERISGHAFYPFPFKFNSSS-SQSLSFSTSFVFAMFPK-L 97 (660)
Q Consensus 27 ~~~f~~~~f~~--~~l~~~g~a~~~~~g~l~Lt~~~-----~~~~G~~~y~~pv~~~~~~-~~~~sFst~F~F~i~~~-~ 97 (660)
+++|+|++|+. +||+|+|||.+.++|.|+||+.. .+++|||+|++||+||++. ++++||+|+|+|.|... .
T Consensus 2 t~sF~f~~F~~~~~~l~l~G~A~i~~~g~l~LT~~~~~~~~~~~~G~a~y~~pi~l~~~~~~~~~sF~t~F~f~i~~~~~ 81 (237)
T d2d3sa1 2 TISFNFNQFHQNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDSTTGNVASFETRFSFSIRQPFP 81 (237)
T ss_dssp EEEEEESSCCSSCTTEEEEETCEECTTSCEECSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSCC
T ss_pred eEEEEeCCCCCCCCCEEEeeeeEeCCCCeEEcCCCCCCCcccccEEEEEeCCCEEeecCCCCceeeEEEEEEEEeecCCC
Confidence 68999999953 68999999999878999999864 4789999999999999987 88999999999999765 3
Q ss_pred CCCCCCceEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCeeEEEcCCccccccccccc
Q 006112 98 PNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARY 177 (660)
Q Consensus 98 ~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~ 177 (660)
...+||||||+|+|... +.+..|++||+++.. ..+++|||||||++|. +||++||||||+|++.|.++.+
T Consensus 82 ~~~g~dGlaFvl~p~~~-~~~~~gg~lG~~~~~----~~~~~vaVEFDT~~n~--~d~~~nHvgI~vns~~s~~~~~--- 151 (237)
T d2d3sa1 82 RPHPADGLVFFIAPPNT-QTGEGGGYFGIYNPL----SPYPFVAVEFDTFRNT--WDPQIPHIGIDVNSVISTKTVP--- 151 (237)
T ss_dssp SSCCCEEEEEEEECSSC-CCCBCGGGTTTBCTT----SCCCCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEEEE---
T ss_pred CCCCCCeEEEEeCCCCc-cCCccccccccccCC----CcCceEEEEEEeecCC--CCCCCCcEEEEcCCCccccccc---
Confidence 34578999999999764 456789999998764 3578999999999997 6999999999999999876553
Q ss_pred cccccccccccccCCCccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeecccCc-------
Q 006112 178 FSDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGT------- 250 (660)
Q Consensus 178 ~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg~------- 250 (660)
+.+.+|+.++|||+||+.+++|+|+|.+.+ +|..|+++..|||+.+|+++||||||||||.
T Consensus 152 ----------~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~ls~~vdL~~~l~~~vyvGFSasTG~~~~~~~~ 219 (237)
T d2d3sa1 152 ----------FTLDNGGIANVVIKYDASTKILHVVLVFPS--LGTIYTIADIVDLKQVLPESVNVGFSAATGDPSGKQRN 219 (237)
T ss_dssp ----------CCCCTTCEEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEEEEEEEECCGGGCCTT
T ss_pred ----------eeecCCCEEEEEEEEECCCCEEEEEEEcCC--CCcccceeeEechHHhCCCcEEEEEEeECCCCccCccc
Confidence 467899999999999999999999998754 6777899999999999999999999999995
Q ss_pred eeeeeeecCcccccCCC
Q 006112 251 RVSDYYILGWSFNKSGP 267 (660)
Q Consensus 251 ~~~~h~i~~wsf~~~gp 267 (660)
..|.|+|++|+|+++.|
T Consensus 220 ~~e~h~I~sWsFss~lp 236 (237)
T d2d3sa1 220 ATETHDILSWSFSASLP 236 (237)
T ss_dssp CCCCCEEEEEEEEEECC
T ss_pred cceeeEEEEeEeEeeCC
Confidence 46999999999998754
|
| >d1g9fa_ b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Soybean (Glycine max) [TaxId: 3847]
Probab=100.00 E-value=1.9e-52 Score=419.58 Aligned_cols=227 Identities=27% Similarity=0.452 Sum_probs=192.2
Q ss_pred CCcceeeeCCCCC--CCeeEecceeEcCCCcEEecCCC------CCeeEEEEeCCCeeeccCC-CCceeEEEEEEEEEec
Q 006112 25 QEENQFIHHGFEG--SKLKLDGLAKIHPNGLLQLTNTS------ERISGHAFYPFPFKFNSSS-SQSLSFSTSFVFAMFP 95 (660)
Q Consensus 25 ~~~~~f~~~~f~~--~~l~~~g~a~~~~~g~l~Lt~~~------~~~~G~~~y~~pv~~~~~~-~~~~sFst~F~F~i~~ 95 (660)
+.+++|+|++|+. +||+|+|+|.+.++|.|+||++. ..++|||+|++||+||++. +.++||+|+|+|.|..
T Consensus 1 a~~~sF~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~~~~~~~~~sf~t~f~F~i~~ 80 (251)
T d1g9fa_ 1 AETVSFSWNKFVPKQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIWDKETGSVASFAASFNFTFYA 80 (251)
T ss_dssp CEEEEEEESSCCC-CTTEEEEETCBCCTTC-CBCSCBC---CBCTTCEEEEEESSCEECBCC-CCCBCEEEEEEEEEEEC
T ss_pred CceEEEEeCCCCCCCCCEEEeeeEEECCCCEEEecCCcCCCcccCceEEEEEeCCCEEccCCCCccceeeEEEEEEEEec
Confidence 3578999999974 58999999999889999999865 3588999999999999987 7889999999999998
Q ss_pred CCCCCCCCceEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCeeEEEcCCccccccccc
Q 006112 96 KLPNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASA 175 (660)
Q Consensus 96 ~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~ 175 (660)
.....+||||||+|+|....+ +..+|+||+++.. ...+++|||||||++|. +||+++|||||+|++.|..+..
T Consensus 81 ~~~~~~gDGlAFvl~p~~~~~-~~~~g~lG~~~~~---~~~~~~vaVEFDT~~n~--~D~~~~Hvgi~~n~~~s~~~~~- 153 (251)
T d1g9fa_ 81 PDTKRLADGLAFFLAPIDTKP-QTHAGYLGLFNEN---ESGDQVVAVEFDTFRNS--WDPPNPHIGINVNSIRSIKTTS- 153 (251)
T ss_dssp SCC--CCEEEEEEEEETTCCC-CCCGGGTTTCCTT---SCCCSCEEEEEECC-CT--TSCSSSEEEEEESSSSCSEEEE-
T ss_pred CCCCCCCCceEEEEecCCCCC-CCccCccCccccc---CCCcceEEEEEecccCC--CCCCCCcEeEEecCcccccccc-
Confidence 888889999999999976544 5788999998864 33578999999999997 7999999999999998876654
Q ss_pred cccccccccccccccCCCccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeecccCcee--e
Q 006112 176 RYFSDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTRV--S 253 (660)
Q Consensus 176 ~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg~~~--~ 253 (660)
+++.+|+.++|||+||+.+++|+|++... .+|..|+++..|||+.+|+++||||||||||... |
T Consensus 154 ------------~~l~~g~~~~v~I~Yd~~~~~L~v~l~~~--~~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~~~~~ 219 (251)
T d1g9fa_ 154 ------------WDLANNKVAKVLITYDASTSLLVASLVYP--SQRTSNILSDVVDLKTSLPEWVRIGFSAATGLDIPGE 219 (251)
T ss_dssp ------------CCCCTTCCEEEEEEEETTTTEEEEEEEEG--GGTEEEEEEEECCC-CCSCSEEEEEEEEEECSSSCCC
T ss_pred ------------eEecCCCEEEEEEEEECCccEEEEEEecC--CCCcceeEEEEecchhhCCCcEEEEEEeecCCCCCCc
Confidence 46789999999999999999999999854 3788899999999999999999999999999754 8
Q ss_pred eeeecCcccccCCCCCcCC
Q 006112 254 DYYILGWSFNKSGPAQNLD 272 (660)
Q Consensus 254 ~h~i~~wsf~~~gp~~~l~ 272 (660)
.|+|++|+|+++.+++..+
T Consensus 220 ~h~I~sWsF~s~~~~~~~~ 238 (251)
T d1g9fa_ 220 SHDVLSWSFASNLPHASSN 238 (251)
T ss_dssp EEEEEEEEEEEEECC----
T ss_pred eeEEEEeEeECCCCCCCcc
Confidence 8999999999886654443
|
| >d1f9ka_ b.29.1.1 (A:) Legume lectin {Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]
Probab=100.00 E-value=1.7e-51 Score=408.35 Aligned_cols=218 Identities=34% Similarity=0.522 Sum_probs=190.1
Q ss_pred CcceeeeCCCC--CCCeeEecceeEcCCCcEEecCCC------CCeeEEEEeCCCeeeccCC-CCceeEEEEEEEEEecC
Q 006112 26 EENQFIHHGFE--GSKLKLDGLAKIHPNGLLQLTNTS------ERISGHAFYPFPFKFNSSS-SQSLSFSTSFVFAMFPK 96 (660)
Q Consensus 26 ~~~~f~~~~f~--~~~l~~~g~a~~~~~g~l~Lt~~~------~~~~G~~~y~~pv~~~~~~-~~~~sFst~F~F~i~~~ 96 (660)
+++||+|++|+ .+||+|+|+|.+.++|.|+||+.. .+++|||+|++||+||++. ++++||+|+|+|.|.+.
T Consensus 1 ~~~SF~f~~F~~~~~~l~l~G~A~~~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~~~~~~~~~sFsT~F~f~i~~~ 80 (234)
T d1f9ka_ 1 ETQSFNFDHFEENSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIWDSTTGNVASFETRFSFNITQP 80 (234)
T ss_dssp CEEEEEESSCCSSCTTEEEEETCEECTTSCEECSCSEETTEECCSCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECC
T ss_pred CceEEEeCCCCCCCCCEEEeeeEEEcCCCEEEeecCCCCCCcccceeEEEEeCCCEEeeCCCCCcCcceEEEEEEEEECC
Confidence 36899999996 368999999999889999999875 3578999999999999987 88999999999999865
Q ss_pred CC-CCCCCceEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCeeEEEcCCccccccccc
Q 006112 97 LP-NYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASA 175 (660)
Q Consensus 97 ~~-~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~ 175 (660)
.. ..+||||||+|+|... +.+..|+++|+++.. ..++.|||||||++|. +||++||||||+|++.|..+.+
T Consensus 81 ~~~~~g~dG~aF~i~p~~~-~~~~~g~~~g~~~~~----~~~~~vaVEFDT~~n~--~Dp~~nHvgi~~ns~~s~~~~~- 152 (234)
T d1f9ka_ 81 YAYPEPADGLTFFMVPPNS-PQGEDGGNLGVFKPP----EGDNAFAVEFDTFQNT--WDPQVPHIGIDVNSIVSSKTLH- 152 (234)
T ss_dssp CSSSCCCEEEEEEEECTTC-CCCCSGGGTTTCCSS----CCSCCEEEEEECSCCT--TCCSSSEEEEEESSSSCSEEEE-
T ss_pred CCCCCccceEEEEECCCCC-CcccccccccccCCC----CccceEEEEEeccccC--CCCCCCcEeEecCCcccccccc-
Confidence 33 4578999999999764 566789999998764 3567899999999997 7999999999999998876553
Q ss_pred cccccccccccccccCCCccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhc--cceeeeeecccCc---
Q 006112 176 RYFSDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQ--DSMYVGLSAATGT--- 250 (660)
Q Consensus 176 ~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~--~~~~vGFsastg~--- 250 (660)
+++.+|+.++|||+||+.+++|+|++.+.. +|..|+|++.|||+.+|+ ++||||||||||.
T Consensus 153 ------------~~l~~G~~~~v~I~Yd~~~~~l~V~l~~~~--~~~~~~ls~~idL~~~l~~~~~v~vGFSasTG~~~~ 218 (234)
T d1f9ka_ 153 ------------FQLENGGVANVVIKYDSPTKILNVVLAFHS--VGTVYTLSNIVDLKQEFPNSEWVNVGLSATTGYQKN 218 (234)
T ss_dssp ------------CCCCTTCCEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCHHHHSTTCSEEEEEEEEEECSSTT
T ss_pred ------------ccccCCCEEEEEEEEcCCCcEEEEEEEeCC--CCccceEEEEEcHHHhcCCCCEEEEEEEeecCCCCC
Confidence 468899999999999999999999999754 566789999999999997 5799999999994
Q ss_pred eeeeeeecCcccccC
Q 006112 251 RVSDYYILGWSFNKS 265 (660)
Q Consensus 251 ~~~~h~i~~wsf~~~ 265 (660)
..|.|+|++|+|+++
T Consensus 219 ~~~~h~I~sWsF~s~ 233 (234)
T d1f9ka_ 219 AVETHEIISWSFTSS 233 (234)
T ss_dssp CCCEEEEEEEEEEEE
T ss_pred ceeeeEEEEEEeEEe
Confidence 568999999999874
|
| >d1g8wa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=3.7e-51 Score=405.97 Aligned_cols=220 Identities=29% Similarity=0.459 Sum_probs=195.6
Q ss_pred CcceeeeCCCCCCCeeEecceeEcCCCcEEecCCC------CCeeEEEEeCCCeeeccCC-CCceeEEEEEEEEEecCCC
Q 006112 26 EENQFIHHGFEGSKLKLDGLAKIHPNGLLQLTNTS------ERISGHAFYPFPFKFNSSS-SQSLSFSTSFVFAMFPKLP 98 (660)
Q Consensus 26 ~~~~f~~~~f~~~~l~~~g~a~~~~~g~l~Lt~~~------~~~~G~~~y~~pv~~~~~~-~~~~sFst~F~F~i~~~~~ 98 (660)
++++|+|++|+.+||+|+|||.+.++|.||||+.. .+++|||+|++||+||++. +.++||+|+|+|.|.+...
T Consensus 2 ~~~sF~f~~F~~~nl~l~GdA~i~~~g~l~LT~~~~~~~~~~~~~G~~~y~~Pi~l~~~~~~~~~sF~t~f~f~i~~~~~ 81 (233)
T d1g8wa_ 2 NDIYFNFQRFNETNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIWDNTTGTVASFATSFTFNIQVPNN 81 (233)
T ss_dssp EEEEEEESSCCGGGEEEEETCEECTTSCEECSCCCSTTCCCTTCEEEEEESSCEECBCTTTCCBEEEEEEEEEECCCCSS
T ss_pred CceEEECCCCCcCcEEEeccEEECCCCEEEecCCCCCCCcccceeEEEEcCCCeEeecCCCCceeeEEEEEEEEEecCCC
Confidence 57899999999999999999999889999999764 3589999999999999987 7889999999999998877
Q ss_pred CCCCCceEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCeeEEEcCCcccccccccccc
Q 006112 99 NYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYF 178 (660)
Q Consensus 99 ~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~ 178 (660)
..+||||||+|+|.... .+..|++||+++..+ ..++.|||||||++|.+ +||+++|||||+|++.|..+.+
T Consensus 82 ~~~gDGlAF~l~~~~~~-~g~~g~~lG~~~g~~---~~~~~vaVEFDT~~N~~-~d~~~~Hvgi~~n~~~s~~~~~---- 152 (233)
T d1g8wa_ 82 AGPADGLAFALVPVGSQ-PKDKGGFLGLFDGSN---SNFHTVAVEFDTLYNKD-WDPTERHIGIDVNSIRSIKTTR---- 152 (233)
T ss_dssp CBCCEEEEEEEEETTCC-CCCCGGGTTTCCSSC---CCCCCEEEEEECSCCTT-TCCSSCEEEEEESSSSCSEEEE----
T ss_pred CCCCCeEEEEEecCCCC-CCcccccCCccccCC---CcccEEEEEeecccCCC-CCCCCCeEEEECCCcceeeecc----
Confidence 77899999999998764 457899999987643 46789999999999987 4999999999999998876654
Q ss_pred ccccccccccccCCCccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeecccCc---eeeee
Q 006112 179 SDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGT---RVSDY 255 (660)
Q Consensus 179 ~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg~---~~~~h 255 (660)
.++.+|+.++|||+||+.+++|.|++.+.+ +|..|+|+..+||+.+||++|||||||+||. ..|.|
T Consensus 153 ---------~~~~~g~~~~~~I~yd~~~~~l~v~l~~~~--~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~~~~~~~h 221 (233)
T d1g8wa_ 153 ---------WDFVNGENAEVLITYDSSTNLLVASLVYPS--QKTSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNVETN 221 (233)
T ss_dssp ---------CCCCTTCCEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTBCCCC
T ss_pred ---------ccccCCcEEEEEEEEeCCCcEEEEEEEeCC--CCCcEEEEEEechhHcCCCcEEEEEEEEcCCCCCCceee
Confidence 357799999999999999999999998654 7778899999999999999999999999994 56889
Q ss_pred eecCcccccC
Q 006112 256 YILGWSFNKS 265 (660)
Q Consensus 256 ~i~~wsf~~~ 265 (660)
+|++|+|+++
T Consensus 222 ~I~sWsFss~ 231 (233)
T d1g8wa_ 222 DVLSWSFASK 231 (233)
T ss_dssp EEEEEEEEEE
T ss_pred EEEEEEEEEE
Confidence 9999999874
|
| >d1g7ya_ b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]
Probab=100.00 E-value=3.1e-51 Score=412.14 Aligned_cols=223 Identities=27% Similarity=0.442 Sum_probs=197.0
Q ss_pred CCcceeeeCCCCCCCeeEecceeEcCCCcEEecCCCC------CeeEEEEeCCCeeeccCC-CCceeEEEEEEEEEecCC
Q 006112 25 QEENQFIHHGFEGSKLKLDGLAKIHPNGLLQLTNTSE------RISGHAFYPFPFKFNSSS-SQSLSFSTSFVFAMFPKL 97 (660)
Q Consensus 25 ~~~~~f~~~~f~~~~l~~~g~a~~~~~g~l~Lt~~~~------~~~G~~~y~~pv~~~~~~-~~~~sFst~F~F~i~~~~ 97 (660)
++.+||+|++|++++|+|+|||.+. ++.|+||++.. .++|||+|++||+||++. +.++||+|+|+|.|.+..
T Consensus 1 a~~~sF~f~~F~~~~l~l~GdA~~~-~~~l~LT~~~~~~~~~~~~~G~a~y~~pv~l~~~~~~~~~sF~t~F~F~i~~~~ 79 (253)
T d1g7ya_ 1 ADIQSFSFKNFNSSSFILQGDATVS-SSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIYDKSTGAVASWATSFTANIFAPN 79 (253)
T ss_dssp CEEEEEEESSCCSSCEEEEETCEEE-TTEEECSCBCTTSCBCSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSS
T ss_pred CcccEEecCCCCcccEEEEeeeEEc-CCEEEeCCCCCCCCcccceeEEEEeCCCeEeecCCCCceeeEEEEEEEEEecCC
Confidence 3568999999999999999999996 78899998653 578999999999999987 889999999999998877
Q ss_pred CCCCCCceEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCeeEEEcCCccccccccccc
Q 006112 98 PNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARY 177 (660)
Q Consensus 98 ~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~ 177 (660)
...+||||||+|+|.+..+ +..+|++|+++..+. ...++.|||||||++|.+ +||+++|||||+|++.|..+++
T Consensus 80 ~~~ggDGlAF~l~~~~~~~-~~~~g~lgl~~~~~~-~~~~~~vaVEFDT~~n~~-~d~~~~Hvgi~~ns~~s~~~~~--- 153 (253)
T d1g7ya_ 80 KSSSADGIAFALVPVGSEP-KSNSGFLGVFDSDVY-DNSAQTVAVEFDTFSNTD-WDPTSRHIGIDVNSIKSIRTAS--- 153 (253)
T ss_dssp GGGCCCEEEEEEEETTCCC-CCCGGGTTTCSCSSC-CGGGCCEEEEEECSCCTT-TCCSSCEEEEEESSSSCSEEEE---
T ss_pred CCCCCCceEEEEeCCCCCC-CCCcccccccccCCC-CCcCceEEEEEeceecCC-CCCCCCcEEEeeCCcccccccC---
Confidence 7779999999999987654 467899999987654 346789999999999987 4999999999999999877664
Q ss_pred cccccccccccccCCCccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeecccC---ceeee
Q 006112 178 FSDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATG---TRVSD 254 (660)
Q Consensus 178 ~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg---~~~~~ 254 (660)
..+.+|+.++|||+||+.+++|+|++... .+|..|+|++.+||+.+||++|||||||||| ...|.
T Consensus 154 ----------~~~~~g~~~~v~I~Yd~~~~~L~v~l~~~--~~~~~~~ls~~vdL~~~l~~~~yvGFSAsTG~~~~~~~~ 221 (253)
T d1g7ya_ 154 ----------WGLANGQNAEILITYNAATSLLVASLVHP--SRRTSYIVSERVDITNELPEYVSIGFSATTGLSEGYTET 221 (253)
T ss_dssp ----------CCCCTTSEEEEEEEEETTTTEEEEEEEET--TTTEEEEEEEECCHHHHSCSEEEEEEEEECCSSSSCCCC
T ss_pred ----------CCccCCCEEEEEEEEeCCcEEEEEEEecC--CCCCceEEEEEechhhcCCCcEEEEEEeEcCCCCCcccc
Confidence 35789999999999999999999999863 3788899999999999999999999999999 45799
Q ss_pred eeecCcccccCC
Q 006112 255 YYILGWSFNKSG 266 (660)
Q Consensus 255 h~i~~wsf~~~g 266 (660)
|+|++|+|++..
T Consensus 222 H~IlsWsF~s~l 233 (253)
T d1g7ya_ 222 HDVLSWSFASKL 233 (253)
T ss_dssp CEEEEEEEEEEE
T ss_pred cEEEEEEeEEeC
Confidence 999999998753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.2e-52 Score=429.16 Aligned_cols=257 Identities=27% Similarity=0.370 Sum_probs=217.8
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
-+|+..+.||+|+||+||+|++..+++.||||++..+. ...++|.+|++++++++|||||+++|+|.+++.+++|||||
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence 36788899999999999999999889999999986543 34678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 495 (660)
++|+|.+++.......++|..+..++.|||+||+|||+ ++|+||||||+||||++++.+||+|||+|+.........
T Consensus 96 ~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~ 172 (287)
T d1opja_ 96 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 172 (287)
T ss_dssp TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEE
T ss_pred cCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCCCcee
Confidence 99999999987766779999999999999999999998 899999999999999999999999999999776555444
Q ss_pred eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHH
Q 006112 496 TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQ 575 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 575 (660)
.....||+.|||||++.++.++.++|||||||++|||++|..|+..... ...+.+....+.. +..... .
T Consensus 173 ~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--~~~~~~~i~~~~~-----~~~~~~----~ 241 (287)
T d1opja_ 173 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYELLEKDYR-----MERPEG----C 241 (287)
T ss_dssp ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHHHHHHTTCC-----CCCCTT----C
T ss_pred eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch--HHHHHHHHhcCCC-----CCCCcc----c
Confidence 5556789999999999999999999999999999999998777654322 1222333333321 111122 2
Q ss_pred HHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 576 MEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 576 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
.+.+.+++..||+.||++|||++||++.|+..
T Consensus 242 ~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 242 PEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 34577889999999999999999999999764
|
| >d1dbna_ b.29.1.1 (A:) Legume lectin {Maackia amurensis, leukoagglutinin [TaxId: 37501]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Maackia amurensis, leukoagglutinin [TaxId: 37501]
Probab=100.00 E-value=1.2e-50 Score=405.42 Aligned_cols=225 Identities=31% Similarity=0.482 Sum_probs=197.7
Q ss_pred CCcceeeeCCCCC--CCeeEecceeEcCCCcEEecCCC-----CCeeEEEEeCCCeeeccCC-CCceeEEEEEEEEEecC
Q 006112 25 QEENQFIHHGFEG--SKLKLDGLAKIHPNGLLQLTNTS-----ERISGHAFYPFPFKFNSSS-SQSLSFSTSFVFAMFPK 96 (660)
Q Consensus 25 ~~~~~f~~~~f~~--~~l~~~g~a~~~~~g~l~Lt~~~-----~~~~G~~~y~~pv~~~~~~-~~~~sFst~F~F~i~~~ 96 (660)
+++++|+|++|.+ .||+|+|+|.+.++|.||||++. .+++|||+|++||+||++. +.++||+|+|+|.|.+.
T Consensus 1 ~~~~sF~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~G~a~y~~pi~l~~~~~~~~~sFst~F~F~i~~~ 80 (239)
T d1dbna_ 1 SDELSFTINNFVPNEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIWGNTTGSVASFSTSFTFVVKAP 80 (239)
T ss_dssp CCEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCS
T ss_pred CCceEEEeCCCCCCCCCEEEeeeeEECCCCEEEccCCCCCCcccceeEEEeecCCEEccCCCCccceEEEEEEEEEEECC
Confidence 3578999999963 68999999999889999999864 4678999999999999987 88999999999999988
Q ss_pred CCCCCCCceEEEEecCCC-CCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCC--CCCCCCeeEEEcCCccccccc
Q 006112 97 LPNYGGHGMAFFISPSTD-FSEAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEF--NDIDGNHVGIDVNGLQSNESA 173 (660)
Q Consensus 97 ~~~~~g~GlaF~l~p~~~-~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~--~d~~~~Hvgid~ns~~s~~~~ 173 (660)
....+||||||+|+|... .+.++.|++||+++..+ .++.++.+||||||++|.++ +||+.+|||||+|++.|..+.
T Consensus 81 ~~~~~gdG~AF~l~~~~~~~~~~~~g~~lGl~~~~~-~~~~~~~~aVEfDT~~n~~~~~~d~~~~hvgid~n~~~s~~~~ 159 (239)
T d1dbna_ 81 NPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSN-SDSSNQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIKTV 159 (239)
T ss_dssp STTSCCEEEEEEEECTTCCCCSSSCGGGTTSCSSSC-CCTTSCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSCSEEE
T ss_pred CCCCCCCCEEEEEeCCCccCCcccCccccccccccC-CCcccCeeeeEEeeeecCCCCCCCCCCceeeEEcCCccccccc
Confidence 777899999999999764 56678899999998764 45678999999999999876 488999999999999987766
Q ss_pred cccccccccccccccccCCCccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeecccCce--
Q 006112 174 SARYFSDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTR-- 251 (660)
Q Consensus 174 ~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg~~-- 251 (660)
+. .+.+|+.+.|||+|++.+++|.|++.+.. +|..|.|+..+||+.+|+++||||||||||..
T Consensus 160 ~~-------------~~~~g~~~~~~i~y~~~~~~l~v~l~~~~--~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~ 224 (239)
T d1dbna_ 160 QW-------------DWINGGVAFATITYLAPNKTLIASLVYPS--NQTTFSVAASVDLKEILPEWVRVGFSAATGYPTE 224 (239)
T ss_dssp EC-------------CCCTTCCEEEEEEEEGGGTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEEEEEEEECSGGG
T ss_pred cc-------------eEeCCceeEEEEEEcCCCCEEEEEEEecC--CCccEEEEEecchHHhcCCcEEEEEEEeCCCCCC
Confidence 43 45589999999999999999999998643 67788999999999999999999999999964
Q ss_pred eeeeeecCcccccC
Q 006112 252 VSDYYILGWSFNKS 265 (660)
Q Consensus 252 ~~~h~i~~wsf~~~ 265 (660)
.|.|+|++|||+++
T Consensus 225 ~~~H~I~sWsFss~ 238 (239)
T d1dbna_ 225 VETHDVLSWSFTST 238 (239)
T ss_dssp CCCCEEEEEEEEEE
T ss_pred cceeEEEEEEeEEe
Confidence 57899999999874
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-51 Score=419.23 Aligned_cols=255 Identities=27% Similarity=0.420 Sum_probs=210.2
Q ss_pred ceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
+-+|+.++.||+|+||.||+|+++ +++.||||++.... ...++|.+|++++++++|||||+++|+|.+ +.+++||||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 347888999999999999999985 57889999996543 345789999999999999999999998864 567999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
|++|+|.+++.......++|.++++|+.||++||+|||+ ++|+||||||+||||++++.+||+|||+|+........
T Consensus 89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCccc
Confidence 999999998865544469999999999999999999998 89999999999999999999999999999987665544
Q ss_pred eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHH
Q 006112 495 HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEE 574 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 574 (660)
......||+.|||||++.++.++.++|||||||++|||+||..|+..... ...+......+.... ....+
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~~~~~~~i~~~~~~~-----~p~~~--- 235 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVIQNLERGYRMV-----RPDNC--- 235 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHHTTCCCC-----CCTTC---
T ss_pred cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC--HHHHHHHHHhcCCCC-----CcccC---
Confidence 45567899999999999999999999999999999999997666544222 122233333332211 11222
Q ss_pred HHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 575 QMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 575 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
.+.+.+++.+||+.||++||||+||++.|+.
T Consensus 236 -~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 236 -PEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp -CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -hHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 3457788899999999999999999998874
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-51 Score=416.38 Aligned_cols=253 Identities=25% Similarity=0.377 Sum_probs=198.1
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 416 (660)
+|+.++.||+|+||+||+|++. +++.||||++... ....++|.+|++++++++|||||+++|+|.+++..++|||||+
T Consensus 6 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 6 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp CEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 5778899999999999999996 5678999998654 3345789999999999999999999999999999999999999
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCcee
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT 496 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 496 (660)
+|+|.+++.... ..++|..+..++.|||+||+|||+ ++|+||||||+|||+++++++||+|||+++..........
T Consensus 84 ~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 84 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp TCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence 999999987653 458999999999999999999998 9999999999999999999999999999987765444444
Q ss_pred eccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHH
Q 006112 497 TNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQM 576 (660)
Q Consensus 497 ~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 576 (660)
....||+.|+|||++.+..++.++|||||||++|||+|+..|+..... ...+.+....+... ..| .. +.
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~--~~~~~~~i~~~~~~--~~p---~~----~~ 228 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSEVVEDISTGFRL--YKP---RL----AS 228 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC--HHHHHHHHHHTCCC--CCC---TT----SC
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC--HHHHHHHHHhcCCC--CCc---cc----cC
Confidence 456799999999999999999999999999999999996555443221 11222233333221 111 11 23
Q ss_pred HHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 577 EIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 577 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
..+.+++..||+.||++||||+||+++|+.
T Consensus 229 ~~l~~li~~cl~~~p~~Rps~~~il~~L~~ 258 (263)
T d1sm2a_ 229 THVYQIMNHCWKERPEDRPAFSRLLRQLAE 258 (263)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 457788999999999999999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-51 Score=418.89 Aligned_cols=249 Identities=23% Similarity=0.342 Sum_probs=211.2
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 416 (660)
.|+.+++||+|+||+||+|++..+|+.||||++........+.+.+|++++++++|||||++++++.+++.+++|||||+
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 100 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence 69999999999999999999999999999999976655567789999999999999999999999999999999999999
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCcee
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT 496 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 496 (660)
+|+|.+++... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+|+.+..... ..
T Consensus 101 gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~ 173 (293)
T d1yhwa1 101 GGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR 173 (293)
T ss_dssp TCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CB
T ss_pred CCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeeccccc-cc
Confidence 99999988754 48999999999999999999998 9999999999999999999999999999987654332 33
Q ss_pred eccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHHH
Q 006112 497 TNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQM 576 (660)
Q Consensus 497 ~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 576 (660)
....||+.|||||++.+..++.++|||||||++|||++|+.||...... +........+.. ...... ...
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~~~~~~~~----~~~~~~----~~s 243 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RALYLIATNGTP----ELQNPE----KLS 243 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHHCSC----CCSSGG----GSC
T ss_pred cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH--HHHHHHHhCCCC----CCCCcc----cCC
Confidence 4568999999999999999999999999999999999999999764432 222222222211 111111 223
Q ss_pred HHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 577 EIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 577 ~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
..+.+++.+||+.||++|||++|+++
T Consensus 244 ~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 244 AIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 45678888999999999999999986
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-51 Score=418.27 Aligned_cols=257 Identities=26% Similarity=0.401 Sum_probs=203.0
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
-+|+..+.||+|+||+||+|++. ..||||++... ..+..+.|.+|++++++++|||||+++++|.+ +.+++|||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred ccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 36788899999999999999874 35999998644 45567889999999999999999999998864 56899999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
||++|+|.+++.... ..++|.++.+++.|||+||+|||+ ++||||||||+||||+.++.+||+|||+|+.......
T Consensus 84 y~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp CCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred cCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 999999999997543 359999999999999999999998 8999999999999999999999999999987654332
Q ss_pred -ceeeccccCccccCcccccC---CCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccc
Q 006112 494 -LHTTNVVGTVGYLAPELLRN---GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEG 569 (660)
Q Consensus 494 -~~~~~~~gt~~Y~aPE~~~~---~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 569 (660)
.......||+.|||||++.+ +.++.++|||||||++|||+||+.||...... ..+......+... |.+ .
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~--~~~~~~~~~~~~~----p~~-~ 232 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIFMVGRGYLS----PDL-S 232 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHHHHHTSCC----CCG-G
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH--HHHHHHHhcCCCC----Ccc-h
Confidence 23345789999999999864 35789999999999999999999999763322 1222222222211 111 1
Q ss_pred cCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 570 IYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
.......+.+.+++.+||+.||++|||++||++.|+..
T Consensus 233 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l 270 (276)
T d1uwha_ 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270 (276)
T ss_dssp GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11222345678889999999999999999999999854
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-51 Score=416.88 Aligned_cols=251 Identities=24% Similarity=0.308 Sum_probs=204.9
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
+|+.++.||+|+||+||+|++..+++.||||++.... .+..+++.+|++++++++|||||++++++.+++.+++|||||
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 85 (271)
T d1nvra_ 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 85 (271)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEecc
Confidence 6899999999999999999999999999999996543 334567999999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC-c
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND-L 494 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~-~ 494 (660)
++|+|.+++.... .+++.++..++.||++||+|||+ ++|+||||||+|||+++++++||+|||+|+....... .
T Consensus 86 ~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 86 SGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp TTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred CCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 9999999997543 59999999999999999999998 8999999999999999999999999999987654432 2
Q ss_pred eeeccccCccccCcccccCCCC-CcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 495 HTTNVVGTVGYLAPELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
..+..+||+.|||||++.+..+ +.++||||+||++|||++|+.||............ . ....... ......
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~-~-~~~~~~~----~~~~~~-- 232 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-W-KEKKTYL----NPWKKI-- 232 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH-H-HTTCTTS----TTGGGS--
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH-H-hcCCCCC----CccccC--
Confidence 2345789999999999988775 67899999999999999999999764433222211 1 1111110 011112
Q ss_pred HHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
...+.+++.+||+.||++|||++|+++
T Consensus 233 --s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 233 --DSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp --CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 234567888899999999999999975
|
| >d1v6ia_ b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3818]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Peanut (Arachis hypogaea) [TaxId: 3818]
Probab=100.00 E-value=2.4e-50 Score=400.66 Aligned_cols=223 Identities=27% Similarity=0.393 Sum_probs=190.7
Q ss_pred CCcceeeeCCCCCC--CeeEecceeEcCCCcEEecCCC-CCeeEEEEeCCCeeeccCC-CCceeEEEEEEEEEecCCCCC
Q 006112 25 QEENQFIHHGFEGS--KLKLDGLAKIHPNGLLQLTNTS-ERISGHAFYPFPFKFNSSS-SQSLSFSTSFVFAMFPKLPNY 100 (660)
Q Consensus 25 ~~~~~f~~~~f~~~--~l~~~g~a~~~~~g~l~Lt~~~-~~~~G~~~y~~pv~~~~~~-~~~~sFst~F~F~i~~~~~~~ 100 (660)
+.+++|+|++|++. +|+|+|||.+.++|.|+||++. .+++|||+|++||+||++. +..+||+|+|+|.|.+.....
T Consensus 1 a~~~sF~~~~F~~~~~~l~l~GdA~i~~~g~l~LT~~~~~~~~G~a~y~~Pi~l~~~~~~~~~sf~t~f~f~i~~~~~~~ 80 (232)
T d1v6ia_ 1 AETVSFNFNSFSEGNPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIWSSATGNVASFLTSFSFEMKDIKDYD 80 (232)
T ss_dssp CEEEEEEESSCCTTCTTEEEEESCEECTTSCEECSCTTSTTCEEEEEESSCEECBCTTTCCBCEEEEEEEEEEECCSSSB
T ss_pred CccEEEECCCCCCCCCCEEEeeeeEEcCCCEEEeCCCCCCCceEEEEcCCCEEccCCCCCccceeEEEEEEEeccCCCCC
Confidence 35789999999864 5999999999889999999865 5899999999999999987 889999999999999888888
Q ss_pred CCCceEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCeeEEEcCCcccccccccccccc
Q 006112 101 GGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSD 180 (660)
Q Consensus 101 ~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~ 180 (660)
+||||||+|+|.....++ +++.|+.......+..++.|||||||++|.+++||+++|||||+|++.+.....
T Consensus 81 ~gDG~AF~l~~~~~~~~~--~~~~g~~~~~~~~~~~~~~~aVEfDT~~n~~~~d~~~~Higid~n~~~s~~~~~------ 152 (232)
T d1v6ia_ 81 PADGIIFFIAPEDTQIPA--GSIGGGTLGVSDTKGAGHFVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVP------ 152 (232)
T ss_dssp CCCEEEEEEEETTCCCCT--TCCCGGGTTTSCTTSEEEEEEEEEECSCCGGGTCCSSCEEEEEEEESSCSEEEE------
T ss_pred CCCeEEEEEECCCCCCCC--CccCCcccccccCCCCCceEEEEEEeEecCCCCCCCCccEeEeeCCcccccccc------
Confidence 999999999997643322 222333333333455789999999999999889999999999999998766543
Q ss_pred ccccccccccCCCccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeecccCce-eeeeeecC
Q 006112 181 EKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTR-VSDYYILG 259 (660)
Q Consensus 181 ~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg~~-~~~h~i~~ 259 (660)
.++.+|+.++|||+||+.+++|+|++.+. ++..|.++..+||+.+|+++||||||||||.. .|.|+|++
T Consensus 153 -------~~~~~g~~~~v~I~Yd~~~~~L~V~~~~~---~~~~~~l~~~vdL~~~l~~~vyvGFSAsTG~~~~~~H~I~s 222 (232)
T d1v6ia_ 153 -------WNSVSGAVVKVTVIYDSSTKTLSVAVTND---NGDITTIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLIRS 222 (232)
T ss_dssp -------CCCCTTCEEEEEEEEETTTTEEEEEEECT---TSCEEEEEEECCHHHHSCSEEEEEEEEECCSSBCCEEEEEE
T ss_pred -------cccCCCCEEEEEEEEeCCceEEEEEEecC---CCCcceEEEEEchhhccCCcEEEEEEEECCCCCCcccEEEE
Confidence 35779999999999999999999999853 56677899999999999999999999999974 69999999
Q ss_pred cccccC
Q 006112 260 WSFNKS 265 (660)
Q Consensus 260 wsf~~~ 265 (660)
|+|+++
T Consensus 223 WsFss~ 228 (232)
T d1v6ia_ 223 WSFTST 228 (232)
T ss_dssp EEEEEE
T ss_pred eEeEEe
Confidence 999975
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-50 Score=419.27 Aligned_cols=255 Identities=27% Similarity=0.420 Sum_probs=198.9
Q ss_pred eeecccccccCccEEEEEEEeCCCCe---EEEEEEeccC-CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHA---EIAVKKVCHD-SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~---~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
.|+..+.||+|+||+||+|++..+++ .||||++... .....++|.+|+++|++++|||||+++|+|.+++.+++||
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~ 106 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT 106 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 57777899999999999999876543 6899998654 3345678999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
|||++|+|.+++.... ..++|.++.+++.|||+||+|||+ ++|+||||||+||||+.++.+||+|||+++......
T Consensus 107 Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 107 EFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp ECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 9999999999887643 359999999999999999999998 999999999999999999999999999998765433
Q ss_pred Cce----eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcc
Q 006112 493 DLH----TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL 567 (660)
Q Consensus 493 ~~~----~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 567 (660)
... .....||+.|||||.+.++.++.++|||||||++|||+| |+.||...... .+......+.... .
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~~~~i~~~~~~~-----~ 254 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DVINAIEQDYRLP-----P 254 (299)
T ss_dssp -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHHTTCCCC-----C
T ss_pred CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---HHHHHHHcCCCCC-----C
Confidence 221 223468999999999999999999999999999999998 89999764332 1222223332211 1
Q ss_pred cccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 568 EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
.......+.+++.+||+.||++||||+||++.|+..
T Consensus 255 ----~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 255 ----PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ----CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 112345577899999999999999999999999753
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=411.23 Aligned_cols=245 Identities=26% Similarity=0.381 Sum_probs=208.4
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
+|+.++.||+|+||+||+|++..+++.||+|++... .....+++.+|++++++++|||||++++++.+++.+++|||
T Consensus 7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE 86 (263)
T d2j4za1 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 86 (263)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence 588899999999999999999999999999998643 23446789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
||++|+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 87 y~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~- 160 (263)
T d2j4za1 87 YAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 160 (263)
T ss_dssp CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred ecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence 999999999997654 48999999999999999999998 999999999999999999999999999998654332
Q ss_pred ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
.....||+.|||||++.+..++.++|||||||++|||++|+.||...... ........+.. .+....+
T Consensus 161 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i~~~~~------~~p~~~s- 228 (263)
T d2j4za1 161 --RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---ETYKRISRVEF------TFPDFVT- 228 (263)
T ss_dssp --CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHTTCC------CCCTTSC-
T ss_pred --ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH---HHHHHHHcCCC------CCCccCC-
Confidence 34568999999999999999999999999999999999999999764432 22222223221 1222222
Q ss_pred HHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
+.+.+++..||+.||++|||++|+++
T Consensus 229 ---~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 229 ---EGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ---HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 34667888899999999999999997
|
| >d1n47a_ b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]
Probab=100.00 E-value=7.9e-50 Score=397.18 Aligned_cols=220 Identities=30% Similarity=0.471 Sum_probs=193.7
Q ss_pred CcceeeeCCCCC--CCeeEecceeEcCCCcEEecCCCC-----CeeEEEEeCCCeeeccCCCCceeEEEEEEEEEecCCC
Q 006112 26 EENQFIHHGFEG--SKLKLDGLAKIHPNGLLQLTNTSE-----RISGHAFYPFPFKFNSSSSQSLSFSTSFVFAMFPKLP 98 (660)
Q Consensus 26 ~~~~f~~~~f~~--~~l~~~g~a~~~~~g~l~Lt~~~~-----~~~G~~~y~~pv~~~~~~~~~~sFst~F~F~i~~~~~ 98 (660)
++++|+|++|+. +||+|+|||.+.++|.|+||++.. +++|||||++||++|++. ..+||+|+|+|.|.+...
T Consensus 2 ~~~sF~f~~F~~~~~~l~l~G~A~i~~~g~i~LT~~~~~~~~~~~~G~~~y~~Pv~l~~~~-~~~sF~t~f~f~i~~~~~ 80 (233)
T d1n47a_ 2 ESTSFSFTNFNPNQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIHDNT-TLASFTTSFSFVMAAPAA 80 (233)
T ss_dssp EEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCBSSSSBCTTCEEEEEESSCEECBCSS-CBCEEEEEEEEECCCSST
T ss_pred CceEEEeCCCCCCCCCeEEecceEECCCCEEEecCCCCCCcCCCceEEEEeCCCEEccCCC-eeeeEEEEEEEEEeCCCC
Confidence 468999999963 699999999998889999998753 589999999999999864 578999999999988877
Q ss_pred CCCCCceEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCeeEEEcCCcccccccccccc
Q 006112 99 NYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYF 178 (660)
Q Consensus 99 ~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~ 178 (660)
..+||||||+|+|.+..+ +..||+|||++..+. +..++.|||||||++|. +||++||||||+|++.|..+.+
T Consensus 81 ~~~gDGlAF~l~~~~~~~-~~~gg~lGl~~~~~~-~~~~~~~aVefDT~~n~--~d~~~~higi~~n~~~s~~~~~---- 152 (233)
T d1n47a_ 81 AAVADGLAFFLAPPDTQP-QARGGFLGLFADRAH-DASYQTVAVEFDTYSNA--WDPNYTHIGIDTNGIESKKTTP---- 152 (233)
T ss_dssp TSCCEEEEEEEECTTCCC-CCCGGGTTTCSSSSC-CGGGCCEEEEEECSCCT--TSCSSCEEEEEESSSSCSEEEE----
T ss_pred CCCCCceEEEECCCCCCC-CCCCCccccccccCC-CCcCceEEEEEEeeecC--CCCCCCceeEccCCcccccccc----
Confidence 789999999999976544 467899999987654 35688999999999997 7999999999999998876654
Q ss_pred ccccccccccccCCCccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeecccC---ceeeee
Q 006112 179 SDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATG---TRVSDY 255 (660)
Q Consensus 179 ~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg---~~~~~h 255 (660)
+.+.+|+.++|||+||+.+++|.|++.+.. +|..|.|+..+||+.+||++|||||||+|| ...|.|
T Consensus 153 ---------~~l~~g~~~~v~I~Y~~~~~~l~v~l~~~~--~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~~~~H 221 (233)
T d1n47a_ 153 ---------FDMVYGEKANIVITYQASTKALAASLVFPV--SQTSYAVSARVDLRDILPEYVRVGFSATTGLNAGVVETH 221 (233)
T ss_dssp ---------CCCCTTSCEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCGGGTSCSEEEEEEEEEECSSTTCCCCC
T ss_pred ---------ceecCCCEEEEEEEEcCCCeEEEEEEEeCC--CCccEEEEEEechHHhcCCcEEEEEEEecCCCCCccccc
Confidence 467799999999999999999999998643 777889999999999999999999999999 457899
Q ss_pred eecCcccccC
Q 006112 256 YILGWSFNKS 265 (660)
Q Consensus 256 ~i~~wsf~~~ 265 (660)
+|++|+|+++
T Consensus 222 ~I~sWsFss~ 231 (233)
T d1n47a_ 222 DIVSWSFAVS 231 (233)
T ss_dssp EEEEEEEEEE
T ss_pred EEEEEEeEEE
Confidence 9999999874
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=412.32 Aligned_cols=255 Identities=25% Similarity=0.367 Sum_probs=197.5
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeee--cCeeEEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR--KGELLLV 411 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV 411 (660)
-+|+.++.||+|+||+||+|+...+|+.||||++.... +...+.+.+|++++++++|||||++++++.+ ++.+++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 36899999999999999999999999999999996543 3446679999999999999999999999864 4568999
Q ss_pred EecCCCCChhhhhhhC--CCCCcchhHHHHHHHHHHHHHHHhhhcc--cCceeccCccCCcEEEcCCCCeEEeeccccee
Q 006112 412 YDYMPNGSLDKILYSN--TRPSLNWFQRFRIIKGVAFGLLYLHEEW--EQVVLHRDIKPANVLLDADLEGKLGDFGLARL 487 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 487 (660)
||||++|+|.+++... .+..+++.+++.++.||+.||+|||+.. ..+|+||||||+||||+.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998642 2346999999999999999999999831 13599999999999999999999999999987
Q ss_pred ccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcc
Q 006112 488 YDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL 567 (660)
Q Consensus 488 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 567 (660)
...... ......||+.|||||++.+..++.++|||||||++|||+||+.||...... .+......+... .+
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---~~~~~i~~~~~~-----~~ 234 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAGKIREGKFR-----RI 234 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHTCCC-----CC
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH---HHHHHHHcCCCC-----CC
Confidence 654332 234578999999999999999999999999999999999999999764432 222333333321 12
Q ss_pred cccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 568 EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
...++ +.+.+++.+||+.||++|||++|++++
T Consensus 235 ~~~~s----~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 235 PYRYS----DELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp CTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CcccC----HHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 22233 346778889999999999999999863
|
| >d1fnya_ b.29.1.1 (A:) Legume lectin {Black locust (Robinia pseudoacacia) [TaxId: 35938]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Black locust (Robinia pseudoacacia) [TaxId: 35938]
Probab=100.00 E-value=6.8e-50 Score=399.53 Aligned_cols=224 Identities=29% Similarity=0.480 Sum_probs=195.9
Q ss_pred CcceeeeCCCCC--CCeeEecceeEcCCCcEEecCCC-----CCeeEEEEeCCCeeeccCC-CCceeEEEEEEEEEecCC
Q 006112 26 EENQFIHHGFEG--SKLKLDGLAKIHPNGLLQLTNTS-----ERISGHAFYPFPFKFNSSS-SQSLSFSTSFVFAMFPKL 97 (660)
Q Consensus 26 ~~~~f~~~~f~~--~~l~~~g~a~~~~~g~l~Lt~~~-----~~~~G~~~y~~pv~~~~~~-~~~~sFst~F~F~i~~~~ 97 (660)
.++||+|++|.. +|++|+|||.+.++|.||||++. .+++|||||++||+||++. +.++||+|+|+|.|.+..
T Consensus 2 ~~~sF~f~~F~~~~~~l~l~G~A~v~~~g~i~LT~~~~~~~~~~~~G~~~y~~Pi~l~~~~~~~~~sF~t~F~F~i~~~~ 81 (237)
T d1fnya_ 2 GSLSFSFPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDSTTGNVASFVTSFTFIIQAPN 81 (237)
T ss_dssp EEEEEEESSCCTTCTTEEEEETCEECTTSCEECSCEETTEECSSCEEEEEESSCEECBCTTTCCBCEEEEEEEEECCCSS
T ss_pred ceEEEEeCCCCCCCCCeEEcccEEEcCCCEEECCCCCCCCcccccEEEEEeCCCeEcccCCCCcceeeEEEEEEEEecCC
Confidence 468999999964 68999999999989999999864 4689999999999999987 788999999999999887
Q ss_pred CCCCCCceEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCeeEEEcCCccccccccccc
Q 006112 98 PNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARY 177 (660)
Q Consensus 98 ~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~ 177 (660)
...+||||||+|+|.+..+ +..+|+||+++..+. +..++.+||||||++|.++ ||+++|||||+|++.|..+.+
T Consensus 82 ~~~~gDG~AF~l~~~~~~~-~~~gg~lg~~~~~~~-~~~~~~~aVefDT~~n~~~-d~~~~Higi~~n~~~s~~~~~--- 155 (237)
T d1fnya_ 82 PATTADGLAFFLAPVDTQP-LDLGGMLGIFKDGYF-NKSNQIVAVEFDTFSNGDW-DPKGRHLGINVNSIESIKTVP--- 155 (237)
T ss_dssp TTSCCEEEEEEEEETTCCC-CCCGGGTTTCC---C-CTTSCCEEEEEECSCCTTT-CCSSSEEEEEESSSSCSEEEE---
T ss_pred CCCCCCeeEEEEcCCCCCc-ccccCcccccCCCCc-cCccceEEEEeccccccCC-CCCCceEEEecCCCccccccc---
Confidence 8889999999999977544 567899999876543 4578899999999999875 999999999999998876654
Q ss_pred cccccccccccccCCCccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeecccC---ceeee
Q 006112 178 FSDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATG---TRVSD 254 (660)
Q Consensus 178 ~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg---~~~~~ 254 (660)
..+.+|+.++|||+||+.+++|.|++.+.+ ++..|+|+..+||+.+||++|||||||+|| ...|.
T Consensus 156 ----------~~~~~g~~~~v~I~Y~~~~~~l~v~l~~~~--~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~s~~~e~ 223 (237)
T d1fnya_ 156 ----------WNWTNGEVANVFISYEASTKSLTASLVYPS--LETSFIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQT 223 (237)
T ss_dssp ----------CCCCTTCCEEEEEEEEGGGTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEEEEEEEECSSTTCCCC
T ss_pred ----------ccccCCcEEEEEEEEeCCccEEEEEEEeCC--CCcceeEEEEechhhcCCCcEEEEEEEECCCCCCcccc
Confidence 356789999999999999999999998754 677889999999999999999999999999 45689
Q ss_pred eeecCcccccCCC
Q 006112 255 YYILGWSFNKSGP 267 (660)
Q Consensus 255 h~i~~wsf~~~gp 267 (660)
|+|++|+|+++.|
T Consensus 224 H~I~sWsF~s~lp 236 (237)
T d1fnya_ 224 NDVLSWSFESNLP 236 (237)
T ss_dssp CEEEEEEEEEEEC
T ss_pred cEEEEeEeEEeCC
Confidence 9999999998654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=416.70 Aligned_cols=251 Identities=22% Similarity=0.301 Sum_probs=208.8
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 416 (660)
.|+.++.||+|+||+||+|++..+++.||||++........+.+.+|++++++++|||||++++++.+++.+++|||||+
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~ 92 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 92 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCC
Confidence 48899999999999999999999999999999987777778899999999999999999999999999999999999999
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCcee
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT 496 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 496 (660)
+|+|.+++.... ..+++.++..++.||+.||.|||+ ++|+||||||+|||++.++++||+|||+|+...... ...
T Consensus 93 ~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~~ 167 (288)
T d2jfla1 93 GGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRR 167 (288)
T ss_dssp TEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HHH
T ss_pred CCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCc-ccc
Confidence 999999986543 359999999999999999999998 999999999999999999999999999997643221 122
Q ss_pred eccccCccccCccccc-----CCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccC
Q 006112 497 TNVVGTVGYLAPELLR-----NGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIY 571 (660)
Q Consensus 497 ~~~~gt~~Y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 571 (660)
....||+.|||||++. ...++.++|||||||++|||+||+.||........ ... ...+.......
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~--~~~-i~~~~~~~~~~------- 237 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV--LLK-IAKSEPPTLAQ------- 237 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--HHH-HHHSCCCCCSS-------
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH--HHH-HHcCCCCCCCc-------
Confidence 3467999999999984 45678999999999999999999999976443221 111 11222111111
Q ss_pred cHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 572 VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 572 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
.......+.+++..||+.||++|||++|+++
T Consensus 238 ~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 238 PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122345678888999999999999999986
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-50 Score=404.34 Aligned_cols=252 Identities=26% Similarity=0.378 Sum_probs=213.2
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 416 (660)
+|+.++.||+|+||+||+|+++ ++..||||++..... ..++|++|++++++++||||++++|+|.+++.+++||||++
T Consensus 5 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 5 DLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 5678889999999999999995 678999999976543 45789999999999999999999999999999999999999
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCcee
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLHT 496 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 496 (660)
+|+|..++.... ..+++..+.+++.|+++||+|||+ ++|+||||||+|||+++++.+||+|||+++..........
T Consensus 83 ~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 83 NGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp TEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred CCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence 999999976543 358899999999999999999998 8999999999999999999999999999987665544445
Q ss_pred eccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHH
Q 006112 497 TNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQ 575 (660)
Q Consensus 497 ~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 575 (660)
....||+.|+|||.+.+..++.++|||||||++|||+| |+.||....... +......+.... .| .. .
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~---~~~~i~~~~~~~--~p---~~----~ 226 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TAEHIAQGLRLY--RP---HL----A 226 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HHHHHHTTCCCC--CC---TT----C
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH---HHHHHHhCCCCC--Cc---cc----c
Confidence 55779999999999999999999999999999999998 899998654332 233333332211 11 11 2
Q ss_pred HHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 576 MEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 576 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
...+.+++..||+.||++|||++||+++|..
T Consensus 227 ~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 227 SEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred cHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 2457888999999999999999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=422.58 Aligned_cols=257 Identities=24% Similarity=0.378 Sum_probs=206.3
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
-+|+.++.||+|+||+||+|++..+++.||+|++.... ....+++.+|+.++++++|||||+++++|.+++.+++||||
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy 85 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 85 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 36899999999999999999999999999999997653 34457899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
|++|+|.+++.+.. .+++..+..++.||+.||.|||+ +++|+||||||+|||++.++++||+|||+|+.....
T Consensus 86 ~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--- 158 (322)
T d1s9ja_ 86 MDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 158 (322)
T ss_dssp CTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred CCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC---
Confidence 99999999997654 48999999999999999999997 248999999999999999999999999999865432
Q ss_pred eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccC------------
Q 006112 495 HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDA------------ 562 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~------------ 562 (660)
.....+||+.|||||++.+..++.++||||+||++|||++|+.||...+.............+.....
T Consensus 159 ~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (322)
T d1s9ja_ 159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238 (322)
T ss_dssp TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence 22346899999999999999999999999999999999999999976543322221111111110000
Q ss_pred ----------------------CCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 563 ----------------------SDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 563 ----------------------~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
..+.+... .....+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSG---VFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp -------CCCCHHHHHHHHHTSCCCCCCBT---TBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccchhHHHHHhhhhccCCccCccc---cCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 00001000 01234677888999999999999999997
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-50 Score=409.10 Aligned_cols=247 Identities=24% Similarity=0.353 Sum_probs=201.6
Q ss_pred cccccCccEEEEEEEeCC--CCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCCC
Q 006112 342 YKATKGGSGKVYRGVLPS--SHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMPN 417 (660)
Q Consensus 342 ~~lg~G~fg~Vy~g~~~~--~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 417 (660)
++||+|+||+||+|.+.. .++.||||++... +....++|.+|++++++++|||||+++|+|.. +..+||||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998743 4578999999653 33456789999999999999999999999965 457899999999
Q ss_pred CChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce--
Q 006112 418 GSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH-- 495 (660)
Q Consensus 418 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~-- 495 (660)
|+|.+++.... .++|.++.+++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 99999998654 49999999999999999999998 899999999999999999999999999999775544332
Q ss_pred eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHH
Q 006112 496 TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEE 574 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 574 (660)
.....||+.|||||.+.++.++.++|||||||++|||+| |+.||...... .+......+.... ....
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~~~~~i~~~~~~~-----~p~~---- 234 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTAMLEKGERMG-----CPAG---- 234 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHHHTTCCCC-----CCTT----
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---HHHHHHHcCCCCC-----CCcc----
Confidence 234579999999999999999999999999999999998 89999864432 2333334443221 1122
Q ss_pred HHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 575 QMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 575 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
....+.+|+.+||+.||++|||+++|++.|+.
T Consensus 235 ~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 235 CPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred cCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 23457788999999999999999999988864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=409.14 Aligned_cols=253 Identities=23% Similarity=0.337 Sum_probs=207.1
Q ss_pred eeeccc-ccccCccEEEEEEEeCC--CCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEE
Q 006112 337 SYKNLY-KATKGGSGKVYRGVLPS--SHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 337 ~~~~l~-~lg~G~fg~Vy~g~~~~--~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
++...+ +||+|+||+||+|.+.. ++..||||++.... ....++|.+|+++|++++|||||+++|+|.. +.+++||
T Consensus 9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvm 87 (285)
T d1u59a_ 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 87 (285)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEE
T ss_pred CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEE
Confidence 455555 49999999999998753 45689999997654 3456789999999999999999999999865 5689999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
|||++|+|.+++.... ..+++.++.+++.|||+||+|||+ ++|+||||||+||||+.++.+||+|||+++......
T Consensus 88 E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 88 EMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp ECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 9999999999986543 459999999999999999999998 899999999999999999999999999999876543
Q ss_pred Cce--eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccc
Q 006112 493 DLH--TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEG 569 (660)
Q Consensus 493 ~~~--~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 569 (660)
... .....||+.|||||++.++.++.++|||||||++|||+| |+.||...... .+......+...+ ...
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~~~i~~~~~~~-----~p~ 235 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFIEQGKRME-----CPP 235 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHHHHTTCCCC-----CCT
T ss_pred cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHHHHHHcCCCCC-----CCC
Confidence 322 234578999999999999999999999999999999998 89999864432 2233334443322 112
Q ss_pred cCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 570 IYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
. ....+.+|+..||+.||++||||.+|++.|+.
T Consensus 236 ~----~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 236 E----CPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp T----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred c----CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 2 23457788999999999999999999998874
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=404.18 Aligned_cols=246 Identities=25% Similarity=0.367 Sum_probs=199.3
Q ss_pred eecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeee----cCeeEEE
Q 006112 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR----KGELLLV 411 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~lV 411 (660)
|+..++||+|+||+||+|++..+++.||+|++... .....+.|.+|++++++++|||||++++++.. +..+++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 34456799999999999999999999999998654 33456789999999999999999999999865 3458999
Q ss_pred EecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCc--eeccCccCCcEEEc-CCCCeEEeecccceec
Q 006112 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQV--VLHRDIKPANVLLD-ADLEGKLGDFGLARLY 488 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDikp~NIll~-~~~~~kl~DFGla~~~ 488 (660)
||||++|+|.+++.... .+++..+..++.||++||+|||+ ++ |+||||||+|||++ +++.+||+|||+|+..
T Consensus 91 mE~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 99999999999997654 48999999999999999999998 66 99999999999996 5789999999999864
Q ss_pred cCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCccc
Q 006112 489 DHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLE 568 (660)
Q Consensus 489 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 568 (660)
... ......||+.|||||++.+ +++.++|||||||++|||++|+.||..... ...+.+....+.. .+.+.
T Consensus 166 ~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~--~~~~~~~i~~~~~----~~~~~ 235 (270)
T d1t4ha_ 166 RAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTSGVK----PASFD 235 (270)
T ss_dssp CTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHHTTTCC----CGGGG
T ss_pred cCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc--HHHHHHHHHcCCC----CcccC
Confidence 332 2345789999999999865 699999999999999999999999975332 1222222222211 11122
Q ss_pred ccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 569 GIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 569 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
.... ..+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~----~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 236 KVAI----PEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GCCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCC----HHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 2222 34678888999999999999999986
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-50 Score=411.33 Aligned_cols=256 Identities=25% Similarity=0.416 Sum_probs=201.4
Q ss_pred eeecccccccCccEEEEEEEeCCCC----eEEEEEEeccCCC-hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSH----AEIAVKKVCHDSD-HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~----~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 411 (660)
.|+..+.||+|+||.||+|++..++ ..||||++..... ...++|.+|++++++++|||||+++|+|.+.+..++|
T Consensus 8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v 87 (283)
T d1mqba_ 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMII 87 (283)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEE
Confidence 3667788999999999999986544 4799999965533 3456799999999999999999999999999999999
Q ss_pred EecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCC
Q 006112 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 491 (660)
||||.+|+|.+++.... ..++|.++.+++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++.....
T Consensus 88 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 88 TEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 99999999999887654 359999999999999999999998 99999999999999999999999999999876543
Q ss_pred CC--ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccc
Q 006112 492 ND--LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEG 569 (660)
Q Consensus 492 ~~--~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 569 (660)
.. .......||+.|||||++.++.++.++|||||||++|||++|..|+...... ..+.+....+.... ..
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~~~~i~~~~~~~-----~~- 235 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMKAINDGFRLP-----TP- 235 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHHTTCCCC-----CC-
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHHHHHHhccCCCC-----Cc-
Confidence 22 2233457899999999999999999999999999999999977666543221 22233333332211 11
Q ss_pred cCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 570 IYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
......+.+|+.+||+.||++||||.||++.|+..
T Consensus 236 ---~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 236 ---MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp ---TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ---hhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 12335578899999999999999999999999764
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-49 Score=407.01 Aligned_cols=256 Identities=28% Similarity=0.408 Sum_probs=203.6
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
-+|+..+.||+|+||+||+|++.++ ..||||++... ....+.|.+|+.++++++|||||+++|+|.+ +++++|||||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 4789999999999999999999654 67999998644 3345789999999999999999999999854 5689999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 495 (660)
++|+|..++.......++|.++..++.||+.||+|||+ ++|+||||||+|||||.++.+||+|||+++.........
T Consensus 94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 99999999876544569999999999999999999998 899999999999999999999999999998776554444
Q ss_pred eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHHH
Q 006112 496 TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEEQ 575 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 575 (660)
.....||+.|+|||++..+.++.++|||||||++|||+||..|+...... .........+.... ... ..
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~i~~~~~~~-----~~~----~~ 239 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVERGYRMP-----CPP----EC 239 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTTCCCC-----CCT----TS
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHHHhcCCCC-----CCc----cc
Confidence 55578999999999999999999999999999999999987776543321 22222233322111 112 22
Q ss_pred HHHHHHHhhhccCCCCCCCCCHHHHHHHhhCCC
Q 006112 576 MEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGGA 608 (660)
Q Consensus 576 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 608 (660)
.+.+.+++.+||+.||++||+|++|++.|+...
T Consensus 240 ~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 240 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 345778899999999999999999999998754
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-49 Score=414.54 Aligned_cols=257 Identities=26% Similarity=0.339 Sum_probs=208.3
Q ss_pred ceeeecccccccCccEEEEEEEeCCCC-----eEEEEEEeccC-CChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCe
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSH-----AEIAVKKVCHD-SDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGE 407 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~-----~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 407 (660)
+-+|+..+.||+|+||+||+|++...+ ..||||++... .....+.+.+|+.++.++ +|||||+++++|.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 346888899999999999999986543 37999998654 334567899999999998 89999999999999999
Q ss_pred eEEEEecCCCCChhhhhhhCCC---------------------CCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccC
Q 006112 408 LLLVYDYMPNGSLDKILYSNTR---------------------PSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKP 466 (660)
Q Consensus 408 ~~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp 466 (660)
+++|||||++|+|.++|..... ..++|.+++.++.||++||+|||+ ++|+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCch
Confidence 9999999999999999975431 348999999999999999999998 8999999999
Q ss_pred CcEEEcCCCCeEEeecccceeccCCCCc-eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCc
Q 006112 467 ANVLLDADLEGKLGDFGLARLYDHGNDL-HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGEL 544 (660)
Q Consensus 467 ~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~ 544 (660)
+|||++.++.+||+|||+|+........ ......||+.|||||++.++.++.++|||||||++|||+| |+.||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999876554433 2345678999999999999999999999999999999997 8999976433
Q ss_pred chHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhh
Q 006112 545 DLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLD 605 (660)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 605 (660)
.. ...+....+...+ ... ...+.+.+|+.+||+.||++|||++||+++|.
T Consensus 273 ~~--~~~~~~~~~~~~~-----~p~----~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 DA--NFYKLIQNGFKMD-----QPF----YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SH--HHHHHHHTTCCCC-----CCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HH--HHHHHHhcCCCCC-----CCC----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 21 1222223322111 111 22345778899999999999999999999995
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=409.44 Aligned_cols=248 Identities=22% Similarity=0.290 Sum_probs=206.3
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
+|+.++.||+|+||+||+|++..+++.||||++... .....+.+.+|++++++++||||+++++++.+++.+++|||
T Consensus 9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE 88 (288)
T d1uu3a_ 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 88 (288)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence 589999999999999999999999999999998643 23445789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC-
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN- 492 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~- 492 (660)
||++|+|.+++.... .+++.++..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+|+.+....
T Consensus 89 y~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 89 YAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred ccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 999999999987654 48999999999999999999998 999999999999999999999999999999875433
Q ss_pred CceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCc
Q 006112 493 DLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 493 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
.......+||+.|||||++.+..++.++||||+||++|||++|+.||....... +......+.. .+...++
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~~i~~~~~------~~p~~~s 234 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL---IFQKIIKLEY------DFPEKFF 234 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHTTCC------CCCTTCC
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH---HHHHHHcCCC------CCCccCC
Confidence 223445689999999999999999999999999999999999999998654322 2222222221 1222233
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
..+.+++..||+.||++|||++|+++
T Consensus 235 ----~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 235 ----PKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp ----HHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred ----HHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 34678888999999999999999754
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.2e-49 Score=408.93 Aligned_cols=250 Identities=25% Similarity=0.378 Sum_probs=206.5
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC---hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD---HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
.|+.++.||+|+||+||+|++..+++.||||++..... ...+.+.+|++++++++|||||++++++.+++.+++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 48999999999999999999999999999999975532 345679999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
||++|+|+.++.... .+++.++..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+....
T Consensus 96 ~~~~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~--- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--- 167 (309)
T ss_dssp CCSEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred ecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCC---
Confidence 999999987776543 59999999999999999999998 9999999999999999999999999999986543
Q ss_pred ceeeccccCccccCcccccC---CCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCccccc
Q 006112 494 LHTTNVVGTVGYLAPELLRN---GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGI 570 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~---~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 570 (660)
.....||+.|||||++.+ +.++.++|||||||++|||++|+.||...... +........ ...... ...
T Consensus 168 --~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~--~~~~~i~~~-~~~~~~----~~~ 238 (309)
T d1u5ra_ 168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIAQN-ESPALQ----SGH 238 (309)
T ss_dssp --BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHS-CCCCCS----CTT
T ss_pred --CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhC-CCCCCC----CCC
Confidence 234679999999999863 46889999999999999999999999754322 222222222 111111 112
Q ss_pred CcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH--HhhCC
Q 006112 571 YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ--YLDGG 607 (660)
Q Consensus 571 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~ 607 (660)
+ .+.+.+++..||+.||++|||++|+++ ++...
T Consensus 239 ~----s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 239 W----SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp S----CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred C----CHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 2 235678888999999999999999987 46543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.1e-49 Score=408.79 Aligned_cols=255 Identities=23% Similarity=0.309 Sum_probs=194.0
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC-hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD-HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
.|+.++.||+|+||+||+|++..+++.||||++..... ...+.+.+|+.++++++|||||++++++.+++.+++|||||
T Consensus 10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~ 89 (307)
T d1a06a_ 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLV 89 (307)
T ss_dssp TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 48889999999999999999999999999999975432 33467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEc---CCCCeEEeecccceeccCCC
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLD---ADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~---~~~~~kl~DFGla~~~~~~~ 492 (660)
++|+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||+. +++.+||+|||+|+......
T Consensus 90 ~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 90 SGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp CSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred CCCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 9999999997643 59999999999999999999998 9999999999999994 57899999999998764432
Q ss_pred CceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCc
Q 006112 493 DLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 493 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
.....+||+.|||||++.+..++.++|||||||++|||++|+.||....... .......+... .........
T Consensus 165 --~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~~i~~~~~~--~~~~~~~~~- 236 (307)
T d1a06a_ 165 --VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK---LFEQILKAEYE--FDSPYWDDI- 236 (307)
T ss_dssp ----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHTTCCC--CCTTTTTTS-
T ss_pred --eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH---HHHHHhccCCC--CCCccccCC-
Confidence 2334679999999999999999999999999999999999999998644322 22222222211 111111122
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCCHHHHHHH--hhCC
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY--LDGG 607 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~ 607 (660)
...+.+++..||+.||++|||++|++++ +.+.
T Consensus 237 ---s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 237 ---SDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp ---CHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred ---CHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 2456788889999999999999999984 5543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.4e-48 Score=412.41 Aligned_cols=252 Identities=23% Similarity=0.278 Sum_probs=210.8
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 416 (660)
.|+.++.||+|+||.||+|++..+|+.||||++........+.+.+|++++++++|||||++++++.+++.+++|||||+
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 106 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 106 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 58899999999999999999999999999999977666667889999999999999999999999999999999999999
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcC--CCCeEEeecccceeccCCCCc
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDA--DLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~--~~~~kl~DFGla~~~~~~~~~ 494 (660)
+|+|.+++.... ..+++.++..++.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||+++......
T Consensus 107 gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~-- 180 (350)
T d1koaa2 107 GGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-- 180 (350)
T ss_dssp SCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS--
T ss_pred CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheeccccc--
Confidence 999999986543 359999999999999999999998 99999999999999954 5789999999998765433
Q ss_pred eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHH
Q 006112 495 HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEE 574 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 574 (660)
......||+.|||||++.+..++.++|||||||++|||++|+.||...... ........+... ..+.... .
T Consensus 181 ~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i~~~~~~--~~~~~~~----~ 251 (350)
T d1koaa2 181 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ETLRNVKSCDWN--MDDSAFS----G 251 (350)
T ss_dssp CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHTCCC--SCCGGGG----G
T ss_pred ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCC--CCccccc----C
Confidence 234568999999999999999999999999999999999999999764332 122222222211 1111111 2
Q ss_pred HHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 575 QMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 575 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
..+.+.+++.+||+.||++|||++|++++
T Consensus 252 ~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 252 ISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 22346788889999999999999999985
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.3e-48 Score=411.15 Aligned_cols=256 Identities=20% Similarity=0.250 Sum_probs=213.3
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 416 (660)
.|+.++.||+|+||.||+|++..+++.||||++........+.+.+|++++++++|||||++++++.+++.+++|||||+
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 109 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 109 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 48999999999999999999999999999999977665666788999999999999999999999999999999999999
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEc--CCCCeEEeecccceeccCCCCc
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLD--ADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~--~~~~~kl~DFGla~~~~~~~~~ 494 (660)
+|+|.+++.... ..+++.++..|+.||+.||+|||+ ++|+||||||+||||+ .++.+||+|||+|+......
T Consensus 110 gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~-- 183 (352)
T d1koba_ 110 GGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-- 183 (352)
T ss_dssp CCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--
T ss_pred CChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCCC--
Confidence 999998876543 359999999999999999999998 9999999999999997 57899999999998875433
Q ss_pred eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHH
Q 006112 495 HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEE 574 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 574 (660)
......||+.|||||++.+..++.++||||+||++|||+||+.||....... .......+... +.......
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~~~i~~~~~~------~~~~~~~~ 254 (352)
T d1koba_ 184 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TLQNVKRCDWE------FDEDAFSS 254 (352)
T ss_dssp CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHHHCCCC------CCSSTTTT
T ss_pred ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhCCCC------CCcccccC
Confidence 2345689999999999999999999999999999999999999997644321 12222222211 11111112
Q ss_pred HHHHHHHHhhhccCCCCCCCCCHHHHHHH--hhCC
Q 006112 575 QMEIVLKLGLFCSHSNPDTRPSMRQVVQY--LDGG 607 (660)
Q Consensus 575 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~ 607 (660)
....+.+|+..||+.||.+|||++|++++ +++.
T Consensus 255 ~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 255 VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 23446788899999999999999999984 6654
|
| >d1ukga_ b.29.1.1 (A:) Legume lectin {Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Legume lectin species: Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]
Probab=100.00 E-value=7.6e-48 Score=385.60 Aligned_cols=223 Identities=26% Similarity=0.447 Sum_probs=194.4
Q ss_pred CcceeeeCCCCC--CCeeEecceeEcCCCcEEecCCC------CCeeEEEEeCCCeeeccCC-CCceeEEEEEEEEEecC
Q 006112 26 EENQFIHHGFEG--SKLKLDGLAKIHPNGLLQLTNTS------ERISGHAFYPFPFKFNSSS-SQSLSFSTSFVFAMFPK 96 (660)
Q Consensus 26 ~~~~f~~~~f~~--~~l~~~g~a~~~~~g~l~Lt~~~------~~~~G~~~y~~pv~~~~~~-~~~~sFst~F~F~i~~~ 96 (660)
+++||+|++|++ +||+|+|+|.+. ++.|+||++. ..++|||+|++||+||++. +.++||+|+|+|.|.+.
T Consensus 2 ~~~sF~f~~F~~~~~~l~l~G~A~i~-~~~i~LT~~~~~~~~~~~~~G~~~y~~Pi~l~~~~~~~~~sF~t~F~f~i~~~ 80 (241)
T d1ukga_ 2 DSLSFGFPTFPSDQKNLIFQGDAQIK-NNAVQLTKTDSNGNPVASTVGRILFSAQVHLWEKSSSRVANFQSQFSFSLKSP 80 (241)
T ss_dssp CEEEEEESSCCSCCSSEEEEETCEEE-TTEEECSCBCTTSCBCSSEEEEEEESSCEECEETTTTEEEEEEEEEEEEEECS
T ss_pred ccEEEEeCCCCCCCCCEEEeeeEEEe-CCEEEeCCCCCCCCccccceEEEEeCCCeecccCCCCceeeeEEEEEEEEecC
Confidence 578999999964 689999999997 7889999864 4689999999999999987 78889999999999876
Q ss_pred CCCCCCCceEEEEecCC-CCCCCCCCCcccccccCCC-CCCCccEEEEEeecccCCCC--CCCCCCeeEEEcCCcccccc
Q 006112 97 LPNYGGHGMAFFISPST-DFSEAVAGSHLGIFNRSNN-GQFTNHIFAIELDTVQSPEF--NDIDGNHVGIDVNGLQSNES 172 (660)
Q Consensus 97 ~~~~~g~GlaF~l~p~~-~~~~~~~g~~lGl~~~~~~-~~~~~~~vaVEFDt~~n~~~--~d~~~~Hvgid~ns~~s~~~ 172 (660)
. ..+|||||||+.|.. ..|.+.+|+++|+++.... +...|+.|||||||++|.+. +||+++|||||+|++.|.++
T Consensus 81 ~-~~~~~g~~f~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~n~~vaVEfDt~~n~~~~~~~~~~~Higid~n~~~s~~~ 159 (241)
T d1ukga_ 81 L-SNGADGIAFFIAPPDTTIPSGSGGGLLGLFAPGTAQNTSANQVIAVEFDTFYAQDSNTWDPNYPHIGIDVNSIRSVKT 159 (241)
T ss_dssp S-SSCCCEEEEEEECTTCCCCTTCCGGGTTTSCGGGTTCGGGCCCEEEEEECCCCTTTCTTSCSSCEEEEEESSSSCSEE
T ss_pred C-CCCCCceEEEEeCCCCCcccccCcccccccccccccCCccCcccceeccCEecCccCCCCCCCccEeeecCCcccccc
Confidence 4 447999999999865 5577788899999877654 35678999999999998754 45889999999999998765
Q ss_pred ccccccccccccccccccCCCccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeecccCcee
Q 006112 173 ASARYFSDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTRV 252 (660)
Q Consensus 173 ~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg~~~ 252 (660)
.+ ..+.+|+.++|||+||+.+++|+|++... +|..|.+++.|||+.+|+++||||||||||...
T Consensus 160 ~~-------------~~~~~g~~~~v~I~Yd~~~~~L~v~~~~~---~~~~~~l~~~vdL~~~l~~~~yvGFSAsTG~~~ 223 (241)
T d1ukga_ 160 VK-------------WDRRDGQSLNVLVTFNPSTRNLDVVATYS---DGTRYEVSYEVDVRSVLPEWVRVGFSAASGEQY 223 (241)
T ss_dssp EE-------------CCCCTTCCEEEEEEEETTTTEEEEEEEET---TCCEEEEEEECCGGGTSCSEEEEEEEEEESSSC
T ss_pred cc-------------cccCCCcEEEEEEEEeCCCcEEEEEEccC---CCCceEEEEEEehHHhCCCcEEEEEEEecCCCC
Confidence 53 35779999999999999999999999864 566788999999999999999999999999999
Q ss_pred eeeeecCcccccCC
Q 006112 253 SDYYILGWSFNKSG 266 (660)
Q Consensus 253 ~~h~i~~wsf~~~g 266 (660)
|.|+|++|+|+++.
T Consensus 224 ~~H~IlsWsFss~l 237 (241)
T d1ukga_ 224 QTHTLESWSFTSTL 237 (241)
T ss_dssp CEEEEEEEEEEEEE
T ss_pred ceeEEEEeEEEEEe
Confidence 99999999998753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=401.27 Aligned_cols=251 Identities=21% Similarity=0.297 Sum_probs=208.0
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC------ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS------DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLL 410 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 410 (660)
.|+.++.||+|+||+||+|++..+|+.||||++.... ....+.+.+|++++++++|||||++++++.+++.+++
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 90 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4888999999999999999999999999999986432 1235789999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCC----CeEEeecccce
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADL----EGKLGDFGLAR 486 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~----~~kl~DFGla~ 486 (660)
|||||++|+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+++
T Consensus 91 v~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 91 ILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhhhh
Confidence 999999999999997654 49999999999999999999998 9999999999999998776 49999999998
Q ss_pred eccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCc
Q 006112 487 LYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPR 566 (660)
Q Consensus 487 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 566 (660)
....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......+.. .
T Consensus 166 ~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~~i~~~~~------~ 234 (293)
T d1jksa_ 166 KIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLANVSAVNY------E 234 (293)
T ss_dssp ECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHTTCC------C
T ss_pred hcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH---HHHHHHhcCC------C
Confidence 7654332 334679999999999999999999999999999999999999998644322 1222222211 1
Q ss_pred ccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 567 LEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 567 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
............+.+++.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 235 FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111111223456788899999999999999999873
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-48 Score=397.03 Aligned_cols=255 Identities=24% Similarity=0.346 Sum_probs=198.3
Q ss_pred ceeeecccccccCccEEEEEEEeCCC---CeEEEEEEeccCCC-hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEE
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSS---HAEIAVKKVCHDSD-HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLL 410 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~---~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 410 (660)
+-+|+..+.||+|+||.||+|++..+ +..||||++..... ...+.|.+|++++++++|||||+++|+|. ++.+++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 34788899999999999999998654 45799999865443 34678999999999999999999999996 467899
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccC
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDH 490 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 490 (660)
|||||++|+|.+++.... ..+++.++..++.||++||.|||+ ++|+||||||+||+++.++.+||+|||+|+....
T Consensus 85 v~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccC
Confidence 999999999999886554 458999999999999999999998 9999999999999999999999999999987765
Q ss_pred CCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccc
Q 006112 491 GNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEG 569 (660)
Q Consensus 491 ~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 569 (660)
..........||+.|+|||.+.++.++.++|||||||++|||+| |..||........ ......+.... ...
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~---~~~i~~~~~~~-----~~~ 232 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRIENGERLP-----MPP 232 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHHHTTCCCC-----CCT
T ss_pred CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH---HHHHHcCCCCC-----CCC
Confidence 55445556778999999999999999999999999999999998 8889876444322 22223332221 112
Q ss_pred cCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 570 IYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
.....+.+++..||+.||++|||++||++.|+.
T Consensus 233 ----~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 233 ----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp ----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 223457788899999999999999999999874
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-48 Score=404.14 Aligned_cols=254 Identities=22% Similarity=0.343 Sum_probs=203.9
Q ss_pred eeecccccccCccEEEEEEEeCCCCe----EEEEEEeccC-CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHA----EIAVKKVCHD-SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLV 411 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 411 (660)
+|+.++.||+|+||+||+|++..+++ +||+|++... ..+..++|.+|++++++++|||||+++|+|.++ ..+++
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v 88 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI 88 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEE
Confidence 59999999999999999999977665 6899988653 345678899999999999999999999999765 56788
Q ss_pred EecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCC
Q 006112 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 491 (660)
+||+.+|+|.+++.... ..+++..+++++.|||+||+|||+ ++|+||||||+||||+.++.+||+|||+|+.....
T Consensus 89 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 99999999999887654 459999999999999999999998 89999999999999999999999999999876554
Q ss_pred CCc-eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccc
Q 006112 492 NDL-HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEG 569 (660)
Q Consensus 492 ~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 569 (660)
... ......||+.|||||++.++.++.++|||||||++|||+| |+.||.......... ....+.... ...
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~---~i~~~~~~~-----~p~ 236 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS---ILEKGERLP-----QPP 236 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHH---HHHHTCCCC-----CCT
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHH---HHHcCCCCC-----CCc
Confidence 332 2334578999999999999999999999999999999998 788887654433322 223332211 111
Q ss_pred cCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 570 IYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
.....+.+++.+||+.||++|||++||+++|+..
T Consensus 237 ----~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 237 ----ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp ----TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----ccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 2234577889999999999999999999988753
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-48 Score=393.70 Aligned_cols=247 Identities=31% Similarity=0.392 Sum_probs=196.5
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeee-cCeeEEEEecC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR-KGELLLVYDYM 415 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~lV~E~~ 415 (660)
+|+.++.||+|+||.||+|++ .++.||||+++.+ ...++|.+|++++++++||||++++|+|.+ ++.+++||||+
T Consensus 8 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 8 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 577788999999999999999 4788999999543 345789999999999999999999999865 46789999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCce
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDLH 495 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 495 (660)
++|+|.++|.......++|..+++|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---- 156 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 156 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCC----
Confidence 99999999976544458999999999999999999998 89999999999999999999999999999865432
Q ss_pred eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHH
Q 006112 496 TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEE 574 (660)
Q Consensus 496 ~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 574 (660)
.....+|..|+|||++.++.++.++|||||||++|||+| |+.||........ ......+.. +.+....
T Consensus 157 ~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~---~~~i~~~~~-----~~~~~~~--- 225 (262)
T d1byga_ 157 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRVEKGYK-----MDAPDGC--- 225 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HHHHTTTCC-----CCCCTTC---
T ss_pred CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH---HHHHHcCCC-----CCCCccC---
Confidence 233568999999999999999999999999999999998 6777765443322 112222222 1122222
Q ss_pred HHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 575 QMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 575 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
...+.+++.+||+.||++||||.|++++|+.
T Consensus 226 -~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~ 256 (262)
T d1byga_ 226 -PPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256 (262)
T ss_dssp -CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 2457788899999999999999999999975
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-47 Score=396.69 Aligned_cols=258 Identities=26% Similarity=0.404 Sum_probs=210.5
Q ss_pred ceeeecccccccCccEEEEEEEeCC-----CCeEEEEEEeccCCC-hhhHHHHHHHHHHhccCCCCceeEeeeeeecCee
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPS-----SHAEIAVKKVCHDSD-HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGEL 408 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~-----~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 408 (660)
+-+|+.++.||+|+||+||+|++.. +++.||||++..... +..++|.+|++++++++||||++++++|...+..
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 4478999999999999999999753 457899999975543 3467899999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhhhCC----------------------CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccC
Q 006112 409 LLVYDYMPNGSLDKILYSNT----------------------RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKP 466 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp 466 (660)
++||||+++|+|.++++... ...++|.+++.|+.||+.||+|||+ ++||||||||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDlKp 168 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLAT 168 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSG
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEEcc
Confidence 99999999999999996432 1348899999999999999999998 9999999999
Q ss_pred CcEEEcCCCCeEEeecccceeccCCCC-ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCC-CCCCCCc
Q 006112 467 ANVLLDADLEGKLGDFGLARLYDHGND-LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRR-PVQPGEL 544 (660)
Q Consensus 467 ~NIll~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~-p~~~~~~ 544 (660)
+|||||.++.+||+|||+|+....... ...+...||+.|+|||++.+..++.++|||||||++|||++|.. ||.....
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 999999999999999999986644322 23345678999999999999999999999999999999999864 5654332
Q ss_pred chHHHHHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 545 DLLDWVIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 545 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
. .+......+.... ..... +..+.+|+..||+.||++||||.||++.|+..
T Consensus 249 ~---e~~~~v~~~~~~~-----~p~~~----~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 249 E---EVIYYVRDGNILA-----CPENC----PLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp H---HHHHHHHTTCCCC-----CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred H---HHHHHHHcCCCCC-----CCccc----hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 2 1223334443321 11222 24577899999999999999999999999864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=401.27 Aligned_cols=248 Identities=24% Similarity=0.282 Sum_probs=210.1
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
+|+.++.||+|+||+||+|+...+++.||||++... .....+++.+|+.+|++++||||+++++++.+++.+++|||
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~e 85 (337)
T d1o6la_ 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccccee
Confidence 588999999999999999999999999999999653 23456789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
||++|+|..++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 86 y~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~- 159 (337)
T d1o6la_ 86 YANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG- 159 (337)
T ss_dssp CCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-
T ss_pred ccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccCC-
Confidence 999999999998754 48889999999999999999998 999999999999999999999999999998654322
Q ss_pred ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
......+||+.|||||++.+..++.++||||+||++|||++|+.||...+... +.+....+.. .+...+++
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~~~~i~~~~~------~~p~~~s~ 230 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFELILMEEI------RFPRTLSP 230 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHCCC------CCCTTSCH
T ss_pred cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH---HHHHHhcCCC------CCCccCCH
Confidence 23445789999999999999999999999999999999999999998755432 2222333321 12233333
Q ss_pred HHHHHHHHHhhhccCCCCCCCCC-----HHHHHHH
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRPS-----MRQVVQY 603 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 603 (660)
.+.+++..||+.||.+||+ ++|++++
T Consensus 231 ----~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 231 ----EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ----HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----HHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 3567888899999999995 8888863
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.5e-47 Score=397.63 Aligned_cols=244 Identities=21% Similarity=0.298 Sum_probs=206.8
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEe
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYD 413 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 413 (660)
+|+.++.||+|+||+||+|++..+|+.||||++... .....+.+.+|+.++++++|||||++++++.+++.+++|||
T Consensus 5 dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 84 (316)
T d1fota_ 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 84 (316)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEee
Confidence 588999999999999999999999999999999643 23456789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCC
Q 006112 414 YMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGND 493 (660)
Q Consensus 414 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~ 493 (660)
||+||+|..++.... .+++..+..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+.....
T Consensus 85 ~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 85 YIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp CCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred ecCCccccccccccc--cccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence 999999999987765 37888889999999999999998 99999999999999999999999999999876432
Q ss_pred ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcH
Q 006112 494 LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVE 573 (660)
Q Consensus 494 ~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 573 (660)
....+||+.|||||++.+..++.++||||+||++|||++|+.||....... .......+.. .+....+
T Consensus 158 --~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~i~~~~~------~~p~~~s- 225 (316)
T d1fota_ 158 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK---TYEKILNAEL------RFPPFFN- 225 (316)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHHCCC------CCCTTSC-
T ss_pred --cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH---HHHHHHcCCC------CCCCCCC-
Confidence 234689999999999999999999999999999999999999998654322 2222222221 1112222
Q ss_pred HHHHHHHHHhhhccCCCCCCCC-----CHHHHHH
Q 006112 574 EQMEIVLKLGLFCSHSNPDTRP-----SMRQVVQ 602 (660)
Q Consensus 574 ~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 602 (660)
..+.+++.+||+.||.+|| |++|+++
T Consensus 226 ---~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 226 ---EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ---HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ---HHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 3466788889999999996 8999986
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=396.33 Aligned_cols=260 Identities=25% Similarity=0.288 Sum_probs=201.3
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecC----eeEEEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKG----ELLLVY 412 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~lV~ 412 (660)
+|...++||+|+||.||+|++ +|+.||||++..... ....+..|+..+.+++|||||+++++|.+++ .+++||
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 466778899999999999998 578999999854321 1222344556667889999999999998764 589999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhc-----ccCceeccCccCCcEEEcCCCCeEEeeccccee
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEE-----WEQVVLHRDIKPANVLLDADLEGKLGDFGLARL 487 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 487 (660)
|||++|+|.++|++. .++|.++++++.|+|.||+|||+. ++++|+||||||+||||+.++.+||+|||+++.
T Consensus 81 Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 999999999999864 489999999999999999999973 247999999999999999999999999999998
Q ss_pred ccCCCCc---eeeccccCccccCcccccCCC------CCcceeEEehHHHHHHHhhCCCCCCCCC------------cch
Q 006112 488 YDHGNDL---HTTNVVGTVGYLAPELLRNGR------GTTSTDVYAFGVFMLEVACGRRPVQPGE------------LDL 546 (660)
Q Consensus 488 ~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~------~t~ksDV~S~Gvvl~elltG~~p~~~~~------------~~~ 546 (660)
....... ......||+.|||||++.+.. ++.++|||||||+||||+||..|+.... ...
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 7654432 234568999999999987543 5679999999999999999988764311 111
Q ss_pred HHHHHHHHhcCCcccCCCCcccccC-cHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 547 LDWVIDYWQKGDVLDASDPRLEGIY-VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 547 ~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
.+........+ ..+|.+.... ..+....+.+|+.+||+.||++|||+.||++.|+.
T Consensus 238 ~~~~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~ 294 (303)
T d1vjya_ 238 VEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp HHHHHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHhcc----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 22222222221 1223332222 34566778999999999999999999999999874
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3e-47 Score=390.26 Aligned_cols=256 Identities=23% Similarity=0.280 Sum_probs=202.4
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHHHHHHHHHhccCCCCceeEeeeeeecC----eeE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKG----ELL 409 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~ 409 (660)
.|+.++.||+|+||+||+|++..+++.||||++.... ....+.|.+|++++++++||||+++++++...+ ..+
T Consensus 8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 87 (277)
T d1o6ya_ 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 87 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence 4889999999999999999999999999999997542 334567999999999999999999999987654 379
Q ss_pred EEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceecc
Q 006112 410 LVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYD 489 (660)
Q Consensus 410 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 489 (660)
+|||||+||+|.+++.... .+++.++..++.||++||+|||+ ++|+||||||+|||++.++..+|+|||.++...
T Consensus 88 lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 88 IVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp EEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred EEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhhhc
Confidence 9999999999999987654 48999999999999999999998 999999999999999999999999999997654
Q ss_pred CCCC--ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcc
Q 006112 490 HGND--LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL 567 (660)
Q Consensus 490 ~~~~--~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 567 (660)
.... .......||+.|||||++.+..++.++|||||||++|||+||+.||...... +........+...
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~~~~~~~~~~~~------- 233 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV--SVAYQHVREDPIP------- 233 (277)
T ss_dssp ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHCCCCC-------
T ss_pred cccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH--HHHHHHHhcCCCC-------
Confidence 4322 2334568999999999999999999999999999999999999999864432 2222222222111
Q ss_pred cccCcHHHHHHHHHHhhhccCCCCCCCC-CHHHHHHHhhC
Q 006112 568 EGIYVEEQMEIVLKLGLFCSHSNPDTRP-SMRQVVQYLDG 606 (660)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~ 606 (660)
...........+.+++.+|++.||++|| |++++++.|.+
T Consensus 234 ~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 234 PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 1111112234577888899999999999 89999988764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-47 Score=393.38 Aligned_cols=259 Identities=27% Similarity=0.375 Sum_probs=205.4
Q ss_pred CceeeecccccccCccEEEEEEEeCCCC---eEEEEEEeccC-CChhhHHHHHHHHHHhccCCCCceeEeeeeee-cCee
Q 006112 334 HRFSYKNLYKATKGGSGKVYRGVLPSSH---AEIAVKKVCHD-SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR-KGEL 408 (660)
Q Consensus 334 ~~~~~~~l~~lg~G~fg~Vy~g~~~~~~---~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~ 408 (660)
..+.+..-+.||+|+||+||+|++..++ ..||||++... .....++|.+|++++++++||||++++|+|.+ ++..
T Consensus 25 ~~~~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 104 (311)
T d1r0pa_ 25 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 104 (311)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEE
T ss_pred HHceeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCce
Confidence 3333333457999999999999986543 46999999754 44566889999999999999999999999875 4689
Q ss_pred EEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceec
Q 006112 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLY 488 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 488 (660)
++|||||++|+|.+++.... ..+++..+.+++.|+|+||.|||+ ++|+||||||+||||++++.+||+|||+++..
T Consensus 105 ~lv~E~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~ 180 (311)
T d1r0pa_ 105 LVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM 180 (311)
T ss_dssp EEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCT
T ss_pred EEEEEEeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhc
Confidence 99999999999999987543 458889999999999999999998 99999999999999999999999999999876
Q ss_pred cCCCCc---eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCC
Q 006112 489 DHGNDL---HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDP 565 (660)
Q Consensus 489 ~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 565 (660)
...... ......||+.|+|||.+.++.++.++||||||+++|||+||+.||..... ..+ +......+.... .|
T Consensus 181 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~-~~~-~~~~i~~g~~~~--~p 256 (311)
T d1r0pa_ 181 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-TFD-ITVYLLQGRRLL--QP 256 (311)
T ss_dssp TTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHTTCCCC--CC
T ss_pred cccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC-HHH-HHHHHHcCCCCC--Cc
Confidence 543221 22346789999999999999999999999999999999998888865321 111 112222332211 11
Q ss_pred cccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 566 RLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 566 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
. ...+.+.+++.+||+.||++||+|.||+++|+..
T Consensus 257 ---~----~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 257 ---E----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp ---T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---c----cCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1 1234577889999999999999999999999864
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-47 Score=393.97 Aligned_cols=257 Identities=24% Similarity=0.334 Sum_probs=199.1
Q ss_pred eeeecccccccCccEEEEEEEeCC-----CCeEEEEEEeccCC-ChhhHHHHHHHHHHhcc-CCCCceeEeeeeeec-Ce
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPS-----SHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRK-GE 407 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~-----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~-~~ 407 (660)
-+|+..+.||+|+||.||+|++.. +++.||||++.... ....+.+.+|+.++.++ +|+||+++++++.+. ..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 468889999999999999999743 34789999987543 34466788899888887 689999999998765 46
Q ss_pred eEEEEecCCCCChhhhhhhCC--------------CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcC
Q 006112 408 LLLVYDYMPNGSLDKILYSNT--------------RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDA 473 (660)
Q Consensus 408 ~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~ 473 (660)
+++|||||++|+|.+++.... ...++|.++..++.||++||+|||+ ++|+||||||+||||++
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeECC
Confidence 899999999999999997542 2358999999999999999999998 99999999999999999
Q ss_pred CCCeEEeecccceeccCCCCc-eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCC-CCCCCCCcchHHHHH
Q 006112 474 DLEGKLGDFGLARLYDHGNDL-HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGR-RPVQPGELDLLDWVI 551 (660)
Q Consensus 474 ~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~-~p~~~~~~~~~~~~~ 551 (660)
++.+||+|||+|+........ ......||+.|||||++.++.++.++|||||||++|||+||. .||...... +.+.
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~--~~~~ 247 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFC 247 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS--HHHH
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH--HHHH
Confidence 999999999999876544332 334568999999999999999999999999999999999975 466543322 2233
Q ss_pred HHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 552 DYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 552 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
.....+.... ..... ...+.+++.+||+.||++|||++||+++|+.
T Consensus 248 ~~~~~~~~~~-----~~~~~----~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 248 RRLKEGTRMR-----APDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp HHHHHTCCCC-----CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhcCCCCC-----CCccC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 3334443222 11222 2357788999999999999999999999975
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.3e-47 Score=387.19 Aligned_cols=251 Identities=26% Similarity=0.350 Sum_probs=207.3
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCCh---------hhHHHHHHHHHHhccC-CCCceeEeeeeeecC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDH---------GMKQFVSEIVSMGKLR-HRNLVQLRGYCRRKG 406 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~---------~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~ 406 (660)
+|+.++.||+|+||+||+|+...+++.||||++...... ..+.+.+|+.++++++ ||||+++++++.+++
T Consensus 4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 83 (277)
T d1phka_ 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 83 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence 588899999999999999999999999999999654321 2346889999999997 999999999999999
Q ss_pred eeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccce
Q 006112 407 ELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLAR 486 (660)
Q Consensus 407 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 486 (660)
.++||||||++|+|.++|.... .+++.++..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 84 ~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 84 FFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred ceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchhee
Confidence 9999999999999999997654 59999999999999999999998 999999999999999999999999999998
Q ss_pred eccCCCCceeeccccCccccCcccccC------CCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcc
Q 006112 487 LYDHGNDLHTTNVVGTVGYLAPELLRN------GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVL 560 (660)
Q Consensus 487 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 560 (660)
...... ..+...||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... ..+....+...
T Consensus 159 ~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~---~~~~i~~~~~~ 233 (277)
T d1phka_ 159 QLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---MLRMIMSGNYQ 233 (277)
T ss_dssp ECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHTCCC
T ss_pred EccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH---HHHHHHhCCCC
Confidence 875433 2345689999999999863 356889999999999999999999998754322 22222333221
Q ss_pred cCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 561 DASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 561 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
...+. ...+ ...+.+++.+||+.||++|||++||+++
T Consensus 234 -~~~~~-~~~~----s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 234 -FGSPE-WDDY----SDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp -CCTTT-GGGS----CHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred -CCCcc-cccC----CHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 11111 1122 2457788889999999999999999864
|
| >d1ioaa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]
Probab=100.00 E-value=2.5e-47 Score=378.37 Aligned_cols=216 Identities=27% Similarity=0.392 Sum_probs=186.1
Q ss_pred CCcceeeeCCCCC-CCeeEecceeEcCCCcEEecCCCC------CeeEEEEeCCCeeeccCCCCceeEEEEEEEEEecCC
Q 006112 25 QEENQFIHHGFEG-SKLKLDGLAKIHPNGLLQLTNTSE------RISGHAFYPFPFKFNSSSSQSLSFSTSFVFAMFPKL 97 (660)
Q Consensus 25 ~~~~~f~~~~f~~-~~l~~~g~a~~~~~g~l~Lt~~~~------~~~G~~~y~~pv~~~~~~~~~~sFst~F~F~i~~~~ 97 (660)
++.++|+|++|+. .+|+|+|||.+.++|.|+||++.. .++|||+|++||++|++ +.++||+|+|+|.|.+.+
T Consensus 1 a~~~sF~f~~F~~~~~l~l~GdA~i~~~g~l~LT~~~~~~~~~~~s~G~a~y~~Pv~l~~~-~~~~sFst~F~f~i~~~~ 79 (228)
T d1ioaa_ 1 ATETSFNFPNFHTDDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIKDS-NNVASFNTNFTFIIRAKN 79 (228)
T ss_dssp CCCCEEEESSCCTTSSEEEEETCEECTTSCEETTCBCTTSSBCSSCBEEEEESSCEECBCS-SCBEEEEEEEEEECCBSC
T ss_pred CccceEEcCCCCCCCcEEEeeeeEEcCCCEEEecCCCCCCccccceeEEEEECCceEecCC-CceeeEEEEEEEEEecCC
Confidence 3568999999976 469999999998889999998754 57899999999999984 578999999999999987
Q ss_pred CCCCCCceEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCeeEEEcCCccccccccccc
Q 006112 98 PNYGGHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARY 177 (660)
Q Consensus 98 ~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~ 177 (660)
...+||||||+|+|.+.. .+..|++||+++... ++..++.|||||||++|. +|++.+|||+++++..
T Consensus 80 ~~~~gDGlAF~l~~~~~~-~~~~g~~lgl~~~~~-~~~~~~~vave~dt~~n~--~~~~~~~~~~~~~~~~--------- 146 (228)
T d1ioaa_ 80 QSISAYGLAFALVPVNSP-PQKKQEFLGIFNTNN-PEPNARTVAVVFNTFKNR--IDFDKNFIKPYVNENC--------- 146 (228)
T ss_dssp TTSCCEEEEEEEEETTCC-CCCCGGGTTTCCCSS-CCGGGCCEEEEEETTTTE--EEEEESSSSCSEEEEC---------
T ss_pred CCCCCCEEEEEEeCCCCC-CCCCccccccccccC-CCCcceeEEEEecCcccc--ccCCCCccceeccccc---------
Confidence 778999999999997754 456889999998654 345789999999999885 5788888888776432
Q ss_pred cccccccccccccCCCccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeecccC---ceeee
Q 006112 178 FSDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATG---TRVSD 254 (660)
Q Consensus 178 ~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg---~~~~~ 254 (660)
...+.+|+.++|||+||+.+++|+|++.+. .+|..|+|++.+||+++|+++|||||||||| +..|.
T Consensus 147 ---------~~~~~~g~~~~v~I~Yd~~~~~l~V~l~~~--~~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~~~~ 215 (228)
T d1ioaa_ 147 ---------DFHKYNGEKTDVQITYDSSNNDLRVFLHFT--VSQVKCSVSATVHLEKEVDEWVSVGFSPTSGLTEDTTET 215 (228)
T ss_dssp ---------CHHHHCSSCEEEEEEEETTTTEEEEEEEET--TTCCEEEEEEECCGGGTSCSEEEEEEEEEECSSTTTCBC
T ss_pred ---------ccccccCcEEEEEEEEcCCCCEEEEEEEeC--CCCceeeEEEEEchHHcCCCcEEEEEEeecCCCCCCceE
Confidence 235678999999999999999999999864 3788899999999999999999999999999 45689
Q ss_pred eeecCcccccC
Q 006112 255 YYILGWSFNKS 265 (660)
Q Consensus 255 h~i~~wsf~~~ 265 (660)
|+|++|+|+++
T Consensus 216 h~I~sWsFss~ 226 (228)
T d1ioaa_ 216 HDVLSWSFSSK 226 (228)
T ss_dssp CEEEEEEEEEE
T ss_pred EEEEEEEeEEe
Confidence 99999999874
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=391.23 Aligned_cols=254 Identities=26% Similarity=0.337 Sum_probs=197.7
Q ss_pred eeecccccccCccEEEEEEEeCCC---CeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSS---HAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLL 410 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~---~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 410 (660)
+|+.++.||+|+||.||+|++... ...||||++... ..+..++|.+|++++++++||||++++|+|.+ +..++
T Consensus 9 d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~l 87 (273)
T d1u46a_ 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKM 87 (273)
T ss_dssp GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred HeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhe
Confidence 588899999999999999987432 347899998653 34556789999999999999999999999975 46789
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccC
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDH 490 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 490 (660)
|||||++|+|.+++.... ..+++..+.+++.|||.||.|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 88 v~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 999999999999886543 359999999999999999999998 8999999999999999999999999999998755
Q ss_pred CCCce--eeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHHHHHHHhcCCcccCCCCcc
Q 006112 491 GNDLH--TTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDWVIDYWQKGDVLDASDPRL 567 (660)
Q Consensus 491 ~~~~~--~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 567 (660)
..... .....||..|+|||.+.+..++.++|||||||++|||+| |+.||....... ......+.+...+ .
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~--~~~~i~~~~~~~~-----~ 236 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--ILHKIDKEGERLP-----R 236 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHTSCCCCC-----C
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH--HHHHHHhCCCCCC-----C
Confidence 43322 234568899999999999999999999999999999998 899997643322 2222223322211 1
Q ss_pred cccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 568 EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 568 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
.... ...+.+|+..||+.||++||||+||++.|+.
T Consensus 237 ~~~~----~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 237 PEDC----PQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cccc----cHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 1122 2457789999999999999999999999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-47 Score=397.07 Aligned_cols=262 Identities=22% Similarity=0.268 Sum_probs=206.9
Q ss_pred eeeccc-ccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhcc-CCCCceeEeeeeee----cCeeEE
Q 006112 337 SYKNLY-KATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRR----KGELLL 410 (660)
Q Consensus 337 ~~~~l~-~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~----~~~~~l 410 (660)
.|+.+. .||+|+||+||+|++..+++.||||++.. .+.+.+|++++.++ +|||||++++++.+ +..+++
T Consensus 12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~i 86 (335)
T d2ozaa1 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 86 (335)
T ss_dssp TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEE
Confidence 577775 49999999999999999999999999853 24677899987655 89999999999865 466899
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcC---CCCeEEeeccccee
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDA---DLEGKLGDFGLARL 487 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~---~~~~kl~DFGla~~ 487 (660)
|||||+||+|.++|.......+++.++..++.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||+|+.
T Consensus 87 vmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~ 163 (335)
T d2ozaa1 87 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163 (335)
T ss_dssp EEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccceeee
Confidence 9999999999999987655579999999999999999999998 99999999999999976 45799999999987
Q ss_pred ccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcch-HHHHHHHHhcCCcccCCCCc
Q 006112 488 YDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDL-LDWVIDYWQKGDVLDASDPR 566 (660)
Q Consensus 488 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~d~~ 566 (660)
...... .....||+.|||||++.+..++.++|||||||++|||+||+.||....... ..........+. ..
T Consensus 164 ~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~------~~ 235 (335)
T d2ozaa1 164 TTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ------YE 235 (335)
T ss_dssp CCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCS------SS
T ss_pred ccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCC------CC
Confidence 654332 345689999999999999899999999999999999999999997543221 121111111111 11
Q ss_pred ccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH--HhhCCCCCCCCC
Q 006112 567 LEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ--YLDGGALLPDIP 614 (660)
Q Consensus 567 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~~~p~~p 614 (660)
+...........+.+++..||+.||++|||+.|+++ ++......|..|
T Consensus 236 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~~~ 285 (335)
T d2ozaa1 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 285 (335)
T ss_dssp CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSSCCCE
T ss_pred CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCCCCCC
Confidence 111111233456788899999999999999999998 366555555544
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=389.59 Aligned_cols=261 Identities=26% Similarity=0.269 Sum_probs=201.0
Q ss_pred cccccccCccEEEEEEEeCCCCeEEEEEEeccCCC-----hhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 340 NLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD-----HGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 340 ~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~-----~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
.++.||+|+||+||+|++..+++.||||++..... ...+.+.+|++++++++|||||++++++..++.+++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 46789999999999999999999999999864422 2245789999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
|.++++..+.... ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~~~~~~~~~--~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~- 155 (299)
T d1ua2a_ 82 METDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR- 155 (299)
T ss_dssp CSEEHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred hcchHHhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence 9888877666433 358999999999999999999998 9999999999999999999999999999987654332
Q ss_pred eeeccccCccccCcccccCC-CCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHHHHHHhcCCcccCCC--------
Q 006112 495 HTTNVVGTVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVIDYWQKGDVLDASD-------- 564 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~~~~~~~~~~~d-------- 564 (660)
.....+||+.|+|||++... .++.++|||||||++|||++|+.||..... +....+.+...........+
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh
Confidence 22346799999999998754 579999999999999999999999976432 22233332221111100000
Q ss_pred --CcccccC----cHHHHHHHHHHhhhccCCCCCCCCCHHHHHH--HhhC
Q 006112 565 --PRLEGIY----VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ--YLDG 606 (660)
Q Consensus 565 --~~l~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~ 606 (660)
....... .....+.+.+++.+||+.||++|||++|+++ +|+.
T Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence 0000000 0112245788899999999999999999997 4653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=392.04 Aligned_cols=254 Identities=26% Similarity=0.346 Sum_probs=203.0
Q ss_pred eeecccccccCccEEEEEEEeCCCCe--EEEEEEeccC-CChhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCeeEEEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHA--EIAVKKVCHD-SDHGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
+|+..+.||+|+||+||+|++..++. .||||++... ..+..++|.+|+++++++ +|||||+++|+|.+++.+++||
T Consensus 11 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ 90 (309)
T d1fvra_ 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 90 (309)
T ss_dssp GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEE
Confidence 45667889999999999999987775 5788887543 444667899999999999 7999999999999999999999
Q ss_pred ecCCCCChhhhhhhC--------------CCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeE
Q 006112 413 DYMPNGSLDKILYSN--------------TRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGK 478 (660)
Q Consensus 413 E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~k 478 (660)
|||++|+|.++|+.. ....++|.++.+++.|||.||.|||+ ++|+||||||+|||++.++.+|
T Consensus 91 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~k 167 (309)
T d1fvra_ 91 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAK 167 (309)
T ss_dssp CCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEE
T ss_pred EecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCceE
Confidence 999999999999754 23569999999999999999999998 8999999999999999999999
Q ss_pred EeecccceeccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCC-CCCCCCcchHHHHHHHHhcC
Q 006112 479 LGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRR-PVQPGELDLLDWVIDYWQKG 557 (660)
Q Consensus 479 l~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~-p~~~~~~~~~~~~~~~~~~~ 557 (660)
|+|||+++....... .....||..|+|||.+.++.++.++|||||||++|||++|.. ||..... ..+......+
T Consensus 168 l~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~---~~~~~~i~~~ 242 (309)
T d1fvra_ 168 IADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYEKLPQG 242 (309)
T ss_dssp ECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHGGGT
T ss_pred Ecccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH---HHHHHHHHhc
Confidence 999999986543222 234568999999999999999999999999999999999765 5654332 2223333333
Q ss_pred CcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 558 DVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 558 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
.. +..... ..+.+.+|+.+||+.||++||||+||++.|+..
T Consensus 243 ~~-----~~~~~~----~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 243 YR-----LEKPLN----CDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp CC-----CCCCTT----BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC-----CCCCcc----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 22 111112 234577888999999999999999999998764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.5e-46 Score=393.45 Aligned_cols=245 Identities=20% Similarity=0.237 Sum_probs=207.8
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
-.|+.++.||+|+||.||+|++..+|+.||||++... .....+.+.+|++++++++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 3699999999999999999999999999999998643 2344578999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
||+.+|+|..++.... .+++.++..++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred ccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 9999999999997654 48999999999999999999998 99999999999999999999999999999876432
Q ss_pred CceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCc
Q 006112 493 DLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 493 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
.....||+.|||||++.+..++.++|||||||++|||+||+.||...... ........+.. .....++
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~~i~~~~~------~~p~~~s 262 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI---QIYEKIVSGKV------RFPSHFS 262 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCC------CCCTTCC
T ss_pred ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH---HHHHHHhcCCC------CCCccCC
Confidence 23468999999999999999999999999999999999999999865432 22222222221 1122222
Q ss_pred HHHHHHHHHHhhhccCCCCCCCC-----CHHHHHH
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRP-----SMRQVVQ 602 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 602 (660)
..+.+++..||+.||.+|+ |++|+++
T Consensus 263 ----~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 263 ----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----HHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 3466788889999999994 8999986
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.8e-46 Score=398.52 Aligned_cols=248 Identities=20% Similarity=0.234 Sum_probs=202.2
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC---ChhhHHH---HHHHHHHhccCCCCceeEeeeeeecCeeEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS---DHGMKQF---VSEIVSMGKLRHRNLVQLRGYCRRKGELLL 410 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~---~~~~~~~---~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 410 (660)
+|+.++.||+|+||.||+|++..+|+.||||++.... ......+ .+|+++++.++|||||++++++.+++.+++
T Consensus 5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~i 84 (364)
T d1omwa3 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 84 (364)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEE
Confidence 5888999999999999999999999999999985321 1122233 345778888899999999999999999999
Q ss_pred EEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccC
Q 006112 411 VYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDH 490 (660)
Q Consensus 411 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~ 490 (660)
|||||++|+|.++|.... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+....
T Consensus 85 vmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 85 ILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 999999999999997654 48889999999999999999998 9999999999999999999999999999987654
Q ss_pred CCCceeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccc
Q 006112 491 GNDLHTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEG 569 (660)
Q Consensus 491 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 569 (660)
.. .....||+.|||||++.. ..++.++|||||||++|||+||+.||..........+....... .+.+..
T Consensus 160 ~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~------~~~~~~ 230 (364)
T d1omwa3 160 KK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM------AVELPD 230 (364)
T ss_dssp SC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSC------CCCCCS
T ss_pred Cc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC------CCCCCC
Confidence 32 344689999999999875 46899999999999999999999999875444333333222111 111222
Q ss_pred cCcHHHHHHHHHHhhhccCCCCCCCCC-----HHHHHH
Q 006112 570 IYVEEQMEIVLKLGLFCSHSNPDTRPS-----MRQVVQ 602 (660)
Q Consensus 570 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 602 (660)
.++ ..+.+++..||+.||++||| ++|+++
T Consensus 231 ~~s----~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 231 SFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp SSC----HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCC----HHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 233 34677888899999999999 688885
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=390.41 Aligned_cols=258 Identities=28% Similarity=0.393 Sum_probs=208.9
Q ss_pred ceeeecccccccCccEEEEEEEeCCCC-------eEEEEEEeccCCC-hhhHHHHHHHHHHhcc-CCCCceeEeeeeeec
Q 006112 335 RFSYKNLYKATKGGSGKVYRGVLPSSH-------AEIAVKKVCHDSD-HGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRK 405 (660)
Q Consensus 335 ~~~~~~l~~lg~G~fg~Vy~g~~~~~~-------~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~ 405 (660)
+-+|+..+.||+|+||.||+|+....+ ..||||++..+.. ....++.+|...+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 347888999999999999999875433 5799999976544 4567899999999888 899999999999999
Q ss_pred CeeEEEEecCCCCChhhhhhhCC--------------CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEE
Q 006112 406 GELLLVYDYMPNGSLDKILYSNT--------------RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLL 471 (660)
Q Consensus 406 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll 471 (660)
+.+++|||||++|+|.++|.... ...+++.++++++.||+.||+|||+ ++||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceee
Confidence 99999999999999999997543 2358999999999999999999998 999999999999999
Q ss_pred cCCCCeEEeecccceeccCCCCc-eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhh-CCCCCCCCCcchHHH
Q 006112 472 DADLEGKLGDFGLARLYDHGNDL-HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVAC-GRRPVQPGELDLLDW 549 (660)
Q Consensus 472 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~ 549 (660)
+.++.+||+|||+++........ ......||+.|+|||.+.++.++.++|||||||++|||++ |+.||...... .
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---~ 245 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---E 245 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---H
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH---H
Confidence 99999999999999877654332 3345678999999999999999999999999999999998 67787654432 3
Q ss_pred HHHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 550 VIDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 550 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
+.+.+..+.... ....+ ...+.+|+.+||+.||++|||+.||++.|++.
T Consensus 246 ~~~~i~~~~~~~-----~p~~~----~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 246 LFKLLKEGHRMD-----KPSNC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp HHHHHHTTCCCC-----CCSSC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHcCCCCC-----CCccc----hHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 334444443222 11222 24578899999999999999999999999753
|
| >d1avba_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=8.5e-47 Score=374.25 Aligned_cols=216 Identities=27% Similarity=0.434 Sum_probs=191.9
Q ss_pred CcceeeeCCCCCCCeeEecceeEcCCCcEEecCC---CCCeeEEEEeCCCeeeccCC-CCceeEEEEEEEEEecCCCCCC
Q 006112 26 EENQFIHHGFEGSKLKLDGLAKIHPNGLLQLTNT---SERISGHAFYPFPFKFNSSS-SQSLSFSTSFVFAMFPKLPNYG 101 (660)
Q Consensus 26 ~~~~f~~~~f~~~~l~~~g~a~~~~~g~l~Lt~~---~~~~~G~~~y~~pv~~~~~~-~~~~sFst~F~F~i~~~~~~~~ 101 (660)
++++|+|++|+.+||+|+|||.+.++|.||||+. ..+++|||+|++||+||++. +.++||+|+|+|.|.+.....+
T Consensus 2 ~~~sf~f~~F~~~nl~l~GdA~v~~~g~i~LT~~~~~~~~~~G~~~y~~Pv~l~~~~~~~~~sF~t~f~f~i~~~~~~~~ 81 (226)
T d1avba_ 2 NDASFNVETFNKTNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQINDRTIDNLASFSTNFTFRINAKNIENS 81 (226)
T ss_dssp EEEEEEESSCCGGGEEEEETCEECTTSCEECSCSSSCCTTCEEEEEESSCEECEEGGGTEEEEEEEEEEEEEEESSTTSC
T ss_pred CceEEECCCCCccceeEecceEECCCCeEEccCCCCCCccceEEEEeCCCeEcccCCCCcccceEEEEEEEEecCCCCCC
Confidence 4689999999989999999999988899999974 45789999999999999987 7889999999999999888889
Q ss_pred CCceEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCeeEEEcCCccccccccccccccc
Q 006112 102 GHGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDE 181 (660)
Q Consensus 102 g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~ 181 (660)
||||||+|+|....+ +..||++|+++. ++|||||+.|...+|+.+||||||+|+..+..+.+..
T Consensus 82 gDG~aF~i~~~~~~~-g~~gg~~gl~~~----------~~v~fdt~~~~~~~d~~~nhi~i~~n~~~s~~~~~~~----- 145 (226)
T d1avba_ 82 AYGLAFALVPVGSRP-KLKGRYLGLFNT----------TNYDRDAHTVAVVFDTVSNRIEIDVNSIRPIATESCN----- 145 (226)
T ss_dssp CEEEEEEEEETTCCC-CCCGGGTTTCSC----------SSCCGGGCCEEEEEETTTTEEEEEESSSSCSEEEECC-----
T ss_pred CceEEEEEccCCCCC-CCccccCCcccc----------ccccccceeccccccCCCCEEEEeCCCCccccccccc-----
Confidence 999999999987544 467889999764 3699999998766799999999999999887776543
Q ss_pred cccccccccCCCccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeecccCc---eeeeeeec
Q 006112 182 KKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGT---RVSDYYIL 258 (660)
Q Consensus 182 ~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg~---~~~~h~i~ 258 (660)
..+.+|+.++|||+||+.+++|+|++.+.+ +|..|.++..+||+.+||++|||||||+||. ..|.|+|+
T Consensus 146 ------~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~~~~~vdL~~~l~~~~y~GFSAaTG~~s~~~~~H~Il 217 (226)
T d1avba_ 146 ------FGHNNGEKAEVRITYDSPKNDLRVSLLYPS--SEEKCHVSATVPLEKEVEDWVSVGFSATSGSKKETTETHNVL 217 (226)
T ss_dssp ------SGGGTTCEEEEEEEEEGGGTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEEEEEEEECSSGGGCEEEEEE
T ss_pred ------cccCCCeEEEEEEEEcCCCcEEEEEEEeCC--CCccEEEEEEecHHHccCCcEEEEEEEEcCCCCCCeeeeEEE
Confidence 457799999999999999999999998754 6778889999999999999999999999995 56899999
Q ss_pred CcccccC
Q 006112 259 GWSFNKS 265 (660)
Q Consensus 259 ~wsf~~~ 265 (660)
+|+|+++
T Consensus 218 sWsF~s~ 224 (226)
T d1avba_ 218 SWSFSSN 224 (226)
T ss_dssp EEEEEEE
T ss_pred EEEeEEe
Confidence 9999874
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-46 Score=389.27 Aligned_cols=254 Identities=20% Similarity=0.261 Sum_probs=208.7
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEecCC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDYMP 416 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 416 (660)
.|+.++.||+|+||+||+|++..+++.||||.+.... .....+.+|+++|++++|||||++++++.+++.+++|||||+
T Consensus 6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~ 84 (321)
T d1tkia_ 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCC
Confidence 4889999999999999999999999999999996543 334568899999999999999999999999999999999999
Q ss_pred CCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCC--CCeEEeecccceeccCCCCc
Q 006112 417 NGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDAD--LEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 417 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~--~~~kl~DFGla~~~~~~~~~ 494 (660)
||+|.+++.... ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.+ ..+||+|||+++......
T Consensus 85 gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~-- 158 (321)
T d1tkia_ 85 GLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-- 158 (321)
T ss_dssp CCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--
T ss_pred CCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccCC--
Confidence 999999997543 358999999999999999999998 999999999999999854 579999999998764432
Q ss_pred eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCcHH
Q 006112 495 HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYVEE 574 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 574 (660)
......||+.|+|||.+.+..++.++||||+||++|||++|+.||....... +......+... +.......
T Consensus 159 ~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~---~~~~i~~~~~~------~~~~~~~~ 229 (321)
T d1tkia_ 159 NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---IIENIMNAEYT------FDEEAFKE 229 (321)
T ss_dssp EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHHTCCC------CCHHHHTT
T ss_pred cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhCCCC------CChhhccC
Confidence 2344678999999999999999999999999999999999999998654322 22222222110 11100011
Q ss_pred HHHHHHHHhhhccCCCCCCCCCHHHHHH--HhhC
Q 006112 575 QMEIVLKLGLFCSHSNPDTRPSMRQVVQ--YLDG 606 (660)
Q Consensus 575 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~ 606 (660)
....+.+++..|++.||++|||++|+++ +++.
T Consensus 230 ~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 230 ISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 1234678889999999999999999998 4654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-46 Score=388.80 Aligned_cols=257 Identities=24% Similarity=0.317 Sum_probs=209.6
Q ss_pred eeeecccccccCccEEEEEEEeC-----CCCeEEEEEEeccCCC-hhhHHHHHHHHHHhcc-CCCCceeEeeeeeecCee
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLP-----SSHAEIAVKKVCHDSD-HGMKQFVSEIVSMGKL-RHRNLVQLRGYCRRKGEL 408 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~-----~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 408 (660)
-+|+..+.||+|+||.||+|++. ..++.||||++..... ....+|.+|+.+++++ +|||||+++|+|.+++..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 36777899999999999999863 4567999999976543 3456799999999999 699999999999999999
Q ss_pred EEEEecCCCCChhhhhhhCC----------------CCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEc
Q 006112 409 LLVYDYMPNGSLDKILYSNT----------------RPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLD 472 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~ 472 (660)
++|||||++|+|.++++... ...+++..+.+++.||++||+|||+ ++|+||||||+|||++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccccccccccc
Confidence 99999999999999997543 2358999999999999999999998 9999999999999999
Q ss_pred CCCCeEEeecccceeccCCCC-ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCC-CCCCCcchHHHH
Q 006112 473 ADLEGKLGDFGLARLYDHGND-LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRP-VQPGELDLLDWV 550 (660)
Q Consensus 473 ~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p-~~~~~~~~~~~~ 550 (660)
.++.+||+|||+++....... .......||+.|+|||.+.++.++.++|||||||++|||+|+..| +...... +.+
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~--~~~ 257 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD--SKF 257 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--HHH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH--HHH
Confidence 999999999999997765433 333457899999999999999999999999999999999995555 4433222 112
Q ss_pred HHHHhcCCcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 551 IDYWQKGDVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 551 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
.+....+... .... .....+.+|+.+||+.||++||||.||++.|+.
T Consensus 258 ~~~i~~~~~~-----~~~~----~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 258 YKMIKEGFRM-----LSPE----HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp HHHHHHTCCC-----CCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHhcCCCC-----CCcc----cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 2222333211 1111 123457888999999999999999999999975
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-46 Score=386.56 Aligned_cols=257 Identities=25% Similarity=0.389 Sum_probs=210.1
Q ss_pred eeeecccccccCccEEEEEEEeCC-----CCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPS-----SHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELL 409 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~-----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 409 (660)
-+|+..++||+|+||+||+|++.. .++.||||++.... .+....|.+|++++++++|||||+++|+|..++..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 367788999999999999998842 35789999996543 344567999999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhhhC--------CCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEee
Q 006112 410 LVYDYMPNGSLDKILYSN--------TRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGD 481 (660)
Q Consensus 410 lV~E~~~~gsL~~~l~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~D 481 (660)
+|||||++|+|.+++... ....+++.++.+++.|+|+||.|||+ ++|+||||||+|||+++++++||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEee
Confidence 999999999999988642 22347899999999999999999998 8999999999999999999999999
Q ss_pred cccceeccCCCCc-eeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCC-CCCCCCCcchHHHHHHHHhcCCc
Q 006112 482 FGLARLYDHGNDL-HTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGR-RPVQPGELDLLDWVIDYWQKGDV 559 (660)
Q Consensus 482 FGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~-~p~~~~~~~~~~~~~~~~~~~~~ 559 (660)
||+++........ ......||+.|+|||.+.++.++.++|||||||++|||+||+ .||...... .+......+..
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~---~~~~~i~~~~~ 253 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---QVLRFVMEGGL 253 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---HHHHHHHTTCC
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHhCCC
Confidence 9999876543332 233457899999999999999999999999999999999986 556543221 22333334433
Q ss_pred ccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhCC
Q 006112 560 LDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDGG 607 (660)
Q Consensus 560 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 607 (660)
.+.. .. ....+.+++.+||+.||++||||+||++.|+..
T Consensus 254 ~~~p-----~~----~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 254 LDKP-----DN----CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp CCCC-----TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred CCCc-----cc----chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 2211 12 234588899999999999999999999999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=392.66 Aligned_cols=247 Identities=23% Similarity=0.339 Sum_probs=206.2
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccC---CChhhHHHHHHHHHHh-ccCCCCceeEeeeeeecCeeEEEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD---SDHGMKQFVSEIVSMG-KLRHRNLVQLRGYCRRKGELLLVY 412 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~-~l~H~nIv~l~g~~~~~~~~~lV~ 412 (660)
+|+.++.||+|+||+||+|++..+++.||||++... .....+.+..|..++. .++|||||++++++.+++.+++||
T Consensus 3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm 82 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 82 (320)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence 588899999999999999999999999999999643 2344567778877765 689999999999999999999999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~ 492 (660)
|||++|+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||+++++++||+|||+++......
T Consensus 83 Ey~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 83 EYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred eecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence 9999999999997654 48889999999999999999998 899999999999999999999999999998654332
Q ss_pred CceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCcccccCc
Q 006112 493 DLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPRLEGIYV 572 (660)
Q Consensus 493 ~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 572 (660)
...+...||+.|+|||++.+..++.++|||||||++|||++|+.||....... +......+. +.+....+
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~~i~~~~------~~~p~~~s 227 (320)
T d1xjda_ 158 -AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFHSIRMDN------PFYPRWLE 227 (320)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHCC------CCCCTTSC
T ss_pred -ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH---HHHHHHcCC------CCCCccCC
Confidence 23445689999999999999999999999999999999999999998654332 233333332 22222232
Q ss_pred HHHHHHHHHHhhhccCCCCCCCCCHH-HHHH
Q 006112 573 EEQMEIVLKLGLFCSHSNPDTRPSMR-QVVQ 602 (660)
Q Consensus 573 ~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl~ 602 (660)
..+.+|+.+||+.||++||+++ |+++
T Consensus 228 ----~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 228 ----KEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ----HHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ----HHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 3467888889999999999996 7764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=381.51 Aligned_cols=263 Identities=24% Similarity=0.300 Sum_probs=204.3
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
+|+.++.||+|+||+||+|++..+++.||||++.... ....+++.+|++++++++|||||++++++.+++.+++||||
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~ 82 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 82 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEee
Confidence 6899999999999999999999999999999996543 23467899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
|. |++..++.......+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+...... .
T Consensus 83 ~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~ 157 (298)
T d1gz8a_ 83 LH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-R 157 (298)
T ss_dssp CS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-B
T ss_pred cC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCc-c
Confidence 96 455555555545569999999999999999999998 999999999999999999999999999998764432 2
Q ss_pred eeeccccCccccCcccccCCC-CCcceeEEehHHHHHHHhhCCCCCCCCCcch-HHHHHHHHhcCCcccCCCCc------
Q 006112 495 HTTNVVGTVGYLAPELLRNGR-GTTSTDVYAFGVFMLEVACGRRPVQPGELDL-LDWVIDYWQKGDVLDASDPR------ 566 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~-~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~d~~------ 566 (660)
......||+.|+|||.+.... ++.++||||+||++|||++|+.||....... ...+.... +...+...+.
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL--GTPDEVVWPGVTSMPD 235 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH--CCCCTTTSTTGGGSTT
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhc--CCCchhhccccccccc
Confidence 233467999999999876655 5789999999999999999999998644321 11112111 1111111000
Q ss_pred -------ccccC----cHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH--hhC
Q 006112 567 -------LEGIY----VEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY--LDG 606 (660)
Q Consensus 567 -------l~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~ 606 (660)
..... .......+.+++.+|++.||++|||++|++++ |+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~ 288 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhcc
Confidence 00000 01112456788889999999999999999985 654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-46 Score=378.25 Aligned_cols=240 Identities=25% Similarity=0.345 Sum_probs=197.9
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCC------hhhHHHHHHHHHHhccC--CCCceeEeeeeeecCee
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD------HGMKQFVSEIVSMGKLR--HRNLVQLRGYCRRKGEL 408 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~--H~nIv~l~g~~~~~~~~ 408 (660)
+|+..+.||+|+||+||+|++..+++.||||++..... ...+++.+|+.++++++ |||||++++++.+++..
T Consensus 5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~ 84 (273)
T d1xwsa_ 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 84 (273)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeE
Confidence 68889999999999999999999999999999864321 12345789999999986 89999999999999999
Q ss_pred EEEEecCCC-CChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCC-CCeEEeecccce
Q 006112 409 LLVYDYMPN-GSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDAD-LEGKLGDFGLAR 486 (660)
Q Consensus 409 ~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~-~~~kl~DFGla~ 486 (660)
++||||+.+ +++.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+|+
T Consensus 85 ~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 85 VLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccccce
Confidence 999999976 67888876543 48999999999999999999998 999999999999999854 789999999998
Q ss_pred eccCCCCceeeccccCccccCcccccCCCC-CcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCC
Q 006112 487 LYDHGNDLHTTNVVGTVGYLAPELLRNGRG-TTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDP 565 (660)
Q Consensus 487 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~ 565 (660)
..... ..+...||+.|+|||++.+..+ +.++||||+||++|||++|+.||...+ .+ ..+..
T Consensus 160 ~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i----~~~~~------ 221 (273)
T d1xwsa_ 160 LLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EI----IRGQV------ 221 (273)
T ss_dssp ECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HH----HHCCC------
T ss_pred ecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HH----hhccc------
Confidence 75432 2345689999999999987665 677999999999999999999997522 11 11111
Q ss_pred cccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 566 RLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 566 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.+...++ ..+.+++.+||+.||++|||++|++++
T Consensus 222 ~~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 222 FFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp CCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1222233 346778889999999999999999873
|
| >d1dhkb_ b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Phytohemagglutinin-L, PHA-L, also arcelin species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1.2e-44 Score=352.73 Aligned_cols=199 Identities=27% Similarity=0.418 Sum_probs=166.4
Q ss_pred CCcceeeeCCCCCCCeeEecceeEcCCCcEEecCCCCCeeEEEEeCCCeeeccCC-CCceeEEEEEEEEEecCCCCCCCC
Q 006112 25 QEENQFIHHGFEGSKLKLDGLAKIHPNGLLQLTNTSERISGHAFYPFPFKFNSSS-SQSLSFSTSFVFAMFPKLPNYGGH 103 (660)
Q Consensus 25 ~~~~~f~~~~f~~~~l~~~g~a~~~~~g~l~Lt~~~~~~~G~~~y~~pv~~~~~~-~~~~sFst~F~F~i~~~~~~~~g~ 103 (660)
+..++|+|++|+.+||+|+|||.+.++|.||||++.++++|||+|++||+||++. +.++||+|+|+|.|.+.+...+||
T Consensus 1 a~~~sF~~~~F~~~~l~l~GdA~v~~~g~i~LT~~~~~~~G~~~y~~Pi~l~~~~~~~~~sF~t~F~f~i~~~~~~~~gd 80 (204)
T d1dhkb_ 1 ATETSFIIDAFNKTNLILQGDATVSSNGNLQLSYNSYDSMSRAFYSAPIQIRDSTTGNVASFDTNFTMNIRTHRQANSAV 80 (204)
T ss_dssp CCCCEEEESSCCGGGEEEESSEEECTTSCEEESSSCSSEEEEEEESSCEESEETTTTEECEEEEEEEEEEECCC---CCS
T ss_pred CccceEECCCCCccCeeEecceEEcCCCeEEeCCCCCCCEEEEEeCCCEeccCCCCcccccEEEEEEEEEecCCCCCCCc
Confidence 3578999999998999999999998899999999999999999999999999987 788999999999999887777999
Q ss_pred ceEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCeeEEEcCCccccccccccccccccc
Q 006112 104 GMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKK 183 (660)
Q Consensus 104 GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~~~ 183 (660)
||||+++|... ...++.|||||||+.| |+++|+|+...... .
T Consensus 81 Glaf~~~~~~~-------------------~~~~~~~~vefDt~~n---------~~~~d~~~~~~~~~-~--------- 122 (204)
T d1dhkb_ 81 GLDFVLVPVQP-------------------ESKGDTVTVEFDTFLS---------RISIDVNNNDIKSV-P--------- 122 (204)
T ss_dssp EEEEEEEEC-------------------------CCEEEEEETTTT---------EEEEEETTEEEEEE-E---------
T ss_pred eEEEEecCCCC-------------------CCCCcEeeEeeEcccc---------cccCcccccccccc-c---------
Confidence 99999998532 1235789999999875 66666666433211 1
Q ss_pred cccccccCCCccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeecccCce---eeeeeecCc
Q 006112 184 EFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTR---VSDYYILGW 260 (660)
Q Consensus 184 ~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg~~---~~~h~i~~w 260 (660)
....+.+|+.++|||+||+.+++|+|++.+.+ +|..+.|++.+||+.+||++||||||||||.. .|+|+|++|
T Consensus 123 --~~~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~l~~~vdL~~~l~~~~yvGFSAaTG~~~~~~e~H~IlsW 198 (204)
T d1dhkb_ 123 --WDVHDYDGQNAEVRITYNSSTKVFSVSLSNPS--TGKSNNVSTTVELEKEVYDWVSVGFSATSGAYQWSYETHDVLSW 198 (204)
T ss_dssp --CCGGGTTTSCEEEEEEEETTTTEEEEEEECTT--TCCEEEEEEECCCCSGGGSEEEEEEEEEECSGGGSCCEEEEEEE
T ss_pred --cccEecCCCEEEEEEEEcCCCEEEEEEEecCC--CCCceeEEEEecchhccCCcEEEEEEeecCCCCCCceeeEEEEE
Confidence 13567799999999999999999999998754 56678899999999999999999999999953 588999999
Q ss_pred ccccC
Q 006112 261 SFNKS 265 (660)
Q Consensus 261 sf~~~ 265 (660)
+|+++
T Consensus 199 sFss~ 203 (204)
T d1dhkb_ 199 SFSSK 203 (204)
T ss_dssp EEEEE
T ss_pred EEEec
Confidence 99863
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=9.7e-45 Score=373.21 Aligned_cols=259 Identities=24% Similarity=0.316 Sum_probs=199.4
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
+|+.+++||+|+||+||+|+++ +++.||||++.... ....+++.+|+.++++++||||+++++++..++..+++|||
T Consensus 3 ~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp SEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5889999999999999999995 67899999996543 23367899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
+.++.+..+.... ..+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++....... .
T Consensus 82 ~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-R 155 (286)
T ss_dssp CSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCc-c
Confidence 9877777666443 459999999999999999999998 899999999999999999999999999998764432 2
Q ss_pred eeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCc-chHHHHHHHHhcCCcc------------
Q 006112 495 HTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGEL-DLLDWVIDYWQKGDVL------------ 560 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~-~~~~~~~~~~~~~~~~------------ 560 (660)
......|++.|+|||.+.. ..++.++||||+||++|||++|+.||..... +....+..........
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence 2334578999999999875 4568999999999999999999999976432 2222222211111000
Q ss_pred ---cCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 561 ---DASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 561 ---~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
....+.............+.+++.+|++.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000010001111122345778889999999999999999985
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-44 Score=372.36 Aligned_cols=261 Identities=25% Similarity=0.317 Sum_probs=198.5
Q ss_pred eeecccccccCccEEEEEEEeCCC-CeEEEEEEeccCC--ChhhHHHHHHHHHHhcc---CCCCceeEeeeeee-----c
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSS-HAEIAVKKVCHDS--DHGMKQFVSEIVSMGKL---RHRNLVQLRGYCRR-----K 405 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~-~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l---~H~nIv~l~g~~~~-----~ 405 (660)
+|+.+++||+|+||+||+|++..+ ++.||||++.... ......+.+|+.+++.+ +||||++++++|.. .
T Consensus 8 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~ 87 (305)
T d1blxa_ 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 87 (305)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred CEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccC
Confidence 689999999999999999998654 6789999986532 23345677888877766 79999999999853 3
Q ss_pred CeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccc
Q 006112 406 GELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLA 485 (660)
Q Consensus 406 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla 485 (660)
..++++||||.++++..... .....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 88 TKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp EEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred ceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchhhh
Confidence 46899999998877765443 334568999999999999999999998 99999999999999999999999999999
Q ss_pred eeccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcc-hHHHHHHHHhcCCccc---
Q 006112 486 RLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELD-LLDWVIDYWQKGDVLD--- 561 (660)
Q Consensus 486 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~--- 561 (660)
+..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ....+...........
T Consensus 164 ~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (305)
T d1blxa_ 164 RIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241 (305)
T ss_dssp CCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred hhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccc
Confidence 865332 2334578999999999999999999999999999999999999999864432 2222222211110000
Q ss_pred ----------CCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 562 ----------ASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 562 ----------~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
...+.....+.....+.+.+|+.+||+.||++|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000011111223456678888999999999999999874
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-44 Score=376.74 Aligned_cols=263 Identities=26% Similarity=0.289 Sum_probs=198.6
Q ss_pred CCCceeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeeeeeec------
Q 006112 332 SPHRFSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK------ 405 (660)
Q Consensus 332 ~~~~~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------ 405 (660)
.|...+|+.++.||+|+||+||+|++..+++.||||++..... ...+|+++|++++||||+++++++...
T Consensus 16 ~~~~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 16 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp CCEEEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred CcccCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence 3556799999999999999999999999999999999965432 234799999999999999999998543
Q ss_pred CeeEEEEecCCCCChhhhhhh-CCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCC-CeEEeecc
Q 006112 406 GELLLVYDYMPNGSLDKILYS-NTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADL-EGKLGDFG 483 (660)
Q Consensus 406 ~~~~lV~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~-~~kl~DFG 483 (660)
..++||||||+++.+..+... .....+++.++..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG 168 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFG 168 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCT
T ss_pred eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEeccc
Confidence 347999999976654444321 233469999999999999999999998 9999999999999999775 89999999
Q ss_pred cceeccCCCCceeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCcc-hHHHHHHHHhc-----
Q 006112 484 LARLYDHGNDLHTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGELD-LLDWVIDYWQK----- 556 (660)
Q Consensus 484 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~~~~~~~~----- 556 (660)
+++....... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...... ....+.+....
T Consensus 169 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 246 (350)
T d1q5ka_ 169 SAKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246 (350)
T ss_dssp TCEECCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred chhhccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHh
Confidence 9987654432 234679999999998765 56899999999999999999999999764322 11111111000
Q ss_pred -----CCcccCCCCcc-----cccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 557 -----GDVLDASDPRL-----EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 557 -----~~~~~~~d~~l-----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
....+..-+.. ...........+.+|+.+||+.||++|||++|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00001111111 111112223457788889999999999999999963
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=369.15 Aligned_cols=261 Identities=26% Similarity=0.331 Sum_probs=198.6
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeee--------c
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR--------K 405 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~--------~ 405 (660)
-+|+.+++||+|+||+||+|++..+|+.||||++... .....+++.+|+++|++++||||+++++++.. +
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 4789999999999999999999999999999998544 33456789999999999999999999998855 3
Q ss_pred CeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccc
Q 006112 406 GELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLA 485 (660)
Q Consensus 406 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla 485 (660)
+.+++|||||.++.+..+... ...++...+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeeccee
Confidence 468999999988777655443 3358888999999999999999998 99999999999999999999999999999
Q ss_pred eeccCCCC---ceeeccccCccccCcccccCC-CCCcceeEEehHHHHHHHhhCCCCCCCCCcchH-HHHHHHHhcCCcc
Q 006112 486 RLYDHGND---LHTTNVVGTVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQPGELDLL-DWVIDYWQKGDVL 560 (660)
Q Consensus 486 ~~~~~~~~---~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~ 560 (660)
+....... .......||+.|+|||.+.+. .++.++||||+||++|||++|+.||........ ..+.+.. +...
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~--~~~~ 242 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC--GSIT 242 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH--CCCC
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhc--CCCC
Confidence 87654322 122335799999999998754 689999999999999999999999986443222 2222221 1111
Q ss_pred cCCCCcc--------------cccCcHHH------HHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 561 DASDPRL--------------EGIYVEEQ------MEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 561 ~~~d~~l--------------~~~~~~~~------~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
....... ......+. ...+.+|+.+||+.||++|||++|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 1110000 00001111 1245678999999999999999999974
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-43 Score=372.19 Aligned_cols=261 Identities=23% Similarity=0.298 Sum_probs=197.6
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccC--CChhhHHHHHHHHHHhccCCCCceeEeeeeeecC------e
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD--SDHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKG------E 407 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~------~ 407 (660)
-.|+.++.||+|+||+||+|++..+++.||||++... .....+++.+|+++|++++|||||+++++|...+ .
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 3689999999999999999999999999999999653 2334678999999999999999999999997654 5
Q ss_pred eEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeeccccee
Q 006112 408 LLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARL 487 (660)
Q Consensus 408 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 487 (660)
+++||||| +.+|..++... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.
T Consensus 98 ~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 98 FYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp CEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccceec
Confidence 79999999 67888877543 49999999999999999999998 9999999999999999999999999999987
Q ss_pred ccCCCCceeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCcchH-HHHHHHHhcC--------
Q 006112 488 YDHGNDLHTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLL-DWVIDYWQKG-------- 557 (660)
Q Consensus 488 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~-~~~~~~~~~~-------- 557 (660)
.... .+...||+.|+|||.+.+ ..++.++||||+||++|||++|+.||........ ..........
T Consensus 171 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (346)
T d1cm8a_ 171 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 246 (346)
T ss_dssp CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred cCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence 6432 345679999999999876 4568999999999999999999999976443211 1111100000
Q ss_pred ----------CcccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH--hhCCC
Q 006112 558 ----------DVLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY--LDGGA 608 (660)
Q Consensus 558 ----------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~~ 608 (660)
...+.....+. .........+.+|+.+||+.||++|||++|++++ |+...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 247 QSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp SCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred cchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 00000000000 0111122346678889999999999999999984 66543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-43 Score=372.38 Aligned_cols=265 Identities=25% Similarity=0.285 Sum_probs=199.4
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC-ChhhHHHHHHHHHHhccCCCCceeEeeeeeecC----eeEEE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS-DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKG----ELLLV 411 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~lV 411 (660)
.|+.++.||+|+||+||+|++..+++.||||++.... ....+++++|+++|++++||||+++++++.... ..+++
T Consensus 9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l 88 (345)
T d1pmea_ 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL 88 (345)
T ss_dssp TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence 3899999999999999999999999999999997543 344678999999999999999999999987653 23455
Q ss_pred EecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCC
Q 006112 412 YDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHG 491 (660)
Q Consensus 412 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~ 491 (660)
++|+.+|+|.+++... .+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 89 VTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 5666799999999754 48999999999999999999998 99999999999999999999999999999876443
Q ss_pred CC--ceeeccccCccccCcccccC-CCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHH-HHHHHhcCCccc------
Q 006112 492 ND--LHTTNVVGTVGYLAPELLRN-GRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDW-VIDYWQKGDVLD------ 561 (660)
Q Consensus 492 ~~--~~~~~~~gt~~Y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-~~~~~~~~~~~~------ 561 (660)
.. .......||+.|+|||++.. ..++.++||||+||++|||++|+.||.........+ ............
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence 22 12345679999999999854 567899999999999999999999997654322111 111111100000
Q ss_pred -------CCCCccccc----CcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH--hhCC
Q 006112 562 -------ASDPRLEGI----YVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY--LDGG 607 (660)
Q Consensus 562 -------~~d~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~ 607 (660)
...+..... ........+.+++..|++.||++|||+.|++++ |+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 000000000 000111346788899999999999999999975 5544
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-43 Score=360.93 Aligned_cols=260 Identities=26% Similarity=0.320 Sum_probs=205.4
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeeecCeeEEEEec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRKGELLLVYDY 414 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 414 (660)
.|+.+++||+|+||+||+|++..+++.||||+++... ....+++.+|+.++++++||||++++++|.+....++|+|+
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~ 82 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence 5899999999999999999999999999999986543 34567899999999999999999999999999999999999
Q ss_pred CCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceeccCCCCc
Q 006112 415 MPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYDHGNDL 494 (660)
Q Consensus 415 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 494 (660)
+.+++|..++.... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||.++.......
T Consensus 83 ~~~~~l~~~~~~~~--~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~- 156 (292)
T d1unla_ 83 CDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp CSEEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-
T ss_pred cccccccccccccc--ccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCc-
Confidence 99999988876543 48899999999999999999998 9999999999999999999999999999987654432
Q ss_pred eeeccccCccccCcccccCCC-CCcceeEEehHHHHHHHhhCCCCCCCCCc--chHHHHHHHHhcCCcc------cCC--
Q 006112 495 HTTNVVGTVGYLAPELLRNGR-GTTSTDVYAFGVFMLEVACGRRPVQPGEL--DLLDWVIDYWQKGDVL------DAS-- 563 (660)
Q Consensus 495 ~~~~~~gt~~Y~aPE~~~~~~-~t~ksDV~S~Gvvl~elltG~~p~~~~~~--~~~~~~~~~~~~~~~~------~~~-- 563 (660)
......+++.|+|||.+.... ++.++||||+||++|||++|+.||..... +....+.......... ...
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T d1unla_ 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence 233456788999999987655 68999999999999999999999765332 1222222221111000 000
Q ss_pred --CCcc-----cccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 564 --DPRL-----EGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 564 --d~~l-----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
.+.. ...........+.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 00111122235677888899999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4e-43 Score=363.42 Aligned_cols=258 Identities=17% Similarity=0.198 Sum_probs=197.4
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCceeEeee-eeecCeeEEEEecC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNLVQLRGY-CRRKGELLLVYDYM 415 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~-~~~~~~~~lV~E~~ 415 (660)
.|+.++.||+|+||+||+|++..+++.||||.+.... ..+++..|++++++++|+|++..+.. ..+.+..++|||||
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 4889999999999999999999999999999986543 23568899999999987776655554 56677889999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEc---CCCCeEEeecccceeccCCC
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLD---ADLEGKLGDFGLARLYDHGN 492 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~---~~~~~kl~DFGla~~~~~~~ 492 (660)
+++|...+.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++ .+..+||+|||+|+.+....
T Consensus 86 -~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 86 -GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp -CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred -CCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 677777665443 358999999999999999999998 9999999999999985 45579999999999875443
Q ss_pred C------ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCCCc
Q 006112 493 D------LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASDPR 566 (660)
Q Consensus 493 ~------~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 566 (660)
. .......||+.|||||.+.+..++.++|||||||++|||++|+.||.........+.......... ....+.
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 239 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-STPIEV 239 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH-HSCHHH
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC-CCChhH
Confidence 2 123456899999999999999999999999999999999999999976433222111111111000 000011
Q ss_pred ccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 567 LEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 567 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
+... .+..+.+++..||+.||++||++.++.+.|+.
T Consensus 240 ~~~~----~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 240 LCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp HTTT----SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred hccC----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 1111 23457788889999999999999998887764
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-43 Score=367.08 Aligned_cols=251 Identities=22% Similarity=0.281 Sum_probs=204.3
Q ss_pred eeecccccccCccEEEEEEEe---CCCCeEEEEEEeccC----CChhhHHHHHHHHHHhccCC-CCceeEeeeeeecCee
Q 006112 337 SYKNLYKATKGGSGKVYRGVL---PSSHAEIAVKKVCHD----SDHGMKQFVSEIVSMGKLRH-RNLVQLRGYCRRKGEL 408 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~---~~~~~~vavK~~~~~----~~~~~~~~~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~ 408 (660)
+|+.++.||+|+||+||+|+. ..+|+.||||.+... .....+.+.+|++++++++| |||+++++++.+....
T Consensus 25 ~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~ 104 (322)
T d1vzoa_ 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL 104 (322)
T ss_dssp GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred ceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCce
Confidence 589999999999999999987 346899999998543 22345778999999999976 8999999999999999
Q ss_pred EEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceec
Q 006112 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLY 488 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 488 (660)
++|||||.+|+|.+++..... +.......++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.+
T Consensus 105 ~~v~e~~~~~~L~~~i~~~~~--~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 105 HLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eeeeecccccHHHHHHHhccc--ccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 999999999999999977653 6778889999999999999998 99999999999999999999999999999877
Q ss_pred cCCCCceeeccccCccccCcccccCC--CCCcceeEEehHHHHHHHhhCCCCCCCCC-cchHHHHHHHHhcCCcccCCCC
Q 006112 489 DHGNDLHTTNVVGTVGYLAPELLRNG--RGTTSTDVYAFGVFMLEVACGRRPVQPGE-LDLLDWVIDYWQKGDVLDASDP 565 (660)
Q Consensus 489 ~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~t~ksDV~S~Gvvl~elltG~~p~~~~~-~~~~~~~~~~~~~~~~~~~~d~ 565 (660)
............|++.|+|||.+... .++.++|||||||+||||++|+.||.... ......+.........
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~------ 253 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP------ 253 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC------
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCC------
Confidence 55444444567899999999998754 46789999999999999999999997643 3333333333222211
Q ss_pred cccccCcHHHHHHHHHHhhhccCCCCCCCC-----CHHHHHH
Q 006112 566 RLEGIYVEEQMEIVLKLGLFCSHSNPDTRP-----SMRQVVQ 602 (660)
Q Consensus 566 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 602 (660)
.+... ....+.+++..||+.||++|| |++|+++
T Consensus 254 ~~~~~----~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 254 PYPQE----MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp CCCTT----SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CCccc----CCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 11122 234567788889999999999 4889986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1e-42 Score=359.24 Aligned_cols=258 Identities=18% Similarity=0.159 Sum_probs=204.6
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCC-CCceeEeeeeeecCeeEEEEecC
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRH-RNLVQLRGYCRRKGELLLVYDYM 415 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~E~~ 415 (660)
.|+..+.||+|+||+||+|++..+++.||||.+.... ..+++.+|+++++.++| +|++.+++++..+...++||||+
T Consensus 6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 5888999999999999999999999999999885443 23567889999999865 89999999999999999999999
Q ss_pred CCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcC-----CCCeEEeecccceeccC
Q 006112 416 PNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDA-----DLEGKLGDFGLARLYDH 490 (660)
Q Consensus 416 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~-----~~~~kl~DFGla~~~~~ 490 (660)
+++|.+++.... ..+++.++..++.|++.||+|||+ ++|+||||||+|||++. ++.+||+|||+|+.+..
T Consensus 84 -~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 84 -GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp -CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred -CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 799999987654 358999999999999999999998 99999999999999974 56799999999998654
Q ss_pred CCC------ceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHHHHHhcCCcccCCC
Q 006112 491 GND------LHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVIDYWQKGDVLDASD 564 (660)
Q Consensus 491 ~~~------~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~d 564 (660)
... .......||+.|||||.+.+..++.++|||||||++|||++|+.||..................... ...
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~-~~~ 237 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS-TPL 237 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH-SCH
T ss_pred CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC-CCh
Confidence 322 1233568999999999999999999999999999999999999999764332221111111111000 000
Q ss_pred CcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHHhhC
Q 006112 565 PRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQYLDG 606 (660)
Q Consensus 565 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 606 (660)
+.+... .++.+.+++..|++.+|++||+++.+.+.|+.
T Consensus 238 ~~l~~~----~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 238 RELCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp HHHTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred HHhcCC----CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 001111 22457778888999999999999998887764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.9e-42 Score=360.73 Aligned_cols=254 Identities=21% Similarity=0.288 Sum_probs=197.5
Q ss_pred eeeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccC-CCCceeEeeeeeec--CeeEEEE
Q 006112 336 FSYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLR-HRNLVQLRGYCRRK--GELLLVY 412 (660)
Q Consensus 336 ~~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~--~~~~lV~ 412 (660)
-+|+.+++||+|+||+||+|++..+++.||||++... ..+++.+|+++|++++ ||||+++++++... ..+++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 3699999999999999999999999999999998643 3567899999999995 99999999998744 5689999
Q ss_pred ecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCC-CeEEeecccceeccCC
Q 006112 413 DYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADL-EGKLGDFGLARLYDHG 491 (660)
Q Consensus 413 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~-~~kl~DFGla~~~~~~ 491 (660)
|||.+++|..+. ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+|+.....
T Consensus 112 e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 112 EHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp ECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 999999998764 248899999999999999999998 9999999999999998655 5899999999876543
Q ss_pred CCceeeccccCccccCcccccCC-CCCcceeEEehHHHHHHHhhCCCCCCCCCcchHHHHH--H---------HHhcCCc
Q 006112 492 NDLHTTNVVGTVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQPGELDLLDWVI--D---------YWQKGDV 559 (660)
Q Consensus 492 ~~~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~~~--~---------~~~~~~~ 559 (660)
.. .....||+.|+|||.+.+. .++.++||||+||+++||++|+.||............ . .......
T Consensus 184 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 184 QE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp CC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred Cc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 32 3456789999999998765 4799999999999999999999999764432211111 0 0000000
Q ss_pred c------cCC--CCc------ccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH
Q 006112 560 L------DAS--DPR------LEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ 602 (660)
Q Consensus 560 ~------~~~--d~~------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 602 (660)
. ... .+. ............+.+|+.+|++.||++|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000 000 000011112234678888999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=361.03 Aligned_cols=257 Identities=22% Similarity=0.236 Sum_probs=191.0
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeee------cCee
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRR------KGEL 408 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~------~~~~ 408 (660)
.|+.++.||+|+||+||+|++..+|+.||||++.... ....+++.+|+.++++++||||+++++++.. ...+
T Consensus 18 ~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~ 97 (355)
T d2b1pa1 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 97 (355)
T ss_dssp TEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred CeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCcee
Confidence 4999999999999999999999999999999997543 3345678999999999999999999999863 3678
Q ss_pred EEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceec
Q 006112 409 LLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLY 488 (660)
Q Consensus 409 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~ 488 (660)
|+|||||.++.+. .+. ..+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+|++|||+++..
T Consensus 98 ~iv~Ey~~~~l~~-~~~----~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 98 YLVMELMDANLCQ-VIQ----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEECCSEEHHH-HHT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEeccchHHHH-hhh----cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhcc
Confidence 9999999665554 442 248899999999999999999998 99999999999999999999999999998865
Q ss_pred cCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcchH-HHHHHHHh------------
Q 006112 489 DHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELDLL-DWVIDYWQ------------ 555 (660)
Q Consensus 489 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~-~~~~~~~~------------ 555 (660)
... ...+...||+.|+|||.+.+..++.++||||+||+++||++|+.||........ ..+.....
T Consensus 170 ~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 170 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred ccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 433 233456799999999999999999999999999999999999999976432211 11111000
Q ss_pred ------cCCcccC--C-----CCc---ccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHHH
Q 006112 556 ------KGDVLDA--S-----DPR---LEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQY 603 (660)
Q Consensus 556 ------~~~~~~~--~-----d~~---l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 603 (660)
.+..... . ... ............+.+|+.+|++.||++|||++|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000 0 000 0011122344568889999999999999999999963
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=358.76 Aligned_cols=259 Identities=22% Similarity=0.275 Sum_probs=197.0
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCC--ChhhHHHHHHHHHHhccCCCCceeEeeeeeec-----CeeE
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDS--DHGMKQFVSEIVSMGKLRHRNLVQLRGYCRRK-----GELL 409 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~~ 409 (660)
.|+.++.||+|+||+||+|++..+++.||||++.... ....+++.+|++++++++|||||++++++... ...+
T Consensus 19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~ 98 (348)
T d2gfsa1 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98 (348)
T ss_dssp TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence 4899999999999999999999999999999997543 23456789999999999999999999998633 3456
Q ss_pred EEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEeecccceecc
Q 006112 410 LVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGDFGLARLYD 489 (660)
Q Consensus 410 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~~~ 489 (660)
+++||+.+|+|.+++... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+|++|||++....
T Consensus 99 ~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 99 YLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp EEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred EEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhcccC
Confidence 777888899999998643 49999999999999999999998 999999999999999999999999999997543
Q ss_pred CCCCceeeccccCccccCcccccCC-CCCcceeEEehHHHHHHHhhCCCCCCCCCcchH-HHHHHHHhcCC---------
Q 006112 490 HGNDLHTTNVVGTVGYLAPELLRNG-RGTTSTDVYAFGVFMLEVACGRRPVQPGELDLL-DWVIDYWQKGD--------- 558 (660)
Q Consensus 490 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~-~~~~~~~~~~~--------- 558 (660)
. ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||........ ..+........
T Consensus 173 ~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (348)
T d2gfsa1 173 D----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248 (348)
T ss_dssp G----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCC
T ss_pred c----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccc
Confidence 2 23446789999999987665 468899999999999999999999986443222 22211111100
Q ss_pred ---------cccCCCCcccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHHH--HhhC
Q 006112 559 ---------VLDASDPRLEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVVQ--YLDG 606 (660)
Q Consensus 559 ---------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~ 606 (660)
........+... .......+.+|+.+|++.||++|||++|+++ +|+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~ 306 (348)
T d2gfsa1 249 ESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306 (348)
T ss_dssp HHHHHHHTTSCCCCCCCHHHH-STTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred hhhhhhhhhcccCCCcchhhh-cCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence 000000000000 0011234678888999999999999999997 4554
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.7e-36 Score=320.09 Aligned_cols=263 Identities=21% Similarity=0.250 Sum_probs=195.6
Q ss_pred eeecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccC-----------CCCceeEeeeeeec
Q 006112 337 SYKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLR-----------HRNLVQLRGYCRRK 405 (660)
Q Consensus 337 ~~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----------H~nIv~l~g~~~~~ 405 (660)
.|+.+++||+|+||+||+|+...+|+.||||+++.. ....+.+.+|++++++++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 399999999999999999999999999999999643 233567888999988875 57899999988654
Q ss_pred --CeeEEEEecCCCCC-hhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCC------
Q 006112 406 --GELLLVYDYMPNGS-LDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLE------ 476 (660)
Q Consensus 406 --~~~~lV~E~~~~gs-L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~------ 476 (660)
...+++|+++..+. ............+++..+..++.||+.||+|||+ ..+|+||||||+||||+.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccce
Confidence 45677777765554 3333444445568889999999999999999997 478999999999999987653
Q ss_pred eEEeecccceeccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHHHHHhhCCCCCCCCCcc----hHHHHHH
Q 006112 477 GKLGDFGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFMLEVACGRRPVQPGELD----LLDWVID 552 (660)
Q Consensus 477 ~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~----~~~~~~~ 552 (660)
+|++|||.++..... .....||+.|+|||.+....++.++||||+||+++||++|+.||.+.+.. ..+....
T Consensus 171 ~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 171 IKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 899999999865332 23467999999999999999999999999999999999999999753221 1111111
Q ss_pred HHh-cCC--------------------cccCCCC-c---------ccccCcHHHHHHHHHHhhhccCCCCCCCCCHHHHH
Q 006112 553 YWQ-KGD--------------------VLDASDP-R---------LEGIYVEEQMEIVLKLGLFCSHSNPDTRPSMRQVV 601 (660)
Q Consensus 553 ~~~-~~~--------------------~~~~~d~-~---------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 601 (660)
... -|. ....... . ............+.+|+..|++.||.+|||++|++
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 000 000 0000000 0 01123456677889999999999999999999999
Q ss_pred HH--hhC
Q 006112 602 QY--LDG 606 (660)
Q Consensus 602 ~~--L~~ 606 (660)
++ |+.
T Consensus 327 ~Hp~f~~ 333 (362)
T d1q8ya_ 327 NHPWLKD 333 (362)
T ss_dssp TCGGGTT
T ss_pred cCcccCC
Confidence 74 653
|
| >d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Concanavalin A species: Jack bean (Canavalia ensiformis) [TaxId: 3823]
Probab=99.97 E-value=2.7e-31 Score=259.42 Aligned_cols=115 Identities=30% Similarity=0.463 Sum_probs=105.8
Q ss_pred CccEEEEEeecccCCCCCCCCCCeeEEEcCCccccccccccccccccccccccccCCCccEEEEEEEeCcceeEEEEEee
Q 006112 136 TNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAP 215 (660)
Q Consensus 136 ~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~ 215 (660)
.|++|||||||++|.+++||++||||||+|++.|.++.+ +++.+|+.++|||+||+.+++|+|++.+
T Consensus 1 an~ivAVEFDT~~N~~~~Dp~~nHIgIdvns~~S~~~~~-------------~~l~~G~~~~v~I~Yd~~~~~L~V~~~~ 67 (237)
T d1nlsa_ 1 ADTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAK-------------WNMQNGKVGTAHIIYNSVDKRLSAVVSY 67 (237)
T ss_dssp CCCEEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEE-------------CCCCTTCEEEEEEEEETTTTEEEEEEEC
T ss_pred CCCEEEEEEECCcCCCCCCCCCCEEEEEeCCCCccceec-------------ccccCCCEEEEEEEEecCCcEEEEEEec
Confidence 379999999999999999999999999999999876654 4688999999999999999999999985
Q ss_pred CCCCCCCCCcceeecCchhhhccceeeeeecccCceeeeeeecCcccccCC
Q 006112 216 VPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTRVSDYYILGWSFNKSG 266 (660)
Q Consensus 216 ~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg~~~~~h~i~~wsf~~~g 266 (660)
. ++..|+|++.+||+++|+++||||||||||...|.|+|++|+|++..
T Consensus 68 ~---~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~h~I~sWsFsS~~ 115 (237)
T d1nlsa_ 68 P---NADSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSKL 115 (237)
T ss_dssp T---TSCCEEEEEECCGGGTSCSEEEEEEEEECSSSCCCCEEEEEEEEEEE
T ss_pred C---CCCCeEEEEEEChHHhCCCcEEEEEEeecCCCccceEEEEEEEEeec
Confidence 3 56778999999999999999999999999999999999999999864
|
| >d1gv9a_ b.29.1.13 (A:) Carbohydrate-recognition domain of P58/ERGIC-53 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Carbohydrate-recognition domain of P58/ERGIC-53 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.95 E-value=3.9e-27 Score=232.76 Aligned_cols=210 Identities=14% Similarity=0.146 Sum_probs=139.5
Q ss_pred ceeeeCCCCC-----CCeeEecceeEcCCCcEEecCCCCCeeEEEEeCCCeeeccCCCCceeEEEEEEEEEecCCCCCCC
Q 006112 28 NQFIHHGFEG-----SKLKLDGLAKIHPNGLLQLTNTSERISGHAFYPFPFKFNSSSSQSLSFSTSFVFAMFPKLPNYGG 102 (660)
Q Consensus 28 ~~f~~~~f~~-----~~l~~~g~a~~~~~g~l~Lt~~~~~~~G~~~y~~pv~~~~~~~~~~sFst~F~F~i~~~~~~~~g 102 (660)
.||..+-+.+ ++..+.|+|.+. ++.|+||++.++++|++||++|+++. +|+|+|+|.+.+. ...+|
T Consensus 9 ~sf~~P~~~~~~~~~~~w~~~G~a~i~-~~~i~LT~~~~~~~G~v~~~~p~~~~-------~F~~~f~f~~~~~-~~~gg 79 (228)
T d1gv9a_ 9 YSFKGPHLVQSDGTVPFWAHAGNAIPS-ADQIRIAPSLKSQRGSVWTKTKAAFE-------NWEVEVTFRVTGR-GRIGA 79 (228)
T ss_dssp GCEECSSCSCTTSCBTTEEEEETCEEC-SSCEEEECSSTTCEEEEEESSCBCCS-------SEEEEEEEEEECS-SSCCC
T ss_pred eccCCCcccCCCCCccceEEeeeEEEE-CCEEEECCCCCCCEEEEEeCCCcccc-------CcEEEEEEeccCC-CCCCC
Confidence 3455454432 357899999987 78899999999999999999999984 4999999999864 34589
Q ss_pred CceEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCeeEEEcCCccc-cccccccccccc
Q 006112 103 HGMAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQS-NESASARYFSDE 181 (660)
Q Consensus 103 ~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s-~~~~~~~~~~~~ 181 (660)
|||||+|+|... ..|+.+|.. ...+-+||||||+.|. +|++.+|+.++.|.... .......+....
T Consensus 80 dG~aF~i~~~~~----~~g~~~G~~-------~~~~glaVefDt~~n~--~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~ 146 (228)
T d1gv9a_ 80 DGLAIWYTENQG----LDGPVFGSA-------DMWNGVGIFFDSFDND--GKKNNPAIVVVGNNGQINYDHQNDGATQAL 146 (228)
T ss_dssp CEEEEEEESSCC----CEEEETTEC-------SCCEEEEEEEECCCC-------CCEEEEEEEESCCCCCHHHHHHHHCS
T ss_pred CEEEEEEecCCC----CCCCccCcC-------CCCceEEEEEEccccc--CCCCCCcEEEEecCCcceeeecCCCccccc
Confidence 999999998643 345555542 2345689999999997 68888888887764331 111111111000
Q ss_pred cccccccccCCCccEEEEEEEeCcceeEEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeecccCceeeeeeecCcc
Q 006112 182 KKEFESLVLESGKPIQIWIDYNGQEKLVNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTRVSDYYILGWS 261 (660)
Q Consensus 182 ~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg~~~~~h~i~~ws 261 (660)
...... ...++..+++||+|+ .+.|+|.+..........+.+...++ ...++++||||||||||...+.|.|++|.
T Consensus 147 ~~~~~~-~~~~~~~~~i~~~~~--~~~l~v~i~~~~~~~~~~~~~~~~~~-~~~l~~~~y~GFTAsTG~~~~~H~I~s~~ 222 (228)
T d1gv9a_ 147 ASCQRD-FRNKPYPVRAKITYY--QKTLTVMINNGFTPDKNDYEFCAKVE-NMVIPTQGHFGISAATGGLADDHDVLSFL 222 (228)
T ss_dssp EEECCC-CBSCSSCEEEEEEEE--TTEEEEEEECSSCCCTTCCEEEEEET-TCCCCSSBEEEEEEECCSSCCEEEEEEEE
T ss_pred cceeee-ecCCceEEEEEEEec--CCEEEEEEeccccCCCcceeEEEEec-ccccCCCEEEEEEEeCCCCcCeEEEEEEE
Confidence 000001 112344556666665 57788888754443333333333333 45689999999999999999999999997
Q ss_pred cc
Q 006112 262 FN 263 (660)
Q Consensus 262 f~ 263 (660)
+.
T Consensus 223 ~~ 224 (228)
T d1gv9a_ 223 TF 224 (228)
T ss_dssp EE
T ss_pred EE
Confidence 64
|
| >d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Legume lectins domain: Concanavalin A species: Jack bean (Canavalia ensiformis) [TaxId: 3823]
Probab=99.90 E-value=1.6e-24 Score=211.21 Aligned_cols=107 Identities=29% Similarity=0.432 Sum_probs=94.2
Q ss_pred cCCcceeeeCCCC--CCCeeEecceeEcCCCcEEecCCC------CCeeEEEEeCCCeeeccCCCCceeEEEEEEEEEec
Q 006112 24 AQEENQFIHHGFE--GSKLKLDGLAKIHPNGLLQLTNTS------ERISGHAFYPFPFKFNSSSSQSLSFSTSFVFAMFP 95 (660)
Q Consensus 24 ~~~~~~f~~~~f~--~~~l~~~g~a~~~~~g~l~Lt~~~------~~~~G~~~y~~pv~~~~~~~~~~sFst~F~F~i~~ 95 (660)
.++.++|+|++|+ +.||+|+|+|.+.++|.||||+.+ ..++|||+|++||+||+++++++||+|+|+|.|.+
T Consensus 122 esn~~~F~f~~F~~~~~nl~l~G~A~i~~~G~l~LT~~~~~~~~~~~s~Gra~y~~Pv~l~d~t~~~~SFsT~F~F~I~~ 201 (237)
T d1nlsa_ 122 ETNALHFMFNQFSKDQKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHIWESSAVVASFEATFTFLIKS 201 (237)
T ss_dssp CEEEEEEEESCCCTTCTTEEEEETCEEEETTEEESSCBCTTSCBCSSCEEEEEESSCEECCCTTEEEEEEEEEEEEECCC
T ss_pred ccccceEEeeecCCCCCCEEEeeeeEecCCCcEEecCCCCCCcccCcceEEEEeCCCEEEECCCCcEeeEEEEEEEEEec
Confidence 3467999999997 469999999999889999999754 46799999999999999888899999999999988
Q ss_pred CCCCCCCCceEEEEecCC-CCCCCCCCCcccccccCC
Q 006112 96 KLPNYGGHGMAFFISPST-DFSEAVAGSHLGIFNRSN 131 (660)
Q Consensus 96 ~~~~~~g~GlaF~l~p~~-~~~~~~~g~~lGl~~~~~ 131 (660)
.. ..+||||||||+|.. .+|.++.||||||||.++
T Consensus 202 ~~-~~~gdG~aF~iap~~~~~p~~~~g~~LGL~n~~n 237 (237)
T d1nlsa_ 202 PD-SHPADGIAFFISNIDSSIPSGSTGRLLGLFPDAN 237 (237)
T ss_dssp SS-SSCCCEEEEEEECTTCCCCTTCCGGGTTTCSSCC
T ss_pred CC-CCCCCCEEEEEeCCCCCCCCCCCCCeeeeccCCC
Confidence 64 458999999999964 678889999999999763
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=1.7e-22 Score=193.40 Aligned_cols=168 Identities=11% Similarity=0.032 Sum_probs=119.7
Q ss_pred cccccccCccEEEEEEEeCCCCeEEEEEEeccCCC------------------hhhHHHHHHHHHHhccCCCCceeEeee
Q 006112 340 NLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSD------------------HGMKQFVSEIVSMGKLRHRNLVQLRGY 401 (660)
Q Consensus 340 ~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~------------------~~~~~~~~Ei~~l~~l~H~nIv~l~g~ 401 (660)
.-++||+|+||+||+|++. +|+.||||.++.... .......+|...+.++.|.+++..+++
T Consensus 4 vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 4578999999999999985 688999998753210 012335578889999999999988765
Q ss_pred eeecCeeEEEEecCCCCChhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhhcccCceeccCccCCcEEEcCCCCeEEee
Q 006112 402 CRRKGELLLVYDYMPNGSLDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEEWEQVVLHRDIKPANVLLDADLEGKLGD 481 (660)
Q Consensus 402 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDikp~NIll~~~~~~kl~D 481 (660)
. ..+++|||+++..+.+ +++....+++.|++.+|+|||+ .+|+||||||+|||++++ .++|+|
T Consensus 83 ~----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp E----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEECC
T ss_pred c----CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEEEE
Confidence 3 2379999998766543 3445667899999999999998 999999999999999865 589999
Q ss_pred cccceeccCCCCceeeccccCccccCcccccCCCCCcceeEEehHHHH
Q 006112 482 FGLARLYDHGNDLHTTNVVGTVGYLAPELLRNGRGTTSTDVYAFGVFM 529 (660)
Q Consensus 482 FGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~t~ksDV~S~Gvvl 529 (660)
||+|+...+........ ..... -.|.+ ..+|..++|+||..--+
T Consensus 146 FG~a~~~~~~~~~~~l~--rd~~~-~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 146 FPQSVEVGEEGWREILE--RDVRN-IITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CTTCEETTSTTHHHHHH--HHHHH-HHHHH-HHHHCCCCCHHHHHHHH
T ss_pred CCCcccCCCCCcHHHHH--HHHHH-HHHHH-cCCCCCcccHHHHHHHH
Confidence 99998754432211000 00000 01111 34667889999976443
|
| >d2a6za1 b.29.1.13 (A:7-227) Emp47p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Emp47p N-terminal domain species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.81 E-value=9.8e-20 Score=177.68 Aligned_cols=196 Identities=11% Similarity=0.124 Sum_probs=125.6
Q ss_pred eeeCCCCC-----CCeeEecceeEcCCCcEEecCCCCCeeEEEEeCCCeeeccCCCCceeEEEEEEEEEecCCCCCCCCc
Q 006112 30 FIHHGFEG-----SKLKLDGLAKIHPNGLLQLTNTSERISGHAFYPFPFKFNSSSSQSLSFSTSFVFAMFPKLPNYGGHG 104 (660)
Q Consensus 30 f~~~~f~~-----~~l~~~g~a~~~~~g~l~Lt~~~~~~~G~~~y~~pv~~~~~~~~~~sFst~F~F~i~~~~~~~~g~G 104 (660)
|+++.+.. ++..+.|+|.+. +|.|+||++ .++.|.+|+++|+++++ +|+++|+|.|... ...+|||
T Consensus 10 ~s~p~~~~~~~~~~~W~~~g~a~~~-~~~i~LTp~-~~~~G~~w~~~~i~~~~------~f~~~~~F~i~g~-~~~ggdG 80 (221)
T d2a6za1 10 YSLPDLINTRKVPNNWQTGEQASLE-EGRIVLTSN-QNSKGSLWLKQGFDLKD------SFTMEWTFRSVGY-SGQTDGG 80 (221)
T ss_dssp GCBCCCTTCCSCCTTEEEEETCEEE-TTEEESCCS-TTCEEEEEESSCEECCS------CEEEEEEEEEESC-CSCCSCE
T ss_pred ccCCCccccccCCCccEEcceeEEE-CCEEEECCC-CCCceEEEECCccccCC------CeEEEEEEEEeCC-CCCCCCc
Confidence 66665521 579999999997 889999997 57889999999999864 4999999999875 3458999
Q ss_pred eEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCeeEEEcCCcccccccccccccccccc
Q 006112 105 MAFFISPSTDFSEAVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDEKKE 184 (660)
Q Consensus 105 laF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~~~~ 184 (660)
|||++++.... ...|+++|..+ ...-+||||||+.|. ....|+.++.++..-....... .....+
T Consensus 81 ~af~~~~~~~~--~~~g~~~G~~~-------~~~GlaV~fDt~~n~----~~~~~~~~ndgt~~~~~~~~~~--~~~~~~ 145 (221)
T d2a6za1 81 ISFWFVQDSNI--PRDKQLYNGPV-------NYDGLQLLVDNNGPL----GPTLRGQLNDGQKPVDKTKIYD--QSFASC 145 (221)
T ss_dssp EEEEEEECSSS--CCCCTBTTBCT-------TCEEEEEEEESCSTT----SSEEEEEEEESSSCCCGGGHHH--HCSEEE
T ss_pred EEEEEEcCCCc--cccccccccCC-------CCceEEEEEECCCCC----CCceEEEecCCCccccccCCcc--ccccee
Confidence 99999975432 23344444321 234589999999873 2223444444333211111100 000000
Q ss_pred ccccc-cCCCccEEEEEEEeCccee-EEEEEeeCCCCCCCCCcceeecCchhhhccceeeeeecccCceeeeeeecCc
Q 006112 185 FESLV-LESGKPIQIWIDYNGQEKL-VNVTLAPVPNPKPSRPLLSTSIDLSQILQDSMYVGLSAATGTRVSDYYILGW 260 (660)
Q Consensus 185 ~~~~~-l~~g~~~~~~I~Y~~~~~~-l~v~~~~~~~~~p~~~~l~~~~dL~~~l~~~~~vGFsastg~~~~~h~i~~w 260 (660)
.+. ..++...+++|+|++.++. |.|.+.. . +...++--.+-++++|+||||+||...+.|.+..+
T Consensus 146 --~~~~~~~~~~~~~~I~y~~~~~~~l~v~id~--~-------~c~~~~~v~lp~~~~~fG~SA~TG~~~~~hd~~~i 212 (221)
T d2a6za1 146 --LMGYQDSSVPSTIRVTYDLEDDNLLKVQVDN--K-------VCFQTRKVRFPSGSYRIGVTAQNGAVNNNAESFEI 212 (221)
T ss_dssp --ECCCTTEEEEEEEEEEEEGGGTSEEEEEETT--E-------EEEEESCCCCCSSEEEEEEEEECCSGGGCCCEEEE
T ss_pred --eecccCCCCCEEEEEEEecCccceEEEEecC--c-------EeEEECCeecCCCCEEEEEEEccCCccCCCceEEE
Confidence 111 2356778999999976654 7887742 1 11112211122457899999999998888876544
|
| >d2a6va1 b.29.1.13 (A:9-226) Emp46p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Concanavalin A-like lectins/glucanases superfamily: Concanavalin A-like lectins/glucanases family: Lectin leg-like domain: Emp46p N-terminal domain species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.81 E-value=2.8e-19 Score=173.69 Aligned_cols=189 Identities=17% Similarity=0.226 Sum_probs=128.1
Q ss_pred CCeeEecceeEcCCCcEEecCCCCCeeEEEEeCCCeeeccCCCCceeEEEEEEEEEecCCCCCCCCceEEEEecCCCCCC
Q 006112 38 SKLKLDGLAKIHPNGLLQLTNTSERISGHAFYPFPFKFNSSSSQSLSFSTSFVFAMFPKLPNYGGHGMAFFISPSTDFSE 117 (660)
Q Consensus 38 ~~l~~~g~a~~~~~g~l~Lt~~~~~~~G~~~y~~pv~~~~~~~~~~sFst~F~F~i~~~~~~~~g~GlaF~l~p~~~~~~ 117 (660)
++..+.|+|.+. +|.|+||++ .++.|++|+..|+.+++ +|+++|+|.|... ...+||||||++++......
T Consensus 22 ~~W~~~G~~~~~-~~~i~LTp~-~~~~G~~w~~~~i~~~~------~f~i~~~F~i~g~-~~~~~dG~afw~~~~~~~~~ 92 (218)
T d2a6va1 22 SQWTLGDKVKLE-EGRFVLTPG-KNTKGSLWLKPEYSIKD------AMTIEWTFRSFGF-RGSTKGGLAFWLKQGNEGDS 92 (218)
T ss_dssp TTEEEEETCEEE-TTEEESCCS-TTCEEEEEESSCBCCSS------CEEEEEEEEEESC-CSCCSCEEEEEEECSCCCCC
T ss_pred CccEECCCEEEE-CCEEEECCC-CCCeeEEEeCCcccccc------cceEEEEEEEeCC-CCCCCCcEEEEEEcCCcccC
Confidence 689999999997 799999998 56789999999999875 4999999999875 34579999999997543211
Q ss_pred -CCCCCcccccccCCCCCCCccEEEEEeecccCCCCCCCCCCeeEEEcCCccccccccccccccc-cccccccccCCCcc
Q 006112 118 -AVAGSHLGIFNRSNNGQFTNHIFAIELDTVQSPEFNDIDGNHVGIDVNGLQSNESASARYFSDE-KKEFESLVLESGKP 195 (660)
Q Consensus 118 -~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~-~~~~~~~~l~~g~~ 195 (660)
+..+|..+.++ =+||||||+.|. .+||.+.+|.-.. +.....+. -+...--...++.+
T Consensus 93 ~~~~~G~~~~f~----------GlaV~fDt~~n~------~~~i~~~~ndGs~----~~~~~~d~~~g~c~~~~~~~~~~ 152 (218)
T d2a6va1 93 TELFGGSSKKFN----------GLMILLRLDDKL------GESVTAYLNDGTK----DLDIESSPYFASCLFQYQDSMVP 152 (218)
T ss_dssp CTBTTTBCSSCE----------EEEEEEEEETTT------EEEEEEEEEESSS----CCCTTTSCCSEEEECCCSSCSSC
T ss_pred CCcccccCCCcc----------eEEEEEECCCCC------CCeEEEEeCCCCc----cccccCCcccceEEecccCCCCc
Confidence 12233333332 269999999874 3678776653111 10000000 00000011346788
Q ss_pred EEEEEEEeCcce-eEEEEEeeCCCCCCCCCcc-eeecCchhhhccceeeeeecccCceeeeeeecCccccc
Q 006112 196 IQIWIDYNGQEK-LVNVTLAPVPNPKPSRPLL-STSIDLSQILQDSMYVGLSAATGTRVSDYYILGWSFNK 264 (660)
Q Consensus 196 ~~~~I~Y~~~~~-~l~v~~~~~~~~~p~~~~l-~~~~dL~~~l~~~~~vGFsastg~~~~~h~i~~wsf~~ 264 (660)
.+++|.|+..+. .++|.+.. +..+ ...|+| ..++++|+||||+||...+.|.|++|++..
T Consensus 153 ~~~~i~Y~~~~~~~l~v~id~-------~~c~~t~~i~l--p~~~~~yfG~SA~Tg~~~d~~dIls~~~~~ 214 (218)
T d2a6va1 153 STLRLTYNPLDNHLLKLQMDN-------RVCFQTRKVKF--MGSSPFRIGTSAINDASKESFEILKMKLYD 214 (218)
T ss_dssp EEEEEEEEGGGTSEEEEEETT-------EEEEEESCCCG--GGTSCBEEEEEEECCTTCCEEEEEEEEEES
T ss_pred EEEEEEEECcccceEEEEeCC-------cEEEEECCeec--CCCCcEEEEEEECCCCCcCcEEEEEEEEEe
Confidence 999999997664 47777641 1111 223343 245679999999999999999999998864
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.43 E-value=5.8e-07 Score=87.82 Aligned_cols=134 Identities=19% Similarity=0.090 Sum_probs=95.3
Q ss_pred ccCcc-EEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccC-CCCceeEeeeeeecCeeEEEEecCCCCChhh
Q 006112 345 TKGGS-GKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLR-HRNLVQLRGYCRRKGELLLVYDYMPNGSLDK 422 (660)
Q Consensus 345 g~G~f-g~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~ 422 (660)
++|+. +.||+... ++..+.+|+...........+.+|...+..+. +--+.+++.++..++..++|||+++|.++.+
T Consensus 22 ~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~ 99 (263)
T d1j7la_ 22 TEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSE 99 (263)
T ss_dssp SCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHH
T ss_pred CCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccc
Confidence 44543 68998764 55678899886655555567788888887764 3336778888888889999999999988865
Q ss_pred hhhhCCCCCcchhHHHHHHHHHHHHHHHhhhc------------------------------------------------
Q 006112 423 ILYSNTRPSLNWFQRFRIIKGVAFGLLYLHEE------------------------------------------------ 454 (660)
Q Consensus 423 ~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------------ 454 (660)
..... .+...++.++++.|+.||+.
T Consensus 100 ~~~~~-------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (263)
T d1j7la_ 100 EYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYD 172 (263)
T ss_dssp HTTTC-------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHH
T ss_pred ccccc-------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHH
Confidence 44211 12334556666666666631
Q ss_pred --------ccCceeccCccCCcEEEcCCCCeEEeeccccee
Q 006112 455 --------WEQVVLHRDIKPANVLLDADLEGKLGDFGLARL 487 (660)
Q Consensus 455 --------~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 487 (660)
....++|+|+.|.|||++++...-|+||+.+..
T Consensus 173 ~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 173 FLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 023489999999999999876677999998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.92 E-value=3.2e-05 Score=74.58 Aligned_cols=131 Identities=18% Similarity=0.153 Sum_probs=84.1
Q ss_pred ccccCcc-EEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCC--CCceeEeeeeeecCeeEEEEecCCCCC
Q 006112 343 KATKGGS-GKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRH--RNLVQLRGYCRRKGELLLVYDYMPNGS 419 (660)
Q Consensus 343 ~lg~G~f-g~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H--~nIv~l~g~~~~~~~~~lV~E~~~~gs 419 (660)
.++.|.. ..||+.... ++..+++|...... ...+..|...++.+.. -.+.+++.++.+++..++|||+++|.+
T Consensus 17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp ECSCTTSSCEEEEEECT-TSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred EcCCcccCCeEEEEEeC-CCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 3455553 578988763 45667888764332 2356777777776643 335677888888888999999998877
Q ss_pred hhhhhhhCCCCCcchhHHHHHHHHHHHHHHHhhh----------------------------------------------
Q 006112 420 LDKILYSNTRPSLNWFQRFRIIKGVAFGLLYLHE---------------------------------------------- 453 (660)
Q Consensus 420 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~---------------------------------------------- 453 (660)
+.+.. . ....++.++++.|.-||+
T Consensus 93 ~~~~~-------~---~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 93 LLSSH-------L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTTSC-------C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred ccccc-------c---cHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 64311 0 011112223333333331
Q ss_pred ---------cccCceeccCccCCcEEEcCCCCeEEeeccccee
Q 006112 454 ---------EWEQVVLHRDIKPANVLLDADLEGKLGDFGLARL 487 (660)
Q Consensus 454 ---------~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~~ 487 (660)
.....++|+|+.|.|||++++..+-|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 1124589999999999999876678999998753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.67 E-value=0.00013 Score=75.28 Aligned_cols=78 Identities=6% Similarity=-0.054 Sum_probs=49.5
Q ss_pred ccccccCccEEEEEEEeCCCCeEEEEEEeccC-------CChhhHHHHHHHHHHhccC---CCCceeEeeeeeecCeeEE
Q 006112 341 LYKATKGGSGKVYRGVLPSSHAEIAVKKVCHD-------SDHGMKQFVSEIVSMGKLR---HRNLVQLRGYCRRKGELLL 410 (660)
Q Consensus 341 l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~-------~~~~~~~~~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~l 410 (660)
.+.+|.|....||+.....+++.++||.-... -+....+...|.+.++.+. ...+.+++.++ +...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence 34578899999999998777888999975321 1123345566887776652 23456666553 445678
Q ss_pred EEecCCCCCh
Q 006112 411 VYDYMPNGSL 420 (660)
Q Consensus 411 V~E~~~~gsL 420 (660)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999977543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.73 E-value=0.0023 Score=65.59 Aligned_cols=74 Identities=19% Similarity=0.281 Sum_probs=48.9
Q ss_pred ccccccCccEEEEEEEeCCC-------CeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCc-eeEeeeeeecCeeEEEE
Q 006112 341 LYKATKGGSGKVYRGVLPSS-------HAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNL-VQLRGYCRRKGELLLVY 412 (660)
Q Consensus 341 l~~lg~G~fg~Vy~g~~~~~-------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~ 412 (660)
++.++.|-.-.+|+...+.. ...|.++... ... ......+|..+++.+.-.++ .++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 45677788889999987532 3455555543 322 23355688888888854444 477777643 5899
Q ss_pred ecCCCCCh
Q 006112 413 DYMPNGSL 420 (660)
Q Consensus 413 E~~~~gsL 420 (660)
||++|..|
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987655
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.45 E-value=0.007 Score=60.03 Aligned_cols=135 Identities=17% Similarity=0.189 Sum_probs=77.8
Q ss_pred cEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCCc-----eeEe--eeeeecCeeEEEEecCCCCChh
Q 006112 349 SGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRNL-----VQLR--GYCRRKGELLLVYDYMPNGSLD 421 (660)
Q Consensus 349 fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~nI-----v~l~--g~~~~~~~~~lV~E~~~~gsL~ 421 (660)
--.||+.+. .+|+.+++|..+.. ....+++..|...+..|....+ +..- ......+..+.++++++|..+.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred cceeEEEEc-CCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 358999887 46778999987543 2345677888888877753322 1211 1234556788999999865432
Q ss_pred h-----------hh-------hhC---CCCCcch-------------------hHHHHHHHHHHHHHHHhh----hcccC
Q 006112 422 K-----------IL-------YSN---TRPSLNW-------------------FQRFRIIKGVAFGLLYLH----EEWEQ 457 (660)
Q Consensus 422 ~-----------~l-------~~~---~~~~l~~-------------------~~~~~i~~~ia~gL~yLH----~~~~~ 457 (660)
. .+ ... .+..+++ ..+..+...+...++.+. +....
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 1 00 000 0111111 111112222222333332 22356
Q ss_pred ceeccCccCCcEEEcCCCCeEEeeccccee
Q 006112 458 VVLHRDIKPANVLLDADLEGKLGDFGLARL 487 (660)
Q Consensus 458 ~ivHrDikp~NIll~~~~~~kl~DFGla~~ 487 (660)
++||+|+.+.|||++++ ..++||+-+..
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeCC--ceEEechhccc
Confidence 89999999999999754 46899998864
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.72 E-value=0.11 Score=50.51 Aligned_cols=145 Identities=14% Similarity=0.025 Sum_probs=75.7
Q ss_pred eecccccccCccEEEEEEEeCCCCeEEEEEEeccCCChhhHHHHHHHHHHhccCCCC-----ceeEe-e--eeeecCeeE
Q 006112 338 YKNLYKATKGGSGKVYRGVLPSSHAEIAVKKVCHDSDHGMKQFVSEIVSMGKLRHRN-----LVQLR-G--YCRRKGELL 409 (660)
Q Consensus 338 ~~~l~~lg~G~fg~Vy~g~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n-----Iv~l~-g--~~~~~~~~~ 409 (660)
...++.+..|---+.|+.+..+ | .+++|+..... ..++...|++++..|.+.+ .+... | +....+...
T Consensus 20 ~~~~~~i~~G~~N~ny~v~t~~-g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~ 95 (316)
T d2ppqa1 20 LTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 95 (316)
T ss_dssp EEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred ceEeecCCCCcccCeEEEEECC-C-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccc
Confidence 4445556677778899988743 3 48889875431 2344555666776664322 22211 1 122344566
Q ss_pred EEEecCCCCChhhh--------------hh----hCCC-----CCcc----------------hhHHHHHHHHHHHHHHH
Q 006112 410 LVYDYMPNGSLDKI--------------LY----SNTR-----PSLN----------------WFQRFRIIKGVAFGLLY 450 (660)
Q Consensus 410 lV~E~~~~gsL~~~--------------l~----~~~~-----~~l~----------------~~~~~~i~~~ia~gL~y 450 (660)
.++.+..+...... ++ .... .... .......+..+...+.-
T Consensus 96 ~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 175 (316)
T d2ppqa1 96 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 175 (316)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred eeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhc
Confidence 77777766443210 00 0000 0000 01111222222222222
Q ss_pred hh-hcccCceeccCccCCcEEEcCCCCeEEeecccce
Q 006112 451 LH-EEWEQVVLHRDIKPANVLLDADLEGKLGDFGLAR 486 (660)
Q Consensus 451 LH-~~~~~~ivHrDikp~NIll~~~~~~kl~DFGla~ 486 (660)
.+ .....++||+|+.++||+++.+...-|.||+.+.
T Consensus 176 ~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 176 HWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 22 1346789999999999999988777899999885
|